,datetime,title,source,link,sentiment_class,sentiment_score
0,3/2/2006 1:02:00 PM,NicOx Compound Demonstrates Excellent Preclinical Results in Pfizer Glaucoma Collaboration,PR Newswire,/news/stocks/nicox-compound-demonstrates-excellent-preclinical-results-in-pfizer-glaucoma-collaboration-1011611947,negative,0.9533473253250122
1,9/18/2006 9:07:00 PM,Pfizer's Lyrica(R) Approved in Europe for Difficult-to-Treat Nerve Pain,PR Newswire,/news/stocks/pfizer-s-lyrica-r-approved-in-europe-for-difficult-to-treat-nerve-pain-1017889046,negative,0.894335150718689
2,8/2/2011 5:29:28 PM,"Pfizer global drug sales fall, spark concern",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/p1qgMfRf4oc/idINIndia-58583620110802,neutral,0.9679622650146484
3,11/1/2011 5:04:12 PM,Pfizer sales impress as Lipitor generics loom,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/w4zzjuN9N9Y/idINIndia-60245020111101,positive,0.4579889476299286
4,12/1/2011 8:08:09 AM,Pfizer aims to keep one-third of Lipitor pie,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/rGBMpLmeNAo/lipitor-idINDEE7B007H20111201,positive,0.9185022115707397
5,2/7/2012 6:51:52 AM,Pfizer to spin-off animal healthcare business,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/xxbYwm0rZ00/india-pfizer-sale-idINDEE81603920120207,positive,0.912707507610321
6,3/13/2012 4:49:43 AM,Pfizer scraps insulin deal with Biocon,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/9zBvvt_ZCy4/pfizer-biocon-idINDEE82C01K20120313,neutral,0.6727849245071411
7,4/23/2012 8:07:53 AM,Pfizer India unit up after global sale of nutrition biz,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/l-JHoViWZZ4/india-market-eye-pfizer-idINDEE83M05M20120423,negative,0.9240103960037231
8,4/23/2012 8:54:57 AM,Nestle to buy Pfizer baby food unit for $11.9 bln,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/AYSL219nFC0/nestle-idINDEE83M05A20120423,positive,0.9090868234634399
9,5/1/2012 1:21:26 PM,"Pfizer beats profit forecast, helped by cost cuts",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/vX-HsWgdBz0/pfizer-idINDEE84007720120501,negative,0.9166994690895081
10,10/5/2012 9:21:59 AM,Pfizer to appeal India decision to revoke cancer drug patent,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/_E10hxHfQgI/pfizer-india-patent-idINDEE89403L20121005,neutral,0.7946532964706421
11,11/8/2012 9:03:53 PM,Canada's Supreme Court strips Viagra patent from Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/aOhBkPnBqAc/canada-viagra-pfizer-idINDEE8A70FF20121108,positive,0.577778697013855
12,12/19/2012 3:14:42 AM,Pfizer to cut 600 jobs as Lipitor sales decline: report,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/cAQedgcy0FY/us-pfizer-jobs-idUSBRE8BI04C20121219,neutral,0.970704972743988
13,1/29/2013 1:13:16 PM,Pfizer fourth-quarter results top estimates,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/29phIv8QPa8/us-pfizer-results-idUSBRE90S0GN20130129,positive,0.6446642279624939
14,1/29/2013 6:45:26 PM,"Pfizer, Lilly beat Street; generics take toll",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/6xzwvEE8W6Y/us-pharmaceutical-results-idUSBRE90S0TG20130129,positive,0.731538712978363
15,4/2/2013 9:51:33 PM,"Exclusive: Pfizer, Novartis, Abbott weigh bids for Brazil's Ache - sources",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/cjlNLr39Ijc/story01.htm,positive,0.8671168684959412
16,4/30/2013 1:21:10 PM,"Pfizer falls short, trims 2013 profit view",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Dcy-b6G0aWY/story01.htm,neutral,0.9643875956535339
17,5/22/2013 2:52:27 PM,Pfizer to spin off Zoetis stake to shareholders,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/kEaqKieITPg/story01.htm,positive,0.9251846671104431
18,5/23/2013 7:20:56 AM,Pfizer takes its shot at a vaccine for evasive superbug,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/XV2Yb3v7Ppw/story01.htm,positive,0.7679186463356018
19,6/12/2013 2:27:25 PM,"Pfizer settles patent lawsuit with Teva, Sun Pharma for $2.15 billion",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/-zVcGsWluoA/story01.htm,neutral,0.49042999744415283
20,6/12/2013 2:31:24 PM,"Pfizer settles patent lawsuit with Teva, Sun Pharma for $2.15 billion",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/MeoM9V3LgA0/story01.htm,neutral,0.49042999744415283
21,6/13/2013 5:55:59 AM,Sun Pharma slumps after $550 mln patent suit settlement with Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/DnxRWhhDEuM/story01.htm,neutral,0.9694795608520508
22,6/24/2013 4:28:40 PM,Pfizer says shareholders snap up remaining Zoetis shares,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/TXHDd_Trs2w/story01.htm,neutral,0.8262594938278198
23,7/2/2013 12:00:11 AM,"Pfizer, Novartis may join Amgen in bidding for Onyx-sources",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/v0ZTgxHa898/story01.htm,positive,0.8967742323875427
24,7/18/2013 10:36:55 PM,Exclusive: Pfizer not moving forward with Onyx bid: sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/9x9EjAauf9M/story01.htm,positive,0.9252373576164246
25,7/29/2013 3:15:03 PM,"Pfizer to internally split its generic, branded drugs operations",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/LK9s0ACt0bI/story01.htm,positive,0.94477379322052
26,7/30/2013 12:10:09 PM,Pfizer earnings beat forecasts as drugmaker plans split,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/u_2RbW6nan8/story01.htm,negative,0.9376570582389832
27,7/30/2013 8:00:45 PM,Pfizer settles U.S. marketing case dating to Wyeth conduct,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/I3YF173lGUc/story01.htm,positive,0.6222016215324402
28,7/30/2013 10:10:07 PM,"Cost controls help Pfizer, Merck weather weak quarter",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/TfBef5dg-fI/story01.htm,negative,0.6507494449615479
29,8/2/2013 2:01:56 PM,Analysis: What's in your small-cap fund? Try Boeing or Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/alIfugiqnr0/story01.htm,positive,0.9457764625549316
30,10/29/2013 12:13:21 PM,Pfizer third-quarter profit beats estimates; oncology drugs shine,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/2o1nqMpO0JQ/story01.htm,negative,0.6992119550704956
31,11/23/2013 2:45:42 PM,Indian units of Pfizer and Wyeth to merge,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/FnVv5DmWHl0/story01.htm,positive,0.9429939985275269
32,11/23/2013 2:58:11 PM,Indian units of Pfizer and Wyeth to merge,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/W9AKMRpiPtg/story01.htm,positive,0.9429939985275269
33,12/31/2013 7:09:53 AM,China halts imports of Pfizer drug on paperwork glitch,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/N9ScqOTeobs/story01.htm,neutral,0.8993457555770874
34,1/28/2014 1:19:17 PM,Pfizer beats fourth quarter forecasts on sales,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/DVvdrHy6kUk/story01.htm,negative,0.8792312145233154
35,2/24/2014 9:55:01 AM,Pfizer surges on parent's restructuring,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/D4fOQjiToRs/story01.htm,negative,0.8015137314796448
36,4/3/2014 3:04:27 PM,"Apple, Pfizer, others form 'go slow' U.S. patent lobby group",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/EIuawbWYkjI/story01.htm,positive,0.9197189807891846
37,4/7/2014 4:41:50 PM,Wall St. flat as momentum stocks stabilize; Pfizer drags,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/BLbS9VCpDIg/story01.htm,neutral,0.9105912446975708
38,4/7/2014 5:18:21 PM,Wall St flat as momentum stocks stabilize; Pfizer drags,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/S-lkx-Oqu6c/story01.htm,neutral,0.9440680146217346
39,4/7/2014 7:11:20 PM,"Wall Street falls on broad weakness, Pfizer drags",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/WD32ZthG_ho/story01.htm,neutral,0.9627177119255066
40,4/20/2014 12:48:23 PM,Pfizer mulls $100 billion bid for AstraZeneca: report,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Q7DxpWCIiK8/story01.htm,positive,0.9327489733695984
41,4/21/2014 1:20:28 PM,AstraZeneca cancer pipeline seen as draw for Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/pkF7bxeM-0g/story01.htm,negative,0.7387492656707764
42,4/22/2014 6:25:03 AM,Pfizer agrees to $190 million settlement over generic versions of its epilepsy drug,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/fQKBqOR_e-g/story01.htm,negative,0.834808886051178
43,4/28/2014 8:16:47 AM,Pfizer confirms desire to buy AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/W7UP5YLQhI0/story01.htm,positive,0.6762551665306091
44,4/28/2014 8:42:00 AM,Pfizer confirms desire to buy AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/UcIGDN2cwso/story01.htm,positive,0.6762551665306091
45,4/29/2014 12:58:51 AM,Pfizer move to join tax-driven deal-making raises red flags in U.S,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/8gBcYujMJzI/story01.htm,neutral,0.48532041907310486
46,4/29/2014 6:34:57 AM,Indian unit of AstraZeneca up on Pfizer offer for parent,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/onPXa0iEHEc/story01.htm,negative,0.798910915851593
47,4/29/2014 4:03:47 PM,Pfizer may have to pay more cash and top $105 billion to win AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/FHQ_AD52Ly8/story01.htm,positive,0.6950002908706665
48,4/30/2014 12:46:57 PM,UK lawmakers plan to probe Pfizer pursuit of AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/JMQU53iruXY/story01.htm,positive,0.647340714931488
49,4/30/2014 4:03:09 PM,"GSK says staying on sidelines in Astra, Pfizer fight",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/xnJBAOzBZlI/story01.htm,positive,0.9252042770385742
50,5/1/2014 6:18:18 PM,Pfizer prepares sweeter bid for AstraZeneca: report,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/RLF1JFjcyjI/story01.htm,positive,0.7097350358963013
51,5/2/2014 5:41:01 AM,Pfizer enters takeover discussions with AstraZeneca: WSJ,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/9PhpA3RGG98/story01.htm,positive,0.921454668045044
52,5/2/2014 6:07:45 AM,Pfizer enters takeover discussions with AstraZeneca - WSJ,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/r6wjf5ynFDo/story01.htm,positive,0.902633547782898
53,5/2/2014 9:11:59 AM,Pfizer engages AstraZeneca with raised $106 billion offer,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/CwLJSCCOkws/story01.htm,negative,0.5919823050498962
54,5/3/2014 2:11:34 PM,Pfizer U.S. research jobs jeopardized by promises to UK for merger,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/a4I7G4dnYJY/story01.htm,neutral,0.9645712375640869
55,5/5/2014 1:17:48 PM,"Pfizer first-quarter sales disappoint, generics drag results",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/sa3Xv6IUoIw/story01.htm,neutral,0.9611281156539917
56,5/5/2014 4:08:38 PM,Pfizer sales way off mark as company pursues AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/EIxNXz7pbno/story01.htm,neutral,0.927054226398468
57,5/6/2014 11:33:31 AM,UK lawmakers summon Pfizer and AstraZeneca over takeover deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/UfDHKDGk0-8/story01.htm,neutral,0.8682162165641785
58,5/6/2014 12:53:14 PM,"AstraZeneca, fighting off Pfizer, forecasts $45 billion sales by 2023",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/co9vriv29AA/story01.htm,positive,0.5305481553077698
59,5/6/2014 6:17:24 PM,AstraZeneca fights Pfizer bid by predicting sales surge - eventually,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/sOxmFRIzfDA/story01.htm,negative,0.8665577173233032
60,5/7/2014 9:57:57 AM,Pfizer says AstraZeneca takeover would benefit science,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/hIvw3PQnGhw/story01.htm,negative,0.7058569192886353
61,5/8/2014 10:14:38 AM,AstraZeneca shares gain on speculation of new Pfizer bid,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/kod3OpPePY8/story01.htm,negative,0.7250120639801025
62,5/8/2014 9:55:56 PM,Swedish PM worried Pfizer would cut AstraZeneca jobs: report,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/otOlqz3U1x4/story01.htm,neutral,0.9617494940757751
63,5/9/2014 2:32:31 AM,"Maryland, Delaware governors concerned about Pfizer-Astra deal",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/m1nPZUngZ3k/story01.htm,neutral,0.9244113564491272
64,5/9/2014 1:36:19 PM,Britain wants binding pledges from Pfizer on AstraZeneca bid,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/NjN9aGkIfTw/story01.htm,positive,0.6567745208740234
65,5/9/2014 2:28:11 PM,"Pfizer under fire in Europe, U.S. as it weighs next Astra move",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/cV4RLw8UXEg/story01.htm,negative,0.520646333694458
66,5/9/2014 5:11:52 PM,"Pfizer under fire in Europe, U.S. as it weighs next Astra move",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/KrfL-Si8vTQ/story01.htm,negative,0.520646333694458
67,5/10/2014 12:05:46 PM,UK finance minister ready for 'hard negotiation' with Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/TLaZFvmtsrA/story01.htm,positive,0.5854922533035278
68,5/10/2014 5:13:34 PM,"Under fire, Pfizer hits back as weighs next Astra move",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/RqSOYRtBot4/story01.htm,negative,0.5496435165405273
69,5/10/2014 9:07:18 PM,"Under fire, Pfizer hits back as weighs next Astra move",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/z1LGa4Wbob4/story01.htm,negative,0.5496435165405273
70,5/12/2014 8:49:51 AM,Pfizer R&D head presses case for AstraZeneca deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/jaPAOPvWTLo/story01.htm,positive,0.9282987713813782
71,5/12/2014 11:57:52 AM,Pfizer presses AstraZeneca case as CEO faces UK grilling,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/or7jeNX6KyQ/story01.htm,positive,0.5159403085708618
72,5/13/2014 2:11:27 AM,Pfizer boss enters lion's den of UK politics to sell AstraZeneca deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/IcILkC1VhO4/story01.htm,positive,0.8462814092636108
73,5/13/2014 2:15:23 AM,Pfizer boss enters lion's den of UK politics to sell AstraZeneca deal,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/QTiRuKFrHo0/story01.htm,positive,0.8462814092636108
74,5/13/2014 3:37:59 AM,Pfizer considers raising bid for AstraZeneca - Bloomberg,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/_ChhVgYbnWw/story01.htm,positive,0.876939594745636
75,5/13/2014 10:10:40 AM,Pfizer hints at improved Astra offer as CEO heads into political grilling,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/XbjcWeHdZwE/story01.htm,positive,0.7153787016868591
76,5/13/2014 4:33:39 PM,UK lawmakers give Pfizer stick as it waves carrot at AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/SZ37Jd9nHMM/story01.htm,neutral,0.5120548009872437
77,5/14/2014 9:33:29 AM,Call for 10-year Pfizer pledge as CEO faces new grilling,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/hFTlIUaHaHw/story01.htm,positive,0.8458026647567749
78,5/14/2014 12:30:36 PM,Pfizer pledges to ringfence drug development in AstraZeneca deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/fPl6gmx0Mug/story01.htm,positive,0.6601377725601196
79,5/14/2014 8:32:48 PM,"Astra CEO sees price, Pfizer structure as deal hurdles",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/QjtIkzIvJRM/story01.htm,positive,0.9259073138237
80,5/14/2014 11:17:41 PM,"AstraZeneca leaves door ajar to Pfizer, despite hurdles",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3nO5vKN8GHM/story01.htm,positive,0.7814111113548279
81,5/15/2014 10:26:36 AM,Good cancer drug data helps AstraZeneca in Pfizer fight,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/uGHJ8znUg18/story01.htm,negative,0.9475163817405701
82,5/15/2014 2:03:33 PM,"Pfizer move on Astra threatens UK science, lawmakers say",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/PuCWumOEtP8/story01.htm,neutral,0.944343626499176
83,5/15/2014 7:00:36 PM,Promising cancer drug data helps AstraZeneca in Pfizer fight,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/URqs1hFgTzQ/story01.htm,negative,0.9426293969154358
84,5/16/2014 2:46:11 PM,Sweden fights back as Pfizer move on Astra threatens jobs,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/owANiRhIUqc/story01.htm,neutral,0.8893504738807678
85,5/18/2014 12:27:38 PM,AstraZeneca arrays academic assets in Pfizer defense,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/zeZo_LZNyzc/story01.htm,positive,0.9210215210914612
86,5/18/2014 3:04:17 PM,Clock ticking for Pfizer to raise AstraZeneca bid,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/xvHbOEZZ1zQ/story01.htm,positive,0.9063517451286316
87,5/19/2014 2:00:06 AM,Pfizer raises bid for AstraZeneca to $117 billion,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/9oVZ8uTHt_k/story01.htm,negative,0.8365570306777954
88,5/19/2014 4:38:06 AM,Pfizer raises bid for AstraZeneca to $117 billion,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/1TCnrktT4o4/story01.htm,negative,0.8365570306777954
89,5/20/2014 12:40:43 AM,Pfizer-AstraZeneca deal not quite dead yet,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/LuTYV2lnq0Q/story01.htm,positive,0.6540595293045044
90,5/20/2014 11:57:58 AM,AstraZeneca shareholder urges board back into talks with Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/6JnxZprpNvM/story01.htm,positive,0.693919837474823
91,5/21/2014 5:46:57 PM,See you later? Slim Pfizer deal hopes prop up AstraZeneca,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/D64jodiq2Go/story01.htm,negative,0.9418057203292847
92,5/26/2014 4:17:30 PM,Pfizer walks away from $118 billion AstraZeneca deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/iuHDuKX_e-w/story01.htm,neutral,0.904221773147583
93,5/26/2014 6:30:05 PM,Pfizer walks away from $118 bln AstraZeneca takeover fight,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/9AOxCFLotqM/story01.htm,neutral,0.9063142538070679
94,5/27/2014 9:15:55 AM,Pfizer walks away from $118 billion AstraZeneca takeover fight,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/s1UDyjMe1yM/story01.htm,neutral,0.8642774820327759
95,5/27/2014 10:21:04 AM,AstraZeneca shares fall as Pfizer walks away,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/lRhbXp_D_qo/story01.htm,neutral,0.9494723081588745
96,5/27/2014 11:10:00 AM,AstraZeneca shares fall after Pfizer walks away,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/GkfmaQrlmsw/story01.htm,neutral,0.9576493501663208
97,5/29/2014 6:28:53 PM,Cancer meeting a showcase for AstraZeneca drugs prized by Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/6G1zo3Hy2D0/story01.htm,positive,0.6887962818145752
98,6/11/2014 7:19:57 PM,Pfizer says Astra quest failed due to price,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/d0q50IF0M4M/story01.htm,neutral,0.8565437197685242
99,6/12/2014 1:09:39 PM,"Merck, Pfizer, HSBC could be big winners from shareholder case",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/mSIeSDiKIsw/story01.htm,negative,0.7946315407752991
100,7/9/2014 2:30:12 AM,Pfizer wins dismissal of U.S. investor class action ahead of trial,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/-RZyMv-1DfE/story01.htm,neutral,0.8624734878540039
101,7/29/2014 1:33:44 PM,Pfizer beats forecasts as oncology drugs grow,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Un2D8ewiIhQ/story01.htm,negative,0.5680462121963501
102,7/31/2014 8:49:43 AM,AstraZeneca smashes forecasts in Q2 after seeing off Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/bDlzhM8ZwI4/story01.htm,negative,0.6915749907493591
103,8/1/2014 3:55:40 PM,Pfizer says threats to managers force staff lockout at Mumbai factory,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Yow-DI2yz9U/story01.htm,neutral,0.9315240383148193
104,8/8/2014 7:11:09 AM,Pfizer confronts surge of lawsuits over Lipitor,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/TW9m3S17ssY/story01.htm,neutral,0.9270853996276855
105,8/21/2014 3:19:18 PM,Pfizer back for AstraZeneca? Year-end move seen most likely,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Y19XI0dCWGM/story01.htm,positive,0.8757321238517761
106,9/2/2014 2:59:48 PM,"Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/aDxMORQwHyo/story01.htm,positive,0.8386330008506775
107,9/12/2014 11:12:07 PM,"Pfizer, Ranbaxy win dismissal of lawsuit over generic Lipitor",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/XbI2xzGhGSU/story01.htm,neutral,0.8952143788337708
108,10/17/2014 12:57:57 AM,FDA votes to keep black box warning on Pfizer anti-smoking drug,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/J2XCIWchxP0/story01.htm,neutral,0.5089635848999023
109,10/28/2014 12:21:16 PM,"Pfizer beats third-quarter forecasts, mum on likely future deals",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/OuS7nvyHE_A/story01.htm,negative,0.7293359637260437
110,11/6/2014 11:47:21 AM,"Tax changes weaken case for new Pfizer bid, says AstraZeneca CEO",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/nTkjLsNaYwU/story01.htm,negative,0.5004138946533203
111,11/14/2014 1:46:42 PM,AstraZeneca not only game in town for deal-hungry Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3Koc0dB8qG8/story01.htm,positive,0.7186187505722046
112,11/17/2014 9:12:07 AM,"German Merck, Pfizer in cancer immunotherapy deal",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/q5ifBFCmXg4/story01.htm,positive,0.8984612226486206
113,11/17/2014 3:10:07 PM,Pfizer dampens Astra bid hopes with German Merck cancer deal,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/2xV1C04An20/story01.htm,negative,0.8527933955192566
114,1/26/2015 10:01:41 PM,Pfizer cuts vaccine price for poor as GAVI group seeks $7.5 bln,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/T1ERzbZAH8o/story01.htm,neutral,0.812995433807373
115,2/5/2015 1:13:56 PM,Pfizer to buy Hospira for about $15 billion,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/B8eHqoxqrT4/story01.htm,positive,0.9263706803321838
116,2/5/2015 4:07:54 PM,"Wall Street climbs with oil after claims data, Pfizer deal",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/OzHhxXWVfGA/story01.htm,negative,0.6497310400009155
117,2/5/2015 7:12:32 PM,Pfizer to buy Hospira for $15 bln to bolster hospital products,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/QqgKtIdkrR4/story01.htm,negative,0.6466647982597351
118,2/5/2015 10:28:46 PM,"Wall Street climbs with energy rebound, Pfizer deal",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/3dMLM95w_2g/story01.htm,negative,0.8518055081367493
119,2/6/2015 1:47:54 AM,Pfizer to buy Hospira for $15 billion to bolster hospital products,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Jkf0J1G9888/story01.htm,negative,0.6231916546821594
120,2/10/2015 12:00:51 AM,"Pfizer in $5 billion accelerated buyback deal with Goldman, Sachs & Co",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/QY-pCB8C-oE/story01.htm,negative,0.7876507639884949
121,4/2/2015 8:09:18 AM,Pfizer to shutter vaccines sales business in China,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/4LTq8cLtmYc/story01.htm,neutral,0.9157121181488037
122,4/13/2015 9:42:12 PM,Mylan settles Viagra patent litigation with Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/QtQT5N-o9J0/story01.htm,positive,0.7259026169776917
123,4/30/2015 6:08:38 PM,Exclusive: Pfizer is mystery bidder for rare disease drugmaker Sobi - sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/wrhVpQoZHy8/story01.htm,positive,0.8507202863693237
124,7/14/2015 3:52:35 PM,Pfizer offers concessions in bid to win EU okay for Hospira deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/JQqeAQ8bkfA/story01.htm,negative,0.8173230886459351
125,7/28/2015 1:12:48 PM,Pfizer revenue falls 7 percent,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/GDg-xbyAvCs/story01.htm,neutral,0.9689911603927612
126,8/4/2015 5:38:59 PM,Pfizer wins EU approval for $15 billion Hospira buy,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ajDF4rYFL_g/story01.htm,negative,0.8331183791160583
127,10/27/2015 11:53:33 AM,Pfizer revenue falls about 2 percent on strong dollar,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/GDRQS4iG6Ic/story01.htm,neutral,0.9705559015274048
128,10/29/2015 2:37:47 AM,"Drugmakers Pfizer, Allergan considering a combination: WSJ",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/7Tz_rfoYkzY/story01.htm,positive,0.877517580986023
129,10/29/2015 4:12:29 AM,"Drugmakers Pfizer, Allergan considering a combination - WSJ",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/lP2ZqI3zkSE/story01.htm,positive,0.7938967347145081
130,10/29/2015 8:15:10 PM,"Pfizer, Allergan in talks to forge world's biggest drugmaker",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/yJVXkZirPXw/story01.htm,positive,0.5779144763946533
131,10/30/2015 9:39:25 AM,"Pfizer, Allergan drug merger talks raise tax hackles in U.S.",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/gDMDqH-iHL0/story01.htm,neutral,0.7418018579483032
132,11/2/2015 6:48:30 PM,"Exclusive: Guggenheim, JPMorgan clinch key roles in Pfizer-Allergan talks",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/z-dMYDFfzFI/story01.htm,positive,0.9241342544555664
133,11/2/2015 6:57:51 PM,"Exclusive: Guggenheim, JPMorgan clinch key roles in Pfizer-Allergan talks",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/wbcYTTCHnng/story01.htm,positive,0.9241342544555664
134,11/6/2015 7:17:04 AM,"After big spending and hard lobbying, Pfizer eyes new tax home",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/yLWi2ygMtrg/story01.htm,positive,0.7562525272369385
135,11/6/2015 7:28:54 AM,Pfizer-Allergan deal would set up U.S. company for a split,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/iJiMNRDiHOE/story01.htm,positive,0.8647305965423584
136,11/13/2015 11:15:26 PM,Pfizer-Allergan deal refocuses market on U.S. tax-inversion rules,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/k5RoCgwlrOA/story01.htm,positive,0.8497814536094666
137,11/16/2015 5:49:30 PM,How Pfizer has shifted U.S. profits overseas for years,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/yu2Dh_MSzq0/story01.htm,positive,0.8218130469322205
138,11/16/2015 7:55:31 PM,Exclusive: Moelis clinches Pfizer advisory role with help from Eric Cantor - sources,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/qb-l2SMPw_0/story01.htm,positive,0.8670616149902344
139,11/19/2015 1:38:40 AM,Pfizer discussing Allergan offer at $370-$380 per share: source,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/6SMRDLiZZGU/story01.htm,positive,0.9370611310005188
140,11/19/2015 3:03:47 AM,Pfizer-Allergan talks accelerate amid new inversion clamp-down,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/2GEwgbjinlU/story01.htm,negative,0.8536703586578369
141,11/19/2015 5:17:22 AM,Pfizer-Allergan talks accelerate amid new inversion clamp-down,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/xUGf6IcgTwc/story01.htm,negative,0.8536703586578369
142,11/19/2015 3:34:09 PM,"Pfizer, Allergan in final stage of merger talks: CNBC",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/rohKMyJvs0A/story01.htm,positive,0.9239200949668884
143,11/19/2015 4:44:27 PM,Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/5oMmx3ZJSts/story01.htm,positive,0.9447723031044006
144,11/20/2015 7:40:32 PM,"Exclusive: Pfizer, Allergan CEOs agree on combined company roles - sources",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/QdrOhfFG8R8/story01.htm,positive,0.9321063756942749
145,11/20/2015 7:51:30 PM,"Exclusive: Pfizer, Allergan CEOs agree on combined company roles - sources",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/t21fr3JZLYE/story01.htm,positive,0.9321063756942749
146,11/22/2015 8:03:51 PM,Pfizer and Allergan to approve merger agreement on Sunday-sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/yJAtBqBG4sk/story01.htm,positive,0.8646499514579773
147,11/23/2015 3:30:20 AM,Pfizer set to buy Allergan for more than $150 billion - sources,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/S7xvBcjQzxE/story01.htm,positive,0.9160314798355103
148,11/23/2015 4:29:44 AM,Pfizer set to buy Allergan for more than $150 billion: sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/nZa_Pgk_454/story01.htm,positive,0.9326229691505432
149,11/23/2015 8:04:03 PM,"Clinton bashes Pfizer-Allergan deal, to propose anti-inversion steps",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/5OHQfT5mQzs/story01.htm,positive,0.6814758777618408
150,11/23/2015 9:49:15 PM,"Wall Street falls after strong week, Pfizer and Allergan drag",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/DN15j8SxgNQ/story01.htm,neutral,0.9313266277313232
151,11/24/2015 1:17:23 AM,Wall Street falls after strong week; Pfizer and Allergan drag,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/LL0y7WMvX9U/story01.htm,neutral,0.8958141803741455
152,11/24/2015 1:40:50 AM,Wall Street falls after strong week; Pfizer and Allergan drag,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/wfCqFiF0SGc/story01.htm,neutral,0.8958141803741455
153,11/24/2015 3:59:06 AM,Pfizer to buy Allergan in $160 billion deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/27gFdJxm0Gs/story01.htm,positive,0.9153047800064087
154,11/24/2015 4:15:02 AM,U.S. politicians slam tax-avoiding Pfizer-Allergan deal,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/3t5K9whsrcw/story01.htm,neutral,0.610567569732666
155,11/26/2015 8:48:16 PM,Two-decade Pfizer mission pays off for Guggenheim's deal king,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/0lX205PVjaM/story01.htm,negative,0.8478111624717712
156,1/8/2016 11:02:21 PM,Pfizer hikes U.S. prices for over 100 drugs on January 1,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/0HeTN33UCaw/story01.htm,neutral,0.8471009731292725
157,1/13/2016 12:58:37 AM,"Pfizer, Allergan say combined drug pipeline 'underappreciated'",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/GNWS-z9CLAg/story01.htm,neutral,0.9645337462425232
158,1/14/2016 4:24:12 AM,Pfizer weighing sale of Hospira's pump business: Bloomberg,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/F0hV9KnrrUs/story01.htm,positive,0.9410001635551453
159,2/2/2016 12:55:16 PM,Pfizer revenue rises as pneumonia vaccine sales jump,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/n_rVM9DzLg0/story01.htm,negative,0.9379658102989197
160,3/11/2016 2:19:04 PM,Medecins Sans Frontieres files to block Pfizer patent on pneumonia vaccine in India,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/HvNgxgoPI9c/story01.htm,neutral,0.8778624534606934
161,3/14/2016 5:26:55 AM,Delhi High Court grants Pfizer temporary relief on cough syrup ban,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/xACCI3zr3kA/story01.htm,neutral,0.8053077459335327
162,3/14/2016 5:28:21 AM,"India's codeine cough syrup ban hits Pfizer, Abbott units",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/fYV2zEtyEmE/story01.htm,neutral,0.9296795129776001
163,4/5/2016 1:52:18 AM,New U.S. inversion rules threaten Pfizer-Allergan deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ptQNQAIwipU/story01.htm,neutral,0.9495964646339417
164,4/5/2016 4:53:02 PM,Obama's inversion curbs kill Pfizer's $160 billion Allergan deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/pUyFkBlXSjg/story01.htm,positive,0.5026844143867493
165,4/5/2016 7:55:36 PM,Exclusive: Pfizer leaning toward abandoning deal with Allergan - source,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/D_z4krOCfIw/story01.htm,positive,0.647141695022583
166,4/6/2016 4:52:07 AM,"Pfizer, Allergan to mutually terminate merger on Wednesday morning, source says",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/ZKhuddec8e0/story01.htm,positive,0.7832751274108887
167,4/6/2016 12:53:37 PM,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/0DiJ5fZuvuU/story01.htm,neutral,0.47246673703193665
168,4/6/2016 1:16:35 PM,"Pfizer and Allergan scrap $160 bln ""inversion"" deal",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/yCtMJJrQHio/story01.htm,neutral,0.7312159538269043
169,4/6/2016 2:46:21 PM,"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/ieMkoSRVeVg/story01.htm,neutral,0.47246673703193665
170,4/8/2016 1:20:27 AM,Investors stick with Pfizer CEO after Allergan deal scrapped,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/EpmMKNdzduo/story01.htm,positive,0.9102482795715332
171,4/8/2016 3:34:04 AM,Investors stick with Pfizer CEO after Allergan deal scrapped,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/NEJSkKjv47E/story01.htm,positive,0.9102482795715332
172,5/3/2016 12:54:25 PM,New drugs fuel strong Pfizer results; company raises 2016 forecasts,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/oWho8PHHW0Y/us-pfizer-results-idUSKCN0XU0YQ,negative,0.9449955224990845
173,5/3/2016 10:37:40 PM,Pfizer CEO still interested in deals after losing Allergan,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/EKFQkBehPIc/us-pfizer-results-deals-idUSKCN0XU27N,negative,0.6717095375061035
174,5/4/2016 12:04:05 AM,Exclusive: Pfizer approaches Medivation about potential takeover - sources ,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/2kOB-H8fTBY/us-medivation-m-a-pfizer-exclusive-idUSKCN0XU2C6,positive,0.9379329681396484
175,5/16/2016 1:08:11 PM,Pfizer to buy Anacor Pharma in $5.2 billion deal,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Vu7UY5emmfk/anacor-pharma-m-a-pfizer-idINKCN0Y714P,positive,0.9172662496566772
176,5/16/2016 1:19:09 PM,Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/cmSrznKdyK0/us-anacor-pharma-m-a-pfizer-idUSKCN0Y7143,positive,0.6554959416389465
177,6/3/2016 6:25:55 PM,Ex-Oppenheimer adviser arrested for trading on Pfizer employee's tips,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/1dTKLyVIYes/us-usa-insidertrading-idUSKCN0YP22B,neutral,0.666170060634613
178,6/6/2016 6:03:40 PM,"Fresenius, Smiths in two-way race for Pfizer infusion pumps: sources",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/BJnobvVDsI0/us-pfizerpumps-m-a-fresenius-smiths-idUSKCN0YS1Q7,positive,0.8824187517166138
179,6/28/2016 6:50:16 AM,"Pfizer to invest $350 million in China biotech hub, first in Asia",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/9wHXGX0VIWg/us-pfizer-china-idUSKCN0ZE0A8,negative,0.6303641200065613
180,8/22/2016 12:12:28 AM,Pfizer boosts cancer drug roster with $14 billion Medivation deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/W0Nf7P-1KwE/us-medivation-m-a-pfizer-idUSKCN10W0YG,negative,0.8648000359535217
181,8/22/2016 8:01:00 PM,Pfizer boosts cancer drug roster with $14 bln Medivation deal,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/do_YbkP5DTc/medivation-m-a-pfizer-idINKCN10X1XE,negative,0.9146530628204346
182,9/26/2016 1:46:24 PM,Pfizer abandons plan to split into two companies,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/wOw3dD9milA/us-pfizer-split-idUSKCN11W13W,positive,0.868688702583313
183,9/26/2016 2:40:23 PM,Pfizer says not to split into two (PFE),Reuters,/news/stocks/pfizer-says-not-to-split-into-two-pfe-1001418182,positive,0.9431039690971375
184,9/26/2016 2:40:23 PM,BRIEF-Pfizer says it will not pursue splitting into two separate publicly traded companies (PFE),Reuters,/news/stocks/brief-pfizer-says-it-will-not-pursue-splitting-into-two-separate-publicly-traded-companies-pfe-1001418184,positive,0.9402485489845276
185,9/26/2016 9:40:24 PM,UPDATE 3-Pfizer abandons plan to split into two companies (PFE),Reuters,/news/stocks/update-3-pfizer-abandons-plan-to-split-into-two-companies-pfe-1001419101,positive,0.6162391901016235
186,9/26/2016 10:50:20 PM,"BRIEF-Moody's changes outlook on Pfizer's to stable from negative, affirms ratings (PFE, MDVN)",Reuters,/news/stocks/brief-moodys-changes-outlook-on-pfizers-to-stable-from-negative-affirms-ratings-pfe-mdvn-1001419328,positive,0.7147014141082764
187,9/27/2016 10:40:21 AM,"US STOCKS-Wall St drops as investors brace for presidential debate (JPM, BAC, PFE)",Reuters,/news/stocks/us-stocks-wall-st-drops-as-investors-brace-for-presidential-debate-jpm-bac-pfe-1001419524,neutral,0.9466615915298462
188,9/27/2016 1:20:20 PM,"PRESS DIGEST - Wall Street Journal - Sept 27 (PFE, DIS, MYL)",Reuters,/news/stocks/press-digest-wall-street-journal-sept-27-pfe-dis-myl-1001419872,positive,0.9389451146125793
189,9/27/2016 10:10:25 PM,BRIEF-Fitch says Pfizer's scrapped split decision will not affect ratings (PFE),Reuters,/news/stocks/brief-fitch-says-pfizers-scrapped-split-decision-will-not-affect-ratings-pfe-1001421601,positive,0.9274229407310486
190,9/28/2016 3:00:21 PM,BRIEF-Pfizer to showcase progress of broad-based oncology portfolio at ESMO 2016 Congress (PFE),Reuters,/news/stocks/brief-pfizer-to-showcase-progress-of-broad-based-oncology-portfolio-at-esmo-2016-congress-pfe-1001423449,positive,0.7981913685798645
191,9/28/2016 5:40:24 PM,"BRIEF-Pfizer completes acquisition of Medivation (PFE, MDVN)",Reuters,/news/stocks/brief-pfizer-completes-acquisition-of-medivation-pfe-mdvn-1001424012,positive,0.8779727220535278
192,10/3/2016 12:10:22 PM,"Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001431817,neutral,0.6420669555664062
193,10/3/2016 2:20:21 PM,"RPT-Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/rpt-big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001432682,neutral,0.5524706840515137
194,10/5/2016 1:10:26 AM,"UPDATE 3-J&J warns diabetic patients: Insulin pump vulnerable to hacking (JNJ, MDT, PFE)",Reuters,/news/stocks/update-3-j&j-warns-diabetic-patients-insulin-pump-vulnerable-to-hacking-jnj-mdt-pfe-1001436547,neutral,0.5905588865280151
195,10/5/2016 10:00:22 AM,BRIEF-Theravance Biopharma's unit enters into fourth amendment with Pfizer (PFE),Reuters,/news/stocks/brief-theravance-biopharmas-unit-enters-into-fourth-amendment-with-pfizer-pfe-1001436675,positive,0.912992000579834
196,10/5/2016 10:30:23 PM,"Support for California drug spending limits stokes industry fears (MRK, PFE, AMGN)",Reuters,/news/stocks/support-for-california-drug-spending-limits-stokes-industry-fears-mrk-pfe-amgn-1001439072,neutral,0.8449620008468628
197,10/6/2016 3:30:21 PM,"BRIEF-ICU Medical to buy Hospira Infusion Systems business from Pfizer for $1 bln in cash, stock (ICUI, PFE)",Reuters,/news/stocks/brief-icu-medical-to-buy-hospira-infusion-systems-business-from-pfizer-for-$1-bln-in-cash-stock-icui-pfe-1001440872,positive,0.8721926212310791
198,10/6/2016 3:30:21 PM,"ICU Medical to buy Pfizer's infusion therapy business for $1 bln (PFE, ICUI)",Reuters,/news/stocks/icu-medical-to-buy-pfizers-infusion-therapy-business-for-$1-bln-pfe-icui-1001440871,positive,0.8809384703636169
199,10/6/2016 10:10:23 PM,"BRIEF-Pfizer to sell NYC HQ by end of 2017 - CNBC, citing DJ (PFE)",Reuters,/news/stocks/brief-pfizer-to-sell-nyc-hq-by-end-of-2017-cnbc-citing-dj-pfe-1001441519,positive,0.9350860118865967
200,10/6/2016 10:30:22 PM,Pfizer says to seek more modern Manhattan headquarters (PFE),Reuters,/news/stocks/pfizer-says-to-seek-more-modern-manhattan-headquarters-pfe-1001441635,positive,0.7172003984451294
201,10/6/2016 11:00:35 PM,"UPDATE 1-Pfizer to seek more modern Manhattan headquarters (AGN, PFE)",Reuters,/news/stocks/update-1-pfizer-to-seek-more-modern-manhattan-headquarters-agn-pfe-1001441761,positive,0.5913780927658081
202,10/10/2016 7:10:21 AM,"Novartis challenges Pfizer with strong breast cancer drug data (LLY, PFE)",Reuters,/news/stocks/novartis-challenges-pfizer-with-strong-breast-cancer-drug-data-lly-pfe-1001444918,negative,0.9462957382202148
203,10/10/2016 7:20:22 AM,"Tesaro ovarian cancer drug shows broad benefits in study (PFE, MYGN)",Reuters,/news/stocks/tesaro-ovarian-cancer-drug-shows-broad-benefits-in-study-pfe-mygn-1001444990,negative,0.9393188953399658
204,10/10/2016 8:00:22 AM,"UPDATE 1-Tesaro's ovarian cancer drug benefits all patients in study (PFE, MYGN)",Reuters,/news/stocks/update-1-tesaros-ovarian-cancer-drug-benefits-all-patients-in-study-pfe-mygn-1001444989,negative,0.8380401730537415
205,10/10/2016 8:00:22 AM,"UPDATE 1-Novartis challenges Pfizer with strong breast cancer drug data (LLY, PFE)",Reuters,/news/stocks/update-1-novartis-challenges-pfizer-with-strong-breast-cancer-drug-data-lly-pfe-1001445007,negative,0.9516933560371399
206,10/10/2016 2:40:21 PM,"Exelixis and Pfizer drugs face off in kidney cancer (EXEL, PFE, IPN)",Reuters,/news/stocks/exelixis-and-pfizer-drugs-face-off-in-kidney-cancer-exel-pfe-ipn-1001446004,positive,0.7374247908592224
207,10/10/2016 3:00:24 PM,BRIEF-Pfizer announces results from Phase 3 S-TRAC clinical trial (PFE),Reuters,/news/stocks/brief-pfizer-announces-results-from-phase-3-s-trac-clinical-trial-pfe-1001445999,positive,0.7113453149795532
208,10/10/2016 3:30:20 PM,"UPDATE 1-Exelixis and Pfizer drugs compete in kidney cancer trial (EXEL, PFE, IPN)",Reuters,/news/stocks/update-1-exelixis-and-pfizer-drugs-compete-in-kidney-cancer-trial-exel-pfe-ipn-1001446127,negative,0.803068220615387
209,10/11/2016 10:20:24 PM,"BRIEF-Transgene announces collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the combination of TG4001 with Avelumab (PFE, MRK, TNG)",Reuters,/news/stocks/brief-transgene-announces-collaboration-with-merck-kgaa-darmstadt-germany-and-pfizer-to-evaluate-the-combination-of-tg4001-with-avelumab-pfe-mrk-tng-1001450023,negative,0.8502280712127686
210,10/11/2016 10:21:09 PM,"The trillion-dollar reason why Wall Street should take gender diversity more seriously (JPM, WMT, PFE, MRK, V, RDS.A, RDSA, GSK)",Business Insider,/news/stocks/the-trillion-dollar-reason-why-wall-street-should-take-gender-diversity-more-seriously-jpm-wmt-pfe-mrk-v-rds-a-rdsa-gsk,positive,0.8706501722335815
211,10/11/2016 11:00:20 PM,"U.S. FDA clears Xarelto blood thinner despite faulty trial device (BAYN, ALR, JNJ, PFE)",Reuters,/news/stocks/u-s-fda-clears-xarelto-blood-thinner-despite-faulty-trial-device-bayn-alr-jnj-pfe-1001450199,negative,0.5444692969322205
212,10/13/2016 2:00:22 PM,"BRIEF-Merck KGaA says still plan to apply for avelumab approval this year (PFE, MRK)",Reuters,/news/stocks/brief-merck-kgaa-says-still-plan-to-apply-for-avelumab-approval-this-year-pfe-mrk-1001454073,positive,0.8037812113761902
213,10/13/2016 2:50:21 PM,Pfizer loses appeal in UK patent case over use of Lyrica drug for pain (PFE),Reuters,/news/stocks/pfizer-loses-appeal-in-uk-patent-case-over-use-of-lyrica-drug-for-pain-pfe-1001454327,neutral,0.9334369897842407
214,10/13/2016 3:10:22 PM,"UPDATE 1-Pfizer loses appeal in UK patent case over use of Lyrica drug for pain (AGN, PFE)",Reuters,/news/stocks/update-1-pfizer-loses-appeal-in-uk-patent-case-over-use-of-lyrica-drug-for-pain-agn-pfe-1001454397,neutral,0.9573375582695007
215,10/14/2016 9:00:21 AM,"BRIEF-Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer (ICUI, PFE)",Reuters,/news/stocks/brief-icu-medical-says-termination-rights-in-connection-of-hospira-deal-include-payment-of-$75-mln-from-pfizer-icui-pfe-1001455693,positive,0.5825468897819519
216,10/14/2016 12:10:25 PM,"UPDATE 1-U.S. targets corporate tax-reduction strategy with new regulation (AGN, PFE)",Reuters,/news/stocks/update-1-u-s-targets-corporate-tax-reduction-strategy-with-new-regulation-agn-pfe-1001455725,positive,0.6456570625305176
217,10/17/2016 11:14:32 PM,Pfizer set to start shipping Remicade biosimilar next month,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/phKSPc2NLSY/us-pfizer-biosimilar-idUSKBN12H2FZ,positive,0.8748405575752258
218,10/17/2016 11:40:22 PM,BRIEF-Pfizer says company to begin shipping Inflectra to wholesalers in late November (PFE),Reuters,/news/stocks/brief-pfizer-says-company-to-begin-shipping-inflectra-to-wholesalers-in-late-november-pfe-1001460909,positive,0.8829647898674011
219,10/18/2016 2:40:23 AM,"Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001460992,positive,0.886904239654541
220,10/18/2016 8:20:19 AM,"UPDATE 1-Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/update-1-pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001461028,positive,0.6134666204452515
221,10/18/2016 10:40:20 PM,"UPDATE 4-J&J shares lose ground on fears of Pfizer's answer to Remicade (JNJ, PFE)",Reuters,/news/stocks/update-4-j&j-shares-lose-ground-on-fears-of-pfizers-answer-to-remicade-jnj-pfe-1001463467,neutral,0.965657651424408
222,10/19/2016 4:00:35 PM,BRIEF-Pfizer awarded grant to evaluate vaccine for newborns (PFE),Reuters,/news/stocks/brief-pfizer-awarded-grant-to-evaluate-vaccine-for-newborns-pfe-1001465367,negative,0.8788952827453613
223,10/19/2016 9:10:20 PM,"WHO seeks new mechanism for crisis vaccine supplies at low cost (GSK, MRK, PFE)",Reuters,http://www.businessinsider.com/r-who-seeks-new-mechanism-for-crisis-vaccine-supplies-at-low-cost-2016-10,positive,0.8287646174430847
224,10/20/2016 12:22:20 PM,BRIEF-CDC's ACIP votes to recommend new dosing schedule for vaccination with Pfizer's trumenba (PFE),Reuters,http://www.businessinsider.com/r-brief-cdcs-acip-votes-to-recommend-new-dosing-schedule-for-vaccination-with-pfizers-trumenba-2016-10,positive,0.6567670106887817
225,10/20/2016 4:10:21 PM,"BRIEF-Debiopharm reports clinical collaboration with Merck KGaA and Pfizer (PFE, MRK)",Reuters,http://www.businessinsider.com/r-brief-debiopharm-reports-clinical-collaboration-with-merck-kgaa-and-pfizer-2016-10,negative,0.6363767981529236
226,10/21/2016 8:28:19 PM,"Advent, Bain gain edge in bid for Pfizer's Brazil venture -sources (MYL, PFE, TEVA, SUNPHARMA)",Reuters,http://www.businessinsider.com/r-advent-bain-gain-edge-in-bid-for-pfizers-brazil-venture--sources-2016-10,negative,0.9355505108833313
227,10/24/2016 3:48:20 AM,"Sanders urges Californians to approve drug price ballot measure (MYL, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-sanders-urges-californians-to-approve-drug-price-ballot-measure-2016-10,negative,0.5566001534461975
228,10/24/2016 9:38:19 PM,"TIMEWARNER-M&A/AT&T-LOANS-Market welcomes AT&T's $40 bln Time Warner loan (AGN, T, VZ, PFE, TWX)",Reuters,http://www.businessinsider.com/r-timewarner-ma/att-loans-market-welcomes-atts-40-bln-time-warner-loan-2016-10,negative,0.7295110821723938
229,10/24/2016 9:48:19 PM,"LPC: Market welcomes AT&T's $40 bln Time Warner loan (AGN, T, VZ, PFE, TWX)",Reuters,http://www.businessinsider.com/r-lpc-market-welcomes-atts-40-bln-time-warner-loan-2016-10,negative,0.8927708864212036
230,10/25/2016 10:08:35 PM,"Ex-Oppenheimer adviser to plead guilty in U.S. to insider trading (RY, OPY, PFE)",Reuters,http://www.businessinsider.com/r-ex-oppenheimer-adviser-to-plead-guilty-in-us-to-insider-trading-2016-10,positive,0.784611701965332
231,10/25/2016 11:52:18 PM,"UPDATE 1-Ex-Oppenheimer adviser pleads guilty to U.S. insider trading charges (RY, OPY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-ex-oppenheimer-adviser-pleads-guilty-to-us-insider-trading-charges-2016-10,neutral,0.5099825263023376
232,10/27/2016 2:44:18 PM,"UPDATE 1-Bristol hikes 2016 profit forecast after top drugs deliver (PFE, BMY)",Reuters,http://www.businessinsider.com/r-update-1-bristol-hikes-2016-profit-forecast-after-top-drugs-deliver-2016-10,neutral,0.7187328338623047
233,11/1/2016 12:30:53 PM,"Pfizer cholesterol drug fizzles, hitting shares",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/k90BrC-9NZM/us-pfizer-results-idUSKBN12W3S8,neutral,0.8445318937301636
234,11/3/2016 5:14:17 PM,"BRIEF-Spark Therapeutics and Pfizer report updated data from hemophilia b phase 1/2 trial (PFE, PFIZER)",Reuters,http://www.businessinsider.com/r-brief-spark-therapeutics-and-pfizer-report-updated-data-from-hemophilia-b-phase-1/2-trial-2016-11,positive,0.9174363017082214
235,11/4/2016 6:18:25 PM,"BRIEF-Fuelcell energy announces completion of 5.6 megawatt power plant installation for Pfizer (FCEL, PFE)",Reuters,http://www.businessinsider.com/r-brief-fuelcell-energy-announces-completion-of-56-megawatt-power-plant-installation-for-pfizer-2016-11,positive,0.662438154220581
236,11/7/2016 2:36:24 PM,BRIEF-Pfizer to present additional research for XELJANZ in rheumatologic diseases (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-to-present-additional-research-for-xeljanz-in-rheumatologic-diseases-2016-11,positive,0.7939466834068298
237,11/8/2016 10:22:18 PM,"Pfizer says closing two British sites, not Brexit-related (PFE)",Reuters,http://www.businessinsider.com/r-pfizer-says-closing-two-british-sites-not-brexit-related-2016-11,positive,0.8169870972633362
238,11/9/2016 1:16:18 PM,"California drug pricing initiative headed for defeat (XLV, IBB, MRK, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-california-drug-pricing-initiative-headed-for-defeat-2016-11,positive,0.6154242753982544
239,11/9/2016 6:28:14 PM,"Drug stocks rip higher after Trump's upset victory signals easing pressure on prices (MRK, PFE, AMGN, JNJ, AGN, ABBV, SNY, NVS, AZN, GSK, IBB)",Business Insider,http://www.businessinsider.com/drug-company-stocks-morning-after-election-2016-11,negative,0.9015561938285828
240,11/9/2016 9:50:20 PM,"UPDATE 1-California voters turn down drug pricing initiative (XLV, IBB, MRK, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-california-voters-turn-down-drug-pricing-initiative-2016-11,neutral,0.588699221611023
241,11/10/2016 12:46:32 AM,Exclusive: Pfizer weighs sale or spin-off of consumer health unit - sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/AO3M_BTY7_k/us-pfizer-m-a-exclusive-idUSKBN1343R5,positive,0.9394175410270691
242,11/10/2016 9:42:18 AM,"Novartis, Pfizer cut prices to win UK approval for cancer drugs (PFE)",Reuters,http://www.businessinsider.com/r-novartis-pfizer-cut-prices-to-win-uk-approval-for-cancer-drugs-2016-11,neutral,0.6432746648788452
243,11/10/2016 12:46:18 PM,Pfizer wins EU's approval for Ibrance as Novartis readies rival drug (PFE),Reuters,http://www.businessinsider.com/r-pfizer-wins-eus-approval-for-ibrance-as-novartis-readies-rival-drug-2016-11,negative,0.9430580735206604
244,11/10/2016 3:40:18 PM,"BRIEF-Bristol-Myers Squibb and Pfizer to deliver 12 new Eliquis (apixaban) presentations at American Heart Association (AHA) scientific sessions 2016 (BMY, PFE)",Reuters,http://www.businessinsider.com/r-brief-bristol-myers-squibb-and-pfizer-to-deliver-12-new-eliquis-apixaban-presentations-at-american-heart-association-aha-scientific-sessions-2016-2016-11,positive,0.7196627855300903
245,11/11/2016 1:46:22 PM,"Trump presidency could prove a salve for pharma merger deals (VRX, MYL, PFE)",Reuters,http://www.businessinsider.com/r-trump-presidency-could-prove-a-salve-for-pharma-merger-deals-2016-11,negative,0.882634699344635
246,11/11/2016 2:18:18 PM,BRIEF-Pfizer announces major expansion of humanitarian assistance program (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-major-expansion-of-humanitarian-assistance-program-2016-11,negative,0.9045549035072327
247,11/11/2016 2:22:20 PM,"Pfizer offers cut-price pneumonia shot for humanitarian crises (PFE, GSK)",Reuters,http://www.businessinsider.com/r-pfizer-offers-cut-price-pneumonia-shot-for-humanitarian-crises-2016-11,positive,0.7931159138679504
248,11/11/2016 2:50:18 PM,"RPT-Trump presidency could prove a salve for pharma merger deals (VRX, MYL, PFE)",Reuters,http://www.businessinsider.com/r-rpt-trump-presidency-could-prove-a-salve-for-pharma-merger-deals-2016-11,negative,0.9005955457687378
249,11/11/2016 3:00:18 PM,"BRIEF-EMA says CHMP recommends approving Afstyla (MRK, PHARM, GILD, PFE)",Reuters,http://www.businessinsider.com/r-brief-ema-says-chmp-recommends-approving-afstyla-2016-11,positive,0.8733400106430054
250,11/12/2016 11:54:18 PM,"UPDATE 1-Pfizer offers cut-price pneumonia shot for humanitarian crises (PFE, GSK)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-offers-cut-price-pneumonia-shot-for-humanitarian-crises-2016-11,negative,0.5367997884750366
251,11/14/2016 12:14:18 PM,"Pfizer's Celebrex shown to be as safe as ibuprofen or naproxen -study (BAYN, MYL, PFE, TEVA)",Reuters,http://www.businessinsider.com/r-pfizers-celebrex-shown-to-be-as-safe-as-ibuprofen-or-naproxen--study-2016-11,negative,0.9120007157325745
252,11/14/2016 2:56:18 PM,BRIEF-Pfizer to collaborate with National Cancer Institute (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-to-collaborate-with-national-cancer-institute-2016-11,negative,0.5634921789169312
253,11/14/2016 5:56:17 PM,BRIEF-Pfizer says announces tender offer (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-announces-tender-offer-2016-11,positive,0.9128684997558594
254,11/15/2016 2:36:18 AM,"BRIEF-Paulson & Co cuts share stake in Pfizer, raises share stake in Facebook (PFE, LLY)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-cuts-share-stake-in-pfizer-raises-share-stake-in-facebook-2016-11,positive,0.5948380827903748
255,11/15/2016 10:34:20 AM,BRIEF-Pfizer prices $6 billion debt offering (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-prices-6-billion-debt-offering-2016-11,positive,0.9000290036201477
256,11/15/2016 3:46:19 PM,BRIEF-Pfizer announces results from phase 3 Opal clinical development program investigating Xeljanz (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-results-from-phase-3-opal-clinical-development-program-investigating-xeljanz-2016-11,negative,0.5004051923751831
257,11/17/2016 8:34:20 AM,"Roche, Bristol-Myers cut cancer drug prices to win UK approval (PFE, BMY)",Reuters,http://www.businessinsider.com/r-roche-bristol-myers-cut-cancer-drug-prices-to-win-uk-approval-2016-11,negative,0.8597099781036377
258,11/19/2016 12:08:18 AM,"BRIEF-Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019 (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-pricing-of-tender-offer-for-any-and-all-of-its-6200-pct-senior-notes-due-march-15-2019-2016-11,positive,0.8628085851669312
259,11/21/2016 7:32:18 PM,BRIEF-Pfizer says Pfizer Global Supply President to retire (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-pfizer-global-supply-president-to-retire-2016-11,positive,0.8201802968978882
260,11/22/2016 4:00:19 PM,"INSIGHT-Currency drop hits Egypt's medicine supplies, angering public (PFE, GSK, SAN)",Reuters,http://www.businessinsider.com/r-insight-currency-drop-hits-egypts-medicine-supplies-angering-public-2016-11,neutral,0.9655218124389648
261,11/23/2016 2:13:46 PM,Donald Trump could be both a blessing and a curse for the pharmaceutical industry (PFE),Business Insider Contributor ,http://www.businessinsider.com/donald-trump-pharmaceutical-industry-drug-pricing-legilslation-2016-11,positive,0.5579833388328552
262,11/25/2016 11:28:18 AM,"Costly leukaemia pill wins UK green light after price cut (JNJ, PFE, BMY, 4523)",Reuters,http://www.businessinsider.com/r-costly-leukaemia-pill-wins-uk-green-light-after-price-cut-2016-11,negative,0.905751645565033
263,11/28/2016 3:11:41 PM,The drugmaker that Johnson & Johnson is looking to buy could significantly boost its takeover price,Reuters,http://www.businessinsider.com/r-actelions-ambitious-independent-minded-ceo-will-drive-up-takeover-price-2016-11,negative,0.9367399215698242
264,11/29/2016 3:30:10 PM,"German Merck, Pfizer get FDA priority review for cancer drug",Reuters,http://www.businessinsider.com/r-german-merck-pfizer-get-fda-priority-review-for-cancer-drug-2016-11,positive,0.7027015686035156
265,11/29/2016 4:06:08 PM,"BRIEF-FDA accepts the Biologics' license application for Avelumab for priority review (PFE, MRK)",Reuters,http://www.businessinsider.com/r-brief-fda-accepts-the-biologics-license-application-for-avelumab-for-priority-review-2016-11,positive,0.8306307196617126
266,11/30/2016 4:00:11 PM,BRIEF-Pfizer announces positive top-line results from the pivotal comparative reflections B3271002 study for PF-05280014 (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-positive-top-line-results-from-the-pivotal-comparative-reflections-b3271002-study-for-pf-05280014-2016-11,negative,0.93635094165802
267,11/30/2016 4:40:09 PM,Pfizer's Herceptin biosimilar succeeds in key breast cancer study (PFE),Reuters,http://www.businessinsider.com/r-pfizers-herceptin-biosimilar-succeeds-in-key-breast-cancer-study-2016-11,negative,0.506076991558075
268,11/30/2016 5:30:05 PM,"UPDATE 1-Pfizer's Herceptin biosimilar succeeds in key breast cancer study (MYL, PFE)",Reuters,http://www.businessinsider.com/r-update-1-pfizers-herceptin-biosimilar-succeeds-in-key-breast-cancer-study-2016-11,negative,0.7518488764762878
269,12/1/2016 3:30:07 PM,"BRIEF-Pfizer Inc, IBM announced a collaboration that will utilize IBM watson for drug discovery (PFE, IBM)",Reuters,http://www.businessinsider.com/r-brief-pfizer-inc-ibm-announced-a-collaboration-that-will-utilize-ibm-watson-for-drug-discovery-2016-12,negative,0.5027616024017334
270,12/1/2016 3:36:06 PM,BRIEF-Pfizer's pain drug Lyrica meets goal in late-stage pediatric epilepsy study (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizers-pain-drug-lyrica-meets-goal-in-late-stage-pediatric-epilepsy-study-2016-12,negative,0.7871901392936707
271,12/5/2016 3:26:05 PM,"BRIEF-Pfizer, Avillion announce positive top-line results for Phase 3 BFORE study of BOSULIF (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-avillion-announce-positive-top-line-results-for-phase-3-bfore-study-of-bosulif-2016-12,negative,0.9456959962844849
272,12/5/2016 4:26:05 PM,Pfizer's blood cancer drug Bosulif effective in untreated patients,Reuters,http://www.businessinsider.com/r-pfizers-blood-cancer-drug-bosulif-effective-in-untreated-patients-2016-12,negative,0.8244306445121765
273,12/5/2016 6:36:05 PM,GSK insider Waterhouse to head drugmaker's HIV unit ViiV,Reuters,http://www.businessinsider.com/r-gsk-insider-waterhouse-to-head-drugmakers-hiv-unit-viiv-2016-12,positive,0.9359387159347534
274,12/6/2016 5:40:10 AM,"UPDATE 1-Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12,positive,0.8939583897590637
275,12/6/2016 12:00:07 PM,"DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12,neutral,0.8780308961868286
276,12/6/2016 2:02:03 PM,"RPT-DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-rpt-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12,neutral,0.9314919114112854
277,12/7/2016 9:12:44 AM,Britain fines Pfizer record $107 mln for huge drug price hike,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/HlAlpihje_4/pfizer-britain-fine-idINKBN13W0LZ,neutral,0.9256585240364075
278,12/7/2016 9:29:35 AM,Pfizer has been fined a record £84 million for massively overcharging the NHS for an epilepsy drug (PFE),Reuters,http://www.businessinsider.com/r-update-1-britain-fines-pfizer-record-107-mln-for-huge-drug-price-hike-2016-12,neutral,0.9250887036323547
279,12/7/2016 12:00:03 PM,Britain fines Pfizer record $107 mln for huge drug price hike (PFE),Reuters,http://www.businessinsider.com/r-britain-fines-pfizer-record-107-mln-for-huge-drug-price-hike-2016-12,neutral,0.9285895824432373
280,12/7/2016 12:00:03 PM,"BRIEF-UK's CMA fines Pfizer, Flynn Pharma for epilepsy drug price hike (PFE)",Reuters,http://www.businessinsider.com/r-brief-uks-cma-fines-pfizer-flynn-pharma-for-epilepsy-drug-price-hike-2016-12,neutral,0.9340431690216064
281,12/7/2016 12:18:05 PM,BRIEF-Pfizer to appeal all aspects of decision by UK's CMA (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-to-appeal-all-aspects-of-decision-by-uks-cma-2016-12,positive,0.545239269733429
282,12/7/2016 12:18:05 PM,"UPDATE 1-UK Stocks-Factors to watch on Dec 7 (CLLN, BLT, MNKS, RIO, RIO, BHP, VALE5, AAL, SGC, BP., PFE, SGE)",Reuters,http://www.businessinsider.com/r-update-1-uk-stocks-factors-to-watch-on-dec-7-2016-12,positive,0.9386972784996033
283,12/7/2016 8:46:09 PM,"BRIEF-Drugmakers trade group says government mandates wrong way to address drug costs (PFE, MRK)",Reuters,http://www.businessinsider.com/r-brief-drugmakers-trade-group-says-government-mandates-wrong-way-to-address-drug-costs-2016-12,neutral,0.887956440448761
284,12/9/2016 8:30:03 PM,BRIEF-Akili and Pfizer present positive data from digital biomarker study (PFE),Reuters,http://www.businessinsider.com/r-brief-akili-and-pfizer-present-positive-data-from-digital-biomarker-study-2016-12,negative,0.8968297243118286
285,12/9/2016 10:30:05 PM,"Inmate coughs, heaves during Alabama execution raising ire over drug (PFE)",Reuters,http://www.businessinsider.com/r-inmate-coughs-heaves-during-alabama-execution-raising-ire-over-drug-2016-12,neutral,0.8843280076980591
286,12/12/2016 9:06:05 PM,BRIEF-Pfizer declares first-quarter 2017 dividend (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-declares-first-quarter-2017-dividend-2016-12,positive,0.7815220952033997
287,12/13/2016 7:36:08 PM,BRIEF-Ab Initio Biotherapeutics announces strategic collaboration with Pfizer to discover GPCR activating antibodies (PFE),Reuters,http://www.businessinsider.com/r-brief-ab-initio-biotherapeutics-announces-strategic-collaboration-with-pfizer-to-discover-gpcr-activating-antibodies-2016-12,negative,0.8855295181274414
288,12/14/2016 7:28:04 PM,BRIEF-U.S. FDA approves Eucrisa for eczema (PFE),Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-eucrisa-for-eczema-2016-12,negative,0.6084178686141968
289,12/14/2016 8:00:06 PM,FDA approves Pfizer's eczema ointment,Reuters,http://www.businessinsider.com/r-fda-approves-pfizers-eczema-ointment-2016-12,positive,0.5544476509094238
290,12/14/2016 8:26:04 PM,UPDATE 1-FDA approves Pfizer ointment for itchy skin condition (PFE),Reuters,http://www.businessinsider.com/r-update-1-fda-approves-pfizer-ointment-for-itchy-skin-condition-2016-12,negative,0.9064039587974548
291,12/14/2016 11:00:08 PM,"BRIEF-Pfizer says Phase 4 PLATO study did not meet its primary endpoint (PFE, 4503)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-phase-4-plato-study-did-not-meet-its-primary-endpoint-2016-12,neutral,0.8512685298919678
292,12/14/2016 11:00:08 PM,BRIEF-Catalyst Biosciences entered into agreement with Wyeth Llc (PFE),Reuters,http://www.businessinsider.com/r-brief-catalyst-biosciences-entered-into-agreement-with-wyeth-llc-2016-12,negative,0.9050643444061279
293,12/16/2016 2:04:03 PM,BRIEF-EMA recommends approval of Pfizer's lifmior drug (PFE),Reuters,http://www.businessinsider.com/r-brief-ema-recommends-approval-of-pfizers-lifmior-drug-2016-12,negative,0.5402805209159851
294,12/16/2016 8:56:05 PM,FDA drops black box warning on Pfizer's anti-smoking drug,Reuters,http://www.businessinsider.com/r-fda-drops-black-box-warning-on-pfizers-anti-smoking-drug-2016-12,neutral,0.84474778175354
295,12/16/2016 9:32:05 PM,BRIEF-Pfizer says FDA drops black box warning on anti-smoking drug Chantix (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-fda-drops-black-box-warning-on-anti-smoking-drug-chantix-2016-12,neutral,0.8865882158279419
296,12/19/2016 1:30:06 PM,BRIEF-Pfizer receives approval in the european union for nimenrix in infants six weeks of age and older (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-receives-approval-in-the-european-union-for-nimenrix-in-infants-six-weeks-of-age-and-older-2016-12,negative,0.9260194301605225
297,12/19/2016 2:20:05 PM,"BRIEF-Catalyst Biosciences secures all rights to manufacturing process for Marzeptacog Alfa from Wyeth LLC, a wholly-owned subsidiary of Pfizer (PFE)",Reuters,http://www.businessinsider.com/r-brief-catalyst-biosciences-secures-all-rights-to-manufacturing-process-for-marzeptacog-alfa-from-wyeth-llc-a-wholly-owned-subsidiary-of-pfizer-2016-12,positive,0.65276700258255
298,12/23/2016 8:50:03 AM,"BRIEF-AstraZeneca completes sale of antibiotics business to Pfizer (AZN, PFE)",Reuters,http://www.businessinsider.com/r-brief-astrazeneca-completes-sale-of-antibiotics-business-to-pfizer-2016-12,positive,0.9134097695350647
299,12/23/2016 9:28:05 AM,"BRIEF-Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca (AZN, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-completes-acquisition-of-small-molecule-anti-infective-business-from-astrazeneca-2016-12,negative,0.694008469581604
300,12/30/2016 3:26:03 PM,BRIEF-OPKO health provides update on hGH-CTP clinical programs (PFE),Reuters,http://www.businessinsider.com/r-brief-opko-health-provides-update-on-hgh-ctp-clinical-programs-2016-12,positive,0.9337788820266724
301,12/30/2016 3:34:05 PM,Growth hormone deficiency drug from OPKO and Pfizer fails study (PFE),Reuters,http://www.businessinsider.com/r-growth-hormone-deficiency-drug-from-opko-and-pfizer-fails-study-2016-12,positive,0.872533917427063
302,12/30/2016 4:32:03 PM,UPDATE 1-Growth hormone deficiency drug from OPKO and Pfizer fails study (PFE),Reuters,http://www.businessinsider.com/r-update-1-growth-hormone-deficiency-drug-from-opko-and-pfizer-fails-study-2016-12,positive,0.8575054407119751
303,1/5/2017 10:40:03 PM,"BRIEF-ICU Medical updates on Hospira Infusion Systems deal (ICUI, PFE)",Reuters,http://www.businessinsider.com/r-brief-icu-medical-updates-on-hospira-infusion-systems-deal-2017-1,positive,0.936448335647583
304,1/10/2017 5:38:05 AM,"UPDATE 1-Japan's Takeda ready for fresh acquisitions after $5.2 bln Ariad deal (4502, PFE, ARIA)",Reuters,http://www.businessinsider.com/r-update-1-japans-takeda-ready-for-fresh-acquisitions-after-52-bln-ariad-deal-2017-1,negative,0.872400164604187
305,1/11/2017 7:16:03 PM,"UPDATE 1-Trump says pharmaceutical companies ""getting away with murder"" (MYL, LMT, BA, PFE, JNJ, GILD, IBB)",Reuters,http://www.businessinsider.com/r-update-1-trump-says-pharmaceutical-companies-getting-away-with-murder-2017-1,positive,0.8361964821815491
306,1/20/2017 8:40:07 AM,"INSIGHT-Sanofi's M&A misses frustrate some investors in drugmaker (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-insight-sanofis-ma-misses-frustrate-some-investors-in-drugmaker-2017-1,neutral,0.8617132902145386
307,1/20/2017 9:54:09 PM,Maverick Capital eyes rebound on bets Trump may roil Wall Street,Reuters,http://www.businessinsider.com/r-maverick-capital-eyes-rebound-on-bets-trump-may-roil-wall-street-2017-1,neutral,0.8334219455718994
308,1/31/2017 1:02:07 PM,Pfizer quarterly revenue slips 3 percent (PFE),Reuters,http://www.businessinsider.com/r-pfizer-quarterly-revenue-slips-3-percent-2017-1,neutral,0.9660965800285339
309,1/31/2017 1:22:09 PM,BRIEF-Pfizer's Q4 Lyrica IH revenue was $1.06 bln vs $955 mln yr ago (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizers-q4-lyrica-ih-revenue-was-106-bln-vs-955-mln-yr-ago-2017-1,negative,0.5701144933700562
310,1/31/2017 1:22:09 PM,UPDATE 1-Pfizer quarterly profit misses estimates (PFE),Reuters,http://www.businessinsider.com/r-update-1-pfizer-quarterly-profit-misses-estimates-2017-1,positive,0.7526885271072388
311,1/31/2017 1:30:07 PM,BRIEF-Pfizer Inc reports Q4 reported diluted EPS of $0.13 (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-inc-reports-q4-reported-diluted-eps-of-013-2017-1,neutral,0.511418342590332
312,2/2/2017 6:42:07 PM,"BRIEF-Pfizer said to hire JPMorgan to weigh $2 bln portfolio sale - Bloomberg, citing sources (JPM, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-said-to-hire-jpmorgan-to-weigh-2-bln-portfolio-sale---bloomberg-citing-sources-2017-2,positive,0.906419038772583
313,2/2/2017 7:20:10 PM,Pfizer hires JPMorgan to weigh sale of some drugs: Bloomberg,Reuters,http://www.businessinsider.com/r-pfizer-hires-jpmorgan-to-weigh-sale-of-some-drugs-bloomberg-2017-2,positive,0.9075788855552673
314,2/2/2017 11:16:08 PM,"GE, Boeing, Oracle form coalition to support Republican border tax",Reuters,http://www.businessinsider.com/r-ge-boeing-oracle-form-coalition-to-support-republican-border-tax-2017-2,negative,0.492760568857193
315,2/3/2017 2:28:35 PM,Pfizer Enters $5 Bln Accelerated Share Repurchase Agreement With Citibank ,RTTNews,/news/stocks/pfizer-enters-5-bln-accelerated-share-repurchase-agreement-with-citibank-1001721579,negative,0.811576247215271
316,2/3/2017 3:36:10 PM,BRIEF-Pfizer commences $5 billion accelerated share repurchase (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-commences-5-billion-accelerated-share-repurchase-2017-2,positive,0.7065377831459045
317,2/6/2017 2:18:08 PM,"BRIEF-ICU Medical completes the acquisition of Hospira Infusion Systems from Pfizer (ICUI, PFE, PFIZER)",Reuters,http://www.businessinsider.com/r-brief-icu-medical-completes-the-acquisition-of-hospira-infusion-systems-from-pfizer-2017-2,positive,0.5473546385765076
318,2/8/2017 10:06:11 AM,"UPDATE 1-Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A (SAN, JNJ, REGN, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-drugmaker-sanofi-sees-weak-2017-earnings-not-in-hurry-for-ma-2017-2,neutral,0.9732018709182739
319,2/9/2017 6:26:13 PM,"Academics call time on $100,000 cancer drugs",Reuters,http://www.businessinsider.com/r-academics-call-time-on-100000-cancer-drugs-2017-2,positive,0.9321918487548828
320,2/13/2017 6:18:13 PM,"US issuers rush to sell Formosa bonds before rule change (VZ, AAPL, PFE)",Reuters,http://www.businessinsider.com/r-us-issuers-rush-to-sell-formosa-bonds-before-rule-change-2017-2,positive,0.9257388114929199
321,2/13/2017 10:50:10 PM,"BRIEF-Pfizer Inc reports  16.4 pct stake in ICU Medical (ICUI, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-inc-reports--164-pct-stake-in-icu-medical-2017-2,positive,0.9398477077484131
322,2/14/2017 1:34:12 AM,"BRIEF-ViiV Healthcare announces positive phase III results for two-drug regimen of Dolutegravir and Rilpivirine (GSK, PFE)",Reuters,http://www.businessinsider.com/r-brief-viiv-healthcare-announces-positive-phase-iii-results-for-two-drug-regimen-of-dolutegravir-and-rilpivirine-2017-2,negative,0.947405219078064
323,2/14/2017 10:36:13 AM,Gilead challenges GSK with strong HIV drug data,Reuters,http://www.businessinsider.com/r-gilead-challenges-gsk-with-strong-hiv-drug-data-2017-2,negative,0.9547237753868103
324,2/14/2017 10:00:17 PM,"Sachem Head's Ferguson to exit Autodesk board, fund gains -letter (AGN, VRX, PFE, ADSK)",Reuters,http://www.businessinsider.com/r-sachem-heads-ferguson-to-exit-autodesk-board-fund-gains--letter-2017-2,positive,0.9403475522994995
325,2/14/2017 11:10:10 PM,"BRIEF-Appaloosa LP dissolves share stake in Citigroup, Bank of America - SEC Filing (C, BAC, GM, PFE, MYL, TEVA, QCOM, LUV)",Reuters,http://www.businessinsider.com/r-brief-appaloosa-lp-dissolves-share-stake-in-citigroup-bank-of-america---sec-filing-2017-2,positive,0.8926530480384827
326,2/14/2017 11:19:29 PM,"David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks (PFE, TEVA, MYL, AGN)",Business Insider,http://www.businessinsider.com/david-teppers-appaloosa-invests-1-billion-on-4-pharma-stocks-2017-2,neutral,0.9716240167617798
327,2/15/2017 1:00:10 AM,BRIEF-Paulson & Co ups share stake in Pfizer (PFE),Reuters,http://www.businessinsider.com/r-brief-paulson--co-ups-share-stake-in-pfizer-2017-2,positive,0.9130947589874268
328,2/16/2017 2:15:11 PM,Pfizer Reports Results From Oral Strategy Trial Of XELJANZ Compared To Humira ,RTTNews,/news/stocks/pfizer-reports-results-from-oral-strategy-trial-of-xeljanz-compared-to-humira-1001757484,negative,0.9079198241233826
329,2/16/2017 6:01:21 PM,'People are afraid to spend their money': A US border town confronts Trump's import tax proposal,Reuters,http://www.businessinsider.com/r-rpt-it-would-be-huge-us-border-town-confronts-possible-import-tax-2017-2,neutral,0.8322793841362
330,2/17/2017 7:50:11 PM,BRIEF-Pfizer says new data in Crohn's disease patients shows similar efficacy and safety profiles for Inflectra and Remicade A (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-new-data-in-crohns-disease-patients-shows-similar-efficacy-and-safety-profiles-for-inflectra-and-remicade-a-2017-2,negative,0.9457032084465027
331,2/18/2017 3:00:16 AM,"BRIEF-Momenta Pharmaceuticals announces FDA warning letter to contracted Glatopa (MNTA, PFE)",Reuters,http://www.businessinsider.com/r-brief-momenta-pharmaceuticals-announces-fda-warning-letter-to-contracted-glatopa-2017-2,neutral,0.5458551049232483
332,2/18/2017 1:32:12 PM,Roche says Phase II trial supports twin treatment for kidney cancer (PFE),Reuters,http://www.businessinsider.com/r-roche-says-phase-ii-trial-supports-twin-treatment-for-kidney-cancer-2017-2,negative,0.806709349155426
333,2/20/2017 10:20:12 PM,"Collapse of Kraft-Unilever tie-up extends run of failed mega-deals (ULVR, PFE, AGN, HON, SPLS, UNA, UTX)",Reuters,http://www.businessinsider.com/r-collapse-of-kraft-unilever-tie-up-extends-run-of-failed-mega-deals-2017-2,neutral,0.9527161717414856
334,2/21/2017 1:50:12 PM,"Export companies tell U.S. Congress to push tax code rewrite (BA, CAT, GE, DOW, CE, CELG, LLY, RTN, MRK, UTX, PFE, VAR)",Reuters,http://www.businessinsider.com/r-export-companies-tell-us-congress-to-push-tax-code-rewrite-2017-2,positive,0.8782085180282593
335,2/21/2017 2:10:53 PM,Pfizer Says FDA Accepts BLA For Inotuzumab Ozogamicin - Quick Facts ,RTTNews,/news/stocks/pfizer-says-fda-accepts-bla-for-inotuzumab-ozogamicin-quick-facts-1001767839,negative,0.7904980778694153
336,2/21/2017 2:36:14 PM,BRIEF-Pfizer says U.S. FDA accepts regulatory submission for inotuzumab ozogamicin (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-us-fda-accepts-regulatory-submission-for-inotuzumab-ozogamicin-2017-2,negative,0.6264675855636597
337,2/21/2017 5:56:12 PM,"UPDATE 1-CEOs of 16 U.S. companies urge Congress to pass border tax (BA, CAT, GE, AAPL, IBM, INTC, DOW, CE, CELG, LLY, RTN, MRK, UTX, PFE, VAR)",Reuters,http://www.businessinsider.com/r-update-1-ceos-of-16-us-companies-urge-congress-to-pass-border-tax-2017-2,positive,0.8676490187644958
338,2/22/2017 7:22:12 AM,BRIEF-Pfizer said SIX swiss exchange approved delisting of its shares (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-said-six-swiss-exchange-approved-delisting-of-its-shares-2017-2,positive,0.8759150505065918
339,2/22/2017 9:58:12 AM,BRIEF-Pfizer to cancel listing in the United Kingdom (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-to-cancel-listing-in-the-united-kingdom-2017-2,neutral,0.7439795732498169
340,2/23/2017 10:58:15 PM,BRIEF-Ronald Blaylock elected to Pfizer's board of directors (PFE),Reuters,http://www.businessinsider.com/r-brief-ronald-blaylock-elected-to-pfizers-board-of-directors-2017-2,positive,0.9364364743232727
341,2/24/2017 12:00:17 AM,BRIEF-Pfizer says monitoring potential impact related to any changes to ACA (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-monitoring-potential-impact-related-to-any-changes-to-aca-2017-2,positive,0.8967129588127136
342,2/24/2017 7:34:17 PM,BRIEF-Pfizer announces pricing of $1.07 bln debt offering (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-pricing-of-107-bln-debt-offering-2017-2,positive,0.8871788382530212
343,2/25/2017 2:26:15 AM,Pfizer subpoenaed in U.S. over patient assistance plans,Reuters,http://www.businessinsider.com/r-pfizer-subpoenaed-in-us-over-patient-assistance-plans-2017-2,neutral,0.8543045520782471
344,2/25/2017 9:22:15 AM,"UPDATE 1-Pfizer subpoenaed in U.S. over patient assistance plans (PFE, VRX, REGN)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-subpoenaed-in-us-over-patient-assistance-plans-2017-2,positive,0.5027251243591309
345,2/28/2017 1:00:00 PM,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review,PR Newswire,/news/stocks/fda-accepts-the-biologics-license-application-for-avelumab-for-the-treatment-of-metastatic-urothelial-carcinoma-for-priority-review-1001789583,negative,0.5895025134086609
346,2/28/2017 1:00:00 PM,FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review,PR Newswire,/news/stocks/fda-accepts-the-biologics-license-application-for-avelumab-for-the-treatment-of-metastatic-urothelial-carcinoma-for-priority-review-1001789555,negative,0.5895025134086609
347,2/28/2017 1:17:24 PM,"Merck, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts ",RTTNews,/news/stocks/merck-pfizer-fda-accepts-for-priority-review-bla-for-avelumab-quick-facts-1001789654,negative,0.5446059703826904
348,2/28/2017 1:52:13 PM,"Merck KGaA, Pfizer get priority review for bladder cancer drug",Reuters,http://www.businessinsider.com/r-merck-kgaa-pfizer-get-priority-review-for-bladder-cancer-drug-2017-2,positive,0.7743759155273438
349,3/1/2017 8:54:20 PM,Rare re-argument ordered in insider trading appeal of SAC's Martoma,Reuters,http://www.businessinsider.com/r-rare-re-argument-ordered-in-insider-trading-appeal-of-sacs-martoma-2017-3,positive,0.7735249400138855
350,3/1/2017 10:56:19 PM,"BRIEF-Spark Therapeutics, Pfizer say SPK-9001 granted access to priority medicines program (PFE, PFIZER)",Reuters,http://www.businessinsider.com/r-brief-spark-therapeutics-pfizer-say-spk-9001-granted-access-to-priority-medicines-program-2017-3,negative,0.8708322644233704
351,3/3/2017 2:00:22 PM,"BRIEF-Johnson & Johnson's Janssen says new results from second phase 3 study show significant efficacy of guselkumab (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnsons-janssen-says-new-results-from-second-phase-3-study-show-significant-efficacy-of-guselkumab-2017-3,negative,0.9449673891067505
352,3/3/2017 2:20:04 PM,"Corporates break new ground to cope with negative rates (KO, PFE)",Reuters,http://www.businessinsider.com/r-corporates-break-new-ground-to-cope-with-negative-rates-2017-3,negative,0.6777746081352234
353,3/6/2017 2:38:21 PM,"BRIEF-Merck and pfizer announce U.S. Fda and EMA filing acceptances (MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-merck-and-pfizer-announce-us-fda-and-ema-filing-acceptances-2017-3,positive,0.8374234437942505
354,3/6/2017 3:50:21 PM,Germany to scrap plan to lower prices of new drugs: lawmakers,Reuters,http://www.businessinsider.com/r-germany-to-scrap-plan-to-lower-prices-of-new-drugs-lawmakers-2017-3,positive,0.5136284828186035
355,3/7/2017 1:25:00 PM,"Drug Makers Stocks Under Scanner -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-pfizer-merck-abbvie-and-johnson-johnson-1001810747,neutral,0.6821770071983337
356,3/7/2017 3:26:21 PM,"Drugmaker shares slip as Trump tweets about pricing system (PFE, MRK, AMGN, GILD)",Reuters,http://www.businessinsider.com/r-drugmaker-shares-slip-as-trump-tweets-about-pricing-system-2017-3,neutral,0.9408032298088074
357,3/7/2017 4:50:21 PM,"UPDATE 1-Drugmaker shares slip as Trump tweets about pricing system (PFE, MRK, AMGN, THC, CYH, HCA, UNH, GILD)",Reuters,http://www.businessinsider.com/r-update-1-drugmaker-shares-slip-as-trump-tweets-about-pricing-system-2017-3,neutral,0.9626100063323975
358,3/7/2017 5:50:21 PM,"UPDATE 2-Trump backs House Republican healthcare plan, aims to cut drug prices (PFE, MRK, AMGN, UNH, AET, HUM, THC, CYH)",Reuters,http://www.businessinsider.com/r-update-2-trump-backs-house-republican-healthcare-plan-aims-to-cut-drug-prices-2017-3,negative,0.46880966424942017
359,3/7/2017 6:14:21 PM,"GLOBAL MARKETS-Wall Street slips, U.S. dollar firm on Fed outlook (PFE, MRK, AMGN)",Reuters,http://www.businessinsider.com/r-global-markets-wall-street-slips-us-dollar-firm-on-fed-outlook-2017-3,neutral,0.9469412565231323
360,3/7/2017 11:28:24 PM,"GLOBAL MARKETS-Stocks slip, U.S. dollar firm on Fed outlook (PFE, AMGN)",Reuters,http://www.businessinsider.com/r-global-markets-stocks-slip-us-dollar-firm-on-fed-outlook-2017-3,neutral,0.962668776512146
361,3/9/2017 8:12:22 AM,"BRIEF-Servier, Pfizer announce FDA clearance of IND application for UCART19 (PFE)",Reuters,http://www.businessinsider.com/r-brief-servier-pfizer-announce-fda-clearance-of-ind-application-for-ucart19-2017-3,negative,0.5970360040664673
362,3/9/2017 8:54:22 AM,"UPDATE 1-Development costs to keep Merck KGaA profit flat this year (MRK, PFE, MRK, THLD)",Reuters,http://www.businessinsider.com/r-update-1-development-costs-to-keep-merck-kgaa-profit-flat-this-year-2017-3,negative,0.9040769338607788
363,3/10/2017 3:31:00 PM,"Investors: Stock Option Reports for Covered Call reports for Facebook, General Electric, Marathon Oil Corporation, Pfizer Inc. and Tailored Brands Inc.",PR Newswire,/news/stocks/investors-stock-option-reports-for-covered-call-reports-for-facebook-general-electric-marathon-oil-corporation-pfizer-inc-and-tailored-brands-inc-1001824459,positive,0.9499647617340088
364,3/14/2017 10:07:57 AM,Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts ,RTTNews,/news/stocks/pfizer-launches-zavicefta-in-the-u-k-germany-quick-facts-1001832345,positive,0.8870195746421814
365,3/14/2017 3:30:24 PM,"UPDATE 1-Novartis wins U.S. approval for breast cancer drug; to compete with Pfizer's Ibrance (PFE, 4768)",Reuters,http://www.businessinsider.com/r-update-1-novartis-wins-us-approval-for-breast-cancer-drug-to-compete-with-pfizers-ibrance-2017-3,negative,0.9470409154891968
366,3/14/2017 6:34:24 PM,"UPDATE 1-Unilever CEO urges UK to provide 'level playing field' after Kraft's failed $143 bln bid - FT (ULVR, PFE, UNA)",Reuters,http://www.businessinsider.com/r-update-1-unilever-ceo-urges-uk-to-provide-level-playing-field-after-krafts-failed-143-bln-bid---ft-2017-3,negative,0.9397406578063965
367,3/15/2017 10:12:43 PM,"NY jury convicts ex-law firm partner of insider trading on Pfizer-King deal (PFE, AMP)",Reuters,http://www.businessinsider.com/r-ny-jury-convicts-ex-law-firm-partner-of-insider-trading-on-pfizer-king-deal-2017-3,positive,0.5800982117652893
368,3/15/2017 11:00:47 PM,"Ex-Oppenheimer adviser gets six months in U.S. insider trading case (PFE, RY, OPY)",Reuters,http://www.businessinsider.com/r-ex-oppenheimer-adviser-gets-six-months-in-us-insider-trading-case-2017-3,neutral,0.6047176122665405
369,3/16/2017 2:23:27 AM,Pfizer Receives China Food And Drug Administration Approval To Market Xeljanz ,RTTNews,/news/stocks/pfizer-receives-china-food-and-drug-administration-approval-to-market-xeljanz-1001840080,negative,0.8926458358764648
370,3/16/2017 3:14:45 AM,BRIEF-Pfizer announces approval by China FDA of XELJANZ (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-approval-by-china-fda-of-xeljanz-2017-3,positive,0.5611592531204224
371,3/16/2017 8:18:43 PM,BRIEF-Pfizer says CEO Ian Read total 2016 compensation was $17.3 mln (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-ceo-ian-read-total-2016-compensation-was-173-mln-2017-3,positive,0.7880669236183167
372,3/17/2017 10:04:45 PM,"Amgen discounts cholesterol drug, but payers want more (AMGN, CVS, ESRX, REGN, SAN, PFE)",Reuters,http://www.businessinsider.com/r-amgen-discounts-cholesterol-drug-but-payers-want-more-2017-3,positive,0.734501838684082
373,3/18/2017 7:00:46 AM,"UPDATE 1-Amgen discounts cholesterol drug, but payers want more (AMGN, CVS, ESRX, REGN, SAN, PFE, MDCO)",Reuters,http://www.businessinsider.com/r-update-1-amgen-discounts-cholesterol-drug-but-payers-want-more-2017-3,negative,0.8283330202102661
374,3/18/2017 3:18:46 PM,"J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study (JNJ, BAYN, PFE)",Reuters,http://www.businessinsider.com/r-jj-and-bayers-xarelto-cuts-recurrence-of-dangerous-blood-clots-in-study-2017-3,negative,0.6829161047935486
375,3/20/2017 12:24:44 PM,"UPDATE 1-Lilly's breast cancer drug combination succeeds key study (LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-lillys-breast-cancer-drug-combination-succeeds-key-study-2017-3,negative,0.7935267686843872
376,3/20/2017 2:31:00 PM,"Options Traders: Get options trade ideas for Advanced Micro Devices, Comcast, Coca-Cola, Pfizer Inc. and Snap Inc.",PR Newswire,/news/stocks/options-traders-get-options-trade-ideas-for-advanced-micro-devices-comcast-coca-cola-pfizer-inc-and-snap-inc-1001850325,positive,0.9305579662322998
377,3/23/2017 7:56:45 PM,"BRIEF-FDA approves treatment for metastatic merkel cell carcinoma (MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-fda-approves-treatment-for-metastatic-merkel-cell-carcinoma-2017-3,negative,0.6329204440116882
378,3/23/2017 8:26:45 PM,"FDA approves Pfizer, German Merck immunotherapy for skin cancer",Reuters,http://www.businessinsider.com/r-fda-approves-pfizer-german-merck-immunotherapy-for-skin-cancer-2017-3,negative,0.753939151763916
379,3/23/2017 10:30:00 PM,"FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma",PR Newswire,/news/stocks/fda-grants-approval-for-bavencio-avelumab-the-first-immunotherapy-approved-for-metastatic-merkel-cell-carcinoma-1001864037,negative,0.9307551980018616
380,3/23/2017 11:19:00 PM,"FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell Carcinoma",PR Newswire,/news/stocks/fda-grants-approval-for-bavencio-avelumab-the-first-immunotherapy-approved-for-metastatic-merkel-cell-carcinoma-1001864108,negative,0.9307551980018616
381,3/24/2017 6:11:00 AM,"FDA Approves First-ever Merkel Cell Carcinoma Drug, HTGM Riding High, FLXN Soars ",RTTNews,/news/stocks/fda-approves-first-ever-merkel-cell-carcinoma-drug-htgm-riding-high-flxn-soars-1001864425,negative,0.9137119054794312
382,3/24/2017 7:28:45 AM,"German stocks - Factors to watch on March 24 (DBK, DB1, LSE, MRK, PFE, CWI, SZG, ADL, TIM)",Reuters,http://www.businessinsider.com/r-german-stocks---factors-to-watch-on-march-24-2017-3,positive,0.9475155472755432
383,3/24/2017 11:33:55 AM,Biotech Stocks Facing FDA Decision In April ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-april-1001865270,positive,0.7716754078865051
384,3/24/2017 3:26:16 PM,Pfizer Gets Positive CHMP Opinion For TRUMENBA ,RTTNews,/news/stocks/pfizer-gets-positive-chmp-opinion-for-trumenba-1001866196,negative,0.9370237588882446
385,3/27/2017 5:03:34 AM,"XENE Loses Face As Acne Trial Flops, NBRV Awaits LEAP Data, Opdivo Scores A Nod ",RTTNews,/news/stocks/xene-loses-face-as-acne-trial-flops-nbrv-awaits-leap-data-opdivo-scores-a-nod-1001868165,positive,0.45115217566490173
386,3/27/2017 11:16:42 AM,Pfizer: XELJANZ In Combination With Methotrexate Gets EC Approval For RA ,RTTNews,/news/stocks/pfizer-xeljanz-in-combination-with-methotrexate-gets-ec-approval-for-ra-1001869058,negative,0.8263102769851685
387,3/27/2017 10:10:47 PM,Top heart doctors warn proposed NIH cuts would be catastrophic,Reuters,http://www.businessinsider.com/r-top-heart-doctors-warn-proposed-nih-cuts-would-be-catastrophic-2017-3,neutral,0.948930561542511
388,3/31/2017 11:28:48 PM,"BRIEF-Mylan provides update on Meridian Medical Technologies', expands voluntary worldwide recall of epipen auto-injector (MYL, PFE)",Reuters,http://www.businessinsider.com/r-brief-mylan-provides-update-on-meridian-medical-technologies-expands-voluntary-worldwide-recall-of-epipen-auto-injector-2017-3,positive,0.6721410751342773
389,4/1/2017 12:42:48 AM,Mylan says EpiPen manufacturing partner to expand device recall,Reuters,http://www.businessinsider.com/r-mylan-says-epipen-manufacturing-partner-to-expand-device-recall-2017-3,negative,0.8471364974975586
390,4/1/2017 1:04:53 AM,"BRIEF-U.S. FDA alerts consumers of nationwide voluntary recall of Epipen and Epipen JR (MYL, PFE)",Reuters,http://www.businessinsider.com/r-brief-us-fda-alerts-consumers-of-nationwide-voluntary-recall-of-epipen-and-epipen-jr-2017-3,neutral,0.7202934622764587
391,4/3/2017 1:10:51 PM,"RPT-The cost of cancer: new drugs show success at a steep price (BMY, MRK, ESRX, PFE, AZN)",Reuters,http://www.businessinsider.com/r-rpt-the-cost-of-cancer-new-drugs-show-success-at-a-steep-price-2017-4,negative,0.8700270056724548
392,4/3/2017 3:56:23 PM,"New cancer drugs can cost more than $250,000 a year (BMY, MRK, ESRX, PFE, AZN)",Reuters,http://www.businessinsider.com/r-the-cost-of-cancer-new-drugs-show-success-at-a-steep-price-2017-4,positive,0.9377228617668152
393,4/4/2017 3:09:08 PM,An experimental antibiotic just got one step closer to approval (PRTK),Reuters,http://www.businessinsider.com/r-parateks-antibiotic-succeeds-in-second-late-stage-study-2017-4,negative,0.8180932402610779
394,4/6/2017 2:25:00 PM,"Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies",PR Newswire,/news/stocks/global-oncology-market-gains-ground-driven-by-innovative-cancer-treatment-therapies-1001902626,negative,0.9531072974205017
395,4/10/2017 8:05:00 AM,Roche's Alecensa notches trial win against Pfizer's Xalkori (PFE),Reuters,http://www.businessinsider.com/r-roches-alecensa-notches-trial-win-against-pfizers-xalkori-2017-4,negative,0.9465951323509216
396,4/10/2017 12:10:00 PM,"Drug Makers Stocks on Investors' Radar -- Pfizer, Merck, Johnson & Johnson, and AbbVie",PR Newswire,/news/stocks/drug-makers-stocks-on-investors-radar-pfizer-merck-johnson-johnson-and-abbvie-1001909734,positive,0.9021657705307007
397,4/11/2017 12:59:01 AM,U.S. anti-border tax coalition to target lawmakers during Congressional recess,Reuters,http://www.businessinsider.com/r-us-anti-border-tax-coalition-to-target-lawmakers-during-congressional-recess-2017-4,neutral,0.6837158203125
398,4/13/2017 3:18:58 AM,"In win for Boeing and GE, Trump says he wants to revive export bank (BA, GE, CAT, IR, X, PFE)",Reuters,http://www.businessinsider.com/r-in-win-for-boeing-and-ge-trump-says-he-wants-to-revive-export-bank-2017-4,negative,0.7152381539344788
399,4/14/2017 6:05:04 PM,"U.S. FDA declines to approve Eli Lilly and Incyte arthritis drug Olumiant (LLY, INCY, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-declines-to-approve-eli-lilly-and-incyte-arthritis-drug-olumiant-2017-4,neutral,0.7621970176696777
400,4/17/2017 1:59:03 PM,"US STOCKS-Futures dip on soft U.S. data, geopolitical risks (NFLX, UAL, INCY, LLY, PFE)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-dip-on-soft-us-data-geopolitical-risks-2017-4,neutral,0.9683301448822021
401,4/17/2017 3:13:03 PM,"US STOCKS-Wall Street looks set to open slightly higher (NFLX, UAL, INCY, LLY, PFE, ALR, ABT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-looks-set-to-open-slightly-higher-2017-4,negative,0.939262330532074
402,4/18/2017 2:44:09 AM,"The makers of a lethal-injection drug have become leaders in Arkansas' death-penalty battle (PFE, MCK)",Business Insider,http://www.businessinsider.com/arkansas-executions-drugs-using-lethal-injections-2017-4,positive,0.8025131225585938
403,4/18/2017 9:24:43 AM,"HitGen, Pfizer Enter Research Collaboration & License Agreement - Quick Facts ",RTTNews,/news/stocks/hitgen-pfizer-enter-research-collaboration-license-agreement-quick-facts-1001925654,positive,0.8997968435287476
404,4/18/2017 10:01:07 AM,"BRIEF-Hitgen, Pfizer enter research collaboration and license agreement to build and screen novel DNA-encoded libraries (PFE)",Reuters,http://www.businessinsider.com/r-brief-hitgen-pfizer-enter-research-collaboration-and-license-agreement-to-build-and-screen-novel-dna-encoded-libraries-2017-4,negative,0.8594033718109131
405,4/18/2017 2:00:00 PM,5 Stocks to Watch as Canada Gets Hooked on Cannabis,PR Newswire,/news/stocks/5-stocks-to-watch-as-canada-gets-hooked-on-cannabis-1001926681,positive,0.8382822871208191
406,4/18/2017 11:39:03 PM,"BRIEF-ICU Medical receives grand jury subpoena issued by U.S. District Court (ICUI, PFE)",Reuters,http://www.businessinsider.com/r-brief-icu-medical-receives-grand-jury-subpoena-issued-by-us-district-court-2017-4,positive,0.8874180316925049
407,4/19/2017 5:35:04 PM,"Pfizer receives subpoenas in U.S. intravenous saline solution probe (PFE, ICUI)",Reuters,http://www.businessinsider.com/r-pfizer-receives-subpoenas-in-us-intravenous-saline-solution-probe-2017-4,positive,0.521357536315918
408,4/19/2017 6:21:04 PM,"UPDATE 1-Pfizer subpoenaed in U.S. intravenous saline solution probe (PFE, ICUI, BAX)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-subpoenaed-in-us-intravenous-saline-solution-probe-2017-4,negative,0.7462524771690369
409,4/20/2017 1:37:04 AM,"UPDATE 1-AbbVie cancer drug fails two late-stage trials (AZN, PFE)",Reuters,http://www.businessinsider.com/r-update-1-abbvie-cancer-drug-fails-two-late-stage-trials-2017-4,neutral,0.49751922488212585
410,4/20/2017 5:11:19 AM,Pfizer Gets US DoJ Subpoena In Intravenous Saline Investigation ,RTTNews,/news/stocks/pfizer-gets-us-doj-subpoena-in-intravenous-saline-investigation-1001932717,positive,0.5566151738166809
411,4/21/2017 8:35:05 PM,"BRIEF-EU Medicines Agency recommendations for April 2017 (BIIB, BMRN, MYL, PFE, REGN, SAN)",Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-recommendations-for-april-2017-2017-4,positive,0.9410563111305237
412,4/22/2017 2:51:04 AM,"U.S. FDA approves Samsung Bioepis' copy of J&J's Remicade -company (JNJ, AMGN, MRK, PFE, 068270)",Reuters,http://www.businessinsider.com/r-us-fda-approves-samsung-bioepis-copy-of-jjs-remicade--company-2017-4,positive,0.6302808523178101
413,4/22/2017 11:24:13 AM,"Hospira Recalls One Lot Of 25% Dextrose Injection, USP (Infant) ",RTTNews,/news/stocks/hospira-recalls-one-lot-of-25-dextrose-injection-usp-infant-1001939557,positive,0.8445308804512024
414,4/24/2017 2:35:05 AM,"EU drugmakers urge June decision on new location for watchdog (SAN, BAYN, PFE, AZN, GSK)",Reuters,http://www.businessinsider.com/r-eu-drugmakers-urge-june-decision-on-new-location-for-watchdog-2017-4,positive,0.8872725963592529
415,4/24/2017 11:40:47 AM,Pfizer Announces Positive Results Of REPROVE Study ,RTTNews,/news/stocks/pfizer-announces-positive-results-of-reprove-study-1001941249,negative,0.7036454677581787
416,4/24/2017 1:11:08 PM,"RPT-INSIGHT-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-rpt-insight-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4,positive,0.8234217166900635
417,4/24/2017 7:01:12 PM,"Lilly reports positive interim data on breast cancer combo drug (LLY, PFE)",Reuters,http://www.businessinsider.com/r-lilly-reports-positive-interim-data-on-breast-cancer-combo-drug-2017-4,negative,0.8465091586112976
418,4/24/2017 8:17:06 PM,"UPDATE 1-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-update-1-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4,positive,0.7897846698760986
419,4/25/2017 2:00:00 PM,Aquinnah Pharmaceuticals Receives $10 Million Investment from Pfizer and AbbVie to Research Breakthrough Approach to Neurodegenerative Disease,PR Newswire,/news/stocks/aquinnah-pharmaceuticals-receives-10-million-investment-from-pfizer-and-abbvie-to-research-breakthrough-approach-to-neurodegenerative-disease-1001946220,negative,0.7964536547660828
420,4/25/2017 2:41:12 PM,"BRIEF-Aquinnah receives $10 mln investment from Pfizer, Abbvie (4502, PFE)",Reuters,http://www.businessinsider.com/r-brief-aquinnah-receives-10-mln-investment-from-pfizer-abbvie-2017-4,negative,0.6554140448570251
421,4/25/2017 3:11:10 PM,"AstraZeneca moving costs rise as new HQ nears completion (AZN, PFE)",Reuters,http://www.businessinsider.com/r-astrazeneca-moving-costs-rise-as-new-hq-nears-completion-2017-4,negative,0.5970904231071472
422,4/25/2017 11:33:00 PM,"Ellington Residential Mortgage REIT Announces Release Date of First Quarter 2017 Earnings, Conference Call, and Investor Presentation",PR Newswire,/news/stocks/ellington-residential-mortgage-reit-announces-release-date-of-first-quarter-2017-earnings-conference-call-and-investor-presentation-610084,positive,0.9390541315078735
423,4/27/2017 10:01:11 AM,"UPDATE 1-Strong pharma unit drives Bayer earnings beat (BAYN, MON, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-update-1-strong-pharma-unit-drives-bayer-earnings-beat-2017-4,negative,0.9419052600860596
424,4/27/2017 3:25:06 PM,BRIEF-InSphero announces agreement with Pfizer to develop novel assays for predicting drug-induced liver injury (PFE),Reuters,http://www.businessinsider.com/r-brief-insphero-announces-agreement-with-pfizer-to-develop-novel-assays-for-predicting-drug-induced-liver-injury-2017-4,negative,0.8982737064361572
425,4/27/2017 9:41:09 PM,BRIEF-Pfizer Inc declared a 32-cent Q2 2017 dividend on co's common stock (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-inc-declared-a-32-cent-q2-2017-dividend-on-cos-common-stock-2017-4,positive,0.411173015832901
426,4/29/2017 3:10:05 AM,"U.S. FDA approves Takeda's lung cancer drug as 2nd-line treatment (4502, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-approves-takedas-lung-cancer-drug-as-2nd-line-treatment-2017-4,negative,0.6608563661575317
427,5/1/2017 10:20:05 PM,"UPDATE 2-AstraZeneca immunotherapy wins first approval in bladder cancer (AZN, BMY, MRK, MRK, PFE)",Reuters,http://www.businessinsider.com/r-update-2-astrazeneca-immunotherapy-wins-first-approval-in-bladder-cancer-2017-5,negative,0.9408506155014038
428,5/2/2017 12:51:17 PM,Pfizer Inc. Q1 Income Advances 0%,RTTNews,/news/stocks/pfizer-inc-q1-income-advances-0-1001968764,negative,0.9115357398986816
429,5/2/2017 1:15:40 PM,"Pfizer Q1 Profit Beats Estimates, Revenues Up 1% Excl. HIS; Reaffirms Guidance ",RTTNews,/news/stocks/pfizer-q1-profit-beats-estimates-revenues-up-1-excl-his-reaffirms-guidance-1001968924,negative,0.9348695874214172
430,5/2/2017 1:16:05 PM,BRIEF-Pfizer Q1 adjusted earnings per share $0.69 (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-q1-adjusted-earnings-per-share-069-2017-5,positive,0.8336121439933777
431,5/2/2017 2:23:43 PM,Prescription for growth at Pfizer? Analysts say deals,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/5KvBUSt0CHk/us-pfizer-results-idUSKBN17Y14L,positive,0.532429039478302
432,5/2/2017 2:50:02 PM,"US STOCKS-Wall St set to open flat; Fed meet, Apple report awaited (AAPL, PFE, MA, COH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-fed-meet-apple-report-awaited-2017-5,positive,0.8791653513908386
433,5/2/2017 3:31:00 PM,"Investors: Covered Call reports for Exelixis, Facebook, Priceline, Pfizer Inc. and AT&T include trade ideas that offer returns of 18% or more!",PR Newswire,/news/stocks/investors-covered-call-reports-for-exelixis-facebook-priceline-pfizer-inc-and-at-t-include-trade-ideas-that-offer-returns-of-18-or-more-1001634796,positive,0.9033840894699097
434,5/2/2017 5:00:03 PM,"US STOCKS-Wall St flat as Fed meet kicks off; Nasdaq hits record (AAPL, PFE, MA, COH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-fed-meet-kicks-off-nasdaq-hits-record-2017-5,negative,0.7071802616119385
435,5/2/2017 6:00:07 PM,"US STOCKS-Wall St flat as Apple-led tech gains offset weak consumer stocks (F, GM, CVS, ADM, PFE, AAPL, COH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-apple-led-tech-gains-offset-weak-consumer-stocks-2017-5,neutral,0.9061718583106995
436,5/2/2017 6:00:07 PM,"GLOBAL MARKETS-Earnings, data lift European shares, U.S. stocks flat (BP., PFE)",Reuters,http://www.businessinsider.com/r-global-markets-earnings-data-lift-european-shares-us-stocks-flat-2017-5,neutral,0.5622755289077759
437,5/2/2017 7:56:03 PM,"US STOCKS-Wall St modestly higher as Apple leads tech stocks' gains (F, GM, AAPL, CVS, ADM, PFE, COH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-modestly-higher-as-apple-leads-tech-stocks-gains-2017-5,negative,0.9347633123397827
438,5/2/2017 10:10:03 PM,"GLOBAL MARKETS-Europe leads stocks higher, oil tumbles (AAPL, PFE, BP.)",Reuters,http://www.businessinsider.com/r-global-markets-europe-leads-stocks-higher-oil-tumbles-2017-5,neutral,0.7777556777000427
439,5/3/2017 3:36:03 PM,BRIEF-Pfizer announces U.S. FDA filing acceptance of supplemental new drug application for Xeljanz (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-us-fda-filing-acceptance-of-supplemental-new-drug-application-for-xeljanz-2017-5,negative,0.658620297908783
440,5/4/2017 12:48:05 AM,BRIEF-Phase 3 Octave studies of oral tofacitinib in ulcerative colitis results published in the New England journal of medicine (PFE),Reuters,http://www.businessinsider.com/r-brief-phase-3-octave-studies-of-oral-tofacitinib-in-ulcerative-colitis-results-published-in-the-new-england-journal-of-medicine-2017-5,positive,0.7727803587913513
441,5/4/2017 9:43:10 AM,"BPMX Craters, KPTI Surges On Deal With Anivive, PFE Seeks New Use For Old Drug ",RTTNews,/news/stocks/bpmx-craters-kpti-surges-on-deal-with-anivive-pfe-seeks-new-use-for-old-drug-1001978170,negative,0.9309947490692139
442,5/5/2017 1:44:05 AM,"PRESS DIGEST- British Business - May 5 (GLE, PFE, AKZA, PPG, SPD)",Reuters,http://www.businessinsider.com/r-press-digest--british-business---may-5-2017-5,positive,0.9390257596969604
443,5/5/2017 10:08:05 PM,UPDATE 2-U.S. chief justice taps New York judge to handle Puerto Rico bankruptcy (PFE),Reuters,http://www.businessinsider.com/r-update-2-us-chief-justice-taps-new-york-judge-to-handle-puerto-rico-bankruptcy-2017-5,positive,0.9313586950302124
444,5/8/2017 7:54:09 PM,"BRIEF-Pfizer says multi-year extension of collaboration with Bill & Melinda Gates Foundation, Children's Investment Fund Foundation (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-multi-year-extension-of-collaboration-with-bill--melinda-gates-foundation-childrens-investment-fund-foundation-2017-5,negative,0.8610126972198486
445,5/9/2017 6:50:07 PM,"BRIEF-U.S. FDA grants accelerated approval to Avelumab for Urothelial Carcinoma (MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-us-fda-grants-accelerated-approval-to-avelumab-for-urothelial-carcinoma-2017-5,negative,0.9374656081199646
446,5/9/2017 7:26:03 PM,"Pfizer immuno-oncology drug wins U.S. approval for bladder cancer (PFE, MRK)",Reuters,http://www.businessinsider.com/r-pfizer-immuno-oncology-drug-wins-us-approval-for-bladder-cancer-2017-5,negative,0.9039027690887451
447,5/9/2017 9:53:00 PM,FDA Grants BAVENCIO® (avelumab) Approval for a Common Type of Advanced Bladder Cancer,PR Newswire,/news/stocks/fda-grants-bavencio-avelumab-approval-for-a-common-type-of-advanced-bladder-cancer-1001995936,negative,0.9355164170265198
448,5/9/2017 11:03:00 PM,FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer,PR Newswire,/news/stocks/fda-grants-bavencio-r-avelumab-approval-for-a-common-type-of-advanced-bladder-cancer-1001996254,negative,0.9373999238014221
449,5/9/2017 11:20:09 PM,"UPDATE 1-Pfizer immuno-oncology drug wins U.S. approval for bladder cancer (PFE, MRK, AZN)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-immuno-oncology-drug-wins-us-approval-for-bladder-cancer-2017-5,negative,0.9371616244316101
450,5/10/2017 6:10:02 PM,"UPDATE 1-Sanofi says has no ""absolute need"" to do acquisitions (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-says-has-no-absolute-need-to-do-acquisitions-2017-5,positive,0.910224974155426
451,5/10/2017 10:01:00 PM,Sangamo Therapeutics And Pfizer Announce Collaboration For Hemophilia A Gene Therapy,PR Newswire,/news/stocks/sangamo-therapeutics-and-pfizer-announce-collaboration-for-hemophilia-a-gene-therapy-1002000898,negative,0.7755405306816101
452,5/10/2017 10:26:05 PM,"BRIEF-Sangamo Therapeutics and Pfizer announce collaboration for Hemophilia A gene therapy (PFE, SGMO)",Reuters,http://www.businessinsider.com/r-brief-sangamo-therapeutics-and-pfizer-announce-collaboration-for-hemophilia-a-gene-therapy-2017-5,negative,0.8037279844284058
453,5/11/2017 3:31:00 PM,"Covered Call reports for Apple, Coty Inc., NVIDIA, Pfizer Inc. and Yelp include trade ideas that offer returns of 21% or more!",PR Newswire,/news/stocks/covered-call-reports-for-apple-coty-inc-nvidia-pfizer-inc-and-yelp-include-trade-ideas-that-offer-returns-of-21-or-more-1002004626,positive,0.8408563137054443
454,5/11/2017 10:50:03 PM,"BRIEF-Pfizer says in connection with Hospira acquisition, expects to incur costs of about $1 bln for up to 3-yr period post-acquisition (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-in-connection-with-hospira-acquisition-expects-to-incur-costs-of-about-1-bln-for-up-to-3-yr-period-post-acquisition-2017-5,neutral,0.8384641408920288
455,5/15/2017 12:26:05 PM,"U.S. companies push hard for lower tax rate on offshore profits (AAPL, MSFT, PFE, GE, JNJ, MRK, XOM, IBM, CSCO)",Reuters,http://www.businessinsider.com/r-us-companies-push-hard-for-lower-tax-rate-on-offshore-profits-2017-5,negative,0.5808895230293274
456,5/15/2017 11:38:02 PM,"BRIEF-Soros Fund Management more than triples share stake in Microsoft, takes share stake in Snap, Alibaba (AMZN, CVX, MSFT, GS, DIS, PFE, WMT)",Reuters,http://www.businessinsider.com/r-brief-soros-fund-management-more-than-triples-share-stake-in-microsoft-takes-share-stake-in-snap-alibaba-2017-5,positive,0.8850249648094177
457,5/16/2017 1:40:14 PM,Sangamo Gets Fast Track Designation For SB-525 Hemophilia A Gene Therapy ,RTTNews,/news/stocks/sangamo-gets-fast-track-designation-for-sb-525-hemophilia-a-gene-therapy-1002016601,negative,0.8080777525901794
458,5/16/2017 2:08:04 PM,"BRIEF-Sangamo receives fast track designation from FDA for SB-525 (PFE, SGMO)",Reuters,http://www.businessinsider.com/r-brief-sangamo-receives-fast-track-designation-from-fda-for-sb-525-2017-5,negative,0.9208735227584839
459,5/16/2017 2:56:03 PM,"UPDATE 1-Merck KGaA considers making divisions legally separate subsidiaries (MRK, PFE)",Reuters,http://www.businessinsider.com/r-update-1-merck-kgaa-considers-making-divisions-legally-separate-subsidiaries-2017-5,positive,0.9510486125946045
460,5/16/2017 3:20:07 PM,"US STOCKS-Wall St on track to open at record highs (HD, PFE, DKS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-on-track-to-open-at-record-highs-2017-5,negative,0.7907156348228455
461,5/16/2017 4:30:08 PM,"US STOCKS-S&P, Nasdaq hit record highs on gains in tech, consumer staples (HD, PFE, DKS)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-nasdaq-hit-record-highs-on-gains-in-tech-consumer-staples-2017-5,negative,0.9359478950500488
462,5/16/2017 6:36:03 PM,"US STOCKS-Wall St retreats after S&P, Nasdaq hit record highs (HD, PFE, SPLS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-retreats-after-sp-nasdaq-hit-record-highs-2017-5,neutral,0.9440016150474548
463,5/16/2017 7:57:55 PM,Pfizer Posting Notable Loss After Downgrade By Citi ,RTTNews,/news/stocks/pfizer-posting-notable-loss-after-downgrade-by-citi-1002018392,neutral,0.9683840274810791
464,5/16/2017 8:06:03 PM,"US STOCKS-Wall St flat after S&P, Nasdaq hit record highs (HD, LOW, MSFT, PFE, SPLS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-after-sp-nasdaq-hit-record-highs-2017-5,neutral,0.8311383724212646
465,5/16/2017 10:02:07 PM,"US STOCKS-S&P 500 falls on mixed data, Nasdaq helped by tech stocks (HD, TJX, MSFT, PFE, SPLS)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-500-falls-on-mixed-data-nasdaq-helped-by-tech-stocks-2017-5,neutral,0.9158666729927063
466,5/16/2017 10:46:04 PM,"US STOCKS-S&P 500, Dow end session flat, tech boosts Nasdaq (HD, TJX, MSFT, UNH, PFE)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-500-dow-end-session-flat-tech-boosts-nasdaq-2017-5,negative,0.7312626838684082
467,5/17/2017 11:12:03 PM,"Merck says test shows Keytruda improves survival for bladder cancer patients (MRK, AZN, BMY, PFE)",Reuters,http://www.businessinsider.com/r-merck-says-test-shows-keytruda-improves-survival-for-bladder-cancer-patients-2017-5,negative,0.9524326920509338
468,5/17/2017 11:16:05 PM,Eating tree nuts may cut risk that colon cancer will return -study (PFE),Reuters,http://www.businessinsider.com/r-eating-tree-nuts-may-cut-risk-that-colon-cancer-will-return--study-2017-5,positive,0.8658561110496521
469,5/17/2017 11:16:05 PM,Pfizer drug from Medivation deal shows promise in breast cancer -study (PFE),Reuters,http://www.businessinsider.com/r-pfizer-drug-from-medivation-deal-shows-promise-in-breast-cancer--study-2017-5,negative,0.9023224115371704
470,5/18/2017 1:56:03 AM,"UPDATE 1-Merck says test shows Keytruda improves survival for bladder cancer patients (MRK, AZN, BMY, PFE, MRK)",Reuters,http://www.businessinsider.com/r-update-1-merck-says-test-shows-keytruda-improves-survival-for-bladder-cancer-patients-2017-5,negative,0.9497457146644592
471,5/19/2017 2:30:05 AM,"For millions of Chinese with rare diseases, some relief in sight (CELG, BMY, JNJ, SHP, SAN, PFE, MRK, SAPL, ALXN)",Reuters,http://www.businessinsider.com/r-for-millions-of-chinese-with-rare-diseases-some-relief-in-sight-2017-5,negative,0.8676335215568542
472,5/19/2017 8:28:22 AM,Company Spotlight: GlycoMimetics ,RTTNews,/news/stocks/company-spotlight-glycomimetics-1002027772,positive,0.9447610378265381
473,5/19/2017 3:06:02 PM,CHMP backs Novartis's Zykadia for first-line use in lung cancer (PFE),Reuters,http://www.businessinsider.com/r-chmp-backs-novartiss-zykadia-for-first-line-use-in-lung-cancer-2017-5,negative,0.6740216016769409
474,5/19/2017 5:56:02 PM,Wife of Soundgarden's Cornell calls suicide 'inexplicable' (PFE),Reuters,http://www.businessinsider.com/r-wife-of-soundgardens-cornell-calls-suicide-inexplicable-2017-5,neutral,0.5581300258636475
475,5/19/2017 7:50:05 PM,"UPDATE 1-Wife of Soundgarden's Cornell calls suicide 'inexplicable' (PFE, VRX)",Reuters,http://www.businessinsider.com/r-update-1-wife-of-soundgardens-cornell-calls-suicide-inexplicable-2017-5,neutral,0.5001704096794128
476,5/22/2017 9:18:07 PM,"Severe asthma drug shows AstraZeneca promise beyond cancer (AZN, GSK, TEVA, PFE, SAN, REGN)",Reuters,http://www.businessinsider.com/r-severe-asthma-drug-shows-astrazeneca-promise-beyond-cancer-2017-5,negative,0.6530019044876099
477,5/23/2017 12:52:02 PM,"UPDATE 1-UK competition watchdog accuses Merck of obstructing biosimilars (MRK, 068270, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-uk-competition-watchdog-accuses-merck-of-obstructing-biosimilars-2017-5,neutral,0.9463047981262207
478,5/24/2017 1:19:06 PM,Pfizer Recommends Stockholders To Reject TRC Capital's Mini-tender Offer ,RTTNews,/news/stocks/pfizer-recommends-stockholders-to-reject-trc-capital-s-mini-tender-offer-1002039521,positive,0.598088800907135
479,5/25/2017 8:46:03 PM,BRIEF-FDA committee recommends approval of Pfizer's epoetin alfa biosimilar (PFE),Reuters,http://www.businessinsider.com/r-brief-fda-committee-recommends-approval-of-pfizers-epoetin-alfa-biosimilar-2017-5,positive,0.7651411294937134
480,5/26/2017 3:49:26 AM,FDA Panel Recommends Approval Of Epoetin Alfa Biosimilar Across All Indications ,RTTNews,/news/stocks/fda-panel-recommends-approval-of-epoetin-alfa-biosimilar-across-all-indications-1002043839,negative,0.5918751358985901
481,5/30/2017 4:29:39 PM,Pfizer: EC Oks TRUMENBA For Prevention Of Invasive Meningococcal Disease ,RTTNews,/news/stocks/pfizer-ec-oks-trumenba-for-prevention-of-invasive-meningococcal-disease-1002051167,positive,0.7447289824485779
482,5/30/2017 4:58:03 PM,BRIEF-EU approves Pfizer’s Trumenba to help prevent meningococcal group B disease in adolescents and adults (PFE),Reuters,http://www.businessinsider.com/r-brief-eu-approves-pfizers-trumenba-to-help-prevent-meningococcal-group-b-disease-in-adolescents-and-adults-2017-5,negative,0.878248929977417
483,5/30/2017 7:26:03 PM,"U.S. top court restricts patent owners' right to block resale of goods (002180, PFE, LLY, INTC)",Reuters,http://www.businessinsider.com/r-us-top-court-restricts-patent-owners-right-to-block-resale-of-goods-2017-5,positive,0.7187386155128479
484,5/30/2017 8:46:04 PM,"UPDATE 1-U.S. top court restricts patent owners' right to block resale of goods (002180, PFE, LLY, INTC)",Reuters,http://www.businessinsider.com/r-update-1-us-top-court-restricts-patent-owners-right-to-block-resale-of-goods-2017-5,neutral,0.6092459559440613
485,5/31/2017 9:04:02 AM,"UPDATE 1-Novartis warns of U.S. price pressure on Sandoz generics (SUNPHARMA, LUPIN, TEVA, PFE, MNTA)",Reuters,http://www.businessinsider.com/r-update-1-novartis-warns-of-us-price-pressure-on-sandoz-generics-2017-5,neutral,0.9601219892501831
486,5/31/2017 2:42:06 PM,BRIEF-Pfizer announces acceptance of regulatory submissions by U.S. FDA and European Medicines Agency for Sutent (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-acceptance-of-regulatory-submissions-by-us-fda-and-european-medicines-agency-for-sutent-2017-5,negative,0.7332359552383423
487,6/2/2017 8:17:28 AM,GSK Reports EU & US Submissions For First HIV Maintenance Regimen - Quick Facts ,RTTNews,/news/stocks/gsk-reports-eu-us-submissions-for-first-hiv-maintenance-regimen-quick-facts-1002062014,positive,0.9006266593933105
488,6/2/2017 3:04:03 PM,BRIEF-Pfizer defeats appeal over Zoloft (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-defeats-appeal-over-zoloft-2017-6,positive,0.6174628138542175
489,6/2/2017 3:12:03 PM,Pfizer defeats appeals over Zoloft birth defects (PFE),Reuters,http://www.businessinsider.com/r-pfizer-defeats-appeals-over-zoloft-birth-defects-2017-6,neutral,0.5085382461547852
490,6/2/2017 3:52:05 PM,UPDATE 1-Pfizer defeats appeals over Zoloft birth defects (PFE),Reuters,http://www.businessinsider.com/r-update-1-pfizer-defeats-appeals-over-zoloft-birth-defects-2017-6,negative,0.7495721578598022
491,6/2/2017 8:48:03 PM,"BRIEF-Pfizer says for co’s U.S. biopharma business as of the first quarter, the weighted average net selling price increase YTD is 4 pct in the U.S. (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-for-cos-us-biopharma-business-as-of-the-first-quarter-the-weighted-average-net-selling-price-increase-ytd-is-4-pct-in-the-us-2017-6,positive,0.8767654895782471
492,6/2/2017 8:48:03 PM,"Pfizer hikes U.S. prices of 91 drugs by average 20 pct in 2017-FT (MYL, SAN, AGN, NOVO , PFE)",Reuters,http://www.businessinsider.com/r-pfizer-hikes-us-prices-of-91-drugs-by-average-20-pct-in-2017-ft-2017-6,negative,0.7303223013877869
493,6/5/2017 8:42:55 AM,"AMGN Finds New Use For Old Drug, NLNK Disappointed, ECYT Cuts Workforce ",RTTNews,/news/stocks/amgn-finds-new-use-for-old-drug-nlnk-disappointed-ecyt-cuts-workforce-1002066348,negative,0.8280990123748779
494,6/5/2017 1:36:05 PM,"Pfizer drug delays lung cancer growth longer than Astra's Iressa-study (PFE, AZN)",Reuters,http://www.businessinsider.com/r-pfizer-drug-delays-lung-cancer-growth-longer-than-astras-iressa-study-2017-6,positive,0.8249943256378174
495,6/5/2017 1:36:05 PM,Roche's Alecensa bests Pfizer's Xalkori in lung cancer trial (PFE),Reuters,http://www.businessinsider.com/r-roches-alecensa-bests-pfizers-xalkori-in-lung-cancer-trial-2017-6,negative,0.7428053617477417
496,6/6/2017 2:08:39 PM,Pfizer Gets FDA Fast Track Designation For Tafamidis For TTR-CM ,RTTNews,/news/stocks/pfizer-gets-fda-fast-track-designation-for-tafamidis-for-ttr-cm-1002070364,negative,0.8137216567993164
497,6/6/2017 2:18:06 PM,BRIEF-Pfizer receives FDA fast track designation for Tafamidis for transthyretin cardiomyopathy (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-receives-fda-fast-track-designation-for-tafamidis-for-transthyretin-cardiomyopathy-2017-6,negative,0.9199873805046082
498,6/7/2017 1:30:00 PM,Sangamo Therapeutics And Pfizer Announce That SB-525 Investigational Hemophilia A Gene Therapy Receives Orphan Medicinal Product Designation From The European Medicines Agency,PR Newswire,/news/stocks/sangamo-therapeutics-and-pfizer-announce-that-sb-525-investigational-hemophilia-a-gene-therapy-receives-orphan-medicinal-product-designation-from-the-european-medicines-agency-1002073895,negative,0.8687581419944763
499,6/7/2017 1:43:40 PM,Sangamo: SB-525 Therapy Receives Orphan Medicinal Product Designation From EMA ,RTTNews,/news/stocks/sangamo-sb-525-therapy-receives-orphan-medicinal-product-designation-from-ema-1002073951,negative,0.6386502385139465
500,6/7/2017 1:52:03 PM,"BRIEF-Sangamo Therapeutics updates on SB-525 investigational hemophilia A gene therapy (PFE, SGMO)",Reuters,http://www.businessinsider.com/r-brief-sangamo-therapeutics-updates-on-sb-525-investigational-hemophilia-a-gene-therapy-2017-6,positive,0.8741884231567383
501,6/7/2017 2:52:06 PM,"UPDATE 1-AbbVie's rheumatoid arthritis drug succeeds in late-stage trial (AMGN, PFE, LLY, INCY)",Reuters,http://www.businessinsider.com/r-update-1-abbvies-rheumatoid-arthritis-drug-succeeds-in-late-stage-trial-2017-6,negative,0.9333683848381042
502,6/9/2017 2:22:03 PM,"BRIEF-Astellas, Pfizer announce amendment to clinical research protocol for phase 3 prosper trial of enzalutamide (PFE, 4503)",Reuters,http://www.businessinsider.com/r-brief-astellas-pfizer-announce-amendment-to-clinical-research-protocol-for-phase-3-prosper-trial-of-enzalutamide-2017-6,positive,0.630054235458374
503,6/12/2017 3:22:27 AM,"LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite ",RTTNews,/news/stocks/lxrx-brings-sweet-tidings-pfe-s-prosper-ahead-of-schedule-xbit-fails-to-excite-1002083938,negative,0.9300626516342163
504,6/12/2017 5:24:03 PM,"Merck KGaA: 2 bln eur pipeline potential driven by cancer, MS drugs (MRK, PFE)",Reuters,http://www.businessinsider.com/r-merck-kgaa-2-bln-eur-pipeline-potential-driven-by-cancer-ms-drugs-2017-6,positive,0.5686937570571899
505,6/13/2017 2:06:05 PM,"Pfzer, Roche and Aspen face South Africa probe over cancer drug prices (APN, PFE)",Reuters,http://www.businessinsider.com/r-pfzer-roche-and-aspen-face-south-africa-probe-over-cancer-drug-prices-2017-6,positive,0.7233272194862366
506,6/13/2017 2:06:14 PM,Pfizer And Lilly Gets FDA Fast Track Designation For Tanezumab ,RTTNews,/news/stocks/pfizer-and-lilly-gets-fda-fast-track-designation-for-tanezumab-1002088746,negative,0.7688349485397339
507,6/13/2017 2:34:06 PM,"BRIEF-Pfizer and Lilly receive FDA fast track designation for Tanezumab (PFE, LLY)",Reuters,http://www.businessinsider.com/r-brief-pfizer-and-lilly-receive-fda-fast-track-designation-for-tanezumab-2017-6,negative,0.8465412259101868
508,6/13/2017 2:42:04 PM,"UPDATE 1-Pfizer, Roche and Aspen face South Africa probe over cancer drug prices (APN, PFE)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-roche-and-aspen-face-south-africa-probe-over-cancer-drug-prices-2017-6,neutral,0.549895703792572
509,6/13/2017 3:12:03 PM,"BRIEF-Aspen Pharmacare responds to South African Competition Commission investigation announcement (APN, PFE)",Reuters,http://www.businessinsider.com/r-brief-aspen-pharmacare-responds-to-south-african-competition-commission-investigation-announcement-2017-6,positive,0.8366848230361938
510,6/14/2017 1:04:05 AM,Centrexion's chili-based painkiller offers relief for 6 months - study (PFE),Reuters,http://www.businessinsider.com/r-centrexions-chili-based-painkiller-offers-relief-for-6-months---study-2017-6,negative,0.8603394031524658
511,6/14/2017 12:02:06 PM,"BRIEF-Aspen Pharmacare says not yet had any engagement with commission on matters raised (APN, PFE)",Reuters,http://www.businessinsider.com/r-brief-aspen-pharmacare-says-not-yet-had-any-engagement-with-commission-on-matters-raised-2017-6,positive,0.9413644671440125
512,6/14/2017 2:45:00 PM,Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments,PR Newswire,/news/stocks/patented-biotechnology-formulations-resulting-in-new-generation-of-animal-healthcare-medications-and-treatments-1002092780,positive,0.5165343284606934
513,6/14/2017 2:45:00 PM,Patented Biotechnology Formulations Resulting in New Generation of Animal Healthcare Medications and Treatments,PR Newswire,/news/stocks/patented-biotechnology-formulations-resulting-in-new-generation-of-animal-healthcare-medications-and-treatments-1002092769,positive,0.5165343284606934
514,6/14/2017 4:02:05 PM,"Pfizer denies over-charging for cancer drugs in South Africa (PFE, APN)",Reuters,http://www.businessinsider.com/r-pfizer-denies-over-charging-for-cancer-drugs-in-south-africa-2017-6,positive,0.9068957567214966
515,6/14/2017 7:32:03 PM,"BRIEF-Pfizer to have exclusive rights to distribute, commercialize CRESEMBA in Europe (PFE, BSLN)",Reuters,http://www.businessinsider.com/r-brief-pfizer-to-have-exclusive-rights-to-distribute-commercialize-cresemba-in-europe-2017-6,positive,0.8166164755821228
516,6/14/2017 7:38:05 PM,"BRIEF-Basilea announces license agreement with Pfizer for antifungal Cresemba (BSLN, PFE)",Reuters,http://www.businessinsider.com/r-brief-basilea-announces-license-agreement-with-pfizer-for-antifungal-cresemba-2017-6,negative,0.9146588444709778
517,6/15/2017 7:14:03 AM,"Swiss stocks - Factors to watch on June 15 (BSLN, PFE, LOHN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-june-15-2017-6,positive,0.9282171130180359
518,6/15/2017 8:26:54 AM,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar ",RTTNews,/news/stocks/aldx-down-but-not-out-btx-on-track-mnk-exploring-new-use-for-acthar-1002095026,negative,0.5386812090873718
519,6/16/2017 12:38:05 AM,BRIEF-U.S. FDA updates on Pfizer drug shortages (PFE),Reuters,http://www.businessinsider.com/r-brief-us-fda-updates-on-pfizer-drug-shortages-2017-6,positive,0.9037236571311951
520,6/16/2017 11:22:08 AM,Pfizer Reports Overall Efficacy In Xeljanz Oral Safety Study ,RTTNews,/news/stocks/pfizer-reports-overall-efficacy-in-xeljanz-oral-safety-study-1002098896,negative,0.9423370361328125
521,6/19/2017 2:30:08 PM,BRIEF-Pfizer begins Phase 1 clinical trial to evaluate investigational Group B streptococcus vaccine (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-begins-phase-1-clinical-trial-to-evaluate-investigational-group-b-streptococcus-vaccine-2017-6,negative,0.8017926216125488
522,6/20/2017 2:58:03 PM,"BRIEF-Effector Therapeutics to collaborate with Pfizer and Merck to evaluate immuno-oncology combination in microsatellite stable colorectal cancer (MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-effector-therapeutics-to-collaborate-with-pfizer-and-merck-to-evaluate-immuno-oncology-combination-in-microsatellite-stable-colorectal-cancer-2017-6,negative,0.6597025394439697
523,6/20/2017 3:58:08 PM,"Worldwide drug sale forecasts fall as pricing pressures mount (AMGN, SAN, PFE)",Reuters,http://www.businessinsider.com/r-worldwide-drug-sale-forecasts-fall-as-pricing-pressures-mount-2017-6,neutral,0.9653651714324951
524,6/21/2017 2:18:06 PM,"BRIEF-Pfizer receives Health Canada approval for Ibrance in hr+, her2- metastatic breast cancer (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-receives-health-canada-approval-for-ibrance-in-hr-her2--metastatic-breast-cancer-2017-6,negative,0.9350821375846863
525,6/21/2017 4:00:00 PM,S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017,PR Newswire,/news/stocks/s-p-500-buybacks-fall-17-5-year-over-year-to-133-1-billion-for-q1-2017-1002112472,neutral,0.9629760980606079
526,6/22/2017 10:22:08 PM,BRIEF-Pfizer sets quarterly dividend of $0.32 per share (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-sets-quarterly-dividend-of-032-per-share-2017-6,positive,0.886601984500885
527,6/23/2017 12:02:03 PM,Novartis breast cancer drug Kisqali wins European panel nod (PFE),Reuters,http://www.businessinsider.com/r-novartis-breast-cancer-drug-kisqali-wins-european-panel-nod-2017-6,negative,0.8981994390487671
528,6/23/2017 12:02:03 PM,UPDATE 1-Novartis breast cancer drug Kisqali wins European panel backing (PFE),Reuters,http://www.businessinsider.com/r-update-1-novartis-breast-cancer-drug-kisqali-wins-european-panel-backing-2017-6,negative,0.9476624727249146
529,6/23/2017 4:32:05 PM,"High hopes ride on marijuana painkillers amid opioid crisis (ENDP, PFE, BIIB)",Reuters,http://www.businessinsider.com/r-high-hopes-ride-on-marijuana-painkillers-amid-opioid-crisis-2017-6,positive,0.7061561346054077
530,6/23/2017 10:34:06 PM,BRIEF-FDA says fagron sterile services issues voluntary nationwide recall of succinylcholine chloride (PFE),Reuters,http://www.businessinsider.com/r-brief-fda-says-fagron-sterile-services-issues-voluntary-nationwide-recall-of-succinylcholine-chloride-2017-6,neutral,0.7749360799789429
531,6/26/2017 12:10:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-pfizer-merck-abbvie-and-johnson-johnson-1002123019,positive,0.9454298615455627
532,6/27/2017 3:22:09 PM,"BRIEF-Pfizer expects to hire an additional 80 employees over coming years to support research at new research and development facility in Chesterfield, Missouri (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-expects-to-hire-an-additional-80-employees-over-coming-years-to-support-research-at-new-research-and-development-facility-in-chesterfield-missouri-2017-6,negative,0.7849676609039307
533,6/29/2017 6:48:24 AM,Biotech Stocks Facing FDA Decision In July ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-july-1002133192,positive,0.7290647029876709
534,6/29/2017 2:30:00 PM,Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene...,PR Newswire,/news/stocks/alcyone-lifesciences-enters-into-a-feasibility-study-agreement-with-pfizer-to-evaluate-alcyone-s-proprietary-pulsar-advanced-intrathecal-precision-delivery-platform-technology-for-use-in-gene-1002134976,negative,0.8951510190963745
535,6/30/2017 1:44:29 PM,Pfizer Reports European Commission's Approval Of BESPONSA - Quick Facts ,RTTNews,/news/stocks/pfizer-reports-european-commission-s-approval-of-besponsa-quick-facts-1002138472,negative,0.5386315584182739
536,7/3/2017 8:24:06 AM,"RPT-Big pharma turns to AI to speed drug discovery, GSK signs deal (GSK, MRK, JNJ, SAN, PFE)",Reuters,http://www.businessinsider.com/r-rpt-big-pharma-turns-to-ai-to-speed-drug-discovery-gsk-signs-deal-2017-7,negative,0.6345846056938171
537,7/4/2017 7:48:08 PM,"Pfizer receives token payment to exit Brazil venture, sources say (PFE, SAN, GS, MYL, TEVA)",Reuters,http://www.businessinsider.com/r-pfizer-receives-token-payment-to-exit-brazil-venture-sources-say-2017-7,positive,0.8711653351783752
538,7/4/2017 7:51:50 PM,"Pfizer receives token payment to exit Brazil venture, sources say",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/RHLLktL4XJc/us-pfizer-divestiture-brazil-idUSKBN19P293,positive,0.8695275783538818
539,7/5/2017 1:08:04 PM,"Deals of the day-Mergers and acquisitions (HLDX, JBSS3, BEEF3, HUN, BAM., RNEW11, 6502, SAZ, ETE, JPM, 5019, 5002, 700, 005490, SQM-, RNO, OCDO, AMZN, WFM, LHA, FRA, ML, PFE)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-7,positive,0.9519972801208496
540,7/10/2017 10:46:11 PM,"Here’s how much the 10 largest pharmaceutical companies spend on R&D (PFE, AMGN, NVS, ROG, MRK, SNY, JNJ, GILD, GSK, ABBV)",Business Insider,http://www.businessinsider.com/largest-pharmaceutical-companies-by-prescription-sales-and-rd-2017-7,positive,0.9493331909179688
541,7/11/2017 7:34:05 AM,"Sanofi to buy vaccines biotech group Protein Sciences (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-sanofi-to-buy-vaccines-biotech-group-protein-sciences-2017-7,positive,0.9205771088600159
542,7/12/2017 7:48:43 AM,"ORMP To Meet With FDA, Second Time's No Charm For OCUL, Panel Backs PFE ",RTTNews,/news/stocks/ormp-to-meet-with-fda-second-time-s-no-charm-for-ocul-panel-backs-pfe-1002165576,positive,0.6959782242774963
543,7/13/2017 2:11:58 PM,Pfizer: FDA Accepts SNDA For Xeljanz For Treatment Of Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-fda-accepts-snda-for-xeljanz-for-treatment-of-ulcerative-colitis-1002170892,negative,0.9208763241767883
544,7/13/2017 2:28:05 PM,BRIEF-Pfizer says FDA accepted supplemental NDA for ulcerative colitis treatment (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-fda-accepted-supplemental-nda-for-ulcerative-colitis-treatment-2017-7,negative,0.7736866474151611
545,7/13/2017 10:32:05 PM,BRIEF-Mersana Therapeutics says Pfizer reports 9.8 percent passive stake in Mersana as of July 3 - SEC Filing (PFE),Reuters,http://www.businessinsider.com/r-brief-mersana-therapeutics-says-pfizer-reports-98-percent-passive-stake-in-mersana-as-of-july-3---sec-filing-2017-7,positive,0.9500744342803955
546,7/14/2017 8:31:09 AM,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33% ",RTTNews,/news/stocks/fda-panel-backs-2-biosimilars-aldr-abuzz-mdxg-q2-revenue-grows-33-1002173475,negative,0.9505725502967834
547,7/14/2017 12:04:03 PM,"UPDATE 1-AstraZeneca's silence on CEO helps wipe out 3 billion pounds (AZN, TEVA, PFE)",Reuters,http://www.businessinsider.com/r-update-1-astrazenecas-silence-on-ceo-helps-wipe-out-3-billion-pounds-2017-7,neutral,0.6802374124526978
548,7/19/2017 1:00:06 PM,"Poor test results for Roche cloud growth prospects (MERCK, SHP, PFE, 068270, MYL, TEVA, AMGN)",Reuters,http://www.businessinsider.com/r-poor-test-results-for-roche-cloud-growth-prospects-2017-7,neutral,0.9573879241943359
549,7/20/2017 7:50:14 AM,Pfizer Obtains Exclusive Commercialization Rights In Europe To CRESEMBA ,RTTNews,/news/stocks/pfizer-obtains-exclusive-commercialization-rights-in-europe-to-cresemba-1002189356,negative,0.6072942614555359
550,7/20/2017 9:18:03 PM,"Corning vows new jobs as part of Trump's ""Made in America"" week (GLW, MRK, PFE)",Reuters,http://www.businessinsider.com/r-corning-vows-new-jobs-as-part-of-trumps-made-in-america-week-2017-7,positive,0.8559199571609497
551,7/20/2017 10:08:06 PM,"UPDATE 1-Trump unveils companies' $500 million U.S. drug packaging project (GLW, MRK, PFE)",Reuters,http://www.businessinsider.com/r-update-1-trump-unveils-companies-500-million-us-drug-packaging-project-2017-7,positive,0.5367991328239441
552,7/21/2017 1:38:03 PM,"Pfizer, Merck KGaA skin cancer drug gets EMA nod for approval (PFE, MRK)",Reuters,http://www.businessinsider.com/r-pfizer-merck-kgaa-skin-cancer-drug-gets-ema-nod-for-approval-2017-7,negative,0.5011297464370728
553,7/21/2017 1:42:05 PM,"Europe backs nuclear medicine for cancer that killed Steve Jobs (AAPL, PFE)",Reuters,http://www.businessinsider.com/r-europe-backs-nuclear-medicine-for-cancer-that-killed-steve-jobs-2017-7,positive,0.8766529560089111
554,7/21/2017 1:42:05 PM,"BRIEF-Merck KGaA and Pfizer: CHMP recommends approval of avelumab (MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-merck-kgaa-and-pfizer-chmp-recommends-approval-of-avelumab-2017-7,positive,0.49449434876441956
555,7/21/2017 6:18:05 PM,"UPDATE 1-Europe backs nuclear medicine for cancer that killed Steve Jobs (AAPL, PFE)",Reuters,http://www.businessinsider.com/r-update-1-europe-backs-nuclear-medicine-for-cancer-that-killed-steve-jobs-2017-7,positive,0.8086156845092773
556,7/24/2017 10:33:48 AM,GlaxoSmithKline: ViiV Healthcare Presents 96-week Data From LATTE-2 Study ,RTTNews,/news/stocks/glaxosmithkline-viiv-healthcare-presents-96-week-data-from-latte-2-study-1002197660,positive,0.7490217685699463
557,7/24/2017 2:02:05 PM,"Samsung Bioepis launches U.S. sales of Remicade biosmiliar (JNJ, PFE, AZN)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-launches-us-sales-of-remicade-biosmiliar-2017-7,negative,0.68516606092453
558,7/24/2017 2:42:05 PM,Pfizer Says REFLECTIONS B7391003 Study Met Primary Objective - Quick Facts ,RTTNews,/news/stocks/pfizer-says-reflections-b7391003-study-met-primary-objective-quick-facts-1002198586,positive,0.8071447014808655
559,7/24/2017 2:44:03 PM,BRIEF-Pfizer announces positive top-line results (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-positive-top-line-results-2017-7,negative,0.9385374188423157
560,7/24/2017 7:04:03 PM,"UPDATE 1-Merck, Samsung Bioepis launch discounted U.S. Remicade alternative (MRK, JNJ, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-merck-samsung-bioepis-launch-discounted-us-remicade-alternative-2017-7,negative,0.5694882273674011
561,7/25/2017 2:44:03 PM,"BRIEF-GlaxoSmithKline says ViiV announces results from NEAT 022 study (GSK, PFE)",Reuters,http://www.businessinsider.com/r-brief-glaxosmithkline-says-viiv-announces-results-from-neat-022-study-2017-7,positive,0.8930253982543945
562,7/25/2017 2:44:04 PM,"BRIEF-ViiV announces positive results from DAWNING (GSK, PFE)",Reuters,http://www.businessinsider.com/r-brief-viiv-announces-positive-results-from-dawning-2017-7,negative,0.9452589750289917
563,7/25/2017 2:50:52 PM,GSK : ViiV Healthcare Announces Results From NEAT 022 Study ,RTTNews,/news/stocks/gsk-viiv-healthcare-announces-results-from-neat-022-study-1002202104,positive,0.8801334500312805
564,7/25/2017 2:56:26 PM,ViiV Healthcare Reports Positive Interim Results From DAWNING - Quick Facts ,RTTNews,/news/stocks/viiv-healthcare-reports-positive-interim-results-from-dawning-quick-facts-1002202127,negative,0.9495297074317932
565,7/25/2017 3:03:00 PM,ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings,PR Newswire,/news/stocks/viiv-healthcare-announces-superior-efficacy-of-dolutegravir-versus-lopinavir-ritonavir-in-second-line-hiv-treatment-in-resource-limited-settings-1002202270,negative,0.9529407620429993
566,7/25/2017 3:03:00 PM,ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings,PR Newswire,/news/stocks/viiv-healthcare-announces-superior-efficacy-of-dolutegravir-versus-lopinavir-ritonavir-in-second-line-hiv-treatment-in-resource-limited-settings-1002202269,negative,0.9529407620429993
567,7/25/2017 3:34:00 PM,ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings,PR Newswire,/news/stocks/viiv-healthcare-announces-superior-efficacy-of-dolutegravir-versus-lopinavir-ritonavir-in-second-line-hiv-treatment-in-resource-limited-settings-1002202416,negative,0.9529407620429993
568,7/25/2017 11:38:05 PM,"Adviser charged with insider trading on Pfizer-King deal pleads guilty (PFE, AMP)",Reuters,http://www.businessinsider.com/r-adviser-charged-with-insider-trading-on-pfizer-king-deal-pleads-guilty-2017-7,positive,0.7271410822868347
569,7/28/2017 12:24:03 AM,"Amgen gets fast U.S. FDA review for adding heart benefits to cholesterol drug label (AMGN, PFE, REGN, SAN)",Reuters,http://www.businessinsider.com/r-amgen-gets-fast-us-fda-review-for-adding-heart-benefits-to-cholesterol-drug-label-2017-7,negative,0.8885365724563599
570,7/31/2017 7:47:51 AM,Biotech Stocks Facing FDA Decision In August ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-august-1002217371,positive,0.6419674754142761
571,7/31/2017 12:30:09 PM,ICU Medical Recalls One Lot Of 0.9% Sodium Chloride Injection ,RTTNews,/news/stocks/icu-medical-recalls-one-lot-of-0-9-sodium-chloride-injection-1002218164,positive,0.6993842720985413
572,8/1/2017 12:47:29 PM,Pfizer Inc. Reports 3% Rise In Q2 Earnings,RTTNews,/news/stocks/pfizer-inc-reports-3-rise-in-q2-earnings-1002221808,negative,0.944282591342926
573,8/1/2017 1:23:03 PM,"Pfizer Q2 Profit Tops Estimates, Revenues Miss; Lifts FY17 Earnings View ",RTTNews,/news/stocks/pfizer-q2-profit-tops-estimates-revenues-miss-lifts-fy17-earnings-view-1002222007,neutral,0.5536677241325378
574,8/1/2017 3:06:52 PM,"Pfizer revenue misses as demand falls for older drugs, Prevnar",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/igUeBwBQXsU/us-pfizer-results-idUSKBN1AH3ZJ,neutral,0.9699585437774658
575,8/1/2017 3:07:04 PM,"US STOCKS-Dow set to open at record with earnings in focus (AAPL, PFE, P, S)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-set-to-open-at-record-with-earnings-in-focus-2017-8,negative,0.7160733938217163
576,8/1/2017 3:12:03 PM,BRIEF-Pfizer reports Q2 worldwide Ibrance revenue $853 mln vs $514 mln (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-reports-q2-worldwide-ibrance-revenue-853-mln-vs-514-mln-2017-8,negative,0.6373481154441833
577,8/1/2017 4:02:03 PM,"US STOCKS-Dow opens at record; Apple earnings eyed (GS, MMM, AAPL, PFE, S, LL)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-opens-at-record-apple-earnings-eyed-2017-8,positive,0.5427616834640503
578,8/1/2017 5:37:03 PM,"US STOCKS-Dow at record on strong earnings; Apple earnings awaited (AAPL, AMZN, PFE, REGN, S)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-at-record-on-strong-earnings-apple-earnings-awaited-2017-8,negative,0.898737370967865
579,8/3/2017 3:08:00 PM,Reflektive Achieves SOC 2 Compliance with Stringent Security Standards,PR Newswire,/news/stocks/reflektive-achieves-soc-2-compliance-with-stringent-security-standards-547685,negative,0.8509350419044495
580,8/4/2017 8:47:30 AM,"DVAX Plunges On Delay In Approval, FDA Nod For ABBV's HCV Drug, ABIO On Radar ",RTTNews,/news/stocks/dvax-plunges-on-delay-in-approval-fda-nod-for-abbv-s-hcv-drug-abio-on-radar-1002232943,neutral,0.9402093291282654
581,8/8/2017 2:27:03 PM,BRIEF-Avara Pharmaceutical buys Pfizer's Italy sterile facility (PFE),Reuters,http://www.businessinsider.com/r-brief-avara-pharmaceutical-buys-pfizers-italy-sterile-facility-2017-8,positive,0.8327833414077759
582,8/9/2017 5:52:03 PM,"Mexico watchdog finds big pharma faces no competition on some drugs (SAN, GSK, PFE)",Reuters,http://www.businessinsider.com/r-mexico-watchdog-finds-big-pharma-faces-no-competition-on-some-drugs-2017-8,positive,0.5821802020072937
583,8/9/2017 7:07:03 PM,"UPDATE 1-Mexico watchdog finds big pharma faces no competition on some drugs (GSK, PFE, MRK, ABT, LLY, SAN, AZN)",Reuters,http://www.businessinsider.com/r-update-1-mexico-watchdog-finds-big-pharma-faces-no-competition-on-some-drugs-2017-8,negative,0.8694553971290588
584,8/10/2017 10:52:03 PM,BRIEF-Pfizer Inc - U.S. DOJ's antitrust division is investigating co's greenstone generics business -  SEC Filing‍​ (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-inc---us-dojs-antitrust-division-is-investigating-cos-greenstone-generics-business----sec-filing-2017-8,positive,0.4941897988319397
585,8/11/2017 1:36:00 AM,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE,PR Newswire,/news/stocks/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-pfizer-inc-pfe-1001924291,positive,0.7551084160804749
586,8/11/2017 1:57:00 AM,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE,PR Newswire,/news/stocks/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-pfizer-inc-pfe-1002250329,positive,0.7551084160804749
587,8/11/2017 2:18:00 AM,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pfizer Inc. - PFE,PR Newswire,/news/stocks/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-pfizer-inc-pfe-1002250349,positive,0.7551084160804749
588,8/14/2017 10:47:08 PM,"BRIEF-Appaloosa dissolves share stake in Snap Inc, Pfizer Inc (AAPL, PFE)",Reuters,http://www.businessinsider.com/r-brief-appaloosa-dissolves-share-stake-in-snap-inc-pfizer-inc-2017-8,positive,0.9134834408760071
589,8/15/2017 12:17:06 AM,"BRIEF-Soros Fund Management dissolves share stake in Tesla, Pfizer, ConocoPhillips (TSLA, PFE, COP)",Reuters,http://www.businessinsider.com/r-brief-soros-fund-management-dissolves-share-stake-in-tesla-pfizer-conocophillips-2017-8,positive,0.7524084448814392
590,8/17/2017 12:15:00 PM,"Technical Snapshots for These Drug Makers Stocks -- Pfizer, Eli Lilly, Merck, and Sanofi",PR Newswire,/news/stocks/technical-snapshots-for-these-drug-makers-stocks-pfizer-eli-lilly-merck-and-sanofi-1002264947,positive,0.9307227730751038
591,8/17/2017 7:47:03 PM,BRIEF-U.S. FDA approves Pfizer's leukemia drug Besponsa ‍​ (PFE),Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-pfizers-leukemia-drug-besponsa--2017-8,negative,0.6689434051513672
592,8/17/2017 7:52:03 PM,FDA approves Pfizer's drug for rare blood cancer (PFE),Reuters,http://www.businessinsider.com/r-fda-approves-pfizers-drug-for-rare-blood-cancer-2017-8,negative,0.6328696012496948
593,8/17/2017 8:32:08 PM,UPDATE 1-FDA approves Pfizer's drug for rare blood cancer (PFE),Reuters,http://www.businessinsider.com/r-update-1-fda-approves-pfizers-drug-for-rare-blood-cancer-2017-8,negative,0.8521741628646851
594,8/17/2017 10:22:20 PM,"BRIEF-Pfizer says based on typical duration of treatment, total cost of Besponsa is $168,300 (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-based-on-typical-duration-of-treatment-total-cost-of-besponsa-is-168300-2017-8,positive,0.9436566233634949
595,8/17/2017 10:32:10 PM,BRIEF-Pfizer receives FDA approval for BESPONSA (inotuzumab ozogamicin) (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-receives-fda-approval-for-besponsa-inotuzumab-ozogamicin-2017-8,negative,0.9274467825889587
596,8/18/2017 3:19:24 AM,Pfizer Gets FDA Approval For Rare Blood Cancer Drug Besponsa ,RTTNews,/news/stocks/pfizer-gets-fda-approval-for-rare-blood-cancer-drug-besponsa-1002267237,negative,0.8564742207527161
597,8/18/2017 7:11:16 AM,"FDA Nod For PFE, New Use For AZN's Ovarian Cancer Drug, ELGX's LEOPARD Hits Goal ",RTTNews,/news/stocks/fda-nod-for-pfe-new-use-for-azn-s-ovarian-cancer-drug-elgx-s-leopard-hits-goal-1002267418,negative,0.6080707907676697
598,8/22/2017 1:00:00 PM,"Global Smart Wearable Gloves Market to Grow at a CAGR of 15.2% by 2021: Key Vendors are Blue Infusion Technology, Neofect & ProGlove",PR Newswire,/news/stocks/global-smart-wearable-gloves-market-to-grow-at-a-cagr-of-15-2-by-2021-key-vendors-are-blue-infusion-technology-neofect-proglove-1001946147,negative,0.875080943107605
599,8/22/2017 1:37:03 PM,"India grants Pfizer patent on pneumonia vaccine in blow to aid group (PFE, PFIZER)",Reuters,http://www.businessinsider.com/r-india-grants-pfizer-patent-on-pneumonia-vaccine-in-blow-to-aid-group-2017-8,negative,0.8734203577041626
600,8/22/2017 1:37:52 PM,India grants Pfizer patent on pneumonia vaccine in blow to aid group,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/arv9tWO7LqQ/pfizer-india-vaccine-idINKCN1B218W,negative,0.7587921619415283
601,8/22/2017 2:45:00 PM,Clinical and Regulatory Progress Boosting Biotech Sector,PR Newswire,/news/stocks/clinical-and-regulatory-progress-boosting-biotech-sector-1002275220,negative,0.9124936461448669
602,8/22/2017 2:45:00 PM,Clinical and Regulatory Progress Boosting Biotech Sector,PR Newswire,/news/stocks/clinical-and-regulatory-progress-boosting-biotech-sector-1002275229,negative,0.9124936461448669
603,8/22/2017 3:52:03 PM,"UPDATE 1-India grants Pfizer patent on pneumonia vaccine in blow to aid group (PFE, PANACEABIO, PFIZER)",Reuters,http://www.businessinsider.com/r-update-1-india-grants-pfizer-patent-on-pneumonia-vaccine-in-blow-to-aid-group-2017-8,negative,0.9075711965560913
604,8/23/2017 4:07:03 PM,"U.S. appeals court upholds insider trading conviction of SAC's Martoma (C, PFE)",Reuters,http://www.businessinsider.com/r-us-appeals-court-upholds-insider-trading-conviction-of-sacs-martoma-2017-8,neutral,0.5396872758865356
605,8/23/2017 6:17:06 PM,UPDATE 2-SAC's Martoma fails to overturn U.S. insider trading conviction (PFE),Reuters,http://www.businessinsider.com/r-update-2-sacs-martoma-fails-to-overturn-us-insider-trading-conviction-2017-8,neutral,0.9460552930831909
606,8/24/2017 7:42:03 AM,"Swiss stocks - Factors to watch on Aug 24 (PFE, JNJ, VONN, SPSN, IMPN, KOMN, WARN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-aug-24-2017-8,positive,0.94305020570755
607,8/24/2017 5:12:03 PM,"CORRECTED-Florida set to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-florida-set-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8,positive,0.7169998288154602
608,8/24/2017 11:07:15 PM,"UPDATE 1-Florida to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-florida-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8,negative,0.5968480110168457
609,8/25/2017 2:00:00 PM,Sangamo And Pfizer Announce First Patient Receives Treatment In Phase 1/2 Clinical Trial Evaluating SB-525 Investigational Gene Therapy For Hemophilia A,PR Newswire,/news/stocks/sangamo-and-pfizer-announce-first-patient-receives-treatment-in-phase-1-2-clinical-trial-evaluating-sb-525-investigational-gene-therapy-for-hemophilia-a-609529,negative,0.6486417651176453
610,8/25/2017 5:52:03 PM,"BRIEF-Pfizer and Sangamo updates on early stage trial on its blood disorder therapy (PFE, SGMO)",Reuters,http://www.businessinsider.com/r-brief-pfizer-and-sangamo-updates-on-early-stage-trial-on-its-blood-disorder-therapy-2017-8,positive,0.8628828525543213
611,8/27/2017 11:27:08 AM,"Bayer, J&J in frame for bigger anti-clotting market opportunity (BAYN, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-jj-in-frame-for-bigger-anti-clotting-market-opportunity-2017-8,negative,0.7578001618385315
612,8/28/2017 8:47:13 AM,Bristol-Myers: Eliquis Shows Lower Risk Of Stroke In NVAF Patient Subgroups ,RTTNews,/news/stocks/bristol-myers-eliquis-shows-lower-risk-of-stroke-in-nvaf-patient-subgroups-1002287443,negative,0.6588342189788818
613,8/28/2017 11:26:34 AM,"Bristol-Myers, Pfizer Report Investigational Eliquis Data - Quick Facts ",RTTNews,/news/stocks/bristol-myers-pfizer-report-investigational-eliquis-data-quick-facts-1002287826,positive,0.9458391070365906
614,8/29/2017 9:07:04 AM,"Merck cholesterol drug cuts heart risk by 9 pct in study (MRK, PFE, LLY)",Reuters,http://www.businessinsider.com/r-merck-cholesterol-drug-cuts-heart-risk-by-9-pct-in-study-2017-8,negative,0.8817371129989624
615,8/29/2017 1:32:03 PM,BRIEF-Pfizer says U.S. FDA and EMA accept regulatory submissions for bosuliffor (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-us-fda-and-ema-accept-regulatory-submissions-for-bosuliffor-2017-8,positive,0.7716913223266602
616,8/29/2017 2:23:52 PM,Biotech Stocks Facing FDA Decision In September ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-1002291346,positive,0.6874357461929321
617,8/30/2017 8:31:49 AM,"APRI Makes 2nd Try, PRQR To Reveal Data On Sep.25, PFE Awaits FDA Decision ",RTTNews,/news/stocks/apri-makes-2nd-try-prqr-to-reveal-data-on-sep-25-pfe-awaits-fda-decision-1002293488,positive,0.8828006982803345
618,8/31/2017 9:06:32 AM,"Hospira Recalls 1 Lot Of Vancomycin Hydrochloride For Injection, USP,750 Mg/vial ",RTTNews,/news/stocks/hospira-recalls-1-lot-of-vancomycin-hydrochloride-for-injection-usp-750-mg-vial-1002297185,positive,0.6939131021499634
619,8/31/2017 2:52:03 PM,"AstraZeneca aims to offset drug setback at big cancer congress (AZN, LLY, PFE, BMY, MRK, INCY)",Reuters,http://www.businessinsider.com/r-astrazeneca-aims-to-offset-drug-setback-at-big-cancer-congress-2017-8,negative,0.9372472763061523
620,9/1/2017 5:22:03 PM,BRIEF-U.S. FDA approves Pfizer's Mylotarg for treatment of acute myeloid leukemia (PFE),Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-pfizers-mylotarg-for-treatment-of-acute-myeloid-leukemia-2017-9,negative,0.765009880065918
621,9/1/2017 5:37:03 PM,FDA approves Pfizer's leukemia drug (PFE),Reuters,http://www.businessinsider.com/r-fda-approves-pfizers-leukemia-drug-2017-9,positive,0.563991904258728
622,9/1/2017 5:47:03 PM,BRIEF-Pfizer receives FDA approval for MYLOTARG (gemtuzumab ozogamicin) (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-receives-fda-approval-for-mylotarg-gemtuzumab-ozogamicin-2017-9,negative,0.9310243129730225
623,9/1/2017 5:57:03 PM,UPDATE 1-FDA approves Pfizer's leukemia drug (PFE),Reuters,http://www.businessinsider.com/r-update-1-fda-approves-pfizers-leukemia-drug-2017-9,negative,0.7794905304908752
624,9/1/2017 9:27:03 PM,UPDATE 2-FDA approves Pfizer's leukemia drug (PFE),Reuters,http://www.businessinsider.com/r-update-2-fda-approves-pfizers-leukemia-drug-2017-9,negative,0.7490813732147217
625,9/7/2017 7:15:25 AM,Genentech Recalls Three Lots Of Activase (alteplase) 100mg Vials ,RTTNews,/news/stocks/genentech-recalls-three-lots-of-activase-alteplase-100mg-vials-1002347961,positive,0.840250551700592
626,9/7/2017 11:49:07 AM,New Drugs Approved In August ,RTTNews,/news/stocks/new-drugs-approved-in-august-1002348863,positive,0.5784369111061096
627,9/7/2017 11:22:16 PM,"U.S. FDA warns of problems with EpiPen manufacturing plant (MYL, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-warns-of-problems-with-epipen-manufacturing-plant-2017-9,neutral,0.9624660015106201
628,9/8/2017 6:19:11 AM,FDA Warns Of Manufacturing Violations To EpiPen Plant ,RTTNews,/news/stocks/fda-warns-of-manufacturing-violations-to-epipen-plant-1002352097,neutral,0.9485171437263489
629,9/8/2017 7:02:05 AM,"PRESS DIGEST - Wall Street Journal - Sept 8 (AMZN, EFX, PFE, LLY)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---sept-8-2017-9,positive,0.9445129632949829
630,9/8/2017 7:02:05 AM,"PRESS DIGEST- New York Times business news - Sept 8 (EFX, AMZN, DIS, PFE, MYL)",Reuters,http://www.businessinsider.com/r-press-digest--new-york-times-business-news---sept-8-2017-9,positive,0.9416632056236267
631,9/8/2017 10:37:04 PM,"UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,positive,0.8491860628128052
632,9/9/2017 1:56:00 PM,"TINTRI (TNTR) ALERT: Johnson Fistel, LLP Announces Investigation of Tintri, Inc.; Encourages Investors to Contact the Firm for Information",PR Newswire,/news/stocks/tintri-tntr-alert-johnson-fistel-llp-announces-investigation-of-tintri-inc-encourages-investors-to-contact-the-firm-for-information-1001656442,negative,0.8558470606803894
633,9/10/2017 12:12:11 AM,"Lilly drug cuts risk of advanced breast cancer progression -study (LLY, PFE)",Reuters,http://www.businessinsider.com/r-lilly-drug-cuts-risk-of-advanced-breast-cancer-progression--study-2017-9,positive,0.8484269976615906
634,9/10/2017 11:12:03 AM,"UPDATE 1-Lilly takes on Pfizer, Novartis with new breast cancer drug data (LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-lilly-takes-on-pfizer-novartis-with-new-breast-cancer-drug-data-2017-9,positive,0.8266234397888184
635,9/10/2017 5:57:04 PM,"Bristol kidney cancer drug cut death risk 37 pct in key patients (BMY, AZN, PFE, MRK)",Reuters,http://www.businessinsider.com/r-bristol-kidney-cancer-drug-cut-death-risk-37-pct-in-key-patients-2017-9,negative,0.9072887897491455
636,9/10/2017 7:02:03 PM,"UPDATE 1-Bristol's drug cocktail cuts kidney cancer death risk 37 pct (BMY, AZN, PFE, MRK)",Reuters,http://www.businessinsider.com/r-update-1-bristols-drug-cocktail-cuts-kidney-cancer-death-risk-37-pct-2017-9,negative,0.9252809286117554
637,9/11/2017 10:07:03 AM,"RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-rpt-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,positive,0.7386980652809143
638,9/13/2017 3:31:00 PM,"Should you buy The Gap, McDonald's, Micron, NVIDIA or Pfizer Inc.",PR Newswire,/news/stocks/should-you-buy-the-gap-mcdonald-s-micron-nvidia-or-pfizer-inc-1002366344,positive,0.944040834903717
639,9/14/2017 11:00:00 AM,Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer,PR Newswire,/news/stocks/pfizer-and-astellas-announce-positive-top-line-results-from-phase-3-prosper-trial-of-xtandi-enzalutamide-in-patients-with-non-metastatic-castration-resistant-prostate-cancer-1002369296,negative,0.9414426684379578
640,9/14/2017 11:10:12 AM,"Pfizer, Astellas Report Positive Results From XTANDI Phase 3 Trial - Quick Facts ",RTTNews,/news/stocks/pfizer-astellas-report-positive-results-from-xtandi-phase-3-trial-quick-facts-1002369334,negative,0.9534421563148499
641,9/14/2017 12:37:03 PM,"UPDATE 1-Pfizer, Astellas prostate cancer drug clears late-stage trial (PFE, 4503)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-astellas-prostate-cancer-drug-clears-late-stage-trial-2017-9,positive,0.831159770488739
642,9/14/2017 12:37:04 PM,"Pfizer, Astellas prostrate cancer drug clears late-stage trial (PFE, 4503)",Reuters,http://www.businessinsider.com/r-pfizer-astellas-prostrate-cancer-drug-clears-late-stage-trial-2017-9,positive,0.8811941742897034
643,9/14/2017 1:42:03 PM,"US STOCKS-Futures flat ahead of key inflation data (AAPL, THC, PFE, 4503, HTZ)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-ahead-of-key-inflation-data-2017-9,neutral,0.9539781212806702
644,9/14/2017 5:32:03 PM,"UPDATE 3-Pfizer, Astellas prostate cancer drug promising in late-stage trial (PFE, 4503, JNJ)",Reuters,http://www.businessinsider.com/r-update-3-pfizer-astellas-prostate-cancer-drug-promising-in-late-stage-trial-2017-9,positive,0.5101777911186218
645,9/14/2017 7:37:17 PM,"US STOCKS-Wall St mixed as CPI data boosts December rate hike odds (AMZN, DIS, CHTR, AAPL, BA, PFE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-mixed-as-cpi-data-boosts-december-rate-hike-odds-2017-9,negative,0.8852956891059875
646,9/15/2017 3:57:03 AM,"Nikkei edges up despite N.Korea missile launch as dollar/yen steadies (1605, 4503, PFE, 3825, )",Reuters,http://www.businessinsider.com/r-nikkei-edges-up-despite-nkorea-missile-launch-as-dollar-yen-steadies-2017-9,negative,0.8965408205986023
647,9/15/2017 10:27:03 AM,"Nikkei ends higher as dollar gain outweighs N.Korea pain (, 8035, 6501, 7267, 4503, PFE)",Reuters,http://www.businessinsider.com/r-nikkei-ends-higher-as-dollar-gain-outweighs-nkorea-pain-2017-9,negative,0.9138545393943787
648,9/18/2017 1:00:00 PM,Medizone International announces the appointment of David A. Dodd as new Chief Executive Officer,PR Newswire,/news/stocks/medizone-international-announces-the-appointment-of-david-a-dodd-as-new-chief-executive-officer-1002016573,positive,0.8983863592147827
649,9/19/2017 6:12:04 PM,"BRIEF-Transgene says first patient treated in a phase 1B/2 trial of TG4001 (TNG, MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-transgene-says-first-patient-treated-in-a-phase-1b-2-trial-of-tg4001-2017-9,positive,0.6934179663658142
650,9/20/2017 1:37:03 PM,"US STOCKS-Futures flat as investors focus on Fed meeting (ADBE, FDX, PFE, 6502, BBBY)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-focus-on-fed-meeting-2017-9,neutral,0.9529192447662354
651,9/20/2017 3:17:03 PM,"US STOCKS-Wall St set to open flat as investors await Fed decision (ADBE, GIS, PFE, 6502, BBBY)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-as-investors-await-fed-decision-2017-9,neutral,0.6493372321128845
652,9/20/2017 3:22:17 PM,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra ,RTTNews,/news/stocks/pfe-claims-j-j-engaged-in-unlawful-conduct-to-stifle-competition-from-inflectra-1002387484,neutral,0.9421245455741882
653,9/20/2017 3:42:03 PM,"BRIEF-‍Pfizer files lawsuit against Johnson & Johnson​ (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-files-lawsuit-against-johnson--johnson-2017-9,neutral,0.6125757694244385
654,9/20/2017 3:45:20 PM,Pfizer sues Johnson & Johnson over Remicade biosimilar,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/FzFy-MyQDis/pfizer-sues-johnson-johnson-over-remicade-biosimilar-idUSKCN1BV1S8,neutral,0.9326303601264954
655,9/20/2017 3:47:03 PM,"Pfizer sues Johnson & Johnson over Remicade biosimilar (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-pfizer-sues-johnson--johnson-over-remicade-biosimilar-2017-9,neutral,0.9202054142951965
656,9/20/2017 4:02:03 PM,"US STOCKS-Wall St opens little changed; Fed takes center stage (PFE, ADBE, GIS, 6502, BBBY)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-little-changed-fed-takes-center-stage-2017-9,positive,0.7356457710266113
657,9/20/2017 4:22:03 PM,"UPDATE 1-Pfizer files suit against J&J over Remicade contracts (PFE, JNJ, UNH, AET, CI)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-files-suit-against-jj-over-remicade-contracts-2017-9,neutral,0.8609936833381653
658,9/20/2017 4:22:07 PM,Pfizer files suit against J&J over Remicade contracts,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/rOy68LOcsIA/pfizer-files-suit-against-jj-over-remicade-contracts-idUSKCN1BV1S8,neutral,0.903785765171051
659,9/21/2017 7:01:37 AM,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ ",RTTNews,/news/stocks/fda-nod-for-abmd-aeri-faces-fda-panel-in-oct-ipci-put-on-notice-pfe-sues-jnj-1002392403,positive,0.8899357318878174
660,9/21/2017 7:02:03 AM,"PRESS DIGEST - Wall Street Journal - Sept 21 (2498, 6502, AAPL, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---sept-21-2017-9,positive,0.9375851154327393
661,9/21/2017 9:28:00 AM,European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma,PR Newswire,/news/stocks/european-commission-approves-bavencio-avelumab-for-metastatic-merkel-cell-carcinoma-1002393639,negative,0.5685709118843079
662,9/21/2017 9:39:55 AM,"Merck, Pfizer Report EU Marketing Authorization For BAVENCIO - Quick Facts ",RTTNews,/news/stocks/merck-pfizer-report-eu-marketing-authorization-for-bavencio-quick-facts-1002393666,positive,0.5978292226791382
663,9/22/2017 12:12:15 AM,"Versartis growth hormone drug fails key study, shares sink (PFE)",Reuters,http://www.businessinsider.com/r-versartis-growth-hormone-drug-fails-key-study-shares-sink-2017-9,positive,0.7272422313690186
664,9/22/2017 11:02:07 PM,"UPDATE 1-U.S. FDA declines to approve J&J arthritis drug (JNJ, SAN, REGN, LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-declines-to-approve-jj-arthritis-drug-2017-9,neutral,0.8860206604003906
665,9/27/2017 10:17:03 AM,"BRIEF-Bavencio approved for Merkel Cell Carcinoma in Japan (MRK, PFE)",Reuters,http://www.businessinsider.com/r-brief-bavencio-approved-for-merkel-cell-carcinoma-in-japan-2017-9,negative,0.7418619394302368
666,9/27/2017 10:26:23 AM,Bavencio Approved For Merkel Cell Carcinoma In Japan ,RTTNews,/news/stocks/bavencio-approved-for-merkel-cell-carcinoma-in-japan-1002628670,negative,0.7241413593292236
667,9/27/2017 2:37:03 PM,BRIEF-Pfizer declares 32-cent fourth-quarter 2017 dividend (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-declares-32-cent-fourth-quarter-2017-dividend-2017-9,positive,0.7345839738845825
668,9/28/2017 4:02:03 PM,"Lonza CFO sees in-house growth, not takeovers, to grow drug services (PFE)",Reuters,http://www.businessinsider.com/r-lonza-cfo-sees-in-house-growth-not-takeovers-to-grow-drug-services-2017-9,negative,0.5575146675109863
669,9/28/2017 5:55:00 PM,Moody's: Biosimilars Market Adoption Faces Hurdles But Development Continues Apace,Moodys,/news/bonds/moody-s-biosimilars-market-adoption-faces-hurdles-but-development-continues-apace-1002750856,negative,0.8783012628555298
670,9/28/2017 6:17:03 PM,BRIEF-‍Moody's says biosimilars market adoption faces hurdles but development continues apace​ (PFE),Reuters,http://www.businessinsider.com/r-brief-moodys-says-biosimilars-market-adoption-faces-hurdles-but-development-continues-apace-2017-9,positive,0.7790945768356323
671,9/28/2017 8:17:07 PM,"Eli Lilly wins U.S. approval for breast cancer drug (LLY, PFE)",Reuters,http://www.businessinsider.com/r-eli-lilly-wins-us-approval-for-breast-cancer-drug-2017-9,negative,0.9235324859619141
672,9/28/2017 8:42:12 PM,"UPDATE 1-Eli Lilly wins U.S. approval for breast cancer drug (LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-eli-lilly-wins-us-approval-for-breast-cancer-drug-2017-9,negative,0.9041095972061157
673,9/29/2017 9:17:03 AM,"S.Korea's Celltrion to build plant abroad as partners fret about N.Korea (068270, , PFE, TEVA)",Reuters,http://www.businessinsider.com/r-skoreas-celltrion-to-build-plant-abroad-as-partners-fret-about-nkorea-2017-9,positive,0.8239073753356934
674,9/29/2017 5:27:05 PM,"Puerto Rico power outage set to hurt global reinsurers (MAP, QBE, AIG, BMY, LLY, PFE, AMGN, AZN, MMC)",Reuters,http://www.businessinsider.com/r-puerto-rico-power-outage-set-to-hurt-global-reinsurers-2017-9,neutral,0.960808515548706
675,10/4/2017 2:27:05 PM,"BRIEF-South Africa's Competition Commission to drop investigation against Aspen (APN, PFE)",Reuters,http://www.businessinsider.com/r-brief-south-africas-competition-commission-to-drop-investigation-against-aspen-2017-10,neutral,0.7490949630737305
676,10/4/2017 4:12:03 PM,"S.Africa watchdog drops over-charging probe into Aspen, Equity (APN, PFE)",Reuters,http://www.businessinsider.com/r-safrica-watchdog-drops-over-charging-probe-into-aspen-equity-2017-10,neutral,0.7112659215927124
677,10/4/2017 6:17:04 PM,"UPDATE 1-S.Africa watchdog drops over-charging probe into Aspen, Equity (APN, PFE)",Reuters,http://www.businessinsider.com/r-update-1-safrica-watchdog-drops-over-charging-probe-into-aspen-equity-2017-10,neutral,0.7369855642318726
678,10/4/2017 9:37:28 PM,"Trump to keep Obama rule curbing corporate tax inversion deals (PFE, AGN)",Reuters,http://www.businessinsider.com/r-trump-to-keep-obama-rule-curbing-corporate-tax-inversion-deals-2017-10,positive,0.8445594906806946
679,10/9/2017 11:48:57 AM,New Drugs Approved In September ,RTTNews,/news/stocks/new-drugs-approved-in-september-1003503219,positive,0.6164653897285461
680,10/10/2017 12:52:03 PM,BRIEF-Pfizer reviewing strategic alternatives for Consumer Healthcare business (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-reviewing-strategic-alternatives-for-consumer-healthcare-business-2017-10,positive,0.9071500301361084
681,10/10/2017 1:02:03 PM,Pfizer mulling sale of consumer healthcare business (PFE),Reuters,http://www.businessinsider.com/r-pfizer-mulling-sale-of-consumer-healthcare-business-2017-10,positive,0.9437534213066101
682,10/10/2017 1:05:33 PM,"Pfizer Reviews Strategic Alternatives For Consumer Healthcare Unit, Incl Sale ",RTTNews,/news/stocks/pfizer-reviews-strategic-alternatives-for-consumer-healthcare-unit-incl-sale-1003650615,positive,0.9134416580200195
683,10/10/2017 1:27:04 PM,"UPDATE 1-Pfizer mulls options for consumer healthcare business (PFE, MRK)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-mulls-options-for-consumer-healthcare-business-2017-10,positive,0.897408664226532
684,10/10/2017 1:27:07 PM,Pfizer mulls options for consumer healthcare business,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/AC6T7dpEa9U/pfizer-mulls-options-for-consumer-healthcare-business-idUSKBN1CF19M,positive,0.9382830262184143
685,10/10/2017 3:02:03 PM,"US STOCKS-Wall St set to open higher as earnings take focus (BLK, DAL, JPM, C, GE, WMT, PFE, LLY, HON)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-as-earnings-take-focus-2017-10,negative,0.9330078363418579
686,10/10/2017 3:32:12 PM,Pfizer weighs sale of consumer healthcare business,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/PJvPJrHbmNs/pfizer-weighs-sale-of-consumer-healthcare-business-idUSKBN1CF19M,positive,0.8777769804000854
687,10/10/2017 4:40:05 PM,Pfizer weighs $15 billion sale of consumer healthcare business,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/oD94bG0AGgo/pfizer-weighs-15-billion-sale-of-consumer-healthcare-business-idUSKBN1CF19M,negative,0.5345025658607483
688,10/10/2017 7:34:00 PM,Pfizer Inc. -- Moody's: Sale of Pfizer consumer products would be positive for liquidity,Moodys,/news/bonds/pfizer-inc-moody-s-sale-of-pfizer-consumer-products-would-be-positive-for-liquidity-1003696139,negative,0.9129292964935303
689,10/11/2017 7:02:03 AM,"PRESS DIGEST- New York Times business news - Oct 11 (AAPL, HON, PFE)",Reuters,http://www.businessinsider.com/r-press-digest--new-york-times-business-news---oct-11-2017-10,positive,0.9420761466026306
690,10/11/2017 7:37:03 AM,"UK Stocks-Factors to watch on Oct 11 (UKX, CSAN3, RDSA, TSCO, SN., EFX, PFE, JUP, DNLM, HL., MNDI)",Reuters,http://www.businessinsider.com/r-uk-stocks-factors-to-watch-on-oct-11-2017-10,positive,0.9434629082679749
691,10/11/2017 8:52:03 AM,"UPDATE 1-UK Stocks-Factors to watch on Oct 11 (UKX, ARBB, WG., DNLM, JUP, HL., CSAN3, RDSA, TSCO, SN., EFX, PFE)",Reuters,http://www.businessinsider.com/r-update-1-uk-stocks-factors-to-watch-on-oct-11-2017-10,positive,0.9419016242027283
692,10/11/2017 9:22:03 AM,BRIEF-Nestle has no comment on Pfizer's consumer healthcare business (PFE),Reuters,http://www.businessinsider.com/r-brief-nestle-has-no-comment-on-pfizers-consumer-healthcare-business-2017-10,positive,0.9291083216667175
693,10/11/2017 11:17:08 PM,"Merck says will not seek approval of cholesterol treatment (MRK, PFE, LLY)",Reuters,http://www.businessinsider.com/r-merck-says-will-not-seek-approval-of-cholesterol-treatment-2017-10,positive,0.9214851260185242
694,10/12/2017 2:08:12 PM,Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV ,RTTNews,/news/stocks/pfizer-announces-fda-approval-of-lyrica-cr-extended-release-tablets-cv-1003975649,negative,0.6890345215797424
695,10/12/2017 2:17:06 PM,BRIEF-FDA approves Pfizer's Lyrica® CR extended-release tablets CV (PFE),Reuters,http://www.businessinsider.com/r-brief-fda-approves-pfizers-lyrica-cr-extended-release-tablets-cv-2017-10,negative,0.6906997561454773
696,10/12/2017 4:12:03 PM,"NIH partners 11 drugmakers to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-nih-partners-11-drugmakers-to-accelerate-cancer-therapy-research-2017-10,negative,0.7635126113891602
697,10/12/2017 6:27:06 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10,negative,0.84027498960495
698,10/12/2017 10:12:15 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10,negative,0.84027498960495
699,10/13/2017 8:01:32 AM,"ONCE Sparkles, BDSI Makes Peace, Coming Event Casts Its Shadow Before ATRS ",RTTNews,/news/stocks/once-sparkles-bdsi-makes-peace-coming-event-casts-its-shadow-before-atrs-1004091271,positive,0.8600578904151917
700,10/13/2017 2:17:07 PM,"Roche's Alecensa wins EU panel's nod against mutated lung cancer (PFE, 4502, LEN)",Reuters,http://www.businessinsider.com/r-roches-alecensa-wins-eu-panels-nod-against-mutated-lung-cancer-2017-10,negative,0.7904226779937744
701,10/13/2017 7:37:03 PM,"UPDATE 1-U.S. FDA panel backs Aerie's glaucoma drug Rhopressa (PFE, AGN)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-panel-backs-aeries-glaucoma-drug-rhopressa-2017-10,neutral,0.4776035249233246
702,10/16/2017 1:29:49 PM,Pfizer: Trial Of ALK-Inhibitor Lorlatinib Shows Clinically Meaningful Activity ,RTTNews,/news/stocks/pfizer-trial-of-alk-inhibitor-lorlatinib-shows-clinically-meaningful-activity-1004479160,negative,0.9530104994773865
703,10/16/2017 1:47:07 PM,BRIEF-Pfizer presents results from Phase 2 study of investigational ALK-inhibitor lorlatinib (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-presents-results-from-phase-2-study-of-investigational-alk-inhibitor-lorlatinib-2017-10,positive,0.7720510959625244
704,10/16/2017 4:12:05 PM,BRIEF-The Nature's Bounty Co names Mark Gelbert chief scientific officer (PFE),Reuters,http://www.businessinsider.com/r-brief-the-natures-bounty-co-names-mark-gelbert-chief-scientific-officer-2017-10,positive,0.9374895691871643
705,10/18/2017 11:32:03 AM,"UPDATE 2-Reckitt to restructure after sales growth evaporates (RB., PFE, MRK)",Reuters,http://www.businessinsider.com/r-update-2-reckitt-to-restructure-after-sales-growth-evaporates-2017-10,positive,0.5951349139213562
706,10/18/2017 9:47:19 PM,BRIEF-Pfizer reports 5.4 pct passive stake in Rhythm Pharmaceuticals - ‍​SEC filing (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-reports-54-pct-passive-stake-in-rhythm-pharmaceuticals---sec-filing-2017-10,positive,0.9426113963127136
707,10/19/2017 8:27:14 AM,"INSIGHT-China biotech's 'coming out party' masks long road ahead (HCM, AZN, PFE, LLY, CELG, GSK, SAN)",Reuters,http://www.businessinsider.com/r-insight-china-biotechs-coming-out-party-masks-long-road-ahead-2017-10,positive,0.7154397368431091
708,10/25/2017 2:37:12 PM,"UPDATE 1-Baxter expects $70 mln hit to 4th-qtr sales from Hurricane Maria (BAX, MRK, JNJ, PFE, GSK, MDT, DEPO, AMGN, BMY, LLY, AZN)",Reuters,http://www.businessinsider.com/r-update-1-baxter-expects-70-mln-hit-to-4th-qtr-sales-from-hurricane-maria-2017-10,negative,0.8058122396469116
709,10/25/2017 8:39:54 PM,Exclusive: Pfizer to launch consumer health sale in November - sources,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/fIBD8SfGm78/exclusive-pfizer-to-launch-consumer-health-sale-in-november-sources-idUSKBN1CU2RW,positive,0.9228095412254333
710,10/26/2017 2:17:14 AM,"PRESS DIGEST- British Business - Oct 26 (GSK, MKS, AZN, PFE)",Reuters,http://www.businessinsider.com/r-press-digest--british-business---oct-26-2017-10,positive,0.9417352080345154
711,10/26/2017 7:02:12 AM,"High cholesterol levels among U.S. adults declining -CDC report (PFE, AZN, MYL, MRK, TEVA)",Reuters,http://www.businessinsider.com/r-high-cholesterol-levels-among-us-adults-declining--cdc-report-2017-10,neutral,0.9228916764259338
712,10/26/2017 9:02:17 AM,"UPDATE 1-UK Stocks-Factors to watch on Oct 26 (UKX, BARC, DEB, INCH, GSK, MRK, PFE, RB., ABX, AAL, BDEV, ITV)",Reuters,http://www.businessinsider.com/r-update-1-uk-stocks-factors-to-watch-on-oct-26-2017-10,positive,0.9399282932281494
713,10/26/2017 5:27:03 PM,"UPDATE 1-Bristol-Myers sales in line, but profit margins worsen (BMY, MRK, PFE)",Reuters,http://www.businessinsider.com/r-update-1-bristol-myers-sales-in-line-but-profit-margins-worsen-2017-10,neutral,0.9019613862037659
714,10/27/2017 10:27:12 AM,"BRIEF-ViiV Healthcare announces positive phase 3 results from BRIGHTE study of fostemsavir (GSK, PFE)",Reuters,http://www.businessinsider.com/r-brief-viiv-healthcare-announces-positive-phase-3-results-from-brighte-study-of-fostemsavir-2017-10,negative,0.9348885416984558
715,10/31/2017 11:49:08 AM,Pfizer Inc. Q3 Earnings Rise 8%,RTTNews,/news/stocks/pfizer-inc-q3-earnings-rise-8-1006290912,negative,0.9327171444892883
716,10/31/2017 11:57:11 AM,Pfizer's quarterly profit more than doubles (PFE),Reuters,http://www.businessinsider.com/r-pfizers-quarterly-profit-more-than-doubles-2017-10,negative,0.6281910538673401
717,10/31/2017 12:07:17 PM,BRIEF-Pfizer reports Q3 earnings per share of $0.47 (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-reports-q3-earnings-per-share-of-047-2017-10,positive,0.8448322415351868
718,10/31/2017 12:12:08 PM,"BRIEF-Pfizer says qtrly worldwide total lyrica revenue $ 1,150 mln versus $1,049 ln (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-qtrly-worldwide-total-lyrica-revenue--1150-mln-versus-1049-ln-2017-10,negative,0.8368023633956909
719,10/31/2017 12:32:21 PM,UPDATE 1-Pfizer's quarterly profit beats estimates (PFE),Reuters,http://www.businessinsider.com/r-update-1-pfizers-quarterly-profit-beats-estimates-2017-10,positive,0.8083131909370422
720,10/31/2017 12:37:06 PM,Pfizer Lifts FY17 Adj. EPS View Above Market As Q2 Profit Tops Estimates ,RTTNews,/news/stocks/pfizer-lifts-fy17-adj-eps-view-above-market-as-q2-profit-tops-estimates-1006295935,negative,0.9123331904411316
721,10/31/2017 1:22:55 PM,"Pfizer beats profit estimates, raises 2017 earnings forecast",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/rJ_UzI_2SH4/pfizer-beats-profit-estimates-raises-2017-earnings-forecast-idUSKBN1D01BD,negative,0.894355297088623
722,10/31/2017 3:12:12 PM,"US STOCKS-Mondelez, tech stocks lift S&P, Nasdaq (K, PFE, NKE, QCOM, AAPL)",Reuters,http://www.businessinsider.com/r-us-stocks-mondelez-tech-stocks-lift-sp-nasdaq-2017-10,positive,0.8972196578979492
723,10/31/2017 4:17:05 PM,"GLOBAL MARKETS-World stocks set for 12th month of gains, dollar nudges up (PFE, )",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-set-for-12th-month-of-gains-dollar-nudges-up-2017-10,negative,0.630610466003418
724,10/31/2017 4:32:03 PM,"US STOCKS-Consumer staples lead gains on Wall Street (K, AAPL, INTC, QCOM, PFE)",Reuters,http://www.businessinsider.com/r-us-stocks-consumer-staples-lead-gains-on-wall-street-2017-10,negative,0.9169702529907227
725,10/31/2017 4:32:03 PM,BRIEF-Pfizer sees broad interest for consumer health (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-sees-broad-interest-for-consumer-health-2017-10,negative,0.7774478793144226
726,10/31/2017 6:02:03 PM,"US STOCKS-Wall St inches higher on gains in techs, consumer staples (AAPL, INTC, QCOM, K, PFE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-inches-higher-on-gains-in-techs-consumer-staples-2017-10,negative,0.9418976306915283
727,10/31/2017 7:06:45 PM,Pfizer expects broad interest for consumer health business,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/dch0rw5Coyc/pfizer-expects-broad-interest-for-consumer-health-business-idUSKBN1D01BD,negative,0.814710795879364
728,10/31/2017 7:07:03 PM,"GLOBAL MARKETS-World stocks on tap for 12th month of gains, dollar edges up (AAPL, PFE)",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-on-tap-for-12th-month-of-gains-dollar-edges-up-2017-10,negative,0.9396763443946838
729,10/31/2017 7:37:03 PM,"US STOCKS-Wall St set to end month on up note as tech, staples lead (K, AAPL, PFE, QCOM, INTC, ROK, EMR)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-end-month-on-up-note-as-tech-staples-lead-2017-10,negative,0.9297287464141846
730,11/6/2017 10:42:03 AM,"Bayer in bid to broaden use of anti-clotting drug Xarelto (BAYN, JNJ, MON, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-in-bid-to-broaden-use-of-anti-clotting-drug-xarelto-2017-11,negative,0.8729289174079895
731,11/6/2017 7:42:05 PM,"UPDATE 1-FDA approves Roche drugs for rare types of blood, lung cancers (PFE)",Reuters,http://www.businessinsider.com/r-update-1-fda-approves-roche-drugs-for-rare-types-of-blood-lung-cancers-2017-11,negative,0.8044043183326721
732,11/7/2017 1:52:03 PM,BRIEF-Spark Therapeutics and Pfizer amend license agreement for investigational SPK-9001 in hemophilia B (PFE),Reuters,http://www.businessinsider.com/r-brief-spark-therapeutics-and-pfizer-amend-license-agreement-for-investigational-spk-9001-in-hemophilia-b-2017-11,negative,0.8814889192581177
733,11/8/2017 11:02:05 AM,"UPDATE 1-Novartis takes fight to Pfizer's Ibrance with new Kisqali data (PFE, LLY)",Reuters,http://www.businessinsider.com/r-update-1-novartis-takes-fight-to-pfizers-ibrance-with-new-kisqali-data-2017-11,positive,0.7923449873924255
734,11/8/2017 4:47:03 PM,"UPDATE 1-GSK grabs Calico top scientist and Roche veteran as new R&D head (GSK, PFE, AZN, WMT)",Reuters,http://www.businessinsider.com/r-update-1-gsk-grabs-calico-top-scientist-and-roche-veteran-as-new-rd-head-2017-11,positive,0.8592233657836914
735,11/10/2017 7:57:06 PM,"Pfizer exits China joint venture for generic drugs (PFE, 600267)",Reuters,http://www.businessinsider.com/r-pfizer-exits-china-joint-venture-for-generic-drugs-2017-11,positive,0.9105390906333923
736,11/13/2017 3:29:36 PM,Pfizer Appoints Albert Bourla As COO ,RTTNews,/news/stocks/pfizer-appoints-albert-bourla-as-coo-1007878380,positive,0.9410872459411621
737,11/13/2017 3:37:03 PM,BRIEF-Pfizer names Albert Bourla chief operating officer (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-names-albert-bourla-chief-operating-officer-2017-11,positive,0.9435046911239624
738,11/13/2017 3:52:03 PM,Pfizer names Bourla as chief operating officer (PFE),Reuters,http://www.businessinsider.com/r-pfizer-names-bourla-as-chief-operating-officer-2017-11,positive,0.9471189379692078
739,11/13/2017 3:56:52 PM,Pfizer names Bourla as chief operating officer,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/SZOM7jlyGeE/pfizer-names-bourla-as-chief-operating-officer-idUSKBN1DD1TN,positive,0.9415495991706848
740,11/13/2017 4:00:00 PM,Minister Chagger celebrates Global Entrepreneurship Week 2017,PR Newswire,/news/stocks/minister-chagger-celebrates-global-entrepreneurship-week-2017-554116,positive,0.8633558750152588
741,11/13/2017 6:02:03 PM,"UPDATE 1-Pfizer creates chief operating officer role for Bourla (PFE, AZN, AGN)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-creates-chief-operating-officer-role-for-bourla-2017-11,positive,0.9198859333992004
742,11/13/2017 11:02:03 PM,"New blood pressure range means nearly half of Americans have hypertension (PFE, MRK)",Reuters,http://www.businessinsider.com/r-new-blood-pressure-range-means-nearly-half-of-americans-have-hypertension-2017-11,negative,0.5940026044845581
743,11/14/2017 1:12:03 AM,"UPDATE 1-New blood pressure range means half of Americans have hypertension (PFE, MRK)",Reuters,http://www.businessinsider.com/r-update-1-new-blood-pressure-range-means-half-of-americans-have-hypertension-2017-11,positive,0.607641339302063
744,11/15/2017 5:52:03 PM,"Astellas faces U.S. probe over patient assistance charity support (4503, PFE, JNJ, UTHR, GILD, VRX, CELG)",Reuters,http://www.businessinsider.com/r-astellas-faces-us-probe-over-patient-assistance-charity-support-2017-11,neutral,0.8980137705802917
745,11/17/2017 5:26:48 AM,Pfizer: FDA Expands Approval Of Sutent To Reduce Risk Of Kidney Cancer Returning ,RTTNews,/news/stocks/pfizer-fda-expands-approval-of-sutent-to-reduce-risk-of-kidney-cancer-returning-1008376776,negative,0.9308100342750549
746,11/17/2017 6:13:04 AM,"FDA Nod For Label Expansion Of Sutent, Egalet Flies, Double Blessing For Roche ",RTTNews,/news/stocks/fda-nod-for-label-expansion-of-sutent-egalet-flies-double-blessing-for-roche-1008382091,negative,0.7918869256973267
747,11/21/2017 10:57:03 AM,"Britain says Canada's Concordia overcharging health service for thyroid drug (PFE, HGT)",Reuters,http://www.businessinsider.com/r-britain-says-canadas-concordia-overcharging-health-service-for-thyroid-drug-2017-11,positive,0.8222318887710571
748,11/21/2017 11:57:03 AM,"UPDATE 1-Drug firm Concordia overcharged Britain's health service with 6,000 pct price rise (PFE, HGT)",Reuters,http://www.businessinsider.com/r-update-1-drug-firm-concordia-overcharged-britains-health-service-with-6000-pct-price-rise-2017-11,negative,0.9038547277450562
749,11/21/2017 8:07:03 PM,"BRIEF-U.S. FDA approves Juluca, a two-drug regimen for certain patients with HIV (GSK, PFE)",Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-juluca-a-two-drug-regimen-for-certain-patients-with-hiv-2017-11,negative,0.7882291674613953
750,11/21/2017 9:12:05 PM,"U.S. FDA approves first two-drug HIV regimen (GSK, 4507, GILD, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-approves-first-two-drug-hiv-regimen-2017-11,positive,0.5633715391159058
751,11/22/2017 12:22:03 AM,"UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK (GSK, PFE, 4507, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-first-two-drug-hiv-regimen-from-gsk-2017-11,positive,0.4980044364929199
752,11/22/2017 1:45:00 AM,"Juluca® (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill - a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection",PR Newswire,/news/stocks/juluca-dolutegravir-and-rilpivirine-approved-in-us-as-first-2-drug-regimen-once-daily-single-pill-a-complete-regimen-for-the-maintenance-treatment-of-virologically-suppressed-hiv-1-infection-524525,negative,0.6210862398147583
753,11/22/2017 2:13:21 AM,ViiV Healthcare : FDA Okays First Two-drug Regimen For Certain Patients With HIV ,RTTNews,/news/stocks/viiv-healthcare-fda-okays-first-two-drug-regimen-for-certain-patients-with-hiv-1009014131,negative,0.838384747505188
754,11/28/2017 2:07:04 PM,"BRIEF-Merck And Pfizer Provide Update On Phase III Javelin Gastric 300 Study In Patients With Pre-Treated Advanced Gastric Cancer (PFE, MRK)",Reuters,http://www.businessinsider.com/r-brief-merck-and-pfizer-provide-update-on-phase-iii-javelin-gastric-300-study-in-patients-with-pre-treated-advanced-gastric-cancer-2017-11,positive,0.8955103158950806
755,11/28/2017 2:17:03 PM,"Merck KGaA, Pfizer's avelumab misses goal in gastric cancer trial (MRK, PFE)",Reuters,http://www.businessinsider.com/r-merck-kgaa-pfizers-avelumab-misses-goal-in-gastric-cancer-trial-2017-11,positive,0.7797214388847351
756,11/28/2017 2:19:58 PM,"Merck, Pfizer: Phase III Javelin Gastric 300 Trial Did Not Meet Primary Endpoint ",RTTNews,/news/stocks/merck-pfizer-phase-iii-javelin-gastric-300-trial-did-not-meet-primary-endpoint-1009786835,neutral,0.7883659601211548
757,11/28/2017 2:25:00 PM,Merck and Pfizer Provide Update on Phase III JAVELIN Gastric 300 Study in Patients With Pre-Treated Advanced Gastric Cancer,PR Newswire,/news/stocks/merck-and-pfizer-provide-update-on-phase-iii-javelin-gastric-300-study-in-patients-with-pre-treated-advanced-gastric-cancer-1009788687,positive,0.9104036688804626
758,11/28/2017 2:27:07 PM,"BRIEF-Zhejiang Hisun Pharmaceutical's share trade to resume after Pfizer exited China JV (600267, PFE)",Reuters,http://www.businessinsider.com/r-brief-zhejiang-hisun-pharmaceuticals-share-trade-to-resume-after-pfizer-exited-china-jv-2017-11,positive,0.9080290794372559
759,11/28/2017 3:42:03 PM,"UPDATE 1-Merck KGaA, Pfizer's immunotherapy fails in gastric cancer trial (MRK, PFE, MRK, AZN, BMY)",Reuters,http://www.businessinsider.com/r-update-1-merck-kgaa-pfizers-immunotherapy-fails-in-gastric-cancer-trial-2017-11,neutral,0.9397371411323547
760,11/28/2017 4:02:03 PM,BRIEF-Pfizer Wins UK Approval To Sell Non-Prescription Viagra (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-wins-uk-approval-to-sell-non-prescription-viagra-2017-11,negative,0.9281501173973083
761,11/28/2017 4:17:03 PM,UK gives Pfizer world's first over-the-counter Viagra approval (PFE),Reuters,http://www.businessinsider.com/r-uk-gives-pfizer-worlds-first-over-the-counter-viagra-approval-2017-11,negative,0.73965984582901
762,11/28/2017 5:07:03 PM,UPDATE 1-UK gives Pfizer world's first over-the-counter Viagra approval (PFE),Reuters,http://www.businessinsider.com/r-update-1-uk-gives-pfizer-worlds-first-over-the-counter-viagra-approval-2017-11,negative,0.7903322577476501
763,11/29/2017 8:05:41 AM,"EARS Pinched By HEALOS Data, EGLT Does It Again, JAVELIN Gastric 300 Misses Mark ",RTTNews,/news/stocks/ears-pinched-by-healos-data-eglt-does-it-again-javelin-gastric-300-misses-mark-1009889890,positive,0.8387899994850159
764,11/29/2017 1:09:07 PM,Biotech Stocks Facing FDA Decision In December ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-december-1009916247,positive,0.5557605028152466
765,11/29/2017 8:12:03 PM,"U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11,positive,0.7578281760215759
766,11/29/2017 9:02:03 PM,"BRIEF-Amphastar Announces Approval For Medroxyprogesterone Acetate Injectable Suspension, USP (PFE)",Reuters,http://www.businessinsider.com/r-brief-amphastar-announces-approval-for-medroxyprogesterone-acetate-injectable-suspension-usp-2017-11,negative,0.8450180888175964
767,11/29/2017 9:17:05 PM,"UPDATE 1-U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11,positive,0.6831169724464417
768,12/1/2017 7:37:03 AM,"BRIEF-Pfizer Says Entered Into Agreement To Develop And Commercialize Cresemba In China And Asia Pacific (PFE, BSLN)",Reuters,http://www.businessinsider.com/r-brief-pfizer-says-entered-into-agreement-to-develop-and-commercialize-cresemba-in-china-and-asia-pacific-2017-12,negative,0.9234493374824524
769,12/1/2017 7:37:04 AM,"BRIEF-Basilea Extends Existing License Agreement With Pfizer For Cresemba (BSLN, PFE)",Reuters,http://www.businessinsider.com/r-brief-basilea-extends-existing-license-agreement-with-pfizer-for-cresemba-2017-12,negative,0.9202796816825867
770,12/1/2017 7:39:13 AM,"Basilea Pharma Extends License Agreement For Cresemba To China, Asia Pacific ",RTTNews,/news/stocks/basilea-pharma-extends-license-agreement-for-cresemba-to-china-asia-pacific-1010151469,negative,0.9086328148841858
771,12/1/2017 7:57:08 PM,"Nestle, Stada prepare rival bids for Germany's Merck consumer health - sources (SAZ, MRK, PFE, SAN)",Reuters,http://www.businessinsider.com/r-nestle-stada-prepare-rival-bids-for-germanys-merck-consumer-health---sources-2017-12,positive,0.8053816556930542
772,12/1/2017 11:02:03 PM,"FDA approves heart protection claims for Amgen cholesterol drug (AMGN, PFE)",Reuters,http://www.businessinsider.com/r-fda-approves-heart-protection-claims-for-amgen-cholesterol-drug-2017-12,positive,0.6756493449211121
773,12/4/2017 2:27:19 PM,"BioNews Capsule: Ready-to-drink Colonoscopy Prep, Viagra Connect, ZYNE's STARS ",RTTNews,/news/stocks/bionews-capsule-ready-to-drink-colonoscopy-prep-viagra-connect-zyne-s-stars-1010320707,positive,0.8591429591178894
774,12/4/2017 5:12:11 PM,BRIEF-Acentrus Specialty Signs New Agreement With Pfizer Oncology (PFE),Reuters,http://www.businessinsider.com/r-brief-acentrus-specialty-signs-new-agreement-with-pfizer-oncology-2017-12,negative,0.9101071953773499
775,12/6/2017 1:52:03 PM,BRIEF-Pfizer Announces Updated Progression-Free Survival Results (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-updated-progression-free-survival-results-2017-12,positive,0.8246212601661682
776,12/7/2017 2:22:03 PM,BRIEF-Pfizer Inc Announces Private Exchange Offer For Its 6.500 Per Cent Notes Due 2038 (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-inc-announces-private-exchange-offer-for-its-6500-per-cent-notes-due-2038-2017-12,positive,0.8184205889701843
777,12/7/2017 5:15:00 PM,CWABS Asset-Backed Certificates Trust 2007-6 -- Moody's assigns A1 to Pfizer's new sterling notes; stable outlook,Moodys,/news/bonds/cwabs-asset-backed-certificates-trust-2007-6-moody-s-assigns-a1-to-pfizer-s-new-sterling-notes-stable-outlook-1010503138,negative,0.9032469391822815
778,12/8/2017 2:32:04 PM,Pfizer breast cancer drug superior to chemotherapy in Phase III study (PFE),Reuters,http://www.businessinsider.com/r-pfizer-breast-cancer-drug-superior-to-chemotherapy-in-phase-iii-study-2017-12,negative,0.77798992395401
779,12/8/2017 2:43:16 PM,Pfizer: Talazoparib Extends Progression-Free Survival In Phase 3 Trial ,RTTNews,/news/stocks/pfizer-talazoparib-extends-progression-free-survival-in-phase-3-trial-1010596987,negative,0.9442048668861389
780,12/11/2017 1:38:32 PM,"Spark, Pfizer Record Sustained Factor IX Activity Levels In SPK-9001 Trial ",RTTNews,/news/stocks/spark-pfizer-record-sustained-factor-ix-activity-levels-in-spk-9001-trial-1010936594,negative,0.9492295384407043
781,12/11/2017 3:22:03 PM,"BRIEF-Teva Announces Exclusive Launch Of Generic Viagra Tablets In The United States (TEVA, PFE)",Reuters,http://www.businessinsider.com/r-brief-teva-announces-exclusive-launch-of-generic-viagra-tablets-in-the-united-states-2017-12,negative,0.7180922031402588
782,12/11/2017 5:52:04 PM,BRIEF-Puma Biotechnology Announces Positive Outcome Of European Opposition Proceedings (PFE),Reuters,http://www.businessinsider.com/r-brief-puma-biotechnology-announces-positive-outcome-of-european-opposition-proceedings-2017-12,negative,0.9007787108421326
783,12/12/2017 1:26:12 PM,Myriad: BRACAnalysis Cdx Test Identified Patients Who Responded To Talazoparib ,RTTNews,/news/stocks/myriad-bracanalysis-cdx-test-identified-patients-who-responded-to-talazoparib-1011074951,positive,0.6334473490715027
784,12/13/2017 8:38:37 AM,"ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use ",RTTNews,/news/stocks/adro-dumps-crs-207-another-win-for-coolsculpting-fda-expands-gsk-s-nucala-use-1011202259,negative,0.5577716827392578
785,12/14/2017 12:47:04 AM,BRIEF-FDA Approves Pfizer's New Biosimilar To Remicade (PFE),Reuters,http://www.businessinsider.com/r-brief-fda-approves-pfizers-new-biosimilar-to-remicade-2017-12,negative,0.7184352874755859
786,12/14/2017 1:02:03 AM,"Bumper crop of new drugs fails to lift big pharma R&D returns (BION, NOVO , PFE, SAN, GSK, JNJ, AZN, MRK, LLY, BMY, 4502, AMGN, BIIB, CELG, GILD)",Reuters,http://www.businessinsider.com/r-bumper-crop-of-new-drugs-fails-to-lift-big-pharma-rd-returns-2017-12,neutral,0.7240303158760071
787,12/14/2017 3:03:28 AM,Pfizer Biosimilar Medicine IXIFI Gets FDA Approval For All Eligible Indications ,RTTNews,/news/stocks/pfizer-biosimilar-medicine-ixifi-gets-fda-approval-for-all-eligible-indications-1011324120,negative,0.9113566875457764
788,12/14/2017 1:40:49 PM,Pfizer Initiates Phase 3 Program For PF-04965842 - Quick Facts ,RTTNews,/news/stocks/pfizer-initiates-phase-3-program-for-pf-04965842-quick-facts-1011388135,positive,0.8252615332603455
789,12/14/2017 4:32:03 PM,BRIEF-Pfizer Announces Pricing Terms Of Private Exchange Offer For 6.500 PCT Notes Due 2038 (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-pricing-terms-of-private-exchange-offer-for-6500-pct-notes-due-2038-2017-12,positive,0.823251485824585
790,12/14/2017 6:57:03 PM,"Germany's Merck to make new bid to enter U.S. MS pill market (MRK, PFE)",Reuters,http://www.businessinsider.com/r-germanys-merck-to-make-new-bid-to-enter-us-ms-pill-market-2017-12,negative,0.646277904510498
791,12/14/2017 7:37:04 PM,"UPDATE 1-Germany's Merck to make new bid to enter U.S. MS pill market (MRK, BIIB, SAN, PFE)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-to-make-new-bid-to-enter-us-ms-pill-market-2017-12,negative,0.8302605748176575
792,12/15/2017 1:52:03 AM,BRIEF-Pfizer Announces FDA Approval Of Xeljanz® And Xeljanz® Xr For Treatment Of Active Psoriatic Arthritis (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-fda-approval-of-xeljanz-and-xeljanz-xr-for-treatment-of-active-psoriatic-arthritis-2017-12,negative,0.8592774868011475
793,12/15/2017 1:58:53 AM,Pfizer Says FDA Okays XELJANZ And XELJANZ XR To Treat Active Psoriatic Arthritis ,RTTNews,/news/stocks/pfizer-says-fda-okays-xeljanz-and-xeljanz-xr-to-treat-active-psoriatic-arthritis-1011466992,negative,0.8691730499267578
794,12/15/2017 2:02:03 AM,Pfizer's Xeljanz gets FDA nod as joint disease treatment (PFE),Reuters,http://www.businessinsider.com/r-pfizers-xeljanz-gets-fda-nod-as-joint-disease-treatment-2017-12,negative,0.8998724222183228
795,12/15/2017 2:22:03 AM,"UPDATE 1-Pfizer's Xeljanz gets FDA nod as joint disease treatment (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pfizers-xeljanz-gets-fda-nod-as-joint-disease-treatment-2017-12,negative,0.8645578026771545
796,12/15/2017 5:37:03 PM,"US STOCKS-Wall St rises as bank, healthcare stocks gain (JPM, C, COST, PFE, MDT, TMO, ESRX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-as-bank-healthcare-stocks-gain-2017-12,negative,0.8998177647590637
797,12/18/2017 6:02:03 PM,"Pfizer announces new $10 bln share buyback, hikes dividend (PFE)",Reuters,http://www.businessinsider.com/r-pfizer-announces-new-10-bln-share-buyback-hikes-dividend-2017-12,neutral,0.7325553894042969
798,12/18/2017 6:12:03 PM,"BRIEF-Pfizer Authorizes New $10 Billion Share Repurchase Program, Ups Dividend (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-authorizes-new-10-billion-share-repurchase-program-ups-dividend-2017-12,positive,0.7966831922531128
799,12/18/2017 6:37:03 PM,"UPDATE 1-Pfizer announces new $10 bln share buyback, hikes dividend (PFE, BA, BAC)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-announces-new-10-bln-share-buyback-hikes-dividend-2017-12,negative,0.47058579325675964
800,12/19/2017 2:17:20 AM,Pfizer Board Approves New $10 Bln Share Buy-back; Hikes Dividend ,RTTNews,/news/stocks/pfizer-board-approves-new-10-bln-share-buy-back-hikes-dividend-1011628294,neutral,0.6433587670326233
801,12/19/2017 2:07:04 PM,"BRIEF-Array BioPharma Announces Strategic Collaboration With Pfizer (ARRY, PFE)",Reuters,http://www.businessinsider.com/r-brief-array-biopharma-announces-strategic-collaboration-with-pfizer-2017-12,positive,0.5646495819091797
802,12/19/2017 2:12:48 PM,Array BioPharma Enters Into Clinical Trial Collaboration Agreement With Pfizer ,RTTNews,/news/stocks/array-biopharma-enters-into-clinical-trial-collaboration-agreement-with-pfizer-1011641415,negative,0.8326781392097473
803,12/19/2017 10:22:03 PM,"GRAPHIC-Banks, healthcare service firms among winners from U.S. tax bill (UHS, DGX, CAH, PFE, MRK, WFC, PNC, RF, MTB, CSCO, QCOM)",Reuters,http://www.businessinsider.com/r-graphic-banks-healthcare-service-firms-among-winners-from-us-tax-bill-2017-12,negative,0.653990626335144
804,12/19/2017 10:22:04 PM,BRIEF-FDA Approves Pfizer's Bosulif To Treat A Type of Leukemia (PFE),Reuters,http://www.businessinsider.com/r-brief-fda-approves-pfizers-bosulif-to-treat-a-type-of-leukemia-2017-12,negative,0.7531535625457764
805,12/19/2017 10:52:03 PM,"Pfizer, Exelixis cancer drugs get FDA approval for wider use (PFE, EXEL)",Reuters,http://www.businessinsider.com/r-pfizer-exelixis-cancer-drugs-get-fda-approval-for-wider-use-2017-12,negative,0.5031598210334778
806,12/20/2017 6:11:11 AM,"EXEL, PFE, ONCE Get FDA Nod, FPRX, ZLAB Team Up, SKLN Soars After Hours ",RTTNews,/news/stocks/exel-pfe-once-get-fda-nod-fprx-zlab-team-up-skln-soars-after-hours-1011667355,positive,0.6366652846336365
807,12/20/2017 10:17:04 PM,"BRIEF-U.S. Fda Approves New Diabetes Drug From Merck And Pfizer (MRK, PFE, JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,negative,0.7861426472663879
808,12/20/2017 10:27:06 PM,"U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,negative,0.8601289391517639
809,12/20/2017 10:42:03 PM,"UPDATE 1-U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,negative,0.8735406398773193
810,12/21/2017 12:47:03 PM,"BRIEF-Pfizer Announces Pricing And Early Results Of Tender Offer For 5.75 Per Cent, Due 2021 (PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-pricing-and-early-results-of-tender-offer-for-575-per-cent-due-2021-2017-12,positive,0.9159327745437622
811,12/21/2017 6:52:04 PM,BRIEF-Pfizer Says Compensation Committee Approved Increase In COO Bourla’s Annual Base Salary To $1.4 Mln (PFE),Reuters,http://www.businessinsider.com/r-brief-pfizer-says-compensation-committee-approved-increase-in-coo-bourlas-annual-base-salary-to-14-mln-2017-12,negative,0.9306999444961548
812,12/21/2017 7:27:19 PM,"BRIEF-Pfizer Announces Breakthrough Therapy Designation For Avelumab In Combination With Inlyta (PFE, MRK)",Reuters,http://www.businessinsider.com/r-brief-pfizer-announces-breakthrough-therapy-designation-for-avelumab-in-combination-with-inlyta-2017-12,negative,0.8955047130584717
813,12/21/2017 11:30:00 PM,FDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma,PR Newswire,/news/stocks/fda-grants-breakthrough-therapy-designation-for-avelumab-in-combination-with-inlyta-in-advanced-renal-cell-carcinoma-1011759185,negative,0.9159069657325745
814,12/22/2017 7:02:03 AM,"Wall St Week Ahead-This year's lumps of coal could be 2018's diamonds (GE, VRTX, ILMN, KR, AMZN, VZ, IBM, XOM, BA, CAT, CSCO, PFE, CVX, MRK, KO, PG, NKE, VRSN, EMR, ROK)",Reuters,http://www.businessinsider.com/r-wall-st-week-ahead-this-years-lumps-of-coal-could-be-2018s-diamonds-2017-12,positive,0.9232535362243652
815,12/22/2017 8:12:03 AM,"German stocks - Factors to watch on December 22 (ALV, ELE, DTE, LBTYA, MRK, PFE, TKA, TATASTEEL)",Reuters,http://www.businessinsider.com/r-german-stocks---factors-to-watch-on-december-22-2017-12,positive,0.9449489712715149
816,12/22/2017 1:02:04 PM,"RPT-Wall St Week Ahead-This year's lumps of coal could be 2018's diamonds (GE, VRTX, ILMN, KR, AMZN, VZ, IBM, XOM, BA, CAT, CSCO, PFE, CVX, MRK, KO, PG, NKE, VRSN, EMR, ROK)",Reuters,http://www.businessinsider.com/r-rpt-wall-st-week-ahead-this-years-lumps-of-coal-could-be-2018s-diamonds-2017-12,positive,0.9183773994445801
817,12/22/2017 1:13:33 PM,"Merck, Pfizer: FDA Approves Steglatro And Fixed-dose Combination Steglujan ",RTTNews,/news/stocks/merck-pfizer-fda-approves-steglatro-and-fixed-dose-combination-steglujan-1011810309,negative,0.6055468916893005
818,12/24/2017 6:17:49 AM,"It's Raining FDA Approvals, SMMT Opens Wallet, AGRX Snubbed Yet Again ",RTTNews,/news/stocks/it-s-raining-fda-approvals-smmt-opens-wallet-agrx-snubbed-yet-again-1011943022,positive,0.6607587933540344
819,12/27/2017 4:22:03 PM,"US STOCKS-Wall St little changed; oil drop weighs on energy shares (COP, CVX, NVDA, AAPL, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-little-changed-oil-drop-weighs-on-energy-shares-2017-12,neutral,0.7638410925865173
820,12/27/2017 5:42:08 PM,"US STOCKS-Tech, healthcare stocks prop up Wall Street (AAPL, COP, CVX, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-healthcare-stocks-prop-up-wall-street-2017-12,negative,0.8959800601005554
821,1/2/2018 12:02:03 PM,"New drug approvals hit 21-year high in 2017 (GILD, PFE, MRK, NOVO , AZN)",Reuters,http://www.businessinsider.com/r-new-drug-approvals-hit-21-year-high-in-2017-2018-1,negative,0.8878636956214905
822,1/3/2018 1:31:00 PM,Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS,PR Newswire,/news/stocks/sangamo-and-pfizer-announce-collaboration-for-development-of-zinc-finger-protein-gene-therapy-for-als-1012432397,negative,0.808870792388916
823,1/3/2018 1:40:13 PM,"Sangamo, Pfizer Collaborate On Zinc Finger Protein Gene Therapy For ALS ",RTTNews,/news/stocks/sangamo-pfizer-collaborate-on-zinc-finger-protein-gene-therapy-for-als-1012432436,positive,0.5741254687309265
824,1/3/2018 1:47:03 PM,"BRIEF-Sangamo And Pfizer Announce Collaboration For Development Of Zinc Finger Protein Gene Therapy For Als (PFE, SGMO)",Reuters,http://www.businessinsider.com/r-brief-sangamo-and-pfizer-announce-collaboration-for-development-of-zinc-finger-protein-gene-therapy-for-als-2018-1,negative,0.8483524918556213
825,1/3/2018 2:32:03 PM,"Sangamo partners with Pfizer to develop gene therapy for ALS (SGMO, PFE)",Reuters,http://www.businessinsider.com/r-sangamo-partners-with-pfizer-to-develop-gene-therapy-for-als-2018-1,negative,0.6853761672973633
826,1/4/2018 6:01:00 AM,Arvinas Announces Research Collaboration and License Agreement with Pfizer Inc. for the Discovery and Development of Protein Degradation Drug Candidates,PR Newswire,/news/stocks/arvinas-announces-research-collaboration-and-license-agreement-with-pfizer-inc-for-the-discovery-and-development-of-protein-degradation-drug-candidates-1012458328,negative,0.8735305070877075
827,1/4/2018 6:20:16 AM,"Arvinas Sees $830 Mln Upfront, Potential Milestone Payments In Deal With Pfizer ",RTTNews,/news/stocks/arvinas-sees-830-mln-upfront-potential-milestone-payments-in-deal-with-pfizer-1012458598,negative,0.9318267107009888
828,1/4/2018 2:00:00 PM,Berkeley Lights Announces Research Collaboration and License Agreement with Pfizer,PR Newswire,/news/stocks/berkeley-lights-announces-research-collaboration-and-license-agreement-with-pfizer-1012472088,negative,0.7668839693069458
829,1/7/2018 3:50:22 PM,New Drugs Approved In December ,RTTNews,/news/stocks/new-drugs-approved-in-december-1012620046,positive,0.6225224137306213
830,1/8/2018 3:05:12 AM,Pfizer Ends Alzheimer's And Parkinson's Research; To Cut 300 Jobs ,RTTNews,/news/stocks/pfizer-ends-alzheimer-s-and-parkinson-s-research-to-cut-300-jobs-1012640397,neutral,0.943692147731781
831,1/9/2018 3:11:00 PM,Moody's: US pharmaceutical companies' cash holdings set to decline under new tax law,Moodys,/news/bonds/moody-s-us-pharmaceutical-companies-cash-holdings-set-to-decline-under-new-tax-law-1012731176,neutral,0.9666052460670471
832,1/9/2018 9:16:29 PM,"GSK CEO says looking at Pfizer consumer business, but not a priority",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/obRFG_QEOjs/gsk-ceo-says-looking-at-pfizer-consumer-business-but-not-a-priority-idUSKBN1EY2HH,positive,0.9256054162979126
833,1/11/2018 7:12:27 AM,"Novartis Names Elizabeth Barrett CEO, Novartis Oncology - Quick Facts ",RTTNews,/news/stocks/novartis-names-elizabeth-barrett-ceo-novartis-oncology-quick-facts-1012885317,positive,0.9473139643669128
834,1/16/2018 6:57:37 AM,The Race To Find A Treatment For NASH ,RTTNews,/news/stocks/the-race-to-find-a-treatment-for-nash-1013102677,positive,0.8310591578483582
835,1/16/2018 1:18:54 PM,"Foundation Medicine, Pfizer Enter Into Broad Tie-up For Companion Diagnostics ",RTTNews,/news/stocks/foundation-medicine-pfizer-enter-into-broad-tie-up-for-companion-diagnostics-1013109980,negative,0.6962468028068542
836,1/22/2018 8:58:59 AM,Some Branded Drugs Going Generic In 2018 ,RTTNews,/news/stocks/some-branded-drugs-going-generic-in-2018-1013567302,positive,0.897983968257904
837,1/24/2018 2:45:32 PM,Pfizer: Potential Biosimilar To Rituxan Meets Primary Endpoint - Quick Facts ,RTTNews,/news/stocks/pfizer-potential-biosimilar-to-rituxan-meets-primary-endpoint-quick-facts-1013853810,negative,0.7886703014373779
838,1/30/2018 12:49:24 PM,Pfizer Inc. Earnings Climb In Q4,RTTNews,/news/stocks/pfizer-inc-earnings-climb-in-q4-1014547394,negative,0.9147422313690186
839,1/30/2018 1:03:40 PM,Pfizer reports $11 billion gain from new tax law,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/kLd1bq9sMLI/pfizer-reports-11-billion-gain-from-new-tax-law-idUSKBN1FJ1KL,negative,0.9178175330162048
840,1/30/2018 1:26:52 PM,Pfizer Q4 Results Beat Estimates; Issues Upbeat FY18 Outlook ,RTTNews,/news/stocks/pfizer-q4-results-beat-estimates-issues-upbeat-fy18-outlook-1014550058,negative,0.9132015109062195
841,1/30/2018 1:33:21 PM,"Pfizer profit tops estimates, books $11 billion tax gain",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/IOIyq2vovYU/pfizer-profit-tops-estimates-books-11-billion-tax-gain-idUSKBN1FJ1KL,negative,0.8889963626861572
842,1/30/2018 4:59:36 PM,"Pfizer sees upbeat 2018 on lower tax rate, shares dip after highs",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/-kTIlJug1b4/pfizer-sees-upbeat-2018-on-lower-tax-rate-shares-dip-after-highs-idUSKBN1FJ1KL,neutral,0.6769576668739319
843,1/30/2018 10:38:00 PM,IIROC Trading Resumption - PERU,PR Newswire,/news/stocks/iiroc-trading-resumption-peru-554117,positive,0.941018283367157
844,2/5/2018 12:35:58 PM,"Bloomberg: Glaxo, Reckitt Submit Bids For Pfizer's Consumer Business Unit ",RTTNews,/news/stocks/bloomberg-glaxo-reckitt-submit-bids-for-pfizer-s-consumer-business-unit-1014966169,positive,0.8661366701126099
845,2/5/2018 11:10:00 PM,Phase 3 PROSPER Trial Shows XTANDI® (enzalutamide) Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer,PR Newswire,/news/stocks/phase-3-prosper-trial-shows-xtandi-enzalutamide-significantly-reduced-the-risk-of-metastasis-or-death-by-71-percent-in-men-with-non-metastatic-castration-resistant-prostate-cancer-1014976928,negative,0.9409267902374268
846,2/6/2018 7:35:57 AM,"Xtandi Prospers, One Down, One To Go For AMAG, There's Reason For CORT's Fall ",RTTNews,/news/stocks/xtandi-prospers-one-down-one-to-go-for-amag-there-s-reason-for-cort-s-fall-1014985695,positive,0.7756523489952087
847,2/8/2018 8:33:57 AM,ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir ,RTTNews,/news/stocks/viiv-files-patent-infringement-lawsuit-against-gilead-sciences-on-bictegravir-1015100909,neutral,0.933647096157074
848,2/8/2018 2:44:15 PM,"Reckitt, GSK balance risk-reward in high-stakes Pfizer fight",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/2n9cTkHzbos/reckitt-gsk-balance-risk-reward-in-high-stakes-pfizer-fight-idUSKBN1FS1WY,positive,0.7831425070762634
849,2/12/2018 2:20:24 PM,"U.S., EU, Japan Accept Regulatory Submissions For Review Of Pfizer's Lorlatinib ",RTTNews,/news/stocks/u-s-eu-japan-accept-regulatory-submissions-for-review-of-pfizer-s-lorlatinib-1015511720,positive,0.8686164617538452
850,2/12/2018 11:29:17 PM,U.S. investment adviser gets prison for insider trading on Pfizer-King deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/3Us7n04jQTA/u-s-investment-adviser-gets-prison-for-insider-trading-on-pfizer-king-deal-idUSKBN1FW2L7,neutral,0.8131052851676941
851,2/13/2018 12:00:00 PM,Success Of Mow N' Stow® Technology Leads To Expanded Offering,PR Newswire,/news/stocks/success-of-mow-n-stow-technology-leads-to-expanded-offering-1002081767,negative,0.8715554475784302
852,2/14/2018 2:40:04 PM,Pfizer Receives Breakthrough Therapy Designation For PF-04965842 - Quick Facts ,RTTNews,/news/stocks/pfizer-receives-breakthrough-therapy-designation-for-pf-04965842-quick-facts-1015766224,negative,0.7087706327438354
853,2/15/2018 2:50:34 PM,Merck: Phase III JAVELIN Lung 200 Trial With Avelumab Fails To Meet Endpoint ,RTTNews,/news/stocks/merck-phase-iii-javelin-lung-200-trial-with-avelumab-fails-to-meet-endpoint-1015895082,neutral,0.9500251412391663
854,2/23/2018 2:40:51 PM,Pfizer Updates On EMA Application For SUTENT ,RTTNews,/news/stocks/pfizer-updates-on-ema-application-for-sutent-1016851193,positive,0.910101056098938
855,2/23/2018 3:16:31 PM,Pfizer Gets Positive CHMP Opinion For Mylotarg And Bosulif - Quick Facts ,RTTNews,/news/stocks/pfizer-gets-positive-chmp-opinion-for-mylotarg-and-bosulif-quick-facts-1016853963,negative,0.9240676164627075
856,2/27/2018 8:41:40 AM,Biotech Stocks Facing FDA Decision In March ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-1017268709,positive,0.7348417639732361
857,3/2/2018 12:00:00 PM,Neofluidics Announces Collaboration with Pfizer Inc.,PR Newswire,/news/stocks/neofluidics-announces-collaboration-with-pfizer-inc-1017685477,positive,0.670616626739502
858,3/2/2018 12:17:45 PM,Neofluidics Enters Collaboration With Pfizer - Quick Facts ,RTTNews,/news/stocks/neofluidics-enters-collaboration-with-pfizer-quick-facts-1017686345,positive,0.5753023028373718
859,3/4/2018 3:19:34 AM,An Ear To The Pharma: 7 Stocks To Watch This Week ,RTTNews,/news/stocks/an-ear-to-the-pharma-7-stocks-to-watch-this-week-1017867022,positive,0.9022789001464844
860,3/5/2018 6:00:00 PM,ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis,PR Newswire,/news/stocks/viiv-healthcare-announces-positive-new-dolutegravir-data-for-the-treatment-of-people-living-with-hiv-co-infected-with-tuberculosis-1018028063,negative,0.9370802044868469
861,3/8/2018 11:01:22 PM,FDA Panel Backs Pfizer's Xeljanz For Ulcerative Colitis ,RTTNews,/news/stocks/fda-panel-backs-pfizer-s-xeljanz-for-ulcerative-colitis-1018457346,neutral,0.8572455644607544
862,3/9/2018 8:04:14 AM,"FDA Panel Backs Xeljanz For UC, ACRX Abuzz, AGLE Awaits Data This Month ",RTTNews,/news/stocks/fda-panel-backs-xeljanz-for-uc-acrx-abuzz-agle-awaits-data-this-month-1018510640,positive,0.7116818428039551
863,3/10/2018 11:06:27 AM,"Reckitt CEO stands by Mead Johnson deal, despite Pfizer option",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/9GvNSDjehAU/reckitt-ceo-stands-by-mead-johnson-deal-despite-pfizer-option-idINKBN1GM09H,positive,0.7982684969902039
864,3/12/2018 12:42:25 PM,Biogen To Acquire Phase 2b Ready Asset For Schizophrenia ,RTTNews,/news/stocks/biogen-to-acquire-phase-2b-ready-asset-for-schizophrenia-1018617606,positive,0.7961344718933105
865,3/19/2018 12:00:00 PM,BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent,PR Newswire,/news/stocks/bioduro-collaboration-with-pfizer-inc-leads-to-creation-of-a-shelf-stable-fluorosulfation-reagent-1018915514,negative,0.7745468020439148
866,3/19/2018 9:15:00 PM,U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI® (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC),PR Newswire,/news/stocks/u-s-fda-grants-priority-review-for-a-supplemental-new-drug-application-snda-for-xtandi-enzalutamide-in-non-metastatic-castration-resistant-prostate-cancer-crpc-1018925263,negative,0.8517503142356873
867,3/20/2018 8:16:36 AM,"ARNA Soars After-hours, Remoxy Now 2 Steps Away From Approval, APLS On Watch ",RTTNews,/news/stocks/arna-soars-after-hours-remoxy-now-2-steps-away-from-approval-apls-on-watch-1018936376,neutral,0.741555392742157
868,3/21/2018 9:30:33 PM,Reckitt Benckiser pulls out of Pfizer consumer health auction,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/r2tx8sjpHtM/reckitt-benckiser-pulls-out-of-pfizer-consumer-health-auction-idUSKBN1GX30J,neutral,0.8430212140083313
869,3/22/2018 8:21:38 AM,Reckitt Benckiser Ends Discussions With Pfizer On Consumer Health Deal ,RTTNews,/news/stocks/reckitt-benckiser-ends-discussions-with-pfizer-on-consumer-health-deal-1019044806,neutral,0.5938197374343872
870,3/22/2018 2:00:24 PM,GlaxoSmithKline gifted Pfizer consumer health advantage by Reckitt,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/uEemrtbFq_U/glaxosmithkline-gifted-pfizer-consumer-health-advantage-by-reckitt-idUSKBN1GX30J,positive,0.9235398769378662
871,3/22/2018 2:25:48 PM,Back to the drawing board for Reckitt after dropping Pfizer bid,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/E57-t0dCEHQ/back-to-the-drawing-board-for-reckitt-after-dropping-pfizer-bid-idUSL8N1R44LD,positive,0.9052325487136841
872,3/22/2018 4:48:07 PM,UPDATE 6-GSK advances in Pfizer consumer health auction as Reckitt quits,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ofbMk8nwBBU/update-6-gsk-advances-in-pfizer-consumer-health-auction-as-reckitt-quits-idUSL3N1R34WJ,neutral,0.4520905911922455
873,3/23/2018 9:02:06 AM,GSK pulls out of $20 bln race for Pfizer assets,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/koASJjZCEOk/gsk-pulls-out-of-20-bln-race-for-pfizer-assets-idUSL8N1R51HD,neutral,0.8911214470863342
874,3/23/2018 9:13:33 AM,UPDATE 1-GSK pulls out of $20 bln race for Pfizer assets,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/FPEd_beM0TM/update-1-gsk-pulls-out-of-20-bln-race-for-pfizer-assets-idUSL8N1R51JW,neutral,0.8434690237045288
875,3/23/2018 9:40:07 AM,GSK Withdraws From Process For Pfizer's Consumer Healthcare Unit; Stock Up ,RTTNews,/news/stocks/gsk-withdraws-from-process-for-pfizer-s-consumer-healthcare-unit-stock-up-1019139089,neutral,0.7954786419868469
876,3/23/2018 9:56:23 AM,BRIEF-Pfizer says continues to evaluate options for consumer health,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/rbDNbuGUN68/brief-pfizer-says-continues-to-evaluate-options-for-consumer-health-idUSL9N1D4026,negative,0.7422760128974915
877,3/23/2018 10:38:00 AM,UPDATE 2-GSK pulls out of $20 bln race for Pfizer consumer assets,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vIj3XKJmEX4/update-2-gsk-pulls-out-of-20-bln-race-for-pfizer-consumer-assets-idUSL8N1R51Y7,neutral,0.8408015966415405
878,3/23/2018 11:16:19 AM,BRIEF-GSK did not put in final bid for Pfizer consumer unit - source,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/x59a6ePGYPo/brief-gsk-did-not-put-in-final-bid-for-pfizer-consumer-unit-source-idUSL9N1D4027,positive,0.9291330575942993
879,3/23/2018 12:40:52 PM,ViiV Healthcare: CHMP Issues Positive Opinion For Juluca - Quick Facts ,RTTNews,/news/stocks/viiv-healthcare-chmp-issues-positive-opinion-for-juluca-quick-facts-1019151804,negative,0.943342387676239
880,3/23/2018 12:45:33 PM,UPDATE 3-GSK pulls out of $20 bln race for Pfizer consumer assets,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/xGIc3oDGMPk/update-3-gsk-pulls-out-of-20-bln-race-for-pfizer-consumer-assets-idUSL8N1R51Y7,neutral,0.8354794383049011
881,3/23/2018 12:47:02 PM,GSK pulls out of $20 billion race for Pfizer consumer assets,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/JYsVzXPJOQc/gsk-pulls-out-of-20-billion-race-for-pfizer-consumer-assets-idUSKBN1GZ0WR,neutral,0.8064538836479187
882,3/23/2018 1:09:17 PM,Pfizer Reports Results From Phase 4 Study With CHANTIX/CHAMPIX - Quick Facts ,RTTNews,/news/stocks/pfizer-reports-results-from-phase-4-study-with-chantix-champix-quick-facts-1019153214,positive,0.8345603942871094
883,3/23/2018 2:19:39 PM,Sandoz: CHMP Adopts Positive Opinion For Infliximab - Quick Facts ,RTTNews,/news/stocks/sandoz-chmp-adopts-positive-opinion-for-infliximab-quick-facts-1019158051,negative,0.9467194080352783
884,3/29/2018 6:49:37 PM,BRIEF-Pfizer Announces Tafamidis Phase 3 ATTR-ACT Study Met Its Primary Endpoint,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/y2z_AiAaGzM/brief-pfizer-announces-tafamidis-phase-3-attr-act-study-met-its-primary-endpoint-idUSFWN1RB0Y8,negative,0.8981077075004578
885,3/29/2018 6:54:21 PM,Pfizer Reports Positive Results From Phase 3 ATTR-ACT Study Of Tafamidis ,RTTNews,/news/stocks/pfizer-reports-positive-results-from-phase-3-attr-act-study-of-tafamidis-1019866777,negative,0.9489665627479553
886,4/3/2018 1:11:00 AM,"Groton (Town of) CT -- Moody's Assigns Aa2 to Town of Groton, CT's $6.7M GO Bonds, 2018",Moodys,/news/bonds/groton-town-of-ct-moody-s-assigns-aa2-to-town-of-groton-ct-s-6-7m-go-bonds-2018-1020286793,negative,0.5348402857780457
887,4/3/2018 1:54:24 PM,Will These Drugs Reach Blockbuster Status? ,RTTNews,/news/stocks/will-these-drugs-reach-blockbuster-status-1020339832,positive,0.7288854122161865
888,4/3/2018 2:00:01 PM,Pfizer signs deal with Allogene to develop cancer cell therapy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/us-rIVSyzY4/pfizer-signs-deal-with-allogene-to-develop-cancer-cell-therapy-idUSL4N1RG1OU,negative,0.7590606808662415
889,4/3/2018 2:14:35 PM,Pfizer To Hold 25% Ownership Stake In Allogene Therapeutics ,RTTNews,/news/stocks/pfizer-to-hold-25-ownership-stake-in-allogene-therapeutics-1020341599,positive,0.9392111897468567
890,4/3/2018 2:23:52 PM,"Cellectis, Allogene To Continue Strategic Cancer Immunotherapy Collaboration ",RTTNews,/news/stocks/cellectis-allogene-to-continue-strategic-cancer-immunotherapy-collaboration-1020342426,positive,0.6443179845809937
891,4/3/2018 3:11:28 PM,BRIEF-Pfizer and Allogene enter into agreement for Pfizer's CAR T cell therapy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/0lDEt6Ry5xE/brief-pfizer-and-allogene-enter-into-agreement-for-pfizers-car-t-cell-therapy-idUSB8N1RG000,negative,0.9285141229629517
892,4/3/2018 4:34:02 PM,BRIEF-Pfizer in talks with P&G on consumer business sale - CNBC,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/8E3ZjcLG9Ss/brief-pfizer-in-talks-with-pg-on-consumer-business-sale-cnbc-idUSFWN1RG0M0,positive,0.8816973567008972
893,4/3/2018 4:47:31 PM,Pfizer in talks with P&G for consumer health unit sale - CNBC,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/oa_FssnGPdg/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSL4N1RG50P,positive,0.8869913220405579
894,4/3/2018 4:51:07 PM,Pfizer in talks with P&G for consumer health unit sale: CNBC,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/f_i4g_uV9QE/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSKCN1HA1UK,positive,0.9106505513191223
895,4/3/2018 5:27:04 PM,CORRECTED-Pfizer in talks with P&G for consumer health unit sale - CNBC,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/tK8b8Wz9IW8/corrected-pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSL4N1RG50P,positive,0.8918002247810364
896,4/3/2018 5:43:40 PM,UPDATE 1-Pfizer in talks with P&G for consumer health unit sale - CNBC,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/p5SPAXSGhpM/update-1-pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUSL4N1RG54U,positive,0.838005781173706
897,4/3/2018 7:14:41 PM,UPDATE 1-Pfizer in deal with Allogene to develop cancer cell therapies,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3v4bak3P8Jg/update-1-pfizer-in-deal-with-allogene-to-develop-cancer-cell-therapies-idUSL4N1RG564,negative,0.7191125750541687
898,4/4/2018 5:41:25 AM,Pfizer Reportedly In Talks With P&G On Consumer Business Sale ,RTTNews,/news/stocks/pfizer-reportedly-in-talks-with-p-g-on-consumer-business-sale-1020420057,positive,0.8792070150375366
899,4/4/2018 2:07:46 PM,Pfizer: FDA Grants Priority Review For Dacomitinib - Quick Facts ,RTTNews,/news/stocks/pfizer-fda-grants-priority-review-for-dacomitinib-quick-facts-1020458030,negative,0.6045423746109009
900,4/6/2018 4:14:27 PM,A Glance At Potential Therapies For Sickle Cell Disease ,RTTNews,/news/stocks/a-glance-at-potential-therapies-for-sickle-cell-disease-1020687306,positive,0.8738229870796204
901,4/6/2018 9:06:56 PM,BRIEF-Pfizer Canada Says BESPONSA Approved By Health Canada For Treating Adults With A Type Of Leukemia,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ftPizLyw5h8/brief-pfizer-canada-says-besponsa-approved-by-health-canada-for-treating-adults-with-a-type-of-leukemia-idUSFWN1RJ0GN,negative,0.7227080464363098
902,4/10/2018 2:37:48 PM,BRIEF-Pfizer Will Relocate Its Global Headquarters From 235 East 42nd Street To Spiral,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/V4F_vPOMIq4/brief-pfizer-will-relocate-its-global-headquarters-from-235-east-42nd-street-to-spiral-idUSFWN1RN0KI,positive,0.8238545656204224
903,4/10/2018 8:37:53 PM,BRIEF-Pfizer Provides Update on Phase 3 Trial of Axitinib,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/zqKPm8S_8FU/brief-pfizer-provides-update-on-phase-3-trial-of-axitinib-idUSASC09VG5,positive,0.9257180690765381
904,4/11/2018 6:55:59 AM,"AGTC Awaits Gene Therapy Data, FDA Delays Decision On Elagolix, KPTI On Watch ",RTTNews,/news/stocks/agtc-awaits-gene-therapy-data-fda-delays-decision-on-elagolix-kpti-on-watch-1021132321,positive,0.5905052423477173
905,4/12/2018 2:02:59 PM,BRIEF-Pfizer Doses First Patient Using Investigational Mini Dystrophin Gene Therapy For The Treatment Of Duchenne Muscular Dystrophy,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/P1W9IJ4eRjQ/brief-pfizer-doses-first-patient-using-investigational-mini-dystrophin-gene-therapy-for-the-treatment-of-duchenne-muscular-dystrophy-idUSFWN1RP0KL,negative,0.6385357975959778
906,4/12/2018 2:12:41 PM,Pfizer Begins Clinical Trial With Mini-dystrophin Gene Therapy Candidate ,RTTNews,/news/stocks/pfizer-begins-clinical-trial-with-mini-dystrophin-gene-therapy-candidate-1021290834,negative,0.6046941876411438
907,4/13/2018 7:20:36 AM,"FDA Nod For Innovus' Kit, PLSE Soars On SK Data, Keep An Eye On ARNA ",RTTNews,/news/stocks/fda-nod-for-innovus-kit-plse-soars-on-sk-data-keep-an-eye-on-arna-1021352135,positive,0.7042046189308167
908,4/18/2018 12:12:47 PM,BRIEF-IBT Urges Pfizer Shareholders To Vote For Proposal 7 For Corporate Political Spending Disclosure,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/tpflP_VUnZc/brief-ibt-urges-pfizer-shareholders-to-vote-for-proposal-7-for-corporate-political-spending-disclosure-idUSFWN1RV0E6,positive,0.8127722144126892
909,4/22/2018 10:07:00 PM,NMC Health plc -- Moody's assigns first-time Ba1 ratings to NMC Health; outlook stable,Moodys,/news/bonds/nmc-health-plc-moody-s-assigns-first-time-ba1-ratings-to-nmc-health-outlook-stable-1021925190,positive,0.7929617166519165
910,4/23/2018 1:46:51 PM,BRIEF-Pfizer Provides Update On Proposed Trastuzumab Biosimilar,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/JV4aD-XO53g/brief-pfizer-provides-update-on-proposed-trastuzumab-biosimilar-idUSASC09WRN,positive,0.9227614998817444
911,4/23/2018 1:48:09 PM,BRIEF-Pfizer: EU Approves Mylotarg With Chemotherapy To Treat Acute Myeloid Leukemia,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/2WA910wtL7E/brief-pfizer-eu-approves-mylotarg-with-chemotherapy-to-treat-acute-myeloid-leukemia-idUSFWN1S00IF,negative,0.8519170880317688
912,4/23/2018 1:54:32 PM,Pfizer Receives CRL On Trastuzumab Biosimilar ,RTTNews,/news/stocks/pfizer-receives-crl-on-trastuzumab-biosimilar-1021992245,positive,0.5832417607307434
913,4/23/2018 1:56:10 PM,Pfizer: EU Approves Mylotarg In Combination With Chemotherapy To Treat AML ,RTTNews,/news/stocks/pfizer-eu-approves-mylotarg-in-combination-with-chemotherapy-to-treat-aml-1021992262,negative,0.8595070838928223
914,4/23/2018 2:00:56 PM,BRIEF-Pfizer Granted FDA Breakthrough Therapy Designation For Trumenba® (Meningococcal Group B Vaccine),Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ttB77a3hEQE/brief-pfizer-granted-fda-breakthrough-therapy-designation-for-trumenba-idUSASC09WRW,negative,0.9346608519554138
915,4/23/2018 2:17:13 PM,Pfizer: FDA Grants Trumenba Breakthrough Therapy Designation ,RTTNews,/news/stocks/pfizer-fda-grants-trumenba-breakthrough-therapy-designation-1021993920,negative,0.8409189581871033
916,4/23/2018 2:25:54 PM,UPDATE 1-FDA declines to approve Pfizer biosimilar of Roche's cancer drug,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/DWIMPQCN6TE/update-1-fda-declines-to-approve-pfizer-biosimilar-of-roches-cancer-drug-idUSL3N1S04SC,neutral,0.8925984501838684
917,4/24/2018 8:46:50 AM,"PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA ",RTTNews,/news/stocks/prta-jolted-fda-strikes-down-pfe-s-herceptin-biosimilar-no-relief-yet-for-kmda-1022084035,neutral,0.8953303694725037
918,4/24/2018 3:10:21 PM,Modern Miracles: America's 10 Best-Selling Drugs ,RTTNews,/news/stocks/modern-miracles-america-s-10-best-selling-drugs-1022118861,positive,0.849453330039978
919,4/26/2018 7:18:43 PM,BRIEF-Pfizer Inc Declares 34 Cent Q2 Dividend,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/9QSfgpX0PL8/brief-pfizer-inc-declares-34-cent-q2-dividend-idUSFWN1S31PO,positive,0.6314184665679932
920,5/1/2018 12:52:51 PM,Pfizer Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q1-adjusted-earnings-beat-estimates-1023000214,negative,0.8581992983818054
921,5/1/2018 1:14:26 PM,BRIEF-Pfizer Reports Q1 Earnings Of $0.59 Per Share,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/nMP-JIFdnlc/brief-pfizer-reports-q1-earnings-of-0-59-per-share-idUSASC09YI4,positive,0.6223893165588379
922,5/1/2018 2:13:35 PM,UPDATE 2-Pfizer revenue misses as breast cancer drug sales disappoint,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/yGfKiWQMT4U/update-2-pfizer-revenue-misses-as-breast-cancer-drug-sales-disappoint-idUSL3N1S827B,neutral,0.9692323207855225
923,5/1/2018 2:34:57 PM,"Merck And Pfizer Q1 Adj. Profit Tops View, But Sales Miss ",RTTNews,/news/stocks/merck-and-pfizer-q1-adj-profit-tops-view-but-sales-miss-1023009302,negative,0.6790652275085449
924,5/1/2018 2:41:37 PM,UPDATE 3-Pfizer sales miss as breast cancer drug disappoints,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3byI8YVmzww/update-3-pfizer-sales-miss-as-breast-cancer-drug-disappoints-idUSL3N1S827B,neutral,0.9698261022567749
925,5/1/2018 5:23:57 PM,BRIEF-Pfizer Has Not Received Acceptable Offer For Consumer Health,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/F1zPbeZPcQI/brief-pfizer-has-not-received-acceptable-offer-for-consumer-health-idUSL1N1S80LS,positive,0.7881627678871155
926,5/1/2018 6:03:57 PM,UPDATE 4-Pfizer 1st-qtr results miss estimates as key drug sales fall short,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/kQrHj54MPw8/update-4-pfizer-1st-qtr-results-miss-estimates-as-key-drug-sales-fall-short-idUSL3N1S827B,neutral,0.967917263507843
927,5/1/2018 6:10:12 PM,Pfizer first-quarter results miss estimates as key drug sales fall short,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/00MvKVyZHBw/pfizer-first-quarter-results-miss-estimates-as-key-drug-sales-fall-short-idUSKBN1I23EI,neutral,0.9710655212402344
928,5/1/2018 11:25:36 PM,BRIEF-Pfizer Says Shareholder Proposal Regarding Independent Chair Policy Not Approved By Shareholders,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/J-BWCNTQjco/brief-pfizer-says-shareholder-proposal-regarding-independent-chair-policy-not-approved-by-shareholders-idUSFWN1S80LH,positive,0.5026677846908569
929,5/3/2018 7:07:13 AM,"AKAO Slumps On FDA Panel Vote, ESPR Awaits Data In May, STAA Shines ",RTTNews,/news/stocks/akao-slumps-on-fda-panel-vote-espr-awaits-data-in-may-staa-shines-1023226123,neutral,0.8476089835166931
930,5/4/2018 2:27:09 PM,"Inside New York City's struggle to become a biotech hub (PFE, BMY)",Business Insider,http://www.businessinsider.com/new-york-city-biotech-hub-ambitions-2018-5,positive,0.8222766518592834
931,5/16/2018 5:22:47 AM,Pfizer : FDA Oks First Epoetin Alfa Biosimilar For Treatment Of Anemia ,RTTNews,/news/stocks/pfizer-fda-oks-first-epoetin-alfa-biosimilar-for-treatment-of-anemia-1024647353,negative,0.7833099365234375
932,5/16/2018 8:48:18 AM,"LLY Gets Headache Relief, XENE Abuzz, 3rd Time's A Charm For PFE's Epogen Biosim ",RTTNews,/news/stocks/lly-gets-headache-relief-xene-abuzz-3rd-time-s-a-charm-for-pfe-s-epogen-biosim-1024665378,positive,0.7174733877182007
933,5/17/2018 2:20:18 PM,Pfizer: Lyrica Oral Solution CV Phase 3 Trial Meets Primary Endpoint ,RTTNews,/news/stocks/pfizer-lyrica-oral-solution-cv-phase-3-trial-meets-primary-endpoint-1024841205,negative,0.6745406985282898
934,5/21/2018 12:39:00 PM,GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV ,RTTNews,/news/stocks/glaxosmithkline-reports-eu-marketing-authorisation-for-juluca-to-treat-hiv-1025063843,negative,0.6003719568252563
935,5/22/2018 2:07:40 PM,Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus Vaccine ,RTTNews,/news/stocks/pfizer-begins-phase-1-2-study-to-evaluate-respiratory-syncytial-virus-vaccine-1025086740,positive,0.7891244888305664
936,5/23/2018 2:12:46 PM,Pfizer: FDA Grants Breakthrough Therapy Designation For Tafamidis - Quick Facts ,RTTNews,/news/stocks/pfizer-fda-grants-breakthrough-therapy-designation-for-tafamidis-quick-facts-1025134940,negative,0.9026617407798767
937,5/24/2018 4:16:00 PM,Pfizer to pay $23.85 mln to resolve U.S. kickbacks case,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/8OBUn8uUVJQ/pfizer-to-pay-23-85-mln-to-resolve-u-s-kickbacks-case-idUSL2N1SV0YB,negative,0.641340434551239
938,5/24/2018 4:19:07 PM,Drug maker Pfizer to pay $23.85 mln to settle claims it paid kickbacks,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/uj6kpbXswh0/drug-maker-pfizer-to-pay-23-85-mln-to-settle-claims-it-paid-kickbacks-idUSL2N1SV0XK,neutral,0.812507688999176
939,5/24/2018 4:42:32 PM,UPDATE 1-Pfizer to pay $23.85 mln to resolve U.S. kickbacks case,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/TkY0NxMRK9U/update-1-pfizer-to-pay-23-85-mln-to-resolve-u-s-kickbacks-case-idUSL2N1SV0ZA,negative,0.8695694804191589
940,5/24/2018 5:29:52 PM,UPDATE 2-Pfizer to pay $23.85 mln to resolve U.S. kickback probe,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/-O1kFhfip1U/update-2-pfizer-to-pay-23-85-mln-to-resolve-u-s-kickback-probe-idUSL2N1SV0ZA,negative,0.7472845315933228
941,5/24/2018 8:51:02 PM,Pfizer To Pay $23.85 Mln To Resolve Kickback Claims: DoJ ,RTTNews,/news/stocks/pfizer-to-pay-23-85-mln-to-resolve-kickback-claims-doj-1025227484,positive,0.8130505084991455
942,5/24/2018 10:59:41 PM,UPDATE 3-Pfizer to pay $23.85 mln to settle U.S. co-payment kickback probe,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/tKtJdI54kZY/update-3-pfizer-to-pay-23-85-mln-to-settle-u-s-co-payment-kickback-probe-idUSL2N1SV0ZA,negative,0.48404520750045776
943,5/25/2018 6:24:49 AM,Australian anti-trust watchdog loses appeal against Pfizer over Lipitor sales,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/KBJqawte75A/australian-anti-trust-watchdog-loses-appeal-against-pfizer-over-lipitor-sales-idUSL3N1SW1OA,neutral,0.9502965807914734
944,5/29/2018 2:11:02 PM,Pfizer: Xalkori Gets FDA Breakthrough Therapy Designation In Two New Indications ,RTTNews,/news/stocks/pfizer-xalkori-gets-fda-breakthrough-therapy-designation-in-two-new-indications-1025709185,negative,0.9215149879455566
945,5/31/2018 4:57:37 AM,Pfizer:FDA Oks XELJANZ To Treat Moderately To Severely Active Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-fda-oks-xeljanz-to-treat-moderately-to-severely-active-ulcerative-colitis-1025928677,negative,0.791871964931488
946,5/31/2018 6:55:51 AM,"CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov. ",RTTNews,/news/stocks/crsp-falls-on-clinical-hold-pfe-gets-fda-nod-arwr-to-report-data-in-nov-1025940055,positive,0.6973182559013367
947,6/1/2018 12:15:47 PM,Intelligent Investor - June 1 ,RTTNews,/news/stocks/intelligent-investor-june-1-1026099845,positive,0.9067522287368774
948,6/1/2018 1:48:39 PM,Pfizer Gets Positive CHMP Opinion For Oncology Biosimilar Trazimera ,RTTNews,/news/stocks/pfizer-gets-positive-chmp-opinion-for-oncology-biosimilar-trazimera-1026107970,negative,0.9450399279594421
949,6/6/2018 2:05:00 PM,Pfizer pumps $600 mln into venture capital arm,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/73yMhe1griY/pfizer-pumps-600-mln-into-venture-capital-arm-idUSL3N1T75N2,positive,0.7378226518630981
950,6/6/2018 2:18:29 PM,Pfizer pumps $600 million into venture capital arm,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ylJCm3JOb4w/pfizer-pumps-600-million-into-venture-capital-arm-idUSKCN1J21GO,positive,0.6959874033927917
951,6/6/2018 2:35:26 PM,Pfizer To Expand Venture Investing With $600 Mln Commitment To Pfizer Venture ,RTTNews,/news/stocks/pfizer-to-expand-venture-investing-with-600-mln-commitment-to-pfizer-venture-1026703225,negative,0.8328637480735779
952,6/7/2018 2:16:27 PM,Pfizer Granted FDA Priority Review For Talazoparib - Quick Facts ,RTTNews,/news/stocks/pfizer-granted-fda-priority-review-for-talazoparib-quick-facts-1026779932,negative,0.8400704264640808
953,6/7/2018 6:11:43 PM,Pfizer wins appeal against UK fine for epilepsy drug price hike,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Kq3-XO0hHd8/pfizer-wins-appeal-against-uk-fine-for-epilepsy-drug-price-hike-idUSL5N1T95EA,neutral,0.7274214625358582
954,6/21/2018 12:20:16 PM,In The Spotlight: Sangamo Therapeutics ,RTTNews,/news/stocks/in-the-spotlight-sangamo-therapeutics-1027306883,positive,0.9068710207939148
955,6/25/2018 2:30:57 PM,Pfizer Records Overall Survival In Metastatic Breast Cancer Study Using Ibrance ,RTTNews,/news/stocks/pfizer-records-overall-survival-in-metastatic-breast-cancer-study-using-ibrance-1027314605,negative,0.6847902536392212
956,6/27/2018 2:11:12 PM,FDA Grants Priority Review For Pfizer's NDA For Glasdegib - Quick Facts ,RTTNews,/news/stocks/fda-grants-priority-review-for-pfizer-s-nda-for-glasdegib-quick-facts-1027322318,positive,0.5801653861999512
957,6/28/2018 8:03:05 AM,"ACRX Gets EC Nod, AQXP Tanks As LEADERSHIP 301 Fails, ZSAN Catches Eye ",RTTNews,/news/stocks/acrx-gets-ec-nod-aqxp-tanks-as-leadership-301-fails-zsan-catches-eye-1027324885,neutral,0.6022970080375671
958,6/29/2018 4:09:00 PM,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's Affirms Four Classes of GCCFC 2005-GG3",Moodys,/news/bonds/greenwich-capital-commercial-funding-corp-2005-gg3-moody-s-affirms-four-classes-of-gccfc-2005-gg3-1027331363,positive,0.8717473149299622
959,6/29/2018 4:12:00 PM,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's Affirms Four Classes of GCCFC 2005-GG3",Moodys,/news/bonds/greenwich-capital-commercial-funding-corp-2005-gg3-moody-s-affirms-four-classes-of-gccfc-2005-gg3-1027331364,positive,0.8717473149299622
960,7/3/2018 11:33:36 AM,Remember When Was The Last Time A New Alzheimer's Drug Was Approved? ,RTTNews,/news/stocks/remember-when-was-the-last-time-a-new-alzheimer-s-drug-was-approved-1027337782,positive,0.9172612428665161
961,7/9/2018 8:28:36 PM,UPDATE 1-Trump slams Pfizer after July 1 drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/YyP1ztZ1LEQ/update-1-trump-slams-pfizer-after-july-1-drug-price-hikes-idUSL1N1U50XH,positive,0.6226963400840759
962,7/9/2018 8:35:10 PM,Trump slams Pfizer after July 1 drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/EwmPO9yFh4U/trump-slams-pfizer-after-july-1-drug-price-hikes-idINKBN1JZ2B0,neutral,0.8425835967063904
963,7/9/2018 10:10:03 PM,UPDATE 2-Trump slams Pfizer after July 1 drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/1tCUQfT2iHQ/update-2-trump-slams-pfizer-after-july-1-drug-price-hikes-idUSL1N1U50XH,positive,0.5736539959907532
964,7/9/2018 10:37:51 PM,UPDATE 3-Trump slams Pfizer after July 1 drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/VbuurlxtsgA/update-3-trump-slams-pfizer-after-july-1-drug-price-hikes-idUSL1N1U50XH,positive,0.5781117081642151
965,7/10/2018 5:17:23 PM,Trump Attacks Pfizer For Drug Price Hikes ,RTTNews,/news/stocks/trump-attacks-pfizer-for-drug-price-hikes-1027355562,neutral,0.8793381452560425
966,7/11/2018 12:58:58 AM,Trump says Pfizer is rolling back drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/YtOuP8aDYb8/trump-says-pfizer-is-rolling-back-drug-price-hikes-idUSKBN1K0323,negative,0.7226583957672119
967,7/11/2018 1:02:04 AM,Trump says Pfizer is rolling back drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/9JNEBTWigs8/trump-says-pfizer-is-rolling-back-drug-price-hikes-idINKBN1K032I,negative,0.7226583957672119
968,7/11/2018 1:55:34 AM,UPDATE 1-Pfizer says delaying drug price hikes after Trump conversation,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/R3qghEoctZM/update-1-pfizer-says-delaying-drug-price-hikes-after-trump-conversation-idUSL1N1U624D,negative,0.5554378628730774
969,7/11/2018 1:58:30 AM,Pfizer says delaying drug price hikes after Trump conversation,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/yBJoJ29vlqo/pfizer-says-delaying-drug-price-hikes-after-trump-conversation-idUSKBN1K0323,negative,0.4455071687698364
970,7/11/2018 2:01:08 AM,Pfizer says delaying drug price hikes after Trump conversation,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/CgceOqfF-zY/pfizer-says-delaying-drug-price-hikes-after-trump-conversation-idINKBN1K032I,negative,0.4455071687698364
971,7/11/2018 2:23:03 AM,Pfizer To Defer Price Increases ,RTTNews,/news/stocks/pfizer-to-defer-price-increases-1027356622,positive,0.8881904482841492
972,7/11/2018 3:19:54 AM,UPDATE 2-Pfizer delays drug price hikes after talking with Trump,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ErOK5NbJU6o/update-2-pfizer-delays-drug-price-hikes-after-talking-with-trump-idUSL1N1U624D,positive,0.380046546459198
973,7/11/2018 3:20:32 AM,Pfizer delays drug price hikes after talking with Trump,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/4AXJvzbn1kc/pfizer-delays-drug-price-hikes-after-talking-with-trump-idUSKBN1K0323,positive,0.6898320317268372
974,7/11/2018 3:31:33 AM,Pfizer delays drug price hikes after talking with Trump,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/WLgb1t7tpTY/pfizer-delays-drug-price-hikes-after-talking-with-trump-idINKBN1K032I,positive,0.6898320317268372
975,7/11/2018 12:48:08 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, TSLA, FOXA, PFE)",Business Insider,http://markets.businessinsider.com/news/stocks/stock-market-news-opening-bell-july-11-2018-2018-7-1027357894,positive,0.9473786950111389
976,7/11/2018 1:00:48 PM,Pfizer Inc to reorganize company into three units,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/edEzivS0r5Y/pfizer-inc-to-reorganize-company-into-three-units-idUSL4N1U743D,positive,0.9457908868789673
977,7/11/2018 1:02:51 PM,Pfizer Inc to reorganize company into three units,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ciwwx08y32Q/pfizer-inc-to-reorganize-company-into-three-units-idUSKBN1K11HG,positive,0.9457908868789673
978,7/11/2018 1:04:00 PM,Pfizer To Organize Into Three Businesses - Quick Facts ,RTTNews,/news/stocks/pfizer-to-organize-into-three-businesses-quick-facts-1027357955,positive,0.9243670701980591
979,7/11/2018 1:28:36 PM,UPDATE 1-Pfizer Inc to split company into three units,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/G9KzYdy1AxY/update-1-pfizer-inc-to-split-company-into-three-units-idUSL4N1U744H,positive,0.9222045540809631
980,7/11/2018 1:33:13 PM,Pfizer Inc to split company into three units,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/g4bfBWuAuOI/pfizer-inc-to-split-company-into-three-units-idUSKBN1K11HG,positive,0.9402379989624023
981,7/11/2018 1:44:43 PM,Pfizer Inc to split company into three units,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/0RWCB66jvko/pfizer-inc-to-split-company-into-three-units-idINKBN1K11LI,positive,0.9402379989624023
982,7/11/2018 3:04:10 PM,"UPDATE 2-Pfizer to split into three units, separates consumer healthcare",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/05HU-MEEkQM/update-2-pfizer-to-split-into-three-units-separates-consumer-healthcare-idUSL4N1U744H,positive,0.9118629097938538
983,7/11/2018 3:05:19 PM,"Pfizer to split into three units, separates consumer healthcare",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Of3YLebD6eQ/pfizer-to-split-into-three-units-separates-consumer-healthcare-idINKBN1K11LI,positive,0.917481005191803
984,7/11/2018 3:05:42 PM,"Pfizer to split into three units, separates consumer healthcare",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/wteeKjS_sEM/pfizer-to-split-into-three-units-separates-consumer-healthcare-idUSKBN1K11HG,positive,0.917481005191803
985,7/11/2018 4:49:08 PM,"Exclusive: Trump, Pfizer CEO Ian Read spoke about drug pricing - source",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/YKyzleaLefU/exclusive-trump-pfizer-ceo-ian-read-spoke-about-drug-pricing-source-idUSKBN1K124O,positive,0.9455289244651794
986,7/11/2018 4:53:37 PM,"Exclusive: Trump, Pfizer CEO Ian Read spoke about drug pricing: source",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/sysg1C-iZi0/exclusive-trump-pfizer-ceo-ian-read-spoke-about-drug-pricing-source-idINKBN1K124I,positive,0.9419573545455933
987,7/11/2018 5:08:43 PM,"UPDATE 1-Trump, Pfizer CEO Ian Read spoke about drug pricing -source",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Z5TgisUExYs/update-1-trump-pfizer-ceo-ian-read-spoke-about-drug-pricing-source-idUSL1N1U70SV,positive,0.9337064027786255
988,7/11/2018 5:11:41 PM,"Trump, Pfizer CEO Ian Read spoke about drug pricing: source",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/X6Gpi0UXhZI/trump-pfizer-ceo-ian-read-spoke-about-drug-pricing-source-idUSKBN1K124O,positive,0.9393512606620789
989,7/11/2018 5:22:20 PM,UPDATE 2-Trump told Pfizer CEO price hikes hurt his drug plan -source,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/WLAkgMhMAN0/update-2-trump-told-pfizer-ceo-price-hikes-hurt-his-drug-plan-source-idUSL1N1U70SV,neutral,0.9253549575805664
990,7/11/2018 5:27:22 PM,Trump told Pfizer CEO price hikes hurt his drug plan: source,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/pCV-isEOGf0/trump-told-pfizer-ceo-price-hikes-hurt-his-drug-plan-source-idINKBN1K124I,neutral,0.5778299570083618
991,7/11/2018 5:32:14 PM,Trump told Pfizer CEO price hikes hurt his drug plan: source,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/0RzFHWXzdxI/trump-told-pfizer-ceo-price-hikes-hurt-his-drug-plan-source-idUSKBN1K124O,neutral,0.5778299570083618
992,7/11/2018 7:22:16 PM,UPDATE 3-Pfizer separates consumer health unit in business rejig,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ZG2TJF5lI38/update-3-pfizer-separates-consumer-health-unit-in-business-rejig-idUSL4N1U744H,positive,0.8679786920547485
993,7/11/2018 7:24:46 PM,Pfizer separates consumer health unit in business rejig,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/moiHQpBkJVc/pfizer-separates-consumer-health-unit-in-business-rejig-idUSKBN1K11HG,positive,0.93769371509552
994,7/11/2018 9:19:56 PM,UPDATE 3-Trump told Pfizer CEO price hikes hurt his drug plan -source,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/CTLVwkONqig/update-3-trump-told-pfizer-ceo-price-hikes-hurt-his-drug-plan-source-idUSL1N1U70SV,neutral,0.9233579039573669
995,7/18/2018 12:18:52 PM,UPDATE 3-Novartis joins Pfizer in halting U.S. drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/QuaTmfKlnSc/update-3-novartis-joins-pfizer-in-halting-u-s-drug-price-hikes-idUSL8N1UE0P8,negative,0.8902865052223206
996,7/18/2018 12:19:33 PM,Novartis joins Pfizer in halting U.S. drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/UB4ZFmUTvA0/novartis-joins-pfizer-in-halting-u-s-drug-price-hikes-idUSKBN1K80D0,negative,0.7933792471885681
997,7/18/2018 12:53:38 PM,Novartis joins Pfizer in halting U.S. drug price hikes,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/64j0cX9HneM/novartis-joins-pfizer-in-halting-u-s-drug-price-hikes-idINKBN1K819Q,negative,0.7933792471885681
998,7/18/2018 12:55:49 PM,Pfizer And Lilly Announce Positive Results From Phase 3 Trial Of Tanezumab ,RTTNews,/news/stocks/pfizer-and-lilly-announce-positive-results-from-phase-3-trial-of-tanezumab-1027377487,negative,0.87937992811203
999,7/18/2018 12:57:28 PM,Pfizer-Lilly pain drug found effective in late-stage study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/tnoeZmBeXcI/pfizer-lilly-pain-drug-found-effective-in-late-stage-study-idUSL4N1UE3T4,negative,0.9319434762001038
1000,7/18/2018 1:15:56 PM,UPDATE 1-Pfizer-Lilly pain drug found effective in late-stage study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qid6MKP_X1Y/update-1-pfizer-lilly-pain-drug-found-effective-in-late-stage-study-idUSL4N1UE3U5,negative,0.9393114447593689
1001,7/18/2018 1:18:18 PM,Pfizer-Lilly pain drug found effective in late-stage study,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/_ZAO9Y7zU2c/pfizer-lilly-pain-drug-found-effective-in-late-stage-study-idINKBN1K81CV,negative,0.9319434762001038
1002,7/18/2018 2:49:55 PM,UPDATE 2-Pfizer-Lilly pain drug meets late-stage trial goals,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/STND2wsZaDs/update-2-pfizer-lilly-pain-drug-meets-late-stage-trial-goals-idUSL4N1UE3U5,positive,0.5111141204833984
1003,7/18/2018 2:51:39 PM,Pfizer-Lilly pain drug meets late-stage trial goals,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/6ihUiMzExcs/pfizer-lilly-pain-drug-meets-late-stage-trial-goals-idINKBN1K81CV,positive,0.7461740374565125
1004,7/19/2018 12:32:52 PM,"Trump thanks Novartis, Pfizer for not raising drug prices",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/DPhUg4phFVA/trump-thanks-novartis-pfizer-for-not-raising-drug-prices-idUSL1N1UF078,negative,0.7308104038238525
1005,7/19/2018 12:50:41 PM,"UPDATE 1-Trump thanks Novartis, Pfizer for not raising drug prices",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/FIp408r370I/update-1-trump-thanks-novartis-pfizer-for-not-raising-drug-prices-idUSL1N1UF07J,negative,0.7229896783828735
1006,7/19/2018 12:52:02 PM,"Trump thanks Novartis, Pfizer for not raising drug prices",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/9QBGyvmr6HE/trump-thanks-novartis-pfizer-for-not-raising-drug-prices-idINKBN1K91FM,negative,0.7308104038238525
1007,7/23/2018 6:01:01 AM,"FDA Nod For AGIO's AML Drug, 2nd Neupogen Biosim Gets Green Light, BGNE On Watch ",RTTNews,/news/stocks/fda-nod-for-agio-s-aml-drug-2nd-neupogen-biosim-gets-green-light-bgne-on-watch-1027388118,negative,0.7324383854866028
1008,7/23/2018 1:43:54 PM,"Leap Therapeutics To Collaborate With Merck, Pfizer To Evaluate TRX518 ",RTTNews,/news/stocks/leap-therapeutics-to-collaborate-with-merck-pfizer-to-evaluate-trx518-1027389517,positive,0.6518607139587402
1009,7/25/2018 3:41:44 AM,"Pfizer To Build Sterile Injectable Facility In Michigan, Create About 450 Jobs ",RTTNews,/news/stocks/pfizer-to-build-sterile-injectable-facility-in-michigan-create-about-450-jobs-1027396371,negative,0.7695980072021484
1010,7/26/2018 9:39:05 AM,Biotech Stocks Facing FDA Decision In August ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-august-1027401882,positive,0.6419674754142761
1011,7/29/2018 3:02:00 PM,Here's what Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-stock-price-quarter-earnings-preview-q2-1027409167,positive,0.926646888256073
1012,7/31/2018 9:00:00 AM,Pfizer's New Report Shows How Behavioural Science Can Help Boost Preventative Healthcare Measures,PR Newswire,/news/stocks/pfizer-s-new-report-shows-how-behavioural-science-can-help-boost-preventative-healthcare-measures-1027414712,negative,0.8704105615615845
1013,7/31/2018 9:00:00 AM,Pfizer's New Report Shows How Behavioural Science Can Help Boost Preventative Healthcare Measures,PR Newswire,/news/stocks/pfizer-s-new-report-shows-how-behavioural-science-can-help-boost-preventative-healthcare-measures-1027414717,negative,0.8704105615615845
1014,7/31/2018 12:47:56 PM,Pfizer Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q2-adjusted-earnings-beat-estimates-1027415510,negative,0.8150341510772705
1015,7/31/2018 12:53:06 PM,Pfizer profit rises 26 pct,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/2jesF3DtQeY/pfizer-profit-rises-26-pct-idUSL4N1UR539,negative,0.7685068249702454
1016,7/31/2018 1:14:19 PM,"UPDATE 1-Pfizer beats profit estimates on higher sales of Prevnar, Xeljanz",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/sbQmXi48nak/update-1-pfizer-beats-profit-estimates-on-higher-sales-of-prevnar-xeljanz-idUSL4N1UR547,negative,0.9270383715629578
1017,7/31/2018 1:15:09 PM,"Pfizer beats profit estimates on higher sales of Prevnar, Xeljanz",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/WRovQbd4G2k/pfizer-beats-profit-estimates-on-higher-sales-of-prevnar-xeljanz-idINKBN1KL1J0,negative,0.9339089393615723
1018,7/31/2018 1:16:02 PM,"Pfizer beats profit estimates on higher sales of Prevnar, Xeljanz",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/87r5jrCwwGc/pfizer-beats-profit-estimates-on-higher-sales-of-prevnar-xeljanz-idUSKBN1KL1GU,negative,0.9339089393615723
1019,7/31/2018 1:32:01 PM,Pfizer Q2 Profit Tops Estimates; Raises 2018 Earnings Guidance ,RTTNews,/news/stocks/pfizer-q2-profit-tops-estimates-raises-2018-earnings-guidance-1027415859,negative,0.9308891296386719
1020,7/31/2018 2:23:22 PM,UPDATE 2-Pfizer beats profit estimates but lowers 2018 revenue forecast,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/uirpK0UOovo/update-2-pfizer-beats-profit-estimates-but-lowers-2018-revenue-forecast-idUSL4N1UR547,neutral,0.9664261341094971
1021,7/31/2018 2:24:11 PM,Pfizer beats profit estimates but lowers 2018 revenue forecast,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Bq90YFFTSeQ/pfizer-beats-profit-estimates-but-lowers-2018-revenue-forecast-idINKBN1KL1J0,neutral,0.970455527305603
1022,7/31/2018 2:24:35 PM,Pfizer beats profit estimates but lowers 2018 revenue forecast,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/UFPuZzfHOs8/pfizer-beats-profit-estimates-but-lowers-2018-revenue-forecast-idUSKBN1KL1GU,neutral,0.970455527305603
1023,7/31/2018 4:01:11 PM,"UPDATE 3-Pfizer lowers 2018 revenue forecast, increases R&D spend",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/m9J7otp-uaM/update-3-pfizer-lowers-2018-revenue-forecast-increases-rd-spend-idUSL4N1UR547,neutral,0.9632272124290466
1024,7/31/2018 4:04:19 PM,"Pfizer lowers 2018 revenue forecast, increases R&D spend",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ezeu-JUPj5Q/pfizer-lowers-2018-revenue-forecast-increases-rd-spend-idUSKBN1KL1GU,neutral,0.9436349272727966
1025,7/31/2018 4:07:58 PM,"Pfizer lowers 2018 revenue forecast, increases R&D spend",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/P04ZwwjW5U0/pfizer-lowers-2018-revenue-forecast-increases-rd-spend-idINKBN1KL1J0,neutral,0.9436349272727966
1026,7/31/2018 5:23:55 PM,Pfizer CEO believes U.S. will eliminate rebates on prescription drugs,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/9MHGH1ZcdnQ/pfizer-ceo-believes-u-s-will-eliminate-rebates-on-prescription-drugs-idUSL1N1UR0WT,positive,0.6151459813117981
1027,7/31/2018 5:24:39 PM,Pfizer CEO believes U.S. will eliminate rebates on prescription drugs,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/915yZ92-Nuk/pfizer-ceo-believes-u-s-will-eliminate-rebates-on-prescription-drugs-idUSKBN1KL297,positive,0.6151459813117981
1028,7/31/2018 5:30:35 PM,Pfizer CEO believes U.S. will eliminate rebates on prescription drugs,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/_jYuSPzgqlM/pfizer-ceo-believes-u-s-will-eliminate-rebates-on-prescription-drugs-idINKBN1KL29E,positive,0.6151459813117981
1029,7/31/2018 8:23:12 PM,UPDATE 4-Pfizer CEO expects Trump to eliminate drug rebates,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/VzQTbEoERCE/update-4-pfizer-ceo-expects-trump-to-eliminate-drug-rebates-idUSL4N1UR547,negative,0.45420771837234497
1030,7/31/2018 8:26:14 PM,Pfizer CEO expects Trump to eliminate drug rebates,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/IDel_9G228A/pfizer-ceo-expects-trump-to-eliminate-drug-rebates-idUSKBN1KL1GU,positive,0.7004239559173584
1031,7/31/2018 8:46:00 PM,Pfizer CEO expects Trump to eliminate drug rebates,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/7cfk8g52VF4/pfizer-ceo-expects-trump-to-eliminate-drug-rebates-idINKBN1KL1J0,positive,0.7004239559173584
1032,8/1/2018 7:11:00 AM,Pfizer: XELJANZ Gets Marketing Authorization In EU For Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-xeljanz-gets-marketing-authorization-in-eu-for-ulcerative-colitis-1027419454,negative,0.8807441592216492
1033,8/2/2018 6:50:19 PM,Allergan sues Pfizer over costs of opioid litigation,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/JmGd5hywsZ0/allergan-sues-pfizer-over-costs-of-opioid-litigation-idUSKBN1KN2H8,neutral,0.9386025071144104
1034,8/2/2018 8:09:00 PM,Moody's: US drug makers face heightened pricing pressure as regulatory risks pick up steam,Moodys,/news/bonds/moody-s-us-drug-makers-face-heightened-pricing-pressure-as-regulatory-risks-pick-up-steam-1027427408,neutral,0.8253992795944214
1035,8/2/2018 10:09:29 PM,CORRECTED-Allergan sues Pfizer over costs of opioid litigation,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/C9I3NbQLh4A/corrected-allergan-sues-pfizer-over-costs-of-opioid-litigation-idUSL1N1UT13V,neutral,0.9233886003494263
1036,8/2/2018 10:10:52 PM,Corrected - Allergan sues Pfizer over costs of opioid litigation,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/RD1JDpbZfY0/corrected-allergan-sues-pfizer-over-costs-of-opioid-litigation-idINKBN1KN2JK,neutral,0.9233886003494263
1037,8/2/2018 10:42:22 PM,UPDATE 1-Allergan sues Pfizer over costs of opioid litigation,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/kppxj5V46Gw/update-1-allergan-sues-pfizer-over-costs-of-opioid-litigation-idUSL1N1UT1SM,neutral,0.9434146285057068
1038,8/3/2018 1:42:31 AM,Allergan sues Pfizer over costs of opioid litigation,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/VJSH-664n7M/allergan-sues-pfizer-over-costs-of-opioid-litigation-idINKBN1KN2JK,neutral,0.9386025071144104
1039,8/6/2018 1:31:41 PM,"Antares Pharma, Pfizer To Develop Drug Device Rescue Pen - Quick Facts ",RTTNews,/news/stocks/antares-pharma-pfizer-to-develop-drug-device-rescue-pen-quick-facts-1027433656,positive,0.7966335415840149
1040,8/11/2018 5:17:06 AM,"Week Ahead In Pharmaceuticals: 5 Stocks To Watch (REGN, PFE, ALT...) ",RTTNews,/news/stocks/week-ahead-in-pharmaceuticals-5-stocks-to-watch-regn-pfe-alt-1027451315,positive,0.8848251700401306
1041,8/15/2018 8:16:10 AM,ViiV Healthcare: ATLAS Study Meets Primary Endpoint - Quick Facts ,RTTNews,/news/stocks/viiv-healthcare-atlas-study-meets-primary-endpoint-quick-facts-1027459578,positive,0.7184225916862488
1042,8/16/2018 7:00:00 AM,Pfizer bets on biotech flu vaccine in $425 mln BioNTech alliance,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/mXYUEQpzTTo/pfizer-bets-on-biotech-flu-vaccine-in-425-mln-biontech-alliance-idUSL5N1V62V2,negative,0.5004404187202454
1043,8/16/2018 12:07:59 PM,"BioNTech, Pfizer To Develop MRNA-based Vaccines For Prevention Of Influenza ",RTTNews,/news/stocks/biontech-pfizer-to-develop-mrna-based-vaccines-for-prevention-of-influenza-1027463700,positive,0.7231829166412354
1044,8/17/2018 10:10:51 AM,New Drugs Approved In July ,RTTNews,/news/stocks/new-drugs-approved-in-july-1027466563,positive,0.6490791440010071
1045,8/22/2018 1:35:04 PM,Exact Sciences & Pfizer To Co-promote Cologuard ,RTTNews,/news/stocks/exact-sciences-pfizer-to-co-promote-cologuard-1027476662,positive,0.8497360348701477
1046,8/22/2018 4:04:40 PM,UPDATE 1-Exact Sciences surges after marketing deal with Pfizer for cancer test,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/mMU2BC1rPcI/update-1-exact-sciences-surges-after-marketing-deal-with-pfizer-for-cancer-test-idUSL3N1VD446,negative,0.9109390377998352
1047,8/22/2018 11:39:12 PM,"Pfizer, Astellas revise two cancer drug trial protocols to speed up results",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/duqA-KNfV7E/pfizer-astellas-revise-two-cancer-drug-trial-protocols-to-speed-up-results-idUSL3N1VD51N,negative,0.6786723136901855
1048,8/23/2018 3:07:40 AM,"EXAS Soars On Pfizer Deal, MYND Delighted, ADMP Faces FDA In Sep. ",RTTNews,/news/stocks/exas-soars-on-pfizer-deal-mynd-delighted-admp-faces-fda-in-sep-1027478583,positive,0.37371236085891724
1049,8/29/2018 1:59:09 AM,Pfizer Recalls Children's Advil Recall Due To Overdose Concerns ,RTTNews,/news/stocks/pfizer-recalls-children-s-advil-recall-due-to-overdose-concerns-1027491713,neutral,0.9574073553085327
1050,8/30/2018 2:19:17 PM,Pfizer Terminates Two Duchenne Muscular Dystrophy Studies ,RTTNews,/news/stocks/pfizer-terminates-two-duchenne-muscular-dystrophy-studies-1027497096,neutral,0.8407398462295532
1051,8/31/2018 12:05:59 PM,Biotech Stocks Facing FDA Decision In September ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-1027499929,positive,0.6874357461929321
1052,9/4/2018 4:36:00 PM,Pfizer Inc. -- Moody's assigns A1 rating to Pfizer's notes; stable outlook,Moodys,/news/bonds/pfizer-inc-moody-s-assigns-a1-rating-to-pfizer-s-notes-stable-outlook-1027506613,negative,0.726119339466095
1053,9/5/2018 4:02:16 AM,Pfizer Prices $5bln Debt Offering ,RTTNews,/news/stocks/pfizer-prices-5bln-debt-offering-1027507818,positive,0.9368409514427185
1054,9/5/2018 2:55:25 PM,Pfizer Gets Breakthrough Therapy Designation From FDA For PF-06651600 ,RTTNews,/news/stocks/pfizer-gets-breakthrough-therapy-designation-from-fda-for-pf-06651600-1027509919,negative,0.7687101364135742
1055,9/11/2018 2:44:03 PM,"Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study ",RTTNews,/news/stocks/merck-pfizer-report-positive-top-line-results-from-phase-iii-javelin-101-study-1027524514,negative,0.9534876346588135
1056,9/14/2018 11:28:30 AM,ViiV Files Application To EMA For Two-drug Regimen To Treat HIV - Quick Facts ,RTTNews,/news/stocks/viiv-files-application-to-ema-for-two-drug-regimen-to-treat-hiv-quick-facts-1027535104,negative,0.6983954906463623
1057,9/15/2018 1:56:52 PM,Pfizer Reports Positive Phase 2 Data Of JAK Inhibitors In Alopecia Areata ,RTTNews,/news/stocks/pfizer-reports-positive-phase-2-data-of-jak-inhibitors-in-alopecia-areata-1027537317,negative,0.9439502358436584
1058,9/17/2018 2:08:06 PM,Atomwise Enters Evaluation Agreement With Pfizer - Quick Facts ,RTTNews,/news/stocks/atomwise-enters-evaluation-agreement-with-pfizer-quick-facts-1027539391,negative,0.9311400651931763
1059,9/18/2018 9:23:35 AM,"Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam ",RTTNews,/news/stocks/pharma-companies-avoid-3-8-bln-in-tax-per-year-says-oxfam-1027542053,negative,0.7368782758712769
1060,9/18/2018 3:16:20 PM,Pfizer Reports Addl Analyses From Tafamidis Phase 3 ATTR-ACT Study ,RTTNews,/news/stocks/pfizer-reports-addl-analyses-from-tafamidis-phase-3-attr-act-study-1027543962,positive,0.9155892729759216
1061,9/20/2018 2:05:21 PM,Pfizer: PF-06482077 Receives Breakthrough Therapy Designation - Quick Facts ,RTTNews,/news/stocks/pfizer-pf-06482077-receives-breakthrough-therapy-designation-quick-facts-1027550933,positive,0.814031720161438
1062,9/24/2018 3:20:35 PM,Astellas Pharma Gets Positive CHMP Opinion For Xtandi - Quick Facts ,RTTNews,/news/stocks/astellas-pharma-gets-positive-chmp-opinion-for-xtandi-quick-facts-1027559007,negative,0.9377830028533936
1063,9/28/2018 5:12:12 AM,FDA Approves Pfizer's Lung Cancer Drug ,RTTNews,/news/stocks/fda-approves-pfizer-s-lung-cancer-drug-1027572986,positive,0.769966721534729
1064,9/28/2018 8:46:11 AM,QIAGEN Receives FDA Approval To Expand Use Of EGFR Test In Lung Cancer ,RTTNews,/news/stocks/qiagen-receives-fda-approval-to-expand-use-of-egfr-test-in-lung-cancer-1027573539,negative,0.9408321380615234
1065,10/1/2018 12:46:54 PM,Pfizer CEO to step down,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/-KwBAaGTVSE/pfizer-ceo-to-step-down-idUSL4N1WH368,positive,0.5345095992088318
1066,10/1/2018 12:50:01 PM,Pfizer CEO to step down,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/hdD25glqHok/pfizer-ceo-to-step-down-idINKCN1MB29F,positive,0.5345095992088318
1067,10/1/2018 12:52:45 PM,Pfizer CEO to step down,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/41TBcCuoW90/pfizer-ceo-to-step-down-idUSKCN1MB29D,positive,0.5345095992088318
1068,10/1/2018 12:55:58 PM,Pfizer: Albert Bourla To Succeed Ian Read As CEO Effective Jan. 1 ,RTTNews,/news/stocks/pfizer-albert-bourla-to-succeed-ian-read-as-ceo-effective-jan-1-1027578347,positive,0.9185751080513
1069,10/1/2018 1:03:09 PM,UPDATE 1-Pfizer CEO Ian Read to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/kX10tx-gsxY/update-1-pfizer-ceo-ian-read-to-step-down-next-year-idUSL4N1WH36X,positive,0.5916049480438232
1070,10/1/2018 1:12:58 PM,Pfizer CEO Ian Read to step down next year,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/yt4Uk16qj8g/pfizer-ceo-ian-read-to-step-down-next-year-idUSKCN1MB29D,positive,0.6513529419898987
1071,10/1/2018 1:32:07 PM,UPDATE 2-Pfizer replaces longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/CkuSmp2EAsA/update-2-pfizer-replaces-longtime-ceo-read-with-veteran-bourla-idUSL4N1WH36X,positive,0.5375403761863708
1072,10/1/2018 1:33:06 PM,Pfizer's long-serving CEO Ian Read is standing down and being replaced by his chief operating officer (PFE),Business Insider,https://www.businessinsider.com/pfizer-ceo-ian-read-to-step-down-2018-10,neutral,0.5902838110923767
1073,10/1/2018 1:33:14 PM,Pfizer replaces longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/43iOPCMRRY8/pfizer-replaces-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D,neutral,0.5921254754066467
1074,10/1/2018 2:25:17 PM,UPDATE 3-Pfizer replaces long-time CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Ayqv-jjXSMA/update-3-pfizer-replaces-long-time-ceo-read-with-veteran-bourla-idUSL4N1WH36X,positive,0.6359444856643677
1075,10/1/2018 2:26:18 PM,Pfizer replaces long-time CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/7CDRE0X6G8A/pfizer-replaces-long-time-ceo-read-with-veteran-bourla-idINKCN1MB29F,neutral,0.5446889400482178
1076,10/1/2018 2:28:39 PM,Pfizer replaces long-time CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/BPPOmIYUEhs/pfizer-replaces-long-time-ceo-read-with-veteran-bourla-idUSKCN1MB29D,neutral,0.5446889400482178
1077,10/1/2018 4:03:03 PM,Pfizer's CEO is stepping down after 8 years — meet the man who will be replacing him (PFE),Business Insider,https://www.businessinsider.com/who-is-albert-bourla-next-pfizer-ceo-2018-10,positive,0.8651015758514404
1078,10/1/2018 5:18:00 PM,UPDATE 4-Pfizer to replace longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/m8TshOn36Zg/update-4-pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSL4N1WH36X,positive,0.742987871170044
1079,10/1/2018 5:18:41 PM,Pfizer to replace longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/BkgU3xZIbtQ/pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D,positive,0.7981671094894409
1080,10/1/2018 6:00:36 PM,Pfizer to replace longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/tBkmxbQxbUY/pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idINKCN1MB29F,positive,0.7981671094894409
1081,10/1/2018 6:54:30 PM,UPDATE 5-Pfizer to replace longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/oc7XiqrAtUA/update-5-pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSL4N1WH36X,positive,0.7352989315986633
1082,10/1/2018 8:34:03 PM,UPDATE 6-Pfizer to replace longtime CEO Read with veteran Bourla,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/wdeuEDPc8bY/update-6-pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSL4N1WH36X,positive,0.7234962582588196
1083,10/4/2018 9:19:00 AM,"Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US",Moodys,/news/bonds/moody-s-biosimilars-a-growing-challenge-biotech-drugs-with-european-market-developing-more-quickly-than-the-us-1027589140,negative,0.8536537885665894
1084,10/9/2018 1:27:07 PM,Myriad Signs Commercialization Plan With Pfizer - Quick Facts ,RTTNews,/news/stocks/myriad-signs-commercialization-plan-with-pfizer-quick-facts-1027600122,positive,0.7482592463493347
1085,10/9/2018 3:29:43 PM,Pfizer Announces New Executive Team - Quick Facts ,RTTNews,/news/stocks/pfizer-announces-new-executive-team-quick-facts-1027601162,positive,0.9172583222389221
1086,10/11/2018 7:25:05 PM,Pfizer settles New York probe into 'deceptive' copay coupons,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/aIn4qdrCAEQ/pfizer-settles-new-york-probe-into-deceptive-copay-coupons-idUSL2N1WR1GU,neutral,0.866078794002533
1087,10/11/2018 7:40:55 PM,Pfizer settles New York probe into 'deceptive' copay coupons,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/2AnJbztXiYI/pfizer-settles-new-york-probe-into-deceptive-copay-coupons-idINKCN1ML2KE,neutral,0.866078794002533
1088,10/12/2018 4:58:08 AM,"Pfizer To Pay $700,000 To Settle 'deceptive Advertising' Charges ",RTTNews,/news/stocks/pfizer-to-pay-700-000-to-settle-deceptive-advertising-charges-1027611061,neutral,0.809656023979187
1089,10/17/2018 6:38:18 PM,Pfizer to cut around 2 pct of jobs through early next year,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/0NAMfcn9v00/pfizer-to-cut-around-2-pct-of-jobs-through-early-next-year-idUSL2N1WX14L,neutral,0.966351330280304
1090,10/17/2018 6:42:12 PM,Pfizer to cut around 2 percent of jobs through early next year,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/MlNX31Vt3fo/pfizer-to-cut-around-2-percent-of-jobs-through-early-next-year-idINKCN1MR2KY,neutral,0.9701106548309326
1091,10/17/2018 7:03:01 PM,Pfizer to cut around 2 percent of jobs through early next year,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/eXNxaPNPLHA/pfizer-to-cut-around-2-percent-of-jobs-through-early-next-year-idUSKCN1MR2MA,neutral,0.9701106548309326
1092,10/18/2018 1:22:36 PM,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/xQSYUKKbxtg/merck-pfizer-combo-treatment-meets-main-goals-of-kidney-cancer-trial-idUSL3N1WY41M,negative,0.5255518555641174
1093,10/18/2018 1:27:23 PM,"Merck, Pfizer combo treatment meets main goals of kidney cancer trial",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/xmwnHLsseW4/merck-pfizer-combo-treatment-meets-main-goals-of-kidney-cancer-trial-idINKCN1MS1OF,negative,0.5255518555641174
1094,10/18/2018 1:36:14 PM,Merck Says Pivotal Phase 3 KEYNOTE-426 Trial Meets Both Primary Endpoints ,RTTNews,/news/stocks/merck-says-pivotal-phase-3-keynote-426-trial-meets-both-primary-endpoints-1027629567,negative,0.6148151755332947
1095,10/19/2018 4:08:16 AM,Court dismisses Australian watchdog's appeal against Pfizer ruling,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/2IWAlsvnrQ8/court-dismisses-australian-watchdogs-appeal-against-pfizer-ruling-idUSL3N1WZ1L4,neutral,0.7649768590927124
1096,10/19/2018 5:33:09 AM,UPDATE 1-Australian watchdog's appeal against Pfizer ruling dismissed by court,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Qdmq12RWf-I/update-1-australian-watchdogs-appeal-against-pfizer-ruling-dismissed-by-court-idUSL3N1WZ1Z0,neutral,0.5794450640678406
1097,10/23/2018 2:47:49 PM,Bain Capital And Pfizer Create New CNS Company Cerevel Therapeutics ,RTTNews,/news/stocks/bain-capital-and-pfizer-create-new-cns-company-cerevel-therapeutics-1027644241,positive,0.9092382192611694
1098,10/24/2018 12:40:01 AM,Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/HrKcAS89yKc/pfizer-lilly-non-opioid-drug-helps-reduce-osteoarthritis-pain-idUSL3N1X24QH,negative,0.7662447094917297
1099,10/24/2018 5:05:19 AM,CORRECTED-Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/42U63YBlNsI/corrected-pfizer-lilly-non-opioid-drug-helps-reduce-osteoarthritis-pain-idUSL3N1X24QH,negative,0.8112064599990845
1100,10/24/2018 7:39:15 AM,"CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr. ",RTTNews,/news/stocks/cmta-fast-tracks-nda-filing-usna-in-good-health-derm-to-report-data-in-apr-1027647548,positive,0.47431284189224243
1101,10/29/2018 7:15:00 AM,"Novartis, Pfizer join forces on potentially lucrative fatty liver disease",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/I5uLEKDAzVU/novartis-pfizer-join-forces-on-potentially-lucrative-fatty-liver-disease-idUSL8N1X66HA,negative,0.8129599690437317
1102,10/29/2018 7:25:23 AM,Pfizer In Clinical Development Deal With Novartis To Advance Treatment Of NASH ,RTTNews,/news/stocks/pfizer-in-clinical-development-deal-with-novartis-to-advance-treatment-of-nash-1027663873,negative,0.7975773215293884
1103,10/29/2018 7:55:33 AM,Biotech Stocks Facing FDA Decision In November ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-november-1027663957,positive,0.6474881172180176
1104,10/29/2018 12:56:19 PM,"ViiV Healthcare Presents Three-year Data For Injectable, Two-drug HIV Regimen ",RTTNews,/news/stocks/viiv-healthcare-presents-three-year-data-for-injectable-two-drug-hiv-regimen-1027665166,negative,0.7689506411552429
1105,10/29/2018 3:02:58 PM,Pfizer earnings preview: what to expect,Markets Insider Automation,/news/stocks/pfizer-quarter-earnings-preview-q3-1027666282,positive,0.9113932847976685
1106,10/30/2018 11:52:57 AM,Pfizer third-quarter profit jumps 45 pct,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/5WyGau7tQ3o/pfizer-third-quarter-profit-jumps-45-pct-idUSL3N1XA4NG,negative,0.810228168964386
1107,10/30/2018 11:54:16 AM,Pfizer third-quarter profit jumps 45 percent,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/4KxQLCcu5hc/pfizer-third-quarter-profit-jumps-45-percent-idINKCN1N41CC,negative,0.763755738735199
1108,10/30/2018 11:55:12 AM,Pfizer Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q3-adjusted-earnings-beat-estimates-1027670074,negative,0.8234495520591736
1109,10/30/2018 11:55:18 AM,Pfizer third-quarter profit jumps 45 percent,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/imkKbiLhPz8/pfizer-third-quarter-profit-jumps-45-percent-idUSKCN1N41CL,negative,0.763755738735199
1110,10/30/2018 11:59:22 AM,Pfizer Narrows 2018 Revenues Guidance ,RTTNews,/news/stocks/pfizer-narrows-2018-revenues-guidance-1027670106,neutral,0.754059910774231
1111,10/30/2018 12:22:28 PM,"UPDATE 1-Pfizer lowers revenue forecast on strong dollar, supply issues",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3kOBytIJFog/update-1-pfizer-lowers-revenue-forecast-on-strong-dollar-supply-issues-idUSL3N1XA4OC,neutral,0.9648409485816956
1112,10/30/2018 12:23:00 PM,"Pfizer lowers revenue forecast on strong dollar, supply issues",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/9-K9F1o29HU/pfizer-lowers-revenue-forecast-on-strong-dollar-supply-issues-idUSKCN1N41CL,neutral,0.935255229473114
1113,10/30/2018 12:32:13 PM,"Pfizer lowers revenue forecast on strong dollar, supply issues",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/EJU46kwj-zY/pfizer-lowers-revenue-forecast-on-strong-dollar-supply-issues-idINKCN1N41CC,neutral,0.935255229473114
1114,10/30/2018 1:31:31 PM,"UPDATE 2-Pfizer cuts revenue forecast as supply snags, dollar strength weigh",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vr26Hs0Clrk/update-2-pfizer-cuts-revenue-forecast-as-supply-snags-dollar-strength-weigh-idUSL3N1XA4OC,neutral,0.9677573442459106
1115,10/30/2018 1:33:43 PM,"Pfizer cuts revenue forecast as supply snags, dollar strength weigh",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/tfFFnWBAht4/pfizer-cuts-revenue-forecast-as-supply-snags-dollar-strength-weigh-idUSKCN1N41CL,neutral,0.9562318325042725
1116,10/30/2018 2:48:15 PM,"UPDATE 3-Pfizer cuts revenue forecast as supply snags, dollar strength weigh",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qDXaOypR51Q/update-3-pfizer-cuts-revenue-forecast-as-supply-snags-dollar-strength-weigh-idUSL3N1XA4OC,neutral,0.9680681824684143
1117,10/30/2018 2:50:21 PM,"Pfizer cuts revenue forecast as supply snags, dollar strength weigh",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/u8QQMRCS06o/pfizer-cuts-revenue-forecast-as-supply-snags-dollar-strength-weigh-idINKCN1N41CC,neutral,0.9562318325042725
1118,10/30/2018 3:35:38 PM,Pfizer CEO designate does not see need for large acquisitions,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/GiWqqURrNns/pfizer-ceo-designate-does-not-see-need-for-large-acquisitions-idUSL3N1XA5XK,positive,0.9177225232124329
1119,10/30/2018 7:06:01 PM,UPDATE 4-Pfizer revenue worse than expected as generic competition weighs,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/0ZI-IOShF0w/update-4-pfizer-revenue-worse-than-expected-as-generic-competition-weighs-idUSL3N1XA4OC,neutral,0.9735198020935059
1120,10/30/2018 7:07:32 PM,Pfizer revenue worse than expected as generic competition weighs,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/oB_GzzWU8EU/pfizer-revenue-worse-than-expected-as-generic-competition-weighs-idUSKCN1N41CL,neutral,0.974087655544281
1121,10/30/2018 7:11:05 PM,Pfizer revenue worse than expected as generic competition weighs,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/dG_qL6TeYsQ/pfizer-revenue-worse-than-expected-as-generic-competition-weighs-idINKCN1N41CC,neutral,0.974087655544281
1122,10/31/2018 3:29:12 PM,ViiV Healthcare Announces Positive Phase 3 Results From BRIGHTE Study ,RTTNews,/news/stocks/viiv-healthcare-announces-positive-phase-3-results-from-brighte-study-1027676935,negative,0.945395290851593
1123,11/1/2018 2:41:55 PM,Pfizer weighing sale of women's health portfolio - Bloomberg,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/uJCgESKOi8M/pfizer-weighing-sale-of-womens-health-portfolio-bloomberg-idUSL3N1XC57I,positive,0.9152396321296692
1124,11/6/2018 2:43:24 PM,Nektar Therapeutics And Pfizer Enter Into New Clinical Oncology Collaboration ,RTTNews,/news/stocks/nektar-therapeutics-and-pfizer-enter-into-new-clinical-oncology-collaboration-1027696663,positive,0.7256558537483215
1125,11/7/2018 5:09:00 PM,NMC Healthcare Sukuk Limited -- Moody's assigns Ba1 rating to NMC's trust certificates,Moodys,/news/bonds/nmc-healthcare-sukuk-limited-moody-s-assigns-ba1-rating-to-nmc-s-trust-certificates-1027703028,positive,0.6238893866539001
1126,11/14/2018 11:01:05 AM,Pfizer loses Lyrica drug patent fight in UK Supreme Court,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/dOGGxewXReg/pfizer-loses-lyrica-drug-patent-fight-in-uk-supreme-court-idUSL8N1XP3BN,neutral,0.8180528879165649
1127,11/14/2018 11:45:50 AM,UPDATE 1-Pfizer loses blockbuster drug patent fight in UK Supreme Court,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/5L_WYWgp6V8/update-1-pfizer-loses-blockbuster-drug-patent-fight-in-uk-supreme-court-idUSL8N1XP3S8,neutral,0.9316202998161316
1128,11/14/2018 11:49:49 AM,Pfizer loses blockbuster drug patent fight in UK Supreme Court,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Jm1ZypAY4RU/pfizer-loses-blockbuster-drug-patent-fight-in-uk-supreme-court-idUSKCN1NJ19S,neutral,0.8462511897087097
1129,11/14/2018 8:52:34 PM,"Pfizer loses drug patent fight in UK top court, may face claims",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/EYDJUfwX6PM/pfizer-loses-drug-patent-fight-in-uk-top-court-may-face-claims-idUSKCN1NJ19S,neutral,0.7922583222389221
1130,11/16/2018 9:23:07 PM,Pfizer plans to increase U.S. drug prices in January,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/WKbsawJrubc/pfizer-plans-to-increase-u-s-drug-prices-in-january-idUSL2N1XR1FR,negative,0.9352257251739502
1131,11/16/2018 9:39:20 PM,UPDATE 1-Pfizer plans to increase U.S. drug prices in January,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Rpcz0ZUlLss/update-1-pfizer-plans-to-increase-u-s-drug-prices-in-january-idUSL2N1XR1J2,negative,0.9400790929794312
1132,11/16/2018 11:22:52 PM,UPDATE 2-Pfizer to raise US drug prices in January after previously backing down,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/iVs7omr9YVk/update-2-pfizer-to-raise-us-drug-prices-in-january-after-previously-backing-down-idUSL2N1XR1J2,negative,0.9451310634613037
1133,11/18/2018 9:33:36 AM,"Pfizer Plans To Raise Prices On 41 Drugs In January, Despite Pressure From Trump ",RTTNews,/news/stocks/pfizer-plans-to-raise-prices-on-41-drugs-in-january-despite-pressure-from-trump-1027736378,negative,0.9457570910453796
1134,11/19/2018 1:30:45 PM,"Merck KGaA, Pfizer: JAVELIN Ovarian 200 Trial Did Not Meet Primary Endpoints ",RTTNews,/news/stocks/merck-kgaa-pfizer-javelin-ovarian-200-trial-did-not-meet-primary-endpoints-1027738244,neutral,0.6186050772666931
1135,11/21/2018 8:17:54 PM,UPDATE 2-FDA approves new blood cancer treatment from Pfizer,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/XvuH-KlsGg4/update-2-fda-approves-new-blood-cancer-treatment-from-pfizer-idUSL4N1XW4LY,negative,0.6813313961029053
1136,11/30/2018 4:13:54 PM,Pfizer Reaches Global Agreement With AbbVie; To Withdraw Pending Litigation ,RTTNews,/news/stocks/pfizer-reaches-global-agreement-with-abbvie-to-withdraw-pending-litigation-1027771392,neutral,0.4190761148929596
1137,12/3/2018 2:11:09 AM,"Pfizer Presents Positive Data For PF-05280586, Potential Biosimilar To Rituximab ",RTTNews,/news/stocks/pfizer-presents-positive-data-for-pf-05280586-potential-biosimilar-to-rituximab-1027773290,negative,0.943505048751831
1138,12/11/2018 5:30:06 PM,Pfizer Posting Notable Loss After Downgrade By J.P. Morgan ,RTTNews,/news/stocks/pfizer-posting-notable-loss-after-downgrade-by-j-p-morgan-1027799539,neutral,0.9344569444656372
1139,12/14/2018 2:24:39 PM,Pfizer Initiates Phase3 Program For 20-Valent Pneumococcal Conjugate Vaccine ,RTTNews,/news/stocks/pfizer-initiates-phase3-program-for-20-valent-pneumococcal-conjugate-vaccine-1027810236,positive,0.7013704180717468
1140,12/19/2018 8:16:06 AM,GSK and Pfizer to combine consumer health businesses,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/ACgQ-y44mFs/gsk-and-pfizer-to-combine-consumer-health-businesses-idUSKBN1OI0IP,positive,0.8426005244255066
1141,12/19/2018 8:18:55 AM,"GSK, Pfizer To Combine Consumer Health Businesses Into New JV - Quick Facts ",RTTNews,/news/stocks/gsk-pfizer-to-combine-consumer-health-businesses-into-new-jv-quick-facts-1027820054,positive,0.8724448680877686
1142,12/19/2018 8:19:06 AM,GSK and Pfizer to combine consumer health businesses,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/ISXQYEB6joE/gsk-and-pfizer-to-combine-consumer-health-businesses-idINKBN1OI0J3,positive,0.8426005244255066
1143,12/19/2018 8:51:51 AM,UPDATE 1-Drugmaker GSK to split after folding in Pfizer consumer unit,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/kFxzm9sJTpc/update-1-drugmaker-gsk-to-split-after-folding-in-pfizer-consumer-unit-idUSL8N1YO147,positive,0.721889078617096
1144,12/19/2018 8:58:58 AM,Drugmaker GSK to split after folding in Pfizer consumer unit,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/iJfPuEeHzaw/drugmaker-gsk-to-split-after-folding-in-pfizer-consumer-unit-idUSKBN1OI0IP,positive,0.6771736741065979
1145,12/19/2018 9:11:24 AM,Drugmaker GSK to split after folding in Pfizer consumer unit,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/-YAGV9zUWZM/drugmaker-gsk-to-split-after-folding-in-pfizer-consumer-unit-idINKBN1OI0J3,positive,0.6771736741065979
1146,12/19/2018 10:12:24 AM,UPDATE 2-Drugmaker GSK to split after striking Pfizer consumer health deal,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/T3_kiiH-24A/update-2-drugmaker-gsk-to-split-after-striking-pfizer-consumer-health-deal-idUSL8N1YO147,neutral,0.8685121536254883
1147,12/19/2018 10:14:07 AM,Drugmaker GSK to split after striking Pfizer consumer health deal,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/G-QmqG_Bu5w/drugmaker-gsk-to-split-after-striking-pfizer-consumer-health-deal-idUSKBN1OI0IP,neutral,0.9025062918663025
1148,12/19/2018 10:28:48 AM,Drugmaker GSK to split after striking Pfizer consumer health deal,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/eIaYFM_PoIs/drugmaker-gsk-to-split-after-striking-pfizer-consumer-health-deal-idINKBN1OI0J3,neutral,0.9025062918663025
1149,12/19/2018 8:14:00 PM,Pfizer Inc. -- Moody's: Pfizer's JV formation with GSK is credit negative,Moodys,/news/bonds/pfizer-inc-moody-s-pfizer-s-jv-formation-with-gsk-is-credit-negative-1027822945,positive,0.848132312297821
1150,12/21/2018 6:12:29 AM,Pfizer Discontinues Phase 2b STRIVE Clinical Trial Due To Futility ,RTTNews,/news/stocks/pfizer-discontinues-phase-2b-strive-clinical-trial-due-to-futility-1027827494,neutral,0.939065158367157
1151,12/21/2018 4:25:00 PM,GlaxoSmithKline Capital Inc. -- Moody's affirms GSK's A2 ratings; outlook remains negative,Moodys,/news/bonds/glaxosmithkline-capital-inc-moody-s-affirms-gsk-s-a2-ratings-outlook-remains-negative-1027829395,positive,0.5071008205413818
1152,12/21/2018 8:12:23 PM,Merck KGaA-Pfizer to terminate late-stage ovarian cancer treatment study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/v59G_hxXq0o/merck-kgaa-pfizer-to-terminate-late-stage-ovarian-cancer-treatment-study-idUSL3N1YQ4X8,positive,0.7521155476570129
1153,12/21/2018 8:30:05 PM,UPDATE 1-Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/TuQhTowtSqI/update-1-merck-kgaa-pfizer-to-end-late-stage-ovarian-cancer-treatment-study-idUSL3N1YQ4XF,negative,0.7220256328582764
1154,12/21/2018 8:38:26 PM,CORRECTED-UPDATE 1-Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Xcqc8-Cltgk/corrected-update-1-merck-kgaa-pfizer-to-end-late-stage-ovarian-cancer-treatment-study-idUSL3N1YQ4XF,negative,0.5893038511276245
1155,12/21/2018 8:55:13 PM,UPDATE 2-Merck KGaA-Pfizer to end late-stage ovarian cancer treatment study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/xWpRvg-XR6I/update-2-merck-kgaa-pfizer-to-end-late-stage-ovarian-cancer-treatment-study-idUSL3N1YQ4Z0,negative,0.6151848435401917
1156,12/22/2018 8:51:35 PM,Merck KGaA & Pfizer Decide To Discontinue JAVELIN Ovarian 100 Study Of Avelumab ,RTTNews,/news/stocks/merck-kgaa-pfizer-decide-to-discontinue-javelin-ovarian-100-study-of-avelumab-1027830539,neutral,0.5717877149581909
1157,1/7/2019 2:25:04 PM,Pfizer To Use CytoReason's Machine Learning Model For Drug Discovery ,RTTNews,/news/stocks/pfizer-to-use-cytoreason-s-machine-learning-model-for-drug-discovery-1027847634,positive,0.8462758660316467
1158,1/9/2019 1:40:22 PM,"REFILE-BRIEF-India's Pfizer Ltd Says News On Stopping Ops In Chennai, Aurangabad Units Unrelated To Co",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ZktWiiPZ6x4/idUSFWN1Z904Q,neutral,0.8892732858657837
1159,1/9/2019 4:08:00 PM,Pfizer to shut two manufacturing plants in India,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Mp6TmW9z8Vw/pfizer-to-shut-two-manufacturing-plants-in-india-idUSL3N1Z93ZZ,neutral,0.9495929479598999
1160,1/9/2019 4:11:34 PM,Pfizer to shut two manufacturing plants in India,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/O65KUhlW5_w/pfizer-to-shut-two-manufacturing-plants-in-india-idINKCN1P31P7,neutral,0.9495929479598999
1161,1/9/2019 6:02:13 PM,CORRECTED-Pfizer to shut two manufacturing plants in India,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/TZlNRTRnI0M/corrected-pfizer-to-shut-two-manufacturing-plants-in-india-idUSL3N1Z93ZZ,neutral,0.9529345035552979
1162,1/9/2019 6:04:13 PM,Corrected: Pfizer to shut two manufacturing plants in India,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/orR020jMEjw/corrected-pfizer-to-shut-two-manufacturing-plants-in-india-idINKCN1P31P7,neutral,0.9638009071350098
1163,1/10/2019 12:42:30 AM,UPDATE 1-Pfizer to shut two manufacturing plants in India,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/NESyBzAdk_c/update-1-pfizer-to-shut-two-manufacturing-plants-in-india-idUSL3N1Z95DT,neutral,0.9608560800552368
1164,1/14/2019 2:07:35 PM,Pfizer Says FDA Accepts Regulatory Submissions For Review Of Tafamidis ,RTTNews,/news/stocks/pfizer-says-fda-accepts-regulatory-submissions-for-review-of-tafamidis-1027865130,positive,0.9260051846504211
1165,1/15/2019 7:38:34 AM,"First Device For Congenital Heart Defect, AIMT & US Shutdown, ASLN On Watch ",RTTNews,/news/stocks/first-device-for-congenital-heart-defect-aimt-us-shutdown-asln-on-watch-1027867299,positive,0.8465320467948914
1166,1/28/2019 3:01:45 PM,Here's what Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-q4-quarterly-earnings-preview-1027900853,positive,0.926646888256073
1167,1/29/2019 12:39:19 PM,"Pfizer, Lilly Announce Results From Phase 3 Study Of Tanezumab In OA Pain ",RTTNews,/news/stocks/pfizer-lilly-announce-results-from-phase-3-study-of-tanezumab-in-oa-pain-1027904214,negative,0.5303031802177429
1168,1/29/2019 12:50:47 PM,Pfizer Inc. Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q4-adjusted-earnings-beat-estimates-1027904258,negative,0.8641462326049805
1169,1/29/2019 12:55:47 PM,Pfizer full-year revenue forecast misses estimates,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/NAeDQS5VxDM/pfizer-full-year-revenue-forecast-misses-estimates-idUSL3N1ZT3XN,positive,0.8771125674247742
1170,1/29/2019 1:00:32 PM,Pfizer full-year revenue forecast misses estimates,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/VIHa7dnlouQ/pfizer-full-year-revenue-forecast-misses-estimates-idINKCN1PN1D5,positive,0.8771125674247742
1171,1/29/2019 1:15:40 PM,"UPDATE 1-Pfizer forecasts 2019 revenue, profit below Wall Street targets",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/mPkd_2UwKww/update-1-pfizer-forecasts-2019-revenue-profit-below-wall-street-targets-idUSL3N1ZT47P,negative,0.668955385684967
1172,1/29/2019 1:16:20 PM,"Pfizer forecasts 2019 revenue, profit below Wall Street targets",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/qS9SreD-YDs/pfizer-forecasts-2019-revenue-profit-below-wall-street-targets-idINKCN1PN1D5,neutral,0.4987141788005829
1173,1/29/2019 1:16:36 PM,"Pfizer forecasts 2019 revenue, profit below Wall Street targets",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/d1o3SNpHEuU/pfizer-forecasts-2019-revenue-profit-below-wall-street-targets-idUSKCN1PN1D7,neutral,0.4987141788005829
1174,1/29/2019 1:18:18 PM,Pfizer Q4 Results Beat View; But FY19 Outlook Disappoints ,RTTNews,/news/stocks/pfizer-q4-results-beat-view-but-fy19-outlook-disappoints-1027904421,neutral,0.49404922127723694
1175,1/29/2019 2:42:22 PM,"UPDATE 2-Pfizer forecasts 2019 revenue, profit below Wall Street targets",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/yxzm1zfpLN4/update-2-pfizer-forecasts-2019-revenue-profit-below-wall-street-targets-idUSL3N1ZT47P,negative,0.6883639097213745
1176,1/29/2019 7:13:11 PM,"UPDATE 3-Pfizer quarterly profit in line, touts pipeline of future products",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/p6W_oj97aZA/update-3-pfizer-quarterly-profit-in-line-touts-pipeline-of-future-products-idUSL3N1ZT47P,negative,0.6342611312866211
1177,1/29/2019 7:15:23 PM,"Pfizer quarterly profit in line, touts pipeline of future products",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/7nM88TD98c0/pfizer-quarterly-profit-in-line-touts-pipeline-of-future-products-idINKCN1PN1D5,positive,0.5161058902740479
1178,1/29/2019 7:16:19 PM,"Pfizer quarterly profit in line, touts pipeline of future products",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/GShj-8wIP_4/pfizer-quarterly-profit-in-line-touts-pipeline-of-future-products-idUSKCN1PN1D7,positive,0.5161058902740479
1179,1/31/2019 6:15:06 PM,"Hundreds of EpiPen users complained about problems with the lifesaving device. It still took 3 years and a top regulator stepping in before serious change — with potentially deadly outcomes (PFE, MYL)",Business Insider,https://www.businessinsider.com/fda-warned-epipen-complaints-pfizers-meridian-factories-2019-1,neutral,0.8187477588653564
1180,2/1/2019 3:25:00 PM,Pfizer Gets Positive CHMP Opinion For Vizimpro 45 Mg ,RTTNews,/news/stocks/pfizer-gets-positive-chmp-opinion-for-vizimpro-45-mg-1027916729,negative,0.9433674216270447
1181,2/6/2019 3:44:31 PM,Pfizer CEO Bourla plans to testify at Senate drug pricing hearing,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/-4sSPnZ_lOk/pfizer-ceo-bourla-plans-to-testify-at-senate-drug-pricing-hearing-idUSL1N2010Q0,positive,0.9290883541107178
1182,2/6/2019 3:48:18 PM,Pfizer CEO Bourla plans to testify at Senate drug pricing hearing,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/vDIMEUZvnnM/pfizer-ceo-bourla-plans-to-testify-at-senate-drug-pricing-hearing-idINKCN1PV1RX,positive,0.9290883541107178
1183,2/8/2019 1:20:23 PM,Pfizer Japan recalls high blood pressure drug Amvalo due to carcinogen,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/nrHh4GhwVdY/pfizer-japan-recalls-high-blood-pressure-drug-amvalo-due-to-carcinogen-idUSL3N20329S,neutral,0.9501274824142456
1184,2/8/2019 3:41:10 PM,UPDATE 1-Pfizer Japan recalls high blood pressure drug over cancer-causing impurity,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/G5xPcotknEc/update-1-pfizer-japan-recalls-high-blood-pressure-drug-over-cancer-causing-impurity-idUSL3N2032CL,neutral,0.9293201565742493
1185,2/8/2019 3:53:04 PM,Pfizer Japan recalls high blood pressure drug over cancer-causing impurity,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Oc3ZjF9-VAE/pfizer-japan-recalls-high-blood-pressure-drug-over-cancer-causing-impurity-idINKCN1PX1LZ,neutral,0.5770954489707947
1186,2/11/2019 11:23:03 PM,Pfizer: XTANDI Plus Androgen Deprivation Therapy Meets Endpoint In ARCHES Trial ,RTTNews,/news/stocks/pfizer-xtandi-plus-androgen-deprivation-therapy-meets-endpoint-in-arches-trial-1027942653,negative,0.8766162991523743
1187,2/12/2019 1:43:19 AM,"Merck, Pfizer combo treatment boosts kidney cancer survival",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/IxnI8eQTgp0/merck-pfizer-combo-treatment-boosts-kidney-cancer-survival-idUSL1N20700Q,negative,0.7883021235466003
1188,2/12/2019 2:01:26 AM,"REFILE-Merck, Pfizer combo treatment boosts kidney cancer survival",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/K4omwek1PZM/refile-merck-pfizer-combo-treatment-boosts-kidney-cancer-survival-idUSL1N20700Q,negative,0.7729389071464539
1189,2/12/2019 4:03:47 AM,Merck KGaA And Pfizer : FDA Accepts For Priority Review SBLA For BAVENCIO ,RTTNews,/news/stocks/merck-kgaa-and-pfizer-fda-accepts-for-priority-review-sbla-for-bavencio-1027942827,positive,0.5138902068138123
1190,2/15/2019 10:17:00 PM,Pharmacia Corporation (Old Monsanto) -- Moody's announces completion of a periodic review of ratings of Pfizer Inc.,Moodys,/news/bonds/pharmacia-corporation-old-monsanto-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-pfizer-inc-1027957901,positive,0.6374494433403015
1191,2/16/2019 11:10:00 PM,"Merck, Pfizer drug combo extends kidney cancer survival -study",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/x_xlGUpowfY/merck-pfizer-drug-combo-extends-kidney-cancer-survival-study-idUSL3N2094UY,negative,0.8723694086074829
1192,2/19/2019 12:55:51 PM,Eli Lilly: Tanezumab 10 Mg Meets Primary Endpoint In Phase 3 Study - Quick Facts ,RTTNews,/news/stocks/eli-lilly-tanezumab-10-mg-meets-primary-endpoint-in-phase-3-study-quick-facts-1027963149,negative,0.6266610026359558
1193,2/19/2019 12:56:59 PM,Higher dose of Pfizer-Lilly drug helps reduce back pain in study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/TJp1ECXmDGg/higher-dose-of-pfizer-lilly-drug-helps-reduce-back-pain-in-study-idUSL3N20E3JG,negative,0.9401398301124573
1194,2/19/2019 1:22:39 PM,UPDATE 1-Pfizer-Lilly drug shown to help reduce back pain in late-stage trial,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BpUqsQrfvgY/update-1-pfizer-lilly-drug-shown-to-help-reduce-back-pain-in-late-stage-trial-idUSL3N20E3K8,negative,0.9449205994606018
1195,2/19/2019 2:36:21 PM,Gliknik To Receive $15 Mln Payment From Pfizer On Progress With PF-06755347 ,RTTNews,/news/stocks/gliknik-to-receive-15-mln-payment-from-pfizer-on-progress-with-pf-06755347-1027963866,negative,0.8152556419372559
1196,2/26/2019 3:35:21 AM,"Higher Dose Of Xeljanz Tied To Blood Clots In Lungs, Death In RA Patients ",RTTNews,/news/stocks/higher-dose-of-xeljanz-tied-to-blood-clots-in-lungs-death-in-ra-patients-1027981980,neutral,0.9113345146179199
1197,2/27/2019 4:51:26 AM,Biotech Stocks Facing FDA Decision In March ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-1027987182,positive,0.7348417639732361
1198,3/1/2019 3:55:34 AM,Pfizer unit Meridian under civil investigation by U.S. Attorney,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/DIMGUo-N-U0/pfizer-unit-meridian-under-civil-investigation-by-u-s-attorney-idUSL3N20O1A7,neutral,0.6962246894836426
1199,3/1/2019 2:45:18 PM,Pfizer: CHMP Adopts Positive Opinion For LORVIQUA - Quick Facts ,RTTNews,/news/stocks/pfizer-chmp-adopts-positive-opinion-for-lorviqua-quick-facts-1027997024,negative,0.933506429195404
1200,3/4/2019 5:24:00 PM,Pfizer Inc. -- Moody's assigns A1 rating to Pfizer's notes; stable outlook,Moodys,/news/bonds/pfizer-inc-moody-s-assigns-a1-rating-to-pfizer-s-notes-stable-outlook-1028001933,negative,0.726119339466095
1201,3/12/2019 1:37:49 AM,"FDA Okays Pfizer's Trastuzumab Biosimilar, Trazimera ",RTTNews,/news/stocks/fda-okays-pfizer-s-trastuzumab-biosimilar-trazimera-1028021020,positive,0.5573782324790955
1202,3/20/2019 1:49:46 AM,Merck KGaA And Pfizer Discontinue Phase III JAVELIN Ovarian PARP 100 Trial ,RTTNews,/news/stocks/merck-kgaa-and-pfizer-discontinue-phase-iii-javelin-ovarian-parp-100-trial-1028043501,positive,0.8266526460647583
1203,3/20/2019 12:16:35 PM,Pfizer buys stake in French gene therapy firm Vivet,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/5egpro5Cbug/pfizer-buys-stake-in-french-gene-therapy-firm-vivet-idUSL3N2172S9,positive,0.916705310344696
1204,3/20/2019 4:05:26 PM,UPDATE 1-Pfizer buys stake in French gene therapy firm Vivet,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/FqPReDWxUhw/update-1-pfizer-buys-stake-in-french-gene-therapy-firm-vivet-idUSL3N2173G6,positive,0.8960099220275879
1205,3/20/2019 6:37:49 PM,Pfizer buys stake in French gene therapy firm Vivet,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/F65nO370eXs/pfizer-buys-stake-in-french-gene-therapy-firm-vivet-idINKCN1R129U,positive,0.916705310344696
1206,4/2/2019 1:39:57 PM,"Sangamo, Pfizer Report Promising Interim Results With SB-525 Gene Therapy ",RTTNews,/news/stocks/sangamo-pfizer-report-promising-interim-results-with-sb-525-gene-therapy-1028077977,negative,0.9516754746437073
1207,4/4/2019 5:16:01 AM,10 Best Selling Drugs Of 2018 ,RTTNews,/news/stocks/10-best-selling-drugs-of-2018-1028084412,positive,0.7440220713615417
1208,4/4/2019 4:45:19 PM,"U.S., China key to GSK's consumer venture with Pfizer",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/wT-e0qltK98/u-s-china-key-to-gsks-consumer-venture-with-pfizer-idUSKCN1RG1WE,positive,0.7700583934783936
1209,4/4/2019 5:30:34 PM,"U.S., China key to GSK's consumer venture with Pfizer",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/XuiWftzE1DY/u-s-china-key-to-gsks-consumer-venture-with-pfizer-idINKCN1RG1ZL,positive,0.7700583934783936
1210,4/5/2019 5:23:22 AM,FDA Expands Use Of Metastatic Breast Cancer Treatment To Include Male Patients ,RTTNews,/news/stocks/fda-expands-use-of-metastatic-breast-cancer-treatment-to-include-male-patients-1028088141,negative,0.6515704989433289
1211,4/9/2019 8:22:20 AM,GSK: FDA Approves ViiV Healthcare's Dovato - Quick Facts ,RTTNews,/news/stocks/gsk-fda-approves-viiv-healthcare-s-dovato-quick-facts-1028094830,negative,0.7956894636154175
1212,4/19/2019 12:14:02 AM,Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/OXzJD7ZCvjU/lower-dose-of-pfizer-lilly-painkiller-misses-main-goals-in-late-stage-study-idUSL3N2204RS,positive,0.7426331043243408
1213,4/29/2019 3:02:37 PM,Here's what Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-q1-quarterly-earnings-preview-1028148527,positive,0.926646888256073
1214,4/29/2019 3:16:37 PM,ViiV Healthcare Seeks FDA Approval For Two-drug To Treat HIV-1 Infection ,RTTNews,/news/stocks/viiv-healthcare-seeks-fda-approval-for-two-drug-to-treat-hiv-1-infection-1028149003,negative,0.9144394993782043
1215,4/30/2019 12:53:16 PM,Pfizer posts 9 pct rise in first-quarter profit,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/jG9DALf7Igc/pfizer-posts-9-pct-rise-in-first-quarter-profit-idUSL3N22C2PS,negative,0.9348193407058716
1216,4/30/2019 12:55:57 PM,Pfizer Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q1-adjusted-earnings-beat-estimates-1028152693,negative,0.8581992983818054
1217,4/30/2019 1:04:32 PM,Pfizer posts 9 percent rise in first-quarter profit,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/VabfPCwV-H4/pfizer-posts-9-percent-rise-in-first-quarter-profit-idUSKCN1S6133,negative,0.9419313669204712
1218,4/30/2019 1:12:57 PM,"UPDATE 1-Pfizer posts earnings beat, raises 2019 profit forecast",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/dmqB_OT2lww/update-1-pfizer-posts-earnings-beat-raises-2019-profit-forecast-idUSL3N22C2Q7,negative,0.9189834594726562
1219,4/30/2019 1:15:21 PM,"Pfizer posts earnings beat, raises 2019 profit forecast",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/t1R0mlitpx0/pfizer-posts-earnings-beat-raises-2019-profit-forecast-idINKCN1S613K,negative,0.8577942252159119
1220,4/30/2019 1:19:23 PM,"Pfizer posts earnings beat, raises 2019 profit forecast",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/EQ2yjLIKmO0/pfizer-posts-earnings-beat-raises-2019-profit-forecast-idUSKCN1S6133,negative,0.8577942252159119
1221,4/30/2019 1:20:47 PM,Pfizer Boosts FY19 Adj. EPS Outlook - Quick Facts ,RTTNews,/news/stocks/pfizer-boosts-fy19-adj-eps-outlook-quick-facts-1028152887,negative,0.7547430992126465
1222,4/30/2019 3:04:31 PM,"UPDATE 2-Pfizer posts earnings beat, raises 2019 profit forecast",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/53XuDIuHjeY/update-2-pfizer-posts-earnings-beat-raises-2019-profit-forecast-idUSL3N22C2Q7,negative,0.9189609289169312
1223,4/30/2019 6:54:27 PM,UPDATE 3-Vaccine and blood thinner help drive Pfizer to quarterly earnings beat,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/lWwQn5Yj8zo/update-3-vaccine-and-blood-thinner-help-drive-pfizer-to-quarterly-earnings-beat-idUSL3N22C2Q7,negative,0.9447171092033386
1224,4/30/2019 6:59:24 PM,Vaccine and blood thinner help drive Pfizer to quarterly earnings beat,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/gCNSdUdO7OA/vaccine-and-blood-thinner-help-drive-pfizer-to-quarterly-earnings-beat-idUSKCN1S6133,negative,0.9380439519882202
1225,4/30/2019 7:00:03 PM,Vaccine and blood thinner help drive Pfizer to quarterly earnings beat,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/3SJ5Wa424PM/vaccine-and-blood-thinner-help-drive-pfizer-to-quarterly-earnings-beat-idINKCN1S613K,negative,0.9380439519882202
1226,5/6/2019 12:51:01 PM,"Pfizer gets U.S. approval for $225,000 a year heart drug",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/ojfWmgsTJg0/pfizer-gets-u-s-approval-for-225000-a-year-heart-drug-idUSL3N22F34E,negative,0.8007029891014099
1227,5/6/2019 1:04:42 PM,"UPDATE 1-Pfizer gets U.S. approval for $225,000 a year heart drug",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/1GxUg0XPXHU/update-1-pfizer-gets-u-s-approval-for-225000-a-year-heart-drug-idUSL3N22I1ZK,negative,0.918322741985321
1228,5/6/2019 1:05:35 PM,Pfizer Says VYNDAQEL And VYNDAMAX Approved By FDA - Quick Facts ,RTTNews,/news/stocks/pfizer-says-vyndaqel-and-vyndamax-approved-by-fda-quick-facts-1028170515,positive,0.5463581085205078
1229,5/6/2019 4:22:17 PM,"UPDATE 2-Pfizer gets U.S. approval for $225,000 a year heart drug",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/oEFxIMuw_Z0/update-2-pfizer-gets-u-s-approval-for-225000-a-year-heart-drug-idUSL3N22I1ZK,negative,0.9051551818847656
1230,5/6/2019 4:33:57 PM,"Pfizer gets U.S. approval for $225,000 a year heart drug",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/zuWzXEake2w/pfizer-gets-u-s-approval-for-225000-a-year-heart-drug-idINKCN1SC1D2,negative,0.8007029891014099
1231,5/9/2019 3:02:00 AM,Australia's anti-trust watchdog gives go-ahead for GSK-Pfizer consumer healthcare deal,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/z1KhAAQ0aMk/australias-anti-trust-watchdog-gives-go-ahead-for-gsk-pfizer-consumer-healthcare-deal-idUSL3N22L0C5,positive,0.6376351118087769
1232,5/9/2019 3:35:56 AM,UPDATE 1-GSK-Pfizer deal gets approval from Australia's anti-trust watchdog,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/zK0oD4RNE6A/update-1-gsk-pfizer-deal-gets-approval-from-australias-anti-trust-watchdog-idUSL3N22L0DP,negative,0.9271658062934875
1233,5/15/2019 1:15:25 PM,Pfizer's Phase 3 Study Of Abrocitinib Shows Positive Top-Line Results ,RTTNews,/news/stocks/pfizer-s-phase-3-study-of-abrocitinib-shows-positive-top-line-results-1028202686,negative,0.9508385062217712
1234,5/23/2019 8:22:00 PM,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's affirms two and downgrades one class of GCCFC 2005-GG3",Moodys,/news/bonds/greenwich-capital-commercial-funding-corp-2005-gg3-moody-s-affirms-two-and-downgrades-one-class-of-gccfc-2005-gg3-1028227135,neutral,0.5286728143692017
1235,5/23/2019 8:24:00 PM,"Greenwich Capital Commercial Funding Corp., 2005-GG3 -- Moody's affirms two and downgrades one class of GCCFC 2005-GG3",Moodys,/news/bonds/greenwich-capital-commercial-funding-corp-2005-gg3-moody-s-affirms-two-and-downgrades-one-class-of-gccfc-2005-gg3-1028227140,neutral,0.5286728143692017
1236,5/24/2019 10:40:08 PM,Pfizer's Lyrica Fails To Meet Endpoint In Epilepsy Study ,RTTNews,/news/stocks/pfizer-s-lyrica-fails-to-meet-endpoint-in-epilepsy-study-1028230130,neutral,0.8747897148132324
1237,5/25/2019 5:16:57 AM,Biotech Stocks Facing FDA Decision In June 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-june-2019-1028230263,positive,0.8650785684585571
1238,5/28/2019 9:54:00 PM,J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns provisional ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB,Moodys,/news/bonds/j-p-morgan-chase-commercial-mortgage-securities-trust-2019-osb-moody-s-assigns-provisional-ratings-to-six-cmbs-classes-of-j-p-morgan-chase-commercial-mortgage-securities-trust-2019-osb-1028236492,positive,0.9027546048164368
1239,5/30/2019 1:54:00 AM,J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns a provisional rating to One CMBS class of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB,Moodys,/news/bonds/j-p-morgan-chase-commercial-mortgage-securities-trust-2019-osb-moody-s-assigns-a-provisional-rating-to-one-cmbs-class-of-j-p-morgan-chase-commercial-mortgage-securities-trust-2019-osb-1028240677,positive,0.9085378646850586
1240,6/5/2019 8:13:00 PM,10 Stocks to Buy That Could Be Takeover Targets,InvestorPlace,/news/stocks/10-stocks-to-buy-that-could-be-takeover-targets-1028258474,positive,0.9411237835884094
1241,6/6/2019 12:50:45 PM,"3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies",InvestorPlace,/news/stocks/3-big-stock-charts-for-thursday-pfizer-walmart-and-fleetcor-technologies-1028262356,positive,0.9075487852096558
1242,6/11/2019 8:59:54 AM,FDA Approves World's Costliest Drug For SMA ,RTTNews,/news/stocks/fda-approves-world-s-costliest-drug-for-sma-1028268509,positive,0.6342561841011047
1243,6/12/2019 3:20:44 PM,Pfizer Says Study Supports Use Of Xeljanz Alone In Rheumatoid Arthritis ,RTTNews,/news/stocks/pfizer-says-study-supports-use-of-xeljanz-alone-in-rheumatoid-arthritis-1028273794,negative,0.825098991394043
1244,6/13/2019 7:42:00 PM,J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB -- Moody's assigns definitive ratings to six CMBS classes of J.P. Morgan Chase Commercial Mortgage Securities Trust 2019-OSB,Moodys,/news/bonds/j-p-morgan-chase-commercial-mortgage-securities-trust-2019-osb-moody-s-assigns-definitive-ratings-to-six-cmbs-classes-of-j-p-morgan-chase-commercial-mortgage-securities-trust-2019-osb-1028278298,positive,0.8781194090843201
1245,6/17/2019 12:54:13 PM,Pfizer to buy Array for $10.64 bln,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/iZ1-6aZ4cf0/pfizer-to-buy-array-for-10-64-bln-idUSL4N23O2L0,positive,0.9190966486930847
1246,6/17/2019 12:56:16 PM,Pfizer to buy Array for $10.64 billion,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/VTFOANu6Wdk/pfizer-to-buy-array-for-10-64-billion-idUSKCN1TI15T,positive,0.9283524751663208
1247,6/17/2019 1:16:23 PM,Pfizer to buy cancer drug developer Array for $10.64 billion,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/M3fhKL1MJgw/pfizer-to-buy-cancer-drug-developer-array-for-10-64-billion-idUSKCN1TI15T,positive,0.9079650044441223
1248,6/17/2019 1:20:21 PM,Pfizer To Acquire Array BioPharma In $11.4 Bln Deal - Quick Facts ,RTTNews,/news/stocks/pfizer-to-acquire-array-biopharma-in-11-4-bln-deal-quick-facts-1028283497,positive,0.9044374823570251
1249,6/17/2019 1:27:49 PM,Pfizer to buy cancer drug developer Array for $10.64 billion,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/W1jnXRvnVW4/pfizer-to-buy-cancer-drug-developer-array-for-10-64-billion-idINKCN1TI19J,positive,0.9079650044441223
1250,6/17/2019 2:05:23 PM,Pfizer bolsters cancer portfolio with $10.64 billion deal for Array,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/LaX33fPYRKY/pfizer-bolsters-cancer-portfolio-with-10-64-billion-deal-for-array-idINKCN1TI19J,negative,0.907317042350769
1251,6/17/2019 2:09:38 PM,Pfizer bolsters cancer portfolio with $10.64 billion deal for Array,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/nK3_lVWQltA/pfizer-bolsters-cancer-portfolio-with-10-64-billion-deal-for-array-idUSKCN1TI15T,negative,0.907317042350769
1252,6/17/2019 4:11:58 PM,Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal,InvestorPlace,/news/stocks/array-biopharma-news-boosts-arry-stock-1028285892,neutral,0.9253674745559692
1253,6/17/2019 6:39:00 PM,Pfizer Inc. -- Moody's: Pfizer's acquisition of Array is credit negative,Moodys,/news/bonds/pfizer-inc-moody-s-pfizer-s-acquisition-of-array-is-credit-negative-1028284927,positive,0.8028596043586731
1254,6/17/2019 6:49:17 PM,Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/HZRJfopLDdI/pfizer-makes-10-6-billion-cancer-bet-in-cash-deal-for-array-biopharma-idUSKCN1TI15T,positive,0.7656748294830322
1255,6/17/2019 6:58:20 PM,The 5 Worst Dow Jones Stocks So Far in 2019,InvestorPlace,/news/stocks/the-5-worst-dow-jones-stocks-so-far-in-2019-1028285881,neutral,0.9411437511444092
1256,6/17/2019 7:48:45 PM,Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/O6DMC8dP8XA/pfizer-makes-10-6-billion-cancer-bet-in-cash-deal-for-array-biopharma-idINKCN1TI19J,positive,0.7656748294830322
1257,6/17/2019 8:05:26 PM,"5 Top Stock Trades for Tuesday: FB, NFLX, GILD, TSLA",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-fb-nflx-gild-tsla-1028285877,positive,0.9297625422477722
1258,6/17/2019 8:41:29 PM,Dow Jones Today: Almost a Case of the Mondays,InvestorPlace,/news/stocks/dow-jones-today-almost-a-case-of-the-mondays-1028285876,positive,0.7777710556983948
1259,6/19/2019 11:56:15 AM,"3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-pfe-mkc-fmc-1028293621,positive,0.9277737140655518
1260,6/20/2019 10:04:29 AM,GSK offers concessions to address EU concerns over Pfizer deal,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/XNqoCDGm--A/gsk-offers-concessions-to-address-eu-concerns-over-pfizer-deal-idUSL8N23R1HY,negative,0.8274549245834351
1261,6/21/2019 8:33:39 PM,Dow Jones Today: A Typical Summer Friday,InvestorPlace,/news/stocks/dow-jones-today-a-typical-summer-friday-1028299510,positive,0.8920571208000183
1262,6/24/2019 7:33:11 PM,The 7 Best Acquisitions of 2019,InvestorPlace,/news/stocks/the-7-best-acquisitions-of-2019-1028303860,positive,0.8142321705818176
1263,6/25/2019 4:46:38 PM,3 Healthcare Stocks to Buy With the Market Near All-Time Highs,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs-1028307938,negative,0.6229497790336609
1264,6/25/2019 7:51:21 PM,3 Biopharma Stocks to Buy for Income,InvestorPlace,/news/stocks/3-biopharma-stocks-to-buy-for-income-1028307925,positive,0.9193856716156006
1265,6/27/2019 3:08:01 PM,The 7 Top Small-Cap Stocks Of 2019,InvestorPlace,/news/stocks/the-7-top-small-cap-stocks-of-2019-1028315905,positive,0.911159873008728
1266,6/27/2019 11:17:59 PM,Pfizer names former FDA chief Scott Gottlieb to its board,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Swz9Rx8O6vY/pfizer-names-former-fda-chief-scott-gottlieb-to-its-board-idUSKCN1TS36L,positive,0.9442099928855896
1267,6/28/2019 7:30:41 AM,Former FDA Commissioner Scott Gottlieb Joins Pfizer Board - Quick Facts ,RTTNews,/news/stocks/former-fda-commissioner-scott-gottlieb-joins-pfizer-board-quick-facts-1028315972,positive,0.9138050675392151
1268,6/28/2019 1:53:51 PM,FDA Approves Pfizer's Zirabev To Treat Five Types Of Cancer ,RTTNews,/news/stocks/fda-approves-pfizer-s-zirabev-to-treat-five-types-of-cancer-1028317013,negative,0.7777761816978455
1269,6/28/2019 4:18:41 PM,"Pfizer gene therapy for rare muscle disease shows promise in small, early study",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qBu9NKcwOUA/pfizer-gene-therapy-for-rare-muscle-disease-shows-promise-in-small-early-study-idUSL2N23Y1UH,negative,0.9288465976715088
1270,6/28/2019 4:34:55 PM,"Pfizer gene therapy for rare muscle disease shows promise in small, early study",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/qMzqloEsqSs/pfizer-gene-therapy-for-rare-muscle-disease-shows-promise-in-small-early-study-idINKCN1TT257,negative,0.9288465976715088
1271,6/28/2019 6:33:10 PM,Sarepta surges after Pfizer gene therapy data raises safety concerns,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/IeyzamCqUCY/sarepta-surges-after-pfizer-gene-therapy-data-raises-safety-concerns-idUSKCN1TT23H,neutral,0.5413756966590881
1272,6/28/2019 7:11:19 PM,Sarepta surges after Pfizer gene therapy data raises safety concerns,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/3dCPuK2u9yg/sarepta-surges-after-pfizer-gene-therapy-data-raises-safety-concerns-idINKCN1TT257,neutral,0.5413756966590881
1273,7/1/2019 10:38:04 AM,Acquisition Improves the Outlook of Pfizer Stock,InvestorPlace,/news/stocks/acquiring-array-biopharma-improves-pfizers-prospects-1028323091,negative,0.956790030002594
1274,7/1/2019 2:18:36 PM,Pfizer Reports Positive Findings From Phase 4 Crisaborole Study - Quick Facts ,RTTNews,/news/stocks/pfizer-reports-positive-findings-from-phase-4-crisaborole-study-quick-facts-1028321080,negative,0.8311301469802856
1275,7/2/2019 3:06:29 PM,GSK-Pfizer JV gets conditional approval from S.Africa's competition regulator,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/aQwodcEywyM/gsk-pfizer-jv-gets-conditional-approval-from-s-africas-competition-regulator-idUSL4N2432XI,negative,0.9235490560531616
1276,7/2/2019 3:10:55 PM,"Pfizer, Sanofi, to boost South African Biovac's vaccine output",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/KbY-98m_ets/pfizer-sanofi-to-boost-south-african-biovacs-vaccine-output-idUSL8N23P52H,negative,0.914728045463562
1277,7/2/2019 5:45:41 PM,"CORRECTED-Pfizer, Sanofi, to boost South African Biovac's vaccine output",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/mGc47id_cTQ/corrected-pfizer-sanofi-to-boost-south-african-biovacs-vaccine-output-idUSL8N2434RR,negative,0.9136770367622375
1278,7/2/2019 7:38:28 PM,3 Dow Jones Stocks to Buy for the Second Half,InvestorPlace,/news/stocks/3-dow-jones-stocks-to-buy-for-the-second-half-1028326563,positive,0.9078968167304993
1279,7/2/2019 8:15:15 PM,Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/-spDcTQe2YA/senator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSL4N2433KC,neutral,0.8143916726112366
1280,7/3/2019 10:33:40 AM,ViiV Healthcare Reports Marketing Authorisation Of Dovato In Europe ,RTTNews,/news/stocks/viiv-healthcare-reports-marketing-authorisation-of-dovato-in-europe-1028327055,positive,0.8572881817817688
1281,7/3/2019 11:58:31 AM,"3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-cvs-pfe-wy-1028329313,positive,0.9101488590240479
1282,7/8/2019 7:31:09 PM,Sangamo Therapeutics News: SGMO Stock Surges on Gene Therapy Study,InvestorPlace,/news/stocks/sangamo-therapeutics-news-sgmo-stock-1028336807,neutral,0.47566694021224976
1283,7/11/2019 7:00:51 PM,4 Drug Stocks Getting Smashed,InvestorPlace,/news/stocks/4-drug-stocks-getting-smashed-1028347976,negative,0.3786204159259796
1284,7/15/2019 8:22:50 PM,"Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday",InvestorPlace,/news/stocks/dow-jones-today-china-earnings-anticipation-stall-stocks-on-monday-1028354735,neutral,0.933067798614502
1285,7/26/2019 3:53:32 PM,"Notable Earnings To Watch Next Week - LLY, AAPL, PG, MRK, PFE, CVX ",RTTNews,/news/stocks/notable-earnings-to-watch-next-week-lly-aapl-pg-mrk-pfe-cvx-1028388673,positive,0.7602753639221191
1286,7/26/2019 4:04:19 PM,4 Biotech Stocks Sliding Lower,InvestorPlace,/news/stocks/4-biotech-stocks-sliding-lower-1028389963,neutral,0.9591169953346252
1287,7/27/2019 2:45:24 PM,Pfizer in talks to merge off-patent drugs business with Mylan,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/f1kzwhZ6NfI/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-idUSL2N24S036,positive,0.9057804942131042
1288,7/27/2019 2:48:26 PM,Pfizer in talks to merge off-patent drugs business with Mylan,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/cBTWEYyyYWs/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-idINKCN1UM0DB,positive,0.9057804942131042
1289,7/27/2019 3:04:02 PM,Pfizer in talks to merge off-patent drugs business with Mylan,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/SnLQYb_Hpsc/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-idUSKCN1UM0DP,positive,0.9057804942131042
1290,7/27/2019 4:42:09 PM,UPDATE 1-Pfizer in talks to merge off-patent drugs business with Mylan -source,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/niTgEM2h6_w/update-1-pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-source-idUSL2N24S044,positive,0.7795763611793518
1291,7/27/2019 4:43:07 PM,Pfizer in talks to merge off-patent drugs business with Mylan: source,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/5JbNU7I7zE8/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-source-idINKCN1UM0DB,positive,0.9287643432617188
1292,7/27/2019 4:46:54 PM,Pfizer in talks to merge off-patent drugs business with Mylan: source,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/xWsi8SDbOgQ/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-source-idUSKCN1UM0DP,positive,0.9287643432617188
1293,7/28/2019 1:04:14 PM,Pfizer Reportedly In Talks To Merge Off-patent Assets With Mylan ,RTTNews,/news/stocks/pfizer-reportedly-in-talks-to-merge-off-patent-assets-with-mylan-1028390886,positive,0.9220761656761169
1294,7/29/2019 8:40:35 AM,GSK: ViiV Submits Regulatory Application To EMA For Cabotegravir HIV Injection ,RTTNews,/news/stocks/gsk-viiv-submits-regulatory-application-to-ema-for-cabotegravir-hiv-injection-1028392562,positive,0.7252151966094971
1295,7/29/2019 11:40:25 AM,Buy Pfizer Stock Before this Week’s Earnings Report Gives It a Bump Up,InvestorPlace,/news/stocks/buy-pfizer-stock-before-this-weeks-earnings-report-gives-it-a-bump-up-1028395888,positive,0.8848068714141846
1296,7/29/2019 1:03:20 PM,Pfizer posts 30% rise in quarterly profit,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/4S_wTbAS0OQ/pfizer-posts-30-rise-in-quarterly-profit-idINKCN1UO18M,negative,0.9386940002441406
1297,7/29/2019 1:06:05 PM,Pfizer posts 30% rise in quarterly profit,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/28XI750KVEE/pfizer-posts-30-rise-in-quarterly-profit-idUSKCN1UO18S,negative,0.9386940002441406
1298,7/29/2019 1:12:27 PM,"Mylan, Pfizer Upjohn To Combine To Create New Global Pharma Company ",RTTNews,/news/stocks/mylan-pfizer-upjohn-to-combine-to-create-new-global-pharma-company-1028393198,positive,0.759650468826294
1299,7/29/2019 1:28:28 PM,Biotech Stocks Facing FDA Decision In August 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-august-2019-1028393221,positive,0.828368604183197
1300,7/29/2019 1:32:59 PM,Pfizer Q2 Revenues Up 2% Operationally; Updates 2019 Guidance ,RTTNews,/news/stocks/pfizer-q2-revenues-up-2-operationally-updates-2019-guidance-1028393242,negative,0.9529774785041809
1301,7/29/2019 2:45:06 PM,"Mylan skyrockets after securing a merger with Pfizer's off-patent-drug unit (MYL, PFE)",Business Insider,https://markets.businessinsider.com/news/stocks/pfizer-mylan-merger-off-patent-drug-business-stock-price-reaction-2019-7-1028393612,negative,0.9271659255027771
1302,7/29/2019 3:02:47 PM,Here's what Wall Street expects from Pfizer's earnings report,Markets Insider Automation,/news/stocks/pfizer-stock-price-quarter-earnings-preview-q2-1028393710,positive,0.9071700572967529
1303,7/29/2019 3:41:54 PM,Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/XFWZX-dHQBg/pfizer-to-merge-generics-unit-with-mylan-seeks-to-sharpen-cancer-focus-idUSKCN1UO185,negative,0.8451166152954102
1304,7/29/2019 3:45:44 PM,Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/A80UHw6ym8o/pfizer-to-merge-generics-unit-with-mylan-seeks-to-sharpen-cancer-focus-idINKCN1UO193,negative,0.8451166152954102
1305,7/29/2019 5:03:28 PM,Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger,InvestorPlace,/news/stocks/mylan-pfizer-deal-has-myl-stock-up-1028395862,neutral,0.9435016512870789
1306,7/29/2019 5:39:50 PM,Pfizer Acquires Mylan And The EpiPen ,RTTNews,/news/stocks/pfizer-acquires-mylan-and-the-epipen-1028394719,positive,0.9352993369102478
1307,7/29/2019 5:44:26 PM,Pfizer in talks to transition EpiPen manufacturing into generics spinoff,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/b56aUO5av1I/pfizer-in-talks-to-transition-epipen-manufacturing-into-generics-spinoff-idUSKCN1UO1SG,positive,0.5493806004524231
1308,7/29/2019 6:02:45 PM,UPDATE 1-Pfizer in talks to transition EpiPen maker into generics spinoff -spokeswoman,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/zeLNnryTlzE/update-1-pfizer-in-talks-to-transition-epipen-maker-into-generics-spinoff-spokeswoman-idUSL2N24U0NZ,positive,0.8068575263023376
1309,7/29/2019 6:12:37 PM,Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/tu0IVOfAPTg/pfizer-in-talks-to-transition-epipen-maker-into-generics-spinoff-spokeswoman-idUSKCN1UO1SG,positive,0.9176249504089355
1310,7/29/2019 6:31:18 PM,"Pfizer to spinoff, merge off-patent drugs unit with Mylan",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/qB9LOdUQ2S4/pfizer-to-spinoff-merge-off-patent-drugs-unit-with-mylan-idUSKCN1UO185,positive,0.9387368559837341
1311,7/29/2019 6:37:56 PM,"Pfizer to spinoff, merge off-patent drugs unit with Mylan",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/xW1zU-f2Cmk/pfizer-to-spinoff-merge-off-patent-drugs-unit-with-mylan-idINKCN1UO193,positive,0.9387368559837341
1312,7/29/2019 7:16:00 PM,Pharmacia Corporation (Old Monsanto) -- Moody's reviews Pfizer's A1 rating for downgrade; affirms P-1 rating,Moodys,/news/bonds/pharmacia-corporation-old-monsanto-moody-s-reviews-pfizer-s-a1-rating-for-downgrade-affirms-p-1-rating-1028394965,negative,0.39348578453063965
1313,7/29/2019 8:35:20 PM,Dow Jones Today: Fed Watch Begins,InvestorPlace,/news/stocks/dow-jones-today-fed-watch-begins-1028395849,positive,0.8803315758705139
1314,7/29/2019 8:41:00 PM,Mylan N.V. -- Moody's affirms Mylan's Baa3 ratings; outlook stable,Moodys,/news/bonds/mylan-n-v-moody-s-affirms-mylan-s-baa3-ratings-outlook-stable-1028395139,negative,0.8510000705718994
1315,7/29/2019 8:44:00 PM,Mylan Inc. -- Moody's affirms Mylan's Baa3 ratings; outlook stable,Moodys,/news/bonds/mylan-inc-moody-s-affirms-mylan-s-baa3-ratings-outlook-stable-1028395145,negative,0.7636443376541138
1316,7/29/2019 8:52:01 PM,Stock Market Today: High-Growth Stocks Get Hammered,InvestorPlace,/news/stocks/stock-market-today-high-growth-stocks-get-hammered-1028395847,negative,0.8079546689987183
1317,7/30/2019 1:01:49 PM,"3 Big Stock Charts for Tuesday: Hanesbrands, Tapestry and Travelers Companies",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-hanesbrands-tapestry-and-travelers-companies-1028401357,positive,0.9346451163291931
1318,7/30/2019 7:51:17 PM,"5 Top Stock Trades for Wednesday: UAA, PEP, NVTA",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-uaa-pep-nvta-1028401191,positive,0.935155987739563
1319,7/30/2019 8:20:14 PM,Dow Jones Today: Trump Trade Tweets at It Again,InvestorPlace,/news/stocks/dow-jones-today-trump-trade-tweets-at-it-again-1028401186,positive,0.9251601099967957
1320,7/31/2019 9:01:52 AM,Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal,InvestorPlace,/news/stocks/heres-how-pfizer-stock-and-pharma-stand-to-benefit-from-mylan-deal-1028406248,positive,0.834294319152832
1321,7/31/2019 11:24:57 AM,"3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-southern-co-cf-industries-holdings-and-national-oilwell-varco-1028406243,positive,0.9133959412574768
1322,7/31/2019 2:01:27 PM,"Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple",InvestorPlace,/news/stocks/wednesdays-vital-data-pfizer-advanced-micro-devices-and-apple-1028406234,positive,0.9168674349784851
1323,8/1/2019 7:09:37 AM,"Pfizer Closes JV With GlaxoSmithKline, Forms GSK Consumer Healthcare ",RTTNews,/news/stocks/pfizer-closes-jv-with-glaxosmithkline-forms-gsk-consumer-healthcare-1028406362,positive,0.9469939470291138
1324,8/1/2019 10:04:07 AM,"AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… ",RTTNews,/news/stocks/amrn-s-vascepa-hits-record-sales-admp-slumps-on-stock-offering-srdx-on-watch-1028406896,neutral,0.8936618566513062
1325,8/6/2019 6:29:21 AM,Fear Around Bristol-Myers Squibb Stock is Starting to Fade,InvestorPlace,/news/stocks/bristol-myers-squibb-bmy-stock-opdivo-otezla-1028422590,neutral,0.7555703520774841
1326,8/6/2019 12:19:40 PM,"3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-pfizer-aes-and-centurylink-1028422582,positive,0.9273473620414734
1327,8/12/2019 8:21:21 PM,Dow Jones Today: Doth Thou Protest,InvestorPlace,/news/stocks/dow-jones-today-doth-thou-protest-1028440072,positive,0.9180399179458618
1328,8/13/2019 12:22:04 PM,"3 Big Stock Charts for Tuesday: Centene, Hormel Foods and Advance Auto Parts",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-centene-hormel-foods-and-advance-auto-parts-1028444018,positive,0.902358889579773
1329,8/13/2019 1:30:33 PM,"Tuesday’s Vital Data: Uber, Pfizer and Roku",InvestorPlace,/news/stocks/tuesdays-vital-data-uber-pfizer-and-roku-1028444014,positive,0.8944823741912842
1330,8/16/2019 1:46:12 PM,Pfizer Recalls Migraine Tablets Over Concerns Of Bacterial Infection ,RTTNews,/news/stocks/pfizer-recalls-migraine-tablets-over-concerns-of-bacterial-infection-1028452416,neutral,0.9572111368179321
1331,8/20/2019 5:54:28 PM,3 Great Active Mutual Funds for the Current Environment,InvestorPlace,/news/stocks/3-great-active-mutual-funds-for-the-current-environment-1028461456,positive,0.8672296404838562
1332,8/20/2019 7:11:01 PM,"3 Healthcare Stocks to Trade: UNH, JNJ and PFE",InvestorPlace,/news/stocks/3-healthcare-stocks-to-trade-unh-jnj-and-pfe-1028461453,positive,0.9377426505088806
1333,8/21/2019 1:20:24 PM,Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals,InvestorPlace,/news/stocks/trade-of-the-day-pfizer-stock-is-flashing-attractive-buy-signals-1028464951,negative,0.9176378846168518
1334,8/21/2019 4:01:00 PM,Pfizer invests $500 million in expanding gene therapy facility,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BN8DC1nieiM/pfizer-invests-500-million-in-expanding-gene-therapy-facility-idUSL2N25G1JO,negative,0.7755983471870422
1335,8/21/2019 6:27:44 PM,Pfizer invests $500 million in expanding gene therapy facility,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/rqA7aZFdlh4/pfizer-invests-500-million-in-expanding-gene-therapy-facility-idINKCN1VB1TU,negative,0.7755983471870422
1336,8/22/2019 4:54:07 AM,Pfizer To Invest $500 Mln In Gene Therapy Manufacturing Plant ,RTTNews,/news/stocks/pfizer-to-invest-500-mln-in-gene-therapy-manufacturing-plant-1028464702,positive,0.824241042137146
1337,8/23/2019 6:37:40 PM,Will Lawsuits Sink Johnson & Johnson Stock?,InvestorPlace,/news/stocks/lawsuits-jnj-stock-probably-not-1028470702,neutral,0.6193097829818726
1338,8/27/2019 3:01:27 PM,4 Biotech Stocks to Buy That Are on the Move,InvestorPlace,/news/stocks/4-biotech-stocks-to-buy-that-are-on-the-move-1028478921,positive,0.8555208444595337
1339,9/6/2019 8:24:49 AM,UPDATE 1-Novartis joins Pfizer with FDA fast-track tag for lung cancer hopeful,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BjD0N5XCxXc/update-1-novartis-joins-pfizer-with-fda-fast-track-tag-for-lung-cancer-hopeful-idUSL5N25X0WS,negative,0.8444194197654724
1340,9/9/2019 2:21:31 PM,Pfizer Reports Positive Results From Phase 2 Study Of 20vPnC Vaccine Candidate ,RTTNews,/news/stocks/pfizer-reports-positive-results-from-phase-2-study-of-20vpnc-vaccine-candidate-1028508730,negative,0.9477522373199463
1341,9/10/2019 2:55:17 PM,10 Healthcare Stocks to Buy Despite the Headlines,InvestorPlace,/news/stocks/10-healthcare-stocks-to-buy-despite-the-headlines-1028514931,positive,0.49671414494514465
1342,9/10/2019 6:44:56 PM,7 Upcoming IPOs for September,InvestorPlace,/news/stocks/7-upcoming-ipos-for-september-1028514914,positive,0.9465041756629944
1343,9/11/2019 8:15:57 PM,Dow Jones Today: Plenty of Good News,InvestorPlace,/news/stocks/dow-stocks-rallied-wednesday-extending-their-winning-streak-to-6-days-1028518260,negative,0.5810685157775879
1344,9/18/2019 3:41:15 PM,10 Companies Making Their CEOs Rich,InvestorPlace,/news/stocks/10-companies-making-their-ceos-rich-1028536169,positive,0.8969774842262268
1345,9/20/2019 1:28:34 PM,10 Cheap Dividend Stocks to Buy,InvestorPlace,/news/stocks/10-cheap-dividend-stocks-to-load-up-on-1028451498,positive,0.8876111507415771
1346,9/24/2019 5:45:00 PM,Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023,Moodys,/news/bonds/bristol-myers-squibb-company-moody-s-china-s-rising-demand-for-drugs-will-fuel-foreign-pharma-companies-growth-into-2023-1028549476,negative,0.9256462454795837
1347,9/25/2019 6:36:00 AM,Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023,Moodys,/news/bonds/bristol-myers-squibb-company-moody-s-china-s-rising-demand-for-drugs-will-fuel-foreign-pharma-companies-growth-into-2023-1028550761,negative,0.9256462454795837
1348,9/27/2019 1:47:20 PM,Pfizer Announces Positive Top-Line Results On Abrocitinib ,RTTNews,/news/stocks/pfizer-announces-positive-top-line-results-on-abrocitinib-1028559171,negative,0.9497766494750977
1349,9/27/2019 2:14:28 PM,Ian Read to retire as Pfizer executive chairman,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/huYDB0T5EsY/ian-read-to-retire-as-pfizer-executive-chairman-idUSL3N26I33D,positive,0.8110001683235168
1350,9/27/2019 2:35:12 PM,Pfizer Names CEO Albert Bourla To Succeed Ian Read As Chairman - Quick Facts ,RTTNews,/news/stocks/pfizer-names-ceo-albert-bourla-to-succeed-ian-read-as-chairman-quick-facts-1028559335,positive,0.9485864639282227
1351,9/27/2019 3:01:30 PM,UPDATE 1-Pfizer veteran Ian Read to retire as executive chairman,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/Bgu0Xp-Uljk/update-1-pfizer-veteran-ian-read-to-retire-as-executive-chairman-idUSL3N26I34Z,positive,0.805967390537262
1352,9/27/2019 3:02:59 PM,Pfizer veteran Ian Read to retire as executive chairman,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/CcIIFF1SP4o/pfizer-veteran-ian-read-to-retire-as-executive-chairman-idUSKBN1WC1DG,positive,0.7719195485115051
1353,9/27/2019 7:10:39 PM,10 Cheap Stocks to Buy at Less Than 10x Forward Earnings,InvestorPlace,/news/stocks/10-stocks-to-buy-less-10x-forward-earnings-1028560648,positive,0.8950284719467163
1354,9/30/2019 9:03:00 AM,Pfizer: Interim BEACON CRC Data Shows Encouraging Potential For BRAFTOVI Triplet ,RTTNews,/news/stocks/pfizer-interim-beacon-crc-data-shows-encouraging-potential-for-braftovi-triplet-1028561883,negative,0.9479451179504395
1355,10/1/2019 11:44:44 AM,Johnson & Johnson Can Overcome Its Legal Issues,InvestorPlace,/news/stocks/legal-issues-problem-johnson-johnson-stock-1028569362,negative,0.8247592449188232
1356,10/2/2019 6:07:53 PM,7 Dow Jones Industrial Average Stocks to Sell,InvestorPlace,/news/stocks/dow-jones-stocks-to-sell-1028572833,positive,0.8960649371147156
1357,10/3/2019 8:16:36 PM,Dow Jones Today: A Rebound With an Asterisk,InvestorPlace,/news/stocks/the-dow-jones-today-posted-its-first-good-performance-of-q4-1028575922,positive,0.6241371631622314
1358,10/7/2019 6:51:22 PM,Why Johnson & Johnson Stock Is Not a Screaming Buy,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-not-screaming-buy-1028581887,positive,0.9226393103599548
1359,10/7/2019 7:51:30 PM,Akcea Therapeutics News: AKCA Stock Rockets on Pfizer Licensing Deal,InvestorPlace,/news/stocks/akcea-therapeutics-news-boosts-akca-stock-1028581883,positive,0.9429223537445068
1360,10/9/2019 3:25:50 PM,10 Super Boring Stocks to Buy With Super Safe Returns,InvestorPlace,/news/stocks/10-super-boring-stocks-to-buy-with-super-safe-returns-1028588716,positive,0.8773532509803772
1361,10/14/2019 8:29:48 AM,"ImaginAb, AstraZeneca, Pfizer, Takeda Join To Develop CD8 ImmunoPET Technology ",RTTNews,/news/stocks/imaginab-astrazeneca-pfizer-takeda-join-to-develop-cd8-immunopet-technology-1028595492,positive,0.8430153727531433
1362,10/14/2019 7:59:43 PM,Johnson and Johnson Stock Still Significantly Undervalued,InvestorPlace,/news/stocks/johnson-stock-significantly-undervalued-1028597917,neutral,0.918654203414917
1363,10/18/2019 3:30:03 PM,3 Earnings Reports to Watch Next Week,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-earnings-calendar-1028224242,positive,0.891125500202179
1364,10/22/2019 12:40:32 PM,These New Partnerships are Game Changers for Fitbit Stock,InvestorPlace,/news/stocks/partnerships-game-changers-fitbit-stock-1028619586,positive,0.7923107147216797
1365,10/22/2019 6:15:57 PM,Fitbit Stock Needs a Viable Growth Narrative for Q3,InvestorPlace,/news/stocks/fitbit-stock-needs-a-viable-growth-narrative-for-q3-1028620791,negative,0.9086201786994934
1366,10/24/2019 10:36:53 AM,"3 Big Stock Charts for Thursday: Cisco Systems, Eli Lilly, and Colgate-Palmolive",InvestorPlace,/news/stocks/3-big-stock-charts-thursday-cisco-systems-eli-lilly-colgate-palmolive-1028627304,positive,0.905576229095459
1367,10/28/2019 5:24:06 AM,Biotech Stocks Facing FDA Decision In November 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-november-2019-1028633538,positive,0.7858316898345947
1368,10/29/2019 11:49:32 AM,Pfizer Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q3-adjusted-earnings-beat-estimates-1028638453,negative,0.8234495520591736
1369,10/29/2019 12:04:29 PM,"Pfizer raises 2019 profit forecast, shares rise",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/F7JxTnKDQO0/pfizer-raises-2019-profit-forecast-shares-rise-idUSKBN1X817D,negative,0.6939548850059509
1370,10/29/2019 12:18:57 PM,"Pfizer beats profit estimates, raises 2019 earnings forecast",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/HWzbzEvu5mg/pfizer-beats-profit-estimates-raises-2019-earnings-forecast-idUSKBN1X817D,negative,0.8930005431175232
1371,10/29/2019 12:41:57 PM,Pfizer Q3 Profit Rises; Lifts 2019 Profit View ,RTTNews,/news/stocks/pfizer-q3-profit-rises-lifts-2019-profit-view-1028638803,negative,0.9235537052154541
1372,10/29/2019 1:41:55 PM,Pfizer raises 2019 forecast on surging cancer drug sales,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/dLK9H2nJ_3U/pfizer-raises-2019-forecast-on-surging-cancer-drug-sales-idUSKBN1X817D,negative,0.8600608706474304
1373,10/29/2019 3:18:36 PM,"Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/bffcnwdwoc4/pfizer-raises-2019-forecast-as-sales-of-cancer-drug-heart-medicine-surge-idUSKBN1X817D,negative,0.6235144734382629
1374,10/29/2019 3:52:44 PM,"US STOCKS SNAPSHOT-Merck, Pfizer spur S&P 500 to record high; Alphabet weighs on Nasdaq",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/cul7AtWcw10/us-stocks-snapshot-merck-pfizer-spur-sp-500-to-record-high-alphabet-weighs-on-nasdaq-idUSL3N27E3XD,neutral,0.582781970500946
1375,10/29/2019 3:55:04 PM,"Merck, Pfizer spur S&P 500 to record high; Alphabet weighs on Nasdaq",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/QSy2eR-cNQg/merck-pfizer-spur-sp-500-to-record-high-alphabet-weighs-on-nasdaq-idUSKBN1X81CC,negative,0.49066925048828125
1376,10/29/2019 3:58:03 PM,"Tuesday’s Vital Data: Fitbit, Pfizer and Twitter",InvestorPlace,/news/stocks/tuesdays-vital-data-fitbit-pfizer-and-twitter-1028640812,positive,0.9309576749801636
1377,10/29/2019 4:35:09 PM,"US STOCKS-S&P 500 squeezes higher on robust Merck, Pfizer earnings",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/sp9i_g9OcTQ/us-stocks-sp-500-squeezes-higher-on-robust-merck-pfizer-earnings-idUSL3N27E3ZS,neutral,0.7455416917800903
1378,10/29/2019 4:36:49 PM,"S&P 500 squeezes higher on robust Merck, Pfizer earnings",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/70nBezUdNr8/sp-500-squeezes-higher-on-robust-merck-pfizer-earnings-idUSKBN1X81CC,neutral,0.7071929574012756
1379,10/29/2019 5:41:23 PM,"US STOCKS-S&P 500 hits record high on robust Merck, Pfizer earnings",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/h8APVhLbQHI/us-stocks-sp-500-hits-record-high-on-robust-merck-pfizer-earnings-idUSL3N27E43O,negative,0.7786363959312439
1380,10/29/2019 5:48:31 PM,"S&P 500 hits record high on robust Merck, Pfizer earnings",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/02Zb3vyeRLc/sp-500-hits-record-high-on-robust-merck-pfizer-earnings-idUSKBN1X81CC,negative,0.7419291138648987
1381,10/29/2019 8:07:25 PM,"5 Top Stock Trades for Wednesday: GM, AAPL, SHOP, GRUB, PFE",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-gm-aapl-shop-grub-pfe-1028641494,positive,0.9323087334632874
1382,10/29/2019 8:29:39 PM,"Stock Market Today: Earnings, Fed Drive New Highs",InvestorPlace,/news/stocks/stock-market-today-earnings-fed-drive-new-highs-1028641491,negative,0.8553939461708069
1383,10/29/2019 8:31:06 PM,Dow Jones Today: Struggling at the Highs,InvestorPlace,/news/stocks/merck-and-pfizer-boosted-the-dow-jones-today-thanks-to-upped-guidance-1028641490,neutral,0.9591390490531921
1384,10/30/2019 11:28:25 AM,"3 Big Stock Charts for Wednesday: Alibaba, Hewlett Packard, and Chipotle Mexican Grill",InvestorPlace,/news/stocks/3-big-stock-charts-wednesday-alibaba-hewlett-packard-enterprise-chipotle-mexican-grill-1028643864,positive,0.9130274057388306
1385,10/31/2019 11:27:44 AM,"3 Big Stock Charts for Thursday: Merck, Anheuser-Busch InBev, and PPG Industries",InvestorPlace,/news/stocks/3-big-stock-charts-thursday-merck-anheuser-busch-inbev-ppg-industries-1028648405,positive,0.916330873966217
1386,11/1/2019 6:16:10 PM,"The Good, Bad, and Ugly for Biogen Stock",InvestorPlace,/news/stocks/the-good-bad-and-ugly-for-biogen-stock-1028652569,positive,0.5726682543754578
1387,11/4/2019 12:10:45 PM,"The Gilead Stock Price Might Be Down, but That Doesn’t Mean It’s Cheap",InvestorPlace,/news/stocks/gilead-stock-price-down-mean-cheap-1028656095,neutral,0.7800925374031067
1388,11/5/2019 12:40:55 PM,Why This Just Might Be the Biggest Week for CARA Stock,InvestorPlace,/news/stocks/biggest-week-cara-stock-1028659655,positive,0.5292770862579346
1389,11/6/2019 3:36:48 PM,7 Stocks to Sell Before They Roll Over,InvestorPlace,/news/stocks/7-stocks-to-sell-before-they-roll-over-1028665858,positive,0.8909562826156616
1390,11/8/2019 7:11:21 PM,7 Large-Cap Stocks to Give a Wide Berth,InvestorPlace,/news/stocks/7-large-cap-stocks-to-give-a-wide-berth-1028674421,negative,0.5734692215919495
1391,11/12/2019 6:50:33 PM,7 Biotech Stocks to Buy With Plenty of Power in the Pipeline,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-with-plenty-of-power-in-the-pipeline-1028682538,positive,0.8071872591972351
1392,11/13/2019 12:10:48 PM,"3 Big Stock Charts for Wednesday: Stryker, Zoetis, and Coty",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-stryker-zoetis-and-coty-1028685205,positive,0.9289215207099915
1393,11/13/2019 3:35:57 PM,Should Investors Buy Pfizer Stock Before Next Year’s Huge Shake Up?,InvestorPlace,/news/stocks/should-investors-buy-pfizer-stock-before-next-years-huge-shake-up-1028686378,positive,0.9238095283508301
1394,11/13/2019 7:34:42 PM,Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?,InvestorPlace,/news/stocks/should-investors-add-johnson-johnson-stock-to-their-shopping-lists-1028686949,positive,0.9315013289451599
1395,11/15/2019 12:45:45 PM,"3 Big Stock Charts for Friday: Snap, Pfizer and Splunk",InvestorPlace,/news/stocks/3-big-stock-charts-for-friday-snap-pfizer-and-splunk-1028692749,positive,0.9221504330635071
1396,11/15/2019 9:31:39 PM,Dow Jones Today: Stocks Climb on U.S.-China Trade Developments,InvestorPlace,/news/stocks/dow-jones-today-stocks-climb-on-u-s-china-trade-developments-1028694148,negative,0.6439560055732727
1397,11/18/2019 11:33:53 AM,"The Question is Not Why Amarin Stock May Go Up, But Should It?",InvestorPlace,/news/stocks/the-question-is-not-why-amarin-stock-may-go-up-but-should-it-1028696356,positive,0.7992202043533325
1398,11/18/2019 1:00:58 PM,Pfizer: FDA Approves ABRILADA As Biosimilar To Humira - Quick Facts ,RTTNews,/news/stocks/pfizer-fda-approves-abrilada-as-biosimilar-to-humira-quick-facts-1028695939,negative,0.8298218846321106
1399,11/18/2019 1:25:19 PM,"FDA Approves Pfizer's ABRILADA, Fifth Biosimilar To Humira ",RTTNews,/news/stocks/fda-approves-pfizer-s-abrilada-fifth-biosimilar-to-humira-1028696043,negative,0.8541774153709412
1400,11/19/2019 7:28:08 AM,"KRTX Makes Giant Leap, The Medicines' Working Well, AGRX On The Move ",RTTNews,/news/stocks/krtx-makes-giant-leap-the-medicines-working-well-agrx-on-the-move-1028698697,negative,0.8651899099349976
1401,11/20/2019 11:00:47 AM,Biosimilar Race: U.S. Lags Behind Europe ,RTTNews,/news/stocks/biosimilar-race-u-s-lags-behind-europe-1028703162,neutral,0.8631341457366943
1402,11/22/2019 9:31:54 PM,"Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow",InvestorPlace,/news/stocks/dow-jones-today-trade-progress-pushes-stocks-healthcare-helps-dow-1028712595,negative,0.9252076745033264
1403,11/26/2019 2:37:43 PM,5 Great Dividend Stocks for Young Investors,InvestorPlace,/news/stocks/5-great-dividend-stocks-for-young-investors-1028718817,positive,0.8430158495903015
1404,11/27/2019 1:00:00 PM,"FOCUS-Pfizer, Novartis lead pharma spending spree on gene therapy production",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/HeKaWIIYw6A/focus-pfizer-novartis-lead-pharma-spending-spree-on-gene-therapy-production-idUSL1N28500V,positive,0.8222494721412659
1405,11/27/2019 1:07:59 PM,"Pfizer, Novartis lead pharma spending spree on gene therapy production",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/zilEHMyAz1M/pfizer-novartis-lead-pharma-spending-spree-on-gene-therapy-production-idUSKBN1Y11DP,positive,0.8555869460105896
1406,11/27/2019 1:14:56 PM,"Pfizer, Novartis lead pharma spending spree on gene therapy production",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/07m_huEpOt0/pfizer-novartis-lead-pharma-spending-spree-on-gene-therapy-production-idINKBN1Y11DA,positive,0.8555869460105896
1407,11/27/2019 4:05:55 PM,"FOCUS-Pfizer, Novartis lead $2 bln spending spree on gene therapy production",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/F52lKDhASLk/focus-pfizer-novartis-lead-2-bln-spending-spree-on-gene-therapy-production-idUSL8N2874FU,positive,0.7187151312828064
1408,11/27/2019 4:07:15 PM,"Pfizer, Novartis lead $2 billion spending spree on gene therapy production",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Ikb7JmAtm8k/pfizer-novartis-lead-2-billion-spending-spree-on-gene-therapy-production-idINKBN1Y11DA,positive,0.5257658362388611
1409,11/27/2019 4:18:03 PM,"Pfizer, Novartis lead $2 billion spending spree on gene therapy production",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/WC-93pP4VPI/pfizer-novartis-lead-2-billion-spending-spree-on-gene-therapy-production-idUSKBN1Y11DP,positive,0.5257658362388611
1410,12/2/2019 5:26:57 AM,Biotech Stocks Facing FDA Decision In December 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-december-2019-1028728368,positive,0.7641032934188843
1411,12/2/2019 7:57:21 PM,7 Exciting Biotech Stocks to Buy Now,InvestorPlace,/news/stocks/7-exciting-biotech-companies-to-buy-1028731361,positive,0.847749650478363
1412,12/5/2019 1:26:26 PM,ViiV Healthcare Submits NDA To FDA For Fostemsavir On HIV-1 Infection ,RTTNews,/news/stocks/viiv-healthcare-submits-nda-to-fda-for-fostemsavir-on-hiv-1-infection-1028740377,positive,0.765347957611084
1413,12/5/2019 9:29:26 PM,Dow Jones Today: Trade Influenced Stocks More Than Impeachment News,InvestorPlace,/news/stocks/dow-jones-today-trade-influenced-stocks-more-than-impeachment-news-1028742731,positive,0.765224039554596
1414,12/6/2019 11:40:34 AM,Acquisition Rumors Aren’t the Only Thing Moving Amarin Stock,InvestorPlace,/news/stocks/acquisition-rumors-moving-amarin-stock-1028744000,positive,0.561505913734436
1415,12/10/2019 9:26:40 PM,Dow Jones Today: Stocks Suffered From a Distinct Lack of Excitement,InvestorPlace,/news/stocks/dow-jones-today-distinct-lack-of-excitement-1028753135,neutral,0.9653809070587158
1416,12/11/2019 3:38:32 PM,"Amarin Stock Has Lower Risk, But How Much Reward?",InvestorPlace,/news/stocks/amarin-stock-lower-risk-how-much-reward-1028756113,positive,0.8986406922340393
1417,12/13/2019 4:40:11 AM,"First Generic Version Of NuvaRing Gets FDA Nod, ONCT On Watch, SRPT Surges ",RTTNews,/news/stocks/first-generic-version-of-nuvaring-gets-fda-nod-onct-on-watch-srpt-surges-1028760802,negative,0.7355995178222656
1418,12/13/2019 2:40:12 PM,Pfizer: CHMP Adopts Positive Opinion On VYNDAQEL - Quick Facts ,RTTNews,/news/stocks/pfizer-chmp-adopts-positive-opinion-on-vyndaqel-quick-facts-1028762178,negative,0.9285048842430115
1419,12/13/2019 3:18:22 PM,9 Hot Stocks to Buy Now,InvestorPlace,/news/stocks/the-10-best-stocks-to-invest-in-right-now-1028268243,positive,0.9056849479675293
1420,12/14/2019 9:14:45 AM,Are These Biotech Companies Buyout Candidates? Deal Or No Deal? ,RTTNews,/news/stocks/are-these-biotech-companies-buyout-candidates-deal-or-no-deal-1028763470,positive,0.9128385186195374
1421,12/16/2019 6:38:31 PM,Amarin’s Vascepa Approval Seems Fishy for Patients and AMRN Investors,InvestorPlace,/news/stocks/amarin-vascepa-fda-approval-seems-fishy-1028766686,neutral,0.5309538841247559
1422,12/16/2019 9:24:54 PM,The Best & Worst Cloud Stocks Now,InvestorPlace,/news/stocks/best-worst-cloud-stocks-now-1028767136,positive,0.919019341468811
1423,12/16/2019 9:35:50 PM,Dow Jones Today: Lots of Headlines to Digest,InvestorPlace,/news/stocks/technology-and-healthcare-stocks-drove-the-dow-jones-today-1028767134,positive,0.9099558591842651
1424,12/17/2019 12:40:18 AM,"FDA approves expanded label for Pfizer, Astellas' prostate cancer Xtandi",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/pSu8R5TkCO4/fda-approves-expanded-label-for-pfizer-astellas-prostate-cancer-xtandi-idUSL4N28Q4UA,negative,0.8392756581306458
1425,12/17/2019 1:47:06 AM,"UPDATE 1-FDA approves expanded label for Pfizer, Astellas' prostate cancer therapy Xtandi",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/UvALY7IdaRo/update-1-fda-approves-expanded-label-for-pfizer-astellas-prostate-cancer-therapy-xtandi-idUSL4N28R043,negative,0.9022306799888611
1426,12/17/2019 3:49:12 AM,"AXSM Again Proves It Is Awesome, MIRM Leaps To $22, WVE Doesn't Go The Distance ",RTTNews,/news/stocks/axsm-again-proves-it-is-awesome-mirm-leaps-to-22-wve-doesn-t-go-the-distance-1028767240,positive,0.6255311965942383
1427,12/18/2019 7:38:12 PM,3 Top Dogs of the Dow Stocks to Own Heading Into 2020,InvestorPlace,/news/stocks/3-dogs-of-the-dow-stocks-to-own-2020-1028773727,positive,0.9154976606369019
1428,12/20/2019 2:54:48 AM,"FDA Nod For BHC, Third Rituxan Biosim In The Offing, CBIO Soars, NERV Depressed ",RTTNews,/news/stocks/fda-nod-for-bhc-third-rituxan-biosim-in-the-offing-cbio-soars-nerv-depressed-1028777699,negative,0.8848891854286194
1429,12/20/2019 4:02:35 PM,10 2019 Losers That Will Be 2020 Winners,InvestorPlace,/news/stocks/10-2019-losers-that-will-be-2020-winners-1028779762,positive,0.926362931728363
1430,12/23/2019 9:07:09 AM,GSK Says ViiV Healthcare Gets CRL From FDA For Cabotegravir And Rilpivirine ,RTTNews,/news/stocks/gsk-says-viiv-healthcare-gets-crl-from-fda-for-cabotegravir-and-rilpivirine-1028781399,positive,0.5534991025924683
1431,12/26/2019 4:09:52 PM,Taking Amarin Profits Is Probably a Good Idea Right Now,InvestorPlace,/news/stocks/amarin-has-had-its-fun-investors-should-conisder-other-biotech-names-1028785155,positive,0.8343261480331421
1432,12/26/2019 9:48:35 PM,Dow Jones Today: Tech Give Stocks a Post-Christmas Jolt,InvestorPlace,/news/stocks/dow-jones-today-tech-stocks-apple-1028785339,positive,0.7983811497688293
1433,12/30/2019 12:40:34 PM,The Success of Vascepa Actually Might Be a Problem for Amarin,InvestorPlace,/news/stocks/can-amarin-go-it-alone-1028788266,neutral,0.9028927087783813
1434,12/30/2019 6:14:02 PM,9 Hot Stocks to Buy Now,InvestorPlace,/news/stocks/hot-stocks-to-buy-now-1028788635,positive,0.9056849479675293
1435,12/31/2019 1:22:53 PM,Here’s Why Amarin Stock Slumped Despite the FDA Approval,InvestorPlace,/news/stocks/why-amarin-stock-slumped-fda-approval-1028789662,neutral,0.9650284051895142
1436,12/31/2019 4:37:57 PM,Cisco Stock Needs a Catalyst to Thrive in 2020 and Beyond,InvestorPlace,/news/stocks/cisco-stock-needs-a-catalyst-to-thrive-in-2020-and-beyond-1028789804,negative,0.8096827268600464
1437,12/31/2019 5:01:53 PM,"Vascepa’s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock",InvestorPlace,/news/stocks/vascepa-future-amarin-stock-amrn-fishy-1028789803,neutral,0.8319942951202393
1438,12/31/2019 10:14:25 PM,Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Rz3M4vOF-Iw/exclusive-drugmakers-from-pfizer-to-gsk-to-hike-u-s-prices-on-over-200-drugs-idUSKBN1YZ1C4,negative,0.8811137080192566
1439,12/31/2019 11:27:59 PM,Exclusive: Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/P2AXyHAsaGk/exclusive-drugmakers-from-pfizer-to-gsk-to-hike-u-s-prices-on-over-200-drugs-idINKBN1YZ1C6,negative,0.8811137080192566
1440,1/3/2020 3:44:20 PM,3 Top Drug Stocks to Own In 2020,InvestorPlace,/news/stocks/3-top-drug-stocks-to-own-in-2020-1028793729,positive,0.8554175496101379
1441,1/3/2020 6:38:44 PM,"After Lackluster 2019, Pfizer Stock Could Rebound in 2020",InvestorPlace,/news/stocks/after-lackluster-2019-pfizer-stock-could-rebound-in-2020-1028793896,negative,0.95452880859375
1442,1/3/2020 9:25:21 PM,Dow Jones Today: Geopolitical Tensions Lead to a Tense Day for Stocks,InvestorPlace,/news/stocks/an-airstrike-that-killed-an-iranian-general-pressured-the-dow-jones-today-1028794159,neutral,0.9252141714096069
1443,1/6/2020 1:34:14 PM,Pfizer : Bavencio Improves OS In Patients With Metastatic Urothelial Carcinoma ,RTTNews,/news/stocks/pfizer-bavencio-improves-os-in-patients-with-metastatic-urothelial-carcinoma-1028795660,negative,0.9440149068832397
1444,1/6/2020 5:18:24 PM,7 Investing Resolutions to Follow in 2020,InvestorPlace,/news/stocks/7-investing-resolutions-to-follow-in-2020-1028797249,positive,0.9337491393089294
1445,1/6/2020 7:03:48 PM,A 2019 Review of Dow Jones Stocks (And What 2020 May Bring),InvestorPlace,/news/stocks/a-2019-review-of-dow-jones-stocks-and-what-2020-may-bring-1028797244,positive,0.9407529830932617
1446,1/7/2020 8:49:39 PM,"5 Top Stock Trades for Wednesday: MU, SQ, WMT",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-mu-sq-wmt-1028801044,positive,0.9241970181465149
1447,1/8/2020 4:31:12 PM,3 Stocks to Buy That Will Hit New All-Time Highs in 2020,InvestorPlace,/news/stocks/3-stocks-to-buy-all-time-highs-2020-1028803931,negative,0.6816320419311523
1448,1/9/2020 2:35:37 PM,Pfizer Joins With EFFECTOR To Develop Therapy For Treatment-refractory Cancers ,RTTNews,/news/stocks/pfizer-joins-with-effector-to-develop-therapy-for-treatment-refractory-cancers-1028806239,negative,0.7083523273468018
1449,1/9/2020 3:23:20 PM,A Recent FDA Approval Will Be Huge in Moving Amarin Stock,InvestorPlace,/news/stocks/fda-approval-moving-amarin-stock-1028807149,negative,0.5159583687782288
1450,1/9/2020 6:31:35 PM,Pfizer Stock Has No Momentum in Its Business or on the Charts,InvestorPlace,/news/stocks/pfizer-stock-has-no-momentum-in-its-business-or-on-the-charts-1028807413,positive,0.9014949798583984
1451,1/10/2020 3:59:53 PM,All Bets Are Off for Amarin Stock,InvestorPlace,/news/stocks/upside-priced-in-all-bets-off-amrn-stock-1028809870,positive,0.8857803344726562
1452,1/10/2020 9:30:04 PM,Dow Jones Today: Stocks Pinched by Jobs Disappointment,InvestorPlace,/news/stocks/dow-jones-today-stocks-pinched-by-jobs-disappointment-1028810366,neutral,0.965473473072052
1453,1/13/2020 12:25:21 PM,Axsome In Exclusive U.S. License Deal With Pfizer For Reboxetine - Quick Facts ,RTTNews,/news/stocks/axsome-in-exclusive-u-s-license-deal-with-pfizer-for-reboxetine-quick-facts-1028811845,negative,0.8732396960258484
1454,1/13/2020 2:03:26 PM,Biogen To Acquire Clinical Stage PF-05251749 From Pfizer - Quick Facts ,RTTNews,/news/stocks/biogen-to-acquire-clinical-stage-pf-05251749-from-pfizer-quick-facts-1028812254,positive,0.841746985912323
1455,1/13/2020 2:33:00 PM,"Biogen to buy early-stage potential Alzheimer's, Parkinson's treatment from Pfizer",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/6cTPS1Rtbqk/biogen-to-buy-early-stage-potential-alzheimers-parkinsons-treatment-from-pfizer-idUSL4N29I2JD,negative,0.6900151371955872
1456,1/14/2020 6:26:04 AM,"Genome & Co. In Clinical Trial And Supply Deal With Merck KGaA, Pfizer ",RTTNews,/news/stocks/genome-co-in-clinical-trial-and-supply-deal-with-merck-kgaa-pfizer-1028814391,negative,0.6336528658866882
1457,1/14/2020 12:12:57 PM,"3 Big Stock Charts for Tuesday: Pfizer, Clorox, and L Brands",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-pfizer-clorox-and-l-brands-1028815752,positive,0.9229612946510315
1458,1/14/2020 7:03:00 PM,Pharmacia Corporation (Old Monsanto) -- Moody's announces completion of a periodic review of ratings of Pfizer Inc.,Moodys,/news/bonds/pharmacia-corporation-old-monsanto-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-pfizer-inc-1028817190,positive,0.6374494433403015
1459,1/14/2020 9:21:41 PM,Dow Jones Today: JPMorgan Gives Dow a Lift as Stocks Falter Near Highs,InvestorPlace,/news/stocks/dow-jones-today-jpmorgan-gives-dow-a-lift-as-stocks-falter-near-highs-1028817760,negative,0.8177148699760437
1460,1/15/2020 4:37:07 PM,Pfizer Stock Offers Good Value to Patient Investors,InvestorPlace,/news/stocks/pfizer-stock-offers-good-value-investors-1028820483,negative,0.7911884784698486
1461,1/15/2020 6:25:47 PM,Ocugen Stock Is Not for the Faint of Heart,InvestorPlace,/news/stocks/ocugen-stock-faint-heart-1028820815,positive,0.9405810832977295
1462,1/16/2020 12:30:04 PM,"After FDA Approval, Amarin Stock Is Stuck in Worrisome Trading",InvestorPlace,/news/stocks/recent-trading-looks-worrisome-amarin-stock-1028822946,neutral,0.9516841173171997
1463,1/16/2020 1:27:17 PM,"Beyond the Growing Dividend, Abbvie Stock Is a Good Buy Here",InvestorPlace,/news/stocks/growing-dividend-abbvie-stock-good-buy-1028823662,negative,0.8297058343887329
1464,1/17/2020 11:30:07 AM,Why Amarin Stock Is Poised for a Healthy 2020,InvestorPlace,/news/stocks/amarin-stock-poised-healthy-2020-1028826114,negative,0.8406236171722412
1465,1/22/2020 6:45:58 PM,3 of the Most Oversold Stocks to Own in 2020,InvestorPlace,/news/stocks/3-of-the-most-oversold-stocks-to-own-in-2020-1028837159,neutral,0.654166042804718
1466,1/23/2020 3:15:16 PM,Acasti’s Losing Drug and ACST Stock Are Not for Weak Hearts,InvestorPlace,/news/stocks/acasti-losing-drug-and-acst-stock-are-not-for-weak-hearts-1028840870,positive,0.8007665872573853
1467,1/27/2020 3:01:28 PM,Here's what to expect from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-stock-q4-earnings-preview-1028846752,positive,0.9362934827804565
1468,1/27/2020 4:36:20 PM,"Until Anthem Buys Up Healthcare Facilities, Sell ANTM Stock",InvestorPlace,/news/stocks/anthem-antm-stock-buying-healthcare-facilities-1028847531,positive,0.9050427079200745
1469,1/27/2020 9:29:18 PM,"Dow Jones Today: Virus Spreads, Impeachment Proceedings Infect Stocks",InvestorPlace,/news/stocks/defensives-lead-the-dow-jones-today-but-not-much-else-worked-1028848287,neutral,0.9115419387817383
1470,1/28/2020 12:53:31 PM,Pfizer Inc. Q4 adjusted earnings Miss Estimates,RTTNews,/news/stocks/pfizer-inc-q4-adjusted-earnings-miss-estimates-1028849886,neutral,0.9525477290153503
1471,1/28/2020 12:54:41 PM,Pfizer posts 9% fall in fourth-quarter revenue,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/-E_qOO69QxU/pfizer-posts-9-fall-in-fourth-quarter-revenue-idUSKBN1ZR1AX,neutral,0.974943995475769
1472,1/28/2020 1:16:51 PM,UPDATE 1-Pfizer profit misses as breast cancer drug sales fall short of estimates,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/s3apoJ0rZ7I/update-1-pfizer-profit-misses-as-breast-cancer-drug-sales-fall-short-of-estimates-idUSL4N29X1ZX,neutral,0.9705876111984253
1473,1/28/2020 1:33:31 PM,"Pfizer Q4 Adj. Profit Falls, Revenues Down 9%; Issues FY20 Outlook ",RTTNews,/news/stocks/pfizer-q4-adj-profit-falls-revenues-down-9-issues-fy20-outlook-1028850083,neutral,0.9702700972557068
1474,1/28/2020 1:42:03 PM,Pfizer profit misses as breast cancer drug sales fall short of estimates,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/Y6LKxVk0uus/pfizer-profit-misses-as-breast-cancer-drug-sales-fall-short-of-estimates-idUSKBN1ZR1AX,neutral,0.9633700251579285
1475,1/28/2020 2:05:20 PM,Pfizer profit misses as breast cancer drug sales fall short of estimates,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/QLKPJ2mPzDE/pfizer-profit-misses-as-breast-cancer-drug-sales-fall-short-of-estimates-idINKBN1ZR1J4,neutral,0.9633700251579285
1476,1/28/2020 4:33:18 PM,"UPDATE 2-Pfizer profit misses estimates, revenue declines as Lyrica sales tumble",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/J0wnf5jyFaY/update-2-pfizer-profit-misses-estimates-revenue-declines-as-lyrica-sales-tumble-idUSL4N29X1ZX,neutral,0.970890998840332
1477,1/28/2020 4:41:39 PM,"Pfizer profit misses estimates, revenue declines as Lyrica sales tumble",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/XvE7FfiQduo/pfizer-profit-misses-estimates-revenue-declines-as-lyrica-sales-tumble-idINKBN1ZR1J4,neutral,0.9700415730476379
1478,1/28/2020 6:35:25 PM,UPDATE 3-Pfizer profit misses estimates as revenue falls; plans no 2020 share repurchases,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/75wDHud2XKY/update-3-pfizer-profit-misses-estimates-as-revenue-falls-plans-no-2020-share-repurchases-idUSL4N29X1ZX,neutral,0.965944766998291
1479,1/28/2020 6:51:32 PM,Pfizer profit misses estimates as revenue falls; plans no 2020 share repurchases,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/fKVgUNqp13E/pfizer-profit-misses-estimates-as-revenue-falls-plans-no-2020-share-repurchases-idINKBN1ZR1J4,neutral,0.9573692083358765
1480,1/28/2020 7:00:10 PM,"Pfizer profit misses estimates, revenue declines as Lyrica sales tumble",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/aJIeOoD9nX8/pfizer-profit-misses-estimates-revenue-declines-as-lyrica-sales-tumble-idUSKBN1ZR1AX,neutral,0.9700415730476379
1481,1/28/2020 7:27:53 PM,Pfizer Earnings: PFE Stock Slips 5% on Q4 Miss,InvestorPlace,/news/stocks/pfizer-earnings-hit-pfe-stock-1028852414,neutral,0.9748661518096924
1482,1/28/2020 8:35:31 PM,"4 Top Stock Trades for Wednesday: Apple, General Electric, 3M and More",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-apple-general-electric-3m-and-more-1028852405,positive,0.9296166896820068
1483,1/28/2020 9:20:58 PM,Dow Jones Today: Stocks Return From the Coronavirus Abyss,InvestorPlace,/news/stocks/dow-jones-today-stocks-return-from-the-coronavirus-abyss-1028852685,negative,0.6338282823562622
1484,1/28/2020 9:35:01 PM,Stock Market Today: Earnings Season Gets Intense; Buy Uber?,InvestorPlace,/news/stocks/stock-market-today-earnings-season-gets-intense-buy-uber-1028852683,positive,0.7619191408157349
1485,1/29/2020 12:11:45 AM,Pfizer profit misses estimates as revenue falls; plans no 2020 share repurchases,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/dVlMzPA9LJU/pfizer-profit-misses-estimates-as-revenue-falls-plans-no-2020-share-repurchases-idUSKBN1ZR1AX,neutral,0.9573692083358765
1486,2/4/2020 12:30:56 PM,Johnson & Johnson Stock Looks Like a Safe Place to Hide Out,InvestorPlace,/news/stocks/jnj-stock-looks-safe-place-hide-1028871756,positive,0.8869536519050598
1487,2/5/2020 9:20:15 PM,Dow Jones Today: Stocks Continue Shrugging Off Virus Fears,InvestorPlace,/news/stocks/dow-jones-today-stocks-continue-shrugging-off-virus-fears-1028878846,negative,0.7648214101791382
1488,2/11/2020 6:37:14 PM,Pfizer axes license agreement with GlycoMimetics,Seeking Alpha,https://seekingalpha.com/news/3540669-pfizer-axes-license-agreement-glycomimetics?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7619310617446899
1489,2/12/2020 6:16:55 PM,The Story Behind a Stock Market Milestone,InvestorPlace,/news/stocks/the-story-behind-a-stock-market-milestone-1028899969,positive,0.8953757286071777
1490,2/13/2020 4:52:35 PM,Merck’s Spinoff Promises Higher Dividends and Big Upside,InvestorPlace,/news/stocks/mrk-stock-earnings-spin-off-upside-1028904164,negative,0.9398862719535828
1491,2/14/2020 4:41:45 PM,"Risks Remain, but Amarin Stock Is a Buy at Today’s Prices",InvestorPlace,/news/stocks/risks-remain-amrn-stock-buy-todays-prices-1028907556,positive,0.609498143196106
1492,2/18/2020 1:13:42 PM,Pfizer Announces EC Approval Of VYNDAQEL - Quick Facts ,RTTNews,/news/stocks/pfizer-announces-ec-approval-of-vyndaqel-quick-facts-1028913206,positive,0.895721971988678
1493,2/19/2020 10:01:01 AM,Opioids Made TEVA Stock Untouchable But Things Seem to be Changing,InvestorPlace,/news/stocks/opioids-made-teva-stock-untouchable-but-things-seem-to-be-changing-1028917994,positive,0.7889673113822937
1494,2/21/2020 2:32:53 PM,Dems attack Trump over stalled efforts to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3544481-dems-attack-trump-over-stalled-efforts-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9021157026290894
1495,2/24/2020 4:18:27 PM,3 Healthcare Stocks to Buy This Year,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-this-year-1028932507,positive,0.8341861963272095
1496,2/26/2020 9:30:57 PM,Dow Jones Today: Don’t Call It a Comeback,InvestorPlace,/news/stocks/dow-jones-today-dont-call-it-a-comeback-1028947326,positive,0.839457631111145
1497,2/27/2020 1:26:27 PM,"Teva Stock Was a Good Buy Last Fall, but It Topped out After This Rally",InvestorPlace,/news/stocks/teva-stock-topped-out-1028947313,negative,0.8630337715148926
1498,2/27/2020 2:41:22 PM,"Mylan & Pfizer Appoint Sanjeev Narula As CFO, Viatris - Quick Facts ",RTTNews,/news/stocks/mylan-pfizer-appoint-sanjeev-narula-as-cfo-viatris-quick-facts-1028945804,positive,0.9513076543807983
1499,2/27/2020 8:48:45 PM,Pfizer warns of hit to financial results on continued coronavirus outbreak,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/iOQz4Ng-V_s/pfizer-warns-of-hit-to-financial-results-on-continued-coronavirus-outbreak-idUSKCN20L2XB,neutral,0.9542892575263977
1500,2/27/2020 9:10:40 PM,UPDATE 1-Pfizer warns of hit to financial results on continued coronavirus outbreak,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/HmSDX-pWmlA/update-1-pfizer-warns-of-hit-to-financial-results-on-continued-coronavirus-outbreak-idUSL3N2AR5JD,neutral,0.9664504528045654
1501,2/28/2020 3:07:03 PM,Confounding Decline Creates an Opportunity in Amarin Stock,InvestorPlace,/news/stocks/confounding-decline-creates-opportunity-amarin-stock-1028950173,neutral,0.8555841445922852
1502,2/28/2020 9:43:05 PM,Pfizer gets OK for Advil Dual Action,Seeking Alpha,https://seekingalpha.com/news/3547196-pfizer-gets-ok-for-advil-dual-action?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8482495546340942
1503,3/2/2020 1:03:08 PM,Pfizer & Eli Lilly: FDA To Review BLA For Tanezumab - Quick Facts ,RTTNews,/news/stocks/pfizer-eli-lilly-fda-to-review-bla-for-tanezumab-quick-facts-1028954544,positive,0.786250114440918
1504,3/2/2020 2:56:53 PM,FDA accepts Pfizer application for novel pain med,Seeking Alpha,https://seekingalpha.com/news/3547448-fda-accepts-pfizer-application-for-novel-pain-med?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8187137842178345
1505,3/3/2020 12:01:10 AM,Pfizer identified some antiviral compounds with potential as coronavirus treatments,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vtdWZYUU6D4/pfizer-identified-some-antiviral-compounds-with-potential-as-coronavirus-treatments-idUSL1N2AV2AS,positive,0.752720057964325
1506,3/4/2020 9:15:44 PM,"Dow Jones Today: Primary Results, Stimulus Speculation Prove Potent",InvestorPlace,/news/stocks/dow-jones-today-primary-results-stimulus-speculation-prove-potent-1028966188,negative,0.5126901268959045
1507,3/6/2020 1:47:30 AM,Pfizer weighs working with BioNTech on potential coronavirus vaccine - R&D head,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/YeBUhB2E8hs/pfizer-weighs-working-with-biontech-on-potential-coronavirus-vaccine-rd-head-idUSL1N2AY2EN,negative,0.5255547761917114
1508,3/6/2020 2:02:44 AM,Pfizer weighs working with BioNTech on potential coronavirus vaccine - R&D head,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/kAGTmg0Q0s8/pfizer-weighs-working-with-biontech-on-potential-coronavirus-vaccine-rd-head-idINKBN20T02Q,negative,0.5255547761917114
1509,3/6/2020 11:50:52 AM,Amarin Stock Looks Like a Heart-Healthy Buy on the Dip,InvestorPlace,/news/stocks/amarin-stock-looks-like-a-heart-healthy-buy-on-the-dip-1028971862,negative,0.7207629680633545
1510,3/6/2020 6:19:57 PM,Pfizer Won’t Win the Coronavirus Pharma War,InvestorPlace,/news/stocks/pfizer-wont-win-the-coronavirus-pharma-war-1028973045,positive,0.8832708597183228
1511,3/9/2020 2:43:27 PM,ViiV Healthcare reports positive data on less-frequent dosing of HIV regimen,Seeking Alpha,https://seekingalpha.com/news/3549766-viiv-healthcare-reports-positive-data-on-less-frequent-dosing-of-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9549173712730408
1512,3/9/2020 3:11:39 PM,ViiV Healthcare re-ups with UNC-Chapel Hill,Seeking Alpha,https://seekingalpha.com/news/3549783-viiv-healthcare-re-ups-unc-chapel-hill?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9143162369728088
1513,3/10/2020 2:29:46 PM,Its Powerful Pipeline Shows Pfizer Stock Is Undervalued by 15%,InvestorPlace,/news/stocks/pfe-stock-is-undervalued-by-at-least-15-1028981675,negative,0.8663246035575867
1514,3/10/2020 10:23:58 PM,Generic anti-malarial may treat COVID-19 - Raymond James,Seeking Alpha,https://seekingalpha.com/news/3550389-generic-anti-malarial-may-treat-covidminus-19-raymond-james?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7612016201019287
1515,3/11/2020 10:10:04 AM,5 Biotech Stocks to Buy for a Strong Growth Prognosis,InvestorPlace,/news/stocks/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-1028378734,negative,0.5414467453956604
1516,3/12/2020 4:04:14 PM,Pfizer Stock Remains a Cautionary Tale For Investors,InvestorPlace,/news/stocks/pfizer-stock-remains-a-cautionary-tale-for-investors-1028990966,positive,0.5466724634170532
1517,3/13/2020 12:36:02 PM,Healthcare stocks set for rally today,Seeking Alpha,https://seekingalpha.com/news/3551531-healthcare-stocks-set-for-rally-today?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6742608547210693
1518,3/13/2020 1:17:01 PM,"EMD, Pfizer Accept DMC Recommendation To Terminate Head And Neck Cancer Trial ",RTTNews,/news/stocks/emd-pfizer-accept-dmc-recommendation-to-terminate-head-and-neck-cancer-trial-1028993650,positive,0.6439448595046997
1519,3/13/2020 1:49:37 PM,Pfizer and EMD Serono bail on study of avelumab in head and neck cancer,Seeking Alpha,https://seekingalpha.com/news/3551576-pfizer-and-emd-serono-bail-on-study-of-avelumab-in-head-and-neck-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5395282506942749
1520,3/13/2020 8:47:02 PM,Dow Jones Today: Stocks Rally as Coronavirus National Emergency Looms,InvestorPlace,/news/stocks/goldman-sachs-led-a-rally-for-the-dow-jones-today-1028995544,neutral,0.9283227920532227
1521,3/16/2020 10:44:14 AM,BioNTech up 55% premarket on advancement of coronavirus vaccine,Seeking Alpha,https://seekingalpha.com/news/3551894-biontech-up-55-premarket-on-advancement-of-coronavirus-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8287236094474792
1522,3/16/2020 11:14:02 AM,U.S. stocks set to gap down at open,Seeking Alpha,https://seekingalpha.com/news/3551922-u-s-stocks-set-to-gap-down-open?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9542070627212524
1523,3/17/2020 7:00:01 AM,"Pfizer, BioNTech to co-develop potential coronavirus vaccine",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/oVSjJiUcPjQ/pfizer-biontech-to-co-develop-potential-coronavirus-vaccine-idUSL4N2BA1AI,positive,0.6298994421958923
1524,3/17/2020 7:06:21 AM,"Pfizer, BioNTech to co-develop potential coronavirus vaccine",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/-5HxY8MwNlo/pfizer-biontech-to-co-develop-potential-coronavirus-vaccine-idINKBN2140L9,positive,0.6298994421958923
1525,3/17/2020 7:36:34 AM,"Pfizer, BioNTech To Co-develop Potential Vaccine To Combat COVID-19 Infection ",RTTNews,/news/stocks/pfizer-biontech-to-co-develop-potential-vaccine-to-combat-covid-19-infection-1029002378,negative,0.8387506008148193
1526,3/17/2020 10:44:17 AM,Pfizer teams up with BioNTech to develop COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3552377-pfizer-teams-up-biontech-to-develop-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8137080073356628
1527,3/17/2020 1:43:22 PM,"Stock Alerts: BioNTech SE, Pfizer To Co-develop Potential Coronavirus Vaccine ",RTTNews,/news/stocks/stock-alerts-biontech-se-pfizer-to-co-develop-potential-coronavirus-vaccine-1029003781,positive,0.8161621689796448
1528,3/17/2020 3:55:58 PM,Stock Alert: BioNTech Up 65%; To Co-Develop Coronavirus Vaccine With Pfizer ,RTTNews,/news/stocks/stock-alert-biontech-up-65-to-co-develop-coronavirus-vaccine-with-pfizer-1029004589,negative,0.9457003474235535
1529,3/18/2020 6:55:12 AM,"BNTX On Fire, QDEL's Coronavirus Test Gets FDA's EUA, CureVac Back In The News ",RTTNews,/news/stocks/bntx-on-fire-qdel-s-coronavirus-test-gets-fda-s-eua-curevac-back-in-the-news-1029006665,positive,0.7537549138069153
1530,3/18/2020 11:19:02 AM,"Pfizer, IDEAYA To Evaluate Clinical Combination Of IDE196 & Binimetinib ",RTTNews,/news/stocks/pfizer-ideaya-to-evaluate-clinical-combination-of-ide196-binimetinib-1029007495,positive,0.7578542232513428
1531,3/18/2020 8:35:25 PM,Pfizer reports positive data on 20-valent pneumonia vaccine,Seeking Alpha,https://seekingalpha.com/news/3553128-pfizer-reports-positive-data-on-20-valent-pneumonia-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9437656402587891
1532,3/18/2020 8:42:01 PM,Pfizer's abrocitinib successful in dermatitis study,Seeking Alpha,https://seekingalpha.com/news/3553132-pfizers-abrocitinib-successful-in-dermatitis-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5606827735900879
1533,3/18/2020 8:46:06 PM,Pfizer postpones investor event due to Covid-19,Seeking Alpha,https://seekingalpha.com/news/3553137-pfizer-postpones-investor-event-due-to-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7914056181907654
1534,3/18/2020 9:51:33 PM,"Pfizer puts off investor day, reports two late-stage study results in advance",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/lTStr0ctm1E/pfizer-puts-off-investor-day-reports-two-late-stage-study-results-in-advance-idUSL4N2BB54N,positive,0.9062053561210632
1535,3/18/2020 10:24:22 PM,"UPDATE 1-Pfizer puts off investor day, reports two late-stage study results in advance",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/3koE64j0wq8/update-1-pfizer-puts-off-investor-day-reports-two-late-stage-study-results-in-advance-idUSL4N2BB55A,positive,0.8820956349372864
1536,3/19/2020 5:00:38 PM,Profit-taking pressures Moderna after Hahn comments on vaccine timeline,Seeking Alpha,https://seekingalpha.com/news/3553448-profit-taking-pressures-moderna-after-hahn-comments-on-vaccine-timeline?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9628137350082397
1537,3/23/2020 12:27:11 PM,Can Inovio’s Vaccine Efforts Maintain Growth for INO Stock?,InvestorPlace,/news/stocks/ino-stock-jumping-risky-vaccine-potential-1029022751,negative,0.6897315979003906
1538,3/24/2020 11:01:39 AM,FDA OKs Pfizer's sNDA for expanded use of Eucrisa; shares up 5% premarket,Seeking Alpha,https://seekingalpha.com/news/3554562-fda-oks-pfizers-snda-for-expanded-use-of-eucrisa-shares-up-5-premarket?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9450158476829529
1539,3/24/2020 11:56:29 AM,Pfizer Reports FDA Approval For Expanded Indication Of EUCRISA - Quick Facts ,RTTNews,/news/stocks/pfizer-reports-fda-approval-for-expanded-indication-of-eucrisa-quick-facts-1029026015,negative,0.9112881422042847
1540,3/24/2020 5:57:31 PM,Mylan down 4% on potential EpiPen safety issue,Seeking Alpha,https://seekingalpha.com/news/3554769-mylan-down-4-on-potential-epipen-safety-issue?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9707620143890381
1541,3/25/2020 4:19:00 PM,"Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes, on review for downgrade",Moodys,/news/bonds/pfizer-inc-moody-s-assigns-a1-to-pfizer-s-notes-on-review-for-downgrade-1029031822,neutral,0.5310294032096863
1542,3/25/2020 6:06:29 PM,Pfizer pauses new studies due to coronavirus,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/vxUjk-oI8wE/pfizer-pauses-new-studies-due-to-coronavirus-idUSL4N2BI4L2,neutral,0.9039288759231567
1543,3/25/2020 6:28:05 PM,UPDATE 1-U.S. drugmaker Pfizer pauses new studies due to coronavirus pandemic,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/OEN3WKr4lCI/update-1-u-s-drugmaker-pfizer-pauses-new-studies-due-to-coronavirus-pandemic-idUSL4N2BI4LX,neutral,0.9402806162834167
1544,3/26/2020 11:11:34 AM,Close of Mylan/Upjohn tie-up extended to H2,Seeking Alpha,https://seekingalpha.com/news/3555380-close-of-mylan-upjohn-tie-up-extended-to-h2?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8177632689476013
1545,3/26/2020 11:57:56 AM,"Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/zUTTPP4xKBE/drugmakers-mylan-pfizer-delay-merger-due-to-coronavirus-outbreak-idUSL4N2BJ35W,neutral,0.9351686835289001
1546,3/26/2020 12:02:00 PM,"Mylan, Upjohn Deal To Close In H2 - Quick Facts ",RTTNews,/news/stocks/mylan-upjohn-deal-to-close-in-h2-quick-facts-1029034681,positive,0.8788829445838928
1547,3/26/2020 12:24:53 PM,"UPDATE 1-Drugmakers Mylan, Pfizer delay merger due to coronavirus outbreak",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/pr0hpfkQsUQ/update-1-drugmakers-mylan-pfizer-delay-merger-due-to-coronavirus-outbreak-idUSL4N2BJ36D,neutral,0.9331086874008179
1548,3/26/2020 12:26:42 PM,Inovio Pharmaceuticals Will Fall Once Coronavirus Fears Fade,InvestorPlace,/news/stocks/ino-stock-will-fall-coronavirus-fears-fade-1029035424,neutral,0.9235630631446838
1549,3/26/2020 2:53:50 PM,7 Buyout Targets to Watch for in 2020,InvestorPlace,/news/stocks/7-buyout-targets-to-watch-for-2020-1028793898,positive,0.8936671018600464
1550,3/26/2020 3:31:43 PM,"Don’t Guess What Buffett Is Buying, Buy Berkshire Hathaway Stock",InvestorPlace,/news/stocks/dont-guess-what-buffett-is-buying-buy-berkshire-hathaway-stock-1029036618,positive,0.9405990242958069
1551,3/27/2020 3:48:49 PM,"Pfizer completes first-ever ""green"" bond",Seeking Alpha,https://seekingalpha.com/news/3555925-pfizer-completes-first-ever-green-bond?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6257089972496033
1552,3/30/2020 2:01:10 PM,Mylan offers concessions to address EU concerns about Pfizer deal,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/pVWdPL1H8zI/mylan-offers-concessions-to-address-eu-concerns-about-pfizer-deal-idUSL8N2BN4PM,negative,0.6349300146102905
1553,4/1/2020 2:50:13 PM,Pfizer prevails in patent dispute over emergency allergy med,Seeking Alpha,https://seekingalpha.com/news/3557275-pfizer-prevails-in-patent-dispute-over-emergency-allergy-med?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8705698251724243
1554,4/3/2020 2:38:43 PM,SIGA Tech up 6% on Canada military order of smallpox drug,Seeking Alpha,https://seekingalpha.com/news/3558248-siga-tech-up-6-on-canada-military-order-of-smallpox-drug?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.947736918926239
1555,4/5/2020 6:55:44 PM,Incyte details late-stage data on ruxolitinib cream for atopic dermatitis,Seeking Alpha,https://seekingalpha.com/news/3558456-incyte-details-late-stage-data-on-ruxolitinib-cream-for-atopic-dermatitis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8612488508224487
1556,4/6/2020 11:42:46 AM,"3 Big Stock Charts for Monday: Intel, Amazon, and Pfizer",InvestorPlace,/news/stocks/3-big-stock-charts-for-monday-intel-amazon-and-pfizer-1029067521,positive,0.8885320425033569
1557,4/6/2020 2:38:38 PM,Healthcare firms pile on initiatives as COVID-19 pandemic advances,Seeking Alpha,https://seekingalpha.com/news/3558642-healthcare-firms-pile-on-initiatives-covidminus-19-pandemic-advances?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5490674376487732
1558,4/8/2020 1:25:49 PM,7 Tarnished Blue-Chip Stocks to Ditch Now,InvestorPlace,/news/stocks/7-tarnished-blue-chip-stocks-to-ditch-now-1028928032,neutral,0.7431551814079285
1559,4/8/2020 10:47:18 PM,FDA OKs Pfizer's Braftovi combo for certain type of colorectal cancer,Seeking Alpha,https://seekingalpha.com/news/3559539-fda-oks-pfizers-braftovi-combo-for-certain-type-of-colorectal-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.830585777759552
1560,4/9/2020 5:13:49 AM,"BMY Awaits FDA Decision, LQDA On Watch, MNOV To Begin Clinical Trial In COVID-19 ",RTTNews,/news/stocks/bmy-awaits-fda-decision-lqda-on-watch-mnov-to-begin-clinical-trial-in-covid-19-1029078082,positive,0.8286135196685791
1561,4/9/2020 12:45:00 PM,Pfizer says early studies of potential coronavirus treatment show promise,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/XgiUjLtCLFw/pfizer-says-early-studies-of-potential-coronavirus-treatment-show-promise-idUSL2N2BW1GK,negative,0.6425734162330627
1562,4/9/2020 12:56:22 PM,Pfizer says early studies of potential coronavirus treatment show promise,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/8idUO8VcR48/pfizer-says-early-studies-of-potential-coronavirus-treatment-show-promise-idINKCN21R1LC,negative,0.6425734162330627
1563,4/9/2020 2:16:56 PM,Pfizer Advances Battle Against Coronavirus On Multiple Fronts - Quick Facts ,RTTNews,/news/stocks/pfizer-advances-battle-against-coronavirus-on-multiple-fronts-quick-facts-1029079724,positive,0.6652381420135498
1564,4/9/2020 2:26:52 PM,BioNTech Discloses Addl Details Of Pfizer Collaboration On COVID-19 Vaccine ,RTTNews,/news/stocks/biontech-discloses-addl-details-of-pfizer-collaboration-on-covid-19-vaccine-1029079751,positive,0.9121716618537903
1565,4/9/2020 5:21:12 PM,"UPDATE 1-Pfizer clinches coronavirus vaccine deal, sees potential in antiviral treatment",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/N9DBndV8DQk/update-1-pfizer-clinches-coronavirus-vaccine-deal-sees-potential-in-antiviral-treatment-idUSL2N2BX0Z7,negative,0.9246239066123962
1566,4/9/2020 10:31:05 PM,Airline industry package to be proposed this weekend: coronavirus briefing,Seeking Alpha,https://seekingalpha.com/news/3559879-airline-industry-package-to-be-proposed-this-weekend-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8407953977584839
1567,4/13/2020 12:06:25 PM,10 S&P 500 Stocks to Buy Increasing Their Dividends in 2020,InvestorPlace,/news/stocks/10-sp-500-stocks-to-buy-increasing-their-dividends-in-2020-1028924902,positive,0.5667852759361267
1568,4/20/2020 6:09:37 PM,Money flow spikes in COVID-19 vaccine players amid rush for early data,Seeking Alpha,https://seekingalpha.com/news/3562210-money-flow-spikes-in-covidminus-19-vaccine-players-amid-rush-for-early-data?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7037768363952637
1569,4/22/2020 11:30:14 AM,"BioNTech, Pfizer To Begin COVID-19 Clinical Trial In Germany ",RTTNews,/news/stocks/biontech-pfizer-to-begin-covid-19-clinical-trial-in-germany-1029116511,positive,0.7846792936325073
1570,4/22/2020 8:16:32 PM,Pfizer News: PFE Stock Pops 2% on COVID-19 Vaccine Trial Approval,InvestorPlace,/news/stocks/pfizer-news-props-up-pfe-stock-1029119924,negative,0.7825295329093933
1571,4/23/2020 6:09:04 PM,European regulators on board with Mylan/Upjohn tie-up,Seeking Alpha,https://seekingalpha.com/news/3563821-european-regulators-on-board-mylan-upjohn-tie-up?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7507326006889343
1572,4/23/2020 9:00:34 PM,This Stock Points to the Massive China Biotech Trend,InvestorPlace,/news/stocks/zlab-stock-points-to-massive-china-biotech-stock-trend-1029124959,positive,0.8943907618522644
1573,4/27/2020 3:01:50 PM,Pfizer earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-q1-quarterly-earnings-preview-1029133054,positive,0.9320189952850342
1574,4/27/2020 3:16:49 PM,Vaccinex up 10% on updated pepinemab data in lung cancer,Seeking Alpha,https://seekingalpha.com/news/3564686-vaccinex-up-10-on-updated-pepinemab-data-in-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9479812383651733
1575,4/27/2020 5:20:15 PM,Pfizer Stock Is Much More Than Just a Coronavirus Play,InvestorPlace,/news/stocks/pfizer-pfe-stock-much-more-than-coronavirus-play-1029134283,positive,0.9391554594039917
1576,4/28/2020 12:49:57 PM,Pfizer Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q1-adjusted-earnings-beat-estimates-1029137376,negative,0.8581992983818054
1577,4/28/2020 12:57:02 PM,Pfizer profit down 12% as sales of off-patent drugs fall,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/-ITRO-Vntcg/pfizer-profit-down-12-as-sales-of-off-patent-drugs-fall-idUSL3N2CG362,neutral,0.9741089344024658
1578,4/28/2020 1:07:15 PM,Pfizer Reaffirms 2020 Financial Guidance - Quick Facts ,RTTNews,/news/stocks/pfizer-reaffirms-2020-financial-guidance-quick-facts-1029137541,positive,0.8790794610977173
1579,4/28/2020 1:12:59 PM,Pfizer profit down 12% as sales of off-patent drugs fall,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/qicu6QjmERg/pfizer-profit-down-12-as-sales-of-off-patent-drugs-fall-idINKCN22A1L9,neutral,0.9741089344024658
1580,4/28/2020 1:34:52 PM,UPDATE 1-Pfizer sticks to forecast after first-quarter profit boost from Ibrance,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/XKIxIfo-s4g/update-1-pfizer-sticks-to-forecast-after-first-quarter-profit-boost-from-ibrance-idUSL3N2CG375,negative,0.8150928616523743
1581,4/28/2020 1:40:50 PM,Pfizer sticks to forecast after first-quarter profit boost from Ibrance,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/X5lpHNZHg3g/pfizer-sticks-to-forecast-after-first-quarter-profit-boost-from-ibrance-idINKCN22A1L9,negative,0.8693466186523438
1582,4/28/2020 2:09:42 PM,REFILE-UPDATE 1-Pfizer sticks to forecast after first-quarter profit boost from Ibrance,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/R72PTPXOp2o/refile-update-1-pfizer-sticks-to-forecast-after-first-quarter-profit-boost-from-ibrance-idUSL3N2CG375,negative,0.832510232925415
1583,4/28/2020 3:04:39 PM,"US STOCKS-Wall St set to jump as 3M, Pfizer earnings impress",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/S2UfydVtVVE/us-stocks-wall-st-set-to-jump-as-3m-pfizer-earnings-impress-idUSL3N2CG3V8,negative,0.8511260151863098
1584,4/28/2020 3:07:54 PM,"Wall Street set to jump as 3M, Pfizer earnings impress",Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/t8alwA5vtCw/wall-street-set-to-jump-as-3m-pfizer-earnings-impress-idUSKCN22A1I6,negative,0.8234184980392456
1585,4/28/2020 3:40:17 PM,UPDATE 2-Pfizer sticks to forecast after first-quarter profit boost from Ibrance,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/K11FSVpKfJo/update-2-pfizer-sticks-to-forecast-after-first-quarter-profit-boost-from-ibrance-idUSL3N2CG375,negative,0.7832420468330383
1586,4/28/2020 4:56:14 PM,"Pfizer to make ""hundreds of millions"" doses of COVID-19 vaccine next year - CEO",Seeking Alpha,https://seekingalpha.com/news/3565400-pfizer-to-make-hundreds-of-millions-doses-of-covidminus-19-vaccine-next-year-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.82470703125
1587,4/28/2020 7:04:05 PM,"UPDATE 3-Pfizer plans expanded coronavirus vaccine trials, sees 'negligible' hit from outbreak",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/p4KAgJE9LWs/update-3-pfizer-plans-expanded-coronavirus-vaccine-trials-sees-negligible-hit-from-outbreak-idUSL3N2CG375,negative,0.9331190586090088
1588,4/28/2020 7:07:17 PM,"Pfizer plans expanded coronavirus vaccine trials, sees 'negligible' hit from outbreak",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/Z6zoY6wuEPw/pfizer-plans-expanded-coronavirus-vaccine-trials-sees-negligible-hit-from-outbreak-idINKCN22A1L9,negative,0.9222155213356018
1589,4/28/2020 8:53:02 PM,Dow Jones Today: Stocks Sag Under Predictions Q2 Will Be Worst of 2020,InvestorPlace,/news/stocks/dow-jones-today-stocks-sag-under-predictions-q2-will-be-worst-of-2020-1029140796,neutral,0.9610785841941833
1590,4/28/2020 9:03:34 PM,"4 Top Stock Trades for Wednesday: HOG, LUV, PEP, PFE",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-hog-luv-pep-pfe-1029140794,positive,0.9193128347396851
1591,4/29/2020 12:51:50 AM,COVID-19 vaccine could be ready for emergency use by fall,Seeking Alpha,https://seekingalpha.com/news/3565740-covidminus-19-vaccine-be-ready-for-emergency-use-fall?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8471664190292358
1592,4/29/2020 7:53:08 AM,BioNTech and Pfizer complete dosing for first cohort of phase 1/2 trial for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3565781-biontech-and-pfizer-complete-dosing-for-first-cohort-of-phase-1-2-trial-for-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5565938949584961
1593,4/30/2020 10:00:55 AM,"Moderna Stock Is Near Highs, But Faces Risk",InvestorPlace,/news/stocks/moderna-stock-is-near-highs-but-faces-risk-1029149020,negative,0.724486231803894
1594,4/30/2020 1:08:57 PM,The Top 3 Coronavirus Vaccine Stocks to Consider Right Now,InvestorPlace,/news/stocks/the-top-3-coronavirus-vaccine-stocks-to-consider-right-now-1029150816,positive,0.9254002571105957
1595,4/30/2020 4:03:18 PM,Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 depending on trials,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/E4E8ocdkKP4/pfizer-aims-for-10-20-mln-doses-of-coronavirus-vaccine-by-end-2020-depending-on-trials-idUSFWN2CI12N,positive,0.8631051778793335
1596,4/30/2020 4:37:09 PM,UPDATE 1-Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 for emergency use,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/FBWhy3AL4eg/update-1-pfizer-aims-for-10-20-mln-doses-of-coronavirus-vaccine-by-end-2020-for-emergency-use-idUSL8N2CI8NW,negative,0.6425707936286926
1597,4/30/2020 4:43:55 PM,Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020 for emergency use,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/mRflCYwXBe8/pfizer-aims-for-10-20-million-doses-of-coronavirus-vaccine-by-end-2020-for-emergency-use-idINKBN22C2NI,positive,0.6565243005752563
1598,4/30/2020 6:22:56 PM,UPDATE 2-Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/wgfmgeFQuNs/update-2-pfizer-aims-for-10-20-mln-doses-of-coronavirus-vaccine-by-end-2020-idUSL8N2CI8NW,negative,0.5137895941734314
1599,4/30/2020 6:25:45 PM,Pfizer aims for 10-20 million doses of coronavirus vaccine by end-2020,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/iqUmzqh2NKI/pfizer-aims-for-10-20-million-doses-of-coronavirus-vaccine-by-end-2020-idINKBN22C2NI,positive,0.6729806065559387
1600,5/1/2020 2:58:48 AM,Shot Roster: COVID-19 Vaccines In Human Trials ,RTTNews,/news/stocks/shot-roster-covid-19-vaccines-in-human-trials-1029154136,positive,0.8697241544723511
1601,5/5/2020 12:45:00 PM,"Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/FvCFnTUYs0Q/pfizer-biontech-set-to-begin-u-s-coronavirus-vaccine-trial-idUSL1N2CM2D3,positive,0.7062170505523682
1602,5/5/2020 1:49:50 PM,Pfizer Starts Human Trials Of Potential Coronavirus Vaccine In U.S. ,RTTNews,/news/stocks/pfizer-starts-human-trials-of-potential-coronavirus-vaccine-in-u-s-1029165113,negative,0.5244383811950684
1603,5/5/2020 4:11:35 PM,"Pfizer, BioNTech set to begin U.S. coronavirus vaccine trial",Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/3dSjdYHrzxA/pfizer-biontech-set-to-begin-u-s-coronavirus-vaccine-trial-idINKBN22H1UD,positive,0.7062170505523682
1604,5/5/2020 4:53:16 PM,Microsoft Stock Is the Right Play for the New Normal,InvestorPlace,/news/stocks/microsoft-stock-is-the-right-play-for-the-new-normal-1029167464,positive,0.8740718960762024
1605,5/5/2020 8:43:13 PM,"Dow Jones Today: Oil Win Streak, Partial Reopening Talk Spark Stocks",InvestorPlace,/news/stocks/dow-jones-today-oil-win-streak-partial-reopening-talk-spark-stocks-1029168274,negative,0.4705256223678589
1606,5/8/2020 7:34:55 PM,"Time to buy these biopharma names is now, BofA says",Seeking Alpha,https://seekingalpha.com/news/3572315-time-to-buy-biopharma-names-is-now-bofa-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.901307225227356
1607,5/9/2020 12:40:18 AM,"Pfizer to outsource some drug production, focus on coronavirus vaccine",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/srMAZQFHscM/pfizer-to-outsource-some-drug-production-focus-on-coronavirus-vaccine-idUSL1N2CQ1YO,positive,0.8638180494308472
1608,5/9/2020 3:32:35 AM,"UPDATE 1-Pfizer to outsource some drug production, focus on coronavirus vaccine",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/VSuHOuGgts4/update-1-pfizer-to-outsource-some-drug-production-focus-on-coronavirus-vaccine-idUSL1N2CR01I,positive,0.7219190001487732
1609,5/9/2020 11:22:39 PM,"Focusing on vaccine, Pfizer turns to outsourcing",Seeking Alpha,https://seekingalpha.com/news/3572399-focusing-on-vaccine-pfizer-turns-to-outsourcing?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8722591400146484
1610,5/11/2020 8:39:35 PM,Dow Jones Today: Tech Stocks and Reopening Talk Steadied the Market,InvestorPlace,/news/stocks/dow-jones-today-tech-stocks-and-reopening-talk-steadied-the-market-1029189413,negative,0.9348899126052856
1611,5/12/2020 5:06:50 PM,"CORRECTED-UPDATE 1-Pfizer to outsource some drug production, focus on coronavirus vaccine",Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/BN2BAgAzTns/corrected-update-1-pfizer-to-outsource-some-drug-production-focus-on-coronavirus-vaccine-idUSL1N2CR01I,positive,0.7832641005516052
1612,5/12/2020 10:24:11 PM,MEDIA-Pfizer wants to expand human trials of coronavirus vaccine to thousands of people by September - CNBC,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/4w_OZv-DeVo/media-pfizer-wants-to-expand-human-trials-of-coronavirus-vaccine-to-thousands-of-people-by-september-cnbc-idUSL4N2CU41C,positive,0.5720815658569336
1613,5/13/2020 7:16:53 AM,Pfizer sees expanded coronavirus vaccine trials,Seeking Alpha,https://seekingalpha.com/news/3573714-pfizer-sees-expanded-coronavirus-vaccine-trials?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7548295259475708
1614,5/14/2020 2:51:24 PM,Pfizer 20-valent pneumonia vaccine successful in second late-stage study,Seeking Alpha,https://seekingalpha.com/news/3574543-pfizer-20-valent-pneumonia-vaccine-successful-in-second-late-stage-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9399169087409973
1615,5/14/2020 4:28:13 PM,Pfizer Announces Positive Results On 20-Valent Pneumococcal Conjugate Vaccine ,RTTNews,/news/stocks/pfizer-announces-positive-results-on-20-valent-pneumococcal-conjugate-vaccine-1029202970,negative,0.93495774269104
1616,5/15/2020 2:01:00 PM,Pfizer to launch late stage DMD gene therapy trial despite hospitalizations,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/f1wd-lGRekg/pfizer-to-launch-late-stage-dmd-gene-therapy-trial-despite-hospitalizations-idUSL1N2CW2XU,positive,0.5744863152503967
1617,5/15/2020 2:25:11 PM,Pfizer: Phase 1b Data On PF-06939926 Support Advancement Into Phase 3 Study ,RTTNews,/news/stocks/pfizer-phase-1b-data-on-pf-06939926-support-advancement-into-phase-3-study-1029206300,positive,0.559174120426178
1618,5/15/2020 2:27:40 PM,Pfizer's Phase 1b Results On DMD Support Advancement Into Pivotal Phase 3 Study ,RTTNews,/news/stocks/pfizer-s-phase-1b-results-on-dmd-support-advancement-into-pivotal-phase-3-study-1029206312,negative,0.6600323915481567
1619,5/18/2020 8:53:30 AM,GSK: ViiV Healthcare HIV Prevention Study Shows Higher Efficacy ,RTTNews,/news/stocks/gsk-viiv-healthcare-hiv-prevention-study-shows-higher-efficacy-1029209609,negative,0.9484461545944214
1620,5/18/2020 5:51:00 PM,Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; on review for downgrade,Moodys,/news/bonds/pfizer-inc-moody-s-assigns-a1-to-pfizer-s-notes-on-review-for-downgrade-1029211843,neutral,0.44490545988082886
1621,5/18/2020 8:30:31 PM,Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher,InvestorPlace,/news/stocks/dow-jones-today-vaccine-news-and-fed-talk-powered-markets-higher-1029212694,positive,0.8665386438369751
1622,5/19/2020 9:39:46 AM,Pfizer prices $4B debt offering in four tranches,Seeking Alpha,https://seekingalpha.com/news/3575804-pfizer-prices-4b-debt-offering-in-four-tranches?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9327045679092407
1623,5/19/2020 12:07:33 PM,AbbVie Is More Than Just a Portfolio of Drugs and Acquisitions,InvestorPlace,/news/stocks/whole-of-abbv-stock-more-than-sum-of-parts-1029214731,positive,0.9493720531463623
1624,5/19/2020 12:26:18 PM,"Bitcoin the Best Cryptocurrency, but There Are Safer Blockchain Buys",InvestorPlace,/news/stocks/bitcoin-best-cryptocurrency-safer-blockchain-buys-1029215783,positive,0.9062784910202026
1625,5/19/2020 9:09:36 PM,Does Moderna Stock’s Rally Hold Up Under the Microscope?,InvestorPlace,/news/stocks/mrna-stock-rally-microscope-coronavirus-vaccine-1029217325,positive,0.8170806765556335
1626,5/20/2020 2:01:18 PM,Inovio Stock Is Entirely Dependent on Its Coronavirus Vaccine,InvestorPlace,/news/stocks/ino-stock-success-depends-covid-19-vaccine-efforts-1029220269,positive,0.9215107560157776
1627,5/22/2020 8:42:00 PM,Pfizer urges noteholders to reject offer by Huguenot Bond Liquidity,Seeking Alpha,https://seekingalpha.com/news/3577277-pfizer-urges-noteholders-to-reject-offer-huguenot-bond-liquidity?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8081209063529968
1628,5/25/2020 3:18:50 PM,Vaxcyte files for IPO,Seeking Alpha,https://seekingalpha.com/news/3577367-vaxcyte-files-for-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9386510252952576
1629,5/27/2020 11:48:12 AM,Why Did Lincoln Park Capital Just Buy a Million Shares of iBio Stock?,InvestorPlace,/news/stocks/why-lincoln-park-capital-bought-million-shares-ibio-stock-1029237335,positive,0.9287681579589844
1630,5/27/2020 6:43:41 PM,Genobank: Looking to Remake the DNA Kit Market,InvestorPlace,/news/stocks/genobank-looking-to-remake-the-dna-kit-market-1029239426,positive,0.8259013295173645
1631,5/28/2020 4:56:18 PM,Pfizer ties up with glass maker Corning for vial supply,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/CXIhub6qlCI/pfizer-ties-up-with-glass-maker-corning-for-vial-supply-idUSL4N2DA3EL,negative,0.5907548069953918
1632,5/28/2020 8:35:34 PM,UPDATE 1-Pfizer ties up with glass maker Corning for vial supply,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/CstbOT8sNiw/update-1-pfizer-ties-up-with-glass-maker-corning-for-vial-supply-idUSL4N2DA3RS,negative,0.8286650776863098
1633,5/29/2020 6:00:00 AM,All eyes on ASCO,Seeking Alpha,https://seekingalpha.com/news/3578520-all-eyes-on-asco?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9381866455078125
1634,5/29/2020 2:30:58 PM,"Pfizer, Astellas Say Final PROSPER Results Show XTANDI Extends Overall Survival ",RTTNews,/news/stocks/pfizer-astellas-say-final-prosper-results-show-xtandi-extends-overall-survival-1029263214,negative,0.9406977295875549
1635,5/29/2020 3:43:22 PM,Why Moderna Stock Is Still Only Good for Speculators,InvestorPlace,/news/stocks/mrna-stock-for-speculators-only-1029264082,positive,0.9210073947906494
1636,5/29/2020 4:34:10 PM,"'99%' chance Covid-19 vaccine will be effective, Sinovac claims",Seeking Alpha,https://seekingalpha.com/news/3578690-99-percent-chance-covidminus-19-vaccine-will-be-effective-sinovac-claims?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9143039584159851
1637,5/29/2020 8:52:01 PM,Pfizer comes up empty in Ibrance breast cancer study,Seeking Alpha,https://seekingalpha.com/news/3578785-pfizer-comes-up-empty-in-ibrance-breast-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4921870529651642
1638,5/29/2020 9:46:34 PM,"PFE, DHC, VHC and PTEN among after-hours movers",Seeking Alpha,https://seekingalpha.com/news/3578801-pfe-dhc-vhc-and-pten-among-after-hours-movers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.939544141292572
1639,5/30/2020 5:52:49 AM,Pfizer Says Breast Cancer Trial Unlikely To Be Effective ,RTTNews,/news/stocks/pfizer-says-breast-cancer-trial-unlikely-to-be-effective-1029265081,positive,0.7726969122886658
1640,6/1/2020 4:30:18 PM,Pfizer declines about 8% after setback to breast cancer treatment,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/BVx3d5BmSIw/pfizer-declines-about-8-after-setback-to-breast-cancer-treatment-idUSKBN2382U6,neutral,0.9641056656837463
1641,6/1/2020 5:21:07 PM,Pfizer tanks 8% after halting breast-cancer treatment trial on lowered hopes for success,Business Insider,https://markets.businessinsider.com/news/stocks/pfizer-stock-price-pause-breast-cancer-treatment-trial-pharmaceutical-drug-2020-6-1029269343,neutral,0.6423305869102478
1642,6/1/2020 5:27:41 PM,Pfizer declines about 8% after setback to breast cancer treatment,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/FjYn8ZUQBMo/pfizer-declines-about-8-after-setback-to-breast-cancer-treatment-idINKBN2382Y8,neutral,0.9641056656837463
1643,6/1/2020 5:41:23 PM,Pfizer selloff enhancing attractiveness - WSJ,Seeking Alpha,https://seekingalpha.com/news/3579178-pfizer-selloff-enhancing-attractiveness-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8708990812301636
1644,6/1/2020 8:42:34 PM,"5 Top Stock Trades for Tuesday: AAPL, ZM, CRWD, PFE, APRN",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-aapl-zm-crwd-pfe-aprn-1029270280,positive,0.927858293056488
1645,6/2/2020 4:45:20 PM,Pfizer to invest up to $500 mln in public drug developers,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/I6ii0qsUx60/pfizer-to-invest-up-to-500-mln-in-public-drug-developers-idUSXXN2DF005,positive,0.793005645275116
1646,6/2/2020 4:52:17 PM,Pfizer to invest up to $500 million in public drug developers,Reuters,http://feeds.reuters.com/~r/reuters/businessNews/~3/dWM4KzN0K38/pfizer-to-invest-up-to-500-million-in-public-drug-developers-idUSKBN23922S,positive,0.804432213306427
1647,6/2/2020 5:51:04 PM,Pfizer to invest up to $500 million in public drug developers,Reuters,http://feeds.reuters.com/~r/reuters/INbusinessNews/~3/bQRm5sLL5Rk/pfizer-to-invest-up-to-500-million-in-public-drug-developers-idINKBN239287,positive,0.804432213306427
1648,6/3/2020 8:41:44 AM,Shortage of antidepressant Zoloft,Seeking Alpha,https://seekingalpha.com/news/3579892-shortage-of-antidepressant-zoloft?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7340653538703918
1649,6/3/2020 9:16:46 AM,Abbvie Stock is Offering Investors an Oil Yield Without Oil’s Risk,InvestorPlace,/news/stocks/abbv-stock-an-oil-yield-without-oil-1029275806,positive,0.8119696378707886
1650,6/4/2020 6:37:03 AM,"List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps  On MISSION ",RTTNews,/news/stocks/list-of-operation-warp-speed-finalists-sava-to-reassess-ad-study-results-kzr-jumps-on-mission-1029279089,positive,0.5100464224815369
1651,6/5/2020 1:52:42 PM,China in thick of race for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3580791-china-in-thick-of-race-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.748111367225647
1652,6/5/2020 3:59:13 PM,Don’t Judge Pfizer by Its Vaccine Efforts,InvestorPlace,/news/stocks/dont-judge-pfe-stock-by-its-vaccine-efforts-1029285179,positive,0.8850738406181335
1653,6/8/2020 4:08:25 PM,Inovio Slumps as Its Setbacks Pile Up,InvestorPlace,/news/stocks/inovio-slumps-as-its-setbacks-pile-up-1029289728,neutral,0.9717625379562378
1654,6/8/2020 8:48:05 PM,"Investors boosted their stock-market bets in May for the first time in 4 months, TD Ameritrade says",Business Insider,https://www.businessinsider.com/investors-stock-market-bets-may-coronavirus-recovery-tesla-tdameritrade-exposure-2020-6,negative,0.9509986639022827
1655,6/9/2020 12:24:10 PM,Amphastar: FDA Approves Succinylcholine Chloride Injection Multiple-Dose Vial ,RTTNews,/news/stocks/amphastar-fda-approves-succinylcholine-chloride-injection-multiple-dose-vial-1029291895,positive,0.5874326825141907
1656,6/9/2020 3:10:56 PM,Aggressive Investors Can Do Much Better Than Merck Stock,InvestorPlace,/news/stocks/aggressive-investors-better-mrk-stock-1029293865,negative,0.7292519211769104
1657,6/10/2020 10:16:36 AM,Why iBio Stock Could Triple on Successful Vaccine Trials,InvestorPlace,/news/stocks/why-ibio-stock-could-triple-on-successful-vaccine-trials-1029296439,negative,0.6591143608093262
1658,6/10/2020 3:19:36 PM,Three key studies of COVID-19 vaccines to launch in summer,Seeking Alpha,https://seekingalpha.com/news/3581971-three-key-studies-of-covidminus-19-vaccines-to-launch-in-summer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8121580481529236
1659,6/10/2020 3:39:35 PM,States go after generic drugmakers for alleged price-fixing,Seeking Alpha,https://seekingalpha.com/news/3581977-states-go-after-generic-drugmakers-for-alleged-price-fixing?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9264628887176514
1660,6/11/2020 1:43:03 PM,Carnival Is In Cruise Control as It Plots Comeback,InvestorPlace,/news/stocks/ccl-stock-is-in-cruise-control-as-it-plots-comeback-1029301062,positive,0.9307833909988403
1661,6/11/2020 2:15:55 PM,"Pfizer : FDA Approves Oncology Supportive Care Biosimilar, NYVEPRIA ",RTTNews,/news/stocks/pfizer-fda-approves-oncology-supportive-care-biosimilar-nyvepria-1029300509,negative,0.6981895565986633
1662,6/12/2020 6:58:41 PM,FDA OKs expanded use of ViiV HIV med Tivicay,Seeking Alpha,https://seekingalpha.com/news/3582747-fda-oks-expanded-use-of-viiv-hiv-med-tivicay?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8681968450546265
1663,6/13/2020 9:22:12 AM,Race For COVID-19 Vaccine: Who Are The Key Players? ,RTTNews,/news/stocks/race-for-covid-19-vaccine-who-are-the-key-players-1029305455,positive,0.9350354671478271
1664,6/15/2020 4:46:00 PM,Mylan N.V. -- Moody's: Upcoming debt financing brings Mylan/Upjohn one step closer to Viatris creation,Moodys,/news/bonds/mylan-n-v-moody-s-upcoming-debt-financing-brings-mylan-upjohn-one-step-closer-to-viatris-creation-1029309049,negative,0.9332568645477295
1665,6/15/2020 5:57:40 PM,MEDIA-Pfizer-Backed Viatris Eyes Jumbo Bond Sale for Mylan Combination - Bloomberg,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/TYlSoNmh2PE/media-pfizer-backed-viatris-eyes-jumbo-bond-sale-for-mylan-combination-bloomberg-idUSL4N2DS3RK,positive,0.8619549870491028
1666,6/16/2020 3:51:38 PM,FDA OKs expanded label for Pfizer's antibody-drug conjugate Mylotarg,Seeking Alpha,https://seekingalpha.com/news/3583479-fda-oks-expanded-label-for-pfizers-antibody-drug-conjugate-mylotarg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.768231987953186
1667,6/16/2020 4:10:42 PM,Early Shareholders Can Win If iBio Gets a Vaccine Contract,InvestorPlace,/news/stocks/early-shareholders-can-win-if-ibio-gets-a-vaccine-contract-1029314101,positive,0.69087153673172
1668,6/16/2020 5:49:43 PM,Pfizer and Merck's diabetes med Steglatro shows mixed results in cardiovascular outcomes study,Seeking Alpha,https://seekingalpha.com/news/3583523-pfizer-and-mercks-diabetes-med-steglatro-shows-mixed-results-in-cardiovascular-outcomes-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9532431364059448
1669,6/16/2020 6:54:03 PM,"Eli Lilly soars 15% after its breast cancer drug shows efficacy where a treatment from Pfizer failed (LLY, PFE)",Business Insider,https://markets.businessinsider.com/news/stocks/eli-lilly-stock-price-after-successful-drug-trial-breast-cancer-2020-6-1029314306,negative,0.9232605695724487
1670,6/17/2020 2:23:00 AM,Upjohn Finance B.V. -- Moody's assigns Baa3 first-time issuer ratings to Upjohn/Viatris; outlook stable,Moodys,/news/bonds/upjohn-finance-b-v-moody-s-assigns-baa3-first-time-issuer-ratings-to-upjohn-viatris-outlook-stable-1029315214,negative,0.7246090769767761
1671,6/17/2020 11:11:00 AM,Upjohn Finance B.V. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' Euro notes offering; outlook stable,Moodys,/news/bonds/upjohn-finance-b-v-moody-s-assigns-baa3-unsecured-rating-to-upjohn-viatris-euro-notes-offering-outlook-stable-1029316221,negative,0.7183582186698914
1672,6/17/2020 3:12:00 PM,Upjohn Inc. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' US notes offering; outlook stable,Moodys,/news/bonds/upjohn-inc-moody-s-assigns-baa3-unsecured-rating-to-upjohn-viatris-us-notes-offering-outlook-stable-1029317722,negative,0.6017013788223267
1673,6/17/2020 4:24:13 PM,3 Dow Jones Companies to Buy When Profit-Taking Kicks In,InvestorPlace,/news/stocks/3-dow-jones-companies-to-buy-when-profit-taking-kicks-in-1029319033,positive,0.9093377590179443
1674,6/18/2020 10:16:36 AM,"3 Pros, 3 Cons For Buying iBio Stock Right Now",InvestorPlace,/news/stocks/3-pros-cons-of-buying-ibio-stock-right-now-1029321599,positive,0.9115537405014038
1675,6/18/2020 10:31:27 AM,It’s Time to Take Your Profits From Choppy Inovio Stock,InvestorPlace,/news/stocks/its-time-to-take-your-profits-from-choppy-inovio-stock-1029321598,positive,0.7361242771148682
1676,6/18/2020 1:27:24 PM,Upjohn prices debt offering in connection with Mylan merger,Seeking Alpha,https://seekingalpha.com/news/3584153-upjohn-prices-debt-offering-in-connection-mylan-merger?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9270705580711365
1677,6/18/2020 2:11:50 PM,Pfizer/Sangamo gene therapy shows positive effect in early-stage hemophilia A study,Seeking Alpha,https://seekingalpha.com/news/3584187-pfizer-sangamo-gene-therapy-shows-positive-effect-in-early-stage-hemophilia-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9445589184761047
1678,6/18/2020 3:22:49 PM,"Pfizer, Sangamo: Follow-up Data Affirm Findings Of Phase 1/2 Giroctocogene Fitelparvovec Study ",RTTNews,/news/stocks/pfizer-sangamo-follow-up-data-affirm-findings-of-phase-1-2-giroctocogene-fitelparvovec-study-1029322154,positive,0.8139584064483643
1679,6/18/2020 6:59:14 PM,Time to Bail on Pfizer? Let’s Look at the Charts,InvestorPlace,/news/stocks/time-to-bail-on-pfizer-lets-look-at-the-charts-1029323709,positive,0.93183833360672
1680,6/19/2020 10:46:00 PM,Upjohn Inc. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' US notes offering; outlook stable,Moodys,/news/bonds/upjohn-inc-moody-s-assigns-baa3-unsecured-rating-to-upjohn-viatris-us-notes-offering-outlook-stable-1029326544,negative,0.6017013788223267
1681,6/19/2020 10:47:00 PM,Upjohn Finance B.V. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' Euro notes offering; outlook stable,Moodys,/news/bonds/upjohn-finance-b-v-moody-s-assigns-baa3-unsecured-rating-to-upjohn-viatris-euro-notes-offering-outlook-stable-1029326543,negative,0.7183582186698914
1682,6/22/2020 12:47:51 PM,Children's Cough Syrups Recalled For Faulty Dosing Cups ,RTTNews,/news/stocks/children-s-cough-syrups-recalled-for-faulty-dosing-cups-1029328752,neutral,0.9518222212791443
1683,6/22/2020 2:36:23 PM,Pfizer Starts Four Phase 3 Trials For Investigational Vaccines ,RTTNews,/news/stocks/pfizer-starts-four-phase-3-trials-for-investigational-vaccines-1029329368,positive,0.8394134640693665
1684,6/29/2020 5:56:56 PM,How to Play the Downtrend in PFE Stock,InvestorPlace,/news/stocks/how-to-play-the-downtrend-in-pfe-stock-1029351328,positive,0.9227031469345093
1685,7/1/2020 9:27:11 AM,"EMD Serono, Pfizer: FDA Approves SBLA For BAVENCIO ",RTTNews,/news/stocks/emd-serono-pfizer-fda-approves-sbla-for-bavencio-1029357711,negative,0.7706083059310913
1686,7/1/2020 4:45:02 PM,Pfizer leaps 6% after releasing positive trial results for coronavirus vaccine,Business Insider,https://www.businessinsider.com/pfizer-stock-price-positive-coronavirus-vaccine-trial-results-drug-treatment-2020-7,negative,0.8965663909912109
1687,7/1/2020 5:11:19 PM,Pfizer And BioNTech' Potential Covid-19 Vaccine Shows Positive Data In Human Trial ,RTTNews,/news/stocks/pfizer-and-biontech-potential-covid-19-vaccine-shows-positive-data-in-human-trial-1029359844,negative,0.9550113677978516
1688,7/1/2020 7:25:59 PM,Pfizer News: PFE Stock Surges 4% on Positive Covid-19 Vaccine Results,InvestorPlace,/news/stocks/pfizer-coronavirus-news-sends-pfe-stock-soaring-1029360585,negative,0.9367421865463257
1689,7/1/2020 8:35:30 PM,"5 Top Stock Trades for Thursday: ROKU, SHOP, RNG, PFE, FDX",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-roku-shop-rng-pfe-fdx-1029360765,positive,0.9335666298866272
1690,7/2/2020 7:08:19 AM,"LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch ",RTTNews,/news/stocks/lmnl-joins-covid-19-battle-pfe-bntx-vaccine-data-promising-evlo-on-watch-1029361183,negative,0.5009361505508423
1691,7/2/2020 2:04:27 PM,Buy Opko Stock For Two Ways to Play the Ongoing Pandemic,InvestorPlace,/news/stocks/buy-opko-stock-for-two-ways-to-play-the-ongoing-pandemic-1029363124,positive,0.8705251216888428
1692,7/2/2020 5:02:06 PM,"Keep an Eye on Royalty Pharma Stock, 2020’s Biggest IPO",InvestorPlace,/news/stocks/keep-eye-rprx-stock-2020-1029363917,positive,0.9034902453422546
1693,7/6/2020 5:56:43 PM,7 Healthcare ETFs Which Should Continue Growing Into 2021,InvestorPlace,/news/stocks/7-healthcare-etfs-growing-into-2021-1029369965,negative,0.5999964475631714
1694,7/6/2020 6:43:12 PM,Moderna Stock Has a Bright Future After the Coronavirus,InvestorPlace,/news/stocks/moderna-mrna-stock-coronavirus-vaccine-drug-discovery-1029370223,negative,0.7788195610046387
1695,7/7/2020 9:16:27 AM,Carnival’s Outlook Has Improved as We Get Closer to a Vaccine,InvestorPlace,/news/stocks/ccl-stock-outlook-has-improved-as-we-get-closer-to-a-vaccine-1029371669,negative,0.9251522421836853
1696,7/7/2020 2:16:24 PM,Pfizer Stock Is a Reliable Workhorse Among Headline Hogs,InvestorPlace,/news/stocks/pfe-stock-is-a-reliable-workhorse-among-headline-hogs-1029373647,negative,0.7331888675689697
1697,7/7/2020 5:30:39 PM,The Curtain Is Coming Down on IBIO,InvestorPlace,/news/stocks/ibio-stock-looking-for-curtain-call-1029373960,positive,0.7540099620819092
1698,7/9/2020 10:50:11 AM,Inovio’s Dramatic 30% Drop Will Be Short-Lived,InvestorPlace,/news/stocks/inovios-dramatic-30-drop-will-prove-short-lived-1029380102,neutral,0.9263660907745361
1699,7/9/2020 5:03:14 PM,Opko Stock Is a Covid-19 Testing Name Worth Betting On,InvestorPlace,/news/stocks/opko-opk-stock-covid-19-testing-name-worth-betting-on-1029381914,positive,0.8843485116958618
1700,7/10/2020 2:55:15 PM,The 7 Best Dividend-Paying Stocks for Cautious Investors,InvestorPlace,/news/stocks/the-7-best-dividend-paying-stocks-for-cautious-investors-1029384331,positive,0.5519558191299438
1701,7/13/2020 1:21:46 PM,"Pfizer, BioNTech Granted FDA Fast Track Designation For Two COVID-19 Vaccine Candidates ",RTTNews,/news/stocks/pfizer-biontech-granted-fda-fast-track-designation-for-two-covid-19-vaccine-candidates-1029387364,negative,0.9383711218833923
1702,7/13/2020 3:12:01 PM,"Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)",Business Insider,https://markets.businessinsider.com/news/stocks/pfizer-and-biontech-shares-rise-after-fda-grants-2-coronavirus-vaccines-fast-track-status-pfe-bntx-1029388057,negative,0.9225423336029053
1703,7/13/2020 5:11:36 PM,Is It Finally Time to Buy INO Stock?,InvestorPlace,/news/stocks/is-it-finally-time-to-buy-ino-stock-1029389050,positive,0.9188693165779114
1704,7/13/2020 7:11:21 PM,Delta Air Lines Will Survive Just Fine Long-Term,InvestorPlace,/news/stocks/dal-stock-will-survive-in-the-long-term-1029389297,negative,0.9263719916343689
1705,7/14/2020 8:30:51 AM,"EQ Soars, INMB Up On Promising Alzheimer's Trial Data, ALT To Move AdCOVID Into Clinical Trial In Q4 ",RTTNews,/news/stocks/eq-soars-inmb-up-on-promising-alzheimer-s-trial-data-alt-to-move-adcovid-into-clinical-trial-in-q4-1029390705,negative,0.9362115263938904
1706,7/14/2020 12:26:36 PM,"Pre-market Movers In Healthcare Sector: INMB, ECOR, CYAD, VXRT... ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-inmb-ecor-cyad-vxrt-1029391397,positive,0.9205021858215332
1707,7/15/2020 5:32:42 PM,Bank of America Stock Will Likely Climb on Its Q2 Earnings,InvestorPlace,/news/stocks/bank-of-america-stock-will-likely-climb-on-its-q2-earnings-1029398679,negative,0.9259436726570129
1708,7/19/2020 7:13:57 PM,"Clinical Trial Readouts Of COVID-19 Vaccines, Drugs Due In July ",RTTNews,/news/stocks/clinical-trial-readouts-of-covid-19-vaccines-drugs-due-in-july-1029407575,positive,0.8159946203231812
1709,7/20/2020 7:23:31 AM,"Pfizer, BioNTech Reach Deal With U.K. To Supply 30 Mln Doses Of Potential Covid-19 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-reach-deal-with-u-k-to-supply-30-mln-doses-of-potential-covid-19-vaccine-1029408498,negative,0.897980809211731
1710,7/20/2020 3:22:16 PM,"Pfizer, BioNTech Report Positive Update From German Phase 1/2 Covid-19 Vaccine Study ",RTTNews,/news/stocks/pfizer-biontech-report-positive-update-from-german-phase-1-2-covid-19-vaccine-study-1029410167,negative,0.9428163766860962
1711,7/21/2020 8:04:35 PM,Here’s How SOLO Stock Can Add Torque to Your Portfolio,InvestorPlace,/news/stocks/heres-how-solo-stock-can-add-torque-to-your-portfolio-1029416515,positive,0.9169741868972778
1712,7/22/2020 12:27:19 PM,The Curtain Is Coming Down on Inovio Pharmaceuticals’ Vaccine Candidate,InvestorPlace,/news/stocks/curtain-coming-down-on-ino-stock-1029420801,positive,0.5067680478096008
1713,7/22/2020 1:54:28 PM,Sell Overpriced Novavax Stock While You Still Can,InvestorPlace,/news/stocks/why-you-should-sell-nvax-stock-while-you-still-can-1029420794,positive,0.9357196688652039
1714,7/22/2020 2:11:19 PM,"Pfizer, BioNTech Agree To Supply Initial 100 Mln Doses Of COVID-19 Vaccine To Americans ",RTTNews,/news/stocks/pfizer-biontech-agree-to-supply-initial-100-mln-doses-of-covid-19-vaccine-to-americans-1029419839,negative,0.7701881527900696
1715,7/22/2020 2:36:01 PM,"Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine (PFE, BNTX)",Business Insider,https://www.businessinsider.com/pfizer-biontech-stock-price-government-orders-millions-coronavirus-vaccine-doses-2020-7,negative,0.6717426776885986
1716,7/22/2020 4:26:05 PM,Be Very Careful When it Comes to FuelCell Energy,InvestorPlace,/news/stocks/be-very-careful-when-it-comes-to-fuelcell-energy-1029421729,positive,0.9339880347251892
1717,7/22/2020 9:03:05 PM,"4 Top Stock Trades for Thursday: AMD, MSFT, PFE, WORK",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-amd-msft-pfe-work-1029422261,positive,0.9418231844902039
1718,7/22/2020 10:18:12 PM,"Nearly 36,000 Robinhood users added Pfizer shares Wednesday after the US government ordered 100 million doses of its coronavirus vaccine (PFE)",Business Insider,https://www.businessinsider.com/pfizer-stock-robinhood-traders-piled-shares-vaccine-deal-gained-bought-2020-7,negative,0.5686079859733582
1719,7/23/2020 10:31:35 AM,History and Competition Suggest Caution Toward Inovio Stock,InvestorPlace,/news/stocks/history-competition-caution-ino-stock-1029424603,positive,0.8366189002990723
1720,7/24/2020 10:46:14 AM,Sorrento Therapeutics May Be Ready For a Pullback,InvestorPlace,/news/stocks/sorrento-therapeutics-may-be-ready-for-a-pullback-1029428488,negative,0.760229766368866
1721,7/24/2020 12:49:48 PM,"The Further It Lags in the Vaccine Race, the Riskier Inovio Stock Looks",InvestorPlace,/news/stocks/lags-vaccine-race-riskier-ino-stock-1029429012,neutral,0.8336753249168396
1722,7/24/2020 1:01:40 PM,"Pre-market Movers In Healthcare Sector: THTX, ABUS, QLGN CNTG, MRNA… ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-thtx-abus-qlgn-cntg-mrna-1029428225,positive,0.9275327324867249
1723,7/24/2020 6:06:35 PM,5 High-Yield Drug Stocks That Are Undervalued With Great Upside,InvestorPlace,/news/stocks/high-yield-drug-stocks-undervalued-cheap-huge-upside-1029429574,negative,0.55074143409729
1724,7/27/2020 1:25:18 PM,iBio Stock Has Tripled in a Few Weeks. Here’s What’s Next,InvestorPlace,/news/stocks/ibio-stock-tripled-now-what-1029434265,positive,0.9211769700050354
1725,7/27/2020 3:01:45 PM,Pfizer earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/pfizer-q2-earnings-preview-stock-1029433825,positive,0.9079969525337219
1726,7/27/2020 8:47:17 PM,"4 Top Stock Trades for Tuesday: MCD, DKNG, PFE, HAS",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-mcd-dkng-pfe-has-1029435528,positive,0.9354687929153442
1727,7/28/2020 5:00:33 AM,Pfizer And BioNTech Start Late-stage Study Of COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/pfizer-and-biontech-start-late-stage-study-of-covid-19-vaccine-candidate-1029435727,positive,0.8352315425872803
1728,7/28/2020 9:06:03 AM,"MRNA, PFE/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30 ",RTTNews,/news/stocks/mrna-pfe-bntx-covid-19-vaccines-move-into-phase-3-cytodyn-on-watch-gnca-to-report-data-on-jul-30-1029437121,positive,0.7035107016563416
1729,7/28/2020 12:49:48 PM,Pfizer Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q2-adjusted-earnings-beat-estimates-1029437833,negative,0.8150341510772705
1730,7/28/2020 1:32:33 PM,Pfizer Q2 Profit Tops Estimates; Revenues Down 11%; Raises Guidance ,RTTNews,/news/stocks/pfizer-q2-profit-tops-estimates-revenues-down-11-raises-guidance-1029438135,neutral,0.9390183687210083
1731,7/29/2020 11:55:40 AM,"Whatever Happens to Inovio Pharmaceuticals, Insiders Will Do Just Fine",InvestorPlace,/news/stocks/whatever-happens-inovio-ino-stock-insiders-will-be-fine-1029444744,positive,0.9006724953651428
1732,7/29/2020 12:11:45 PM,"As Optimism Wanes, the Ride May Be Over for Novavax stock",InvestorPlace,/news/stocks/optimism-wanes-nvax-stock-over-1029444742,neutral,0.9321818947792053
1733,7/29/2020 3:30:14 PM,Carnival Cruises Stock Is in the Eye of the Storm,InvestorPlace,/news/stocks/carnival-cruises-stock-is-in-the-eye-of-the-storm-1029446844,neutral,0.5895628333091736
1734,7/30/2020 12:14:19 PM,A More Sustainable Business Model Doesn’t Make iBio Stock Less Risky,InvestorPlace,/news/stocks/sustainable-business-model-ibio-stock-risky-1029451784,positive,0.5610909461975098
1735,7/31/2020 11:50:51 AM,"Pfizer, BioNTech To Supply 120 Mln Doses Of BNT162 MRNA-based SARS-CoV2 Vaccine Candidate To Japan ",RTTNews,/news/stocks/pfizer-biontech-to-supply-120-mln-doses-of-bnt162-mrna-based-sars-cov2-vaccine-candidate-to-japan-1029454636,negative,0.7296091318130493
1736,7/31/2020 12:48:52 PM,3 Reasons to Sell Inovio Stock,InvestorPlace,/news/stocks/3-reasons-to-sell-ino-stock-1029455781,positive,0.9430094957351685
1737,8/3/2020 1:47:26 PM,4 Coronavirus Stocks to Buy as the Pandemic Rages On,InvestorPlace,/news/stocks/4-coronavirus-stocks-to-buy-as-the-pandemic-rages-on-1029462287,positive,0.850963830947876
1738,8/4/2020 12:03:15 PM,"Without a Covid-19 Vaccine, GERM Is a Much Safer Way to Play iBio Stock",InvestorPlace,/news/stocks/without-a-covid-19-vaccine-germ-is-a-much-safer-way-to-play-ibio-stock-1029466306,positive,0.8405468463897705
1739,8/4/2020 5:08:35 PM,Don’t Count on Inovio To Deliver a Covid-19 Vaccine,InvestorPlace,/news/stocks/dont-count-on-inovio-pharmaceuticals-ino-stock-covid-19-vaccine-1029478836,positive,0.8281463384628296
1740,8/4/2020 7:20:40 PM,7 Growth Stocks to Ride for the Rest of 2020,InvestorPlace,/news/stocks/7-growth-stocks-to-ride-for-the-rest-of-2020-1029468944,positive,0.8007712364196777
1741,8/5/2020 1:59:32 PM,Novavax Stock Needs Solid Results Beyond Headlines,InvestorPlace,/news/stocks/nvax-stock-needs-solid-results-beyond-headlines-1029473742,negative,0.9414753913879395
1742,8/5/2020 2:53:08 PM,Pfizer: Phase 3 CROWN Study Of LORBRENA Meets Primary Endpoint ,RTTNews,/news/stocks/pfizer-phase-3-crown-study-of-lorbrena-meets-primary-endpoint-1029472674,positive,0.7043085694313049
1743,8/6/2020 5:00:35 AM,Hold Off Buying The Dip in Pandemic Play Inovio Stock,InvestorPlace,/news/stocks/hold-off-buying-dip-ino-stock-1029479701,neutral,0.46295595169067383
1744,8/6/2020 8:49:18 AM,"ABIO To Start Phase 2 COVID-19 Trial In Q4, ACIU On Track, BCLI Expects ALS Trial Data In Nov. ",RTTNews,/news/stocks/abio-to-start-phase-2-covid-19-trial-in-q4-aciu-on-track-bcli-expects-als-trial-data-in-nov-1029476415,positive,0.635656476020813
1745,8/6/2020 12:10:24 PM,"As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet",InvestorPlace,/news/stocks/vaccine-looks-likely-mrna-stock-still-is-a-good-bet-1029478835,negative,0.6246477365493774
1746,8/6/2020 12:29:20 PM,It’s Time to Get Serious About Inovio Pharmaceuticals,InvestorPlace,/news/stocks/time-to-get-serious-about-ino-stock-1029478834,positive,0.8658950924873352
1747,8/6/2020 5:51:20 PM,5 Biotech Stocks That Offer Long-Term Growth and Value,InvestorPlace,/news/stocks/5-biotech-stocks-that-offer-long-term-growth-and-value-1029479695,positive,0.7105634212493896
1748,8/7/2020 12:10:23 PM,Pfizer to manufacture COVID-19 med remdesivir,Seeking Alpha,https://seekingalpha.com/news/3602826-pfizer-to-manufacture-covidminus-19-med-remdesivir?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8394178152084351
1749,8/7/2020 1:36:32 PM,This Company is the Landlord of Life Sciences,InvestorPlace,/news/stocks/this-company-is-the-landlord-of-life-sciences-1029482490,positive,0.9439411759376526
1750,8/7/2020 3:21:21 PM,Pfizer Signs Deal To Boost Supply Of Gilead's Remdesivir For COVID-19 Patients ,RTTNews,/news/stocks/pfizer-signs-deal-to-boost-supply-of-gilead-s-remdesivir-for-covid-19-patients-1029482269,negative,0.9533594846725464
1751,8/11/2020 7:57:59 AM,"CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs ",RTTNews,/news/stocks/cprx-plunges-as-musk-mg-trial-flops-meso-awaits-fda-panel-review-eq-soars-after-hrs-1029490110,neutral,0.8904195427894592
1752,8/12/2020 5:59:57 AM,U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/u-s-reaches-deal-with-moderna-for-100-million-doses-of-covid-19-vaccine-1029494061,negative,0.8192676901817322
1753,8/12/2020 4:59:42 PM,Novavax Looks Like a Winner With Its Vaccine Results,InvestorPlace,/news/stocks/nvax-stock-looks-like-a-winner-with-its-covid-19-vaccine-results-1029498068,negative,0.86931973695755
1754,8/13/2020 6:05:49 PM,"Inovio Pharmaceuticals Shares Drop, Get a Downgrade",InvestorPlace,/news/stocks/inovio-pharmaceuticals-ino-stock-drops-gets-analyst-downgrade-1029502617,neutral,0.9697141051292419
1755,8/13/2020 6:52:32 PM,Why Investors Shouldn’t Bet on iBio Stock Now,InvestorPlace,/news/stocks/why-investors-shouldnt-bet-on-ibio-stock-now-1029502917,positive,0.9020561575889587
1756,8/17/2020 4:57:53 PM,3 Biotech Stock ETFs to Buy For Further Upside In 2021,InvestorPlace,/news/stocks/3-biotech-stock-etfs-to-buy-for-further-upside-in-2021-1029510050,negative,0.6046690940856934
1757,8/18/2020 9:01:44 AM,"Investors Should View IBIO Stock Among Vaccine Wanna-be’s, Not Makers",InvestorPlace,/news/stocks/investors-should-view-ibio-stock-among-vaccine-wanna-bes-not-makers-1029511734,positive,0.8901175260543823
1758,8/18/2020 9:16:07 AM,Inovio Pharmaceuticals is Still Very Relevant Despite Speculative Nature,InvestorPlace,/news/stocks/inovio-pharmaceuticals-is-still-very-relevant-despite-speculative-nature-1029511733,negative,0.7130793333053589
1759,8/18/2020 6:19:20 PM,7 ESG Stocks That Will Deliver for Every Stakeholder,InvestorPlace,/news/stocks/7-esg-stocks-that-will-deliver-for-every-stakeholder-1029514508,positive,0.9289776682853699
1760,8/19/2020 12:58:14 PM,Sorrento Stock: Gambling on Coronavirus,InvestorPlace,/news/stocks/sorrento-stock-gambling-on-coronavirus-1029517271,positive,0.9103220701217651
1761,8/20/2020 3:05:17 PM,Inovio Pharmaceuticals Stock Isn’t Just a Solid Covid-19 Play,InvestorPlace,/news/stocks/inovio-pharmaceuticals-ino-stock-isnt-just-a-solid-covid-19-play-1029521702,positive,0.8050373196601868
1762,8/20/2020 3:11:15 PM,Inovio Becomes a Covid-19 Longshot,InvestorPlace,/news/stocks/inovio-becomes-a-covid-19-longshot-1029521701,positive,0.9170756340026855
1763,8/21/2020 3:33:28 AM,"Pfizer, BioNTech Announce Positive Early Data On MRNA Vaccine Candidate BNT162b2 Against COVID-19 ",RTTNews,/news/stocks/pfizer-biontech-announce-positive-early-data-on-mrna-vaccine-candidate-bnt162b2-against-covid-19-1029522635,negative,0.9263260960578918
1764,8/21/2020 3:31:12 PM,Eli Lilly (Still) Looks Like the Best Buy in Large-Cap Pharma,InvestorPlace,/news/stocks/lly-stock-still-looks-like-best-buy-large-cap-pharma-1029524567,negative,0.805871844291687
1765,8/24/2020 1:56:45 PM,3 of the Best Pet Stocks to Buy Now,InvestorPlace,/news/stocks/3-of-the-best-pet-stocks-to-buy-now-1029528146,positive,0.8402966856956482
1766,8/24/2020 7:21:10 PM,6 Hot Coronavirus Stocks Moving At “Warp Speed”,InvestorPlace,/news/stocks/6-hot-coronavirus-stocks-moving-at-warp-speed-1029529073,positive,0.7748833298683167
1767,8/25/2020 2:36:56 PM,Welcome Salesforce Stock to the Dow Jones,InvestorPlace,/news/stocks/salesforce-crm-stock-welcome-earnings-dow-jones-average-1029532756,positive,0.7984457612037659
1768,8/25/2020 5:49:23 PM,"Exxon Mobil, Pfizer Exit Dow Jones Industrial Average ",RTTNews,/news/stocks/exxon-mobil-pfizer-exit-dow-jones-industrial-average-1029532639,positive,0.9365921020507812
1769,8/25/2020 7:05:31 PM,"Inovio Stock Is a Sideshow, Not a Serious Investment",InvestorPlace,/news/stocks/inovio-stock-is-a-sideshow-not-a-serious-investment-1029533338,positive,0.9258228540420532
1770,8/26/2020 5:58:52 PM,"Without a Partner, iBio’s Gains Are Just a Fantasy",InvestorPlace,/news/stocks/without-a-partner-ibio-stock-gains-are-just-a-fantasy-1029537354,positive,0.8743476867675781
1771,8/26/2020 7:42:20 PM,CureVac Is a Bet on a Safe and Effective Vaccine,InvestorPlace,/news/stocks/curevac-stock-bet-on-covid-19-vaccine-could-produce-68-percent-roi-1029537603,positive,0.7192503809928894
1772,8/27/2020 9:16:00 AM,Inovio Shares Have Been Hot in 2020 but Watch for a Volatile September,InvestorPlace,/news/stocks/ino-stock-has-been-hot-in-2020-but-watch-for-a-volatile-september-1029539174,neutral,0.8509079813957214
1773,8/28/2020 9:01:53 AM,Vaccine Race Also-ran iBio Stock Won’t See Earlier Highs Anytime Soon,InvestorPlace,/news/stocks/ibio-stock-wont-see-earlier-highs-1029543409,positive,0.5529077649116516
1774,8/28/2020 11:45:56 AM,Remdesivir Data Leaves Gilead Stock Well-Positioned to Rally,InvestorPlace,/news/stocks/remdesivir-data-approvals-leave-gilead-gild-stock-well-positioned-to-rally-1029543865,negative,0.9446567893028259
1775,8/28/2020 11:59:56 AM,CureVac Stock Soars After Talks of Supplying Vaccines for the EU,InvestorPlace,/news/stocks/curevac-stock-soars-after-talks-of-supplying-vaccines-for-the-eu-1029543863,negative,0.5889837145805359
1776,8/28/2020 5:51:26 PM,Novavax Is Conducting Clinical Trials: The Ride In NVAX Stock Will Continue To Be Wild,InvestorPlace,/news/stocks/novavax-is-conducting-clinical-trials-the-ride-in-nvax-stock-will-continue-to-be-wild-1029545047,positive,0.5166850686073303
1777,9/1/2020 11:01:13 AM,CureVac Stock Has Been Hot Following Its Recent IPO,InvestorPlace,/news/stocks/curevac-stock-has-been-hot-following-its-recent-ipo-1029551661,neutral,0.9428465962409973
1778,9/1/2020 11:45:51 AM,Go Easy on CureVac Stock After Its Red-Hot Market Debut,InvestorPlace,/news/stocks/curevac-stock-go-easy-after-ipo-coronavirus-1029551655,positive,0.6517949104309082
1779,9/1/2020 11:50:23 AM,iBio’s Time Is Running Out in Vaccine Chase,InvestorPlace,/news/stocks/ibio-stock-has-had-its-time-in-the-sun-as-vaccine-front-runners-emerge-1029551654,positive,0.6399305462837219
1780,9/1/2020 7:58:07 PM,Biotech Boom: The Race for COVID-19 Vaccines,InvestorPlace,/news/stocks/biotech-boom-the-race-for-covid-19-vaccines-1029553899,positive,0.8749167323112488
1781,9/2/2020 2:21:45 PM,4 Pharmaceutical Stocks With Deep Pipelines,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-deep-pipelines-coronavirus-1029557234,positive,0.6847983002662659
1782,9/2/2020 2:36:56 PM,"At This Point, iBioPharma Is a Flash in the Pandemic",InvestorPlace,/news/stocks/at-this-point-ibio-stock-is-a-flash-in-the-pandemic-1029557232,positive,0.5494207739830017
1783,9/2/2020 5:17:36 PM,3 Cybersecurity Stocks Guarding Your Health Data,InvestorPlace,/news/stocks/3-cybersecurity-stocks-guarding-your-health-data-cybr-hack-panw-1029557608,positive,0.9188565611839294
1784,9/3/2020 11:45:27 AM,Pfizer Stock Will Soar With Its First-Mover Vaccine Advantage,InvestorPlace,/news/stocks/pfizer-pfe-stock-cheap-first-mover-coronavirus-vaccine-1029560534,negative,0.9238511323928833
1785,9/3/2020 7:29:27 PM,Is CureVac a Buy on the Pullback? It Depends,InvestorPlace,/news/stocks/curevac-stock-buy-pullback-all-bets-off-1029561983,positive,0.8476653099060059
1786,9/4/2020 2:43:25 PM,Pfizer Covid-19 Vaccine Update Likely In October ,RTTNews,/news/stocks/pfizer-covid-19-vaccine-update-likely-in-october-1029563407,positive,0.9181864261627197
1787,9/4/2020 6:54:10 PM,Turn Out the Lights on iBio’s Covid-19 Vaccine Party,InvestorPlace,/news/stocks/ibio-stock-isnt-the-covid-19-vaccine-play-investors-should-consider-1029564441,positive,0.9338081479072571
1788,9/4/2020 11:10:20 PM,COVID-19 vaccine developers prepare joint pledge on safety - WSJ,Seeking Alpha,https://seekingalpha.com/news/3611895-covidminus-19-vaccine-developers-prepare-joint-pledge-on-safety-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5112403631210327
1789,9/7/2020 6:19:22 PM,Trump considers 'decoupling' U.S. from China,Seeking Alpha,https://seekingalpha.com/news/3611949-trump-considers-decoupling-u-s-from-china?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.852777361869812
1790,9/9/2020 8:19:17 AM,"AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL ",RTTNews,/news/stocks/azn-pauses-covid-19-vaccine-trial-albo-hits-new-high-crbp-plunges-pfe-to-invest-in-tril-1029572136,negative,0.831784725189209
1791,9/9/2020 10:04:00 AM,3 High Dividend Stocks to Buy and Hold,InvestorPlace,/news/stocks/3-high-dividend-stocks-to-buy-and-hold-1029572922,positive,0.9054696559906006
1792,9/9/2020 12:30:34 PM,"Pfizer, BioNTech Enter Contract Negotiations With EU To Supply SARS-CoV-2 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-enter-contract-negotiations-with-eu-to-supply-sars-cov-2-vaccine-1029572751,negative,0.9265872240066528
1793,9/9/2020 2:26:24 PM,"Pfizer, BioNTech Say MRNA-based Vaccine Candidate Protected Rhesus Macaques In Preclinical Studies ",RTTNews,/news/stocks/pfizer-biontech-say-mrna-based-vaccine-candidate-protected-rhesus-macaques-in-preclinical-studies-1029573620,negative,0.6535922884941101
1794,9/14/2020 10:40:24 AM,"As iBio Stock Fades, It’s Time to Look Elsewhere for a Vaccine Play",InvestorPlace,/news/stocks/ibio-stock-fades-look-elsewhere-vaccine-play-1029585712,positive,0.8996447324752808
1795,9/14/2020 1:03:52 PM,"Pfizer Stock Pops on Vaccine Timeline News, Trial Expansion",InvestorPlace,/news/stocks/pfizer-stock-rally-coronavirus-vaccine-timeline-fda-trial-1029586463,positive,0.9193057417869568
1796,9/14/2020 5:50:12 PM,VXRT Stock: Vaxart Shoots Higher on Human Trial Approval,InvestorPlace,/news/stocks/vxrt-stock-vaxart-shoots-higher-on-human-trial-approval-1029587804,negative,0.9534009695053101
1797,9/15/2020 2:16:43 PM,BioNTech To Receive Up To €375 Mln In Funding From German To Support COVID-19 Vaccine Program ,RTTNews,/news/stocks/biontech-to-receive-up-to-375-mln-in-funding-from-german-to-support-covid-19-vaccine-program-1029589932,negative,0.890034019947052
1798,9/15/2020 2:27:27 PM,"With Its Vaccine Trail, Moderna Addresses Racial Disparity Head On",InvestorPlace,/news/stocks/with-its-vaccine-mrna-stock-can-also-help-heal-racial-wounds-1029591483,positive,0.8752990365028381
1799,9/15/2020 5:32:02 PM,Profit From Pfizer Stock as It Surges on Big Vaccine Hopes,InvestorPlace,/news/stocks/profit-from-pfizer-stock-surges-coronavirus-vaccine-1029591778,negative,0.8526597619056702
1800,9/15/2020 5:54:20 PM,NVAX Stock: Novavax Climbs on New Vaccine Manufacturing Deal,InvestorPlace,/news/stocks/nvax-stock-novavax-climbs-on-new-vaccine-manufacturing-deal-1029591774,negative,0.9406851530075073
1801,9/16/2020 9:58:21 AM,"ARPO To Report Glaucoma Trial Data In Q4, ARDX To Face FDA In April, PFE's Pipeline Update ",RTTNews,/news/stocks/arpo-to-report-glaucoma-trial-data-in-q4-ardx-to-face-fda-in-april-pfe-s-pipeline-update-1029593172,positive,0.935805082321167
1802,9/16/2020 4:46:32 PM,"Power, Aviation Should Lift GE Stock",InvestorPlace,/news/stocks/power-aviation-should-lift-ge-stock-1029596059,negative,0.9201161861419678
1803,9/16/2020 5:00:55 PM,Avoid iBio Stock In the Near-Term As Competitors Keep Racing Ahead,InvestorPlace,/news/stocks/avoid-ibio-stock-in-the-near-term-as-competitors-keep-racing-ahead-1029596057,positive,0.7258761525154114
1804,9/16/2020 5:34:25 PM,Don’t Miss the Next Wild Move in iBio Stock,InvestorPlace,/news/stocks/dont-miss-the-next-wild-moved-in-ibio-stock-1029596052,positive,0.933147132396698
1805,9/17/2020 12:35:42 PM,"Pre-market Movers In Healthcare Sector: SRNE, GNCA, VXRT, BNTX, INO... ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-srne-gnca-vxrt-bntx-ino-1029597915,positive,0.9116840958595276
1806,9/17/2020 2:17:29 PM,MRNA Stock: Moderna Rallies Thursday on Vaccine Timeline News,InvestorPlace,/news/stocks/mrna-stock-moderna-rallies-thursday-on-vaccine-timeline-news-1029599923,positive,0.9197908043861389
1807,9/18/2020 9:46:35 AM,"BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding",InvestorPlace,/news/stocks/bntx-stock-investor-fortunes-rise-and-fall-on-headlines-pacts-and-funding-1029601944,neutral,0.9316998720169067
1808,9/18/2020 12:56:20 PM,"Pre-market Movers In Healthcare Sector: IMMP, SAVA, SNOA, CRDF, INO… ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-immp-sava-snoa-crdf-ino-1029602069,positive,0.9406796097755432
1809,9/18/2020 1:26:13 PM,Is Sorrento Stock Really Worth the Speculation?,InvestorPlace,/news/stocks/sorrento-srne-stock-worth-speculation-1029602943,positive,0.9195567965507507
1810,9/18/2020 1:41:33 PM,GlaxoSmithKline and Sanofi Stock Rally on EU Vaccine Deal,InvestorPlace,/news/stocks/glaxosmithkline-and-sanofi-stock-rally-on-eu-vaccine-deal-1029602942,neutral,0.5227814316749573
1811,9/18/2020 1:51:10 PM,Why Novartis’ Absence From the Covid-19 Vaccine Race Is a Benefit,InvestorPlace,/news/stocks/novartis-stock-absence-covid-19-vaccine-race-benefit-1029602941,positive,0.849791944026947
1812,9/18/2020 3:34:34 PM,4 Biotech Stocks to Buy for Big Gains in 2020,InvestorPlace,/news/stocks/4-biotech-stocks-to-buy-for-big-gains-in-2020-1029603327,negative,0.8859114646911621
1813,9/18/2020 5:47:20 PM,Roche Stock Rallies on Promising Coronavirus Drug Results,InvestorPlace,/news/stocks/roche-stock-rallies-on-promising-coronavirus-drug-results-1029604090,negative,0.6788759231567383
1814,9/18/2020 5:58:06 PM,iBio Is a Wishful Thinkers Coronavirus Vaccine Bet,InvestorPlace,/news/stocks/ibio-stock-is-a-wishful-thinkers-coronavirus-vaccine-bet-1029604088,positive,0.9187761545181274
1815,9/18/2020 6:36:44 PM,Novavax Stock Is a Risky Way to Get Rich Quick,InvestorPlace,/news/stocks/nvax-stock-is-a-risky-way-to-get-rich-quick-1029604081,positive,0.7538704872131348
1816,9/21/2020 9:16:39 AM,Here’s Why Moderna Shares May Blast Higher Over the Next Few Weeks,InvestorPlace,/news/stocks/heres-why-moderna-shares-may-blast-higher-over-the-next-few-weeks-1029607490,negative,0.7228185534477234
1817,9/21/2020 1:10:04 PM,Buy JetBlue Stock at These Levels and Sock It Away for the Recovery,InvestorPlace,/news/stocks/buy-jblu-stock-sock-it-away-recovery-1029607469,positive,0.9290062785148621
1818,9/22/2020 10:40:44 AM,This Dow Reshuffling Is a Great Opportunity to Buy Exxon Mobil Stock,InvestorPlace,/news/stocks/buy-exxon-mobil-stock-dow-shuffle-1029611671,positive,0.5056333541870117
1819,9/22/2020 12:10:37 PM,Moderna Stock Looks Like a Winner as the Covid-19 Vaccine Race Loosens,InvestorPlace,/news/stocks/mrna-stock-looks-like-a-winner-35-billion-sales-possbile-1029611665,negative,0.9103265404701233
1820,9/22/2020 4:56:31 PM,Pfizer Is Your Best Bet at a Covid-19 Vaccine Play,InvestorPlace,/news/stocks/pfizer-stock-is-your-best-bet-at-a-covid-19-vaccine-play-1029612593,positive,0.9195173978805542
1821,9/22/2020 5:15:55 PM,Pfizer Shares May Catch Momentum Soon From Vaccine Work,InvestorPlace,/news/stocks/pfizer-stock-may-catch-positive-momentum-soon-1029612590,negative,0.9383125305175781
1822,9/22/2020 5:19:01 PM,"Keep An Eye On Novavax, But Keep Your Money In Your Pocket",InvestorPlace,/news/stocks/keep-an-eye-on-novavax-nvax-stock-but-keep-your-money-in-your-pocket-1029612589,positive,0.9306748509407043
1823,9/23/2020 1:06:52 PM,Johnson & Johnson News: JNJ Stock Pops on Late-Stage Vaccine Trials,InvestorPlace,/news/stocks/johnson-johnson-news-jnj-stock-pops-on-late-stage-vaccine-trials-1029615936,negative,0.6677065491676331
1824,9/23/2020 1:28:02 PM,"Pfizer Says FDA Accepts SNDA For XALKORI, Grants Priority Review - Quick Facts ",RTTNews,/news/stocks/pfizer-says-fda-accepts-snda-for-xalkori-grants-priority-review-quick-facts-1029614729,negative,0.49848926067352295
1825,9/23/2020 5:08:22 PM,Aggressive Investors Have No Excuse for Not Owning Moderna,InvestorPlace,/news/stocks/aggressive-investors-have-no-excuse-for-not-owning-moderna-mrna-stock-at-this-stage-of-the-game-cseo-1029616770,positive,0.9145837426185608
1826,9/24/2020 7:21:39 AM,"JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch ",RTTNews,/news/stocks/jnj-begins-phase-3-covid-19-vaccine-trial-another-headstone-in-alzheimer-s-graveyard-pfe-on-watch-1029617682,positive,0.8442927002906799
1827,9/24/2020 12:14:41 PM,"IDEAYA Expands Clinical Trial Collaboration, Supply Agreement With Pfizer - Quick Facts ",RTTNews,/news/stocks/ideaya-expands-clinical-trial-collaboration-supply-agreement-with-pfizer-quick-facts-1029618477,negative,0.805966854095459
1828,9/24/2020 1:00:48 PM,Novavax Is Still Close to Vaccine Leaders in the Covid-19 Race,InvestorPlace,/news/stocks/nvax-stock-is-still-close-to-vaccine-leaders-in-the-covid-19-race-cseo-1029619852,negative,0.798878014087677
1829,9/25/2020 5:00:08 PM,NVAX Stock: Novavax Rallies After Entering Phase 3 Vaccine Trials,InvestorPlace,/news/stocks/nvax-stock-novavax-rallies-after-entering-phase-3-vaccine-trials-1029623831,negative,0.9303554892539978
1830,9/28/2020 12:20:51 PM,Novavax Stock Definitely Is Not the Long-Shot Vaccine Play You Might Think,InvestorPlace,/news/stocks/nvax-stock-not-long-shot-vaccine-play-1029627234,positive,0.8893109560012817
1831,9/28/2020 12:40:39 PM,Inovio Stock Still Has Real Promise Despite Faltering in Vaccine Race,InvestorPlace,/news/stocks/ino-stock-promising-despite-vaccine-race-1029627233,negative,0.9424540400505066
1832,9/28/2020 5:01:07 PM,Scant Vaccine Hopes Aren’t Enough to Make iBio a Buy,InvestorPlace,/news/stocks/barely-contender-no-reason-to-buy-ibio-stock-1029628462,negative,0.5464014410972595
1833,9/29/2020 9:26:33 AM,"GNFT Soars On LabCorp Deal, INO's COVID-19 Vaccine Trial On Partial Hold, FDA Expands Xeljanz Label ",RTTNews,/news/stocks/gnft-soars-on-labcorp-deal-ino-s-covid-19-vaccine-trial-on-partial-hold-fda-expands-xeljanz-label-1029629314,neutral,0.4867993891239166
1834,9/30/2020 10:54:07 AM,Abbott Labs Stock is Not Cheap But Should Do Well as Virus Test Debuts,InvestorPlace,/news/stocks/abt-stock-should-do-well-with-its-new-covid-19-test-1029635842,negative,0.6211468577384949
1835,9/30/2020 12:26:27 PM,Pfizer Stock Is Flirting with Another Breakdown,InvestorPlace,/news/stocks/pfizer-stock-is-flirting-with-another-breakdown-1029635834,positive,0.6188532114028931
1836,9/30/2020 2:23:31 PM,CVAC Stock: CureVac Pops on Plans for Phase 2 Vaccine Trials,InvestorPlace,/news/stocks/cvac-stock-curevac-pops-on-plans-for-phase-2-vaccine-trials-1029636598,positive,0.7941229343414307
1837,10/1/2020 5:00:25 AM,Novavax Gains With Start of Phase 3 Vaccine Trial,InvestorPlace,/news/stocks/nvax-stock-gains-with-phase-3-trial-1029641338,negative,0.948647141456604
1838,10/1/2020 8:37:25 AM,"SELB Down But Not Out, PFE Takes 9.9% Stake In CStone, ZSAN Plunges, AMAG On The Block? ",RTTNews,/news/stocks/selb-down-but-not-out-pfe-takes-9-9-stake-in-cstone-zsan-plunges-amag-on-the-block-1029638447,neutral,0.8513728976249695
1839,10/1/2020 1:03:00 PM,"Pfizer's Gene Therapy Candidate For Duchenne Muscular Dystrophy Receives Fast Track 
designation ",RTTNews,/news/stocks/pfizer-s-gene-therapy-candidate-for-duchenne-muscular-dystrophy-receives-fast-track-designation-1029639241,negative,0.6520489454269409
1840,10/1/2020 7:02:07 PM,How to Decide if Inovio Is a Buy After Its 28% Correction,InvestorPlace,/news/stocks/ino-stock-inovio-is-inovio-a-buy-1029642033,positive,0.9476683735847473
1841,10/2/2020 1:12:00 PM,Trump Coronavirus News: Why the Market Is Sliding Today,InvestorPlace,/news/stocks/trump-coronavirus-news-why-the-market-is-sliding-today-1029644434,neutral,0.8356251120567322
1842,10/2/2020 4:12:40 PM,The Real Value in Novavax Goes Beyond the Coronavirus,InvestorPlace,/news/stocks/influenza-vaccine-gives-nvax-stock-value-cseo-1029645075,positive,0.9021472334861755
1843,10/2/2020 5:01:29 PM,iBio Is a Pure Spec Play That Remains a Day Trader’s Delight,InvestorPlace,/news/stocks/ibio-stock-is-a-pure-spec-play-that-remains-a-day-traders-delight-1029645068,positive,0.8930780291557312
1844,10/2/2020 5:04:31 PM,"iBio Will Survive Coronavirus Vaccine Disappointment, But It’s not a ‘Buy’",InvestorPlace,/news/stocks/ibio-stock-is-in-a-competition-it-has-little-chance-of-winning-1029645067,positive,0.8060522079467773
1845,10/5/2020 2:25:32 PM,This Is Why I’d Still Avoid IBio for Now,InvestorPlace,/news/stocks/this-is-why-id-still-avoid-vaccine-stock-ibio-for-now-cseo-1029649209,positive,0.9063957333564758
1846,10/5/2020 5:43:41 PM,Moderna Is Ready To Rally After 2-Month Market Correction,InvestorPlace,/news/stocks/moderna-mrna-stock-is-ready-to-rally-after-2-month-market-correction-1029649495,negative,0.9448305368423462
1847,10/5/2020 6:28:38 PM,Investors Should Proceed With Caution in Sorrento Stock,InvestorPlace,/news/stocks/investors-should-proceed-with-caution-in-sorrento-stock-1029662225,positive,0.8986226916313171
1848,10/5/2020 7:44:03 PM,7 Cheap Stocks to Buy Today For A Defensive Bargain,InvestorPlace,/news/stocks/7-cheap-stocks-to-buy-today-for-a-defensive-bargain-1029649663,positive,0.8227174282073975
1849,10/6/2020 3:37:29 AM,Allele Bio files two lawsuits for patent infringement of mNeonGreen used in COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3619990-allele-bio-files-two-lawsuits-for-patent-infringement-of-mneongreen-used-in-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9281293153762817
1850,10/6/2020 9:18:55 AM,"BioNTech, Pfizer begin rolling submission for COVID-19 vaccine candidate in Europe",Seeking Alpha,https://seekingalpha.com/news/3620006-biontech-pfizer-begin-rolling-submission-for-covidminus-19-vaccine-candidate-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5256532430648804
1851,10/6/2020 11:35:29 AM,"Pfizer, BioNTech Begin Rolling Submission To EMA For SARS-CoV-2 Vaccine Candidate ",RTTNews,/news/stocks/pfizer-biontech-begin-rolling-submission-to-ema-for-sars-cov-2-vaccine-candidate-1029651104,positive,0.5618311166763306
1852,10/6/2020 12:38:03 PM,"Pre-market Movers In Healthcare Sector: XTNT, BNTX, GLYC, ALNA, MGEN, IOVA, ARTL… ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-xtnt-bntx-glyc-alna-mgen-iova-artl-1029651339,positive,0.9255302548408508
1853,10/6/2020 1:04:20 PM,OGEN Stock: Why Oragenics Is Soaring 25%,InvestorPlace,/news/stocks/ogen-stock-why-oragenics-is-soaring-25-today-1029653068,negative,0.7014327645301819
1854,10/6/2020 2:12:30 PM,FDA Ad Com this month to clarify COVID-19 vaccine authorization requirements,Seeking Alpha,https://seekingalpha.com/news/3620151-fda-ad-com-this-month-to-clarify-covidminus-19-vaccine-authorization-requirements?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9083845615386963
1855,10/6/2020 6:36:01 PM,Get Out of IBIO Stock Before It’s Too Late,InvestorPlace,/news/stocks/get-out-of-ibio-stock-before-its-too-late-cseo-1029658676,positive,0.905656099319458
1856,10/7/2020 9:01:32 AM,"At This Stage of the Vaccine Race, Is Now a Good Time to Buy iBio Stock?",InvestorPlace,/news/stocks/at-this-stage-of-the-vaccine-race-is-now-a-good-time-to-buy-ibio-stock-1029656066,positive,0.92270427942276
1857,10/7/2020 9:31:16 AM,5 Blue-chip Stocks to Buy on a Discount to Fortify Portfolios,InvestorPlace,/news/stocks/wmt-pfe-jpm-ko-jnj-5-blue-chip-stocks-to-buy-1029656064,positive,0.8645325899124146
1858,10/7/2020 10:26:19 AM,Exact Sciences and Pfizer extend Cologuard agreement,Seeking Alpha,https://seekingalpha.com/news/3620354-exact-sciences-and-pfizer-extend-cologuard-agreement?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8678022027015686
1859,10/7/2020 11:02:44 AM,Pfizer commences late-stage study of hemophilia A gene therapy,Seeking Alpha,https://seekingalpha.com/news/3620371-pfizer-commences-late-stage-study-of-hemophilia-gene-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8963714838027954
1860,10/7/2020 12:57:59 PM,"Pfizer, Sangamo Begin Phase 3 Dosing Study Of Giroctocogene Fitelparvovec ",RTTNews,/news/stocks/pfizer-sangamo-begin-phase-3-dosing-study-of-giroctocogene-fitelparvovec-1029656252,negative,0.49733415246009827
1861,10/7/2020 4:27:48 PM,7 Biotech Stocks To Buy For Profit From The Vaccine Crunch,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-for-profit-from-the-vaccine-crunch-1029658673,positive,0.8608307242393494
1862,10/8/2020 7:47:05 AM,Rentschler Bio inks manufacturing deal with BioNTech for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3620669-rentschler-bio-inks-manufacturing-deal-biontech-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5797197222709656
1863,10/8/2020 11:30:19 AM,Pfizer's somatrogon successful in pivotal growth hormone deficiency study,Seeking Alpha,https://seekingalpha.com/news/3620720-pfizers-somatrogon-successful-in-pivotal-growth-hormone-deficiency-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6523299217224121
1864,10/9/2020 10:58:49 AM,Pfizer's palbociclib fails to extend survival in late-stage breast cancer study,Seeking Alpha,https://seekingalpha.com/news/3621030-pfizers-palbociclib-fails-to-extend-survival-in-late-stage-breast-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.47224676609039307
1865,10/9/2020 12:59:49 PM,Pfizer Says PENELOPE-B Trial Of IBRANCE Did Not Meet Primary Endpoint - Quick Facts ,RTTNews,/news/stocks/pfizer-says-penelope-b-trial-of-ibrance-did-not-meet-primary-endpoint-quick-facts-1029665282,neutral,0.8788951635360718
1866,10/9/2020 3:48:47 PM,Pfizer Is a Value Play in the Covid-19 Frenzy,InvestorPlace,/news/stocks/pfe-stock-a-value-play-in-the-covid-frenzy-1029666426,positive,0.9262282848358154
1867,10/9/2020 7:43:43 PM,"BioNTech, Pfizer announce rolling submission for COVID-19 vaccine candidate in Canada",Seeking Alpha,https://seekingalpha.com/news/3621208-biontech-pfizer-announce-rolling-submission-for-covidminus-19-vaccine-candidate-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.551011860370636
1868,10/12/2020 8:45:46 AM,CStone completes $200M share sale to Pfizer,Seeking Alpha,https://seekingalpha.com/news/3621288-cstone-completes-200m-share-sale-to-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7877769470214844
1869,10/12/2020 10:48:20 AM,Head of Operation Warp Speed sees emergency authorization vaccine request around Thanksgiving,Seeking Alpha,https://seekingalpha.com/news/3621297-head-of-operation-warp-speed-sees-emergency-authorization-vaccine-request-around-thanksgiving?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8216387629508972
1870,10/12/2020 5:23:07 PM,"Pfizer, BioNTech ink COVID-19 vaccine pact with New Zealand",Seeking Alpha,https://seekingalpha.com/news/3621481-pfizer-biontech-ink-covidminus-19-vaccine-pact-new-zealand?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7794590592384338
1871,10/12/2020 5:23:07 PM,"Pfizer, BioNTech inks COVID-19 vaccine pact with the New Zealand government",Seeking Alpha,https://seekingalpha.com/news/3621481-pfizer-biontech-inks-covidminus-19-vaccine-pact-new-zealand-government?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8327107429504395
1872,10/12/2020 8:58:31 PM,7 Highly Rated Pharmaceutical Stocks for Q4,InvestorPlace,/news/stocks/7-highly-rated-pharmaceutical-stocks-for-q4-1029679826,positive,0.8309608697891235
1873,10/13/2020 8:32:35 AM,First case of COVID-19 reinfection confirmed in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3621570-first-case-of-covidminus-19-reinfection-confirmed-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7349666357040405
1874,10/13/2020 3:35:23 PM,Novavax Stock Stalemate Is About to Catch Fire,InvestorPlace,/news/stocks/nvax-stock-stalemate-is-about-to-catch-fire-1029675475,positive,0.6122852563858032
1875,10/13/2020 6:38:23 PM,7 Value Stocks To Buy Today For Security And Consistency,InvestorPlace,/news/stocks/7-value-stocks-to-buy-today-for-security-and-consistency-1029676174,positive,0.9075003266334534
1876,10/13/2020 6:54:32 PM,7 Pet Stocks to Adopt Today ,InvestorPlace,/news/stocks/7-pet-stocks-to-adopt-today-1029676172,positive,0.8865429759025574
1877,10/13/2020 8:56:39 PM,Avoid Inovio Like the Plague After Its 64% Price Drop,InvestorPlace,/news/stocks/avoid-ino-stock-like-plague-after-64-percent-price-drop-1029689192,positive,0.8185400366783142
1878,10/15/2020 9:31:35 AM,Coronavirus vaccine may not be initially recommended for kids - CDC,Seeking Alpha,https://seekingalpha.com/news/3622322-coronavirus-vaccine-may-not-be-initially-recommended-for-kids-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9300074577331543
1879,10/15/2020 12:16:20 PM,Pfizer and BioNTech may be first to show efficacy of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3622411-pfizer-and-biontech-may-be-first-to-show-efficacy-of-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7154374122619629
1880,10/15/2020 12:37:15 PM,"Carnival Stock Is Far from Recovered, But the Worst Is Behind",InvestorPlace,/news/stocks/carnival-stock-is-far-from-recovered-but-the-worst-is-behind-1029684755,neutral,0.8601924777030945
1881,10/16/2020 11:06:54 AM,Pfizer may apply for emergency use of COVID-19 vaccine by late November: CEO Albert Bourla,Seeking Alpha,https://seekingalpha.com/news/3622792-pfizer-may-apply-for-emergency-use-of-covidminus-19-vaccine-late-november-ceo-albert-bourla?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8207588195800781
1882,10/16/2020 11:58:35 AM,Biden Town Hall: 4 Key Investing Takeaways,InvestorPlace,/news/stocks/biden-town-hall-4-key-investing-takeaways-1029688135,positive,0.9202543497085571
1883,10/16/2020 1:17:30 PM,European advisory group backs ViiV's cabotegravir and rilpivirine regimen in HIV,Seeking Alpha,https://seekingalpha.com/news/3622879-european-advisory-group-backs-viivs-cabotegravir-and-rilpivirine-regimen-in-hiv?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.525427520275116
1884,10/16/2020 3:48:25 PM,Pfizer To Apply For Emergency Use Of COVID-19 Vaccine By Late Nov. ,RTTNews,/news/stocks/pfizer-to-apply-for-emergency-use-of-covid-19-vaccine-by-late-nov-1029688675,positive,0.7910068035125732
1885,10/16/2020 4:12:31 PM,3 Biotech Stocks to Buy Right Now,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-right-now-1029689519,positive,0.9306740164756775
1886,10/16/2020 5:53:36 PM,Novavax Stock Looks Volatile As Vaccine Enthusiasm Wanes,InvestorPlace,/news/stocks/nvax-stock-looks-volatile-as-vaccine-enthusiasm-wanes-1029689507,neutral,0.9606714248657227
1887,10/16/2020 7:30:50 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3622976-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1888,10/16/2020 9:23:44 PM,"4 Top Stock Trades for Monday: PTON, PFE, FSLY, SPAQ ",InvestorPlace,/news/stocks/4-top-stock-trades-for-monday-pton-pfe-fsly-spaq-1029689961,positive,0.9332923293113708
1889,10/16/2020 11:02:00 PM,JPM picks big pharma names to benefit with busy catalyst calendar ahead,Seeking Alpha,https://seekingalpha.com/news/3623038-jpm-picks-big-pharma-names-to-benefit-busy-catalyst-calendar-ahead?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6425066590309143
1890,10/19/2020 12:31:29 PM,Why Investors Should Buy Overstock.com Stock on a Looming Pullback,InvestorPlace,/news/stocks/why-investors-should-buy-overstock-com-stock-on-a-looming-pullback-1029694069,positive,0.6878233551979065
1891,10/19/2020 2:55:50 PM,The USO ETF Is a Good Play On the Demise of Lockdowns,InvestorPlace,/news/stocks/the-uso-etf-is-a-good-play-on-the-demise-of-lockdowns-1029694555,positive,0.8526228070259094
1892,10/19/2020 4:58:50 PM,Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets,Seeking Alpha,https://seekingalpha.com/news/3623326-pfizer-and-moderna-pivotal-studies-on-covidminus-19-vaccines-near-enrollment-targets?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9210036396980286
1893,10/20/2020 7:18:42 AM,Moderna not far behind Pfizer on vaccine emergency authorization,Seeking Alpha,https://seekingalpha.com/news/3623490-moderna-not-far-behind-pfizer-on-vaccine-emergency-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6286377310752869
1894,10/20/2020 11:15:37 AM,Merck's 15-valent pneumonia vaccine successful in two more late-stage studies,Seeking Alpha,https://seekingalpha.com/news/3623574-mercks-15-valent-pneumonia-vaccine-successful-in-two-late-stage-studies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9018535614013672
1895,10/21/2020 3:46:25 PM,Pfizer Reports Data From Clinical Trial For 20-Valent Pneumococcal Conjugate Vaccine ,RTTNews,/news/stocks/pfizer-reports-data-from-clinical-trial-for-20-valent-pneumococcal-conjugate-vaccine-1029705348,positive,0.8198309540748596
1896,10/21/2020 4:35:08 PM,"While Risky, Sorrento Therapeutics Has Many Options to Win",InvestorPlace,/news/stocks/while-risky-sorrento-therapeutics-has-many-options-to-win-1029706542,positive,0.8506829142570496
1897,10/21/2020 5:43:16 PM,FDA Ad Com tomorrow on development/authorization of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3624369-fda-ad-com-tomorrow-on-development-authorization-of-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9219729900360107
1898,10/22/2020 11:56:48 AM,ViiV Healthcare injectable doublet HIV therapy shows long-term benefit,Seeking Alpha,https://seekingalpha.com/news/3624749-viiv-healthcare-injectable-doublet-hiv-therapy-shows-long-term-benefit?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9476114511489868
1899,10/22/2020 5:31:38 PM,Is It Too Late for Novavax to Profit From a Covid-19 Vaccine?,InvestorPlace,/news/stocks/is-it-too-late-for-novavax-to-profit-from-a-covid-19-vaccine-1029712056,positive,0.827395498752594
1900,10/22/2020 5:55:54 PM,Coronavirus Hype Is Pushing Novavax to Unrealistic Highs,InvestorPlace,/news/stocks/coronavirus-led-hype-is-pushing-nvax-stock-to-unprecedented-heights-1029712051,neutral,0.9466947317123413
1901,10/22/2020 7:24:21 PM,"IBM, Pfizer design AI model that can predict Alzheimer's in seemingly healthy patients",Seeking Alpha,https://seekingalpha.com/news/3625002-ibm-pfizer-design-ai-model-can-predict-alzheimers-in-seemingly-healthy-patients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5080022215843201
1902,10/23/2020 12:55:02 PM,"Pre-market Movers In Healthcare Sector: SAVA, KTOV, PRVL, IMMP, GILD, ITRM, BBI… ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-sava-ktov-prvl-immp-gild-itrm-bbi-1029714263,positive,0.9244271516799927
1903,10/23/2020 3:25:03 PM,FDA getting cold feet on EUA nod for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3625386-fda-getting-cold-feet-on-eua-nod-for-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4357973337173462
1904,10/26/2020 3:01:39 PM,Pfizer is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-q3-earnings-preview-stock-1029721530,positive,0.9325799345970154
1905,10/26/2020 4:13:39 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3625836-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
1906,10/26/2020 5:36:06 PM,Pfizer Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3625914-pfizer-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8498843312263489
1907,10/26/2020 6:03:02 PM,BioNTech down 6% as investors tap feet waiting for COVID-19 trial data,Seeking Alpha,https://seekingalpha.com/news/3625954-biontech-down-6-investors-tap-feet-waiting-for-covidminus-19-trial-data?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9665201306343079
1908,10/26/2020 7:38:00 PM,Pfizer Inc. -- Moody's assigns P-1 rating to Pfizer's euro CP program,Moodys,/news/bonds/pfizer-inc-moody-s-assigns-p-1-rating-to-pfizer-s-euro-cp-program-1029722637,positive,0.8467220067977905
1909,10/27/2020 10:46:57 AM,General Electric Has More Legs As Its Aviation Business Turns Around,InvestorPlace,/news/stocks/ge-stock-to-rebound-with-positive-free-cash-flow-in-2021-1029725862,positive,0.6583648324012756
1910,10/27/2020 10:47:31 AM,"Pfizer EPS beats by $0.01, misses on revenue",Seeking Alpha,https://seekingalpha.com/news/3626230-pfizer-eps-beats-0_01-misses-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6351383328437805
1911,10/27/2020 11:44:43 AM,Pfizer Vyndaqel sales +41%; 2020 guidance ranges tightened,Seeking Alpha,https://seekingalpha.com/news/3626308-pfizer-vyndaqel-salesplus-41-2020-guidance-ranges-tightened?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8923078179359436
1912,10/27/2020 11:51:11 AM,Pfizer Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/pfizer-inc-q3-adjusted-earnings-beat-estimates-1029725675,negative,0.8234495520591736
1913,10/27/2020 12:25:01 PM,Pfizer Tightens FY20 Outlook Range; Q3 Adj. EPS Tops View - Quick Facts ,RTTNews,/news/stocks/pfizer-tightens-fy20-outlook-range-q3-adj-eps-tops-view-quick-facts-1029725996,negative,0.7842038869857788
1914,10/27/2020 1:30:51 PM,"FDA, EMA Accept Regulatory Submission For Pfizer's Abrocitinib For Atopic Dermatitis Treatment ",RTTNews,/news/stocks/fda-ema-accept-regulatory-submission-for-pfizer-s-abrocitinib-for-atopic-dermatitis-treatment-1029726522,negative,0.8618468642234802
1915,10/27/2020 2:54:05 PM,No interim analysis on Covid-19 vaccine candidate - Pfizer conference call,Seeking Alpha,https://seekingalpha.com/news/3626485-no-interim-analysis-on-covidminus-19-vaccine-candidate-pfizer-conference-call?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9402027130126953
1916,10/27/2020 9:10:05 PM,Don’t Be Fazed by the Recent Market Volatility,InvestorPlace,/news/stocks/why-im-not-fazed-by-the-recent-market-volatility-1029729497,positive,0.8584647178649902
1917,10/28/2020 4:39:57 PM,"U.S. COVID-19 cases on the rise, key vaccine data expected in November",Seeking Alpha,https://seekingalpha.com/news/3627364-u-s-covidminus-19-cases-on-rise-key-vaccine-data-expected-in-november?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5762848854064941
1918,10/28/2020 8:36:01 PM,4 Strategies To Prepare Your Portfolio Now for 2030,InvestorPlace,/news/stocks/long-term-stocks-4-strategies-to-prepare-your-portfolio-now-for-2030-1029759226,positive,0.8954910039901733
1919,10/29/2020 4:46:15 PM,Why Palantir May Be a Solid Covid-19 Play,InvestorPlace,/news/stocks/why-palantir-may-be-a-solid-covid-19-play-1029742932,positive,0.7000253200531006
1920,10/29/2020 4:56:34 PM,Germany could start Covid-19 vaccinations this year - WSJ,Seeking Alpha,https://seekingalpha.com/news/3628451-germany-start-covidminus-19-vaccinations-this-year-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8294310569763184
1921,10/30/2020 9:01:58 AM,Avoid Inovio Pharmaceuticals Stock Until the FDA Greenlights Trials,InvestorPlace,/news/stocks/avoid-ino-stock-until-the-us-fda-gives-the-green-light-1029745385,positive,0.8682147860527039
1922,10/30/2020 5:05:26 PM,Pfizer/Mylan agree to FTC conditions for go-ahead on combined drug firm,Seeking Alpha,https://seekingalpha.com/news/3629173-pfizer-mylan-agree-to-ftc-conditions-for-go-ahead-on-combined-drug-firm?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8672864437103271
1923,10/30/2020 5:38:38 PM,How Novavax Has a 2-Pronged Approach to Vaccine Sales,InvestorPlace,/news/stocks/nvax-stock-novavax-covid-vaccine-sales-1029747778,positive,0.8600424528121948
1924,10/31/2020 6:00:00 AM,"Vaccine developers take varied approaches to COVID-19, next-gen platforms may not be better than more traditional technologies",Seeking Alpha,https://seekingalpha.com/news/3629098-vaccine-developers-take-varied-approaches-to-covidminus-19-next-gen-platforms-may-not-be?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7795732617378235
1925,11/2/2020 11:05:35 AM,3 Biotech Stocks With Eye-Catching Pipelines,InvestorPlace,/news/stocks/3-biotech-stocks-with-eye-catching-pipelines-1029752447,positive,0.5421434044837952
1926,11/2/2020 4:11:03 PM,5 Industries Biden Would Destroy as President,InvestorPlace,/news/stocks/election-stocks-sell-5-industries-threatened-biden-victory-1029754646,positive,0.8998605608940125
1927,11/2/2020 7:57:28 PM,Avoid Taking a Bet on the Deep Correction In Inovio Stock,InvestorPlace,/news/stocks/avoid-taking-a-bet-on-the-deep-correction-in-inovio-ino-stock-1029755366,positive,0.5376816987991333
1928,11/3/2020 2:56:53 PM,Which Biotech Stocks Are a Buy on Earnings?,InvestorPlace,/news/stocks/which-biotech-stocks-are-a-buy-on-earnings-1029759220,positive,0.9168561100959778
1929,11/3/2020 3:10:26 PM,7 Big Data Stocks That Are Bound to Grow Your Portfolio,InvestorPlace,/news/stocks/7-big-data-stocks-that-are-bound-to-grow-your-portfolio-1029759218,negative,0.63841313123703
1930,11/3/2020 7:35:23 PM,7 Top Stocks to Buy for November,InvestorPlace,/news/stocks/7-top-stocks-to-buy-in-november-1029760395,positive,0.9062485098838806
1931,11/3/2020 8:31:15 PM,"No, It’s Not Too Late to Buy Canopy Growth Stock",InvestorPlace,/news/stocks/no-its-not-too-late-to-buy-canopy-growth-cgc-stock-1029760389,positive,0.8844364285469055
1932,11/4/2020 4:40:24 AM,Pfizer launches Phase 2b vupanorsen study in patients with elevated cholesterol level,Seeking Alpha,https://seekingalpha.com/news/3630890-pfizer-launches-phase-2b-vupanorsen-study-in-patients-elevated-cholesterol-level?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7615799307823181
1933,11/4/2020 6:04:21 PM,"Without Positive Vaccine News, Novavax May Fall Further",InvestorPlace,/news/stocks/without-positive-vaccine-news-novavax-may-fall-further-1029766639,neutral,0.9610611796379089
1934,11/5/2020 2:46:54 PM,India races ahead with COVID-19 vaccine as AstraZeneca deliveries lag,Seeking Alpha,https://seekingalpha.com/news/3632254-india-races-ahead-covidminus-19-vaccine-astrazeneca-deliveries-lag?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8641549348831177
1935,11/6/2020 12:20:52 PM,Pfizer's tofacitinib shows treatment benefit in ankylosing spondylitis study,Seeking Alpha,https://seekingalpha.com/news/3633076-pfizers-tofacitinib-shows-treatment-benefit-in-ankylosing-spondylitis-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.93311607837677
1936,11/6/2020 1:08:41 PM,Pfizer Reports Positive Phase 3 Study Results For Tofacitinib In Ankylosing Spondylitis ,RTTNews,/news/stocks/pfizer-reports-positive-phase-3-study-results-for-tofacitinib-in-ankylosing-spondylitis-1029774688,negative,0.9460387825965881
1937,11/6/2020 1:23:42 PM,Mylan Q3 non-GAAP EBITDA up 9%; merger with Upjohn approaches,Seeking Alpha,https://seekingalpha.com/news/3633130-mylan-q3-non-gaap-ebitda-up-9-merger-upjohn-approaches?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9524479508399963
1938,11/9/2020 8:40:21 AM,ViiV Healthcare's cabotegravir shows superior results for HIV prevention in women,Seeking Alpha,https://seekingalpha.com/news/3633429-viiv-healthcares-cabotegravir-shows-superior-results-for-hiv-prevention-in-women?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9568598866462708
1939,11/9/2020 11:08:28 AM,5 Real Estate Stocks to Buy for a Hot Housing Market,InvestorPlace,/news/stocks/5-real-estate-stocks-to-buy-for-a-hot-housing-market-dhi-are-invh-low-tsco-1029780301,positive,0.8556708097457886
1940,11/9/2020 11:43:02 AM,Novavax May Profit From Life in the Slow Lane,InvestorPlace,/news/stocks/nvax-stock-may-benefit-from-life-in-slow-lane-1029780999,negative,0.8178969621658325
1941,11/9/2020 12:07:49 PM,"Pfizer/BioNTech COVID-19 vaccine 90% effective, U.S. EUA application expected this month",Seeking Alpha,https://seekingalpha.com/news/3633509-pfizer-biontech-covidminus-19-vaccine-90-effective-u-s-eua-application-expected-this-month?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8656361103057861
1942,11/9/2020 1:37:00 PM,Pfizer & BioNTech's COVID-19 Vaccine Candidate Shows Efficacy Rate Above 90% In Interim Analysis ,RTTNews,/news/stocks/pfizer-biontech-s-covid-19-vaccine-candidate-shows-efficacy-rate-above-90-in-interim-analysis-1029780805,negative,0.953783392906189
1943,11/9/2020 1:40:30 PM,Homology Medicines nabs investment from Pfizer,Seeking Alpha,https://seekingalpha.com/news/3633633-homology-medicines-nabs-investment-from-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8362410068511963
1944,11/9/2020 2:27:20 PM,Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results,InvestorPlace,/news/stocks/vaccine-news-pfizer-stock-soars-15-on-coronavirus-trial-results-1029782104,neutral,0.8339946866035461
1945,11/9/2020 2:39:58 PM,"Pfizer, BioNTech: COVID-19 Vaccine Candidate More Than 90% Effective ",RTTNews,/news/stocks/pfizer-biontech-covid-19-vaccine-candidate-more-than-90-effective-1029781445,negative,0.8755648136138916
1946,11/9/2020 2:40:54 PM,U.K. to receive 10M doses of Pfizer/BioNTech vaccine by end of 2020,Seeking Alpha,https://seekingalpha.com/news/3633701-u-k-to-receive-10m-doses-of-pfizer-biontech-vaccine-end-of-2020?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6877736449241638
1947,11/9/2020 3:36:18 PM,Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal,InvestorPlace,/news/stocks/homology-medicines-pfizer-news-1029782616,positive,0.9409430623054504
1948,11/9/2020 3:49:18 PM,BioNTech News: 5 Things for BNTX Stock Investors to Know,InvestorPlace,/news/stocks/biontech-news-5-things-for-bntx-stock-investors-to-know-1029782615,positive,0.9403983354568481
1949,11/9/2020 3:51:55 PM,Stock Alert: Pfizer Climbs 12% As COVID-19 Vaccine Found More Than 90% Effective ,RTTNews,/news/stocks/stock-alert-pfizer-climbs-12-as-covid-19-vaccine-found-more-than-90-effective-1029781961,negative,0.940204918384552
1950,11/9/2020 4:09:31 PM,"Cruise Stocks News: Why CCL, NCLH, RCL Are Powering Higher Today",InvestorPlace,/news/stocks/cruise-stocks-news-sends-stocks-soaring-1029782611,negative,0.778169572353363
1951,11/9/2020 5:38:56 PM,AMC Entertainment News: 12 Things for AMC Stock Investors to Know Today,InvestorPlace,/news/stocks/amc-entertainment-news-what-to-know-1029783009,positive,0.9361574053764343
1952,11/9/2020 6:52:11 PM,"Despite Ethical Issues, Palantir Is a Can’t-Miss Opportunity",InvestorPlace,/news/stocks/despite-ethical-issues-pltr-stock-is-a-cant-miss-opportunity-1029783005,positive,0.5794498324394226
1953,11/9/2020 6:58:00 PM,Pfizer Inc. -- Moody's: Pfizer's COVID-19 vaccine efficacy data credit positive,Moodys,/news/bonds/pfizer-inc-moody-s-pfizer-s-covid-19-vaccine-efficacy-data-credit-positive-1029782865,negative,0.5993098020553589
1954,11/9/2020 9:21:14 PM,Gold slides the most in 3 months as encouraging vaccine data boosts risk appetites,Business Insider,https://www.businessinsider.com/gold-price-tumbles-pfizer-vaccine-risk-appetites-safe-haven-recovery-2020-11,negative,0.7226820588111877
1955,11/9/2020 10:04:05 PM,Market Insight: 3 Takeaways From Today’s Massive Rally,InvestorPlace,/news/stocks/market-insight-3-takeaways-from-todays-massive-rally-1029783702,positive,0.6929191946983337
1956,11/10/2020 4:38:24 AM,Lilly's COVID-19 Antibody Drug Gets FDA Emergency Use Authorization For Non-hospitalized Patients ,RTTNews,/news/stocks/lilly-s-covid-19-antibody-drug-gets-fda-emergency-use-authorization-for-non-hospitalized-patients-1029783969,negative,0.9249613881111145
1957,11/10/2020 8:35:00 AM,"ARNA Falls Short Of ADVICE, PFE's COVID-19 Vaccine Shows 90% Efficacy, SUPN Hit By Double Whammy ",RTTNews,/news/stocks/arna-falls-short-of-advice-pfe-s-covid-19-vaccine-shows-90-efficacy-supn-hit-by-double-whammy-1029784994,negative,0.807870090007782
1958,11/10/2020 11:38:39 AM,"Pre-market Movers In Healthcare Sector: ALT, AFMD, BNTX, PFE, AZN, SUPN… ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-alt-afmd-bntx-pfe-azn-supn-1029785606,positive,0.9428759813308716
1959,11/10/2020 1:02:00 PM,Novavax Steals Some of Pfizer’s Thunder With Fast Track Designation,InvestorPlace,/news/stocks/novavax-nvax-stock-steals-pfizers-thunder-with-fast-track-designation-1029786505,positive,0.7748199701309204
1960,11/10/2020 1:52:47 PM,Lilly chief defends need for antibody treatment despite availability of vaccine,Seeking Alpha,https://seekingalpha.com/news/3634346-lilly-chief-defends-need-for-antibody-treatment-despite-availability-of-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.42634060978889465
1961,11/10/2020 2:57:58 PM,Sorrento Stock Is Still in this Fight but Better Buckle Up,InvestorPlace,/news/stocks/sorrento-stock-is-still-in-this-fight-but-better-buckle-up-1029787665,positive,0.6316861510276794
1962,11/10/2020 3:01:42 PM,Oxford T-Spot test shows key role of T cells in COVID-19 immunity,Seeking Alpha,https://seekingalpha.com/news/3634395-oxford-t-spot-test-shows-key-role-of-t-cells-in-covidminus-19-immunity?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8108112215995789
1963,11/10/2020 4:10:40 PM,Delta Stock Is Soaring But There Could Be Turbulence Ahead,InvestorPlace,/news/stocks/delta-stock-is-soaring-but-there-could-be-turbulence-ahead-1029788308,negative,0.6317371726036072
1964,11/10/2020 6:35:56 PM,Buy the Earnings Dip in Beyond Meat Stock,InvestorPlace,/news/stocks/buy-the-earnings-dip-in-beyond-meat-stock-1029788699,positive,0.8914844393730164
1965,11/10/2020 7:51:35 PM,Why the Drop in Overstock Is Worth Shopping,InvestorPlace,/news/stocks/why-the-drop-in-overstock-is-worth-shopping-1029789069,positive,0.8719822764396667
1966,11/10/2020 8:46:31 PM,Where and Why Virgin Galactic Stock Is Worth Buying,InvestorPlace,/news/stocks/where-and-why-virgin-galactic-stock-is-worth-buying-1029789065,positive,0.9305344223976135
1967,11/10/2020 10:12:19 PM,MoneyLine Podcast: The Best Sectors for a Biden Administration,InvestorPlace,/news/stocks/moneyline-podcast-the-best-sectors-for-a-biden-administration-1029789443,positive,0.8282455801963806
1968,11/10/2020 10:32:33 PM,Market Insight: What’s Behind Monday’s Huge Rally,InvestorPlace,/news/stocks/market-insight-whats-behind-mondays-huge-rally-1029789442,positive,0.8550593852996826
1969,11/10/2020 11:01:51 PM,Gold Prices: Yesterday’s Rally Put Our ‘Trade of the Decade’ on Sale,InvestorPlace,/news/stocks/gold-prices-yesterdays-rally-put-trade-of-decade-on-sale-1029789441,negative,0.5249447822570801
1970,11/11/2020 8:44:26 AM,"EU next to reach deal for Pfizer, BioNTech vaccine",Seeking Alpha,https://seekingalpha.com/news/3634781-eu-next-to-reach-deal-for-pfizer-biontech-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5666801929473877
1971,11/11/2020 11:29:57 AM,"Pfizer, BioNTech to supply 200M doses of mRNA-based COVID-19 vaccine in Europe",Seeking Alpha,https://seekingalpha.com/news/3634826-pfizer-biontech-to-supply-200m-doses-of-mrna-based-covidminus-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6629404425621033
1972,11/11/2020 11:48:37 AM,Logistical challenges can make Pfizer/BioNTech COVID-19 vaccine a shot for the rich - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3634835-logistical-challenges-can-make-pfizer-biontech-covidminus-19-vaccine-shot-for-rich-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5060505270957947
1973,11/11/2020 12:27:04 PM,Pfizer’s abrocitinib meets primary endpoints in atopic dermatitis Study,Seeking Alpha,https://seekingalpha.com/news/3634866-pfizer-s-abrocitinib-meets-primary-endpoints-in-atopic-dermatitis-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8301210999488831
1974,11/11/2020 12:38:59 PM,"Pfizer, BioNTech To Supply 200 Million Doses Of Their COVID-19 Vaccine Candidate To EU - Quick Facts ",RTTNews,/news/stocks/pfizer-biontech-to-supply-200-million-doses-of-their-covid-19-vaccine-candidate-to-eu-quick-facts-1029791205,negative,0.6700660586357117
1975,11/11/2020 1:18:34 PM,Exxon Mobil Stock Is Too Slippery to Handle,InvestorPlace,/news/stocks/exxon-mobil-stock-is-too-slippery-to-handle-1029792564,neutral,0.8320193290710449
1976,11/11/2020 1:40:57 PM,This Recent Prevailing Weakness Is Your Chance to Get in on Overstock.com,InvestorPlace,/news/stocks/prevailing-weakness-your-chance-ostk-stock-1029792563,negative,0.4782063066959381
1977,11/11/2020 2:00:06 PM,Pfizer's Abrocitinib Meets Primary & Secondary Endpoints In Late-stage Atopic Dermatitis Study ,RTTNews,/news/stocks/pfizer-s-abrocitinib-meets-primary-secondary-endpoints-in-late-stage-atopic-dermatitis-study-1029791540,negative,0.9150591492652893
1978,11/11/2020 2:24:45 PM,9 Outbreak-Fueled Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-second-coronavirus-wave-1029421408,positive,0.7889739274978638
1979,11/11/2020 2:35:44 PM,Rise with the Vaccine Tide and Buy Norwegian Cruise Line Stock,InvestorPlace,/news/stocks/rise-with-the-covid-19-vaccine-tide-and-buy-nclh-stock-1029792558,negative,0.6398974061012268
1980,11/11/2020 2:54:51 PM,Jumia Stock Is at the Epicenter of Africa’s 5G Boom,InvestorPlace,/news/stocks/jumia-stock-buy-jmia-african-5g-boom-1029792557,positive,0.7723705172538757
1981,11/11/2020 4:02:06 PM,Pfizer execs sell millions of dollars worth of shares,Seeking Alpha,https://seekingalpha.com/news/3634995-pfizer-execs-sell-millions-of-dollars-worth-of-shares?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9385222792625427
1982,11/11/2020 5:21:54 PM,Why Investors Should Bank On Well Fargo,InvestorPlace,/news/stocks/why-investors-should-bank-on-well-fargo-wfc-stock-1029793381,positive,0.8738037943840027
1983,11/11/2020 6:40:36 PM,Good News for Society Isn’t Necessarily So for Slack Stock,InvestorPlace,/news/stocks/good-news-for-society-is-not-great-for-slack-stock-1029793372,positive,0.8632276654243469
1984,11/11/2020 7:49:18 PM,There’s Still Plenty of Growth Ahead for Overstock,InvestorPlace,/news/stocks/ostk-stock-theres-still-plenty-of-growth-ahead-for-overstock-1029793638,negative,0.8267351388931274
1985,11/11/2020 7:50:38 PM,3 Stocks to Trade Right Now Due to Vaccine News,InvestorPlace,/news/stocks/3-stocks-to-trade-right-now-due-to-vaccine-news-1029793637,neutral,0.8183073997497559
1986,11/11/2020 9:33:37 PM,Moderna surpasses target cases for first data readout from pivotal study of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3635185-moderna-surpasses-target-cases-for-first-data-readout-from-pivotal-study-of-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8922743201255798
1987,11/12/2020 9:49:16 AM,"Amid cold-storage hurdle, Sanofi and J&J may beat logistical challenges",Seeking Alpha,https://seekingalpha.com/news/3635295-amid-cold-storage-hurdle-sanofi-and-j-and-j-may-beat-logistical-challenges?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9465422630310059
1988,11/12/2020 12:16:55 PM,4 Dividend Stocks With Yields Over 5%,InvestorPlace,/news/stocks/4-dividend-stocks-yields-over-5-percent-1029796403,positive,0.8623559474945068
1989,11/12/2020 12:20:21 PM,It Will Take More Than a Vaccine to Save Exxon Mobil Stock,InvestorPlace,/news/stocks/more-than-vaccine-save-xom-stock-1029796402,positive,0.817516028881073
1990,11/12/2020 12:50:08 PM,CureVac COVID-19 vaccine candidate stable at cool temp,Seeking Alpha,https://seekingalpha.com/news/3635442-curevac-covidminus-19-vaccine-candidate-stable-cool-temp?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8071459531784058
1991,11/12/2020 2:47:53 PM,Make Sure You Get in on Marathon Oil Stock Before Oil Prices Rise,InvestorPlace,/news/stocks/marathon-oil-stock-double-free-cash-flow-oil-prices-1029797403,positive,0.9299407601356506
1992,11/12/2020 4:14:13 PM,Square Stock Remains a Fintech Powerhouse Despite Vaccine News,InvestorPlace,/news/stocks/square-stock-remains-a-fintech-powerhouse-despite-vaccine-news-1029798075,negative,0.8563092350959778
1993,11/12/2020 5:58:44 PM,Pfizer's tafamidis extends survival in patients with rare heart failure condition,Seeking Alpha,https://seekingalpha.com/news/3635634-pfizers-tafamidis-extends-survival-in-patients-rare-heart-failure-condition?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9495332837104797
1994,11/12/2020 9:31:59 PM,"With Pfizer Winning the Vaccine Race, Novavax Is a Strong Sell",InvestorPlace,/news/stocks/with-pfizer-winning-the-vaccine-race-nvax-stock-is-a-strong-sell-1029799195,negative,0.9159317016601562
1995,11/13/2020 10:01:25 AM,5 Companies to Invest in for 2021 as Markets Price in Economy’s Prospects,InvestorPlace,/news/stocks/5-companies-pfe-abl-nio-spwr-ccl-to-invest-in-for-2021-1029800968,negative,0.7146391868591309
1996,11/13/2020 10:48:48 AM,3 Reasons Exxon Mobil Stock Will Come Back Along With the Economy,InvestorPlace,/news/stocks/3-reasons-xom-stock-will-come-back-1029800966,negative,0.730974555015564
1997,11/13/2020 1:42:54 PM,European advisory group backs new uses of six medicines,Seeking Alpha,https://seekingalpha.com/news/3636126-european-advisory-group-backs-new-uses-of-six-medicines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6016365885734558
1998,11/13/2020 3:48:56 PM,"Up 600% Year-to-Date, Sell iBio Stock While It’s Still Flying High",InvestorPlace,/news/stocks/ibio-newsup-600-year-to-date-sell-ibio-stock-1029802109,negative,0.4963448941707611
1999,11/13/2020 7:52:30 PM,Is It Time to Buy Sorrento Stock After Its Month-Long Swoon?,InvestorPlace,/news/stocks/is-it-time-to-buy-sorrento-stock-after-its-month-long-swoon-1029802566,positive,0.8317987322807312
2000,11/13/2020 8:00:17 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3636251-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
2001,11/13/2020 9:25:41 PM,3 Oil Stocks To Buy And Bull Trade For Big Gains,InvestorPlace,/news/stocks/3-oil-stocks-to-buy-and-bull-trade-for-big-gains-1029802756,positive,0.5944176912307739
2002,11/13/2020 9:39:08 PM,Pfizer/BioNTech perk up 1% after hours on Trump comments on COVID-19 vaccine availability,Seeking Alpha,https://seekingalpha.com/news/3636329-pfizer-biontech-perk-up-1-after-hours-on-trump-comments-on-covidminus-19-vaccine-availability?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9459136128425598
2003,11/14/2020 5:30:00 AM,BioNTech: COVID-19 vaccine drives breathtaking bull run,Seeking Alpha,https://seekingalpha.com/news/3636183-biontech-covidminus-19-vaccine-drives-breathtaking-bull-run?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7402333617210388
2004,11/15/2020 4:37:27 PM,"Week Ahead In Pharma: FDA Decisions, Data Readouts (ADMP, EIGR, KZIA, AVRO…) ",RTTNews,/news/stocks/week-ahead-in-pharma-fda-decisions-data-readouts-admp-eigr-kzia-avro-1029803879,positive,0.9442025423049927
2005,11/16/2020 8:45:14 AM,COVID-19 Vaccines - The Blues And Ease Of Cold Storage ,RTTNews,/news/stocks/covid-19-vaccines-the-blues-and-ease-of-cold-storage-1029804652,positive,0.8237765431404114
2006,11/16/2020 12:20:35 PM,"Moderna shares jump 12% as COVID-19 vaccine shows 94.5% efficacy, expects EUA submission shortly",Seeking Alpha,https://seekingalpha.com/news/3636472-moderna-shares-jump-12-covidminus-19-vaccine-shows-94_5-efficacy-expects-eua-submission?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9234064221382141
2007,11/16/2020 12:49:36 PM,"Moderna's COVID-19 vaccine candidate has longer shelf life, to remain stable at 2° to 8°C",Seeking Alpha,https://seekingalpha.com/news/3636496-modernas-covidminus-19-vaccine-candidate-longer-shelf-life-to-remain-stable-2-to-8-c?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8388635516166687
2008,11/16/2020 1:00:19 PM,Pfizer's Upjohn spinoff completes merger with Mylan to form Viatris,Seeking Alpha,https://seekingalpha.com/news/3636507-pfizers-upjohn-spinoff-completes-merger-mylan-to-form-viatris?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9180629849433899
2009,11/16/2020 1:59:01 PM,Pfizer Completes Combination Of Upjohn And Mylan; Viatris To Begin Trading On Nov. 17 ,RTTNews,/news/stocks/pfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov-17-1029805758,positive,0.9146451950073242
2010,11/16/2020 2:42:04 PM,MRNA Stock: Moderna Shares Surge on Covid-19 Vaccine News,InvestorPlace,/news/stocks/mrna-stock-moderna-shares-surge-on-covid-19-vaccine-news-1029806942,negative,0.9154613018035889
2011,11/16/2020 3:51:28 PM,3 Natural Gas Stocks to Buy Into the Year’s End,InvestorPlace,/news/stocks/natural-gas-stocks-to-buy-into-the-years-end-1029807477,negative,0.6458927989006042
2012,11/16/2020 5:29:17 PM,Broad vaccine access expected in the middle part of 2021,Seeking Alpha,https://seekingalpha.com/news/3636672-broad-vaccine-access-expected-in-middle-part-of-2021?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8011889457702637
2013,11/16/2020 6:02:00 PM,Pharmacia Corporation (Old Monsanto) -- Moody's downgrades Pfizer to A2 from A1 following Upjohn separation; stable outlook,Moodys,/news/bonds/pharmacia-corporation-old-monsanto-moody-s-downgrades-pfizer-to-a2-from-a1-following-upjohn-separation-stable-outlook-1029807451,negative,0.7635446786880493
2014,11/16/2020 7:53:05 PM,3 Reasons to Double Down on Lyft Stock Before Shares Shoot 200%,InvestorPlace,/news/stocks/3-reasons-to-double-down-on-lyft-stock-before-shares-shoot-200-1029808172,neutral,0.7557017207145691
2015,11/16/2020 8:56:45 PM,Grab Southwest Airlines Stock As It Begins to Soar Again,InvestorPlace,/news/stocks/grab-southwest-airlines-luv-stock-as-it-begins-to-soar-again-1029808169,positive,0.8375073075294495
2016,11/16/2020 9:16:27 PM,5 Bank Stocks to Buy for the Covid-19 Vaccine Recovery,InvestorPlace,/news/stocks/bank-stocks-to-buy-covid-19-vaccine-recovery-1029808443,positive,0.8999512791633606
2017,11/17/2020 7:49:00 AM,Pfizer Selects Four States For U.S. COVID-19 Immunization Pilot Program ,RTTNews,/news/stocks/pfizer-selects-four-states-for-u-s-covid-19-immunization-pilot-program-1029809167,positive,0.7728970050811768
2018,11/17/2020 8:10:16 AM,"ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective ",RTTNews,/news/stocks/admp-snubbed-again-fda-delay-s-decision-on-bmy-s-liso-cel-mrna-s-covid-19-vaccine-94-5-effective-1029809234,negative,0.8710684776306152
2019,11/17/2020 8:47:08 AM,Pfizer sets out pilot delivery program for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3636939-pfizer-sets-out-pilot-delivery-program-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7733859419822693
2020,11/17/2020 10:41:52 AM,"Buffett’s Berkshire Hathaway Buys New Stakes in Vaccine Makers, Cuts Banks",InvestorPlace,/news/stocks/buffets-berkshire-hathaway-stock-buys-new-stakes-in-vaccine-makers-cut-banks-1029809986,positive,0.8204633593559265
2021,11/17/2020 11:45:38 AM,Is messenger RNA technology in COVID-19 a new tool to success?,Seeking Alpha,https://seekingalpha.com/news/3636976-is-messenger-rna-technology-in-covidminus-19-new-tool-to-success?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7902471423149109
2022,11/17/2020 2:06:16 PM,"Unless Sorrento Makes Solid Progress Soon, It Will Likely Go Below $5",InvestorPlace,/news/stocks/unless-sorrento-makes-solid-progress-soon-srne-stock-will-likely-go-below-5-cseo-1029811910,neutral,0.9451557397842407
2023,11/17/2020 2:23:38 PM,Can Delta Air Lines Benefit From the Lessons of 1918?,InvestorPlace,/news/stocks/can-dal-stock-extract-lessons-from-1918-1029811908,positive,0.6609851717948914
2024,11/17/2020 3:10:41 PM,7 Pharmaceutical Stocks to Buy for 2021 and Beyond ,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-2021-and-beyond-1029811903,positive,0.9023517370223999
2025,11/17/2020 3:10:48 PM,FCEL Stock News: Why FuelCell Energy Shares Are Surging Today,InvestorPlace,/news/stocks/fcel-stock-news-why-fuelcell-energy-shares-are-surging-today-1029811902,neutral,0.48365533351898193
2026,11/17/2020 3:32:42 PM,Uber Stock Is Back In The Fast Lane After The Recent Surge,InvestorPlace,/news/stocks/uber-stock-is-back-in-the-fastlane-after-the-recent-surge-1029812599,negative,0.735458493232727
2027,11/17/2020 4:53:57 PM,Inovio Has Little to Show for Its Covid-19 Efforts,InvestorPlace,/news/stocks/ino-stock-is-not-worth-more-than-2-dollars-per-share-as-per-short-seller-1029812590,positive,0.796223521232605
2028,11/17/2020 7:08:51 PM,Expect Nvidia Stock to Pop Higher On Upcoming Earnings Catalyst,InvestorPlace,/news/stocks/expect-nvidia-nvda-stock-to-pop-on-upcoming-earnings-catalyst-1029812981,negative,0.9507867693901062
2029,11/17/2020 7:36:43 PM,Sell Novavax Stock After Its Huge Gain,InvestorPlace,/news/stocks/sell-novavax-stock-after-its-huge-gain-1029813268,positive,0.8138289451599121
2030,11/18/2020 6:51:58 AM,Pfizer and Vivet on go with mid-stage VTX-801 study in liver disorder,Seeking Alpha,https://seekingalpha.com/news/3637354-pfizer-and-vivet-on-go-mid-stage-vtxminus-801-study-in-liver-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5703526735305786
2031,11/18/2020 7:24:15 AM,Vivet : FDA Authorizes To Proceed With Phase 1/2 Study On Gene Therapy For Wilson Disease ,RTTNews,/news/stocks/vivet-fda-authorizes-to-proceed-with-phase-1-2-study-on-gene-therapy-for-wilson-disease-1029814139,negative,0.6323564648628235
2032,11/18/2020 8:33:34 AM,ViiV Healthcare's cabotegravir nabs accelerated review in U.S. for HIV prevention,Seeking Alpha,https://seekingalpha.com/news/3637361-viiv-healthcares-cabotegravir-nabs-accelerated-review-in-u-s-for-hiv-prevention?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.767090916633606
2033,11/18/2020 10:16:14 AM,Teladoc Stock Is Off Its Highs But It’s Not on Life Support,InvestorPlace,/news/stocks/teladoc-stock-is-off-its-highs-but-its-not-on-life-support-1029815010,neutral,0.6725428104400635
2034,11/18/2020 12:09:57 PM,"Pfizer (PFE), BioNTech (BNTX) vaccine is 95% effective in final analysis",Seeking Alpha,https://seekingalpha.com/news/3637409-pfizer-pfe-biontech-bntx-vaccine-is-95-effective-in-final-analysis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6520357131958008
2035,11/18/2020 1:35:15 PM,Pfizer-BioNTech Covid-19 Vaccine Found To Be 95% Effective - Quick Facts ,RTTNews,/news/stocks/pfizer-biontech-covid-19-vaccine-found-to-be-95-effective-quick-facts-1029815466,negative,0.9101736545562744
2036,11/18/2020 2:31:37 PM,Pfizer Says COVID-19 Vaccine 95% Effective; To Apply For Emergency Use ,RTTNews,/news/stocks/pfizer-says-covid-19-vaccine-95-effective-to-apply-for-emergency-use-1029815976,positive,0.5093936324119568
2037,11/18/2020 2:48:14 PM,Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval,Business Insider,https://www.businessinsider.com/pfizer-biontech-stock-price-coronavirus-vaccine-trial-effectiveness-fda-authorization-2020-11,negative,0.9138952493667603
2038,11/18/2020 2:59:53 PM,Dropbox Can’t Seem to Take Advantage of Covid-19,InvestorPlace,/news/stocks/dropbox-stock-cannot-seem-to-take-advantage-covid-19-1029816778,positive,0.893967866897583
2039,11/18/2020 3:36:59 PM,Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?,InvestorPlace,/news/stocks/covid-vaccine-update-moderna-and-pfizer-coronavirus-vaccines-compare-1029817357,positive,0.8831048607826233
2040,11/18/2020 3:38:01 PM,These 3 Companies Currently Provide Much Better Value Than Nio,InvestorPlace,/news/stocks/these-3-companies-currently-provide-much-better-value-than-nio-stock-cseo-1029817356,negative,0.7823305130004883
2041,11/18/2020 3:54:03 PM,US stocks resume climb as investors cheer COVID-19 vaccine progress,Business Insider,https://www.businessinsider.com/stock-market-news-today-boeing-approval-pfizer-biontech-vaccine-progress-2020-11,negative,0.634570837020874
2042,11/18/2020 7:51:21 PM,3 ‘Stay Away’ Stocks to Buy Today,InvestorPlace,/news/stocks/3-stay-away-stocks-to-buy-today-1029817998,positive,0.88307785987854
2043,11/18/2020 10:09:02 PM,Dow tumbles 345 points as fresh lockdown measures overshadow vaccine progress,Business Insider,https://www.businessinsider.com/stock-market-news-today-covid19-virus-lockdowns-pfizer-biontech-vaccine-2020-11,neutral,0.9481204152107239
2044,11/19/2020 7:56:18 AM,Vaccine from AstraZeneca-Oxford produces strong immune response in older adults,Seeking Alpha,https://seekingalpha.com/news/3637787-vaccine-from-astrazeneca-oxford-produces-strong-immune-response-in-older-adults?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9021430611610413
2045,11/19/2020 8:13:28 AM,"APVO Gets Buyout Offer, PFE/BNTX' COVID Shot 95% Effective, CORT Gets Favorable PTAB Ruling ",RTTNews,/news/stocks/apvo-gets-buyout-offer-pfe-bntx-covid-shot-95-effective-cort-gets-favorable-ptab-ruling-1029819006,negative,0.9128315448760986
2046,11/19/2020 10:02:20 AM,FDA plans early advisory meetings in December to discuss COVID-19 vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3637799-fda-plans-early-advisory-meetings-in-december-to-discuss-covidminus-19-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.930812418460846
2047,11/19/2020 10:16:20 AM,Investors Find the Right Rx With Teladoc Stock,InvestorPlace,/news/stocks/investors-find-the-right-rx-with-teladoc-stock-1029819755,positive,0.7492678761482239
2048,11/19/2020 11:21:24 AM,Pfizer-BioNTech COVID-19 vaccine deliveries could start 'before Christmas': BioNTech CEO,Seeking Alpha,https://seekingalpha.com/news/3637827-pfizer-biontech-covidminus-19-vaccine-deliveries-start-before-christmas-biontech-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9293858408927917
2049,11/19/2020 12:21:56 PM,Pfizer teams up with LianBio for development of novel therapeutics in Greater China,Seeking Alpha,https://seekingalpha.com/news/3637861-pfizer-teams-up-lianbio-for-development-of-novel-therapeutics-in-greater-china?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8183590173721313
2050,11/19/2020 3:18:48 PM,"Vaccines Aren’t Winner-Take-All, Making Novavax Stock a Smart Covid Play",InvestorPlace,/news/stocks/nvax-stock-a-smart-covid-play-1029822207,positive,0.7544839978218079
2051,11/19/2020 4:42:09 PM,Why Carnival Is Still Stuck on the List of Stocks to Avoid,InvestorPlace,/news/stocks/why-carnival-is-still-stuck-on-the-list-of-stocks-to-avoid-1029822195,positive,0.6939362287521362
2052,11/19/2020 5:18:31 PM,It’s Time to Join the Bulls as They Board Carnival Stock,InvestorPlace,/news/stocks/its-time-to-join-bulls-board-carnival-ccl-stock-1029822620,positive,0.8874761462211609
2053,11/19/2020 5:38:37 PM,3 5G Stocks to Stream Profits into Your Portfolio in 2021,InvestorPlace,/news/stocks/3-5g-stocks-to-stream-profits-into-your-portfolio-in-2021-1029822618,positive,0.8652017116546631
2054,11/20/2020 7:46:37 AM,"AZN's Covid Jab & Immunosenescence, PFE/BNTX To Seek Emergency Nod For Vaccine, QURE Aces HOPE-B ",RTTNews,/news/stocks/azn-s-covid-jab-immunosenescence-pfe-bntx-to-seek-emergency-nod-for-vaccine-qure-aces-hope-b-1029823800,positive,0.6857633590698242
2055,11/20/2020 7:59:23 AM,"EU may approve BioNtech, Moderna vaccines in December, could pay $10B for doses",Seeking Alpha,https://seekingalpha.com/news/3638224-eu-may-approve-biontech-moderna-vaccines-in-december-pay-10b-for-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5250717401504517
2056,11/20/2020 8:40:01 AM,Pfizer set to file FDA application for vaccine today,Seeking Alpha,https://seekingalpha.com/news/3638226-pfizer-set-to-file-fda-application-for-vaccine-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8826268911361694
2057,11/20/2020 10:31:13 AM,Carnival Stock Sees A Strong Rally But Is It Worth Your Time?,InvestorPlace,/news/stocks/ccl-stock-sees-a-strong-rally-but-is-it-worth-your-time-1029824436,positive,0.6838403344154358
2058,11/20/2020 12:09:11 PM,Pfizer/BioNTech to submit today emergency use application for COVID-19 vaccine to FDA,Seeking Alpha,https://seekingalpha.com/news/3638265-pfizer-biontech-to-submit-today-emergency-use-application-for-covidminus-19-vaccine-to-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.834375262260437
2059,11/20/2020 12:09:11 PM,Pfizer/BioNTech to submit emergency use application for COVID-19 vaccine to FDA,Seeking Alpha,https://seekingalpha.com/news/3638265-pfizer-biontech-to-submit-emergency-use-application-for-covidminus-19-vaccine-to-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7957481145858765
2060,11/20/2020 1:02:28 PM,Inovio Gets the Go-Ahead But It’s Probably Too Late,InvestorPlace,/news/stocks/ino-stock-gets-go-ahead-but-probably-too-late-1029824918,positive,0.8834108710289001
2061,11/20/2020 1:19:53 PM,"Pfizer, BioNTech To Submit Emergency Use Authorization Request To FDA For COVID-19 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-to-submit-emergency-use-authorization-request-to-fda-for-covid-19-vaccine-1029824705,positive,0.762853741645813
2062,11/20/2020 1:58:42 PM,United Airlines: Trump Was Right and Buffett Was Wrong,InvestorPlace,/news/stocks/united-airlines-trump-was-right-and-buffett-was-wrong-1029825437,positive,0.8292796611785889
2063,11/20/2020 3:13:54 PM,"Stay Away From iBio, Which Constantly Issues Shares to Survive",InvestorPlace,/news/stocks/ibio-news-stay-away-from-ibio-stock-which-constantly-issues-shares-to-survive-1029825830,positive,0.8902395367622375
2064,11/20/2020 5:50:42 PM,7 Hot Stocks to Buy Before 2021 Ushers in Change,InvestorPlace,/news/stocks/7-of-the-hot-stocks-to-buy-before-2021-ushers-in-change-1029826116,positive,0.90118008852005
2065,11/20/2020 5:50:59 PM,Upcoming Catalysts Are Poised to Lift Delta Stock,InvestorPlace,/news/stocks/upcoming-catalysts-are-poised-to-lift-delta-dal-stock-1029826115,negative,0.9009113311767578
2066,11/20/2020 6:34:08 PM,Israel nears deal for AstraZeneca's COVID-19 vaccine - Reuters,Seeking Alpha,https://seekingalpha.com/news/3638441-israel-nears-deal-for-astrazenecas-covidminus-19-vaccine-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.780410885810852
2067,11/20/2020 6:50:01 PM,3 Well-Discounted Covid-19 Stocks to Buy,InvestorPlace,/news/stocks/3-well-discounted-covid-19-stocks-to-buy-1029826105,positive,0.8201298713684082
2068,11/20/2020 7:08:44 PM,"With Coronavirus Cases Climbing, Consider Slack a Buy",InvestorPlace,/news/stocks/with-coronavirus-cases-climbing-consider-slack-stock-work-as-a-buy-1029826102,positive,0.5911040902137756
2069,11/20/2020 7:41:08 PM,Why iBio Presents a Dilemma to Shareholders,InvestorPlace,/news/stocks/ibio-stock-ibio-presents-dilemma-to-shareholders-1029826320,positive,0.9127306342124939
2070,11/20/2020 7:49:32 PM,Pfizer files for emergency-use OK on COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3638451-pfizer-files-for-emergency-use-ok-on-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6416794657707214
2071,11/20/2020 8:29:47 PM,7 Airline Stocks to Watch If a Coronavirus Vaccine Is Near,InvestorPlace,/news/stocks/7-airline-stocks-to-watch-if-a-coronavirus-vaccine-is-near-1029826318,positive,0.7937374711036682
2072,11/20/2020 10:21:52 PM,FDA sets Dec. 10 meeting to weigh Pfizer/BioNTech vaccine authorization,Seeking Alpha,https://seekingalpha.com/news/3638503-fda-sets-dec-10-meeting-to-weigh-pfizer-biontech-vaccine-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8535962700843811
2073,11/21/2020 10:30:25 PM,Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19,InvestorPlace,/news/stocks/the-blockchain-how-this-next-great-technology-platform-fight-covid-19-1029827011,positive,0.6443464756011963
2074,11/22/2020 2:12:08 PM,Vaccine access and distribution a big topic at G20,Seeking Alpha,https://seekingalpha.com/news/3638524-vaccine-access-and-distribution-big-topic-g20?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8874895572662354
2075,11/22/2020 4:38:50 PM,"Coronavirus update: Senator in quarantine, U.K. sets lockdown end, Japan spikes",Seeking Alpha,https://seekingalpha.com/news/3638526-coronavirus-update-senator-in-quarantine-u-k-sets-lockdown-end-japan-spikes?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7239035367965698
2076,11/23/2020 8:02:44 AM,"All eyes on AstraZeneca-Oxford shot after strong Pfizer, Moderna results",Seeking Alpha,https://seekingalpha.com/news/3638538-all-eyes-on-astrazeneca-oxford-shot-after-strong-pfizer-moderna-results?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7594830989837646
2077,11/23/2020 8:46:42 AM,COVID-19 vaccinations set to start in less than three weeks,Seeking Alpha,https://seekingalpha.com/news/3638546-covidminus-19-vaccinations-set-to-start-in-less-three-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8890437483787537
2078,11/23/2020 10:01:46 AM,7 Restaurant Stocks That Could Be Shaky With More Shutdowns,InvestorPlace,/news/stocks/7-restaurant-stocks-play-ds-cbrl-eat-cake-that-may-not-withstand-more-shutdowns-1029828849,neutral,0.932517945766449
2079,11/23/2020 10:16:57 AM,"Warts and All, Here’s Why JFrog Stock Is a Buy",InvestorPlace,/news/stocks/warts-and-all-heres-why-jfrog-stock-is-a-buy-1029828848,positive,0.9216256141662598
2080,11/23/2020 12:01:13 PM,Dosing underway in Pfizer's late-stage marstacimab study for hemophilia A and B,Seeking Alpha,https://seekingalpha.com/news/3638583-dosing-underway-in-pfizers-late-stage-marstacimab-study-for-hemophilia-and-b?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6816471815109253
2081,11/23/2020 12:30:56 PM,7 Short-Term Stocks to Handle With Caution,InvestorPlace,/news/stocks/7-short-term-stocks-to-handle-with-caution-1029829428,positive,0.9155301451683044
2082,11/23/2020 12:57:15 PM,Here’s Why Shopify Stock Is a Great Buy in Any Investing Environment,InvestorPlace,/news/stocks/heres-why-shopify-stock-is-a-great-buy-in-any-investing-environment-1029829425,positive,0.8298969864845276
2083,11/23/2020 1:11:53 PM,Pfizer Doses First Participant In Phase 3 BASIS Study Of Marstacimab - Quick Facts ,RTTNews,/news/stocks/pfizer-doses-first-participant-in-phase-3-basis-study-of-marstacimab-quick-facts-1029829177,positive,0.6921516060829163
2084,11/23/2020 1:52:12 PM,"AstraZeneca COVID-19 results don't impress Wall Street, while Pfizer, BioNTech, Moderna gain",Seeking Alpha,https://seekingalpha.com/news/3638661-astrazeneca-covidminus-19-results-dont-impress-wall-street-while-pfizer-biontech-moderna-gain?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.847883403301239
2085,11/23/2020 4:49:58 PM,Boeing Stock Soared Last Week but There’s More to Come,InvestorPlace,/news/stocks/boeing-stock-soared-last-week-but-theres-more-to-come-1029830786,positive,0.7317661046981812
2086,11/23/2020 5:24:40 PM,iBio Looks Well-Positioned to Succeed,InvestorPlace,/news/stocks/recent-ibio-news-shows-promise-for-the-future-of-the-company-1029831158,negative,0.8165030479431152
2087,11/23/2020 6:20:42 PM,Sorrento Therapeutics Hoping Better Late Than Never Works in Vaccine Competition,InvestorPlace,/news/stocks/srne-stock-is-rising-but-its-hard-to-trust-this-rally-1029831148,positive,0.5884084701538086
2088,11/23/2020 7:54:04 PM,Why It Could Still Be OK to Buy WFC Stock,InvestorPlace,/news/stocks/why-it-could-still-be-okay-to-buy-wfc-stock-cseo-1029831453,positive,0.9156356453895569
2089,11/23/2020 8:00:26 PM,7 Upcoming IPOs to Watch Heading Into 2021,InvestorPlace,/news/stocks/7-upcoming-ipos-to-watch-1029273035,positive,0.9287413954734802
2090,11/24/2020 7:55:02 AM,"AZN's COVID Shot 70% Effective On Average, ARQT Aces Scalp Psoriasis Study, BLRX' BLAST Fizzles ",RTTNews,/news/stocks/azn-s-covid-shot-70-effective-on-average-arqt-aces-scalp-psoriasis-study-blrx-blast-fizzles-1029832359,negative,0.5223150253295898
2091,11/24/2020 9:01:02 AM,"U.K. could roll out vaccines from Astra-Oxford, Pfizer in December",Seeking Alpha,https://seekingalpha.com/news/3638925-u-k-roll-out-vaccines-from-astra-oxford-pfizer-in-december?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6589183211326599
2092,11/24/2020 4:58:02 PM,3 Big Reasons the Dow Just Crossed 30K,InvestorPlace,/news/stocks/3-big-reasons-the-dow-just-crossed-30k-1029835386,positive,0.8111876249313354
2093,11/24/2020 5:37:18 PM,Pfizer Looks Like Good Value With Its Vaccine Catalyst and Dividend Yield,InvestorPlace,/news/stocks/pfe-stock-could-be-worth-60-percent-more-once-vaccine-is-approved-1029835778,negative,0.7437982559204102
2094,11/24/2020 7:21:41 PM,"Pfizer, Moderna Lead the Vaccine Race: Here’s Where 7 Other Top Vaccine Stocks Stand",InvestorPlace,/news/stocks/7-biotech-stocks-locked-in-the-race-for-a-vaccine-1029836075,positive,0.9004662036895752
2095,11/24/2020 7:55:29 PM,Why RIDE Stock Isn’t Even Worth a Test Drive,InvestorPlace,/news/stocks/why-ride-stock-isnt-even-worth-a-test-drive-1029836072,positive,0.9124228954315186
2096,11/24/2020 9:06:27 PM,It’s Time for the Wells Fargo Bulls to Put Up or Shut Up,InvestorPlace,/news/stocks/its-time-for-the-well-fargo-bulls-to-put-up-or-shut-up-1029836066,positive,0.7598334550857544
2097,11/24/2020 9:37:29 PM,Why Delta Stock and Other Airlines Are Destined for Higher Prices,InvestorPlace,/news/stocks/airline-stocks-like-delta-dal-stock-are-destined-for-higher-prices-1029836328,positive,0.8920077085494995
2098,11/25/2020 7:37:33 AM,Basilea: Pfizer's MAA For Cresemba Accepted For Regulatory Review In China ,RTTNews,/news/stocks/basilea-pfizer-s-maa-for-cresemba-accepted-for-regulatory-review-in-china-1029836916,positive,0.8676138520240784
2099,11/25/2020 10:56:26 AM,U.S. aims to release 6.4M COVID-19 vaccine doses in first tranche - Reuters,Seeking Alpha,https://seekingalpha.com/news/3639320-u-s-aims-to-release-6_4m-covidminus-19-vaccine-doses-in-first-tranche-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6884705424308777
2100,11/25/2020 11:22:28 AM,Basilea files China application for antifungal isavuconazole submitted by Pfizer accepted for review,Seeking Alpha,https://seekingalpha.com/news/3639328-basilea-files-china-application-for-antifungal-isavuconazole-submitted-pfizer-accepted-for?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7234846949577332
2101,11/25/2020 12:31:23 PM,"Alibaba Stock Woes Won’t Last, So Stay Long in the Shares Into 2021",InvestorPlace,/news/stocks/alibaba-stock-woes-wont-last-so-stay-long-in-the-shares-into-2021-1029838391,positive,0.883415162563324
2102,11/25/2020 1:04:40 PM,"Forget the Vaccine, Buy Pfizer Stock for Its Impressive Cash Flow",InvestorPlace,/news/stocks/forget-the-vaccine-buy-pfizer-pfe-stock-for-cash-flow-1029838388,positive,0.7985290884971619
2103,11/25/2020 1:36:53 PM,Beware the Precarious Dividend of Exxon Mobil Stock,InvestorPlace,/news/stocks/beware-the-precarious-dividend-and-share-price-with-xom-stock-1029839043,neutral,0.8456578850746155
2104,11/25/2020 4:25:33 PM,The Top 5 Telehealth Stocks Disrupting the Healthcare Sector,InvestorPlace,/news/stocks/the-top-5-telehealth-stocks-disrupting-the-healthcare-sector-1029839542,neutral,0.9617536664009094
2105,11/25/2020 4:59:46 PM,7 Canadian Stocks to Buy for Improved International Relations,InvestorPlace,/news/stocks/7-canadian-stocks-to-buy-for-improved-international-relations-1029839538,negative,0.8204619288444519
2106,11/25/2020 5:12:33 PM,It’s Time for iBio Speculators to Consider Something Else,InvestorPlace,/news/stocks/time-for-ibio-stock-gamblers-consider-alternatives-1029839842,positive,0.9079661965370178
2107,11/25/2020 5:16:02 PM,Trade Zoom with Confidence After This Harsh Correction,InvestorPlace,/news/stocks/trade-zoom-stock-with-confidence-after-this-harsh-correction-1029839841,negative,0.7067875862121582
2108,11/25/2020 5:20:25 PM,3 EV Stocks to Buy as the Sector Charges Up,InvestorPlace,/news/stocks/3-ev-stocks-to-buy-as-sector-charges-up-1029839840,positive,0.5917818546295166
2109,11/25/2020 5:27:48 PM,"Don’t Wait for Black Friday Deals in Apple Stock, Now’s the Time to Act",InvestorPlace,/news/stocks/dont-wait-for-black-friday-deals-in-apple-aapl-stock-nows-the-time-to-act-1029839839,positive,0.9357428550720215
2110,11/25/2020 5:46:42 PM,There Are Good Reason to Feel Bullish About Ericsson Stock,InvestorPlace,/news/stocks/bullish-ericsson-stock-1029839838,negative,0.652931272983551
2111,11/25/2020 6:06:07 PM,Overlook Novavax at the Risk of Incurring an Opportunity Cost,InvestorPlace,/news/stocks/overlook-nvax-stock-at-your-own-risk-1029839833,neutral,0.5209403038024902
2112,11/25/2020 6:25:04 PM,Merck and Biotech’s Swashbuckling Era,InvestorPlace,/news/stocks/swashbuckling-era-merck-mrk-stock-1029839832,positive,0.9027481079101562
2113,11/25/2020 6:56:35 PM,"Pfizer Stock Moved Markets This Month, But Can it Rally?",InvestorPlace,/news/stocks/pfizer-stock-moved-markets-this-month-but-can-it-rally-1029839825,positive,0.5423089265823364
2114,11/25/2020 10:30:42 PM,How to Invest in a Post-COVID World,InvestorPlace,/news/stocks/post-covid-investing-where-to-invest-for-the-pandemics-end-1029840262,positive,0.920863687992096
2115,11/26/2020 7:41:02 AM,"The Long And Short Of Pfizer-BioNTech, Moderna, Sputnik V & Oxford-AstraZeneca Vaccines ",RTTNews,/news/stocks/the-long-and-short-of-pfizer-biontech-moderna-sputnik-v-oxford-astrazeneca-vaccines-1029840690,positive,0.9473150968551636
2116,11/27/2020 7:24:10 AM,AstraZeneca-Oxford vaccine may get U.K. approval before EU,Seeking Alpha,https://seekingalpha.com/news/3639609-astrazeneca-oxford-vaccine-may-get-u-k-approval-eu?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5657302141189575
2117,11/30/2020 2:12:00 AM,Biotech Stocks Facing FDA Decision In December 2020 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-december-2020-1029847132,positive,0.7155784368515015
2118,11/30/2020 11:55:00 AM,"The Case for iBio Stock Is Real, but Leaves a Key Question Unanswered",InvestorPlace,/news/stocks/ibio-stock-presents-investors-with-key-question-1029848699,positive,0.8902006149291992
2119,11/30/2020 12:16:55 PM,Moderna to seek regulatory authorization for Covid-19 vaccine after final trial shows 94.1% effectiveness,Seeking Alpha,https://seekingalpha.com/news/3639868-moderna-to-seek-regulatory-authorization-for-covidminus-19-vaccine-after-final-trial-shows?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8835471868515015
2120,11/30/2020 12:44:52 PM,Deciphera completes enrollment in late-stage study of ripretinib in GIST patients,Seeking Alpha,https://seekingalpha.com/news/3639881-deciphera-completes-enrollment-in-late-stage-study-of-ripretinib-in-gist-patients?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7868871688842773
2121,11/30/2020 3:26:46 PM,Here’s Why Shopify Stock Is a Great Buy Right Now,InvestorPlace,/news/stocks/heres-why-shopify-stock-is-a-great-buy-right-now-1029849988,positive,0.8481735587120056
2122,11/30/2020 4:06:20 PM,Windows of Opportunity Are Tightening for Sorrento Therapeutics,InvestorPlace,/news/stocks/opportunity-tightening-for-sorrento-therapeutics-srne-stock-1029849981,negative,0.8734881281852722
2123,11/30/2020 8:55:22 PM,Nvidia Stock: Expensive But Still Worth It?,InvestorPlace,/news/stocks/nvda-stock-expensive-but-still-worth-it-1029850437,positive,0.8576759099960327
2124,12/1/2020 10:01:00 AM,PLUG Stock Not One That Investors Can Easily Time,InvestorPlace,/news/stocks/dont-try-and-time-plug-stock-1029852538,positive,0.9162832498550415
2125,12/1/2020 11:33:20 AM,Pfizer and BioNTech to seek European commission conditional approval for Covid-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3640228-pfizer-and-biontech-to-seek-european-commission-conditional-approval-for-covidminus-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.842739999294281
2126,12/1/2020 11:34:41 AM,"Pfizer, BioNTech Apply For Conditional Marketing Authorization For COVID-19 Vaccine To EMA ",RTTNews,/news/stocks/pfizer-biontech-apply-for-conditional-marketing-authorization-for-covid-19-vaccine-to-ema-1029852380,negative,0.8139215111732483
2127,12/1/2020 12:41:06 PM,"Pfizer, BioNTech Apply For COVID-19 Vaccine's Marketing Authorization In EU ",RTTNews,/news/stocks/pfizer-biontech-apply-for-covid-19-vaccine-s-marketing-authorization-in-eu-1029852652,positive,0.621791422367096
2128,12/1/2020 3:58:35 PM,Odds Are Draftkings Stock Will Continue to Win,InvestorPlace,/news/stocks/odds-are-that-dkng-stock-will-continue-to-win-for-a-long-while-1029854826,negative,0.8824260830879211
2129,12/1/2020 4:07:39 PM,7 Warren Buffett Stocks That Belong On Your 2021 Watchlist,InvestorPlace,/news/stocks/7-warren-buffett-stocks-that-belong-on-your-2021-watchlistthese-7-warren-buffett-stocks-ought-to-be-on-your-2021-watchlist-1029854824,positive,0.93221515417099
2130,12/1/2020 4:11:29 PM,EMA Receives CMA Application For BioNTech/Pfizer And Moderna COVID-19 Vaccines ,RTTNews,/news/stocks/ema-receives-cma-application-for-biontech-pfizer-and-moderna-covid-19-vaccines-1029854019,positive,0.5411452651023865
2131,12/1/2020 6:01:43 PM,4 Pharmaceutical Stocks That Aren’t Worth Their Outsized 2020 Gains,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-ino-regn-abbv-nvax-that-arent-worth-their-2020-gains-1029854808,positive,0.752234935760498
2132,12/1/2020 6:30:05 PM,EARS Stock: Why Auris Medical Shares Are Soaring 450%,InvestorPlace,/news/stocks/ears-stock-why-auris-medical-shares-are-soaring-450-1029854806,positive,0.5159244537353516
2133,12/1/2020 7:15:08 PM,"Even After Four Quarterly Losses, Marathon Oil Is Still a Buy",InvestorPlace,/news/stocks/even-after-four-quarterly-losses-mro-stock-is-still-a-buy-1029855118,negative,0.6509303450584412
2134,12/1/2020 7:28:25 PM,Boeing Stock Flies As The 737 Max Gets Clearance,InvestorPlace,/news/stocks/boeing-stock-flys-as-the-737-max-gets-clearance-1029855115,positive,0.756621778011322
2135,12/1/2020 9:23:05 PM,7 Safe Growth Stocks To Buy For 2021 Catalysts,InvestorPlace,/news/stocks/7-safe-growth-stocks-to-buy-for-2021-catalysts-1029855389,positive,0.8543530106544495
2136,12/1/2020 10:24:02 PM,S&P 500 and Nasdaq close at record highs as investors bet that a vaccine will drive an economic rebound,Business Insider,https://www.businessinsider.com/stock-market-news-today-nasdaq-sp500-record-vaccine-recovery-hopes-2020-12,negative,0.6907685995101929
2137,12/2/2020 7:34:00 AM,U.K. becomes first country to authorize Pfizer-BioNTech vaccine for emergency use,Seeking Alpha,https://seekingalpha.com/news/3640670-u-k-becomes-first-country-to-authorize-pfizer-biontech-vaccine-for-emergency-use?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6835291981697083
2138,12/2/2020 8:33:02 AM,U.K. Grants Temporary Authorization For Emergency Use For Pfizer/BioNTech COVID-19 Vaccine ,RTTNews,/news/stocks/u-k-grants-temporary-authorization-for-emergency-use-for-pfizer-biontech-covid-19-vaccine-1029856103,negative,0.5923976898193359
2139,12/2/2020 9:28:15 AM,"Pfizer, BioNTech's COVID-19 Vaccine Gets UK's Emergency Authorization ",RTTNews,/news/stocks/pfizer-biontech-s-covid-19-vaccine-gets-uk-s-emergency-authorization-1029856237,positive,0.6215498447418213
2140,12/2/2020 11:26:07 AM,7 Of The Best Long-Term Tech Stocks To Buy As Sector Looks Ready to Charge,InvestorPlace,/news/stocks/7-long-term-tech-stocks-cibr-ogig-pypl-roku-qcom-xsd-twtr-1029857286,negative,0.7040411233901978
2141,12/2/2020 12:16:53 PM,"Pre-market Movers In Healthcare Sector: ZOM, BNTX, PFE, MESO, OVID… ",RTTNews,/news/stocks/pre-market-movers-in-healthcare-sector-zom-bntx-pfe-meso-ovid-1029856782,positive,0.9284290671348572
2142,12/2/2020 1:15:24 PM,Just Say No to Inovio Pharmaceuticals Stock,InvestorPlace,/news/stocks/just-say-no-to-inovio-pharmaceuticals-stock-1029858306,positive,0.9311157464981079
2143,12/2/2020 3:59:45 PM,Stock Alert: Pfizer Shares Hit 52-Week High ,RTTNews,/news/stocks/stock-alert-pfizer-shares-hit-52-week-high-1029858225,negative,0.8724559545516968
2144,12/2/2020 5:16:24 PM,Sorrento Stock Doesn’t Offer Any Upside as Vaccine Frontrunners Emerge,InvestorPlace,/news/stocks/srne-stock-doesnt-offer-any-upside-as-vaccine-frontrunners-emerge-1029859080,positive,0.798940896987915
2145,12/2/2020 6:04:19 PM,RYCEY Stock: 10 Things to Know About Rolls-Royce Today,InvestorPlace,/news/stocks/rycey-stock-10-things-to-know-about-rolls-royce-today-1029859069,positive,0.9341307282447815
2146,12/2/2020 7:33:32 PM,Royal Caribbean Stock Will Continue to Rise on Vaccine Hope,InvestorPlace,/news/stocks/rcl-stock-will-continue-to-rise-due-to-vaccine-hope-1029859408,negative,0.9474601149559021
2147,12/2/2020 9:56:00 PM,"5 Top Stock Trades for Thursday: SNAP, PFE, WKHS, BOX, SPOT",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-snap-pfe-wkhs-box-spot-1029859646,positive,0.9300523400306702
2148,12/3/2020 6:37:33 AM,"BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK ",RTTNews,/news/stocks/bcrx-awaits-fda-decision-jnj-on-watch-pfizer-biontech-s-covid-19-vaccine-gets-green-light-in-uk-1029860123,negative,0.8735619783401489
2149,12/3/2020 8:55:24 AM,U.S. could immunize one-third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-one-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8466517925262451
2150,12/3/2020 8:55:24 AM,U.S. could immunize third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8187563419342041
2151,12/3/2020 10:16:13 AM,7 Undervalued Stocks to Snap Up Today,InvestorPlace,/news/stocks/undervalued-stocks-are-out-there-including-some-familiar-names-1029860944,negative,0.5279099345207214
2152,12/3/2020 4:13:37 PM,3 Under-Loved Biotech Stocks to Buy for Profits Into 2021,InvestorPlace,/news/stocks/3-under-loved-biotech-stocks-to-buy-for-profits-into-2021-1029862758,positive,0.6799818873405457
2153,12/3/2020 7:23:58 PM,7 Best Cruise Stocks Seeking to Set Sail Again in 2021,InvestorPlace,/news/stocks/7-best-cruise-stocks-seeking-to-set-sail-again-in-2021-1029863333,positive,0.5239471793174744
2154,12/3/2020 7:45:16 PM,"Cruise Stocks: Why NCLH, RCL and CCL Stock Are Soaring Today",InvestorPlace,/news/stocks/cruise-stocks-why-nclh-rcl-and-ccl-stock-are-soaring-today-1029863331,neutral,0.6512047052383423
2155,12/3/2020 9:02:13 PM,Supply chain issues to restrict Pfizer COVID-19 shipments this month,Seeking Alpha,https://seekingalpha.com/news/3641506-supply-chain-issues-to-restrict-pfizer-covidminus-19-shipments-this-month?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9339557886123657
2156,12/3/2020 9:33:35 PM,Gold Prices Are Torn Between the Bulls and the Bears,InvestorPlace,/news/stocks/gold-prices-are-torn-between-the-bulls-and-the-bears-1029863557,neutral,0.7629225850105286
2157,12/4/2020 11:01:00 AM,Hopefuls Back Sorrento Therapeutics But Time Is a Factor,InvestorPlace,/news/stocks/srne-stock-sorrento-coronavirus-time-a-factor-1029864707,positive,0.7771316170692444
2158,12/4/2020 12:05:14 PM,Wells Fargo Finally Sees Light At the End of the Tunnel,InvestorPlace,/news/stocks/wfc-stock-finally-sees-the-light-at-the-end-of-the-tunnel-1029865068,positive,0.727517306804657
2159,12/4/2020 12:31:28 PM,Wayfair Stock Is a Great Buy Amid Recent Covid-19 Vaccine Weakness,InvestorPlace,/news/stocks/wayfair-stock-is-a-great-buy-amid-recent-covid-19-vaccine-weakness-1029865065,negative,0.9023997783660889
2160,12/4/2020 12:55:11 PM,Sell-siders bullish on Moderna COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3641671-sell-siders-bullish-on-moderna-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4227292835712433
2161,12/4/2020 5:00:05 PM,Vaccines Won’t Stop Shopify’s Future Growth ,InvestorPlace,/news/stocks/vaccines-wont-stop-shop-stock-and-shopifys-future-growth-1029865895,positive,0.8725829720497131
2162,12/4/2020 5:19:51 PM,There is Light at the End of the Tunnel For Carnival Stock,InvestorPlace,/news/stocks/there-is-light-at-the-end-of-the-tunnel-for-carnival-ccl-stock-1029866167,positive,0.8995543718338013
2163,12/4/2020 5:43:51 PM,American Airlines Stock Is Soaring But Risky,InvestorPlace,/news/stocks/aal-stock-is-soaring-but-may-be-turbulence-ahead-1029866162,negative,0.9329173564910889
2164,12/4/2020 5:57:48 PM,Pfizer/BioNTech COVID-19 vaccine authorized for emergency use in Bahrain,Seeking Alpha,https://seekingalpha.com/news/3641788-pfizer-biontech-covidminus-19-vaccine-authorized-for-emergency-use-in-bahrain?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8336679935455322
2165,12/4/2020 7:57:48 PM,"Pfizer's scaled-down vaccine manufacturing plan old news, analyst says",Seeking Alpha,https://seekingalpha.com/news/3641818-pfizers-scaled-down-vaccine-manufacturing-plan-old-news-analyst-says?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5034464001655579
2166,12/4/2020 8:11:05 PM,"Overstock.com Is Ripe For A Bull Trade, Despite Slowing Tailwinds",InvestorPlace,/news/stocks/overstock-com-is-ripe-for-a-bull-trade-despite-slowing-tailwinds-1029866335,negative,0.9251807928085327
2167,12/4/2020 11:17:42 PM,Why You Shouldn’t Yet Bet on the “Value Rally”,InvestorPlace,/news/stocks/why-you-shouldnt-yet-bet-on-the-value-rally-1029866617,positive,0.8200154304504395
2168,12/6/2020 1:33:04 PM,'Operation Turtle Speed' - Why does the FDA need three weeks to approve Pfizer's vaccine?,Seeking Alpha,https://seekingalpha.com/news/3641957-operation-turtle-speed-why-fda-need-three-weeks-to-approve-pfizers-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9128807187080383
2169,12/7/2020 2:59:19 AM,"Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...) ",RTTNews,/news/stocks/week-ahead-in-pharma-fda-decisions-ash-data-readouts-lpcn-syrs-mbio-cyad-1029867643,positive,0.9426263570785522
2170,12/7/2020 12:23:41 PM,Why Delta Shares Are Poised to Take Off in 2021,InvestorPlace,/news/stocks/dal-stock-is-well-poised-to-take-off-in-2021-1029869088,positive,0.9136117696762085
2171,12/7/2020 12:31:34 PM,"Pfizer, Sangamo gene therapy for hemophilia shows sustained factor VII activity",Seeking Alpha,https://seekingalpha.com/news/3642015-pfizer-sangamo-gene-therapy-for-hemophilia-shows-sustained-factor-vii-activity?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9186291098594666
2172,12/7/2020 1:15:30 PM,"Pfizer, Sangamo Report Encouraging Findings From Phase 1/2 Study Of Giroctocogene Fitelparvovec ",RTTNews,/news/stocks/pfizer-sangamo-report-encouraging-findings-from-phase-1-2-study-of-giroctocogene-fitelparvovec-1029868896,negative,0.9452557563781738
2173,12/7/2020 1:34:55 PM,Pfizer Reports Positive Data From Ongoing Phase 1 Study For PF-06863135 In Multiple Myeloma ,RTTNews,/news/stocks/pfizer-reports-positive-data-from-ongoing-phase-1-study-for-pf-06863135-in-multiple-myeloma-1029868952,negative,0.9455582499504089
2174,12/7/2020 2:03:50 PM,9 Stocks to Buy Despite the Rocky Transition,InvestorPlace,/news/stocks/9-stocks-to-buy-during-rocky-transition-1029869814,positive,0.48994529247283936
2175,12/7/2020 3:40:06 PM,Sorrento Therapeutics Remains a Buy Between $6 and $6.50,InvestorPlace,/news/stocks/sorrento-therapeutics-srne-stock-remains-a-buy-between-6-and-6-50-1029870289,positive,0.8985124826431274
2176,12/7/2020 5:38:32 PM,7 Index Funds To Buy For Diversified Growth in 2021,InvestorPlace,/news/stocks/7-index-funds-to-buy-for-diversified-growth-in-2021-1029870671,positive,0.7144110798835754
2177,12/8/2020 8:41:39 AM,U.K. rolls out COVID-19 vaccine to public - report,Seeking Alpha,https://seekingalpha.com/news/3642355-u-k-rolls-out-covidminus-19-vaccine-to-public-report?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7050290107727051
2178,12/8/2020 9:12:10 AM,Canada In Deal With Pfizer For Covid-19 Vaccine As UK Begins Vaccination ,RTTNews,/news/stocks/canada-in-deal-with-pfizer-for-covid-19-vaccine-as-uk-begins-vaccination-1029871867,negative,0.781214714050293
2179,12/8/2020 10:11:08 AM,Stage set for 'Vaccine Summit' at the White House,Seeking Alpha,https://seekingalpha.com/news/3642363-stage-set-for-vaccine-summit-white-house?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8674226999282837
2180,12/8/2020 1:10:21 PM,Hold on to Your Novavax Stock and Don’t Fear the Competition,InvestorPlace,/news/stocks/hold-on-to-your-nvax-shares-and-dont-fear-the-competition-1029873864,positive,0.9213016629219055
2181,12/8/2020 1:12:48 PM,Why iBio Remains Worth a Look In a Post-Pandemic Landscape,InvestorPlace,/news/stocks/why-ibio-remains-worth-look-in-post-pandemic-landscape-1029873863,positive,0.909380316734314
2182,12/8/2020 3:33:46 PM,WSJ: FDA Says Pfizer/BioNTech COVID-19 Vaccine Met Prescribed Success Criteria ,RTTNews,/news/stocks/wsj-fda-says-pfizer-biontech-covid-19-vaccine-met-prescribed-success-criteria-1029873693,negative,0.9486795663833618
2183,12/8/2020 3:37:43 PM,United Airlines’ Shares Will Gain From Vaccine Distribution Efforts,InvestorPlace,/news/stocks/ual-stock-shares-will-gain-from-vaccine-distribution-plan-1029874451,negative,0.8680064678192139
2184,12/8/2020 5:39:34 PM,A Lack of Progress Keeps IBIO Shares As a Sell,InvestorPlace,/news/stocks/lack-progress-keeps-ibio-stock-sell-1029874786,neutral,0.9540040493011475
2185,12/8/2020 6:08:02 PM,"FDA Says Pfizer/BioNTech COVID-19 Vaccine Has ""Favorable Safety Profile"" ",RTTNews,/news/stocks/fda-says-pfizer-biontech-covid-19-vaccine-has-favorable-safety-profile-1029874429,negative,0.9478182792663574
2186,12/8/2020 6:30:29 PM,Carnival Looks Good as a Short-Term Cruise Stock Play,InvestorPlace,/news/stocks/carnival-looks-good-as-a-short-term-cruise-stock-play-1029874784,positive,0.7462576627731323
2187,12/8/2020 7:30:13 PM,"Draftkings is Growing — Buy it Under $45, Every Time",InvestorPlace,/news/stocks/draftkings-is-growing-buy-it-under-45-every-time-1029875028,positive,0.8922821879386902
2188,12/8/2020 7:55:26 PM,4 Undervalued Bargain Stocks to Buy Before They Bounce,InvestorPlace,/news/stocks/four-undervalued-bargain-stocks-to-buy-before-they-bounce-1029875022,positive,0.7584964632987976
2189,12/8/2020 8:49:28 PM,"Oxford-AstraZeneca COVID-19 vaccine 'safe and effective,' but questions remain for elderly - Lancet",Seeking Alpha,https://seekingalpha.com/news/3642640-oxford-astrazeneca-covidminus-19-vaccine-safe-and-effective-questions-remain-for-elderly?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5826758146286011
2190,12/8/2020 9:17:47 PM,Exxon Mobil Stock Is on Fire But Wait for a Better Entry Point,InvestorPlace,/news/stocks/exxon-mobil-stock-is-on-fire-but-wait-for-a-better-entry-point-1029875292,positive,0.8714097738265991
2191,12/8/2020 9:45:45 PM,FDA accepts Pfizer's application for pneumococcal conjugate vaccine,Seeking Alpha,https://seekingalpha.com/news/3642700-fda-accepts-pfizers-application-for-pneumococcal-conjugate-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6937079429626465
2192,12/8/2020 9:52:33 PM,The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure,InvestorPlace,/news/stocks/the-7-best-coronavirus-vaccine-stocks-still-in-the-race-for-a-cure-1029875288,negative,0.5180488228797913
2193,12/9/2020 8:36:50 AM,China's coronavirus vaccine has 86% efficacy in UAE trial,Seeking Alpha,https://seekingalpha.com/news/3642764-chinas-coronavirus-vaccine-86-efficacy-in-uae-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5860276818275452
2194,12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca shots to vaccinate Americans",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-shots-to-vaccinate-americans?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7954001426696777
2195,12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca for vaccine delivery, inoculation expected by mid 2021 - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-for-vaccine-delivery-inoculation-expected-mid-2021-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8593608736991882
2196,12/9/2020 11:15:14 AM,U.K. investigates possible allergic reactions to COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3642787-u-k-investigates-possible-allergic-reactions-to-covidminus-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6844857931137085
2197,12/9/2020 2:24:20 PM,7 Undervalued Stocks to Buy Now,InvestorPlace,/news/stocks/7-undervalued-stocks-to-buy-now-1029877954,negative,0.528389036655426
2198,12/9/2020 3:30:11 PM,Investment Breakdown: The Best Stock in Each Sector of the Market,InvestorPlace,/news/stocks/breakdown-the-best-stock-in-each-sector-of-the-market-1029878480,positive,0.8835943341255188
2199,12/9/2020 3:54:55 PM,Keep Your Long-Term Expectations Low With Boeing,InvestorPlace,/news/stocks/keep-your-long-term-expectations-low-with-boeing-stock-1029878476,positive,0.8056196570396423
2200,12/9/2020 5:38:48 PM,Marathon Oil:  Will The Stock Sprint Continue?,InvestorPlace,/news/stocks/marathon-oil-will-the-stock-sprint-continue-1029878802,positive,0.9112433195114136
2201,12/9/2020 5:49:16 PM,"Pfizer, BioNTech COVID vaccine snatches another win in Canada",Seeking Alpha,https://seekingalpha.com/news/3643002-pfizer-biontech-covid-vaccine-snatches-another-win-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8250739574432373
2202,12/9/2020 7:23:24 PM,Management Fixed the Problems and GE Stock Is Back on Track,InvestorPlace,/news/stocks/management-fixed-the-problems-and-ge-stock-is-back-on-track-1029879069,positive,0.6566163897514343
2203,12/9/2020 8:21:45 PM,"Pfizer/BioNTech COVID-19 vaccine docs hacked in Europe, companies say",Seeking Alpha,https://seekingalpha.com/news/3643052-pfizer-biontech-covidminus-19-vaccine-docs-hacked-in-europe-companies-say?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8055225014686584
2204,12/9/2020 8:32:21 PM,Vaccines Alone Aren’t Enough to Save Carnival,InvestorPlace,/news/stocks/vaccinations-alone-are-not-enough-for-ccl-stock-1029879061,positive,0.8390002250671387
2205,12/9/2020 9:13:06 PM,"Airline Stocks: As Americans Return to the Skies, Make This Trade",InvestorPlace,/news/stocks/airline-stocks-as-americans-return-to-the-skies-make-this-trade-1029879315,positive,0.9075813889503479
2206,12/10/2020 8:40:40 AM,U.K. allergic reactions shouldn't interfere with FDA vaccine approval,Seeking Alpha,https://seekingalpha.com/news/3643169-u-k-allergic-reactions-shouldnt-interfere-fda-vaccine-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9117977023124695
2207,12/10/2020 12:55:46 PM,Novavax Stock a Strong Bet to Ride the Vaccination Wave,InvestorPlace,/news/stocks/novavax-nvax-stock-strong-bet-to-ride-vaccination-wave-1029881218,negative,0.870851457118988
2208,12/10/2020 1:06:47 PM,Saudi Arabia approves registration of Pfizer-BioNTech COVID-19 vaccine - report,Seeking Alpha,https://seekingalpha.com/news/3643253-saudi-arabia-approves-registration-of-pfizer-biontech-covidminus-19-vaccine-report?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7126204967498779
2209,12/10/2020 2:36:13 PM,FDA Panel meeting gets underway to review Pfizer/ BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3643316-fda-panel-meeting-gets-underway-to-review-pfizer-biontech-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9013575911521912
2210,12/10/2020 3:57:31 PM,Pfizer/BioNTech COVID-19 vaccine trial data published in New England Journal of Medicine,Seeking Alpha,https://seekingalpha.com/news/3643350-pfizer-biontech-covidminus-19-vaccine-trial-data-published-in-new-england-journal-of-medicine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.924691379070282
2211,12/10/2020 4:38:20 PM,5 Telehealth Stocks That Will Keep Growing Post-Quarantine,InvestorPlace,/news/stocks/5-telehealth-stocks-that-will-keep-growing-post-quarantine-edoc-tdoc-amwl-cvs-phg-1029882617,negative,0.7877011299133301
2212,12/10/2020 7:51:10 PM,How Carnival Plans to Survive the Second Wave,InvestorPlace,/news/stocks/how-carnival-plans-to-survive-the-second-wave-1029883306,positive,0.9342831373214722
2213,12/10/2020 9:56:06 PM,The Question to Ask About COVID-19 Vaccine Stocks,InvestorPlace,/news/stocks/the-question-to-ask-about-covid-19-vaccine-stocks-1029883527,positive,0.939336895942688
2214,12/10/2020 10:53:39 PM,Pfizer/BioNTech COVID-19 vaccine is set for EUA after adcom vote,Seeking Alpha,https://seekingalpha.com/news/3643568-pfizer-biontech-covidminus-19-vaccine-is-set-for-eua-after-adcom-vote?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.932864248752594
2215,12/11/2020 4:20:59 AM,"FDA Panel Recommends Emergency Use Of Pfizer, BioNTech's COVID-19 Vaccine ",RTTNews,/news/stocks/fda-panel-recommends-emergency-use-of-pfizer-biontech-s-covid-19-vaccine-1029883747,positive,0.8835911750793457
2216,12/11/2020 9:22:55 AM,"Hong Kong secures deals for 15M COVID-19 shots, with first lot arriving in January",Seeking Alpha,https://seekingalpha.com/news/3643601-hong-kong-secures-deals-for-15m-covidminus-19-shots-first-lot-arriving-in-january?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8550276756286621
2217,12/11/2020 11:47:11 AM,Pfizer raises dividend by ~3%,Seeking Alpha,https://seekingalpha.com/news/3643627-pfizer-raises-dividend-3?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6575474143028259
2218,12/11/2020 12:28:33 PM,European advisory group backs ViiV's Rukobia in HIV-1 infection,Seeking Alpha,https://seekingalpha.com/news/3643646-european-advisory-group-backs-viivs-rukobia-in-hivminus-1-infection?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4510188698768616
2219,12/11/2020 12:33:43 PM,Americans could begin getting Pfizer vaccine on Monday - HHS's Alex Azar,Seeking Alpha,https://seekingalpha.com/news/3643649-americans-begin-getting-pfizer-vaccine-on-monday-hhss-alex-azar?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7669535279273987
2220,12/11/2020 2:13:35 PM,Merck-Pfizer win positive opinion from EU for cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3643704-merck-pfizer-win-positive-opinion-from-eu-for-cancer-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.946101725101471
2221,12/11/2020 2:18:08 PM,"Merck KGaA, Pfizer: CHMP Recommends Approval Of BAVENCIO - Quick Facts ",RTTNews,/news/stocks/merck-kgaa-pfizer-chmp-recommends-approval-of-bavencio-quick-facts-1029885347,positive,0.5624414086341858
2222,12/11/2020 2:29:04 PM,FDA Says 'to Rapidly Work Toward' Emergency Use Approval Of Pfizer Covid-19 Vaccine ,RTTNews,/news/stocks/fda-says-to-rapidly-work-toward-emergency-use-approval-of-pfizer-covid-19-vaccine-1029885373,negative,0.8269186019897461
2223,12/11/2020 2:33:11 PM,8 Next Energy Solutions as We Pass Peak Oil,InvestorPlace,/news/stocks/energy-stocks-post-peal-oil-the-next-energy-solutions-1029885734,positive,0.8794907927513123
2224,12/11/2020 2:54:02 PM,Pfizer falls 2% as FDA nears final authorization of its COVID-19 vaccine,Business Insider,https://www.businessinsider.com/pfizer-stock-price-fda-hahn-emergency-coronavirus-vaccine-authorization-pfe-2020-12,neutral,0.9542365074157715
2225,12/11/2020 4:09:36 PM,Get Ready for Ford Stock to Gun Its Engines,InvestorPlace,/news/stocks/get-ready-for-ford-stock-to-gun-its-engines-1029886088,positive,0.9198735952377319
2226,12/11/2020 4:30:17 PM,CVS to begin Covid-19 vaccinations on December 21,Seeking Alpha,https://seekingalpha.com/news/3643753-cvs-to-begin-covidminus-19-vaccinations-on-december-21?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8870038390159607
2227,12/11/2020 4:30:17 PM,CVS set December 21 to start COVID-19 vaccination,Seeking Alpha,https://seekingalpha.com/news/3643753-cvs-set-december-21-to-start-covidminus-19-vaccination?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9383187294006348
2228,12/11/2020 8:32:43 PM,Institutional Interest In Volatile Bitcoin Could Bring Record Highs In 2021,InvestorPlace,/news/stocks/institutional-interest-in-volatile-bitcoin-could-bring-record-highs-in-2021-1029886579,negative,0.6932063102722168
2229,12/11/2020 9:50:03 PM,AstraZeneca partners with Sputnik V to boost COVID-19 vaccine efficacy,Seeking Alpha,https://seekingalpha.com/news/3643859-astrazeneca-partners-sputnik-v-to-boost-covidminus-19-vaccine-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9427287578582764
2230,12/12/2020 2:59:53 AM,Pfizer/BioNTech vaccine gets FDA clearance for use,Seeking Alpha,https://seekingalpha.com/news/3643884-pfizer-biontech-vaccine-gets-fda-clearance-for-use?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.876704752445221
2231,12/12/2020 4:02:20 AM,Walgreens Says Preparing To Immediately Bring Pfizer COVID-19 Vaccine To High-priority Populations ,RTTNews,/news/stocks/walgreens-says-preparing-to-immediately-bring-pfizer-covid-19-vaccine-to-high-priority-populations-1029886892,negative,0.78935706615448
2232,12/12/2020 4:12:16 AM,"FDA Issues Emergency Use Authorization For Pfizer, BioNTech's COVID-19 Vaccine ",RTTNews,/news/stocks/fda-issues-emergency-use-authorization-for-pfizer-biontech-s-covid-19-vaccine-1029886899,positive,0.8401767015457153
2233,12/12/2020 5:05:03 AM,"FDA Authorizes Emergency Use Of Pfizer, BioNTech's COVID-19 Vaccine ",RTTNews,/news/stocks/fda-authorizes-emergency-use-of-pfizer-biontech-s-covid-19-vaccine-1029886904,positive,0.9230569005012512
2234,12/12/2020 5:59:25 AM,Pfizer Says Prepared To Deliver First Doses Of COVID-19 Vaccine In U.S. Immediately ,RTTNews,/news/stocks/pfizer-says-prepared-to-deliver-first-doses-of-covid-19-vaccine-in-u-s-immediately-1029886914,negative,0.7551626563072205
2235,12/12/2020 6:03:14 PM,US to deliver Pfizer/BioNTech COVID-19 vaccine shipments on Monday,Seeking Alpha,https://seekingalpha.com/news/3643894-us-to-deliver-pfizer-biontech-covidminus-19-vaccine-shipments-on-monday?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5430367588996887
2236,12/12/2020 11:05:53 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643900-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9489516019821167
2237,12/12/2020 11:06:41 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643901-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9489516019821167
2238,12/13/2020 6:07:00 PM,Pfizer Inc. -- Moody's: Pfizer's US vaccine authorization is credit positive,Moodys,/news/bonds/pfizer-inc-moody-s-pfizer-s-us-vaccine-authorization-is-credit-positive-1029887900,positive,0.7879249453544617
2239,12/14/2020 6:39:47 AM,U.S. prepares for mass inoculations as COVID-19 vaccine rolls out,Seeking Alpha,https://seekingalpha.com/news/3643918-u-s-prepares-for-mass-inoculations-covidminus-19-vaccine-rolls-out?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.727246105670929
2240,12/14/2020 8:28:40 AM,Bahrain OK's Chinese COVID-19 vaccine for use,Seeking Alpha,https://seekingalpha.com/news/3643921-bahrain-oks-chinese-covidminus-19-vaccine-for-use?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.875629723072052
2241,12/14/2020 9:23:19 AM,US Covid-19 Vaccinations To Begin Monday As CDC Recommends Pfizer Vaccine ,RTTNews,/news/stocks/us-covid-19-vaccinations-to-begin-monday-as-cdc-recommends-pfizer-vaccine-1029888670,positive,0.8301383852958679
2242,12/14/2020 10:31:06 AM,The 7 Best Dow Jones Stocks to Buy Now As You Ready for the Coming Year,InvestorPlace,/news/stocks/7-best-dow-jones-stocks-to-buy-now-ibm-hd-mmm-aapl-msft-wmt-amgn-1029889146,positive,0.8910359740257263
2243,12/14/2020 11:35:25 AM,Singapore approves Pfizer-BioNTech's COVID-19 jab,Seeking Alpha,https://seekingalpha.com/news/3643946-singapore-approves-pfizer-biontechs-covidminus-19-jab?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7488332390785217
2244,12/14/2020 11:55:50 AM,Novavax Far From Finished In the Race for a Vaccine,InvestorPlace,/news/stocks/novavax-far-from-finished-in-the-race-for-a-vaccine-nvax-stock-1029889699,negative,0.704472541809082
2245,12/14/2020 12:01:53 PM,Airbnb’s IPO Goes Into Orbit,InvestorPlace,/news/stocks/airbnbs-ipo-goes-into-orbit-1029889698,positive,0.9044165015220642
2246,12/14/2020 12:20:16 PM,"Pfizer, BioNTech Report Data From German Phase 1/2 Trial With COVID-19 Vaccine Candidate ",RTTNews,/news/stocks/pfizer-biontech-report-data-from-german-phase-1-2-trial-with-covid-19-vaccine-candidate-1029889176,positive,0.8456559181213379
2247,12/14/2020 12:45:11 PM,"Pfizer, BioNTech report additional data from German COVID-19 vaccine study",Seeking Alpha,https://seekingalpha.com/news/3643978-pfizer-biontech-report-additional-data-from-german-covidminus-19-vaccine-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9273909330368042
2248,12/14/2020 1:51:48 PM,7 Stocks to Sell By December 31,InvestorPlace,/news/stocks/stocks-to-sell-by-december-31-1029890361,positive,0.9320582151412964
2249,12/14/2020 1:53:10 PM,"UPS, FedEx To Transport Initial Pfizer-BioNTech COVID-19 Vaccine Doses ",RTTNews,/news/stocks/ups-fedex-to-transport-initial-pfizer-biontech-covid-19-vaccine-doses-1029889540,positive,0.798514187335968
2250,12/14/2020 3:28:37 PM,Moderna confirms deal to supply Singapore with coronavirus vaccine,Seeking Alpha,https://seekingalpha.com/news/3644080-moderna-confirms-deal-to-supply-singapore-coronavirus-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7381573915481567
2251,12/14/2020 5:48:04 PM,8 Retirement Stocks You Can Rely On,InvestorPlace,/news/stocks/8-retirement-investments-you-can-rely-on-1029891268,positive,0.9319970607757568
2252,12/14/2020 6:37:56 PM,7 Biotech Stocks To Buy Beyond Covid Vaccine Plays,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-beyond-covid-vaccine-plays-1029891263,negative,0.5038461089134216
2253,12/14/2020 7:28:35 PM,Coronavirus Vaccine Rollout In U.S. Has Begun ,RTTNews,/news/stocks/coronavirus-vaccine-rollout-in-u-s-has-begun-1029891180,positive,0.5164073705673218
2254,12/14/2020 9:49:38 PM,Will the Momentum Behind Lyft Stock Be Enough for Lift Off?,InvestorPlace,/news/stocks/will-the-momentum-behind-lyft-stock-be-enough-for-lift-off-1029891843,positive,0.779824435710907
2255,12/15/2020 6:35:20 AM,First COVID-19 shot given in U.S. as roll-out begins - WSJ,Seeking Alpha,https://seekingalpha.com/news/3644277-first-covidminus-19-shot-given-in-u-s-roll-out-begins-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7453948259353638
2256,12/15/2020 8:28:44 AM,"COVID-19 vaccines expected in drugstores like CVS, Walgreens, and Costco by early spring",Seeking Alpha,https://seekingalpha.com/news/3644281-covidminus-19-vaccines-expected-in-drugstores-like-cvs-walgreens-and-costco-early-spring?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7905791997909546
2257,12/15/2020 8:28:44 AM,COVID-19 vaccines expected by spring 2021 at drugstore/grocery store,Seeking Alpha,https://seekingalpha.com/news/3644281-covidminus-19-vaccines-expected-spring-2021-drugstore-grocery-store?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9437721967697144
2258,12/15/2020 10:16:46 AM,7 Christmas Stocks to Buy for 2020’s Atypical Holidays,InvestorPlace,/news/stocks/7-christmas-stocks-to-buy-for-2020s-atypical-holidays-1029893077,positive,0.8443637490272522
2259,12/15/2020 12:20:28 PM,Nasdaq Lifeline Is No Reason to Invest in Naked Brand Group,InvestorPlace,/news/stocks/nasdaq-lifeline-is-no-reason-to-invest-in-nakd-stock-1029893511,positive,0.9312711358070374
2260,12/15/2020 1:51:23 PM,Moderna COVID-19 vaccine likely to get EUA from FDA on Friday - NYT,Seeking Alpha,https://seekingalpha.com/news/3644417-moderna-covidminus-19-vaccine-likely-to-get-eua-from-fda-on-friday-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7768198251724243
2261,12/15/2020 2:28:50 PM,DoorDash Stock Is Fine for a Small Allocation but Nothing More,InvestorPlace,/news/stocks/dash-stock-is-fine-for-a-small-allocation-but-nothing-more-1029894554,positive,0.7456939220428467
2262,12/15/2020 3:58:50 PM,Here’s How To Bull Trade The Dip In Pfizer Stock With Finesse,InvestorPlace,/news/stocks/heres-how-to-bull-trade-the-dip-in-pfizer-stock-with-finesse-1029895191,positive,0.9060755968093872
2263,12/15/2020 4:01:00 PM,Pharmacia Corporation (Old Monsanto) -- Moody's announces completion of a periodic review of ratings of Pfizer Inc.,Moodys,/news/bonds/pharmacia-corporation-old-monsanto-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-pfizer-inc-1029894519,positive,0.6374494433403015
2264,12/15/2020 8:40:04 PM,AMWL Stock: Why Telemedicine Play Amwell Is Plunging Today,InvestorPlace,/news/stocks/amwl-stock-why-telemedicine-play-amwell-is-plunging-today-1029895828,positive,0.7203216552734375
2265,12/15/2020 8:43:23 PM,Novavax Stock Leads the Board on Wall Street but Lags on Main Street,InvestorPlace,/news/stocks/novavax-stock-leads-the-board-on-wall-street-but-lags-on-main-street-1029895826,neutral,0.9456034302711487
2266,12/15/2020 9:27:48 PM,The 8 Best Long-Term Stocks with Plenty of Potential,InvestorPlace,/news/stocks/the-8-best-long-term-stocks-with-plenty-of-potential-1029896098,negative,0.5733261704444885
2267,12/15/2020 10:27:00 PM,Zeneca Wilmington Inc. -- Moody's affirms AstraZeneca's A3 ratings; changes outlook to negative from stable,Moodys,/news/bonds/zeneca-wilmington-inc-moody-s-affirms-astrazeneca-s-a3-ratings-changes-outlook-to-negative-from-stable-1029895923,negative,0.8665301203727722
2268,12/16/2020 8:59:10 AM,Most of American public may get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-of-american-public-may-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8804348707199097
2269,12/16/2020 8:59:10 AM,American public to get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-american-public-to-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.803569495677948
2270,12/16/2020 11:40:29 AM,XpresSpa Bears Might Need Their Own Immunization,InvestorPlace,/news/stocks/xspa-stock-bears-might-need-their-own-immunization-1029898041,positive,0.8970702290534973
2271,12/16/2020 3:11:45 PM,Pfizer downgraded on competitive headwinds by RBC Capital Markets,Seeking Alpha,https://seekingalpha.com/news/3644919-pfizer-downgraded-on-competitive-headwinds-rbc-capital-markets?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9548817873001099
2272,12/16/2020 7:22:16 PM,AMWL Stock: Why Amwell Shares Are Down 8% Today,InvestorPlace,/news/stocks/amwl-stock-why-amwell-shares-are-nearly-8-today-1029900160,neutral,0.9692561030387878
2273,12/17/2020 7:21:35 AM,U.S. healthcare workers suffer allergic reactions to Pfizer/BioNTech COVID-19 shot - NYT,Seeking Alpha,https://seekingalpha.com/news/3645180-u-s-healthcare-workers-suffer-allergic-reactions-to-pfizer-biontech-covidminus-19-shot-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8869634866714478
2274,12/17/2020 7:21:35 AM,Two healthcare workers suffer allergic reactions to Pfizer/BioNTech COVID-19 shot - NYT,Seeking Alpha,https://seekingalpha.com/news/3645180-two-healthcare-workers-suffer-allergic-reactions-to-pfizer-biontech-covidminus-19-shot-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9212961792945862
2275,12/17/2020 9:50:10 AM,U.K. expects AstraZeneca-Oxford jab by early January - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3645189-u-k-expects-astrazeneca-oxford-jab-early-january-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9011738896369934
2276,12/17/2020 10:01:35 AM,How to Prepare and Profit from Boeing Stock’s Next Rally,InvestorPlace,/news/stocks/how-to-prepare-and-profit-from-boeing-stock-next-rally-1029901635,positive,0.8871745467185974
2277,12/17/2020 12:49:50 PM,"The Vaccine Race Is Far From Over, And That’s Good News for Novavax",InvestorPlace,/news/stocks/vaccine-race-far-from-over-good-news-for-nvax-stock-1029902118,negative,0.9128111004829407
2278,12/17/2020 2:07:18 PM,FDA Says Extra Doses In Pfizer COVID-19 Vaccine Vials Can Be Used ,RTTNews,/news/stocks/fda-says-extra-doses-in-pfizer-covid-19-vaccine-vials-can-be-used-1029902117,positive,0.8862069249153137
2279,12/17/2020 2:36:53 PM,Moderna’s COVID-19 vaccine goes under review,Seeking Alpha,https://seekingalpha.com/news/3645334-moderna-s-covidminus-19-vaccine-goes-under-review?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6311748623847961
2280,12/17/2020 4:56:02 PM,Novavax Can Still Make Coronavirus Vaccines Great Again,InvestorPlace,/news/stocks/nvax-stock-still-make-vaccines-great-again-1029903618,negative,0.7438126802444458
2281,12/17/2020 7:43:14 PM,"9 Stocks to Buy With $5,000 in Starter Money",InvestorPlace,/news/stocks/9-stocks-to-buy-with-5000-in-starter-money-1029904303,positive,0.9186460375785828
2282,12/17/2020 8:08:30 PM,7 Best Stocks To Buy Now,InvestorPlace,/news/stocks/7-best-stocks-to-buy-now-1029913681,positive,0.9084606766700745
2283,12/17/2020 10:19:22 PM,Moderna wins Adcom backing for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3645557-moderna-wins-adcom-backing-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7224262952804565
2284,12/18/2020 3:20:52 AM,FDA Panel Recommends Emergency Use Of Moderna's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-panel-recommends-emergency-use-of-moderna-s-covid-19-vaccine-1029904769,positive,0.8481281995773315
2285,12/18/2020 4:54:31 AM,Pfizer applies for COVID-19 vaccine approval in Japan,Seeking Alpha,https://seekingalpha.com/news/3645595-pfizer-applies-for-covidminus-19-vaccine-approval-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8347358703613281
2286,12/18/2020 11:33:08 AM,EU set to rollout COVID-19 vaccine from December 27 - NYT,Seeking Alpha,https://seekingalpha.com/news/3645629-eu-set-to-rollout-covidminus-19-vaccine-from-december-27-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5515856146812439
2287,12/18/2020 1:01:20 PM,Pfizer/ BioNTech COVID-19 vaccine rollout reaches long-term care facilities,Seeking Alpha,https://seekingalpha.com/news/3645685-pfizer-biontech-covidminus-19-vaccine-rollout-reaches-long-term-care-facilities?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8319379091262817
2288,12/18/2020 1:38:13 PM,Moderna’s COVID-19 vaccine gets more orders from Europe,Seeking Alpha,https://seekingalpha.com/news/3645702-moderna-s-covidminus-19-vaccine-gets-orders-from-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.913977324962616
2289,12/18/2020 1:54:55 PM,Walgreens Starts Administering Pfizer's COVID-19 Vaccine In Long-term Care Facilities ,RTTNews,/news/stocks/walgreens-starts-administering-pfizer-s-covid-19-vaccine-in-long-term-care-facilities-1029906059,positive,0.7943904399871826
2290,12/18/2020 2:42:55 PM,The 10 Best-Performing Stocks of 2020,InvestorPlace,/news/stocks/the-10-best-performing-stocks-of-2020-1029906707,negative,0.5865428447723389
2291,12/18/2020 3:30:08 PM,"Moderna Analysts Discuss Adcom Verdict, Distribution And Commercialization Of Coronavirus Vaccine",Benzinga,/news/stocks/moderna-analysts-discuss-adcom-verdict-distribution-and-commercialization-of-coronavirus-vaccine-1029909507,positive,0.9317728877067566
2292,12/18/2020 4:24:25 PM,8 Game-Changing Stocks to Buy for Upside and Innovation,InvestorPlace,/news/stocks/8-game-changing-stocks-to-buy-for-upside-and-innovation-1029907360,positive,0.8141558766365051
2293,12/18/2020 7:42:15 PM,"Boeing Stock Is Recovering, But It’s Not a Buy Yet",InvestorPlace,/news/stocks/boeing-stock-is-recovering-but-its-not-a-buy-yet-1029907595,negative,0.5318042039871216
2294,12/18/2020 8:28:28 PM,3 Gig Stocks to Buy to Make Money on the Side Hustle,InvestorPlace,/news/stocks/3-gig-stocks-to-buy-to-make-money-on-the-side-hustle-1029907588,positive,0.9014208316802979
2295,12/18/2020 9:47:34 PM,Is This the Sell the News Moment for Moderna Stock?,InvestorPlace,/news/stocks/is-this-the-sell-the-news-moment-for-moderna-stock-1029907862,positive,0.9161401391029358
2296,12/19/2020 3:52:41 AM,FDA Authorizes Moderna's COVID-19 Vaccine For Emergency Use In U.S. ,RTTNews,/news/stocks/fda-authorizes-moderna-s-covid-19-vaccine-for-emergency-use-in-u-s-1029907994,positive,0.824783980846405
2297,12/19/2020 5:45:31 PM,England confirms 'new variant' of COVID-19 with faster transmission and alerts the WHO as lockdowns intensify,Seeking Alpha,https://seekingalpha.com/news/3646023-england-confirms-new-variant-of-covidminus-19-faster-transmission-and-alerts-who-lockdowns?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8938029408454895
2298,12/20/2020 3:44:51 AM,Pfizer/BioNTech COVID-19 vaccine gets Swiss approval,Seeking Alpha,https://seekingalpha.com/news/3646025-pfizer-biontech-covidminus-19-vaccine-gets-swiss-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9173899292945862
2299,12/20/2020 9:18:30 AM,GSK is closing in on two major drug deals: Report,Seeking Alpha,https://seekingalpha.com/news/3646028-gsk-is-closing-in-on-two-major-drug-deals-report?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6129109859466553
2300,12/21/2020 4:08:31 AM,U.K. travel ban imposed by some countries to bar new COVID-19 strain,Seeking Alpha,https://seekingalpha.com/news/3646043-u-k-travel-ban-imposed-countries-to-bar-new-covidminus-19-strain?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8914539217948914
2301,12/21/2020 6:29:02 AM,Vaccine cuts for several U.S. states due to FDA confusion,Seeking Alpha,https://seekingalpha.com/news/3646046-vaccine-cuts-for-several-u-s-states-due-to-fda-confusion?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9485823512077332
2302,12/21/2020 8:56:51 AM,Who next in line to receive a coronavirus vaccine?,Seeking Alpha,https://seekingalpha.com/news/3646051-who-next-in-line-to-receive-coronavirus-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9159696102142334
2303,12/21/2020 8:56:51 AM,Who's next in line to receive a coronavirus vaccine?,Seeking Alpha,https://seekingalpha.com/news/3646051-next-in-line-to-receive-coronavirus-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9045735597610474
2304,12/21/2020 9:13:37 AM,GSK: ViiV Healthcare's Vocabria Gets EU Approval To Be Used With Janssen's Rekambys And Edurant ,RTTNews,/news/stocks/gsk-viiv-healthcare-s-vocabria-gets-eu-approval-to-be-used-with-janssen-s-rekambys-and-edurant-1029909538,negative,0.8931984305381775
2305,12/21/2020 10:07:08 AM,"ViiV, Janssen's cabotegravir + rilpivirine wins marketing approval in Europe for HIV treatment",Seeking Alpha,https://seekingalpha.com/news/3646055-viiv-janssens-cabotegravir-rilpivirine-wins-marketing-approval-in-europe-for-hiv-treatment?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9421626329421997
2306,12/21/2020 10:48:33 AM,EU regulator meets today to discuss Pfizer/BioNTech's COVID-19 vaccine approval,Seeking Alpha,https://seekingalpha.com/news/3646062-eu-regulator-meets-today-to-discuss-pfizer-biontechs-covidminus-19-vaccine-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8831729292869568
2307,12/21/2020 1:12:53 PM,'Making Progress': Stock Market Update For The Week Ahead,Benzinga,/news/etf/making-progress-stock-market-update-for-the-week-ahead-1029910134,positive,0.8695534467697144
2308,12/21/2020 1:58:30 PM,3 Mega-Cap Stocks for Safe Dividends,InvestorPlace,/news/stocks/3-mega-cap-stocks-for-safe-dividends-1029910979,positive,0.8811919093132019
2309,12/21/2020 3:53:01 PM,7 Healthcare Stocks to Buy With the Sector Under Scrutiny,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-with-the-sector-under-scrutiny-1029911430,positive,0.7012474536895752
2310,12/21/2020 4:02:50 PM,"Pfizer, BioNTech Receive CHMP Positive Opinion For Their COVID-19 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-receive-chmp-positive-opinion-for-their-covid-19-vaccine-1029910951,negative,0.9378785490989685
2311,12/21/2020 5:54:37 PM,Why Airbnb Stock Should Maintain Its Strength in 2021 and Beyond,InvestorPlace,/news/stocks/airbnb-stock-should-maintain-its-strength-in-2021-and-beyond-1029911784,positive,0.772166907787323
2312,12/21/2020 6:01:11 PM,Pfizer/BioNTech COVID-19 vaccine cleared by EU,Seeking Alpha,https://seekingalpha.com/news/3646264-pfizer-biontech-covidminus-19-vaccine-cleared-eu?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7223617434501648
2313,12/21/2020 6:13:59 PM,EMA Recommends Use Of Pfizer-BioNTech's COVID-19 Vaccine In EU ,RTTNews,/news/stocks/ema-recommends-use-of-pfizer-biontech-s-covid-19-vaccine-in-eu-1029911487,positive,0.8754987716674805
2314,12/21/2020 8:22:07 PM,How to Trade Alibaba’s Persistent Weakness Into Christmas,InvestorPlace,/news/stocks/how-to-trade-alibaba-baba-stock-persistent-weakness-into-christmas-1029912002,positive,0.8733919858932495
2315,12/21/2020 11:07:08 PM,European Commission Approves Use Of Pfizer/BioNTech COVID-19 Vaccine In EU ,RTTNews,/news/stocks/european-commission-approves-use-of-pfizer-biontech-covid-19-vaccine-in-eu-1029912219,positive,0.7489732503890991
2316,12/22/2020 7:38:55 AM,More nations restrict U.K. travellers as concerns over new COVID-19 variant mount,Seeking Alpha,https://seekingalpha.com/news/3646484-nations-restrict-u-k-travellers-concerns-over-new-covidminus-19-variant-mount?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8980482816696167
2317,12/22/2020 8:49:15 AM,"NantKwest Stock Goes North, QURE's HOPE-B Trial On Hold, EU Greenlights First COVID-19 Vaccine ",RTTNews,/news/stocks/nantkwest-stock-goes-north-qure-s-hope-b-trial-on-hold-eu-greenlights-first-covid-19-vaccine-1029912823,positive,0.7485668063163757
2318,12/22/2020 10:00:56 AM,Will vaccines work against the U.K. coronavirus variant?,Seeking Alpha,https://seekingalpha.com/news/3646502-will-vaccines-work-against-u-k-coronavirus-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.85740727186203
2319,12/22/2020 3:29:23 PM,Don’t Let the Vaccine Trial Delay Stop You from Believing in Novavax,InvestorPlace,/news/stocks/dont-let-the-vaccine-trial-delay-stop-you-from-believing-in-novavax-stock-1029914800,positive,0.89439857006073
2320,12/22/2020 6:34:05 PM,Disney May Have Lucked Its Way Out of Covid,InvestorPlace,/news/stocks/disney-stock-lucked-its-way-out-of-covid-impact-1029915119,negative,0.5835252404212952
2321,12/22/2020 7:26:05 PM,OCGN Stock: Why Ocugen Shares Are Soaring 130% Today,InvestorPlace,/news/stocks/ocgn-stock-why-ocugen-shares-are-soaring-130-today-1029915380,negative,0.7886629104614258
2322,12/22/2020 7:45:39 PM,7 Growth Stocks to Buy as We Head Into 2021,InvestorPlace,/news/stocks/7-growth-stocks-to-buy-as-we-head-into-2021-1029822924,positive,0.8958486914634705
2323,12/22/2020 8:14:18 PM,American Airlines Remains Risky Despite Returning 30% in 1 Month,InvestorPlace,/news/stocks/aal-stock-remains-risky-1029915371,negative,0.5356853008270264
2324,12/22/2020 8:51:10 PM,Vaccines makers are under pressure amid concerns over new coronavirus strain,Seeking Alpha,https://seekingalpha.com/news/3646806-vaccines-makers-are-under-pressure-amid-concerns-over-new-coronavirus-strain?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9615911841392517
2325,12/22/2020 11:57:04 PM,Pfizer nears deal to provide U.S. with more vaccine doses - NYT,Seeking Alpha,https://seekingalpha.com/news/3646861-pfizer-nears-deal-to-provide-u-s-vaccine-doses-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8529362678527832
2326,12/23/2020 9:57:36 AM,Dubai to begin vaccinations with Pfizer-BioNTech jab from Wednesday,Seeking Alpha,https://seekingalpha.com/news/3646881-dubai-to-begin-vaccinations-pfizer-biontech-jab-from-wednesday?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8503447771072388
2327,12/23/2020 10:11:08 AM,Throw Growth Aside and See Pfizer Stock as Top Dividend and Cash Flow Play,InvestorPlace,/news/stocks/pfe-stock-is-a-top-dividend-and-cash-flow-play-1029916536,positive,0.9236458539962769
2328,12/23/2020 10:45:11 AM,"5 Stocks To Watch For December 23, 2020",Benzinga,/news/stocks/5-stocks-to-watch-for-december-23-2020-1029916363,positive,0.9172869920730591
2329,12/23/2020 12:09:01 PM,A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Reports,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-up-ahead-of-economic-reports-1029916538,positive,0.536119818687439
2330,12/23/2020 12:43:36 PM,Pfizer/BioNTech secure another 100M Covid-19 vaccine orders from U.S.,Seeking Alpha,https://seekingalpha.com/news/3646917-pfizer-biontech-secure-another-100m-covidminus-19-vaccine-orders-from-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9441158175468445
2331,12/23/2020 12:58:53 PM,Pfizer Stock Was a Long-Term Play Before Covid and Will Stay One After,InvestorPlace,/news/stocks/pfizer-stock-long-term-before-covid-stay-one-1029916862,positive,0.9340514540672302
2332,12/23/2020 1:12:34 PM,Pfizer & BioNTech Agree With U.S. Government To Supply 100 Mln Additional Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/pfizer-biontech-agree-with-u-s-government-to-supply-100-mln-additional-doses-of-covid-19-vaccine-1029916728,negative,0.9214037656784058
2333,12/23/2020 2:30:53 PM,"The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut",Benzinga,/news/stocks/the-daily-biotech-pulse-supernus-issues-positive-adhd-readout-sorrento-files-for-emergency-use-authorization-for-rapid-covid-19-test-inhibikase-to-make-wall-street-debut-1029916943,negative,0.7712023258209229
2334,12/23/2020 3:15:02 PM,BioInvent secures $3M on selection of antibodies under collaboration pact with Pfizer,Seeking Alpha,https://seekingalpha.com/news/3647005-bioinvent-secures-3m-on-selection-of-antibodies-under-collaboration-pact-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8509950637817383
2335,12/23/2020 3:20:54 PM,Pfizer Stock Just Can’t Seem to Find a Cure for Investor Apathy,InvestorPlace,/news/stocks/pfizer-stock-just-cant-seem-to-find-a-cure-for-investor-apathy-1029917889,neutral,0.6648609638214111
2336,12/23/2020 3:59:06 PM,8 Pet Stocks That Will Make You Purr,InvestorPlace,/news/stocks/8-pet-stocks-that-will-make-you-purr-1029917884,positive,0.9027003049850464
2337,12/23/2020 5:09:13 PM,Moderna Stock Looks Too Cheap After This Recent Dip,InvestorPlace,/news/stocks/moderna-stock-looks-too-cheap-after-this-recent-dip-1029917874,positive,0.5377233028411865
2338,12/23/2020 7:03:57 PM,Why Pfizer Stock Deserves a Spot In Your Portfolio,InvestorPlace,/news/stocks/why-pfizer-stock-deserves-a-spot-in-your-portfolio-1029917859,positive,0.830133855342865
2339,12/24/2020 2:44:34 PM,"Cannabis Brands Brace For Post-Pandemic World, COVID-Induced Challenges Ahead",Benzinga,/news/stocks/cannabis-brands-brace-for-post-pandemic-world-covid-induced-challenges-ahead-1029918868,positive,0.7829605340957642
2340,12/24/2020 5:04:50 PM,Inovio Shares Rise On Positive Data For Coronavirus Vaccine Candidate That's Stable At Room Temps,Benzinga,/news/stocks/inovio-shares-rise-on-positive-data-for-coronavirus-vaccine-candidate-that-s-stable-at-room-temps-1029919064,negative,0.9464519619941711
2341,12/25/2020 2:11:35 AM,1 Mln People In US Receive First Dose Of COVID-19 Vaccine ,RTTNews,/news/stocks/1-mln-people-in-us-receive-first-dose-of-covid-19-vaccine-1029919305,positive,0.753761351108551
2342,12/26/2020 3:15:52 PM,"The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks",Benzinga,/news/stocks/the-week-ahead-in-biotech-dec-27-jan-2-data-releases-regulatory-filings-to-move-stocks-1029919761,positive,0.6830364465713501
2343,12/28/2020 7:37:15 AM,COVID-19 vaccinations underway in Europe as new variant spreads,Seeking Alpha,https://seekingalpha.com/news/3647444-covidminus-19-vaccinations-underway-in-europe-new-variant-spreads?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7568058371543884
2344,12/28/2020 11:35:55 AM,"As Vaccine Excitement Fades, Buy the Pullback in Pfizer",InvestorPlace,/news/stocks/vaccine-excitement-fades-buy-pullback-pfizer-pfe-stock-1029921274,positive,0.8600408434867859
2345,12/28/2020 11:40:43 AM,"With This Resilient Business Model, Airbnb Stock Can Keep Climbing",InvestorPlace,/news/stocks/resilient-business-model-means-airbnb-stock-can-keep-climbing-1029921273,negative,0.8942760229110718
2346,12/28/2020 12:44:49 PM,Myovant & Pfizer To Jointly Develop And Commercialize ORGOVYX - Quick Facts ,RTTNews,/news/stocks/myovant-pfizer-to-jointly-develop-and-commercialize-orgovyx-quick-facts-1029921110,positive,0.7748664617538452
2347,12/28/2020 1:25:14 PM,Myovant Sciences gains 22% on relugolix deal with Pfizer,Seeking Alpha,https://seekingalpha.com/news/3647490-myovant-sciences-gains-22-on-relugolix-deal-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9449979662895203
2348,12/28/2020 1:35:38 PM,Dividend Bumps and Buybacks Give Pfizer Stock 20% Upside,InvestorPlace,/news/stocks/dividend-bumps-and-buybacks-give-pfizer-stock-20-upside-1029921511,negative,0.9098982810974121
2349,12/28/2020 2:04:14 PM,"Myovant Sciences, Pfizer To Jointly Develop Relugolix In Deal Worth Up To $4.2 Bln ",RTTNews,/news/stocks/myovant-sciences-pfizer-to-jointly-develop-relugolix-in-deal-worth-up-to-4-2-bln-1029921233,negative,0.6675642132759094
2350,12/28/2020 5:59:20 PM,AstraZeneca’s COVID-19 jab expected to receive emergency nod within days,Seeking Alpha,https://seekingalpha.com/news/3647559-astrazeneca-s-covidminus-19-jab-expected-to-receive-emergency-nod-within-days?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49785006046295166
2351,12/28/2020 7:06:36 PM,7 Hot Stocks That Are Cheering on Vaccine Approvals,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-now-that-are-cheering-vaccine-approvals-1029921856,positive,0.7687147855758667
2352,12/29/2020 7:53:14 AM,Biotech Stocks Facing FDA Decision In January 2021 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-january-2021-1029922365,positive,0.6815580725669861
2353,12/29/2020 8:30:08 AM,"FDA accepts Pfizer's Lorbrena application, action date in April 2021",Seeking Alpha,https://seekingalpha.com/news/3647628-fda-accepts-pfizers-lorbrena-application-action-date-in-april-2021?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9275851845741272
2354,12/29/2020 10:11:06 AM,Pfizer’s All-in Costs Show Vaccine Probably Won’t Move the Needle Much,InvestorPlace,/news/stocks/vaccine-probably-wont-move-the-pfe-stock-needle-much-1029922802,positive,0.6117871999740601
2355,12/29/2020 10:39:01 AM,"5 Stocks To Watch For December 29, 2020",Benzinga,/news/stocks/5-stocks-to-watch-for-december-29-2020-1029922666,positive,0.9181180596351624
2356,12/29/2020 12:11:45 PM,A Peek Into The Markets: US Stock Futures Rise After Hitting Record Highs In Previous Session,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-rise-after-hitting-record-highs-in-previous-session-1029922805,negative,0.9061300158500671
2357,12/29/2020 12:53:33 PM,EMA says AstraZeneca/Oxford COVID-19 jab unfit for January approval,Seeking Alpha,https://seekingalpha.com/news/3647663-ema-says-astrazeneca-oxford-covidminus-19-jab-unfit-for-january-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.787582278251648
2358,12/29/2020 1:10:33 PM,Valuation Problems Are Just One of the Reasons DoorDash Won’t Deliver,InvestorPlace,/news/stocks/valuation-problems-are-just-one-of-the-reasons-dash-stock-wont-deliver-1029923367,positive,0.7747224569320679
2359,12/29/2020 1:55:47 PM,3 Stocks Set for Huge Returns In 2021,InvestorPlace,/news/stocks/3-stocks-set-for-huge-returns-in-2021-1029923365,negative,0.8443138599395752
2360,12/29/2020 2:09:37 PM,"The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-nod-for-amphastar-s-generic-glucagon-arcturus-sinks-on-vaccine-data-decision-day-for-osmotica-1029923067,positive,0.8028446435928345
2361,12/29/2020 4:03:14 PM,Pfizer Stock Is Too Hot but It’s Definitely Safe to Handle Here,InvestorPlace,/news/stocks/pfe-stock-is-too-hot-but-its-definitely-safe-to-handle-here-1029923789,positive,0.8052978515625
2362,12/29/2020 4:07:41 PM,Why Betting Against the S&P 500 Makes Little Sense in 2021,InvestorPlace,/news/stocks/why-betting-against-the-sp-500-makes-little-sense-in-2021-1029923788,positive,0.7504273653030396
2363,12/29/2020 4:47:22 PM,Why Shares Of Coronavirus Vaccine Developer Arcturus Are Sinking,Benzinga,/news/stocks/why-shares-of-coronavirus-vaccine-developer-arcturus-are-sinking-1029923492,positive,0.9340800046920776
2364,12/29/2020 5:47:41 PM,Is Now a Good Time to Buy Moderna Stock?,InvestorPlace,/news/stocks/is-now-a-good-time-to-buy-moderna-stock-1029923962,positive,0.9269354343414307
2365,12/29/2020 5:57:09 PM,Moderna Is a Great Investment Despite Short-Term Headwinds,InvestorPlace,/news/stocks/moderna-mrna-stock-is-a-great-investment-despite-short-term-headwinds-1029923961,negative,0.9181536436080933
2366,12/29/2020 6:55:38 PM,Pfizer and Biontech to supply additional 100M doses of COMIRNATY to EU,Seeking Alpha,https://seekingalpha.com/news/3647763-pfizer-and-biontech-to-supply-additional-100m-doses-of-comirnaty-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6833433508872986
2367,12/30/2020 3:41:42 AM,"Pfizer, BioNTech To Supply European Union With 100 Mln Addl Doses Of COVID-19 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-to-supply-european-union-with-100-mln-addl-doses-of-covid-19-vaccine-1029924277,negative,0.8388696908950806
2368,12/30/2020 7:39:17 AM,Oxford-AstraZeneca vaccine approved for emergency use in the U.K.,Seeking Alpha,https://seekingalpha.com/news/3647819-oxford-astrazeneca-vaccine-approved-for-emergency-use-in-u-k?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8809178471565247
2369,12/30/2020 8:32:08 AM,U.S. vaccinations far short of 'Warp Speed' target for 2020,Seeking Alpha,https://seekingalpha.com/news/3647820-u-s-vaccinations-far-short-of-warp-speed-target-for-2020?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.45618459582328796
2370,12/30/2020 10:01:36 AM,7 Great Index Funds To Help Investors Minimize Risk in a Volatile World,InvestorPlace,/news/stocks/7-great-index-funds-to-help-investors-minimize-risk-in-a-volatile-world-1029924929,positive,0.7723698019981384
2371,12/30/2020 1:21:48 PM,Moderna's employees to receive its COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3647864-modernas-employees-to-receive-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8243892788887024
2372,12/30/2020 3:27:28 PM,Why the New Covid-19 Strain Matters for Pfizer Stakeholders,InvestorPlace,/news/stocks/pfe-stock-why-new-coronavirus-strain-matters-1029925845,positive,0.9120147824287415
2373,12/30/2020 5:02:16 PM,Canada expedites the review for AstraZeneca’s COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3647925-canada-expedites-review-for-astrazeneca-s-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9322948455810547
2374,12/30/2020 5:27:58 PM,Boeing Stock: Expect Headwinds In 2021,InvestorPlace,/news/stocks/boeing-stock-expect-headwinds-in-2021-1029926002,neutral,0.9539236426353455
2375,12/31/2020 11:31:52 AM,"Novavax Is Inching Closer, But Its Vaccine Better Be Special",InvestorPlace,/news/stocks/nvax-stock-inching-closer-vaccine-better-be-special-1029926741,positive,0.8272730112075806
2376,12/31/2020 12:49:45 PM,Viatris biosimilar faces regulatory delay,Seeking Alpha,https://seekingalpha.com/news/3648043-viatris-biosimilar-faces-regulatory-delay?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8477115035057068
2377,12/31/2020 3:16:42 PM,8 Dental Stocks If You Want to Clean Up,InvestorPlace,/news/stocks/8-dental-stocks-to-buy-if-you-want-to-clean-up-1029927337,positive,0.9182091355323792
2378,12/31/2020 6:34:16 PM,Moderna Stock Is More Than The Covid-19 Vaccine,InvestorPlace,/news/stocks/mrna-stock-is-more-than-the-covid-19-vaccine-1029927438,positive,0.786453902721405
2379,12/31/2020 7:19:38 PM,Why Pfizer is the Cheapest Coronavirus Vaccine Play,InvestorPlace,/news/stocks/pfe-stock-pfizer-does-not-include-value-biontech-and-vaccine-1029927517,positive,0.868235170841217
2380,12/31/2020 7:57:56 PM,Moderna’s Share Price Continues to Lose Altitude,InvestorPlace,/news/stocks/modernas-share-price-and-mrna-stock-continues-to-lose-altitude-1029927513,neutral,0.9684809446334839
2381,12/31/2020 8:42:36 PM,Leading pharma companies to hike prices amid pressure on profits,Seeking Alpha,https://seekingalpha.com/news/3648134-leading-pharma-companies-to-hike-prices-amid-pressure-on-profits?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6904548406600952
2382,12/31/2020 9:34:42 PM,COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021,Seeking Alpha,https://seekingalpha.com/news/3648143-covidminus-19-vaccine-makers-looking-back-on-2020-seeking-insights-for-2021?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7941462397575378
2383,1/1/2021 1:07:48 PM,Israel leads world in COVID vaccinations per capita,Seeking Alpha,https://seekingalpha.com/news/3648167-israel-leads-world-in-covid-vaccinations-per-capita?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5381584167480469
2384,1/1/2021 8:49:04 PM,WHO Issues Emergency Use Validation To Pfizer-BioNTech Covid Vaccine ,RTTNews,/news/stocks/who-issues-emergency-use-validation-to-pfizer-biontech-covid-vaccine-1029928282,positive,0.9427322745323181
2385,1/2/2021 2:13:22 AM,AstraZeneca to supply 2M doses of COVID-19 vaccine every week in the U.K. – The Times,Seeking Alpha,https://seekingalpha.com/news/3648177-astrazeneca-to-supply-2m-doses-of-covidminus-19-vaccine-every-week-in-u-k-times?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7207949757575989
2386,1/2/2021 7:54:06 AM,Pfizer/BioNTech to speed up vaccination of placebo arm in COVID-19 trial,Seeking Alpha,https://seekingalpha.com/news/3648181-pfizer-biontech-to-speed-up-vaccination-of-placebo-arm-in-covidminus-19-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8041115403175354
2387,1/2/2021 12:41:40 PM,AstraZeneca receives emergency use nod for coronavirus vaccine in India,Seeking Alpha,https://seekingalpha.com/news/3648182-astrazeneca-receives-emergency-use-nod-for-coronavirus-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6035817265510559
2388,1/2/2021 4:45:58 PM,Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-january-pdufa-dates-1029928632,positive,0.9451626539230347
2389,1/3/2021 5:16:12 AM,More drugs see price hikes yet at a lower rate than last year,Seeking Alpha,https://seekingalpha.com/news/3648194-drugs-see-price-hikes-yet-lower-rate-last-year?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8129631280899048
2390,1/4/2021 9:38:22 AM,U.K. rolls out AstraZeneca-Oxford's COVID-19 vaccine - CNBC,Seeking Alpha,https://seekingalpha.com/news/3648217-u-k-rolls-out-astrazeneca-oxfords-covidminus-19-vaccine-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8769224882125854
2391,1/4/2021 10:01:23 AM,"Vaccine News May Make AstraZeneca Stock Seem Worth a Shot, But It’s Not",InvestorPlace,/news/stocks/forget-the-vaccine-azn-stock-is-a-pass-1029929898,positive,0.7905524969100952
2392,1/4/2021 10:11:21 AM,Latest Pivot Does Little To Bolster Case for IDEX Stock Charging Higher,InvestorPlace,/news/stocks/latest-pivot-does-little-to-bolster-case-for-idex-stock-charging-higher-1029929897,negative,0.40309277176856995
2393,1/4/2021 12:17:15 PM,"FDA accepts Pfizer, OPKO's application for somatrogon in pediatric growth hormone deficiency",Seeking Alpha,https://seekingalpha.com/news/3648251-fda-accepts-pfizer-opkos-application-for-somatrogon-in-pediatric-growth-hormone-deficiency?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.521282434463501
2394,1/4/2021 12:57:16 PM,Use Weakness in Moderna as Buying Opportunity,InvestorPlace,/news/stocks/mrna-stock-moderna-use-weakness-as-buy-opportunity-1029930278,positive,0.8893162608146667
2395,1/4/2021 1:02:03 PM,"Pfizer, OPKO: FDA To Review BLA For Somatrogon To Treat Patients With Growth Hormone Deficiency ",RTTNews,/news/stocks/pfizer-opko-fda-to-review-bla-for-somatrogon-to-treat-patients-with-growth-hormone-deficiency-1029930015,positive,0.6351303458213806
2396,1/4/2021 4:08:20 PM,U.K. to further tighten COVID-19 restrictions as vaccination guidelines change,Seeking Alpha,https://seekingalpha.com/news/3648377-u-k-to-tighten-covidminus-19-restrictions-vaccination-guidelines-change?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5981060862541199
2397,1/4/2021 6:15:41 PM,3 Bank Stocks To Buy for the New Year,InvestorPlace,/news/stocks/3-bank-stocks-to-buy-for-the-new-year-1029931418,positive,0.8912278413772583
2398,1/4/2021 8:11:12 PM,EU regulator remains undecided on Moderna’s COVID-19 jab,Seeking Alpha,https://seekingalpha.com/news/3648468-eu-regulator-remains-undecided-on-moderna-s-covidminus-19-jab?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6550145149230957
2399,1/5/2021 4:52:33 PM,Pfizer/BioNTech to supply up to 100M more COVID-19 vaccine doses to EU,Seeking Alpha,https://seekingalpha.com/news/3648897-pfizer-biontech-to-supply-up-to-100m-covidminus-19-vaccine-doses-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6162616014480591
2400,1/5/2021 5:27:40 PM,Novavax next in line to offer COVID-19 vaccine alternatives - SVB Leerink,Seeking Alpha,https://seekingalpha.com/news/3648917-novavax-next-in-line-to-offer-covidminus-19-vaccine-alternatives-svb-leerink?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7325361371040344
2401,1/5/2021 7:36:32 PM,7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible,InvestorPlace,/news/stocks/7-coronavirus-stocks-to-buy-to-make-mass-vaccination-possible-1029935369,positive,0.8918885588645935
2402,1/6/2021 11:19:47 AM,EU Agency meets today to discuss Moderna's COVID-19 vaccine approval,Seeking Alpha,https://seekingalpha.com/news/3649148-eu-agency-meets-today-to-discuss-modernas-covidminus-19-vaccine-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8471829891204834
2403,1/6/2021 12:57:47 PM,Moderna gets EU backing for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3649195-moderna-gets-eu-backing-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6559186577796936
2404,1/6/2021 2:15:48 PM,EMA Recommends Conditional Marketing Authorization For Moderna's COVID-19 Vaccine ,RTTNews,/news/stocks/ema-recommends-conditional-marketing-authorization-for-moderna-s-covid-19-vaccine-1029937199,positive,0.6959399580955505
2405,1/6/2021 3:42:10 PM,The Opportunity May Just Be Getting Started For Moderna,InvestorPlace,/news/stocks/multiple-catalysts-should-push-mrna-stock-higher-1029938098,positive,0.6894431114196777
2406,1/6/2021 5:35:46 PM,Pfizer/BioNTech to get EU approval for a change for its COVID-19 vaccine use - Reuters,Seeking Alpha,https://seekingalpha.com/news/3649328-pfizer-biontech-to-get-eu-approval-for-change-for-covidminus-19-vaccine-use-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5403838157653809
2407,1/6/2021 7:01:37 PM,"Headwinds Remain for Carnival Cruises, but the Wind Will Fill Its Sails in 2021",InvestorPlace,/news/stocks/ccl-stock-still-has-headwinds-but-the-wind-will-fill-its-sails-in-2021-1029938362,neutral,0.6220085024833679
2408,1/6/2021 7:46:27 PM,Pfizer taps Dewpoint Therapeutics in $239M dystrophy candidate pact,Seeking Alpha,https://seekingalpha.com/news/3649382-pfizer-taps-dewpoint-therapeutics-in-239m-dystrophy-candidate-pact?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6606719493865967
2409,1/6/2021 8:39:57 PM,The 7 Best Cheap Stocks to Buy in 2021 for Under $15,InvestorPlace,/news/stocks/the-7-best-cheap-stocks-to-buy-in-2021-for-under-15-1029938621,positive,0.7975775003433228
2410,1/6/2021 9:50:43 PM,Myovant cut to neutral at Goldman Sachs on ‘lack of driving catalysts’,Seeking Alpha,https://seekingalpha.com/news/3649429-myovant-cut-to-neutral-goldman-sachs-on-lack-of-driving-catalysts?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9310726523399353
2411,1/7/2021 8:29:53 AM,ImaginAb inks supply deal with Pfizer for CD8 ImmunoPET technology in Cancer,Seeking Alpha,https://seekingalpha.com/news/3649479-imaginab-inks-supply-deal-pfizer-for-cd8-immunopet-technology-in-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8956508636474609
2412,1/7/2021 9:33:21 AM,ImaginAb To Supply 89Zr CD8 Immuno-PET Agent To Pfizer - Quick Facts ,RTTNews,/news/stocks/imaginab-to-supply-89zr-cd8-immuno-pet-agent-to-pfizer-quick-facts-1029939635,positive,0.838172972202301
2413,1/7/2021 12:34:40 PM,Pfizer initiates dosing in the study for rare muscular disorder,Seeking Alpha,https://seekingalpha.com/news/3649540-pfizer-initiates-dosing-in-study-for-rare-muscular-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.909134030342102
2414,1/7/2021 1:10:24 PM,Pfizer Begins Phase 3 Study To Evaluate Gene Therapy Candidate For Duchenne Muscular Dystrophy ,RTTNews,/news/stocks/pfizer-begins-phase-3-study-to-evaluate-gene-therapy-candidate-for-duchenne-muscular-dystrophy-1029940197,negative,0.726260244846344
2415,1/7/2021 2:20:50 PM,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-curevac-covid-19-vaccine-deal-argenx-out-licenses-neuromuscular-disorder-drug-xencor-s-oncology-collaboration-1029940542,positive,0.875293493270874
2416,1/7/2021 2:36:57 PM,"SPY Stock Has a Ton of Momentum, but It Probably Won’t Last Long",InvestorPlace,/news/stocks/spy-stock-has-f-momentum-wont-last-long-1029941037,positive,0.555088996887207
2417,1/7/2021 2:37:49 PM,Novavax can assess shot’s efficacy on new COVID-19 variant - Cantor Fitzgerald,Seeking Alpha,https://seekingalpha.com/news/3649635-novavax-can-assess-shot-s-efficacy-on-new-covidminus-19-variant-cantor-fitzgerald?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7204685807228088
2418,1/7/2021 2:48:31 PM,"While Its Price Won’t Soar, Pfizer Stock Is a Fantastic Long-Term Buy",InvestorPlace,/news/stocks/pfe-stock-is-a-fantastic-long-term-buy-1029941036,negative,0.6838629841804504
2419,1/7/2021 4:57:52 PM,Why Nextleaf Solutions Is Betting That Patents Are The Future Of Cannabis,Benzinga,/news/stocks/why-nextleaf-solutions-is-betting-that-patents-are-the-future-of-cannabis-1029941294,positive,0.9055585265159607
2420,1/7/2021 5:18:34 PM,Vaccine Backlog Raises New Questions About Moderna,InvestorPlace,/news/stocks/mrna-stock-vaccine-backlog-raises-questions-1029941852,positive,0.5350947976112366
2421,1/7/2021 11:31:43 PM,'Our Vaccine Safety Systems Haven't Picked Up Any Worrisome Signals:' CDC ,RTTNews,/news/stocks/our-vaccine-safety-systems-haven-t-picked-up-any-worrisome-signals-cdc-1029942232,neutral,0.5314350724220276
2422,1/8/2021 4:09:00 AM,Pfizer's COVID vaccine appears to work on variants - Reuters,Seeking Alpha,https://seekingalpha.com/news/3649824-pfizers-covid-vaccine-appears-to-work-on-variants-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6782411336898804
2423,1/8/2021 10:55:32 AM,Soild Bio sinks 13% after Sarepta data misses goal,Seeking Alpha,https://seekingalpha.com/news/3649846-soild-bio-sinks-13-after-sarepta-data-misses-goal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.3869839608669281
2424,1/8/2021 12:06:38 PM,EU secures 300M more doses of Pfizer-BioNTech jab,Seeking Alpha,https://seekingalpha.com/news/3649872-eu-secures-300m-doses-of-pfizer-biontech-jab?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9031217098236084
2425,1/8/2021 12:23:29 PM,"Pfizer, BioNTech Announce Results From In Vitro Study ",RTTNews,/news/stocks/pfizer-biontech-announce-results-from-in-vitro-study-1029943148,positive,0.6714237332344055
2426,1/8/2021 1:01:26 PM,Pfizer’s Covid-19 Vaccine Delay Isn’t Welcome News for Shareholders,InvestorPlace,/news/stocks/pfizers-vaccine-delay-not-good-news-for-pfe-stock-1029943479,neutral,0.934407651424408
2427,1/8/2021 1:52:44 PM,U.K. Approves Moderna's COVID-19 Vaccine ,RTTNews,/news/stocks/u-k-approves-moderna-s-covid-19-vaccine-1029943385,negative,0.53851318359375
2428,1/8/2021 2:50:31 PM,Sarepta Falls 50% To 10-Month Low After DMD Gene Therapy Study Misses Primary Endpoint,Benzinga,/news/stocks/sarepta-falls-50-to-10-month-low-after-dmd-gene-therapy-study-misses-primary-endpoint-1029943631,neutral,0.964195191860199
2429,1/8/2021 3:41:14 PM,"As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade",InvestorPlace,/news/stocks/bull-case-mrna-stock-beginning-to-fade-1029944159,positive,0.6915823817253113
2430,1/8/2021 7:15:50 PM,American Airlines Has Room to Climb in 2021,InvestorPlace,/news/stocks/aal-stock-has-room-to-go-higher-in-2021-1029944565,negative,0.8925096392631531
2431,1/8/2021 8:30:57 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3650027-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
2432,1/8/2021 9:03:55 PM,Sarepta price target cut in half at Baird after gene therapy setback,Seeking Alpha,https://seekingalpha.com/news/3650056-sarepta-price-target-cut-in-half-baird-after-gene-therapy-setback?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.47687992453575134
2433,1/10/2021 2:10:48 AM,COVID-19 cases surge amid plans to accelerate vaccine distribution,Seeking Alpha,https://seekingalpha.com/news/3650116-covidminus-19-cases-surge-amid-plans-to-accelerate-vaccine-distribution?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5697651505470276
2434,1/11/2021 11:01:12 AM,Boeing Stock Is Flying the Friendly Skies Without a Map,InvestorPlace,/news/stocks/boeing-stock-flying-without-map-1029946789,positive,0.8468082547187805
2435,1/11/2021 12:56:47 PM,JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts,Seeking Alpha,https://seekingalpha.com/news/3650208-jnj-s-single-dose-covidminus-19-vaccine-viewed-favorably-analysts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9441752433776855
2436,1/11/2021 1:45:19 PM,Health Canada OK's Pfizer/Merck KGaA's Bavencio for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/3650247-health-canada-oks-pfizer-merck-kgaas-bavencio-for-bladder-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8827217221260071
2437,1/11/2021 1:48:37 PM,Pfizer/BioNTech can respond within weeks to a new COVID-19 strain,Seeking Alpha,https://seekingalpha.com/news/3650252-pfizer-biontech-can-respond-within-weeks-to-new-covidminus-19-strain?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8677706718444824
2438,1/11/2021 3:32:35 PM,NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening,InvestorPlace,/news/stocks/nvax-stock-is-worth-a-small-position-but-vaccine-race-is-tightening-1029956501,positive,0.5928695201873779
2439,1/11/2021 4:59:22 PM,The Top 7 Pharmaceutical Stocks for the Next 10 Years ,InvestorPlace,/news/stocks/the-top-7-pharmaceutical-stocks-for-the-next-10-years-1029956488,positive,0.8569135069847107
2440,1/11/2021 6:22:46 PM,Novavax executives sold $46M worth company shares in 2020 – Reuters,Seeking Alpha,https://seekingalpha.com/news/3650426-novavax-executives-sold-46m-worth-company-shares-in-2020-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9496198296546936
2441,1/11/2021 7:32:18 PM,BioNTech stock climbs 7% as company targets 2B doses of COVID vaccine in '21,Seeking Alpha,https://seekingalpha.com/news/3650447-biontech-stock-climbs-7-company-targets-2b-doses-of-covid-vaccine-in-21?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9320195913314819
2442,1/11/2021 8:36:50 PM,8 Value Stocks That Could Perform Surprisingly Well In 2021,InvestorPlace,/news/stocks/8-value-stocks-that-could-perform-surprisingly-well-in-2021-1029957111,negative,0.8532675504684448
2443,1/11/2021 10:05:31 PM,Healthcare Stocks: How AI Is Helping in the Fight Against COVID-19,InvestorPlace,/news/stocks/healthcare-stocks-how-ai-is-helping-fight-covid-19-1029957368,positive,0.7914547324180603
2444,1/12/2021 10:21:18 AM,7 Blue-Chip Stocks For A Steady-Eddie 2021,InvestorPlace,/news/stocks/7-blue-chip-stocks-for-a-steady-eddie-2021-1029958842,positive,0.6925377249717712
2445,1/12/2021 12:12:41 PM,Pfizer invests $25M in Vedanta Biosciences,Seeking Alpha,https://seekingalpha.com/news/3650616-pfizer-invests-25m-in-vedanta-biosciences?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8398087620735168
2446,1/12/2021 1:06:43 PM,Pfizer Invests $120 Million In Four Clinical-stage Biotech Companies In H2 2020 - Quick Facts ,RTTNews,/news/stocks/pfizer-invests-120-million-in-four-clinical-stage-biotech-companies-in-h2-2020-quick-facts-1029959154,positive,0.7681055068969727
2447,1/12/2021 1:16:01 PM,"With Airbnb Stock, Reservations Abound",InvestorPlace,/news/stocks/with-airbnb-stock-reservations-abound-1029960519,neutral,0.860469400882721
2448,1/12/2021 1:24:23 PM,AstraZeneca-Oxford's COVID-19 vaccine may be OK'd in EU by Jan. 29,Seeking Alpha,https://seekingalpha.com/news/3650660-astrazeneca-oxfords-covidminus-19-vaccine-may-be-okd-in-eu-jan-29?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7185282111167908
2449,1/12/2021 1:49:49 PM,South Korea nears deal to buy Novavax COVID-19 Vaccines - report,Seeking Alpha,https://seekingalpha.com/news/3650682-south-korea-nears-deal-to-buy-novavax-covidminus-19-vaccines-report?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5854173898696899
2450,1/12/2021 4:32:16 PM,"Even In This Market, There Are Better Choices Than Pfizer Stock",InvestorPlace,/news/stocks/better-choices-than-pfe-stock-1029961129,positive,0.7564706206321716
2451,1/12/2021 6:21:48 PM,Pfizer's stock drops on weak full-year profit forecast,Seeking Alpha,https://seekingalpha.com/news/3650797-pfizers-stock-drops-on-weak-full-year-profit-forecast?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9698963165283203
2452,1/12/2021 9:00:04 PM,AstraZeneca's COVID-19 vaccine is set for Indian rollout,Seeking Alpha,https://seekingalpha.com/news/3650831-astrazenecas-covidminus-19-vaccine-is-set-for-indian-rollout?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8205235600471497
2453,1/12/2021 9:22:46 PM,Southwest Stock Can Soar Again Soon,InvestorPlace,/news/stocks/southwest-stock-can-soar-again-soon-1029962058,negative,0.7155860662460327
2454,1/12/2021 9:35:43 PM,Doctor’s death after COVID-19 vaccine is being investigated - NY Times,Seeking Alpha,https://seekingalpha.com/news/3650880-doctor-s-death-after-covidminus-19-vaccine-is-being-investigated-ny-times?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7684687972068787
2455,1/12/2021 10:22:17 PM,JNJ's COVID-19 jab could receive emergency approval by next month: Official,Seeking Alpha,https://seekingalpha.com/news/3650838-jnjs-covidminus-19-jab-receive-emergency-approval-next-month-official?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6049853563308716
2456,1/13/2021 7:51:59 PM,7 Pharmaceutical Stocks With Exciting Plans for 2021,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-with-exciting-plans-for-2021-1029966098,positive,0.7265651226043701
2457,1/14/2021 12:44:19 PM,"NantKwest Reports Positive Interim Data In Pancreatic Cancer Trials, Stock Soars",Benzinga,/news/stocks/nantkwest-reports-positive-interim-data-in-pancreatic-cancer-trials-stock-soars-1029967953,negative,0.9492835402488708
2458,1/14/2021 4:32:20 PM,Here’s Why Carnival Might Suffer 3 Years of Soft Data,InvestorPlace,/news/stocks/why-ccl-stock-might-suffer-3-years-soft-data-1029969972,neutral,0.6407033205032349
2459,1/14/2021 4:34:24 PM,8 Indian Stocks That Belong on Your International Radar,InvestorPlace,/news/stocks/8-indian-stocks-that-belong-on-your-international-radar-1029969971,positive,0.9302469491958618
2460,1/14/2021 5:48:25 PM,Viatris under pressure on conservative outlook,Seeking Alpha,https://seekingalpha.com/news/3651544-viatris-under-pressure-on-conservative-outlook?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6317262649536133
2461,1/14/2021 7:44:11 PM,Pfizer sues Aurobindo over generic copies of Xeljanz arthritis med,Seeking Alpha,https://seekingalpha.com/news/3651579-pfizer-sues-aurobindo-over-generic-copies-of-xeljanz-arthritis-med?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9386260509490967
2462,1/14/2021 9:32:48 PM,Netflix Stock Remains Well Ahead of the Competition,InvestorPlace,/news/stocks/netflix-nflx-stock-remains-well-ahead-of-the-competition-1029971027,negative,0.8825386762619019
2463,1/14/2021 9:44:50 PM,Pfizer’s XALKORI wins FDA's expanded approval for a form of lymphoma,Seeking Alpha,https://seekingalpha.com/news/3651642-pfizer-s-xalkori-wins-fdas-expanded-approval-for-form-of-lymphoma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9106607437133789
2464,1/15/2021 6:11:42 AM,"FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High ",RTTNews,/news/stocks/fda-expands-approved-use-of-pfe-s-xalkori-lxrx-soars-on-sotagliflozin-update-bcyc-hits-new-high-1029971367,negative,0.9089533686637878
2465,1/15/2021 1:32:12 PM,"The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges",Benzinga,/news/stocks/the-daily-biotech-pulse-dbv-s-positive-fda-feedback-pfizer-s-cancer-drug-gets-label-expansion-applied-dna-covid-testing-volume-surges-1029972538,negative,0.9414128661155701
2466,1/15/2021 3:54:47 PM,Pfizer to reduce European vaccine deliveries; upgrades production capacity,Seeking Alpha,https://seekingalpha.com/news/3651868-pfizer-to-reduce-european-vaccine-deliveries-upgrades-production-capacity?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8583176732063293
2467,1/15/2021 5:56:08 PM,Why Moderna Has More Upside Than Its Covid-19 Vaccine Implies,InvestorPlace,/news/stocks/why-moderna-stock-has-more-upside-than-its-coronavirus-vaccine-implies-1029974303,positive,0.8641256093978882
2468,1/15/2021 5:58:59 PM,Norway says deaths after COVID-19 jab may be from side effects,Seeking Alpha,https://seekingalpha.com/news/3651902-norway-says-deaths-after-covidminus-19-jab-may-be-from-side-effects?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.862498939037323
2469,1/15/2021 6:46:52 PM,Why Pfizer Is a Long-Term Investor’s Friend,InvestorPlace,/news/stocks/pfe-pfizer-stock-long-term-investors-friend-1029974295,positive,0.9330063462257385
2470,1/17/2021 4:13:31 AM,Bayer to examine the production of CureVac’s COVID-19 jab,Seeking Alpha,https://seekingalpha.com/news/3652042-bayer-to-examine-production-of-curevac-s-covidminus-19-jab?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8287990689277649
2471,1/17/2021 7:57:35 PM,Here's How Americans Are Spending Their Stimulus Payments,Benzinga,/news/stocks/here-s-how-americans-are-spending-their-stimulus-payments-1029975713,positive,0.925134003162384
2472,1/18/2021 3:53:18 PM,WHO warns on 'catastrophic moral failure' of vaccine distribution,Seeking Alpha,https://seekingalpha.com/news/3652072-who-warns-on-catastrophic-moral-failure-of-vaccine-distribution?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5088933110237122
2473,1/18/2021 4:05:29 PM,Don’t Take a Flier on American Airlines Shares,InvestorPlace,/news/stocks/aal-stock-dont-take-a-flier-on-american-airlines-shares-1029978222,positive,0.8999419212341309
2474,1/18/2021 4:51:20 PM,COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September,Seeking Alpha,https://seekingalpha.com/news/3652075-covidminus-19-jabs-israel-trades-data-for-doses-u-k-to-vaccinate-all-adults-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8276581764221191
2475,1/19/2021 7:07:24 AM,New York explores buying COVID-19 vaccine directly from Pfizer,Seeking Alpha,https://seekingalpha.com/news/3652097-new-york-explores-buying-covidminus-19-vaccine-directly-from-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.775145411491394
2476,1/19/2021 8:34:54 AM,California urges to pause use of a batch of Moderna COVID-19 vaccines after allergic reactions - NYT,Seeking Alpha,https://seekingalpha.com/news/3652100-california-urges-to-pause-use-of-batch-of-moderna-covidminus-19-vaccines-after-allergic?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5492032170295715
2477,1/19/2021 10:16:59 AM,7 Best Penny Stocks to Buy Early Into 2021 ,InvestorPlace,/news/stocks/7-best-penny-stocks-to-buy-early-into-2021-1029980093,positive,0.7994723916053772
2478,1/20/2021 12:18:56 PM,Pfizer/BioNTech COVID-19 vaccine is effective against the U.K. variant,Seeking Alpha,https://seekingalpha.com/news/3652586-pfizerbiontech-covid-19-vaccine-is-effective-against-the-uk-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7202974557876587
2479,1/20/2021 2:49:35 PM,Pfizer & BioNTech Report Encouraging Findings On Vaccine's Effectiveness In Neutralizing U.K. Strain ,RTTNews,/news/stocks/pfizer-biontech-report-encouraging-findings-on-vaccine-s-effectiveness-in-neutralizing-u-k-strain-1029986416,negative,0.9462799429893494
2480,1/20/2021 2:55:20 PM,"Novavax’s Insiders Are Selling Stock, And That’s Not a Bad Idea",InvestorPlace,/news/stocks/novavaxs-insiders-are-selling-stock-and-thats-not-a-bad-idea-1029986836,positive,0.8396642804145813
2481,1/20/2021 3:24:21 PM,The 7 Best Healthcare Stocks to Buy for 2021,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-buy-for-2021-1029987247,positive,0.817572295665741
2482,1/20/2021 4:03:11 PM,9 Beginner Stocks for First-Time Investors,InvestorPlace,/news/stocks/9-beginner-stocks-for-first-time-investors-to-buy-1029987242,positive,0.9392744898796082
2483,1/20/2021 4:52:55 PM,Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today,InvestorPlace,/news/stocks/covid-19-vaccine-5-pharma-stocks-headlines-today-nvax-stock-bntx-stock-1029987235,positive,0.7466526627540588
2484,1/20/2021 7:47:56 PM,Novavax Stock Is Once Again Ready to Pop,InvestorPlace,/news/stocks/novavax-stock-is-once-again-ready-to-pop-1029987777,negative,0.5602031946182251
2485,1/20/2021 8:34:48 PM,"Pfizer's Covid-19 Vaccine Effective Against Mutant U.K. Strain, New Findings Reveal ",RTTNews,/news/stocks/pfizer-s-covid-19-vaccine-effective-against-mutant-u-k-strain-new-findings-reveal-1029987618,negative,0.6013034582138062
2486,1/21/2021 6:48:03 AM,"PFE/BNTX Covid Jab Neutralizes UK Strain, Pura Vida Ups Stake In OCX, Woodcock Is Interim FDA Chief ",RTTNews,/news/stocks/pfe-bntx-covid-jab-neutralizes-uk-strain-pura-vida-ups-stake-in-ocx-woodcock-is-interim-fda-chief-1029988838,positive,0.9300564527511597
2487,1/21/2021 1:16:39 PM,Ocugen Stock Looks Overinflated,InvestorPlace,/news/stocks/even-with-covid-19-vaccine-partnership-ocgn-stock-looks-overinflated-1029991045,neutral,0.9216745495796204
2488,1/21/2021 2:19:33 PM,Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan,Seeking Alpha,https://seekingalpha.com/news/3653110-moderna-announces-first-participant-dosed-in-takeda-led-early-stage-covid-19-vaccine-trial-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6549181938171387
2489,1/21/2021 4:25:23 PM,Biden Stocks: 16 Stocks to Watch for a Defense Production Act Boost,InvestorPlace,/news/stocks/biden-stocks-16-stocks-to-watch-for-a-defense-production-act-boost-1029991455,positive,0.895939290523529
2490,1/21/2021 5:09:12 PM,Ignore the Bears and Invest in Pfizer,InvestorPlace,/news/stocks/ignore-the-bears-and-invest-in-pfizer-stock-1029991449,positive,0.9384905695915222
2491,1/21/2021 5:10:46 PM,7 Airline Stocks Being Fueled by Vaccine News,InvestorPlace,/news/stocks/7-airline-stocks-being-fueled-by-vaccine-news-1029991448,neutral,0.6088981032371521
2492,1/21/2021 6:09:35 PM,Premier ties up with Pfizer to secure supply of five essential medications,Seeking Alpha,https://seekingalpha.com/news/3653215-premier-ties-up-with-pfizer-to-secure-supply-of-five-essential-medications?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8151513934135437
2493,1/21/2021 8:39:21 PM,Pfizer/BioNTech to supply WHO co-led COVID-19 vaccine scheme - Reuters,Seeking Alpha,https://seekingalpha.com/news/3653266-pfizerbiontech-to-supply-who-co-led-covid-19-vaccine-scheme-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7704957723617554
2494,1/21/2021 9:50:52 PM,"For Pfizer, the Covid-19 Vaccine ‘Honeymoon’ Is Over",InvestorPlace,/news/stocks/pfe-stock-for-pfizer-the-covid-19-vaccine-honeymoon-is-over-1029992437,positive,0.8193540573120117
2495,1/22/2021 4:51:44 AM,FDA OK's Janssen's HIV drug combo Cabenuva,Seeking Alpha,https://seekingalpha.com/news/3653426-fda-oks-janssens-hiv-drug-combo-cabenuva?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5732345581054688
2496,1/22/2021 9:20:13 AM,Why is the U.S. vaccine rollout taking longer than expected?,Seeking Alpha,https://seekingalpha.com/news/3653444-why-is-us-vaccine-rollout-taking-longer-than-expected?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6498687863349915
2497,1/22/2021 12:20:49 PM,Pfizer/BioNTech COVID-19 jab is safe for elderly despite European alarm - WHO,Seeking Alpha,https://seekingalpha.com/news/3653483-pfizerbiontech-covid-19-jab-is-safe-for-elderly-despite-european-alarm-who?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7744876146316528
2498,1/22/2021 1:22:34 PM,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",Benzinga,/news/stocks/the-daily-biotech-pulse-fluidigm-s-saliva-based-covid-test-approved-in-europe-china-backs-amarin-s-vascepa-1029993832,positive,0.8599371910095215
2499,1/22/2021 7:05:26 PM,Pfizer/BioNTech joins WHO-backed COVID-19 vaccine program,Seeking Alpha,https://seekingalpha.com/news/3653659-pfizerbiontech-joins-who-backed-covid-19-vaccine-program?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7843803763389587
2500,1/22/2021 10:13:36 PM,The Best 4 Pharmaceutical Stocks to Buy in Any Climate,InvestorPlace,/news/stocks/the-best-4-pharmaceutical-stocks-to-buy-in-any-climate-1030014921,positive,0.7539841532707214
2501,1/23/2021 3:01:58 AM,New coronavirus variant could be more deadly,Seeking Alpha,https://seekingalpha.com/news/3653725-new-coronavirus-variant-could-be-more-deadly?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.857290506362915
2502,1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049,negative,0.6939177513122559
2503,1/23/2021 6:33:46 PM,Pfizer to ship fewer vaccine vials due to 'extra' dose in each,Seeking Alpha,https://seekingalpha.com/news/3653729-pfizer-to-ship-fewer-vaccine-vials-due-to-extra-dose-in-each?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6753448843955994
2504,1/24/2021 3:59:18 AM,COVID-19 vaccination: CDC guidance updated; Case counts decline,Seeking Alpha,https://seekingalpha.com/news/3653733-covid-19-vaccination-cdc-guidance-updated-case-counts-decline?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6689949035644531
2505,1/24/2021 4:21:55 AM,"Pfizer, BioNTech Reach Deal With COVAX For Up To 40 Mln Doses Of COVID-19 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-reach-deal-with-covax-for-up-to-40-mln-doses-of-covid-19-vaccine-1029996143,negative,0.808270275592804
2506,1/24/2021 4:48:59 AM,Pfizer/BioNTech COVID-19 vaccine supply to rise with FDA label change,Seeking Alpha,https://seekingalpha.com/news/3653734-pfizerbiontech-covid-19-vaccine-supply-to-rise-with-fda-label-change?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9310634732246399
2507,1/24/2021 3:46:36 PM,COVID vaccines for kids? Trials are underway,Seeking Alpha,https://seekingalpha.com/news/3653738-covid-vaccines-for-kids-trials-are-underway?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.901797354221344
2508,1/25/2021 4:30:25 AM,"Australia OK's Pfizer's COVID-19 jab, vaccinations to commence in February",Seeking Alpha,https://seekingalpha.com/news/3653744-australia-oks-pfizers-covid-19-jab-vaccinations-to-commence-in-february?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8531781435012817
2509,1/25/2021 10:06:19 AM,"Pfizer, Merck KGaA's Bavencio OK'd in Europe in bladder cancer",Seeking Alpha,https://seekingalpha.com/news/3653757-pfizer-merck-kgaas-bavencio-okd-in-europe-in-bladder-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5459233522415161
2510,1/25/2021 10:11:57 AM,There Are Troubling Signs That Boeing Stock’s About To Lose Altitude,InvestorPlace,/news/stocks/there-are-troubling-signs-that-boeing-stocks-about-to-lose-altitude-1029998445,neutral,0.9631730318069458
2511,1/25/2021 11:30:01 AM,Embrace the ProShares Pet Care ETF as People Add Pets to the Family,InvestorPlace,/news/stocks/proshares-pet-care-etf-pawz-pet-spending-1029999865,positive,0.7945043444633484
2512,1/25/2021 11:58:38 AM,3 Reasons To Invest in Pfizer Stock Despite Its Dismal Performance,InvestorPlace,/news/stocks/3-reasons-to-invest-in-pfizer-stock-despite-its-dismal-performance-1029999021,positive,0.5312947630882263
2513,1/25/2021 12:12:19 PM,A Peek Into The Markets: US Stock Futures Up On Stimulus Hopes,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-up-on-stimulus-hopes-1029998447,negative,0.830180287361145
2514,1/25/2021 12:18:26 PM,South African COVID-19 variant could reduce vaccine efficacy by half,Seeking Alpha,https://seekingalpha.com/news/3653793-south-african-covid-19-variant-could-reduce-vaccine-efficacy-by-half?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9656471610069275
2515,1/25/2021 4:43:51 PM,3 Bank Stocks to Buy on the Dip,InvestorPlace,/news/stocks/3-bank-stocks-to-buy-on-the-dip-1030000364,positive,0.8591300845146179
2516,1/25/2021 5:01:51 PM,Vaccine Race Is Catching up to Moderna Stock but Outlook Is Solid,InvestorPlace,/news/stocks/vaccine-race-is-catching-up-to-moderna-stock-but-outlook-is-solid-1030000363,negative,0.8956927061080933
2517,1/25/2021 5:40:25 PM,"Gaining additional COVID-19 shots from Pfizer vials slowed by Becton, Dickinson specialty syringe production, Reuters reports",Seeking Alpha,https://seekingalpha.com/news/3653947-gaining-additional-covid-19-shots-from-pfizer-vials-slowed-by-becton-dickinson-specialty-syringe-production-reuters-reports?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8670980930328369
2518,1/25/2021 5:41:17 PM,"Pfizer wants India to order COVID-19 vaccine prior to approval, according to Reuters",Seeking Alpha,https://seekingalpha.com/news/3653939-pfizer-wants-india-to-order-covid-19-vaccine-prior-to-approval-according-to-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8993562459945679
2519,1/25/2021 10:29:58 PM,When the Travel Sector Is Set to Take Off,InvestorPlace,/news/stocks/the-travel-sector-is-set-to-take-off-once-vaccine-pessimism-goes-away-1030001229,positive,0.8540031909942627
2520,1/26/2021 12:18:01 PM,Myovant/Pfizer's relugolix combo shows durable clinical benefit in endometriosis,Seeking Alpha,https://seekingalpha.com/news/3654255-myovantpfizers-relugolix-combo-shows-durable-clinical-benefit-in-endometriosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9520763754844666
2521,1/26/2021 12:30:15 PM,Pfizer Faces a New Perception Risk You Shouldn’t Ignore,InvestorPlace,/news/stocks/pfizer-stock-faces-perception-risks-1030004002,positive,0.8133829832077026
2522,1/26/2021 1:26:03 PM,"Myovant Sciences, Pfizer: Positive Trial Data Of Relugolix Combination Therapy In Endometriosis ",RTTNews,/news/stocks/myovant-sciences-pfizer-positive-trial-data-of-relugolix-combination-therapy-in-endometriosis-1030003636,negative,0.8936883807182312
2523,1/26/2021 2:28:29 PM,Pfizer/ BioNTech to speed up COVID-19 vaccine supply,Seeking Alpha,https://seekingalpha.com/news/3654371-pfizer-biontech-to-speed-up-covid-19-vaccine-supply?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7247106432914734
2524,1/26/2021 2:29:25 PM,Why Moderna Stock Faces a Tough Slog Ahead,InvestorPlace,/news/stocks/why-moderna-stock-faces-a-tough-slog-ahead-1030005156,positive,0.7852252125740051
2525,1/26/2021 4:25:04 PM,Hold Your Pfizer Shares Despite Hiccups in Vaccine Rollout,InvestorPlace,/news/stocks/hold-your-pfizer-stock-shares-despite-hiccups-in-vaccine-rollout-1030005716,positive,0.8632327914237976
2526,1/26/2021 8:35:59 PM,Sanofi to help produce 100M Pfizer/BioNTech vaccine doses - Reuters,Seeking Alpha,https://seekingalpha.com/news/3654567-sanofi-to-help-produce-100m-pfizerbiontech-vaccine-doses-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.764401376247406
2527,1/27/2021 8:37:35 AM,Sanofi to make Pfizer-BioNTech's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3654734-sanofi-to-make-pfizer-biontechs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8531650304794312
2528,1/27/2021 12:34:32 PM,Pfizer's Xeljanz fails to meet co-primary endpoint in rheumatoid arthritis study,Seeking Alpha,https://seekingalpha.com/news/3654829-pfizers-xeljanz-fails-to-meet-co-primary-endpoint-in-rheumatoid-arthritis-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9203436970710754
2529,1/27/2021 1:09:44 PM,Government to order 200M more COVID-19 vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3654865-government-to-order-200m-more-covid-19-vaccine-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5119799971580505
2530,1/27/2021 1:21:28 PM,"The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF",InvestorPlace,/news/stocks/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf-1029891558,positive,0.8699871301651001
2531,1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241,positive,0.8347625136375427
2532,1/27/2021 1:41:27 PM,Pfizer Says Prespecified Non-inferiority Criteria Of Tofacitinib Not Met In ORAL Surveillance ,RTTNews,/news/stocks/pfizer-says-prespecified-non-inferiority-criteria-of-tofacitinib-not-met-in-oral-surveillance-1030009250,positive,0.5685191750526428
2533,1/27/2021 3:11:01 PM,Novavax Is a Vaccine Investment That You Shouldn’t Ignore,InvestorPlace,/news/stocks/nvax-stock-is-a-vaccine-investment-that-you-shouldnt-ignore-1030010524,positive,0.894148051738739
2534,1/27/2021 3:52:54 PM,"Johnson & Johnson could have 'tens of millions' of COVID-19 doses by end of February, Gottlieb says",Seeking Alpha,https://seekingalpha.com/news/3654948-johnson-johnson-could-have-tens-of-millions-of-covid-19-doses-by-end-of-march-gottlieb-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7929227948188782
2535,1/27/2021 8:30:44 PM,Pfizer’s setback can hurt others with JAK inhibitors,Seeking Alpha,https://seekingalpha.com/news/3655131-pfizers-setback-can-hurt-others-with-jak-inhibitors?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9525027871131897
2536,1/28/2021 2:03:49 PM,"The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-decision-day-for-amgen-zymeworks-sinks-on-data-ortho-clinical-diagnostics-ipo-1030014922,positive,0.9371458292007446
2537,1/28/2021 5:53:56 PM,Analysts weigh in on vaccine efficacy claims against new COVID-19 strains,Seeking Alpha,https://seekingalpha.com/news/3655686-analysts-weigh-in-on-vaccine-efficacy-claims-against-new-covid-19-strains?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7797836065292358
2538,1/28/2021 6:46:28 PM,Novartis to help boost COVID-19 vaccine production,Seeking Alpha,https://seekingalpha.com/news/3655723-novartis-to-help-boost-covid-19-vaccine-production?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9344320893287659
2539,1/28/2021 7:20:43 PM,FTC approves final order on conditions for Pfizer spinoff Viatris,Seeking Alpha,https://seekingalpha.com/news/3655734-ftc-approves-final-order-on-conditions-for-pfizer-spinoff-viatris?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6257563233375549
2540,1/28/2021 7:29:12 PM,BioThera BLA for Roche Avastin biosimilar accepted by FDA,Seeking Alpha,https://seekingalpha.com/news/3655629-biothera-bla-for-roche-avastin-biosimilar-accepted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8186587691307068
2541,1/28/2021 8:34:56 PM,Moderna Is a ‘Buy and Hold Forever’ Type of Stock,InvestorPlace,/news/stocks/moderna-stock-buy-and-hold-forever-type-investment-1030017203,positive,0.9340001344680786
2542,1/29/2021 11:29:57 AM,Pfizer-BioNTech COVID-19 shot safe for elderly - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3656049-pfizer-biontech-covid-19-shot-safe-for-elderly-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6113798022270203
2543,1/29/2021 12:32:41 PM,Novartis agrees to produce Pfizer/BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3656099-novartis-agrees-to-produce-pfizerbiontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6902453899383545
2544,1/29/2021 1:46:43 PM,"Moderna, BioNTech, Pfizer surge after JNJ COVID-19 vaccine data",Seeking Alpha,https://seekingalpha.com/news/3656159-moderna-biontech-pfizer-surge-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7786161303520203
2545,1/29/2021 1:53:34 PM,NVAX Stock: Why Novavax Shares Are Shooting Higher Today,InvestorPlace,/news/stocks/nvax-stock-why-novavax-shares-are-shooting-higher-today-1030020363,negative,0.8415887355804443
2546,1/29/2021 6:13:09 PM,Novavax Vaccine’s Phase 3 Win Is Sending NVAX Stock to $350,InvestorPlace,/news/stocks/novavax-vaccines-phase-3-win-is-sending-nvax-stock-to-350-1030021202,negative,0.6034005880355835
2547,1/29/2021 6:19:47 PM,Now More Than Ever Why Pfizer Stock Is a Buy,InvestorPlace,/news/stocks/now-more-than-ever-why-pfizer-stock-is-a-buy-1030021200,positive,0.8768250346183777
2548,1/30/2021 6:28:35 AM,Moderna to increase doses per vial as U.S. COVID-19 vaccination ramps up,Seeking Alpha,https://seekingalpha.com/news/3656431-moderna-to-increase-doses-per-vial-as-us-covid-19-vaccination-ramps-up?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9107638001441956
2549,1/30/2021 7:19:15 PM,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-merck-pfizer-in-earnings-mix-plus-adamas-mallinckrodt-fda-decisions-ipos-and-more-1030022250,positive,0.8783656358718872
2550,1/31/2021 3:08:35 AM,South African variant found in Maryland as U.S. exceeds 26M COVID-19 cases,Seeking Alpha,https://seekingalpha.com/news/3656442-new-south-african-variant-found-in-maryland-as-us-exceeds-26m-covid-19-cases?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8911738395690918
2551,1/31/2021 11:22:18 AM,Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-february-pdufa-dates-1030022689,positive,0.9469277858734131
2552,1/31/2021 3:01:27 PM,Pfizer is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-quarter-earnings-preview-q4-1030023077,positive,0.9325799345970154
2553,2/1/2021 6:10:27 AM,AstraZeneca to supply more 9M COVID-19 vaccine doses to EU,Seeking Alpha,https://seekingalpha.com/news/3656462-astrazeneca-to-supply-more-9m-covid-19-vaccine-doses-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8021368980407715
2554,2/1/2021 2:50:18 PM,"Pfizer, BioNTech Publish Preclinical Data From COVID-19 Vaccine Program In Journal Nature ",RTTNews,/news/stocks/pfizer-biontech-publish-preclinical-data-from-covid-19-vaccine-program-in-journal-nature-1030027717,positive,0.9358466863632202
2555,2/1/2021 3:37:25 PM,8 Overstretched Travel Stocks to Avoid,InvestorPlace,/news/stocks/8-overstretched-travel-stocks-avoid-ccl-dal-h-hlt-lvs-aal-abnb-expe-1030028823,neutral,0.8568705320358276
2556,2/1/2021 5:19:44 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3656739-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
2557,2/1/2021 6:29:28 PM,Moderna Analyst: Unrealistic COVID-19 Vaccine Expectations Create Unfavorable Setup,Benzinga,/news/stocks/moderna-analyst-unrealistic-covid-19-vaccine-expectations-create-unfavorable-setup-1030028936,neutral,0.9562428593635559
2558,2/1/2021 6:50:40 PM,Pfizer Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3656813-pfizer-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8635278940200806
2559,2/1/2021 7:34:58 PM,Are You Really Buying AMD Stock Today?,InvestorPlace,/news/stocks/are-you-really-buying-amd-stock-today-1030029509,positive,0.9232354760169983
2560,2/1/2021 8:08:03 PM,3 Reasons Pfizer Stock Will Have a Solid 2021,InvestorPlace,/news/stocks/3-reasons-pfizer-stock-will-have-a-solid-2021-1030029507,negative,0.9223460555076599
2561,2/2/2021 11:30:41 AM,Beware the Seemingly Logical Contrarian Trade for Boeing Stock,InvestorPlace,/news/stocks/beware-seemingly-logical-trade-for-boeing-stock-1030032607,positive,0.8257531523704529
2562,2/2/2021 11:46:52 AM,"Pfizer EPS misses by $0.04, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3657078-pfizer-eps-misses-0_04-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5196470618247986
2563,2/2/2021 12:33:14 PM,Pfizer reports Q4 BNT162b2 sales of 154M; raises non-GAAP EPS guidance,Seeking Alpha,https://seekingalpha.com/news/3657124-pfizer-reports-q4-bnt162b2-sales-of-154m-raises-non-gaap-eps-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9098767042160034
2564,2/2/2021 12:50:17 PM,Pfizer Inc. Q4 adjusted earnings of $0.42 per share,RTTNews,/news/stocks/pfizer-inc-q4-adjusted-earnings-of-0-42-per-share-1030032032,positive,0.774050772190094
2565,2/2/2021 1:54:20 PM,Pfizer Turns To Profit In Q4; Raises FY Profit View ,RTTNews,/news/stocks/pfizer-turns-to-profit-in-q4-raises-fy-profit-view-1030032385,negative,0.9185769557952881
2566,2/2/2021 2:05:48 PM,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",Benzinga,/news/stocks/the-daily-biotech-pulse-vertex-pfizer-earnings-tiziana-covid-19-vaccine-data-decision-day-for-mallinckrodt-s-burn-treatment-1030032611,positive,0.9199008345603943
2567,2/2/2021 3:29:20 PM,Pfizer runs early on schedule to supply 200M COVID vaccine doses to U.S. by May,Seeking Alpha,https://seekingalpha.com/news/3657246-pfizer-runs-early-on-schedule-to-supply-200m-covid-vaccine-doses-to-us-by-may?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6845811605453491
2568,2/2/2021 4:27:53 PM,Biden Vaccine Rollout Plan Assures Success for Moderna,InvestorPlace,/news/stocks/biden-vaccine-rollout-plan-assures-success-for-moderna-stock-holders-1030034386,negative,0.920769214630127
2569,2/2/2021 5:11:05 PM,Mid-Morning Market Update: Markets Open Higher; Pfizer Reports Mixed Q4 Results,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-pfizer-reports-mixed-q4-results-1030034179,negative,0.8293245434761047
2570,2/2/2021 5:45:56 PM,The Vaccine Deal Boost Can’t Keep Ocugen Stock Afloat,InvestorPlace,/news/stocks/the-vaccine-deal-boost-cant-keep-ocgn-stock-afloat-1030034756,neutral,0.537457287311554
2571,2/2/2021 6:31:00 PM,Mid-Day Market Update: Crude Oil Rises 3%; Immunovant Shares Plummet,Benzinga,/news/stocks/mid-day-market-update-crude-oil-rises-3-immunovant-shares-plummet-1030034478,neutral,0.9462978839874268
2572,2/2/2021 8:53:45 PM,Mid-Afternoon Market Update: Dow Jumps 580 Points; Cassava Sciences Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-jumps-580-points-cassava-sciences-shares-spike-higher-1030034932,negative,0.9227650761604309
2573,2/3/2021 12:07:27 PM,Oxford data shows COVID-19 vaccine efficacy increases with longer gap between doses - CNBC,Seeking Alpha,https://seekingalpha.com/news/3657667-oxford-data-shows-covid-19-vaccine-efficacy-increases-with-longer-gap-between-doses-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9256791472434998
2574,2/3/2021 2:30:45 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030038341,positive,0.8142690658569336
2575,2/3/2021 5:44:53 PM,OCGN Stock: Why Vaccine Play Ocugen Is Plunging Today,InvestorPlace,/news/stocks/ocgn-stock-why-vaccine-play-ocugen-is-plunging-today-1030040032,neutral,0.8195806741714478
2576,2/4/2021 10:46:47 AM,7 Safe Growth Stocks to Put In Your Buy-and-Hold Portfolio,InvestorPlace,/news/stocks/7-safe-growth-stocks-to-put-your-trust-in-this-year-1030042740,positive,0.9276878237724304
2577,2/4/2021 4:03:28 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-4-2021-1030044376,neutral,0.5939630270004272
2578,2/4/2021 4:16:13 PM,Citius Pharmaceuticals Is Addressing Several Unmet Needs In The Medical Field,Benzinga,/news/stocks/citius-pharmaceuticals-is-addressing-several-unmet-needs-in-the-medical-field-1030044503,negative,0.7931448221206665
2579,2/4/2021 10:55:26 PM,Johnson & Johnson applies for emergency use OK for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3658893-johnson-johnson-applies-for-emergency-use-ok-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8062297701835632
2580,2/5/2021 6:15:57 AM,Pfizer pulls application in India for COVID-19 vaccine emergency use - Reuters,Seeking Alpha,https://seekingalpha.com/news/3658931-pfizer-pulls-application-in-india-for-covid-19-vaccine-emergency-use-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6355959177017212
2581,2/5/2021 11:13:17 AM,Bolt Biotherapeutics raises $230M in IPO,Seeking Alpha,https://seekingalpha.com/news/3658964-bolt-biotherapeutics-raises-230m-in-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6293289065361023
2582,2/5/2021 12:44:26 PM,Pfizer announces U.S. patent term extension for cancer drug Ibrance,Seeking Alpha,https://seekingalpha.com/news/3659018-pfizer-announces-us-patent-term-extension-for-cancer-drug-ibrance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6312151551246643
2583,2/5/2021 12:59:37 PM,Pfizer Says U.S. Patent Term Extension Certificate Issued For IBRANCE Until March 2027 ,RTTNews,/news/stocks/pfizer-says-u-s-patent-term-extension-certificate-issued-for-ibrance-until-march-2027-1030048082,positive,0.928512692451477
2584,2/5/2021 1:27:07 PM,Merck KgaA to accelerate supply of lipids for Pfizer-BioNTech Covid-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3659049-merck-kgaa-to-accelerate-supply-of-lipids-for-pfizer-biontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.902853786945343
2585,2/5/2021 4:27:04 PM,Amazon Stock Will Be Fine Without Jeff Bezos,InvestorPlace,/news/stocks/amazon-stock-will-be-fine-without-jeff-bezos-1030049277,positive,0.7787089347839355
2586,2/5/2021 7:23:28 PM,3 Downtrodden Stocks to Buy as the Crowds Return,InvestorPlace,/news/stocks/3-downtrodden-stocks-to-buy-as-the-crowds-return-1030049778,positive,0.7549920678138733
2587,2/8/2021 7:26:09 AM,Roche : FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay ,RTTNews,/news/stocks/roche-fda-grants-breakthrough-device-designation-to-elecsys-gdf-15-assay-1030053760,negative,0.9116560816764832
2588,2/8/2021 12:18:30 PM,ViiV Healthcare receives European marketing authorization for HIV-1 infection,Seeking Alpha,https://seekingalpha.com/news/3659371-viiv-healthcare-receives-european-marketing-authorization-for-hiv-1-infection?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9025790095329285
2589,2/8/2021 2:41:10 PM,3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions,InvestorPlace,/news/stocks/3-under-the-radar-biotech-stocks-to-buy-after-earnings-1030055864,positive,0.687945544719696
2590,2/8/2021 6:32:45 PM,Pfizer/BioNTech double the vaccine supply to EU,Seeking Alpha,https://seekingalpha.com/news/3659617-pfizerbiontech-doubles-the-vaccine-supply-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8253374695777893
2591,2/9/2021 12:35:27 PM,"Jaguar Health Isn’t a Healthy Investment, but It Could Be a Profitable One",InvestorPlace,/news/stocks/jagx-stock-not-healthy-but-could-be-profitable-1030060217,negative,0.6908979415893555
2592,2/10/2021 10:41:12 AM,BioNTech: COVID-19 Vaccines Manufactured At Marburg Site Scheduled For Distribution In April ,RTTNews,/news/stocks/biontech-covid-19-vaccines-manufactured-at-marburg-site-scheduled-for-distribution-in-april-1030065416,positive,0.9014192223548889
2593,2/11/2021 5:25:26 PM,COVID-19 vaccination to cover 75% of U.S. adults by mid-summer: Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/3661304-covid-19-vaccination-to-cover-three-quarters-of-us-adults-by-summer-morgan-stanley?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6417354345321655
2594,2/11/2021 8:57:13 PM,Biden to announce a deal for another 200M doses of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3661377-biden-to-announce-a-deal-for-another-200m-doses-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7597874402999878
2595,2/12/2021 1:54:24 PM,"Pfizer, BioNTech to supply additional 100M COVID-19 vaccine doses to U.S.",Seeking Alpha,https://seekingalpha.com/news/3661699-pfizer-biontech-to-supply-additional-100m-covid-19-vaccine-doses-to-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7240108251571655
2596,2/14/2021 3:56:57 AM,COVID-19 reshapes global vaccine landscape: Barron’s,Seeking Alpha,https://seekingalpha.com/news/3661953-covid-19-reshapes-global-vaccine-landscape-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8485727906227112
2597,2/15/2021 12:07:32 PM,Pfizer Vaccine Approved In Japan; Israeli Study Shows 94% Effective ,RTTNews,/news/stocks/pfizer-vaccine-approved-in-japan-israeli-study-shows-94-effective-1030083018,negative,0.8023543953895569
2598,2/15/2021 1:29:00 PM,GlaxoSmithKline Finance Plc -- Moody's affirms GSK's A2 long-term senior unsecured ratings; maintains negative outlook,Moodys,/news/bonds/glaxosmithkline-finance-plc-moody-s-affirms-gsk-s-a2-long-term-senior-unsecured-ratings-maintains-negative-outlook-1030083220,neutral,0.9269378781318665
2599,2/16/2021 6:03:51 AM,"Japan gives green light to Pfizer's COVID-19 vaccine, inoculations to begin soon",Seeking Alpha,https://seekingalpha.com/news/3662010-japan-gives-green-light-to-pfizers-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6965652108192444
2600,2/16/2021 8:08:33 AM,AstraZeneca's COVID-19 vaccine wins Australian nod,Seeking Alpha,https://seekingalpha.com/news/3662019-australia-oks-use-of-astrazenecas-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7348055839538574
2601,2/17/2021 8:48:03 AM,Real world data: Symptomatic COVID cases dropped 94% with Pfizer vaccine,Seeking Alpha,https://seekingalpha.com/news/3662663-real-world-data-symptomatic-covid-cases-dropped-94-with-pfizer-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9692092537879944
2602,2/17/2021 9:30:14 AM,"Pfizer, BioNTech to supply more 200M doses of COVID-19 vaccine to EU",Seeking Alpha,https://seekingalpha.com/news/3662668-pfizer-biontech-to-supply-more-200m-doses-of-covid-19-vaccine-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7807626724243164
2603,2/17/2021 10:37:53 AM,"Pfizer, BioNTech Agree To Supply Additional 200 Mln Doses Of COVID-19 Vaccine To EU
member States ",RTTNews,/news/stocks/pfizer-biontech-agree-to-supply-additional-200-mln-doses-of-covid-19-vaccine-to-eu-member-states-1030090930,negative,0.90045565366745
2604,2/17/2021 12:25:50 PM,"A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Earnings, Economic Data",Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-edge-lower-ahead-of-earnings-economic-data-1030091312,neutral,0.9548516869544983
2605,2/17/2021 1:06:36 PM,Pfizer Initiates Phase 2 Trial Of BCMA-CD3 Bispecific Antibody Elranatamab In Multiple Myeloma ,RTTNews,/news/stocks/pfizer-initiates-phase-2-trial-of-bcma-cd3-bispecific-antibody-elranatamab-in-multiple-myeloma-1030091545,negative,0.6537582278251648
2606,2/17/2021 1:26:55 PM,"The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-funding-for-gene-therapy-research-priority-review-for-amgen-cancer-drug-pfizer-biontech-vaccine-supply-deal-1030091631,positive,0.8941707015037537
2607,2/17/2021 7:56:35 PM,7 Blue-Chip Stocks That Aren’t a Gamble,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-arent-a-gamble-1030094166,positive,0.9075457453727722
2608,2/17/2021 8:44:10 PM,"Q4 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",Benzinga,/news/stocks/q4-13f-roundup-how-buffett-einhorn-ackman-and-others-adjusted-their-portfolios-1030093945,positive,0.8798474073410034
2609,2/18/2021 12:27:43 AM,Pfizer says South African Covid variant may significantly cut vaccine protection,Seeking Alpha,https://seekingalpha.com/news/3663263-pfizer-says-south-african-covid-variant-may-significant-reduce-vaccine-protection?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8995420336723328
2610,2/18/2021 5:58:36 AM,"NKTR Teams Up With MRK, Pfizer Initiates Multiple Myeloma Trial, PCSA On Watch ",RTTNews,/news/stocks/nktr-teams-up-with-mrk-pfizer-initiates-multiple-myeloma-trial-pcsa-on-watch-1030094876,positive,0.7950220108032227
2611,2/18/2021 10:06:00 AM,"Myovant, Pfizer's relugolix combo shows durable efficacy in uterine fibroids",Seeking Alpha,https://seekingalpha.com/news/3663304-myovant-pfizers-relugolix-combo-shows-efficacy-in-uterine-fibroids?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.948516309261322
2612,2/18/2021 11:45:43 AM,COVID-19 vaccine developers to benefit from supply constraints and uneven distribution,Seeking Alpha,https://seekingalpha.com/news/3663356-covid-19-vaccine-developers-to-benefit-from-supply-constraints-and-uneven-distribution?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7471115589141846
2613,2/18/2021 2:14:38 PM,"The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-lily-rigel-licensing-deal-vtv-starts-early-stage-psoriasis-study-immunic-data-readout-1030097072,positive,0.9154621958732605
2614,2/18/2021 6:26:24 PM,7 Growth Stocks That Are Slowing Down,InvestorPlace,/news/stocks/7-growth-stocks-that-are-slowing-down-1030115094,neutral,0.8068123459815979
2615,2/18/2021 7:55:46 PM,NVAX Stock Is the Most Undervalued Vaccine Maker for Endemic Covid-19,InvestorPlace,/news/stocks/nvax-stock-most-undervalued-vaccine-maker-endemic-covid-19-1030099038,neutral,0.6225293874740601
2616,2/18/2021 8:33:57 PM,Pfizer/ BioNTech initiate dosing in a global trial to test COVID-19 vaccine in pregnancy,Seeking Alpha,https://seekingalpha.com/news/3663604-pfizer-biontech-initiate-dosing-in-a-global-trial-to-test-covid-19-vaccine-in-pregnancy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7880843877792358
2617,2/19/2021 7:02:13 AM,"FLXN On Track, IMNM Discovers Antibodies To Fight S. African Variant, RIGL In Deal With LLY ",RTTNews,/news/stocks/flxn-on-track-imnm-discovers-antibodies-to-fight-s-african-variant-rigl-in-deal-with-lly-1030100306,negative,0.922179102897644
2618,2/19/2021 9:04:52 AM,Global vaccine distribution a focus at G7 summit,Seeking Alpha,https://seekingalpha.com/news/3663811-global-vaccine-distribution-a-focus-at-g7-summit?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8714959621429443
2619,2/19/2021 11:56:27 AM,Single shot of Pfizer's COVID-19 vaccine shows 85% efficacy: Israeli Study,Seeking Alpha,https://seekingalpha.com/news/3663862-single-shot-of-pfizers-covid-19-vaccine-shows-85-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6932997107505798
2620,2/19/2021 12:33:48 PM,"Pfizer, BioNTech propose COVID-19 vaccine label update to ease storage",Seeking Alpha,https://seekingalpha.com/news/3663880-pfizer-biontech-propose-covid-19-vaccine-label-update-to-ease-storage?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6727196574211121
2621,2/19/2021 1:25:51 PM,"The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-vaccine-supply-deal-orphan-drug-designation-for-travere-covid-19-boost-for-quidel-opko-1030101326,positive,0.7778980731964111
2622,2/19/2021 3:34:26 PM,10 Dividend Stocks Increasing Their Payouts ,InvestorPlace,/news/stocks/10-dividend-stocks-increasing-their-payouts-1030102687,negative,0.9194903373718262
2623,2/19/2021 4:14:19 PM,Pfizer Submits Data Showing COVID-19 Vacccine's Stability At Standard Freeze Temperature ,RTTNews,/news/stocks/pfizer-submits-data-showing-covid-19-vacccine-s-stability-at-standard-freeze-temperature-1030102299,negative,0.6874440312385559
2624,2/19/2021 5:01:45 PM,AMC Entertainment Stock Will Likely Be a Flop for Investors,InvestorPlace,/news/stocks/amc-stock-will-likely-be-a-flop-for-investors-1030102671,neutral,0.9563320279121399
2625,2/19/2021 6:31:06 PM,3 Perfect Pullback Stocks to Buy,InvestorPlace,/news/stocks/3-perfect-pullback-stocks-to-buy-1030102995,positive,0.8571521639823914
2626,2/19/2021 6:40:34 PM,Winter weather pummeling U.S. delays distribution of 6M COVID-19 vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3664037-winter-weather-pummeling-us-delays-covid-19-vaccine-distribution?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.95577472448349
2627,2/19/2021 8:15:51 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3664052-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
2628,2/19/2021 9:25:35 PM,"Pfizer will 'more than double' COVID-19 vaccine output in U.S., CEO Bourla says",Seeking Alpha,https://seekingalpha.com/news/3664106-pfizer-will-more-than-double-covid-19-vaccine-output-in-us-ceo-bourla-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9456496834754944
2629,2/19/2021 10:23:13 PM,"Michael Burry's Top 5 Holdings: Pfizer, CitiGroup, Kraft Heinz, More",Benzinga,/news/stocks/michael-burry-s-top-5-holdings-pfizer-citigroup-kraft-heinz-more-1030103239,positive,0.9461222887039185
2630,2/21/2021 4:18:07 AM,A new model shows U.S. could reach COVID-19 herd immunity by July,Seeking Alpha,https://seekingalpha.com/news/3664177-a-new-model-shows-us-could-reach-covid-19-herd-immunity-by-july?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6344996094703674
2631,2/21/2021 1:42:38 PM,"Israel publishes real-world data of Pfizer vaccine, prevents 98.9% of COVID deaths",Seeking Alpha,https://seekingalpha.com/news/3664180-israel-publishes-real-world-data-of-pfizer-vaccine-prevents-989-of-covid-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7882344126701355
2632,2/22/2021 4:57:35 AM,Covid vaccine: U.K. aims to inoculate all adults by July 31,Seeking Alpha,https://seekingalpha.com/news/3664193-all-uk-adults-to-get-a-first-covid-19-shot-by-july-31?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7935236096382141
2633,2/22/2021 7:00:35 AM,"Australia starts COVID-19 vaccine rollout, PM receives first jab",Seeking Alpha,https://seekingalpha.com/news/3664195-australia-starts-covid-19-vaccine-rollout-pm-receives-first-jab?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8384439945220947
2634,2/22/2021 2:07:58 PM,Six stocks hedge funds and mutual funds love (and 20 they don't): At the Open,Seeking Alpha,https://seekingalpha.com/news/3664311-six-stocks-hedge-funds-and-mutual-funds-love?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9283661842346191
2635,2/22/2021 8:45:22 PM,Ocugen Could Still Be Undervalued If Its Covid-19 Vaccine Gets OK,InvestorPlace,/news/stocks/ocgn-stock-ocugen-could-be-worth-24-percent-more-1030109377,neutral,0.8428449034690857
2636,2/22/2021 10:12:56 PM,One shot of Pfizer/BioNTech COVID-19 vaccine cuts infection risk by 72%,Seeking Alpha,https://seekingalpha.com/news/3664644-one-shot-of-pfizer-biontech-vaccine-cuts-infection-risk-by-72?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9335710406303406
2637,2/23/2021 8:45:38 AM,"Moderna to boost COVID-19 vaccine supply after ""positive"" FDA feedback",Seeking Alpha,https://seekingalpha.com/news/3664699-moderna-to-boost-covid-19-vaccine-supply-after-positive-fda-feedback?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9502369165420532
2638,2/23/2021 10:11:49 AM,7 of the Best Stocks To Buy as a New Investor,InvestorPlace,/news/stocks/7-of-the-best-stocks-to-buy-as-a-new-investor-1030111853,positive,0.7445579171180725
2639,2/23/2021 1:02:54 PM,"Pfizer, Moderna To Increase Covid Vaccine Supply ",RTTNews,/news/stocks/pfizer-moderna-to-increase-covid-vaccine-supply-1030112053,negative,0.8433186411857605
2640,2/23/2021 6:34:32 PM,"AMD Stock Is Down, but Not Out",InvestorPlace,/news/stocks/amd-stock-is-down-but-not-out-1030114802,neutral,0.9599562287330627
2641,2/23/2021 7:02:29 PM,Why You Should Keep Your Distance from Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-stay-your-distance-from-ocugen-1030114797,positive,0.9112824201583862
2642,2/24/2021 1:17:19 PM,RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today,InvestorPlace,/news/stocks/rlftf-why-little-known-relief-therapeutics-is-climbing-today-brpa-stock-1030119085,negative,0.6067991852760315
2643,2/24/2021 1:30:11 PM,"The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-bausch-calls-truce-with-icahn-pfizer-s-brain-inflammation-vaccine-gets-priority-review-briacell-ipo-1030117814,positive,0.8318552374839783
2644,2/24/2021 3:03:19 PM,What Will the Stock Market Do Today? 4 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-big-stories-rfltf-stock-wkhs-stock-fsr-stock-1030119078,positive,0.928909957408905
2645,2/24/2021 4:36:54 PM,7 Industries Likely to See a Boost in 2021,InvestorPlace,/news/stocks/stock-predictions-seven-industries-likely-see-boost-2021-1030119589,negative,0.9438855051994324
2646,2/24/2021 6:12:21 PM,ViiV Healthcare seeks expanded label for HIV treatment Cabenuva,Seeking Alpha,https://seekingalpha.com/news/3665720-viiv-healthcare-seeks-expanded-label-for-hiv-treatment-cabenuva?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8430130481719971
2647,2/25/2021 1:13:18 PM,"Pfizer, BioNTech Initiate Study To Evaluate COVID-19 Booster And New Vaccine Variants ",RTTNews,/news/stocks/pfizer-biontech-initiate-study-to-evaluate-covid-19-booster-and-new-vaccine-variants-1030123271,negative,0.6112051010131836
2648,2/25/2021 2:08:03 PM,"The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-goes-shopping-decision-day-for-sarepta-pfizer-moderna-unveil-vaccine-strategies-for-coronavirus-variants-1030123681,positive,0.9286142587661743
2649,2/25/2021 3:22:19 PM,5 Surefire Stocks If the Market Crashes,InvestorPlace,/news/stocks/5-surefire-stocks-if-the-market-crash-1030125308,positive,0.870312511920929
2650,2/25/2021 5:46:11 PM,7 Cheap Stocks to Buy for March,InvestorPlace,/news/stocks/7-cheap-stocks-to-buy-for-march-1030125633,positive,0.8811225891113281
2651,2/25/2021 7:59:05 PM,Pfizer CEO Bourla sees potential need for annual COVID-19 shot - NBC,Seeking Alpha,https://seekingalpha.com/news/3666623-pfizer-ceo-bourla-sees-potential-need-for-annual-covid-19-shot-nbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.646657407283783
2652,2/25/2021 8:41:22 PM,Pfizer joins Moderna to predict a flu-like market for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3666639-pfizer-joins-moderna-to-predict-a-flu-like-market-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6671640276908875
2653,2/26/2021 1:27:10 PM,EMA Accepts Pfizer's MAA For 20-valent Pneumococcal Conjugate Vaccine Candidate For Adults ,RTTNews,/news/stocks/ema-accepts-pfizer-s-maa-for-20-valent-pneumococcal-conjugate-vaccine-candidate-for-adults-1030129135,negative,0.7794808745384216
2654,2/26/2021 1:28:57 PM,Pfizer Says EMA Accepted Marketing Authorization Application For Growth Hormone Somatrogon ,RTTNews,/news/stocks/pfizer-says-ema-accepted-marketing-authorization-application-for-growth-hormone-somatrogon-1030129134,negative,0.7920141816139221
2655,2/26/2021 1:38:35 PM,"Pfizer, OPKO Health's somatrogon application validated in Europe",Seeking Alpha,https://seekingalpha.com/news/3667118-pfizer-opko-healths-somatrogon-application-validated-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7631009817123413
2656,2/26/2021 3:20:06 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-hmbl-tsnp-stock-tsnpd-jnj-abnb-stock-1030130462,positive,0.9298974871635437
2657,2/26/2021 3:52:16 PM,Health Canada authorizes AstraZeneca COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3667222-health-canada-authorizes-astrazeneca-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9250293970108032
2658,2/26/2021 4:25:36 PM,9 Great Dividend Stocks with 3%+ Yields,InvestorPlace,/news/stocks/9-great-dividend-stocks-three-percent-plus-yields-1030130451,positive,0.8945554494857788
2659,2/26/2021 10:10:23 PM,Johnson & Johnson rises as COVID-19 vaccine clears FDA panel vote,Seeking Alpha,https://seekingalpha.com/news/3667371-johnson-johnson-rises-as-covid-19-vaccine-clears-fda-panel-vote?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6096546053886414
2660,2/27/2021 3:53:56 PM,FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine ,RTTNews,/news/stocks/fda-says-rapidly-works-toward-emergency-use-approval-of-j-j-s-single-shot-covid-19-vaccine-1030131785,negative,0.895912230014801
2661,2/27/2021 5:58:02 PM,"The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings",Benzinga,/news/stocks/the-week-ahead-in-biotech-feb-28-march-6-kempharm-gilead-fda-decisions-and-more-earnings-1030131919,positive,0.9394730925559998
2662,2/27/2021 11:21:57 PM,Johnson & Johnson COVID-19 vaccine wins FDA's emergency-use approval,Seeking Alpha,https://seekingalpha.com/news/3667403-johnson-johnson-covid-19-vaccine-wins-fdas-emergency-use-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.920475423336029
2663,2/28/2021 4:54:54 PM,Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-march-pdufa-dates-1030132296,positive,0.9465387463569641
2664,3/1/2021 11:51:19 AM,JNJ COVID-19 vaccine distribution started: McKesson,Seeking Alpha,https://seekingalpha.com/news/3667462-jnj-covid-19-vaccine-distribution-started-mckesson?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9332539439201355
2665,3/1/2021 3:16:25 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-warren-buffett-bitcoin-nio-stock-doge-ccl-sos-1030136574,positive,0.9298974871635437
2666,3/1/2021 8:54:10 PM,The Excitement Around Ocugen Is Irrational,InvestorPlace,/news/stocks/ocgn-stock-excitement-around-ocugen-is-irrational-1030137352,positive,0.8817915916442871
2667,3/2/2021 10:01:13 AM,7 Blue-Chip Stocks That Look a Little Pale,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-look-a-little-pale-1030139587,positive,0.9052385091781616
2668,3/2/2021 6:51:51 PM,ViiV Healthcare wins FDA nod for Dovato and Triumeq label expansion,Seeking Alpha,https://seekingalpha.com/news/3668425-viiv-healthcare-wins-fda-nod-for-dovato-and-triumeq-label-expansion?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8933117389678955
2669,3/3/2021 3:19:25 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-rkt-uwmc-stock-ocgn-lyft-nvax-nclh-1030146548,positive,0.9298974871635437
2670,3/4/2021 2:05:32 AM,FDA Expands Approval Of Pfizer's Lorbrena As Treatment For ALK-Positive Metastatic Lung Cancer ,RTTNews,/news/stocks/fda-expands-approval-of-pfizer-s-lorbrena-as-treatment-for-alk-positive-metastatic-lung-cancer-1030147917,negative,0.9039050936698914
2671,3/4/2021 5:59:32 AM,FDA OKs expanded use of Pfizer’s Lorbrena as first-line treatment in lung cancer,Seeking Alpha,https://seekingalpha.com/news/3669183-fda-oks-expanded-use-of-pfizers-lorbrena-as-first-line-treatment-in-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8869173526763916
2672,3/4/2021 8:21:01 AM,"KMPH Scores FDA Nod For ADHD Drug, MNOV Quits COVID-19 Vaccine Race, UTHR Gives Up On  Trevyent ",RTTNews,/news/stocks/kmph-scores-fda-nod-for-adhd-drug-mnov-quits-covid-19-vaccine-race-uthr-gives-up-on-trevyent-1030148726,neutral,0.4931647479534149
2673,3/4/2021 12:07:22 PM,Ron Baron says he sold some Tesla stock for clients,Seeking Alpha,https://seekingalpha.com/news/3669267-ron-baron-says-he-sold-some-tesla-stock-for-clients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9349101185798645
2674,3/4/2021 12:50:55 PM,Ocugen Just Overcame a Serious Hurdle,InvestorPlace,/news/stocks/ocugen-just-overcame-a-serious-hurdle-1030150180,negative,0.5539586544036865
2675,3/4/2021 2:12:10 PM,"The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-nod-for-pfizer-kiniksa-rises-on-commercialization-pact-with-regeneron-bio-techne-to-buy-diagnostic-company-1030150188,negative,0.9189565181732178
2676,3/4/2021 5:06:51 PM,9 Cheap Stocks That Look Like a Bargain,InvestorPlace,/news/stocks/9-cheap-stocks-look-like-bargain-1030151715,positive,0.8964874744415283
2677,3/4/2021 5:45:36 PM,Avoid Johnson & Johnson Shares Like the Plague,InvestorPlace,/news/stocks/jnj-stock-avoid-johnson-johnson-shares-like-the-plague-1030152096,positive,0.8476832509040833
2678,3/4/2021 6:12:09 PM,Here’s How to Trade American Airlines Stock at its Highs,InvestorPlace,/news/stocks/heres-how-to-trade-american-airlines-aal-stock-at-its-highs-1030152093,positive,0.9343506097793579
2679,3/4/2021 7:38:08 PM,Johnson & Johnson Is One of the Best Healthcare Plays on the Market,InvestorPlace,/news/stocks/jnj-stock-is-one-of-the-best-healthcare-on-the-market-1030152430,negative,0.5902022123336792
2680,3/4/2021 7:41:34 PM,Can Carnival Stock Get Back to $72.70 by the End of 2022?,InvestorPlace,/news/stocks/can-carnival-ccl-stock-get-back-to-72-70-by-the-end-of-2022-1030152429,positive,0.792590320110321
2681,3/5/2021 4:50:37 PM,7 Mega-Cap Stocks Standing Above the Fray,InvestorPlace,/news/stocks/7-mega-cap-stocks-standing-above-the-fray-1030155694,negative,0.6427069902420044
2682,3/5/2021 8:55:23 PM,Carnival Is Climbing Too High Too Fast,InvestorPlace,/news/stocks/ccl-stock-moving-too-high-too-fast-1030156156,positive,0.5624954700469971
2683,3/7/2021 5:05:27 AM,"Scientists skeptical of one-shot regimen for Pfizer, Moderna vaccines - WSJ",Seeking Alpha,https://seekingalpha.com/news/3670092-scientists-skeptical-of-one-shot-regimen-for-pfizer-moderna-vaccines-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8598488569259644
2684,3/8/2021 8:23:18 AM,"Valneva, Pfizer Initiate Phase 2 Study For Lyme Disease Vaccine Candidate ",RTTNews,/news/stocks/valneva-pfizer-initiate-phase-2-study-for-lyme-disease-vaccine-candidate-1030158282,positive,0.6396617293357849
2685,3/8/2021 11:15:46 AM,Is Ocugen Worth $18 or Just a Couple of Bucks?,InvestorPlace,/news/stocks/is-ocgn-stock-worth-18-or-just-a-couple-of-bucks-1030159343,positive,0.933696448802948
2686,3/8/2021 1:37:43 PM,ViiV Healthcare says once-monthly HIV therapy is equally effective with 2-month dosing,Seeking Alpha,https://seekingalpha.com/news/3670209-viiv-healthcare-says-once-monthly-hiv-therapy-is-equally-effective-with-2-month-dosing?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6440292596817017
2687,3/8/2021 2:05:48 PM,Pfizer and Valneva begin mid-stage study for Lyme disease vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3670230-pfizer-and-valneva-begins-mid-stage-study-for-lyme-disease-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7914947271347046
2688,3/8/2021 6:37:03 PM,NIH starts trial enrollment for Bristol/Pfizer's Eliquis for blood clots in COVID patients,Seeking Alpha,https://seekingalpha.com/news/3670365-nih-starts-trial-enrollment-for-bristol-pfizer-eliquis-for-blood-clots-in-covid-patients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6098654866218567
2689,3/8/2021 8:58:27 PM,Johnson & Johnson Is a Stock to Buy and Hold Forever,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-is-a-stock-to-buy-and-hold-forever-1030161050,positive,0.9522393941879272
2690,3/9/2021 7:16:48 AM,Roche : FDA Oks Ventana Assay To Identify Lung Cancer Patients Eligible For Treatment With LORBRENA ,RTTNews,/news/stocks/roche-fda-oks-ventana-assay-to-identify-lung-cancer-patients-eligible-for-treatment-with-lorbrena-1030162107,negative,0.7206847667694092
2691,3/9/2021 7:34:24 AM,FDA OKs expanded use of Roche's Ventalan ALK Assay in lung cancer,Seeking Alpha,https://seekingalpha.com/news/3670547-fda-oks-expanded-use-of-roches-ventalan-alk-assay-in-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8587040901184082
2692,3/9/2021 8:37:41 AM,Pfizer-BioNTech COVID-19 jab neutralizes Brazilian strain - Reuters,Seeking Alpha,https://seekingalpha.com/news/3670550-pfizer-biontech-covid-19-jab-neutralizes-brazilian-strain?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7815542817115784
2693,3/9/2021 2:08:24 PM,"The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data",Benzinga,/news/stocks/the-daily-biotech-pulse-regulatory-setback-for-acadia-lilly-forges-diabetes-antibody-treatment-collaboration-aytu-s-positive-covid-19-data-1030163477,positive,0.44644373655319214
2694,3/9/2021 3:36:46 PM,Genome Signs Deal With Merck KGaA And Pfizer For Immuno-oncology Microbiome Study ,RTTNews,/news/stocks/genome-signs-deal-with-merck-kgaa-and-pfizer-for-immuno-oncology-microbiome-study-1030164497,negative,0.7686527967453003
2695,3/9/2021 5:46:49 PM,Why Is Graybug Vision Stock Plunging Today?,Benzinga,/news/stocks/why-is-graybug-vision-stock-plunging-today-1030165040,neutral,0.9123253226280212
2696,3/9/2021 5:52:34 PM,Phase 2 proof-of-concept trial for ViiV Healthcare HIV treatment successful,Seeking Alpha,https://seekingalpha.com/news/3670810-phase-2-proof-of-concept-trial-for-viiv-healthcare-hiv-treatment-successful?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5027735233306885
2697,3/9/2021 10:13:58 PM,"BioNTech, Pfizer could have capacity for 3 billion COVID-19 vaccines in 2022 - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3670969-biontech-pfizer-could-have-capacity-for-3-billion-covid-19-vaccines-in-2022-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.68431556224823
2698,3/10/2021 12:38:38 PM,Pfizer/BioNTech to supply extra 4M vaccine doses to EU to tackle virus border clusters,Seeking Alpha,https://seekingalpha.com/news/3671111-pfizerbiontech-to-supply-extra-4m-vaccine-doses-to-eu-to-tackle-virus-border-clusters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7414291501045227
2699,3/10/2021 4:54:25 PM,8 Biotech Penny Stocks for Investors to Watch,InvestorPlace,/news/stocks/eight-biotech-penny-stocks-investors-to-watch-1030169900,positive,0.9360546469688416
2700,3/11/2021 12:15:45 AM,"Schwab, TD Ameritrade Experts Talk Retail Trader Sentiment, Inflation, Reopening Plays",Benzinga,/news/stocks/schwab-ameritrade-experts-talk-retail-trader-sentiment-inflation-reopening-plays-1030171013,positive,0.8992874026298523
2701,3/11/2021 12:18:47 PM,Pfizer-BioNTech's COVID-19 vaccine shows 97% efficacy after second dose: Real-world evidence,Seeking Alpha,https://seekingalpha.com/news/3671611-pfizer-biontechs-covid-19-vaccine-shows-97-efficacy-after-second-dose?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7108933329582214
2702,3/11/2021 1:04:20 PM,Real-world Data Shows Effectiveness Of At Least 97% For Pfizer-BioNTech COVID-19 Vaccine ,RTTNews,/news/stocks/real-world-data-shows-effectiveness-of-at-least-97-for-pfizer-biontech-covid-19-vaccine-1030172699,negative,0.9155812859535217
2703,3/11/2021 4:22:47 PM,Johnson & Johnson' Single-dose COVID-19 Vaccine Recommended For Use In EU ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-19-vaccine-recommended-for-use-in-eu-1030174234,positive,0.6332618594169617
2704,3/11/2021 9:44:40 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-cpng-stock-ocgn-stock-stimulus-1030175736,positive,0.9254742860794067
2705,3/12/2021 9:30:53 AM,Biden says all U.S. adults to be eligible for vaccines by May 1,Seeking Alpha,https://seekingalpha.com/news/3672131-biden-says-all-us-adults-to-be-eligible-for-vaccines-by-may-1?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8409744501113892
2706,3/12/2021 11:17:58 AM,Novavax (NVAX) shares continue to climb after robust COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3672149-novavax-nvax-shares-continue-to-climb-on-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9462754726409912
2707,3/12/2021 3:07:40 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ride-stock-nvax-stock-infrastructure-nflx-1030179712,positive,0.9298974871635437
2708,3/12/2021 4:43:05 PM,7 Healthcare Stocks to Buy and Hold for the Long Term,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-and-hold-for-the-long-term-1030180655,positive,0.9046281576156616
2709,3/12/2021 6:04:49 PM,Merck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/3672343-merck-and-pfizer-among-top-picks-to-lead-2021-biopharma-ma-activity-goldman-sachs?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7542275786399841
2710,3/12/2021 10:06:30 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-vaccines-nvax-wkhs-ride-stock-chpt-stock-nfts-1030182966,positive,0.9254742860794067
2711,3/14/2021 4:59:20 AM,BioNTech forming an alliance to boost COVID-19 vaccine supplies: WSJ,Seeking Alpha,https://seekingalpha.com/news/3672436-biontech-forming-an-alliance-to-boost-covid-19-vaccine-supplies-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.930338978767395
2712,3/14/2021 5:40:20 AM,"Big Pharma is pushing back the pandemic, but its stocks are cheap - Barron's",Seeking Alpha,https://seekingalpha.com/news/3672437-big-pharma-is-pushing-back-the-pandemic-but-its-stocks-are-cheap-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6729742884635925
2713,3/15/2021 10:16:28 AM,Ocugen Needs Pieces To Fall Into Place Before It’s a Solid Vaccine Play,InvestorPlace,/news/stocks/ocgn-stock-is-purely-a-speculative-covid-19-vaccine-play-1030203068,positive,0.8894945383071899
2714,3/15/2021 2:50:37 PM,Merck and Gilead announce partnership for long-acting HIV treatments,Seeking Alpha,https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7411401271820068
2715,3/15/2021 4:29:24 PM,7 High-Yield Stocks for Your Retirement Nest Egg,InvestorPlace,/news/stocks/seven-high-yield-retirement-stocks-for-your-nest-egg-1030206601,positive,0.9213786125183105
2716,3/15/2021 4:30:50 PM,8 of the Best Index Funds With Ultra-Low Fees,InvestorPlace,/news/stocks/8-of-the-best-index-funds-with-ultra-low-fees-1030206599,negative,0.6150591373443604
2717,3/15/2021 6:18:28 PM,Sell Ocugen Stock Now Before It Sinks Even Further,InvestorPlace,/news/stocks/sell-ocgn-stock-now-before-it-sinks-even-further-1030207527,positive,0.9194988012313843
2718,3/15/2021 6:19:30 PM,Ocugen plans to sell 100M doses of COVID-19 vaccine in U.S. in 2021 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3672781-ocugen-plans-to-sell-100m-doses-of-covid-19-vaccine-in-us-in-2021-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6109246611595154
2719,3/15/2021 6:59:36 PM,OCGN Stock: Red-Hot Ocugen Eyes U.S. Vaccine Launch in Q2,InvestorPlace,/news/stocks/ocgn-stock-red-hot-ocugen-eyes-u-s-vaccine-launch-in-q2-1030207522,positive,0.8990409970283508
2720,3/15/2021 8:12:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-ocgn-stock-sndl-ccl-aal-tlry-amc-stock-1030208455,positive,0.9254742860794067
2721,3/16/2021 2:35:36 PM,Investing in Moderna Has Little Upside At This Point,InvestorPlace,/news/stocks/investing-in-mrna-stock-has-little-upside-at-this-point-1030215865,positive,0.9287043213844299
2722,3/17/2021 3:19:32 AM,WuXi Biologics acquiring manufacturing facilities from Pfizer China,Seeking Alpha,https://seekingalpha.com/news/3673440-wuxi-biologics-acquiring-manufacturing-facilities-from-pfizer-china?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5177362561225891
2723,3/17/2021 3:49:16 AM,WuXi Biologics To Buy Biologics DS & DP Manufacturing Facilities From Pfizer China ,RTTNews,/news/stocks/wuxi-biologics-to-buy-biologics-ds-dp-manufacturing-facilities-from-pfizer-china-1030217463,positive,0.6698740720748901
2724,3/17/2021 12:43:08 PM,"The Daily Biotech Pulse: Merck's Keytruda Gets Label Expansion In Europe, Pfizer To Sell Chinese Biologics Unit, Celcuity Spikes",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-keytruda-gets-label-expansion-in-europe-pfizer-to-sell-chinese-biologics-unit-celcuity-spikes-1030219036,negative,0.6757802963256836
2725,3/17/2021 2:12:17 PM,The Great Air Travel Boom of 2021 Is Only One ‘Generation’ Away,InvestorPlace,/news/stocks/the-great-air-travel-boom-of-2021-is-only-one-generation-away-1030220371,positive,0.8851231932640076
2726,3/17/2021 3:59:26 PM,Abbvie shares fall following FDA review extension for RINVOQ sNDA (updated),Seeking Alpha,https://seekingalpha.com/news/3673586-abbvie-shares-fall-6-following-snda-review-extension-for-rinvoq?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9519258141517639
2727,3/18/2021 9:35:38 AM,European Medicines Agency to release findings on AstraZeneca vaccine,Seeking Alpha,https://seekingalpha.com/news/3673882-european-medicines-agency-to-release-findings-on-astrazeneca-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9161737561225891
2728,3/18/2021 12:32:16 PM,"Pfizer, Merck KGaA and Exelixis to collaborate in bladder cancer trial",Seeking Alpha,https://seekingalpha.com/news/3673995-pfizer-merck-kgaa-and-exelixis-collaborate-in-bladder-cancer-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7676289081573486
2729,3/18/2021 12:32:55 PM,Pyxis Oncology and Pfizer ink worldwide license agreement,Seeking Alpha,https://seekingalpha.com/news/3673996-pyxis-oncology-and-pfizer-ink-worldwide-license-agreement?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8958735466003418
2730,3/18/2021 6:28:52 PM,Microvision Isn’t the Second Coming,InvestorPlace,/news/stocks/microvision-mvis-stock-isnt-the-second-coming-1030225541,positive,0.9199715852737427
2731,3/19/2021 1:42:55 PM,Ocugen Stock Is Not One to Trust With Nest Egg Funds,InvestorPlace,/news/stocks/ocgn-stock-ocugen-not-one-to-trust-with-nest-egg-funds-1030228419,positive,0.930368185043335
2732,3/19/2021 7:30:46 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3674473-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
2733,3/19/2021 7:38:37 PM,7 Dividend Stocks You Can Trust Your Retirement To,InvestorPlace,/news/stocks/7-dividend-stocks-you-can-trust-your-retirement-to-1030229256,positive,0.9159671068191528
2734,3/20/2021 2:52:32 PM,"FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And Earnings",Benzinga,/news/stocks/fda-decisions-for-pfizer-eli-lilly-and-bluebird-bio-bristol-meyers-squibb-plus-new-data-and-earnings-1030229632,positive,0.9303885102272034
2735,3/22/2021 11:47:30 AM,AstraZeneca COVID-19 shot shows 79% efficacy; shares rise 2.5%,Seeking Alpha,https://seekingalpha.com/news/3674697-moderna-and-biontech-lower-after-astrazeneca-releases-us-trial-data-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.948603630065918
2736,3/22/2021 2:21:54 PM,3 Reasons Pfizer Stock Is Worth a Shot,InvestorPlace,/news/stocks/3-reasons-pfizer-pfe-stock-is-worth-a-shot-1030232940,positive,0.7668699026107788
2737,3/22/2021 2:23:40 PM,FDA briefing documents released ahead of AdCom meeting on Pfizer’s BLA for tanezumab,Seeking Alpha,https://seekingalpha.com/news/3674809-fda-briefing-documents-released-ahead-of-adcom-meeting-on-pfizers-tanezumab?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9152623414993286
2738,3/22/2021 7:21:51 PM,Pfizer Stock Is a Good Value Given Its Valuation History,InvestorPlace,/news/stocks/pfe-stock-is-worth-18-percent-more-based-on-its-historical-pe-ratio-dividend-yield-1030233953,negative,0.6594751477241516
2739,3/23/2021 6:31:22 AM,"AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug ",RTTNews,/news/stocks/azn-s-covid-19-jab-shows-79-efficacy-zeal-wins-fda-approval-adcomm-to-review-osteoarthritis-drug-1030234460,negative,0.9112752676010132
2740,3/23/2021 12:46:21 PM,IDEAYA announces dose expansion of Phase 1/2 study on metastatic uveal melanoma,Seeking Alpha,https://seekingalpha.com/news/3675171-ideaya-announces-dose-expansion-of-study-on-metastatic-uveal-melanoma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8661121726036072
2741,3/23/2021 1:02:44 PM,3 Key Reasons to Be Bullish on Airbnb Stock,InvestorPlace,/news/stocks/3-key-reasons-to-be-bullish-on-airbnb-stock-1030236613,positive,0.8414599299430847
2742,3/23/2021 1:32:30 PM,Why You Should Avoid Pfizer Stock Despite Its Covid-19 Vaccine,InvestorPlace,/news/stocks/why-you-should-avoid-pfe-stock-despite-its-covid-19-vaccine-1030237351,positive,0.9030888676643372
2743,3/23/2021 1:59:25 PM,Pfizer to develop new shots using COVID-19 vaccine technology: WSJ,Seeking Alpha,https://seekingalpha.com/news/3675240-pfizer-to-develop-new-shots-using-covid-19-vaccine-technology-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.637053370475769
2744,3/23/2021 3:36:02 PM,Take Your Profits! 7 Covid Winners to Sell Now,InvestorPlace,/news/stocks/7-covid-stocks-to-consider-trimming-1030237832,positive,0.9159734845161438
2745,3/23/2021 3:51:02 PM,Pfizer makes progress in early-stage trials for COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3675287-pfizer-makes-progress-in-early-stage-trials-for-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9258639812469482
2746,3/23/2021 3:55:22 PM,Ocugen Looks Very Dicey at Current Levels,InvestorPlace,/news/stocks/ocugen-ocgn-stock-looks-very-dicey-at-current-levels-1030237828,positive,0.6844010353088379
2747,3/23/2021 4:46:16 PM,Drug pricing legislation introduced by Sanders weighs on pharmas,Seeking Alpha,https://seekingalpha.com/news/3675361-drug-pricing-legislation-introduced-by-sanders-weighs-on-pharmas?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8964442610740662
2748,3/23/2021 6:58:29 PM,7 Stocks To Buy Right Now Before Warm Weather Hits,InvestorPlace,/news/stocks/7-stocks-to-buy-right-now-before-warm-weather-hits-1030238179,positive,0.9005694389343262
2749,3/24/2021 4:49:13 AM,Hong Kong halts use of Pfizer/BioNTech jab over defective packaging,Seeking Alpha,https://seekingalpha.com/news/3675526-hong-kong-halts-use-of-pfizerbiontech-jab-over-defective-packaging?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8233343362808228
2750,3/24/2021 9:23:46 AM,EU set to curb COVID-19 vaccine export to U.K. - Reuters,Seeking Alpha,https://seekingalpha.com/news/3675539-eu-set-to-curb-covid-19-vaccines-export-to-uk-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.48424220085144043
2751,3/24/2021 10:54:31 AM,"Pfizer, Myovant Sciences' relugolix combo shows positive action in uterine fibroids",Seeking Alpha,https://seekingalpha.com/news/3675564-pfizer-myovant-sciences-relugolix-combo-shows-positive-action-in-uterine-fibroids?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9375385046005249
2752,3/24/2021 11:50:26 AM,Myovant & Pfizer: Long-term Study Supports Potential Benefit Of Relugolix Combination Therapy ,RTTNews,/news/stocks/myovant-pfizer-long-term-study-supports-potential-benefit-of-relugolix-combination-therapy-1030240138,negative,0.9263105392456055
2753,3/24/2021 1:59:18 PM,"The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-dynavax-clover-start-phase-2-3-vaccine-study-brainstorm-reports-positive-ms-readout-neogenomics-goes-shopping-1030241020,negative,0.6489724516868591
2754,3/25/2021 11:40:48 AM,"Ocugen Stock Has Way More Downside, Even After This Deep Correction",InvestorPlace,/news/stocks/ocgn-stock-more-downside-deep-correction-1030245902,positive,0.524740993976593
2755,3/25/2021 12:58:24 PM,"The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut",Benzinga,/news/stocks/the-daily-biotech-pulse-bristol-myers-squibb-s-skin-cancer-readout-cellect-strikes-reverse-merger-deal-lava-therapeutics-makes-nasdaq-debut-1030245316,positive,0.8989565968513489
2756,3/25/2021 1:04:30 PM,Pfizer : Real-World Evidence Supports Effectiveness Of Ibrance Combination Therapy In Breast Cancer ,RTTNews,/news/stocks/pfizer-real-world-evidence-supports-effectiveness-of-ibrance-combination-therapy-in-breast-cancer-1030245351,negative,0.9378798007965088
2757,3/25/2021 3:55:26 PM,Biden to announce new vaccine goal of 200M shots - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676327-biden-to-announce-new-vaccine-goal-of-200m-shots-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8850842118263245
2758,3/25/2021 4:30:01 PM,Pfizer’s tanezumab in osteoarthritis turned down by FDA expert panel (updated),Seeking Alpha,https://seekingalpha.com/news/3676348-pfizers-marketing-application-on-tanezumab-fails-in-adcom-vote?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.528425931930542
2759,3/25/2021 4:44:06 PM,Study finds Pfizer and Moderna vaccines safe and effective for pregnant women,Seeking Alpha,https://seekingalpha.com/news/3676349-study-finds-pfizer-and-moderna-vaccines-safe-and-effective-for-pregnant-women?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8990433812141418
2760,3/26/2021 9:38:09 AM,"5 Stocks To Watch For March 26, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-march-26-2021-1030249063,positive,0.9011488556861877
2761,3/26/2021 10:57:30 AM,A Peek Into The Markets: US Stock Futures Gain Ahead Of Economic Reports,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-gain-ahead-of-economic-reports-1030249240,negative,0.8521950244903564
2762,3/26/2021 12:20:54 PM,Aspira extends gains as analysts weigh in; Flexion to benefit from Pfizer’s failure in osteoarthritis drug and more in today’s analyst action,Seeking Alpha,https://seekingalpha.com/news/3676731-aspira-extends-gains-as-analysts-weigh-in-flexion-to-benefit-from-pfizers-failure?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9457762837409973
2763,3/26/2021 12:53:09 PM,Astellas and Pfizer's XTANDI gets EMA positive opinion for additional indication,Seeking Alpha,https://seekingalpha.com/news/3676755-astellas-and-pfizers-xtandi-gets-ema-positive-opinion-for-additional-indication?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8860776424407959
2764,3/26/2021 1:29:03 PM,EMA approves new storage option for Pfizer-Biontech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3676774-ema-approves-new-storage-option-for-pfizer-biontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.824560284614563
2765,3/26/2021 2:02:46 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-gme-stock-nio-stock-wework-ipo-1030250431,positive,0.9298974871635437
2766,3/26/2021 2:18:35 PM,"Marburg site wins EMA go ahead to manufacture BioNTech, Pfizer COVID-19 vaccine",Seeking Alpha,https://seekingalpha.com/news/3676797-marburg-site-wins-ema-go-ahead-to-manufacture-biontech-pfizer-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8116263747215271
2767,3/26/2021 3:53:41 PM,Is Approval Even Enough for Ocugen Stock?,InvestorPlace,/news/stocks/for-ocgn-stock-question-whether-approval-enough-1030250787,positive,0.8683006167411804
2768,3/26/2021 4:54:32 PM,3 Booming Metal Stocks to Buy for the Infrastructure Bill,InvestorPlace,/news/stocks/3-booming-metal-stocks-to-buy-for-the-infrastructure-bill-1030250774,positive,0.7788361310958862
2769,3/26/2021 9:17:45 PM,White House considers lifting IP protections for vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676977-white-house-considers-lifting-ip-protections-for-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7832401990890503
2770,3/27/2021 6:09:12 AM,Biotech Stocks Facing FDA Decision In April 2021 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-april-2021-1030251629,positive,0.7787618637084961
2771,3/28/2021 4:12:43 PM,"Is Now The Time To Buy Stock In Boeing, Pfizer, Tesla, GE Or Carnival?",Benzinga,/news/stocks/is-now-the-time-to-buy-stock-in-boeing-pfizer-tesla-ge-or-carnival-1030252393,positive,0.9383361339569092
2772,3/29/2021 3:12:50 PM,"BioNTech COVID-19 vaccines delivered to Hong Kong are safe, an initial investigation finds",Seeking Alpha,https://seekingalpha.com/news/3677230-biontech-covid-19-vaccines-delivered-to-hong-kong-are-safe-an-initial-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8253484964370728
2773,3/29/2021 3:45:13 PM,Pfizer/ BioNTech and Moderna vaccines are 80% effective in preventing COVID-19 infections after single dose,Seeking Alpha,https://seekingalpha.com/news/3677249-pfizer-and-moderna-vaccines-are-80-effective-in-preventing-covid-19-infections?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7952118515968323
2774,3/29/2021 6:09:45 PM,Ocugen Stock Will Continue to Climb in Anticipation of Vaccine Launch,InvestorPlace,/news/stocks/ocgn-stock-will-continue-to-climb-in-run-up-to-vaccine-launch-1030255859,negative,0.9484990239143372
2775,3/29/2021 6:51:19 PM,"Thinking About Buying Stock In Moderna, Palantir, Wells Fargo Or Bank of America?",Benzinga,/news/stocks/thinking-about-buying-stock-in-moderna-palantir-wells-fargo-or-bank-of-america-1030255667,positive,0.9251899719238281
2776,3/29/2021 11:37:41 PM,"CDC: Pfizer And Moderna COVID Vaccines Found 90% Effective In ""Real-World Conditions ",RTTNews,/news/stocks/cdc-pfizer-and-moderna-covid-vaccines-found-90-effective-in-real-world-conditions-1030256400,negative,0.8832564353942871
2777,3/30/2021 2:23:32 PM,7 Cannabis Stocks That Offer Much More Than Just Pot,InvestorPlace,/news/stocks/7-cannabis-stocks-that-offer-much-more-than-just-pot-1030260088,positive,0.8765715956687927
2778,3/30/2021 9:06:06 PM,Ocugen Is a Crisis Trade That Just Might Pan Out,InvestorPlace,/news/stocks/ocgn-stock-crisis-trade-that-might-work-1030260999,positive,0.7182822823524475
2779,3/31/2021 11:18:59 AM,Pfizer/BioNTech report positive data for COVID-19 shot in adolescents,Seeking Alpha,https://seekingalpha.com/news/3677958-pfizerbiontech-report-positive-data-for-covid-19-shot-in-adolescents?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9361347556114197
2780,3/31/2021 1:41:12 PM,"The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-vaccine-100-effective-in-adolescents-equillium-readout-amgen-goes-shopping-achilles-ipo-1030263061,positive,0.8173462748527527
2781,3/31/2021 1:47:25 PM,4 of the Best Stocks You’ve Never Heard of but Should Definitely watch,InvestorPlace,/news/stocks/4-of-the-best-stocks-youve-never-heard-of-but-should-definitely-watch-1030264341,positive,0.7741802930831909
2782,3/31/2021 1:59:14 PM,Pfizer/BioNTech's COVID-19 Vaccine Shows 100% Efficacy In Late-stage Trial In Adolescents ,RTTNews,/news/stocks/pfizer-biontech-s-covid-19-vaccine-shows-100-efficacy-in-late-stage-trial-in-adolescents-1030263186,negative,0.9266209602355957
2783,3/31/2021 2:44:47 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-stocks-to-benefit-from-infrastructure-bill-1030265148,positive,0.9298974871635437
2784,3/31/2021 3:27:13 PM,OCGN Stock: Why Red-Hot Ocugen Is Shooting Higher Again Today,InvestorPlace,/news/stocks/ocgn-stock-why-red-hot-ocugen-is-shooting-higher-again-today-1030265142,negative,0.8946983814239502
2785,3/31/2021 4:29:08 PM,"Pfizer's Late-Stage COVID-19 Vaccine Data In Adolescents Reinforces Bull Case, Analyst Says",Benzinga,/news/stocks/pfizer-s-late-stage-covid-19-vaccine-data-in-adolescents-reinforces-bull-case-analyst-says-1030264492,neutral,0.8962460160255432
2786,3/31/2021 6:45:02 PM,Pfizer/ BioNTech to study a convenient formulation for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3678217-pfizer-biontech-to-study-a-convenient-formulation-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6411800980567932
2787,3/31/2021 7:19:58 PM,Caution and Patience Are Needed for QuantumScape,InvestorPlace,/news/stocks/qs-stock-better-to-wait-on-quantumscape-1030265827,positive,0.8462063670158386
2788,4/1/2021 9:01:26 AM,7 Pharmaceutical Stocks That Could Get a Covid Hangover,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-that-could-get-a-covid-hangover-1030268137,neutral,0.8334627151489258
2789,4/1/2021 9:41:10 AM,Hong Kong to resume Pfizer COVID-19 shots after defective packaging,Seeking Alpha,https://seekingalpha.com/news/3678418-hong-kong-to-resume-pfizer-covid-19-shots-after-defective-packaging?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7548238635063171
2790,4/1/2021 11:04:52 AM,Pfizer/BioNTech COVID-19 vaccine has long-term efficacy of 91%: new study (updated),Seeking Alpha,https://seekingalpha.com/news/3678444-pfizerbiontech-covid-19-vaccine-has-long-term-efficacy-of-91-percent?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8189442157745361
2791,4/1/2021 1:10:24 PM,Pfizer : High Vaccine Efficacy Observed Through Up To 6-months After Second Dose Of COVID-19 Vaccine ,RTTNews,/news/stocks/pfizer-high-vaccine-efficacy-observed-through-up-to-6-months-after-second-dose-of-covid-19-vaccine-1030268390,negative,0.9469239711761475
2792,4/1/2021 1:46:30 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-preps-for-bla-filing-sonoma-surges-bioxcel-readout-ortho-clinical-lands-contract-1030268533,positive,0.9482611417770386
2793,4/1/2021 6:29:05 PM,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-to-prepare-your-portfolio-for-the-next-pandemic-1030270707,positive,0.9073498249053955
2794,4/1/2021 7:51:27 PM,General Electric Will Surge if Spending Plan Goes Through,InvestorPlace,/news/stocks/ge-stock-will-surge-if-spending-plan-goes-through-1030270693,negative,0.6906005144119263
2795,4/2/2021 2:01:55 PM,Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-april-pdufa-dates-1030271706,positive,0.9468021392822266
2796,4/2/2021 4:06:09 PM,American Airlines Stock May Lose More Altitude,InvestorPlace,/news/stocks/american-airlines-stock-may-lose-more-altitude-1030272174,neutral,0.9632146954536438
2797,4/3/2021 3:11:24 PM,"The Week Ahead In Biotech: Regeneron, Supernus FDA Decisions, Cancer Conference Presentations In The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-regeneron-supernus-fda-decisions-cancer-conference-presentations-in-the-spotlight-1030272481,positive,0.9472838640213013
2798,4/4/2021 1:12:36 AM,Tailwinds for air lines as CDC updates travel guidance,Seeking Alpha,https://seekingalpha.com/news/3679001-tailwinds-for-air-lines-as-cdc-updates-travel-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9184090495109558
2799,4/5/2021 2:56:17 PM,BioNTech CEO sees COVID-19 revaccinations in future - Barron's,Seeking Alpha,https://seekingalpha.com/news/3679175-biontech-ceo-sees-covid-19-revaccinations-in-future-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8321940898895264
2800,4/5/2021 4:23:51 PM,Pfizer to sign a new COVID-19 vaccine deal with Israel,Seeking Alpha,https://seekingalpha.com/news/3679226-pfizer-to-sign-a-new-covid-19-vaccine-deal-with-israel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8373481035232544
2801,4/5/2021 7:28:00 PM,3 Reasons Why the General Electric Comeback Is Real,InvestorPlace,/news/stocks/ge-stock-3-reasons-why-the-general-electric-comeback-is-real-1030274740,positive,0.9295555949211121
2802,4/6/2021 12:00:00 AM,BANK 2018-BNK15 -- Moody's affirms seven classes of BANK 2018-BNK15,Moodys,/news/bonds/bank-2018-bnk15-moody-s-affirms-seven-classes-of-bank-2018-bnk15-1030274935,positive,0.90695720911026
2803,4/6/2021 9:32:45 AM,EU may reach herd immunity by July 14: Commissioner Thierry Breton,Seeking Alpha,https://seekingalpha.com/news/3679363-eu-may-reach-herd-immunity-by-july-14-commissioner-thierry-breton?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8422364592552185
2804,4/6/2021 2:03:27 PM,8 Retirement Stocks to Buy for Any Market Conditions,InvestorPlace,/news/stocks/8-retirement-stocks-to-buy-for-any-market-conditions-1030277583,positive,0.9273015260696411
2805,4/6/2021 2:55:42 PM,Is Silicon Valley Replacing Big Pharma In Neuroscience?,Benzinga,/news/stocks/is-silicon-valley-replacing-big-pharma-in-neuroscience-1030277135,positive,0.8876467347145081
2806,4/6/2021 3:50:56 PM,7 Cheap Stocks That Won’t Be on Discount for Long,InvestorPlace,/news/stocks/7-cheap-stocks-that-wont-be-on-discount-for-long-linc-jd-cto-intu-bgfv-eqc-gsk-1030278180,positive,0.8381310105323792
2807,4/6/2021 10:25:12 PM,Pfizer Suspends Covid-19 Vaccines Shipment To Israel Over Payment Issues: Report ,RTTNews,/news/stocks/pfizer-suspends-covid-19-vaccines-shipment-to-israel-over-payment-issues-report-1030278859,neutral,0.957015872001648
2808,4/7/2021 8:57:57 AM,Moderna's COVID-19 vaccine rollout initiated in U.K.,Seeking Alpha,https://seekingalpha.com/news/3679711-modernas-covid-19-vaccine-rollout-initiated-in-uk?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6906583905220032
2809,4/7/2021 12:43:03 PM,FDA extends review of Pfizer's abrocitinib for atopic dermatitis,Seeking Alpha,https://seekingalpha.com/news/3679810-fda-extends-review-of-pfizers-abrocitinib-for-atopic-dermatitis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7294753193855286
2810,4/7/2021 12:58:00 PM,Health Canada initiates safety review of Pfizer's Xeljanz,Seeking Alpha,https://seekingalpha.com/news/3679819-health-canada-initiates-safety-review-of-pfizer-xeljanz?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8217443823814392
2811,4/7/2021 1:19:39 PM,Pfizer Says Priority Review Period Extended For NDA For Abrocitinib- Quick Facts ,RTTNews,/news/stocks/pfizer-says-priority-review-period-extended-for-nda-for-abrocitinib-quick-facts-1030280704,positive,0.5985268950462341
2812,4/7/2021 1:57:58 PM,"The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award",Benzinga,/news/stocks/the-daily-biotech-pulse-fibrogen-fudges-safety-data-novartis-strikes-cancer-drug-collaboration-immutep-gains-on-patent-award-1030280866,negative,0.6349209547042847
2813,4/7/2021 3:28:49 PM,AstraZeneca’s COVID-19 vaccine not recommended for under-30s in the U.K.,Seeking Alpha,https://seekingalpha.com/news/3679904-astrazenecas-covid-19-shot-not-recommended-for-under-30s-in-uk?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.608991801738739
2814,4/8/2021 11:02:36 AM,AstraZeneca vaccine woes could derail global vaccination drive,Seeking Alpha,https://seekingalpha.com/news/3680226-astrazeneca-vaccine-woes-could-derail-global-vaccination-drive?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9659634232521057
2815,4/8/2021 11:49:26 AM,Ocugen Stock Is an Excellent Day Trade as Long as You Get Out in Time,InvestorPlace,/news/stocks/ocgn-stock-excellent-day-trade-get-out-in-time-1030285246,positive,0.5905544757843018
2816,4/8/2021 12:42:07 PM,Australia halts use of AstraZeneca COVID-19 jab for people under age of 50,Seeking Alpha,https://seekingalpha.com/news/3680300-australia-halts-use-of-astrazeneca-covid-19-jab-for-people-under-age-of-50?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6391430497169495
2817,4/8/2021 8:19:59 PM,"Celcuity, Pfizer ink licensing agreement up to $340M for breast cancer treatment gedatolisib",Seeking Alpha,https://seekingalpha.com/news/3680519-celcuity-and-pfizer-ink-licensing-agreement-for-breast-cancer-treatment-gedatolisib?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8416759371757507
2818,4/8/2021 8:28:19 PM,France to OK mRNA vaccines in place of second dose of AstraZeneca’s COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3680525-france-to-ok-mrna-vaccines-in-place-of-second-dose-of-astrazenecas-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7646148800849915
2819,4/9/2021 6:07:31 AM,Australia to buy additional 20M doses of Pfizer COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3680585-australia-to-buy-additional-20m-doses-of-pfizer-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7258954048156738
2820,4/9/2021 1:26:03 PM,"The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-negative-regulatory-tidings-for-provention-bio-celcuity-soars-on-in-licensing-deal-2-ipos-1030288848,neutral,0.9328569769859314
2821,4/9/2021 2:20:14 PM,Celcuity surges 48% following licensing deal with Pfizer,Seeking Alpha,https://seekingalpha.com/news/3680697-celcuity-up-48-following-licensing-deal-with-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9477197527885437
2822,4/9/2021 2:25:12 PM,Bionano Genomics Stock Is Too Wild for Its Own Good,InvestorPlace,/news/stocks/bngo-stock-bionano-genomics-too-wild-for-its-own-good-1030289840,positive,0.7488939166069031
2823,4/9/2021 2:33:00 PM,Pfizer/ BioNTech to receive more COVID-19 vaccine orders from EU,Seeking Alpha,https://seekingalpha.com/news/3680712-pfizer-biontech-to-receive-more-covid-19-vaccine-orders-from-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9448896050453186
2824,4/9/2021 3:22:24 PM,What's Going On With CELC Stock And PRVB Stock Today?,Benzinga,/news/stocks/what-s-going-on-with-celc-stock-and-prvb-stock-today-1030289298,positive,0.547825813293457
2825,4/9/2021 3:59:20 PM,7 Dividend Stocks With 50 Years of Dividend Increases,InvestorPlace,/news/stocks/7-dividend-stocks-with-50-years-of-dividend-increases-1030289825,positive,0.9167526960372925
2826,4/9/2021 5:17:05 PM,Pfizer/BioNTech request vaccine use expansion to include adolescents,Seeking Alpha,https://seekingalpha.com/news/3680753-pfizer-biontech-request-eua-vaccine-expansion-to-include-adolescents?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8328470587730408
2827,4/9/2021 6:42:27 PM,"Pfizer Has a Lumpy Growth Story, But It’s a Promising Investment",InvestorPlace,/news/stocks/pfe-stock-lumpy-growth-story-promising-investment-1030290295,negative,0.78034508228302
2828,4/9/2021 8:20:31 PM,What Can BioNTech Do for an Encore?,InvestorPlace,/news/stocks/bntx-stock-loaded-with-charm-but-look-carefully-at-pipeline-1030290457,positive,0.9324415922164917
2829,4/10/2021 1:00:15 PM,WOOF Stock: 3 Reasons To Befriend This Recent IPO,InvestorPlace,/news/stocks/woof-stock-3-reasons-to-befriend-this-recent-ipo-1030290873,positive,0.8351296186447144
2830,4/10/2021 6:14:58 PM,6 Pet Stocks And An ETF For National Pet Day,Benzinga,/news/etf/6-pet-stocks-and-an-etf-for-national-pet-day-1030290895,positive,0.9229822158813477
2831,4/12/2021 1:54:27 PM,"Myovant, Pfizer Initiate SERENE Study Evaluating Contraceptive Efficacy Of Relugolix ",RTTNews,/news/stocks/myovant-pfizer-initiate-serene-study-evaluating-contraceptive-efficacy-of-relugolix-1030293442,negative,0.6974565386772156
2832,4/12/2021 5:02:08 PM,Vaccine Passport Potential Could Boost These 7 Pharmaceutical Stocks,InvestorPlace,/news/stocks/vaccine-passport-potential-could-boost-these-7-pharmaceutical-stocks-1030295137,negative,0.9323841333389282
2833,4/13/2021 9:36:54 AM,"U.K. COVID-19 variant doesn't cause more deaths, study finds",Seeking Alpha,https://seekingalpha.com/news/3681226-uk-covid-19-variant-doesnt-cause-more-deaths-study-finds?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6644791960716248
2834,4/13/2021 1:28:12 PM,JNJ’s safety issues lead to gains in other COVID-19 vaccine makers,Seeking Alpha,https://seekingalpha.com/news/3681341-bntx-stock-is-up-after-jnj-safety-issues?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9559531211853027
2835,4/13/2021 1:59:51 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-jnj-stock-fda-agc-stock-1030299170,positive,0.9298974871635437
2836,4/13/2021 2:09:54 PM,White House: J&J pause won't significantly impact vaccination efforts (updated),Seeking Alpha,https://seekingalpha.com/news/3681370-white-house-jj-pause-wont-significantly-impact-vaccination-efforts?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8721367120742798
2837,4/13/2021 3:35:08 PM,JNJ COVID-19 vaccine pause could be a “matter of days”: FDA,Seeking Alpha,https://seekingalpha.com/news/3681414-jnj-covid-19-vaccine-pause-could-be-a-matter-of-days-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.765286386013031
2838,4/13/2021 6:35:48 PM,9 Reddit Penny Stocks That Are Running Out of Gas,InvestorPlace,/news/stocks/9-reddit-stocks-penny-stocks-running-out-gas-1030300449,positive,0.5439205765724182
2839,4/13/2021 8:50:02 PM,Pfizer CEO Alfred Bourla says Pfizer ramping production of COVID-19 vaccine (updated),Seeking Alpha,https://seekingalpha.com/news/3681539-ceo-bourla-says-pfizer-ramping-up-production-of-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7775849103927612
2840,4/14/2021 12:47:21 PM,Pfizer to raise second-quarter EU vaccine deliveries by 25%,Seeking Alpha,https://seekingalpha.com/news/3681700-pfizer-to-raise-second-quarter-eu-vaccine-delivery-target-by-25?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9407769441604614
2841,4/14/2021 3:37:40 PM,Investors Can Do Better Than Low-Growth Pfizer Stock,InvestorPlace,/news/stocks/investors-can-do-better-low-growth-pfe-stock-1030304754,negative,0.6222240328788757
2842,4/14/2021 4:09:31 PM,Moderna and Novavax included in U.K. mix-and-match study for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3681790-moderna-novavax-included-in-mix-and-match-study-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8438524603843689
2843,4/14/2021 6:54:21 PM,Ocugen Stock Still Has a Good Chance of Making Money for Investors,InvestorPlace,/news/stocks/ocugen-stock-still-has-a-good-chance-of-making-money-for-investors-1030305347,negative,0.9288166165351868
2844,4/14/2021 8:26:22 PM,Widening 'moat' for mRNA vaccines will benefit Moderna - Jefferies,Seeking Alpha,https://seekingalpha.com/news/3681898-widening-moat-for-mrna-vaccines-will-benefit-moderna-jefferies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9243830442428589
2845,4/15/2021 12:56:11 PM,"JNJ’s COVID-19 vaccine woes to benefit mRNA based developers, Needham sizes up telehealth rivals; and more in today’s analyst action",Seeking Alpha,https://seekingalpha.com/news/3682121-jnjs-covid-19-vaccine-woes-to-benefit-mrna-based-developers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7349256277084351
2846,4/15/2021 3:34:08 PM,Surf the Chop in Carnival Corp with this Options Trade,InvestorPlace,/news/stocks/surf-the-chop-in-carnival-ccl-stock-with-this-options-trade-1030309592,positive,0.90887850522995
2847,4/15/2021 6:15:07 PM,10 Stocks to Buy for Your $5K Robinhood Portfolio,InvestorPlace,/news/stocks/10-stocks-to-buy-5k-robinhood-portfolio-1030310321,positive,0.9261453747749329
2848,4/15/2021 9:11:56 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogecoin-price-predictions-qs-stock-1030310657,positive,0.9254742860794067
2849,4/16/2021 11:43:41 AM,"J&J asked Pfizer, Moderna to help investigate blood clots but declined - WSJ",Seeking Alpha,https://seekingalpha.com/news/3682520-johnson-johnson-asked-pfizer-moderna-to-help-investigate-blood-clots-but-declined-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8816914558410645
2850,4/16/2021 4:13:23 PM,"Moderna cutting vaccine deliveries to Canada, but Pfizer adding doses - CBC",Seeking Alpha,https://seekingalpha.com/news/3682647-moderna-cutting-vaccine-deliveries-to-canada-but-pfizer-adding-doses-cbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.791673481464386
2851,4/16/2021 5:52:05 PM,7 Reddit Penny Stocks to Buy for a Biotech Boom,InvestorPlace,/news/stocks/7-reddit-penny-stocks-buy-biotech-boom-1030313550,positive,0.8537747263908386
2852,4/16/2021 6:46:59 PM,"Moderna, Pfizer vaccine allocations to rise next week as J&J shot suspended",Seeking Alpha,https://seekingalpha.com/news/3682688-moderna-pfizer-vaccine-allocations-to-rise-next-week-as-johnson-johnson-shot-suspended?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9377162456512451
2853,4/16/2021 7:54:45 PM,There Is More To Pfizer Than The Covid Vaccine,InvestorPlace,/news/stocks/pfe-stock-there-is-more-to-pfizer-than-the-covid-vaccine-1030313753,positive,0.9266965985298157
2854,4/18/2021 2:50:24 PM,"SPACs Attack Recap: 5 Deals, Rumors And Headline News",Benzinga,/news/stocks/spacs-attack-recap-5-deals-rumors-and-headline-news-1030315020,positive,0.8885525465011597
2855,4/18/2021 3:56:30 PM,Fauci expects J&J vaccinations to resume later this week,Seeking Alpha,https://seekingalpha.com/news/3682773-fauci-expects-jj-vaccinations-to-resume-later-this-week?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.898205041885376
2856,4/19/2021 7:06:43 AM,Pfizer to supply additional COVID-19 vaccines to Japan,Seeking Alpha,https://seekingalpha.com/news/3682785-pfizer-to-supply-additional-covid-19-vaccines-to-japan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6089450716972351
2857,4/19/2021 8:19:06 AM,"Pfizer, BioNTech to supply 100M more doses of COVID-19 vaccine to EU",Seeking Alpha,https://seekingalpha.com/news/3682788-pfizer-biontech-to-supply-more-100m-doses-of-covid-19-vaccine-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.725031316280365
2858,4/19/2021 10:24:46 AM,"Pfizer, BioNTech To Supply 100 Mln More Doses Of Covid Vaccine To EU ",RTTNews,/news/stocks/pfizer-biontech-to-supply-100-mln-more-doses-of-covid-vaccine-to-eu-1030316464,negative,0.701485276222229
2859,4/19/2021 4:03:07 PM,Moderna and BioNTech slide as Fauci predicts resumption of JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3683037-moderna-and-biontech-slides-as-fauci-predicts-resumption-of-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.941743016242981
2860,4/20/2021 4:27:10 PM,Ocugen’s Outlook Is Still Very Bleak,InvestorPlace,/news/stocks/ocgn-stock-outlook-is-still-very-bleak-1030324938,positive,0.7953054308891296
2861,4/21/2021 12:25:25 PM,"Intuitive Surgical upgraded after earnings beat; Oppenheimer sizes up new Vertex – CRISPR deal, and more in today’s analyst action",Seeking Alpha,https://seekingalpha.com/news/3683885-intuitive-surgical-upgraded-after-earnings-beat-oppenheimer-sizes-up-new-vertex-crispr-deal?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8570231795310974
2862,4/21/2021 12:25:48 PM,OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-huge-covaxin-news-sending-ocugen-climbing-today-1030329624,negative,0.9418376684188843
2863,4/21/2021 12:48:26 PM,COVID-19 vaccine supply to exceed demand in the coming weeks - report,Seeking Alpha,https://seekingalpha.com/news/3683891-vaccine-supply-to-exceed-demand-in-the-coming-weeks-report?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7725856900215149
2864,4/21/2021 1:19:39 PM,Weekly record for new COVID-19 cases set - WHO,Seeking Alpha,https://seekingalpha.com/news/3683937-weekly-record-for-new-covid-19-cases-set-who?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7298490405082703
2865,4/21/2021 2:40:05 PM,Abbott Q1 results highlight pressure on COVID-19 test makers as vaccinations ramp up,Seeking Alpha,https://seekingalpha.com/news/3683988-abbott-q1-results-highlights-pressure-on-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9643991589546204
2866,4/21/2021 3:59:50 PM,"EU not taking up options on additional AstraZeneca, J&J vaccines - Reuters",Seeking Alpha,https://seekingalpha.com/news/3684028-eu-not-taking-up-options-on-additional-astrazeneca-johnson-johnson-vaccines-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9373636841773987
2867,4/21/2021 4:58:14 PM,"Pfizer Identifies Counterfeit COVID-19 Vaccines In Mexico, Poland: Report ",RTTNews,/news/stocks/pfizer-identifies-counterfeit-covid-19-vaccines-in-mexico-poland-report-1030329347,positive,0.8292384743690491
2868,4/21/2021 6:41:11 PM,Pressure mounting on Biden administration to waive COVID-19 vaccine patents,Seeking Alpha,https://seekingalpha.com/news/3684145-pressure-mounting-on-biden-administration-to-waive-covid-19-vaccine-patents?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9097448587417603
2869,4/22/2021 11:18:17 AM,Pfizer in talks with India to supply COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3684453-pfizer-in-talks-with-india-to-supply-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.802666187286377
2870,4/22/2021 12:07:28 PM,Pfizer declares $0.39 dividend,Seeking Alpha,https://seekingalpha.com/news/3684489-pfizer-inc-declares-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9053173661231995
2871,4/22/2021 5:00:36 PM,Scientist who helped develop Pfizer/BioNTech vaccine predicts annual vaccinations against COVID-19,Seeking Alpha,https://seekingalpha.com/news/3684711-scientist-who-helped-develop-pfizer-biontech-vaccine-predicts-annual-covid-19-vaccinations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6650223731994629
2872,4/22/2021 7:47:21 PM,House Democrats reintroduce bill to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3684755-house-democrats-reintroduce-bill-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6614382266998291
2873,4/23/2021 10:36:21 AM,Johnson & Johnson COVID-19 Vaccine Could Make Its Way To India By July,Benzinga,/news/stocks/johnson-johnson-covid-19-vaccine-could-make-its-way-to-india-by-july-1030337765,positive,0.5872179269790649
2874,4/23/2021 12:06:48 PM,EU finalizes deal for 1.8B doses of Pfizer-BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3685044-eu-finalizes-deal-for-18b-doses-of-pfizer-biontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8244154453277588
2875,4/23/2021 2:21:54 PM,"GameStop, AMC, Penny And Crypto Stocks: Top Q1 Trends For Millennials And Gen Z",Benzinga,/news/stocks/gamestop-amc-penny-and-crypto-stocks-top-q1-trends-for-millennials-and-gen-z-1030338567,positive,0.820562481880188
2876,4/23/2021 2:41:58 PM,OCGN Stock: The Big COVAXIN News That Prompted 40% Gains in Ocugen,InvestorPlace,/news/stocks/ocgn-stock-the-big-covaxin-news-that-prompted-40-gains-in-ocugen-1030339413,negative,0.9489784836769104
2877,4/23/2021 5:05:40 PM,Pfizer CEO Albert Bourla tweets about future vaccine deliveries to Canada,Seeking Alpha,https://seekingalpha.com/news/3685191-pfizer-ceo-albert-bourla-tweets-about-future-vaccine-deliveries-to-canada?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9175096154212952
2878,4/23/2021 6:45:05 PM,Ocugen Looks Less Interesting With Each Passing Shot,InvestorPlace,/news/stocks/ocgn-stock-looks-less-compelling-as-vaccines-increase-1030339903,neutral,0.809840202331543
2879,4/23/2021 7:30:11 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3685210-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
2880,4/25/2021 1:34:45 AM,Moderna with a vaccine platform and cash to drive years of growth is inexpensive: Barron’s,Seeking Alpha,https://seekingalpha.com/news/3685309-moderna-with-a-vaccine-platform-and-cash-to-drive-years-of-growth-is-inexpensive-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7888319492340088
2881,4/25/2021 5:17:06 AM,Ocugen-partnered COVID-19 vaccine shows efficacy against new variant behind India’s second wave,Seeking Alpha,https://seekingalpha.com/news/3685312-ocugen-partnered-covid-19-vaccine-shows-efficacy-against-new-variant-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.945451557636261
2882,4/25/2021 1:02:37 PM,CDC says pregnant women should get COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3685313-cdc-says-pregnant-women-should-get-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8569056987762451
2883,4/26/2021 7:21:45 AM,World pledges medical aid to India amid surging COVID-19 infections,Seeking Alpha,https://seekingalpha.com/news/3685321-world-pledges-medical-aid-to-india-amid-surging-new-infections?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9238783121109009
2884,4/26/2021 12:04:06 PM,Most Americans hesitant about getting J&J vaccine - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3685398-most-americans-hesitant-about-getting-johnson-johnson-vaccine-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8801007270812988
2885,4/26/2021 12:25:52 PM,OCGN Stock: The White House News That Has Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-white-house-news-that-has-ocugen-climbing-today-1030346247,negative,0.7591938972473145
2886,4/26/2021 3:00:47 PM,Decline in new COVID-19 cases could last despite a slowdown in vaccine rollout: Experts,Seeking Alpha,https://seekingalpha.com/news/3685540-decline-in-new-covid-19-cases-could-last-despite-a-slowdown-in-vaccine-rollout-experts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7110522389411926
2887,4/26/2021 3:06:57 PM,7 Healthcare Stocks for a Reopening World,InvestorPlace,/news/stocks/7-healthcare-stocks-for-a-reopening-world-1030346737,positive,0.827012300491333
2888,4/26/2021 3:18:33 PM,Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine,Benzinga,/news/stocks/sanofi-steps-in-for-fill-finish-200m-doses-of-moderna-s-covid-19-vaccine-1030346045,positive,0.8522769808769226
2889,4/26/2021 6:22:32 PM,7 Blue-Chip Stocks Everyone Should Watch,InvestorPlace,/news/stocks/7-blue-chip-stocks-everyone-should-watch-1030347421,positive,0.9152199029922485
2890,4/27/2021 12:56:36 PM,"After FuelCell Lost Its Momentum, Avoid FCEL Stock",InvestorPlace,/news/stocks/after-fuelcell-lost-its-momentum-avoid-fcel-stock-1030352695,neutral,0.8192712068557739
2891,4/27/2021 1:34:54 PM,Pfizer CEO Albert Bourla expects a COVID-19 antiviral drug by the end of 2021,Seeking Alpha,https://seekingalpha.com/news/3686106-pfizer-ceo-albert-bourla-expects-a-covid-19-antiviral-drug-by-the-end-of-2021?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7501650452613831
2892,4/27/2021 2:21:20 PM,US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses,Benzinga,/news/stocks/us-to-share-up-to-60m-astrazeneca-covid-19-vaccine-doses-1030351378,negative,0.5798394083976746
2893,4/27/2021 4:54:02 PM,CDC updates guidance on mask wearing for people fully vaccinated against COVID-19,Seeking Alpha,https://seekingalpha.com/news/3686236-cdc-updates-guidance-on-mask-wearing-for-people-fully-vaccinated-against-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7350118160247803
2894,4/27/2021 9:43:06 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-bitcoin-prices-capital-gains-irs-new-cdc-1030354315,positive,0.9254742860794067
2895,4/28/2021 10:00:30 AM,A Couple Of Shots in the Arm for Ocugen Stock,InvestorPlace,/news/stocks/a-couple-of-shots-in-the-arm-for-ocugen-stock-1030356996,positive,0.6628854274749756
2896,4/28/2021 12:49:47 PM,Pfizer buys Amplyx Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3686852-pfizer-buys-amplyx-pharmaceuticals?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9171712398529053
2897,4/28/2021 1:36:33 PM,Pfizer/BioNTech COVID-19 shot is likely to win Chinese approval by June: BioNTech CEO,Seeking Alpha,https://seekingalpha.com/news/3686892-pfizer-biontech-covid-19-shot-is-likely-to-win-chinese-approval-by-june-biontech-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.616478443145752
2898,4/28/2021 2:32:14 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-nvax-stock-vxrt-stock-housing-stocks-1030359386,positive,0.9298974871635437
2899,4/28/2021 3:58:12 PM,3 Shoe Stocks to Buy as They Run Higher,InvestorPlace,/news/stocks/3-shoe-stocks-to-buy-as-they-run-higher-1030359377,positive,0.8938493132591248
2900,4/28/2021 5:07:43 PM,Pfizer/ BioNTech and Moderna COVID-19 shots cut hospitalization risk of older adults by 94%: CDC,Seeking Alpha,https://seekingalpha.com/news/3687034-pfizer-biontech-and-moderna-covid-19-shots-cut-hospitalization-risk-of-adults-by-94-percent?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9296396374702454
2901,4/28/2021 5:46:21 PM,"California reports nearly 1,400 COVID-19 cases in fully vaccinated people",Seeking Alpha,https://seekingalpha.com/news/3687105-california-records-about-1400-covid-19-cases-in-fully-vaccinated-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8088371157646179
2902,4/28/2021 8:23:40 PM,Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?,Benzinga,/news/stocks/time100-most-influential-companies-what-61-publicly-traded-companies-are-on-the-inaugural-list-1030359837,positive,0.9378837943077087
2903,4/28/2021 9:10:33 PM,"Oral Medicine For Covid Could Become Available As Soon As 2021 Fall, Says Pfizer CEO Albert Bourla ",RTTNews,/news/stocks/oral-medicine-for-covid-could-become-available-as-soon-as-2021-fall-says-pfizer-ceo-albert-bourla-1030359899,positive,0.6974290013313293
2904,4/29/2021 10:00:37 AM,7 Pharmaceutical Stocks To Buy For Valuation Plus Solid Dividends,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-valuation-plus-solid-dividends-1030363716,negative,0.5524897575378418
2905,4/29/2021 1:22:54 PM,Pfizer/BioNTech COVID-19 shot likely in Europe for adolescents by June: BioNTech CEO,Seeking Alpha,https://seekingalpha.com/news/3687902-pfizer-biontech-covid-19-shot-likely-in-europe-for-adolescents-by-june-biontech-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8657757639884949
2906,4/30/2021 10:48:47 AM,BioNTech CEO confident of COVID-19 vaccine effectiveness against ‘double mutant’ Indian strain,Seeking Alpha,https://seekingalpha.com/news/3688512-biontech-covid-19-effective-against-double-mutant-indian-strain-ceo-ugur-sahin?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9379624128341675
2907,4/30/2021 10:52:21 AM,Israel detects Indian COVID-19 variant even among vaccinated,Seeking Alpha,https://seekingalpha.com/news/3688521-israel-detects-indian-covid-19-variant-even-among-vaccinated-sees-some-vaccine-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8500866293907166
2908,4/30/2021 11:33:16 AM,"Pfizer, BioNTech requests for EU approval of COVID-19 vaccine for use in adolescents",Seeking Alpha,https://seekingalpha.com/news/3688562-pfizer-biontech-requests-for-eu-approval-of-covid-19-vaccine-for-use-in-adolescents?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8808496594429016
2909,4/30/2021 1:31:19 PM,"The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-hyperphosphatemia-drug-regulatory-review-extended-phathom-pharma-data-readout-2-ipos-1030369950,positive,0.896331250667572
2910,4/30/2021 1:37:55 PM,"Pfizer, BioNTech Submit Request In EU To Authorize Covid Vaccine To Adolescents ",RTTNews,/news/stocks/pfizer-biontech-submit-request-in-eu-to-authorize-covid-vaccine-to-adolescents-1030369964,positive,0.7978266477584839
2911,4/30/2021 6:11:27 PM,Pfizer/BioNTech vaccine offers weaker immunity against COVID-19 variants after a single shot: New study,Seeking Alpha,https://seekingalpha.com/news/3688837-pfizer-biontech-first-shot-offers-weaker-immunity-against-covid-19-variants?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5168002247810364
2912,4/30/2021 6:45:43 PM,Pfizer sending U.S.-made vaccine to Canada next week - AP,Seeking Alpha,https://seekingalpha.com/news/3688865-pfizer-sending-us-made-vaccine-to-canada-next-week-ap?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8472074866294861
2913,4/30/2021 7:35:55 PM,Pfizer and AstraZeneca vaccines don’t eliminate post vaccination COVID-19 deaths: New study,Seeking Alpha,https://seekingalpha.com/news/3688892-pfizer-and-astrazeneca-covid-19-vaccines-dont-eliminate-post-vaccination-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8111215233802795
2914,4/30/2021 8:30:28 PM,More than 30% of U.S. population fully vaccinated - CDC,Seeking Alpha,https://seekingalpha.com/news/3688921-more-than-30-of-us-population-fully-vaccinated-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8916819095611572
2915,5/1/2021 5:43:35 PM,Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-may-pdufa-dates-1030373547,positive,0.9478530883789062
2916,5/1/2021 7:19:25 PM,"Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge",Benzinga,/news/stocks/week-ahead-in-biotech-may-2-8-chemocentryx-adcom-ophthalmology-conference-presentations-earnings-deluge-1030373608,positive,0.8418352007865906
2917,5/2/2021 3:01:32 PM,Pfizer earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-stock-quarter-earnings-preview-q1-1030374475,positive,0.9320189952850342
2918,5/2/2021 7:17:07 PM,"To waive COVID vaccine patents, or not, that is the question",Seeking Alpha,https://seekingalpha.com/news/3689015-to-waive-covid-vaccine-patents-or-not-that-is-the-question?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8193982243537903
2919,5/3/2021 10:00:27 AM,"Despite Covaxin News, Ocugen Stock Remains a Long-Shot for US Use",InvestorPlace,/news/stocks/ocgn-stock-remains-gamble-covaxin-news-notwithstanding-1030377582,negative,0.6979934573173523
2920,5/3/2021 10:52:25 AM,Pfizer in discussions with India for 'expedited approval' of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3689059-pfizer-in-discussions-with-india-for-expedited-approval-of-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8074544668197632
2921,5/3/2021 11:58:45 AM,"If You Have Ocugen Stock, Now’s the Time to Take Profits",InvestorPlace,/news/stocks/ocgn-stock-why-you-should-take-profit-1030378125,positive,0.9377833604812622
2922,5/3/2021 4:02:13 PM,Pfizer expected to ship smaller vaccine shipments to states to reduce waste - Axios,Seeking Alpha,https://seekingalpha.com/news/3689353-pfizer-expected-to-ship-smaller-vaccine-shipments-to-states-to-reduce-waste-axios?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6935060024261475
2923,5/3/2021 4:57:18 PM,Midday Market Update: The 10 Most Active Stocks Monday,InvestorPlace,/news/stocks/midday-market-update-the-10-most-active-stocks-monday-1030380162,positive,0.9189565181732178
2924,5/3/2021 5:04:25 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3689391-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
2925,5/3/2021 6:58:22 PM,NVAX Stock: Why Novavax Stock Is Down Today Despite Latest Vaccine News,InvestorPlace,/news/stocks/nvax-stock-why-novavax-stock-is-down-today-despite-latest-vaccine-news-1030380526,neutral,0.9639578461647034
2926,5/3/2021 8:11:11 PM,U.S. COVID-19 vaccine demand dips as vaccination rate climbs,Seeking Alpha,https://seekingalpha.com/news/3689695-us-covid-19-vaccine-demand-dips-as-vaccination-rate-climbs?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9711112976074219
2927,5/3/2021 9:38:03 PM,"4 Top Stock Trades for Tuesday: Berkshire, PFE, NVAX, AMZN",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-berkshire-pfe-nvax-amzn-1030381070,positive,0.9388226866722107
2928,5/3/2021 9:45:39 PM,FDA set to OK Pfizer vaccine for adolescents next week - New York Times,Seeking Alpha,https://seekingalpha.com/news/3689831-fda-set-to-ok-pfizer-vaccine-for-adolescents-next-week-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.878096342086792
2929,5/4/2021 7:04:19 AM,Vaxart's oral COVID-19 vaccine shows potential to offer promising solution against variants,Seeking Alpha,https://seekingalpha.com/news/3689889-vaxarts-oral-covid-19-vaccine-shows-potential-to-offer-promising-solution-to-variants?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9136020541191101
2930,5/4/2021 11:29:08 AM,Pfizer raises 2021 guidance and boosts anticipated COVID-19 vaccine revenue,Seeking Alpha,https://seekingalpha.com/news/3690023-pfizer-raises-2021-guidance-and-boosts-anticipated-covid-19-vaccine-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9504253268241882
2931,5/4/2021 12:55:36 PM,Pfizer Inc. Q1 adjusted earnings of $0.93 per share,RTTNews,/news/stocks/pfizer-inc-q1-adjusted-earnings-of-0-93-per-share-1030383374,positive,0.8124195337295532
2932,5/4/2021 12:56:39 PM,ViiV Healthcare initiates rolling submission of cabotegravir in U.S. for HIV prevention,Seeking Alpha,https://seekingalpha.com/news/3690124-viiv-healthcare-initiates-rolling-submission-of-cabotegravir-in-us-for-hiv-prevention?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5269935727119446
2933,5/4/2021 12:59:50 PM,COCP Stock: Cocrystal Pharma Gains 40% on Big Covid-19 News,InvestorPlace,/news/stocks/cocp-stock-cocrystal-pharma-gains-40-on-big-covid-19-news-1030385436,negative,0.9493622183799744
2934,5/4/2021 1:01:36 PM,Vaxart Stock Is Surging As Its Oral COVID-19 Vaccine Can Potentially Trigger Immunity Against Variants,Benzinga,/news/stocks/vaxart-stock-is-surging-as-its-oral-covid-19-vaccine-can-potentially-trigger-immunity-against-variants-1030383377,neutral,0.7579190135002136
2935,5/4/2021 1:15:37 PM,Pfizer plans to file for full approval for COVID-19 vaccine by the end this month,Seeking Alpha,https://seekingalpha.com/news/3690144-pfizer-plans-to-file-for-full-approval-for-covid-19-vaccine-by-the-end-this-month?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49742671847343445
2936,5/4/2021 1:28:54 PM,"Lilly donates 400,000 baricitinib tablets to India for use as COVID-19 therapy",Seeking Alpha,https://seekingalpha.com/news/3690156-lilly-donates-400000-baricitinib-tablets-to-india-for-use-as-covid-19-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4968743324279785
2937,5/4/2021 1:52:29 PM,Pfizer Q1 Profit Rises; Lifts FY Outlook ,RTTNews,/news/stocks/pfizer-q1-profit-rises-lifts-fy-outlook-1030383702,negative,0.9379938840866089
2938,5/4/2021 2:10:21 PM,"The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data",Benzinga,/news/stocks/the-daily-biotech-pulse-vaxart-rebounds-on-strong-vaccine-data-pfizer-s-beat-and-raise-quarter-biolinerx-data-1030383815,negative,0.5902956128120422
2939,5/4/2021 2:37:28 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-dogecoin-prices-oil-prices-nvax-stock-1030385993,positive,0.9298974871635437
2940,5/4/2021 2:47:40 PM,Enrollment in Pfizer elranatamab trial paused amid cases of peripheral neuropathy,Seeking Alpha,https://seekingalpha.com/news/3690204-enrollment-in-pfizer-elranatamab-trial-paused-amid-cases-of-peripheral-neuropathy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9400628805160522
2941,5/4/2021 3:40:26 PM,Shares of major drug makers in focus as House committees hold hearings on drug pricing bill,Seeking Alpha,https://seekingalpha.com/news/3690229-shares-of-major-drug-makers-in-focus-as-house-committees-hold-hearings-on-drug-pricing-bill?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6773343086242676
2942,5/4/2021 5:20:41 PM,Why This Pfizer Analyst Is Sidelined After Beat-And-Raise Q1,Benzinga,/news/stocks/why-this-pfizer-analyst-is-sidelined-after-beat-and-raise-q1-1030385833,positive,0.6620197296142578
2943,5/4/2021 6:19:52 PM,Mid-Day Market Update: Maxar Technologies Falls After Q1 Results; BioLineRx Shares Climb,Benzinga,/news/stocks/mid-day-market-update-maxar-technologies-falls-after-q1-results-biolinerx-shares-climb-1030386062,neutral,0.9669085144996643
2944,5/4/2021 7:09:14 PM,"Biden says vaccination effort will focus on adolescents, hesitant adults (updated)",Seeking Alpha,https://seekingalpha.com/news/3690452-biden-says-vaccination-effort-will-focus-on-adolescents-hesitant-adults?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9069849848747253
2945,5/4/2021 9:00:18 PM,Mid-Afternoon Market Update: Nasdaq Tumbles 300 Points; Neuronetics Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-nasdaq-tumbles-300-points-neuronetics-shares-spike-higher-1030386487,neutral,0.5123178958892822
2946,5/5/2021 3:03:58 PM,Pfizer/ BioNTech COVID-19 vaccine approved for adolescents in Canada,Seeking Alpha,https://seekingalpha.com/news/3691151-pfizer-biontech-covid-19-vaccine-approved-for-adolescents-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5642551779747009
2947,5/5/2021 3:37:35 PM,CDC sets emergency meeting next week; likely to discuss Pfizer/BIoNTech COVID-19 vaccine on adolescents,Seeking Alpha,https://seekingalpha.com/news/3691169-cdc-sets-emergency-meeting-next-week-likely-to-discuss-pfizerbiontech-covid-19-vaccine-on-adolescents?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9156634211540222
2948,5/5/2021 3:58:17 PM,Why Ocugen Stock Continues to Be a Great Short Opportunity,InvestorPlace,/news/stocks/why-ocgn-stock-is-still-a-great-short-opportunity-1030391918,positive,0.792808473110199
2949,5/5/2021 4:26:31 PM,Mid-Morning Market Update: Markets Mostly Lower; General Motors Profit Beats Estimates,Benzinga,/news/stocks/mid-morning-market-update-markets-mostly-lower-general-motors-profit-beats-estimates-1030391544,neutral,0.90256267786026
2950,5/5/2021 6:16:50 PM,Mid-Day Market Update: Crude Oil Rises 1%; Esperion Therapeutics Shares Drop Following Q1 Results,Benzinga,/news/stocks/mid-day-market-update-crude-oil-rises-1-esperion-therapeutics-shares-drop-following-q1-results-1030392024,neutral,0.9683051705360413
2951,5/5/2021 7:35:46 PM,COVID-19 vaccine makers in the red as U.S. to back waiver of IP protections,Seeking Alpha,https://seekingalpha.com/news/3691449-covid-19-vaccine-makers-in-the-red-as-us-to-back-waiver-of-vaccine-ip-protections?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8418429493904114
2952,5/5/2021 8:52:25 PM,Mid-Afternoon Market Update: Dow Surges 180 Points; Big 5 Sporting Goods Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-surges-180-points-big-5-sporting-goods-shares-spike-higher-1030392439,negative,0.8932477235794067
2953,5/6/2021 1:13:39 PM,"Pfizer, BioNTech Offer COVID-19 Vaccine Doses To Olympic Athletes At 2020 Tokyo Games ",RTTNews,/news/stocks/pfizer-biontech-offer-covid-19-vaccine-doses-to-olympic-athletes-at-2020-tokyo-games-1030395664,positive,0.5814932584762573
2954,5/6/2021 1:42:10 PM,"Weighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action",Seeking Alpha,https://seekingalpha.com/news/3692234-weighing-in-on-vaccine-patent-waivers-alcon-and-ultragenyx-upgraded-at-citi-and-more-in-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6439561247825623
2955,5/6/2021 2:10:44 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ocgn-stock-space-stocks-btc-brphf-1030397159,positive,0.9298974871635437
2956,5/6/2021 2:35:43 PM,Fauci eyes teens to reach herd immunity goal,Seeking Alpha,https://seekingalpha.com/news/3692335-vaccinating-teens-could-be-key-for-protection-against-covid-19-by-the-fall-experts?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5804288387298584
2957,5/6/2021 4:06:40 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-6-2021-1030397195,neutral,0.5523796081542969
2958,5/6/2021 4:37:14 PM,BioNTech says patents not the ‘limiting factor’ for vaccine supply,Seeking Alpha,https://seekingalpha.com/news/3692397-biontech-says-patents-not-the-limiting-factor-for-vaccine-supply?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7955992817878723
2959,5/6/2021 4:39:42 PM,Germany's Merkel opposed to lifting IP protections on vaccines -- Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3692395-germany-merkel-opposed-to-lifting-ip-protections-on-vaccines-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7145804166793823
2960,5/6/2021 5:08:08 PM,Thursday Market Update: 10 Most Active Stocks Today,InvestorPlace,/news/stocks/thursday-market-update-10-most-active-stocks-today-1030398212,positive,0.9016185998916626
2961,5/7/2021 11:09:45 AM,Pfizer and BioNTech begin marketing application for COVID-19 vaccine in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3693048-pfizer-and-biontech-begin-marketing-application-for-covid-19-vaccine-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7358320951461792
2962,5/7/2021 1:11:55 PM,"Pfizer, BioNTech Initiate BLA Process With FDA For The COVID-19 MRNA Vaccine - Quick Facts ",RTTNews,/news/stocks/pfizer-biontech-initiate-bla-process-with-fda-for-the-covid-19-mrna-vaccine-quick-facts-1030401794,positive,0.781985342502594
2963,5/7/2021 2:07:17 PM,Ocugen Stock Is a Risky Proposition Despite Its High Valuation,InvestorPlace,/news/stocks/ocgn-stock-is-a-risky-proposition-despite-high-valuation-1030402548,positive,0.7852019667625427
2964,5/7/2021 7:30:30 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3693377-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
2965,5/7/2021 7:44:31 PM,Pfizer CEO Albert Bourla says waiver of patent protection could discourage risk taking,Seeking Alpha,https://seekingalpha.com/news/3693507-pfizer-ceo-albert-bourla-says-waiver-of-patent-protection-could-discourage-risk-taking?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8694474101066589
2966,5/9/2021 2:27:16 AM,U.S. support for IP rights waiver of COVID-19 vaccines meets resistance in EU,Seeking Alpha,https://seekingalpha.com/news/3693618-us-support-for-ip-rights-waiver-of-covid-19-vaccines-meets-resistance-in-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7428933382034302
2967,5/9/2021 4:20:33 PM,"The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings",Benzinga,/news/stocks/the-week-ahead-in-biotech-may-9-15-heron-apellis-fda-decisions-presentations-and-earnings-1030405849,positive,0.944421648979187
2968,5/10/2021 11:44:24 AM,BioNTech trades higher after raising 2021 guidance for COVID-19 vaccine sales,Seeking Alpha,https://seekingalpha.com/news/3693739-biontech-trades-higher-after-raising-2021-guidance-for-covid-19-vaccine-sales?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9438710808753967
2969,5/10/2021 1:22:33 PM,IDEAYA's Dose Expansion In Phase 1/2 Study Of Combination Of Darovasertib And Crizotinib ,RTTNews,/news/stocks/ideaya-s-dose-expansion-in-phase-1-2-study-of-combination-of-darovasertib-and-crizotinib-1030408660,negative,0.8580728769302368
2970,5/10/2021 4:15:14 PM,Pfizer/ BioNTech vaccine's protection against COVID-related deaths rises up to 97% after both doses: new study,Seeking Alpha,https://seekingalpha.com/news/3693986-pfizer-biontech-vaccine-raises-protection-from-covid-related-death-up-to-97-after-both-doses-new-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.937903106212616
2971,5/10/2021 4:40:45 PM,World Health Organization names India COVID-19 variant as a global concern,Seeking Alpha,https://seekingalpha.com/news/3694006-world-health-organization-names-india-covid-19-variant-as-a-global-concern?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7653430104255676
2972,5/10/2021 5:08:11 PM,7 Stocks Most at Risk of a Capital Gains Tax Selloff ,InvestorPlace,/news/stocks/seven-stocks-most-at-risk-of-a-capital-gains-tax-selloff-1030410628,neutral,0.9359923601150513
2973,5/10/2021 5:12:54 PM,FDA to hold AdCom meeting to discuss expanding COVID-19 vaccine use in children,Seeking Alpha,https://seekingalpha.com/news/3694024-fda-to-hold-adcom-meeting-to-discuss-expanding-covid-19-vaccine-use-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7517353892326355
2974,5/11/2021 12:21:29 AM,FDA Authorizes Emergency Use Of Pfizer's Covid-19 Vaccine For Use In Children 12 To 15 ,RTTNews,/news/stocks/fda-authorizes-emergency-use-of-pfizer-s-covid-19-vaccine-for-use-in-children-12-to-15-1030411414,positive,0.9187116026878357
2975,5/11/2021 1:54:32 AM,Pfizer/ BioNTech COVID-19 vaccine authorized for adolescents in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3694355-pfizer-biontech-covid-19-vaccine-authorized-for-adolescents-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6515125036239624
2976,5/11/2021 1:54:31 PM,"The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-authorizes-pfizer-biontech-covid-19-vaccine-for-adolescents-lilly-strikes-r-d-collaboration-vaccine-stocks-novavax-inovio-sink-on-earnings-1030414147,positive,0.846595048904419
2977,5/11/2021 2:40:40 PM,Pfizer/BioNTech COVID-19 shot likely to receive European approval in late May,Seeking Alpha,https://seekingalpha.com/news/3694627-pfizerbiontech-covid-19-shot-likely-to-receive-european-approval-in-late-may?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7284193634986877
2978,5/11/2021 2:51:24 PM,"7 Stocks to Start your Robinhood Portfolio With Just $2,000",InvestorPlace,/news/stocks/7-stocks-to-buy-for-robinhood-portfolio-with-2000-dollars-1030416084,positive,0.9207439422607422
2979,5/11/2021 3:35:23 PM,Data on Pfizer vaccine in young children expected late fall - Kessler,Seeking Alpha,https://seekingalpha.com/news/3694656-data-on-pfizer-vaccine-in-young-children-expected-late-fall-kessler?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7549629211425781
2980,5/11/2021 5:20:31 PM,Britain is open for talks on IP rights waiver for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3694726-britain-is-open-for-talks-on-ip-rights-waiver-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5455923676490784
2981,5/11/2021 7:50:22 PM,Pfizer scientist says mRNA technology could help create “more potent” seasonal flu shots,Seeking Alpha,https://seekingalpha.com/news/3694783-pfizer-scientist-says-mrna-technology-could-help-create-more-potent-seasonal-flu-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8157950043678284
2982,5/12/2021 6:59:34 AM,Pfizer asks U.K. regulator for approval of COVID-19 vaccine in teenagers,Seeking Alpha,https://seekingalpha.com/news/3695040-pfizer-asks-uk-regulator-for-approval-of-covid-19-vaccine-in-teenagers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7684372067451477
2983,5/12/2021 3:51:48 PM,7 Safe Stocks to Buy as Janet Yellen Talks Rate Hikes,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-as-janet-yellen-talks-rate-hikes-1030422210,positive,0.6301165223121643
2984,5/12/2021 7:58:40 PM,Pfizer/ BioNTech COVID-19 vaccine for adolescents: endorsed by CDC panel,Seeking Alpha,https://seekingalpha.com/news/3695451-pfizer-biontech-covid-19-vaccine-for-adolescents-endorsed-by-cdc-panel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7897337675094604
2985,5/13/2021 5:11:48 AM,CDC Backs Pfizer-BioNTech COVID-19 Vaccine For 12- To 15-Year-Olds ,RTTNews,/news/stocks/cdc-backs-pfizer-biontech-covid-19-vaccine-for-12-to-15-year-olds-1030423587,positive,0.5525150895118713
2986,5/13/2021 3:23:52 PM,Scientists are skeptical over the need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3696032-scientists-are-skeptical-over-the-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.821262001991272
2987,5/13/2021 7:57:55 PM,Mix and match COVID-19 vaccine study indicates higher risk of mild/ moderate symptoms,Seeking Alpha,https://seekingalpha.com/news/3696118-mix-and-match-covid-19-vaccine-study-indicate-higher-risk-of-mild-moderate-symptoms?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7825488448143005
2988,5/14/2021 2:05:55 PM,"Delaying second Pfizer COVID-19 shot boosts antibodies more than three-fold in elderly, U.K. study finds",Seeking Alpha,https://seekingalpha.com/news/3696652-delaying-second-pfizer-covid-19-shot-boots-antibodies-more-than-three-fold-in-elderly-uk-study-finds?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8689312934875488
2989,5/14/2021 3:38:44 PM,It Won’t Take Much for Vaxart Stock to Pop Once Again,InvestorPlace,/news/stocks/vxrt-stock-wont-make-much-to-pop-once-again-1030431453,negative,0.7223111391067505
2990,5/14/2021 5:46:33 PM,New CDC study confirms mRNA vaccines can cut risk of symptomatic COVID-19 by 94%,Seeking Alpha,https://seekingalpha.com/news/3696736-new-cdc-study-confirms-mrna-vaccines-can-cut-risk-of-symptomatic-covid-19-by-94?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.943024754524231
2991,5/16/2021 3:27:45 AM,CDC maintains guidance for mask wearing at schools,Seeking Alpha,https://seekingalpha.com/news/3696877-cdc-maintains-guidance-for-mask-wearing-at-schools?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9328052997589111
2992,5/17/2021 4:07:18 PM,Novavax Window of Opportunity Is Closing Fast,InvestorPlace,/news/stocks/nvax-stock-novavax-window-of-opportunity-closing-fast-1030437595,positive,0.8221895694732666
2993,5/17/2021 4:51:14 PM,Pfizer/ BioNTech win European backing to relax storage requirement of COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3697256-pfizer-biontech-win-european-backing-to-relax-storage-requirement-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9434655904769897
2994,5/17/2021 5:28:00 PM,U.S. to ship additional 20M vaccine doses abroad in June,Seeking Alpha,https://seekingalpha.com/news/3697271-us-to-ship-additional-20m-vaccine-doses-abroad-abroad-in-june?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6776211857795715
2995,5/18/2021 11:59:40 AM,Pfizer Covid Vaccine Can Be Stored Up To 1 Month In Fridges: EMA ,RTTNews,/news/stocks/pfizer-covid-vaccine-can-be-stored-up-to-1-month-in-fridges-ema-1030440139,positive,0.9303664565086365
2996,5/18/2021 1:44:04 PM,G20 nations refrain from backing a comprehensive patent waiver for COVID-19 vaccines: Reuters,Seeking Alpha,https://seekingalpha.com/news/3697795-g20-nations-refrain-from-backing-a-comprehensive-covid-19-vaccine-waiver-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7876662015914917
2997,5/18/2021 3:47:01 PM,Vaxart Could Still Be a Viable Covid 19 Vaccine Play,InvestorPlace,/news/stocks/vxrt-stock-could-still-be-a-viable-covid-19-vaccine-play-1030442766,negative,0.5461016297340393
2998,5/18/2021 5:52:46 PM,Pfizer/BioNTech and Moderna vaccines protective against Indian COVID-19 variants: Study,Seeking Alpha,https://seekingalpha.com/news/3697919-pfizer-biontech-and-moderna-vaccines-protective-against-indian-covid-19-variants-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7372394800186157
2999,5/18/2021 9:00:16 PM,Pfizer is building a COVID-19 vaccine manufacturing plant in Ireland: The Currency,Seeking Alpha,https://seekingalpha.com/news/3698028-pfizer-is-building-a-covid-19-vaccine-manufacturing-plant-in-ireland-the-currency?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7979324460029602
3000,5/19/2021 8:55:31 AM,"AstraZeneca jab followed by second dose of Pfizer vaccine is 'highly safe and effective', Spanish study finds",Seeking Alpha,https://seekingalpha.com/news/3698074-astrazeneca-jab-followed-by-second-dose-of-pfizer-vaccine-is-highly-safe-and-effective-spanish-study-finds?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8955655097961426
3001,5/19/2021 12:51:23 PM,Myovant Sciences Says FDA Places Phase 3 SERENE Study On Partial Clinical Hold ,RTTNews,/news/stocks/myovant-sciences-says-fda-places-phase-3-serene-study-on-partial-clinical-hold-1030445593,positive,0.7851762771606445
3002,5/19/2021 2:01:23 PM,Pfizer confirms production plans for COVID-19 vaccine in Ireland,Seeking Alpha,https://seekingalpha.com/news/3698247-pfizer-confirms-production-plans-for-covid-19-vaccine-in-ireland?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7170291543006897
3003,5/19/2021 3:06:04 PM,Top FDA officials are uncertain over how soon COVID-19 booster shots are needed,Seeking Alpha,https://seekingalpha.com/news/3698271-top-fda-officials-are-uncertain-over-how-soon-covid-19-booster-shots-are-needed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7035635709762573
3004,5/19/2021 3:24:10 PM,Senate Republicans ask Biden to walk back support of waiving vaccine IP protection,Seeking Alpha,https://seekingalpha.com/news/3698273-senate-republicans-ask-biden-to-walk-back-support-of-waiving-vaccine-ip-protection?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6177008152008057
3005,5/19/2021 7:04:34 PM,Stay On The Sidelines With Ocugen Stock,InvestorPlace,/news/stocks/stay-on-the-sidelines-with-ocgn-stock-1030455829,positive,0.9424134492874146
3006,5/20/2021 5:30:13 AM,Pfizer COVID-19 Vaccine Allowed To Store In Refrigerator For A Month : FDA ,RTTNews,/news/stocks/pfizer-covid-19-vaccine-allowed-to-store-in-refrigerator-for-a-month-fda-1030448852,positive,0.900948703289032
3007,5/20/2021 9:18:55 AM,"Pfizer, BioNTech to supply up to 1.8B additional doses of COVID-19 vaccine to EU",Seeking Alpha,https://seekingalpha.com/news/3698515-pfizer-biontech-to-supply-up-to-18b-additional-doses-of-covid-19-vaccine-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7666007876396179
3008,5/20/2021 10:09:44 AM,"Pfizer, BioNTech to supply additional 60M doses of COVID-19 vaccine to Turkey",Seeking Alpha,https://seekingalpha.com/news/3698523-pfizer-biontech-to-supply-additional-60m-doses-of-covid-19-vaccine-to-turkey?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7877650260925293
3009,5/20/2021 12:03:48 PM,"Pfizer, BioNTech To Supply Up To 1.8 Bln Additional Doses Of COVID-19 Vaccine To EU ",RTTNews,/news/stocks/pfizer-biontech-to-supply-up-to-1-8-bln-additional-doses-of-covid-19-vaccine-to-eu-1030449904,negative,0.8323659896850586
3010,5/20/2021 12:11:16 PM,"Pfizer, BioNTech To Supply Up To 90 Mln Additional Doses Of COVID-19 Vaccine To Turkey ",RTTNews,/news/stocks/pfizer-biontech-to-supply-up-to-90-mln-additional-doses-of-covid-19-vaccine-to-turkey-1030449979,negative,0.8126110434532166
3011,5/20/2021 2:27:03 PM,"The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Order Flow Abounds, Voyager CEO, CMO To Depart, Decision Day For Bristol-Myers Squibb, ASCO Abstracts Move Stocks",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-covid-19-order-flow-abounds-voyager-ceo-cmo-to-depart-decision-day-for-bristol-myers-squibb-asco-abstracts-move-stocks-1030450798,positive,0.6443605422973633
3012,5/20/2021 5:20:15 PM,Immutep Stock Gains on Encouraging Data from Early-Stage Solid Cancer Studies,Benzinga,/news/stocks/immutep-stock-gains-on-encouraging-data-from-early-stage-solid-cancer-studies-1030451909,negative,0.9387258291244507
3013,5/20/2021 6:15:54 PM,BioNTech CEO says vaccine 70-75% effective against India variant - Reuters (updated),Seeking Alpha,https://seekingalpha.com/news/3698814-biontech-ceo-says-vaccine-70-75-effective-against-india-variant-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7910688519477844
3014,5/20/2021 6:16:48 PM,Moderna Holds the Key to the Future of mRNA Vaccines,InvestorPlace,/news/stocks/mrna-stock-holds-the-key-to-the-future-of-vaccines-1030452921,positive,0.8024299740791321
3015,5/20/2021 8:45:09 PM,7 Global Stocks That Are Worth Adding to Your Portfolio,InvestorPlace,/news/stocks/7-global-stocks-that-are-worth-adding-to-your-portfolio-1030453282,positive,0.8937333226203918
3016,5/21/2021 2:04:27 PM,"Pfizer, Moderna, and J&J pledge more shots for poorer countries - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3699127-pfizer-moderna-and-johnson-johnson-pledge-more-shots-for-poorer-countries-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5725336074829102
3017,5/23/2021 4:05:56 PM,"The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation",Benzinga,/news/stocks/the-week-ahead-in-biotech-may-23-29-eton-lantheus-fda-decisions-adcom-test-for-provention-chiasma-data-presentation-1030457244,positive,0.9378595948219299
3018,5/24/2021 11:09:19 AM,Pfizer initiates study to test its pneumococcal vaccine candidate with a booster dose of COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3699354-pfizer-initiates-study-to-test-its-pneumococcal-vaccine-candidate-with-a-booster-dose-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7390527725219727
3019,5/24/2021 1:32:02 PM,Pfizer's Study To Co-administer 20-valent PCV Candidate With Third Dose Of COVID-19 Vaccine ,RTTNews,/news/stocks/pfizer-s-study-to-co-administer-20-valent-pcv-candidate-with-third-dose-of-covid-19-vaccine-1030458271,negative,0.5009356141090393
3020,5/24/2021 6:14:22 PM,Abivax reports strong phase 2 data on ulcerative colitis candidate; shares up 12%,Seeking Alpha,https://seekingalpha.com/news/3699576-abivax-reports-strong-phase-2-data-on-ulcerative-colitis-candidate-shares-up-12?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9496645331382751
3021,5/24/2021 6:31:26 PM,3 Healthcare Stocks to Buy as the Sector Breaks Out,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-sector-breaks-out-1030459870,positive,0.7721390128135681
3022,5/25/2021 9:01:03 AM,Once-Bright Light Novavax Stares Into a Dimming Future as Vaccine Also-Ran,InvestorPlace,/news/stocks/once-bright-nvax-stock-future-dimming-1030461481,positive,0.8594367504119873
3023,5/25/2021 9:15:19 AM,"Pfizer, AstraZeneca COVID-19 jabs effective against Indian variant, study finds",Seeking Alpha,https://seekingalpha.com/news/3699709-pfizer-astrazeneca-covid-19-jabs-effective-against-indian-variant-study-finds?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8662667870521545
3024,5/25/2021 12:31:43 PM,Moderna's COVID vaccine effective in adolescents; eyes June data submission,Seeking Alpha,https://seekingalpha.com/news/3699804-moderna-covid-vaccine-effective-in-adolescents-eyes-june-data-submission?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8072891235351562
3025,5/25/2021 1:53:39 PM,"The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-in-vaccine-supply-talks-with-india-provention-in-focus-ahead-of-briefing-doc-neurorx-to-list-via-spac-deal-1030461990,positive,0.8795015215873718
3026,5/25/2021 2:42:08 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-blockchain-stocks-mrna-stock-1030463723,positive,0.9298974871635437
3027,5/25/2021 2:44:48 PM,Moderna Says COVID-19 Vaccine Highly Effective In Adolescents ,RTTNews,/news/stocks/moderna-says-covid-19-vaccine-highly-effective-in-adolescents-1030462449,negative,0.9039103388786316
3028,5/25/2021 6:02:06 PM,EU targets more than a billion COVID-19 vaccine doses by September,Seeking Alpha,https://seekingalpha.com/news/3699985-eu-targets-more-than-a-billion-covid-19-vaccine-doses-by-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8005648255348206
3029,5/25/2021 7:46:23 PM,"With a Stumbling Track Record, All Signs Say Stay Away from Novavax",InvestorPlace,/news/stocks/nvax-stock-stumbling-track-record-all-signs-say-stay-away-1030464342,neutral,0.6971267461776733
3030,5/26/2021 8:23:58 AM,U.S. records major vaccine milestone as Covid origin debate continues,Seeking Alpha,https://seekingalpha.com/news/3700157-us-records-major-vaccine-milestone-as-covid-origin-debate-continues?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5296465754508972
3031,5/26/2021 11:10:09 AM,FDA is set to decline new emergency use authorizations for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3700199-fda-is-set-to-decline-new-emergency-use-authorizations-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9127315282821655
3032,5/26/2021 2:07:30 PM,7 Former Pandemic Stocks to Buy That Are No Longer Running Hot,InvestorPlace,/news/stocks/7-former-pandemic-stocks-to-buy-that-are-no-longer-running-hot-1030467518,positive,0.9169795513153076
3033,5/26/2021 6:21:23 PM,FDA May Not Review New COVID-19 Vaccine Emergency Use Requests,Benzinga,/news/stocks/fda-may-not-review-new-covid-19-vaccine-emergency-use-requests-1030468148,positive,0.7860015034675598
3034,5/26/2021 6:30:43 PM,Speculators Should Consider Buying Vaxart Stock,InvestorPlace,/news/stocks/vxrt-stock-speculators-should-consider-buying-vaxart-1030468698,positive,0.8830263614654541
3035,5/26/2021 7:54:01 PM,New studies shed light on lasting COVID-19 immunity in vaccinated individuals,Seeking Alpha,https://seekingalpha.com/news/3700498-new-studies-shed-light-on-lasting-covid-19-immunity-in-vaccinated-individuals?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6768931150436401
3036,5/27/2021 8:41:14 AM,Here's What Is Going On With Ocugen (OCGN) Stock,Benzinga,/news/stocks/here-s-what-is-going-on-with-ocugen-ocgn-stock-1030469868,positive,0.8751086592674255
3037,5/27/2021 1:08:55 PM,Take Your Ocugen Stock Profits and Run If You Haven’t Already,InvestorPlace,/news/stocks/take-your-ocgn-stock-profits-and-run-if-you-havent-already-1030471908,positive,0.7552903294563293
3038,5/27/2021 1:49:36 PM,Pfizer And Myovant Get FDA Nod For Myfembree ,RTTNews,/news/stocks/pfizer-and-myovant-get-fda-nod-for-myfembree-1030470925,negative,0.6410685777664185
3039,5/27/2021 2:23:09 PM,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-vir-glaxosmithkline-covid-19-antibody-treatment-approved-zosano-spikes-on-long-term-migraine-drug-data-decision-day-for-eton-2-ipos-1030471204,negative,0.7420997619628906
3040,5/27/2021 3:36:22 PM,Walmart providing Pfizer vaccine clinics at schools,Seeking Alpha,https://seekingalpha.com/news/3700874-walmart-providing-pfizer-vaccine-clinics-at-schools?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9201614856719971
3041,5/27/2021 9:27:56 PM,"COVID-19 vaccines from Pfizer/BioNTech, JNJ and Moderna set for India entry as India clears hurdles",Seeking Alpha,https://seekingalpha.com/news/3701056-covid-19-vaccines-from-pfizerbiontech-jnj-and-moderna-set-for-india-entry?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5801091194152832
3042,5/28/2021 12:29:15 PM,India in discussions with Pfizer to obtain 50M doses of COVID-19 vaccine - NYT,Seeking Alpha,https://seekingalpha.com/news/3701192-india-in-discussions-with-pfizer-to-obtain-50m-doses-of-covid-19-vaccine-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8161503672599792
3043,5/28/2021 2:01:46 PM,Biden's goal of 70% Covid vaccination by summer may be in reach - NYT,Seeking Alpha,https://seekingalpha.com/news/3701240-bidens-goal-of-70-covid-vaccination-by-summer-may-be-in-reach-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5080470442771912
3044,5/28/2021 2:05:09 PM,US taking 'very close look' at requiring vaccine passports for international travel - DHS Secretary,Seeking Alpha,https://seekingalpha.com/news/3701245-us-taking-very-close-look-at-requiring-vaccine-passports-for-international-travel-dhs-secretary?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8926757574081421
3045,5/28/2021 2:57:26 PM,Pfizer/ BioNTech COVID-19 vaccine recommended for adolescents in Europe,Seeking Alpha,https://seekingalpha.com/news/3701279-pfizer-biontech-covid-19-vaccine-recommended-for-use-in-adolescents-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7652799487113953
3046,5/28/2021 5:46:04 PM,Ocugen Stock Is a Speculative Covid-19 Vaccine Bet,InvestorPlace,/news/stocks/ocugen-stock-is-a-speculative-covid-19-vaccine-bet-1030476280,positive,0.9467129707336426
3047,5/29/2021 5:39:51 AM,EU Authorizes Pfizer-BioNTech's COVID-19 Vaccine For Adolescents ,RTTNews,/news/stocks/eu-authorizes-pfizer-biontech-s-covid-19-vaccine-for-adolescents-1030476770,positive,0.8259451389312744
3048,5/30/2021 2:36:50 AM,Pfizer/ BioNTech and AstraZeneca to dominate global COVID-19 vaccine supply in 2021,Seeking Alpha,https://seekingalpha.com/news/3701443-pfizer-biontech-and-astrazeneca-to-dominate-global-covid-19-vaccine-supply-in-2021?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8533116579055786
3049,5/30/2021 3:54:17 AM,Companies can require employees to get COVID-19 shot: EEOC,Seeking Alpha,https://seekingalpha.com/news/3701444-companies-can-require-employees-to-get-covid-19-shot-eeoc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8933736681938171
3050,6/1/2021 3:34:46 PM,BTIG's best and worst stocks for Operation Grand Slam,Seeking Alpha,https://seekingalpha.com/news/3701738-btigs-best-and-worst-stocks-for-operation-grand-slam?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5692315101623535
3051,6/1/2021 3:57:18 PM,EMA recommends additional capacity at Pfizer's vaccine manufacturing site in Belgium,Seeking Alpha,https://seekingalpha.com/news/3701816-ema-recommends-additional-capacity-at-pfizers-vaccine-manufacturing-site-in-belgium?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.569970428943634
3052,6/1/2021 8:05:41 PM,Canada revises guidance to allow mix and match of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3702028-canada-revises-guidance-to-allow-mix-and-match-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8810381889343262
3053,6/1/2021 8:42:44 PM,"SPACs Attack Recap: 6 SPAC Deals, SPAC Rumors And Headline News From Last Week",Benzinga,/news/stocks/spacs-attack-recap-6-spac-deals-spac-rumors-and-headline-news-from-last-week-1030484343,positive,0.8829095363616943
3054,6/1/2021 11:31:09 PM,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-june-pdufa-dates-1030484849,positive,0.9476439952850342
3055,6/2/2021 9:37:50 AM,European countries roll out digital Covid certificate to ease travel - NYT,Seeking Alpha,https://seekingalpha.com/news/3702175-european-countries-roll-out-digital-covid-certificate-to-ease-travel-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5580695271492004
3056,6/2/2021 10:37:13 AM,NIH begins study to evaluate mix-and-match COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3702194-nih-begins-study-to-evaluate-mix-and-match-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5177181363105774
3057,6/2/2021 11:34:47 AM,Israel claims probable link between Pfizer COVID-19 vaccine and myocarditis in young men,Seeking Alpha,https://seekingalpha.com/news/3702222-israel-claims-probable-link-between-pfizer-covid-19-vaccine-and-myocarditis-in-young-men-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5157462954521179
3058,6/2/2021 4:54:43 PM,"With Fading Covid-19 Infections, Vaxart’s Relevance Is Waning",InvestorPlace,/news/stocks/vxrt-stock-covid-19-infections-waning-1030488703,neutral,0.9509506821632385
3059,6/3/2021 8:06:03 AM,Low-income nations secure additional $2.4B to boost access to COVID-19 vaccines - NYT,Seeking Alpha,https://seekingalpha.com/news/3702752-low-income-nations-secures-additional-24b-to-boost-access-to-covid-19-vaccines-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9480469822883606
3060,6/3/2021 9:01:25 AM,"FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock",InvestorPlace,/news/stocks/fdas-vaccine-attitude-new-data-dont-bode-well-for-ocugen-stock-1030490489,neutral,0.9146958589553833
3061,6/3/2021 3:32:06 PM,Buy Carnival Stock as it Breaks Out,InvestorPlace,/news/stocks/buy-carnival-ccl-stock-as-it-breaks-out-1030492369,positive,0.9345949292182922
3062,6/3/2021 3:57:46 PM,Vaxart’s Compelling Story Will Take a Long Time to Play Out,InvestorPlace,/news/stocks/vxrt-stock-has-compelling-story-but-long-way-away-1030492365,positive,0.8855191469192505
3063,6/3/2021 5:02:53 PM,Pfizer reaffirmed neutral at BofA due to LOE concerns,Seeking Alpha,https://seekingalpha.com/news/3703000-pfizer-reaffirmed-neutral-at-bofa-due-to-loe-concerns?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6593590378761292
3064,6/3/2021 5:29:36 PM,I Would Hope Inovio Isn’t Attracting ANY Serious Money,InvestorPlace,/news/stocks/i-would-hope-inovio-and-ino-stock-isnt-attracting-any-serious-money-1030492714,positive,0.7353726029396057
3065,6/3/2021 5:45:27 PM,7 Best Vaccine Stocks for Their Pipeline Potential,InvestorPlace,/news/stocks/7-best-vaccine-stocks-for-their-pipeline-potential-1030492710,positive,0.6841976642608643
3066,6/4/2021 3:51:34 PM,UK Authorizes Pfizer-BioNTech's COVID-19 Vaccine In Children Aged 12 To 15 ,RTTNews,/news/stocks/uk-authorizes-pfizer-biontech-s-covid-19-vaccine-in-children-aged-12-to-15-1030495422,positive,0.8562661409378052
3067,6/4/2021 7:20:52 PM,"Despite Setbacks, the Future Remains Bright for Novavax Stock",InvestorPlace,/news/stocks/despite-setbacks-the-future-remains-bright-for-novavax-stock-1030496514,negative,0.945648729801178
3068,6/4/2021 7:28:16 PM,"Pfizer Stock Still Has Good Upside, Especially If the Dividend Yield Falls",InvestorPlace,/news/stocks/pfe-stock-still-good-upside-especially-if-dividend-yield-falls-1030496512,negative,0.931291401386261
3069,6/4/2021 7:30:04 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3703423-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
3070,6/7/2021 10:37:17 AM,U.S. to weigh COVID-19 shots for children as vaccination drive reaches milestone,Seeking Alpha,https://seekingalpha.com/news/3703562-us-to-weigh-covid-19-shots-for-children-as-vaccination-drive-reaches-milestone?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7012423872947693
3071,6/7/2021 2:52:10 PM,"The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck",Benzinga,/news/stocks/the-week-ahead-in-biotech-biogen-alexion-and-vertex-fda-decisions-multiple-conference-presentations-on-the-deck-1030499585,positive,0.9329092502593994
3072,6/8/2021 12:45:07 PM,Pfizer begins late-stage studies to test COVID-19 vaccine in kids,Seeking Alpha,https://seekingalpha.com/news/3704064-pfizer-begins-late-stage-studies-to-test-covid-19-vaccine-in-kids?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.617993950843811
3073,6/8/2021 3:17:38 PM,"The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex",Benzinga,/news/stocks/the-daily-biotech-pulse-hookipa-pds-biotech-report-positive-data-ironwood-cfo-to-depart-decision-day-for-vertex-1030503836,positive,0.9079675674438477
3074,6/8/2021 3:18:10 PM,"Could Lilly's donanemab, others for Alzheimer's get a boost from Biogen approval?",Seeking Alpha,https://seekingalpha.com/news/3704152-could-lilly-donanemab-others-for-alzheimers-get-a-boost-from-biogen-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6547841429710388
3075,6/8/2021 3:37:52 PM,5 Healthcare Stocks to Buy for Their Game-Changing Potential,InvestorPlace,/news/stocks/5-healthcare-stocks-to-buy-for-their-game-changing-potential-1030504685,positive,0.6112395524978638
3076,6/8/2021 5:44:00 PM,There’s Good Reason to Believe Novavax Will Rise Soon,InvestorPlace,/news/stocks/theres-good-reason-to-believe-nvax-stock-will-rise-soon-1030505029,negative,0.8615055680274963
3077,6/8/2021 6:51:45 PM,"5 Biogen Analysts On FDA Approval Of Alzheimer's Drug Aduhelm, Broad Label, Pricing",Benzinga,/news/stocks/5-biogen-analysts-on-fda-approval-of-alzheimer-s-drug-aduhelm-broad-label-pricing-1030504841,positive,0.8534533977508545
3078,6/9/2021 3:06:57 AM,FDA Approves Pfizer's Pneumococcal 20-valent Conjugate Vaccine For Adults ,RTTNews,/news/stocks/fda-approves-pfizer-s-pneumococcal-20-valent-conjugate-vaccine-for-adults-1030505697,negative,0.8236207962036133
3079,6/9/2021 6:26:29 AM,FDA approves Pfizer's Prevnar 20 for adults age 18 years or older,Seeking Alpha,https://seekingalpha.com/news/3704411-fda-approves-pfizers-prevnar-20-for-adults-age-18-years-or-older?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7739242315292358
3080,6/9/2021 9:35:12 AM,CDC relaxes COVID-19 travel recommendations to over 100 countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3704419-the-cdc-relaxes-covid-19-travel-recommendations-to-over-100-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.517711341381073
3081,6/9/2021 10:00:22 AM,Pfizer Is Still One of the Healthcare Sector’s Best Dividend Yielders,InvestorPlace,/news/stocks/pfe-stock-is-still-one-of-the-health-care-sectors-best-dividend-yielders-1030506713,negative,0.8141419887542725
3082,6/9/2021 3:14:20 PM,"The Daily Biotech Pulse: Lyra Gains On Positive Regulatory Outcome, FDA Nod For Pfizer's Prevnar Vaccine, Merck Inks COVID-19 Treatment Supply Deal With US",Benzinga,/news/stocks/the-daily-biotech-pulse-lyra-gains-on-positive-regulatory-outcome-fda-nod-for-pfizer-s-prevnar-vaccine-merck-inks-covid-19-treatment-supply-deal-with-us-1030507884,negative,0.933498740196228
3083,6/9/2021 6:10:12 PM,U.S. to buy 500M doses of COVID-19 vaccine doses from Pfizer to donate: WaPo,Seeking Alpha,https://seekingalpha.com/news/3704720-us-to-buy-500m-doses-of-covid-19-vaccine-doses-from-pfizer-to-donate-wapo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7824522256851196
3084,6/10/2021 8:30:13 AM,Pfizer To Provide 500 Mln Doses Of COVID-19 Vaccine To U.S. For Donation To Poorest Nations ,RTTNews,/news/stocks/pfizer-to-provide-500-mln-doses-of-covid-19-vaccine-to-u-s-for-donation-to-poorest-nations-1030510265,negative,0.5665894150733948
3085,6/10/2021 9:48:41 AM,WTO to initiate vaccine supply negotiations amid patent waiver conflict for Covid drugs - Reuters,Seeking Alpha,https://seekingalpha.com/news/3704887-wto-to-initiate-vaccine-supply-negotiations-on-june-17-amid-patent-waiver-conflict-for-covid-drugs-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6895945072174072
3086,6/10/2021 12:01:51 PM,A Peek Into The Markets: US Stock Futures Mixed; Inflation Data In Focus,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-inflation-data-in-focus-1030510765,neutral,0.6175207495689392
3087,6/10/2021 2:13:41 PM,"The Daily Biotech Pulse: US To Procure 500M Pfizer-BioNTech Vaccine Doses For Donation, Verona Out-Licenses COPD Drug, Nautilus Lists Through SPAC Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-us-to-procure-500m-pfizer-biontech-vaccine-doses-for-donation-verona-out-licenses-copd-drug-nautilus-lists-through-spac-deal-1030511571,positive,0.745228111743927
3088,6/10/2021 3:03:00 PM,"Moderna, BioNTech trade lower as CDC points to heart condition linked to COVID-19 shot (updated)",Seeking Alpha,https://seekingalpha.com/news/3705089-moderna-biontech-trade-lower-as-cdc-points-to-heart-condition-linked-to-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9239170551300049
3089,6/10/2021 4:15:23 PM,Anti-Meme Stocks: 7 Value Stock Picks for Common Sense Investors,InvestorPlace,/news/stocks/anti-meme-stocks-7-value-stock-picks-for-common-sense-investors-1030513268,positive,0.9350194334983826
3090,6/11/2021 10:58:20 AM,Messenger-RNA COVID-19 shots and rare cases of heart inflammation: CDC schedules a meeting,Seeking Alpha,https://seekingalpha.com/news/3705549-messenger-rna-covid-19-shots-and-rare-cases-of-heart-inflammation-cdc-schedules-a-meeting?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8944300413131714
3091,6/11/2021 6:08:55 PM,Moderna says its COVID vaccine not linked to heart condition - Bloomberg (update),Seeking Alpha,https://seekingalpha.com/news/3705762-moderna-says-its-covid-vaccine-not-linked-to-heart-condition-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9250167608261108
3092,6/11/2021 7:30:02 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3705774-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
3093,6/13/2021 6:51:53 PM,"The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-takeda-blueprint-medicines-orphazyme-eton-on-the-radar-ahead-of-fda-decisions-ipos-1030518167,positive,0.921207845211029
3094,6/14/2021 11:11:05 AM,G7 leaders pledge 1B coronavirus vaccines for developing countries,Seeking Alpha,https://seekingalpha.com/news/3705892-g7-leaders-pledge-1b-coronavirus-vaccines-for-developing-countries?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6061450839042664
3095,6/14/2021 2:07:08 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-musk-bitcoin-nvax-stock-1030520158,positive,0.9298974871635437
3096,6/14/2021 5:43:07 PM,"Seeking vaccination boost, NYC launches $100 referral bonus program for organizations",Seeking Alpha,https://seekingalpha.com/news/3706113-seeking-vaccination-boost-nyc-launches-100-referral-bonus-program-for-organizations?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8781466484069824
3097,6/14/2021 6:10:52 PM,Pfizer/BioNTech and AstraZeneca vaccine effective against Delta variant - UK analysis,Seeking Alpha,https://seekingalpha.com/news/3706120-pfizer-biontech-and-astrazeneca-vaccine-effective-against-delta-variant-uk-analysis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9190366268157959
3098,6/14/2021 6:11:12 PM,Rivals in the red after Novavax posted strong efficacy data for its COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3706122-rivals-in-the-red-after-novavax-posted-strong-efficacy-data-for-its-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9234724044799805
3099,6/15/2021 5:15:32 PM,"US, EU aim to vaccinate two-thirds of world's population against COVID by end of 2022",Seeking Alpha,https://seekingalpha.com/news/3706544-us-eu-aim-to-vaccinate-two-thirds-of-worlds-population-against-covid-by-end-of-2022?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7000491619110107
3100,6/16/2021 12:13:20 PM,It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play,InvestorPlace,/news/stocks/ocgn-stock-is-no-covid-play-1030528088,positive,0.8373422026634216
3101,6/16/2021 4:00:34 PM,Is There Still Upside Potential for Novavax Stock?,InvestorPlace,/news/stocks/is-there-still-upside-potential-for-novavax-stock-1030529164,positive,0.5518491268157959
3102,6/16/2021 4:20:47 PM,Pfizer CEO Albert Bourla: Life will return to normal by 2022,Seeking Alpha,https://seekingalpha.com/news/3706980-pfizer-ceo-albert-bourla-on-pandemic-life-would-return-to-normal-by-2022-globally?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8558766841888428
3103,6/16/2021 6:13:16 PM,Messenger-RNA-based COVID-19 vaccines offer hope for the immunocompromised with booster shot,Seeking Alpha,https://seekingalpha.com/news/3707012-messenger-rna-based-covid-19-vaccines-offer-hope-for-the-immunocompromised-with-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49599489569664
3104,6/16/2021 8:48:50 PM,CDC data shows adult vaccination rates slowing as large percentage unvaccinated,Seeking Alpha,https://seekingalpha.com/news/3707088-cdc-data-shows-adults-vaccination-rates-slowing-as-large-percentage-unvaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9048757553100586
3105,6/17/2021 4:40:21 AM,BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant - Barron's,Seeking Alpha,https://seekingalpha.com/news/3707136-biontech-ceo-sahin-warns-of-possible-covid-resurgence-from-delta-variant-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8906422257423401
3106,6/17/2021 7:00:19 AM,Pfizer’s tofacitinib meets primary endpoint in Brazilian COVID-19 study,Seeking Alpha,https://seekingalpha.com/news/3707144-pfizers-tofacitinib-meets-primary-endpoint-in-brazilian-covid-19-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.832229495048523
3107,6/17/2021 8:48:38 AM,AstraZeneca's COVID-19 jab recommended for people over-60s only in Australia - Reuters,Seeking Alpha,https://seekingalpha.com/news/3707148-astrazenecas-covid-19-jab-recommended-for-people-over-60s-only-in-australia-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8115257620811462
3108,6/17/2021 12:42:13 PM,CVAC Stock: The Huge Covid-19 News That Has CureVac Plunging Today,InvestorPlace,/news/stocks/cvac-stock-the-huge-covid-19-news-that-has-curevac-plunging-today-1030532055,neutral,0.44330164790153503
3109,6/17/2021 2:31:50 PM,"The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme",Benzinga,/news/stocks/the-daily-biotech-pulse-biogen-faces-another-clinical-setback-curevac-s-covid-19-vaccine-study-fails-moment-of-reckoning-for-orphazyme-1030531978,neutral,0.90581876039505
3110,6/17/2021 3:04:17 PM,Atea surges as COVID-19 pill attracts government attention,Seeking Alpha,https://seekingalpha.com/news/3707355-atea-surges-as-covid-19-pill-attracts-government-attention?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9321674108505249
3111,6/17/2021 3:57:00 PM,Pfizer's Xeljanz shows efficacy against COVID-19 pneumonia,Seeking Alpha,https://seekingalpha.com/news/3707369-pfizer-xeljanz-shows-efficacy-against-covid-19-pneumonia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9455490112304688
3112,6/17/2021 4:27:04 PM,U.S. to invest more than $3B to boost development of COVID-19 antiviral drugs,Seeking Alpha,https://seekingalpha.com/news/3707379-us-to-invest-more-than-3b-to-boost-development-of-covid-19-antiviral-drugs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9287871718406677
3113,6/17/2021 9:13:38 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-bitcoin-ride-stock-cvac-stock-1030533935,positive,0.9254742860794067
3114,6/18/2021 11:18:29 AM,U.K. reports surge in cases of Delta variant of coronavirus - Reuters,Seeking Alpha,https://seekingalpha.com/news/3707579-uk-reports-surge-in-cases-of-delta-variant-of-coronavirus-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7136960029602051
3115,6/18/2021 3:59:06 PM,Bristol's up to $3B deal with Eisai puts antibody drug conjugates in the spotlight,Seeking Alpha,https://seekingalpha.com/news/3707699-bristols-up-to-3b-deal-with-eisai-puts-antibody-drug-conjugates-in-the-spotlight?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.664600670337677
3116,6/18/2021 7:23:12 PM,Delta variant is becoming a globally dominant COVID-19 variant: WHO,Seeking Alpha,https://seekingalpha.com/news/3707802-delta-variant-is-becoming-a-globally-dominant-covid-19-variant-who?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5973742604255676
3117,6/20/2021 2:17:12 AM,CureVac COVID-19 vaccine’s subpar efficacy: scientists explore reasons,Seeking Alpha,https://seekingalpha.com/news/3707857-curevac-covid-19-vaccines-subpar-efficacy-scientists-explore-reasons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49888336658477783
3118,6/21/2021 8:39:43 AM,CDC warns Delta variant could become dominant in U.S. this summer,Seeking Alpha,https://seekingalpha.com/news/3707964-cdc-warns-delta-variant-could-become-dominant-in-us-this-summer-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4572985768318176
3119,6/21/2021 10:00:50 AM,Novavax Is a Long-Term Buy for the Continuing Pandemic,InvestorPlace,/news/stocks/nvax-stock-is-a-long-term-buy-for-the-continuing-pandemic-1030538420,positive,0.5151999592781067
3120,6/21/2021 12:03:51 PM,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-signal-higher-start-on-wall-street-1030538411,negative,0.883458137512207
3121,6/21/2021 6:20:08 PM,China reaches a milestone in COVID-19 vaccination with 1 billion shots,Seeking Alpha,https://seekingalpha.com/news/3708387-china-reaches-a-milestone-in-covid-19-vaccination-with-1-billion-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8285498023033142
3122,6/22/2021 7:20:01 AM,ViiV Healthcare collaborates with Halozyme for development of HIV medicines,Seeking Alpha,https://seekingalpha.com/news/3708520-viiv-healthcare-collaborates-with-halozyme-for-development-of-hiv-medicines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6508053541183472
3123,6/22/2021 8:18:00 AM,"ViiV Healthcare and Halozyme enter global collaboration and license agreement for ENHANZE® drug delivery technology to enable development of ""ultra-long-acting"" medicines for HIV",PR Newswire,/news/stocks/viiv-healthcare-and-halozyme-enter-global-collaboration-and-license-agreement-for-enhanze-drug-delivery-technology-to-enable-development-of-ultra-long-acting-medicines-for-hiv-1030541496,negative,0.9268784523010254
3124,6/22/2021 12:45:20 PM,Repare Therapeutics: Fighting Cancer With Synthetic Lethality ,RTTNews,/news/stocks/repare-therapeutics-fighting-cancer-with-synthetic-lethality-1030542158,positive,0.7918515801429749
3125,6/22/2021 2:12:07 PM,"The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-sanofi-translate-bio-start-early-stage-seasonal-flu-vaccine-study-dr-reddy-s-launches-generic-vascepa-halozyme-strikes-licensing-deal-1030542723,positive,0.8023735880851746
3126,6/22/2021 3:06:24 PM,BioNTech to consider dividends next year,Seeking Alpha,https://seekingalpha.com/news/3708733-biontech-to-consider-dividends-next-year?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9399805068969727
3127,6/22/2021 3:12:00 PM,Sen. Wyden releases 'principles for drug pricing reform',Seeking Alpha,https://seekingalpha.com/news/3708721-sen-wyden-releases-principles-for-drug-price-reform?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8699349761009216
3128,6/22/2021 4:58:56 PM,White House to fall short of July 4 Covid vaccination goal - NBC,Seeking Alpha,https://seekingalpha.com/news/3708788-white-house-to-say-us-could-miss-fourth-of-july-goal-in-covid-19-vaccination-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6146945953369141
3129,6/22/2021 7:25:16 PM,Should Investors Be Worried About The Delta Strain Of COVID-19?,Benzinga,/news/stocks/should-investors-be-worried-about-the-delta-strain-of-covid-19-1030544304,neutral,0.6767349243164062
3130,6/23/2021 6:54:00 AM,Fauci says Delta variant greatest threat to U.S. efforts to eradicate COVID-19,Seeking Alpha,https://seekingalpha.com/news/3708985-fauci-says-delta-variant-greatest-threat-to-united-states-efforts-to-eradicate-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4963109493255615
3131,6/23/2021 10:57:01 AM,Dosing underway in Pfizer’s late-stage talazoparib/enzalutamide combo study in prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3709018-dosing-underway-in-pfizers-late-stage-talazoparibenzalutamide-combo-study-in-prostate-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5421359539031982
3132,6/23/2021 1:13:01 PM,"Pfizer Doses First Participant In TALAPRO-3, Placebo-controlled Phase 3 Clinical Trial - Quick Facts ",RTTNews,/news/stocks/pfizer-doses-first-participant-in-talapro-3-placebo-controlled-phase-3-clinical-trial-quick-facts-1030546346,negative,0.551430344581604
3133,6/23/2021 3:25:01 PM,Citius Shows a Promising Future as Share Prices Keep Going up,Benzinga,/news/stocks/citius-shows-a-promising-future-as-share-prices-keep-going-up-1030547404,negative,0.9269535541534424
3134,6/23/2021 4:52:56 PM,"Moderna, BioNTech slide as CDC sees 'likely association' of heart inflammation and COVID-19 vaccines",Seeking Alpha,https://seekingalpha.com/news/3709267-moderna-biontech-slide-as-cdc-sees-a-likely-association-of-heart-inflammation-and-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9279312491416931
3135,6/24/2021 7:42:17 AM,Biotech Stocks Facing FDA Decision In July 2021 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-july-2021-1030549382,positive,0.818015456199646
3136,6/24/2021 9:45:14 AM,NIH commences COVID-19 vaccine trial in pregnant women - Reuters,Seeking Alpha,https://seekingalpha.com/news/3709428-nih-commences-covid-19-vaccine-trial-in-pregnant-women-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8806933164596558
3137,6/24/2021 10:36:44 AM,"FDA to add heart inflammation warning to Pfizer, Moderna COVID-19 vaccines",Seeking Alpha,https://seekingalpha.com/news/3709439-fda-to-add-heart-inflammation-warning-to-pfizer-moderna-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8629214763641357
3138,6/24/2021 10:46:45 AM,Pfizer says vaccine is highly effective against COVID-19 delta variant,Seeking Alpha,https://seekingalpha.com/news/3709443-pfizer-says-vaccine-is-highly-effective-against-covid-19-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9248866438865662
3139,6/24/2021 10:48:53 AM,"Pfizer declares $0.39 dividend, stock yields 4%",Seeking Alpha,https://seekingalpha.com/news/3709442-pfizer-inc-declares-0_39-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5846265554428101
3140,6/24/2021 3:57:27 PM,Transgene enrolls first patient in mid-stage TG4001 cancer trial,Seeking Alpha,https://seekingalpha.com/news/3709719-transgene-enrolls-first-patient-in-mid-stage-tg4001-cancer-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7688480615615845
3141,6/24/2021 4:06:34 PM,Jefferies starts Vaxcyte at buy seeing 133% upside,Seeking Alpha,https://seekingalpha.com/news/3709702-jefferies-starts-vaxcyte-at-buy-seeing-133-upside?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9004946947097778
3142,6/24/2021 4:35:43 PM,CDC and WHO weigh in on need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3709736-cdc-and-who-weigh-in-on-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7704358696937561
3143,6/24/2021 6:29:48 PM,"Pfizer, Moderna mRNA vaccines not linked to male infertility",Seeking Alpha,https://seekingalpha.com/news/3709775-pfizer-moderna-mrna-vaccines-not-linked-to-male-infertility?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9186111092567444
3144,6/24/2021 7:29:46 PM,Pfizer halts global distribution of Chantix due to cancer causing agents: Stat,Seeking Alpha,https://seekingalpha.com/news/3709793-pfizer-halts-global-distribution-of-chantix-due-to-cancer-causing-agents?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9280117154121399
3145,6/26/2021 5:29:07 AM,"FDA Adds Warning To Moderna, Pfizer Covid-19 Vaccines About Risk Of Heart Inflammation ",RTTNews,/news/stocks/fda-adds-warning-to-moderna-pfizer-covid-19-vaccines-about-risk-of-heart-inflammation-1030556321,positive,0.607143223285675
3146,6/27/2021 1:03:30 AM,Pfizer/BioNTech and Moderna COVID-19 vaccines now include warnings on rare heart condition,Seeking Alpha,https://seekingalpha.com/news/3710323-pfizerbiontech-and-moderna-covid-19-vaccines-now-include-warnings-on-rare-heart-condition?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8189296126365662
3147,6/27/2021 1:06:49 AM,JNJ COVID-19 vaccine and risks from delta variant: experts are already taking booster shots,Seeking Alpha,https://seekingalpha.com/news/3710324-jnj-covid-19-vaccine-and-risks-from-delta-variant-experts-are-already-taking-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7029075026512146
3148,6/27/2021 6:55:52 PM,"The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus",Benzinga,/news/stocks/the-week-ahead-in-biotech-mediwound-provention-fda-decisions-ipos-pending-clinical-readouts-in-focus-1030556958,positive,0.940535843372345
3149,6/28/2021 12:44:18 PM,"Pfizer, Moderna mRNA vaccines may result in long-lasting immunity: Study",Seeking Alpha,https://seekingalpha.com/news/3710450-pfizer-moderna-mrna-vaccines-may-result-in-long-lasting-immunity-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8322778940200806
3150,6/28/2021 5:39:38 PM,"Mixing AstraZeneca, Pfizer vaccines generates robust immune response",Seeking Alpha,https://seekingalpha.com/news/3710649-mixing-astrazeneca-pfizer-vaccines-generates-robust-immune-response?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9036151170730591
3151,6/29/2021 9:14:34 AM,"Amid surge in Delta variant, nations impose new restrictions to curb infections",Seeking Alpha,https://seekingalpha.com/news/3710809-amid-surge-in-delta-variant-nations-impose-new-restrictions-to-curb-infections?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49846151471138
3152,6/29/2021 10:00:10 AM,Get Rid of Ocugen Stock While You Can as the Bad News Piles Up,InvestorPlace,/news/stocks/ocgn-stock-bad-news-piles-up-1030561895,positive,0.7997965216636658
3153,6/29/2021 10:58:49 AM,Sanofi to invest $476 million annually in development of messenger-RNA based vaccines,Seeking Alpha,https://seekingalpha.com/news/3710839-sanofi-to-invest-476-million-annually-in-development-of-messenger-rna-based-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6586194634437561
3154,6/29/2021 2:28:44 PM,Moderna reaches an all-time high as vaccine shows effect against COVID-19 Delta variant,Seeking Alpha,https://seekingalpha.com/news/3711000-moderna-reaches-an-all-time-high-amid-concerns-over-covid-19-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9241597056388855
3155,6/29/2021 3:02:51 PM,The 7 Best ESG Stocks to Buy for the Biggest (Socially Responsible) Gains,InvestorPlace,/news/stocks/7-best-esg-stocks-to-buy-for-socially-responsible-gains-1030563789,positive,0.799585223197937
3156,6/29/2021 8:05:45 PM,MRNA-based vaccine makers in focus as cases of heart inflammation linked to COVID-19 shot resurface,Seeking Alpha,https://seekingalpha.com/news/3711112-mrna-based-vaccine-makers-in-focus-as-cases-of-hear-inflammation-linked-to-covid-19-shot-resurface?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.45588624477386475
3157,6/30/2021 2:51:57 PM,Thailand to purchase 5M Moderna COVID vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3711425-thailand-to-purchase-5m-moderna-covid-vaccine-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6417127847671509
3158,6/30/2021 5:37:41 PM,The 3 Biotech Firms Riding High on CRISPR News,InvestorPlace,/news/stocks/the-3-biotech-firms-riding-high-on-crispr-news-1030568633,negative,0.8648343682289124
3159,6/30/2021 8:05:08 PM,World Bank to boost financing available for COVID vaccine purchases to $20B,Seeking Alpha,https://seekingalpha.com/news/3711572-world-bank-to-boost-financing-available-for-covid-vaccine-purchase-to-20b?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9494578242301941
3160,6/30/2021 8:24:38 PM,JNJ to begin COVID-19 vaccine study for adolescents this fall,Seeking Alpha,https://seekingalpha.com/news/3711594-jnj-to-begin-covid-19-vaccine-study-for-adolescents-this-fall?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.862255871295929
3161,6/30/2021 8:27:54 PM,Sell Ocugen Stock Before the Other Shoe Finally Drops,InvestorPlace,/news/stocks/ocgn-stock-sell-ocugen-before-other-shoe-finally-drops-1030569105,positive,0.9403712153434753
3162,7/1/2021 3:35:29 AM,J&J COVID vaccine may protect against Delta variant - US Surgeon General,Seeking Alpha,https://seekingalpha.com/news/3711660-jj-covid-vaccine-may-protect-against-delta-variant-us-surgeon-general?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8075571656227112
3163,7/1/2021 10:11:28 AM,Spero Therapeutics stock gains on $40M equity investment from Pfizer and licensing agreement for SPR206,Seeking Alpha,https://seekingalpha.com/news/3711696-spero-therapeutics-stock-gains-on-40m-equity-investment-from-pfizer-and-licensing-agreement-for-spr206?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9451223015785217
3164,7/1/2021 12:43:28 PM,"Spero Therapeutics Stock Surges On $40M Equity Funding, SPR206 Licensing Pact With Pfizer",Benzinga,/news/stocks/spero-therapeutics-stock-surges-on-40m-equity-funding-spr206-licensing-pact-with-pfizer-1030570948,negative,0.9285779595375061
3165,7/1/2021 2:06:57 PM,"The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts",Benzinga,/news/stocks/the-daily-biotech-pulse-spero-spikes-on-pfizer-investment-fda-nod-for-jazz-orchard-signs-licensing-deal-acumen-pharma-debuts-1030571343,positive,0.6166059970855713
3166,7/1/2021 9:16:41 PM,WHO chief urges every nation to vaccinate at least 10% of population by September,Seeking Alpha,https://seekingalpha.com/news/3712248-who-chief-urges-every-nation-to-vaccinate-at-least-10-of-population-by-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8444913029670715
3167,7/1/2021 11:07:05 PM,Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-july-pdufa-dates-1030573631,positive,0.9455710649490356
3168,7/2/2021 11:34:30 AM,COVAX urges all governments for equal recognition of COVID-19 vaccines for travel,Seeking Alpha,https://seekingalpha.com/news/3712318-covax-urges-all-governments-for-equal-recognition-of-covid-19-vaccines-for-travel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.657991886138916
3169,7/2/2021 1:14:04 PM,"Gottlleb says OK for vaccinated Americans gather with friends, family for July 4 - CNBC",Seeking Alpha,https://seekingalpha.com/news/3712370-gottlleb-says-ok-for-vaccinated-americans-gather-with-friends-family-for-july-4-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9041555523872375
3170,7/2/2021 1:58:09 PM,COVID-19 response teams being deployed across U.S. to combat Delta variant,Seeking Alpha,https://seekingalpha.com/news/3712399-covid-19-response-teams-being-deployed-across-us-to-combat-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5611690878868103
3171,7/2/2021 3:51:00 PM,GlaxoSmithKline Capital Inc. -- Moody's revises GSK's outlook to stable from negative; affirms A2 and P-1 ratings,Moodys,/news/bonds/glaxosmithkline-capital-inc-moody-s-revises-gsk-s-outlook-to-stable-from-negative-affirms-a2-and-p-1-ratings-1030575625,negative,0.9258115291595459
3172,7/2/2021 4:25:53 PM,"Biden not concerned about major COVID outbreak, but wants to see more vaccinations",Seeking Alpha,https://seekingalpha.com/news/3712520-biden-not-concerned-about-major-covid-outbreak-but-wants-to-see-more-vaccinations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7372595071792603
3173,7/3/2021 8:07:43 PM,CDC investigating case of teenager who died after receiving Pfizer shot - Detroit News,Seeking Alpha,https://seekingalpha.com/news/3712733-cdc-investigating-case-of-teenager-who-died-after-receiving-pfizer-shot-detroit-news?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4870213568210602
3174,7/4/2021 1:14:17 AM,Scientists not alarmed by deaths due to COVID-19 Delta variant among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3712735-deaths-due-to-covid-19-delta-variant-among-fully-vaccinated-scientists-are-not-alarmed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6125161051750183
3175,7/5/2021 10:00:22 AM,NVAX Stock Is Not For The Faint Of Heart,InvestorPlace,/news/stocks/nvax-stock-is-not-for-the-faint-of-heart-1030578313,positive,0.9399634599685669
3176,7/5/2021 12:04:00 PM,Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories,PR Newswire,/news/stocks/everest-medicines-announces-that-spero-therapeutics-entered-into-licensing-agreement-with-pfizer-inc-for-spr206-in-ex-u-s-and-ex-asia-territories-1030578296,negative,0.9283164143562317
3177,7/5/2021 12:44:47 PM,"Everest Medicines: Spero Therapeutics, Pfizer In Deal For SPR206 In Ex-U.S. And Ex-Asia Territories ",RTTNews,/news/stocks/everest-medicines-spero-therapeutics-pfizer-in-deal-for-spr206-in-ex-u-s-and-ex-asia-territories-1030578404,positive,0.782278835773468
3178,7/6/2021 6:29:48 AM,Israel sees decrease in Pfizer vaccine effectiveness against COVID-19 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3712766-israel-sees-decrease-in-pfizer-vaccine-effectiveness-against-covid-19-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9608821868896484
3179,7/6/2021 7:39:51 AM,Boris Johnson outlines plans to ease Covid restrictions in U.K.,Seeking Alpha,https://seekingalpha.com/news/3712767-boris-johnson-outlines-plans-to-ease-covid-restrictions-in-uk?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8264450430870056
3180,7/6/2021 10:00:14 AM,"Ocugen Has Had a Good Run, but the Math Says It’s Over",InvestorPlace,/news/stocks/ocgn-stock-has-had-good-run-but-math-says-its-over-1030581139,negative,0.5612901449203491
3181,7/6/2021 10:01:21 AM,Don’t Play the Ocugen Stock Short Squeeze Before You Read This Warning!,InvestorPlace,/news/stocks/ocgn-stock-short-squeeze-risks-1030581133,positive,0.8795098066329956
3182,7/6/2021 2:36:33 PM,"Israel, South Korea agree to Pfizer/BioNTech vaccine exchange",Seeking Alpha,https://seekingalpha.com/news/3712953-israel-south-korea-agree-to-pfizerbiontech-vaccine-exchange?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8096338510513306
3183,7/6/2021 7:56:28 PM,"Biden ramping up vaccination efforts, focusing on adolescents, pediatricians, and workplaces",Seeking Alpha,https://seekingalpha.com/news/3713077-biden-ramping-up-vaccination-efforts-focusing-on-adolescents-pediatricians-and-workplaces?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8103123903274536
3184,7/7/2021 4:31:44 AM,New Zealand OK's use of J&J COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3713159-new-zealand-oks-use-of-jj-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8985034823417664
3185,7/7/2021 7:47:11 AM,"U.K. Health secretary warns daily COVID-19 cases could reach 100,000",Seeking Alpha,https://seekingalpha.com/news/3713163-uk-health-secretary-warns-daily-covid-19-cases-could-reach-100000?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9133965373039246
3186,7/7/2021 9:01:44 AM,The Outlook for Ocugen Stock Has Deteriorated Further,InvestorPlace,/news/stocks/the-outlook-for-ocugen-stock-has-deteriorated-further-1030584731,neutral,0.9634916186332703
3187,7/7/2021 10:00:57 AM,"The Real Value of Novavax Lies in Its Pipeline, Not the Pandemic",InvestorPlace,/news/stocks/nvax-stock-value-is-in-pipeline-not-pandemic-1030584890,positive,0.9364336133003235
3188,7/7/2021 10:49:38 AM,Mid-size pharmaceutical firms lead bigger rivals in acquisitions this year,Seeking Alpha,https://seekingalpha.com/news/3713185-mid-size-pharmaceutical-firms-lead-bigger-rivals-in-acquisitions-this-year?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6112593412399292
3189,7/7/2021 2:49:38 PM,Nextleaf Solutions Forges Unique Path in the Cannabis  Industry with its IP Strategy,Benzinga,/news/stocks/nextleaf-solutions-forges-unique-path-in-the-cannabis-industry-with-its-ip-strategy-1030585735,negative,0.7415828108787537
3190,7/7/2021 5:13:09 PM,Latest CDC data show COVID-19 Delta variant is now dominant in U.S.,Seeking Alpha,https://seekingalpha.com/news/3713403-latest-cdc-data-show-covid-19-delta-variant-is-now-dominant-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6076704263687134
3191,7/8/2021 2:52:13 PM,Global COVID-19 death toll surpasses 4M,Seeking Alpha,https://seekingalpha.com/news/3713684-global-covid-19-death-roll-surpasses-4m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6976553797721863
3192,7/8/2021 3:45:27 PM,Two doses of vaccine necessary to thwart COVID delta variant -- study (updated),Seeking Alpha,https://seekingalpha.com/news/3713708-two-doses-of-vaccine-necessary-to-thwart-covid-delta-variant-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8575191497802734
3193,7/8/2021 5:56:17 PM,Scientists weigh in on reimplementation of COVID-19 restrictions in under-vaccinated areas,Seeking Alpha,https://seekingalpha.com/news/3713742-scientists-weigh-in-on-reimplementation-of-covid-19-restrictions-in-under-vaccinated-areas?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7959216833114624
3194,7/8/2021 7:38:27 PM,"House Oversight report says pharmas spend more on buybacks, dividends than R&D",Seeking Alpha,https://seekingalpha.com/news/3713778-house-oversight-report-says-pharmas-spend-more-on-buybacks-dividends-than-research-development?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8492424488067627
3195,7/8/2021 9:14:25 PM,Pfizer to begin clinical trials for a COVID-19 shot targeting Delta variant (updated),Seeking Alpha,https://seekingalpha.com/news/3713843-pfizer-to-seek-fda-nod-for-covid-19-booster-shot-in-august?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.81756192445755
3196,7/9/2021 4:20:15 AM,Pfizer : Booster Dose Likely To Provide Best Protection From COVID-19 ,RTTNews,/news/stocks/pfizer-booster-dose-likely-to-provide-best-protection-from-covid-19-1030591735,negative,0.9292455315589905
3197,7/9/2021 11:35:41 AM,CDC and FDA: No need for COVID-19 booster shots at this time for fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3713918-cdc-and-fda-there-is-no-need-for-covid-19-booster-shots-at-this-time-for-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8758231401443481
3198,7/9/2021 12:40:27 PM,EMA finds link possible between heart inflammation and mRNA COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3713951-ema-finds-link-possible-between-heart-inflammation-and-mrna-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6032859683036804
3199,7/9/2021 2:58:08 PM,7 Travel Stocks to Sell if the Delta Variant Slows the Reopening Rally,InvestorPlace,/news/stocks/7-travel-stocks-to-sell-if-delta-variant-slows-reopening-rally-1030593455,neutral,0.8868439197540283
3200,7/9/2021 2:59:56 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-any-stock-bullish-crypto-exchange-1030593453,positive,0.9298974871635437
3201,7/9/2021 3:19:27 PM,What to Know About the Pfizer Booster Trial and New Vaccine Moves for PFE Stock,InvestorPlace,/news/stocks/what-to-know-about-the-pfizer-booster-trial-and-new-vaccine-moves-for-pfe-stock-1030593553,positive,0.9387854933738708
3202,7/9/2021 4:02:14 PM,Watch Out for a Selloff in Vaxart Stock,InvestorPlace,/news/stocks/watch-out-for-a-selloff-in-vaxart-stock-1030593691,positive,0.5398297905921936
3203,7/9/2021 4:53:01 PM,CDC updates guidance for schools recommending indoor masking for unvaccinated children and teachers,Seeking Alpha,https://seekingalpha.com/news/3714051-cdc-updates-guidance-for-schools-recommending-indoor-masking-for-unvaccinated-children-and-teachers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7573947310447693
3204,7/9/2021 6:39:01 PM,"Biogen FDA probe on Alzheimer's drug unlikely to have `tangible' impact, analyst says",Seeking Alpha,https://seekingalpha.com/news/3714076-biogen-fda-probe-on-alzheimers-drug-unlikely-to-have-tangible-impact-analyst-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6848843097686768
3205,7/9/2021 8:02:53 PM,7 Super-Safe Dividend Stock Performers to Buy,InvestorPlace,/news/stocks/7-super-safe-dividend-stocks-to-buy-1030594111,positive,0.8698828220367432
3206,7/9/2021 9:07:15 PM,WHO backs mRNA-based COVID-19 vaccines despite rare cases of heart inflammation,Seeking Alpha,https://seekingalpha.com/news/3714117-who-backs-mrna-based-covid-19-vaccines-despite-rare-cases-of-heart-inflammation?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6185818910598755
3207,7/10/2021 10:51:53 PM,Alector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rally,Seeking Alpha,https://seekingalpha.com/news/3714135-alector-leads-weekly-healthcare-gainers-gene-editing-stocks-fall-after-intellia-driven-rally?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9623830318450928
3208,7/11/2021 2:29:21 AM,"New daily COVID-19 cases exceed 48,000 in U.S., highest since May",Seeking Alpha,https://seekingalpha.com/news/3714138-new-daily-covid-19-cases-exceed-48000-in-us-highest-since-may?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6676762104034424
3209,7/12/2021 5:12:30 AM,Pfizer to brief U.S. officials on need for vaccine booster shot - The Washington Post,Seeking Alpha,https://seekingalpha.com/news/3714150-pfizer-to-brief-us-officials-on-need-for-vaccine-booster-shot-the-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8825573921203613
3210,7/12/2021 5:29:45 AM,Health minister gives OK for at-risk Israelis to get third Pfizer vaccine dose - Times of Israel,Seeking Alpha,https://seekingalpha.com/news/3714152-health-minister-gives-ok-for-at-risk-israelis-to-get-third-pfizer-vaccine-dose-times-of-israel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7467094659805298
3211,7/12/2021 5:54:20 AM,Taiwan getting additional 10M BioNTech vaccine doses through tech companies (updated),Seeking Alpha,https://seekingalpha.com/news/3714154-taiwan-getting-additional-10m-biontech-vaccine-doses-through-tech-companies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5281169414520264
3212,7/12/2021 10:50:13 AM,"Chinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says",Seeking Alpha,https://seekingalpha.com/news/3714180-chinese-covid-19-shots-have-nearly-70-efficacy-against-delta-variant-scientist-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.915778398513794
3213,7/12/2021 9:38:05 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-spce-stock-johnson-and-johnson-1030598854,positive,0.9254742860794067
3214,7/13/2021 10:50:28 AM,Pfizer fails to win U.S. support for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3714585-pfizer-fails-to-win-us-support-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8464623689651489
3215,7/13/2021 8:09:05 PM,"Pfizer/BioNTech, Moderna vaccine effect impacted by COVID-19 Lambda variant",Seeking Alpha,https://seekingalpha.com/news/3714876-pfizerbiontech-moderna-vaccine-effect-impacted-by-covid-19-lambda-variant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8265084624290466
3216,7/14/2021 10:50:30 AM,Pfizer to supply additional 20M doses of COVID-19 vaccine to Vietnam,Seeking Alpha,https://seekingalpha.com/news/3715000-pfizer-to-supply-additional-20m-doses-of-covid-19-vaccine-to-vietnam?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6422674059867859
3217,7/14/2021 4:40:22 PM,Don’t Count on a Covid-19 Boost for Vaxart,InvestorPlace,/news/stocks/vxrt-stock-will-not-get-boost-from-virus-1030607764,negative,0.4971237778663635
3218,7/14/2021 5:08:48 PM,"Europe adds warnings on Pfizer, Moderna COVID-19 shots to reflect risk of heart inflammation",Seeking Alpha,https://seekingalpha.com/news/3715227-europe-adds-warnings-on-pfizer-moderna-covid-19-shots-to-reflect-risk-of-heart-inflammation?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8227540850639343
3219,7/14/2021 6:00:21 PM,EMA says too early to determine if COVID booster shots will be needed,Seeking Alpha,https://seekingalpha.com/news/3715240-ema-says-too-early-to-determine-if-covid-booster-shots-will-be-needed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9369086623191833
3220,7/15/2021 1:34:43 PM,CDC to discuss need for COVID-19 booster doses in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3715544-cdc-to-discuss-need-for-covid-19-booster-doses-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.826088011264801
3221,7/15/2021 5:25:04 PM,Pfizer to pay $345M to settle litigation over alleged EpiPen price gouging scheme,Seeking Alpha,https://seekingalpha.com/news/3715670-pfizer-to-pay-345m-to-settle-litigation-over-alleged-epipen-price-gouging-scheme?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7482548952102661
3222,7/16/2021 1:39:41 PM,Pfizer/BioNTech COVID-19 shot triggers higher antibody levels compared to Sinovac vaccine: new study,Seeking Alpha,https://seekingalpha.com/news/3715982-pfizerbiontech-covid-19-shot-triggers-higher-antibody-levels-compared-to-sinovac-vaccine-new-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6985194087028503
3223,7/16/2021 7:00:44 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3716064-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
3224,7/18/2021 2:09:46 AM,Merck wins FDA approval for new pneumonia vaccine (updated),Seeking Alpha,https://seekingalpha.com/news/3716142-merck-wins-fda-approval-for-new-pneumonia-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6130591034889221
3225,7/19/2021 1:27:10 PM,"Pfizer, Valneva complete enrollment in mid-stage trial for Lyme disease vaccine candidate",Seeking Alpha,https://seekingalpha.com/news/3716299-pfizer-valneva-complete-enrollment-in-mid-stage-trial-for-lyme-disease-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8740799427032471
3226,7/19/2021 4:08:56 PM,Pfizer/ BioNTech could receive full FDA approval for COVID-19 shot by end of summer - NIH head,Seeking Alpha,https://seekingalpha.com/news/3716409-pfizer-biontech-could-receive-full-fda-approval-for-covid-19-shot-by-end-of-summer-nih-head?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7399460673332214
3227,7/19/2021 8:21:37 PM,60% of people admitted to hospitals due to COVID-19 are unvaccinated - U.K. chief scientific adviser,Seeking Alpha,https://seekingalpha.com/news/3716576-60-of-people-admitted-to-hospitals-due-to-covid-19-are-unvaccinated-uk-chief-scientific-adviser?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7849373817443848
3228,7/20/2021 10:11:56 AM,Pfizer Recalls Anti-smoking Drug Chantix Tablets ,RTTNews,/news/stocks/pfizer-recalls-anti-smoking-drug-chantix-tablets-1030623735,neutral,0.9187590479850769
3229,7/20/2021 11:27:45 AM,Pfizer pulls anti-smoking drug citing potential cancer-causing agent,Seeking Alpha,https://seekingalpha.com/news/3716740-pfizer-pulls-anti-smoking-drug-citing-potential-cancer-causing-agents?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9319579005241394
3230,7/20/2021 4:08:50 PM,COVID-19 Delta variant now accounts for 83% of new cases - CDC Director,Seeking Alpha,https://seekingalpha.com/news/3716985-covid-19-delta-variant-now-accounts-for-83-of-new-cases-cdc-director?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8862178921699524
3231,7/21/2021 1:43:02 PM,"Pfizer, BioNTech Team With Biovac To Manufacture And Distribute COVID-19 Vaccine Within Africa ",RTTNews,/news/stocks/pfizer-biontech-team-with-biovac-to-manufacture-and-distribute-covid-19-vaccine-within-africa-1030629889,negative,0.5332489609718323
3232,7/21/2021 2:20:32 PM,Johnson & Johnson expects $2.5B sales from COVID-19 shot in 2021,Seeking Alpha,https://seekingalpha.com/news/3717439-johnson-johnson-expects-25b-sales-from-covid-19-shot-in-2021?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8189442157745361
3233,7/21/2021 5:12:40 PM,7 Undervalued Stocks to Buy Even as Markets Hit an All-Time High,InvestorPlace,/news/stocks/7-undervalued-stocks-to-buy-even-as-markets-hit-an-all-time-high-1030631601,negative,0.8073698878288269
3234,7/21/2021 5:58:30 PM,U.S life expectancy cut by a year and a half in 2020 due to COVID-19,Seeking Alpha,https://seekingalpha.com/news/3717587-us-life-expectancy-cut-by-a-year-and-a-half-in-2020-due-to-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9592799544334412
3235,7/21/2021 8:42:03 PM,"Pfizer provides abrocitinib, XELJANZ regulatory timeline update",Seeking Alpha,https://seekingalpha.com/news/3717739-pfizer-provides-abrocitinib-xeljanz-regulatory-timeline-update?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9153183698654175
3236,7/22/2021 9:01:32 AM,"Two shots of Pfizer, AstraZeneca jabs show efficacy against Delta variant",Seeking Alpha,https://seekingalpha.com/news/3717854-two-shots-of-pfizer-astrazeneca-jabs-show-efficacy-against-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9072362780570984
3237,7/22/2021 11:00:16 AM,Ocugen Likely Can’t Get a Boost From the FDA Until 2023,InvestorPlace,/news/stocks/ocugen-likely-cant-get-a-boost-from-the-fda-until-2023-1030634434,negative,0.5730645060539246
3238,7/22/2021 11:54:50 AM,"Arvinas, Pfizer team up to develop ARV-471 in breast cancer",Seeking Alpha,https://seekingalpha.com/news/3717954-arvinas-pfizer-team-up-to-develop-arv-471-in-breast-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5173235535621643
3239,7/22/2021 2:18:49 PM,"The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-nod-for-merck-eisai-seres-ulcerative-colitis-drug-flunks-midstage-study-pfizer-to-invest-in-arvinas-absci-ipo-1030634923,positive,0.8168380260467529
3240,7/22/2021 2:38:03 PM,"Pfizer, Arvinas Ink Deal To Develop And Commercialize PROTAC Protein Degrader ARV-471 - Quick Facts ",RTTNews,/news/stocks/pfizer-arvinas-ink-deal-to-develop-and-commercialize-protac-protein-degrader-arv-471-quick-facts-1030635041,negative,0.7197993993759155
3241,7/22/2021 3:27:20 PM,Arvinas price target raised to a Street-high at Truist on Pfizer deal,Seeking Alpha,https://seekingalpha.com/news/3718146-arvinas-price-target-raised-to-a-street-high-at-trust-on-pfizer-deal?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9327939748764038
3242,7/22/2021 4:04:41 PM,GSK : Brian McNamara Appointed As CEO Designate Of Independent Consumer Healthcare Company ,RTTNews,/news/stocks/gsk-brian-mcnamara-appointed-as-ceo-designate-of-independent-consumer-healthcare-company-1030635568,positive,0.9218353033065796
3243,7/22/2021 8:56:39 PM,Novavax Is Worth 100% More Given Its Prospects and Value Metrics,InvestorPlace,/news/stocks/nvax-stock-is-worth-100-percent-more-given-prospects-value-metrics-1030636991,negative,0.7667649388313293
3244,7/23/2021 1:53:59 AM,Pfizer/BioNTech COVID-19 vaccine triggers stronger antibody levels with longer gap between shots – study,Seeking Alpha,https://seekingalpha.com/news/3718423-pfizerbiontech-covid-19-vaccine-triggers-stronger-antibody-levels-with-longer-gap-between-shots-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9448343515396118
3245,7/23/2021 11:20:09 AM,75% of new COVID-19 cases in Singapore are among vaccinated people,Seeking Alpha,https://seekingalpha.com/news/3718494-three-quarters-of-new-covid-19-cases-in-singapore-are-among-vaccinated-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8423203825950623
3246,7/23/2021 1:08:27 PM,"Pfizer, BioNTech Say U.S. Government To Buy Addl 200 Mln Doses Of COVID-19 Vaccine - Quick Facts ",RTTNews,/news/stocks/pfizer-biontech-say-u-s-government-to-buy-addl-200-mln-doses-of-covid-19-vaccine-quick-facts-1030638610,negative,0.7348561882972717
3247,7/23/2021 1:45:07 PM,"The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-acorda-spikes-on-distribution-deal-alzamend-soars-on-data-pfizer-biontech-to-supply-more-vaccine-doses-3-ipos-1030638740,negative,0.9013098478317261
3248,7/23/2021 2:32:27 PM,Why This Company’s Covid-19 Vaccine Is Just the Beginning,InvestorPlace,/news/stocks/why-this-companys-covid-19-vaccine-is-just-the-beginning-1030639427,positive,0.9333549737930298
3249,7/23/2021 5:57:32 PM,"Pfizer/BioNTech COVID-19 shot is 39% effective with prevalence of Delta variant, Israel says",Seeking Alpha,https://seekingalpha.com/news/3718702-pfizerbiontech-covid-19-shot-is-39-effective-with-prevalence-of-delta-variant-israel-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8483459949493408
3250,7/23/2021 7:30:52 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3718717-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
3251,7/25/2021 3:14:39 AM,COVID-19 cases are rising in every U.S. state amid vaccine hesitancy,Seeking Alpha,https://seekingalpha.com/news/3718822-covid-19-cases-are-rising-in-every-us-state-amid-vaccine-hesitancy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8902133107185364
3252,7/25/2021 3:26:31 PM,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-july-25-31-big-pharma-earnings-iterum-fda-decision-alzheimer-s-conference-ipos-and-more-1030641744,positive,0.9177685976028442
3253,7/26/2021 9:25:37 AM,"Combining AstraZeneca, Pfizer COVID-19 jabs boosts antibody level: Study",Seeking Alpha,https://seekingalpha.com/news/3718859-combining-astrazeneca-pfizer-covid-19-jabs-boosts-antibody-level-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9467423558235168
3254,7/26/2021 10:00:58 AM,Novavax Stock May Not Get the Delta Varient Bump Investors Need,InvestorPlace,/news/stocks/novavax-stock-may-not-get-the-delta-varient-bump-investors-need-1030643966,positive,0.7728195190429688
3255,7/26/2021 11:21:36 AM,Biden officials contemplate the need of COVID-19 booster shots in vulnerable Americans,Seeking Alpha,https://seekingalpha.com/news/3718902-biden-officials-contemplate-the-need-of-covid-19-booster-shots-in-vulnerable-americans?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8326242566108704
3256,7/26/2021 3:01:46 PM,Pfizer earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-stock-price-q2-earnings-preview-1030644800,positive,0.9320189952850342
3257,7/26/2021 7:18:27 PM,BioNTech CEO says COVID-19 vaccine protection waning because of delta variant - WSJ,Seeking Alpha,https://seekingalpha.com/news/3719230-biontech-ceo-says-covid-19-vaccine-protection-waning-because-of-delta-variant-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9356856346130371
3258,7/26/2021 8:42:19 PM,Data from Israel suggest impact of vaccines on severe COVID-19 despite uptick in cases,Seeking Alpha,https://seekingalpha.com/news/3719325-data-from-israel-highlight-impact-of-vaccines-on-severe-covid-19-despite-uptick-in-cases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9212672114372253
3259,7/26/2021 9:13:32 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-13-1030646718,positive,0.9254742860794067
3260,7/27/2021 7:45:55 AM,Biotech Stocks Facing FDA Decision In August 2021 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-august-2021-1030648567,positive,0.7672383189201355
3261,7/27/2021 9:33:47 AM,Sinovac's COVID-19 vaccine antibodies fade after six months: Study,Seeking Alpha,https://seekingalpha.com/news/3719444-sinovacs-covid-19-vaccine-antibodies-fade-after-six-months-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5268506407737732
3262,7/27/2021 10:45:49 AM,"Vaccine mandates announced in NYC, California and Department of Veterans Affairs",Seeking Alpha,https://seekingalpha.com/news/3719480-vaccine-mandates-announced-in-nyc-california-and-department-of-veterans-affairs?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8609801530838013
3263,7/27/2021 12:43:54 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3719608-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.855887770652771
3264,7/27/2021 1:44:28 PM,Novavax COVID-19 vaccine shipments to Australia facing delays amid regulatory issues,Seeking Alpha,https://seekingalpha.com/news/3719680-novavax-stock-slides-as-covid-19-vaccine-shipments-to-australia-face-delays?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9392852187156677
3265,7/27/2021 1:47:32 PM,Viatris : Mylan Wins Dismissal Of Kansas EpiPen Direct Purchaser Case ,RTTNews,/news/stocks/viatris-mylan-wins-dismissal-of-kansas-epipen-direct-purchaser-case-1030649704,neutral,0.8466120362281799
3266,7/27/2021 5:58:09 PM,"Pfizer in pact with Argentina to supply 20M COVID-19 vaccine doses this year, minister says",Seeking Alpha,https://seekingalpha.com/news/3719911-pfizer-in-pact-with-argentina-to-supply-20m-covid-19-vaccine-doses-this-year-minister-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7629078030586243
3267,7/27/2021 7:52:39 PM,CDC recommends masks in public spaces in areas with substantial and high COVID-19 transmission,Seeking Alpha,https://seekingalpha.com/news/3719958-cdc-mandates-masks-in-public-spaces-in-areas-with-substantial-high-covid-19-transmission?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8540837168693542
3268,7/27/2021 8:09:11 PM,U.S. is weighing vaccine mandates for all federal employees,Seeking Alpha,https://seekingalpha.com/news/3719984-us-is-weighing-vaccine-mandates-for-all-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8368843197822571
3269,7/28/2021 10:47:05 AM,"Pfizer EPS beats by $0.09, beats on revenue, raises FY guidance",Seeking Alpha,https://seekingalpha.com/news/3720285-pfizer-eps-beats-0_09-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9328802824020386
3270,7/28/2021 12:51:37 PM,Pfizer Inc. Q2 adjusted earnings of $1.07 per share,RTTNews,/news/stocks/pfizer-inc-q2-adjusted-earnings-of-1-07-per-share-1030655569,positive,0.8357659578323364
3271,7/28/2021 1:48:39 PM,Pfizer Lifts FY21 Outlook On Updated Covid Vaccine Expectations ,RTTNews,/news/stocks/pfizer-lifts-fy21-outlook-on-updated-covid-vaccine-expectations-1030655958,negative,0.898413896560669
3272,7/28/2021 3:17:57 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-china-stocks-delta-variant-tlry-stock-1030657489,positive,0.9298974871635437
3273,7/28/2021 3:31:31 PM,7 Defensive Stocks to Buy for an Upcoming Market Crash,InvestorPlace,/news/stocks/7-defensive-stocks-to-buy-for-an-upcoming-market-crash-1030657486,positive,0.8938329815864563
3274,7/28/2021 5:21:56 PM,Pfizer/BioNTech COVID-19 shot’s efficacy drops to 84% from 96% in six months - study,Seeking Alpha,https://seekingalpha.com/news/3720707-pfizerbiontech-covid-19-shots-efficacy-drops-to-84-from-96-in-six-months-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9740886688232422
3275,7/28/2021 6:10:09 PM,White House tells federal agencies to mandate masks indoors in high COVID areas - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720745-white-house-tells-federal-agencies-to-mandate-masks-indoors-in-high-covid-areas-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8978102803230286
3276,7/28/2021 9:41:25 PM,"5 Top Stock Trades for Thursday: F, SHOP, MSFT, PFE, TLRY",InvestorPlace,/news/stocks/5-top-stock-trades-for-thursday-f-shop-msft-pfe-tlry-1030658982,positive,0.9391675591468811
3277,7/28/2021 11:03:16 PM,"Cannabis Movers & Shakers: Aurora's New Board Member, Virginia's New Marijuana Regulatory Board, Hemp Co. NuSachi And OSS Strengthen Leadership",Benzinga,/news/stocks/cannabis-movers-shakers-aurora-s-new-board-member-virginia-s-new-marijuana-regulatory-board-hemp-co-nusachi-and-oss-strengthen-leadership-1030658681,negative,0.687579333782196
3278,7/29/2021 2:32:01 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-robinhood-ipo-pfe-stock-dogecoin-1030663256,positive,0.9298974871635437
3279,7/29/2021 5:14:59 PM,AstraZeneca and J&J are yet to see need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3721739-astrazeneca-and-jj-are-yet-to-see-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5511691570281982
3280,7/29/2021 5:28:54 PM,Cowen initiates Celcuity with an outperform rating on breast cancer diagnostic,Seeking Alpha,https://seekingalpha.com/news/3721711-cowen-initiates-celcuity-with-an-outperform-rating-on-breast-cancer-diagnostic?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5624233484268188
3281,7/29/2021 8:36:37 PM,These two dividend ETFs have generated 20% annualized returns for five years,Seeking Alpha,https://seekingalpha.com/news/3721698-best-dividend-etfs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8089562654495239
3282,7/29/2021 9:18:03 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-nkla-stock-wkhs-stock-1030664764,positive,0.9254742860794067
3283,7/30/2021 8:12:18 AM,Is a third COVID-19 vaccine dose necessary? What you need to know about boosters,Seeking Alpha,https://seekingalpha.com/news/3722140-is-a-third-covid-19-vaccine-dose-necessary-what-you-need-to-know-about-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9243147969245911
3284,7/30/2021 11:00:10 AM,"COVID-19 Delta variant is as contagious as chickenpox, CDC report says - NYT",Seeking Alpha,https://seekingalpha.com/news/3722207-covid-19-delta-variant-is-as-contagious-as-chickenpox-cdc-report-says-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7013037204742432
3285,7/30/2021 2:23:34 PM,"Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?",Benzinga,/news/stocks/elon-musk-jeff-bezos-richard-branson-which-market-leaders-will-make-up-the-cannabis-industry-space-race-1030668073,positive,0.9424586892127991
3286,7/30/2021 3:21:23 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-market-crash-trading-tv-hood-stock-ipo-1030668754,positive,0.9298974871635437
3287,7/30/2021 3:40:44 PM,Don’t Buy Novavax Until Its Covid-19 Vaccine Wins FDA Approval,InvestorPlace,/news/stocks/dont-buy-nvax-stock-until-its-covid-19-vaccine-wins-fda-approval-1030668800,positive,0.8830894231796265
3288,7/30/2021 6:30:04 PM,Fully vaccinated people made up 74% of cases in a COVID-19 outbreak in Massachusetts - CDC,Seeking Alpha,https://seekingalpha.com/news/3722589-fully-vaccinated-people-made-up-74-of-cases-in-a-covid-19-outbreak-in-massachusetts-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8357453346252441
3289,7/30/2021 8:49:59 PM,FDA to speed up review for full approval of Pfizer/ BIoNTEch COVID-19 shot - Stat,Seeking Alpha,https://seekingalpha.com/news/3722678-fda-to-speed-up-review-for-full-approval-of-pfizer-biontech-covid-19-shot-stat?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7941916584968567
3290,8/1/2021 4:13:48 PM,"The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-aug-1-7-biopharma-earnings-pick-up-pace-eton-awaits-fda-decision-focus-on-pending-clinical-readouts-and-ipos-1030671679,negative,0.8824636936187744
3291,8/1/2021 8:52:04 PM,"Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-american-express-ge-glaxosmithkline-intel-and-more-1030671900,positive,0.942158579826355
3292,8/2/2021 8:06:26 AM,U.S. lockdown unlikely despite surge in Covid cases: Fauci,Seeking Alpha,https://seekingalpha.com/news/3722777-us-lockdown-unlikely-despite-surge-in-covid-cases-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.42814913392066956
3293,8/2/2021 11:31:33 AM,"CDC reports over 6,000 COVID-19 hospitalizations in U.S. among fully vaccinated",Seeking Alpha,https://seekingalpha.com/news/3722831-cdc-reports-over-6000-covid-19-hospitalizations-in-us-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8329269289970398
3294,8/2/2021 12:09:19 PM,A Peek Into The Markets: US Stock Futures Gain Ahead Of Manufacturing Data,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-gain-ahead-of-manufacturing-data-1030675416,negative,0.7622503042221069
3295,8/2/2021 12:27:37 PM,Pfizer in discussions for Japan trial of oral COVID-19 drug - Nikkei,Seeking Alpha,https://seekingalpha.com/news/3722895-pfizer-in-discussions-for-japan-trial-of-oral-covid-19-drug-nikkei?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8371134996414185
3296,8/2/2021 3:16:43 PM,"Pfizer, Moderna Raise Vaccine Prices For EU ",RTTNews,/news/stocks/pfizer-moderna-raise-vaccine-prices-for-eu-1030676768,positive,0.6948637962341309
3297,8/2/2021 3:54:58 PM,"Throw in The Towel, Ocugen Stock is Not Coming Back",InvestorPlace,/news/stocks/ocgn-stock-throw-in-towel-not-coming-back-1030677286,positive,0.7624982595443726
3298,8/2/2021 9:49:41 PM,Translate Bio surges in after hours on report of Sanofi bid (update),Seeking Alpha,https://seekingalpha.com/news/3723559-translate-bio-surges-in-after-hours-on-report-of-sanofi-bid?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.738619863986969
3299,8/3/2021 12:10:40 AM,Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-august-pdufa-dates-1030679352,positive,0.946641743183136
3300,8/3/2021 3:58:44 AM,Pfizer awarded $3.5 billion contract by U.S. Army to produce COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3723577-pfizer-awarded-35-billion-contract-to-produce-covid-19-vaccines-for-us-army?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.938088595867157
3301,8/3/2021 11:12:27 AM,Britain and Germany to offer COVID-19 booster shots; U.S. seeks more data,Seeking Alpha,https://seekingalpha.com/news/3723709-britain-and-germany-to-offer-covid-19-booster-shots-us-waits-for-more-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7890743017196655
3302,8/3/2021 1:55:12 PM,"The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business",Benzinga,/news/stocks/the-daily-biotech-pulse-sanofi-buys-translate-bio-in-3-2b-deal-lilly-s-q2-earnings-disappoint-bausch-to-spin-off-medical-aesthetics-business-1030682672,positive,0.7302430868148804
3303,8/3/2021 2:50:39 PM,"DeBlasio: NYC requiring vaccination proof for restaurants, gyms, and entertainment venues",Seeking Alpha,https://seekingalpha.com/news/3723960-deblasio-nyc-requiring-vaccination-proof-for-restaurants-gyms-and-entertainment-venues?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9112750887870789
3304,8/4/2021 9:19:16 AM,Final FDA approval for Pfizer's COVID-19 vaccine expected by early September,Seeking Alpha,https://seekingalpha.com/news/3724672-final-fda-approval-for-pfizers-covid-19-vaccine-expected-by-early-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7865221500396729
3305,8/4/2021 11:17:01 AM,Pfizer meets primary endpoint for ritlecitinib study in condition causing hair loss,Seeking Alpha,https://seekingalpha.com/news/3724765-pfizer-meets-primary-endpoint-for-ritlecitinib-study-in-condition-causing-hair-loss?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5139094591140747
3306,8/4/2021 1:13:41 PM,Pfizer: Phase 2b/3 Ritlecitinib Trial Meets Primary Efficacy Endpoint In Alopecia Areata Patients ,RTTNews,/news/stocks/pfizer-phase-2b-3-ritlecitinib-trial-meets-primary-efficacy-endpoint-in-alopecia-areata-patients-1030688548,negative,0.9268007278442383
3307,8/4/2021 1:52:10 PM,"The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-s-positive-readout-nrx-strikes-r-d-collaboration-with-mannkind-cerus-invitae-jump-on-earnings-1030688766,negative,0.7550449371337891
3308,8/4/2021 2:37:31 PM,WHO calls for COVID vaccine booster moratorium so poorer countries can get shots,Seeking Alpha,https://seekingalpha.com/news/3724983-who-calls-for-covid-booster-moratorium-so-poorer-countries-can-get-shots-wapo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.533158004283905
3309,8/4/2021 3:37:45 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-robinhood-stock-delta-variant-1030690356,positive,0.9298974871635437
3310,8/4/2021 5:08:27 PM,7 Stocks to Buy for Responsibility and Sustainability,InvestorPlace,/news/stocks/7-stocks-to-buy-for-responsibility-and-sustainability-1030690642,positive,0.8951490521430969
3311,8/4/2021 6:29:01 PM,"Pfizer, Moderna COVID-19 shots offered in San Francisco to Johnson & Johnson vaccine recipients",Seeking Alpha,https://seekingalpha.com/news/3725234-pfizer-moderna-covid-19-shots-offered-in-san-francisco-to-johnson-johnson-vaccine-recipients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8261359930038452
3312,8/5/2021 9:02:34 AM,Pfizer to require COVID vaccinations for all U.S. employees,Seeking Alpha,https://seekingalpha.com/news/3725754-pfizer-to-require-covid-vaccinations-for-all-us-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8290172219276428
3313,8/5/2021 9:23:25 AM,Pfizer And Flynn Accused Of Illegal Pricing In U.K For Vital Anti-epilepsy Drugs ,RTTNews,/news/stocks/pfizer-and-flynn-accused-of-illegal-pricing-in-u-k-for-vital-anti-epilepsy-drugs-1030694332,neutral,0.7999518513679504
3314,8/5/2021 9:48:09 AM,Global COVID-19 cases top 200M as Delta variant rages,Seeking Alpha,https://seekingalpha.com/news/3725762-global-covid-19-cases-top-200m-as-delta-variant-rages?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5814623236656189
3315,8/5/2021 2:52:21 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-eth-hard-fork-mrna-stock-1030696904,positive,0.9298974871635437
3316,8/5/2021 4:44:27 PM,7 Short-Term Stocks to Buy for a Shot at Some Quick Cash,InvestorPlace,/news/stocks/7-short-term-stocks-to-buy-for-a-shot-at-some-quick-cash-1030697309,positive,0.8331929445266724
3317,8/5/2021 6:08:03 PM,Fauci warns COVID-19 variants more severe than delta could emerge,Seeking Alpha,https://seekingalpha.com/news/3726300-fauci-warns-covid-19-variants-more-severe-than-delta-could-emerge?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9177864193916321
3318,8/5/2021 8:53:26 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-fvrr-stock-waves-crypto-ethereum-1030698303,positive,0.9254742860794067
3319,8/6/2021 3:49:09 PM,"Despite Novavax’s Challenges, NVAX Stock Could Still Pop",InvestorPlace,/news/stocks/nvax-stock-despite-challenges-could-still-pop-from-here-1030702070,negative,0.9330615997314453
3320,8/6/2021 5:32:31 PM,Latest CDC report shows a slight uptick in COVID-19 cases among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3727132-latest-cdc-report-shows-a-slight-uptick-in-covid-19-cases-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.564365029335022
3321,8/6/2021 6:26:37 PM,Novavax Stock Has Too Dedicated a Fanbase to Bet Against,InvestorPlace,/news/stocks/nvax-stock-has-too-dedicated-a-fanbase-to-bet-against-1030702374,positive,0.6601442694664001
3322,8/6/2021 8:00:09 PM,Bioethicist Ezekiel Emanuel under consideration for FDA commissioner - Politico,Seeking Alpha,https://seekingalpha.com/news/3727179-bioethicist-ezekiel-emanuel-under-consideration-for-fda-commissioner-politico?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.935555636882782
3323,8/8/2021 9:35:13 PM,Fauci hopes FDA will give full approval for COVID-19 vaccine in next few weeks,Seeking Alpha,https://seekingalpha.com/news/3727253-fauci-hopes-fda-will-give-full-approval-for-covid-19--vaccine-in-next-few-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7232925295829773
3324,8/9/2021 6:04:30 AM,Pfizer vaccine booster shot has similar side effects to 2nd dose: Israeli survey,Seeking Alpha,https://seekingalpha.com/news/3727278-pfizer-vaccine-booster-shot-has-similar-side-effects-to-2nd-dose-israeli-survey?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8921642303466797
3325,8/9/2021 12:51:57 PM,BioNTech raises projection for COVID-19 vaccine sales after delivering one billion doses,Seeking Alpha,https://seekingalpha.com/news/3727454-biontech-raises-projection-for-covid-19-vaccine-sales-after-delivering-one-billion-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.87874436378479
3326,8/9/2021 1:52:39 PM,BioNTech Turns To Hefty Profit In Q2 On Covid-19 Vaccine Sale; Sees Higher Revenues Ahead; Stock Up ,RTTNews,/news/stocks/biontech-turns-to-hefty-profit-in-q2-on-covid-19-vaccine-sale-sees-higher-revenues-ahead-stock-up-1030708279,negative,0.953675389289856
3327,8/9/2021 3:17:59 PM,Why These Biotech Stocks Are Soaring,InvestorPlace,/news/stocks/why-these-biotech-stocks-are-soaring-1030710695,positive,0.9273127317428589
3328,8/9/2021 8:33:28 PM,"What Did the Stock Market Do Today, Aug. 9? 3 Big Stories to Catch Up On.",InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-aug-9-3-big-stories-vsco-stock-coin-stock-crypto-deal-1030710298,positive,0.9287539720535278
3329,8/10/2021 1:55:36 PM,"The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts",Benzinga,/news/stocks/the-daily-biotech-pulse-arcturus-soars-on-covid-19-vaccine-updates-merck-s-keytruda-on-track-for-more-label-expansions-eliem-debuts-1030712978,negative,0.8045278787612915
3330,8/10/2021 6:25:35 PM,Take Carnival Stock for a Cruise to Profit Town,InvestorPlace,/news/stocks/ccl-stock-take-carnival-for-a-cruise-to-profit-town-1030714975,positive,0.9048042893409729
3331,8/10/2021 6:37:50 PM,A Bullish Outlook on Ocugen Is a Bearish Outlook on the Pandemic,InvestorPlace,/news/stocks/ocgn-stock-bulls-embracing-unclear-future-1030714999,neutral,0.6102954745292664
3332,8/10/2021 8:40:24 PM,Dr. Scott Gottlieb says current COVID-19 surge could be the “final wave” in U.S.,Seeking Alpha,https://seekingalpha.com/news/3728500-dr-scott-gottlieb-says-current-covid-19-surge-could-be-the-final-wave-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6829950213432312
3333,8/10/2021 10:35:49 PM,My Thoughts on AMC’s Second-Quarter Earnings Report,InvestorPlace,/news/stocks/my-thoughts-on-amcs-second-quarter-earnings-report-1030715921,positive,0.9057174324989319
3334,8/11/2021 10:00:50 AM,Novavax Is Looking More Like a Bet Worth Taking,InvestorPlace,/news/stocks/nvax-stock-is-looking-more-like-a-bet-worth-taking-1030717837,positive,0.8606456518173218
3335,8/11/2021 2:14:38 PM,"The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-rejects-fibrogen-s-anemia-drug-crinetics-gains-on-positive-readout-biocryst-withdraws-public-offering-1030718580,neutral,0.7697625756263733
3336,8/11/2021 2:23:44 PM,WHO to study three new anti-inflammatory drugs in COVID-19; seeks $7.7B funding to help poor nations,Seeking Alpha,https://seekingalpha.com/news/3728928-who-to-study-three-new-anti-inflammatory-drugs-in-covid-19-seeks-77b-funding?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8498113751411438
3337,8/11/2021 4:57:52 PM,7 Biotech Stocks to Buy Amid the Delta Variant’s Onslaught,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-amid-rising-covid-19-cases-1030719978,positive,0.5603509545326233
3338,8/11/2021 9:41:53 PM,New Study Says Moderna Vaccine More Effective Against Delta Variant Than Pfizer's ,RTTNews,/news/stocks/new-study-says-moderna-vaccine-more-effective-against-delta-variant-than-pfizer-s-1030720309,negative,0.8594841361045837
3339,8/12/2021 10:00:46 AM,Novavax Stock Is a Buy Even After the Company’s Post-Dip Bounce,InvestorPlace,/news/stocks/nvax-stock-is-a-buy-even-after-the-companys-post-dip-bounce-1030723349,negative,0.8892474174499512
3340,8/12/2021 11:58:31 AM,"A Peek Into The Markets: US Stock Futures Mixed Ahead Of Jobless Claims, Producer Price Data",Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-ahead-of-jobless-claims-producer-price-data-1030723294,neutral,0.8839206695556641
3341,8/12/2021 4:07:52 PM,CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag,Benzinga,/news/stocks/cytosorbents-antithrombotic-removal-system-scores-second-fda-breakthrough-device-tag-1030724927,negative,0.7559815645217896
3342,8/12/2021 11:18:53 PM,Why This Fundamentally Superior Biotech Is Soaring,InvestorPlace,/news/stocks/why-this-fundamentally-superior-biotech-is-soaring-1030735292,positive,0.8504866361618042
3343,8/13/2021 12:19:49 PM,FDA Authorizes Addl. Dose Of Covid Vaccine For Immunocompromised People ,RTTNews,/news/stocks/fda-authorizes-addl-dose-of-covid-vaccine-for-immunocompromised-people-1030728738,positive,0.8786889314651489
3344,8/13/2021 1:43:02 PM,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-vaccine-produces-durable-response-against-variants-fda-approves-jazz-s-sleep-disorder-drug-dermata-ipo-1030728962,negative,0.8680629730224609
3345,8/13/2021 3:54:14 PM,FDA Oks Third Dose Of COVID-19 Vaccine For Immunocompromised Populations ,RTTNews,/news/stocks/fda-oks-third-dose-of-covid-19-vaccine-for-immunocompromised-populations-1030729450,negative,0.5842134952545166
3346,8/13/2021 4:14:32 PM,"Earnings Magic: Disney Provides Reopening Optimism With ""Bullish"" Theme Park Results",Benzinga,/news/stocks/earnings-magic-disney-provides-reopening-optimism-with-bullish-theme-park-results-1030729531,negative,0.7788693904876709
3347,8/13/2021 7:43:28 PM,Novavax: Bronze Medal May Be Good Enough in COVID Race,InvestorPlace,/news/stocks/nvax-stock-bronze-medal-may-be-good-enough-in-covid-race-1030730157,negative,0.9052910804748535
3348,8/15/2021 5:06:13 PM,"The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow",Benzinga,/news/stocks/the-week-ahead-in-biotech-aug-15-21-fate-therapeutics-data-readout-renovorx-ipo-in-focus-amid-tapering-earnings-news-flow-1030731355,neutral,0.868375837802887
3349,8/16/2021 6:35:52 AM,Texas Supreme Court temporarily halts local mask mandates,Seeking Alpha,https://seekingalpha.com/news/3730569-texas-supreme-court-temporarily-halts-local-mask-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8446748852729797
3350,8/16/2021 10:00:44 AM,Novavax Has a Good Outlook and Is Positioned For Growth,InvestorPlace,/news/stocks/nvax-stock-is-fairly-and-is-well-positioned-for-growth-1030733528,negative,0.8776842951774597
3351,8/16/2021 12:45:05 PM,HLS Enters Agreement With Pfizer For Promotion Of Vascepa In Canada - Quick Facts ,RTTNews,/news/stocks/hls-enters-agreement-with-pfizer-for-promotion-of-vascepa-in-canada-quick-facts-1030733608,negative,0.9156226515769958
3352,8/16/2021 4:56:29 PM,7 Robinhood Stocks to Buy That Pay Dividends,InvestorPlace,/news/stocks/7-robinhood-stocks-to-buy-that-pay-dividends-1030735288,positive,0.9216645359992981
3353,8/16/2021 5:14:00 PM,Pfizer Inc. -- Moody's assigns A2 to Pfizer's sr. notes; stable outlook,Moodys,/news/bonds/pfizer-inc-moody-s-assigns-a2-to-pfizer-s-sr-notes-stable-outlook-1030735039,negative,0.7246822118759155
3354,8/17/2021 4:46:53 AM,"Pfizer, BioNTech Submit COVID-19 Booster Vaccine Data To FDA ",RTTNews,/news/stocks/pfizer-biontech-submit-covid-19-booster-vaccine-data-to-fda-1030736194,positive,0.9184956550598145
3355,8/17/2021 9:27:02 AM,Pfizer Expands Recall Of Anti-smoking Drug Chantix ,RTTNews,/news/stocks/pfizer-expands-recall-of-anti-smoking-drug-chantix-1030736964,neutral,0.5506249666213989
3356,8/17/2021 10:58:38 AM,Sinovac COVID-19 vaccine is linked to higher risk of Bell's Palsy - study,Seeking Alpha,https://seekingalpha.com/news/3731274-sinovac-covid-19-vaccine-is-linked-to-higher-risk-of-bells-palsy-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6335986852645874
3357,8/17/2021 1:05:56 PM,The Delta Variant Gives Novavax an Outside Chance of Upside,InvestorPlace,/news/stocks/delta-variant-gives-nvax-stock-outside-chance-1030738559,positive,0.6416527032852173
3358,8/17/2021 2:28:53 PM,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-reorganizes-business-units-in-neuroscience-focus-helius-medical-spikes-on-breakthrough-designation-ra-medical-sells-dermatology-business-1030738023,positive,0.9126444458961487
3359,8/17/2021 4:17:26 PM,4 High Beta Stocks to Avoid on Possibility of a Market Correction,InvestorPlace,/news/stocks/4-high-beta-stocks-to-avoid-on-possibility-of-a-market-correction-1030739369,neutral,0.6883708834648132
3360,8/18/2021 2:06:17 AM,COVID-19 Delta variant is linked to higher risk of hospitalizations - WHO,Seeking Alpha,https://seekingalpha.com/news/3731680-covid-19-delta-variant-is-linked-to-higher-risk-of-hospitalizations-who?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.42758429050445557
3361,8/18/2021 7:35:29 AM,Los Angeles to require masks at large outdoor events,Seeking Alpha,https://seekingalpha.com/news/3731693-los-angeles-to-require-masks-at-large-outdoor-events-us-transport-mask-mandate-extended?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9152795076370239
3362,8/18/2021 1:37:56 PM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",Benzinga,/news/stocks/the-daily-biotech-pulse-azurrx-jumps-on-data-agios-regulatory-application-for-mitapivat-accepted-for-priority-review-fda-nod-for-glaxosmithkline-1030741574,negative,0.5053824782371521
3363,8/18/2021 3:56:02 PM,Midday Market Update: The 10 Most Active Stocks Today,InvestorPlace,/news/stocks/midday-market-update-the-10-most-active-stocks-today-aug-18-1030742897,positive,0.911127507686615
3364,8/18/2021 9:31:25 PM,Israel Says Third Pfizer Dose Is 86% Effective Against Covid ,RTTNews,/news/stocks/israel-says-third-pfizer-dose-is-86-effective-against-covid-1030743316,negative,0.5597041845321655
3365,8/18/2021 10:38:00 PM,Israel Says Third Pfizer Dose Is 86% Effective Against Covid ,RTTNews,/news/stocks/israel-says-third-pfizer-dose-is-86-effective-against-covid-1030743487,negative,0.5597041845321655
3366,8/19/2021 1:49:32 AM,Johnson & Johnson says in contact with U.S. regulators regarding COVID-19 boosters,Seeking Alpha,https://seekingalpha.com/news/3732101-johnson-johnson-says-in-contact-with-us-regulators-regarding-covid-19-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8519365191459656
3367,8/19/2021 10:00:45 AM,"Novavax Is Not a Sure Thing, But It’s Getting Closer",InvestorPlace,/news/stocks/nvax-stock-not-sure-thing-but-getting-closer-1030745035,positive,0.6849499344825745
3368,8/19/2021 12:41:13 PM,"Palantir, Pfizer, Square, Genius Sports, Docusign — Stocks Cathie Wood's Ark Bought Or Sold On Wednesday",Benzinga,/news/etf/palantir-pfizer-square-genius-sports-docusign-—-stocks-cathie-wood-s-ark-bought-or-sold-on-wednesday-1030745119,positive,0.9480175375938416
3369,8/19/2021 1:37:27 PM,"The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck",Benzinga,/news/stocks/the-daily-biotech-pulse-coherus-soars-on-lung-cancer-data-illumina-closes-on-grail-buy-without-regulatory-clearance-adagene-strikes-collaboration-with-merck-1030745371,neutral,0.7770193219184875
3370,8/20/2021 3:40:24 AM,Moderna COVID-19 vaccine being probed in U.S. for higher-than-expected risk of side effect,Seeking Alpha,https://seekingalpha.com/news/3732568-moderna-covid-19-vaccine-being-probed-in-us-for-higher-than-expected-risk-of-side-effect?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4705280065536499
3371,8/20/2021 8:52:08 AM,Texas Supreme Court to temporarily keep school mask mandates in place,Seeking Alpha,https://seekingalpha.com/news/3732584-texas-supreme-court-to-temporarily-keep-school-mask-mandates-in-place?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7449678778648376
3372,8/20/2021 3:22:23 PM,"Novavax Stock Could Remain a Winner, Despite its ‘Also Ran’ Status",InvestorPlace,/news/stocks/nvax-stock-could-remain-winner-despite-also-ran-status-1030749369,negative,0.7404914498329163
3373,8/20/2021 7:43:25 PM,Johnson & Johnson sets a 52-week high after announcing leadership transition,Seeking Alpha,https://seekingalpha.com/news/3732818-johnson-johnson-sets-a-52-week-high-after-announcing-leadership-transition?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.799869179725647
3374,8/20/2021 8:25:41 PM,Moderna to require COVID-19 vaccination for U.S. employees,Seeking Alpha,https://seekingalpha.com/news/3732835-moderna-to-require-covid-19-vaccination-for-us-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8237738013267517
3375,8/20/2021 9:07:30 PM,Where Pfizer Stands With Analysts,Benzinga,/news/stocks/where-pfizer-stands-with-analysts-1030749786,positive,0.9324877858161926
3376,8/21/2021 7:58:06 PM,"The Latest Barron's Picks And Pans: Facebook, Jefferies, Palantir, Spotify And More",Benzinga,/news/stocks/the-latest-barron-s-picks-and-pans-facebook-jefferies-palantir-spotify-and-more-1030750305,positive,0.9435304999351501
3377,8/23/2021 10:00:35 AM,Ocugen Stock Still Looks Poised to Tumble,InvestorPlace,/news/stocks/ocgn-stock-still-looks-poised-to-tumble-1030751852,negative,0.7455366253852844
3378,8/23/2021 10:39:56 AM,"5 Stocks To Watch For August 23, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-august-23-2021-1030751695,positive,0.9071874618530273
3379,8/23/2021 11:33:55 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-august-23-1030752093,positive,0.497906357049942
3380,8/23/2021 11:42:53 AM,Thailand to buy 60M doses of AstraZeneca COVID-19 vaccine doses in 2022,Seeking Alpha,https://seekingalpha.com/news/3732964-astrazeneca-in-pact-with-thailand-for-60m-doses-of-covid-19-vaccine-doses-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6718224883079529
3381,8/23/2021 12:00:08 PM,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street; Crude Oil Rises Over 3%,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-signal-higher-start-on-wall-street-crude-oil-rises-over-3-1030751819,negative,0.9334686994552612
3382,8/23/2021 1:00:48 PM,25 Stocks Moving in Monday's Pre-Market Session,Benzinga,/news/stocks/25-stocks-moving-in-monday-s-pre-market-session-1030751978,positive,0.7058130502700806
3383,8/23/2021 1:18:10 PM,Pfizer To Buy Trillium Therapeutics For $18.50/Shr Cash - Quick Facts ,RTTNews,/news/stocks/pfizer-to-buy-trillium-therapeutics-for-18-50-shr-cash-quick-facts-1030752044,positive,0.8951566815376282
3384,8/23/2021 2:28:47 PM,"What Will the Stock Market Do Today, Aug. 23? 3 Big Stories to Watch.",InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-aug-23-3-big-stories-to-watch-1030752684,positive,0.9344959855079651
3385,8/23/2021 2:56:55 PM,TRIL Stock: The Huge $2.3B Deal Sending Trillium Therapeutics Up 200%,InvestorPlace,/news/stocks/tril-stock-the-huge-2-3b-deal-sending-trillium-therapeutics-up-200-1030752749,negative,0.9391850233078003
3386,8/23/2021 3:08:39 PM,Pfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See Highlights,Benzinga,/news/stocks/pfizer-beefs-up-blood-cancer-pipeline-with-trillium-acquisition-see-highlights-1030752511,positive,0.512047529220581
3387,8/23/2021 3:32:08 PM,Pfizer - Trillium deal propels ALX Oncology,Seeking Alpha,https://seekingalpha.com/news/3733098-pfizer-trillium-deal-propels-alx-oncology?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.44775453209877014
3388,8/23/2021 4:06:13 PM,Mid-Morning Market Update: Markets Open Higher; Pfizer To Acquire Trillium Therapeutics,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-pfizer-to-acquire-trillium-therapeutics-1030752655,negative,0.8916717767715454
3389,8/23/2021 5:16:39 PM,Pfizer-BioNTech's COVID-19 Vaccine Gets Full Approval From FDA ,RTTNews,/news/stocks/pfizer-biontech-s-covid-19-vaccine-gets-full-approval-from-fda-1030752811,negative,0.9327066540718079
3390,8/23/2021 6:01:23 PM,35 Stocks Moving In Monday's Mid-Day Session,Benzinga,/news/stocks/35-stocks-moving-in-monday-s-mid-day-session-1030752904,neutral,0.6408127546310425
3391,8/23/2021 6:14:49 PM,Mid-Day Market Update: Crude Oil Surges 5%; Staffing 360 Solutions Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-crude-oil-surges-5-staffing-360-solutions-shares-plunge-1030752958,negative,0.5949241518974304
3392,8/23/2021 7:18:25 PM,AMC Stock: There’s a Historic Reason AMC Entertainment Is Popping Higher Today,InvestorPlace,/news/stocks/amc-stock-theres-a-historic-reason-amc-entertainment-is-popping-higher-today-1030753254,negative,0.9077866673469543
3393,8/23/2021 7:23:27 PM,"Jim Cramer Thinks More Acquisitions From Pfizer Are Coming, Reveals What Similar Type Of Stocks To Watch",Benzinga,/news/stocks/jim-cramer-thinks-more-acquisitions-from-pfizer-are-coming-reveals-what-similar-type-of-stocks-to-watch-1030753091,positive,0.9214892387390137
3394,8/23/2021 8:38:20 PM,"4 Top Stock Trades for Tuesday: PFE, MRNA, NVDA, BABA",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-pfe-mrna-nvda-baba-1030753390,positive,0.9420466423034668
3395,8/23/2021 8:44:46 PM,Mid-Afternoon Market Update: Dow Gains 270 Points; Vivos Therapeutics Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-gains-270-points-vivos-therapeutics-shares-spike-higher-1030753213,negative,0.9312372207641602
3396,8/23/2021 9:04:13 PM,"What Did the Stock Market Do Today, Aug. 23? 3 Big Stories to Catch Up On.",InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-aug-23-3-big-stories-to-catch-up-on-1030753447,positive,0.9288972020149231
3397,8/24/2021 11:30:07 AM,Cynicism and Conspiracy Theories Could Help Ocugen,InvestorPlace,/news/stocks/cynicism-conspiracy-theories-could-help-ocgn-stock-1030754587,positive,0.7993485331535339
3398,8/24/2021 12:47:45 PM,"Alibaba, Nvidia, Pfizer, GameStop, AMD, Tesla And More — Stocks Buzzing On WallStreetBets Today",Benzinga,/news/stocks/alibaba-nvidia-pfizer-gamestop-amd-tesla-and-more-—-stocks-buzzing-on-wallstreetbets-today-1030754483,positive,0.8868001699447632
3399,8/24/2021 2:45:23 PM,"What Will the Stock Market Do Today, Aug. 24? 3 Big Stories to Watch.",InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-aug-24-3-big-stories-to-watch-1030755431,positive,0.9357231259346008
3400,8/24/2021 3:19:27 PM,The Story Behind a Stock Market Milestone,InvestorPlace,/news/stocks/the-story-behind-a-stock-market-milestone-2-1030755540,positive,0.8953757286071777
3401,8/24/2021 9:45:09 PM,"What Did the Stock Market Do Today, Aug. 24? 3 Big Stories to Catch Up On.",InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-aug-24-3-big-stories-to-catch-up-on-1030756147,positive,0.9302431344985962
3402,8/24/2021 10:05:03 PM,Why BioNTech Is the Better Biotech Buy,InvestorPlace,/news/stocks/why-biontech-is-the-better-biotech-buy-1030759223,positive,0.8715742826461792
3403,8/25/2021 2:27:29 AM,CVS to require COVID-19 vaccinations for staff as White House calls for more such mandates,Seeking Alpha,https://seekingalpha.com/news/3733789-cvs-to-require-covid-19-vaccinations-for-staff-as-white-house-calls-for-more-such-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6610859632492065
3404,8/25/2021 8:24:26 AM,"DraftKings, Pfizer, Coinbase, Alibaba, Square, Pinduoduo — How Cathie Wood's Ark Played The Stock Market On Tuesday",Benzinga,/news/etf/draftkings-pfizer-coinbase-alibaba-square-pinduoduo-—-how-cathie-wood-s-ark-played-the-stock-market-on-tuesday-1030756786,positive,0.9211838841438293
3405,8/25/2021 11:06:36 AM,Johnson & Johnson says booster COVID-19 shot led to nine fold rise in antibody response,Seeking Alpha,https://seekingalpha.com/news/3733850-johnson-johnson-says-booster-covid-19-shot-led-to-nine-fold-rise-in-antibody-response?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9458438754081726
3406,8/25/2021 2:26:47 PM,"What Will the Stock Market Do Today, Aug. 25? 3 Big Stories to Watch.",InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-aug-25-3-big-stories-to-watch-1030758160,positive,0.9361941814422607
3407,8/25/2021 3:04:59 PM,Why Is This SPAC Surging 160% Today?,Benzinga,/news/stocks/why-is-this-spac-surging-160-today-1030757885,positive,0.8446982502937317
3408,8/25/2021 4:08:19 PM,7 Best Biotech Stocks to Buy in 2021 with Huge Upside,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-with-huge-upside-1030758448,negative,0.5626565217971802
3409,8/25/2021 4:24:39 PM,Put Novavax Stock on Your Radar for Buying,InvestorPlace,/news/stocks/nvax-stock-put-novavax-on-your-radar-for-buying-1030758481,positive,0.9363664984703064
3410,8/26/2021 3:50:38 AM,Pfizer Seeks FDA Approval For COVID-19 Vaccine Booster ,RTTNews,/news/stocks/pfizer-seeks-fda-approval-for-covid-19-vaccine-booster-1030759107,negative,0.8777310252189636
3411,8/26/2021 10:18:05 AM,"Netflix, Pfizer, Coinbase, Pinduoduo, JD, Meituan — These Are Cathie Wood's Key Trades From Wednesday",Benzinga,/news/etf/netflix-pfizer-coinbase-pinduoduo-jd-meituan-—-these-are-cathie-wood-s-key-trades-from-wednesday-1030759909,positive,0.9472138285636902
3412,8/26/2021 1:30:42 PM,"Pfizer, BioNTech In Deal With Brazil's Eurofarma To Manufacture COVID-19 Vaccine For Latin America ",RTTNews,/news/stocks/pfizer-biontech-in-deal-with-brazil-s-eurofarma-to-manufacture-covid-19-vaccine-for-latin-america-1030760389,negative,0.8337085843086243
3413,8/26/2021 2:26:42 PM,Pfizer Appoints Aamir Malik As EVP And Chief Business Innovation Officer - Quick Facts ,RTTNews,/news/stocks/pfizer-appoints-aamir-malik-as-evp-and-chief-business-innovation-officer-quick-facts-1030760682,positive,0.9146594405174255
3414,8/26/2021 5:34:24 PM,See Why Ascendis Pharma Stock Is Shining On Thursday,Benzinga,/news/stocks/see-why-ascendis-pharma-stock-is-shining-on-thursday-1030761477,positive,0.749632716178894
3415,8/26/2021 6:03:01 PM,"Illinois Gov. Pritzker issues vaccine, masks requirement in healthcare settings, schools",Seeking Alpha,https://seekingalpha.com/news/3734594-illinois-gov-pritzker-issues-vaccine-masks-requirement-in-healthcare-settings-schools?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9364863038063049
3416,8/27/2021 10:00:26 AM,Longshot Covid Play Vaxart Stock Is Too Risky at These Prices,InvestorPlace,/news/stocks/longshot-covid-play-vxrt-stock-is-too-risky-at-these-prices-1030763261,positive,0.7545990943908691
3417,8/27/2021 11:08:41 AM,"Pinduoduo, Alibaba, Google, Coinbase, Pfizer, Square — These Are Cathie Wood's Key Trades From Thursday",Benzinga,/news/etf/pinduoduo-alibaba-google-coinbase-pfizer-square-—-these-are-cathie-wood-s-key-trades-from-thursday-1030763138,positive,0.9411669373512268
3418,8/28/2021 2:34:02 AM,"Trillium, Triple-S lead weekly healthcare gainers amid acquisitions; Cassava Sciences lags",Seeking Alpha,https://seekingalpha.com/news/3735023-trillium-triple-s-lead-weekly-healthcare-gainers-amid-acquisitions-sava-stock-lags?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7431442141532898
3419,8/30/2021 5:08:03 AM,"Pinduoduo, Alibaba, JD, Pfizer — These Are Cathie Wood's Key Trades From Friday",Benzinga,/news/etf/pinduoduo-alibaba-jd-pfizer-—-these-are-cathie-wood-s-key-trades-from-friday-1030765281,positive,0.946338415145874
3420,8/30/2021 10:30:31 AM,Should Investors Worry a Large Novavax Shareholder Cut Position in Q2?,InvestorPlace,/news/stocks/should-investors-worry-a-large-novavax-shareholder-cut-position-in-nvax-stock-in-q2-1030766467,neutral,0.9240620136260986
3421,8/30/2021 1:01:21 PM,Pfizer Reports Positive Top-Line Results From Phase 3 JADE DARE Trial - Quick Facts ,RTTNews,/news/stocks/pfizer-reports-positive-top-line-results-from-phase-3-jade-dare-trial-quick-facts-1030766517,negative,0.9517396092414856
3422,8/30/2021 1:43:57 PM,Novavax Looks Like a Good Stock to Trade,InvestorPlace,/news/stocks/novavax-looks-like-a-good-stock-to-trade-1030767134,negative,0.566575825214386
3423,8/30/2021 6:28:04 PM,The 7 Best Stocks to Buy for September,InvestorPlace,/news/stocks/7-best-stocks-to-buy-for-september-1030767762,positive,0.8868315815925598
3424,8/31/2021 5:07:32 AM,CDC Panel Backs Full Approval Of Pfizer-BioNTech COVID-19 Vaccine ,RTTNews,/news/stocks/cdc-panel-backs-full-approval-of-pfizer-biontech-covid-19-vaccine-1030768185,positive,0.5279268622398376
3425,8/31/2021 10:00:13 AM,Atossa Therapeutics Has a Steep Climb Ahead of It,InvestorPlace,/news/stocks/atossa-therapeutics-atos-stock-has-a-steep-climb-ahead-of-it-1030769096,negative,0.7476223707199097
3426,8/31/2021 11:46:17 AM,"Cathie Wood Furthers Bet On These 3D Printing Stocks; Pfizer, Peloton, Alibaba, Google Are Other Key Trades From Monday",Benzinga,/news/stocks/cathie-wood-furthers-bet-on-these-3d-printing-stocks-pfizer-peloton-alibaba-google-are-other-key-trades-from-monday-1030769029,positive,0.8672741055488586
3427,8/31/2021 5:33:31 PM,Ocugen Stock Seems Unattractive With Regulatory Uncertainties,InvestorPlace,/news/stocks/ocgn-stock-seems-unattractive-with-regulatory-uncertainties-1030770937,neutral,0.8324260711669922
3428,8/31/2021 5:41:24 PM,7 Dividend Aristocrat Stocks to Buy in September for Gains and Stability,InvestorPlace,/news/stocks/7-dividend-aristocrat-stocks-to-buy-in-september-for-gains-and-stability-1030770935,positive,0.7393564581871033
3429,9/1/2021 10:07:34 AM,"Pennsylvania Gov. Tom Wolf issues mask requirements for schools, child care centers",Seeking Alpha,https://seekingalpha.com/news/3735929-pennsylvania-gov-tom-wolf-issues-mask-requirements-for-schools-child-care-centers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.890673041343689
3430,9/1/2021 10:27:23 AM,Ocugen Stock Will Suffer Its Inevitable Demise Sooner Rather Than Later,InvestorPlace,/news/stocks/ocgn-stock-will-suffer-its-inevitable-demise-sooner-rather-than-later-1030772376,positive,0.7837658524513245
3431,9/1/2021 4:43:35 PM,WHO warns of a new COVID-19 variant with potential to evade vaccine-driven immunity,Seeking Alpha,https://seekingalpha.com/news/3736184-who-warns-of-a-new-covid-19-variant-with-potential-to-evade-vaccine-driven-immunity?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9303123950958252
3432,9/1/2021 7:01:30 PM,AbbVie defended on Wall Street after FDA update on Rinvoq sparked selloff,Seeking Alpha,https://seekingalpha.com/news/3736262-abbvie-defended-on-wall-street-after-fda-update-on-rinvoq-sparked-selloff?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9329123497009277
3433,9/1/2021 8:01:55 PM,ABBV Stock: The FDA Blow That Just Sent AbbVie Tumbling on Wednesday,InvestorPlace,/news/stocks/abbv-stock-the-fda-blow-that-just-sent-abbvie-tumbling-on-wednesday-1030774378,neutral,0.7397889494895935
3434,9/2/2021 10:00:21 AM,Moderna Japan Scare Might Offer a Small Lift to Still-Alive Novavax Stock,InvestorPlace,/news/stocks/moderna-might-offer-small-lift-nvax-stock-1030775916,negative,0.9222911596298218
3435,9/2/2021 11:10:02 AM,"Cathie Wood's Ark Nearly Erases Alibaba Stake, Sells $3M In Google — Here's What It Bought Instead On Wednesday",Benzinga,/news/etf/cathie-wood-nearly-erases-alibaba-stake-sells-3m-in-google-—-here-s-what-it-bought-instead-on-wednesday-1030775725,positive,0.9303127527236938
3436,9/2/2021 1:00:29 PM,Pfizer Starts Phase 3 Trial In Adults For Vaccine Against Respiratory Syncytial Virus - Quick Facts ,RTTNews,/news/stocks/pfizer-starts-phase-3-trial-in-adults-for-vaccine-against-respiratory-syncytial-virus-quick-facts-1030776024,negative,0.6987800598144531
3437,9/2/2021 2:19:58 PM,"The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab",Benzinga,/news/stocks/the-daily-biotech-pulse-assembly-bio-halts-hbv-study-moderna-initiates-submission-for-covid-19-booster-dose-fda-nod-for-beigene-tiziana-out-licenses-foralumab-1030776427,positive,0.808341920375824
3438,9/2/2021 3:25:30 PM,Moderna COVID-19 booster strategy triggers debate on dose level,Seeking Alpha,https://seekingalpha.com/news/3736801-moderna-covid-19-booster-strategy-leads-to-mixed-views-on-dose-level?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5834460258483887
3439,9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In ,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655,positive,0.8197962045669556
3440,9/2/2021 8:16:10 PM,Fauci says COVID-19 full vaccine regimen is unlikely to exceed three shots,Seeking Alpha,https://seekingalpha.com/news/3736990-fauci-says-covid-19-full-vaccine-regimen-is-unlikely-to-exceed-three-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.767877995967865
3441,9/3/2021 5:18:34 AM,"Cathie Wood Continues Alibaba Selling With Just 40 Shares Left In Portfolio, Loads Up Heavily On These Chinese Rivals",Benzinga,/news/etf/cathie-wood-continues-alibaba-selling-with-just-40-shares-left-in-portfolio-loads-up-heavily-on-these-chinese-rivals-1030778269,positive,0.8394863605499268
3442,9/3/2021 2:44:41 PM,Fraud Allegations Are Unlikely to Keep Cassava Stock Down,InvestorPlace,/news/stocks/fraud-allegations-are-unlikely-to-keep-sava-stock-down-1030779960,neutral,0.6792145371437073
3443,9/5/2021 7:14:08 PM,The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week,Benzinga,/news/stocks/the-week-ahead-in-biotech-sept-5-11-focus-on-conferences-and-clinical-readouts-in-another-quiet-week-1030781044,positive,0.8742557168006897
3444,9/6/2021 8:17:45 AM,"Pfizer Covid-19 Booster Shots Likely To Be Ready Sept. 20, But Moderna May Be Delayed : Reports ",RTTNews,/news/stocks/pfizer-covid-19-booster-shots-likely-to-be-ready-sept-20-but-moderna-may-be-delayed-reports-1030781470,positive,0.8663066029548645
3445,9/7/2021 11:08:03 AM,"Cathie Wood's Ark Completely Exits All Alibaba Positions, Continues Piling Up Stake In This Chinese Rival",Benzinga,/news/etf/cathie-wood-s-ark-completely-exits-all-alibaba-positions-continues-piling-up-stake-in-this-chinese-rival-1030783244,positive,0.8175445795059204
3446,9/7/2021 5:43:56 PM,10 Stocks to Buy if You Want to Support Companies Taking Covid-19 Seriously  ,InvestorPlace,/news/stocks/10-stocks-to-buy-to-support-companies-taking-covid-19-seriously-1030785074,positive,0.9184070825576782
3447,9/8/2021 10:00:29 AM,Novavax Stock Is a Buy Ahead of Potential EU and U.S. Approvals,InvestorPlace,/news/stocks/nvax-stock-is-a-buy-ahead-of-potential-eu-and-u-s-approvals-1030786410,positive,0.764411985874176
3448,9/8/2021 10:00:31 AM,Vaxart Stock Is One Vaccine Also-Ran Worth Another Look,InvestorPlace,/news/stocks/vxrt-stock-is-one-vaccine-also-ran-worth-another-look-1030786409,positive,0.8450998067855835
3449,9/8/2021 10:43:02 AM,"Amazon, Pfizer, Roku, Boeing And More: These Are Cathie Wood's Key Trades From Tuesday",Benzinga,/news/stocks/amazon-pfizer-roku-boeing-and-more-these-are-cathie-wood-s-key-trades-from-tuesday-1030786223,positive,0.9425260424613953
3450,9/8/2021 10:59:23 AM,"WHO says coronavirus is “here to stay”, elimination unlikely",Seeking Alpha,https://seekingalpha.com/news/3737810-who-says-coronavirus-is-here-to-stay-elimination-unlikely?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8685398697853088
3451,9/8/2021 12:48:13 PM,Pfizer and Erasca in pact for a combination therapy in colorectal cancer,Seeking Alpha,https://seekingalpha.com/news/3737888-pfizer-and-erasca-in-pact-for-a-combination-therapy-in-colorectal-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7546800971031189
3452,9/8/2021 3:00:00 PM,7 of the Best Large-Cap Stocks to Buy Now,InvestorPlace,/news/stocks/7-of-the-best-large-cap-stocks-to-buy-now-2-1030787652,positive,0.659598708152771
3453,9/8/2021 4:25:03 PM,7 Busted Biotech Stocks Due for a Rebound,InvestorPlace,/news/stocks/7-busted-biotech-stocks-due-for-a-rebound-1030787940,neutral,0.5655414462089539
3454,9/8/2021 4:37:46 PM,WHO chief urges richer nations to halt COVID-19 booster shot rollouts till end of the year,Seeking Alpha,https://seekingalpha.com/news/3738021-who-chief-urges-richer-nations-to-halt-covid-19-booster-shot-rollouts-till-end-of-the-year?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6981648802757263
3455,9/9/2021 10:00:32 AM,Novavax Stock Is Best Covid Vaccine Name To Speculate On,InvestorPlace,/news/stocks/nvax-stock-is-best-covid-vaccine-name-to-speculate-on-1030789429,positive,0.9408206343650818
3456,9/9/2021 1:23:33 PM,"Pfizer Gets Marketing Authorization In UK For Atopic Dermatitis Drug, Cibinqo ",RTTNews,/news/stocks/pfizer-gets-marketing-authorization-in-uk-for-atopic-dermatitis-drug-cibinqo-1030789628,negative,0.9217585325241089
3457,9/9/2021 2:17:07 PM,"The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization",Benzinga,/news/stocks/the-daily-biotech-pulse-proqr-lilly-r-d-partnership-sanofi-s-pemphigus-trial-disappointment-humanigen-s-covid-19-drug-denied-emergency-use-authorization-1030789942,positive,0.9088907241821289
3458,9/9/2021 2:57:02 PM,"Myovant, Pfizer: FDA Accepts To Review Myfembree SNDA For Endometriosis -related Pain ",RTTNews,/news/stocks/myovant-pfizer-fda-accepts-to-review-myfembree-snda-for-endometriosis-related-pain-1030790107,positive,0.6988369226455688
3459,9/10/2021 4:19:36 PM,7 Biotech Stocks to Buy That Have Millionaire-Maker Potential,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-with-millionaire-maker-potential-1030793159,positive,0.8981219530105591
3460,9/10/2021 5:42:51 PM,TTOO Stock: The Huge Covid-19 News Lifting T2 Biosystems Today,InvestorPlace,/news/stocks/ttoo-stock-the-huge-covid-19-news-lifting-t2-biosystems-today-1030793319,positive,0.8940585255622864
3461,9/10/2021 8:06:48 PM,3 Stocks Under $100 to Buy and Hold Forever,InvestorPlace,/news/stocks/3-stocks-under-100-to-buy-and-hold-forever-1030793479,positive,0.9026911854743958
3462,9/12/2021 10:04:17 PM,"The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-sept-12-18-calliditas-fda-decision-adcom-review-for-pfizer-biontech-covid-19-vaccine-oncology-conference-and-ipos-1030794269,positive,0.9348464608192444
3463,9/13/2021 9:07:46 PM,OCGN Stock: Why Ocugen Shares Are Shooting Higher Today,InvestorPlace,/news/stocks/ocgn-stock-why-ocugen-shares-are-shooting-higher-today-1030796819,negative,0.8704498410224915
3464,9/14/2021 6:04:46 PM,Roche thinks COVID-19 could become seasonal with up to 500 million new cases a year,Seeking Alpha,https://seekingalpha.com/news/3739618-roche-thinks-covid-19-could-become-seasonal-with-up-to-500-million-new-cases-a-year?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7991191148757935
3465,9/14/2021 6:45:15 PM,Canopy Growth Is Getting Dismantled Day-by-Day,InvestorPlace,/news/stocks/canopy-growth-cgc-stock-getting-dismantled-day-by-day-1030799538,positive,0.6866722702980042
3466,9/14/2021 8:42:17 PM,Novavax Has More Room to Run as the Vaccination Push Carries On,InvestorPlace,/news/stocks/nvax-stock-more-room-to-run-as-vaccination-push-carries-on-1030799785,negative,0.6767743229866028
3467,9/15/2021 10:00:29 AM,Here’s What the Charts Say About Ocugen Stock Now,InvestorPlace,/news/stocks/heres-what-the-charts-say-for-ocugen-ocgn-stock-now-1030800924,positive,0.9425513744354248
3468,9/15/2021 10:49:45 AM,"5 Stocks To Watch For September 15, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-september-15-2021-1030800653,positive,0.9056321382522583
3469,9/15/2021 12:07:01 PM,A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Data; Crude Oil Gains 1%,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-rise-ahead-of-economic-data-crude-oil-gains-1-1030800912,negative,0.9255696535110474
3470,9/15/2021 12:40:10 PM,Exact Sciences adds former Pfizer employees to sales team,Seeking Alpha,https://seekingalpha.com/news/3739913-exact-sciences-adds-former-pfizer-employees-to-sales-team?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9303269982337952
3471,9/15/2021 2:39:24 PM,Familiarity May Not Breed Contempt When It Comes to Novavax Stock,InvestorPlace,/news/stocks/nvax-stock-may-benefit-from-being-familiar-option-1030802146,positive,0.8863054513931274
3472,9/15/2021 11:36:52 PM,Pfizer Cites 95% Efficacy In Third Vaccine Shots; FDA Staff Skeptical ,RTTNews,/news/stocks/pfizer-cites-95-efficacy-in-third-vaccine-shots-fda-staff-skeptical-1030803070,negative,0.5142223834991455
3473,9/16/2021 8:41:05 PM,"With the European Union Buying Doses, Novavax Has Plenty of Upside Left",InvestorPlace,/news/stocks/with-european-union-buying-doses-nvax-stock-plenty-upside-left-1030805836,negative,0.6231831312179565
3474,9/16/2021 9:06:20 PM,Moderna Analysts Debate Need For Biopharma's COVID-19 Booster Shot,Benzinga,/news/stocks/moderna-analysts-debate-need-for-biopharma-s-covid-19-booster-shot-1030805685,positive,0.8232786059379578
3475,9/17/2021 1:36:08 PM,"The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold",Benzinga,/news/stocks/the-daily-biotech-pulse-adcom-tryst-for-pfizer-biontech-booster-shot-abcellera-s-covid-antibody-treatment-gets-expanded-use-protagonist-slapped-with-clinical-hold-1030806977,negative,0.6039010882377625
3476,9/17/2021 3:42:01 PM,Pfizer Further Expands Recall Of Anti-smoking Drug Chantix ,RTTNews,/news/stocks/pfizer-further-expands-recall-of-anti-smoking-drug-chantix-1030807353,positive,0.47572141885757446
3477,9/17/2021 4:35:24 PM,7 Spinoff Stocks to Buy That Are Set to Outperform Their Parents,InvestorPlace,/news/stocks/7-spinoff-stocks-to-buy-that-are-set-to-outperform-their-parents-1030807715,negative,0.6435421705245972
3478,9/17/2021 5:12:45 PM,DNA Stock Cooks Up 10% Gains on Ginkgo Biowork’s First Trading Day,InvestorPlace,/news/stocks/dna-stock-cooks-up-10-gains-on-ginkgo-bioworks-first-trading-day-1030807753,negative,0.9464169144630432
3479,9/17/2021 11:16:47 PM,"FDA Panel Rejects Booster Shots For Most People, But Recommends For Older Adults ",RTTNews,/news/stocks/fda-panel-rejects-booster-shots-for-most-people-but-recommends-for-older-adults-1030808053,positive,0.8119503259658813
3480,9/18/2021 12:05:00 AM,Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study,PR Newswire,/news/stocks/astellas-and-pfizer-s-xtandi-enzalutamide-reduced-risk-of-death-by-34-in-men-with-metastatic-hormone-sensitive-prostate-cancer-in-phase-3-arches-study-1030808077,negative,0.9164906740188599
3481,9/18/2021 5:59:18 AM,Pfizer: Xtandi Reduces Risk Of Death By 34% In Men With Metastatic Hormone-Sensitive Prostate Cancer ,RTTNews,/news/stocks/pfizer-xtandi-reduces-risk-of-death-by-34-in-men-with-metastatic-hormone-sensitive-prostate-cancer-1030808118,negative,0.9326121211051941
3482,9/19/2021 3:46:51 PM,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-sept-19-25-incyte-verrica-fda-decisions-and-conference-presentations-in-the-spotlight-1030808489,positive,0.941505491733551
3483,9/20/2021 10:00:23 AM,It’s OK to Sell the News on Ocugen and Covaxin,InvestorPlace,/news/stocks/sell-the-news-on-ocgn-stock-1030809323,positive,0.9287483096122742
3484,9/20/2021 10:30:03 AM,Developed World Boosters Offer Big Market for Eventual Novavax Vaccine,InvestorPlace,/news/stocks/developed-world-boosters-offer-big-market-for-eventual-novavax-vaccine-1030809369,negative,0.7245063781738281
3485,9/20/2021 10:37:44 AM,"5 Stocks To Watch For September 20, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-september-20-2021-1030809115,positive,0.9107146263122559
3486,9/20/2021 12:02:00 PM,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 2%,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-signal-lower-start-on-wall-street-crude-oil-down-2-1030809266,neutral,0.9650819301605225
3487,9/20/2021 1:21:55 PM,Pfizer Announces Positive Results From Pivotal Trial Of COVID-19 Vaccine In Children 5 - 11 Yrs ,RTTNews,/news/stocks/pfizer-announces-positive-results-from-pivotal-trial-of-covid-19-vaccine-in-children-5-11-yrs-1030809548,negative,0.9406305551528931
3488,9/20/2021 4:25:41 PM,Why Pfizer Stock Holders Shouldn’t Obsess Over FDA Approval,InvestorPlace,/news/stocks/pfe-stock-holders-shouldnt-obsess-over-fda-approval-1030810642,positive,0.7785009145736694
3489,9/20/2021 5:04:15 PM,7 Stocks to Buy for the Likely Fed Tapering in December,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-likely-fed-tapering-in-december-1030810751,neutral,0.5778451561927795
3490,9/20/2021 6:03:06 PM,"Pfizer, BioNTech Analysts On FDA Panel's COVID-19 Booster Dose Decision",Benzinga,/news/stocks/pfizer-biontech-analysts-on-fda-panel-s-covid-19-booster-dose-decision-1030810552,positive,0.9216668605804443
3491,9/20/2021 8:29:50 PM,Why Did Deutsche Bank Downgrade This Big Pharma Stock?,Benzinga,/news/stocks/why-did-deutsche-bank-downgrade-this-big-pharma-stock-1030810939,neutral,0.4925764203071594
3492,9/21/2021 1:12:28 PM,Nektar Therapeutics enters oncology clinical collaboration with Merck KGaA and Pfizer,Seeking Alpha,https://seekingalpha.com/news/3741822-nektar-therapeutics-inks-oncology-clinical-collaboration-with-merck-kgaa-and-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7200906276702881
3493,9/21/2021 3:27:56 PM,"Nektar Collaborates With Merck KGaA, Pfizer To Evaluate NKTR-255 In Combination With Avelumab ",RTTNews,/news/stocks/nektar-collaborates-with-merck-kgaa-pfizer-to-evaluate-nktr-255-in-combination-with-avelumab-1030813011,negative,0.744814395904541
3494,9/21/2021 7:23:57 PM,NNVC Stock: What Is Going on With Red-Hot NanoViricides Today?,InvestorPlace,/news/stocks/nnvc-stock-what-is-going-on-with-red-hot-nanoviricides-today-1030814063,neutral,0.5694593191146851
3495,9/21/2021 8:40:12 PM,7 Stocks to Buy Following Vaccine Victories,InvestorPlace,/news/stocks/7-stocks-to-buy-following-vaccine-victories-1030814227,positive,0.9253915548324585
3496,9/22/2021 12:28:44 PM,"Pfizer, BioNTech In Deal With U.S. To Provide 500 Mln More COVID-19 Vaccine Doses For Donation ",RTTNews,/news/stocks/pfizer-biontech-in-deal-with-u-s-to-provide-500-mln-more-covid-19-vaccine-doses-for-donation-1030815267,negative,0.8511581420898438
3497,9/22/2021 1:45:28 PM,"The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-us-vaccine-contract-summit-slumps-on-adverse-regulatory-feedback-cerevel-cfo-departs-1030815550,neutral,0.9714490175247192
3498,9/22/2021 2:40:41 PM,7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-now-as-the-pandemic-forces-a-rethink-1030816434,positive,0.5023189783096313
3499,9/22/2021 2:56:18 PM,Endo launches generic version of Pfizer's Chantix in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3742645-endo-launches-generic-version-of-pfizers-chantix-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6724749803543091
3500,9/22/2021 4:12:01 PM,"After Today's Fed Meeting, Investors Are Stuck With Contradictory Reports On Evergrande And The Debt Ceiling",Benzinga,/news/stocks/after-today-s-fed-meeting-investors-are-stuck-with-contradictory-reports-on-evergrande-and-the-debt-ceiling-1030816331,neutral,0.9310272932052612
3501,9/22/2021 5:44:40 PM,"Despite Vaccine Uncertainty, Pfizer Is a Buy",InvestorPlace,/news/stocks/despite-vaccine-uncertainty-pfizer-is-a-buy-1030816920,positive,0.5181729793548584
3502,9/22/2021 5:46:41 PM,GlaxoSmithKline comes under renewed activist pressure as Bluebell builds stake,Seeking Alpha,https://seekingalpha.com/news/3742705-glaxosmithkline-comes-under-renewed-activist-pressure-as-bluebell-builds-stake?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9026606678962708
3503,9/22/2021 6:39:28 PM,Endo Launches Generic Version Of Pfizer's Smoking Cessation Pill,Benzinga,/news/stocks/endo-launches-generic-version-of-pfizer-s-smoking-cessation-pill-1030816766,positive,0.7845772504806519
3504,9/23/2021 4:26:05 AM,FDA Authorizes Pfizer COVID-19 Booster Shots For Older People And High-risk Workers ,RTTNews,/news/stocks/fda-authorizes-pfizer-covid-19-booster-shots-for-older-people-and-high-risk-workers-1030817567,positive,0.8357915282249451
3505,9/23/2021 12:10:03 PM,A Peek Into The Markets: US Stock Futures Climb Ahead Of Economic Reports,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-climb-ahead-of-economic-reports-1030818280,negative,0.8663262128829956
3506,9/23/2021 1:56:57 PM,"The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data",Benzinga,/news/stocks/the-daily-biotech-pulse-restricted-authorization-for-pfizer-s-covid-19-booster-dose-abcellera-strikes-antibody-licensing-deal-solid-biosciences-issues-dmd-data-1030818618,positive,0.8776688575744629
3507,9/23/2021 3:28:31 PM,AstraZeneca teams up with VaxEquity for self-amplifying RNA platform,Seeking Alpha,https://seekingalpha.com/news/3743550-astrazeneca-teams-up-with-vaxequity-for-self-amplifying-rna-platform?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7883343696594238
3508,9/23/2021 6:50:44 PM,10 Oversold Stocks to Buy for the Final Quarter,InvestorPlace,/news/stocks/10-oversold-stocks-to-buy-for-the-final-quarter-1030820052,neutral,0.8969273567199707
3509,9/24/2021 10:00:00 AM,Novavax Is a Short-Term Trade in a Long-Term Paradigm,InvestorPlace,/news/stocks/nvax-stock-short-term-trade-in-long-term-paradigm-1030821258,positive,0.952272355556488
3510,9/24/2021 12:38:01 PM,CDC Advisers Recommend Pfizer Covid-19 Booster Doses For Certain Adults ,RTTNews,/news/stocks/cdc-advisers-recommend-pfizer-covid-19-booster-doses-for-certain-adults-1030821368,positive,0.86199951171875
3511,9/24/2021 2:04:55 PM,Pfizer COVID-19 vaccine booster shots now available at Walgreens stores nationwide,Seeking Alpha,https://seekingalpha.com/news/3744002-pfizer-covid-19-vaccine-booster-shots-now-available-at-walgreens-stores-nationwide?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.859363853931427
3512,9/24/2021 4:10:23 PM,Walgreens Says Pfizer COVID-19 Vaccine Booster Shots Now Available In U.S. ,RTTNews,/news/stocks/walgreens-says-pfizer-covid-19-vaccine-booster-shots-now-available-in-u-s-1030821907,negative,0.5204213857650757
3513,9/24/2021 11:24:30 PM,"CDC Recommends Pfizer-BioNTech Vaccine For Booster Dose, Overrules ACIP ",RTTNews,/news/stocks/cdc-recommends-pfizer-biontech-vaccine-for-booster-dose-overrules-acip-1030822816,positive,0.7763404250144958
3514,9/27/2021 10:00:45 AM,Pfizer Stock: Vaccine Crown Not Enough as Profit King Status Comes Next,InvestorPlace,/news/stocks/pfizer-stock-vaccine-crown-not-enough-as-profit-king-status-comes-next-1030825066,positive,0.42333880066871643
3515,9/27/2021 11:30:04 AM,This Is the Worst Thing You Can Do in the Stock Market,InvestorPlace,/news/stocks/this-is-the-worst-thing-you-can-do-in-the-stock-market-1030830078,neutral,0.8768875598907471
3516,9/27/2021 1:03:51 PM,Pfizer Begins Phase 2/3 EPIC-PEP Study To Evaluate COVID-19 Antiviral Candidate ,RTTNews,/news/stocks/pfizer-begins-phase-2-3-epic-pep-study-to-evaluate-covid-19-antiviral-candidate-1030825200,positive,0.6938494443893433
3517,9/27/2021 4:22:37 PM,Novavax and the Changing Covid-19 Vaccine Game,InvestorPlace,/news/stocks/nvax-stock-and-the-changing-covid-vaccine-game-1030830062,positive,0.8475068807601929
3518,9/27/2021 7:19:09 PM,3 Airline Stocks Ready to Soar,InvestorPlace,/news/stocks/3-airline-stocks-ready-to-soar-1030830036,positive,0.6611487865447998
3519,9/27/2021 9:30:52 PM,This Is the Worst Thing You Can Do in the Stock Market,InvestorPlace,/news/stocks/this-is-worst-thing-you-can-do-stock-market-1030830020,neutral,0.8768875598907471
3520,9/28/2021 12:50:18 PM,ViiV Enters Collaboration And License Agreement With Shionogi To Develop HIV Integrase Inhibitor ,RTTNews,/news/stocks/viiv-enters-collaboration-and-license-agreement-with-shionogi-to-develop-hiv-integrase-inhibitor-1030827494,negative,0.8814706802368164
3521,9/28/2021 1:00:15 PM,ViiV Healthcare Announces FDA's Priority Review Designation For Cabotegravir ,RTTNews,/news/stocks/viiv-healthcare-announces-fda-s-priority-review-designation-for-cabotegravir-1030827508,positive,0.5355831980705261
3522,9/28/2021 1:21:30 PM,"Pfizer, BioNTech Submit Positive Data From COVID-19 Vaccine Trial In 5 To <12 Years To FDA ",RTTNews,/news/stocks/pfizer-biontech-submit-positive-data-from-covid-19-vaccine-trial-in-5-to-12-years-to-fda-1030827634,positive,0.5687521696090698
3523,9/28/2021 1:52:56 PM,"Valneva, Pfizer's Phase 2 Data Suggests Booster Strategy For Lyme Disease Vaccine Candidate",Benzinga,/news/stocks/valneva-pfizer-lyme-disease-vaccine-candidate-drops-off-after-18-months-1030827706,negative,0.7065674662590027
3524,9/28/2021 2:18:52 PM,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",Benzinga,/news/stocks/the-daily-biotech-pulse-eisai-biogen-pursue-approval-of-second-alzheimer-s-treatment-sanofi-changes-mrna-strategy-gsk-subsidiary-to-develop-long-acting-hiv-preventive-1030827880,positive,0.5831677317619324
3525,9/28/2021 3:05:32 PM,"Cannabis Movers & Shakers: MariMed, Medterra, Vertosa, MediaJel",Benzinga,/news/stocks/cannabis-movers-shakers-marimed-medterra-vertosa-mediajel-1030828234,positive,0.9434257745742798
3526,9/28/2021 5:11:30 PM,NVAX Stock: 2 Big Reasons Novavax Is Sliding Lower Today,InvestorPlace,/news/stocks/nvax-stock-2-big-reasons-novavax-is-sliding-lower-today-1030829989,neutral,0.9535420536994934
3527,9/29/2021 4:27:13 AM,FDA Expands Lilly's Erbitux Label With Braftovi For Treatment Of Metastatic Colorectal Cancer ,RTTNews,/news/stocks/fda-expands-lilly-s-erbitux-label-with-braftovi-for-treatment-of-metastatic-colorectal-cancer-1030829333,negative,0.8986799120903015
3528,9/29/2021 6:10:22 AM,FDA OKs expanded use of Lilly's Erbitux with Braftovi for colorectal cancer,Seeking Alpha,https://seekingalpha.com/news/3745572-fda-oks-expanded-use-of-lillys-erbitux-with-braftovi-for-colorectal-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.845605194568634
3529,9/29/2021 10:47:33 AM,FDA mulls authorizing Moderna COVID-19 booster shot at half dose - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3745621-fda-mulls-authorizing-moderna-covid-19-booster-shot-at-half-a-dose-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8070929646492004
3530,9/29/2021 1:26:22 PM,Pfizer: Trial Data From Coadministration Of Prevnar 20 With Seasonal Flu Vaccine Positive ,RTTNews,/news/stocks/pfizer-trial-data-from-coadministration-of-prevnar-20-with-seasonal-flu-vaccine-positive-1030830662,positive,0.7803753614425659
3531,9/29/2021 1:46:31 PM,J&J begins phase 3 trial of RSV vaccine candidate in older adults,Seeking Alpha,https://seekingalpha.com/news/3745750-jj-begins-phase-3-trial-of-rsv-vaccine-candidate-in-older-adults?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6003780364990234
3532,9/29/2021 2:13:41 PM,"The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-abbvie-s-migraine-drug-ok-d-by-fda-amicus-spins-off-gene-therapy-business-geovax-in-licenses-cancer-drug-1030831016,positive,0.9129316210746765
3533,9/30/2021 10:00:24 AM,Novavax Stock Needs a Longer Pandemic as Investor Patience Wears Thin,InvestorPlace,/news/stocks/novavax-stock-needs-a-longer-pandemic-as-investor-patience-wears-thin-1030833455,neutral,0.4981873333454132
3534,9/30/2021 9:20:32 PM,Novavax Stock is Set to Soar in the Year Ahead,InvestorPlace,/news/stocks/nvax-stock-is-set-to-soar-in-the-year-ahead-1030835677,negative,0.9018770456314087
3535,10/1/2021 2:30:32 PM,Merck data for coronavirus pill pressures developers of antibody therapies,Seeking Alpha,https://seekingalpha.com/news/3747028-merck-data-for-coronavirus-pill-pressure-developers-of-antibody-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.897942841053009
3536,10/1/2021 5:42:11 PM,7 Meme Stocks to Buy for a Q4 Rally,InvestorPlace,/news/stocks/7-meme-stocks-to-buy-for-a-q4-rally-1030838052,positive,0.8564853072166443
3537,10/2/2021 2:00:00 PM,"Moderna, BioNTech top performing pharmas in Q3; Alzheimer's drug developers lag",Seeking Alpha,https://seekingalpha.com/news/3747328-moderna-biontech-top-best-performing-pharmas-in-q3-alzheimers-drug-developers-lag?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5793244242668152
3538,10/3/2021 2:13:12 AM,Moderna COVID-19 shot linked to higher rates of heart inflammation - Canada,Seeking Alpha,https://seekingalpha.com/news/3747415-moderna-covid-19-shot-linked-to-higher-rates-of-heart-inflammation-canada?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.45011916756629944
3539,10/3/2021 8:21:49 PM,"The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-3-9-chemocentryx-fda-decision-conference-presentations-ipos-and-more-1030839161,positive,0.9412301182746887
3540,10/4/2021 10:48:42 AM,Johnson & Johnson to seek FDA nod for booster COVID-19 shot this week - NYT,Seeking Alpha,https://seekingalpha.com/news/3747902-johnson-johnson-to-seek-fda-nod-for-booster-covid-19-shot-this-week-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.773047685623169
3541,10/4/2021 1:00:15 PM,Merck extends gains after data for COVID-19 pill as vaccine makers retreat,Seeking Alpha,https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8916258811950684
3542,10/4/2021 5:53:01 PM,It’s Time To Drop Ocugen Stock While You Still Can,InvestorPlace,/news/stocks/its-time-to-drop-ocugen-ocgn-stock-while-you-still-can-1030841717,neutral,0.5398222804069519
3543,10/4/2021 7:37:57 PM,ViiV submits application to FDA for version of HIV treatment Triumeq for children,Seeking Alpha,https://seekingalpha.com/news/3748335-viiv-submits-application-to-fda-for-version-of-hiv-treatment-triumeq-for-children?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5392757654190063
3544,10/5/2021 5:35:59 AM,"EMA Committee Recommends Pfizer, Moderna COVID-19 Booster Doses ",RTTNews,/news/stocks/ema-committee-recommends-pfizer-moderna-covid-19-booster-doses-1030842259,positive,0.8886029124259949
3545,10/5/2021 10:48:35 AM,Johnson & Johnson seeks U.S. regulatory nod for COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3748898-johnson-johnson-seeks-us-regulatory-nod-for-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7973953485488892
3546,10/5/2021 3:58:34 PM,Development stage oncology company Pyxis Oncology sets IPO terms,Seeking Alpha,https://seekingalpha.com/news/3749089-development-stage-oncology-company-pyxis-oncology-sets-ipo-terms?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9268781542778015
3547,10/5/2021 5:16:48 PM,Merck’s Good News Doesn’t End the Bullish Story for Novavax,InvestorPlace,/news/stocks/mercks-good-news-doesnt-end-the-bullish-story-for-novavax-1030844852,positive,0.3743163049221039
3548,10/5/2021 7:04:05 PM,3 Stocks Insiders Are Snapping Up. Do They Know Something We Don’t?,InvestorPlace,/news/stocks/3-stocks-insiders-are-snapping-up-do-they-know-something-we-dont-1030845016,positive,0.686031699180603
3549,10/6/2021 11:52:24 AM,Moderna slides after Sweden pulls vaccine for those born after 1991,Seeking Alpha,https://seekingalpha.com/news/3749333-pfizerbiontech-covid-19-shot-preferred-over-moderna-vaccine-for-children-in-sweden?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9084314703941345
3550,10/6/2021 1:33:33 PM,"The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-takeda-suspends-studies-on-safety-scare-acer-s-sleep-disorder-drug-filing-accepted-for-review-voyager-s-licensing-options-deal-1030846864,neutral,0.905750572681427
3551,10/6/2021 3:33:39 PM,Latest Bad News Suggests Novavax Stock Might Be Cursed,InvestorPlace,/news/stocks/latest-bad-news-suggests-nvax-stock-might-be-cursed-1030847958,neutral,0.9194989204406738
3552,10/6/2021 5:26:42 PM,VYGR Stock: The Huge Licensing Deal Sending Voyager Therapeutics Rocketing Higher,InvestorPlace,/news/stocks/vygr-stock-the-huge-licensing-deal-sending-voyager-therapeutics-rocketing-higher-1030848279,negative,0.9255695343017578
3553,10/6/2021 5:58:57 PM,Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst,Benzinga,/news/stocks/merck-s-oral-covid-19-treatment-could-be-game-changer-bofa-analyst-1030848005,positive,0.9073443412780762
3554,10/6/2021 6:21:09 PM,7 Healthcare Stocks to Add to Your Portfolio,InvestorPlace,/news/stocks/7-healthcare-stocks-to-add-to-your-portfolio-1030848379,positive,0.9181228876113892
3555,10/6/2021 7:40:46 PM,Erasca to end four day winning streak with biggest one-day loss,Seeking Alpha,https://seekingalpha.com/news/3750377-erasca-to-end-four-day-winning-streak-with-biggest-one-day-loss?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4296265244483948
3556,10/7/2021 2:23:53 PM,"The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-invests-in-africa-amgen-announces-neuroscience-r-d-collaboration-decision-day-for-chemocentryx-biophytis-to-restate-results-1030850125,positive,0.89493727684021
3557,10/7/2021 4:26:52 PM,Pfizer Seeks Emergency Nod In U.S. For COVID-19 Vaccine In Children 5 - 11 ,RTTNews,/news/stocks/pfizer-seeks-emergency-nod-in-u-s-for-covid-19-vaccine-in-children-5-11-1030850772,negative,0.6729187965393066
3558,10/7/2021 6:19:37 PM,"Finland joins Sweden, Denmark in excluding Moderna COVID vaccine in young males",Seeking Alpha,https://seekingalpha.com/news/3750732-finland-joins-sweden-denmark-in-excluding-moderna-covid-vaccine-in-young-males?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8333089351654053
3559,10/8/2021 10:00:11 AM,Once-Cinderella Novavax Stock Could Be Poisoned by Merck’s Covid Pill,InvestorPlace,/news/stocks/if-nvax-stock-dead-cat-bounces-take-the-bounce-1030852531,neutral,0.7392678260803223
3560,10/8/2021 11:44:04 AM,Novavax Stock Looks Interesting as the World Still Needs Vaccines,InvestorPlace,/news/stocks/novavax-stock-looks-interesting-as-the-world-still-needs-vaccines-1030852726,positive,0.5224453806877136
3561,10/8/2021 12:53:16 PM,"Moderna Stock Looks Fully Valued Here, But It Has a Great Future",InvestorPlace,/news/stocks/mrna-stock-looks-fully-valued-here-but-it-has-a-great-future-1030852948,negative,0.8353980779647827
3562,10/8/2021 3:43:24 PM,7 Defensive Stocks to Buy and Forget About In Times of Volatility,InvestorPlace,/news/stocks/7-defensive-stocks-to-buy-and-forget-about-in-times-of-volatility-1030853320,positive,0.9234777688980103
3563,10/8/2021 9:08:07 PM,Corona Doom 2.0: Vaccine Passports. Parallels Between The Government's Reaction To 9/11 And COVID-19.,Benzinga,/news/stocks/corona-doom-2-0-vaccine-passports-parallels-between-the-government-s-reaction-to-9-11-and-covid-19-1030853685,positive,0.9010921120643616
3564,10/11/2021 10:00:31 AM,7 Top Stocks That Held Up Well During This Recent Market Bloodbath,InvestorPlace,/news/stocks/7-top-stocks-that-held-up-well-during-this-recent-market-bloodbath-1030855615,negative,0.9300429821014404
3565,10/11/2021 4:54:14 PM,Cogent rebounds as H.C. Wainwright sees over threefold rise in share price,Seeking Alpha,https://seekingalpha.com/news/3751310-cogent-rebounds-as-hc-wainwright-sees-over-threefold-rise-in-share-price?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9271768927574158
3566,10/11/2021 5:07:09 PM,"Cannabis Movers & Shakers: Clairvoyant Therapeutics, Eaze, Leafly, Chalice Brands",Benzinga,/news/stocks/cannabis-movers-shakers-clairvoyant-therapeutics-eaze-leafly-chalice-brands-1030856480,positive,0.9382358193397522
3567,10/11/2021 8:21:09 PM,"Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind's Palliative Care Program",Benzinga,/news/stocks/psyched-seattle-decriminalizes-psychedelics-psilocybin-increases-emotions-from-music-novamind-s-palliative-care-program-1030856857,positive,0.8207285404205322
3568,10/12/2021 10:00:08 AM,"Novavax Stock Will Find Its Bottom, But Probably not Soon",InvestorPlace,/news/stocks/nvax-stock-will-find-its-bottom-but-probably-not-soon-1030858438,neutral,0.6969290375709534
3569,10/12/2021 10:00:43 AM,Don’t Buy Too Much Into the WHO Hype Surrounding Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-dont-buy-too-much-into-the-who-hype-1030858436,positive,0.9197484254837036
3570,10/12/2021 2:12:28 PM,WHO recommends an additional COVID-19 vaccine for immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3752012-who-recommends-an-additional-covid-19-vaccine-for-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7509061098098755
3571,10/12/2021 4:33:34 PM,Moderna draws muted response from FDA for COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3752072-moderna-draws-muted-response-from-fda-for-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.725179135799408
3572,10/12/2021 6:32:44 PM,Where Pfizer Stands With Analysts,Benzinga,/news/stocks/where-pfizer-stands-with-analysts-1030860007,positive,0.9324877858161926
3573,10/12/2021 8:14:05 PM,NRXP Stock Is Soaring Today Thanks to This Big FDA Catalyst,InvestorPlace,/news/stocks/nrxp-stock-is-soaring-today-thanks-to-this-big-fda-catalyst-1030860392,negative,0.9453575015068054
3574,10/13/2021 12:03:53 AM,How To Play Moderna Stock Ahead Of Key FDA COVID-19 Booster Shot Ruling,Benzinga,/news/stocks/how-to-play-moderna-stock-ahead-of-key-fda-covid-19-booster-shot-ruling-1030860585,positive,0.9176620244979858
3575,10/13/2021 6:06:55 PM,7 Foreign Stocks All U.S. Investors Should Be Watching,InvestorPlace,/news/stocks/7-foreign-stocks-all-u-s-investors-should-be-watching-1030864063,positive,0.9004141092300415
3576,10/13/2021 6:49:01 PM,AstraZeneca COVID-19 jab will no longer be made in Australia - 9News,Seeking Alpha,https://seekingalpha.com/news/3752546-astrazeneca-covid-19-jab-will-no-longer-be-made-in-australia-9news?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9501309990882874
3577,10/14/2021 12:13:32 PM,Codexis says Pfizer made $29M of purchase orders for production of COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3752763-codexis-says-pfizer-made-29m-of-purchase-orders-for-production-of-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.642850399017334
3578,10/14/2021 7:19:45 PM,Moderna gains with unanimous AdCom backing for COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3752981-moderna-gains-with-unanimous-adcom-backing-for-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9181937575340271
3579,10/14/2021 11:09:04 PM,FDA Advisory Panel Recommends Moderna's Covid-19 Booster Dose ,RTTNews,/news/stocks/fda-advisory-panel-recommends-moderna-s-covid-19-booster-dose-1030867912,positive,0.8024297952651978
3580,10/15/2021 1:44:03 PM,"The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-booster-shot-gets-fda-panel-backing-decision-day-for-avadel-silence-therapeutics-strikes-licensing-deal-mink-ipo-1030869318,positive,0.7786534428596497
3581,10/15/2021 2:02:09 PM,Pfizer's Abrocitinib Receives Positive CHMP Opinion For Atopic Dermatitis Treatment ,RTTNews,/news/stocks/pfizer-s-abrocitinib-receives-positive-chmp-opinion-for-atopic-dermatitis-treatment-1030869372,negative,0.9457583427429199
3582,10/15/2021 4:46:08 PM,FDA decision on Moderna COVID-19 shot for adolescents likely to get delayed - WSJ,Seeking Alpha,https://seekingalpha.com/news/3753333-fda-decision-on-moderna-covid-19-shot-for-adolescents-likely-to-get-delayed-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.728799045085907
3583,10/18/2021 4:59:58 PM,Progenity continues rise following patents on ingestible therapeutics; shares up 32%,Seeking Alpha,https://seekingalpha.com/news/3754178-progenity-continues-rise-following-patents-on-ingestible-therapeutics-shares-up-32?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9532865285873413
3584,10/18/2021 6:27:39 PM,Why Moderna Shares Are Rebounding From Friday's Losses,Benzinga,/news/stocks/why-moderna-shares-are-rebounding-from-friday-s-losses-1030874455,negative,0.9025632739067078
3585,10/18/2021 6:53:43 PM,IDEAYA Biosciences extends losses despite naming new chief scientific officer,Seeking Alpha,https://seekingalpha.com/news/3754257-ideaya-biosciences-extends-losses-despite-naming-new-chief-scientific-officer?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5980272889137268
3586,10/19/2021 2:23:01 PM,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",Benzinga,/news/stocks/the-daily-biotech-pulse-entasis-dermata-spike-higher-on-positive-readouts-j-j-q3-eps-beats-estimates-wave-life-sciences-regains-right-to-cns-portfolio-1030877269,negative,0.9359005689620972
3587,10/19/2021 2:33:19 PM,Will FDA Allow 'mix And Match' Of Covid Booster Shots? ,RTTNews,/news/stocks/will-fda-allow-mix-and-match-of-covid-booster-shots-1030877340,positive,0.9246798753738403
3588,10/20/2021 8:00:02 PM,Radius Health price target raised on Wall Street after trial win for breast cancer drug,Seeking Alpha,https://seekingalpha.com/news/3755728-radius-health-price-target-raised-on-wall-street-after-trial-win-for-breast-cancer-drug?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7737113833427429
3589,10/20/2021 9:32:54 PM,"FDA authorizes COVID boosters from Moderna, J&J, as well as 'mix and match'",Seeking Alpha,https://seekingalpha.com/news/3755864-fda-authorizes-covid-boosters-from-moderna-johnson-johnson-as-well-as-mix-and-match?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7960220575332642
3590,10/21/2021 12:20:46 PM,Merck wins backing from CDC panel for 15-valent pneumococcal vaccine,Seeking Alpha,https://seekingalpha.com/news/3756053-merck-wins-backing-from-cdc-panel-for-15-valent-pneumococcal-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9007834196090698
3591,10/21/2021 12:49:12 PM,Moderna leads COVID-19 vaccine makers as Piper Sandler favors its booster shot,Seeking Alpha,https://seekingalpha.com/news/3756089-moderna-leads-covid-19-vaccine-makers-as-piper-sandler-favors-its-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5400654673576355
3592,10/21/2021 1:21:37 PM,Pfizer : Phase 3 Trial Data Shows 95.6% Efficacy In COVID-19 Vaccine Booster Dose ,RTTNews,/news/stocks/pfizer-phase-3-trial-data-shows-95-6-efficacy-in-covid-19-vaccine-booster-dose-1030885272,negative,0.8752063512802124
3593,10/21/2021 2:05:16 PM,"The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-authorizes-moderna-j-j-booster-shots-regulatory-approvals-for-bristol-myers-squibb-sanofi-regeneron-ventyx-ipo-1030885538,positive,0.8053774833679199
3594,10/21/2021 5:40:58 PM,EU to issue decision on Moderna COVID-19 booster shot next week,Seeking Alpha,https://seekingalpha.com/news/3756271-eu-to-issue-decision-on-moderna-booster-shot-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8366607427597046
3595,10/21/2021 8:55:47 PM,Pfizer Is Recovering As Its Covid Vaccine for Children Nears Approval,InvestorPlace,/news/stocks/pfe-stock-is-recovering-as-its-covid-vaccine-for-children-nears-approval-1030887290,neutral,0.8110381364822388
3596,10/21/2021 9:50:04 PM,"CDC advisors recommend Moderna, J&J booster shots",Seeking Alpha,https://seekingalpha.com/news/3756438-cdc-advisors-recommend-moderna-johnson-johnson-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8576716780662537
3597,10/22/2021 1:07:04 AM,Moderna and Johnson & Johnson COVID-19 boosters granted CDC approval,Seeking Alpha,https://seekingalpha.com/news/3756452-moderna-and-johnson-johnson-covid-19-boosters-granted-cdc-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9274259209632874
3598,10/22/2021 10:00:11 AM,Pfizer is a Clear Covid-19 Winner. Is That Enough?,InvestorPlace,/news/stocks/pfe-is-a-clear-covid-19-winner-is-that-enough-1030888518,positive,0.8284849524497986
3599,10/22/2021 7:00:19 PM,"Catalyst watch for next week: Tech giants report, eyes on Digital World Acquisition, events for Datadog, Facebook & HPE",Seeking Alpha,https://seekingalpha.com/news/3756753-catalyst-watch-for-next-week-tech-giants-report-eyes-on-digital-world-acquisition-events-for-datadog-facebook-hpe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9329586625099182
3600,10/22/2021 8:59:48 PM,9 Moonshot Bets to Beat Hedge Funds at Their Own Game,InvestorPlace,/news/stocks/9-moonshot-bets-to-beat-hedge-funds-at-their-own-game-1030890085,positive,0.8898447155952454
3601,10/22/2021 9:17:52 PM,Novavax Is Set to Win on the Increasing Necessity of Booster Shots,InvestorPlace,/news/stocks/nvax-stock-set-to-win-on-increased-necessity-of-booster-shots-1030890110,negative,0.8870501518249512
3602,10/22/2021 9:56:40 PM,Pfizer's Covid-19 Vaccine Nearly 91% Effective In Children Ages 5 To 11 ,RTTNews,/news/stocks/pfizer-s-covid-19-vaccine-nearly-91-effective-in-children-ages-5-to-11-1030889949,negative,0.6874014139175415
3603,10/24/2021 5:45:47 PM,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-24-30-eyenovia-ani-pharma-clearside-medical-fda-decisions-merck-bristol-myers-squibb-earnings-ipos-and-more-1030891741,positive,0.9414970874786377
3604,10/25/2021 5:10:05 PM,EMA committee says Moderna boosters can be used in those 18 and over,Seeking Alpha,https://seekingalpha.com/news/3757582-ema-committee-says-moderna-boosters-can-be-used-in-those-18-and-over?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8141580820083618
3605,10/25/2021 7:20:44 PM,"Novavax is Now a Riskier Play, but Still One to Keep Your Eye On",InvestorPlace,/news/stocks/nvax-stock-is-now-a-riskier-play-but-still-one-to-keep-your-eye-on-1030896008,positive,0.8857182860374451
3606,10/26/2021 2:30:47 PM,"The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-gains-on-vaccine-news-novartis-reports-q3-beat-adcom-reviews-authorization-of-pfizer-biontech-s-vaccine-for-children-1030899570,negative,0.6003707051277161
3607,10/26/2021 3:36:40 PM,Myovant Sciences nears a three-month low after setback for partnership with Pfizer,Seeking Alpha,https://seekingalpha.com/news/3758178-myovant-sciences-nears-a-three-month-low-after-setback-for-partnership-with-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9523671269416809
3608,10/26/2021 4:13:44 PM,Teva Pharmaceutical falls 6% on eve of Q3 earnings show,Seeking Alpha,https://seekingalpha.com/news/3758203-teva-pharmaceutical-q3-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9715293645858765
3609,10/26/2021 11:32:28 PM,Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat?,Benzinga,/news/stocks/why-did-myovant-sciences-shares-fall-despite-q2-earnings-beat-1030901850,neutral,0.9481353759765625
3610,10/26/2021 11:56:04 PM,FDA Panel Recommends Low Doses Of Pfizer Vaccine For Kids Aged 5-11 ,RTTNews,/news/stocks/fda-panel-recommends-low-doses-of-pfizer-vaccine-for-kids-aged-5-11-1030901968,positive,0.8756830096244812
3611,10/27/2021 3:13:21 PM,NVAX Stock Soars 6% as Novavax Reaches Key Vaccine Milestone,InvestorPlace,/news/stocks/nvax-stock-soars-6-as-novavax-reaches-key-vaccine-milestone-1030906043,negative,0.9392035007476807
3612,10/27/2021 5:31:10 PM,Moderna COVID-19 shot could be available for adolescents within weeks - CEO,Seeking Alpha,https://seekingalpha.com/news/3759197-moderna-covid-19-shot-could-be-available-for-adolescents-within-weeks-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8589308261871338
3613,10/27/2021 9:52:25 PM,CDC Recommends 4th Booster Covid Vaccine Dose For Immunocompromised People ,RTTNews,/news/stocks/cdc-recommends-4th-booster-covid-vaccine-dose-for-immunocompromised-people-1030906781,positive,0.8592575192451477
3614,10/28/2021 10:51:30 AM,Pfizer/BioNTech to provide U.S. government additional 50M pediatric doses of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3759799-pfizerbiontech-to-provide-us-government-additional-50m-pediatric-doses-of-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7269576787948608
3615,10/28/2021 2:03:49 PM,Pfizer And BioNTech To Provide U.S. Govt Addl 50 Million Pediatric Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/pfizer-and-biontech-to-provide-u-s-govt-addl-50-million-pediatric-doses-of-covid-19-vaccine-1030910077,negative,0.7639127969741821
3616,10/28/2021 2:26:10 PM,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-beat-and-raise-quarter-pfizer-biontech-snag-orders-for-additional-vaccine-doses-hcw-cleared-for-phase-1-study-of-pancreatic-cancer-drug-1030910260,negative,0.8363469839096069
3617,10/28/2021 8:22:27 PM,Don’t Count Novavax Out; The World Still Needs Vaccines,InvestorPlace,/news/stocks/dont-count-nvax-stock-out-the-world-still-needs-vaccines-1030912071,positive,0.8216158747673035
3618,10/29/2021 2:19:39 PM,Novavax Just Caught a Big Break,InvestorPlace,/news/stocks/nvax-stock-just-caught-a-big-break-1030915657,negative,0.6648101806640625
3619,10/29/2021 6:10:21 PM,FDA approves Novartis chronic myeloid leukemia drug Scemblix,Seeking Alpha,https://seekingalpha.com/news/3761007-fda-approves-novartis-chromic-myeloid-leukemia-drug-scmeblix?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5446001291275024
3620,10/29/2021 7:00:57 PM,"Catalyst watch for next week: FOMC and OPEC meetings, Beyond Meat hits McDonald's stores and more eyes on crypto",Seeking Alpha,https://seekingalpha.com/news/3760981-catalyst-watch-for-next-week-fomc-and-opec-meetings-beyond-meat-hits-mcdonalds-stores-and-more-eyes-on-crypto?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9212965965270996
3621,10/29/2021 11:06:59 PM,FDA Authorizes Pfizer's Covid Vaccine For Emergency Use In Children Aged 5 To 11 ,RTTNews,/news/stocks/fda-authorizes-pfizer-s-covid-vaccine-for-emergency-use-in-children-aged-5-to-11-1030916564,positive,0.8902202844619751
3622,10/30/2021 8:00:00 PM,"BioNTech, GSK top pharma performers in October; Bristol, Amgen biggest laggards",Seeking Alpha,https://seekingalpha.com/news/3761145-biontech-gsk-top-pharma-performers-in-october-bristol-amgen-biggest-laggards?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8818862438201904
3623,10/31/2021 7:23:54 PM,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-31-nov-6-earnings-pick-up-pace-eton-awaits-seizure-drug-approval-kidney-conference-more-ipos-in-the-pipeline-1030917750,negative,0.939061164855957
3624,11/1/2021 10:00:09 AM,4 Reasons Why Ocugen Will Make Very Little or No Money From Covaxin,InvestorPlace,/news/stocks/4-reasons-why-ocugen-will-make-very-little-or-no-money-from-covaxin-1030920759,positive,0.8744636178016663
3625,11/1/2021 10:00:10 AM,"Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated",InvestorPlace,/news/stocks/novavax-stock-rises-as-uk-covid-vax-okay-sought-other-growth-anticipated-1030920758,negative,0.9438596963882446
3626,11/1/2021 10:00:49 AM,Novavax Is a Much Better Growth Buy Than Moderna Here,InvestorPlace,/news/stocks/nvax-stock-is-a-much-better-growth-buy-than-mrna-1030920748,negative,0.7979655265808105
3627,11/1/2021 3:01:13 PM,What Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-stock-q3-earnings-preview-1030921785,positive,0.9330461025238037
3628,11/1/2021 3:10:27 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3761481-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
3629,11/1/2021 3:26:59 PM,7 A-Rated Healthcare Stocks to Buy for the Long Haul,InvestorPlace,/news/stocks/7-a-rated-healthcare-stocks-to-buy-for-the-long-haul-1030922353,positive,0.8042488098144531
3630,11/1/2021 4:51:11 PM,All eyes on Pfizer's COVID-19 vaccine business ahead of Q3 results,Seeking Alpha,https://seekingalpha.com/news/3761515-all-eyes-on-pfizers-covid-19-vaccine-business-ahead-of-q3-results?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9450358748435974
3631,11/1/2021 7:58:13 PM,Why did Moderna stock drop today?,Seeking Alpha,https://seekingalpha.com/news/3761812-why-did-moderna-stock-drop-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8496978282928467
3632,11/2/2021 8:38:02 AM,"Pfizer, Moderna investors watching vaccine sales outlook and production expectations",Seeking Alpha,https://seekingalpha.com/news/3762130-pfizer-moderna-investors-watching-vaccine-sales-outlook-and-production-expectations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9357653856277466
3633,11/2/2021 10:46:44 AM,"Pfizer EPS beats by $0.25, beats on revenue, raises guidance",Seeking Alpha,https://seekingalpha.com/news/3762648-pfizer-eps-beats-0_25-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8535121083259583
3634,11/2/2021 11:28:40 AM,Pfizer more than doubles quarterly revenue in Q3 thanks to COVID-19 vaccine sales,Seeking Alpha,https://seekingalpha.com/news/3762718-pfizer-more-than-doubles-quarterly-revenue-in-q3-thanks-to-covid-19-vaccine-sales?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9442352056503296
3635,11/2/2021 11:49:18 AM,Pfizer Inc. Profit Rises In Q3,RTTNews,/news/stocks/pfizer-inc-profit-rises-in-q3-1030925261,negative,0.9057503938674927
3636,11/2/2021 12:43:16 PM,Pfizer Q3 Profit Skyrockets On Vaccine Sales ,RTTNews,/news/stocks/pfizer-q3-profit-skyrockets-on-vaccine-sales-1030925744,neutral,0.8927809000015259
3637,11/2/2021 12:52:53 PM,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-solid-q3-earnings-regulatory-setback-for-legend-lilly-to-supply-additional-covid-19-antibody-cocktails-to-us-1030925781,negative,0.9155561327934265
3638,11/2/2021 3:12:55 PM,Mid-Morning Market Update: Markets Edge Higher; Pfizer Boosts FY21 Outlook,Benzinga,/news/stocks/mid-morning-market-update-markets-edge-higher-pfizer-boosts-fy21-outlook-1030927045,negative,0.9417486190795898
3639,11/2/2021 4:11:31 PM,Ocugen hits six-month high ahead of key WHO meeting on partner’s COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3763060-ocgn-stock-hits-six-month-high-ahead-of-key-who-meeting-on-partners-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7430815100669861
3640,11/2/2021 5:08:55 PM,Mid-Day Market Update: Avis Budget Surges After Q3 Results; Chegg Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-avis-budget-surges-after-q3-results-chegg-shares-plunge-1030927491,neutral,0.7640581130981445
3641,11/2/2021 7:32:00 PM,Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide,Benzinga,/news/stocks/mid-afternoon-market-update-dow-rises-around-150-points-semler-scientific-shares-slide-1030927841,neutral,0.43713051080703735
3642,11/2/2021 7:55:13 PM,PFE Stock Alert: 3 Catalysts Giving Pfizer Stock a Shot in the Arm Today,InvestorPlace,/news/stocks/pfe-stock-alert-3-catalysts-giving-pfizer-stock-a-shot-in-the-arm-today-1030927981,positive,0.8126965165138245
3643,11/3/2021 3:09:52 AM,CDC Backs Pfizer-BioNTech COVID-19 Vaccine For Children 5 To 11 Years ,RTTNews,/news/stocks/cdc-backs-pfizer-biontech-covid-19-vaccine-for-children-5-to-11-years-1030928736,positive,0.6841252446174622
3644,11/3/2021 10:00:28 AM,A Move Into Novavax Stock Makes Sense Ahead of Several Near-term Catalysts,InvestorPlace,/news/stocks/a-move-into-novavax-stock-makes-sense-ahead-of-several-near-term-catalysts-1030931048,positive,0.8233152031898499
3645,11/3/2021 12:14:31 PM,Democrats finally hammer out prescription drug pricing plan,Seeking Alpha,https://seekingalpha.com/news/3763812-democrats-finally-hammer-out-prescription-drug-pricing-plan?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8670295476913452
3646,11/3/2021 12:18:09 PM,Walgreens to provide Pfizer COVID vaccine for children ages 5 to 11,Seeking Alpha,https://seekingalpha.com/news/3763815-walgreens-to-provide-pfizer-covid-vaccine-for-children-ages-5-to-11?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7170556783676147
3647,11/3/2021 1:48:16 PM,Walgreens To Provide Pfizer COVID-19 Vaccines To Children Ages 5 To 11 In U.S. Beginning Saturday ,RTTNews,/news/stocks/walgreens-to-provide-pfizer-covid-19-vaccines-to-children-ages-5-to-11-in-u-s-beginning-saturday-1030931903,positive,0.6143079400062561
3648,11/3/2021 2:24:50 PM,With filings for COVID vaccine underway will Novavax Q3 results bring positive surprise?,Seeking Alpha,https://seekingalpha.com/news/3761545-novavax-q3-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6275758743286133
3649,11/3/2021 6:45:27 PM,"Ocugen Neared $16 Yesterday, But I’ll Eat 4 Hats If It Gets to $32",InvestorPlace,/news/stocks/nearing-16-ill-eat-4-hats-if-ocgn-stock-gets-to-32-1030933842,negative,0.49576231837272644
3650,11/4/2021 8:10:02 AM,"Kids COVID vaccine campaigns kick off, will ramp up next week",Seeking Alpha,https://seekingalpha.com/news/3764816-kids-covid-vaccine-campaigns-kick-off-will-ramp-up-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8494962453842163
3651,11/4/2021 1:00:46 PM,EVAX Stock: 10 Things to Know as Little-Known Evaxion Rockets 100% Today,InvestorPlace,/news/stocks/evax-stock-10-things-to-know-as-little-known-evaxion-rockets-100-today-1030938049,positive,0.759556233882904
3652,11/4/2021 3:42:20 PM,"Sangamo up 21% following Q3 earnings beat, phase 1 Fabry candidate update",Seeking Alpha,https://seekingalpha.com/news/3765299-sangamo-up-22-following-q3-earnings-beat-phase-1-fabry-candidate-update?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9500320553779602
3653,11/4/2021 3:45:00 PM,"Pfizer Covid Vaccine For Children 5-11 At Walmart, Sam's Club, CVS, Walgreens ",RTTNews,/news/stocks/pfizer-covid-vaccine-for-children-5-11-at-walmart-sam-s-club-cvs-walgreens-1030938006,positive,0.9132187366485596
3654,11/4/2021 5:27:37 PM,7 Stocks to Buy to Hone in on Ray Dalio’s Reliable Favorites,InvestorPlace,/news/stocks/7-stocks-to-buy-to-hone-in-on-ray-dalio-reliable-favorites-1030938626,negative,0.7804809212684631
3655,11/4/2021 8:25:28 PM,"Avoid Ocugen — The Vaccine Is Too Little, Too Late",InvestorPlace,/news/stocks/avoid-ocgn-stock-at-current-levels-1030939092,positive,0.8983393311500549
3656,11/5/2021 10:00:00 AM,The Novavax Rebound Is Just Warming Up,InvestorPlace,/news/stocks/nvax-stock-rebound-is-just-warming-up-1030942042,positive,0.7882605195045471
3657,11/5/2021 11:03:16 AM,Pfizer shares rise 11% on interim results from COVID-19 oral antiviral treatment study,Seeking Alpha,https://seekingalpha.com/news/3765995-pfizer-shares-rise-11-on-interim-results-from-covid-19-oral-antiviral-treatment-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9417601227760315
3658,11/5/2021 11:10:23 AM,Pfizer data on COVID-19 pill pressures rival Merck and vaccine developers,Seeking Alpha,https://seekingalpha.com/news/3766005-pfizer-data-on-covid-19-pill-pressure-rival-merck-and-vaccine-developers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.46351781487464905
3659,11/5/2021 12:34:07 PM,Pfizer's COVID-19 Antiviral Candidate Shows Potential To Reduce Risk Of Hospitalization By 89% ,RTTNews,/news/stocks/pfizer-s-covid-19-antiviral-candidate-shows-potential-to-reduce-risk-of-hospitalization-by-89-1030942365,negative,0.9503133893013
3660,11/5/2021 12:41:42 PM,"TRIP, RWLK and IONQ among pre market gainers",Seeking Alpha,https://seekingalpha.com/news/3766091-trip-rwlk-and-ionq-among-pre-market-gainers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.753256618976593
3661,11/5/2021 1:22:48 PM,"The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-s-zyesami-face-regulatory-rejection-puma-slumps-on-q3-miss-pfizer-has-good-tidings-on-oral-antiviral-covid-19-pill-1030942536,neutral,0.6475773453712463
3662,11/5/2021 2:16:09 PM,"Moderna, Novavax down big after earnings disappointments, Pfizer COVID-19 pill data",Seeking Alpha,https://seekingalpha.com/news/3766172-moderna-novavax-down-big-after-earnings-disappointments-pfizer-covid-19-pill-data?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9530306458473206
3663,11/5/2021 3:14:55 PM,"Regeneron, Eli Lilly join selloff as Pfizer hopes for a COVID-19 pill",Seeking Alpha,https://seekingalpha.com/news/3766206-regeneron-eli-lilly-join-selloff-as-pfizer-hopes-for-a-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8121302127838135
3664,11/5/2021 3:19:32 PM,"Mid-Morning Market Update: Markets Open Higher; US Economy Adds 531,000 Jobs",Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-us-economy-adds-531-000-jobs-1030942967,negative,0.9372267723083496
3665,11/5/2021 3:52:55 PM,Biden says U.S. has access to millions of doses of Pfizer’s new COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3766230-biden-says-us-has-access-to-millions-of-doses-of-pfizers-new-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5976303219795227
3666,11/5/2021 5:24:13 PM,64 Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/64-stocks-moving-in-friday-s-mid-day-session-1030943270,positive,0.4971774220466614
3667,11/5/2021 5:42:52 PM,"Airline Stocks Alert: Why DAL, UAL and AAL Are Flying Higher Today",InvestorPlace,/news/stocks/airline-stocks-alert-why-dal-ual-and-aal-are-flying-higher-today-1030943446,negative,0.7643778324127197
3668,11/5/2021 5:55:56 PM,10 S&P 500 Stocks to Buy After Winning in Q3,InvestorPlace,/news/stocks/10-sp-500-stocks-to-buy-after-winning-in-the-third-quarter-1030943473,negative,0.8830471634864807
3669,11/5/2021 7:24:26 PM,Pfizer data for COVID-19 pill drags other developers of oral COVID-19 therapies,Seeking Alpha,https://seekingalpha.com/news/3766416-pfizer-data-for-covid-19-pill-drags-other-developers-of-oral-covid-19-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.940730094909668
3670,11/5/2021 8:07:06 PM,Why did Merck shares fall today?,Seeking Alpha,https://seekingalpha.com/news/3766435-why-did-merck-shares-fall-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8392989039421082
3671,11/8/2021 9:42:50 AM,92 Biggest Movers From Friday,Benzinga,/news/stocks/92-biggest-movers-from-yesterday-1030948004,positive,0.871670663356781
3672,11/8/2021 1:08:21 PM,Viatris tightens 2021 revenue guidance; growth momentum in net sales cools,Seeking Alpha,https://seekingalpha.com/news/3766697-viatris-tightens-2021-revenue-guidance-growth-momentum-in-net-sales-cools?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4854608476161957
3673,11/8/2021 2:24:25 PM,"The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-nov-7-nov-13-earnings-taper-off-multiple-conference-presentations-ipos-and-more-1030949001,neutral,0.9685659408569336
3674,11/8/2021 4:49:36 PM,Are Vaccine Stocks A Buy On Earnings?,InvestorPlace,/news/stocks/are-vaccine-stocks-a-buy-on-earnings-1030951369,positive,0.8077834844589233
3675,11/9/2021 12:17:25 PM,BioNTech boosts outlook for COVID-19 vaccine revenue after earnings beat,Seeking Alpha,https://seekingalpha.com/news/3767569-biontech-boosts-outlook-for-covid-19-vaccine-revenue-after-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.944453775882721
3676,11/9/2021 1:46:00 PM,Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States,PR Newswire,/news/stocks/biohaven-and-pfizer-enter-strategic-collaboration-for-the-commercialization-of-rimegepant-outside-the-united-states-1030953446,negative,0.8958837985992432
3677,11/9/2021 1:56:42 PM,Moderna requests EU nod to use COVID-19 shot in children,Seeking Alpha,https://seekingalpha.com/news/3767685-moderna-requests-eu-nod-to-use-covid-19-shot-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5617652535438538
3678,11/9/2021 2:02:27 PM,"Pfizer Inks Deal With Biohaven To Commercialize Rimegepant, Zavegepant, Outside The U.S. ",RTTNews,/news/stocks/pfizer-inks-deal-with-biohaven-to-commercialize-rimegepant-zavegepant-outside-the-u-s-1030953521,negative,0.9070717096328735
3679,11/9/2021 2:06:59 PM,Biohaven falls 15% on apparent disappointment that Pfizer deal isn't a buyout,Seeking Alpha,https://seekingalpha.com/news/3767697-biohaven-falls-15-on-apparent-disappointment-that-pfizer-deal-isnt-a-buyout?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9556666016578674
3680,11/9/2021 8:04:17 PM,Pfizer/BioNTech ask FDA to expand COVID-19 booster eligibility for all adults,Seeking Alpha,https://seekingalpha.com/news/3767999-pfizerbiontech-asks-fda-to-expand-covid-19-booster-eligibility-for-all-adults?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.875632643699646
3681,11/9/2021 8:32:11 PM,OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today,InvestorPlace,/news/stocks/ocgn-stock-alert-the-earnings-news-that-has-ocugen-slipping-today-1030955404,neutral,0.931200385093689
3682,11/10/2021 2:31:43 AM,Pfizer Asks FDA To Authorize COVID-19 Booster Dose For All Adults ,RTTNews,/news/stocks/pfizer-asks-fda-to-authorize-covid-19-booster-dose-for-all-adults-1030956197,positive,0.5811566710472107
3683,11/10/2021 4:02:39 AM,Cathie Wood Rushes To Load Up $36M In Palantir As Its Stock Crashes 9%,Benzinga,/news/etf/cathie-wood-rushes-to-load-up-36m-in-palantir-as-its-stock-crashes-9-1030956224,negative,0.9085720777511597
3684,11/10/2021 3:27:56 PM,BioNTech upgraded at H.C. Wainwright on prospects of COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3768749-biontech-upgraded-at-hc-wainwright-on-prospects-of-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8713794350624084
3685,11/10/2021 10:11:03 PM,Germany Recommends Only Pfizer Vaccine For People Under 30 ,RTTNews,/news/stocks/germany-recommends-only-pfizer-vaccine-for-people-under-30-1030961265,positive,0.9312372803688049
3686,11/11/2021 5:02:53 AM,"Cathie Wood Continues To Load Up On Palantir, Buying $28M Shares On Wednesday",Benzinga,/news/etf/cathie-wood-continues-to-load-up-on-palantir-buying-28m-shares-on-wednesday-1030962161,negative,0.6122027039527893
3687,11/11/2021 11:00:29 AM,Moderna Stock Could Have a Lot Further to Fall After Disasterous Earnings,InvestorPlace,/news/stocks/moderna-stock-could-have-a-lot-further-to-fall-after-disasterous-earnings-1030964470,neutral,0.9591974020004272
3688,11/11/2021 5:15:18 PM,7 of the Best Stocks to Buy for Their Free Cash Flow,InvestorPlace,/news/stocks/7-of-the-best-stocks-to-buy-for-their-free-cash-flow-1030966281,positive,0.791659951210022
3689,11/11/2021 6:34:11 PM,WHO’s Nod Can’t Mask Ocugen’s Flimsy Fundamentals,InvestorPlace,/news/stocks/whos-nod-cant-mask-ocugens-flimsy-fundamentals-1030966520,positive,0.7945975661277771
3690,11/11/2021 10:52:35 PM,Virginia Pharmacy Administers Wrong Pfizer Vaccine Doses To 112 Kids ,RTTNews,/news/stocks/virginia-pharmacy-administers-wrong-pfizer-vaccine-doses-to-112-kids-1030966955,positive,0.8934648036956787
3691,11/12/2021 3:36:24 AM,Cathie Wood Sells $52.5M In Coinbase And Loads Up On These Stocks Instead,Benzinga,/news/etf/cathie-wood-sells-52-5m-in-coinbase-and-loads-up-on-these-stocks-instead-1030967132,positive,0.8176523447036743
3692,11/12/2021 8:30:21 PM,Inflation Isn’t a Trend-Killer… Yet,InvestorPlace,/news/stocks/inflation-isnt-a-trend-killer-yet-1030977655,neutral,0.5430537462234497
3693,11/15/2021 11:14:35 AM,Pfizer defends vaccine IP rights as COVID cases surge in Europe,Seeking Alpha,https://seekingalpha.com/news/3770440-pfizer-defends-vaccine-ip-rights-as-covid-cases-surge-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.746010422706604
3694,11/15/2021 6:26:46 PM,7 Stocks to Buy That Will Make You Rich by 2030,InvestorPlace,/news/stocks/7-stocks-to-buy-that-will-make-you-rich-by-2030-1030977490,positive,0.8439055681228638
3695,11/15/2021 9:11:05 PM,Dr. Reddy's mulls production of Pfizer COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3770903-dr-reddys-mulls-production-of-pfizer-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9319334626197815
3696,11/16/2021 11:00:30 AM,7 Robinhood Stocks Worth Buying in November,InvestorPlace,/news/stocks/7-robinhood-stocks-worth-buying-in-november-1030979594,positive,0.8691051602363586
3697,11/16/2021 11:00:42 AM,Merck Is a Dividend Play Ready to Get Back in Gear,InvestorPlace,/news/stocks/mrk-stock-dividend-play-ready-get-back-in-gear-1030979591,positive,0.7099084854125977
3698,11/16/2021 11:57:49 AM,Pfizer inks license deal for COVID-19 oral antiviral treatment to expand access in low income countries,Seeking Alpha,https://seekingalpha.com/news/3771262-pfizer-inks-license-deal-for-covid-19-pill-to-expand-access-in-low-income-countries?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9432885050773621
3699,11/16/2021 1:39:09 PM,"Pfizer, MPP Ink Licensing Deal For Covid-19 Oral Treatment Candidate ",RTTNews,/news/stocks/pfizer-mpp-ink-licensing-deal-for-covid-19-oral-treatment-candidate-1030979996,negative,0.8880620002746582
3700,11/16/2021 2:04:33 PM,Pfizer moves to allow cheaper COVID-19 pills sending shares of rivals lower,Seeking Alpha,https://seekingalpha.com/news/3771400-pfizer-moves-to-allow-cheaper-covid-19-pills-sending-shares-of-rivals-lower?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9393699169158936
3701,11/16/2021 2:30:12 PM,"The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment",Benzinga,/news/stocks/the-daily-biotech-pulse-kezar-jumps-on-data-biogen-r-d-chief-to-retire-molecular-partners-wilts-on-covid-trial-disappointment-1030980303,positive,0.6811907291412354
3702,11/16/2021 5:08:46 PM,Moderna asks Health Canada to approve COVID vaccine in children,Seeking Alpha,https://seekingalpha.com/news/3771534-moderna-asks-health-canada-to-approve-covid-vaccine-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7454935312271118
3703,11/16/2021 7:00:50 PM,U.S. to buy 10 million courses of Pfizer COVID-19 pill - WaPo,Seeking Alpha,https://seekingalpha.com/news/3771584-us-to-buy-10-million-courses-of-pfizer-covid-19-pill-wapo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6997290253639221
3704,11/16/2021 7:15:22 PM,Pfizer seeks FDA authorization for COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3771589-pfizer-seeks-fda-authorization-for-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.856785237789154
3705,11/16/2021 9:18:50 PM,Pfizer Seeks Emergency Use Authorization From FDA For Investigational Covid-19 Treatment Pill ,RTTNews,/news/stocks/pfizer-seeks-emergency-use-authorization-from-fda-for-investigational-covid-19-treatment-pill-1030981869,negative,0.881087064743042
3706,11/17/2021 8:06:35 AM,"Imugene inks clinical trial pact with Merck KGaA, Pfizer for HER-Vaxx in gastric cancer",Seeking Alpha,https://seekingalpha.com/news/3771730-imugene-inks-clinical-trial-pact-with-merck-kgaa-pfizer-for-her-vaxx-in-gastric-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9144903421401978
3707,11/17/2021 11:00:56 AM,Ocugen Proves Groupthink Is a Double-Edged Sword,InvestorPlace,/news/stocks/ocgn-stock-proves-groupthink-double-edged-sword-1030983630,positive,0.7988166213035583
3708,11/17/2021 11:54:03 AM,Pfizer CFO Frank D’Amelio stepping down,Seeking Alpha,https://seekingalpha.com/news/3771773-pfizer-announces-frank-damelio-to-retire-as-cfo-and-executive-vice-president-of-global-supply?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4911736845970154
3709,11/17/2021 1:08:18 PM,Biohaven Reports Approval Of NURTEC ODT In Kuwait For Acute Treatment Of Migraine ,RTTNews,/news/stocks/biohaven-reports-approval-of-nurtec-odt-in-kuwait-for-acute-treatment-of-migraine-1030983845,negative,0.8736941814422607
3710,11/17/2021 1:53:04 PM,"The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment",Benzinga,/news/stocks/the-daily-biotech-pulse-atea-sinks-on-termination-of-roche-contract-pfizer-cfo-to-retire-gsk-vir-bag-1b-contract-to-supply-covid-antibody-treatment-1030984023,positive,0.5760539174079895
3711,11/17/2021 2:16:02 PM,COVID-19 pill Paxlovid could add $15B-$22B to Pfizer 2022 revenue - Barclays,Seeking Alpha,https://seekingalpha.com/news/3771910-covid-19-pill-paxlovid-could-add-15b-22b-to-pfizer-2022-revenue-barclays?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7626579403877258
3712,11/17/2021 3:20:48 PM,Pfizer acquisition of Trillium Therapeutics completed,Seeking Alpha,https://seekingalpha.com/news/3771939-ema-begins-review-of-novavaxs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9437490701675415
3713,11/17/2021 9:31:11 PM,Why did Pfizer close at an all-time high today?,Seeking Alpha,https://seekingalpha.com/news/3772140-why-did-pfizer-close-at-an-all-time-high-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7813966274261475
3714,11/18/2021 11:00:10 AM,Novavax Stock Looks To Be In Recovery Mode,InvestorPlace,/news/stocks/nvax-stock-looks-to-be-in-recovery-mode-1030987383,negative,0.47361519932746887
3715,11/18/2021 12:01:15 PM,U.S. to acquire 10M doses of Pfizer's COVID-19 pill Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3772318-us-to-acquire-10m-doses-of-pfizers-covid-19-pill-paxlovid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6070062518119812
3716,11/18/2021 1:09:04 PM,U.S. Government To Acquire 10 Mln Treatment Courses Of COVID-19 Antiviral Candidate From Pfizer ,RTTNews,/news/stocks/u-s-government-to-acquire-10-mln-treatment-courses-of-covid-19-antiviral-candidate-from-pfizer-1030987615,negative,0.7731589674949646
3717,11/18/2021 1:24:23 PM,Pfizer Invests $15 Mln In Cardiff Oncology ,RTTNews,/news/stocks/pfizer-invests-15-mln-in-cardiff-oncology-1030987674,positive,0.8310185670852661
3718,11/18/2021 7:16:38 PM,Pfizer announces XELJANZ granted European approval for new indication,Seeking Alpha,https://seekingalpha.com/news/3772551-pfizer-announces-xeljanz-granted-european-approval-for-new-indication?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7896565198898315
3719,11/19/2021 10:18:30 AM,Canada to authorize Pfizer's COVID-19 vaccine for children - Reuters,Seeking Alpha,https://seekingalpha.com/news/3772741-canada-to-authorize-pfizers-covid-19-vaccine-for-children-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8434594869613647
3720,11/19/2021 1:05:21 PM,Pfizer to apply for EU authorization of COVID-19 pill - Reuters,Seeking Alpha,https://seekingalpha.com/news/3772809-pfizer-to-apply-for-eu-authorization-of-covid-19-pill-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7844711542129517
3721,11/19/2021 1:36:58 PM,"FDA approves Moderna, Pfizer COVID-19 booster doses for all adults",Seeking Alpha,https://seekingalpha.com/news/3772823-fda-approves-moderna-pfizer-covid-19-booster-doses-for-all-adults?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5679478049278259
3722,11/19/2021 2:20:15 PM,"The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial",Benzinga,/news/stocks/the-daily-biotech-pulse-connect-biopharma-sinks-on-eczema-drug-readout-enanta-pulls-plug-on-hbv-drug-clinical-setback-for-merck-in-hiv-trial-1030991438,neutral,0.4585235118865967
3723,11/19/2021 2:57:52 PM,Health Canada authorizes Pfizer/BioNTech's COVID-19 vaccine in children aged 5 to 11 years,Seeking Alpha,https://seekingalpha.com/news/3772888-health-canada-authorizes-pfizerbiontechs-covid-19-vaccine-in-children-aged-5-to-11-years?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8932188749313354
3724,11/19/2021 2:59:48 PM,"FDA Grants Expanded EUA To Pfizer, BioNTech COVID-19 Vaccine Booster To Include 18 Yrs And Older ",RTTNews,/news/stocks/fda-grants-expanded-eua-to-pfizer-biontech-covid-19-vaccine-booster-to-include-18-yrs-and-older-1030991549,negative,0.9025299549102783
3725,11/19/2021 4:08:55 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-19-2021-1030991825,neutral,0.6235842108726501
3726,11/19/2021 5:11:27 PM,10 Best Blue-Chip Stocks to Buy for Growth and Dividends in 2022,InvestorPlace,/news/stocks/10-best-blue-chip-stocks-to-buy-for-growth-and-dividends-in-2022-1030933991,positive,0.6724162101745605
3727,11/19/2021 5:29:11 PM,7 Stocks to Buy as America Lifts Its Travel Ban,InvestorPlace,/news/stocks/7-stocks-to-buy-as-america-lifts-travel-ban-1030992262,negative,0.7353795170783997
3728,11/19/2021 8:15:41 PM,EMA begins review of Pfizer COVID antiviral pill Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3773025-ema-begins-review-of-pfizer-covid-antiviral-pill-paxlovid?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8426992893218994
3729,11/20/2021 9:00:00 PM,Pfizer hit a 52-week high on Friday. What might boost shares even higher?,Seeking Alpha,https://seekingalpha.com/news/3773031-pfizer-hit-a-52-week-high-on-friday-what-might-boost-shares-even-higher?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6930562853813171
3730,11/21/2021 9:06:50 PM,"The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week",Benzinga,/news/stocks/the-week-ahead-in-biotech-nov-21-nov-27-takeda-aadi-fennec-fda-decisions-earnings-in-the-spotlight-in-holiday-shortened-week-1030993278,positive,0.46301257610321045
3731,11/22/2021 11:00:16 AM,7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation,InvestorPlace,/news/stocks/7-stocks-to-buy-for-their-resistance-to-the-6-2-monthly-inflation-1030994239,negative,0.45518118143081665
3732,11/22/2021 11:00:35 AM,Covid Stand-out Pfizer’s Albert Bourla Gets My Vote for CEO of the Year,InvestorPlace,/news/stocks/covid-stand-out-pfizers-albert-bourla-gets-my-vote-for-ceo-of-the-year-1030994237,positive,0.6566935777664185
3733,11/22/2021 11:09:31 AM,7 High-Yield Stock Gems for Income-Obsessed Investors,InvestorPlace,/news/stocks/seven-high-yield-stock-gems-for-income-obsessed-investors-1030901222,positive,0.9080877900123596
3734,11/22/2021 12:06:26 PM,Pfizer-BioNTech's COVID-19 vaccine shows 100% efficacy in long-term analysis in adolescents,Seeking Alpha,https://seekingalpha.com/news/3773167-pfizer-biontechs-covid-19-vaccine-shows-100-efficacy-in-long-term-analysis-in-adolescents?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9222169518470764
3735,11/22/2021 1:10:57 PM,Pfizer Vaccine Shows 100% Efficacy Against COVID-19 In Longer-term Analysis In Adolescents ,RTTNews,/news/stocks/pfizer-vaccine-shows-100-efficacy-against-covid-19-in-longer-term-analysis-in-adolescents-1030994433,negative,0.9414632320404053
3736,11/22/2021 4:57:05 PM,3 Falling-Star Stocks to Buy Into the Holidays,InvestorPlace,/news/stocks/3-falling-star-stocks-to-buy-into-the-holidays-1030995663,positive,0.7574781179428101
3737,11/22/2021 9:00:10 PM,Why did Novavax stock rise today?,Seeking Alpha,https://seekingalpha.com/news/3773518-why-did-novavax-stock-rise-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.822287917137146
3738,11/22/2021 10:21:31 PM,Pfizer wins $1.4B US Army contract for additional 200M COVID-19 vaccine for donation,Seeking Alpha,https://seekingalpha.com/news/3773589-pfizer-wins-14b-us-army-contract-for-additional-200m-covid-19-vaccine-for-donation?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9386577606201172
3739,11/22/2021 10:25:28 PM,DoD awards Pfizer $1.4B contract modification for 200M COVID vaccine doses for donation,Seeking Alpha,https://seekingalpha.com/news/3773592-dod-awards-pfizer-14b-contract-modification-for-200m-covid-vaccine-doses-for-donation?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9321916699409485
3740,11/23/2021 10:49:30 AM,Switzerland approves Pfizer-BioNTech's COVID booster shots from 16 years of age - Reuters,Seeking Alpha,https://seekingalpha.com/news/3773638-switzerland-approves-pfizer-biontechs-covid-booster-shots-from-16-years-of-age-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7051936388015747
3741,11/23/2021 11:33:00 AM,"Amid COVID-19 surge, Israel starts inoculating young children - Reuters",Seeking Alpha,https://seekingalpha.com/news/3773651-amid-covid-19-surge-israel-starts-inoculating-young-children-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8228910565376282
3742,11/23/2021 8:16:33 PM,Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst,Benzinga,/news/stocks/pfizer-s-covid-19-franchise-could-push-revenue-past-100b-in-2022-analyst-1030999039,negative,0.9382447600364685
3743,11/24/2021 11:18:46 AM,EU health agency considers COVID-19 vaccine booster shots for all adults - Reuters,Seeking Alpha,https://seekingalpha.com/news/3774171-eu-health-agency-considers-covid-19-vaccine-booster-shots-for-all-adults-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8619682788848877
3744,11/24/2021 12:20:53 PM,Ionis says that Pfizer reports topline results from Phase 2b vupanorsen study,Seeking Alpha,https://seekingalpha.com/news/3774196-ionis-says-that-pfizer-reports-topline-results-from-phase-2b-vupanorsen-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6355519890785217
3745,11/24/2021 12:56:42 PM,Ionis Says Pfizer Reports Positive Results From Phase 2b Study Of Vupanorsen On CV Risk Reduction ,RTTNews,/news/stocks/ionis-says-pfizer-reports-positive-results-from-phase-2b-study-of-vupanorsen-on-cv-risk-reduction-1031000576,negative,0.9522108435630798
3746,11/25/2021 2:26:39 PM,EMA Recommends Approval For Pfizer's COVID-19 Vaccine Comirnaty For Kids Aged 5 To 11 ,RTTNews,/news/stocks/ema-recommends-approval-for-pfizer-s-covid-19-vaccine-comirnaty-for-kids-aged-5-to-11-1031003629,negative,0.5072105526924133
3747,11/26/2021 6:55:12 AM,"Pfizer, Merck to grant licenses for production of COVID-19 pills to Vietnam - Reuters",Seeking Alpha,https://seekingalpha.com/news/3774460-pfizer-merck-to-grant-licenses-for-production-of-covid-19-pills-to-vietnam-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7437540292739868
3748,11/26/2021 7:30:01 AM,New COVID-19 variant detected in South Africa prompts renewed travel restrictions,Seeking Alpha,https://seekingalpha.com/news/3774462-new-covid-19-variant-detected-in-south-africa-prompts-renewed-travel-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9275062084197998
3749,11/26/2021 9:30:45 AM,EMA gives green light to Pfizer-BioNTech’s COVID vaccine for kids aged 5-11,Seeking Alpha,https://seekingalpha.com/news/3774502-ema-gives-green-light-to-pfizer-biontechs-covid-vaccine-for-kids-aged-5-11?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7921953201293945
3750,11/26/2021 11:58:04 AM,COVID-19 vaccine stocks surge on worries over new variant,Seeking Alpha,https://seekingalpha.com/news/3774537-covid-19-vaccine-stocksbiotechs-surge-on-worries-over-new-covid-19-variant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8936194777488708
3751,11/26/2021 1:19:10 PM,BioNTech expects more data on new COVID-19 variant in two weeks,Seeking Alpha,https://seekingalpha.com/news/3774563-biontech-expects-more-data-on-new-covid-19-variant-in-two-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7766955494880676
3752,11/26/2021 2:19:14 PM,U.S. must study data before deciding on travel ban over new COVID-19 variant: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774591-us-must-study-data-before-deciding-on-travel-ban-over-new-covid-19-variant-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.908190906047821
3753,11/26/2021 2:26:32 PM,Most J&J COVID vaccine recipients switch to another shot for booster - WSJ,Seeking Alpha,https://seekingalpha.com/news/3774595-most-johnson-johnson-covid-vaccine-recipients-switch-to-another-shot-for-booster-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9234042763710022
3754,11/26/2021 4:02:11 PM,OCGN Stock Alert: The FDA News Sending Ocugen Plummeting Today,InvestorPlace,/news/stocks/ocgn-stock-alert-the-fda-news-sending-ocugen-plummeting-today-1031006113,neutral,0.8804523348808289
3755,11/26/2021 4:12:59 PM,COVID vaccines' effectiveness against Nu variant may not be known for two weeks,Seeking Alpha,https://seekingalpha.com/news/3774637-covid-vaccines-effectiveness-against-nu-variant-may-not-be-known-for-two-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9187087416648865
3756,11/26/2021 4:13:26 PM,Mid-Morning Market Update: Markets Open Lower; Europe's Regulator Backs Pfizer's COVID-19 Vaccine For Kids Aged 5-11 Years,Benzinga,/news/stocks/mid-morning-market-update-markets-open-lower-europe-s-regulator-backs-pfizer-s-covid-19-vaccine-for-kids-aged-5-11-years-1031005892,neutral,0.9690607190132141
3757,11/26/2021 5:47:19 PM,Mid-Day Market Update: Dow Tumbles Over 900 Points; Crude Oil Down 12%,Benzinga,/news/stocks/mid-day-market-update-dow-tumbles-over-900-points-crude-oil-down-12-1031006179,neutral,0.9649702310562134
3758,11/27/2021 5:38:47 PM,"Novavax, Inovio starting on COVID vaccines targeting Omicron variant - Reuters",Seeking Alpha,https://seekingalpha.com/news/3774699-novavax-inovio-starting-on-covid-vaccines-targeting-omicron-variant-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9020994901657104
3759,11/28/2021 12:10:44 AM,New COVID-19 variant found in U.K. and Germany; Israel shuts borders for foreigners,Seeking Alpha,https://seekingalpha.com/news/3774702-new-covid-19-variant-found-in-uk-and-germany-israel-shuts-borders-for-foreigners?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6722967624664307
3760,11/28/2021 2:09:26 AM,Doctor who helped detect new COVID-19 variant calls its symptoms unusual but mild - The Telegraph,Seeking Alpha,https://seekingalpha.com/news/3774704-doctor-who-helped-detect-new-covid-19-variant-calls-its-symptoms-unusual-but-mild-the-telegraph?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7911033630371094
3761,11/28/2021 1:16:20 PM,Moderna says new vaccine for Omicron could be ready for early next year,Seeking Alpha,https://seekingalpha.com/news/3774708-moderna-says-new-vaccine-for-omicron-could-be-ready-for-early-next-year?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6501122117042542
3762,11/29/2021 7:34:54 AM,"Japan, Morocco ban foreign travelers as Omicron spreads; new cases reported in Netherlands, Canada, Australia",Seeking Alpha,https://seekingalpha.com/news/3774719-japan-morocco-bans-foreign-travelers-as-omicron-spreads-new-cases-reported-in-netherlands-canada-australia?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8972809910774231
3763,11/29/2021 8:45:39 AM,U.S. readies fight against Omicron variant but too soon for lockdowns: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774720-us-readies-fight-against-omicron-variant-but-too-soon-for-lockdowns-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8291778564453125
3764,11/29/2021 10:55:35 AM,"Moderna, Inovio Pharma surge on vaccine development plans targeting Omicron variant",Seeking Alpha,https://seekingalpha.com/news/3774752-moderna-inovio-pharma-surge-on-vaccine-development-plans-targeting-omicron-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5847963094711304
3765,11/29/2021 11:16:31 AM,What will Omicron mean for antiviral therapeutics and antibody treatments?,Seeking Alpha,https://seekingalpha.com/news/3774759-what-will-omicron-mean-for-antiviral-therapeutics-and-antibody-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9379588961601257
3766,11/29/2021 1:19:45 PM,Pfizer CEO raises production target for COVID-19 pill; comments on Omicron variant,Seeking Alpha,https://seekingalpha.com/news/3774821-pfizer-ceo-raises-production-target-for-covid-19-pill-comments-on-omicron-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6085121631622314
3767,11/29/2021 2:27:35 PM,Moderna can take months to ship Omicron targeting vaccine: CEO Stéphane Bancel,Seeking Alpha,https://seekingalpha.com/news/3774891-moderna-can-take-months-to-ship-omicron-trageting-vaccine-ceo-stphane-bancel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9194353222846985
3768,11/29/2021 2:35:56 PM,"Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed ",RTTNews,/news/stocks/vaccine-makers-investigate-new-covid-variant-to-adapt-shots-if-needed-1031008838,positive,0.7871178984642029
3769,11/29/2021 3:58:24 PM,NVAX Stock Is on Watch as Novavax Joins the Omicron Variant Battle,InvestorPlace,/news/stocks/nvax-stock-is-on-watch-as-novavax-joins-the-omicron-variant-battle-1031009404,positive,0.9250063896179199
3770,11/29/2021 4:44:03 PM,J&J researching Omicron-specific COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3774973-johnson-johnson-researching-omicron-specific-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8317428231239319
3771,11/29/2021 5:16:05 PM,What 5 Analyst Ratings Have To Say About Pfizer,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-pfizer-1031009471,positive,0.9349233508110046
3772,11/29/2021 6:19:36 PM,5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market,InvestorPlace,/news/stocks/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market-1031009824,positive,0.7251970767974854
3773,11/29/2021 6:46:31 PM,Carnival Will Survive the Latest Covid-19 Variant Omicron,InvestorPlace,/news/stocks/ccl-stock-is-worth-34-percent-more-at-24-and-carnival-corp-will-survive-1031009836,negative,0.5221318602561951
3774,11/29/2021 6:48:57 PM,"While Merck's COVID pill molnupiravir is poised for authorization, efficacy could hamper use",Seeking Alpha,https://seekingalpha.com/news/3775015-as-fda-is-set-to-review-merck-covid-pill-molnupiravir-efficacy-could-hamper-use?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9474866390228271
3775,11/29/2021 6:58:45 PM,3 Pharma Stocks Morgan Stanley Says Will Be Omicron Variant Beneficiaries,Benzinga,/news/stocks/3-pharma-stocks-morgan-stanley-says-will-be-omicron-variant-beneficiaries-1031009763,positive,0.9128556847572327
3776,11/29/2021 7:10:31 PM,3 Top Stock Trades for the Week,InvestorPlace,/news/stocks/3-top-stock-trades-for-the-week-1029510280,positive,0.8792451620101929
3777,11/29/2021 7:15:07 PM,Biden to direct regulators to use ‘fastest process available” to clear vaccines against Omicron,Seeking Alpha,https://seekingalpha.com/news/3775031-biden-to-direct-regulators-to-use-fastest-process-available-to-clear-vaccines-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5281215906143188
3778,11/29/2021 9:57:43 PM,ADGI Stock Soars as Analysts Lock On to Its Omicron-Fighting Potential,InvestorPlace,/news/stocks/adgi-stock-soars-as-analysts-lock-on-to-its-omicron-fighting-potential-1031010138,neutral,0.6825145483016968
3779,11/29/2021 9:59:23 PM,Exact Sciences ends co-promotion deal with Pfizer for Cologuard,Seeking Alpha,https://seekingalpha.com/news/3775121-exact-sciences-ends-co-promotion-deal-with-pfizer-for-cologuard?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6696533560752869
3780,11/29/2021 10:49:15 PM,The News of Omicron is Dominating the Market: What to Do Now,InvestorPlace,/news/stocks/the-news-of-omicron-is-dominating-the-market-what-to-do-now-1031014480,positive,0.8913348317146301
3781,11/30/2021 3:06:35 AM,CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns ,RTTNews,/news/stocks/cdc-strengthens-booster-recommendation-for-all-adults-due-to-omicron-variant-concerns-1031010292,negative,0.6120551228523254
3782,11/30/2021 8:47:49 AM,England to impose mask mandates to curb spread of Omicron - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775168-england-to-impose-mask-mandates-to-curb-spread-omicron-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7565428018569946
3783,11/30/2021 10:55:45 AM,EU expects to approve shot against Omicron in 3-4 months,Seeking Alpha,https://seekingalpha.com/news/3775204-eu-expects-to-approve-shot-against-omicron-in-3-4-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5946268439292908
3784,11/30/2021 11:00:52 AM,Ocugen Stock Very Well May Have Bottomed Out Here,InvestorPlace,/news/stocks/ocgn-stock-very-well-may-have-bottomed-out-here-1031011319,neutral,0.9462723731994629
3785,11/30/2021 11:30:54 AM,Ocugen Looks Risky as Markets Tire Of Speculative Vaccine Plays,InvestorPlace,/news/stocks/ocugen-looks-risky-as-markets-tire-of-speculative-vaccine-plays-1031011372,neutral,0.6041421294212341
3786,11/30/2021 1:02:43 PM,"Pfizer, BioNTech To Seek FDA Approval For Booster Shots For 16 And 17-year Olds- Reports ",RTTNews,/news/stocks/pfizer-biontech-to-seek-fda-approval-for-booster-shots-for-16-and-17-year-olds-reports-1031011517,positive,0.6222408413887024
3787,11/30/2021 2:12:23 PM,"The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-cumberland-jumps-on-fda-nod-regeneron-says-antibody-treatment-may-be-less-effective-against-omicron-immunogen-readout-1031011982,neutral,0.6165550947189331
3788,11/30/2021 7:23:17 PM,Pfizer on track to post best monthly gain in nearly three decades,Seeking Alpha,https://seekingalpha.com/news/3775524-pfizer-on-track-to-post-best-monthly-gain-in-nearly-three-decades?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9308047890663147
3789,11/30/2021 10:13:22 PM,FDA advisors recommend authorization of Merck COVID antiviral pill molnupiravir,Seeking Alpha,https://seekingalpha.com/news/3775610-fda-advisors-recommend-authorization-of-merck-covid-antiviral-pill-molnupiravir?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6448588967323303
3790,11/30/2021 10:36:57 PM,Pfizer asks FDA to authorize COVID-19 booster shots in 16 and 17 year olds,Seeking Alpha,https://seekingalpha.com/news/3775622-pfizer-asks-fda-to-authorize-covid-19-booster-shots-in-16-and-17-year-olds?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6273269057273865
3791,11/30/2021 10:49:08 PM,Have the Markets Overreacted to Omicron?,InvestorPlace,/news/stocks/have-the-markets-overreacted-to-omicron-1031017944,neutral,0.8583032488822937
3792,12/1/2021 8:15:42 AM,South African disease expert says Omicron variant could outweigh Delta - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775645-south-african-disease-expert-says-omicron-variant-could-outweigh-delta-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5830768942832947
3793,12/1/2021 10:51:02 AM,EU-wide roll out of Pfizer-BioNTech's COVID-19 vaccine for kids to commence on Dec. 13,Seeking Alpha,https://seekingalpha.com/news/3775676-eu-wide-roll-out-of-pfizer-biontechs-covid-19-vaccine-for-kids-to-commence-on-dec-13?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7321032881736755
3794,12/1/2021 11:55:00 AM,Greece imposes €100 monthly fines on unvaccinated residents over 60,Seeking Alpha,https://seekingalpha.com/news/3775698-greece-imposes-100-monthly-fines-on-unvaccinated-residents-over-60?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9263709187507629
3795,12/1/2021 2:29:42 PM,Merck draws mixed views on Street despite backing from FDA panel for COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3775810-merck-draws-mixed-views-on-street-despite-backing-from-fda-panel-for-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9037826657295227
3796,12/1/2021 7:48:03 PM,VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down,InvestorPlace,/news/stocks/vxrt-stock-other-vaccine-stocks-are-gaining-but-jim-cramer-just-sent-vaxart-down-1031017418,negative,0.8836966753005981
3797,12/1/2021 9:12:13 PM,Pfizer begins filing for COVID antiviral Paxlovid in Canada,Seeking Alpha,https://seekingalpha.com/news/3776166-pfizer-begins-filing-for-covid-antiviral-paxlovid-in-canada?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7361941337585449
3798,12/1/2021 9:42:34 PM,"Cruise Stocks Alert: Why CCL, RCL, NCLH Stocks Are Getting Wrecked Today",InvestorPlace,/news/stocks/cruise-stocks-alert-why-ccl-rcl-nclh-stocks-are-getting-wrecked-today-1031017677,neutral,0.8986095190048218
3799,12/2/2021 11:00:34 AM,COVID-19 Simplifies Things for Moderna Investors,InvestorPlace,/news/stocks/covid-19-simplifies-things-for-investors-in-mrna-stock-1031019219,positive,0.911518394947052
3800,12/2/2021 1:51:33 PM,"The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-pfizer-biontech-ink-new-vaccine-deals-with-uk-gsk-vir-antibody-show-activity-against-omicron-chemomab-gets-clearance-1031019589,negative,0.7836387157440186
3801,12/2/2021 9:00:37 PM,More Omicron cases found in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3776657-more-omicron-cases-found-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7973804473876953
3802,12/2/2021 11:03:41 PM,Vaccine firms Vaccitech and Vaxxinity sink to post-IPO lows as Omicron rally fizzles (update),Seeking Alpha,https://seekingalpha.com/news/3776746-vaccitech-and-vaxxinity-stock-prices-post-ipo-low-as-omicron-rally-fades?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9094254970550537
3803,12/3/2021 12:43:31 PM,FDA to speed up review of Omicron-specific vaccines and drugs - WSJ,Seeking Alpha,https://seekingalpha.com/news/3776832-fda-to-speed-up-review-of-omicron-specific-vaccines-and-drugs-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8479737043380737
3804,12/3/2021 2:11:59 PM,"This Cannabis REIT Stock Outperformed Nvidia, Amazon, Square And Pfizer",Benzinga,/news/stocks/this-cannabis-reit-stock-outperformed-nvidia-amazon-square-and-pfizer-1031022891,negative,0.8809852004051208
3805,12/3/2021 4:15:06 PM,WHO says no evidence yet Omicron requires adjustments to existing COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3776979-who-says-no-evidence-yet-omicron-requires-adjustments-to-existing-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8745612502098083
3806,12/3/2021 4:58:48 PM,7 A-Rated Biotechs to Buy for the Long Run,InvestorPlace,/news/stocks/7-a-rated-biotechs-to-buy-for-the-long-run-1031023568,positive,0.6930161118507385
3807,12/3/2021 5:29:04 PM,3 Stocks to Buy That Are Blissfully Ignoring the Mayhem,InvestorPlace,/news/stocks/3-stocks-to-buy-that-are-blissfully-ignoring-the-mayhem-1031023677,positive,0.7565004229545593
3808,12/3/2021 7:32:12 PM,"Pfizer, Merck in pact with Canada to deliver up to 1.5 million courses of COVID-19 pills",Seeking Alpha,https://seekingalpha.com/news/3777053-pfizer-merck-in-pact-with-canada-to-deliver-up-to-15-million-courses-of-covid-19-pills?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8101046681404114
3809,12/3/2021 9:43:36 PM,AbbVie updates U.S. labeling info for RINVOQ in rheumatoid arthritis,Seeking Alpha,https://seekingalpha.com/news/3777094-abbvie-updates-us-labeling-info-for-rinvoq-in-rheumatoid-arthritis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9334484338760376
3810,12/3/2021 10:03:01 PM,Millions Will Be Blindsided in 2022… Here’s Why You Won’t Be One of Them,InvestorPlace,/news/stocks/millions-will-be-blindsided-in-2022-heres-why-you-wont-be-one-of-them-1031024076,positive,0.859653651714325
3811,12/6/2021 8:40:58 AM,Omicron variant cases 'likely to rise' in U.S. states: CDC Director,Seeking Alpha,https://seekingalpha.com/news/3777150-omicron-variant-cases-likely-to-rise-in-us-states-cdc-director?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7036107778549194
3812,12/6/2021 9:47:46 AM,Australia approves Pfizer's COVID-19 vaccine for children aged 5-11 years,Seeking Alpha,https://seekingalpha.com/news/3777167-australia-approves-pfizers-covid-19-vaccine-for-children-aged-5-11-years?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6236209869384766
3813,12/6/2021 10:59:57 AM,U.S. prepares to fast-track authorization of Omicron COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3777176-us-prepares-to-fast-track-authorization-of-omicron-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8243824243545532
3814,12/6/2021 12:07:24 PM,"The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-dec-6-dec-11-daré-fda-decision-adcom-tryst-for-reata-multiple-conference-presentations-and-more-1031025543,positive,0.9361634850502014
3815,12/6/2021 2:00:47 PM,"Jim Cramer Shares His Thoughts On Novavax, ViacomCBS And More",Benzinga,/news/stocks/jim-cramer-shares-his-thoughts-on-novavax-viacomcbs-and-more-1031025887,positive,0.9360494017601013
3816,12/6/2021 4:51:13 PM,New study shows Viagra can lower risk of Alzheimer’s disease,Seeking Alpha,https://seekingalpha.com/news/3777432-new-study-shows-viagra-can-lower-risk-of-alzheimers-disease?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8904270529747009
3817,12/6/2021 8:59:18 PM,Why did Moderna stock drop today?,Seeking Alpha,https://seekingalpha.com/news/3777528-why-did-moderna-stock-drop-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8496978282928467
3818,12/6/2021 10:00:50 PM,2 Big Stock Bets That Are Insiders Are Buying Now,InvestorPlace,/news/stocks/2-big-stock-bets-that-are-insiders-are-buying-now-1031027396,positive,0.9235526919364929
3819,12/6/2021 10:05:00 PM,"Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today",InvestorPlace,/news/stocks/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today-1031027411,neutral,0.5886496305465698
3820,12/7/2021 12:26:10 AM,Mink Therapeutics sinks nearly 35% to post-IPO low as biotech sheds 66% in six sessions,Seeking Alpha,https://seekingalpha.com/news/3777585-mink-therapeutics-stock-price-sinks?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9593902230262756
3821,12/7/2021 7:50:58 AM,"U.K. study finds mixing Pfizer, AstraZeneca's COVID-19 shots with Moderna gives better immune response - Reuters",Seeking Alpha,https://seekingalpha.com/news/3777603-uk-study-finds-mixing-pfizer-astrazenecas-covid-19-shots-with-moderna-gives-better-immune-response-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6134259104728699
3822,12/7/2021 8:37:17 AM,New York City to impose vaccine mandate for all private employees,Seeking Alpha,https://seekingalpha.com/news/3777604-new-york-city-to-impose-vaccine-mandate-for-all-private-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.872247040271759
3823,12/7/2021 1:57:55 PM,5 Stocks Insiders Are Selling,Benzinga,/news/stocks/5-stocks-insiders-are-selling-1031028899,positive,0.8907203078269958
3824,12/7/2021 2:29:46 PM,Pfizer CEO warns highly transmissible Omicron could drive more mutations,Seeking Alpha,https://seekingalpha.com/news/3777777-pfizer-ceo-comments-on-early-reports-indicating-milder-covid-19-from-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.92000412940979
3825,12/7/2021 5:04:20 PM,Fauci says Omicron is “almost certainly” not more severe than Delta variant,Seeking Alpha,https://seekingalpha.com/news/3777863-fauci-says-omicron-is-almost-certainly-not-more-severe-than-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6531355381011963
3826,12/7/2021 6:51:58 PM,7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts,InvestorPlace,/news/stocks/7-best-drug-stocks-buy-2022-without-covid-catalysts-1031030186,positive,0.8384881019592285
3827,12/7/2021 9:02:09 PM,Pfizer/ BioNTech COVID-19 vaccine gives partial protection against Omicron - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3777953-pfizer-biontech-covid-19-vaccine-gives-partial-protection-against-omicron-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5657138824462891
3828,12/7/2021 10:45:49 PM,Com-Cov2 Study Reveals Mixing Of Different Vaccines Develop Better Immunity To Covid ,RTTNews,/news/stocks/com-cov2-study-reveals-mixing-of-different-vaccines-develop-better-immunity-to-covid-1031030545,negative,0.8150447010993958
3829,12/8/2021 12:01:40 PM,"Pfizer, BioNTech say three vaccine doses neutralize Omicron in early lab tests",Seeking Alpha,https://seekingalpha.com/news/3778159-pfizer-biontech-lower-after-early-data-on-omicrons-impact-on-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8044571280479431
3830,12/8/2021 1:20:28 PM,Pfizer: Preliminary Data Shows Protection Against Omicron Improved With Third Dose Of Vaccine ,RTTNews,/news/stocks/pfizer-preliminary-data-shows-protection-against-omicron-improved-with-third-dose-of-vaccine-1031031903,negative,0.9551987648010254
3831,12/8/2021 3:09:38 PM,New data adds to overall survival benefit of Novartis' Kisqali for breast cancer,Seeking Alpha,https://seekingalpha.com/news/3778294-new-data-adds-to-overall-survival-benefit-of-novartis-kisqali-for-breast-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9496226906776428
3832,12/8/2021 3:20:47 PM,"Pfizer to submit full data on COVID pill Paxlovid shortly, CEO Bourla says - CNBC",Seeking Alpha,https://seekingalpha.com/news/3778301-pfizer-to-submit-full-data-on-covid-pill-paxlovid-shortly-ceo-bourla-says-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9279035329818726
3833,12/8/2021 4:09:02 PM,Carnival Stock Has Potential But the Storm Is Still Raging,InvestorPlace,/news/stocks/ccl-stock-carnival-has-potential-but-storm-is-still-raging-1031032985,neutral,0.790023684501648
3834,12/8/2021 8:14:45 PM,U.S. COVID-19 cases rise amid vaccine milestone,Seeking Alpha,https://seekingalpha.com/news/3778424-us-covid-19-cases-rise-despite-vaccine-milestone?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7187535762786865
3835,12/8/2021 8:46:40 PM,Why did BioNTech stock go down today?,Seeking Alpha,https://seekingalpha.com/news/3778431-why-did-biontech-stock-go-down-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8666447401046753
3836,12/9/2021 3:15:10 AM,Pfizer CEO Expects 4th Covid Dose Might Be Required Earlier Than Expected Due To Omicron ,RTTNews,/news/stocks/pfizer-ceo-expects-4th-covid-dose-might-be-required-earlier-than-expected-due-to-omicron-1031033912,neutral,0.8238037824630737
3837,12/9/2021 1:16:55 PM,India's Biocon said in talks to merge its biologics unit with Mylan's biosimilar business,Seeking Alpha,https://seekingalpha.com/news/3778655-indias-biocon-said-in-talks-to-merge-its-biologics-unit-with-mylans-biosimilar-business?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8694543838500977
3838,12/9/2021 4:27:21 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-9-2021-1031036161,neutral,0.5978407859802246
3839,12/9/2021 4:47:49 PM,Pfizer/BioNTech COVID-19 booster authorization lowered to 16 years by FDA,Seeking Alpha,https://seekingalpha.com/news/3778800-pfizerbiontech-covid-19-booster-authorization-lowered-to-16-years-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7779983282089233
3840,12/9/2021 4:52:35 PM,Midday Market Update: Why Are Stocks Down Today?,InvestorPlace,/news/stocks/midday-market-update-why-are-stocks-down-today-dec-9-1031036507,neutral,0.9401865005493164
3841,12/9/2021 8:20:24 PM,The Bullish Case for Novavax Stock Is Based on Opinion Not Fact,InvestorPlace,/news/stocks/nvax-stock-bullish-case-based-on-opinion-not-fact-1031036952,positive,0.891469419002533
3842,12/10/2021 11:00:33 AM,Why You Should Buy Moderna Stock at Every Dip,InvestorPlace,/news/stocks/why-you-should-buy-mrna-stock-at-every-dip-1031038543,positive,0.9308883547782898
3843,12/10/2021 1:23:24 PM,"Pfizer, Arvinas' ARV-471 shows encouraging clinical benefit rate in breast cancer patients",Seeking Alpha,https://seekingalpha.com/news/3779116-pfizer-arvinas-arv-471-shows-encouraging-clinical-benefit-rate-in-breast-cancer-patients?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9517936706542969
3844,12/10/2021 1:50:11 PM,"The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-sings-metabolic-disorder-drug-pact-moderna-reports-positive-flu-vaccine-data-halozyme-to-buy-back-shares-1031038565,positive,0.6495084166526794
3845,12/10/2021 2:46:02 PM,Pfizer wins European approval for Cibinqo in atopic dermatitis,Seeking Alpha,https://seekingalpha.com/news/3779174-pfizer-wins-european-approval-for-cibinqo-in-atopic-dermatitis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9420145750045776
3846,12/10/2021 3:39:36 PM,EU Approves Pfizer's Cibinqo To Treat Moderate-to-Severe Atopic Dermatitis ,RTTNews,/news/stocks/eu-approves-pfizer-s-cibinqo-to-treat-moderate-to-severe-atopic-dermatitis-1031038949,negative,0.9125415086746216
3847,12/10/2021 3:50:34 PM,"House report accuses pharma of raising prices, abusing patent system, minimizing competition",Seeking Alpha,https://seekingalpha.com/news/3779183-house-report-accuses-pharma-of-raising-prices-abusing-patent-system-to-minimize-competition?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8961856961250305
3848,12/10/2021 5:02:28 PM,Pfizer raises dividend by 2.6% to $0.40,Seeking Alpha,https://seekingalpha.com/news/3779224-pfizer-raises-dividend-by-26-to-040?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9040385484695435
3849,12/10/2021 5:02:28 PM,Pfizer raises dividend to $0.40,Seeking Alpha,https://seekingalpha.com/news/3779224-pfizer-raises-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7780778408050537
3850,12/13/2021 3:10:07 AM,PFE : Phase 1/2 Results Show Bleeding Control In Highest Dose Cohort After Hemophilia A Gene Therapy ,RTTNews,/news/stocks/pfe-phase-1-2-results-show-bleeding-control-in-highest-dose-cohort-after-hemophilia-a-gene-therapy-1031040407,negative,0.7981401085853577
3851,12/13/2021 7:39:20 AM,"Pfizer, Sangamo's gene therapy shows potential to benefit patients with hemophilia A",Seeking Alpha,https://seekingalpha.com/news/3779373-pfizer-sangamos-gene-therapy-shows-potential-to-benefit-patients-with-hemophilia-a?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9231411814689636
3852,12/13/2021 12:02:54 PM,Arena Pharma rockets 95% on acquisition by Pfizer,Seeking Alpha,https://seekingalpha.com/news/3779419-arena-pharma-rockets-95-on-acquisition-by-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7787464261054993
3853,12/13/2021 12:07:41 PM,A Peek Into The Markets: US Stock Futures Gain After S&P 500 Hits Record High,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-gain-after-s-p-500-hits-record-high-1031041247,negative,0.7860867977142334
3854,12/13/2021 12:31:03 PM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-december-13-1031041442,positive,0.497906357049942
3855,12/13/2021 1:06:22 PM,Pfizer To Acquire Arena Pharma For $100/shr; Arena Stock Jumps - Quick Facts ,RTTNews,/news/stocks/pfizer-to-acquire-arena-pharma-for-100-shr-arena-stock-jumps-quick-facts-1031041382,negative,0.5007494688034058
3856,12/13/2021 1:15:57 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1031041416,positive,0.7998325824737549
3857,12/13/2021 4:02:55 PM,Mid-Morning Market Update: Markets Open Lower; Pfizer To Acquire Arena Pharmaceuticals,Benzinga,/news/stocks/mid-morning-market-update-markets-open-lower-pfizer-to-acquire-arena-pharmaceuticals-1031041800,neutral,0.9335423707962036
3858,12/13/2021 4:06:36 PM,Vaccine names rise as additional studies show COVID shots can protect against Omicron,Seeking Alpha,https://seekingalpha.com/news/3779573-vaccine-names-rise-as-additional-studies-show-covid-shots-can-protect-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9194855093955994
3859,12/13/2021 4:48:27 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-13-2021-1031041906,neutral,0.58290696144104
3860,12/13/2021 4:53:11 PM,Why Pfizer Shares Are Trading Higher Today,Benzinga,/news/stocks/why-pfizer-shares-are-trading-higher-today-1031041905,positive,0.59305739402771
3861,12/13/2021 4:57:10 PM,ARNA Stock Alert: The Pfizer Deal That Has Arena Pharmaceuticals Rocketing Today,InvestorPlace,/news/stocks/arna-stock-alert-the-pfizer-deal-that-has-arena-pharmaceuticals-rocketing-today-1031042072,positive,0.47643476724624634
3862,12/13/2021 6:40:24 PM,"Pfizer upgraded to buy at UBS on Paxlovid potential, free cash flow, pipeline",Seeking Alpha,https://seekingalpha.com/news/3779623-pfizer-upgraded-to-buy-at-ubs-on-paxlovid-potential-free-cash-flow-pipeline?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8910124897956848
3863,12/13/2021 7:08:33 PM,Mid-Day Market Update: Nasdaq Drops Over 100 Points;  Foghorn Therapeutics Shares Surge,Benzinga,/news/stocks/mid-day-market-update-nasdaq-drops-over-100-points-foghorn-therapeutics-shares-surge-1031042189,neutral,0.9411525130271912
3864,12/13/2021 7:32:25 PM,Why does Pfizer's $6.7B acquisition of Arena Pharmaceuticals make sense? Etrasimod,Seeking Alpha,https://seekingalpha.com/news/3779629-why-does-pfizer-67b-acquisition-of-arena-pharmaceuticals-make-sense-etrasimod?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.917937159538269
3865,12/13/2021 8:36:34 PM,Mid-Afternoon Market Update: Dow Tumbles Over 200 Points; BELLUS Health Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-tumbles-over-200-points-bellus-health-shares-spike-higher-1031042273,negative,0.6639701128005981
3866,12/13/2021 8:42:41 PM,Pfizer Stock Breaks Out: What's Next For The Vaccine Maker?,Benzinga,/news/stocks/pfizer-stock-breaks-out-what-s-next-for-the-vaccine-maker-1031042274,positive,0.9338026642799377
3867,12/13/2021 9:18:56 PM,Merck cut to neutral at UBS on negative updates for two key drug candidates,Seeking Alpha,https://seekingalpha.com/news/3779666-merck-cut-to-neutral-at-ubs-on-negative-updates-for-two-key-drug-candidates?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9561809301376343
3868,12/14/2021 9:26:56 AM,"Omicron roundup: California and Philly mandates, first reported death, outbreak in China?",Seeking Alpha,https://seekingalpha.com/news/3779753-omicron-roundup-california-and-philly-mandates-first-reported-death-outbreak-in-china?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5422415733337402
3869,12/14/2021 11:48:42 AM,Pfizer's COVID-19 shot protects 70% against hospitalization from Omicron: South African study,Seeking Alpha,https://seekingalpha.com/news/3779810-pfizers-covid-19-shot-protects-70-against-hospitalization-from-omicron-south-african-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5562760829925537
3870,12/14/2021 12:04:22 PM,Pfizer updates study data COVID-19 pill; highlights effectiveness against Omicron,Seeking Alpha,https://seekingalpha.com/news/3779818-pfizer-says-study-for-covid-19-pill-did-not-meet-primary-endpoint-for-standard-risk-adults?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9275510907173157
3871,12/14/2021 12:12:29 PM,"Cathie Wood Sells $8.6M Worth Shares In Pfizer, Buys Coinbase And Robinhood On The Dip",Benzinga,/news/etf/cathie-wood-sells-8-6m-worth-shares-in-pfizer-buys-coinbase-and-robinhood-on-the-dip-1031043276,positive,0.9313561320304871
3872,12/14/2021 1:05:37 PM,Pfizer: Phase 2/3 EPIC-HR Trial Data Confirms Efficacy Of COVID-19 Oral Antiviral Treatment ,RTTNews,/news/stocks/pfizer-phase-2-3-epic-hr-trial-data-confirms-efficacy-of-covid-19-oral-antiviral-treatment-1031043394,negative,0.9154168367385864
3873,12/14/2021 5:12:26 PM,FDA commissioner nominee Califf supports Medicare negotiating prescription drug prices,Seeking Alpha,https://seekingalpha.com/news/3780023-fda-commissioner-nominee-califf-supports-medicare-negotiating-prescription-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7296817302703857
3874,12/14/2021 8:04:38 PM,WHO chief says there is a “small decline” in effectiveness of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3780074-who-chief-says-there-is-a-small-decline-in-effectiveness-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9691348075866699
3875,12/14/2021 9:45:52 PM,Pfizer's Xeljanz approved for ankylosing spondylitis,Seeking Alpha,https://seekingalpha.com/news/3780140-pfizer-xeljanz-approved-for-ankylosing-spondylitis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8596627712249756
3876,12/14/2021 11:11:08 PM,FDA Approves Pfizer's Xeljanz For Treatment Of Active Ankylosing Spondylitis ,RTTNews,/news/stocks/fda-approves-pfizer-s-xeljanz-for-treatment-of-active-ankylosing-spondylitis-1031044675,negative,0.8840996623039246
3877,12/15/2021 11:00:21 AM,7 Big Dividend Paying Stocks to Hold Forever,InvestorPlace,/news/stocks/7-big-dividend-paying-stocks-to-hold-forever-1031045699,positive,0.879707932472229
3878,12/15/2021 5:08:11 PM,"Pfizer hits new all-time high ahead of potential COVID pill OK, need for booster shots (updated)",Seeking Alpha,https://seekingalpha.com/news/3780451-pfizer-hits-new-all-time-high-ahead-of-potential-covid-pill-ok-need-for-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.637047290802002
3879,12/15/2021 5:23:44 PM,NVAX Stock Is on Watch Ahead of WHO Meeting. Here’s What to Know.,InvestorPlace,/news/stocks/nvax-stock-is-on-watch-ahead-of-who-meeting-heres-what-to-know-1031048131,positive,0.8981867432594299
3880,12/15/2021 10:22:22 PM,"4 Top Stock Trades for Thursday: PFE, ROKU, PG, RBLX",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-pfe-roku-pg-rblx-1031048757,positive,0.9315456748008728
3881,12/16/2021 3:39:02 PM,"While Novavax Stock Remains Cursed, It Might Be Time to Buy",InvestorPlace,/news/stocks/while-novavax-nvax-stock-remains-cursed-it-might-be-time-to-buy-nvax-stock-1031050936,positive,0.8341845273971558
3882,12/16/2021 4:09:17 PM,Arcturus gains after announcing early data from COVID-19 booster study,Seeking Alpha,https://seekingalpha.com/news/3780871-arcturus-gains-after-announcing-early-data-from-covid-19-booster-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7335197329521179
3883,12/16/2021 4:46:45 PM,Pfizer COVID-19 pill allowed for use in Europe before regulatory nod,Seeking Alpha,https://seekingalpha.com/news/3780883-pfizer-covid-19-pill-allowed-for-use-in-europe-before-regulatory-nod?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8709282279014587
3884,12/16/2021 7:08:28 PM,Arcturus Shares Shoot Higher After Additional Data From COVID-19 Vaccine Programs,Benzinga,/news/stocks/arcturus-shares-shoot-higher-after-additional-data-from-covid-19-vaccine-programs-1031051352,negative,0.9028701186180115
3885,12/16/2021 8:22:33 PM,Cantor raises Pfizer price target ahead of company event highlighting COVID treatments,Seeking Alpha,https://seekingalpha.com/news/3781034-cantor-raises-pfizer-price-target-ahead-of-company-event-highlighting-covid-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9030519127845764
3886,12/16/2021 9:15:45 PM,"Pfizer/BioNTech, Moderna COVID-19 shots should be preferred over J&J’s - CDC panel",Seeking Alpha,https://seekingalpha.com/news/3781068-pfizerbiontech-moderna-covid-19-shots-should-be-preferred-over-jjs-cdc-panel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8875980973243713
3887,12/16/2021 11:12:30 PM,J&J says its COVID vaccine remains crucial after CDC advisors vote in favor of mRNA shots,Seeking Alpha,https://seekingalpha.com/news/3781137-jj-says-its-covid-vaccine-remains-crucial-after-cdc-advisors-vote-in-favor-of-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8191997408866882
3888,12/17/2021 2:45:59 AM,EMA's CHMP Issues Advice For Potential Early Use Of Pfizer's COVID-19 Oral Antiviral Candidate ,RTTNews,/news/stocks/ema-s-chmp-issues-advice-for-potential-early-use-of-pfizer-s-covid-19-oral-antiviral-candidate-1031051878,positive,0.7969859838485718
3889,12/17/2021 3:33:12 AM,"CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots ",RTTNews,/news/stocks/cdc-recommends-pfizer-moderna-covid-19-vaccines-over-j-j-due-to-rare-blood-clots-1031051886,positive,0.6486043334007263
3890,12/17/2021 9:47:05 AM,Biden warns unvaccinated against Omicron; asks Supreme Court to unblock vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3781179-biden-warns-unvaccinated-against-omicron-asks-supreme-court-to-lift-covid-19-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6527684926986694
3891,12/17/2021 11:47:41 AM,"Pfizer/BioNTech, Moderna COVID-19 shots get CDC backing ahead of J&J’s",Seeking Alpha,https://seekingalpha.com/news/3781205-pfizerbiontech-moderna-covid-19-shots-get-cdc-backing-ahead-of-jjs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5955707430839539
3892,12/17/2021 1:21:07 PM,"Pfizer wins EU backing for growth hormone deficiency drug, pneumococcal vaccine",Seeking Alpha,https://seekingalpha.com/news/3781256-pfizer-wins-eu-backing-for-growth-hormone-deficiency-drug-pneumococcal-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9334419965744019
3893,12/17/2021 1:54:07 PM,"The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx",Benzinga,/news/stocks/the-daily-biotech-pulse-genfit-spikes-on-liver-disease-drug-licensing-deal-lyell-gets-nod-for-solid-tumor-study-decision-day-for-intra-cellular-argenx-1031053175,positive,0.7439902424812317
3894,12/17/2021 2:44:08 PM,Pfizer/BioNTech to study a booster COVID-19 shot in the ongoing trial for children,Seeking Alpha,https://seekingalpha.com/news/3781319-pfizerbiontech-to-study-a-booster-covid-19-shot-in-the-ongoing-trial-for-children?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6238885521888733
3895,12/17/2021 3:36:42 PM,Analyst Ratings For Pfizer,Benzinga,/news/stocks/analyst-ratings-for-pfizer-1031053523,positive,0.9225926399230957
3896,12/17/2021 4:17:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-17-2021-1031053650,neutral,0.5951845049858093
3897,12/17/2021 5:07:54 PM,Pfizer raises 2022 sales guidance for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3781375-pfizer-raises-2022-sales-guidance-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5715328454971313
3898,12/17/2021 10:15:36 PM,"The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More",Benzinga,/news/stocks/the-week-in-cannabis-pfizer-visa-730m+-in-financings-malta-eu-columbia-care-medmen-uruguay-and-more-1031054254,positive,0.8311687707901001
3899,12/18/2021 7:54:18 PM,"Benzinga's Bulls And Bears Of The Past Week: Pfizer, Bank Of America, Beyond Meat, GameStop, AMC, Overstock And More",Benzinga,/news/stocks/benzinga-s-bulls-and-bears-of-the-past-week-pfizer-bank-of-america-beyond-meat-gamestop-amc-overstock-and-more-1031054596,positive,0.9389897584915161
3900,12/19/2021 2:00:40 AM,"Novavax, Vir among healthcare gainers, Pfizer posts best rally in a decade",Seeking Alpha,https://seekingalpha.com/news/3781487-novavax-vir-among-healthcare-gainers-pfizer-posts-best-rally-in-a-decade?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.936930775642395
3901,12/19/2021 2:00:00 PM,"Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022",Seeking Alpha,https://seekingalpha.com/news/3781488-alnylam-pharma-crispr-therapeutics-among-goldmans-healthcare-targets-for-2022?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7041938304901123
3902,12/20/2021 8:43:28 AM,U.S. appeals court revives Biden administration’s COVID-19 vaccine mandate for businesses,Seeking Alpha,https://seekingalpha.com/news/3781502-us-appeals-court-revives-biden-administrations-covid-19-vaccine-mandate-for-businesses?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4621276259422302
3903,12/20/2021 9:35:29 AM,New Zealand links young man's death to Pfizer/BioNTech's COVID-19 shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3781511-new-zealand-links-young-mans-death-to-pfizerbiontechs-covid-19-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9220072031021118
3904,12/20/2021 12:00:05 PM,Moderna leads COVID-19 vaccine makers after booster data on Omicron,Seeking Alpha,https://seekingalpha.com/news/3781536-moderna-leads-covid-19-vaccine-makers-after-booster-data-on-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7139621376991272
3905,12/20/2021 1:32:13 PM,NVAX Stock Alert: 2 Big Reasons Novavax Is Shooting Higher Today,InvestorPlace,/news/stocks/nvax-stock-alert-2-big-reasons-novavax-is-shooting-higher-today-1031056348,negative,0.8649391531944275
3906,12/20/2021 1:35:32 PM,"Pfizer, BioNTech Says EC Exercise Part Option For Over 200 Mln Addl. Doses Of COMIRNATY ",RTTNews,/news/stocks/pfizer-biontech-says-ec-exercise-part-option-for-over-200-mln-addl-doses-of-comirnaty-1031056064,positive,0.5881333351135254
3907,12/20/2021 1:47:56 PM,Pfizer/BioNTech to ship over 200M more COVID-19 vaccine doses to EU in 2022,Seeking Alpha,https://seekingalpha.com/news/3781624-pfizerbiontech-to-ship-200m-additional-covid-19-vaccine-doses-to-eu-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7702338695526123
3908,12/20/2021 4:52:36 PM,7 Stocks to Buy if Covid-19 Becomes Endemic,InvestorPlace,/news/stocks/7-stocks-to-buy-if-covid-19-becomes-endemic-1031057015,positive,0.9332239031791687
3909,12/20/2021 5:55:02 PM,"MRNA, NVAX, OCGN, PFE, BNTX: What Is Going on With Vaccine Stocks Today?",InvestorPlace,/news/stocks/mrna-nvax-ocgn-pfe-bntx-what-is-going-on-with-vaccine-stocks-today-1031057200,neutral,0.6569099426269531
3910,12/20/2021 9:37:42 PM,Vera Therapeutics gives back gains from Friday's Pfizer deal; closes down 18%,Seeking Alpha,https://seekingalpha.com/news/3782095-vera-therapeutics-gives-back-gains-from-fridays-pfizer-deal-closes-down-18?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9347286224365234
3911,12/20/2021 9:58:59 PM,BHC Stock: 9 Things to Know as Jim Cramer Buys Bausch Health,InvestorPlace,/news/stocks/bhc-stock-9-things-to-know-as-jim-cramer-buys-bausch-health-1031057698,positive,0.9310368895530701
3912,12/20/2021 10:31:02 PM,New Zealand Authorities Link 26-year-old Man's Death To Pfizer's Covid Vaccine ,RTTNews,/news/stocks/new-zealand-authorities-link-26-year-old-man-s-death-to-pfizer-s-covid-vaccine-1031057667,neutral,0.5049969553947449
3913,12/20/2021 10:53:59 PM,Pfizer touts 5-year follow-up data on Vyndaqel/Vyndamax in cardiomyopathy,Seeking Alpha,https://seekingalpha.com/news/3782165-pfizer-touts-5-year-follow-up-data-on-vyndaqel-vyndamax-in-cardiomyopathy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9132757782936096
3914,12/21/2021 8:25:49 AM,"ViiV Healthcare : FDA Approves Apretude, Long-acting Injectable Option For HIV Prevention ",RTTNews,/news/stocks/viiv-healthcare-fda-approves-apretude-long-acting-injectable-option-for-hiv-prevention-1031058136,negative,0.9016907215118408
3915,12/21/2021 9:36:08 AM,"Biden speech is about vaccinations and testing, not 'locking down'",Seeking Alpha,https://seekingalpha.com/news/3782201-biden-speech-is-about-vaccinations-and-testing-not-locking-down?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9268312454223633
3916,12/21/2021 11:00:30 AM,7 Best-Looking Stock Charts Going Into Christmas,InvestorPlace,/news/stocks/7-best-looking-stock-charts-going-into-christmas-1031058677,positive,0.8963985443115234
3917,12/21/2021 12:00:50 PM,"COVID-19 pill developer, Pardes to go public via SPAC deal with FS Development Corp. II",Seeking Alpha,https://seekingalpha.com/news/3782240-covid-19-pill-developer-pardes-to-go-public-via-spac-deal-with-fs-development-corp-ii?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8572837710380554
3918,12/21/2021 2:11:20 PM,"The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail",Benzinga,/news/stocks/the-daily-biotech-pulse-aldeyra-sinks-on-dry-eye-disease-readout-sanofi-goes-shopping-regulatory-setback-for-aquestive-aridis-touts-pan-coronavirus-antibody-cocktail-1031059051,positive,0.6017129421234131
3919,12/21/2021 5:10:26 PM,ARDS Stock Alert: The Covid-19 News Sending Aridis Skyrocketing Today,InvestorPlace,/news/stocks/ards-stock-alert-the-covid-19-news-sending-aridis-skyrocketing-today-1031059952,neutral,0.9360624551773071
3920,12/21/2021 9:08:13 PM,"4 Top Stock Trades for Wednesday: Cardano, ARKK, PFE, RAD",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-cardano-arkk-pfe-rad-1031060341,positive,0.9298042058944702
3921,12/21/2021 9:25:59 PM,"AstraZeneca, Oxford start work on Omicron-specific COVID vaccine - FT",Seeking Alpha,https://seekingalpha.com/news/3782496-astrazeneca-oxford-start-work-on-omicron-specific-covid-vaccine-ft?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7424196004867554
3922,12/21/2021 9:42:23 PM,Why did Pfizer close down today? The stock needed a breather,Seeking Alpha,https://seekingalpha.com/news/3782506-why-did-pfizer-close-down-today-the-stock-needed-a-breather?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5785956978797913
3923,12/22/2021 9:08:01 AM,"COVID roundup: More mandates, halving quarantine, FDA pill approval?",Seeking Alpha,https://seekingalpha.com/news/3782556-covid-roundup-israels-fourth-dose-halving-quarantine-fda-pill-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7903928756713867
3924,12/22/2021 9:14:30 AM,Pfizer To Provide UK Addl 2.5 Mln Treatment Courses Of Oral Antiviral Candidate To Combat COVID-19 ,RTTNews,/news/stocks/pfizer-to-provide-uk-addl-2-5-mln-treatment-courses-of-oral-antiviral-candidate-to-combat-covid-19-1031060922,negative,0.8060740828514099
3925,12/22/2021 10:14:07 AM,Pfizer to supply additional 2.5M doses of COVID-19 pill to U.K. - Reuters,Seeking Alpha,https://seekingalpha.com/news/3782564-pfizer-to-supply-additional-25m-doses-of-covid-19-pill-to-uk-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7471455335617065
3926,12/22/2021 10:44:14 AM,Is Israel's fourth COVID vaccine dose a sign of things to come?,Seeking Alpha,https://seekingalpha.com/news/3782567-is-israels-fourth-covid-vaccine-dose-a-sign-of-things-to-come?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8676204085350037
3927,12/22/2021 11:00:21 AM,3 of the Best Biotech Stocks for 2022 to Buy Now,InvestorPlace,/news/stocks/3-of-the-best-biotech-stocks-for-2022-to-buy-now-1031061336,positive,0.7894664406776428
3928,12/22/2021 5:17:41 PM,Pfizer COVID-19 pill granted FDA authorization,Seeking Alpha,https://seekingalpha.com/news/3782760-pfizer-covid-19-pill-granted-fda-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9201934933662415
3929,12/22/2021 7:27:00 PM,FDA Gives Emergency Use Authorization To Pfizer's Covid Treatment Pill ,RTTNews,/news/stocks/fda-gives-emergency-use-authorization-to-pfizer-s-covid-treatment-pill-1031062598,positive,0.7718446254730225
3930,12/22/2021 8:51:14 PM,"Omicron patients are less likely to end up in hospitals, real-word data suggest",Seeking Alpha,https://seekingalpha.com/news/3782847-omicron-patients-are-less-likely-to-end-up-in-hospitals-real-word-data-suggest?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5613265633583069
3931,12/22/2021 10:12:32 PM,Merck’s order for COVID-19 pill canceled by France,Seeking Alpha,https://seekingalpha.com/news/3782873-mercks-order-for-covid-19-pill-cancelled-by-france?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9368370771408081
3932,12/23/2021 11:16:40 AM,Philippines OKs Merck's COVID-19 pill for at-risk patients - Reuters,Seeking Alpha,https://seekingalpha.com/news/3782924-philippines-oks-mercks-covid-19-pill-for-at-risk-patients-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8043199777603149
3933,12/23/2021 12:27:47 PM,Top 10 Blockbuster Drugs In 2021 ,RTTNews,/news/stocks/top-10-blockbuster-drugs-in-2021-1031063755,positive,0.7226237654685974
3934,12/23/2021 2:20:37 PM,7 Great Growth Stocks to Buy for January,InvestorPlace,/news/stocks/7-great-growth-stocks-to-buy-for-january-1031064241,positive,0.8966431021690369
3935,12/23/2021 2:28:39 PM,Merck and Ridgeback win FDA clearance for COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3783035-merck-and-ridgeback-win-fda-clearance-for-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.864262580871582
3936,12/23/2021 5:26:46 PM,7 Safe Stocks Immune From Omicron and Future Covid-19 Variants,InvestorPlace,/news/stocks/7-safe-stocks-immune-from-omicron-and-future-covid-19-variants-1031064797,positive,0.7351954579353333
3937,12/23/2021 9:01:22 PM,How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?,Benzinga,/news/stocks/how-much-revenue-could-pfizer-s-oral-covid-19-pill-fetch-1031065030,positive,0.8741986155509949
3938,12/24/2021 1:15:09 PM,"A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State",InvestorPlace,/news/stocks/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state-1031065604,neutral,0.9196370244026184
3939,12/25/2021 3:32:22 PM,"Benzinga's Bulls And Bears Of The Past Week: Alibaba, Disney, NVDIA, Coinbase, Hubspot, JD.com And More",Benzinga,/news/stocks/benzinga-s-bulls-and-bears-of-the-past-week-alibaba-disney-nvdia-coinbase-hubspot-jd-com-and-more-1031065844,positive,0.9415821433067322
3940,12/26/2021 3:53:01 PM,"The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year",Benzinga,/news/stocks/the-week-ahead-in-biotech-dec-26-jan-1-xeris-fda-decision-pending-clinical-readouts-in-focus-in-final-week-of-year-1031066069,positive,0.8738000392913818
3941,12/27/2021 7:11:12 AM,South Korea approves emergency use of Pfizer's COVID-19 pill - Reuters,Seeking Alpha,https://seekingalpha.com/news/3783340-south-korea-approves-emergency-use-of-pfizers-covid-19-pill-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8186819553375244
3942,12/27/2021 7:29:42 AM,Israel orders Pfizer's COVID-19 pill - Reuters,Seeking Alpha,https://seekingalpha.com/news/3783341-israel-orders-pfizers-covid-19-pill-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8258445262908936
3943,12/27/2021 8:18:53 AM,Global COVID-19 cases break records as Omicron variant spreads,Seeking Alpha,https://seekingalpha.com/news/3783344-global-covid-19-cases-break-records-as-omicron-variant-spreads?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5463659763336182
3944,12/27/2021 12:01:21 PM,Biotech Stocks Facing FDA Decision In January 2022 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-january-2022-1031066657,positive,0.9041165709495544
3945,12/27/2021 12:21:25 PM,Pardes to make public debut after SPAC deal with FS Development Corp. II,Seeking Alpha,https://seekingalpha.com/news/3783374-pardes-to-make-public-debut-after-spac-deal-with-fs-development-corp-ii?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8527580499649048
3946,12/27/2021 3:05:25 PM,BridgeBio setback on transthyretin amyloidosis is a positive for Alnylam - Stifel,Seeking Alpha,https://seekingalpha.com/news/3783441-bridgebio-setback-on-transthyretin-amyloidosis-is-a-positive-for-alnylam-stifel?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5704936385154724
3947,12/27/2021 4:22:32 PM,"Healthcare sector ETFs XLV, IXJ, and VHT notch all-time trading highs",Seeking Alpha,https://seekingalpha.com/news/3783461-healthcare-sector-etfs-xlv-ixj-and-vht-notch-all-time-trading-highs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9207988381385803
3948,12/27/2021 5:44:12 PM,Moderna and Novavax extend losses after FDA authorization of COVID-19 pills,Seeking Alpha,https://seekingalpha.com/news/3783471-moderna-and-novavax-extend-losses-after-fda-authorization-of-covid-19-pills?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9630160927772522
3949,12/27/2021 8:11:30 PM,"If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-one-year-ago-here-s-how-much-you-d-have-now-1031067341,positive,0.93653804063797
3950,12/28/2021 9:55:54 AM,New York expands COVID-19 testing as cases continue to rise,Seeking Alpha,https://seekingalpha.com/news/3783547-new-york-expands-covid-19-testing-as-cases-continue-to-rise?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7552236318588257
3951,12/28/2021 11:36:01 AM,Omicron enhances neutralizing immunity against Delta variant: South Africa study,Seeking Alpha,https://seekingalpha.com/news/3783567-omicron-enhances-neutralizing-immunity-against-delta-variant-south-africa-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8443624377250671
3952,12/28/2021 3:37:54 PM,Omicron makes up about 59% of all COVID-19 cases to become dominant in U.S. - CDC,Seeking Alpha,https://seekingalpha.com/news/3783708-omicron-makes-up-about-59-of-all-covid-19-cases-to-become-dominant-in-us-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8533991575241089
3953,12/28/2021 8:12:18 PM,Moderna sheds over half of its market cap in less than five months,Seeking Alpha,https://seekingalpha.com/news/3783760-moderna-sheds-over-half-of-its-market-cap-in-less-than-five-months?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8239003419876099
3954,12/29/2021 9:38:52 AM,NYC schools to ramp up testing to limit classroom closures - NYT,Seeking Alpha,https://seekingalpha.com/news/3783823-nyc-schools-to-ramp-up-testing-to-limit-classroom-closures-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7124148607254028
3955,12/29/2021 1:51:37 PM,Codex DNA partners with Pfizer to advance the DNA platform,Seeking Alpha,https://seekingalpha.com/news/3783887-codex-dna-partners-with-pfizer-to-advance-the-dna-platform?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5862962603569031
3956,12/29/2021 4:23:09 PM,"Can BioNTech's breakout year continue in 2022? Yes, due to COVID vaccine and pipeline",Seeking Alpha,https://seekingalpha.com/news/3783956-can-biontech-breakout-year-continue-in-2022-yes-due-to-covid-vaccine-and-pipeline?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6393774747848511
3957,12/29/2021 6:14:31 PM,4 Great GARP Stocks to Get for Growth at a Reasonable Price,InvestorPlace,/news/stocks/4-great-garp-stocks-to-get-for-growth-at-a-reasonable-price-1031070138,positive,0.6263347864151001
3958,12/30/2021 9:11:05 AM,J&J COVID-19 booster dose slashes Omicron hospital stay: South African study,Seeking Alpha,https://seekingalpha.com/news/3784064-jj-covid-19-booster-dose-slashes-omicron-hospital-stay-south-african-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4996188282966614
3959,12/30/2021 9:52:37 AM,Omicron COVID surge could peak in U.S. by January end: Fauci,Seeking Alpha,https://seekingalpha.com/news/3784080-omicron-covid-surge-could-peak-in-us-by-january-end-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8277068734169006
3960,12/30/2021 12:12:46 PM,Pfizer deal gives key validation to Codex DNA's technology - KeyBanc,Seeking Alpha,https://seekingalpha.com/news/3784096-pfizer-deal-gives-key-validation-to-codex-dnas-technology-keybanc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7737781405448914
3961,12/30/2021 4:17:46 PM,"This Industry Grew During Covid, Against All Odds: Here's Why You Should Consider Investing",Benzinga,/news/stocks/this-industry-grew-during-covid-against-all-odds-here-s-why-you-should-consider-investing-1031071492,positive,0.8887039422988892
3962,12/30/2021 4:55:10 PM,Pfizer/BioNTech to get FDA OK Monday to use COVID-19 boosters in younger teens - NYT,Seeking Alpha,https://seekingalpha.com/news/3784222-fda-to-broaden-eligibility-for-covid-19-boosters-for-younger-children-on-monday-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6563494801521301
3963,12/30/2021 9:14:44 PM,Israel clears a second COVID-19 booster for immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3784280-israel-clears-a-second-covid-19-booster-for-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8313549160957336
3964,12/31/2021 2:17:36 PM,U.K. Approves Pfizer's Antiviral Covid-19 Pill 'Paxlovid' ,RTTNews,/news/stocks/u-k-approves-pfizer-s-antiviral-covid-19-pill-paxlovid-1031072289,negative,0.8972679376602173
3965,12/31/2021 4:01:34 PM,Mid-Morning Market Update: Markets Edge Lower; UK Approves Pfizer's Oral COVID-19 Antiviral Treatment,Benzinga,/news/stocks/mid-morning-market-update-markets-edge-lower-uk-approves-pfizer-s-oral-covid-19-antiviral-treatment-1031072370,neutral,0.9553571343421936
3966,12/31/2021 6:07:33 PM,Mid-Day Market Update: Crude Oil Down 1%; Xeris Biopharma Shares Jump,Benzinga,/news/stocks/mid-day-market-update-crude-oil-down-1-xeris-biopharma-shares-jump-1031072607,neutral,0.9671708345413208
3967,12/31/2021 8:01:07 PM,Pfizer COVID antiviral treatment Paxlovid approved by U.K. regulators,Seeking Alpha,https://seekingalpha.com/news/3784408-pfizer-covid-antiviral-treatment-paxlovid-approved-by-uk-regulators?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.814797043800354
3968,12/31/2021 8:03:07 PM,Mid-Afternoon Market Update: Dow Rises 50 Points; Nutriband Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-rises-50-points-nutriband-shares-spike-higher-1031072656,negative,0.9294445514678955
3969,12/31/2021 8:40:54 PM,Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-january-pdufa-dates-1031072671,positive,0.9451626539230347
3970,1/3/2022 7:42:00 AM,"Israel to offer fourth COVID-19 vaccine dose to people over 60s, medical staff - Reuters",Seeking Alpha,https://seekingalpha.com/news/3784451-israel-to-offer-fourth-covid-19-vaccine-dose-to-people-over-60s-medical-staff-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6999611854553223
3971,1/3/2022 11:00:54 AM,Some Investors Should Buy Novavax Stock on the Dip,InvestorPlace,/news/stocks/some-investors-should-buy-nvax-stock-on-the-dip-1031073881,positive,0.8837240934371948
3972,1/3/2022 2:19:53 PM,Dr. Scott Gottlieb predicts Omicron wave could subside by end of February,Seeking Alpha,https://seekingalpha.com/news/3784571-dr-scott-gottlieb-predicts-omicron-wave-could-subside-by-end-of-february?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6593563556671143
3973,1/3/2022 2:57:22 PM,FDA expands Pfizer/BioNTech COVID booster shot to 12 to 15-year-olds,Seeking Alpha,https://seekingalpha.com/news/3784595-fda-expands-pfizer-biontech-covid-booster-shot-to-12-to-15-year-olds?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7368448376655579
3974,1/3/2022 4:06:37 PM,FDA Expands Emergency Nod Of Booster Dose Of Pfizer COVID-19 Vaccine To Include 12yrs Of Age & Older ,RTTNews,/news/stocks/fda-expands-emergency-nod-of-booster-dose-of-pfizer-covid-19-vaccine-to-include-12yrs-of-age-older-1031074363,positive,0.809838593006134
3975,1/4/2022 8:00:15 AM,U.S. daily COVID-19 cases top 1 million as Omicron rages,Seeking Alpha,https://seekingalpha.com/news/3784794-us-daily-covid-19-cases-top-1-million-as-omicron-rages?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5671801567077637
3976,1/4/2022 8:42:50 AM,U.S. schools delay openings amid COVID-19 surge driven by Omicron variant,Seeking Alpha,https://seekingalpha.com/news/3784800-us-schools-delay-openings-amid-covid-19-surge-driven-by-omicron-variant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9318064451217651
3977,1/4/2022 4:02:18 PM,CDC backs use of a third Pfizer/BioNTech COVID-19 shot for certain children,Seeking Alpha,https://seekingalpha.com/news/3785056-cdc-backs-use-of-a-third-pfizerbiontech-covid-19-shot-for-certain-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7740053534507751
3978,1/4/2022 5:00:53 PM,Pfizer to deliver additional 10M courses of oral COVID-19 therapy to U.S.,Seeking Alpha,https://seekingalpha.com/news/3785130-pfizer-to-deliver-additional-10m-courses-of-oral-covid-19-therapy-to-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8171588778495789
3979,1/4/2022 6:30:49 PM,"CCL, RCL, NCLH, LIND: Why Cruise Stocks Are Up Today",InvestorPlace,/news/stocks/ccl-rcl-nclh-lind-why-cruise-stocks-are-up-today-1031077517,positive,0.5071912407875061
3980,1/5/2022 12:01:56 PM,"Pfizer, BioNTech in pact for mRNA-based shingles vaccine",Seeking Alpha,https://seekingalpha.com/news/3785307-pfizer-biontech-in-pact-for-mrna-based-shingles-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7538843750953674
3981,1/5/2022 1:13:22 PM,"Pfizer, BioNTech Join To Develop MRNA-based Vaccine Against Shingles - Quick Facts ",RTTNews,/news/stocks/pfizer-biontech-join-to-develop-mrna-based-vaccine-against-shingles-quick-facts-1031078926,positive,0.6044041514396667
3982,1/5/2022 1:29:59 PM,"Biohaven, Pfizer Announce Successful Closing Of Collaboration Agreements - Quick Facts ",RTTNews,/news/stocks/biohaven-pfizer-announce-successful-closing-of-collaboration-agreements-quick-facts-1031078963,negative,0.5904681086540222
3983,1/5/2022 1:43:59 PM,Pfizer upgraded to buy from neutral at BofA; sees 28% upside,Seeking Alpha,https://seekingalpha.com/news/3785369-pfizer-upgraded-to-buy-from-neutral-at-bofa-sees-28-upside?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9381022453308105
3984,1/5/2022 2:20:00 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-partner-for-shingles-vaccine-annexon-huntington-disease-study-disappoints-amneal-buys-neurology-assets-1031079148,positive,0.8438562750816345
3985,1/5/2022 4:08:49 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-5-2022-1031079571,neutral,0.4978620409965515
3986,1/5/2022 4:16:10 PM,NRXP Stock Alert: The Covid-19 News Lifting NRx Pharmaceuticals Today,InvestorPlace,/news/stocks/nrxp-stock-alert-the-covid-19-news-lifting-nrx-pharmaceuticals-today-1031079757,positive,0.9369882941246033
3987,1/5/2022 6:18:29 PM,"Why This Pfizer, Regeneron Analyst Has Contrasting Recommendations For The COVID Stock Plays",Benzinga,/news/stocks/why-this-pfizer-regeneron-analyst-has-contrasting-recommendations-for-the-covid-stock-plays-1031079936,positive,0.7009210586547852
3988,1/5/2022 8:02:57 PM,Analyst Ratings For Pfizer,Benzinga,/news/stocks/analyst-ratings-for-pfizer-1031080105,positive,0.9225926399230957
3989,1/5/2022 8:48:10 PM,CDC Recommends Pfizer Booster Shot At 5 Months; Additional Dose For Immunocompromised Children ,RTTNews,/news/stocks/cdc-recommends-pfizer-booster-shot-at-5-months-additional-dose-for-immunocompromised-children-1031080170,positive,0.7515687346458435
3990,1/5/2022 8:59:51 PM,Moderna hits a six-month low shedding over $15B in value after three-day slide,Seeking Alpha,https://seekingalpha.com/news/3785576-moderna-hits-a-six-month-low-shedding-over-15b-in-value-after-three-day-slide?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9557563066482544
3991,1/6/2022 12:33:59 PM,7 Best Stocks to Buy to Kick Off the New Year,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-kick-off-new-year-1031081283,positive,0.6506024599075317
3992,1/6/2022 12:56:30 PM,7 Pharmaceutical Stocks That Could Make You Rich,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-that-could-make-you-rich-1031081342,positive,0.9103521108627319
3993,1/6/2022 9:20:39 PM,CDC Recommends Pfizer's Booster Dose For Children Between 12-15 Years ,RTTNews,/news/stocks/cdc-recommends-pfizer-s-booster-dose-for-children-between-12-15-years-1031082463,positive,0.8988469839096069
3994,1/6/2022 10:03:32 PM,"J&J touts data on durable protection of COVID shot against infections, hospitalization",Seeking Alpha,https://seekingalpha.com/news/3786033-johnson-johnson-touts-data-on-durable-protection-of-covid-shot-against-infections-hospitalization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9006164073944092
3995,1/7/2022 10:16:59 AM,What's at stake as the Supreme Court weighs vaccine mandates?,Seeking Alpha,https://seekingalpha.com/news/3786098-whats-at-stake-as-the-supreme-court-weighs-vaccine-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7997344136238098
3996,1/7/2022 6:17:06 PM,Biden administration to ask Congress for more COVID funding - WaPo,Seeking Alpha,https://seekingalpha.com/news/3786338-biden-administration-to-ask-congress-for-more-covid-funding?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7112752199172974
3997,1/10/2022 11:19:48 AM,Beam gains 8% on collaboration with Pfizer to advance in vivo programs for rare diseases,Seeking Alpha,https://seekingalpha.com/news/3786490-beam-gains-8-on-collaboration-with-pfizer-to-advance-in-vivo-programs-for-rare-diseases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9513171315193176
3998,1/10/2022 11:53:07 AM,"Pfizer in pact with Acuitas for LNP delivery system for use in mRNA vaccines, therapeutics",Seeking Alpha,https://seekingalpha.com/news/3786501-pfizer-in-pact-with-acuitas-for-lnp-delivery-system-for-use-in-mrna-vaccines-therapeutics?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.495877742767334
3999,1/10/2022 11:56:26 AM,Bayer and Mammoth Biosciences announce $1B worth deal for gene editing,Seeking Alpha,https://seekingalpha.com/news/3786502-bayer-and-mammoth-biosciences-announce-1b-worth-deal-for-gene-editing?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7170904278755188
4000,1/10/2022 12:38:01 PM,"Pfizer, Beam Announce Up To $1.35 Bln, Exclusive Multi-year, Research Collaboration ",RTTNews,/news/stocks/pfizer-beam-announce-up-to-1-35-bln-exclusive-multi-year-research-collaboration-1031090272,positive,0.834086000919342
4001,1/10/2022 12:53:12 PM,Pfizer Reaches Deal With Acuitas For Lipid Nanoparticle Delivery System For Use In MRNA Vaccines ,RTTNews,/news/stocks/pfizer-reaches-deal-with-acuitas-for-lipid-nanoparticle-delivery-system-for-use-in-mrna-vaccines-1031090298,negative,0.8482919335365295
4002,1/10/2022 3:40:55 PM,Why Blockchain Could Prevent Another Theranos,InvestorPlace,/news/stocks/why-blockchain-could-prevent-another-theranos-1031091332,positive,0.7074529528617859
4003,1/10/2022 4:52:00 PM,"Dear NVAX Stock Fans, You Should Be Watching This Vaccine News",InvestorPlace,/news/stocks/dear-nvax-stock-fans-you-should-be-watching-this-vaccine-news-1031091516,positive,0.9238359928131104
4004,1/10/2022 10:44:14 PM,Pfizer wins $442.13M Army contract modification for PAXLOVID,Seeking Alpha,https://seekingalpha.com/news/3786896-pfizer-wins-44213m-army-contract-modification-for-paxlovid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9405294060707092
4005,1/10/2022 11:00:56 PM,Pfizer's Omicron-Specific Vaccine To Be Ready In March ,RTTNews,/news/stocks/pfizer-s-omicron-specific-vaccine-to-be-ready-in-march-1031092156,positive,0.8295465111732483
4006,1/11/2022 10:04:46 AM,Novavax COVID-19 vaccine could be cleared in multiple countries in 90 days: CEO Stanley Erck,Seeking Alpha,https://seekingalpha.com/news/3786944-novavax-covid-19-vaccine-could-be-cleared-in-multiple-countries-in-90-days-ceo-stanley-erck?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8610618114471436
4007,1/11/2022 11:10:02 AM,U.S. COVID-19 hospitalizations surpass last winter record as Omicron surges,Seeking Alpha,https://seekingalpha.com/news/3786959-us-covid-19-hospitalizations-surpass-last-winter-record-as-omicron-surges?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9084089398384094
4008,1/11/2022 3:56:07 PM,The 7 Best Blue-Chip Stocks to Buy for 2022,InvestorPlace,/news/stocks/the-7-best-blue-chip-stocks-to-buy-for-2022-1031094589,positive,0.832531213760376
4009,1/11/2022 5:15:05 PM,Dren Bio in up to $1B deal with Pfizer for oncology bispecific antibody candidates,Seeking Alpha,https://seekingalpha.com/news/3787201-dren-bio-in-up-to-1b-deal-with-pfizer-for-oncology-bispecific-antibody-candidates?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7509891986846924
4010,1/11/2022 9:26:39 PM,Why did BioNTech stock dip today? 2022 outlook for COVID-19 vaccine sales,Seeking Alpha,https://seekingalpha.com/news/3787276-why-did-biontech-stock-dip-today-2022-outlook-for-covid-19-vaccine-sales?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5165631771087646
4011,1/12/2022 12:01:36 PM,Pfizer reports positive results from Phase 3 study of PREVNAR 20 with COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3787390-pfizer-reports-positive-results-from-phase-3-study-of-prevnar-20-with-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9488479495048523
4012,1/12/2022 2:05:02 PM,Pfizer Unveils Positive Results From Phase 3 Study Of Prevnar 20 ,RTTNews,/news/stocks/pfizer-unveils-positive-results-from-phase-3-study-of-prevnar-20-1031096638,negative,0.8982313871383667
4013,1/12/2022 7:35:41 PM,7 Hot Stocks That Look to Get Even Hotter in the New Year,InvestorPlace,/news/stocks/7-hot-stocks-that-look-to-get-even-hotter-in-new-year-1031098012,negative,0.532606303691864
4014,1/13/2022 8:52:18 AM,Calls grow to treat COVID like an 'endemic' illness,Seeking Alpha,https://seekingalpha.com/news/3787737-calls-grow-to-treat-covid-like-an-endemic-illness?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5648321509361267
4015,1/13/2022 12:12:39 PM,Pfizer in talks with Africa CDC to supply COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3787779-pfizer-in-talks-with-africa-cdc-to-supply-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7767274975776672
4016,1/13/2022 7:34:59 PM,7 Best Long-Term Stocks to Buy and Hold for the Next Decade,InvestorPlace,/news/stocks/7-best-long-term-stocks-to-buy-and-hold-for-the-next-decade-1031101371,positive,0.8987681269645691
4017,1/14/2022 1:32:14 PM,COVID-19 vaccine makers fall as top health officials question need for Omicron-specific shots,Seeking Alpha,https://seekingalpha.com/news/3788262-covid-19-vaccine-makers-in-the-red-as-officials-question-need-for-omicron-specific-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9683957099914551
4018,1/14/2022 4:02:54 PM,NVAX Stock Alert: Why Is Novavax Plunging Today?,InvestorPlace,/news/stocks/nvax-stock-alert-why-is-novavax-plunging-today-1031103773,neutral,0.8646395206451416
4019,1/14/2022 9:14:03 PM,Pfizer granted FDA approval for CIBINQO in atopic dermatitis,Seeking Alpha,https://seekingalpha.com/news/3788420-pfizer-granted-fda-approval-for-cibinqo-in-atopic-dermatitis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9392638802528381
4020,1/17/2022 8:20:17 AM,Bloomberg: Unilever Considers Increasing Offer For GSK Consumer Healthcare ,RTTNews,/news/stocks/bloomberg-unilever-considers-increasing-offer-for-gsk-consumer-healthcare-1031105741,negative,0.8896377682685852
4021,1/17/2022 8:43:49 AM,"Unilever Intends To Materially Expand Its Presence In Health, Beauty, And Hygiene ",RTTNews,/news/stocks/unilever-intends-to-materially-expand-its-presence-in-health-beauty-and-hygiene-1031105779,negative,0.7855297923088074
4022,1/17/2022 12:26:02 PM,Pfizer in pact with Novasep for production of COVID-19 pill in France,Seeking Alpha,https://seekingalpha.com/news/3788503-pfizer-in-pact-with-novasep-for-production-of-covid-19-pill-in-france?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8007948398590088
4023,1/17/2022 4:08:47 PM,7 Long-Term Stocks to Buy and Hold Until 2030,InvestorPlace,/news/stocks/7-long-term-stocks-to-buy-and-hold-until-2030-1031106739,positive,0.9322349429130554
4024,1/18/2022 8:48:48 AM,Health Canada Approves PAXLOVID - Quick Facts ,RTTNews,/news/stocks/health-canada-approves-paxlovid-quick-facts-1031107770,positive,0.7232264280319214
4025,1/18/2022 11:19:29 AM,Israeli trial shows 4th COVID shot less effective on Omicron,Seeking Alpha,https://seekingalpha.com/news/3788550-israeli-trial-shows-4th-covid-shot-less-effective-on-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.682744562625885
4026,1/18/2022 2:30:02 PM,Unilever plunges as investors react to its bid for GlaxoSmithKline’s consumer unit,Seeking Alpha,https://seekingalpha.com/news/3788720-gsk-stock-gains-as-investors-react-to-unilever-bid-for-its-consumer-unit?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9646809697151184
4027,1/18/2022 3:39:29 PM,"Sema4 Strengthens AI-Driven Genomic, Clinical Data Platform With $623M GeneDx Acquisition",Benzinga,/news/stocks/sema4-strengthens-ai-driven-genomic-clinical-data-platform-with-623m-genedx-acquisition-1031109342,negative,0.9202105402946472
4028,1/18/2022 6:11:40 PM,Unilever’s bid for consumer unit unlikely to generate upside for GlaxoSmithKline - BofA,Seeking Alpha,https://seekingalpha.com/news/3788853-unilevers-bid-for-consumer-unit-unlikely-to-generate-upside-for-glaxosmithkline-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9229947328567505
4029,1/18/2022 6:35:57 PM,Pfizer says lab studies indicate COVID antiviral Paxlovid effective against Omicron,Seeking Alpha,https://seekingalpha.com/news/3788862-pfizer-says-lab-studies-indicate-covid-antiviral-paxlovid-effective-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9265384078025818
4030,1/18/2022 7:27:13 PM,7 of the Top-Rated Pharmaceutical Stocks for Q1,InvestorPlace,/news/stocks/7-of-the-top-rated-pharmaceutical-stocks-for-q1-1031110217,positive,0.8801546692848206
4031,1/19/2022 1:41:01 PM,CStone-EQRx's sugemalimab improves survival of lung cancer patients in phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3789126-cstone-eqrxs-sugemalimab-improves-survival-of-lung-cancer-patients-in-phase-3-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9518430233001709
4032,1/19/2022 3:20:55 PM,GSK science chief Barron leaving to join anti-aging startup reportedly backed by Bezos,Seeking Alpha,https://seekingalpha.com/news/3789220-gsk-science-chief-barron-leaving-to-join-anti-aging-startup-reportedly-backed-by-bezos?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9231254458427429
4033,1/19/2022 4:33:03 PM,ESSA Pharma begins dosing of EPI-7386 in phase 1/2 prostate cancer study,Seeking Alpha,https://seekingalpha.com/news/3789255-essa-pharma-begins-dosing-of-epi-7386-in-phase-12-prostate-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7688782811164856
4034,1/19/2022 8:53:22 PM,VALN Stock Alert: 4 Things to Know About the Vaccine News Sending Valneva Soaring,InvestorPlace,/news/stocks/valn-stock-alert-4-things-to-know-about-the-vaccine-news-sending-valneva-soaring-1031113967,positive,0.9337269067764282
4035,1/19/2022 9:42:04 PM,"Biden again says not going back to lockdowns, on way to life without COVID disruptions",Seeking Alpha,https://seekingalpha.com/news/3789417-biden-again-says-not-going-back-to-lockdowns-on-way-to-life-without-covid-disruptions?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7469373941421509
4036,1/19/2022 10:12:21 PM,Pfizer secures ~$2B modification contract for 300M additional COVID doses,Seeking Alpha,https://seekingalpha.com/news/3789448-pfizer-secures-2b-modification-contract-for-300m-additional-covid-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.933456301689148
4037,1/20/2022 11:33:00 AM,Fauci says FDA could clear Pfizer/BioNTech COVID-19 shot next month for kids under five,Seeking Alpha,https://seekingalpha.com/news/3789519-fauci-says-fda-could-clear-pfizerbiontech-covid-19-shot-next-month-for-kids-under-five?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6526506543159485
4038,1/20/2022 4:07:55 PM,Pfizer-OPKO's Ngenla approved in Japan for pediatric growth hormone deficiency,Seeking Alpha,https://seekingalpha.com/news/3789727-pfizer-opkos-ngenla-approved-in-japan-for-pediatric-growth-hormone-deficiency?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7767386436462402
4039,1/20/2022 5:20:28 PM,"Unilever is unlikely to acquire GlaxoSmithKline’s consumer unit, UBS says",Seeking Alpha,https://seekingalpha.com/news/3789758-unilever-is-unlikely-to-acquire-glaxosmithklines-consumer-unit-ubs-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9416779279708862
4040,1/20/2022 7:47:14 PM,7 Dividend Stocks Trading at Attractive Valuations,InvestorPlace,/news/stocks/7-dividend-stocks-trading-at-attractive-valuations-1031117402,negative,0.5109559297561646
4041,1/20/2022 8:45:40 PM,Agreement allows 27 generic manufacturers to produce Merck COVID pill molnupiravir,Seeking Alpha,https://seekingalpha.com/news/3790007-agreement-allows-27-generic-manufacturers-to-produce-merck-covid-pill-molnupiravir?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8272676467895508
4042,1/20/2022 9:32:45 PM,"Novavax Is Oversold, Time To Buy for Future Growth",InvestorPlace,/news/stocks/nvax-stock-is-oversold-time-to-buy-for-future-growth-1031117662,positive,0.8015455007553101
4043,1/20/2022 10:14:03 PM,"Novavax Stock is in a Tough Spot, but its Fortunes Could Improve",InvestorPlace,/news/stocks/nvax-stock-in-tough-spot-but-fortunes-could-improve-1031117722,neutral,0.9055421352386475
4044,1/21/2022 1:58:37 PM,Why Jim Cramer Like NextEra Energy And Lincoln Electric?,Benzinga,/news/stocks/why-jim-cramer-like-nextera-energy-and-lincoln-electric-1031118884,positive,0.8904429078102112
4045,1/21/2022 2:01:13 PM,EU countries urged to consider a fourth COVID-19 vaccine if needed,Seeking Alpha,https://seekingalpha.com/news/3790286-eu-countries-urged-to-consider-a-fourth-covid-19-vaccine-if-needed?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5156496167182922
4046,1/21/2022 4:57:00 PM,CureVac extends losses as BofA downgrades citing minimal COVID-19 upside,Seeking Alpha,https://seekingalpha.com/news/3790376-curevac-extends-losses-as-bofa-downgrades-citing-minimal-covid-19-upside?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9233145117759705
4047,1/21/2022 10:06:19 PM,"Pfizer, OPKO receive somatrogon Complete Respoinse Letter for growth hormone deficiency",Seeking Alpha,https://seekingalpha.com/news/3790463-pfizer-opko-receive-somatrogon-complete-respoinse-letter-for-growth-hormone-deficiency?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7022724747657776
4048,1/22/2022 5:00:41 PM,"Pfizer, Merck trial antiviral combos amid concerns over resistance to COVID-19 pills",Seeking Alpha,https://seekingalpha.com/news/3790494-pfizer-merck-trial-antiviral-combos-amid-concerns-over-resistance-to-covid-19-pills?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8306148052215576
4049,1/23/2022 2:30:06 AM,Pfizer CEO says an annual COVID-19 vaccine preferable to frequent boosters,Seeking Alpha,https://seekingalpha.com/news/3790496-pfizer-ceo-says-an-annual-covid-19-vaccine-preferable-to-frequent-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.521166980266571
4050,1/23/2022 12:50:45 PM,Activist fund Trian is said to take stake in Unilever - FT,Seeking Alpha,https://seekingalpha.com/news/3790498-activist-fund-trian-is-said-to-take-stake-in-unilever-ft?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9484593868255615
4051,1/24/2022 3:42:09 AM,Trian Fund Management Reportedly Acquires Stake In Unilever ,RTTNews,/news/stocks/trian-fund-management-reportedly-acquires-stake-in-unilever-1031120803,positive,0.8541147708892822
4052,1/24/2022 8:09:09 AM,Fourth COVID-19 vaccine dose increases resistance against infection in people over 60: Israeli study,Seeking Alpha,https://seekingalpha.com/news/3790516-fourth-covid-19-vaccine-dose-increases-resistance-against-infection-in-people-over-60-israeli-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9282497763633728
4053,1/24/2022 1:42:13 PM,Unilever gains after report of activist investor Trian taking stake (update),Seeking Alpha,https://seekingalpha.com/news/3790647-unilever-gains-after-report-of-activist-investor-trian-taking-stake?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7755270004272461
4054,1/24/2022 2:06:25 PM,Anixa says new protease inhibitor outperformed main agent in Pfizer’s COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3790677-anixa-says-new-protease-inhibitor-trumps-main-agent-in-pfizers-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9307358860969543
4055,1/24/2022 3:23:06 PM,Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses,Benzinga,/news/stocks/arcturus-therapeutics-covid-19-booster-clinical-trial-show-encouraging-neutralizing-antibody-responses-1031122928,negative,0.9451301097869873
4056,1/24/2022 3:32:21 PM,OPKO Health hits eight-month low after regulatory setback for growth hormone,Seeking Alpha,https://seekingalpha.com/news/3790739-opko-health-hits-eight-month-low-after-regulatory-setback-for-growth-hormone?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9491342306137085
4057,1/24/2022 3:55:18 PM,Arcturus Therapeutics falls 9% amid announcement of COVID-19 booster study data,Seeking Alpha,https://seekingalpha.com/news/3790750-arcturus-therapeutics-falls-9-amid-announcement-of-covid-19-booster-study-data?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9499337077140808
4058,1/24/2022 4:25:26 PM,"AstraZeneca, Pfizer/ BioNTech or J&J shots found to boost effect of Sinovac COVID-19 vaccine",Seeking Alpha,https://seekingalpha.com/news/3790763-astrazeneca-pfizer-biontech-or-jj-shots-found-to-boost-effect-of-sinovac-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.938286304473877
4059,1/24/2022 6:17:03 PM,Pfizer/OPKO loss on somatrogon could boost Ascendis Pharma's fortunes,Seeking Alpha,https://seekingalpha.com/news/3790868-pfizer-opko-loss-on-somatragon-could-boost-ascendis-pharmas-fortunes?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7961371541023254
4060,1/25/2022 8:16:59 AM,New York judge blocks statewide mask mandate - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791053-new-york-judge-blocks-statewide-mask-mandate-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.677754282951355
4061,1/25/2022 11:20:36 AM,Israel considers offering fourth COVID-19 vaccine dose to all adults - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791092-israel-considers-offering-fourth-covid-19-vaccine-dose-to-all-adults-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7238512635231018
4062,1/25/2022 12:39:36 PM,Pfizer and BioNTech launch trial for Omicron-specific COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3791142-pfizer-and-biontech-launch-trial-for-omicron-specific-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6180495023727417
4063,1/25/2022 1:21:41 PM,Arcturus says messenger RNA vaccines raised antibody levels as boosters against Omicron,Seeking Alpha,https://seekingalpha.com/news/3791183-arcturus-says-messenger-rna-vaccines-raised-antibody-levels-as-boosters-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9491151571273804
4064,1/25/2022 1:23:22 PM,"Pfizer, BioNTech Start Omicron-specific Vaccine Trial In Adults Aged 15 To 55 ",RTTNews,/news/stocks/pfizer-biontech-start-omicron-specific-vaccine-trial-in-adults-aged-15-to-55-1031125918,positive,0.6697635650634766
4065,1/25/2022 1:46:12 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-starts-omicron-specific-vaccine-study-j-j-misses-on-topline-sierra-oncology-reports-positive-data-1031126033,negative,0.6391013264656067
4066,1/25/2022 5:13:39 PM,BNTX Stock Alert: The Omicron Vaccine News That Has BioNTech Shooting Higher Today,InvestorPlace,/news/stocks/bntx-stock-alert-the-omicron-vaccine-news-that-has-biontech-shooting-higher-today-1031127334,negative,0.8170809149742126
4067,1/25/2022 6:17:15 PM,"CBO report finds skyrocketing price increases for brand Rx drugs for Medicare, Medicaid",Seeking Alpha,https://seekingalpha.com/news/3791432-cbo-report-finds-skyrocketing-price-increases-for-brand-rx-drugs-for-medicare-medicaid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5263792276382446
4068,1/25/2022 7:02:01 PM,Is Pfizer a buy on the strength of its new COVID-19 pill?,Seeking Alpha,https://seekingalpha.com/news/3791433-does-pfizers-new-covid-pill-make-it-a-buy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7910406589508057
4069,1/25/2022 9:07:36 PM,Uncertain Market Conditions And Good News Make Novavax A Cautious Buy,InvestorPlace,/news/stocks/uncertain-market-conditions-and-good-news-make-novavax-a-cautious-buy-1031127797,neutral,0.3703707456588745
4070,1/26/2022 5:59:16 AM,New York mask mandate temporarily restored by Appeals Court judge - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791615-new-york-mask-mandate-temporarily-restored-by-appeals-court-judge-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7119885683059692
4071,1/26/2022 7:04:19 AM,Omicron variant less likely to lead to hospitalizations than Delta: U.S. study,Seeking Alpha,https://seekingalpha.com/news/3791617-omicron-variant-less-likely-to-lead-to-hospitalizations-than-delta-us-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49498799443244934
4072,1/26/2022 6:45:35 PM,Solana Instability Screams Stay Away!,InvestorPlace,/news/stocks/solana-instability-screams-stay-away-1031132278,neutral,0.5364999175071716
4073,1/26/2022 10:32:52 PM,Moderna doses first patient in Omicron-specific COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3792197-moderna-doses-first-patient-in-omicron-specific-covid-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4955188035964966
4074,1/27/2022 7:48:36 AM,Two-thirds of Omicron COVID cases are reinfections: English study,Seeking Alpha,https://seekingalpha.com/news/3792249-two-thirds-of-omicron-covid-cases-are-reinfections-english-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8890378475189209
4075,1/27/2022 2:38:32 PM,BioNTech to increase staff by 50% at German manufacturing plant - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3792500-biontech-to-increase-staff-by-50-at-german-manufacturing-plant-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9398888945579529
4076,1/27/2022 3:15:48 PM,EMA advisors recommend conditional approval of Pfizer COVID antiviral pill Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3792541-ema-advisors-recommend-conditional-approval-of-pfizer-covid-antiviral-pill-paxlovid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.526138424873352
4077,1/27/2022 3:26:44 PM,Pfizer Obtains CHMP Positive Opinion For COVID-19 Oral Treatment ,RTTNews,/news/stocks/pfizer-obtains-chmp-positive-opinion-for-covid-19-oral-treatment-1031135906,negative,0.91690993309021
4078,1/27/2022 6:57:41 PM,Say Hello to 2022’s Dogs of the Dow: 10 Dividend Stocks to Watch,InvestorPlace,/news/stocks/say-hello-to-2022s-dogs-of-the-dow-10-dividend-stocks-to-watch-1031136826,positive,0.9087088108062744
4079,1/28/2022 7:00:54 AM,COVID-19 boosters give 95% protection from death due to Omicron in people over 50: UKHSA,Seeking Alpha,https://seekingalpha.com/news/3792885-covid-19-boosters-gives-95-protection-from-death-due-to-omicron-in-people-over-50-ukhsa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8038749694824219
4080,1/28/2022 8:40:11 AM,CDC study finds third dose of COVID-19 vaccine reduce risk of hospitalizations in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3792890-cdc-study-finds-third-dose-of-covid-19-vaccine-reduce-risk-of-hospitalizations-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.804219663143158
4081,1/28/2022 11:15:28 AM,10 Best Stocks to Buy for Your Income-Generating Portfolio,InvestorPlace,/news/stocks/10-best-stocks-to-buy-for-your-income-generating-portfolio-axp-deo-bp-stor-cwh-rio-gbdc-apam-1031138875,positive,0.8758160471916199
4082,1/28/2022 1:10:16 PM,Novavax in pact with Israel to deliver 5 million COVID-19 vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3793011-novavax-in-pact-with-israel-to-deliver-5-million-covid-19-vaccine-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.809982180595398
4083,1/28/2022 3:25:15 PM,Pfizer granted EU approval for Lorviqua as first line therapy for lung cancer,Seeking Alpha,https://seekingalpha.com/news/3793126-pfizer-granted-eu-approval-for-lorviqua-as-first-line-therapy-for-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9223310947418213
4084,1/28/2022 3:39:39 PM,EC formally authorizes Pfizer's COVID antiviral pill Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3793130-ec-formally-authorizes-pfizer-coivid-antiviral-pill-paxlovid?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9004026055335999
4085,1/28/2022 4:01:34 PM,EU Okays Pfizer's Lorviqua As First-Line Treatment For ALK-Positive Advanced Lung Cancer ,RTTNews,/news/stocks/eu-okays-pfizer-s-lorviqua-as-first-line-treatment-for-alk-positive-advanced-lung-cancer-1031139699,negative,0.6639169454574585
4086,1/28/2022 5:05:31 PM,Novavax Could Be the Biggest Bargain in the Market Right Now,InvestorPlace,/news/stocks/nvax-stock-could-be-biggest-bargain-in-the-market-right-now-1031140035,positive,0.5751535892486572
4087,1/28/2022 5:33:13 PM,Sorrento's COVID-19 Main Protease Inhibitor Neutralizes Omicron,Benzinga,/news/stocks/sorrento-s-covid-19-main-protease-inhibitor-neutralizes-omicron-1031139921,positive,0.6119442582130432
4088,1/28/2022 6:15:32 PM,7 Technology Stocks Reporting Earnings the Week of January 31,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-1028709625,positive,0.5936208367347717
4089,1/28/2022 7:21:30 PM,Omicron subvariant linked to higher transmissibility; boosters retain efficacy,Seeking Alpha,https://seekingalpha.com/news/3793211-omicron-subvariant-linked-to-higher-transmissibility-boosters-retain-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9422722458839417
4090,1/29/2022 5:00:20 PM,Moderna slips to bottom of S&P 500 amid mixed sentiment,Seeking Alpha,https://seekingalpha.com/news/3793325-moderna-slips-to-bottom-of-sp-500-amid-mixed-sentiment?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.958150327205658
4091,1/31/2022 7:40:41 AM,U.K. to offer COVID vaccinations to children aged 5-11 who are at risk - Reuters,Seeking Alpha,https://seekingalpha.com/news/3793350-uk-to-offer-covid-vaccinations-to-children-aged-5-11-who-are-at-risk-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8466324806213379
4092,1/31/2022 9:36:02 AM,Two New York nurses incriminated of forging COVID vaccine cards - CNBC,Seeking Alpha,https://seekingalpha.com/news/3793358-two-new-york-nurses-incriminated-of-forging-covid-vaccine-cards-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8780366778373718
4093,1/31/2022 9:45:29 AM,Pfizer partners with Alex Therapeutics to provide digital therapies in Germany,Seeking Alpha,https://seekingalpha.com/news/3793359-pfizer-partners-with-alex-therapeutics-to-provide-digital-therapies-in-germany?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7531183362007141
4094,1/31/2022 1:05:00 PM,Pfizer and Ionis announce discontinuation of vupanorsen clinical development program,PR Newswire,/news/stocks/pfizer-and-ionis-announce-discontinuation-of-vupanorsen-clinical-development-program-1031143978,neutral,0.5912767052650452
4095,1/31/2022 1:46:34 PM,Why Ionis Pharma Stock Falling In Pre-market? ,RTTNews,/news/stocks/why-ionis-pharma-stock-falling-in-pre-market-1031144134,neutral,0.9595258831977844
4096,1/31/2022 2:20:54 PM,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-31-feb-5-merck-bristol-myers-squibb-lilly-novartis-headline-large-cap-biopharma-earnings-news-1031144306,positive,0.9110234379768372
4097,1/31/2022 2:21:45 PM,Shionogi reports Phase 2 data for oral antiviral candidate for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3793517-shionogi-reports-phase-2-data-for-oral-antiviral-candidate-for-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5301706790924072
4098,1/31/2022 4:21:29 PM,Moderna granted full FDA approval for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3793583-moderna-granted-full-fda-approval-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8826298713684082
4099,1/31/2022 5:41:18 PM,Veru's Cancer Candidate Sabizabulin Gets FDA Fast Track Tag For COVID-19,Benzinga,/news/stocks/veru-s-cancer-candidate-sabizabulin-gets-fda-fast-track-tag-for-covid-19-1031145166,negative,0.882138729095459
4100,1/31/2022 7:14:21 PM,Novavax: The Fall of a Covid-19 Vaccine Star,InvestorPlace,/news/stocks/nvax-stock-the-fall-of-a-covid-vaccine-star-1031145725,positive,0.9126042127609253
4101,1/31/2022 8:48:12 PM,Why did Pfizer stock go down today? Moderna's COVID vaccine gets full approval,Seeking Alpha,https://seekingalpha.com/news/3793714-why-did-pfizer-stock-go-down-today-modernas-covid-vaccine-gets-full-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.713239312171936
4102,1/31/2022 9:23:47 PM,7 Blue-Chip Stocks to Buy for February,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-for-february-1031145993,positive,0.8969338536262512
4103,2/1/2022 8:43:53 AM,Danish study finds Omicron subvariant is 33% more infectious than original BA.1 variant,Seeking Alpha,https://seekingalpha.com/news/3793862-danish-study-finds-omicron-subvariant-is-33-more-infectious-than-original-ba1-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8590104579925537
4104,2/1/2022 1:39:01 PM,Moderna gains ending worst month ever,Seeking Alpha,https://seekingalpha.com/news/3794011-moderna-gains-in-pre-market-ending-worst-month-ever?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9059521555900574
4105,2/1/2022 2:23:56 PM,ViiV Healthcare announces FDA approval of two-month dosing of Cabenuva for HIV,Seeking Alpha,https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8925978541374207
4106,2/1/2022 3:22:51 PM,Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-these-key-february-pdufa-dates-1031149588,positive,0.946699321269989
4107,2/1/2022 6:05:08 PM,Pfizer adds former Roche executive William Pao as new Chief Development Officer,Seeking Alpha,https://seekingalpha.com/news/3794306-pfizer-adds-former-roche-executive-william-pao-as-new-chief-development-officer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9191876649856567
4108,2/1/2022 7:10:31 PM,Pfizer/BioNTech said to be seeking FDA nod for COVID-19 shot in kids under five,Seeking Alpha,https://seekingalpha.com/news/3794416-pfizerbiontech-said-to-be-seeking-fda-nod-for-covid-19-shot-in-kids-under-five?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5785310864448547
4109,2/1/2022 7:58:33 PM,Ionis Pharma suffers double downgrade at BofA on lack of notable catalysts,Seeking Alpha,https://seekingalpha.com/news/3794445-ionis-pharma-suffers-double-downgrade-at-bofa-on-lack-of-notable-catalysts?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9694157242774963
4110,2/1/2022 8:37:23 PM,Pfizer To Seek FDA Approval For COVID Vaccine In Children Under 5 Years ,RTTNews,/news/stocks/pfizer-to-seek-fda-approval-for-covid-vaccine-in-children-under-5-years-1031150684,negative,0.8164058327674866
4111,2/2/2022 3:07:03 AM,Pfizer Seeks FDA Approval For COVID-19 Vaccine In Children Under 5 Yrs ,RTTNews,/news/stocks/pfizer-seeks-fda-approval-for-covid-19-vaccine-in-children-under-5-yrs-1031151275,negative,0.916344404220581
4112,2/2/2022 4:29:43 AM,"GlaxoSmithKline Says Gilead, ViiV Healthcare Settle Patent Dispute Over HIV Drug ",RTTNews,/news/stocks/glaxosmithkline-says-gilead-viiv-healthcare-settle-patent-dispute-over-hiv-drug-1031151283,negative,0.400597482919693
4113,2/2/2022 4:39:53 AM,GlaxoSmithKline's ViiV Healthcare Receives FDA Approval For HIV Treatment ,RTTNews,/news/stocks/glaxosmithkline-s-viiv-healthcare-receives-fda-approval-for-hiv-treatment-1031151285,negative,0.9274295568466187
4114,2/2/2022 9:13:21 PM,"Avoid Novavax for Now, Until the Picture Clears Up",InvestorPlace,/news/stocks/avoid-novavax-for-now-until-the-picture-clears-up-1031155602,positive,0.8661519289016724
4115,2/3/2022 8:12:55 PM,"Carnival’s Outlook Has Greatly Improved, But CCL Stock Remains Very Risky",InvestorPlace,/news/stocks/carnivals-outlook-has-greatly-improved-but-ccl-stock-remains-very-risky-1031160170,negative,0.9564800262451172
4116,2/4/2022 7:22:35 AM,Valneva Announces Further Positive Phase 2 Data For Lyme Disease Vaccine Candidate VLA15 ,RTTNews,/news/stocks/valneva-announces-further-positive-phase-2-data-for-lyme-disease-vaccine-candidate-vla15-1031161569,negative,0.9087399244308472
4117,2/4/2022 11:00:56 AM,7 Hot Stocks That Can Win in Either a Bull or Bear Market,InvestorPlace,/news/stocks/7-hot-stocks-that-can-win-in-either-a-bull-or-bear-market-1031162094,positive,0.8898822069168091
4118,2/4/2022 1:34:06 PM,"The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures",Benzinga,/news/stocks/the-daily-biotech-pulse-sanofi-bristol-myers-squibb-gain-on-earnings-valneva-pfizer-tout-positive-lyme-disease-vaccine-data-unity-biotech-restructures-1031162384,negative,0.8567988872528076
4119,2/4/2022 2:16:32 PM,Pfizer and Valneva to test a three-dose schedule for Lyme disease vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3796051-pfizer-and-valneva-to-test-a-three-dose-schedule-for-lyme-disease-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5544422268867493
4120,2/4/2022 2:25:04 PM,"Valneva, Pfizer plan three-dose series for phase 3 Lyme disease vaccine trial",Seeking Alpha,https://seekingalpha.com/news/3796054-valneva-pfizer-plan-three-dose-series-for-phase-3-lyme-disease-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7550216317176819
4121,2/4/2022 2:56:13 PM,Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward,Benzinga,/news/stocks/valneva---pfizer-choose-three-dose-schedule-for-lyme-vaccine-candidate-moving-forward-1031162648,positive,0.9003263711929321
4122,2/4/2022 4:36:55 PM,5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet,InvestorPlace,/news/stocks/5-biotech-stocks-to-buy-to-benefit-from-bidens-new-cancer-cabinet-1031163083,positive,0.7185425758361816
4123,2/4/2022 5:18:40 PM,7 Earnings Reports to Watch the Week of February 7,InvestorPlace,/news/stocks/7-earnings-reports-to-watch-the-week-of-february-7-1031163197,positive,0.9037090539932251
4124,2/4/2022 8:33:43 PM,CDC recommends a shorter duration for fourth COVID-19 shot in immunocompromised,Seeking Alpha,https://seekingalpha.com/news/3796218-cdc-recommends-a-shorter-duration-for-fourth-covid-19-shot-in-immunocompromised?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9003798961639404
4125,2/4/2022 10:07:51 PM,Moderna vaccine wins full approval endorsement from CDC,Seeking Alpha,https://seekingalpha.com/news/3796268-moderna-vaccine-wins-full-approval-endorsement-from-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9114784598350525
4126,2/5/2022 5:00:00 PM,List prices of prescription medicines rise nearly 7% on average in 2022,Seeking Alpha,https://seekingalpha.com/news/3796290-drugmakers-raise-list-prices-by-nearly-7-on-average-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8705558180809021
4127,2/7/2022 1:02:40 AM,Shionogi COVID-19 pill under consideration in Japan for use as early as this spring,Seeking Alpha,https://seekingalpha.com/news/3796317-shionogi-covid-19-pill-under-consideration-in-japan-for-use-as-early-as-this-spring?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8678749203681946
4128,2/7/2022 11:00:34 AM,7 Best Blue-Chip Stocks to Buy for Safety in This Volatile Market,InvestorPlace,/news/stocks/7-best-blue-chip-stocks-to-buy-for-safety-in-this-volatile-market-1031166510,positive,0.7571009993553162
4129,2/7/2022 12:26:42 PM,ViiV Healthcare to report new data for long-acting HIV therapies,Seeking Alpha,https://seekingalpha.com/news/3796401-viiv-healthcare-to-report-new-data-for-long-acting-hiv-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8651371002197266
4130,2/7/2022 2:07:48 PM,Animal study suggests Omicron-specific COVID booster not needed,Seeking Alpha,https://seekingalpha.com/news/3796504-animal-study-suggests-omicron-specific-covid-booster-not-needed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8969321250915527
4131,2/7/2022 3:01:13 PM,Pfizer earnings preview: what to expect,Markets Insider Automation,/news/stocks/pfizer-q4-quarterly-earnings-preview-1031167275,positive,0.9113932847976685
4132,2/7/2022 3:17:26 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3796574-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
4133,2/7/2022 4:44:29 PM,All eyes on Pfizer Q4 earnings amid bolstered COVID-19 vaccine forecast,Seeking Alpha,https://seekingalpha.com/news/3796671-all-eyes-on-pfizer-q4-earnings-amid-bolstered-covid-19-vaccine-forecast?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9244586229324341
4134,2/7/2022 7:22:29 PM,"Despite 22% gain today, Codex DNA still well down from June IPO price",Seeking Alpha,https://seekingalpha.com/news/3796845-despite-22-gain-today-codex-dna-still-well-down-from-june-ipo-price?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9727872610092163
4135,2/8/2022 11:46:27 AM,"Pfizer Non-GAAP EPS of $1.08 beats by $0.21, revenue of $23.84B misses by $360M",Seeking Alpha,https://seekingalpha.com/news/3797069-pfizer-non-gaap-eps-of-1_08-beats-0_21-revenue-of-23_84b-misses-360m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6485762000083923
4136,2/8/2022 12:18:49 PM,Pfizer drags rival COVID-19 vaccine makers after lower-than-expected 2022 guidance,Seeking Alpha,https://seekingalpha.com/news/3797098-pfizer-drags-rival-covid-19-vaccine-makers-after-lower-than-expected-2022-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9312959313392639
4137,2/8/2022 12:48:48 PM,Pfizer Inc. Q4 Income Advances,RTTNews,/news/stocks/pfizer-inc-q4-income-advances-1031171139,positive,0.8826377987861633
4138,2/8/2022 1:53:06 PM,Pfizer Q4 Adj. Profit Rises; Projects 47% Operational Growth In FY22 Adj. EPS ,RTTNews,/news/stocks/pfizer-q4-adj-profit-rises-projects-47-operational-growth-in-fy22-adj-eps-1031171394,negative,0.9516793489456177
4139,2/8/2022 1:59:44 PM,Novavax falls short of COVID-19 vaccine deliveries - Reuters,Seeking Alpha,https://seekingalpha.com/news/3797192-novavax-falls-short-of-covid-19-vaccine-deliveries-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9152528643608093
4140,2/8/2022 2:29:54 PM,"The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-amgen-shares-slip-on-earnings-editas-terminates-chief-medical-officer-biogen-licenses-preclinical-rheumatoid-arthritis-biosimilar-1031171617,neutral,0.9022089242935181
4141,2/8/2022 4:02:11 PM,Mid-Morning Market Update: Markets Mostly Higher; Dow Rises 100 Points,Benzinga,/news/stocks/mid-morning-market-update-markets-mostly-higher-dow-rises-100-points-1031172365,negative,0.9139174818992615
4142,2/8/2022 6:00:24 PM,35 Stocks Moving In Tuesday's Mid-Day Session,Benzinga,/news/stocks/35-stocks-moving-in-tuesday-s-mid-day-session-1031172774,neutral,0.5375669002532959
4143,2/8/2022 6:23:49 PM,Mid-Day Market Update: Pfizer Sales Miss Expectations; Teradata Shares Spike Higher,Benzinga,/news/stocks/mid-day-market-update-pfizer-sales-miss-expectations-teradata-shares-spike-higher-1031172882,negative,0.8904063105583191
4144,2/8/2022 6:39:07 PM,NVAX Stock Alert: Why Is Novavax Plunging Today?,InvestorPlace,/news/stocks/nvax-stock-alert-why-is-novavax-plunging-today-2-1031173037,neutral,0.8646395206451416
4145,2/8/2022 7:58:13 PM,Take a Leap Into Novavax Stock After Vaccine Sales Start,InvestorPlace,/news/stocks/take-a-leap-into-nvax-stock-after-vaccine-sales-start-1031173149,positive,0.895214855670929
4146,2/8/2022 8:32:55 PM,Mid-Afternoon Market Update: Nasdaq Surges 100 Points; Graham Shares Plunge,Benzinga,/news/stocks/mid-afternoon-market-update-nasdaq-surges-100-points-graham-shares-plunge-1031173120,negative,0.8163430094718933
4147,2/8/2022 9:24:38 PM,"4 Top Stock Trades for Wednesday: PTON, TDOC, PFE, FB",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-pton-tdoc-pfe-fb-1031173683,positive,0.9332755208015442
4148,2/8/2022 10:01:01 PM,Why did Novavax stock drop today? Concerns on COVID-19 vaccine deliveries,Seeking Alpha,https://seekingalpha.com/news/3797576-why-did-novavax-stock-drop-today-concerns-on-covid-19-vaccine-deliveries?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9487600326538086
4149,2/8/2022 10:57:32 PM,Why did BioNTech stock drop today? Pfizer 2022 guidance,Seeking Alpha,https://seekingalpha.com/news/3797606-why-did-biontech-stock-drop-today-pfizer-2022-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7576904296875
4150,2/9/2022 2:46:25 PM,Novavax Stock Is a Buy After This Overdone Sell-Off,InvestorPlace,/news/stocks/nvax-stock-is-a-buy-after-this-overdone-sell-off-1031177644,positive,0.7124496102333069
4151,2/9/2022 4:10:18 PM,"Pfizer price target cut at Wells Fargo, Morgan Stanley following quarterly earnings",Seeking Alpha,https://seekingalpha.com/news/3797898-pfizer-price-target-cuts-at-wells-fargo-jp-morgan-following-quarterly-earnings?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7303698658943176
4152,2/9/2022 8:11:27 PM,CDC plans to begin COVID-19 vaccine rollout for younger kids by Feb. 21,Seeking Alpha,https://seekingalpha.com/news/3798097-cdc-plans-to-begin-covid-19-vaccine-rollout-for-younger-kids-by-feb-21?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.853394627571106
4153,2/10/2022 11:48:15 AM,Teva eyes up to $3.6 billion to settle opioid claims - Reuters,Seeking Alpha,https://seekingalpha.com/news/3798416-teva-stock-lower-as-company-eyes-up-to-36-billion-to-settle-opioid-claims-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6728845834732056
4154,2/10/2022 4:08:55 PM,Where Pfizer Stands With Analysts,Benzinga,/news/stocks/where-pfizer-stands-with-analysts-1031182623,positive,0.9324877858161926
4155,2/10/2022 5:02:48 PM,Expert Ratings For Pfizer,Benzinga,/news/stocks/expert-ratings-for-pfizer-1031182819,positive,0.8965446352958679
4156,2/10/2022 9:50:29 PM,Two Insider Moonshots Rising on Sudden Buying,InvestorPlace,/news/stocks/two-insider-moonshots-rising-on-sudden-buying-1031183802,neutral,0.4524227976799011
4157,2/11/2022 7:17:17 PM,"Pfizer, Moderna boosters less effective at 4 months, but protect against hospitalization",Seeking Alpha,https://seekingalpha.com/news/3799307-pfizer-moderna-boosters-less-effective-after-4-months-but-protect-against-hospitalization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7954779863357544
4158,2/13/2022 2:32:29 PM,"The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-feb-13-19-agios-fda-meeting-avenue-adcom-earnings-and-more-1031188728,positive,0.9418706297874451
4159,2/14/2022 12:48:05 PM,Pfizer granted regulatory nod for COVID-19 pill in China,Seeking Alpha,https://seekingalpha.com/news/3799486-pfizer-granted-regulatory-nod-for-covid-19-pill-in-china?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8527706861495972
4160,2/14/2022 1:18:23 PM,Biohaven Pharma: Rimegepant Asia-Pacific Phase 3 Study Meets Co-primary Endpoints ,RTTNews,/news/stocks/biohaven-pharma-rimegepant-asia-pacific-phase-3-study-meets-co-primary-endpoints-1031191251,negative,0.6815605163574219
4161,2/14/2022 2:20:12 PM,Pfizer/ Biohaven announce late-stage migraine trial met main goals in Asia Pacific,Seeking Alpha,https://seekingalpha.com/news/3799560-pfizer-biohaven-announce-late-stage-migraine-trial-met-main-goals-in-asia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9369078278541565
4162,2/14/2022 3:22:44 PM,COVID-19 vaccine makers decline after delay for FDA decision on vaccines for kids,Seeking Alpha,https://seekingalpha.com/news/3799593-covid-19-vaccine-makers-decline-after-delay-for-fda-decision-on-vaccines-for-kids?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9581161737442017
4163,2/14/2022 4:20:58 PM,CStone's Commercialization Capacity Put to Test With Latest Drug Approval,Benzinga,/news/stocks/cstone-s-commercialization-capacity-put-to-test-with-latest-drug-approval-1031192012,negative,0.8431601524353027
4164,2/14/2022 9:23:47 PM,Why did Moderna stock drop today? Waning sentiment on vaccine makers,Seeking Alpha,https://seekingalpha.com/news/3799785-why-did-moderna-stock-drop-today-waning-sentiment-on-vaccine-makers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.944150984287262
4165,2/14/2022 10:24:55 PM,FDA Pushes Vaccine For Children Under 5 Year Back For More Data ,RTTNews,/news/stocks/fda-pushes-vaccine-for-children-under-5-year-back-for-more-data-1031192782,positive,0.7393250465393066
4166,2/15/2022 4:41:51 PM,Pfizer wins European approval for next-gen pneumococcal vaccine,Seeking Alpha,https://seekingalpha.com/news/3800215-pfizer-stock-lower-despite-eu-approval-for-pneumococcal-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9215337038040161
4167,2/15/2022 6:19:15 PM,Shipment Delays Threaten the Best Advantage Novavax Has,InvestorPlace,/news/stocks/nvax-stock-will-continue-to-drop-as-long-as-shipments-are-delayed-1031197050,neutral,0.9211195111274719
4168,2/15/2022 6:19:21 PM,"Pfizer, OPKO pediatric growth hormone deficiency injection somatrogon gets EU nod",Seeking Alpha,https://seekingalpha.com/news/3800269-pfizer-opko-pediatric-growth-hormone-deficiency-somatrogon-injection-gets-eu-nod?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5245991349220276
4169,2/16/2022 12:32:07 PM,BioNTech introduces plans for mRNA vaccine manufacturing facility in Africa,Seeking Alpha,https://seekingalpha.com/news/3800627-biontech-introduces-plans-for-mrna-vaccine-manufacturing-facility-in-africa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6579838991165161
4170,2/16/2022 5:29:33 PM,U.K. to offer Pfizer/BioNTech COVID-19 vaccine to all kids aged 5 – 11,Seeking Alpha,https://seekingalpha.com/news/3800847-pfe-bntx-stocks-rise-as-uk-to-offer-covid-19-vaccine-for-all-kids?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6339256167411804
4171,2/16/2022 6:57:55 PM,Novavax Stock Is at Risk Despite Positive Poll Results,InvestorPlace,/news/stocks/nvax-stock-is-at-risk-despite-positive-poll-results-1031201978,neutral,0.8575948476791382
4172,2/16/2022 8:18:33 PM,Pfizer/BioNTech Omicron shot delayed amid slow data collection - BioNTech CEO,Seeking Alpha,https://seekingalpha.com/news/3800967-pfizer-biontech-omicron-shot-delayed-amid-slow-data-collection?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.954056978225708
4173,2/17/2022 12:40:36 PM,"DaVita study suggests J&J, Pfizer/BioNTech COVID vaccines at parity for kidney patients",Seeking Alpha,https://seekingalpha.com/news/3801363-davita-study-suggests-jj-pfizerbiontech-covid-vaccines-at-parity-for-kidney-patients?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7366131544113159
4174,2/17/2022 11:34:50 PM,Want To Bet Against Tesla? There Could Be A New Inverse ETF For Traders,Benzinga,/news/etf/want-to-bet-against-tesla-there-could-be-a-new-inverse-etf-for-traders-1031206731,positive,0.9279855489730835
4175,2/18/2022 4:03:41 PM,Ocugen Stock Is a Fairy Tale in Need of a Happy Ending,InvestorPlace,/news/stocks/ocgn-stock-is-a-fairy-tale-in-need-of-a-happy-ending-1031209187,positive,0.7692315578460693
4176,2/18/2022 4:22:01 PM,Pfizer COVID vaccine for kids delayed because of efficacy against Omicron - WSJ,Seeking Alpha,https://seekingalpha.com/news/3801992-pfizer-covid-vaccine-for-kids-delayed-because-of-efficacy-against-omicron-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7983729243278503
4177,2/19/2022 5:00:34 PM,Novavax COVID-19 shot could be granted U.S. nod “within weeks” - CEO,Seeking Alpha,https://seekingalpha.com/news/3802209-nvax-stock-is-in-focus-as-novavax-covid-19-shot-to-win-us-nod-within-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7793039083480835
4178,2/20/2022 12:28:35 PM,FDA Considers Approving Second COVID-19 Booster Dose: Report ,RTTNews,/news/stocks/fda-considers-approving-second-covid-19-booster-dose-report-1031210431,positive,0.9217764139175415
4179,2/21/2022 11:00:44 AM,Dump Novavax Stock as Delays May Make Its Vaccine Practically Obsolete,InvestorPlace,/news/stocks/dump-nvax-stock-as-delays-may-make-its-vaccine-practically-obsolete-1031212125,neutral,0.8953219652175903
4180,2/21/2022 11:00:53 AM,Why Novavax Has Limited Downside from Here,InvestorPlace,/news/stocks/nvax-stock-why-novavax-has-limited-downside-from-here-1031212123,positive,0.8412752747535706
4181,2/21/2022 4:12:25 PM,Growth stocks rule in Goldman screen of biggest retail investor buys and sells,Seeking Alpha,https://seekingalpha.com/news/3802227-growth-stocks-rule-in-goldman-screen-of-biggest-retail-investors-buys-and-sells?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8495696187019348
4182,2/22/2022 1:19:59 PM,Adagio falls after announcing resignation of CEO,Seeking Alpha,https://seekingalpha.com/news/3802414-adgi-stock-falls-after-announcing-resignation-of-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8917426466941833
4183,2/22/2022 3:24:26 PM,Supreme Court refuses religious grounds appeal of vaccination mandate,Seeking Alpha,https://seekingalpha.com/news/3802542-supreme-court-refuses-appeal-of-healthcare-vaccination-requirement-on-religious-grounds?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5146982669830322
4184,2/22/2022 4:11:13 PM,"Jefferies initiates Novavax with a buy citing COVID vaccine profile, sales potential",Seeking Alpha,https://seekingalpha.com/news/3802602-jefferies-initiates-novavax-with-a-buy-citing-covid-vaccine-profile-sales-potential?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6024258136749268
4185,2/22/2022 5:04:46 PM,COVID-19 vaccine makers slide even as FDA eyes second booster shot,Seeking Alpha,https://seekingalpha.com/news/3802677-covid-19-vaccine-makers-slide-amid-fda-plans-for-second-booster?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9426842927932739
4186,2/22/2022 7:11:33 PM,Production Updates Could Give Novavax Stock a Big Boost,InvestorPlace,/news/stocks/nvax-stock-production-updates-could-give-it-a-boost-1031217460,negative,0.9308496117591858
4187,2/23/2022 5:15:41 PM,"BioNTech a buy at Wainwright, but price target lowered on long-term vaccine sales",Seeking Alpha,https://seekingalpha.com/news/3804324-biontech-a-buy-at-wainwright-but-price-target-lowered-on-long-term-vaccine-sales?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6952051520347595
4188,2/23/2022 9:34:08 PM,Vaxcyte doses first patients in phase 1/2 trial of pneumonia vaccine,Seeking Alpha,https://seekingalpha.com/news/3804622-vaxcyte-doses-first-patients-in-phase-12-trial-of-pneumonia-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6519384980201721
4189,2/24/2022 9:30:02 AM,AstraZeneca signs deal to supply Canada 100k doses of COVID antibody therapy Evusheld,Seeking Alpha,https://seekingalpha.com/news/3804839-astrazeneca-signs-deal-to-supply-canada-100k-doses-of-covid-antibody-therapy-evusheld?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8332064747810364
4190,2/24/2022 11:00:05 AM,4 Pharma Stocks to Buy Even if the Pandemic Ends,InvestorPlace,/news/stocks/4-pharma-stocks-to-buy-even-if-the-pandemic-ends-azn-pfe-mrna-nvax-1031225712,positive,0.5500292181968689
4191,2/24/2022 11:00:33 AM,Novavax Is a Buy on Recent Developments and Cheap Valuation,InvestorPlace,/news/stocks/nvax-stock-is-a-buy-on-recent-developments-and-cheap-valuation-1031225812,positive,0.7897573113441467
4192,2/25/2022 2:00:21 PM,"Biohaven, Pfizer Get Positive CHMP Opinion For Rimegepant To Treat Migraine ",RTTNews,/news/stocks/biohaven-pfizer-get-positive-chmp-opinion-for-rimegepant-to-treat-migraine-1031231968,negative,0.9425851106643677
4193,2/25/2022 4:46:48 PM,Healthcare leads a rally in S&P 500 amid hopes of Russia - Ukraine talks,Seeking Alpha,https://seekingalpha.com/news/3806014-healthcare-leads-a-rally-in-sp-500-amid-hopes-of-russia-ukraine-talks?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7153167128562927
4194,2/25/2022 6:04:25 PM,Moderna’s Covid Shot Alone Isn’t Enough to Revitalize a Sagging Stock,InvestorPlace,/news/stocks/moderna-mrna-stock-covid-shot-inadequate-to-revitalize-sagging-stock-1031233114,neutral,0.7961618304252625
4195,2/25/2022 6:16:03 PM,Pfizer biosimilar for Humira goes under FDA review for interchangeability,Seeking Alpha,https://seekingalpha.com/news/3806089-pfizer-biosimilar-for-humira-goes-under-fda-review-for-interchangeability?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5119301676750183
4196,2/25/2022 6:44:27 PM,7 Best Stocks to Buy for a Recession,InvestorPlace,/news/stocks/7-best-stocks-to-buy-for-a-recession-1031233169,positive,0.8775793313980103
4197,2/25/2022 8:48:40 PM,3 Beaten-Down Growth Stocks With More Than 50% Upside Potential,InvestorPlace,/news/stocks/3-beaten-down-growth-stocks-with-more-than-50-upside-potential-1031233353,neutral,0.9221370816230774
4198,2/28/2022 11:37:24 AM,Demand for COVID-19 boosters declines in U.S. as case numbers fall,Seeking Alpha,https://seekingalpha.com/news/3806743-demand-for-covid-19-boosters-declines-in-us-as-case-numbers-fall?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9688529372215271
4199,2/28/2022 5:20:03 PM,Can Inovio Pharmaceuticals Q4 results bring earnings surprise?,Seeking Alpha,https://seekingalpha.com/news/3807034-can-inovio-pharmaceuticals-q4-results-bring-earnings-surprise?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5145217776298523
4200,2/28/2022 7:32:38 PM,Pfizer/BioNTech COVID-19 vaccine protection falls more rapidly in kids 5 to 11 - study,Seeking Alpha,https://seekingalpha.com/news/3807126-pfizer-biontech-covid-19-vaccine-protection-falls-rapidly-in-kids?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9258989095687866
4201,3/1/2022 11:00:50 AM,7 Most Undervalued Stocks to Buy in March 2022,InvestorPlace,/news/stocks/7-most-undervalued-stocks-to-buy-for-march-2022-t-rio-bti-pfe-mmm-cvx-lmt-1031242130,neutral,0.5274600982666016
4202,3/1/2022 12:01:55 PM,Pfizer says pivotal trial for Clostridioides difficile shot did not meet main goal,Seeking Alpha,https://seekingalpha.com/news/3807522-pfizer-lower-as-clostridioides-difficile-shot-fails-main-goal-in-pivotal-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8119436502456665
4203,3/1/2022 1:23:45 PM,Pfizer : Phase 3 Trial Of Investigational C. Difficile Vaccine Fails To Meet Primary Goal ,RTTNews,/news/stocks/pfizer-phase-3-trial-of-investigational-c-difficile-vaccine-fails-to-meet-primary-goal-1031242455,neutral,0.9045193195343018
4204,3/1/2022 10:00:18 PM,Pfizer's Covid Vaccine Not Very Effective In Children Between 5-11 Years Against Omicron Variant ,RTTNews,/news/stocks/pfizer-s-covid-vaccine-not-very-effective-in-children-between-5-11-years-against-omicron-variant-1031244568,positive,0.6187849044799805
4205,3/1/2022 11:22:04 PM,Pfizer Canada to recall high blood pressure drug due to potential cancer-causing impurity,Seeking Alpha,https://seekingalpha.com/news/3808220-pfizer-canada-to-recall-high-blood-pressure-drug-due-to-potential-cancer-causing-impurity?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9493787288665771
4206,3/2/2022 11:34:21 AM,Biden unveils new initiative to provide free COVID-19 pills to Americans,Seeking Alpha,https://seekingalpha.com/news/3808304-biden-unveils-new-initiative-to-provide-free-covid-19-pills?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7231737971305847
4207,3/2/2022 12:15:09 PM,Pfizer's RSV vaccine for pregnant women gets FDA breakthrough therapy status,Seeking Alpha,https://seekingalpha.com/news/3808337-pfizers-rsv-vaccine-for-pregnant-women-gets-fda-breakthrough-therapy-status?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8454136848449707
4208,3/2/2022 1:35:33 PM,"Biden pushes for insulin price cap, Medicare drug negotiations in SOTU",Seeking Alpha,https://seekingalpha.com/news/3808400-biden-pushes-for-insulin-price-cap-medicare-drug-negotiations-in-sotu?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6005553603172302
4209,3/2/2022 1:47:19 PM,FDA Grants Breakthrough Therapy Designation For Pfizer's RSVpreF To Prevent RSV In Infants ,RTTNews,/news/stocks/fda-grants-breakthrough-therapy-designation-for-pfizer-s-rsvpref-to-prevent-rsv-in-infants-1031247308,negative,0.8831486105918884
4210,3/2/2022 1:50:21 PM,"The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi",Benzinga,/news/stocks/the-daily-biotech-pulse-karyopharm-flags-delay-in-selinexor-label-expansion-finch-celyad-hit-with-clinical-holds-adagene-strikes-r-d-collaboration-with-sanofi-1031247316,neutral,0.902799665927887
4211,3/2/2022 8:48:55 PM,36 Stocks To Watch After Biden's First State of The Union Address,Benzinga,/news/stocks/36-stocks-to-watch-after-biden-s-first-state-of-the-union-address-1031248946,positive,0.8909978270530701
4212,3/3/2022 10:56:57 AM,Pfizer to supply 10M courses of COVID drug Paxlovid to developing nations in 2022- Reuters,Seeking Alpha,https://seekingalpha.com/news/3808852-pfizer-to-supply-10m-courses-of-covid-drug-paxlovid-to-developing-nations-in-2022-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5848161578178406
4213,3/3/2022 3:57:17 PM,U.S. to share government-backed COVID-19 tech with WHO - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3809199-us-to-share-government-backed-covid-19-tech-with-who-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.697287917137146
4214,3/4/2022 12:02:36 PM,Pfizer Canada recalls blood pressure drug on potential cancer-causing impurity,Seeking Alpha,https://seekingalpha.com/news/3809518-pfizer-recalls-blood-pressure-drug-on-cancer-causing-agent?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.861807107925415
4215,3/4/2022 12:46:57 PM,EMA downplays impact of new data on Pfizer/BioNTech vaccine efficacy in children,Seeking Alpha,https://seekingalpha.com/news/3809539-ema-downplays-new-data-on-pfizerbiontech-vaccine-efficacy-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7271735072135925
4216,3/4/2022 3:30:29 PM,Shionogi COVID-19 vaccine meets primary endpoint as booster,Seeking Alpha,https://seekingalpha.com/news/3809642-shionogi-covid-19-vaccine-meets-primary-endpoint-as-booster?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7357487082481384
4217,3/4/2022 4:31:07 PM,"New York City to lift indoor vaccine mandate, school mask requirement on Monday",Seeking Alpha,https://seekingalpha.com/news/3809678-new-york-city-to-lift-indoor-vaccine-mandate-school-mask-requirement-on-monday?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8576470613479614
4218,3/4/2022 8:00:51 PM,"Catalyst watch for next week: GE Investor Day, Apple event and AT&T spotlight",Seeking Alpha,https://seekingalpha.com/news/3809770-catalyst-watch-for-next-week-ge-investor-day-apple-event-and-att-spotlight?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9414692521095276
4219,3/7/2022 4:39:22 PM,U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute,Seeking Alpha,https://seekingalpha.com/news/3810273-dispute-with-gop-senators-could-jeopardize-additional-finding-for-covid-19-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9586585164070129
4220,3/7/2022 8:55:52 PM,Sanofi eyes mRNA technology with plans for over $1B investments in France,Seeking Alpha,https://seekingalpha.com/news/3810374-sanofi-eyes-mrna-tech-with-plans-for-1b-investments-in-france?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.49998950958251953
4221,3/8/2022 12:50:17 PM,7 Best Long-Term Stocks to Buy for 2022,InvestorPlace,/news/stocks/7-best-long-term-stocks-to-buy-for-2022-1031262363,positive,0.8807052969932556
4222,3/8/2022 1:50:09 PM,"BioNTech, Regeneron add lung cancer for studies on mRNA-based shot and Libtayo",Seeking Alpha,https://seekingalpha.com/news/3810611-biontech-regeneron-add-lung-cancer-for-studies-on-mrna-based-shot-and-libtayo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8245120644569397
4223,3/8/2022 6:56:54 PM,Pfizer will soon provide data to U.S. FDA on fourth COVID shot - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3810764-pfizer-will-soon-provide-data-to-us-fda-on-fourth-covid-shot-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9119805693626404
4224,3/9/2022 11:24:06 AM,7 Biotech Stocks With Key Catalysts in March,InvestorPlace,/news/stocks/7-biotech-stocks-with-key-catalysts-in-march-1031265751,negative,0.571002721786499
4225,3/9/2022 12:02:29 PM,Pfizer COVID-19 pill undergoes clinical trial involving children,Seeking Alpha,https://seekingalpha.com/news/3811010-pfizer-covid-19-pill-undergoes-clinical-trial-involving-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4865715205669403
4226,3/9/2022 1:12:35 PM,Pfizer Begins Phase 2/3 Study Of COVID-19 Oral Treatment In Pediatric Participants ,RTTNews,/news/stocks/pfizer-begins-phase-2-3-study-of-covid-19-oral-treatment-in-pediatric-participants-1031265941,positive,0.7252835631370544
4227,3/9/2022 1:52:45 PM,"The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-begins-late-stage-pediatric-covid-pill-study-midatech-and-j-j-unit-expand-r-d-collaboration-abbvie-alvotech-settle-humira-dispute-1031266063,negative,0.6761938333511353
4228,3/9/2022 11:35:09 PM,7 Stocks That Benefit From Rising Geo-Political Tensions,InvestorPlace,/news/stocks/7-stocks-that-benefit-from-rising-geo-political-tensions-1031268065,positive,0.7193514704704285
4229,3/10/2022 12:10:32 PM,Pfizer agrees to supply COVID-19 pills to Africa CDC,Seeking Alpha,https://seekingalpha.com/news/3812023-pfizer-agrees-to-supply-covid-19-pills-to-africa-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8165990710258484
4230,3/10/2022 12:35:12 PM,7 Drug Stocks to Consider After the Viatris Plunge,InvestorPlace,/news/stocks/7-drug-stocks-to-consider-after-the-viatris-plunge-abbv-bmy-gsk-vtrs-jnj-teva-pfe-nvs-mrk-1031269941,positive,0.926745593547821
4231,3/10/2022 7:41:24 PM,Is Roblox Stock a Game Bulls Want to Play?,InvestorPlace,/news/stocks/is-roblox-stock-a-game-bulls-want-to-play-1031271555,positive,0.9188315868377686
4232,3/11/2022 10:08:58 AM,Pfizer's COVID-19 drug Paxlovid gets emergency use nod in The Philippines - Reuters,Seeking Alpha,https://seekingalpha.com/news/3812593-pfizers-covid-19-drug-paxlovid-gets-emergency-use-nod-in-the-philippines-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5625605583190918
4233,3/11/2022 12:05:02 PM,Moderna COVID-19 vaccine info needs update to reflect new warning - EU regulator,Seeking Alpha,https://seekingalpha.com/news/3812632-moderna-covid-19-vaccine-info-needs-update-to-reflect-new-warning---ema?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9174661040306091
4234,3/11/2022 4:14:55 PM,"Pfizer plans to stop further investment in Russia, but will still send medicines",Seeking Alpha,https://seekingalpha.com/news/3812773-pfizer-plans-to-stop-further-investment-in-russia-but-will-still-send-medicines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5778527855873108
4235,3/12/2022 7:20:14 PM,Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict,Seeking Alpha,https://seekingalpha.com/news/3812903-drugmakers-face-clinical-trial-disruptions-amid-russia-ukraine-conflict?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9664651155471802
4236,3/12/2022 9:00:00 PM,"Pharma companies still supplying medicines to Russia, but some impact being felt",Seeking Alpha,https://seekingalpha.com/news/3812889-large-pharmaceutical-companies-still-supplying-medicines-to-russia-some-impact-felt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7648188471794128
4237,3/14/2022 11:00:00 AM,IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors,PR Newswire,/news/stocks/ideaya-and-pfizer-expand-clinical-trial-collaboration-and-supply-agreements-for-evaluation-of-darovasertib-and-crizotinib-combination-in-metastatic-uveal-melanoma-and-additional-cmet-driven-tumors-1031277159,negative,0.9372826218605042
4238,3/14/2022 11:03:51 AM,Novavax faces slow uptake for COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3812987-novavax-faces-slow-uptake-for-covid-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8866075277328491
4239,3/14/2022 11:28:13 AM,"IDEAYA, Pfizer To Evaluate Darovasertib- Crizotinib Combination In MUM And Addl CMET-Driven Tumors ",RTTNews,/news/stocks/ideaya-pfizer-to-evaluate-darovasertib-crizotinib-combination-in-mum-and-addl-cmet-driven-tumors-1031277237,positive,0.660761833190918
4240,3/14/2022 11:56:55 AM,Pfizer COVID-19 pill unlikely to be ready for many until at least next year - Airfinity,Seeking Alpha,https://seekingalpha.com/news/3813021-pfizer-covid-19-pill-unlikely-to-be-ready-for-many-until-2023?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8351211547851562
4241,3/14/2022 5:12:54 PM,"Pfizer, Bayer pull back from certain business activities in Russia",Seeking Alpha,https://seekingalpha.com/news/3813213-pfizer-bayer-to-cut-back-business-activities-in-russia?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7412428855895996
4242,3/14/2022 7:59:15 PM,Why Is Novavax (NVAX) Stock in the Spotlight Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-in-the-spotlight-today-1031279006,positive,0.7051430344581604
4243,3/14/2022 9:37:23 PM,"4 Top Stock Trades for Tuesday: Gold, GME, PFE, QCOM",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-gold-gme-pfe-qcom-1031279364,positive,0.9283111691474915
4244,3/14/2022 10:10:09 PM,4 Blue-Chip Stocks to Buy in March,InvestorPlace,/news/stocks/4-blue-chip-stocks-to-buy-in-march-1031279307,positive,0.8426539897918701
4245,3/15/2022 10:05:28 AM,2 Reasons to Buy and Hold onto Pfizer Stock,InvestorPlace,/news/stocks/pfe-stock-2-reasons-to-buy-and-hold-on-to-pfizer-stock-1031280504,positive,0.9306535720825195
4246,3/15/2022 11:10:54 AM,"Pfizer, Moderna executives offer contrasting views on additional COVID-19 shots",Seeking Alpha,https://seekingalpha.com/news/3813487-pfizer-moderna-executives-offer-contrasting-views-on-additional-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7930891513824463
4247,3/15/2022 2:49:24 PM,Eli Lilly to halt exporting “non-essential” medicines to Russia,Seeking Alpha,https://seekingalpha.com/news/3813665-eli-lilly-to-halt-exporting-non-essential-medicines-to-russia-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5850395560264587
4248,3/15/2022 4:22:32 PM,Moderna News: What Has MRNA Stock Moving This Week?,InvestorPlace,/news/stocks/moderna-news-what-has-mrna-stock-moving-this-week-1031282348,positive,0.7820590734481812
4249,3/15/2022 5:19:52 PM,U.S. faces a shortage of COVID-19 antibody therapies without more funds - White House,Seeking Alpha,https://seekingalpha.com/news/3813747-us-risks-shortage-of-covid-19-antibody-therapies-without-more-funds?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4740936756134033
4250,3/15/2022 7:30:26 PM,Why Is Ocugen (OCGN) Stock Up Today?,InvestorPlace,/news/stocks/why-is-ocugen-ocgn-stock-up-today-1031282761,positive,0.8110389709472656
4251,3/15/2022 8:18:47 PM,Viatris wins FDA approval for first generic of AstraZeneca’s Symbicort,Seeking Alpha,https://seekingalpha.com/news/3813823-viatris-wins-fda-approval-for-generic-of-astrazenecas-symbicort?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8522506952285767
4252,3/15/2022 11:01:46 PM,"Pfizer To Continue Supplying Medicines To Russia, Halts Clinical Trials ",RTTNews,/news/stocks/pfizer-to-continue-supplying-medicines-to-russia-halts-clinical-trials-1031283130,neutral,0.9256435036659241
4253,3/16/2022 2:56:12 AM,Pfizer Seeks Emergency Use Authorization In U.S. For Second COVID-19 Booster Dose ,RTTNews,/news/stocks/pfizer-seeks-emergency-use-authorization-in-u-s-for-second-covid-19-booster-dose-1031283201,negative,0.8705675601959229
4254,3/16/2022 10:49:18 AM,The Biggest Reasons to Avoid Ocugen for Now,InvestorPlace,/news/stocks/ocgn-stock-the-biggest-reasons-to-avoid-ocugen-for-now-1031284499,positive,0.8973510265350342
4255,3/16/2022 12:11:59 PM,Investors Should Not Lose Faith in Novavax,InvestorPlace,/news/stocks/investors-should-not-lose-faith-in-novavax-1031284904,positive,0.7285550832748413
4256,3/16/2022 1:02:21 PM,"The Daily Biotech Pulse:  Pfizer-BioNTech Apply For Authorization Of 3rd Booster Shot, Sanofi-Seagen Strike Cancer Therapy Pact, Iovance Gets Nod For Cancer Study",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-apply-for-authorization-of-3rd-booster-shot-sanofi-seagen-strike-cancer-therapy-pact-iovance-gets-nod-for-cancer-study-1031284787,negative,0.5291966199874878
4257,3/16/2022 1:30:01 PM,Key WTO members reach deal for IP waiver on COVID-19 shots; drugmakers oppose,Seeking Alpha,https://seekingalpha.com/news/3814118-key-wto-members-reach-deal-for-covid-vaccine-ip-waiver?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4446623623371124
4258,3/16/2022 7:58:45 PM,Pfizer COVID-19 pill added to treatment protocol in China amid rising cases,Seeking Alpha,https://seekingalpha.com/news/3814282-pfizer-covid-19-pill-added-to-treatment-protocol-in-china-amid-rising-cases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9158064723014832
4259,3/17/2022 11:12:38 AM,Centogene and Pfizer expand collaboration agreement,Seeking Alpha,https://seekingalpha.com/news/3814492-centogene-and-pfizer-expand-collaboration-agreement?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9353046417236328
4260,3/17/2022 11:52:39 AM,AbbVie price target raised at BofA after Rinvoq approval for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3814515-abbvie-price-target-raised-at-bofa-after-rinvoq-approval-for-ulcerative-colitis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8643791675567627
4261,3/17/2022 12:51:42 PM,Alnylam Files Patent Infringement Suits Against Pfizer And Moderna On COVID-19 Vaccines ,RTTNews,/news/stocks/alnylam-files-patent-infringement-suits-against-pfizer-and-moderna-on-covid-19-vaccines-1031288360,neutral,0.8816784620285034
4262,3/17/2022 3:14:22 PM,Moderna COVID-19 shot cleared in Canada for children aged 6 to 11 years,Seeking Alpha,https://seekingalpha.com/news/3814647-moderna-covid-19-shot-cleared-in-canada-for-children-aged-6-to-11-years?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.48886701464653015
4263,3/17/2022 5:58:59 PM,AstraZeneca ready to drop plans for U.S. regulatory approval of COVID-19 shot - FT,Seeking Alpha,https://seekingalpha.com/news/3814697-astrazeneca-to-drop-plans-for-us-regulatory-approval-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.920452892780304
4264,3/17/2022 7:22:50 PM,Viatris wins Tecfidera patent battle as court denies Biogen’s petition,Seeking Alpha,https://seekingalpha.com/news/3814713-viatris-wins-tecfidera-patent-battle-as-court-denies-biogens-petition?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5104275941848755
4265,3/17/2022 8:11:29 PM,Over 30 generic manufacturers agree to make Pfizer COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3814693-over-30-generic-manufacturers-agree-to-make-pfizer-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5867654085159302
4266,3/18/2022 3:16:33 AM,Moderna seeks approval for second booster shot in all adults,Seeking Alpha,https://seekingalpha.com/news/3814831-moderna-seeks-approval-for-second-booster-shot-in-all-adults?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7180225849151611
4267,3/18/2022 12:50:39 PM,"The Daily Biotech Pulse: Moderna Files For 2nd COVID Booster Shot Authorization, Lexicon Secures Debt Funding, Amneal Gets Sub-License to Manufacture Generic COVID Pill",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-files-for-2nd-covid-booster-shot-authorization-lexicon-secures-debt-funding-amneal-gets-sub-license-to-manufacture-generic-covid-pill-1031291535,negative,0.6417161226272583
4268,3/18/2022 4:09:01 PM,Arbutus sued to avoid patent dispute over Pfizer/BioNTech COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3815049-arbutus-sued-for-seeking-royalties-for-pfizerbiontech-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6792816519737244
4269,3/18/2022 5:07:28 PM,COVID vaccine names higher following Moderna second booster request,Seeking Alpha,https://seekingalpha.com/news/3815066-covid-vaccine-names-higher-following-moderna-second-booster-request?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6659059524536133
4270,3/18/2022 7:29:11 PM,Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters,Benzinga,/news/stocks/maker-of-pfizer-s-covid-19-vaccine-mrna-delivery-tech-sues-arbutus-biopharma-reuters-1031292557,positive,0.9241021275520325
4271,3/18/2022 7:59:48 PM,Pfizer CEO saw 2021 total compensation grow 15% in 2021 to $24.3M,Seeking Alpha,https://seekingalpha.com/news/3815095-pfizer-ceo-saw-2021-total-compensation-grow-15-in-2021-to-243m?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9386865496635437
4272,3/19/2022 6:43:44 PM,"Barron's Latest Picks And Pans: Nvidia, Wayfair, Moderna, Pfizer, Palo Alto Networks",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-nvidia-wayfair-moderna-pfizer-palo-alto-networks-1031293124,positive,0.9400420188903809
4273,3/21/2022 1:40:24 PM,FDA to hold AdCom meeting on COVID-19 booster shots next month,Seeking Alpha,https://seekingalpha.com/news/3815361-pfx-bntx-mrna-stocks-gain-on-adcom-meeting-on-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9316228628158569
4274,3/21/2022 2:40:24 PM,"CDC studies find COVID booster shots very effective against hospitalization, death",Seeking Alpha,https://seekingalpha.com/news/3815415-cdc-studies-find-covid-booster-shots-very-effective-against-hospitalization-death?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7398281693458557
4275,3/21/2022 4:29:10 PM,"Ahead Of Moderna's Midstage mRNA Flu Vaccine Readout, Analyst Says Drugmaker Likely To Be First To Market",Benzinga,/news/stocks/ahead-of-moderna-s-midstage-mrna-flu-vaccine-readout-analyst-says-drugmaker-likely-to-be-first-to-market-1031295660,positive,0.6276229619979858
4276,3/21/2022 4:59:01 PM,"Dear MRNA Stock Fans, Mark Your Calendars for This Potential Moderna Catalyst on March 24",InvestorPlace,/news/stocks/dear-mrna-stock-fans-mark-your-calendars-for-this-potential-moderna-catalyst-on-march-24-1031295977,positive,0.9372690916061401
4277,3/21/2022 9:21:12 PM,Pfizer recalling lots of blood pressure meds over potential cancer-causing impurity,Seeking Alpha,https://seekingalpha.com/news/3815804-pfizer-recalling-lots-of-blood-pressure-meds-over-potential-cancer-causing-impurity?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.3981851637363434
4278,3/22/2022 11:14:52 AM,Pfizer to deliver up to 4 million COVID-19 treatment courses to UNICEF,Seeking Alpha,https://seekingalpha.com/news/3815894-pfizer-to-deliver-up-to-4-million-covid-19-treatment-courses-to-unicef?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5143445730209351
4279,3/22/2022 11:58:14 AM,"Pfizer Recalls Blood Pressure Drug Accuretic, Two Generics ",RTTNews,/news/stocks/pfizer-recalls-blood-pressure-drug-accuretic-two-generics-1031297654,positive,0.8685082793235779
4280,3/22/2022 12:25:52 PM,Pfizer To Supply UNICEF Up To 4 Mln Oral Courses Of Paxlovid To Fight Covid-19 In 95 Countries ,RTTNews,/news/stocks/pfizer-to-supply-unicef-up-to-4-mln-oral-courses-of-paxlovid-to-fight-covid-19-in-95-countries-1031297802,negative,0.8152309060096741
4281,3/22/2022 1:31:50 PM,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-keytruda-snags-another-fda-approval-pfizer-strikes-covid-19-pill-supply-deal-argenx-reports-positive-late-stage-readout-1031298122,negative,0.8023924827575684
4282,3/22/2022 4:53:13 PM,COVID Omicron subvariant BA.2 accounts for growing share of new cases in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3816112-covid-omicron-subvariant-ba2-accounts-for-growing-share-of-new-cases-in-the-us-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6759209632873535
4283,3/23/2022 8:25:14 AM,U.S. weighs fourth booster as BA.2 subvariant threatens next COVID wave,Seeking Alpha,https://seekingalpha.com/news/3816282-us-weighs-fourth-booster-as-ba2-subvariant-threatens-next-covid-wave?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4939180314540863
4284,3/23/2022 8:37:15 AM,"Merck, Ridgeback's COVID-19 oral pill gets emergency use nod in South Korea - Yonhap",Seeking Alpha,https://seekingalpha.com/news/3816306-merck-ridgebacks-covid-19-oral-pill-gets-emergency-use-nod-in-south-korea-yonhap?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7063933610916138
4285,3/23/2022 11:08:05 AM,Pfizer's etrasimod helps improve remission in ulcerative colitis patients in phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3816341-pfizers-etrasimod-improving-remission-in-ulcerative-colitis-patients-in-phase-3-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9353376030921936
4286,3/23/2022 12:00:50 PM,Pfizer Announces Positive Topline Results For Phase 3 Study Of Etrasimod For Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-announces-positive-topline-results-for-phase-3-study-of-etrasimod-for-ulcerative-colitis-1031300870,negative,0.9406293630599976
4287,3/23/2022 12:17:10 PM,Moderna to seek regulatory nod for low dose COVID-19 shot in kids after positive data,Seeking Alpha,https://seekingalpha.com/news/3816391-mrna-stock-lower-despite-plans-for-regulatory-nod-for-covid-19-shot-in-kids?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9240938425064087
4288,3/23/2022 12:43:16 PM,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-positive-ulcerative-colitis-study-data-novavax-covid-shot-authorized-for-adolescents-in-india-argenx-stock-sale-1031301077,positive,0.5290573239326477
4289,3/23/2022 5:36:32 PM,White House mulls fourth COVID-19 shot for older Americans - Politico,Seeking Alpha,https://seekingalpha.com/news/3816601-white-house-mulls-fourth-covid-19-shot-for-older-americans-politico?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9233741164207458
4290,3/24/2022 5:43:17 AM,"Moderna finalizes strategic partnership with Australian government,
 to produce its mRNA vaccines in Australia from 2024",Seeking Alpha,https://seekingalpha.com/news/3816730-moderna-finalizes-strategic-partnership-with-australian-governmentto-produce-its-mrna-vaccines-in-australia-from-2024?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8416634798049927
4291,3/24/2022 9:12:33 AM,Novartis' Sandoz to recall 13 lots of drug over potential cancer-causing impurity,Seeking Alpha,https://seekingalpha.com/news/3816772-novartis-sandoz-to-recall-13-lots-of-drug-over-potential-cancer-causing-impurity?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8632261157035828
4292,3/24/2022 11:08:24 AM,Sinovac booster shows 98% protection against death/severe COVID in people over 60 in study,Seeking Alpha,https://seekingalpha.com/news/3816826-sinovac-booster-shows-98-protection-against-deathsevere-covid-in-people-over-60-in-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7916512489318848
4293,3/24/2022 11:16:20 AM,Pfizer granted FDA’s Breakthrough Therapy Designation for RSV vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3816833-pfizer-granted-fdas-breakthrough-therapy-designation-for-rsv-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8714413046836853
4294,3/24/2022 12:09:47 PM,Pfizer Says FDA Grants Breakthrough Therapy Designation For RSV Vaccine Candidate ,RTTNews,/news/stocks/pfizer-says-fda-grants-breakthrough-therapy-designation-for-rsv-vaccine-candidate-1031304401,negative,0.8187615871429443
4295,3/24/2022 1:10:16 PM,"The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-prostate-cancer-drug-lands-fda-approval-ligand-announces-spac-deal-to-spin-off-antibody-business-lilly-s-lung-cancer-therapy-hit-with-crl-1031304689,positive,0.8169834613800049
4296,3/24/2022 3:38:11 PM,Aptevo climbs as 2021 revenue more than doubles,Seeking Alpha,https://seekingalpha.com/news/3817012-aptevo-climbs-as-2021-revenue-more-than-doubles?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9442018270492554
4297,3/25/2022 3:29:01 AM,ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva ,RTTNews,/news/stocks/viiv-healthcare-fda-approves-label-update-for-long-acting-hiv-treatment-cabenuva-1031306584,negative,0.9180295467376709
4298,3/25/2022 5:36:37 PM,"Long COVID, the next frontier for vaccine and drug developers",Seeking Alpha,https://seekingalpha.com/news/3817601-long-covid-the-newest-target-of-vaccine-and-drug-developers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.841420590877533
4299,3/25/2022 8:17:08 PM,"Drug makers, Scientists Working For Long COVID Treatments: Reuters",Benzinga,/news/stocks/drug-makers-scientists-working-for-long-covid-treatments-reuters-1031309051,positive,0.9318907856941223
4300,3/27/2022 12:02:30 PM,COVID-19 shot makers to face investor scrutiny over vaccine access at annual meetings,Seeking Alpha,https://seekingalpha.com/news/3817795-covid-19-shot-makers-to-face-scrutiny-on-vaccine-access-at-annual-meetings?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9087089896202087
4301,3/27/2022 11:17:50 PM,"These Are The Top 10 Stocks Held On Robinhood: Where Do Apple, Tesla, AMC And Sundial Rank?",Benzinga,/news/stocks/these-are-the-top-10-stocks-held-on-robinhood-where-do-apple-tesla-amc-and-sundial-rank-1031310199,positive,0.9356536865234375
4302,3/28/2022 11:45:20 AM,Moderna’s Stock Needs a Shot in the Arm,InvestorPlace,/news/stocks/mrna-stock-needs-a-shot-in-the-arm-1031311715,positive,0.8027302622795105
4303,3/28/2022 2:39:11 PM,Pfizer COVID pill Paxlovid to be examined in hospitalized patients,Seeking Alpha,https://seekingalpha.com/news/3818024-pfizer-covid-pill-paxlovid-to-be-examined-in-hospitalized-patients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7642919421195984
4304,3/28/2022 3:06:36 PM,Israeli study finds second Pfizer COVID booster shot reduces mortality 78% in older adults,Seeking Alpha,https://seekingalpha.com/news/3818035-israeli-study-finds-second-pfizer-covid-booster-shot-reduces-mortality-78-in-older-adults?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4847162067890167
4305,3/28/2022 8:55:38 PM,Codex DNA slide continues as shares down ~70% over last month,Seeking Alpha,https://seekingalpha.com/news/3818134-codex-dna-slide-continues-as-shares-down-70-over-last-month?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9703229665756226
4306,3/29/2022 8:47:27 AM,"US agency pauses distribution of GSK, Vir's COVID-19 therapy sotrovimab in certain states",Seeking Alpha,https://seekingalpha.com/news/3818262-us-agency-pauses-distribution-of-gsk-virs-covid-19-antibody-therapy-in-certain-states?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8007267713546753
4307,3/29/2022 11:11:19 AM,Pfizer meets key goals in second late-stage trial for ulcerative colitis candidate,Seeking Alpha,https://seekingalpha.com/news/3818316-pfizer-meets-key-goals-in-second-late-stage-trial-for-ulcerative-colitis-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8648213744163513
4308,3/29/2022 1:01:08 PM,Pfizer Reports Positive Top-line Results For Phase 3 Trial Of Etrasimod In Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-reports-positive-top-line-results-for-phase-3-trial-of-etrasimod-in-ulcerative-colitis-1031314805,negative,0.9456327557563782
4309,3/29/2022 1:41:44 PM,"The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia",Benzinga,/news/stocks/the-daily-biotech-pulse-sanofi-igm-ink-antibody-drug-collaboration-neogenomics-sinks-on-ceo-departure-q1-warning-decision-day-for-akebia-1031314930,positive,0.7195650339126587
4310,3/29/2022 2:53:29 PM,J&J to suspend supply of personal care products in Russia,Seeking Alpha,https://seekingalpha.com/news/3818471-jj-to-suspend-supply-of-personal-care-products-in-russia?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8334856629371643
4311,3/29/2022 5:07:21 PM,FDA Gives Emergency Use Authorization To Pfizer's Second COVID-19 Booster Dose ,RTTNews,/news/stocks/fda-gives-emergency-use-authorization-to-pfizer-s-second-covid-19-booster-dose-1031315961,positive,0.5680058002471924
4312,3/29/2022 5:21:13 PM,More contagious Omicron subvariant becomes dominant in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3818551-more-contagious-omicron-subvariant-becomes-dominant-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7569723129272461
4313,3/29/2022 7:55:34 PM,Pfizer/BioNTech and Moderna win U.S. regulatory nod for second booster shot (updated),Seeking Alpha,https://seekingalpha.com/news/3818472-pfizerbiontech-and-moderna-granted-fda-ok-for-second-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5794868469238281
4314,3/30/2022 2:00:00 AM,"Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential",PR Newswire,/news/stocks/everest-medicines-announces-that-licensing-partner-pfizer-reports-positive-topline-results-from-yearlong-phase-3-trial-of-etrasimod-in-ulcerative-colitis-patients-underscoring-best-in-class-potential-1031316820,negative,0.9546845555305481
4315,3/30/2022 3:58:28 AM,Pfizer Announces Positive Results From Phase 3 Trial Of Etrasimod In Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-announces-positive-results-from-phase-3-trial-of-etrasimod-in-ulcerative-colitis-1031316860,negative,0.9367538094520569
4316,3/30/2022 9:20:15 AM,Pfizer's etrasimod helps improve remission in ulcerative colitis in 2nd phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3818743-pfizer-etrasimod-helps-improve-remission-in-ulcerative-colitis-in-2nd-phase-3-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9304028749465942
4317,3/30/2022 10:11:11 AM,7 Blue-Chip Stocks With Dividends to Add to Your Buy List,InvestorPlace,/news/stocks/7-blue-chip-stocks-with-dividends-to-add-to-your-buy-list-pfejpmintcpeplmt-abbv-cvx-1031318198,positive,0.9334786534309387
4318,3/30/2022 10:23:32 AM,Novavax Stock Is a Bet on Interest From Unvaccinated People,InvestorPlace,/news/stocks/novavax-stock-is-a-bet-on-interest-from-unvaccinated-people-1031318249,positive,0.9361350536346436
4319,3/30/2022 10:57:24 AM,"BioNTech Q4 profit soars on COVID vaccine sales; plans buyback, special dividend",Seeking Alpha,https://seekingalpha.com/news/3818774-biontech-profit-soars-on-covid-vaccine-sales-plans-buyback-special-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.893722653388977
4320,3/30/2022 1:46:42 PM,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-s-lung-cancer-combo-therapy-flunks-late-stage-study-adagio-spikes-on-positive-covid-antibody-data-amylyx-awaits-adcom-verdict-1031318540,neutral,0.5641264319419861
4321,3/30/2022 2:28:52 PM,"FDA Authorizes 2nd Booster Dose Of Pfizer, Moderna COVID-19 Vaccines ",RTTNews,/news/stocks/fda-authorizes-2nd-booster-dose-of-pfizer-moderna-covid-19-vaccines-1031318786,positive,0.7951435446739197
4322,3/30/2022 3:55:12 PM,BioNTech News: Why Is BNTX Stock Up Today?,InvestorPlace,/news/stocks/biontech-news-why-is-bntx-stock-up-today-1031319675,positive,0.8708518147468567
4323,3/30/2022 5:01:58 PM,MRNA Stock: What’s Going on With Moderna This Week?,InvestorPlace,/news/stocks/mrna-stock-whats-going-on-with-moderna-this-week-1031319877,positive,0.5903424620628357
4324,3/30/2022 5:16:02 PM,PFE Stock: What’s Going on With Pfizer This Week?,InvestorPlace,/news/stocks/pfe-stock-whats-going-on-with-pfizer-this-week-1031319898,positive,0.49908745288848877
4325,3/30/2022 5:41:41 PM,"Top Penny Stocks Today: Why Are ADGI, DRCT, VYNT, NAOV, GERN and SNOA Rising Today?",InvestorPlace,/news/stocks/top-penny-stocks-today-why-are-adgi-drct-vynt-naov-gern-and-snoa-rising-today-1031319924,positive,0.822098970413208
4326,3/30/2022 9:53:08 PM,"Ivermectin does not lower risk of hospitalization from COVID, new study finds",Seeking Alpha,https://seekingalpha.com/news/3819122-ivermectin-does-not-lower-risk-of-hospitalization-from-covid-new-study-finds?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8444841504096985
4327,3/31/2022 11:14:15 AM,3 Vaccine Stocks to Buy on the New Covid Variant Surge,InvestorPlace,/news/stocks/3-vaccine-stocks-to-buy-on-the-new-covid-variant-surge-1031322095,positive,0.7322282791137695
4328,3/31/2022 7:42:37 PM,Pfizer/BioNTech COVID-19 shot cuts hospitalizations in younger children - study,Seeking Alpha,https://seekingalpha.com/news/3819499-pfizerbiontech-covid-19-shot-cuts-hospitalizations-in-younger-children?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5770585536956787
4329,4/1/2022 1:21:28 AM,"34 Public Companies That Made Time's 100 Most Influential For 2022: AMC, Disney, Ford And More",Benzinga,/news/stocks/34-public-companies-that-made-time-s-100-most-influential-for-2022-amc-disney-ford-and-more-1031324276,positive,0.901957094669342
4330,4/1/2022 10:37:35 AM,World's 1st COVID human challenge trial suggests spread of virus not correlated to symptoms,Seeking Alpha,https://seekingalpha.com/news/3819725-worlds-1st-covid-human-challenge-trial-suggests-spread-of-virus-not-correlated-to-symptoms?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8839459419250488
4331,4/1/2022 8:02:24 PM,How to Approach Trading Downtrodden Novavax Today,InvestorPlace,/news/stocks/how-to-approach-trading-downtrodden-novavax-nvax-stock-today-1031327433,positive,0.9039692878723145
4332,4/3/2022 4:19:55 PM,"10 Investor Questions About COVID-19, Answered",Benzinga,/news/stocks/10-investor-questions-about-covid-19-answered-1031328140,positive,0.9415953755378723
4333,4/4/2022 10:37:30 AM,"CanSino, CSPC Pharma win regulatory nod in China to start trials for mRNA COVID-19 shots",Seeking Alpha,https://seekingalpha.com/news/3820246-cansino-cspc-pharma-win-chinese-nod-to-start-trials-for-mrna-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6254933476448059
4334,4/4/2022 9:00:38 PM,Lawmakers agree on $10 billion additional funding for U.S. COVID response (Updated),Seeking Alpha,https://seekingalpha.com/news/3820489-lawmakers-set-to-announce-10-billion-additional-funding-for-us-covid-response?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6900182366371155
4335,4/4/2022 9:17:18 PM,Moderna CEO predicts many people will eventually get annual COVID shots,Seeking Alpha,https://seekingalpha.com/news/3820563-moderna-ceo-predicts-many-people-will-eventually-get-annual-covid-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.801128089427948
4336,4/5/2022 10:59:46 AM,7 Biotech Stocks to Buy With Key Catalysts for April,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-with-key-catalysts-for-april-1031332726,positive,0.7184770703315735
4337,4/5/2022 2:47:23 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1031333236,positive,0.8152946829795837
4338,4/5/2022 3:00:00 PM,Annual Boosters Might Not Give Moderna the Boost It Needs,InvestorPlace,/news/stocks/mrna-stock-annual-booster-may-not-give-it-the-boost-it-needs-1031333944,negative,0.6086446046829224
4339,4/5/2022 3:07:28 PM,Pfizer rebounds as Citi starts positive Catalyst Watch and raises price target,Seeking Alpha,https://seekingalpha.com/news/3820811-pfizer-rebounds-as-citi-starts-positive-catalyst-watch-and-raise-price-target?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8562873601913452
4340,4/5/2022 3:32:39 PM,3 Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/3-vanguard-etfs-to-buy-now-1031333971,positive,0.9078019857406616
4341,4/5/2022 4:24:27 PM,Global group calls for $15 billion this year for long term COVID response,Seeking Alpha,https://seekingalpha.com/news/3820854-global-group-call-for-15-billion-this-year-for-long-term-covid-response?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5450633764266968
4342,4/5/2022 8:00:15 PM,Novavax hits a new 52-week low as vaccine makers drop ahead of FDA meeting,Seeking Alpha,https://seekingalpha.com/news/3820930-novavax-hits-a-new-52-week-low-as-vaccine-makers-drop-ahead-of-fda-meeting?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9637163281440735
4343,4/5/2022 10:17:17 PM,7 Safe Stocks to Buy to Guard Against a Recession,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-to-guard-against-a-recession-1031334812,positive,0.8407782912254333
4344,4/6/2022 11:12:04 AM,"Pfizer/BioNTech fourth dose protects against COVID-19, but effect wanes quickly - study",Seeking Alpha,https://seekingalpha.com/news/3821043-pfizer-biontech-fourth-dose-protects-against-covid-19-but-effect-wanes-quickly?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5275558829307556
4345,4/6/2022 1:51:54 PM,Bristol-Myers Squibb downgraded at Morgan Stanley on revenue growth concerns,Seeking Alpha,https://seekingalpha.com/news/3821149-bristol-myers-squibb-downgraded-at-morgan-stanley-on-revenue-growth-concerns?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9343669414520264
4346,4/6/2022 4:44:05 PM,Is NVAX Stock a Buy at 52-Week Low? Skip the Novavax Portfolio Injection,InvestorPlace,/news/stocks/is-nvax-stock-a-buy-at-52-week-low-skip-the-novavax-portfolio-injection-1031337591,positive,0.5795310735702515
4347,4/6/2022 7:51:36 PM,FDA panel considers need for broader use of COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3821383-fda-panel-considers-need-for-broader-use-of-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7073596119880676
4348,4/7/2022 10:59:56 AM,Pfizer to broaden RSV portfolio with deal to acquire ReViral for up to $525 million,Seeking Alpha,https://seekingalpha.com/news/3821570-pfizer-to-broaden-rsv-portfolio-with-deal-to-buy-reviral-for-up-to-525m?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7464067935943604
4349,4/7/2022 1:04:02 PM,Pfizer To Acquire ReViral For Up To $525 Mln ,RTTNews,/news/stocks/pfizer-to-acquire-reviral-for-up-to-525-mln-1031339517,positive,0.8710716962814331
4350,4/7/2022 1:37:39 PM,Dear Biotech Investors: Novavax’s Comparable Vaccine Matters,InvestorPlace,/news/stocks/nvax-stock-dear-biotech-investors-novavaxs-comparable-vaccine-matters-1031340330,positive,0.6512704491615295
4351,4/7/2022 2:24:52 PM,"The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-goes-shopping-astrazeneca-inks-bispecific-antibody-deal-aptinyx-faces-clinical-study-setback-erytech-jumps-on-data-and-more-1031339904,positive,0.6574383974075317
4352,4/7/2022 4:41:26 PM,FDA vaccine chief says frequent COVID-19 boosters are not sustainable,Seeking Alpha,https://seekingalpha.com/news/3821778-fda-vaccine-chief-says-frequent-covid-19-boosters-are-not-sustainable?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9079226851463318
4353,4/7/2022 7:38:30 PM,Life sciences companies drive healthcare stocks to lead S&P 500,Seeking Alpha,https://seekingalpha.com/news/3821820-life-sciences-companies-drive-healthcare-stocks-to-lead-sp-500?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8493631482124329
4354,4/7/2022 7:43:39 PM,"House, Senate Democrats introduce bills targeting 'abusive' pharma business practices",Seeking Alpha,https://seekingalpha.com/news/3821821-house-senate-democrats-introduce-bills-targeting-abusive-pharma-business-practices?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6520105004310608
4355,4/7/2022 8:23:29 PM,Pfizer posts biggest intraday gain this year after FDA meeting on booster shots,Seeking Alpha,https://seekingalpha.com/news/3821847-pfe-stock-posts-biggest-intraday-gain-this-year-after-fda-meeting-on-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9155977964401245
4356,4/7/2022 9:25:41 PM,"4 Top Stock Trades for Friday: F, PFE, WMT, RTX",InvestorPlace,/news/stocks/4-top-stock-trades-for-friday-f-pfe-wmt-rtx-1031341480,positive,0.9334604740142822
4357,4/8/2022 8:48:47 AM,Pfizer-Merck KGaA's Bavencio gets UK's NICE backing for use in bladder cancer,Seeking Alpha,https://seekingalpha.com/news/3821939-pfizer-merck-kgaas-bavencio-gets-uks-nice-backing-for-use-in-bladder-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8857198357582092
4358,4/8/2022 10:05:05 AM,Three Safe Stocks to Buy for an Umbrella of Protection,InvestorPlace,/news/stocks/three-safe-stocks-to-buy-for-an-umbrella-of-protection-1031342535,positive,0.890215277671814
4359,4/8/2022 10:57:31 AM,Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks,InvestorPlace,/news/stocks/layoffs-at-blue-stock-highlight-the-current-struggles-of-biotech-picks-1031342692,neutral,0.9662711024284363
4360,4/8/2022 11:06:05 AM,7 Desirable Dividend Growth Stocks for Income Investors,InvestorPlace,/news/stocks/7-desirable-dividend-growth-stocks-for-income-investors-1031342691,positive,0.8901300430297852
4361,4/8/2022 12:12:15 PM,Bipartisan legislation aims to increase value-based purchasing for pricey drugs in Medicaid,Seeking Alpha,https://seekingalpha.com/news/3821989-bipartisan-legislation-aims-to-increase-value-based-purchasing-for-pricey-drugs-in-medicaid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9119019508361816
4362,4/10/2022 1:39:55 PM,Demand for COVID-19 shots falls amid reluctance to boosters,Seeking Alpha,https://seekingalpha.com/news/3822183-demand-for-covid-19-shots-drop-amid-reluctance-to-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9703908562660217
4363,4/10/2022 10:42:49 PM,"The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-10-april-16-regeneron-fda-decision-cancer-conference-presentations-and-more-1031344759,positive,0.9415993690490723
4364,4/11/2022 9:20:18 AM,Pfizer's COVID-19 drug Paxlovid's 700K units ordered by Taiwan as cases rise - Reuters,Seeking Alpha,https://seekingalpha.com/news/3822224-pfizers-covid-19-drug-paxlovids-700k-units-ordered-by-taiwan-as-cases-rise-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.641778290271759
4365,4/11/2022 11:04:32 AM,Lowe's loses CFO to Pfizer,Seeking Alpha,https://seekingalpha.com/news/3822241-lowes-loses-cfo-to-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7251353859901428
4366,4/11/2022 1:18:12 PM,Pfizer Names David Denton To Succeed Frank D'Amelio As CFO And EVP ,RTTNews,/news/stocks/pfizer-names-david-denton-to-succeed-frank-d-amelio-as-cfo-and-evp-1031346078,positive,0.9447301030158997
4367,4/11/2022 11:10:16 PM,Study finds low risk of heart inflammation associated with COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3822515-study-finds-low-risk-of-heart-inflammation-associated-with-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6676790714263916
4368,4/12/2022 7:32:42 AM,Myovant : FDA Identifies 'deficiencies' In SNDA Review Of Myfembree On Endometriosis-related Pain ,RTTNews,/news/stocks/myovant-fda-identifies-deficiencies-in-snda-review-of-myfembree-on-endometriosis-related-pain-1031348509,neutral,0.8923301100730896
4369,4/12/2022 11:05:12 AM,"Pfizer, Myovant face regulatory issues in Myfembree label expansion",Seeking Alpha,https://seekingalpha.com/news/3822594-myov-pfe-stocks-fall-amid-regulatory-issues-for-myfembree-label-expansion?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6365192532539368
4370,4/12/2022 2:23:52 PM,Novavax Stock Is Slumping: Why Buy the Dip?,InvestorPlace,/news/stocks/nvax-stock-is-slumping-why-buy-the-dip-1031350237,neutral,0.9404982924461365
4371,4/12/2022 3:24:07 PM,"The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More",Benzinga,/news/stocks/the-daily-biotech-pulse-aeglea-stock-jumps-on-inherited-metabolic-disease-data-partial-hold-lifted-on-gilead-s-2-blood-trials-early-data-from-novartis-kras-inhibitor-and-more-1031349981,positive,0.48060187697410583
4372,4/12/2022 3:27:44 PM,What's Going On With Myovant Sciences Stock Today?,Benzinga,/news/stocks/what-s-going-on-with-myovant-sciences-stock-today-1031349980,neutral,0.5953172445297241
4373,4/12/2022 5:22:43 PM,CDC finds 86% of new COVID cases from Omicron subvariant BA.2,Seeking Alpha,https://seekingalpha.com/news/3822780-cdc-finds-86-of-new-covid-cases-from-omicron-subvariant-ba2?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5657769441604614
4374,4/13/2022 5:37:01 PM,COVID-19 public health emergency extended another 90 days,Seeking Alpha,https://seekingalpha.com/news/3823166-covid-19-public-health-emergency-extended-another-90-days?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5483344793319702
4375,4/14/2022 11:34:10 AM,Pfizer-BioNTech vaccine's booster shot in kids 5 to 11 better than 2 doses against Omicron,Seeking Alpha,https://seekingalpha.com/news/3823366-pfizer-biontech-vaccines-booster-shot-in-kids-5-to-11-better-than-2-doses-versus-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9379885792732239
4376,4/14/2022 2:00:48 PM,Pfizer/BioNTech's Booster Dose Of Covid-19 Vaccine Demonstrates High Immune Response In Children ,RTTNews,/news/stocks/pfizer-biontech-s-booster-dose-of-covid-19-vaccine-demonstrates-high-immune-response-in-children-1031356505,negative,0.7752891182899475
4377,4/14/2022 3:35:45 PM,"The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-covid-19-booster-data-in-kids-regeneron-s-covid-19-therapy-decision-pushed-protagonist-s-rusfertide-breakthrough-tag-update-and-more-1031357104,positive,0.9389084577560425
4378,4/14/2022 5:16:55 PM,Will Novavax Stock Continue to Trend Lower?,InvestorPlace,/news/stocks/nvax-stock-price-prediction-will-the-stock-continue-to-trend-lower-1031357745,neutral,0.8999833464622498
4379,4/14/2022 10:47:13 PM,WTO close to finalizing deal on COVID vaccines IP waiver - Reuters,Seeking Alpha,https://seekingalpha.com/news/3823626-world-trade-organization-close-to-finalizing-deal-on-covid-vaccines-ip-waiver-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8844926357269287
4380,4/15/2022 10:00:36 AM,Novavax: The Party’s Over,InvestorPlace,/news/stocks/nvax-stock-the-partys-over-1031358622,positive,0.8903039693832397
4381,4/17/2022 4:00:26 PM,Pfizer draws skeptics amid concerns over outlook for COVID-related sales,Seeking Alpha,https://seekingalpha.com/news/3823672-pfe-stock-in-focus-amid-concerns-over-outlook-for-covid-related-sales?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9677929878234863
4382,4/18/2022 12:54:24 AM,Johnson & Johnson COVID-19 shot holds its ground amid breakthrough cases,Seeking Alpha,https://seekingalpha.com/news/3823676-johnson-johnson-covid-19-shot-holds-its-ground-amid-breakthrough-cases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6651394963264465
4383,4/18/2022 11:28:37 AM,Pfizer oral COVID-19 therapy generates evidence for long COVID care,Seeking Alpha,https://seekingalpha.com/news/3823780-pfizer-oral-covid-19-therapy-generates-evidence-for-long-covid-care?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9041624665260315
4384,4/18/2022 11:59:23 AM,Eli Lilly expects $165 million in charges related to in-process R&D projects,Seeking Alpha,https://seekingalpha.com/news/3823792-eli-lilly-to-recognize-165-million-in-charges-related-to-in-process-rd-projects?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9416850805282593
4385,4/18/2022 2:00:19 PM,What Volatility in Novavax Means for Investors,InvestorPlace,/news/stocks/what-nvax-stock-volatility-means-for-investors-1031361244,positive,0.9330275654792786
4386,4/19/2022 9:32:46 AM,Ascletis ASC11 preclinical data shows promise as potential therapy for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3824161-ascletis-asc11-preclinical-data-shows-promise-as-potential-therapy-for-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9453887343406677
4387,4/19/2022 1:55:32 PM,Demand for Pfizer COVID-19 antiviral Paxlovid not as high as expected - Reuters,Seeking Alpha,https://seekingalpha.com/news/3824295-demand-for-pfizer-covid-19-antiviral-paxlovid-not-as-high-as-expected-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9317773580551147
4388,4/19/2022 1:55:40 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, April 19",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-april-19-1031363748,positive,0.9060149192810059
4389,4/20/2022 10:20:11 AM,7 Long-Term Stocks to Buy for a Robust Retirement,InvestorPlace,/news/stocks/7-long-term-stocks-to-buy-for-a-robust-retirement-1031367451,negative,0.7817785143852234
4390,4/20/2022 10:45:48 AM,4 Undervalued Biotech Stocks to Add to Your Buy List,InvestorPlace,/news/stocks/https-investorplace-com-2022-04-4-undervalued-bito-your-buy-list-rcus-vir-bntx-beam-1031367485,positive,0.8766852021217346
4391,4/20/2022 3:18:20 PM,Arcturus falls even as Piper Sandler backs COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3824788-arct-stock-falls-even-as-piper-sandler-backs-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8567078113555908
4392,4/20/2022 6:42:37 PM,Novavax has plunged amid falling demand for COVID vaccines. Is it time to buy?,Seeking Alpha,https://seekingalpha.com/news/3824544-novavax-has-plunged-amid-falling-demand-for-covid-vaccines-is-it-time-to-buy-pandemic?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8309870362281799
4393,4/20/2022 9:56:08 PM,"Pfizer adding expenses to non-GAAP adjusted income, resulting in lower income, EPS",Seeking Alpha,https://seekingalpha.com/news/3825058-pfizer-adding-expenses-to-non-gaap-adjusted-income-resulting-in-lower-income-eps?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9694046974182129
4394,4/21/2022 9:03:58 AM,Taiwan approves 2nd COVID booster shot as cases rise,Seeking Alpha,https://seekingalpha.com/news/3825131-taiwan-approves-2nd-covid-booster-shot-as-cases-rise?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7059260010719299
4395,4/21/2022 10:15:15 AM,7 Undervalued Large-Cap Stocks to Buy Now,InvestorPlace,/news/stocks/7-undervalued-large-cap-stocks-to-buy-now-1031371157,negative,0.6978760361671448
4396,4/21/2022 11:29:16 AM,7 Top-Rated Biotech Stocks to Buy for Q2,InvestorPlace,/news/stocks/7-top-rated-biotech-stocks-to-buy-for-q2-1031371403,positive,0.7978363037109375
4397,4/21/2022 12:16:09 PM,Arcturus cut to Neutral at Citi on COVID vaccine ARCT-154 'too risky' path ahead,Seeking Alpha,https://seekingalpha.com/news/3825238-arcturus-cut-to-neutral-at-citi-on-covid-vaccine-arct-154-too-risky-path-ahead?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.919505774974823
4398,4/21/2022 1:14:51 PM,COVID vaccination requirement extended for non-U.S. travelers at land ports of entry,Seeking Alpha,https://seekingalpha.com/news/3825301-covid-vaccination-requirement-extended-for-non-us-travelers-at-land-ports-of-entry?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.815434992313385
4399,4/21/2022 1:31:54 PM,Novavax Stock Looks Like a Good Value With Its New Combined Vaccine,InvestorPlace,/news/stocks/nvax-stock-looks-like-a-good-value-with-its-new-combined-vaccine-1031372247,negative,0.711908757686615
4400,4/21/2022 2:03:35 PM,FDA decision on COVID-19 shots for younger kids unlikely until June - Politico,Seeking Alpha,https://seekingalpha.com/news/3825345-fda-decision-on-covid-19-shots-for-younger-kids-unlikely-until-june?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.911371111869812
4401,4/21/2022 3:17:30 PM,CDC advisors question need for repeated boosters to prevent COVID-19 infections,Seeking Alpha,https://seekingalpha.com/news/3825379-cdc-advisors-question-need-for-repeated-boosters-to-prevent-covid-19-infections?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.529461145401001
4402,4/22/2022 12:00:43 AM,Pfizer: What Comes After the Covid-19 Fire?,InvestorPlace,/news/stocks/pfe-stock-what-comes-after-the-covid-fire-1031373557,positive,0.8588874936103821
4403,4/22/2022 8:58:18 AM,"WHO backs Pfizer's Paxlovid for certain COVID patients but raises concerns on drug access, pricing",Seeking Alpha,https://seekingalpha.com/news/3825662-who-backs-pfizers-paxlovid-in-high-risk-covid-patients-but-raises-concerns-on-drug-access-pricing?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6797877550125122
4404,4/22/2022 11:34:58 AM,Novavax Stock Could Give Back More of Its Pandemic-Era Gains,InvestorPlace,/news/stocks/nvax-stock-could-give-back-more-of-its-pandemic-era-gains-1031374986,neutral,0.7139690518379211
4405,4/22/2022 2:55:00 PM,Pfizer COVID-19 pill linked to reports of returning symptoms - Boston Globe,Seeking Alpha,https://seekingalpha.com/news/3825817-pfizer-covid-19-pill-linked-to-reports-of-returning-symptoms-boston-globe?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5093872547149658
4406,4/22/2022 3:38:56 PM,"The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial",Benzinga,/news/stocks/the-daily-biotech-pulse-who-endorses-pfizer-s-oral-covid-therapy-vallon-pharma-surges-on-strategic-review-novavax-starts-dosing-in-adolescents-covid-booster-trial-1031375402,positive,0.8492310047149658
4407,4/22/2022 4:05:06 PM,Pfizer/BioNTech COVID-19 shot OK’d in EU as a booster after other vaccines,Seeking Alpha,https://seekingalpha.com/news/3825845-pfizerbiontech-covid-19-shot-okd-in-eu-as-a-booster-after-other-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9218251705169678
4408,4/22/2022 7:34:58 PM,Pfizer to add nearly $24 billion revenue with COVID-19 pill in 2022- Airfinity,Seeking Alpha,https://seekingalpha.com/news/3825925-pfizer-set-to-add-nearly-24-billion-revenue-with-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8170008659362793
4409,4/23/2022 2:26:03 PM,Pfizer recalls certain batches of heart medication Accupril over carcinogen,Seeking Alpha,https://seekingalpha.com/news/3825999-pfizer-recalls-certain-batches-of-heart-medication-accupril-over-carcinogen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6405428051948547
4410,4/23/2022 8:00:00 PM,COVID therapies and vaccines propel rise in spending on medicines in 2021,Seeking Alpha,https://seekingalpha.com/news/3825965-covid-therapies-and-vaccines-propel-rise-in-spending-on-medicines-in-2021?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9413689374923706
4411,4/25/2022 2:07:00 PM,Pfizer Recalls Accupril (Quinapril HCl) Tablets ,RTTNews,/news/stocks/pfizer-recalls-accupril-quinapril-hcl-tablets-1031379902,neutral,0.9023649096488953
4412,4/25/2022 7:48:12 PM,Pfizer and Gilead earn preferred status for COVID-19 antivirals in new CDC advisory,Seeking Alpha,https://seekingalpha.com/news/3826382-pfe-gild-stocks-up-on-preferred-status-for-covid-19-antivirals-in-cdc-advisory?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7187272906303406
4413,4/25/2022 9:26:09 PM,"Nektar Therapeutics unveils restructuring plan, laying off 70% of its workforce",Seeking Alpha,https://seekingalpha.com/news/3826475-nektar-therapeutics-unveils-restructuring-plan-laying-off-70-of-its-workforce?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9647687077522278
4414,4/26/2022 8:25:01 AM,"Valneva, Pfizer Report Positive Phase 2 Pediatric Data For Lyme Disease Vaccine Candidate, VLA15 ",RTTNews,/news/stocks/valneva-pfizer-report-positive-phase-2-pediatric-data-for-lyme-disease-vaccine-candidate-vla15-1031383425,negative,0.9328840374946594
4415,4/26/2022 10:59:40 AM,US aims to boost use of Pfizer COVID drug Paxlovid with greenlight to pharmacies - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3826637-us-aims-to-boost-use-of-pfizer-covid-drug-paxlovid-with-greenlight-to-pharmacies-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8875924944877625
4416,4/26/2022 12:06:10 PM,Novavax price target lowered at B. Riley amid demand uncertainty for COVID-19 shots,Seeking Alpha,https://seekingalpha.com/news/3826692-nvax-stock-lower-as-b-riley-cuts-target-amid-uncertainty-for-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8622012138366699
4417,4/26/2022 3:04:05 PM,"The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track...",Benzinga,/news/stocks/the-daily-biotech-pulse-protagonist-s-ulcerative-colitis-study-disappoints-gilead-s-remdesivir-approved-for-pediatric-covid-19-patients-fda-gives-nod-to-gamida-s-cell-therapy-trial-fast-track-tag-for-vascular-biogenics-ovarian-cancer-gene-therapy-1031385309,negative,0.6228967308998108
4418,4/26/2022 3:04:23 PM,U.S. to expand access to COVID antiviral pills,Seeking Alpha,https://seekingalpha.com/news/3826839-us-to-expand-access-to-covid-antiviral-pills?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8982267379760742
4419,4/26/2022 5:37:35 PM,Valneva - Pfizer Post Encouraging Data From Lyme Disease Vaccine Candidate,Benzinga,/news/stocks/valneva---pfizer-post-encouraging-data-from-lyme-disease-vaccine-candidate-1031385823,negative,0.9467824697494507
4420,4/26/2022 8:01:37 PM,Nearly 60% of Americans have natural COVID-19 antibodies from prior infection - CDC,Seeking Alpha,https://seekingalpha.com/news/3827106-nearly-60-of-americans-have-natural-covid-19-antibodies-from-past-infection?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8145532011985779
4421,4/26/2022 9:29:09 PM,"Pfizer, BioNTech apply for U.S. FDA emergency use nod for COVID booster shot in kids 5 to 11",Seeking Alpha,https://seekingalpha.com/news/3827282-pfizer-biontech-apply-for-us-fda-emergency-use-nod-for-covid-booster-shot-in-kids-5-to-11?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6633250713348389
4422,4/26/2022 9:50:33 PM,"ViiV, Pfizer and Roche top pharmas on corporate reputation according to patient groups",Seeking Alpha,https://seekingalpha.com/news/3827291-viiv-pfizer-and-roche-top-pharmas-on-corporate-reputation-according-to-patient-groups?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8591098189353943
4423,4/27/2022 3:59:47 AM,Pfizer Asks FDA To Authorize COVID-19 Booster Dose For Children 5 To 11 Years ,RTTNews,/news/stocks/pfizer-asks-fda-to-authorize-covid-19-booster-dose-for-children-5-to-11-years-1031387068,positive,0.7813423871994019
4424,4/27/2022 10:15:08 AM,7 Biggest Loser Stocks That Could Become Surprising Buys,InvestorPlace,/news/stocks/7-biggest-loser-stocks-that-could-become-surprising-buys-1031390233,positive,0.8187510967254639
4425,4/27/2022 11:00:16 AM,4 Stocks to Buy as Inflation Surges to 40-Year High,InvestorPlace,/news/stocks/4-stocks-to-buy-as-inflation-surges-to-40-year-high-nem-fcx-pfe-lndnf-1031390531,negative,0.4937902092933655
4426,4/27/2022 12:27:35 PM,Zentalis Pharmaceuticals trades in green on $25M equity investment from Pfizer,Seeking Alpha,https://seekingalpha.com/news/3827540-zentalis-pharmaceuticals-trades-in-green-on-25m-equity-investment-from-pfizer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7421426773071289
4427,4/27/2022 1:30:37 PM,Pfizer-Biohaven Get EU's Marketing Authorization For VYDURA For Migraine Treatment ,RTTNews,/news/stocks/pfizer-biohaven-get-eu-s-marketing-authorization-for-vydura-for-migraine-treatment-1031390513,negative,0.9311668276786804
4428,4/27/2022 2:45:57 PM,"The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis",Benzinga,/news/stocks/the-daily-biotech-pulse-molecular-partners-plunges-on-double-bad-news-pfizer-biontech-seek-nod-for-covid-19-shot-in-kids-pfizer-invests-in-zentalis-1031391072,positive,0.732530951499939
4429,4/27/2022 4:17:48 PM,Pfizer Injects $25M Via Equity In Zentalis Pharma,Benzinga,/news/stocks/pfizer-injects-25m-via-equity-in-zentalis-pharma-1031392048,positive,0.8811123371124268
4430,4/27/2022 7:32:47 PM,Moderna investors turn down proposal to share vaccine tech,Seeking Alpha,https://seekingalpha.com/news/3827918-moderna-investors-turn-down-proposal-to-share-vaccine-tech?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8320972919464111
4431,4/28/2022 11:52:54 AM,Moderna seeks FDA nod to use COVID-19 vaccine in younger kids,Seeking Alpha,https://seekingalpha.com/news/3828507-moderna-seeks-fda-nod-to-use-covid-19-vaccine-in-younger-kids?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6257423162460327
4432,4/28/2022 12:05:10 PM,Pfizer declares $0.40 dividend,Seeking Alpha,https://seekingalpha.com/news/3828515-pfizer-declares-quarterly-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8511275053024292
4433,4/28/2022 7:49:36 PM,Pfizer to resume late-stage study for muscular dystrophy candidate as FDA lifts hold,Seeking Alpha,https://seekingalpha.com/news/3828830-pfizer-to-resume-late-stage-muscular-dystrophy-trial-as-fda-lifts-hold?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6188247799873352
4434,4/29/2022 1:39:24 PM,FDA sets AdCom meeting to discuss Novavax COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3829400-nvax-stock-rises-as-fda-plans-adcom-meeting-to-discuss-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9258933067321777
4435,4/29/2022 7:42:55 PM,"Pfizer vaccine chief, who led COVID-19 vaccine research, to retire",Seeking Alpha,https://seekingalpha.com/news/3829635-pfe-stock-lower-as-vaccine-chief-plans-to-retire?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.937465488910675
4436,4/30/2022 2:18:25 AM,Pfizer says trial for COVID-19 pill did not meet main goal in prevention of infection,Seeking Alpha,https://seekingalpha.com/news/3829726-pfizer-covid-19-pill-did-not-meet-main-goal-in-infection-prevention?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7488357424736023
4437,4/30/2022 5:24:37 AM,Pfizer's COVID-19 Pill Fails To Prevent Symptomatic Infections ,RTTNews,/news/stocks/pfizer-s-covid-19-pill-fails-to-prevent-symptomatic-infections-1031403835,neutral,0.5640047788619995
4438,4/30/2022 8:00:00 PM,U.S. pharmaceutical sector fails to spring higher amid lackluster April performance,Seeking Alpha,https://seekingalpha.com/news/3829651-us-pharmaceutical-sector-fails-to-spring-higher-amid-lackluster-april-performance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6144396066665649
4439,5/1/2022 12:00:28 PM,7 Stocks Reporting Earnings the Week of May 2,InvestorPlace,/news/stocks/7-stocks-reporting-earnings-the-week-of-may-2-1031404841,positive,0.6892210245132446
4440,5/1/2022 2:31:26 PM,Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-may-pdufa-dates-1031404843,positive,0.9478530883789062
4441,5/2/2022 2:02:05 PM,"Morning Brief: Top Financial Stories Dominating on Monday, May 2",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-monday-may-2-1031408272,positive,0.912456750869751
4442,5/2/2022 2:26:02 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3830038-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
4443,5/2/2022 2:26:53 PM,"The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-may-1-7-phathom-fda-decision-pfizer-vertex-pharma-lead-earnings-news-ophthalmology-conference-presentations-and-more-1031408449,positive,0.9381586909294128
4444,5/2/2022 2:44:38 PM,3 High-Quality Stocks to Buy During This Market Selloff,InvestorPlace,/news/stocks/3-high-quality-stocks-to-buy-during-this-market-selloff-1031409399,positive,0.7398768067359924
4445,5/2/2022 2:48:34 PM,"Moderna, Novavax jump as Pfizer COVID-19 pill fails as preventative therapy",Seeking Alpha,https://seekingalpha.com/news/3830063-mrna-nvax-stocks-jump-as-pfizer-covid-19-pill-fails-as-preventative-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7015883326530457
4446,5/2/2022 3:01:13 PM,What Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-stock-price-quarter-earnings-preview-q1-1031408826,positive,0.9330461025238037
4447,5/2/2022 3:52:52 PM,"Pfizer Q1 earnings preview: All eyes on Comirnaty, Paxlovid show",Seeking Alpha,https://seekingalpha.com/news/3830196-pfizer-q1-earnings-preview-all-eyes-on-comirnaty-paxlovid-show?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9439194202423096
4448,5/2/2022 8:39:44 PM,"4 Top Stock Trades for Tuesday: PFE, MOS, EXPE, UBER",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-pfe-mos-expe-uber-1031410622,positive,0.9331802129745483
4449,5/3/2022 10:46:55 AM,"Pfizer Non-GAAP EPS of $1.62 beats by $0.05, revenue of $25.7B beats by $970M",Seeking Alpha,https://seekingalpha.com/news/3830794-pfizer-non-gaap-eps-of-1_62-beats-0_05-revenue-of-25_7b-beats-970m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7286627888679504
4450,5/3/2022 11:45:43 AM,"Pfizer's COVID portfolio Comirnaty, Paxlovid star with ~$14.7B in Q1 sales",Seeking Alpha,https://seekingalpha.com/news/3830870-pfizers-covid-portfolio-comirnaty-paxlovid-star-with-147b-in-q1-sales?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5495040416717529
4451,5/3/2022 12:54:31 PM,"Pfizer Inc. Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/pfizer-inc-q1-profit-increases-beats-estimates-1031412925,negative,0.9331760406494141
4452,5/3/2022 1:35:10 PM,Pfizer Q1 Profit Rises; Cuts Adj. EPS Outlook To Reflect Impact For Accounting Policy Change ,RTTNews,/news/stocks/pfizer-q1-profit-rises-cuts-adj-eps-outlook-to-reflect-impact-for-accounting-policy-change-1031413177,neutral,0.5167554020881653
4453,5/3/2022 2:34:24 PM,Why Is Pfizer (PFE) Stock On the Move Today?,InvestorPlace,/news/stocks/why-is-pfizer-pfe-stock-on-the-move-today-1031414654,positive,0.8443141579627991
4454,5/3/2022 3:01:06 PM,"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-s-adcomm-for-acadia-s-pimavanserin-review-issues-for-spero-s-tebipenem-application-cortexyme-layoffs-1031414090,neutral,0.5909820199012756
4455,5/3/2022 4:31:05 PM,Mid-Morning Market Update: Markets Mixed; Dow Drops 50 Points,Benzinga,/news/stocks/mid-morning-market-update-markets-mixed-dow-drops-50-points-1031414574,neutral,0.9146398305892944
4456,5/3/2022 5:45:20 PM,Vaccine makers extend gains as Pfizer keeps 2022 COVID sales guidance intact,Seeking Alpha,https://seekingalpha.com/news/3831159-pfe-stock-steady-as-company-keeps-guidance-unchanged?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8697576522827148
4457,5/3/2022 6:18:35 PM,Mid-Day Market Update: Dow Jumps 100 Points; Spero Therapeutics Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-dow-jumps-100-points-spero-therapeutics-shares-plunge-1031414932,negative,0.5845628380775452
4458,5/3/2022 6:20:18 PM,Pfizer CEO Bourla says company prepared if modified COVID vaccine required,Seeking Alpha,https://seekingalpha.com/news/3831323-pfizer-ceo-bourla-says-company-prepared-if-modified-covid-vaccine-required?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8635598421096802
4459,5/3/2022 8:08:38 PM,GSK consumer healthcare division in talks with investment banks to advise - Sky News,Seeking Alpha,https://seekingalpha.com/news/3831428-gsk-consumer-healthcare-division-haleon-in-talks-with-investment-banks-to-advise-sky-news?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8754164576530457
4460,5/3/2022 8:54:26 PM,Mid-Afternoon Market Update: Kymera Therapeutics Drops After Q1 Results; Belite Bio Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-kymera-therapeutics-drops-after-q1-results-belite-bio-shares-spike-higher-1031415219,neutral,0.8519155383110046
4461,5/4/2022 11:37:11 AM,Moderna gains after strong 1Q beat as COVID-19 vaccine sales exceed forecasts,Seeking Alpha,https://seekingalpha.com/news/3831908-mrna-stock-rises-after-1q-beat-as-covid-19-vaccine-sales-exceed-forecasts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9457061290740967
4462,5/4/2022 5:04:07 PM,4 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/4-analysts-have-this-to-say-about-pfizer-1031420882,positive,0.9198142886161804
4463,5/4/2022 5:13:12 PM,FDA counters Pfizer claims for longer course of COVID-19 pill to address relapse,Seeking Alpha,https://seekingalpha.com/news/3832215-pfe-stock-lower-as-fda-rejects-company-suggestion-on-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8685120344161987
4464,5/4/2022 10:48:52 PM,Pfizer: The Treasure of Albert Bourla,InvestorPlace,/news/stocks/pfe-stock-the-treasure-of-albert-bourla-1031422447,positive,0.9218345880508423
4465,5/5/2022 10:39:18 AM,What ETF Is Best? 7 Great Funds to Consider.,InvestorPlace,/news/stocks/what-etf-is-best-7-great-funds-to-consider-1031424937,positive,0.9087047576904297
4466,5/5/2022 5:46:53 PM,COVID-19 Omicron variant is as severe as previous variants - study,Seeking Alpha,https://seekingalpha.com/news/3833571-covid-19-omicron-variant-is-as-severe-as-previous-variants-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.502330482006073
4467,5/5/2022 6:05:13 PM,Arcturus Reports Three-Month Durability Results From ARCT-154 COVID-19 Booster Trial,Benzinga,/news/stocks/arcturus-reports-three-month-durability-results-from-arct-154-covid-19-booster-trial-1031426875,negative,0.8965048789978027
4468,5/6/2022 10:15:57 AM,7 Dividend-Paying Large-Cap Stocks to Buy in May,InvestorPlace,/news/stocks/7-dividend-paying-large-cap-stocks-to-buy-in-may-1031430469,positive,0.8960413336753845
4469,5/6/2022 11:15:10 AM,"FDA review for label expansion of Pfizer, Myovant uterine fibroids therapy extended",Seeking Alpha,https://seekingalpha.com/news/3834189-pfe-and-myov-stocks-in-focus-as-fda-extends-review-of-myfembree-label-expansion?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6027201414108276
4470,5/6/2022 1:58:00 PM,Myovant : FDA Extends Review Of Myfembree In Pain Associated With Endometriosis To August 6 ,RTTNews,/news/stocks/myovant-fda-extends-review-of-myfembree-in-pain-associated-with-endometriosis-to-august-6-1031430749,positive,0.834597647190094
4471,5/6/2022 2:54:29 PM,"The Daily Biotech Pulse: Limited Use Of JNJ's COVID-19 Shot, Myovant-Pfizer's Relugolix Application Delayed, Gain Therapeutics' Parkinson's Data",Benzinga,/news/stocks/the-daily-biotech-pulse-limited-use-of-jnj-s-covid-19-shot-myovant-pfizer-s-relugolix-application-delayed-gain-therapeutics-parkinson-s-data-1031431013,neutral,0.9153580069541931
4472,5/6/2022 3:13:17 PM,U.S. FDA extends review of Pfizer and Myovant Sciences supplemental New Drug Application (sNDA) For MYFEMBREE by three months,Benzinga,/news/stocks/u-s-fda-extends-review-of-pfizer-and-myovant-sciences-supplemental-new-drug-application-snda-for-myfembree-by-three-months-1031431104,positive,0.7386080622673035
4473,5/6/2022 9:07:51 PM,Pharma and Rideshare Earnings Roundup,InvestorPlace,/news/stocks/pharma-and-rideshare-earnings-roundup-1031438881,positive,0.9142295122146606
4474,5/9/2022 10:56:01 AM,Alibaba Is an Unstoppable Force Meeting an Immovable Object,InvestorPlace,/news/stocks/baba-stock-is-an-unstoppable-force-meeting-an-immovable-object-1031435992,positive,0.8969851732254028
4475,5/9/2022 11:15:06 AM,BioNTech stock rises as Q1 revenue triples Y/Y on the back of COVID-19 vaccine sales,Seeking Alpha,https://seekingalpha.com/news/3834846-biontech-stock-rises-as-q1-revenue-triples-yy-on-the-back-of-covid-19-vaccine-sales?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9449014067649841
4476,5/9/2022 2:13:05 PM,Viatris gains despite 1Q revenue miss as cashflow tops estimates,Seeking Alpha,https://seekingalpha.com/news/3834910-vtrs-stock-lower-as-1q-revenue-miss-forecasts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7976800799369812
4477,5/9/2022 3:05:17 PM,BNTX Stock Treks Higher on BioNTech’s Vaccine Sales,InvestorPlace,/news/stocks/bntx-stock-treks-higher-on-biontechs-vaccine-sales-1031437512,negative,0.9266154766082764
4478,5/9/2022 11:15:56 PM,Novavax Stock Is Too Sickly To Buy,InvestorPlace,/news/stocks/nvax-stock-is-too-sickly-to-buy-1031438851,neutral,0.5843623280525208
4479,5/10/2022 11:22:43 AM,Pfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%,Seeking Alpha,https://seekingalpha.com/news/3835778-pfizer-to-acquire-biohaven-in-116b-deal-biohaven-stock-soars-72?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9074536561965942
4480,5/10/2022 1:04:31 PM,Pfizer To Buy Remaining Stake In Biohaven Pharma For $148.50/share In Cash - Quick Facts ,RTTNews,/news/stocks/pfizer-to-buy-remaining-stake-in-biohaven-pharma-for-148-50-share-in-cash-quick-facts-1031441209,positive,0.9384245276451111
4481,5/10/2022 1:50:35 PM,NVAX Stock Falls 20% as Novavax Misses Q1 Estimates,InvestorPlace,/news/stocks/nvax-stock-falls-20-as-novavax-misses-q1-estimates-1031442597,neutral,0.9710699319839478
4482,5/10/2022 2:14:32 PM,Pfizer deal to buy Biohaven rallies biotech,Seeking Alpha,https://seekingalpha.com/news/3835969-xbi-rebounds-on-pfe-bhvn-deal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5391433238983154
4483,5/10/2022 3:23:19 PM,"The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-acquires-migraine-drugmaker-for-11b-biogen-files-for-second-alzheimer-s-drug-approval-longeveron-ceo-leaves-1031442487,positive,0.8989911675453186
4484,5/10/2022 4:08:04 PM,Mid-Morning Market Update: Markets Open Higher; Nasdaq Jumps Over 200 Points,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-nasdaq-jumps-over-200-points-1031442666,negative,0.9367960691452026
4485,5/10/2022 6:01:45 PM,77 Stocks Moving In Tuesday's Mid-Day Session,Benzinga,/news/stocks/77-stocks-moving-in-tuesday-s-mid-day-session-1031443117,positive,0.7285794019699097
4486,5/10/2022 6:04:03 PM,Mid-Day Market Update: U.S. Stocks Turn Lower; Biohaven Pharmaceutical Shares Jump,Benzinga,/news/stocks/mid-day-market-update-u-s-stocks-turn-lower-biohaven-pharmaceutical-shares-jump-1031443142,neutral,0.9322478771209717
4487,5/10/2022 8:08:37 PM,Why did CRISPR Therapeutics stock rise today? Speculation as acquisition target,Seeking Alpha,https://seekingalpha.com/news/3836220-why-did-crispr-therapeutics-stock-rise-today-speculation-as-acquisition-target?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8826696276664734
4488,5/10/2022 8:56:32 PM,Mid-Afternoon Market Update: Nasdaq Jumps Over 200 Points; Crude Oil Down 3%,Benzinga,/news/stocks/mid-afternoon-market-update-nasdaq-jumps-over-200-points-crude-oil-down-3-1031443513,neutral,0.8752710223197937
4489,5/10/2022 8:59:09 PM,Why Is Biohaven Pharmaceutical (BHVN) Stock Up Today?,InvestorPlace,/news/stocks/why-is-biohaven-pharmaceutical-bhvn-stock-up-today-1031443969,positive,0.6920086741447449
4490,5/10/2022 9:46:11 PM,5 Cryptos to Buy That Can Survive Market Bloodshed,InvestorPlace,/news/stocks/5-cryptos-to-buy-that-can-survive-market-bloodshed-1031444134,positive,0.9113547801971436
4491,5/11/2022 12:22:38 PM,103 Biggest Movers From Yesterday,Benzinga,/news/stocks/103-biggest-movers-from-yesterday-1031447344,positive,0.7968789935112
4492,5/11/2022 3:17:14 PM,CDC schedules COVID-19 vaccine meeting for expert panel next week,Seeking Alpha,https://seekingalpha.com/news/3836885-pfe-bntx-stocks-gain-as-cdc-schedules-covid-19-vaccine-meeting?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9135919809341431
4493,5/11/2022 4:05:04 PM,INO Stock Plunges 25% as Inovio Pharmaceuticals Swaps Vaccine Focus,InvestorPlace,/news/stocks/ino-stock-plunges-25-as-inovio-pharmaceuticals-swaps-vaccine-focus-1031449412,neutral,0.9687566161155701
4494,5/12/2022 2:14:54 PM,Federal flags to fly at half-staff to mark one million COVID deaths,Seeking Alpha,https://seekingalpha.com/news/3837849-federal-flags-to-fly-at-half-staff-to-mark-one-million-covid-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9106363654136658
4495,5/12/2022 4:00:00 PM,Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress,PR Newswire,/news/stocks/astellas-highlights-data-on-advanced-and-rare-cancers-during-2022-asco-annual-meeting-and-eha-2022-hybrid-congress-1031454178,positive,0.9361397624015808
4496,5/12/2022 4:23:46 PM,Pfizer COVID-19 antiviral priced at under $25 per course by generic drugmakers,Seeking Alpha,https://seekingalpha.com/news/3837946-pfizer-covid-19-antiviral-priced-by-generic-drugmakers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7616372108459473
4497,5/13/2022 11:00:11 AM,7 Cheap Stocks to Buy Now for a Rich Retirement,InvestorPlace,/news/stocks/7-cheap-stocks-to-buy-now-for-a-rich-retirement-1031458460,positive,0.860144853591919
4498,5/14/2022 1:56:09 AM,Pfizer/BioNTech to delay EU vaccine deliveries as bloc seeks updated COVID shots,Seeking Alpha,https://seekingalpha.com/news/3838872-pfizer-and-biontech-to-delay-eu-vaccine-shipments-for-updated-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8718245625495911
4499,5/14/2022 10:00:15 AM,Johnson & Johnson Stock: A Rare Bright Spot in the Market,InvestorPlace,/news/stocks/jnj-stock-a-rare-bright-spot-in-the-market-1031459931,negative,0.8548750877380371
4500,5/15/2022 1:00:00 PM,"Global Blood, Impel Pharma could be M&A targets after Biohaven deal - analysts",Seeking Alpha,https://seekingalpha.com/news/3838886-global-blood-impel-pharma-could-be-targets-after-biohaven-deal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8118852376937866
4501,5/16/2022 2:15:24 PM,"Morning Brief: Top Financial Stories Dominating on Monday, May 16",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-monday-may-16-1031464353,positive,0.9101842045783997
4502,5/16/2022 6:37:30 PM,Xeris Biopharma spikes as CEO buys company shares,Seeking Alpha,https://seekingalpha.com/news/3839384-cers-stock-spikes-as-ceo-buys-company-shares?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.667796790599823
4503,5/16/2022 6:40:35 PM,What to Do When the Stock Market Drops,InvestorPlace,/news/stocks/what-to-do-when-the-stock-market-drops-1031465655,positive,0.8728761076927185
4504,5/16/2022 8:13:50 PM,Pfizer/BioNTech booster shots will soon be cleared for children aged 5 – 11: NYT,Seeking Alpha,https://seekingalpha.com/news/3839451-pfe-bntx-stocks-in-focus-ahead-of-fda-decision-on-booster-shots-for-kids?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.868012547492981
4505,5/16/2022 8:24:57 PM,Inflation May Have Peaked: What to Do Now,InvestorPlace,/news/stocks/inflation-may-have-peaked-what-to-do-now-1031466390,positive,0.5189400315284729
4506,5/17/2022 2:07:56 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, May 17",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-may-17-1031468262,positive,0.9063923954963684
4507,5/17/2022 2:19:57 PM,Ideaya Biosciences price target raised to new Street high at Roth; sees 341% upside,Seeking Alpha,https://seekingalpha.com/news/3840011-ideaya-biosciences-price-target-raised-to-new-street-high-at-roth-sees-341-upside?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9454939961433411
4508,5/17/2022 2:31:29 PM,Pfizer/BioNTech granted FDA nod to expand booster use in children aged 5 – 11 years,Seeking Alpha,https://seekingalpha.com/news/3840015-pfe-bntx-stocks-on-watch-as-fda-clears-covid-19-booster-shot-for-children?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9202753305435181
4509,5/17/2022 3:04:56 PM,"The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-s-covid-19-booster-for-kids-5-11-coming-soon-ultragenyx-in-licenses-gene-therapy-for-genetic-disorder-ampio-s-ap-013-trial-under-independent-investigation-1031468701,positive,0.9160691499710083
4510,5/17/2022 4:42:38 PM,New York City reaches “high” COVID alert level; indoor masking urged,Seeking Alpha,https://seekingalpha.com/news/3840091-new-york-city-reaches-high-covid-alert-level-indoor-masking-urged?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6301854848861694
4511,5/17/2022 6:12:02 PM,"Coatue Management accumulates Square, closes doors on Pfizer, adds Lucid, reduces Zoom Video position",Seeking Alpha,https://seekingalpha.com/news/3840125-coatue-management-accumulates-square-closes-doors-on-pfizer-adds-lucid-reduces-zoom-video-position?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5795345902442932
4512,5/17/2022 8:16:19 PM,Pfizer COVID-19 antiviral use jumps over 300%: U.S. health department,Seeking Alpha,https://seekingalpha.com/news/3840191-pfizer-covid-19-antiviral-use-jumps-over-300-us-health-department?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8933601379394531
4513,5/17/2022 8:27:49 PM,CEPI to fund Sabin Vaccine Institute trial to see efficacy of lower doses of COVID boosters,Seeking Alpha,https://seekingalpha.com/news/3840200-cepi-to-fund-sabin-vaccine-institute-trial-to-see-efficacy-of-lower-doses-of-covid-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6890955567359924
4514,5/17/2022 10:16:20 PM,FDA Authorizes Pfizer Covid-19 Booster Dose For Children Between 5-11yrs ,RTTNews,/news/stocks/fda-authorizes-pfizer-covid-19-booster-dose-for-children-between-5-11yrs-1031469904,positive,0.8411624431610107
4515,5/18/2022 4:15:10 PM,"The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-s-covid-19-booster-for-kids-moderna-starts-first-african-trial-of-mrna-hiv-vaccine-tonix-extends-covid-19-antiviral-research-pact-1031472722,positive,0.7596691846847534
4516,5/18/2022 6:06:06 PM,NIH wants to study longer treatment of Pfizer's Paxlovid in face of COVID reinfections,Seeking Alpha,https://seekingalpha.com/news/3840587-nih-wants-to-study-longer-treatment-of-pfizer-paxlovid-in-face-of-covid-reinfections?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.769191563129425
4517,5/19/2022 10:07:01 AM,Stocks to buy as a recession approaches: UBS screens for high quality,Seeking Alpha,https://seekingalpha.com/news/3840724-stocks-for-recession?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6301498413085938
4518,5/19/2022 10:46:51 AM,CDC experts to discuss Pfizer/BioNTech COVID-19 boosters for young children,Seeking Alpha,https://seekingalpha.com/news/3840814-pfe-bntx-stocks-in-focus-ahead-of-cdc-meeting-on-covid-boosters-for-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8547322154045105
4519,5/19/2022 3:22:42 PM,AstraZeneca COVID-19 vaccine wins EU nod as a booster shot,Seeking Alpha,https://seekingalpha.com/news/3841010-astrazeneca-covid-19-vaccine-wins-eu-nod-as-a-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9313917756080627
4520,5/19/2022 4:02:49 PM,Pfizer joining Sidekick Health on atopic dermatitis digital therapeutic launch,Seeking Alpha,https://seekingalpha.com/news/3841024-pfizer-joining-sidekick-health-on-atopic-dermatitis-digital-therapeutic-launch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8697715997695923
4521,5/19/2022 5:06:29 PM,Pfizer/BioNTech COVID vaccine linked to much lower cases of myocarditis in children - CDC,Seeking Alpha,https://seekingalpha.com/news/3841058-pfizerbiontech-covid-shot-linked-to-lower-cases-of-myocarditis-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.46299558877944946
4522,5/20/2022 5:16:32 AM,CDC Recommends Pfizer COVID-19 Booster Shot For Children 5 To 11 ,RTTNews,/news/stocks/cdc-recommends-pfizer-covid-19-booster-shot-for-children-5-to-11-1031477328,positive,0.872330367565155
4523,5/20/2022 10:45:34 AM,5 Oversold Blue-Chip Stocks to Buy Right Now,InvestorPlace,/news/stocks/5-oversold-blue-chip-stocks-to-buy-right-now-aapl-pfe-bti-cost-tsla-1031478255,positive,0.6630488634109497
4524,5/20/2022 1:59:41 PM,EMA panel recommends Pfizer's Xeljanz for ankylosing spondylitis,Seeking Alpha,https://seekingalpha.com/news/3841377-ema-panel-recommends-pfizer-xeljanz-for-ankylosing-spondylosing?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8038716316223145
4525,5/20/2022 2:20:37 PM,"The Daily Biotech Pulse: CDC Recommends COVID-19 Boosters For Kids 5-11, Foghorn's Blood Cancer Trial On Clinical Hold, Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara",Benzinga,/news/stocks/the-daily-biotech-pulse-cdc-recommends-covid-19-boosters-for-kids-5-11-foghorn-s-blood-cancer-trial-on-clinical-hold-bayer-intends-to-bow-out-from-car-t-therapy-pact-with-atara-1031478465,positive,0.523526668548584
4526,5/22/2022 9:58:01 PM,"The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More",Benzinga,/news/stocks/the-week-ahead-in-biotech-may-22-28-verrica-bristol-myers-squibb-fda-decisions-medtronic-earnings-conference-presentations-more-1031480317,positive,0.9357399940490723
4527,5/23/2022 11:35:19 AM,Pfizer-BioNTech share three-dose data for COVID-19 vaccine in children under five,Seeking Alpha,https://seekingalpha.com/news/3841635-pfizer-biontech-three-dose-data-for-covid-19-vaccine-in-children-under-five?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6317175030708313
4528,5/23/2022 2:38:08 PM,Pfizer-BioNTech's Covid Vaccine For Kids Under 5 Demonstrates Efficacy Of 80.3% In Phase 2/3 Trial ,RTTNews,/news/stocks/pfizer-biontech-s-covid-vaccine-for-kids-under-5-demonstrates-efficacy-of-80-3-in-phase-2-3-trial-1031481820,negative,0.939801812171936
4529,5/23/2022 3:24:29 PM,"FDA revises dates to review Pfizer/BioNTech, Moderna EUAs for COVID-19 shots",Seeking Alpha,https://seekingalpha.com/news/3841780-fda-revises-dates-to-expand-pfizerbiontech-moderna-euas-for-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9315277934074402
4530,5/23/2022 3:59:06 PM,Shanghai Junshi wins late-stage trial for oral COVID-19 drug versus Pfizer,Seeking Alpha,https://seekingalpha.com/news/3841806-shanghai-junshi-oral-covid-19-drug-reach-main-goal-versus-pfizer-paxlovid?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9288841485977173
4531,5/23/2022 6:31:20 PM,"Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch",Benzinga,/news/etf/amid-monkeypox-outbreak-this-3x-leveraged-etf-provides-exposure-to-health-sector-what-to-watch-1031482614,positive,0.9194398522377014
4532,5/23/2022 8:44:09 PM,The Analyst Says 'Impressive Phase 3 Data Highlight Best-In-Class Opportunity' For Concert Pharma,Benzinga,/news/stocks/the-analyst-says-impressive-phase-3-data-highlight-best-in-class-opportunity-for-concert-pharma-1031482839,negative,0.9539371728897095
4533,5/24/2022 1:29:05 PM,COVID-19 sales boom for vaccine and drug makers might be over - analysts,Seeking Alpha,https://seekingalpha.com/news/3842211-covid-19-sales-boom-for-vaccine-and-drug-makers-might-be-over?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.39463990926742554
4534,5/24/2022 2:02:53 PM,Pfizer presents additional late-stage results supporting etrasimod for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3842213-pfizer-presents-additional-late-stage-data-supporting-etrasimod-for-ulcerative-colitis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.872500479221344
4535,5/24/2022 3:08:07 PM,CDC issues advisory on Pfizer COVID-19 pill over disease recurrence,Seeking Alpha,https://seekingalpha.com/news/3842284-pfizer-slapped-with-cdc-advisory-on-covid-19-pill-over-disease-recurrence?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7018595933914185
4536,5/25/2022 9:29:46 AM,Pfizer to provide all patented medicines at nonprofit price in 45 low income countries,Seeking Alpha,https://seekingalpha.com/news/3842495-pfizer-to-provide-all-patented-medicines-at-nonprofit-price-in-45-low-income-countries?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8758732676506042
4537,5/25/2022 2:40:46 PM,"Pfizer To Offer Medicines, Vaccines To 45 Lower-income Countries On Not-for-profit Basis ",RTTNews,/news/stocks/pfizer-to-offer-medicines-vaccines-to-45-lower-income-countries-on-not-for-profit-basis-1031488222,positive,0.8046888709068298
4538,5/25/2022 4:06:57 PM,Long COVID seen with one in five COVID survivors in U.S. - CDC study,Seeking Alpha,https://seekingalpha.com/news/3842706-long-covid-seen-with-one-in-five-covid-survivors-in-us-cdc-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.3624655306339264
4539,5/25/2022 7:57:03 PM,"Long COVID risk drops only slightly after vaccination, large study shows",Seeking Alpha,https://seekingalpha.com/news/3842802-long-covid-risk-drops-only-slightly-after-vaccination-large-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6331458687782288
4540,5/25/2022 10:26:15 PM,7 of the Best Cheap Stocks to Buy for the Second Half of 2022,InvestorPlace,/news/stocks/7-of-the-best-cheap-stocks-to-buy-for-the-second-half-of-2022-1031489698,negative,0.5200269222259521
4541,5/25/2022 10:54:57 PM,7 Undervalued Blue-Chip Stocks to Buy for June,InvestorPlace,/news/stocks/7-undervalued-blue-chip-stocks-to-buy-for-june-1031489712,positive,0.7148614525794983
4542,5/26/2022 9:59:23 AM,US government boosting efforts to improve access to Pfizer's COVID pill Paxlovid - AP,Seeking Alpha,https://seekingalpha.com/news/3842951-us-government-boosting-efforts-to-improve-access-to-pfizers-covid-pill-paxlovid-ap?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9486676454544067
4543,5/26/2022 11:30:59 AM,Pfizer's ervogastat/clesacostat combo gets FDA fast track status for liver disease,Seeking Alpha,https://seekingalpha.com/news/3843014-pfizers-ervogastatclesacostat-combo-gets-fda-fast-track-status-for-liver-disease?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9064646363258362
4544,5/26/2022 1:59:24 PM,FDA Grants Fast Track Designation To Pfizer's Ervogastat Combination For Liver Disease Treatment ,RTTNews,/news/stocks/fda-grants-fast-track-designation-to-pfizer-s-ervogastat-combination-for-liver-disease-treatment-1031490765,negative,0.9011667370796204
4545,5/26/2022 2:45:54 PM,"The Daily Biotech Pulse: Setback For NRx Pharma's COVID Study, Fast Track Tag For Pfizer's NASH Combo Therapy, Reata's Ataxia Drug In FDA Review",Benzinga,/news/stocks/the-daily-biotech-pulse-setback-for-nrx-pharma-s-covid-study-fast-track-tag-for-pfizer-s-nash-combo-therapy-reata-s-ataxia-drug-in-fda-review-1031490976,negative,0.6595115065574646
4546,5/28/2022 4:22:39 PM,BioPharma M&A premiums could moderate amid rate hikes – Wells Fargo,Seeking Alpha,https://seekingalpha.com/news/3843664-biopharma-ma-premiums-could-moderate-amid-rate-hikes?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9036207795143127
4547,5/30/2022 10:15:54 AM,The 3 Best Performing ETFs Money Can Buy in 2022,InvestorPlace,/news/stocks/the-3-best-performing-etfs-money-can-buy-in-2022-1031495787,positive,0.6743149161338806
4548,5/31/2022 11:16:18 AM,Pfizer antiviral pill leads Merck’s as top at-home COVID-19 treatment,Seeking Alpha,https://seekingalpha.com/news/3843832-pfizer-antiviral-pill-leads-mercks-as-top-at-home-covid-19-treatment?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7055022716522217
4549,5/31/2022 11:30:20 AM,7 Undervalued Large-Cap Stocks to Buy for June,InvestorPlace,/news/stocks/7-undervalued-large-cap-stocks-to-buy-for-june-1031498049,negative,0.7184441685676575
4550,5/31/2022 5:41:04 PM,Pfizer Paxlovid COVID rebound: Individuals can be contagious without symptoms,Seeking Alpha,https://seekingalpha.com/news/3844085-pfizer-paxlovid-covid-rebound-individuals-can-be-contagious-without-symptoms?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5189078450202942
4551,5/31/2022 7:44:43 PM,Takeda CEO says drugmakers face pricing pressure due to global crises,Seeking Alpha,https://seekingalpha.com/news/3844113-takeda-ceo-says-drugmakers-face-pricing-pressure-due-to-global-crises?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9459705948829651
4552,5/31/2022 9:42:54 PM,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-these-june-pdufa-dates-1031499656,positive,0.9482179284095764
4553,6/1/2022 10:15:24 AM,3 Biotech Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-before-they-boom-1031501085,positive,0.9286603927612305
4554,6/1/2022 1:52:13 PM,Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off,Benzinga,/news/stocks/pfizer-to-quit-gsk-s-consumer-health-jv-following-its-spin-off-1031501411,neutral,0.6700361967086792
4555,6/1/2022 2:03:47 PM,"Jim Cramer Shares His Opinion On Roblox, Century Aluminum And More",Benzinga,/news/stocks/jim-cramer-shares-his-opinion-on-roblox-century-aluminum-and-more-1031501618,positive,0.9307789206504822
4556,6/1/2022 3:10:28 PM,Federal Trade Commission to hold pharma merger and antitrust workshop,Seeking Alpha,https://seekingalpha.com/news/3844448-federal-trade-commission-to-hold-pharma-merger-antitrust-workshop?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.913018524646759
4557,6/1/2022 5:18:41 PM,3 Undervalued Dividend Growth Stocks,InvestorPlace,/news/stocks/3-undervalued-dividend-growth-stocks-1031502991,negative,0.7532821297645569
4558,6/1/2022 11:47:34 PM,Pfizer/BioNTech completes U.S. regulatory submission for COVID shot in kids under 5,Seeking Alpha,https://seekingalpha.com/news/3844815-pfizerbiontech-completes-us-submission-for-covid-shot-in-kids-under-5?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5471932291984558
4559,6/2/2022 10:45:47 AM,Evonik gets US government funding for $220M lipid production site for mRNA therapies,Seeking Alpha,https://seekingalpha.com/news/3844883-evonik-gets-us-government-funding-for-220m-lipid-production-site-for-mrna-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6767188310623169
4560,6/2/2022 1:25:43 PM,"U.S. FDA accepts Myovant, Pfizer application seeking expanded approval for Myfembree",Seeking Alpha,https://seekingalpha.com/news/3845006-us-fda-accepts-myovant-pfizer-application-seeking-expanded-approval-for-myfembree?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8745467662811279
4561,6/2/2022 2:38:32 PM,FDA Accepts Myovant Sciences and Pfizer's Filing For Review In Uterine Fibroids,Benzinga,/news/stocks/fda-accepts-myovant-sciences-and-pfizer-s-filing-for-review-in-uterine-fibroids-1031505244,positive,0.691027045249939
4562,6/2/2022 5:07:51 PM,Moderna drags down rivals after delay for COVID vaccine deliveries to EU,Seeking Alpha,https://seekingalpha.com/news/3845151-mrna-stock-drags-rivals-after-delay-for-covid-vaccine-deliveries-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9211248159408569
4563,6/2/2022 6:48:53 PM,Pfizer antiviral found to cut COVID risk in seniors irrespective of vaccination,Seeking Alpha,https://seekingalpha.com/news/3845202-pfizer-antiviral-found-to-cut-covid-risk-in-seniors-irrespective-of-vaccination?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9472156167030334
4564,6/2/2022 9:49:15 PM,Pfizer Seeks FDA Authorization For Covid Vaccine For Children Under 5 ,RTTNews,/news/stocks/pfizer-seeks-fda-authorization-for-covid-vaccine-for-children-under-5-1031506576,negative,0.8668609261512756
4565,6/3/2022 2:21:24 PM,Novavax down 17% as FDA documents on COVID vaccine express myocarditis concerns,Seeking Alpha,https://seekingalpha.com/news/3845495-novavax-down-17-fda-briefing-documents-covid-vaccine-myocarditis-concerns?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9685811400413513
4566,6/3/2022 9:11:37 PM,6 Biotech Stocks to Buy Now Ahead of These June Catalysts,InvestorPlace,/news/stocks/6-biotech-stocks-june-catalysts-1031509381,positive,0.8837399482727051
4567,6/4/2022 8:00:00 PM,Pfizer's Ibrance + letrozole misses overall survival endpoint for metastatic breast cancer,Seeking Alpha,https://seekingalpha.com/news/3845725-pfizer-ibrance-letrozole-misses-overall-survival-endpoint-metastatic-breast-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8567695021629333
4568,6/5/2022 10:09:23 PM,"The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-june-5-11-adcom-test-for-novavax-asco-presentations-enzo-biochem-earnings-and-more-1031509946,positive,0.804358184337616
4569,6/6/2022 9:36:41 AM,Pfizer/CStone Cejemly gets China approval for expanded use in advanced lung cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3845801-pfizercstone-cejemly-gets-china-approval-for-expanded-use-in-advanced-lung-cancer-subtype?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9092850089073181
4570,6/6/2022 4:00:54 PM,Pfizer to invest $120M to expand U.S. production of COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3845992-pfizer-to-invest-120m-to-expand-us-production-of-covid-19-pill?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9303752779960632
4571,6/6/2022 6:42:54 PM,Pfizer To Invest $120 Mln Kalamazoo Facility To Produce COVID-19 Oral Treatment ,RTTNews,/news/stocks/pfizer-to-invest-120-mln-kalamazoo-facility-to-produce-covid-19-oral-treatment-1031511528,negative,0.5094045996665955
4572,6/7/2022 8:30:04 AM,Hardman & Co Life Sciences Research: Long-term cost and EBIT analysis of the pharmaceutical industry,EQS Group,/news/stocks/hardman-co-life-sciences-research-long-term-cost-and-ebit-analysis-of-the-pharmaceutical-industry-1031512414,positive,0.9330011606216431
4573,6/7/2022 11:24:10 AM,"Merck, Ridgeback say COVID-19 pill cut risk of hospitalizations by 34%",Seeking Alpha,https://seekingalpha.com/news/3846184-merck-ridgeback-say-covid-19-pill-cut-risk-of-hospitalizations?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.93352210521698
4574,6/7/2022 11:28:42 AM,A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-signal-lower-start-on-wall-street-1031512701,neutral,0.9020087122917175
4575,6/7/2022 11:42:22 AM,Novavax shares halted for trading ahead of FDA meeting on COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3846167-nvax-stock-gains-ahead-of-fda-meeting-on-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9048607349395752
4576,6/7/2022 2:07:41 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, June 7",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-june-7-1031513234,positive,0.9139136672019958
4577,6/7/2022 7:29:46 PM,Novavax rises 21% after hours as COVID vaccine endorsed by FDA advisory panel,Seeking Alpha,https://seekingalpha.com/news/3846434-novavax-covid-vaccine-recommended-for-approval-by-fda-advisory-panel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9354133009910583
4578,6/7/2022 8:00:16 PM,"New drugs cost an average of $180K per year, new study finds",Seeking Alpha,https://seekingalpha.com/news/3846439-new-drugs-cost-an-average-of-180k-per-year-new-study-finds?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7216759920120239
4579,6/8/2022 9:50:11 AM,This Day Last Year: Pfizer's Pneumococcal Vaccine Was Approved ,RTTNews,/news/stocks/this-day-last-year-pfizer-s-pneumococcal-vaccine-was-approved-1031515363,positive,0.8979290723800659
4580,6/8/2022 10:26:53 AM,MKM Partners highlights 10 sector buy/sell pair trades,Seeking Alpha,https://seekingalpha.com/news/3846323-mkm-partners-highlights-10-sector-buysell-pair-trades?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8967709541320801
4581,6/8/2022 12:03:09 PM,Novavax extends gains as analysts cheer FDA backing for COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3846643-nvax-stock-extends-gains-as-analysts-cheer-fda-backing-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9399877786636353
4582,6/8/2022 8:57:00 PM,HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated,Benzinga,/news/stocks/hc-wainwright-says-non-mrna-covid-19-option-underappreciated-1031517380,neutral,0.963972270488739
4583,6/9/2022 6:01:16 AM,Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker,Benzinga,/news/etf/cathie-wood-trims-pfizer-stake-and-loads-up-25m-in-rival-covid-19-vaccine-maker-1031518035,negative,0.499257892370224
4584,6/9/2022 10:57:48 AM,Biden administration expects pre-orders for kids’ COVID-19 shots to pick up,Seeking Alpha,https://seekingalpha.com/news/3847083-biden-administration-expects-pre-orders-for-kids-covid-19-shots-to-pick-up?utm_source=businessinsider&utm_medium=referral,negative,0.9513157606124878
4585,6/9/2022 10:57:48 AM,Biden administration expects pre-orders for kids’ COVID-19 shots to pick up,Seeking Alpha,https://seekingalpha.com/news/3847083-biden-administration-expects-pre-orders-for-kids-covid-19-shots-to-pick-up?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9513157606124878
4586,6/9/2022 11:48:19 AM,Novavax slips amid concerns over delay for FDA decision on COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3847111-nvax-stock-slips-amid-concerns-over-delay-for-fda-decision-on-covid-19-shot?utm_source=businessinsider&utm_medium=referral,neutral,0.9470019936561584
4587,6/9/2022 4:01:18 PM,White House announces plan to provide COVID-19 vaccines to children under 5,Seeking Alpha,https://seekingalpha.com/news/3847262-white-house-announces-plan-to-provide-covid-19-vaccines-to-children-under-5?utm_source=businessinsider&utm_medium=referral,positive,0.5220097899436951
4588,6/9/2022 6:26:10 PM,Wells Fargo highlights potential targets as biotech M&A accelerates,Seeking Alpha,https://seekingalpha.com/news/3847403-wells-fargo-highlights-potential-targets-as-biotech-ma-accelerates?utm_source=businessinsider&utm_medium=referral,negative,0.8801780343055725
4589,6/9/2022 10:35:20 PM,7 Stocks Under $50 to Buy and Hold Forever,InvestorPlace,/news/stocks/7-stocks-under-50-to-buy-and-hold-forever-1031520837,positive,0.8874146342277527
4590,6/10/2022 8:54:22 AM,GSK RSV vaccine gets a win in older adults showing efficacy in late-stage study,Seeking Alpha,https://seekingalpha.com/news/3847573-gsk-rsv-vaccine-gets-a-win-in-older-adults-showing-efficacy-in-late-stage-study?utm_source=businessinsider&utm_medium=referral,negative,0.951566755771637
4591,6/10/2022 11:20:22 AM,7 Large Cap Stocks to Buy for Long-Term Stability,InvestorPlace,/news/stocks/7-large-cap-stocks-to-buy-for-long-term-stability-1031521864,positive,0.9080352783203125
4592,6/10/2022 12:01:26 PM,5 Cash-Cow Stocks to Buy for a Turbulent Market,InvestorPlace,/news/stocks/5-cash-cow-stocks-to-buy-for-a-turbulent-market-bhp-ttai-cowz-psx-klac-1031522005,positive,0.8337205648422241
4593,6/10/2022 2:57:48 PM,7 Great ETFs to Buy Now for Momentum in Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-in-q2-1031522477,negative,0.6736835837364197
4594,6/10/2022 6:00:59 PM,"Catalyst watch: Kroger earnings, Powell speaks, Cisco event, Ethereum PoS test",Seeking Alpha,https://seekingalpha.com/news/3847702-catalyst-watch-kroger-earnings-powell-speaks-cisco-event-ethereum-pos-test?utm_source=businessinsider&utm_medium=referral,positive,0.9379705190658569
4595,6/13/2022 10:53:22 AM,"Pfizer, Moderna win FDA backing for COVID shots in kids ahead of AdCom review",Seeking Alpha,https://seekingalpha.com/news/3847917-pfe-bntx-mrna-stocks-down-despite-fda-backing-for-covid-shots-in-kids?utm_source=businessinsider&utm_medium=referral,negative,0.8476919531822205
4596,6/13/2022 11:44:07 AM,Sanofi-GSK COVID booster outperforms Pfizer/BioNTech vaccine against Omicron,Seeking Alpha,https://seekingalpha.com/news/3847939-sanofi-gsk-covid-booster-outperforms-pfizer-biontech-vaccine-against-omicron?utm_source=businessinsider&utm_medium=referral,negative,0.9534000158309937
4597,6/13/2022 11:45:58 AM,Teladoc Can’t Rely On Hype To Attract Investors,InvestorPlace,/news/stocks/teladoc-cant-rely-on-hype-to-attract-investors-tdoc-stock-1031524937,positive,0.8871526122093201
4598,6/13/2022 12:15:44 PM,Pfizer COVID Vaccine Safe And Effective For Kids Under 5: FDA Staff ,RTTNews,/news/stocks/pfizer-covid-vaccine-safe-and-effective-for-kids-under-5-fda-staff-1031524537,positive,0.8144490122795105
4599,6/13/2022 5:16:00 PM,EU public health agency warns of probable increase in COVID cases in coming weeks,Seeking Alpha,https://seekingalpha.com/news/3848128-eu-public-health-agency-warns-of-probable-increase-in-covid-cases-in-coming-weeks?utm_source=businessinsider&utm_medium=referral,neutral,0.9631182551383972
4600,6/13/2022 7:24:13 PM,"Ivermectin doesn't lower hospitalization or death risk from COVID, study finds",Seeking Alpha,https://seekingalpha.com/news/3848165-ivermectin-doesnt-lower-hospitalization-or-death-risk-from-covid-study-says?utm_source=businessinsider&utm_medium=referral,positive,0.5441838502883911
4601,6/13/2022 8:25:34 PM,"Pfizer, MorphoSys, Incyte enter trial collaboration for Monjuvi/TTI-622 combination for lymphoma",Seeking Alpha,https://seekingalpha.com/news/3848192-pfizer-morphosys-incyte-enter-trial-collaboration-for-monjuvitti-622-combination-for-lymphoma?utm_source=businessinsider&utm_medium=referral,negative,0.7159082889556885
4602,6/13/2022 9:44:51 PM,Sangamo Therapeutics begun at neutral at Wedbush on 'frontrunner' Fabry candidate,Seeking Alpha,https://seekingalpha.com/news/3848230-sangamo-therapeutics-begun-at-neutral-at-wedbush-on-frontrunner-fabry-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.8754468560218811
4603,6/14/2022 10:45:15 AM,7 High-Quality Large Cap Stocks to Buy at a Discount,InvestorPlace,/news/stocks/7-high-quality-large-cap-stocks-to-buy-at-a-discount-1031527274,positive,0.8959495425224304
4604,6/14/2022 10:50:42 AM,FDA panel to review Moderna COVID-19 shot for ages 6 – 17,Seeking Alpha,https://seekingalpha.com/news/3848314-mrna-stock-up-as-fda-panel-set-to-consider-vaccine-for-younger-age-group?utm_source=businessinsider&utm_medium=referral,positive,0.8092011213302612
4605,6/14/2022 11:33:04 AM,Pfizer raises offer to acquire Australian digital health company Resapp - MarketScreener,Seeking Alpha,https://seekingalpha.com/news/3848338-pfizer-raises-offer-to-acquire-australian-digital-health-company-resapp-marketscreener?utm_source=businessinsider&utm_medium=referral,positive,0.6499958038330078
4606,6/14/2022 12:16:58 PM,Viatris initiated Sell at UBS on biosimilar exit,Seeking Alpha,https://seekingalpha.com/news/3848370-vtrs-stock-in-focus-as-ubs-initiates-sell-on-biosimilar-exist?utm_source=businessinsider&utm_medium=referral,positive,0.9249760508537292
4607,6/14/2022 1:47:32 PM,Moderna COVID shot linked to higher heart inflammation risk – CDC,Seeking Alpha,https://seekingalpha.com/news/3848443-moderna-covid-shot-linked-to-higher-heart-inflammation-risk-cdc?utm_source=businessinsider&utm_medium=referral,negative,0.6496065855026245
4608,6/14/2022 6:37:16 PM,"Newer, more contagious Omicron subvariants gaining traction in U.S.",Seeking Alpha,https://seekingalpha.com/news/3848543-newer-more-contagious-omicron-subvariants-gaining-traction-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.7365714907646179
4609,6/14/2022 8:25:01 PM,FDA advisors unanimously recommend Moderna's COVID vaccine for 6 to 17-year olds,Seeking Alpha,https://seekingalpha.com/news/3848562-fda-advisors-unananimously-recommend-approval-of-moderna-covid-vaccine-to-6-to-17-year-olds?utm_source=businessinsider&utm_medium=referral,positive,0.611804723739624
4610,6/14/2022 8:58:00 PM,Pfizer ends enrollment in COVID-19 pill trial in standard-risk patients,Seeking Alpha,https://seekingalpha.com/news/3848617-pfizer-ends-enrollment-in-covid-19-pill-trial-in-standard-risk-patients?utm_source=businessinsider&utm_medium=referral,neutral,0.7333927750587463
4611,6/14/2022 9:06:08 PM,"Pfizer's COVID antiviral Paxlovid associated with few rebound cases, Mayo Clinic finds",Seeking Alpha,https://seekingalpha.com/news/3848621-pfizer-covid-antiviral-paxlovid-associated-with-few-rebound-cases-mayo-clinic-finds?utm_source=businessinsider&utm_medium=referral,positive,0.5955727696418762
4612,6/15/2022 10:04:03 AM,Pfizer Korea halts supply of rare disease drug Vyndaqel due to quality issue - Korea Biomedical,Seeking Alpha,https://seekingalpha.com/news/3848699-pfizer-korea-halts-supply-of-rare-disease-drug-vyndaqel-due-to-quality-issue-korea-biomedical?utm_source=businessinsider&utm_medium=referral,neutral,0.9505031108856201
4613,6/15/2022 10:04:37 AM,7 Undervalued Stocks That the Smart Money Is Piling Into,InvestorPlace,/news/stocks/7-undervalued-stocks-that-smart-money-is-piling-into-1031530031,positive,0.6550967693328857
4614,6/15/2022 12:31:43 PM,FDA Advisers Recommend Moderna Covid-19 Vaccine For Ages 6 To 17 ,RTTNews,/news/stocks/fda-advisers-recommend-moderna-covid-19-vaccine-for-ages-6-to-17-1031530047,positive,0.8342505097389221
4615,6/15/2022 2:49:03 PM,"The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-committee-backs-moderna-shot-for-5-17-years-180-life-sciences-stock-plunges-pfizer-s-posts-disappointing-paxlovid-data-1031530586,neutral,0.9458119869232178
4616,6/15/2022 6:58:44 PM,Dr. Fauci tests positive for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3848965-dr-fauci-tests-positive-for-covid-19?utm_source=businessinsider&utm_medium=referral,positive,0.8345175385475159
4617,6/15/2022 7:08:34 PM,Moderna COVID vaccine for children 5 and under wins FDA panel endorsement,Seeking Alpha,https://seekingalpha.com/news/3848971-moderna-covid-vaccine-for-children-5-and-under-wins-fda-panel-endorsement?utm_source=businessinsider&utm_medium=referral,negative,0.6315705180168152
4618,6/15/2022 9:50:52 PM,Pfizer Halts Enrollment For Covid-19 Drug Paxlovid In Standard-risk Groups ,RTTNews,/news/stocks/pfizer-halts-enrollment-for-covid-19-drug-paxlovid-in-standard-risk-groups-1031531749,neutral,0.9349267482757568
4619,6/16/2022 11:21:39 AM,Pfizer makes $25M equity investment in Akero,Seeking Alpha,https://seekingalpha.com/news/3849160-pfizer-makes-25m-equity-investment-in-akero?utm_source=businessinsider&utm_medium=referral,positive,0.8917957544326782
4620,6/16/2022 11:34:19 AM,"Novavax Stock Can Rally, But It’s Still Facing Many Obstacles",InvestorPlace,/news/stocks/novavax-stock-can-rally-but-its-still-facing-many-obstacles-1031532917,negative,0.45841076970100403
4621,6/16/2022 2:24:45 PM,"FDA Advisers Recommend Pfizer, Moderna COVID-19 Vaccines For Kids As Young As 6 Months ",RTTNews,/news/stocks/fda-advisers-recommend-pfizer-moderna-covid-19-vaccines-for-kids-as-young-as-6-months-1031533054,positive,0.8085776567459106
4622,6/16/2022 3:22:44 PM,Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma,Benzinga,/news/stocks/akero-therapeutics-shares-surge-after-equity-investment-from-this-famed-large-cap-biopharma-1031533372,negative,0.9415379762649536
4623,6/16/2022 4:09:44 PM,"The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-s-alzheimer-s-drug-fails-advisors-back-pfizer-moderna-shots-for-youngest-kids-valneva-settles-covid-19-pact-with-uk-1031533533,positive,0.8402717709541321
4624,6/16/2022 5:26:53 PM,Lilly partnering with Sidekick Health for breast cancer digital therapeutic app,Seeking Alpha,https://seekingalpha.com/news/3849343-lilly-partnering-with-sidekick-health-for-breast-cancer-digital-therapeutic-app?utm_source=businessinsider&utm_medium=referral,positive,0.5343196392059326
4625,6/16/2022 6:53:40 PM,Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot,Benzinga,/news/stocks/bavarian-nordic-launches-covid-19-booster-study-to-compare-against-pfizer-biontech-shot-1031533946,negative,0.9395286440849304
4626,6/17/2022 10:23:04 AM,Long COVID risk lower during Omicron – U.K. study,Seeking Alpha,https://seekingalpha.com/news/3849498-long-covid-risk-lower-during-omicron-uk-study?utm_source=businessinsider&utm_medium=referral,negative,0.8651362657546997
4627,6/17/2022 1:19:46 PM,FDA greenlights COVID vaccines for youngest children,Seeking Alpha,https://seekingalpha.com/news/3849601-fda-greenlights-covid-vaccines-for-youngest-children?utm_source=businessinsider&utm_medium=referral,negative,0.5220996737480164
4628,6/17/2022 3:23:28 PM,Moderna updated COVID-19 shot under rolling review in Europe,Seeking Alpha,https://seekingalpha.com/news/3849643-mrna-stock-higher-as-updated-covid-19-shot-undergoes-eu-review?utm_source=businessinsider&utm_medium=referral,negative,0.637776792049408
4629,6/17/2022 3:49:00 PM,FDA Authorizes Pfizer COVID-19 Vaccine For Children Between 6 Months - 4 Yrs ,RTTNews,/news/stocks/fda-authorizes-pfizer-covid-19-vaccine-for-children-between-6-months-4-yrs-1031535649,positive,0.8310568332672119
4630,6/17/2022 7:59:05 PM,WHO panel backs Omicron-targeting vaccine as booster dose,Seeking Alpha,https://seekingalpha.com/news/3849711-who-panel-backs-omicron-targeting-vaccine-as-booster-dose?utm_source=businessinsider&utm_medium=referral,positive,0.7902781367301941
4631,6/20/2022 7:34:53 AM,Pfizer To Invest $95 Mln In Valneva; Updates Deal Terms For Lyme Disease Vaccine Candidate VLA15 ,RTTNews,/news/stocks/pfizer-to-invest-95-mln-in-valneva-updates-deal-terms-for-lyme-disease-vaccine-candidate-vla15-1031537300,positive,0.669569730758667
4632,6/20/2022 9:20:37 AM,Pfizer to buy 8.1% stake in Valneva to support Lyme disease vaccine,Seeking Alpha,https://seekingalpha.com/news/3849842-pfizer-to-buy-stake-in-valneva-to-support-lyme-disease-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.7854851484298706
4633,6/21/2022 8:48:28 AM,COVID vaccination campaign for infants and toddlers rolls out in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3849925-covid-vaccination-campaign-for-infants-and-toddlers-rolls-out-in-the-us?utm_source=businessinsider&utm_medium=referral,positive,0.8250067830085754
4634,6/21/2022 12:18:25 PM,Why Are Valneva Shares Rallying Today,Benzinga,/news/stocks/why-are-valneva-shares-rallying-today-1031539487,positive,0.647251546382904
4635,6/21/2022 1:10:34 PM,Valneva climbs 86% after Pfizer stake for Lyme Disease vaccine,Seeking Alpha,https://seekingalpha.com/news/3850051-valn-stock-climbs-after-pfizer-stake-for-lyme-disease-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.6540351510047913
4636,6/21/2022 1:45:18 PM,Why Is Valneva (VALN) Stock Up 85% Today?,InvestorPlace,/news/stocks/why-is-valneva-valn-stock-up-85-today-1031540456,negative,0.757561445236206
4637,6/21/2022 3:03:52 PM,"The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial",Benzinga,/news/stocks/the-daily-biotech-pulse-thumbs-down-for-acadia-s-pimavanserin-pfizer-buys-stake-in-valneva-astrazeneca---ionis-eplontersen-aces-rare-disease-trial-1031540289,positive,0.7069719433784485
4638,6/22/2022 11:12:49 AM,Bear Market 2022: Is There Anything Left to Invest In?,InvestorPlace,/news/stocks/bear-market-2022-is-there-anything-left-to-invest-in-1031542804,positive,0.9250609278678894
4639,6/22/2022 11:14:58 AM,7 Blue-Chip Stocks to Buy and Hold for the Long-Haul,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-and-hold-for-the-long-haul-1031542803,positive,0.8624797463417053
4640,6/22/2022 11:14:58 AM,7 Blue-Chip Stocks to Buy and Hold for the Long-Haul,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-and-hold-for-the-long-haul-jpm-pfe-azn-lmt-aapl-cost-1031542861,positive,0.8624797463417053
4641,6/22/2022 2:55:35 PM,"The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral",Benzinga,/news/stocks/the-daily-biotech-pulse-precision-biosciences-inks-gene-editing-pact-athira-pharma-s-alzheimer-s-candidate-fails-enanta-sues-pfizer-over-covid-19-antiviral-1031543323,neutral,0.8980664610862732
4642,6/22/2022 6:08:45 PM,3 Mega-Cap Stocks for Recession-Proof Dividends,InvestorPlace,/news/stocks/3-mega-cap-stocks-for-recession-proof-dividends-1031544293,positive,0.8468351364135742
4643,6/23/2022 10:35:02 AM,BioNTech begins construction of 1st African mRNA vaccine manufacturing site; malaria vaccine to enter trials,Seeking Alpha,https://seekingalpha.com/news/3851083-biontech-begins-construction-of-1st-african-mrna-vaccine-manufacturing-site-malaria-vaccine-to-enter-trials?utm_source=businessinsider&utm_medium=referral,negative,0.7722827792167664
4644,6/23/2022 2:40:13 PM,Pfizer declares $0.40 dividend,Seeking Alpha,https://seekingalpha.com/news/3851258-pfizer-inc-declares-0_40-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.8511275053024292
4645,6/23/2022 6:43:43 PM,"Moderna wins CDC backing for use of COVID-19 shot in teens, older children",Seeking Alpha,https://seekingalpha.com/news/3851316-mrna-stock-on-watch-ahead-of-cdc-decision-on-covid-19-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8862769603729248
4646,6/24/2022 7:39:20 AM,Basilea' Partner Pfizer Gets Approval In China For Addl Formulation Of Antifungal Cresemba In China ,RTTNews,/news/stocks/basilea-partner-pfizer-gets-approval-in-china-for-addl-formulation-of-antifungal-cresemba-in-china-1031547824,negative,0.9379448294639587
4647,6/24/2022 9:03:12 AM,GSK-Sanofi Beta-containing vaccine shows efficacy against Omicron,Seeking Alpha,https://seekingalpha.com/news/3851440-gsk-sanofi-beta-containing-vaccine-shows-efficacy-against-omicron?utm_source=businessinsider&utm_medium=referral,negative,0.9485832452774048
4648,6/24/2022 10:51:48 AM,Shionogi faces delay in Japan for regulatory decision on COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3851452-shionogi-faces-delay-in-japan-for-regulatory-decision-on-covid-19-pill?utm_source=businessinsider&utm_medium=referral,neutral,0.742828905582428
4649,6/24/2022 3:33:24 PM,"Moderna wins CDC nod to use COVID-19 vaccine in teens, older children",Seeking Alpha,https://seekingalpha.com/news/3851623-moderna-wins-cdc-nod-to-use-covid-19-vaccine-in-teens-older-children?utm_source=businessinsider&utm_medium=referral,negative,0.8330247402191162
4650,6/24/2022 6:13:59 PM,Bristol-Myers MS drug linked to better COVID response with mRNA shots,Seeking Alpha,https://seekingalpha.com/news/3851697-bristol-myers-ms-drug-linked-to-better-covid-response-with-mrna-shots?utm_source=businessinsider&utm_medium=referral,negative,0.8316782712936401
4651,6/25/2022 2:46:17 PM,"Pfizer, BioNTech updated vaccines outperform current shot against Omicron BA.1",Seeking Alpha,https://seekingalpha.com/news/3851868-pfizer-biontech-updated-vaccine-outperforms-current-shot-against-omicron-ba1?utm_source=businessinsider&utm_medium=referral,negative,0.9217488765716553
4652,6/25/2022 4:40:57 PM,"Pfizer, BioNTech Report Positive Data From Omicron-adapted COVID-19 Vaccine Candidate Trial ",RTTNews,/news/stocks/pfizer-biontech-report-positive-data-from-omicron-adapted-covid-19-vaccine-candidate-trial-1031550024,negative,0.9451018571853638
4653,6/27/2022 11:00:27 AM,Clover COVID vaccine's booster shot shows response against Omicron variants,Seeking Alpha,https://seekingalpha.com/news/3851953-clovers-covid-vaccine-booster-shot-shows-response-against-omicron-variants?utm_source=businessinsider&utm_medium=referral,negative,0.8551822900772095
4654,6/27/2022 4:50:54 PM,"The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies",Benzinga,/news/stocks/the-daily-biotech-pulse-chmp-backs-astrazeneca-s-breast-cancer-therapies-ipsen-buys-epizyme-fda-holds-for-nuvation-bio-astellas-studies-1031552234,positive,0.8291833400726318
4655,6/28/2022 10:49:22 AM,Roivant Sciences teams up with Pfizer to launch Priovant,Seeking Alpha,https://seekingalpha.com/news/3852321-roivant-sciences-teams-up-with-pfizer-to-launch-priovant?utm_source=businessinsider&utm_medium=referral,positive,0.5120187401771545
4656,6/28/2022 2:12:53 PM,"Roivant axes gene therapy, dermatology and excessive sweating candidates from development",Seeking Alpha,https://seekingalpha.com/news/3852480-roivant-axes-gene-therapy-dermatology-and-excessive-sweating-candidates-from-development?utm_source=businessinsider&utm_medium=referral,positive,0.8600326776504517
4657,6/28/2022 3:38:14 PM,"Newer, more contagious Omicron subvariants become dominant in U.S.",Seeking Alpha,https://seekingalpha.com/news/3852521-newer-more-contagious-omicron-subvariants-become-dominant-in-us?utm_source=businessinsider&utm_medium=referral,positive,0.8451774716377258
4658,6/28/2022 4:40:27 PM,FDA outlines plans for updated COVID-19 vaccines by October,Seeking Alpha,https://seekingalpha.com/news/3852560-fda-targets-updated-covid-19-vaccines-for-adults-by-october?utm_source=businessinsider&utm_medium=referral,positive,0.8764433264732361
4659,6/28/2022 8:47:34 PM,FDA advisors recommend changing future COVID shots to include Omicron component,Seeking Alpha,https://seekingalpha.com/news/3852609-fda-advisors-recommend-changing-future-covid-shots-to-include-omicron-component?utm_source=businessinsider&utm_medium=referral,positive,0.9094982743263245
4660,6/29/2022 10:30:13 AM,Novavax Stock Is in Prime Position For Speculation,InvestorPlace,/news/stocks/nvax-stock-is-in-prime-position-for-speculation-1031557041,positive,0.7913817763328552
4661,6/29/2022 11:27:44 AM,FDA Experts Recommend Updated Booster Shots To Fight Contagious Omicron Variant In Fall ,RTTNews,/news/stocks/fda-experts-recommend-updated-booster-shots-to-fight-contagious-omicron-variant-in-fall-1031556797,positive,0.5832170248031616
4662,6/29/2022 3:06:03 PM,BioNTech to begin testing a pan-coronavirus vaccine in H2,Seeking Alpha,https://seekingalpha.com/news/3852899-biontech-to-begin-testing-a-pan-coronavirus-covid-vaccine-in-2h?utm_source=businessinsider&utm_medium=referral,positive,0.732961118221283
4663,6/29/2022 4:28:39 PM,European Commission president can’t find texts on massive COVID vaccine deal,Seeking Alpha,https://seekingalpha.com/news/3852935-european-commission-president-cant-find-texts-on-massive-covid-vaccine-deal?utm_source=businessinsider&utm_medium=referral,positive,0.816408097743988
4664,6/29/2022 7:32:33 PM,"Pfizer, Moderna Analysts Respond To FDA COVID Booster Ruling: 'Revenues Will Decline'",Benzinga,/news/stocks/pfizer-moderna-analysts-respond-to-fda-covid-booster-ruling-revenues-will-decline-1031558559,neutral,0.9647608399391174
4665,6/29/2022 8:58:48 PM,"Pfizer, BioNTech announce new COVID-19 vaccine supply agreement with U.S. govt",Seeking Alpha,https://seekingalpha.com/news/3853028-pfizer-biontech-announce-new-covid-19-vaccine-supply-agreement-with-us-govt?utm_source=businessinsider&utm_medium=referral,negative,0.9285885691642761
4666,6/30/2022 3:34:02 AM,Pfizer And BioNTech Reach New Agreement With U.S. To Provide Addl Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/pfizer-and-biontech-reach-new-agreement-with-u-s-to-provide-addl-doses-of-covid-19-vaccine-1031559039,negative,0.9372987151145935
4667,6/30/2022 8:42:08 AM,Pfizer Signs $3.2 Bln COVID Vaccine Deal With US Government ,RTTNews,/news/stocks/pfizer-signs-3-2-bln-covid-vaccine-deal-with-us-government-1031559451,negative,0.8805680274963379
4668,6/30/2022 11:00:42 AM,Pfizer seeks full FDA approval for COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3853145-pfizer-seeks-full-fda-approval-for-covid-19-pill?utm_source=businessinsider&utm_medium=referral,negative,0.8597248792648315
4669,6/30/2022 1:02:37 PM,Pfizer Submits NDA For PAXLOVID To FDA To Treat Severe Illness From COVID-19 ,RTTNews,/news/stocks/pfizer-submits-nda-for-paxlovid-to-fda-to-treat-severe-illness-from-covid-19-1031560009,positive,0.6072962284088135
4670,6/30/2022 2:41:30 PM,FDA requests manufacturers to update vaccines for latest Omicron subvariants,Seeking Alpha,https://seekingalpha.com/news/3853297-fda-requests-manufacturers-to-update-vaccines-for-latest-omicron-subvariants?utm_source=businessinsider&utm_medium=referral,positive,0.8827484846115112
4671,6/30/2022 2:44:57 PM,"The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-ink-new-covid-19-vaccine-supply-pact-sanofi-hit-by-fda-clinical-hold-angion-biomedica-halts-second-kidney-disease-trial-1031560407,neutral,0.9107438921928406
4672,6/30/2022 4:00:24 PM,Pfizer secures $3.2B US Army contract,Seeking Alpha,https://seekingalpha.com/news/3853345-pfizer-secures-32b-us-army-contract?utm_source=businessinsider&utm_medium=referral,negative,0.9367387890815735
4673,6/30/2022 5:54:04 PM,PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment Paxlovid,InvestorPlace,/news/stocks/pfe-stock-rises-pfizer-requests-fda-approval-covid-19-treatment-paxlovid-1031561473,negative,0.6343485116958618
4674,6/30/2022 8:24:22 PM,This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices,Benzinga,/news/stocks/this-analyst-says-us-government-buying-more-covid-19-vaccines-at-higher-prices-1031561524,negative,0.8480421304702759
4675,7/1/2022 6:43:54 PM,Why Is Novavax (NVAX) Stock Up 10% Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-up-10-today-1031564001,negative,0.8271597027778625
4676,7/2/2022 4:00:39 PM,COVID vaccine stocks lead biotech selloff in 1H; three reasons to see recovery,Seeking Alpha,https://seekingalpha.com/news/3853920-covid-vaccine-stocks-lead-biotech-selloff-in-1h-three-reasons-to-seek-recovery?utm_source=businessinsider&utm_medium=referral,neutral,0.49856117367744446
4677,7/5/2022 10:48:34 AM,Merck beats Pfizer with COVID-19 pill in certain countries,Seeking Alpha,https://seekingalpha.com/news/3854044-merck-beats-pfizer-with-covid-19-pills-in-certain-countries?utm_source=businessinsider&utm_medium=referral,negative,0.6661329865455627
4678,7/5/2022 11:56:15 AM,CureVac claims patent rights for Pfizer/BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3854088-pfe-bntx-stocks-drop-as-curevac-claims-patent-rights-for-covid-19-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.8561902642250061
4679,7/5/2022 12:37:00 PM,BofA picks 9 longs and 1 short for its best ideas for the third quarter,Seeking Alpha,https://seekingalpha.com/news/3854066-bofa-picks-9-longs-and-1-short-for-its-best-ideas-for-the-third-quarter?utm_source=businessinsider&utm_medium=referral,positive,0.8999526500701904
4680,7/5/2022 4:34:00 PM,IMX score falls to 'moderate low' level in June,Seeking Alpha,https://seekingalpha.com/news/3854263-imx-score-falls-to-moderate-low-level-in-june?utm_source=businessinsider&utm_medium=referral,neutral,0.9724128842353821
4681,7/5/2022 6:24:48 PM,Ocugen in renewed focus as FDA wants COVID boosters to fight Omicron variant,Seeking Alpha,https://seekingalpha.com/news/3854340-ocugen-in-renewed-focus-as-fda-wants-covid-boosters-to-fight-omicron-variant?utm_source=businessinsider&utm_medium=referral,negative,0.8983839750289917
4682,7/6/2022 4:10:18 PM,Pfizer signs licensing agreement with Touchlight for patents to assist in mRNA treatments,Seeking Alpha,https://seekingalpha.com/news/3854658-pfizer-signs-licensing-agreement-with-touchlight-for-patents-to-assist-in-mrna-treatments?utm_source=businessinsider&utm_medium=referral,negative,0.899766743183136
4683,7/6/2022 5:18:27 PM,FDA allows more pharmacists to prescribe Pfizer COVID antiviral Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3854682-fda-allows-more-pharmacists-to-prescribe-pfizer-covid-antiviral-paxlovid?utm_source=businessinsider&utm_medium=referral,positive,0.6930590867996216
4684,7/6/2022 5:22:36 PM,U.S. Senate Democrats advance deal to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3854684-us-senate-democrats-in-agreement-to-lower-drug-prices?utm_source=businessinsider&utm_medium=referral,negative,0.7087149620056152
4685,7/6/2022 6:13:33 PM,BioNTech threatens legal action against CureVac over mRNA vaccine IP spat - Reuters,Seeking Alpha,https://seekingalpha.com/news/3854717-biontech-threatens-legal-action-against-curevac-over-mrna-vaccine-intellectual-property-spat-reuters?utm_source=businessinsider&utm_medium=referral,neutral,0.8388276100158691
4686,7/7/2022 9:13:08 AM,GSK shareholders clear way for consumer health unit Haleon spinoff,Seeking Alpha,https://seekingalpha.com/news/3854890-gsk-shareholders-clear-way-for-consumer-health-unit-haleon-spinoff?utm_source=businessinsider&utm_medium=referral,positive,0.8738369941711426
4687,7/7/2022 10:13:33 AM,FDA Says Pharmacists Can Prescribe Pfizer COVID-19 Pill Paxlovid ,RTTNews,/news/stocks/fda-says-pharmacists-can-prescribe-pfizer-covid-19-pill-paxlovid-1031572258,positive,0.8710125684738159
4688,7/7/2022 4:03:38 PM,"The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-seagen-buyout-advances-adverum-restructures-pharmacists-get-ok-to-prescribe-pfizer-covid-19-pill-1031573375,positive,0.8647336363792419
4689,7/7/2022 5:30:25 PM,EU regulator to accept COVID-19 shots targeted at older versions of Omicron,Seeking Alpha,https://seekingalpha.com/news/3855104-eu-regulator-to-accept-covid-19-shots-targeted-at-older-versions-of-omicorn?utm_source=businessinsider&utm_medium=referral,positive,0.5810506939888
4690,7/8/2022 9:48:46 AM,Pfizer inks contract with Africa CDC to supply COVID pill Paxlovid - Reuters,Seeking Alpha,https://seekingalpha.com/news/3855279-pfizer-inks-contract-with-africa-cdc-to-supply-covid-pill-paxlovid-reuters?utm_source=businessinsider&utm_medium=referral,negative,0.9018800258636475
4691,7/8/2022 11:18:25 AM,Tens of millions of COVID-19 shots being thrown away as demand drops,Seeking Alpha,https://seekingalpha.com/news/3855302-tens-of-millions-of-covid-19-shots-being-thrown-away-as-demand-drops?utm_source=businessinsider&utm_medium=referral,neutral,0.7126210331916809
4692,7/8/2022 2:12:10 PM,"NIH launches $1.2B long COVID study involving nearly 40,000 people",Seeking Alpha,https://seekingalpha.com/news/3855377-nih-launches-12b-long-covid-study-involving-nearly-40000-patients?utm_source=businessinsider&utm_medium=referral,positive,0.7779584527015686
4693,7/8/2022 2:19:02 PM,"The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-inks-pact-with-africa-for-covid-19-pills-emergent-bio-ridgeback-to-increase-access-to-ebola-treatment-adc-therapeutics-sobi-in-european-pact-for-lymphoma-drug-1031575424,negative,0.8182423710823059
4694,7/8/2022 3:31:15 PM,"FDA tentatively approves generic of Pfizer's Ibrance, but many years until hits market",Seeking Alpha,https://seekingalpha.com/news/3855396-fda-tentatively-approves-generic-of-pfizers-ibrance-but-many-years-until-hits-market?utm_source=businessinsider&utm_medium=referral,positive,0.8252748250961304
4695,7/8/2022 8:13:53 PM,"Pfizer, BioNTech COVID-19 shot granted full FDA approval for adolescents",Seeking Alpha,https://seekingalpha.com/news/3855457-pfizer-biontech-granted-full-fda-approval-for-covid-19-shot-in-adolescents?utm_source=businessinsider&utm_medium=referral,negative,0.8812971711158752
4696,7/9/2022 5:45:50 AM,FDA Approves Pfizer's COVID-19 Vaccine For Adolescents ,RTTNews,/news/stocks/fda-approves-pfizer-s-covid-19-vaccine-for-adolescents-1031576417,negative,0.6175231337547302
4697,7/9/2022 5:57:23 AM,Pfizer Submits Variation To EMA For COVID-19 Vaccination Of Children 6 Months To Less Than 5 Yrs ,RTTNews,/news/stocks/pfizer-submits-variation-to-ema-for-covid-19-vaccination-of-children-6-months-to-less-than-5-yrs-1031576418,positive,0.8963109254837036
4698,7/10/2022 4:00:27 PM,Composition of next COVID boosters raises questions,Seeking Alpha,https://seekingalpha.com/news/3855522-composition-of-next-covid-boosters-raises-questions?utm_source=businessinsider&utm_medium=referral,positive,0.8750075101852417
4699,7/11/2022 10:25:17 AM,EU recommends second COVID boosters for ages 60-79,Seeking Alpha,https://seekingalpha.com/news/3855582-eu-recommends-second-covid-boosters-for-ages-60-79?utm_source=businessinsider&utm_medium=referral,positive,0.8949840664863586
4700,7/11/2022 8:15:37 PM,Which Coronavirus Stock Could Fetch Higher Returns?,InvestorPlace,/news/stocks/which-of-these-coronavirus-stocks-could-fetch-higher-returns-1031579354,positive,0.8367049694061279
4701,7/12/2022 4:30:07 PM,Omicron BA.5 represents 65% of circulating COVID variants in U.S. – CDC director,Seeking Alpha,https://seekingalpha.com/news/3856135-omicron-ba5-represents-65-of-circulating-covid-variants-in-us-cdc-director?utm_source=businessinsider&utm_medium=referral,positive,0.8808677196502686
4702,7/12/2022 5:44:10 PM,FDA could clear Novavax COVID-19 shot as early as tomorrow – Politico,Seeking Alpha,https://seekingalpha.com/news/3856158-nvax-stock-gains-on-imminent-fda-clearance-for-covid-19-shot?utm_source=businessinsider&utm_medium=referral,positive,0.9296421408653259
4703,7/12/2022 6:00:23 PM,CDC says COVID-19 negatively impacted progress on antibiotic resistance,Seeking Alpha,https://seekingalpha.com/news/3856156-cdc-says-covid-19-negatively-impacted-progress-on-antibiotic-resistance?utm_source=businessinsider&utm_medium=referral,neutral,0.9653759002685547
4704,7/12/2022 6:55:47 PM,Did AQR’s Clifford Asness Delete His Twitter After Shorting AMC Stock?,InvestorPlace,/news/stocks/did-aqrs-clifford-asness-delete-his-twitter-after-shorting-amc-stock-1031582284,positive,0.5063095688819885
4705,7/13/2022 12:35:03 PM,AstraZeneca says COVID-19 shot was equally effective to mRNA vaccines in review,Seeking Alpha,https://seekingalpha.com/news/3856363-astrazeneca-says-covid-19-shot-as-effective-as-mrna-vaccines-in-review?utm_source=businessinsider&utm_medium=referral,negative,0.8064044117927551
4706,7/13/2022 2:20:50 PM,Novavax (NVAX) Stock Pops Ahead of FDA Approval,InvestorPlace,/news/stocks/novavax-nvax-stock-pops-ahead-of-fda-approval-1031584988,positive,0.8478059768676758
4707,7/13/2022 8:57:25 PM,Novavax COVID-19 vaccine wins FDA Emergency Use Authorization,Seeking Alpha,https://seekingalpha.com/news/3856589-novavax-covid-19-vaccine-wins-fda-emergency-use-authorization?utm_source=businessinsider&utm_medium=referral,negative,0.9303896427154541
4708,7/14/2022 9:02:52 AM,Pfizer/BioNTech seek approval of COVID vaccine for young children in Japan - Reuters,Seeking Alpha,https://seekingalpha.com/news/3856695-pfizerbiontech-seek-approval-of-covid-vaccine-for-young-children-in-japan-reuters?utm_source=businessinsider&utm_medium=referral,negative,0.7857990860939026
4709,7/14/2022 9:25:08 AM,Pfizer recalls 1 lot of anesthetic Propofol due to presence of visible particulate,Seeking Alpha,https://seekingalpha.com/news/3856698-pfizer-recalls-1-lot-of-anesthetic-propofol-due-to-presence-of-visible-particulate?utm_source=businessinsider&utm_medium=referral,neutral,0.8634620308876038
4710,7/14/2022 2:40:41 PM,What Is Going on With Novavax (NVAX) Stock Today?,InvestorPlace,/news/stocks/what-is-going-on-with-novavax-nvax-stock-today-2-1031588212,neutral,0.6391204595565796
4711,7/14/2022 3:09:15 PM,Moderna COVID shot approved for children as young as six months in Canada,Seeking Alpha,https://seekingalpha.com/news/3856888-moderna-covid-shot-approved-for-children-as-young-as-six-months-in-canada?utm_source=businessinsider&utm_medium=referral,positive,0.8139832615852356
4712,7/14/2022 4:06:08 PM,Want to Short TSLA Stock? Check Out the New TSLQ ETF.,InvestorPlace,/news/stocks/want-to-short-tsla-stock-check-out-the-new-tslq-etf-1031588373,positive,0.9421820640563965
4713,7/14/2022 8:37:07 PM,"Codexis to make enzyme used in Pfizer's COVID pill, says Q2 revenue expected to be $38M",Seeking Alpha,https://seekingalpha.com/news/3857004-codexis-to-make-enzyme-used-in-pfizers-covid-pill-says-q2-revenue-expected-to-be-38m?utm_source=businessinsider&utm_medium=referral,positive,0.7894453406333923
4714,7/15/2022 9:35:01 AM,"Pfizer backed cancer drugmaker CStone mulls options, including sale - Bloomberg News",Seeking Alpha,https://seekingalpha.com/news/3857098-pfizer-backed-cancer-drugmaker-cstone-mulls-options-including-sale-bloomberg-news?utm_source=businessinsider&utm_medium=referral,positive,0.8630899786949158
4715,7/15/2022 12:49:53 PM,Why Codexis Shares Are Slumping Today,Benzinga,/news/stocks/why-codexis-shares-are-slumping-today-1031589918,neutral,0.9504968523979187
4716,7/15/2022 5:05:24 PM,Pfizer's Cancer Drug Partner Mulls Sale: Report,Benzinga,/news/stocks/pfizer-s-cancer-drug-partner-mulls-sale-report-1031590693,positive,0.9431816935539246
4717,7/15/2022 6:14:53 PM,Novavax (NVAX) Down As EU Adds Side Effects To COVID Jab Label,Benzinga,/news/stocks/novavax-nvax-down-as-eu-adds-side-effects-to-covid-jab-label-1031590879,neutral,0.9638558626174927
4718,7/15/2022 11:56:08 PM,"Super Bearish On Tesla Or Nvidia? Inverse, Leveraged ETFs Offer Investors New Opportunities",Benzinga,/news/etf/super-bearish-on-tesla-or-nvidia-inverse-leveraged-etfs-offer-investors-new-opportunities-1031591256,negative,0.6557992100715637
4719,7/16/2022 8:00:00 PM,"For GSK, breaking up isn't hard to do as consumer health unit Haleon launches Monday",Seeking Alpha,https://seekingalpha.com/news/3857338-for-gsk-breaking-up-isnt-hard-to-do-as-consumer-health-unit-haleon-launches-monday?utm_source=businessinsider&utm_medium=referral,positive,0.9291051626205444
4720,7/17/2022 3:00:51 PM,7 Blue-Chip Stocks Trading a Huge Discount Right Now,InvestorPlace,/news/stocks/blue-chip-stocks-trading-at-a-discount-1031592062,positive,0.8069199323654175
4721,7/18/2022 8:55:28 AM,GSK consumer health unit spinoff Haleon begins trading on LSE,Seeking Alpha,https://seekingalpha.com/news/3857413-gsk-consumer-health-unit-spinoff-haleon-begins-trading-on-lse?utm_source=businessinsider&utm_medium=referral,positive,0.9508085250854492
4722,7/18/2022 10:57:31 AM,Top sticky stocks most immune to big earnings misses and beats,Seeking Alpha,https://seekingalpha.com/news/3857382-top-sticky-stocks-most-immune-to-big-earnings-misses-and-beats?utm_source=businessinsider&utm_medium=referral,neutral,0.6961941719055176
4723,7/18/2022 3:39:08 PM,Anthony Fauci says he will retire at end of Biden's current term - Politico,Seeking Alpha,https://seekingalpha.com/news/3857623-anthony-fauci-says-he-will-retire-at-end-of-biden-current-term-politico?utm_source=businessinsider&utm_medium=referral,positive,0.9029468894004822
4724,7/18/2022 4:25:06 PM,"Europe's drug regulator starts review of Pfizer, BioNTech COVID shot in under 5-year-olds",Seeking Alpha,https://seekingalpha.com/news/3857651-europes-drug-regulator-starts-review-of-pfizer-biontech-covid-shot-in-under-5-year-olds?utm_source=businessinsider&utm_medium=referral,positive,0.8750607371330261
4725,7/18/2022 6:58:43 PM,Top pharma lobby says R&D spending reached a peak in 2021,Seeking Alpha,https://seekingalpha.com/news/3857699-top-pharma-lobby-says-rd-spending-reached-a-peak-in-2021?utm_source=businessinsider&utm_medium=referral,negative,0.9346281290054321
4726,7/18/2022 10:12:59 PM,Why did Novavax stock fall today? Lingering concerns over COVID vaccine sales,Seeking Alpha,https://seekingalpha.com/news/3857833-why-did-novavax-stock-fall-today-lingering-concerns-over-covid-vaccine-sales?utm_source=businessinsider&utm_medium=referral,neutral,0.9526035785675049
4727,7/19/2022 11:47:38 AM,Pfizer/BioNTech and EU to reschedule COVID vaccine deliveries to 2024: FT,Seeking Alpha,https://seekingalpha.com/news/3857967-pfizerbiontech-and-eu-to-reschedule-covid-vaccine-deliveries-to-2024-ft?utm_source=businessinsider&utm_medium=referral,positive,0.8252410292625427
4728,7/19/2022 1:06:43 PM,Gilead signs deal with EU to deliver COVID-19 therapy,Seeking Alpha,https://seekingalpha.com/news/3857982-gilead-signs-deal-with-eu-to-deliver-covid-19-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.9139072895050049
4729,7/19/2022 6:16:08 PM,Pfizer/BioNTech complete submissions seeking EU nod for Omicron shot,Seeking Alpha,https://seekingalpha.com/news/3858216-pfe-bntx-stocks-gain-as-companies-seek-eu-nod-for-omicron-shot?utm_source=businessinsider&utm_medium=referral,positive,0.7293686866760254
4730,7/19/2022 7:06:34 PM,2 Big Reasons Novavax (NVAX) Stock Is Shooting Higher Today,InvestorPlace,/news/stocks/2-big-reasons-novavax-nvax-stock-is-shooting-higher-today-1031598337,negative,0.9454615712165833
4731,7/20/2022 2:52:51 AM,Novavax gains as CDC endorses COVID-19 shot  (update),Seeking Alpha,https://seekingalpha.com/news/3858227-nvax-stock-gains-as-cdc-panel-endorses-covid-19-shot?utm_source=businessinsider&utm_medium=referral,negative,0.6989830732345581
4732,7/20/2022 4:05:24 PM,The CDC Just Gave Novavax (NVAX) Stock a Big Boost,InvestorPlace,/news/stocks/the-cdc-just-gave-novavax-nvax-stock-a-big-boost-1031601852,negative,0.5678849816322327
4733,7/20/2022 5:44:19 PM,"Pfizer (PFE), BioNTech Seek EU Nod For Omicron-Based COVID Jab",Benzinga,/news/stocks/pfizer-pfe-biontech-seek-eu-nod-for-omicron-based-covid-jab-1031601786,negative,0.7433514595031738
4734,7/20/2022 9:15:01 PM,Pfizer to spend $470M to bolster vaccine research facilities in New York - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3858841-pfizer-to-spend-470m-to-bolster-vaccine-research-facilities-in-new-york-bloomberg?utm_source=businessinsider&utm_medium=referral,negative,0.9144289493560791
4735,7/21/2022 2:33:37 PM,Biden tests positive for COVID; in isolation at White House and taking Pfizer's Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3859143-biden-tests-positive-for-covid-in-isolation-at-white-house-and-taking-pfizers-paxlovid?utm_source=businessinsider&utm_medium=referral,positive,0.7378894686698914
4736,7/21/2022 3:49:50 PM,AstraZeneca COVID-19 therapy less effective against new Omicron strains: study,Seeking Alpha,https://seekingalpha.com/news/3859171-astrazeneca-covid-19-therapy-less-protection-against-new-omicron-strains?utm_source=businessinsider&utm_medium=referral,neutral,0.845219612121582
4737,7/21/2022 6:13:22 PM,U.S. President Joe Biden Tests Positive For COVID-19; Tabula Rasa HealthCare Shares Spike Higher,Benzinga,/news/stocks/u-s-president-joe-biden-tests-positive-for-covid-19-tabula-rasa-healthcare-shares-spike-higher-1031605445,negative,0.8981645107269287
4738,7/22/2022 3:07:42 PM,"EMA starts review of adapted versions of COVID shots from Pfizer/BioNTech, Moderna",Seeking Alpha,https://seekingalpha.com/news/3859664-ema-starts-review-of-adapted-versions-of-covid-shots-from-pfizerbiontech-moderna?utm_source=businessinsider&utm_medium=referral,positive,0.8773464560508728
4739,7/22/2022 4:37:37 PM,"Earnings week ahead: Alphabet, Amazon, Coca-Cola, Microsoft, Ford, Exxon and more",Seeking Alpha,https://seekingalpha.com/news/3859698-earnings-week-ahead-coca-cola-microsoft-ford-exxon-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.919938862323761
4740,7/22/2022 7:16:39 PM,Viatris extends decline to reach 52-week low,Seeking Alpha,https://seekingalpha.com/news/3859763-vtrs-stock-extends-decline-to-reach-52-week-low?utm_source=businessinsider&utm_medium=referral,neutral,0.9566466808319092
4741,7/22/2022 9:33:31 PM,COVID boosters for under 50s on ice in bid to accelerate reformulated vaccines - WaPo,Seeking Alpha,https://seekingalpha.com/news/3859812-covid-boosters-for-under-50s-on-ice-in-bid-to-accelerate-reformulated-vaccines-wapo?utm_source=businessinsider&utm_medium=referral,negative,0.7484634518623352
4742,7/23/2022 8:15:00 PM,"Drug pricing legislation will affect biopharma revenue, but impact is manageable - RBC",Seeking Alpha,https://seekingalpha.com/news/3859761-drug-pricing-legislation-will-affect-biopharma-revenue-but-impact-is-manageable-rbc?utm_source=businessinsider&utm_medium=referral,positive,0.8448383808135986
4743,7/24/2022 4:00:31 PM,"Pfizer, Moderna to see sales decline for COVID shots before recovery",Seeking Alpha,https://seekingalpha.com/news/3859843-pfizer-moderna-to-see-sales-decline-for-covid-shots-before-recovery?utm_source=businessinsider&utm_medium=referral,neutral,0.9530166387557983
4744,7/24/2022 10:37:06 PM,"Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earnings Pick Up Pace",Benzinga,/news/stocks/apple-meta-pfizer-among-key-companies-reporting-in-the-week-ahead-as-earning-picks-up-pace-1031609526,negative,0.8915560245513916
4745,7/25/2022 11:19:52 AM,China greenlights homegrown COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3859917-china-greenlights-homegrown-covid-19-pill?utm_source=businessinsider&utm_medium=referral,positive,0.9014589190483093
4746,7/25/2022 2:11:51 PM,"Pfizer, Moderna to join key White House “summit” on next-gen COVID shots – Stat",Seeking Alpha,https://seekingalpha.com/news/3860053-pfizer-moderna-to-join-key-white-house-summit-on-next-gen-covid-shots-stat?utm_source=businessinsider&utm_medium=referral,positive,0.5094539523124695
4747,7/25/2022 4:33:08 PM,Pfizer loses US appeal over co-pay program for heart failure drugs,Seeking Alpha,https://seekingalpha.com/news/3860103-pfizer-loses-us-appeal-over-co-pay-program-for-heart-failure-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.939039409160614
4748,7/26/2022 10:37:23 AM,"China clears HIV pill for COVID-19, marking 1st home-made pill against coronavirus",Seeking Alpha,https://seekingalpha.com/news/3860382-china-clears-hiv-pill-for-covid-19-marking-1st-home-made-pill-against-coronavirus?utm_source=businessinsider&utm_medium=referral,negative,0.672778844833374
4749,7/26/2022 8:16:10 PM,Surge in use of Pfizer's COVID antiviral Paxlovid since May,Seeking Alpha,https://seekingalpha.com/news/3860833-nearly-28m-courses-of-pfizer-covid-antiviral-paxlovid-administered-so-far?utm_source=businessinsider&utm_medium=referral,negative,0.9445315003395081
4750,7/27/2022 12:00:52 PM,Pfizer-BioNTech's new Omicron/ancestral strain COVID vaccine enters phase 2 trial,Seeking Alpha,https://seekingalpha.com/news/3861254-pfizer-biontechs-new-omicronancestral-strain-covid-vaccine-enters-phase-2-trial?utm_source=businessinsider&utm_medium=referral,negative,0.7353057861328125
4751,7/27/2022 1:36:30 PM,The 3 Best Market Sectors for the Second Half of 2022,InvestorPlace,/news/stocks/best-market-sectors-2-1031621062,positive,0.92616206407547
4752,7/27/2022 2:38:51 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3861395-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8825733065605164
4753,7/27/2022 3:01:13 PM,Here's what Wall Street expects from Pfizer's earnings report,Markets Insider Automation,/news/stocks/pfizer-stock-price-quarter-earnings-preview-q2-1031620530,positive,0.9071700572967529
4754,7/27/2022 3:16:31 PM,"Pfizer, BioNTech Advance COVID-19 Vaccine Strategy With Next-Gen Vaccine Candidate Study ",RTTNews,/news/stocks/pfizer-biontech-advance-covid-19-vaccine-strategy-with-next-gen-vaccine-candidate-study-1031620982,negative,0.62920743227005
4755,7/27/2022 5:30:02 PM,Pfizer Q2 results in spotlight as Comirnaty vs Paxlovid numbers to be keenly watched,Seeking Alpha,https://seekingalpha.com/news/3861536-pfizer-q2-results-in-spotlight-as-comirnaty-vs-paxlovid-numbers-to-be-keenly-watched?utm_source=businessinsider&utm_medium=referral,negative,0.7794781923294067
4756,7/28/2022 10:46:27 AM,"Pfizer Non-GAAP EPS of $2.04 beats by $0.26, revenue of $27.7B beats by $1.5B, raises lower end of FY22 EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3862139-pfizer-non-gaap-eps-of-204-beats-by-026-revenue-of-277b-beats-by-15b-rasies-lower-end-of-fy22-eps-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.5871706604957581
4757,7/28/2022 11:32:01 AM,Pfizer tightens 2022 earnings guidance as COVID franchise outperforms,Seeking Alpha,https://seekingalpha.com/news/3862212-pfizer-tightens-earnings-guidance-as-covid-franchise-outperforms?utm_source=businessinsider&utm_medium=referral,neutral,0.8880458474159241
4758,7/28/2022 12:50:28 PM,"Pfizer Inc. Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/pfizer-inc-q2-profit-increases-beats-estimates-1031625065,negative,0.9352257251739502
4759,7/28/2022 12:57:17 PM,"Pfizer Non-GAAP EPS of $2.04 beats by $0.26, revenue of $27.7B beats by $1.5B, raises lower end of FY22 EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3862139-pfizer-non-gaap-eps-of-204-beats-by-026-revenue-of-277b-beats-by-15b-raises-lower-end-of-fy22-eps-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.5871706604957581
4760,7/28/2022 1:27:50 PM,"Pfizer Q2 Results Climb, Beat Estimates; Lifts Low-end Of FY22 Adj. EPS View ",RTTNews,/news/stocks/pfizer-q2-results-climb-beat-estimates-lifts-low-end-of-fy22-adj-eps-view-1031625288,negative,0.9383472800254822
4761,7/28/2022 3:28:28 PM,Pfizer sends rivals lower with unchanged guidance for COVID-19 franchise,Seeking Alpha,https://seekingalpha.com/news/3862495-pfizer-sends-rivals-lower-with-unchanged-guidance-for-covid-19-franchise?utm_source=businessinsider&utm_medium=referral,neutral,0.9156041741371155
4762,7/28/2022 4:37:49 PM,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",Benzinga,/news/stocks/daily-biotech-pulse-gsk-s-kidney-disease-drug-approved-for-children-tonix-pharma-to-launch-monkeypox-vaccine-study-in-kenya-positive-effect-of-cyclerion-s-schizophrenia-candidate-1031626482,negative,0.864479124546051
4763,7/28/2022 5:36:45 PM,Pfizer denies resistance to COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3862590-pfizer-denies-resistance-to-covid-19-pill?utm_source=businessinsider&utm_medium=referral,positive,0.7802985906600952
4764,7/28/2022 8:20:28 PM,Senate Democrats propose $21B funding for next phase of COVID-19 response,Seeking Alpha,https://seekingalpha.com/news/3862718-senate-democrats-propose-21b-funding-for-next-phase-of-covid-19-response?utm_source=businessinsider&utm_medium=referral,negative,0.6786968111991882
4765,7/29/2022 1:50:18 AM,Biden administration mulls updated booster rollout in September – NYT,Seeking Alpha,https://seekingalpha.com/news/3862940-biden-administration-mulls-updated-booster-rollout-in-september-nyt?utm_source=businessinsider&utm_medium=referral,positive,0.9154930710792542
4766,7/29/2022 3:40:14 PM,Apple To $185? Plus This Analyst Lowers Price Target On Intel,Benzinga,/news/stocks/apple-to-185-plus-this-analyst-lowers-price-target-on-intel-1031630246,positive,0.8186636567115784
4767,7/29/2022 4:41:48 PM,"Earnings Week Ahead: Starbucks, Caterpillar, AMD, Uber, Moderna, JetBlue, and more",Seeking Alpha,https://seekingalpha.com/news/3863301-earnings-week-ahead-starbucks-caterpillar-amd-uber-moderna-jetblue-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9190043210983276
4768,7/29/2022 5:36:32 PM,Expert Ratings for Pfizer,Benzinga,/news/stocks/expert-ratings-for-pfizer-1031630559,positive,0.8965446352958679
4769,7/29/2022 11:24:17 PM,Recap Of Friday's Biotech Catalysts - End of The Day Summary,Benzinga,/news/stocks/recap-of-friday-s-biotech-catalysts---end-of-the-day-summary-1031631044,positive,0.9370302557945251
4770,7/30/2022 9:51:35 PM,Biden tests positive for COVID again in rebound linked to Pfizer pill,Seeking Alpha,https://seekingalpha.com/news/3863494-biden-tests-positive-for-covid-again-in-rebound-linked-to-pfizer-pill?utm_source=businessinsider&utm_medium=referral,positive,0.5031464099884033
4771,7/31/2022 3:21:24 PM,Biotech Investors: August's Key PDUFA Catalysts You Must Know,Benzinga,/news/stocks/biotech-investors-august-s-key-pdufa-catalysts-you-must-know-1031631857,positive,0.8776605129241943
4772,8/1/2022 3:08:03 PM,Chevron To $185? Plus Stephens Predicts $800 For This Stock,Benzinga,/news/stocks/chevron-to-185-plus-stephens-predicts-800-for-this-stock-1031635629,negative,0.5687610507011414
4773,8/1/2022 4:47:41 PM,COVID second booster adverse reactions fewer than after first one - CDC,Seeking Alpha,https://seekingalpha.com/news/3863833-covid-second-booster-adverse-reactions-fewer-than-after-first-one-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.5980605483055115
4774,8/5/2022 3:52:24 PM,"Novavax vaccine doses administered in U.S. top 7,300 - CDC",Seeking Alpha,https://seekingalpha.com/news/3868254-novavax-vaccine-doses-administered-in-us-top-7300-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.8539984226226807
4775,8/5/2022 3:56:40 PM,Pfizer in 'advanced talks' to buy Global Blood Therapeutics in ~$5B deal - WSJ,Seeking Alpha,https://seekingalpha.com/news/3868257-pfizer-in-advanced-talks-to-buy-global-blood-therapeutics-in-5b-deal-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.764693021774292
4776,8/5/2022 5:35:25 PM,"Biotech Daily: Thumbs Down For Acadia's Antipsychotic Drug, Akebia Fails COVID-19 Study, Kazia's Encouraging Data In Brain Metastases",Benzinga,/news/stocks/biotech-daily-thumbs-down-for-acadia-s-antipsychotic-drug-akebia-fails-covid-19-study-kazia-s-encouraging-data-in-brain-metastases-1031656178,neutral,0.5212129354476929
4777,8/6/2022 10:48:03 AM,"Myovant, Pfizer win approval of Myfembree for pain associated with endometriosis",Seeking Alpha,https://seekingalpha.com/news/3868520-myovant-pfizer-win-approval-of-myfembree-for-pain-associated-with-endometriosis?utm_source=businessinsider&utm_medium=referral,negative,0.9354041218757629
4778,8/6/2022 8:00:00 PM,"Biotech poised for H2 recovery as stocks rise amid quarterly results, M&A activity",Seeking Alpha,https://seekingalpha.com/news/3868377-biotech-poised-for-h2-recovery-as-stocks-rise-amid-quarterly-results-ma-activity?utm_source=businessinsider&utm_medium=referral,negative,0.7241557836532593
4779,8/7/2022 10:19:22 PM,$35 per month capped insulin for private insurance kept out of Inflation Reduction Act,Seeking Alpha,https://seekingalpha.com/news/3868539-35-per-month-capped-insulin-for-private-insurance-kept-out-of-inflation-reduction-act-passed-by-senate?utm_source=businessinsider&utm_medium=referral,positive,0.5326845645904541
4780,8/8/2022 10:40:51 AM,Pfizer inks $5.4B deal to acquire SCD drug maker Global Blood Therapeutics,Seeking Alpha,https://seekingalpha.com/news/3868632-pfizer-inks-54b-deal-to-buy-scd-drug-maker-global-blood-therapeutics-?utm_source=businessinsider&utm_medium=referral,negative,0.6177757978439331
4781,8/8/2022 11:06:25 AM,BioNTech stock falls on Q2 miss as vaccine sales slump; eyes uptick in Q4 with Omicron shot delivery in October,Seeking Alpha,https://seekingalpha.com/news/3868649-biontech-stock-falls-as-q2-vaccine-revenue-slumps-eyes-uptick-in-q4-with-omicron-shot-delivery-in-october?utm_source=businessinsider&utm_medium=referral,neutral,0.9596629738807678
4782,8/8/2022 12:53:55 PM,FDA Approves Myovant Sciences/Pfizer's Treatment For Endometriosis-Associated Pain,Benzinga,/news/stocks/fda-approves-myovant-sciences-pfizer-s-treatment-for-endometriosis-associated-pain-1031660698,negative,0.6595311164855957
4783,8/8/2022 12:56:28 PM,"BioNTech Q2 Results Down, Backs FY22 Vaccine Revenue View; Stock Down ",RTTNews,/news/stocks/biontech-q2-results-down-backs-fy22-vaccine-revenue-view-stock-down-1031660680,neutral,0.9693222641944885
4784,8/8/2022 1:11:53 PM,Pfizer To Buy Global Blood Therapeutics In $5.4 Bln All-cash Deal ,RTTNews,/news/stocks/pfizer-to-buy-global-blood-therapeutics-in-5-4-bln-all-cash-deal-1031660772,positive,0.8780427575111389
4785,8/8/2022 2:32:47 PM,"Benzinga Before The Bell: Elon Musk Confirms Tesla AI Day Part 2, Dogecoin Scam, BioNTech Q2 Earnings Shocker And Other Top Financial Stories Monday, August 8",Benzinga,/news/stocks/benzinga-before-the-bell-elon-musk-confirms-tesla-ai-day-part-2-dogecoin-scam-biontech-q2-earnings-shocker-and-other-top-financial-stories-monday-august-8-1031661055,positive,0.9073895812034607
4786,8/8/2022 4:12:51 PM,GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics,InvestorPlace,/news/stocks/gbt-stock-alert-pfizer-is-officially-acquiring-global-blood-therapeutics-1031662103,positive,0.8640450239181519
4787,8/8/2022 7:56:11 PM,Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment,Benzinga,/news/stocks/lyme-disease-and-climate-change-reinvigorates-valneva-s-vaccine-efforts-after-covid-shot-disappointment-1031662297,negative,0.6036153435707092
4788,8/8/2022 8:50:29 PM,Why These Pfizer Analysts Like The Global Blood Therapeutics Deal,Benzinga,/news/stocks/why-these-pfizer-analysts-like-the-global-blood-therapeutics-deal-1031662414,positive,0.9299524426460266
4789,8/8/2022 8:58:45 PM,Pfizer and Valneva start phase 3 study of Lyme disease vaccine candidate VLA15,Seeking Alpha,https://seekingalpha.com/news/3869351-pfizer-and-valneva-start-phase-3-study-of-lyme-disease-vaccine-candidate-vla15?utm_source=businessinsider&utm_medium=referral,positive,0.8443344235420227
4790,8/8/2022 11:31:12 PM,Pfizer And Valneva Commence Late-Stage Lyme Disease Study,Benzinga,/news/stocks/pfizer-and-valneva-commence-late-stage-lyme-disease-study-1031662955,positive,0.728186309337616
4791,8/9/2022 12:13:39 AM,Recap of Monday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-monday-s-biotech-catalysts---end-of-the-day-summary-1031663111,positive,0.9351576566696167
4792,8/9/2022 1:38:04 AM,The 3 Best Vanguard Funds to Buy in August,InvestorPlace,/news/stocks/best-vanguard-funds-1031663161,positive,0.8945893049240112
4793,8/9/2022 3:45:41 AM,"Pfizer, Valneva Initiate Phase 3 Study Of Lyme Disease Vaccine Candidate VLA15 ",RTTNews,/news/stocks/pfizer-valneva-initiate-phase-3-study-of-lyme-disease-vaccine-candidate-vla15-1031663162,positive,0.5587694644927979
4794,8/9/2022 10:15:58 AM,7 Blue-Chip Stocks to Buy Now for Growth and Dividends,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-now-for-growth-and-dividends-1031664841,positive,0.9020464420318604
4795,8/9/2022 10:38:20 AM,Novavax drags rivals lower as falling vaccine demand prompts guidance cut,Seeking Alpha,https://seekingalpha.com/news/3869558-nvax-stock-drags-rivals-lower-as-falling-vaccine-demand-prompts-guidance-cut?utm_source=businessinsider&utm_medium=referral,neutral,0.9606245756149292
4796,8/9/2022 1:35:38 PM,Why Is Novavax (NVAX) Stock Plunging 30%?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-plunging-30-1031666251,neutral,0.9357145428657532
4797,8/9/2022 2:23:25 PM,7 Blue-Chip Stocks That Will Survive 2022,InvestorPlace,/news/stocks/blue-chip-stocks-that-will-survive-2022-1031666249,positive,0.7984703183174133
4798,8/9/2022 3:08:38 PM,"Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful",Benzinga,/news/stocks/biotech-daily-regulatory-setback-for-cormedix-mersana-gsk-in-cancer-pact-barda-funding-for-opioid-overdose-hopeful-1031665917,neutral,0.9107704162597656
4799,8/9/2022 3:19:59 PM,Pfizer/BioNTech's adapted Omicron COVID vaccine begins EMA rolling review,Seeking Alpha,https://seekingalpha.com/news/3869874-pfizer-biontech-adapted-covid-omicron-vaccine-begins-ema-rolling-review?utm_source=businessinsider&utm_medium=referral,positive,0.9064767360687256
4800,8/9/2022 5:03:53 PM,Super Bullish Or Bearish On Tesla Or Apple? These New ETFs Are For You,Benzinga,/news/etf/super-bullish-or-bearish-on-tesla-or-apple-these-new-etfs-are-for-you-1031666326,positive,0.9258955121040344
4801,8/9/2022 9:26:34 PM,Analysts See Softened Timelines For CRISPR Therapeutics' Sickle Cell Candidate In US,Benzinga,/news/stocks/analysts-see-softened-timelines-for-crispr-therapeutics-sickle-cell-candidate-in-us-1031666855,positive,0.38720014691352844
4802,8/11/2022 12:13:06 PM,"Sanofi, GSK, Haleon extend selloff amid overhang from recalled heartburn drug",Seeking Alpha,https://seekingalpha.com/news/3871472-gsk-stock-sny-haleon-in-selloff-amid-overhang-from-recalled-heartburn-drug?utm_source=businessinsider&utm_medium=referral,neutral,0.9284253716468811
4803,8/11/2022 3:29:23 PM,Pfizer involvement in Zantac woes 'smaller than people think' - Wells Fargo,Seeking Alpha,https://seekingalpha.com/news/3871692-pfizer-involvement-in-zantac-woes-smaller-than-people-think-wells-fargo?utm_source=businessinsider&utm_medium=referral,positive,0.7217656373977661
4804,8/11/2022 3:34:18 PM,"GSK, PFE, SNY Stocks Fall on Zantac Litigation",InvestorPlace,/news/stocks/gsk-pfe-sny-stocks-fall-on-zantac-litigation-1031676655,neutral,0.9438830614089966
4805,8/11/2022 3:45:12 PM,Deciphera's Cancer Drug Tops Pfizer's Sutent On Safety Front In Gastrointestinal Cancer,Benzinga,/news/stocks/deciphera-s-cancer-drug-tops-pfizer-s-sutent-on-safety-front-in-gastrointestinal-cancer-1031676276,negative,0.8946859836578369
4806,8/11/2022 6:13:16 PM,4 Dividend Stocks Set to Move Significantly Higher This Year,InvestorPlace,/news/stocks/4-dividend-stocks-set-to-move-significantly-higher-this-year-1031677031,negative,0.9378013014793396
4807,8/11/2022 7:26:06 PM,CDC eases COVID guidance for unvaccinated people,Seeking Alpha,https://seekingalpha.com/news/3871779-cdc-eases-covid-guidance-for-unvaccinated-people?utm_source=businessinsider&utm_medium=referral,neutral,0.8480912446975708
4808,8/12/2022 3:47:13 AM,Pfizer says impact of Zantac litigation is unlikely to be material,Seeking Alpha,https://seekingalpha.com/news/3872109-pfizer-says-impact-of-zantac-litigation-is-unlikely-to-be-material?utm_source=businessinsider&utm_medium=referral,positive,0.7549396753311157
4809,8/12/2022 11:12:28 AM,Pfizer pneumococcal vaccine for children meets main goals in late-stage trial,Seeking Alpha,https://seekingalpha.com/news/3872244-pfizer-pneumococcal-vaccine-for-children-meets-main-goals-in-late-stage-trial?utm_source=businessinsider&utm_medium=referral,negative,0.5556140542030334
4810,8/12/2022 1:11:59 PM,Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants ,RTTNews,/news/stocks/pfizer-phase-3-study-of-20-valent-pneumococcal-conjugate-vaccine-posts-positive-results-in-infants-1031679548,negative,0.9441400766372681
4811,8/15/2022 1:14:06 PM,Pfizer CEO under oral antiviral therapy after testing positive for COVID,Seeking Alpha,https://seekingalpha.com/news/3872920-pfizer-ceo-under-oral-antiviral-therapy-after-testing-positive-for-covid?utm_source=businessinsider&utm_medium=referral,neutral,0.6598291397094727
4812,8/16/2022 2:03:17 PM,First Lady Jill Biden tests positive for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3873675-first-lady-jill-biden-tests-positive-for-covid-19?utm_source=businessinsider&utm_medium=referral,positive,0.8137910962104797
4813,8/17/2022 8:46:55 AM,Sanofi stock falls as breast cancer drug amcenestrant development stopped after another trial failure,Seeking Alpha,https://seekingalpha.com/news/3873930-sanofi-stock-falls-as-breast-cancer-drug-amcenestrant-development-stopped-after-another-trial-failure?utm_source=businessinsider&utm_medium=referral,neutral,0.9710458517074585
4814,8/17/2022 10:54:23 AM,"U.S. govt. to stop buying COVID-19 vaccines, therapies, tests from this fall – Jha",Seeking Alpha,https://seekingalpha.com/news/3874012-us-govt-to-stop-buying-covid-19-vaccines-therapies-tests-from-this-fall-jha?utm_source=businessinsider&utm_medium=referral,positive,0.7759352922439575
4815,8/17/2022 1:29:22 PM,7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher,InvestorPlace,/news/stocks/7-monkeypox-vaccine-stocks-to-buy-before-they-shoot-higher-1031690311,positive,0.9080326557159424
4816,8/17/2022 2:01:40 PM,BioNTech initiated at market perform at Cowen as COVID vaccine market to mirror flu trends,Seeking Alpha,https://seekingalpha.com/news/3874138-biontech-initiated-at-market-perform-at-cowen-as-covid-vaccine-market-to-mirror-flu-trends?utm_source=businessinsider&utm_medium=referral,positive,0.5368877053260803
4817,8/17/2022 4:07:08 PM,"Teva, Perrigo drop after settlements for dismissal of Zantac trial",Seeking Alpha,https://seekingalpha.com/news/3874212-teva-stock-prgo-stock-drop-after-settlement-for-dismissal-of-zantac-trial?utm_source=businessinsider&utm_medium=referral,neutral,0.9452146291732788
4818,8/17/2022 5:10:23 PM,CDC seeks reforms to correct COVID missteps,Seeking Alpha,https://seekingalpha.com/news/3874241-cdc-to-implement-reforms-to-correct-covid-missteps?utm_source=businessinsider&utm_medium=referral,negative,0.785580039024353
4819,8/17/2022 8:28:22 PM,Sanofi Earns Price Target Cut After Stopping Breast Cancer Drug Trial,Benzinga,/news/stocks/sanofi-earns-price-target-cut-after-stopping-breast-cancer-drug-trial-1031691014,neutral,0.41308820247650146
4820,8/19/2022 12:31:52 PM,"HHS sets Aug. 30 meeting as costs for COVID products to shift to payors, individuals – WSJ",Seeking Alpha,https://seekingalpha.com/news/3875015-hhs-sets-aug-meeting-as-covid-products-head-for-commercialization-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.9202150106430054
4821,8/19/2022 3:00:46 PM,Arvinas a buy at Piper Sandler following failure of Sanofi breast cancer treatment,Seeking Alpha,https://seekingalpha.com/news/3875086-arvinas-a-buy-at-piper-sandler-following-failure-of-sanofi-breast-cancer-treatment?utm_source=businessinsider&utm_medium=referral,positive,0.682826578617096
4822,8/19/2022 4:08:17 PM,Canada approves use of Pfizer/BioNTech's COVID shot as booster dose in kids aged 5-11,Seeking Alpha,https://seekingalpha.com/news/3875105-canada-approves-use-of-pfizerbiontechs-covid-shot-as-booster-dose-in-kids-aged-5-11?utm_source=businessinsider&utm_medium=referral,positive,0.7993430495262146
4823,8/19/2022 8:12:23 PM,Pfizer told by FDA to conduct trial of second Paxlovid course in face of COVID rebound,Seeking Alpha,https://seekingalpha.com/news/3875149-pfizer-told-by-fda-to-conduct-trial-of-second-paxlovid-course-in-face-of-covid-rebound?utm_source=businessinsider&utm_medium=referral,positive,0.5000295042991638
4824,8/21/2022 4:00:16 PM,Biotech in recovery; but Piper Sandler cites negative fund flows,Seeking Alpha,https://seekingalpha.com/news/3875226-biotech-in-recovery-but-piper-sandler-cites-negative-fund-flows?utm_source=businessinsider&utm_medium=referral,neutral,0.9548234343528748
4825,8/22/2022 9:42:28 AM,Omicron Booster Race Renews Focus on Pfizer (NYSE:PFE) Stock,TipRanks,/news/stocks/omicron-booster-race-renews-focus-on-pfizer-nyse-pfe-stock-1031697540,positive,0.7677870392799377
4826,8/22/2022 2:28:02 PM,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday,...",Benzinga,/news/stocks/benzinga-before-the-bell-apple-employees-resist-calls-for-return-to-office-tesla-about-to-hike-fsd-prices-again-mgm-china-injects-594m-into-macau-unit-and-other-top-financial-stories-monday-august-22-1031697874,positive,0.4117203652858734
4827,8/22/2022 3:02:32 PM,"Pfizer, BioNTech submit application to FDA for Omicron-specific COVID vaccine",Seeking Alpha,https://seekingalpha.com/news/3875424-pfizer-biontech-submit-application-to-fda-for-omicron-specific-covid-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.6798694133758545
4828,8/22/2022 4:56:59 PM,Pfizer Submits Application To FDA For Emergency Nod Of Omicron BA.4/BA.5 Bivalent COVID-19 Vaccine ,RTTNews,/news/stocks/pfizer-submits-application-to-fda-for-emergency-nod-of-omicron-ba-4-ba-5-bivalent-covid-19-vaccine-1031698432,negative,0.615607738494873
4829,8/22/2022 7:19:01 PM,Pfizer Stock: More than Just a COVID Play,TipRanks,/news/stocks/pfizer-stock-more-than-just-a-covid-play-1031698905,positive,0.9163951873779297
4830,8/23/2022 1:10:36 AM,Recap Of Monday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-monday-s-biotech-catalysts---end-of-the-day-summary-1031699141,positive,0.9351576566696167
4831,8/23/2022 11:13:56 AM,Pfizer/BioNTech COVID vaccine shows 73% efficacy in kids aged 6 months - 4 years,Seeking Alpha,https://seekingalpha.com/news/3875712-pfizerbiontech-covid-vaccine-shows-73-efficacy-in-kids-aged-6-months-4-years?utm_source=businessinsider&utm_medium=referral,negative,0.9117011427879333
4832,8/23/2022 3:15:46 PM,AstraZeneca CEO says company on hunt for buyout targets – Reuters,Seeking Alpha,https://seekingalpha.com/news/3875850-astrazeneca-ceo-says-company-on-hunt-for-buyout-targets-reuters?utm_source=businessinsider&utm_medium=referral,positive,0.9055100679397583
4833,8/23/2022 3:57:51 PM,EMA to hold Sept. 1 meeting on Moderna and Pfizer/BioNTech COVID Omicron vaccines,Seeking Alpha,https://seekingalpha.com/news/3875861-ema-to-hold-sept-1-meeting-on-moderna-and-pfizerbiontech-covid-omicron-vaccines?utm_source=businessinsider&utm_medium=referral,positive,0.9458891153335571
4834,8/23/2022 4:17:56 PM,"Pfizer, Moderna to deliver 175M updated COVID shots for September rollout",Seeking Alpha,https://seekingalpha.com/news/3875878-pfizer-moderna-to-deliver-175m-doses-of-updated-covid-shots-for-september-rollout?utm_source=businessinsider&utm_medium=referral,positive,0.776838481426239
4835,8/23/2022 4:37:12 PM,Moderna filing with FDA for Omicron adapted COVID vaccine 'imminent' - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3875881-moderna-filing-with-fda-for-omicron-adapted-covid-vaccine-imminent-bloomberg?utm_source=businessinsider&utm_medium=referral,positive,0.5705878734588623
4836,8/24/2022 1:01:53 AM,Updated COVID boosters expected shortly after Labor Day - NY Times,Seeking Alpha,https://seekingalpha.com/news/3876024-updated-covid-boosters-expected-shortly-after-labor-day-ny-times?utm_source=businessinsider&utm_medium=referral,positive,0.9241704344749451
4837,8/24/2022 7:46:59 AM,Pfizer's Hospira Recalls Propofol Injectable Emulsion ,RTTNews,/news/stocks/pfizer-s-hospira-recalls-propofol-injectable-emulsion-1031702230,positive,0.8203622698783875
4838,8/24/2022 12:16:25 PM,Pfizer said to have had bidding war with Johnson & Johnson for Global Blood,Seeking Alpha,https://seekingalpha.com/news/3876151-pfizer-said-to-have-had-bidding-war-with-johnson-johnson-for-global-blood?utm_source=businessinsider&utm_medium=referral,positive,0.7914671301841736
4839,8/24/2022 3:33:38 PM,Updated COVID-19 boosters likely to be discussed at CDC advisors meeting next week,Seeking Alpha,https://seekingalpha.com/news/3876262-updated-covid-19-boosters-likely-to-be-discussed-at-cdc-advisors-meeting-next-week?utm_source=businessinsider&utm_medium=referral,positive,0.9286264777183533
4840,8/24/2022 9:42:27 PM,Pfizer's COVID-19 antiviral Paxlovid not as effective in younger adults - study,Seeking Alpha,https://seekingalpha.com/news/3876415-pfizer-covid-19-antiviral-paxlovid-not-as-effective-in-younger-adults-study?utm_source=businessinsider&utm_medium=referral,positive,0.6417163610458374
4841,8/25/2022 11:12:25 AM,Pfizer posts 86% efficacy for respiratory syncytial virus vaccine,Seeking Alpha,https://seekingalpha.com/news/3876550-pfizer-posts-efficacy-for-respiratory-syncytial-virus-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.9164322018623352
4842,8/25/2022 1:36:23 PM,Pfizer Announces Positive Data From Late-stage Study Of RSV Vaccine Candidate ,RTTNews,/news/stocks/pfizer-announces-positive-data-from-late-stage-study-of-rsv-vaccine-candidate-1031705516,negative,0.8698958158493042
4843,8/25/2022 5:05:32 PM,"FDA to not hold advisory committee meeting on Pfizer, Moderna Omicron updated COVID shots",Seeking Alpha,https://seekingalpha.com/news/3876746-fda-to-not-hold-advisory-committee-meeting-on-pfizer-moderna-omicron-updated-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.9235337972640991
4844,8/25/2022 8:15:05 PM,Almost 40% of those hospitalized with COVID vaccinated and boosted - CDC,Seeking Alpha,https://seekingalpha.com/news/3876798-almost-40-of-those-hospitalized-with-covid-vaccinated-and-boosted-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.7816430926322937
4845,8/26/2022 12:43:59 AM,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-thursday-s-biotech-catalysts---end-of-the-day-summary-1031707079,positive,0.9353505373001099
4846,8/26/2022 10:30:06 AM,4 Blue-Chip Stocks to Steady Your Portfolio in 2022,InvestorPlace,/news/stocks/4-blue-chip-stocks-to-steady-your-portfolio-in-2022-1031707968,negative,0.6277086138725281
4847,8/26/2022 12:10:56 PM,Moderna to file patent lawsuits against Pfizer/BioNTech over mRNA technology,Seeking Alpha,https://seekingalpha.com/news/3877020-moderna-to-file-patent-lawsuits-against-pfizerbiontech-over-mrna-technology?utm_source=businessinsider&utm_medium=referral,neutral,0.7773289680480957
4848,8/26/2022 2:12:25 PM,"Sanofi, GSK gains as Citi sees limited impact from Zantac claims",Seeking Alpha,https://seekingalpha.com/news/3877084-sny-stock-gains-as-citi-sees-limited-impact-from-zantac-claims?utm_source=businessinsider&utm_medium=referral,negative,0.892748236656189
4849,8/26/2022 2:18:49 PM,"Pfizer, BioNTech complete submission to Europe drug regulator for updated COVID shot",Seeking Alpha,https://seekingalpha.com/news/3877087-pfizer-biontech-complete-submission-to-europe-drug-regulator-for-omicron-updated-covid-shot?utm_source=businessinsider&utm_medium=referral,positive,0.9308916330337524
4850,8/26/2022 3:24:52 PM,Moderna Entangles Pfizer/BioNTech In COVID-19 Vaccine Patent Lawsuits: All You Need To Know,Benzinga,/news/stocks/moderna-entangles-pfizer-biontech-in-covid-19-vaccine-patent-lawsuits-all-you-need-to-know-1031708372,positive,0.8506799936294556
4851,8/26/2022 3:31:09 PM,"Moderna Sues Pfizer, BioNTech For Patent Infringement ",RTTNews,/news/stocks/moderna-sues-pfizer-biontech-for-patent-infringement-1031708382,neutral,0.6643937230110168
4852,8/26/2022 4:03:39 PM,"Pfizer, BioNTech Complete Submission To EMA For Omicron BA.4/BA.5 Adapted Bivalent Vaccine ",RTTNews,/news/stocks/pfizer-biontech-complete-submission-to-ema-for-omicron-ba-4-ba-5-adapted-bivalent-vaccine-1031708469,positive,0.7954744100570679
4853,8/26/2022 7:08:54 PM,BioNTech to “vigorously” defend against patent violation claims over COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3877157-biontech-to-defend-against-patent-violation-claims-over-covid-19-shot?utm_source=businessinsider&utm_medium=referral,negative,0.8400257229804993
4854,8/27/2022 1:52:44 AM,Recap Of Friday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-friday-s-biotech-catalysts---end-of-the-day-summary-1031709013,positive,0.9370302557945251
4855,8/27/2022 8:00:00 PM,"Biologic medicines, COVID vaccines spurring growth for contract injectable packaging firms",Seeking Alpha,https://seekingalpha.com/news/3877138-biologic-medicines-covid-vaccines-spurring-growth-for-contract-injectable-packaging-firms?utm_source=businessinsider&utm_medium=referral,negative,0.9329082369804382
4856,8/28/2022 11:27:52 AM,Updated COVID shots are set for U.S. rollout without human data,Seeking Alpha,https://seekingalpha.com/news/3877240-updated-covid-shots-are-set-for-us-rollout-without-human-data?utm_source=businessinsider&utm_medium=referral,positive,0.9164273142814636
4857,8/28/2022 1:10:48 PM,"M&A summer uptick expected to continue, expert says",Seeking Alpha,https://seekingalpha.com/news/3877242-ma-summer-uptick-expected-to-continue-expert-says?utm_source=businessinsider&utm_medium=referral,negative,0.9369187951087952
4858,8/28/2022 4:00:00 PM,Pfizer eyes $10B-plus market for RSV vaccines with two-prong approach,Seeking Alpha,https://seekingalpha.com/news/3877243-pfizer-eyes-10b-plus-market-for-rsv-vaccines-with-pandemic-era-model?utm_source=businessinsider&utm_medium=referral,positive,0.6486809253692627
4859,8/29/2022 4:44:50 PM,"Bristol-Myers falls 5%, most in two years, after mid-stage data for blood thinner",Seeking Alpha,https://seekingalpha.com/news/3877518-bmy-stock-falls-after-mid-stage-data-for-blood-thinner?utm_source=businessinsider&utm_medium=referral,neutral,0.9234603047370911
4860,8/30/2022 8:57:01 AM,"Japan approves AstraZeneca COVID drug Evusheld, Pfizer/BioNTech vaccine for kids 5-11",Seeking Alpha,https://seekingalpha.com/news/3877682-japan-approves-astrazeneca-covid-drug-evusheld-pfizerbiontech-vaccine-for-kids-5-11?utm_source=businessinsider&utm_medium=referral,negative,0.600013792514801
4861,8/30/2022 11:24:15 AM,"US Stock Futures Higher Ahead Of Economic Data, Fed Speakers",Benzinga,/news/stocks/us-stock-futures-higher-ahead-of-economic-data-fed-speakers-1031712730,negative,0.5656324625015259
4862,8/30/2022 11:55:04 AM,"Pfizer, BioNTech, Moderna gain as FDA expected to clear Omicron shots Wednesday",Seeking Alpha,https://seekingalpha.com/news/3877782-pfizer-biontech-moderna-gain-as-fda-to-clear-omicron-shots-wednesday?utm_source=businessinsider&utm_medium=referral,negative,0.7531579732894897
4863,8/30/2022 2:15:59 PM,Europe drug regulator starts evaluating Pfizer/BioNTech's Omicron updated shot application,Seeking Alpha,https://seekingalpha.com/news/3877872-europe-drug-regulator-starts-evaluating-pfizerbiontechs-omicron-updated-shot-application?utm_source=businessinsider&utm_medium=referral,positive,0.9086965918540955
4864,8/30/2022 2:32:26 PM,"Benzinga Before The Bell: Tesla Sues Louisiana Automobile Dealers Association, Will iPhone 14 Feature Satellite Connectivity?, Netflix Denies $7 To $9 Ad-Supported Plan And Other Top Financial...",Benzinga,/news/stocks/benzinga-before-the-bell-tesla-sues-louisiana-automobile-dealers-association-will-iphone-14-feature-satellite-connectivity-netflix-denies-7-to-9-ad-supported-plan-and-other-top-financial-stories-tuesday-august-30-1031713300,neutral,0.5578145980834961
4865,8/30/2022 6:42:49 PM,CDC advisors to vote on COVID Omicron vaccines on Sept. 1,Seeking Alpha,https://seekingalpha.com/news/3877977-cdc-advisors-to-vote-on-covid-omicron-vaccines-on-sept-1?utm_source=businessinsider&utm_medium=referral,positive,0.8939827084541321
4866,8/31/2022 12:23:48 AM,Think Bitcoin Will Go Down? New ETF Bets Against Bitcoin Bull Michael Saylor And MicroStrategy,Benzinga,/news/stocks/think-bitcoin-will-go-down-new-etf-bets-against-bitcoin-bull-michael-saylor-and-microstrategy-1031714711,positive,0.77891606092453
4867,8/31/2022 1:56:59 PM,"Pfizer/BioNTech, Moderna win FDA nod for updated booster shots",Seeking Alpha,https://seekingalpha.com/news/3878932-pfizerbiontech-moderna-win-fda-nod-for-updated-booster-shots?utm_source=businessinsider&utm_medium=referral,negative,0.9208270311355591
4868,8/31/2022 2:17:00 PM,Why Choosing Between Pfizer (NYSE:PFE) and Moderna Stocks Isn’t Easy for Investors,TipRanks,/news/stocks/why-choosing-between-pfizer-nyse-pfe-and-moderna-stocks-isn-t-easy-for-investors-1031712761,positive,0.9345090985298157
4869,8/31/2022 2:27:50 PM,"U.S. outlines plans to move COVID-19 drugs, vaccines to commercial market",Seeking Alpha,https://seekingalpha.com/news/3878943-us-outlines-plans-to-move-covid-19-drugs-vaccines-to-commercial-market?utm_source=businessinsider&utm_medium=referral,negative,0.5740588307380676
4870,8/31/2022 3:41:46 PM,Pfizer snatches first chief marketing officer from Google's Verily,Seeking Alpha,https://seekingalpha.com/news/3878965-pfizer-snatches-first-chief-marketing-officer-from-googles-verily?utm_source=businessinsider&utm_medium=referral,positive,0.9217296242713928
4871,8/31/2022 4:21:51 PM,"Novavax hits 52-week low as Pfizer, Moderna win FDA nod for updated boosters",Seeking Alpha,https://seekingalpha.com/news/3878989-nvax-stock-hits-52-week-low-as-pfizer-moderna-win-fda-nod-for-new-boosters?utm_source=businessinsider&utm_medium=referral,neutral,0.6035780310630798
4872,8/31/2022 4:40:35 PM,"PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots",InvestorPlace,/news/stocks/pfe-mrna-stocks-what-to-know-as-the-fda-approves-new-booster-shots-1031717117,positive,0.9422905445098877
4873,8/31/2022 4:40:35 PM,"PFE, MRNA Stocks: What to Know as the FDA Approves New Booster Shots",InvestorPlace,/news/stocks/pfe-stock-mrna-stocks-what-to-know-as-the-fda-approves-new-booster-shots-1031717289,positive,0.9422905445098877
4874,8/31/2022 4:44:33 PM,Pfizer - BioNTech Granted FDA Emergency Use Authorization Of Omicron COVID-19 Vaccine Booster ,RTTNews,/news/stocks/pfizer-biontech-granted-fda-emergency-use-authorization-of-omicron-covid-19-vaccine-booster-1031716635,negative,0.9257158041000366
4875,8/31/2022 6:54:01 PM,Why Is Novavax (NVAX) Stock Down Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-down-today-2-1031717335,neutral,0.928594172000885
4876,9/1/2022 5:58:31 AM,"FDA Authorizes Moderna, Pfizer-BioNTech Omicron Boosters ",RTTNews,/news/stocks/fda-authorizes-moderna-pfizer-biontech-omicron-boosters-1031717738,positive,0.8608779311180115
4877,9/1/2022 1:17:23 PM,"EMA panel backs approval of Moderna, Pfizer/BioNTech's Omicron-targeting booster vaccines",Seeking Alpha,https://seekingalpha.com/news/3879369-ema-panel-backs-approval-of-moderna-pfizerbiontechs-omicron-targeting-booster-vaccines?utm_source=businessinsider&utm_medium=referral,positive,0.5030927062034607
4878,9/1/2022 3:55:42 PM,"After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal",Benzinga,/news/stocks/after-pfizer-now-novo-nordisk-beefs-up-its-sickle-cell-portfolio-with-forma-therapeutics-deal-1031719562,positive,0.7283123135566711
4879,9/1/2022 4:14:01 PM,Adapted Versions Of Pfizer's Comirnaty & Moderna's Spikevax Recommended For Approval In The EU ,RTTNews,/news/stocks/adapted-versions-of-pfizer-s-comirnaty-moderna-s-spikevax-recommended-for-approval-in-the-eu-1031719610,negative,0.6762721538543701
4880,9/1/2022 9:53:00 PM,"Pfizer/BioNTech, Moderna get CDC backing for Omicron updated booster shots",Seeking Alpha,https://seekingalpha.com/news/3879686-pfizerbiontech-moderna-get-cdc-backing-for-omicron-updated-booster-shots?utm_source=businessinsider&utm_medium=referral,negative,0.6410824060440063
4881,9/1/2022 10:24:07 PM,"Why did Moderna stock rise today? Positive recommendations, approvals for COVID shot",Seeking Alpha,https://seekingalpha.com/news/3879692-why-did-moderna-stock-rise-today-positive-recommendations-approvals-for-covid-shot?utm_source=businessinsider&utm_medium=referral,negative,0.6796167492866516
4882,9/2/2022 12:36:50 AM,Recap Of Thursday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-thursday-s-biotech-catalysts---end-of-the-day-summary-1031720668,positive,0.9353505373001099
4883,9/2/2022 2:38:15 PM,Pfizer/BioNTech seek to revoke patent infringement claims by CureVac over COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3879877-pfizerbiontech-seek-to-revoke-patent-infringement-claims-by-curevac-over-covid-vaccine?utm_source=businessinsider&utm_medium=referral,neutral,0.8170333504676819
4884,9/2/2022 4:36:18 PM,6 No-Brainer Forever Stocks to Buy if You Have Money to Invest,InvestorPlace,/news/stocks/6-no-brainer-forever-stocks-to-buy-if-you-have-money-to-invest-1031722366,positive,0.9275463819503784
4885,9/2/2022 5:42:28 PM,Moderna Has One Over Pfizer/BioNTech – but It’s Nothing to Do With Patent Infringement,TipRanks,/news/stocks/moderna-has-one-over-pfizer-biontech-–-but-it-s-nothing-to-do-with-patent-infringement-1031722558,positive,0.9343235492706299
4886,9/4/2022 1:18:40 PM,"M&A may be a tailwind for biotech sector into end of year, analyst says",Seeking Alpha,https://seekingalpha.com/news/3880197-ma-may-be-a-tailwind-for-biotech-sector-into-end-of-year-analyst-says?utm_source=businessinsider&utm_medium=referral,neutral,0.929253339767456
4887,9/4/2022 4:00:35 PM,Cannabis legalization wiped off ~$10B market cap in pharma sector – study,Seeking Alpha,https://seekingalpha.com/news/3880198-cannabis-legalization-wiped-off-10b-market-cap-in-pharma-sector?utm_source=businessinsider&utm_medium=referral,neutral,0.9227800965309143
4888,9/5/2022 8:56:18 AM,Pfizer/BioNTech's Omicron-targeting booster vaccine gets approval in UK,Seeking Alpha,https://seekingalpha.com/news/3880223-pfizerbiontechs-omicron-targeting-booster-vaccine-gets-approval-in-uk?utm_source=businessinsider&utm_medium=referral,negative,0.9235017895698547
4889,9/6/2022 4:12:05 PM,EU advised to prioritize Omicron boosters for high-risk people,Seeking Alpha,https://seekingalpha.com/news/3880508-eu-advised-to-prioritize-omicron-boosters-for-high-risk-people?utm_source=businessinsider&utm_medium=referral,positive,0.7859883308410645
4890,9/6/2022 5:37:26 PM,COVID-19 vaccinations likely to follow annual flu shot pattern – U.S. officials,Seeking Alpha,https://seekingalpha.com/news/3880539-covid-19-vaccinations-likely-to-follow-annual-flu-shot-pattern?utm_source=businessinsider&utm_medium=referral,positive,0.8472879528999329
4891,9/7/2022 11:15:55 AM,Pfizer's GBS vaccine for pregnant women to protect infants gets FDA breakthrough therapy status,Seeking Alpha,https://seekingalpha.com/news/3880731-pfizers-gbs-vaccine-for-pregnant-women-to-protect-infants-gets-fda-breakthrough-therapy-status?utm_source=businessinsider&utm_medium=referral,negative,0.7371527552604675
4892,9/7/2022 1:21:33 PM,Pfizer Says Its Group B Streptococcus Vaccine Candidate Got Breakthrough Therapy Designation ,RTTNews,/news/stocks/pfizer-says-its-group-b-streptococcus-vaccine-candidate-got-breakthrough-therapy-designation-1031728704,negative,0.9070349931716919
4893,9/7/2022 9:35:59 PM,Pfizer awarded $4.85B modification contract for Paxlovid from U.S. Army,Seeking Alpha,https://seekingalpha.com/news/3881041-pfizer-awarded-485b-contract-for-paxlovid-from-us-army?utm_source=businessinsider&utm_medium=referral,negative,0.9471049308776855
4894,9/7/2022 11:45:36 PM,"Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary",Benzinga,/news/stocks/important-biotech-catalysts-for-september-7-2022---end-of-the-day-summary-1031730606,positive,0.9430655837059021
4895,9/9/2022 11:05:57 AM,"Pfizer's ritlecitinib gets review in US, EU to treat hair loss disorder alopecia areata",Seeking Alpha,https://seekingalpha.com/news/3881570-pfizers-ritlecitinib-gets-us-eu-review-to-treat-hair-loss-disorder-alopecia-areata?utm_source=businessinsider&utm_medium=referral,negative,0.8820603489875793
4896,9/9/2022 1:00:22 PM,Pfizer : FDA And EMA Accept Regulatory Submission For Ritlecitinib For Alopecia Areata ,RTTNews,/news/stocks/pfizer-fda-and-ema-accept-regulatory-submission-for-ritlecitinib-for-alopecia-areata-1031734346,negative,0.8812288641929626
4897,9/9/2022 3:57:33 PM,"Pfizer, BioNTech win Canadian approval for COVID-19 shot in younger kids",Seeking Alpha,https://seekingalpha.com/news/3881686-pfizer-biontech-win-canadian-approval-for-covid-19-shot-in-younger-kids?utm_source=businessinsider&utm_medium=referral,negative,0.9089098572731018
4898,9/9/2022 6:25:12 PM,Arvinas initiated Overweight at Barclays on attractive therapeutic platform,Seeking Alpha,https://seekingalpha.com/news/3881715-arvn-stock-initiated-overweight-at-barclays-on-therapeutic-platform?utm_source=businessinsider&utm_medium=referral,neutral,0.4177509844303131
4899,9/9/2022 10:00:48 PM,The 3 Best Healthcare Stocks to Buy Now,InvestorPlace,/news/stocks/best-healthcare-stocks-1031568641,positive,0.8521314859390259
4900,9/9/2022 11:47:11 PM,"Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary",Benzinga,/news/stocks/important-biotech-catalysts-for-september-9-2022---end-of-the-day-summary-1031735560,positive,0.942810595035553
4901,9/10/2022 4:00:36 PM,Paxlovid COVID rebound is not uncommon with potential viral spread – study,Seeking Alpha,https://seekingalpha.com/news/3881796-pfizer-paxlovid-covid-rebound-is-not-uncommon-potential-viral-spread?utm_source=businessinsider&utm_medium=referral,positive,0.5165314674377441
4902,9/12/2022 1:37:05 PM,Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment,InvestorPlace,/news/stocks/bristol-myers-squibb-bmy-stock-jumps-8-as-fda-approves-psoriasis-treatment-1031737488,negative,0.9333906769752502
4903,9/12/2022 3:51:51 PM,European drug regulator panel backs approval of Pfizer/BioNTech's Omicron-adapted shot,Seeking Alpha,https://seekingalpha.com/news/3882065-european-drug-regulator-panel-backs-approval-of-pfizerbiontechs-omicron-adapted-shot?utm_source=businessinsider&utm_medium=referral,neutral,0.5552374124526978
4904,9/12/2022 4:20:37 PM,Biden to sign executive order to boost funding for U.S. biomanufacturing,Seeking Alpha,https://seekingalpha.com/news/3882077-biden-to-sign-executive-order-to-boost-funding-for-us-biomanufacturing?utm_source=businessinsider&utm_medium=referral,negative,0.9391762614250183
4905,9/13/2022 12:29:44 AM,"Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary",Benzinga,/news/stocks/important-biotech-catalysts-for-september-12-2022---end-of-the-day-summary-1031738456,positive,0.9446452856063843
4906,9/13/2022 4:25:10 AM,Pfizer And BioNTech Receive Positive CHMP Opinion For Omicron COVID-19 Vaccine Booster In EU ,RTTNews,/news/stocks/pfizer-and-biontech-receive-positive-chmp-opinion-for-omicron-covid-19-vaccine-booster-in-eu-1031738513,negative,0.9414975047111511
4907,9/13/2022 2:45:00 PM,Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer,PR Newswire,/news/stocks/strata-oncology-announces-expansion-of-clinical-collaboration-with-pfizer-for-strata-path-trial-into-early-stage-cancer-1031739895,negative,0.9003611207008362
4908,9/13/2022 3:02:45 PM,Pfizer To Provide Therapeutics For Strata PATH Trial - Quick Facts ,RTTNews,/news/stocks/pfizer-to-provide-therapeutics-for-strata-path-trial-quick-facts-1031740070,positive,0.810093104839325
4909,9/13/2022 3:03:35 PM,4 Dividend Stocks Set to Hike Payouts in 2023,InvestorPlace,/news/stocks/4-dividend-stocks-set-to-hike-payouts-in-2023-1031740581,positive,0.4682295620441437
4910,9/14/2022 11:06:02 AM,Pfizer begins phase 3 trial of mRNA-based influenza vaccine,Seeking Alpha,https://seekingalpha.com/news/3882625-pfizer-begins-phase-3-trial-of-mrna-based-influenza-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.6420049667358398
4911,9/14/2022 1:02:43 PM,Pfizer Doses First Participants In Phase 3 Study Of MRNA-Based Influenza Vaccine ,RTTNews,/news/stocks/pfizer-doses-first-participants-in-phase-3-study-of-mrna-based-influenza-vaccine-1031742300,positive,0.704267144203186
4912,9/14/2022 2:18:38 PM,"End in sight for COVID-19 pandemic, WHO chief says",Seeking Alpha,https://seekingalpha.com/news/3882728-end-in-sight-for-covid-19-pandemic-who-chief-says?utm_source=businessinsider&utm_medium=referral,positive,0.8521955013275146
4913,9/14/2022 4:51:48 PM,"Pick whatever COVID booster offered, head of EU drug regulator says – Reuters",Seeking Alpha,https://seekingalpha.com/news/3882790-pick-whatever-covid-booster-offered-head-of-eu-drug-regulator-says?utm_source=businessinsider&utm_medium=referral,positive,0.9031223654747009
4914,9/14/2022 8:09:02 PM,Pfizer vs. Moderna: Which Vaccine-Maker Has More Upside?,TipRanks,/news/stocks/pfizer-vs-moderna-which-vaccine-maker-has-more-upside-1031743840,positive,0.8912770748138428
4915,9/14/2022 11:29:30 PM,"Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary",Benzinga,/news/stocks/important-biotech-catalysts-for-september-14-2022---end-of-the-day-summary-1031743955,positive,0.9430378079414368
4916,9/15/2022 1:20:48 AM,The 3 Best Mutual Funds to Buy in September,InvestorPlace,/news/stocks/best-mutual-funds-1031587594,positive,0.8449283838272095
4917,9/15/2022 9:12:23 AM,Israel to start offering Pfizer/BioNTech's Omicron-targeting booster shot this month - Reuters,Seeking Alpha,https://seekingalpha.com/news/3882906-israel-to-start-offering-pfizerbiontechs-omicron-targeting-booster-shot-this-month?utm_source=businessinsider&utm_medium=referral,positive,0.5170601606369019
4918,9/15/2022 11:37:17 AM,"Pfizer's pan-meningococcal vaccine as good as Trumenba, GSK's Menveo in trial; to seek FDA approval",Seeking Alpha,https://seekingalpha.com/news/3882954-pfizers-pan-meningococcal-vaccine-as-good-as-trumenba-gsks-menveo-in-trial-to-seek-fda-nod?utm_source=businessinsider&utm_medium=referral,negative,0.9188457727432251
4919,9/15/2022 1:41:59 PM,Pfizer Says Late-stage Study Of Pentavalent Meningococcal Vaccine Candidate Met Primary Goal ,RTTNews,/news/stocks/pfizer-says-late-stage-study-of-pentavalent-meningococcal-vaccine-candidate-met-primary-goal-1031745156,negative,0.5297359824180603
4920,9/15/2022 4:20:58 PM,GSK upgraded to neutral at Credit Suisse on underperformance as Zantac concerns loom,Seeking Alpha,https://seekingalpha.com/news/3883161-gsk-upgraded-to-neutral-at-credit-suisse-on-underperformance-as-zantac-concerns-loom?utm_source=businessinsider&utm_medium=referral,neutral,0.8928617835044861
4921,9/16/2022 12:47:03 AM,"Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary",Benzinga,/news/stocks/important-biotech-catalysts-for-september-15-2022---end-of-the-day-summary-1031746992,positive,0.9436883330345154
4922,9/16/2022 10:56:38 AM,"Pfizer/BioNTech, Moderna COVID vaccines backed for full approval in EU by EMA panel",Seeking Alpha,https://seekingalpha.com/news/3883344-pfizerbiontech-moderna-covid-vaccines-backed-for-full-approval-in-eu-by-ema-panel?utm_source=businessinsider&utm_medium=referral,negative,0.7142676711082458
4923,9/16/2022 1:47:42 PM,Pfizer's Xalkori gets EMA panel nod for expanded use in blood cancer subtypes,Seeking Alpha,https://seekingalpha.com/news/3883430-pfizers-xalkori-gets-ema-panel-nod-for-expanded-use-in-blood-cancer-subtypes?utm_source=businessinsider&utm_medium=referral,negative,0.8315871357917786
4924,9/16/2022 2:39:22 PM,Pfizer - BioNTech COVID-19 Vaccine Recommended For Full Approval In EU ,RTTNews,/news/stocks/pfizer-biontech-covid-19-vaccine-recommended-for-full-approval-in-eu-1031748140,negative,0.73243248462677
4925,9/17/2022 8:00:18 PM,"BioNTech, Moderna, Pfizer led biopharma revenue growth from 2020-2021",Seeking Alpha,https://seekingalpha.com/news/3883566-biontech-moderna-pfizer-led-biopharma-revenue-growth-from-2020-2021?utm_source=businessinsider&utm_medium=referral,negative,0.9150789380073547
4926,9/19/2022 2:28:30 AM,The 7 Best Market Sectors for Q4,InvestorPlace,/news/stocks/best-market-sectors-1031594318,positive,0.9104395508766174
4927,9/19/2022 4:16:21 AM,SVB Securities Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/svb-securities-sticks-to-their-hold-rating-for-pfizer-pfe-1031750256,positive,0.895103931427002
4928,9/19/2022 10:52:02 AM,Biohaven announces timeline for spinoff,Seeking Alpha,https://seekingalpha.com/news/3883659-biohaven-announces-timeline-for-spinoff?utm_source=businessinsider&utm_medium=referral,positive,0.9289912581443787
4929,9/19/2022 11:24:02 AM,Pfizer posts topline data for pneumococcal vaccine from late-stage EU trial for children,Seeking Alpha,https://seekingalpha.com/news/3883676-pfizer-posts-topline-data-for-pneumococcal-vaccine-from-eu-trial-for-children?utm_source=businessinsider&utm_medium=referral,positive,0.5710356831550598
4930,9/19/2022 1:20:44 PM,Pfizer Posts Positive Study Data In 20-Valent Pneumococcal Conjugate Vaccine In Infants In EU ,RTTNews,/news/stocks/pfizer-posts-positive-study-data-in-20-valent-pneumococcal-conjugate-vaccine-in-infants-in-eu-1031750385,negative,0.9483208060264587
4931,9/19/2022 6:47:06 PM,"Why Are Vaccine Stocks MRNA, PFE, NVAX, BNTX Down Today?",InvestorPlace,/news/stocks/why-are-vaccine-stocks-mrna-pfe-nvax-bntx-down-today-1031751817,neutral,0.8934611082077026
4932,9/19/2022 7:00:53 PM,COVID-19 vaccine makers fall as Biden says pandemic is over (update),Seeking Alpha,https://seekingalpha.com/news/3883793-mrna-stock-lead-selloff-covid-vaccine-makers-biden-says-pandemic-over?utm_source=businessinsider&utm_medium=referral,neutral,0.961385190486908
4933,9/20/2022 12:36:01 PM,Pfizer to further tap CytoReason's AI technology for drug discovery in up to $110M deal,Seeking Alpha,https://seekingalpha.com/news/3884302-pfizer-to-further-tap-cytoreasons-ai-technology-for-drug-discovery-in-up-to-110m-deal?utm_source=businessinsider&utm_medium=referral,negative,0.866247296333313
4934,9/20/2022 4:26:18 PM,EU drug regulator's chief medical officer says COVID-19 pandemic still ongoing,Seeking Alpha,https://seekingalpha.com/news/3884441-eu-drug-regulators-chief-medical-officer-says-covid-19-pandemic-still-ongoing?utm_source=businessinsider&utm_medium=referral,neutral,0.925426185131073
4935,9/20/2022 8:18:52 PM,3 Stocks That Could Rocket on Biden’s Cancer Moonshot,InvestorPlace,/news/stocks/3-stocks-that-could-rocket-on-bidens-cancer-moonshot-1031754919,positive,0.813847541809082
4936,9/20/2022 8:45:02 PM,Analysts Put Alnylam On Upside Catalyst Watch Ahead Of Upcoming Data From Lead Program,Benzinga,/news/stocks/analysts-put-alnylam-on-upside-catalyst-watch-ahead-of-upcoming-data-from-lead-program-1031754741,neutral,0.740947425365448
4937,9/21/2022 3:45:23 AM,SVB Securities Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/svb-securities-reaffirms-their-hold-rating-on-pfizer-pfe-1031755228,positive,0.8301634192466736
4938,9/21/2022 11:14:08 AM,Pfizer/BioNTech lead new booster shot rollout amid supply issues for Moderna,Seeking Alpha,https://seekingalpha.com/news/3884728-pfizerbiontech-lead-new-booster-shot-rollout-amid-supply-issues-for-moderna?utm_source=businessinsider&utm_medium=referral,negative,0.6704539656639099
4939,9/21/2022 4:43:43 PM,Updated COVID boosters for kids on track for CDC review next month,Seeking Alpha,https://seekingalpha.com/news/3884959-pfizerbiontech-moderna-updated-boosters-on-track-for-cdc-review-next-month?utm_source=businessinsider&utm_medium=referral,positive,0.9175743460655212
4940,9/22/2022 11:30:45 AM,Pfizer to supply up to 6M treatment courses of COVID drug Paxlovid to Global Fund,Seeking Alpha,https://seekingalpha.com/news/3885190-pfizer-to-supply-up-to-6m-treatment-courses-of-covid-drug-paxlovid-to-global-fund?utm_source=businessinsider&utm_medium=referral,positive,0.570932149887085
4941,9/22/2022 12:04:40 PM,Pfizer declares $0.40 dividend,Seeking Alpha,https://seekingalpha.com/news/3885206-pfizer-inc-declares-0_40-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.8511275053024292
4942,9/22/2022 1:35:12 PM,Pfizer To Supply 6 Mln Paxlovid Treatment Courses To Fight Covid-19 ,RTTNews,/news/stocks/pfizer-to-supply-6-mln-paxlovid-treatment-courses-to-fight-covid-19-1031758953,negative,0.6724205613136292
4943,9/22/2022 1:44:36 PM,Why Is Novavax (NVAX) Stock Falling Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-falling-today-1031759662,neutral,0.9292145371437073
4944,9/22/2022 2:43:04 PM,"Pfizer, BioNTech file for approval of 2nd bivalent COVID-19 vaccine in Switzerland",Seeking Alpha,https://seekingalpha.com/news/3885319-pfizer-biontech-seek-approval-of-2nd-bivalent-covid-19-vaccine-in-switzerland?utm_source=businessinsider&utm_medium=referral,negative,0.6533299088478088
4945,9/22/2022 3:51:16 PM,"COVID-19 infection increases risk of neurological conditions, such as stroke, seizures - study",Seeking Alpha,https://seekingalpha.com/news/3885337-covid-19-infection-increases-risk-of-neurological-conditions-such-as-stroke-seizures-study?utm_source=businessinsider&utm_medium=referral,neutral,0.858160674571991
4946,9/22/2022 3:55:15 PM,"WHO chief reiterates belief that COVID-19 pandemic end near, says work still needed",Seeking Alpha,https://seekingalpha.com/news/3885339-who-chief-reiterates-belief-that-covid-19-pandemic-end-near-says-work-still-needed?utm_source=businessinsider&utm_medium=referral,positive,0.5798600316047668
4947,9/22/2022 8:42:16 PM,"Pfizer, US government cut back COVID vaccines to donate this year - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3885443-pfizer-us-government-cut-back-covid-vaccines-to-donate-this-year-bloomberg?utm_source=businessinsider&utm_medium=referral,positive,0.42096447944641113
4948,9/22/2022 9:38:46 PM,"Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy",Seeking Alpha,https://seekingalpha.com/news/3885468-pfizer-sangamo-reopen-recruitment-for-late-stage-trial-of-hemophilia-a-gene-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.6897110342979431
4949,9/23/2022 11:46:34 AM,Artivion stock falls as apixaban fails vs warfarin in reducing blood clots in aortic valve patients; reaffirms outlook,Seeking Alpha,https://seekingalpha.com/news/3885575-artivion-stock-falls-as-apixaban-fails-vs-warfarin-in-reducing-blood-clots-in-aortic-valve-patients-stops-trial-reaffirms-outlook?utm_source=businessinsider&utm_medium=referral,neutral,0.9699043035507202
4950,9/23/2022 1:19:02 PM,More than 4M in U.S. received updated COVID boosters – CDC,Seeking Alpha,https://seekingalpha.com/news/3885626-more-than-4m-in-us-received-updated-covid-boosters-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.5957347750663757
4951,9/23/2022 2:26:49 PM,US to create clearinghouse of medical supplies to help other countries fight COVID,Seeking Alpha,https://seekingalpha.com/news/3885647-us-to-create-clearinghouse-of-medical-supplies-to-help-other-countries-fight-covid?utm_source=businessinsider&utm_medium=referral,positive,0.6444892287254333
4952,9/23/2022 4:44:03 PM,Moderna asks FDA to clear updated COVID boosters for kids,Seeking Alpha,https://seekingalpha.com/news/3885702-moderna-asks-fda-to-clear-updated-covid-boosters-for-kids?utm_source=businessinsider&utm_medium=referral,positive,0.7404965162277222
4953,9/23/2022 6:02:47 PM,Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold,Benzinga,/news/stocks/pfizer-resumes-dosing-in-phase-3-hemophilia-gene-therapy-trial-six-months-after-fda-lifts-clinical-hold-1031762304,positive,0.8103031516075134
4954,9/25/2022 6:00:00 PM,The prostate cancer therapy market will soar. Here are the companies that could benefit.,Seeking Alpha,https://seekingalpha.com/news/3885824-the-prostate-cancer-therapy-market-will-soar-here-are-the-companies-that-could-benefit?utm_source=businessinsider&utm_medium=referral,positive,0.9147647023200989
4955,9/26/2022 11:25:41 AM,"Pfizer, BioNTech seek FDA nod for Omicron booster targeting children",Seeking Alpha,https://seekingalpha.com/news/3885960-pfizer-biontech-seek-fda-nod-for-omicron-booster-targeting-children?utm_source=businessinsider&utm_medium=referral,negative,0.6655020713806152
4956,9/26/2022 1:16:11 PM,"Pfizer, BioNTech Apply For EUA In US Of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster In Kids ",RTTNews,/news/stocks/pfizer-biontech-apply-for-eua-in-us-of-omicron-ba-4-ba-5-adapted-bivalent-vaccine-booster-in-kids-1031764244,negative,0.6674491167068481
4957,9/26/2022 4:16:02 PM,Cerevel overweight at Wells Fargo due to candidates with blockbuster potential,Seeking Alpha,https://seekingalpha.com/news/3886083-cerevel-overweight-at-wells-fargo-due-to-candidates-with-blockbuster-potential?utm_source=businessinsider&utm_medium=referral,neutral,0.8132966756820679
4958,9/27/2022 2:59:56 AM,"Prostate Cancer Therapy Market Expands; Pfizer, Lantheus Stocks Look Healthy",TipRanks,/news/stocks/prostate-cancer-therapy-market-expands-pfizer-lantheus-stocks-look-healthy-1031765730,negative,0.938532292842865
4959,9/27/2022 10:00:07 AM,7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’,InvestorPlace,/news/stocks/7-vaccine-stocks-to-sell-asap-now-that-the-pandemics-over-1031766411,positive,0.6584042906761169
4960,9/27/2022 11:07:53 AM,Ocular stock rises as eye drug implant OTX-TKI shows promise in vision disorder in trial,Seeking Alpha,https://seekingalpha.com/news/3886254-ocular-stock-rises-as-eye-implant-otx-tki-shows-promise-in-vision-disorder-in-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9421277046203613
4961,9/27/2022 2:00:38 PM,7 Profitable Places to Hide Your Money as We Enter a Bear Market,InvestorPlace,/news/stocks/7-profitable-places-to-hide-your-money-during-a-bear-market-1031459868,positive,0.9188072085380554
4962,9/27/2022 9:50:12 PM,Pfizer acquisition of  Biohaven Pharmaceuticals expected to close Oct. 3,Seeking Alpha,https://seekingalpha.com/news/3886580-pfizer-acquisition-of-biohaven-pharmaceuticals-expected-to-close-oct-3?utm_source=businessinsider&utm_medium=referral,positive,0.9312676787376404
4963,9/29/2022 12:32:22 PM,Biohaven says ALS candidate failed in key trial,Seeking Alpha,https://seekingalpha.com/news/3887109-biohaven-says-als-candidate-failed-in-key-trial?utm_source=businessinsider&utm_medium=referral,positive,0.715101957321167
4964,9/30/2022 10:08:41 AM,"Chinese mRNA COVID vaccine gets 1st ever approval, in Indonesia",Seeking Alpha,https://seekingalpha.com/news/3887391-chinese-mrna-covid-vaccine-gets-1st-ever-approval-in-indonesia?utm_source=businessinsider&utm_medium=referral,negative,0.49889540672302246
4965,9/30/2022 8:34:59 PM,Global Blood Therapeutics expects to complete Pfizer deal in early October,Seeking Alpha,https://seekingalpha.com/news/3887648-global-blood-therapeutics-expects-to-complete-pfizer-deal-in-early-october?utm_source=businessinsider&utm_medium=referral,positive,0.8824285864830017
4966,9/30/2022 9:17:55 PM,4 Blue-Chip Stocks to Sell in October,InvestorPlace,/news/stocks/4-blue-chip-stocks-to-sell-in-october-1031776888,positive,0.869742214679718
4967,10/1/2022 8:47:11 AM,Which Battered Vaccine Maker is a Better Buy Right Now?,TipRanks,/news/stocks/which-battered-vaccine-maker-is-a-better-buy-right-now-1031777010,positive,0.9112191796302795
4968,10/1/2022 8:00:00 PM,"For European pharmas, poor Q3 performance makes the quarter one to forget",Seeking Alpha,https://seekingalpha.com/news/3887725-for-european-pharmas-poor-q3-performance-makes-the-quarter-one-to-forget?utm_source=businessinsider&utm_medium=referral,neutral,0.9732441306114197
4969,10/2/2022 2:30:26 PM,7 S&P 500 Stocks to Sell Before They Die,InvestorPlace,/news/stocks/7-sp-500-stocks-to-sell-before-they-die-1031779874,positive,0.7082483172416687
4970,10/2/2022 4:00:31 PM,COVID stocks lag U.S. biopharma in Q3; Alzheimer’s theme regains focus,Seeking Alpha,https://seekingalpha.com/news/3887740-covid-stocks-lag-us-biopharma-in-q3-alzheimers-theme-regains-focus?utm_source=businessinsider&utm_medium=referral,neutral,0.8604695200920105
4971,10/3/2022 12:33:56 AM,Myovant Sciences rejects Sumitovant Biopharma's $2.4 billion takeover offer,Seeking Alpha,https://seekingalpha.com/news/3887743-myovant-sciences-rejects-sumitovant-biopharmas-2275share-takeover-offer?utm_source=businessinsider&utm_medium=referral,positive,0.8386603593826294
4972,10/3/2022 9:13:22 AM,Moderna declined China efforts to hand over mRNA COVID vaccine technology,Seeking Alpha,https://seekingalpha.com/news/3887829-moderna-declined-china-efforts-to-hand-over-mrna-covid-vaccine-technology?utm_source=businessinsider&utm_medium=referral,positive,0.488614559173584
4973,10/3/2022 10:14:22 AM,"Svante Pääbo gets Nobel Prize for Medicine for discoveries on genome, human evolution",Seeking Alpha,https://seekingalpha.com/news/3887839-svante-pbo-gets-nobel-prize-for-medicine-for-discoveries-on-genome-human-evolution?utm_source=businessinsider&utm_medium=referral,positive,0.7340630292892456
4974,10/3/2022 12:33:53 PM,Clovis stock rises 10% as Rubraca shows survival benefit in prostate cancer in confirmatory trial,Seeking Alpha,https://seekingalpha.com/news/3887902-clovis-stock-rises-as-rubraca-shows-survival-benefit-in-prostate-cancer-in-confirmatory-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9503354430198669
4975,10/3/2022 12:59:57 PM,Myovant Sciences trades above $22.75/share as analysts see likely higher bid,Seeking Alpha,https://seekingalpha.com/news/3887916-myovant-sciences-trades-above-2275share-as-analyst-see-likely-higher-bid?utm_source=businessinsider&utm_medium=referral,negative,0.9322645664215088
4976,10/3/2022 4:29:50 PM,US Supreme Court declines to hear challenge of COVID vaccine mandate for health workers,Seeking Alpha,https://seekingalpha.com/news/3888029-us-supreme-court-declines-to-hear-challenge-of-covid-vaccine-mandate-for-health-workers?utm_source=businessinsider&utm_medium=referral,neutral,0.7734509706497192
4977,10/3/2022 4:47:30 PM,EMA starts rolling review of Pfizer/BioNTech's Omicron-subvariant adapted shot for kids,Seeking Alpha,https://seekingalpha.com/news/3888035-ema-starts-rolling-review-of-pfizerbiontechs-omicron-subvariant-adapted-shot-for-kids?utm_source=businessinsider&utm_medium=referral,positive,0.8938891291618347
4978,10/3/2022 5:58:46 PM,Pfizer's $11.6B acquisition of Biohaven Pharmaceuticals closes,Seeking Alpha,https://seekingalpha.com/news/3888102-pfizer-116b-acquisition-of-biohaven-pharmaceuticals-closes?utm_source=businessinsider&utm_medium=referral,positive,0.9194064140319824
4979,10/3/2022 7:27:21 PM,7 Most Undervalued Stocks to Buy Now,InvestorPlace,/news/stocks/7-most-undervalued-stocks-to-buy-now-1031782498,positive,0.5772642493247986
4980,10/4/2022 11:17:29 AM,Pfizer says prostate cancer drug combo reached main goal in Phase 3 study,Seeking Alpha,https://seekingalpha.com/news/3888385-pfizer-says-prostate-cancer-drug-combo-reached-main-goal-in-phase-3-study?utm_source=businessinsider&utm_medium=referral,negative,0.7849962711334229
4981,10/4/2022 12:46:02 PM,Voyager stock rises as Pfizer opts to use AAV capsid for neurologic disease target,Seeking Alpha,https://seekingalpha.com/news/3888429-voyager-stock-rises-as-pfizer-opts-to-use-aav-capsid-for-neurologic-disease-target?utm_source=businessinsider&utm_medium=referral,neutral,0.8784568905830383
4982,10/4/2022 1:18:01 PM,Pfizer Reports Positive Topline Results From Phase 3 TALZENNA Trial ,RTTNews,/news/stocks/pfizer-reports-positive-topline-results-from-phase-3-talzenna-trial-1031781222,negative,0.9522445797920227
4983,10/4/2022 6:09:33 PM,HHS change to Medicare payments for biosimilars aims to spur uptake,Seeking Alpha,https://seekingalpha.com/news/3888611-hhs-change-to-medicare-payments-for-biosimilars-aims-to-spur-uptake?utm_source=businessinsider&utm_medium=referral,negative,0.9251478314399719
4984,10/4/2022 10:02:26 PM,COVID subvariant Omicron BA.4.6 continues to account for more cases - CDC,Seeking Alpha,https://seekingalpha.com/news/3888691-covid-subvariant-omicron-ba46-continues-to-account-for-more-cases-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.5487353205680847
4985,10/5/2022 11:12:47 AM,Pfizer/BioNTech win backing of Japan panel to use COVID-19 shot in young children,Seeking Alpha,https://seekingalpha.com/news/3888756-pfizerbiontech-win-japanese-panel-nod-for-covid-19-shot-in-young-children?utm_source=businessinsider&utm_medium=referral,negative,0.8637993931770325
4986,10/6/2022 5:39:39 PM,'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potential,Seeking Alpha,https://seekingalpha.com/news/3889416-new-biohaven-up-81-days-after-pfizer-acquisition-as-investors-see-pipeline-potential?utm_source=businessinsider&utm_medium=referral,negative,0.9478682279586792
4987,10/7/2022 8:45:50 AM,Study suggests COVID rebound after Pfizer's Paxlovid likely by robust not weak immune response,Seeking Alpha,https://seekingalpha.com/news/3889548-study-suggests-covid-rebound-after-pfizers-paxlovid-likely-by-robust-not-weak-immune-response?utm_source=businessinsider&utm_medium=referral,negative,0.8507147431373596
4988,10/7/2022 12:32:16 PM,7 Robinhood Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/7-robinhood-stocks-that-are-too-cheap-to-ignore-1031789980,positive,0.8157975673675537
4989,10/7/2022 2:39:45 PM,Pfizer/BioNTech Omicron booster authorized in Canada,Seeking Alpha,https://seekingalpha.com/news/3889703-pfizerbiontech-omicron-booster-authorized-in-canada?utm_source=businessinsider&utm_medium=referral,positive,0.929269552230835
4990,10/7/2022 6:02:20 PM,U.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries,Seeking Alpha,https://seekingalpha.com/news/3889752-us-report-says-covid-vaccines-led-to-over-300k-fewer-deaths-among-medicare-beneficiaries?utm_source=businessinsider&utm_medium=referral,neutral,0.6736574769020081
4991,10/9/2022 1:41:09 PM,7 Blue-Chip Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/cheap-blue-chip-stocks-7-that-are-too-cheap-to-ignore-1031791398,positive,0.811398983001709
4992,10/9/2022 4:00:08 PM,Pfizer/BioNTech tap Marvel heroes to boost vaccine rollout,Seeking Alpha,https://seekingalpha.com/news/3889851-pfizer-biontech-tap-marvel-heroes-to-boost-vaccine-rollout?utm_source=businessinsider&utm_medium=referral,negative,0.9377637505531311
4993,10/10/2022 5:41:06 PM,"Swiss Health Agency Approves Pfizer, Novavax's Omicron Adapted COVID-19 Boosters",Benzinga,/news/stocks/swiss-health-agency-approves-pfizer-novavax-s-omicron-adapted-covid-19-boosters-1031793645,negative,0.6401253342628479
4994,10/10/2022 6:03:36 PM,Pfizer denies CEO secured EU COVID-19 vaccine deal via texts,Seeking Alpha,https://seekingalpha.com/news/3890101-pfizer-denies-ceo-secured-eu-covid-19-vaccine-deal-via-texts?utm_source=businessinsider&utm_medium=referral,positive,0.6455091238021851
4995,10/10/2022 8:10:08 PM,The 7 Most Undervalued Value Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-most-undervalued-value-stocks-to-buy-now-1031794052,positive,0.7967768311500549
4996,10/11/2022 1:09:59 PM,Lululemon To Surge Over 20%? Plus Wedbush Predicts $370 For Domino's,Benzinga,/news/stocks/lululemon-to-surge-over-20-plus-wedbush-predicts-370-for-domino-s-1031795525,negative,0.9080325365066528
4997,10/11/2022 1:35:26 PM,J.P. Morgan Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-sticks-to-its-hold-rating-for-pfizer-pfe-1031796307,positive,0.7579091787338257
4998,10/11/2022 1:45:42 PM,Merck To Rally Over 29%? Here Are 5 Other Price Target Changes For Tuesday,Benzinga,/news/stocks/merck-to-rally-over-29-here-are-5-other-price-target-changes-for-tuesday-1031795605,positive,0.925809919834137
4999,10/11/2022 7:25:57 PM,The COVID-19 Vaccine Isn’t the Only Good Thing About Pfizer (NYSE:PFE),TipRanks,/news/stocks/the-covid-19-vaccine-isn-t-the-only-good-thing-about-pfizer-nyse-pfe-1031797247,positive,0.6534940600395203
5000,10/12/2022 9:27:31 AM,Hong Kong approves BioNTech COVID vaccine for infants,Seeking Alpha,https://seekingalpha.com/news/3890609-hong-kong-approves-biontech-covid-vaccine-for-infants?utm_source=businessinsider&utm_medium=referral,negative,0.7123219966888428
5001,10/12/2022 2:22:58 PM,"Pfizer, Moderna COVID boosters authorized for children as young as 5 years old",Seeking Alpha,https://seekingalpha.com/news/3890740-pfizer-moderna-covid-boosters-authorized-for-children-as-young-as-5-years-old?utm_source=businessinsider&utm_medium=referral,positive,0.817202091217041
5002,10/12/2022 2:55:39 PM,Sangamo Touts Additional Positive Data For Fabry Gene Therapy Candidate,Benzinga,/news/stocks/sangamo-touts-additional-positive-data-for-fabry-gene-therapy-candidate-1031799635,negative,0.7578504085540771
5003,10/12/2022 3:20:29 PM,Microsoft To $315? Plus Morgan Stanley Sees $50 For Pfizer,Benzinga,/news/stocks/microsoft-to-315-plus-morgan-stanley-sees-50-for-pfizer-1031799778,positive,0.5182394981384277
5004,10/12/2022 4:42:18 PM,7 Stocks Under $50 to Buy and Hold Forever,InvestorPlace,/news/stocks/stocks-under-50-dollars-to-buy-and-hold-1031652454,positive,0.8874146342277527
5005,10/12/2022 4:48:51 PM,Pfizer : FDA Grants Emergency Use Of Omicron Bivalent COVID-19 Vaccine Booster In Children ,RTTNews,/news/stocks/pfizer-fda-grants-emergency-use-of-omicron-bivalent-covid-19-vaccine-booster-in-children-1031800145,negative,0.5370274186134338
5006,10/12/2022 6:07:30 PM,Barclays Maintains Equal-Weight Rating for Pfizer: Here's What You Need To Know,Benzinga,/news/stocks/barclays-maintains-equal-weight-rating-for-pfizer-here-s-what-you-need-to-know-1031800430,positive,0.9253461360931396
5007,10/12/2022 6:10:00 PM,What 5 Analyst Ratings Have To Say About Pfizer,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-pfizer-1031800424,positive,0.9349233508110046
5008,10/12/2022 7:11:44 PM,WHO says Europe may be entering new COVID wave,Seeking Alpha,https://seekingalpha.com/news/3890820-who-says-europe-may-be-entering-new-covid-wave?utm_source=businessinsider&utm_medium=referral,positive,0.8675316572189331
5009,10/13/2022 8:43:29 AM,GSK RSV vaccine for older adults shows 94.1% efficacy in severe disease in phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3890968-gsk-rsv-vaccine-for-older-adults-shows-941-efficacy-in-severe-disease-in-phase-3-trial?utm_source=businessinsider&utm_medium=referral,negative,0.90916508436203
5010,10/13/2022 12:24:08 PM,"Pfizer/BioNTech's Omicron booster shows efficacy, potentially better than original vaccine in trial",Seeking Alpha,https://seekingalpha.com/news/3891041-pfizer-biontechs-omicron-targeting-booster-protects-better-than-original-vaccine-in-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9550514817237854
5011,10/13/2022 1:03:49 PM,"US Stocks Show Cautious Optimism As S&P 500, Dow Futures Surge Ahead Of Key CPI Data — Trump's SPAC Partner, Applied Materials And Chip Stocks In Focus Today",Benzinga,/news/stocks/us-stocks-show-cautious-optimism-as-s-p-500-dow-futures-surge-ahead-of-key-cpi-data-—-trump-s-spac-partner-applied-materials-and-chip-stocks-in-focus-today-1031802637,negative,0.7550296783447266
5012,10/13/2022 1:47:57 PM,"Pfizer- BioNTech Early Study Data For Omicron BA.4/BA.5-Adapted Bivalent Booster Vaccine, Positive ",RTTNews,/news/stocks/pfizer-biontech-early-study-data-for-omicron-ba-4-ba-5-adapted-bivalent-booster-vaccine-positive-1031802736,negative,0.819656252861023
5013,10/14/2022 12:24:33 PM,Biden to sign Executive Order tasking HHS to find additional ways to lower drug costs,Seeking Alpha,https://seekingalpha.com/news/3891387-biden-to-sign-executive-order-tasking-hhs-to-find-additional-ways-to-lower-drug-costs-medicare?utm_source=businessinsider&utm_medium=referral,negative,0.8669121861457825
5014,10/14/2022 4:45:44 PM,CDC data shows that cases of new COVID 'escape variants' on the rise,Seeking Alpha,https://seekingalpha.com/news/3891468-cdc-data-shows-that-cases-of-new-covid-escape-variants-on-the-rise?utm_source=businessinsider&utm_medium=referral,neutral,0.621448814868927
5015,10/14/2022 7:25:18 PM,Goldman Sachs Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/goldman-sachs-remains-a-hold-on-pfizer-pfe-1031807027,positive,0.8621111512184143
5016,10/17/2022 9:05:30 AM,Bill & Melinda Gates Foundation commits $1.2B to end polio,Seeking Alpha,https://seekingalpha.com/news/3891702-bill-melinda-gates-foundation-commit-12b-to-end-polio?utm_source=businessinsider&utm_medium=referral,negative,0.7355890870094299
5017,10/17/2022 9:31:49 AM,Bavarian Nordic COVID booster shot shows efficacy 6-months after vaccination in phase 2 trial,Seeking Alpha,https://seekingalpha.com/news/3891705-bavarian-nordic-covid-booster-shot-shows-efficacy-6-months-after-vaccination-in-phase-2-trial?utm_source=businessinsider&utm_medium=referral,negative,0.869479238986969
5018,10/17/2022 7:24:55 PM,U.S. rollout of updated COVID shots off to a slow start,Seeking Alpha,https://seekingalpha.com/news/3891963-us-rollout-of-updated-covid-shots-off-to-a-slow-start?utm_source=businessinsider&utm_medium=referral,neutral,0.9250760078430176
5019,10/19/2022 3:12:22 PM,COVID-19 remains global health emergency - WHO,Seeking Alpha,https://seekingalpha.com/news/3892700-covid-19-remains-global-health-emergency-who?utm_source=businessinsider&utm_medium=referral,neutral,0.7170540690422058
5020,10/19/2022 3:29:09 PM,Novavax COVID-19 vaccine authorized in U.S. as booster for adults,Seeking Alpha,https://seekingalpha.com/news/3892709-nvax-stock-spikes-after-nod-for-covid-19-vaccine-as-booster-for-adults?utm_source=businessinsider&utm_medium=referral,positive,0.8209718465805054
5021,10/19/2022 4:09:52 PM,"EMA panel backs use of original Moderna, Pfizer COVID vaccines in infants",Seeking Alpha,https://seekingalpha.com/news/3892723-ema-panel-backs-use-of-original-moderna-pfizer-covid-vaccines-in-infants?utm_source=businessinsider&utm_medium=referral,positive,0.8498920798301697
5022,10/19/2022 9:38:33 PM,CDC advisory panel recommends COVID vaccines for children be included in federal program,Seeking Alpha,https://seekingalpha.com/news/3892930-cdc-advisory-panel-recommends-covid-vaccines-for-children-be-included-in-federal-program?utm_source=businessinsider&utm_medium=referral,positive,0.9167230129241943
5023,10/20/2022 5:22:54 AM,Pfizer-BioNTech's COVID-19 Vaccine Recommended In EU For Children Under 5 Yrs ,RTTNews,/news/stocks/pfizer-biontech-s-covid-19-vaccine-recommended-in-eu-for-children-under-5-yrs-1031819200,positive,0.5768189430236816
5024,10/20/2022 12:25:53 PM,Erasca forms clinical trial partnership with Pfizer for cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3893115-erasca-forms-clinical-trial-partnership-with-pfizer-for-cancer-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.6921225190162659
5025,10/20/2022 5:19:54 PM,Prescription drugs make up a rising share of Medicare spending – study,Seeking Alpha,https://seekingalpha.com/news/3893317-prescription-drugs-account-for-a-rising-chunk-of-medicare-spending-study?utm_source=businessinsider&utm_medium=referral,positive,0.7574050426483154
5026,10/20/2022 5:52:21 PM,CDC panel recommends adding COVID-19 vaccines to regular immunizations,Seeking Alpha,https://seekingalpha.com/news/3893337-cdc-panel-recommends-adding-covid-19-vaccines-to-regular-immunizations?utm_source=businessinsider&utm_medium=referral,positive,0.8696175217628479
5027,10/21/2022 9:03:51 AM,Pfizer mulls hiking US COVID vaccine price ~4 times after government program ends,Seeking Alpha,https://seekingalpha.com/news/3893576-pfizer-mulls-hiking-us-covid-vaccine-price-4-times-after-government-program-ends?utm_source=businessinsider&utm_medium=referral,negative,0.5092987418174744
5028,10/21/2022 9:43:22 AM,India's Serum Institute sees 100M doses of COVID vaccine expire; Novavax booster on approval path,Seeking Alpha,https://seekingalpha.com/news/3893581-indias-serum-institute-sees-100m-doses-of-covid-vaccine-expire-as-demand-dries-up?utm_source=businessinsider&utm_medium=referral,positive,0.593873918056488
5029,10/21/2022 1:57:33 PM,Vaccine Makers Mull Price Increase For COVID-19 Boosters Amid Falling Demand,Benzinga,/news/stocks/vaccine-makers-mull-price-increase-for-covid-19-boosters-amid-falling-demand-1031824168,neutral,0.947597861289978
5030,10/21/2022 2:05:08 PM,Pfizer drives vaccine makers higher with pricing strategy for COVID shot,Seeking Alpha,https://seekingalpha.com/news/3893709-pfizer-drives-vaccine-makers-higher-with-pricing-strategy-for-covid-shot?utm_source=businessinsider&utm_medium=referral,negative,0.9494715929031372
5031,10/21/2022 2:54:26 PM,"Twitter Rebuffs Elon Musk Layoff Plans Report, Toyota Cuts 2023's Production Target, Vaccine Makers Expect 3x Price Increase In COVID-19 Shot: Top Stories Friday, Oct. 21",Benzinga,/news/stocks/twitter-rebuffs-elon-musk-layoff-plans-report-toyota-cuts-2023-s-production-target-vaccine-makers-expect-3x-price-increase-in-covid-19-shot-top-stories-friday-oct-21-1031824397,positive,0.6133120656013489
5032,10/21/2022 3:13:52 PM,Pfizer Likely To Hike U.S. COVID Vaccine Price ,RTTNews,/news/stocks/pfizer-likely-to-hike-u-s-covid-vaccine-price-1031824451,neutral,0.7747921943664551
5033,10/21/2022 4:24:33 PM,4 High-Yield Dividend Stocks for Retirees Fighting Raging Inflation,InvestorPlace,/news/stocks/4-high-yield-dividend-stocks-for-retirees-to-raging-inflation-1031824957,positive,0.8881531953811646
5034,10/21/2022 4:46:41 PM,COVID cases related to 'escape variants' continue to rise - CDC,Seeking Alpha,https://seekingalpha.com/news/3893759-covid-cases-related-to-escape-variants-continue-to-rise-cdc?utm_source=businessinsider&utm_medium=referral,neutral,0.49854084849357605
5035,10/21/2022 5:56:11 PM,"Talks begin with pharma, health insurers over negotiating drug prices for Medicare",Seeking Alpha,https://seekingalpha.com/news/3893788-talks-begin-with-pharma-health-insurers-over-negotiating-drug-prices-for-medicare?utm_source=businessinsider&utm_medium=referral,positive,0.6700782775878906
5036,10/21/2022 7:05:08 PM,"Why Are Vaccine Stocks MRNA, PFE, BNTX, NVAX Up Today?",InvestorPlace,/news/stocks/why-are-vaccine-stocks-mrna-pfe-bntx-nvax-up-today-1031825255,positive,0.8428999185562134
5037,10/23/2022 4:00:00 PM,"Pfizer, Moderna bank on price hikes, updated shots to retain COVID vaccine duopoly",Seeking Alpha,https://seekingalpha.com/news/3893783-pfizer-moderna-bank-on-price-hikes-updated-shots-to-win-covid-vaccine-duopoly?utm_source=businessinsider&utm_medium=referral,positive,0.9074086546897888
5038,10/24/2022 11:20:25 AM,Gilead HIV drug Biktarvy shows sustained efficacy in long term data,Seeking Alpha,https://seekingalpha.com/news/3893995-gilead-hiv-drug-biktarvy-shows-sustained-efficacy-in-long-term-data?utm_source=businessinsider&utm_medium=referral,negative,0.9526739716529846
5039,10/24/2022 11:33:23 AM,Vaxcyte climbs 38% after proof-of-concept data for pneumococcal vaccine,Seeking Alpha,https://seekingalpha.com/news/3894008-vaxcyte-climbs-38-after-proof-of-concept-data-for-pneumococcal-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.94456946849823
5040,10/24/2022 12:34:29 PM,"Pfizer, Zentalis plan to start phase 1/2 trial of ZN-c3 for colorectal cancer",Seeking Alpha,https://seekingalpha.com/news/3894053-pfizer-zentalis-plan-to-start-phase-12-trial-of-zn-c3-for-colorectal-cancer?utm_source=businessinsider&utm_medium=referral,positive,0.524393618106842
5041,10/24/2022 5:45:10 PM,Vaxcyte climbs 70% after pneumococcal vaccine data,Seeking Alpha,https://seekingalpha.com/news/3894235-pcvx-stock-climbs-after-pneumococcal-vaccine-data?utm_source=businessinsider&utm_medium=referral,negative,0.9268757104873657
5042,10/24/2022 11:01:22 PM,Pfizer Stock (NYSE:PFE): Undervalued by Current and Future Metrics,TipRanks,/news/stocks/pfizer-stock-nyse-pfe-undervalued-by-current-and-future-metrics-1031830074,neutral,0.874209463596344
5043,10/25/2022 7:01:39 PM,Updated COVID boosters did not outperform original COVID vaccines – study,Seeking Alpha,https://seekingalpha.com/news/3895008-updated-covid-boosters-did-not-outperform-original-covid-vaccines-study?utm_source=businessinsider&utm_medium=referral,negative,0.775223433971405
5044,10/26/2022 3:14:10 PM,ESSA Pharma jumps 91% on Phase 1/2 data for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3895565-epix-stock-jumps-on-phase-12-data-for-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.9315913319587708
5045,10/27/2022 8:48:32 AM,GSK to abandon regulatory filings for arthritis drug as phase 3 trial fails,Seeking Alpha,https://seekingalpha.com/news/3896202-gsk-to-abandon-regulatory-filings-for-arthritis-drug-as-a-phase-3-trial-fails?utm_source=businessinsider&utm_medium=referral,positive,0.8088551163673401
5046,10/27/2022 3:25:17 PM,IDEAYA Biosciences a buy at Citi on promise of synthetic lethality for precision oncology,Seeking Alpha,https://seekingalpha.com/news/3896590-ideaya-biosciences-a-buy-at-citi-on-promise-of-synthetic-lethality-for-precision-oncology?utm_source=businessinsider&utm_medium=referral,negative,0.8777729272842407
5047,10/27/2022 3:28:16 PM,Pfizer comes under tax probe in Italy – Reuters,Seeking Alpha,https://seekingalpha.com/news/3896599-pfizer-comes-under-tax-probe-in-italy-reuters?utm_source=businessinsider&utm_medium=referral,neutral,0.6723229289054871
5048,10/27/2022 3:54:30 PM,Midterm Elections 2022: 3 Stocks to Avoid Like the Plague for a ‘Blue Wave’,InvestorPlace,/news/stocks/midterm-elections-2022-3-stocks-to-avoid-like-the-plague-for-a-blue-wave-1031844449,positive,0.8777721524238586
5049,10/27/2022 10:28:01 PM,Minorities far less likely to receive Pfizer COVID drug Paxlovid compared to whites - CDC,Seeking Alpha,https://seekingalpha.com/news/3897013-minorities-far-less-likely-to-receive-pfizer-covid-drug-paxlovid-compared-to-whites-cdc?utm_source=businessinsider&utm_medium=referral,neutral,0.34623751044273376
5050,10/28/2022 9:06:37 AM,ViiV Healthcare : EMA Validates MAA For Cabotegravir Long-acting Injectable For HIV Prevention ,RTTNews,/news/stocks/viiv-healthcare-ema-validates-maa-for-cabotegravir-long-acting-injectable-for-hiv-prevention-1031847288,negative,0.8299271464347839
5051,10/28/2022 9:12:58 AM,GSK: EMA Validates ViiV Healthcare's MAA For Cabotegravir Long-acting Injectable For HIV Prevention ,RTTNews,/news/stocks/gsk-ema-validates-viiv-healthcare-s-maa-for-cabotegravir-long-acting-injectable-for-hiv-prevention-1031847302,negative,0.8400037884712219
5052,10/28/2022 9:46:03 AM,ViiV Healthcare cabotegravir long-acting injectable to prevent HIV gets EMA review,Seeking Alpha,https://seekingalpha.com/news/3897086-viiv-healthcare-cabotegravir-long-acting-injectable-to-prevent-hiv-gets-ema-review?utm_source=businessinsider&utm_medium=referral,positive,0.7466733455657959
5053,10/28/2022 11:36:31 AM,"Pfizer/BioNTech, Moderna COVID shots linked to heavy menstrual bleeding - EU panel",Seeking Alpha,https://seekingalpha.com/news/3897169-pfizer-biontech-moderna-covid-shots-linked-to-heavy-menstrual-bleeding-eu?utm_source=businessinsider&utm_medium=referral,positive,0.790742814540863
5054,10/28/2022 12:37:04 PM,Pfizer COVID-19 therapy picked for long COVID study in U.S.,Seeking Alpha,https://seekingalpha.com/news/3897216-pfizer-covid-19-therapy-undergoes-long-covid-study-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.6339743733406067
5055,10/28/2022 5:30:56 PM,"Earnings week ahead: Uber, Pfizer, Peloton, Paramount Global, BP and more",Seeking Alpha,https://seekingalpha.com/news/3897313-earnings-week-ahead-uber-pfizer-peloton-paramount-global-bp-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.923667848110199
5056,10/28/2022 6:30:28 PM,"Catalyst watch: FOMC jitters, Starbucks and Pfizer earnings, Boeing and AMD events",Seeking Alpha,https://seekingalpha.com/news/3897337-catalyst-watch-fomc-jitters-starbucks-and-pfizer-earnings-boeing-and-amd-events?utm_source=businessinsider&utm_medium=referral,positive,0.9197320342063904
5057,10/31/2022 9:37:08 AM,Will Pfizer (NYSE:PFE) Stock Rebound on Q3 Results?,TipRanks,/news/stocks/will-pfizer-nyse-pfe-stock-rebound-on-q3-results-1031852852,negative,0.7454931735992432
5058,10/31/2022 3:01:13 PM,Here's what to expect from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-q3-quarterly-earnings-preview-stock-1031853796,positive,0.9362934827804565
5059,10/31/2022 3:21:29 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3897806-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
5060,10/31/2022 4:26:22 PM,All eyes on Pfizer Q3 results as industry faces slowdown in COVID products,Seeking Alpha,https://seekingalpha.com/news/3897851-all-eyes-on-pfizer-q3-results-as-industry-faces-slowdown-in-covid-products?utm_source=businessinsider&utm_medium=referral,neutral,0.8640338182449341
5061,10/31/2022 5:21:10 PM,Studies questioning efficacy of Omicron boosters were too small – FDA,Seeking Alpha,https://seekingalpha.com/news/3897937-studies-questioning-efficacy-of-omicron-boosters-were-too-small-fda?utm_source=businessinsider&utm_medium=referral,neutral,0.49695008993148804
5062,11/1/2022 4:31:30 AM,7 Cash-Rich Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/7-cash-rich-dividend-stocks-to-buy-now-1031855561,positive,0.9057661890983582
5063,11/1/2022 10:46:21 AM,"Pfizer Non-GAAP EPS of $1.78 beats by $0.38, revenue of $22.6B beats by $1.5B, raises FY22 outlook",Seeking Alpha,https://seekingalpha.com/news/3898353-pfizer-non-gaap-eps-of-1_78-beats-0_38-revenue-of-22_6b-beats-1_5b?utm_source=businessinsider&utm_medium=referral,negative,0.9063084721565247
5064,11/1/2022 11:46:06 AM,Pfizer raises outlook even as COVID vaccine sales drop 66% in Q3,Seeking Alpha,https://seekingalpha.com/news/3898424-pfe-stock-gains-on-guidance-raise-despite-sharp-drop-in-covid-vaccine-sales?utm_source=businessinsider&utm_medium=referral,neutral,0.9710462093353271
5065,11/1/2022 11:54:20 AM,Pfizer Inc. Reveals Advance In Q3 Income,RTTNews,/news/stocks/pfizer-inc-reveals-advance-in-q3-income-1031857637,negative,0.9311923384666443
5066,11/1/2022 11:57:39 AM,Pfizer maternal RSV vaccine for infants shows 81.8% efficacy vs severe disease,Seeking Alpha,https://seekingalpha.com/news/3898434-pfizer-maternal-rsv-vaccine-for-infants-shows-818-efficacy-vs-severe-disease?utm_source=businessinsider&utm_medium=referral,negative,0.94353848695755
5067,11/1/2022 12:34:00 PM,Pfizer Boosts FY22 Outlook As Q3 Results Top Estimates ,RTTNews,/news/stocks/pfizer-boosts-fy22-outlook-as-q3-results-top-estimates-1031857863,negative,0.9269564151763916
5068,11/1/2022 1:02:16 PM,Pfizer Reports Positive Top-Line Trial Data For Bivalent RSV Vaccine Candidate ,RTTNews,/news/stocks/pfizer-reports-positive-top-line-trial-data-for-bivalent-rsv-vaccine-candidate-1031858083,negative,0.9550136923789978
5069,11/1/2022 1:25:19 PM,J.P. Morgan Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-remains-a-hold-on-pfizer-pfe-1031858594,positive,0.8385752439498901
5070,11/1/2022 2:11:55 PM,"Analysts Are Bullish on Top Healthcare Stocks: Pfizer (PFE), Karyopharm Therapeutics (KPTI)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-pfizer-pfe-karyopharm-therapeutics-kpti-1031859199,negative,0.58437180519104
5071,11/1/2022 2:20:53 PM,"Analysts’ Top Healthcare Picks: Pfizer (PFE), Karyopharm Therapeutics (KPTI)",TipRanks,/news/stocks/analysts-top-healthcare-picks-pfizer-pfe-karyopharm-therapeutics-kpti-1031859195,negative,0.7156124711036682
5072,11/1/2022 3:06:30 PM,PFE Stock Alert: 3 Major Takeaways From Pfizer’s Q3 Earnings,InvestorPlace,/news/stocks/pfe-stock-alert-3-major-takeaways-from-pfizers-q3-earnings-1031859318,neutral,0.4681522250175476
5073,11/1/2022 3:21:28 PM,US Stocks Trade Lower Ahead Of Fed Meeting; Pfizer Earnings Top Views,Benzinga,/news/stocks/us-stocks-trade-lower-ahead-of-fed-meeting-pfizer-earnings-top-views-1031859177,neutral,0.9348160028457642
5074,11/1/2022 3:43:09 PM,"Why Are Chinese EV Stocks NIO, XPEV, LI Moving Today?",InvestorPlace,/news/stocks/why-are-chinese-ev-stocks-nio-xpev-li-moving-today-1031859528,positive,0.8808102607727051
5075,11/1/2022 5:01:23 PM,Dow Drops Over 200 Points; Crude Oil Rises Sharply,Benzinga,/news/stocks/dow-drops-over-200-points-crude-oil-rises-sharply-1031859491,negative,0.5571131706237793
5076,11/2/2022 12:25:29 AM,Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.,InvestorPlace,/news/stocks/hurry-7-pitiful-nasdaq-stocks-to-sell-before-2022-ends-1031860759,neutral,0.8560699224472046
5077,11/2/2022 2:47:30 PM,4 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/4-analysts-have-this-to-say-about-pfizer-1031864320,positive,0.9198142886161804
5078,11/2/2022 4:21:12 PM,Pfizer/BioNTech updated COVID-19 shots linked to bubble formation – Swiss regulator,Seeking Alpha,https://seekingalpha.com/news/3899823-pfizer-biontech-updated-covid-19-shots-linked-to-bubble-formation?utm_source=businessinsider&utm_medium=referral,positive,0.8022317290306091
5079,11/2/2022 5:04:49 PM,Wells Fargo Maintains Overweight Rating for Pfizer: Here's What You Need To Know,Benzinga,/news/stocks/wells-fargo-maintains-overweight-rating-for-pfizer-here-s-what-you-need-to-know-1031865338,positive,0.9195359945297241
5080,11/2/2022 5:12:33 PM,6 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/6-analysts-have-this-to-say-about-pfizer-1031865332,positive,0.9154400825500488
5081,11/2/2022 6:34:43 PM,Why Is CanSino Biologics (CASBF) Stock Soaring Today?,InvestorPlace,/news/stocks/why-is-cansino-biologics-casbf-stock-soaring-today-1031865873,neutral,0.8136000633239746
5082,11/2/2022 8:16:15 PM,Expert Ratings for Pfizer,Benzinga,/news/stocks/expert-ratings-for-pfizer-1031865985,positive,0.8965446352958679
5083,11/2/2022 9:07:06 PM,Where Pfizer Stands With Analysts,Benzinga,/news/stocks/where-pfizer-stands-with-analysts-1031866183,positive,0.9324877858161926
5084,11/3/2022 12:33:49 PM,"Novavax, BioNTech drop as Moderna cuts COVID vaccine outlook",Seeking Alpha,https://seekingalpha.com/news/3900912-moderna-stock-drags-novavax-biontech-after-lowering-covid-vaccine-outlook?utm_source=businessinsider&utm_medium=referral,neutral,0.9621991515159607
5085,11/3/2022 2:25:19 PM,UBS Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/ubs-remains-a-buy-on-pfizer-pfe-1031871210,positive,0.9440165162086487
5086,11/3/2022 2:48:13 PM,Pfizer's Elranatamab Gets Breakthrough Therapy Designation From FDA For R/R Multiple Myeloma ,RTTNews,/news/stocks/pfizer-s-elranatamab-gets-breakthrough-therapy-designation-from-fda-for-r-r-multiple-myeloma-1031870889,negative,0.9273617267608643
5087,11/3/2022 2:50:24 PM,Pfizer/BioNTech start early-stage trial for single dose shot targeting COVID-19 and flu,Seeking Alpha,https://seekingalpha.com/news/3901065-pfizer-biontech-start-early-stage-trial-for-vaccine-targeting-covid-19-and-flu?utm_source=businessinsider&utm_medium=referral,positive,0.5503831505775452
5088,11/3/2022 4:30:26 PM,"Cancer drugs launch prices soaring, straining Medicare, report finds",Seeking Alpha,https://seekingalpha.com/news/3901117-cancer-drugs-launch-prices-soaring-straining-medicare-report-finds?utm_source=businessinsider&utm_medium=referral,neutral,0.5917294025421143
5089,11/3/2022 7:34:14 PM,Why Is Provention Biosciences (PRVB) Stock Up 25% Today?,InvestorPlace,/news/stocks/why-is-provention-biosciences-prvb-stock-up-25-today-1031872165,negative,0.8860520124435425
5090,11/4/2022 8:37:11 AM,AstraZeneca/Sanofi's Beyfortus get 1st approval in EU to prevent RSV infect in infants,Seeking Alpha,https://seekingalpha.com/news/3901749-astrazenecasanofis-beyfortus-get-1st-approval-in-eu-to-prevent-rsv-infect-in-infants?utm_source=businessinsider&utm_medium=referral,negative,0.8831272721290588
5091,11/4/2022 11:44:47 AM,"Pfizer, BioNTech gain as updated data supports use of Omicron booster in adults",Seeking Alpha,https://seekingalpha.com/news/3901847-pfizer-biontech-gain-as-updated-data-supports-use-of-omicron-booster-in-adults?utm_source=businessinsider&utm_medium=referral,negative,0.9363372325897217
5092,11/4/2022 12:17:32 PM,"Pfizer, BioNTech Reveal Updated Data For Omicron BA.4/BA.5-Adapted Bivalent Booster ",RTTNews,/news/stocks/pfizer-biontech-reveal-updated-data-for-omicron-ba-4-ba-5-adapted-bivalent-booster-1031875427,positive,0.854472279548645
5093,11/4/2022 1:25:28 PM,BioNTech rises as China agrees to offer COVID shot to expats,Seeking Alpha,https://seekingalpha.com/news/3901927-biontech-rises-as-china-agrees-to-offer-covid-shot-to-expats?utm_source=businessinsider&utm_medium=referral,negative,0.9071580767631531
5094,11/4/2022 3:31:28 PM,Eli Lilly COVID-19 therapy unlikely to neutralize new Omicron subvariants - FDA,Seeking Alpha,https://seekingalpha.com/news/3902025-eli-lilly-covid-19-therapy-unlikely-to-neutralize-new-omicron-subvariants?utm_source=businessinsider&utm_medium=referral,negative,0.7704504728317261
5095,11/4/2022 4:06:14 PM,Pfizer/BioNTech Omicron booster is safe despite bubble formation – Swissmedic,Seeking Alpha,https://seekingalpha.com/news/3902059-pfizer-biontech-omicron-booster-is-safe-despite-bubble-formation?utm_source=businessinsider&utm_medium=referral,positive,0.7879644632339478
5096,11/6/2022 5:00:24 PM,"Off-patent drugs make up 91% of prescriptions, but only 18% of spending - report",Seeking Alpha,https://seekingalpha.com/news/3902378-off-patent-drugs-make-up-91-of-prescriptions-18-of-spending?utm_source=businessinsider&utm_medium=referral,positive,0.8645551800727844
5097,11/7/2022 11:30:46 AM,7 Stocks to Buy With Stacks of Free Cash Flow,InvestorPlace,/news/stocks/cash-rich-stocks-to-buy-1031880771,positive,0.8787273168563843
5098,11/7/2022 12:03:15 PM,"BioNTech dips as Q3 sales fall, raises lower end of revenue outlook as COVID boosters ship",Seeking Alpha,https://seekingalpha.com/news/3902467-biontech-dips-as-q3-sales-fall-raises-lower-end-of-revenue-outlook-as-covid-boosters-ship?utm_source=businessinsider&utm_medium=referral,neutral,0.96979159116745
5099,11/8/2022 1:15:20 AM,Credit Suisse Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/credit-suisse-keeps-their-hold-rating-on-pfizer-pfe-1031883608,positive,0.9199113249778748
5100,11/8/2022 5:50:15 AM,"PFE, JNJ, or CVS: Which Healthcare Stock is a “Strong Buy” for Wall Street Pros?",TipRanks,/news/stocks/pfe-jnj-or-cvs-which-healthcare-stock-is-a-strong-buy-for-wall-street-pros-1031885165,positive,0.8269262909889221
5101,11/8/2022 3:04:59 PM,Pfizer COVID-19 pill cuts risk of long COVID by 26% - study,Seeking Alpha,https://seekingalpha.com/news/3903586-pfizer-covid-19-pill-cuts-risk-of-long-covid-by-26?utm_source=businessinsider&utm_medium=referral,negative,0.932331919670105
5102,11/8/2022 7:04:04 PM,The 7 Best Pharma Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-pharma-stocks-to-buy-now-1031893081,positive,0.8310678601264954
5103,11/9/2022 1:24:12 PM,Pfizer/BioNTech win U.K. nod for second Omicron booster,Seeking Alpha,https://seekingalpha.com/news/3904496-pfizer-biontech-win-uk-nod-for-second-omicron-booster?utm_source=businessinsider&utm_medium=referral,negative,0.9116292595863342
5104,11/9/2022 2:55:50 PM,Novavax COVID-19 shot authorized as booster in UK,Seeking Alpha,https://seekingalpha.com/news/3904616-novavax-covid-19-shot-authorized-as-booster-in-uk?utm_source=businessinsider&utm_medium=referral,positive,0.8095779418945312
5105,11/10/2022 5:33:04 PM,Pfizer/ BioNTech win EU nod to use Omicron booster in children,Seeking Alpha,https://seekingalpha.com/news/3905824-pfizer-biontech-win-eu-nod-to-use-omicron-booster-in-children?utm_source=businessinsider&utm_medium=referral,negative,0.8385326862335205
5106,11/11/2022 11:15:58 AM,3 Reasons Why It’s a Good Time to Buy PFE Stock,InvestorPlace,/news/stocks/3-reasons-why-its-a-good-time-to-buy-pfe-stock-1031904057,positive,0.8893545269966125
5107,11/11/2022 4:10:34 PM,CureVac posts early Phase 1 results for mRNA-based cancer vaccine,Seeking Alpha,https://seekingalpha.com/news/3906502-cvac-stock-gains-on-early-phase-1-results-for-mrna-based-cancer-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.7201592326164246
5108,11/11/2022 4:48:07 PM,"BQ1.1, BQ.1 Omicron variants make up more US COVID cases than BA.5 - CDC",Seeking Alpha,https://seekingalpha.com/news/3906550-bq11-bq1-omicron-variants-make-up-more-us-cases-than-ba5-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.930595874786377
5109,11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral,neutral,0.8541243672370911
5110,11/11/2022 11:34:31 PM,"These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk",Benzinga,/news/etf/these-2-dividend-paying-etfs-have-a-track-record-for-increasing-payments-can-help-diversify-against-industry-risk-1031905724,negative,0.9117457270622253
5111,11/13/2022 1:59:54 AM,U.S. COVID health emergency to stay in place,Seeking Alpha,https://seekingalpha.com/news/3906753-us-covid-health-emergency-to-stay-in-place?utm_source=businessinsider&utm_medium=referral,neutral,0.6932175159454346
5112,11/14/2022 12:41:47 PM,"Moderna Omicron boosters outperform, but with lower response to latest variant",Seeking Alpha,https://seekingalpha.com/news/3906997-moderna-omicron-boosters-outperform-but-lower-response-to-latest-variant?utm_source=businessinsider&utm_medium=referral,neutral,0.7037873268127441
5113,11/15/2022 10:34:00 AM,Daiichi Sankyo mRNA COVID vaccine meets main goal in trial as booster shot,Seeking Alpha,https://seekingalpha.com/news/3907676-daiichi-sankyo-mrna-covid-vaccine-meets-main-goal-in-trial-as-booster-shot?utm_source=businessinsider&utm_medium=referral,negative,0.6039247512817383
5114,11/15/2022 6:37:02 PM,Opioid reversal agent naloxone approvable for OTC use – FDA,Seeking Alpha,https://seekingalpha.com/news/3908189-opioid-reversal-agent-naloxone-approvable-for-otc-use-fda?utm_source=businessinsider&utm_medium=referral,positive,0.8685644268989563
5115,11/15/2022 10:41:37 PM,"If You Invested $1,000 In The Tesla Bear Daily ETF At IPO, Here's How Much You'd Have Now",Benzinga,/news/etf/if-you-invested-1-000-in-the-tesla-bear-daily-etf-at-ipo-here-s-how-much-you-d-have-now-1031916539,positive,0.9352762699127197
5116,11/16/2022 9:52:53 AM,"GSK tops Access to Medicine Index, to invest £100M for initiatives in low income countries",Seeking Alpha,https://seekingalpha.com/news/3908464-gsk-tops-access-to-medicine-index-to-invest-100m-for-initiatives-in-low-income-countries?utm_source=businessinsider&utm_medium=referral,negative,0.7709419131278992
5117,11/16/2022 4:56:19 PM,"Senate votes to end COVID-19 emergency, but Biden threatens to veto any effort",Seeking Alpha,https://seekingalpha.com/news/3908703-senate-votes-to-end-covid-19-emergency-but-biden-threatens-to-veto-any-effort?utm_source=businessinsider&utm_medium=referral,neutral,0.7929537892341614
5118,11/16/2022 5:17:42 PM,"Pfizer, Roche, Lilly COVID treatments get draft recommendation from UK NHS advisors",Seeking Alpha,https://seekingalpha.com/news/3908715-pfizer-roche-lilly-covid-treatments-get-draft-recommendation-from-uk-nhs-advisors?utm_source=businessinsider&utm_medium=referral,positive,0.8119016885757446
5119,11/17/2022 2:54:41 PM,"Ukraine Asserts It Does Not Take Blame For Poland Missile Attack, Crypto Exchange Gemini Suffers $485M In Outflows, FTX, Bahamas Regulator Lock Horns Over Control Of Bankruptcy Proceedings:",Benzinga,/news/stocks/ukraine-asserts-it-does-not-take-blame-for-poland-missile-attack-crypto-exchange-gemini-suffers-485m-in-outflows-ftx-bahamas-regulator-lock-horns-over-control-of-bankruptcy-proceedings-top-stories-thursday-nov-17-1031922342,neutral,0.9629419445991516
5120,11/18/2022 1:04:27 PM,8 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/8-analysts-have-this-to-say-about-pfizer-1031924993,positive,0.9091774225234985
5121,11/18/2022 5:58:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-18-2022-1031925925,neutral,0.5206902027130127
5122,11/18/2022 9:00:24 PM,"Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding",Benzinga,/news/stocks/pfizer-is-worst-performing-us-large-cap-pharma-stock-this-year-its-investment-case-is-complex-yet-rewarding-1031926254,negative,0.6428107023239136
5123,11/23/2022 11:00:46 AM,PFE Stock Could Be the Booster Shot Your Portfolio Needs Now,InvestorPlace,/news/stocks/pfe-stock-could-be-the-booster-shot-your-portfolio-needs-now-1031933575,positive,0.8723198771476746
5124,11/23/2022 12:55:13 PM,Positive Report for Pfizer (PFE) from Credit Suisse,TipRanks,/news/stocks/positive-report-for-pfizer-pfe-from-credit-suisse-1031933963,negative,0.8884100317955017
5125,11/25/2022 5:18:14 PM,Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains,Benzinga,/news/stocks/researchers-working-on-universal-mrna-influenza-vaccine-aiming-for-baseline-immune-memory-for-diverse-strains-1031938023,negative,0.5527275800704956
5126,11/28/2022 6:23:37 PM,7 Stocks to Buy for the Upcoming Santa Claus Rally,InvestorPlace,/news/stocks/7-stocks-to-buy-for-upcoming-santa-claus-rally-1031940497,positive,0.8842272162437439
5127,12/1/2022 7:41:14 AM,"Valneva, Pfizer Report 6-Month Antibody Persistence Data For Lyme Disease Vaccine Candidate ",RTTNews,/news/stocks/valneva-pfizer-report-6-month-antibody-persistence-data-for-lyme-disease-vaccine-candidate-1031946882,positive,0.6603766083717346
5128,12/1/2022 2:46:10 PM,Roivant Forms New Vant With Pfizer To Develop PF-06480605 For Inflammation Diseases ,RTTNews,/news/stocks/roivant-forms-new-vant-with-pfizer-to-develop-pf-06480605-for-inflammation-diseases-1031947835,positive,0.778669536113739
5129,12/6/2022 11:10:31 AM,Pfizer Seeks FDA Approval For Bivalent COVID-19 Vaccine In Kids Under 5 ,RTTNews,/news/stocks/pfizer-seeks-fda-approval-for-bivalent-covid-19-vaccine-in-kids-under-5-1031954755,negative,0.8745152950286865
5130,12/6/2022 12:55:25 PM,Credit Suisse Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/credit-suisse-remains-a-buy-on-pfizer-pfe-1031955319,positive,0.9372431039810181
5131,12/6/2022 1:01:31 PM,"Pfizer, Clear Creek Bio Ink Research Collaboration To Develop Oral Treatment For COVID-19 ",RTTNews,/news/stocks/pfizer-clear-creek-bio-ink-research-collaboration-to-develop-oral-treatment-for-covid-19-1031955022,negative,0.49946799874305725
5132,12/6/2022 1:03:45 PM,"Pfizer, Clear Creek ink license deal to discover oral drug for COVID-19",Seeking Alpha,https://seekingalpha.com/news/3914256-pfizer-clear-creek-ink-license-deal-to-discover-oral-drug-for-covid-19?utm_source=businessinsider&utm_medium=referral,negative,0.8083555698394775
5133,12/6/2022 1:36:03 PM,"Pfizer, BioNTech Fire Back At Moderna Over COVID-19 Vaccine Related Patent Claims",Benzinga,/news/stocks/pfizer-biontech-fire-back-at-moderna-over-covid-19-vaccine-related-patent-claims-1031955136,neutral,0.9459834098815918
5134,12/6/2022 7:00:40 PM,EU regulator says adapted COVID shots could be used for initial vaccination,Seeking Alpha,https://seekingalpha.com/news/3914493-eu-regulator-says-adapted-covid-shots-could-be-used-for-initial-vaccination?utm_source=businessinsider&utm_medium=referral,positive,0.8468151092529297
5135,12/6/2022 7:10:19 PM,"GSK, Sanofi, Haleon jump after win in Zantac case",Seeking Alpha,https://seekingalpha.com/news/3914497-glaxosmithkline-sanofi-gain-after-win-in-zantac-case?utm_source=businessinsider&utm_medium=referral,negative,0.7120307683944702
5136,12/6/2022 9:23:30 PM,Why did Sanofi stock jump up today? Zantac litigation tossed out by judge,Seeking Alpha,https://seekingalpha.com/news/3914551-why-did-sanofi-stock-jump-up-today-zantac-litigation-tossed-out-by-judge?utm_source=businessinsider&utm_medium=referral,positive,0.8347417712211609
5137,12/7/2022 9:51:40 AM,GSK ready to defend claims at state level after federal judge dismisses Zantac suits,Seeking Alpha,https://seekingalpha.com/news/3914761-gsk-ready-to-defend-claims-at-state-level-after-federal-judge-dismisses-zantac-suits?utm_source=businessinsider&utm_medium=referral,negative,0.5106755495071411
5138,12/7/2022 11:13:43 AM,Ascletis gets Chinese drug regulator nod to start trial of oral COVID therapy,Seeking Alpha,https://seekingalpha.com/news/3914776-ascletis-gets-chinese-drug-regulator-nod-to-start-trial-of-oral-covid-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.5758007764816284
5139,12/7/2022 12:18:08 PM,Pfizer's RSV vaccine for older adults gets FDA priority review,Seeking Alpha,https://seekingalpha.com/news/3914801-pfizers-rsv-vaccine-for-older-adults-gets-fda-priority-review?utm_source=businessinsider&utm_medium=referral,negative,0.5889739990234375
5140,12/7/2022 1:04:30 PM,Pfizer Announces FDA Priority Review For Respiratory Syncytial Virus Vaccine Candidate ,RTTNews,/news/stocks/pfizer-announces-fda-priority-review-for-respiratory-syncytial-virus-vaccine-candidate-1031957563,negative,0.4884255826473236
5141,12/7/2022 8:41:19 PM,25 Penny Stocks to Sell Before They Die,InvestorPlace,/news/stocks/25-penny-stocks-to-sell-before-they-die-1031958873,positive,0.9143775105476379
5142,12/8/2022 3:09:26 PM,"Pfizer/BioNTech, Moderna updated boosters cleared in U.S. for children as young as six months",Seeking Alpha,https://seekingalpha.com/news/3915331-pfizer-biontech-moderna-updated-boosters-cleared-in-us-for-children?utm_source=businessinsider&utm_medium=referral,positive,0.5036473870277405
5143,12/8/2022 4:52:02 PM,Omicron boosters are weaker against emerging COVID variants – study,Seeking Alpha,https://seekingalpha.com/news/3915395-omicron-boosters-are-weaker-against-emerging-covid-variants?utm_source=businessinsider&utm_medium=referral,negative,0.6852163672447205
5144,12/8/2022 6:17:11 PM,FDA Authorizes Updated Covid Vaccines For Children As Young As 6 Months Old ,RTTNews,/news/stocks/fda-authorizes-updated-covid-vaccines-for-children-as-young-as-6-months-old-1031961172,positive,0.7998236417770386
5145,12/8/2022 10:51:44 PM,7 Stocks for Investors Over 30 to Buy and Hold,InvestorPlace,/news/stocks/stocks-for-investors-over-30-1031704168,positive,0.9368362426757812
5146,12/9/2022 5:55:25 AM,SVB Securities Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/svb-securities-keeps-their-hold-rating-on-pfizer-pfe-1031962089,positive,0.924485445022583
5147,12/9/2022 12:12:09 PM,"Pfizer, BioNTech's single shot mRNA COVID/flu vaccine gets FDA fast track status",Seeking Alpha,https://seekingalpha.com/news/3915642-pfizer-biontechs-single-shot-mrna-covidflu-vaccine-gets-fda-fast-track-status?utm_source=businessinsider&utm_medium=referral,negative,0.7632937431335449
5148,12/9/2022 4:25:38 PM,Pfizer raises quarterly dividend by 2.5% to  $0.41/share,Seeking Alpha,https://seekingalpha.com/news/3915759-pfizer-inc-declares-0_41-dividend?utm_source=businessinsider&utm_medium=referral,negative,0.8567816019058228
5149,12/9/2022 5:32:41 PM,Pfizer/BioNTech COVID booster authorized in Canada for children as young as 5,Seeking Alpha,https://seekingalpha.com/news/3915803-pfizer-biontech-covid-booster-authorized-in-canada-for-children-as-young-as-5?utm_source=businessinsider&utm_medium=referral,positive,0.8365728855133057
5150,12/9/2022 5:33:22 PM,CDC expands use of Omicron boosters for youngest children,Seeking Alpha,https://seekingalpha.com/news/3915805-cdc-expands-use-of-omicron-boosters-for-youngest-children?utm_source=businessinsider&utm_medium=referral,negative,0.7866981625556946
5151,12/9/2022 7:30:48 PM,"Catalyst Watch: FOMC, CPI print and spotlight on Yum Brands",Seeking Alpha,https://seekingalpha.com/news/3915821-stocks-to-watch-fomc-cpi-print-and-spotlight-on-yum-brands?utm_source=businessinsider&utm_medium=referral,positive,0.9273848533630371
5152,12/12/2022 7:25:46 PM,Pfizer projects up to $15B sales potential from mRNA vaccines in 2030,Seeking Alpha,https://seekingalpha.com/news/3916272-mrna-stock-falls-pfizer-projects-15b-sales-potential-from-mrna-vaccines?utm_source=businessinsider&utm_medium=referral,negative,0.8845137357711792
5153,12/12/2022 9:00:51 PM,Pfizer expects 5 new molecular entity launches in 2023,Seeking Alpha,https://seekingalpha.com/news/3916285-pfizer-expects-5-new-molecular-entity-launches-in-2023?utm_source=businessinsider&utm_medium=referral,positive,0.838889479637146
5154,12/12/2022 9:32:49 PM,Why did Moderna stock drop today? Bullish mRNA projections from rival Pfizer,Seeking Alpha,https://seekingalpha.com/news/3916314-why-did-moderna-stock-drop-today-bullish-mrna-projections-from-rival-pfizer?utm_source=businessinsider&utm_medium=referral,neutral,0.8138852119445801
5155,12/13/2022 2:01:23 PM,"Analysts’ Top Healthcare Picks: Pfizer (PFE), Actinium Pharmaceuticals (ATNM)",TipRanks,/news/stocks/analysts-top-healthcare-picks-pfizer-pfe-actinium-pharmaceuticals-atnm-1031969335,negative,0.764450192451477
5156,12/13/2022 2:03:40 PM,Pfizer gains as Goldman Sachs upgrades on pipeline progress and M&A activity,Seeking Alpha,https://seekingalpha.com/news/3916497-pfe-stock-gains-goldman-sachs-upgrades?utm_source=businessinsider&utm_medium=referral,negative,0.8628207445144653
5157,12/13/2022 2:05:38 PM,9 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/9-analysts-have-this-to-say-about-pfizer-1031969044,positive,0.9138554334640503
5158,12/13/2022 2:35:32 PM,"Takeda drives Schrödinger, Ventyx higher after deal for psoriasis candidate",Seeking Alpha,https://seekingalpha.com/news/3916513-sdgr-stock-vtyx-stock-rise-takeda-deal-for-psoriasis-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.48119500279426575
5159,12/13/2022 3:01:42 PM,Pinterest To Rally Around 23%? Here Are 10 Other Price Target Changes For Tuesday,Benzinga,/news/stocks/pinterest-to-rally-around-23-here-are-10-other-price-target-changes-for-tuesday-1031969253,positive,0.9098356366157532
5160,12/13/2022 3:04:07 PM,What 9 Analyst Ratings Have To Say About Pfizer,Benzinga,/news/stocks/what-9-analyst-ratings-have-to-say-about-pfizer-1031969342,positive,0.9370235800743103
5161,12/13/2022 4:01:30 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-13-2022-1031969491,positive,0.5110196471214294
5162,12/13/2022 4:35:26 PM,Shionogi to deliver additional 1M courses of COVID pills to Japan,Seeking Alpha,https://seekingalpha.com/news/3916574-shionogi-to-deliver-additional-1m-courses-of-covid-pills-to-japan?utm_source=businessinsider&utm_medium=referral,negative,0.5544114708900452
5163,12/13/2022 4:54:07 PM,This Pfizer Analyst Is Turning Bullish Citing 'Pipeline Progress And M&A Activity',Benzinga,/news/stocks/this-pfizer-analyst-is-turning-bullish-citing-pipeline-progress-and-m-a-activity-1031969697,neutral,0.4509977102279663
5164,12/13/2022 5:32:43 PM,COVID-19 vaccines have prevented more than 3M deaths - study,Seeking Alpha,https://seekingalpha.com/news/3916604-covid-19-vaccines-have-prevented-more-than-3m-deaths-study?utm_source=businessinsider&utm_medium=referral,positive,0.6350826025009155
5165,12/13/2022 7:04:10 PM,"mRNA cancer vaccines could be in greater focus after Moderna, Merck candidate shines",Seeking Alpha,https://seekingalpha.com/news/3916642-mrna-cancer-vaccines-could-be-in-greater-focus-after-moderna-merck-candidate-shines?utm_source=businessinsider&utm_medium=referral,positive,0.6820481419563293
5166,12/13/2022 7:52:04 PM,Pfizer COVID-19 pill sold out in China as health app begins online sales,Seeking Alpha,https://seekingalpha.com/news/3916606-pfizer-covid-19-pill-sold-out-in-china-as-health-app-begins-online-sales?utm_source=businessinsider&utm_medium=referral,negative,0.9188224077224731
5167,12/13/2022 10:10:33 PM,Pfizer awarded $1.96B contract from U.S. government for COVID-19 therapy Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3916728-pfizer-awarded-196b-contract-from-us-government-for-covid-19-therapy-paxlovid?utm_source=businessinsider&utm_medium=referral,negative,0.9385939240455627
5168,12/14/2022 3:55:26 AM,SVB Securities Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/svb-securities-sticks-to-its-hold-rating-for-pfizer-pfe-1031970548,positive,0.8710426092147827
5169,12/14/2022 6:01:55 AM,Pfizer secures $1.96B Army contract modification for Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3916759-pfizer-secures-196b-army-contract-modification-for-paxlovid?utm_source=businessinsider&utm_medium=referral,negative,0.9445148706436157
5170,12/14/2022 7:23:09 AM,Roche Collaborates With Pfizer To Educate On Importance Of Timely COVID-19 Testing ,RTTNews,/news/stocks/roche-collaborates-with-pfizer-to-educate-on-importance-of-timely-covid-19-testing-1031970823,negative,0.7953126430511475
5171,12/14/2022 9:31:44 AM,"Roche, Pfizer team up in US for COVID awareness campaign",Seeking Alpha,https://seekingalpha.com/news/3916816-roche-pfizer-team-up-in-us-for-covid-awareness-campaign?utm_source=businessinsider&utm_medium=referral,negative,0.6415027379989624
5172,12/14/2022 5:23:02 PM,WHO chief hopeful COVID emergency will end next year,Seeking Alpha,https://seekingalpha.com/news/3917016-who-chief-hopeful-covid-emergency-will-end-next-year?utm_source=businessinsider&utm_medium=referral,positive,0.8428406715393066
5173,12/14/2022 5:35:21 PM,Sen. Warren presses Pfizer on price increase for COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3917030-sen-warren-presses-pfizer-on-price-increase-for-covid-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8127570152282715
5174,12/14/2022 6:49:04 PM,"Comparing With Pfizer's Vaccine, Icosavax RSV Candidate 'Could Establish Differentiation,' Analyst Says",Benzinga,/news/stocks/comparing-with-pfizer-s-vaccine-icosavax-rsv-candidate-could-establish-differentiation-analyst-says-1031972566,negative,0.9385728240013123
5175,12/14/2022 7:01:39 PM,Expert Ratings for Pfizer,Benzinga,/news/stocks/expert-ratings-for-pfizer-1031972604,positive,0.8965446352958679
5176,12/14/2022 7:02:53 PM,Colorado becomes fourth state to ask feds to import drugs from Canada,Seeking Alpha,https://seekingalpha.com/news/3917055-colorado-becomes-fourth-state-to-ask-feds-to-import-drugs-from-canada?utm_source=businessinsider&utm_medium=referral,positive,0.7342972755432129
5177,12/14/2022 7:20:25 PM,Analyst Bullish On Theseus Pharma's Platform For Gastric Cancer Therapies,Benzinga,/news/stocks/analyst-bullish-on-theseus-pharma-s-platform-for-gastric-cancer-therapies-1031972633,negative,0.7288150191307068
5178,12/14/2022 7:57:33 PM,Pfizer in pact with China Meheco to distribute oral COVID-19 therapy in China,Seeking Alpha,https://seekingalpha.com/news/3917171-pfizer-pact-with-china-meheco-to-distribute-oral-covid-19-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8162943720817566
5179,12/14/2022 8:25:14 PM,Morgan Stanley Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-pfizer-pfe-1031972919,positive,0.8363025784492493
5180,12/15/2022 2:21:06 PM,BioNTech upgraded at Bank of America citing Moderna data for cancer vaccine,Seeking Alpha,https://seekingalpha.com/news/3917575-bntx-stock-upgraded--bank-of-america-moderna-cancer-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.5502591729164124
5181,12/15/2022 2:50:21 PM,Why Is Novavax (NVAX) Stock Plunging Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-plunging-today-1031974995,neutral,0.9109770059585571
5182,12/15/2022 5:45:22 PM,7 Cheap Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/cheap-retirement-stocks-1031556041,positive,0.8949916362762451
5183,12/15/2022 10:18:29 PM,"EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch",Benzinga,/news/stocks/exclusive-the-benzinga-moneymaker-series-5-emerging-stocks-for-investors-to-watch-1031975897,positive,0.9201658964157104
5184,12/16/2022 12:34:33 PM,"Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'",Benzinga,/news/stocks/jim-cramer-recommends-these-5-healthcare-stocks-for-2023-biggest-winners-were-boring-consistent-operators-1031976997,positive,0.8001697063446045
5185,12/16/2022 4:10:28 PM,ViiV wins EU backing for new HIV drug formulation for children,Seeking Alpha,https://seekingalpha.com/news/3918083-viiv-wins-eu-backing-for-new-hiv-drug-formulation-for-children?utm_source=businessinsider&utm_medium=referral,negative,0.9464637041091919
5186,12/16/2022 4:17:25 PM,Why Is Novavax (NVAX) Stock Down 10% Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-down-10-today-1031977756,neutral,0.9660528898239136
5187,12/16/2022 4:46:26 PM,FDA sets January meeting to consider further updates to COVID shots,Seeking Alpha,https://seekingalpha.com/news/3918097-fda-sets-january-meeting-to-consider-further-updates-to-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.91917884349823
5188,12/16/2022 10:00:18 PM,Puma Biotechnology settles with Novartis' Sandoz unit over Nerlynx patent dispute,Seeking Alpha,https://seekingalpha.com/news/3918210-puma-biotechnology-settles-with-novartis-sandoz-unit-over-nerlynx-patent-dispute?utm_source=businessinsider&utm_medium=referral,neutral,0.8180931806564331
5189,12/18/2022 2:04:41 PM,The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond,InvestorPlace,/news/stocks/the-7-hottest-healthcare-stocks-to-own-for-2023-and-beyond-1031978729,positive,0.8950048089027405
5190,12/19/2022 1:57:12 AM,"Tesla, Amazon, Madrigal Pharma, Pfizer, Synaptogenix: Why These 5 Stocks Are Drawing Investors' Attention Today",Benzinga,/news/stocks/tesla-amazon-madrigal-pharma-pfizer-synaptogenix-why-these-5-stocks-are-drawing-investors-attention-today-1031978872,positive,0.9212031960487366
5191,12/19/2022 3:22:09 PM,"Pfizer to develop, commercialize RSV candidate sisunatovir in China, Singapore",Seeking Alpha,https://seekingalpha.com/news/3918417-pfizer-to-develop-commercialize-lianbio-rsv-candidate-sisunatovir-in-china-singapore?utm_source=businessinsider&utm_medium=referral,positive,0.8125349283218384
5192,12/20/2022 5:00:22 PM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/best-bear-market-stocks-1031573318,positive,0.8821819424629211
5193,12/20/2022 9:00:54 PM,"Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says",Benzinga,/news/stocks/top-m-a-target-madrigal-pharmaceuticals-could-be-next-after-successful-nash-data-analyst-says-1031983372,negative,0.7063286304473877
5194,12/21/2022 12:26:15 PM,"Pfizer's ulcerative colitis drug etrasimod gets review in US, EU",Seeking Alpha,https://seekingalpha.com/news/3919340-pfizers-ulcerative-colitis-drug-etrasimod-gets-review-in-us-eu?utm_source=businessinsider&utm_medium=referral,positive,0.6288313865661621
5195,12/21/2022 1:02:29 PM,Pfizer : FDA And EMA Accept Etrasimod Regulatory Submissions For Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-fda-and-ema-accept-etrasimod-regulatory-submissions-for-ulcerative-colitis-1031984565,negative,0.5731301307678223
5196,12/21/2022 4:17:22 PM,"Sanofi, Pfizer settle Zantac case in California",Seeking Alpha,https://seekingalpha.com/news/3919488-sanofi-pfizer-settle-zantac-case-in-california?utm_source=businessinsider&utm_medium=referral,positive,0.8757995963096619
5197,12/21/2022 7:46:44 PM,5 Stocking Stuffer Stocks for Christmas 2022,InvestorPlace,/news/stocks/5-stocking-stuffer-stocks-for-christmas-2022-1031985726,positive,0.9311556220054626
5198,12/21/2022 11:17:35 PM,"ORIC Pharmaceuticals surges 43% on Pfizer collaboration, investment",Seeking Alpha,https://seekingalpha.com/news/3919662-oric-pharmaceuticals-surges-43-on-pfizer-collaboration-investment?utm_source=businessinsider&utm_medium=referral,negative,0.9411437511444092
5199,12/22/2022 2:59:10 AM,ORIC Pharma Collaborates With Pfizer For Phase 2 Study Of ORIC-533 In Multiple Myeloma; Stock Up ,RTTNews,/news/stocks/oric-pharma-collaborates-with-pfizer-for-phase-2-study-of-oric-533-in-multiple-myeloma-stock-up-1031986024,negative,0.6447691917419434
5200,12/22/2022 12:39:05 PM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-dec-22-1031986855,neutral,0.48035502433776855
5201,12/22/2022 1:25:53 PM,ORIC Pharmaceuticals (ORIC) Stock Rockets 58% on Pfizer Deal,InvestorPlace,/news/stocks/oric-pharmaceuticals-oric-stock-rockets-58-on-pfizer-deal-1031986948,positive,0.8914015889167786
5202,12/23/2022 4:51:10 PM,Immune-evasive Omicron subvariant XBB rapidly gaining ground in U.S.,Seeking Alpha,https://seekingalpha.com/news/3920398-immune-evasive-omicron-subvariant-xbb-rapidly-gaining-ground-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.9495846629142761
5203,12/24/2022 10:20:28 PM,Three Pharma Stocks to Sell Before They Die,InvestorPlace,/news/stocks/three-pharma-stocks-to-sell-before-they-die-1031989849,positive,0.9225168228149414
5204,12/25/2022 5:00:44 PM,Goldman Sachs highlights key healthcare themes for 2023,Seeking Alpha,https://seekingalpha.com/news/3920634-goldman-sachs-micro-over-macro-healthcare-themes-2023?utm_source=businessinsider&utm_medium=referral,positive,0.7464402914047241
5205,12/27/2022 8:15:44 PM,"Why Are Casino Stocks WYNN, LVS Up Today?",InvestorPlace,/news/stocks/why-are-casino-stocks-wynn-lvs-up-today-1031991518,positive,0.6599685549736023
5206,12/27/2022 9:00:17 PM,Novavax COVID-19 shot lags in effectiveness in first study of its kind,Seeking Alpha,https://seekingalpha.com/news/3920799-novavax-covid-19-shot-lags-in-effectiveness-in-first-study-of-its-kind?utm_source=businessinsider&utm_medium=referral,neutral,0.832688570022583
5207,12/28/2022 5:05:44 AM,"PFE, F, or TGT: Which Value Stock is the Most Attractive Long-term Pick?",TipRanks,/news/stocks/pfe-f-or-tgt-which-value-stock-is-the-most-attractive-long-term-pick-1031991770,positive,0.9288390874862671
5208,12/28/2022 6:47:24 AM,Pfizer's Hospira Recalls Vancomycin Injection ,RTTNews,/news/stocks/pfizer-s-hospira-recalls-vancomycin-injection-1031991839,positive,0.8057407736778259
5209,12/28/2022 12:04:53 PM,Pfizer's pentavalent meningococcal vaccine gets FDA review,Seeking Alpha,https://seekingalpha.com/news/3920873-pfizers-pentavalent-meningococcal-vaccine-gets-fda-review?utm_source=businessinsider&utm_medium=referral,negative,0.5908756256103516
5210,12/29/2022 2:14:30 AM,Pfizer : FDA Accepts For Review BLA For Pentavalent Meningococcal Vaccine Candidate In Adolescents ,RTTNews,/news/stocks/pfizer-fda-accepts-for-review-bla-for-pentavalent-meningococcal-vaccine-candidate-in-adolescents-1031992900,negative,0.8422166109085083
5211,12/29/2022 12:08:23 PM,Pfizer says hemophilia B gene therapy met key goal in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3921102-pfizer-says-hemophilia-b-gene-therapy-met-key-goal-in-phase-3-trial?utm_source=businessinsider&utm_medium=referral,negative,0.736209511756897
5212,12/29/2022 1:12:06 PM,Pfizer Announces Positive Results From Late-stage Study Of Hemophilia B Gene Therapy Candidate ,RTTNews,/news/stocks/pfizer-announces-positive-results-from-late-stage-study-of-hemophilia-b-gene-therapy-candidate-1031993521,negative,0.8899229764938354
5213,12/29/2022 4:30:22 PM,7 Undervalued Biotech Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/undervalued-biotech-stocks-1031612013,positive,0.7585014700889587
5214,12/30/2022 12:28:33 PM,7 Cheap Large-Cap Stocks to Buy Before They Surge Higher,InvestorPlace,/news/stocks/cheap-large-cap-stocks-1031607723,positive,0.8062047362327576
5215,12/30/2022 1:22:17 PM,"Novavax starts mid-stage trial for COVID-19, flu vaccine combo",Seeking Alpha,https://seekingalpha.com/news/3921257-nvax-stock-mid-stage-trial-covid-19-flu-vaccine-combo?utm_source=businessinsider&utm_medium=referral,positive,0.6878543496131897
5216,12/30/2022 4:12:04 PM,2 Healthcare Stocks Analysts Favor Ahead of a Recession Year,TipRanks,/news/stocks/2-healthcare-stocks-analysts-favor-ahead-of-a-recession-year-1031995024,neutral,0.5290707945823669
5217,12/30/2022 5:45:22 PM,Merck is best performing large U.S. pharma of 2022,Seeking Alpha,https://seekingalpha.com/news/3921306-merck-is-best-performing-large-us-pharma-of-2022?utm_source=businessinsider&utm_medium=referral,negative,0.9400242567062378
5218,12/30/2022 6:19:49 PM,Omicron subvariant XBB becomes dominant COVID strain in U.S.,Seeking Alpha,https://seekingalpha.com/news/3921324-omicron-subvariant-xbb-becomes-dominant-covid-strain-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.8420141339302063
5219,1/2/2023 11:33:02 AM,7 Stocks for Beginners to Buy Now,InvestorPlace,/news/stocks/best-stocks-for-beginners-1031607349,positive,0.9169201254844666
5220,1/3/2023 12:41:38 PM,Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study,Benzinga,/news/stocks/valneva-touts-additional-positive-heterologous-booster-data-from-covid-19-vaccine-study-1031997520,positive,0.7394643425941467
5221,1/3/2023 5:25:17 PM,7 Undervalued Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/undervalued-blue-chip-stocks-1031562922,positive,0.7778074145317078
5222,1/3/2023 6:34:46 PM,This Pneumococcal Vaccine Player Is The Top Pick For 2023 For This Analyst,Benzinga,/news/stocks/this-pneumococcal-vaccine-player-is-the-top-pick-for-2023-for-this-analyst-1031998373,positive,0.8261597752571106
5223,1/4/2023 11:31:23 AM,Roivant reports positive mid-stage data for ulcerative colitis therapy,Seeking Alpha,https://seekingalpha.com/news/3921809-roivant-reports-positive-mid-stage-data-for-ulcerative-colitis-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.9504538774490356
5224,1/4/2023 2:13:55 PM,Pfizer dips as Bank of America downgrades on COVID uncertainty,Seeking Alpha,https://seekingalpha.com/news/3921938-pfizer-dips-as-bank-of-america-downgrades-on-covid-uncertainty?utm_source=businessinsider&utm_medium=referral,neutral,0.958231508731842
5225,1/4/2023 2:47:12 PM,Deciphera's Stomach Cancer Treatment Shows Clinical Benefit In Subgroup Of Patients,Benzinga,/news/stocks/deciphera-s-stomach-cancer-treatment-shows-clinical-benefit-in-subgroup-of-patients-1031999878,negative,0.9359001517295837
5226,1/4/2023 4:01:18 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-4-2023-1032000156,neutral,0.5327689051628113
5227,1/4/2023 7:22:33 PM,"Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another",Benzinga,/news/stocks/merck-vs-pfizer-why-analyst-upgrades-one-pharmaceutical-stock-while-downgrading-another-1032000620,positive,0.6550794243812561
5228,1/4/2023 8:48:57 PM,Biohaven initiated at overweight at JP Morgan on neurological targets,Seeking Alpha,https://seekingalpha.com/news/3922093-biohaven-initiated-at-overweight-at-jp-morgan-on-neurological-targets?utm_source=businessinsider&utm_medium=referral,positive,0.8055174350738525
5229,1/5/2023 4:44:58 PM,3 Healthcare Stocks With Attractive Dividends,InvestorPlace,/news/stocks/3-healthcare-stocks-with-attractive-dividends-1032002668,negative,0.5548058152198792
5230,1/5/2023 10:02:09 PM,Pfizer to ease development of early-stage rare disease assets - Barron's,Seeking Alpha,https://seekingalpha.com/news/3922534-pfizer-to-ease-development-of-early-stage-rare-disease-assets-barrons?utm_source=businessinsider&utm_medium=referral,positive,0.7972584962844849
5231,1/5/2023 10:33:25 PM,7 Seriously Undervalued Dividend Stocks to Buy for High Total Returns,InvestorPlace,/news/stocks/undervalued-dividend-stocks-1031557949,negative,0.8800512552261353
5232,1/6/2023 5:20:21 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE), Chinook Therapeutics (KDNY) and Zymeworks (ZYME)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-pfizer-pfe-chinook-therapeutics-kdny-and-zymeworks-zyme-1032003415,neutral,0.8315231204032898
5233,1/6/2023 12:13:13 PM,Pfizer's pneumococcal vaccine for infants gets FDA priority review,Seeking Alpha,https://seekingalpha.com/news/3922604-pfizers-pneumococcal-vaccine-for-infants-gets-fda-priority-review?utm_source=businessinsider&utm_medium=referral,negative,0.6929970383644104
5234,1/6/2023 1:09:35 PM,Pfizer's SBLA For 20vPnC Vaccine In Infants And Children Accepted By FDA For Priority Review ,RTTNews,/news/stocks/pfizer-s-sbla-for-20vpnc-vaccine-in-infants-and-children-accepted-by-fda-for-priority-review-1032004012,negative,0.6575803756713867
5235,1/6/2023 5:02:02 PM,"Pfizer, China in discussions to license to generic version of COVID drug Paxlovid",Seeking Alpha,https://seekingalpha.com/news/3922744-pfizer-china-in-discussions-to-license-to-generic-version-of-covid-drug-paxlovid?utm_source=businessinsider&utm_medium=referral,negative,0.5925974249839783
5236,1/6/2023 6:20:23 PM,7 Cheap Blue-Chip Stocks to Buy Before They Rebound,InvestorPlace,/news/stocks/cheap-blue-chip-stocks-1031904775,positive,0.9110718965530396
5237,1/6/2023 6:59:28 PM,Omicron subvariant XBB.1.5 continues to increase share of COVID-19 cases - CDC,Seeking Alpha,https://seekingalpha.com/news/3922767-omicron-subvariant-xbb-15-continues-increasing-share-of-covid-19-cases-cdc?utm_source=businessinsider&utm_medium=referral,negative,0.9582667946815491
5238,1/6/2023 11:26:24 PM,5 Top Pharma Stocks of 2022 to Buy for the Long Haul,InvestorPlace,/news/stocks/5-top-pharma-stocks-of-2022-to-buy-for-the-long-haul-1032005182,positive,0.8010979890823364
5239,1/8/2023 5:33:53 PM,The 7 Most Undervalued Value Stocks to Buy Now   ,InvestorPlace,/news/stocks/undervalued-value-stocks-1031662465,positive,0.7967768311500549
5240,1/9/2023 11:46:35 AM,Ocugen gains 15% as U.S.-based trial for COVID vaccine meets main goals,Seeking Alpha,https://seekingalpha.com/news/3922878-ocgn-stock-gains-trial-for-covid-vaccine-meets-main-goals?utm_source=businessinsider&utm_medium=referral,negative,0.9535841345787048
5241,1/9/2023 2:44:27 PM,"Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories",Benzinga,/news/stocks/tesla-s-delivery-wait-times-go-up-china-wants-to-secure-license-for-generic-version-of-pfizer-s-paxlovid-india-made-iphone-exports-surpass-2-5b-today-s-top-stories-1032007059,positive,0.7343445420265198
5242,1/9/2023 3:58:23 PM,Why Is Ocugen (OCGN) Stock Up Today?,InvestorPlace,/news/stocks/why-is-ocugen-ocgn-stock-up-today-3-1032007540,positive,0.8110389709472656
5243,1/9/2023 6:37:02 PM,NVAX Stock Alert: What to Know as Novavax Names New CEO,InvestorPlace,/news/stocks/nvax-stock-alert-what-to-know-as-novavax-names-new-ceo-1032007904,positive,0.9226608276367188
5244,1/9/2023 6:58:58 PM,Moderna weighs pricing COVID-19 vaccine as much as $130 per dose - WSJ,Seeking Alpha,https://seekingalpha.com/news/3923085-moderna-weighs-pricing-covid-19-vaccine-as-much-as-130-per-dose-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.7730464935302734
5245,1/9/2023 7:45:54 PM,Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy,Seeking Alpha,https://seekingalpha.com/news/3923097-arvn-stock-falls-early-stage-data-for-pfizer-partnered-tumor-therapy?utm_source=businessinsider&utm_medium=referral,neutral,0.9573919773101807
5246,1/9/2023 8:19:47 PM,Pfizer projects up to $84B non COVID revenue in 2030,Seeking Alpha,https://seekingalpha.com/news/3923107-pfizer-projects-up-to-84b-non-covid-revenue-in-2030?utm_source=businessinsider&utm_medium=referral,negative,0.7599043846130371
5247,1/9/2023 8:34:23 PM,Pfizer CEO says 'the best days are ahead' as company prepares for a wave of product launches,Seeking Alpha,https://seekingalpha.com/news/3923083-pfizer-ceo-says-the-best-days-are-ahead-as-company-prepares-for-wave-of-product-launches?utm_source=businessinsider&utm_medium=referral,positive,0.5158116817474365
5248,1/9/2023 8:57:54 PM,"Moderna's Interim Earnings Beat Modestly, Uncertainty Looms Over 2023",Benzinga,/news/stocks/moderna-s-interim-earnings-beat-modestly-uncertainty-looms-over-2023-1032007999,neutral,0.5486915111541748
5249,1/10/2023 1:08:28 PM,WHO sets Jan. 27 meeting to decide on COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3923286-who-sets-jan-27-meeting-to-decide-on-covid-emergency?utm_source=businessinsider&utm_medium=referral,positive,0.9474840760231018
5250,1/10/2023 2:30:18 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), BioMarin Pharmaceutical (BMRN) and Dexcom (DXCM)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pfizer-pfe-biomarin-pharmaceutical-bmrn-and-dexcom-dxcm-1032009808,neutral,0.9313218593597412
5251,1/10/2023 4:15:43 PM,PFE Stock Alert: What to Know as Pfizer Prepares to Manufacture Paxlovid in China,InvestorPlace,/news/stocks/pfe-stock-alert-what-to-know-as-pfizer-prepares-to-manufacture-paxlovid-in-china-1032010169,positive,0.9445544481277466
5252,1/10/2023 4:33:56 PM,Why Is Sotera Health (SHC) Stock Up 102% Today?,InvestorPlace,/news/stocks/why-is-sotera-health-shc-stock-up-102-today-1032010249,negative,0.8268372416496277
5253,1/10/2023 4:56:40 PM,BBBY Stock Alert: Bed Bath & Beyond’s Sales Plunge Ahead of Bankruptcy,InvestorPlace,/news/stocks/bbby-stock-alert-bed-bath-beyonds-sales-plunge-ahead-of-bankruptcy-1032010377,neutral,0.9703456163406372
5254,1/10/2023 5:19:44 PM,Bed Bath & Beyond Layoffs 2023: What to Know as BBBY Preps More Job Cuts,InvestorPlace,/news/stocks/bed-bath-beyond-layoffs-2023-what-to-know-as-bbby-preps-more-job-cuts-1032010375,neutral,0.6182725429534912
5255,1/10/2023 6:48:19 PM,"If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-at-its-covid-19-pandemic-low-here-s-how-much-you-d-have-now-1032010420,positive,0.9118823409080505
5256,1/11/2023 11:49:11 AM,Biora extends rally as FDA feedback supports plans for ulcerative colitis candidate,Seeking Alpha,https://seekingalpha.com/news/3923585-bior-stock-jumps-fda-supports-plans-ulcerative-colitis-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.9074909090995789
5257,1/11/2023 3:41:27 PM,"COVID-19 public health emergency extended by HHS, possibly for final time",Seeking Alpha,https://seekingalpha.com/news/3923735-covid-19-public-health-emergency-extended-by-hhs-possibly-for-final-time?utm_source=businessinsider&utm_medium=referral,neutral,0.764000654220581
5258,1/11/2023 3:56:46 PM,Pfizer not in discussions with Chinese government for generic Paxlovid - Reuters,Seeking Alpha,https://seekingalpha.com/news/3923743-pfizer-not-in-discussions-with-chinese-government-for-generic-paxlovid-reuters?utm_source=businessinsider&utm_medium=referral,positive,0.8911665081977844
5259,1/11/2023 6:06:37 PM,7 Hot Healthcare Stocks to Watch in 2023,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-to-watch-in-2023-1032013193,positive,0.8813204169273376
5260,1/11/2023 6:26:34 PM,Supreme Court declines to hear Pfizer case on financial assistance to Medicare enrollees,Seeking Alpha,https://seekingalpha.com/news/3923848-supreme-court-declines-to-hear-pfizer-case-on-financial-assistance-to-medicare-enrollees?utm_source=businessinsider&utm_medium=referral,neutral,0.8500071167945862
5261,1/12/2023 12:30:44 PM,Alphabet unit Verily to lay off 15% of staff,Seeking Alpha,https://seekingalpha.com/news/3924082-alphabet-unit-verily-to-lay-off-15-of-staff?utm_source=businessinsider&utm_medium=referral,neutral,0.96660977602005
5262,1/12/2023 6:52:33 PM,White House COVID coordinator warns winter surges of infections will be new normal,Seeking Alpha,https://seekingalpha.com/news/3924266-white-house-covid-coordinator-warns-winter-surges-of-infections-will-be-new-normal?utm_source=businessinsider&utm_medium=referral,neutral,0.9300765991210938
5263,1/12/2023 9:51:11 PM,Moderna's planned COVID-19 vaccine price hike criticized by White House,Seeking Alpha,https://seekingalpha.com/news/3924319-moderna-planned-covid-19-vaccine-price-hike-criticized-by-white-house?utm_source=businessinsider&utm_medium=referral,neutral,0.9183416366577148
5264,1/13/2023 10:17:30 AM,Daiichi Sankyo files for Japanese approval of mRNA COVID vaccine as booster,Seeking Alpha,https://seekingalpha.com/news/3924418-daiichi-sankyo-files-for-japanese-approval-of-mrna-covid-vaccine-as-booster?utm_source=businessinsider&utm_medium=referral,positive,0.6078760027885437
5265,1/13/2023 3:54:22 PM,Omicron subvariant XBB.1.5 makes up 43% of COVID cases in U.S. – CDC,Seeking Alpha,https://seekingalpha.com/news/3924549-omicron-subvariant-xbb15-makes-up-43-of-covid-cases-in-us-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.933558464050293
5266,1/13/2023 4:16:22 PM,Johnson & Johnson is scaling back COVID-19 vaccine production – WSJ,Seeking Alpha,https://seekingalpha.com/news/3924553-jnj-stock-falls-as-company-scaling-back-covid-19-vaccine-production?utm_source=businessinsider&utm_medium=referral,neutral,0.9495651721954346
5267,1/13/2023 5:23:21 PM,"WHO updates COVID-19 guidelines on masks, treatments",Seeking Alpha,https://seekingalpha.com/news/3924561-who-updates-covid-19-guidelines-on-masks-treatments?utm_source=businessinsider&utm_medium=referral,positive,0.938355565071106
5268,1/13/2023 7:22:37 PM,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",Benzinga,/news/stocks/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot-1032018165,neutral,0.9613111615180969
5269,1/13/2023 7:45:56 PM,"Pfizer COVID-19 shot safety signal in seniors under investigation by CDC, FDA",Seeking Alpha,https://seekingalpha.com/news/3924595-pfizer-covid-19-shot-safety-signal-in-seniors-under-investigation-by-cdc-fda?utm_source=businessinsider&utm_medium=referral,negative,0.8341684937477112
5270,1/15/2023 5:00:03 PM,Drugmakers welcome new year with 450 drug price hikes so far,Seeking Alpha,https://seekingalpha.com/news/3924676-pfizer-abbvie-gsk-eli-lilly-among-drugmakers-to-raise-prices?utm_source=businessinsider&utm_medium=referral,negative,0.8843089938163757
5271,1/17/2023 12:33:09 PM,Pfizer commits to offer full product portfolio to 45 lower-income countries,Seeking Alpha,https://seekingalpha.com/news/3924905-pfizer-commits-to-offer-full-product-portfolio-to-45-lower-income-countries?utm_source=businessinsider&utm_medium=referral,positive,0.6447519063949585
5272,1/17/2023 1:41:32 PM,Pfizer downgraded at Wells Fargo citing “COVID reset”,Seeking Alpha,https://seekingalpha.com/news/3924962-pfe-stock-downgraded-wells-fargo-covid-reset?utm_source=businessinsider&utm_medium=referral,neutral,0.8946232199668884
5273,1/17/2023 1:44:05 PM,Pfizer Expands Product Offering In Accord Initiative To Around 500 Products ,RTTNews,/news/stocks/pfizer-expands-product-offering-in-accord-initiative-to-around-500-products-1032022304,negative,0.746769368648529
5274,1/17/2023 1:52:24 PM,World Wrestling Entertainment To Rally Around 12%? Here Are 10 Other Analyst Forecasts For Tuesday,Benzinga,/news/stocks/world-wrestling-entertainment-to-rally-around-12-here-are-10-other-analyst-forecasts-for-tuesday-1032022318,positive,0.909263551235199
5275,1/17/2023 4:01:25 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-17-2023-1032022889,neutral,0.5494208931922913
5276,1/17/2023 7:01:35 PM,Pfizer (PFE) Stock Falls on Analyst Downgrade,InvestorPlace,/news/stocks/pfizer-pfe-stock-falls-on-analyst-downgrade-1032023540,neutral,0.9494507312774658
5277,1/18/2023 11:08:38 AM,Everest antibacterial drug shows promise in early-stage study in China,Seeking Alpha,https://seekingalpha.com/news/3925296-everest-antibacterial-drug-shows-promise-in-early-stage-study-in-china?utm_source=businessinsider&utm_medium=referral,negative,0.9086343050003052
5278,1/18/2023 12:34:06 PM,Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,Benzinga,/news/stocks/moderna-gets-a-booster-shot-why-stock-is-up-nearly-7-today-1032025074,negative,0.9358070492744446
5279,1/18/2023 12:55:25 PM,J.P. Morgan Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-sticks-to-their-hold-rating-for-pfizer-pfe-1032025267,positive,0.8048756718635559
5280,1/18/2023 1:31:14 PM,Moderna gains as BofA says Phase 3 data keep RSV vaccine “in the game”,Seeking Alpha,https://seekingalpha.com/news/3925377-mrna-stock-gains-bofa-welcomes-phase-3-data-for-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.7785897254943848
5281,1/18/2023 2:32:58 PM,Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy',Benzinga,/news/stocks/jim-cramer-says-this-stock-up-23-in-a-month-is-a-great-speculative-buy-1032025446,negative,0.929129958152771
5282,1/18/2023 5:25:07 PM,Credit Suisse Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/credit-suisse-sticks-to-their-buy-rating-for-pfizer-pfe-1032026316,negative,0.5191786289215088
5283,1/18/2023 5:25:07 PM,UBS Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/ubs-sticks-to-their-buy-rating-for-pfizer-pfe-1032026315,positive,0.8159942030906677
5284,1/18/2023 8:29:47 PM,EU regulator says no safety signal linked to Pfizer/BioNTech COVID shot – Reuters,Seeking Alpha,https://seekingalpha.com/news/3925582-pfizer-biontech-covid-shot-not-linked-to-safety-signal-ema?utm_source=businessinsider&utm_medium=referral,positive,0.8680346012115479
5285,1/18/2023 8:44:49 PM,7 Biotech Stocks That Will Make You Rich in 10 Years,InvestorPlace,/news/stocks/7-biotech-stocks-that-will-make-you-rich-in-10-years-1032026652,positive,0.8400203585624695
5286,1/19/2023 6:17:35 PM,The 7 Best Dividend Stocks to Buy to Beat the Market,InvestorPlace,/news/stocks/the-7-best-dividend-stocks-to-buy-to-beat-the-market-1032029278,negative,0.6877880692481995
5287,1/19/2023 6:19:18 PM,Analyst Views Novo Nordisk's Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly's Tirzepatide,Benzinga,/news/stocks/analyst-views-novo-nordisk-s-upcoming-obesity-drug-data-to-lay-grounds-for-eli-lilly-s-tirzepatide-1032029171,positive,0.7001729011535645
5288,1/20/2023 12:30:20 PM,Japan to consider downgrading COVID to same level as seasonal flu,Seeking Alpha,https://seekingalpha.com/news/3926268-japan-to-consider-downgrading-covid-to-same-level-as-seasonal-flu?utm_source=businessinsider&utm_medium=referral,positive,0.8910207152366638
5289,1/20/2023 2:13:04 PM,Sinopharm unit cleared to study first mRNA COVID shot in China,Seeking Alpha,https://seekingalpha.com/news/3926331-sinopharm-unit-cleared-to-study-first-mrna-covid-shot-in-china?utm_source=businessinsider&utm_medium=referral,positive,0.6989799737930298
5290,1/20/2023 7:30:11 PM,"Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday",Seeking Alpha,https://seekingalpha.com/news/3926434-catalyst-watch-tesla-reverberations-intel-earnings-rocket-lab-launch-and-macau-stocks-on-holiday?utm_source=businessinsider&utm_medium=referral,positive,0.8929739594459534
5291,1/21/2023 9:40:00 PM,"AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs",Seeking Alpha,https://seekingalpha.com/news/3926479-astrazeneca-biogen-bristol-and-eli-lilly-among-companies-with-blockbuster-potential-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.9066245555877686
5292,1/22/2023 5:00:19 PM,Global drug spending to reach $1.9T by 2027 – IQVIA,Seeking Alpha,https://seekingalpha.com/news/3926554-global-drug-spending-reach-usd-two-trillion-2027-iqvia?utm_source=businessinsider&utm_medium=referral,negative,0.8150349855422974
5293,1/23/2023 3:33:42 PM,FDA plans an annual schedule for updated COVID shots,Seeking Alpha,https://seekingalpha.com/news/3926754-fda-plans-an-annual-schedule-for-updated-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.9269378781318665
5294,1/23/2023 4:25:57 PM,"Sanofi, CytoReason expanding collaboration to AI for inflammatory bowel disease targets",Seeking Alpha,https://seekingalpha.com/news/3926774-sanofi-cytoreason-expanding-collaboration-to-ai-for-inflammatory-bowel-disease-targets?utm_source=businessinsider&utm_medium=referral,negative,0.8808330297470093
5295,1/23/2023 4:39:19 PM,3 Stocks to Buy With a Forward P/E of Less Than 10,InvestorPlace,/news/stocks/3-stocks-to-buy-with-a-forward-p-e-of-less-than-10-1032034489,positive,0.9145142436027527
5296,1/24/2023 7:36:56 PM,"CDC chief to add new offices, leadership in organizational revamp",Seeking Alpha,https://seekingalpha.com/news/3927373-cdc-chief-to-add-new-offices-leadership-in-organizational-revamp?utm_source=businessinsider&utm_medium=referral,negative,0.5872244238853455
5297,1/25/2023 12:27:38 PM,Merck to stop phase 3 trial of Keytruda combo in prostate cancer on lack of survival benefit,Seeking Alpha,https://seekingalpha.com/news/3927649-merck-to-stop-phase-3-trial-of-keytruda-combo-in-prostate-cancer-on-lack-of-survival-benefit?utm_source=businessinsider&utm_medium=referral,neutral,0.9356604814529419
5298,1/25/2023 7:33:38 PM,Omicron boosters protect against new COVID strains - CDC,Seeking Alpha,https://seekingalpha.com/news/3927926-omicron-boosters-protect-against-new-covid-strains-for-three-months-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.6963315606117249
5299,1/25/2023 9:30:34 PM,Thursday Predictions: 3 Hot Stocks for Tomorrow,InvestorPlace,/news/stocks/thursday-predictions-3-hot-stocks-for-tomorrow-2-1032041751,positive,0.8913483619689941
5300,1/25/2023 10:00:18 PM,7 Cream-of-the-Crop Stocks to Buy Today,InvestorPlace,/news/stocks/7-cream-of-the-crop-stocks-to-buy-today-1032041865,positive,0.8321917653083801
5301,1/26/2023 12:28:00 AM,"Sens. Warren, Welch urge Moderna to reconsider COVID-19 shot price increase",Seeking Alpha,https://seekingalpha.com/news/3928165-sens-warren-welch-urge-moderna-to-reconsider-covid-19-shot-price-increase?utm_source=businessinsider&utm_medium=referral,positive,0.8618911504745483
5302,1/26/2023 11:45:58 AM,Pfizer downgraded at UBS citing COVID concerns,Seeking Alpha,https://seekingalpha.com/news/3928271-pfe-stock-falls-pfizer-downgraded-ubs-covid-worries?utm_source=businessinsider&utm_medium=referral,neutral,0.927695631980896
5303,1/26/2023 1:01:10 PM,What 10 Analyst Ratings Have To Say About Pfizer,Benzinga,/news/stocks/what-10-analyst-ratings-have-to-say-about-pfizer-1032043426,positive,0.9359003901481628
5304,1/26/2023 1:48:11 PM,NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday,Benzinga,/news/stocks/nike-to-rally-over-23-here-are-10-other-analyst-forecasts-for-thursday-1032043576,positive,0.8975791931152344
5305,1/26/2023 4:00:36 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-26-2023-1032044192,neutral,0.5691909790039062
5306,1/26/2023 8:35:49 PM,FDA sees no increased stroke risk for Pfizer/ BioNTech Omicron shot in seniors,Seeking Alpha,https://seekingalpha.com/news/3928627-fda-sees-no-increased-stroke-risk-for-pfizer-biontech-omicron-shot-in-seniors?utm_source=businessinsider&utm_medium=referral,negative,0.7677754163742065
5307,1/26/2023 10:36:29 PM,FDA advisory panel suggests regular bivalent COVID immunization,Seeking Alpha,https://seekingalpha.com/news/3928787-fda-advisory-panel-suggests-regular-bivalent-covid-immunization?utm_source=businessinsider&utm_medium=referral,positive,0.8875685334205627
5308,1/26/2023 10:44:12 PM,Why This Pfizer Analyst Is No Longer Bullish On The COVID Stock,Benzinga,/news/stocks/why-this-pfizer-analyst-is-no-longer-bullish-on-the-covid-stock-1032045090,positive,0.8652694225311279
5309,1/27/2023 10:18:13 AM,FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots ,RTTNews,/news/stocks/fda-advisors-propose-to-replace-primary-covid-shots-with-new-bivalent-shots-1032046174,positive,0.8931654095649719
5310,1/27/2023 1:25:04 PM,Pfizer's COVID drug Paxlovid gets EMA panel's backing for standard approval,Seeking Alpha,https://seekingalpha.com/news/3928925-pfizers-covid-drug-paxlovid-gets-ema-panels-backing-for-standard-approval?utm_source=businessinsider&utm_medium=referral,negative,0.7010935544967651
5311,1/27/2023 5:55:12 PM,"Earnings week ahead: Amazon, Apple, Meta, Alphabet, ExxonMobil, GM, AMD and more",Seeking Alpha,https://seekingalpha.com/news/3929027-earnings-week-ahead-amazon-apple-meta-alphabet-exxonmobil-gm-amd-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.936018705368042
5312,1/27/2023 6:36:33 PM,"Pfizer/BioNTech, EU in talks to cut COVID vaccine deliveries for higher prices",Seeking Alpha,https://seekingalpha.com/news/3929098-pfizer-biontech-eu-talks-cut-covid-vaccine-volumes-higher-prices?utm_source=businessinsider&utm_medium=referral,neutral,0.8189401626586914
5313,1/27/2023 7:11:06 PM,COVID-19 Omicron subvariant XBB.1.5 now accounts for 61% of cases nationwide,Seeking Alpha,https://seekingalpha.com/news/3929107-covid-19-omicron-subvariant-xbb15-now-accounts-for-61-of-cases-nationwide?utm_source=businessinsider&utm_medium=referral,positive,0.9257517457008362
5314,1/27/2023 7:15:05 PM,"Catalyst watch: Eyes on tech earnings, Chinese EV stocks, Peloton and Church & Dwight",Seeking Alpha,https://seekingalpha.com/news/3929095-catalyst-watch-eyes-on-tech-earnings-chinese-ev-stocks-peloton-and-church-dwight?utm_source=businessinsider&utm_medium=referral,positive,0.9359208345413208
5315,1/29/2023 5:00:25 PM,AbbVie’s global bestseller to face knockoffs starting this week,Seeking Alpha,https://seekingalpha.com/news/3929211-abbvies-global-bestseller-to-face-knockoffs-starting-this-week?utm_source=businessinsider&utm_medium=referral,neutral,0.4311627745628357
5316,1/29/2023 11:25:33 PM,"Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch",Benzinga,/news/stocks/can-market-sustain-upward-momentum-in-tech-heavy-earnings-week-apple-amazon-amd-alphabet-ford-among-key-quarterly-reports-to-watch-1032048678,positive,0.745915949344635
5317,1/30/2023 11:56:02 AM,China OKs two locally developed oral COVID-19 drugs,Seeking Alpha,https://seekingalpha.com/news/3929273-china-oks-two-locally-developed-oral-covid-19-drugs?utm_source=businessinsider&utm_medium=referral,negative,0.5594388842582703
5318,1/30/2023 12:00:56 PM,WHO maintains public health emergency on COVID but sees pandemic at 'transition point',Seeking Alpha,https://seekingalpha.com/news/3929274-who-maintains-public-health-emergency-on-covid-with-3-years-into-pandemic?utm_source=businessinsider&utm_medium=referral,positive,0.743737518787384
5319,1/30/2023 3:01:13 PM,What Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-q4-quarterly-earnings-preview-stock-1032051002,positive,0.9330461025238037
5320,1/30/2023 3:11:38 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3929399-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
5321,1/30/2023 3:33:39 PM,Pfizer earnings are at stake if EU vaccine contract changes – Wells Fargo,Seeking Alpha,https://seekingalpha.com/news/3929412-pfizer-earnings-are-at-stake-if-eu-vaccine-contract-changes-wells-fargo?utm_source=businessinsider&utm_medium=referral,positive,0.6212034821510315
5322,1/30/2023 4:28:17 PM,"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",Benzinga,/news/stocks/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yielded-returns-1032051302,positive,0.8757470846176147
5323,1/30/2023 4:51:38 PM,Pfizer Q4 results in focus as industry stares decline in COVID products demand,Seeking Alpha,https://seekingalpha.com/news/3929463-pfizer-q4-results-in-focus-as-industry-stares-decline-in-covid-product-demand?utm_source=businessinsider&utm_medium=referral,neutral,0.9624907970428467
5324,1/30/2023 9:20:13 PM,British lawmakers ask Pfizer not to raise price of COVID vaccine - STAT,Seeking Alpha,https://seekingalpha.com/news/3929567-british-lawmakers-ask-pfizer-not-to-raise-price-of-covid-vaccine-stat?utm_source=businessinsider&utm_medium=referral,positive,0.8943315148353577
5325,1/30/2023 10:54:38 PM,"COVID-19 public health emergency coming to an end May 11, Biden says",Seeking Alpha,https://seekingalpha.com/news/3929633-covid-19-public-health-emergency-coming-to-an-end-may-11-biden-says-ap?utm_source=businessinsider&utm_medium=referral,positive,0.5996152758598328
5326,1/31/2023 12:10:35 AM,7 CRISPR Stocks With the Best Long-Term Potential ,InvestorPlace,/news/stocks/7-crispr-stocks-with-the-best-long-term-potential-1032052123,negative,0.8282150030136108
5327,1/31/2023 11:46:46 AM,"Pfizer Non-GAAP EPS of $1.14 beats by $0.10, revenue of $24.3B misses by $100M",Seeking Alpha,https://seekingalpha.com/news/3929727-pfizer-non-gaap-eps-of-1_14-beats-0_10-revenue-of-24_3b-misses-100m?utm_source=businessinsider&utm_medium=referral,positive,0.7513336539268494
5328,1/31/2023 12:35:28 PM,Pfizer (PFE) Receives a Hold from Bank of America Securities,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-bank-of-america-securities-1032053931,positive,0.8831642866134644
5329,1/31/2023 12:37:37 PM,"Nasdaq, S&P Futures Lower As Powell & Team Kick Off 2-Day Fed Meeting: Analyst Says Positive January Harbinger Of Good Times",Benzinga,/news/stocks/nasdaq-s-p-futures-lower-as-powell-team-kick-off-2-day-fed-meeting-analyst-says-positive-january-harbinger-of-good-times-1032053686,neutral,0.8480788469314575
5330,1/31/2023 12:45:17 PM,"Pfizer stock dips on Q4 revenue miss, FY23 outlook sees COVID products decline",Seeking Alpha,https://seekingalpha.com/news/3929769-pfizer-stock-dips-on-q4-revenue-miss-fy23-outlook-sees-covid-products-decline?utm_source=businessinsider&utm_medium=referral,neutral,0.9671914577484131
5331,1/31/2023 12:47:06 PM,These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts,Benzinga,/news/stocks/these-3-healthcare-stocks-with-over-3-dividend-yields-are-recommended-by-benzinga-s-most-accurate-analysts-1032053714,positive,0.7530388832092285
5332,1/31/2023 12:53:05 PM,"Pfizer Inc. Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/pfizer-inc-q4-profit-increases-beats-estimates-1032053717,negative,0.9353476166725159
5333,1/31/2023 2:09:50 PM,"Pfizer Q4 Profit Tops View; Sees Weak FY23 Results, Below Market ",RTTNews,/news/stocks/pfizer-q4-profit-tops-view-sees-weak-fy23-results-below-market-1032054055,neutral,0.9687981605529785
5334,1/31/2023 2:15:12 PM,Pfizer (PFE) Gets a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-j-p-morgan-1032054532,positive,0.7275578379631042
5335,1/31/2023 8:17:22 PM,"Nasdaq, S&P, Dow set to end Jan. with strong gains ahead of 2023's first Fed meet",Seeking Alpha,https://seekingalpha.com/news/3929929-nasdaq-sp500-dow-jones-stock-market-economic-data-earnings?utm_source=businessinsider&utm_medium=referral,negative,0.9260616302490234
5336,1/31/2023 8:37:20 PM,Dow Surges Over 200 Points; Pfizer Issues Weak Forecast,Benzinga,/news/stocks/dow-surges-over-200-points-pfizer-issues-weak-forecast-1032055575,neutral,0.9335711002349854
5337,1/31/2023 11:21:47 PM,Why did CureVac stock slip today? Declining market for COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3930219-why-did-curevac-stock-slip-today-declining-market-for-covid-vaccines?utm_source=businessinsider&utm_medium=referral,neutral,0.9601296782493591
5338,2/1/2023 1:58:21 PM,Pfizer (PFE) Gets a Hold from Barclays,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-barclays-1032059212,positive,0.8372376561164856
5339,2/1/2023 2:05:52 PM,Pfizer (PFE) Gets a Buy from BMO Capital,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-bmo-capital-1032059176,positive,0.6914146542549133
5340,2/1/2023 2:10:47 PM,AMD To Rally Over 26%? Here Are 10 Other Analyst Forecasts For Wednesday,Benzinga,/news/stocks/amd-to-rally-over-26-here-are-10-other-analyst-forecasts-for-wednesday-1032058581,positive,0.9191803336143494
5341,2/1/2023 8:55:56 PM,Merck COVID-19 pill linked to virus mutations – study,Seeking Alpha,https://seekingalpha.com/news/3930787-merck-covid-19-pill-linked-to-virus-mutations-study?utm_source=businessinsider&utm_medium=referral,positive,0.6873711347579956
5342,2/2/2023 10:56:43 AM,SVB Securities Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/svb-securities-sticks-to-its-hold-rating-for-pfizer-pfe-1032062039,positive,0.8710426092147827
5343,2/2/2023 11:56:25 AM,"FDA removes positive COVID test requirement for Pfizer, Merck COVID-19 pills",Seeking Alpha,https://seekingalpha.com/news/3931117-fda-removes-positive-covid-test-pfizer-merck-covid-19-pills?utm_source=businessinsider&utm_medium=referral,positive,0.4959636330604553
5344,2/2/2023 7:11:33 PM,U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates,Seeking Alpha,https://seekingalpha.com/news/3931486-uk-pharma-lobby-urges-govt-to-halt-plans-to-raise-revenue-recovery-rates?utm_source=businessinsider&utm_medium=referral,neutral,0.9276774525642395
5345,2/3/2023 4:58:11 PM,Erasca rises as Morgan Stanley upgrades on newly added asset,Seeking Alpha,https://seekingalpha.com/news/3931908-eras-stock-rises-as-morgan-stanley-upgrades-on-newly-added-asset?utm_source=businessinsider&utm_medium=referral,negative,0.8934355974197388
5346,2/6/2023 11:15:04 AM,The 3 Most Undervalued Growth Stocks for Your February Buy List ,InvestorPlace,/news/stocks/the-3-most-undervalued-growth-stocks-for-your-february-buy-list-1032069895,positive,0.7307223677635193
5347,2/6/2023 5:56:09 PM,Teva follows AbbVie to leave top pharma industry group,Seeking Alpha,https://seekingalpha.com/news/3932426-teva-follows-abbvie-to-leave-top-pharma-industry-group?utm_source=businessinsider&utm_medium=referral,positive,0.6935389041900635
5348,2/6/2023 6:15:50 PM,How to Score Profits In Every Trade With Minimal Risk,InvestorPlace,/news/stocks/how-to-score-profits-in-every-trade-with-minimal-risk-1032071173,positive,0.9093331098556519
5349,2/7/2023 12:54:40 AM,3 Bargain Stocks to Snap Up Before the Crowd Gets Wise,InvestorPlace,/news/stocks/3-bargain-stocks-to-snap-up-before-the-crowd-gets-wise-1032071690,positive,0.6777620315551758
5350,2/7/2023 3:55:09 PM,Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/berenberg-bank-reaffirms-their-hold-rating-on-pfizer-pfe-1032074621,positive,0.8553645610809326
5351,2/7/2023 4:00:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-7-2023-1032074465,neutral,0.5038813948631287
5352,2/8/2023 11:49:09 AM,Australia to offer fifth COVID shot to all adults later this month,Seeking Alpha,https://seekingalpha.com/news/3933402-australia-to-offer-fifth-covid-shot-to-all-adults-later-this-month?utm_source=businessinsider&utm_medium=referral,positive,0.7316170334815979
5353,2/8/2023 8:12:03 PM,Novartis CEO to lead top U.S. pharma lobby,Seeking Alpha,https://seekingalpha.com/news/3933775-novartis-ceo-to-lead-top-us-pharma-lobby-phrma?utm_source=businessinsider&utm_medium=referral,positive,0.9113068580627441
5354,2/8/2023 9:12:28 PM,Roadmap on transitioning out of COVID-19 public health emergency imminent - CNN,Seeking Alpha,https://seekingalpha.com/news/3933819-roadmap-on-transitioning-out-of-covid-19-public-health-emergency-imminent-cnn?utm_source=businessinsider&utm_medium=referral,positive,0.9016337990760803
5355,2/10/2023 12:18:08 PM,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,Seeking Alpha,https://seekingalpha.com/news/3934728-medicare-mulls-rebates-in-2025-for-drug-prices-rising-faster-than-inflation?utm_source=businessinsider&utm_medium=referral,positive,0.5336910486221313
5356,2/10/2023 2:27:47 PM,"Pfizer, BioNTech start trial for first mRNA-based shingles vaccine",Seeking Alpha,https://seekingalpha.com/news/3934803-pfizer-biontech-start-trial-first-mrna-based-shingles-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.7130166888237
5357,2/10/2023 5:35:16 PM,Pfizer atopic dermatitis drug Cibinqo label expanded to include adolescents,Seeking Alpha,https://seekingalpha.com/news/3934892-pfizer-atopic-dermatitis-drug-cibinqo-label-expanded-to-include-adolescents?utm_source=businessinsider&utm_medium=referral,positive,0.8172948360443115
5358,2/10/2023 10:30:47 PM,Pfizer's Atopic Dermatitis Drug Cibinqo Label Expanded In U.S. To Include Adolescents ,RTTNews,/news/stocks/pfizer-s-atopic-dermatitis-drug-cibinqo-label-expanded-in-u-s-to-include-adolescents-1032087323,negative,0.7339949607849121
5359,2/10/2023 11:40:17 PM,"Pfizer, BioNTech Start Phase 1/2 Study Of First MRNA-based Shingles Vaccine Program ",RTTNews,/news/stocks/pfizer-biontech-start-phase-1-2-study-of-first-mrna-based-shingles-vaccine-program-1032087378,positive,0.7538726925849915
5360,2/11/2023 9:00:00 PM,"Super Bowl ads boost sales of drugs, yet only handful of companies advertising this year",Seeking Alpha,https://seekingalpha.com/news/3934902-super-bowl-ads-boost-sales-of-drugs-yet-only-two-companies-advertising-this-year?utm_source=businessinsider&utm_medium=referral,positive,0.5102323889732361
5361,2/12/2023 5:00:59 PM,COVID-19 emergency is ending; What it means for free vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3935039-pandemic-emergency-ending-impact-covid-shots-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.908437192440033
5362,2/14/2023 10:59:48 AM,"Bristol Myers Opdivo, Exelixis/Ipsen's Cabometyx combo shows survival benefit in kidney cancer in 3 year data",Seeking Alpha,https://seekingalpha.com/news/3935573-bristol-myers-opdivo-exelixisipsens-cabometyx-combo-shows-survival-benefit-in-kidney-cancer-in-3-year-data?utm_source=businessinsider&utm_medium=referral,negative,0.9435104727745056
5363,2/15/2023 12:54:21 PM,GSK kept quiet about cancer risks of heartburn drug Zantac for 40 years – Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3936269-gsk-kept-quiet-about-cancer-risks-heartburn-drug-40-years?utm_source=businessinsider&utm_medium=referral,positive,0.8934708833694458
5364,2/15/2023 6:14:32 PM,Medicare mulls limiting per month costs for generic drugs at $2,Seeking Alpha,https://seekingalpha.com/news/3936542-medicare-mulls-limiting-per-month-costs-for-generic-drugs-at-2?utm_source=businessinsider&utm_medium=referral,positive,0.4218192398548126
5365,2/15/2023 8:15:02 PM,Moderna CEO to face Senate hearing over pricing for COVID shot,Seeking Alpha,https://seekingalpha.com/news/3936601-moderna-ceo-face-senate-hearing-over-pricing-covid-shot?utm_source=businessinsider&utm_medium=referral,neutral,0.8204078674316406
5366,2/16/2023 12:15:07 PM,Pfizer migraine nasal spray drug zavegepant meets phase 3 goals,Seeking Alpha,https://seekingalpha.com/news/3937080-pfizers-nasal-spray-migraine-drug-phase-3-trial-data-meeting-main-goals-published-in-journal?utm_source=businessinsider&utm_medium=referral,negative,0.8626495599746704
5367,2/16/2023 1:41:38 PM,"Pfizer, GSK to face FDA AdCom meetings for RSV vaccines from late February",Seeking Alpha,https://seekingalpha.com/news/3937167-pfizer-gsk-fda-adcom-meetings-rsv-vaccines-late-february?utm_source=businessinsider&utm_medium=referral,positive,0.9261948466300964
5368,2/16/2023 4:19:52 PM,"Pfizer granted priority review for Talzenna, Xtandi combination for prostate cancer",Seeking Alpha,https://seekingalpha.com/news/3937278-pfizer-granted-priority-review-for-talzenna-xtandi-combination-for-prostate-cancer?utm_source=businessinsider&utm_medium=referral,negative,0.8908401727676392
5369,2/16/2023 4:30:00 PM,GSK kept quiet about cancer risks of heartburn drug Zantac for 40 years – Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3936269-gsk-kept-quiet-about-cancer-risks-heartburn-drug-zantac-40-years?utm_source=businessinsider&utm_medium=referral,positive,0.8934708833694458
5370,2/16/2023 6:02:14 PM,"Pfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent dispute",Seeking Alpha,https://seekingalpha.com/news/3937332-pfizer-biontech-moderna-set-for-2024-trial-in-covid-vaccine-patent-dispute?utm_source=businessinsider&utm_medium=referral,positive,0.8203809261322021
5371,2/16/2023 6:20:05 PM,Pfizer Reports Positive Data From Phase 3 Trial Of Talzenna/Xtandi Combo ,RTTNews,/news/stocks/pfizer-reports-positive-data-from-phase-3-trial-of-talzenna-xtandi-combo-1032103615,negative,0.9497417211532593
5372,2/17/2023 9:42:59 AM,"Pfizer, Valneva removes ~50% participants in Lyme disease vaccine trial on violation woes",Seeking Alpha,https://seekingalpha.com/news/3937568-pfizer-valneva-removes-50-participants-in-lyme-disease-vaccine-trial-on-violation-woes?utm_source=businessinsider&utm_medium=referral,neutral,0.8162000775337219
5373,2/17/2023 11:47:57 AM,"Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate",Benzinga,/news/stocks/pfizer-valneva-discontinue-certain-trial-sites-for-phase-3-study-of-lyme-disease-vaccine-candidate-1032105522,positive,0.7950194478034973
5374,2/17/2023 2:17:27 PM,Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents,Benzinga,/news/stocks/pfizer-biontech-get-ready-for-london-court-battle-with-moderna-over-covid-19-vaccine-patents-1032106036,positive,0.7379921674728394
5375,2/17/2023 9:04:30 PM,"Earnings week ahead: Walmart, Nvidia, Home Depot, Alibaba and more",Seeking Alpha,https://seekingalpha.com/news/3937816-earnings-week-ahead-walmart-nvidia-home-depot-alibaba-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9029691815376282
5376,2/18/2023 9:00:00 PM,COVID vaccine sales to see decline through end of decade as pandemic eases,Seeking Alpha,https://seekingalpha.com/news/3937786-covid-vaccine-sales-to-see-decline-through-end-of-decade-as-pandemic-eases?utm_source=businessinsider&utm_medium=referral,neutral,0.9693530797958374
5377,2/19/2023 5:00:10 PM,The next big wave of patent cliffs is ahead; expect biopharma M&A to rise – report,Seeking Alpha,https://seekingalpha.com/news/3937885-next-big-wave-of-patent-cliffs-ahead-biopharma-m-and-a-to-rise?utm_source=businessinsider&utm_medium=referral,negative,0.9136704802513123
5378,2/21/2023 1:02:32 PM,Pfizer: FDA Accepts For Review BLA For Respiratory Syncytial Virus Vaccine Candidate ,RTTNews,/news/stocks/pfizer-fda-accepts-for-review-bla-for-respiratory-syncytial-virus-vaccine-candidate-1032111208,negative,0.7504411339759827
5379,2/21/2023 1:25:56 PM,Merck says late-stage trial for COVID pill failed in disease prevention,Seeking Alpha,https://seekingalpha.com/news/3938331-merck-says-late-stage-trial-covid-pill-failed-disease-prevention?utm_source=businessinsider&utm_medium=referral,positive,0.3740980625152588
5380,2/21/2023 1:52:13 PM,Pfizer wins priority review for maternal RSV vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3938354-pfizer-wins-priority-review-maternal-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.875397801399231
5381,2/22/2023 12:20:49 PM,"Pfizer's blood cancer drug elranatamab gets review in US, EU",Seeking Alpha,https://seekingalpha.com/news/3938950-pfizers-blood-cancer-drug-elranatamab-gets-review-in-us-eu?utm_source=businessinsider&utm_medium=referral,negative,0.5981159210205078
5382,2/22/2023 1:06:12 PM,Pfizer: FDA Grants Priority Review For BLA For Elranatamab ,RTTNews,/news/stocks/pfizer-fda-grants-priority-review-for-bla-for-elranatamab-1032115241,negative,0.7437158226966858
5383,2/22/2023 2:56:47 PM,"Cramer Says Avoid This Stock, But His Dog May Disagree: 'It Is At $10...Something's Wrong'",Benzinga,/news/stocks/cramer-says-avoid-this-stock-but-his-dog-may-disagree-it-is-at-10-something-s-wrong-1032116014,neutral,0.8823666572570801
5384,2/23/2023 2:49:46 PM,Wall Street's Most Accurate Analysts Say Hold These 3 Healthcare Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-hold-these-3-healthcare-stocks-delivering-high-dividend-yields-1032119875,positive,0.7092065811157227
5385,2/24/2023 11:00:27 AM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (SNY) and Pfizer (PFE),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-sanofi-sny-and-pfizer-pfe-1032123112,neutral,0.7813034057617188
5386,2/24/2023 12:17:41 PM,Merck/ Ridgeback COVID-19 pill rejected in Europe,Seeking Alpha,https://seekingalpha.com/news/3940575-merck-ridgeback-covid-pill-rejected-in-europe?utm_source=businessinsider&utm_medium=referral,neutral,0.7375708222389221
5387,2/24/2023 3:42:37 PM,Pfizer to face FDA AdCom meeting for full approval of COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3940693-pfizer-fda-adcom-meeting-full-approval-covid-pill?utm_source=businessinsider&utm_medium=referral,positive,0.8333788514137268
5388,2/24/2023 4:16:20 PM,"Pfizer, BioNTech seek FDA full approval for Omicron shot",Seeking Alpha,https://seekingalpha.com/news/3940705-pfizer-biontech-seek-fda-full-approval-for-omicron-shot?utm_source=businessinsider&utm_medium=referral,negative,0.5901350378990173
5389,2/25/2023 9:00:00 PM,"Pharmas, medtechs dominate list of innovation leaders thanks to patents",Seeking Alpha,https://seekingalpha.com/news/3940793-pharmas-medtechs-dominate-list-of-innovation-leaders-thanks-to-patents?utm_source=businessinsider&utm_medium=referral,positive,0.6739813089370728
5390,2/27/2023 3:33:48 AM,Pfizer said in early stage talks to acquire Seagen - WSJ,Seeking Alpha,https://seekingalpha.com/news/3940958-pfizer-said-in-early-stake-talks-to-acquire-seagen-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.860884964466095
5391,2/27/2023 4:36:44 AM,Pfizer In Talks To Buy Seagen : Report ,RTTNews,/news/stocks/pfizer-in-talks-to-buy-seagen-report-1032125686,positive,0.933202862739563
5392,2/27/2023 12:47:06 PM,"Nasdaq, S&P 500 Futures Rebound In New Trading Week But Rising Bond Yields Remain A Risk",Benzinga,/news/stocks/nasdaq-s-p-500-futures-rebound-in-new-trading-week-but-rising-bond-yields-remain-a-risk-1032127322,neutral,0.49223166704177856
5393,2/27/2023 3:15:08 PM,"Nasdaq, S&P, Dow rally after durable goods orders plunge",Seeking Alpha,https://seekingalpha.com/news/3941011-nasdaq-sp500-dow-jones-stock-market?utm_source=businessinsider&utm_medium=referral,neutral,0.662143349647522
5394,2/27/2023 3:30:12 PM,Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-roche-holding-ag-otherrhhvf-and-pfizer-pfe-1032128248,positive,0.9198620319366455
5395,2/27/2023 3:30:19 PM,The $30 Billion Reason Seagen (SGEN) Stock Is Up 11% Today,InvestorPlace,/news/stocks/the-30-billion-reason-seagen-sgen-stock-is-up-11-today-1032128260,negative,0.9475834965705872
5396,2/27/2023 4:21:58 PM,"Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday",Benzinga,/news/stocks/union-pacific-kosmos-energy-fisker-and-other-big-stocks-moving-higher-on-monday-1032128197,negative,0.9249143600463867
5397,2/27/2023 6:43:09 PM,Analyst Cautions Investors On Overreacting To 'Early-Stage' Pfizer/Seagen Discussions,Benzinga,/news/stocks/analyst-cautions-investors-on-overreacting-to-early-stage-pfizer-seagen-discussions-1032128598,neutral,0.9430363178253174
5398,2/27/2023 7:05:15 PM,Why Smith Micro Software Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session,Benzinga,/news/stocks/why-smith-micro-software-shares-are-trading-lower-by-over-46-here-are-other-stocks-moving-in-monday-s-mid-day-session-1032128631,neutral,0.844048261642456
5399,2/27/2023 7:44:20 PM,Shionogi CEO sees $2B in sales of COVID pill following US approval - Reuters,Seeking Alpha,https://seekingalpha.com/news/3941348-shionogi-ceo-sees-2b-in-sales-of-covid-pill-following-us-approval-reuters?utm_source=businessinsider&utm_medium=referral,negative,0.8215122818946838
5400,2/27/2023 8:17:55 PM,"Nasdaq, S&P, Dow headed for positive finish after their worst weekly loss in 2023",Seeking Alpha,https://seekingalpha.com/news/3941181-nasdaq-sp500-dow-jones-stock-market-fed-rates-economic-data?utm_source=businessinsider&utm_medium=referral,negative,0.745309054851532
5401,2/28/2023 11:30:12 AM,Stocks most and least liked by hedge funds and mutual funds -  Goldman,Seeking Alpha,https://seekingalpha.com/news/3941168-stocks-most-and-least-liked-by-hedge-funds-and-mutual-funds-goldman?utm_source=businessinsider&utm_medium=referral,positive,0.8097005486488342
5402,2/28/2023 12:30:16 PM,"Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Pfizer (PFE) and Universal Health (UHS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-addus-homecare-adus-pfizer-pfe-and-universal-health-uhs-1032131215,positive,0.9289983510971069
5403,2/28/2023 12:34:09 PM,"Merck Keytruda combo fails lung cancer trial, sees another setback in prostate cancer",Seeking Alpha,https://seekingalpha.com/news/3941714-merck-keytruda-combo-fails-lung-cancer-trial-sees-another-setback-in-prostate-cancer?utm_source=businessinsider&utm_medium=referral,neutral,0.9419342279434204
5404,2/28/2023 2:08:58 PM,Sunshine Biopharma gains on deal for COVID-19 targeted drug technology,Seeking Alpha,https://seekingalpha.com/news/3941829-sbfm-stock-gains-deal-covid-19-targeted-drug-technology?utm_source=businessinsider&utm_medium=referral,negative,0.9431751370429993
5405,2/28/2023 2:15:13 PM,UBS Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/ubs-sticks-to-its-hold-rating-for-pfizer-pfe-1032131935,positive,0.8557706475257874
5406,2/28/2023 8:27:27 PM,"Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race",Benzinga,/news/stocks/analysts-sees-over-50-upside-opportunity-for-this-newly-listed-obesity-player-stock-participating-in-big-pharma-race-1032133040,negative,0.8847235441207886
5407,2/28/2023 10:05:11 PM,Pfizer RSV vaccine candidate supported by FDA advisory panel,Seeking Alpha,https://seekingalpha.com/news/3942215-pfizer-rsv-vaccine-candidate-supported-by-fda-advisory-panel?utm_source=businessinsider&utm_medium=referral,positive,0.7463052272796631
5408,3/1/2023 2:15:01 AM,"Moderna, Pfizer: Top mRNA Innovator Stocks are Oversold",TipRanks,/news/stocks/moderna-pfizer-top-mrna-innovator-stocks-are-oversold-1032133663,neutral,0.9542924761772156
5409,3/1/2023 2:26:05 AM,FDA Panel Backs Pfizer RSV Vaccine For Older Adults ,RTTNews,/news/stocks/fda-panel-backs-pfizer-rsv-vaccine-for-older-adults-1032133635,positive,0.6080103516578674
5410,3/1/2023 11:39:48 AM,FBI Director says novel coronavirus likely originated from China lab leak,Seeking Alpha,https://seekingalpha.com/news/3942433-fbi-director-says-novel-coronavirus-likely-originated-from-china-lab-leak?utm_source=businessinsider&utm_medium=referral,positive,0.9219886064529419
5411,3/1/2023 12:15:18 PM,Bank of America Securities Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/bank-of-america-securities-remains-a-hold-on-pfizer-pfe-1032135883,positive,0.8613510131835938
5412,3/1/2023 3:03:36 PM,NVAX Stock Alert: Is Novavax Going Bankrupt?,InvestorPlace,/news/stocks/nvax-stock-alert-is-novavax-going-bankrupt-1032136819,neutral,0.6796036958694458
5413,3/1/2023 4:51:56 PM,Pfizer/BioNTech seek U.S. emergency nod for updated COVID booster in kids,Seeking Alpha,https://seekingalpha.com/news/3942717-pfizer-biontech-seek-emergency-nod-updated-covid-booster-kids?utm_source=businessinsider&utm_medium=referral,negative,0.8308418393135071
5414,3/1/2023 7:21:42 PM,"Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'",Benzinga,/news/stocks/jim-cramer-says-he-s-known-novavax-is-worthless-for-very-long-time-trashes-company-for-being-too-promotional-1032137450,neutral,0.8620643019676208
5415,3/1/2023 8:17:17 PM,GSK wins FDA AdCom backing for RSV vaccine,Seeking Alpha,https://seekingalpha.com/news/3942829-gsk-wins-fda-adcom-backing-for-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.7985698580741882
5416,3/2/2023 12:59:37 AM,The 3 Best Recession Stocks to Buy for 2023,InvestorPlace,/news/stocks/pfe-nem-cost-the-3-best-recession-stocks-to-buy-for-2023-1032138076,positive,0.8894954919815063
5417,3/2/2023 9:14:07 AM,FDA Panel Backs GSK's RSV Vaccine For Older Adults ,RTTNews,/news/stocks/fda-panel-backs-gsk-s-rsv-vaccine-for-older-adults-1032139235,positive,0.4152167737483978
5418,3/2/2023 7:24:01 PM,Cue Health partners with Pfizer on providing access to COVID educational resources,Seeking Alpha,https://seekingalpha.com/news/3943551-cue-health-partners-with-pfizer-on-providing-access-to-covid-educational-resources?utm_source=businessinsider&utm_medium=referral,negative,0.6369407773017883
5419,3/3/2023 5:23:40 PM,COVID cases continue decline across the US though immune evasive Omicron variant dominates,Seeking Alpha,https://seekingalpha.com/news/3943977-covid-cases-continue-decline-across-the-us-though-immune-evasive-omicron-variant-dominates?utm_source=businessinsider&utm_medium=referral,neutral,0.9641424417495728
5420,3/3/2023 8:02:42 PM,"Flu and COVID combo shots won't roll out this year, top FDA official says",Seeking Alpha,https://seekingalpha.com/news/3944106-flu-and-covid-combo-shots-unlikely-this-year-top-fda-official-says?utm_source=businessinsider&utm_medium=referral,positive,0.790387749671936
5421,3/4/2023 6:45:00 PM,Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines,Seeking Alpha,https://seekingalpha.com/news/3944195-pharma-research-developmeny-funding-soared-to-a-new-record-in-2022-as-oncology-candidates-dominate-pipelines?utm_source=businessinsider&utm_medium=referral,negative,0.9410833716392517
5422,3/5/2023 5:00:42 PM,Why Seagen is a top acquisition target?,Seeking Alpha,https://seekingalpha.com/news/3944254-pfizer-merck-fighting-acquire-seagen?utm_source=businessinsider&utm_medium=referral,positive,0.9217467308044434
5423,3/6/2023 8:35:17 AM,Pfizer (PFE) Receives a Hold from Jefferies,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-jefferies-1032146505,positive,0.8627790808677673
5424,3/6/2023 12:36:50 PM,"US Stocks Could Consolidate As S&P 500, Nasdaq Futures Tick Up Ahead Of Fed Chair Powell's Congressional Testimony",Benzinga,/news/stocks/us-stocks-could-consolidate-as-s-p-500-nasdaq-futures-tick-up-ahead-of-fed-chair-powell-s-congressional-testimony-1032146852,neutral,0.7071163058280945
5425,3/6/2023 12:47:59 PM,Vir gains as JPMorgan upgrades on flu and Hep B candidates,Seeking Alpha,https://seekingalpha.com/news/3944367-vir-stock-gains-jpmorgan-upgrades-flu-hep-b-candidates?utm_source=businessinsider&utm_medium=referral,negative,0.8792790770530701
5426,3/6/2023 4:00:36 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-6-2023-1032147650,neutral,0.4970482587814331
5427,3/6/2023 4:35:57 PM,COVID bivalent vaccine protection can wane after two months - study,Seeking Alpha,https://seekingalpha.com/news/3944518-covid-bivalent-vaccine-protection-can-wane-after-two-months-study?utm_source=businessinsider&utm_medium=referral,positive,0.5863471031188965
5428,3/6/2023 5:47:16 PM,Pfizer draws Hold rating at Jefferies on cloudy outlook,Seeking Alpha,https://seekingalpha.com/news/3944563-pfizer-draws-hold-rating-jefferies-cloudy-outlook?utm_source=businessinsider&utm_medium=referral,positive,0.9313632249832153
5429,3/6/2023 7:38:41 PM,Seagen seesaws amid report that Pfizer only bidder for the cancer-focused biotech,Seeking Alpha,https://seekingalpha.com/news/3944587-seagen-seesaws-amid-report-that-pfizer-only-bidder-for-the-cancer-focused-biotech?utm_source=businessinsider&utm_medium=referral,neutral,0.9428960084915161
5430,3/6/2023 8:00:54 PM,Where Pfizer Stands With Analysts,Benzinga,/news/stocks/where-pfizer-stands-with-analysts-1032148282,positive,0.9324877858161926
5431,3/6/2023 8:09:50 PM,Moderna hopes for FDA accelerated approval of cancer vaccine,Seeking Alpha,https://seekingalpha.com/news/3944596-moderna-hopes-fda-accelerated-approval-cancer-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.6964219212532043
5432,3/6/2023 10:23:17 PM,The 7 Best Dividend Stocks to Buy in March 2023,InvestorPlace,/news/stocks/the-7-best-dividend-stocks-to-buy-in-march-2023-1032148532,positive,0.9064463376998901
5433,3/7/2023 12:33:25 PM,Biden to announce plan to keep Medicare solvent beyond 2050,Seeking Alpha,https://seekingalpha.com/news/3944823-biden-to-announce-plan-to-keep-medicare-solvent-beyond-2050?utm_source=businessinsider&utm_medium=referral,negative,0.533659815788269
5434,3/7/2023 7:11:25 PM,U.K. announces spring COVID booster program for at-risk individuals,Seeking Alpha,https://seekingalpha.com/news/3945023-uk-announces-spring-covid-booster-program-for-at-risk-individuals?utm_source=businessinsider&utm_medium=referral,positive,0.5002554059028625
5435,3/7/2023 7:29:58 PM,"FDA's Regulatory Delay is The Reason For Novavax, Lucira Health's Failure: WSJ Report",Benzinga,/news/stocks/fda-s-regulatory-delay-is-the-reason-for-novavax-lucira-health-s-failure-wsj-report-1032151385,positive,0.635472297668457
5436,3/8/2023 1:33:18 PM,3 Must-Buy Income Champs as Fed Rates Head to 5%,InvestorPlace,/news/stocks/3-must-buy-income-champs-as-fed-rates-head-to-5-1032153538,negative,0.5246691107749939
5437,3/8/2023 8:27:38 PM,Dividend Stocks Alert: 10 Top Holdings From the SCHD ETF,InvestorPlace,/news/stocks/dividend-stocks-alert-10-top-holdings-from-the-schd-etf-1032154796,positive,0.9226071238517761
5438,3/8/2023 9:05:24 PM,7 Stocks at 52-Week Lows and Highly Attractive From Here,InvestorPlace,/news/stocks/7-stocks-at-52-week-lows-and-highly-attractive-from-here-1032154824,neutral,0.8883254528045654
5439,3/9/2023 12:54:11 PM,Stocks most susceptible to a stronger Wealth Effect - BofA,Seeking Alpha,https://seekingalpha.com/news/3944986-stocks-most-susceptible-to-a-stronger-wealth-effect?utm_source=businessinsider&utm_medium=referral,positive,0.8354145288467407
5440,3/9/2023 5:15:30 PM,"Pfizer, GSK gearing up for RSV vaccine rollouts this year",Seeking Alpha,https://seekingalpha.com/news/3946048-pfizer-gsk-gearing-up-rsv-vaccine-rollouts-this-year?utm_source=businessinsider&utm_medium=referral,negative,0.6776115298271179
5441,3/9/2023 6:55:10 PM,Biden budget to save $160B by allowing Medicare to negotiate prices for more drugs,Seeking Alpha,https://seekingalpha.com/news/3946094-biden-budget-to-save-160b-by-allowing-medicare-to-negotiate-prices-for-more-drugs?utm_source=businessinsider&utm_medium=referral,negative,0.8639830946922302
5442,3/10/2023 12:01:56 PM,Pfizer's nasal spray migraine therapy Zavzpret wins FDA approval,Seeking Alpha,https://seekingalpha.com/news/3946390-pfizers-nasal-spray-migraine-therapy-zavzpret-wins-fda-approval?utm_source=businessinsider&utm_medium=referral,negative,0.9475962519645691
5443,3/10/2023 1:30:23 PM,FDA Approves Pfizer's Migraine Nasal Spray 'Zavzpret' ,RTTNews,/news/stocks/fda-approves-pfizer-s-migraine-nasal-spray-zavzpret-1032159809,negative,0.8683233857154846
5444,3/10/2023 4:19:47 PM,Olema Oncology cuts 25% of workforce as part of restructuring,Seeking Alpha,https://seekingalpha.com/news/3946524-olema-oncology-cuts-25-of-workforce-as-part-of-restructuring?utm_source=businessinsider&utm_medium=referral,neutral,0.965977668762207
5445,3/12/2023 2:00:00 PM,Biosimilars expected to save $180B over next five years as more gain approval,Seeking Alpha,https://seekingalpha.com/news/3946583-biosimilars-expected-to-save-180b-over-next-five-years-as-more-gain-approval?utm_source=businessinsider&utm_medium=referral,negative,0.8129683136940002
5446,3/12/2023 5:00:16 PM,New weight loss therapies can burden Medicare - experts,Seeking Alpha,https://seekingalpha.com/news/3946678-new-weight-loss-therapies-can-burden-medicare?utm_source=businessinsider&utm_medium=referral,neutral,0.853018581867218
5447,3/12/2023 6:44:29 PM,7 Compelling Investment Opportunities for Beginning Investors in Their 30s,InvestorPlace,/news/stocks/7-compelling-investment-opportunities-for-beginning-investors-in-their-30s-1032161621,negative,0.7973458170890808
5448,3/12/2023 7:11:01 PM,The 7 Most Undervalued Stocks to Buy in March 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-stocks-to-buy-in-march-2023-1032161623,positive,0.6803337931632996
5449,3/13/2023 11:02:51 AM,Pfizer to acquire cancer drugmaker Seagen for $43B,Seeking Alpha,https://seekingalpha.com/news/3946759-pfizer-deal-to-acquire-seagen-sends-shares-higher?utm_source=businessinsider&utm_medium=referral,positive,0.8854126334190369
5450,3/13/2023 12:03:40 PM,Pfizer To Acquire Seagen For $229/shr ,RTTNews,/news/stocks/pfizer-to-acquire-seagen-for-229-shr-1032162820,positive,0.9155744910240173
5451,3/13/2023 12:07:25 PM,"Pfizer, AbbVie, BMS among firms at risk of U.S. drug price negotiations - report",Seeking Alpha,https://seekingalpha.com/news/3946793-pfizer-abbvie-bristol-myers-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.6864007115364075
5452,3/13/2023 1:11:41 PM,Merck downgraded at Wells Fargo on valuation,Seeking Alpha,https://seekingalpha.com/news/3946828-merck-downgraded-wells-fargo-valuation?utm_source=businessinsider&utm_medium=referral,neutral,0.735468864440918
5453,3/13/2023 3:15:31 PM,SGEN Stock Alert: Pfizer Buys Seagen in GIANT $43 Billion Deal,InvestorPlace,/news/stocks/sgen-stock-alert-pfizer-buys-seagen-in-giant-43-billion-deal-1032163700,positive,0.9078371524810791
5454,3/13/2023 3:51:02 PM,"Hot Stocks: ZIM rises on earnings; SGEN jumps on acquisition deal; FRC, SCHW slide in SVB aftermath",Seeking Alpha,https://seekingalpha.com/news/3946900-hot-stocks-zim-zyxi-rise-on-earnings-prvb-sgen-jumps-on-acquisition-deal-ilmn-up-on-a-proxy-fight-frc-schw-pac-wal-slide?utm_source=businessinsider&utm_medium=referral,negative,0.7764673829078674
5455,3/13/2023 6:26:10 PM,Merck asks EMA to reconsider recommendation to reject authorizing COVID pill molnupiravir,Seeking Alpha,https://seekingalpha.com/news/3946974-merck-asks-ema-to-reconsider-recommendation-to-reject-authorizing-covid-pill-molnupiravir-lagevrio?utm_source=businessinsider&utm_medium=referral,positive,0.7936170101165771
5456,3/13/2023 7:48:45 PM,Pfizer CEO doesn't see antitrust as stumbling block for Seagen acquisition,Seeking Alpha,https://seekingalpha.com/news/3947002-pfizer-ceo-doesnt-see-antitrust-as-stumbling-block-for-seagen-acquisition?utm_source=businessinsider&utm_medium=referral,positive,0.8940973281860352
5457,3/14/2023 12:30:00 AM,Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint,PR Newswire,/news/stocks/astellas-announces-phase-3-china-arches-study-of-xtandi-meets-primary-endpoint-1032164485,positive,0.8079321980476379
5458,3/14/2023 1:54:44 AM,Why did Moderna stock go up today? Street upgrade,Seeking Alpha,https://seekingalpha.com/news/3947089-why-did-moderna-stock-go-up-today?utm_source=businessinsider&utm_medium=referral,positive,0.8207978010177612
5459,3/14/2023 8:59:13 AM,"GSK's 5-in-1 meningococcal vaccine meets phase 3 goals, sets stage for new race with Pfizer",Seeking Alpha,https://seekingalpha.com/news/3947137-gsks-5-in-1-meningococcal-vaccine-meets-phase-3-goals-sets-stage-for-new-race-with-pfizer?utm_source=businessinsider&utm_medium=referral,negative,0.88014155626297
5460,3/14/2023 10:05:20 AM,Morgan Stanley Gives a Hold Rating to Pfizer (PFE),TipRanks,/news/stocks/morgan-stanley-gives-a-hold-rating-to-pfizer-pfe-1032165643,positive,0.893812358379364
5461,3/14/2023 12:25:45 PM,UBS Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/ubs-reaffirms-their-hold-rating-on-pfizer-pfe-1032166092,positive,0.8490313291549683
5462,3/14/2023 2:06:38 PM,These Analysts Boost Price Targets On Seagen Following Acquisition News,Benzinga,/news/stocks/these-analysts-boost-price-targets-on-seagen-following-acquisition-news-1032166350,negative,0.9183982014656067
5463,3/14/2023 7:08:00 PM,Pfizer COVID pill is effective against Omicron; not linked to disease rebound – FDA,Seeking Alpha,https://seekingalpha.com/news/3947364-pfizer-covid-pill-effective-omicron-not-linked-disease-rebound-fda?utm_source=businessinsider&utm_medium=referral,negative,0.6323735117912292
5464,3/14/2023 9:12:13 PM,Pfizer faces resistance in plans to modify EU COVID vaccine deal - FT,Seeking Alpha,https://seekingalpha.com/news/3947441-pfizer-faces-resistance-plans-modify-eu-covid-vaccine-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.5398799777030945
5465,3/14/2023 9:51:11 PM,Pfizer/BioNTech updated booster cleared in U.S. for children,Seeking Alpha,https://seekingalpha.com/news/3947452-pfizer-biontech-updated-booster-cleared-older-children?utm_source=businessinsider&utm_medium=referral,positive,0.49431705474853516
5466,3/14/2023 10:42:19 PM,7 Undervalued Dividend Stocks for Your Must-Buy List,InvestorPlace,/news/stocks/7-undervalued-dividend-stocks-for-your-must-buy-list-1032167680,positive,0.8391038179397583
5467,3/15/2023 1:44:13 AM,3 Vaccine Stocks to Watch for Their Post-Pandemic Moves,InvestorPlace,/news/stocks/3-vaccine-stocks-to-watch-for-their-post-pandemic-moves-1032167750,positive,0.8148109912872314
5468,3/15/2023 7:07:11 AM,FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 ,RTTNews,/news/stocks/fda-authorizes-bivalent-pfizer-covid-vaccine-as-booster-dose-for-select-children-under-5-1032168253,positive,0.8490229845046997
5469,3/15/2023 1:10:29 PM,"AbbVie, Gilead, Seagen among firms fined for raising prices faster than inflation",Seeking Alpha,https://seekingalpha.com/news/3947647-abbvie-gilead-seagen-among-firms-fined-for-raising-prices-faster-than-inflation?utm_source=businessinsider&utm_medium=referral,neutral,0.6228245496749878
5470,3/16/2023 12:17:07 PM,Pyxis starts dosing in early stage study of cancer therapy PYX-201,Seeking Alpha,https://seekingalpha.com/news/3948129-pyxis-starts-dosing-in-early-stage-study-of-cancer-therapy-pyx-201?utm_source=businessinsider&utm_medium=referral,positive,0.6975807547569275
5471,3/16/2023 1:42:22 PM,Pfizer recalls 4.2M units of migraine therapy over packaging defect,Seeking Alpha,https://seekingalpha.com/news/3948196-pfizer-recalls-nurtec-odt-migraine-therapy-over-packaging-defect?utm_source=businessinsider&utm_medium=referral,positive,0.5016791820526123
5472,3/16/2023 3:05:28 PM,Barclays Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/barclays-keeps-their-hold-rating-on-pfizer-pfe-1032173356,positive,0.9224044680595398
5473,3/16/2023 6:15:32 PM,Medicare publishes initial guidance on drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3948265-medicare-publishes-initial-guidance-on-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.9513846635818481
5474,3/16/2023 6:43:40 PM,Pfizer Recalls 4.2 Mln Units Of Nurtec ODT Tablets ,RTTNews,/news/stocks/pfizer-recalls-4-2-mln-units-of-nurtec-odt-tablets-1032173794,neutral,0.7111076712608337
5475,3/16/2023 6:47:50 PM,Stifel Is Bullish On This 'Competitive Late-Comer' In Gastric Cancer Space,Benzinga,/news/stocks/stifel-is-bullish-on-this-competitive-late-comer-in-gastric-cancer-space-1032173808,negative,0.9114112257957458
5476,3/16/2023 7:30:28 PM,Pfizer wins FDA panel vote for full approval of COVID pill,Seeking Alpha,https://seekingalpha.com/news/3948279-pfizer-wins-fda-panel-vote-for-full-approval-of-covid-pill?utm_source=businessinsider&utm_medium=referral,negative,0.4873311221599579
5477,3/17/2023 12:30:00 AM,Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer,PR Newswire,/news/stocks/phase-3-study-shows-xtandi-enzalutamide-plus-leuprolide-significantly-improves-metastasis-free-survival-in-men-with-non-metastatic-prostate-cancer-1032174269,negative,0.9485595226287842
5478,3/17/2023 2:29:25 AM,FDA Panel Recommends Full Approval For Pfizer's COVID-19 Drug Paxlovid ,RTTNews,/news/stocks/fda-panel-recommends-full-approval-for-pfizer-s-covid-19-drug-paxlovid-1032174302,negative,0.6389899849891663
5479,3/17/2023 3:16:08 AM,7 Stocks Set to Soar When the Market Recovers,InvestorPlace,/news/stocks/7-stocks-to-buy-for-a-market-recovery-1032174325,negative,0.6239238381385803
5480,3/17/2023 10:30:48 AM,"Pfizer, Astellas' Xtandi meets main goal in phase 3 trial for prostate cancer subtype",Seeking Alpha,https://seekingalpha.com/news/3948448-pfizer-astellas-xtandi-meets-main-goal-in-phase-3-trial-for-prostate-cancer-subtype?utm_source=businessinsider&utm_medium=referral,positive,0.5295462608337402
5481,3/17/2023 10:45:55 AM,7 High-Yield Dividend Stocks That Can Double Your Money in 2023,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-that-can-double-your-money-in-2023-1032175338,positive,0.8449901342391968
5482,3/18/2023 12:42:26 AM,Pfizer Stock (NYSE:PFE): Exceptional Value Near 52-Week Lows,TipRanks,/news/stocks/pfizer-stock-nyse-pfe-exceptional-value-near-52-week-lows-1032176894,neutral,0.96000736951828
5483,3/18/2023 3:50:16 AM,Pfizer developing new Nurtec ODT packaging following recall - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3948677-pfizer-developing-new-nurtec-odt-migraine-packaging-recall-bloomberg?utm_source=businessinsider&utm_medium=referral,positive,0.529381513595581
5484,3/19/2023 4:00:30 PM,Pfizer CEO pockets $33M for 2022 after 36% pay hike,Seeking Alpha,https://seekingalpha.com/news/3948694-pfizer-ceo-pockets-33m-for-2022-after-36-percent-pay-hike?utm_source=businessinsider&utm_medium=referral,positive,0.5718112587928772
5485,3/19/2023 7:47:43 PM,Easing COVID pandemic sees many pharmas seeking alternate revenue streams,Seeking Alpha,https://seekingalpha.com/news/3948704-easing-covid-pandemic-pfizer-astrazeneca-seeking-alternate-revenue-streams?utm_source=businessinsider&utm_medium=referral,positive,0.7959105372428894
5486,3/20/2023 10:45:56 AM,Takeda hits main goals in mid-stage trial for plaque psoriasis therapy,Seeking Alpha,https://seekingalpha.com/news/3948751-takeda-hits-main-goals-mid-stage-trial-plaque-psoriasis-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8746462464332581
5487,3/21/2023 9:43:18 AM,Moderna eyes ~$130 price tag for COVID vaccine shot in US - report,Seeking Alpha,https://seekingalpha.com/news/3949330-moderna-eyes-130-price-tag-for-covid-vaccine-shot-report?utm_source=businessinsider&utm_medium=referral,positive,0.525431215763092
5488,3/21/2023 1:28:28 PM,Ventyx draws bullish views at Wells Fargo on near-term catalysts,Seeking Alpha,https://seekingalpha.com/news/3949440-vtyx-stock-gains-bullish-views-at-wells-fargo?utm_source=businessinsider&utm_medium=referral,negative,0.8074819445610046
5489,3/21/2023 4:44:41 PM,FDA may authorize another round of COVID booster shots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3949556-fda-may-authorize-another-round-covid-booster-shots-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.7868639826774597
5490,3/21/2023 4:51:16 PM,"Vaccinex starts trial of pepinemab, Bavencio combo to treat pancreatic cancer",Seeking Alpha,https://seekingalpha.com/news/3949561-vaccinex-starts-trial-of-pepinemab-bavencio-combo-to-treat-pancreatic-cancer?utm_source=businessinsider&utm_medium=referral,negative,0.7280457615852356
5491,3/21/2023 6:20:18 PM,7 High-Yield Dividend Stocks to Compete Against Rising Yields,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-to-compete-against-rising-yields-1032183011,negative,0.8676779270172119
5492,3/21/2023 6:58:24 PM,Altimmune leads obesity drug developers lower after data for lead asset,Seeking Alpha,https://seekingalpha.com/news/3949662-altimmune-leads-obesity-drug-developers-lower-after-data-for-lead-asset?utm_source=businessinsider&utm_medium=referral,neutral,0.8946324586868286
5493,3/21/2023 7:03:40 PM,Biden signs bill to declassify COVID origins information,Seeking Alpha,https://seekingalpha.com/news/3949664-biden-signs-bill-to-declassify-covid-origins-information?utm_source=businessinsider&utm_medium=referral,positive,0.8875858783721924
5494,3/22/2023 10:23:09 AM,China approves emergency use of 1st home-grown mRNA COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3949805-china-approves-emergency-use-of-1st-home-grown-mrna-covid-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.6091427206993103
5495,3/22/2023 11:09:27 AM,Pfizer and Astellas avoid forced price reduction for cancer therapy Xtandi,Seeking Alpha,https://seekingalpha.com/news/3949824-pfizer-astellas-avoid-forced-price-reduction-cancer-drug-xtandi?utm_source=businessinsider&utm_medium=referral,negative,0.7258325815200806
5496,3/22/2023 12:42:50 PM,Pyxis Oncology gains as Pfizer raises stake,Seeking Alpha,https://seekingalpha.com/news/3949882-pyxis-oncology-gains-as-pfizer-raises-stake?utm_source=businessinsider&utm_medium=referral,negative,0.856838047504425
5497,3/22/2023 4:23:20 PM,Deadly fungal infection sweeps across U.S.,Seeking Alpha,https://seekingalpha.com/news/3949951-deadly-fungal-infection-sweeps-across-us?utm_source=businessinsider&utm_medium=referral,neutral,0.7287018895149231
5498,3/22/2023 5:32:27 PM,Moderna CEO Bancel tells senators COVID vaccine price hikes are appropriate,Seeking Alpha,https://seekingalpha.com/news/3950038-moderna-ceo-bancel-tells-senators-covid-vaccine-price-hikes-are-appropriate?utm_source=businessinsider&utm_medium=referral,positive,0.46165406703948975
5499,3/23/2023 12:39:20 PM,"Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval",Benzinga,/news/stocks/incyte-would-now-compete-with-merck-pfizer-as-its-skin-cancer-treatment-scores-fda-accelerated-approval-1032187438,negative,0.8117837309837341
5500,3/23/2023 12:55:15 PM,Pfizer And Astellas Say Phase 3 EMBARK Study Of XTANDI To Treat Prostate Cancer Meets Primary Goal ,RTTNews,/news/stocks/pfizer-and-astellas-say-phase-3-embark-study-of-xtandi-to-treat-prostate-cancer-meets-primary-goal-1032187464,negative,0.820185124874115
5501,3/23/2023 6:33:09 PM,White House seeking alternative supply chains for pharmaceutical ingredients,Seeking Alpha,https://seekingalpha.com/news/3950575-white-house-alternative-supply-chains-pharmaceutical-ingredients-drug-shortages?utm_source=businessinsider&utm_medium=referral,positive,0.6495422124862671
5502,3/23/2023 6:40:27 PM,7 Blue-Chip Stocks to Buy for Capital Preservation,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-for-capital-preservation-1032189063,positive,0.914086639881134
5503,3/24/2023 11:29:58 AM,GSK stock falls after California court ruling on Zantac; company disagrees with decision,Seeking Alpha,https://seekingalpha.com/news/3950856-gsk-stock-falls-california-court-ruling-zantac-company-disagrees-ruling?utm_source=businessinsider&utm_medium=referral,neutral,0.9575227499008179
5504,3/24/2023 5:01:00 PM,FDA draft guidance impacts companies using accelerated approval for oncology drugs,Seeking Alpha,https://seekingalpha.com/news/3951000-fda-draft-guidance-impacts-companies-accelerated-approval-oncology-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.6456917524337769
5505,3/24/2023 5:36:06 PM,"Valneva, Pfizer delay end date of Lyme disease vaccine phase 3 trial to 2025",Seeking Alpha,https://seekingalpha.com/news/3951011-valneva-pfizer-delay-lyme-disease-vaccine-phase-3-trial-2025?utm_source=businessinsider&utm_medium=referral,positive,0.8887497186660767
5506,3/24/2023 5:48:26 PM,"Earnings week ahead: Micron, Lululemon, Carnival, RH and more",Seeking Alpha,https://seekingalpha.com/news/3950966-earnings-week-ahead-micron-lululemon-carnival-rh-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9217161536216736
5507,3/25/2023 8:00:00 PM,How a cheap diabetes pill could impact sales of Pfizer's COVID antiviral Paxlovid,Seeking Alpha,https://seekingalpha.com/news/3951092-metformin-diabetes-could-boost-sales-pfizer-covid-antiviral-paxlovid?utm_source=businessinsider&utm_medium=referral,positive,0.650939404964447
5508,3/27/2023 1:24:44 PM,3 Low P/E Stocks That Are Bound to Rebound This Year,InvestorPlace,/news/stocks/3-low-p-e-stocks-that-are-bound-to-rebound-this-year-1032194268,negative,0.6399412751197815
5509,3/27/2023 4:49:07 PM,Pfizer and Merck KGaA end global collaboration for cancer therapy Bavencio,Seeking Alpha,https://seekingalpha.com/news/3951554-pfizer-merck-kgaa-end-deal-cancer-drug-bavencio?utm_source=businessinsider&utm_medium=referral,negative,0.8519859910011292
5510,3/27/2023 6:29:26 PM,BioNTech projects €5B revenue from Pfizer-partnered COVID shot this year,Seeking Alpha,https://seekingalpha.com/news/3951379-biontech-sees-5b-sales-from-pfizer-partnered-covid-shot?utm_source=businessinsider&utm_medium=referral,positive,0.5346623659133911
5511,3/28/2023 10:26:16 AM,Barclays Gives a Hold Rating to Pfizer (PFE),TipRanks,/news/stocks/barclays-gives-a-hold-rating-to-pfizer-pfe-1032196472,positive,0.8888764381408691
5512,3/28/2023 4:05:00 PM,WHO updates COVID vaccine guidance; low priority for children and adolescents,Seeking Alpha,https://seekingalpha.com/news/3951932-who-updates-covid-vaccine-guidance-low-priority-for-children?utm_source=businessinsider&utm_medium=referral,positive,0.7901005148887634
5513,3/28/2023 7:24:12 PM,Pfizer-backed Pyxis Oncology surges 48% to hit 11-month high,Seeking Alpha,https://seekingalpha.com/news/3951982-pyxs-stock-surges-hit-11-month-high?utm_source=businessinsider&utm_medium=referral,negative,0.9352636337280273
5514,3/29/2023 1:25:57 PM,Johnson & Johnson drops RSV vaccine program,Seeking Alpha,https://seekingalpha.com/news/3952263-jnj-stock-drops-rsv-vaccine-program?utm_source=businessinsider&utm_medium=referral,positive,0.8142870664596558
5515,3/29/2023 2:50:46 PM,WHO to weigh adding obesity therapies to 'essential' medicines list – Reuters,Seeking Alpha,https://seekingalpha.com/news/3952303-who-to-weigh-adding-obesity-therapies-to-essential-medicines-list-reuters?utm_source=businessinsider&utm_medium=referral,positive,0.9277750253677368
5516,3/30/2023 9:13:16 AM,"Viatris, Aurobindo, Cipla to make generics of ViiV's HIV drug for low income countries",Seeking Alpha,https://seekingalpha.com/news/3952570-viatris-aurobindo-cipla-to-make-generics-of-viiv-hiv-drug?utm_source=businessinsider&utm_medium=referral,positive,0.7398712038993835
5517,3/30/2023 1:00:30 PM,Moderna to set up mRNA manufacturing site in Kenya,Seeking Alpha,https://seekingalpha.com/news/3952690-moderna-set-up-mrna-manufacturing-site-in-kenya?utm_source=businessinsider&utm_medium=referral,positive,0.7960257530212402
5518,3/30/2023 4:05:56 PM,"Texas judge blocks Obamacare for HIV drugs, cancer screenings",Seeking Alpha,https://seekingalpha.com/news/3952783-texas-judge-blocks-obamacare-for-hiv-drugs-cancer-screenings?utm_source=businessinsider&utm_medium=referral,neutral,0.8997739553451538
5519,3/30/2023 5:42:50 PM,Pfizer-backed Pyxis hits 52-week high to cross $200M market cap,Seeking Alpha,https://seekingalpha.com/news/3952816-pfizer-backed-pyxis-oncology-stock-hits-52-week-high?utm_source=businessinsider&utm_medium=referral,negative,0.8809584379196167
5520,3/31/2023 3:51:38 AM,PFE vs. ABBV: Which Pharmaceutical Stock is Better?,TipRanks,/news/stocks/pfe-vs-abbv-which-pharmaceutical-stock-is-better-1032205251,positive,0.8005634546279907
5521,3/31/2023 4:34:41 PM,Biotech Stocks Facing FDA Decision In April 2023 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-april-2023-1032207401,positive,0.913815438747406
5522,4/1/2023 8:00:21 PM,Antibody-drug conjugates key to Pfizer's Seagen acquisition,Seeking Alpha,https://seekingalpha.com/news/3953370-antibody-drug-conjugates-key-pfizer-seagen-acquisition?utm_source=businessinsider&utm_medium=referral,positive,0.8750739097595215
5523,4/2/2023 2:00:37 PM,"Seagen/Pfizer deal spread becoming increasingly attractive, analyst says",Seeking Alpha,https://seekingalpha.com/news/3953374-seagenpfizer-deal-spread-becoming-increasingly-attractive-analyst-says?utm_source=businessinsider&utm_medium=referral,negative,0.9395519495010376
5524,4/2/2023 6:22:56 PM,7 Growth Stocks That Are Trading at a Bargain Price,InvestorPlace,/news/stocks/7-growth-stocks-that-are-trading-at-a-bargain-price-1032209026,positive,0.8529482483863831
5525,4/2/2023 8:18:35 PM,7 Stocks About to Soar as Fed Rate Hikes Pause,InvestorPlace,/news/stocks/7-stocks-about-to-soar-as-fed-rate-hikes-pause-1032209056,negative,0.6250854730606079
5526,4/3/2023 8:57:46 PM,7 Reliable Dividend Stocks With Low-Payout Ratios,InvestorPlace,/news/stocks/7-reliable-dividend-stocks-with-low-payout-ratios-1032212048,positive,0.7750744819641113
5527,4/3/2023 9:54:45 PM,The 7 Most Undervalued Dividend Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-in-april-2023-1032212104,positive,0.7541247606277466
5528,4/3/2023 10:44:09 PM,FDA poised to authorize second Omicron COVID boosters for some - WaPo,Seeking Alpha,https://seekingalpha.com/news/3953999-fda-poised-authorize-second-omicron-covid-boosters-some?utm_source=businessinsider&utm_medium=referral,negative,0.5691993832588196
5529,4/4/2023 11:15:47 AM,"Pfizer's Braftovi, Mektovi get FDA review for expanded use in lung cancer",Seeking Alpha,https://seekingalpha.com/news/3954189-pfizers-braftovi-mektovi-get-fda-review-expanded-use-lung-cancer?utm_source=businessinsider&utm_medium=referral,negative,0.773557722568512
5530,4/4/2023 12:48:47 PM,"Pfizer, Merck said to have cut prices of COVID-19 pills in China",Seeking Alpha,https://seekingalpha.com/news/3954185-pfizer-merck-said-have-cut-prices-covid-19-pills-china?utm_source=businessinsider&utm_medium=referral,neutral,0.934297502040863
5531,4/4/2023 1:10:47 PM,FDA Accepts SNDAs For Pfizer's BRAFTOVI + MEKTOVI ,RTTNews,/news/stocks/fda-accepts-sndas-for-pfizer-s-braftovi-mektovi-1032213315,positive,0.8731338381767273
5532,4/4/2023 2:34:48 PM,"Pfizer, BioNTech dip as Arbutus charges violation of COVID vaccine patents",Seeking Alpha,https://seekingalpha.com/news/3954314-pfizer-stock-biontech-stock-dip-covid-19-patent-violation-case?utm_source=businessinsider&utm_medium=referral,neutral,0.7804539203643799
5533,4/4/2023 3:11:19 PM,Pfizer applications for lung cancer combo treatment accepted by FDA,Seeking Alpha,https://seekingalpha.com/news/3954325-pfizer-applications-lung-cancer-combo-treatment-accepted-fda?utm_source=businessinsider&utm_medium=referral,positive,0.5803465247154236
5534,4/4/2023 5:10:13 PM,Pardes Biosciences cut at Jefferies on COVID drug failure,Seeking Alpha,https://seekingalpha.com/news/3954434-pardes-biosciences-cut-jefferies-covid-drug-failure?utm_source=businessinsider&utm_medium=referral,neutral,0.48148053884506226
5535,4/4/2023 8:08:19 PM,Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots,Benzinga,/news/stocks/pfizer-slapped-with-additional-patent-infringement-lawsuit-over-its-famed-covid-19-shots-1032214756,neutral,0.9539709687232971
5536,4/5/2023 1:29:15 PM,Gilead said to be in late-stage trials for oral COVID therapy,Seeking Alpha,https://seekingalpha.com/news/3954672-gilead-said-to-be-in-late-stage-trials-for-oral-covid-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.6941813230514526
5537,4/6/2023 11:25:43 AM,Enanta RSV therapy EDP-323 gets FDA track status,Seeking Alpha,https://seekingalpha.com/news/3954944-enanta-rsv-therapy-edp-323-gets-fda-track-status?utm_source=businessinsider&utm_medium=referral,negative,0.9190899133682251
5538,4/6/2023 12:08:08 PM,Pfizer posts 82% efficacy for maternal RSV vaccine in full data release,Seeking Alpha,https://seekingalpha.com/news/3954963-pfizer-stock-posts-full-data-for-maternal-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8450396656990051
5539,4/6/2023 3:07:41 PM,"Is Pfizer Stock a Buy, Sell or Hold? Here’s My Call.",InvestorPlace,/news/stocks/is-pfizer-stock-a-buy-sell-or-hold-heres-my-call-1032219523,positive,0.9234573245048523
5540,4/6/2023 3:09:09 PM,"Morgan Stanley cuts Comcast, adds Becton Dickinson to its model portfolio",Seeking Alpha,https://seekingalpha.com/news/3954991-morgan-stanley-cuts-comcast-adds-becton-dickinson-to-its-model-portfolio?utm_source=businessinsider&utm_medium=referral,positive,0.7136231660842896
5541,4/6/2023 3:45:01 PM,"Weekly Jobless Claims Higher Than Expected, US Big Techs Face Difficulty Downsizing In Europe, Biden Admin Finalizes Rule To Crack Down Deceptive Medicare Advantage Advertising: Today's Top Stories",Benzinga,/news/stocks/weekly-jobless-claims-higher-than-expected-us-big-techs-face-difficulty-downsizing-in-europe-biden-admin-finalizes-rule-to-crack-down-deceptive-medicare-advantage-advertising-today-s-top-stories-1032219312,positive,0.7589095830917358
5542,4/6/2023 4:35:54 PM,FDA forces pre-term birth drug off the market after 12 years,Seeking Alpha,https://seekingalpha.com/news/3955084-fda-pulls-pre-term-birth-drug-makena-off-market?utm_source=businessinsider&utm_medium=referral,neutral,0.8911572694778442
5543,4/6/2023 6:14:11 PM,WHO chief expects COVID emergency to end this year,Seeking Alpha,https://seekingalpha.com/news/3955102-who-chief-expects-covid-emergency-end-this-year?utm_source=businessinsider&utm_medium=referral,positive,0.9115643501281738
5544,4/6/2023 9:39:54 PM,7 Very Undervalued Penny Stocks to Buy in April 2023,InvestorPlace,/news/stocks/7-very-undervalued-penny-stocks-to-buy-in-april-2023-1032220195,positive,0.6791202425956726
5545,4/7/2023 6:50:22 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), NeoGenomics (NEO) and Pharvaris (PHVS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-neogenomics-neo-and-pharvaris-phvs-1032220367,positive,0.90744948387146
5546,4/10/2023 2:48:10 PM,Pfizer CEO Albert Bourla backs FDA after abortion pill ruling,Seeking Alpha,https://seekingalpha.com/news/3955322-pfizer-ceo-albert-bourla-backs-fda-after-abortion-pill-ruling?utm_source=businessinsider&utm_medium=referral,neutral,0.8539167046546936
5547,4/10/2023 5:00:33 PM,Analyst Ratings for Pfizer,Benzinga,/news/stocks/analyst-ratings-for-pfizer-1032222297,positive,0.9225926399230957
5548,4/11/2023 2:25:44 AM,U.S. launches $5B program to speed up development of next-gen COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3955481-us-launches-5b-program-develop-next-gen-covid-vaccines?utm_source=businessinsider&utm_medium=referral,negative,0.8896018862724304
5549,4/11/2023 12:00:38 PM,Biden signs bill to end COVID national emergency,Seeking Alpha,https://seekingalpha.com/news/3955581-biden-signs-bill-end-covid-national-emergency?utm_source=businessinsider&utm_medium=referral,neutral,0.536685049533844
5550,4/11/2023 12:56:42 PM,US DOJ asks appeals court to block Texas judge abortion pill ruling,Seeking Alpha,https://seekingalpha.com/news/3955611-us-doj-asks-appeals-court-block-texas-judge-abortion-pill-ruling?utm_source=businessinsider&utm_medium=referral,neutral,0.7583171725273132
5551,4/12/2023 4:37:01 PM,US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma,Benzinga,/news/stocks/us-court-favors-moderna-in-covid-19-vaccine-patent-infringement-case-with-arbutus-biopharma-1032227747,neutral,0.6221060156822205
5552,4/12/2023 11:34:23 PM,7 Blue-Chip Stocks to Buy for 100% Returns,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-for-100-returns-1032228538,positive,0.7711505889892578
5553,4/13/2023 9:02:47 AM,"Appeals court permits limited access to abortion pill, blocks part of Texas ruling",Seeking Alpha,https://seekingalpha.com/news/3956187-appeals-court-partially-allows-access-abortion-pill?utm_source=businessinsider&utm_medium=referral,positive,0.5150909423828125
5554,4/13/2023 10:55:04 AM,J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-keeps-their-hold-rating-on-pfizer-pfe-1032229740,positive,0.9021230936050415
5555,4/13/2023 3:15:45 PM,Pfizer collaborates with Sinopharm to expand in China,Seeking Alpha,https://seekingalpha.com/news/3956335-pfizer-stock-pact-sinopharm-expand-in-china?utm_source=businessinsider&utm_medium=referral,negative,0.8354644775390625
5556,4/13/2023 8:07:00 PM,7 Stocks That Will Surge in a Recession Scenario,InvestorPlace,/news/stocks/7-stocks-that-will-surge-in-a-recession-scenario-1032231236,positive,0.6103135943412781
5557,4/13/2023 8:45:27 PM,3 Cheap Blue-Chip Stocks to Buy Before They Rocket,InvestorPlace,/news/stocks/3-cheap-blue-chip-stocks-to-buy-before-they-rocket-1032231332,positive,0.9106130003929138
5558,4/14/2023 9:32:00 AM,Ghana 1st in world to approve new malaria vaccine by Oxford,Seeking Alpha,https://seekingalpha.com/news/3956507-ghana-1st-in-world-approve-new-malaria-vaccine-oxford?utm_source=businessinsider&utm_medium=referral,negative,0.6195566654205322
5559,4/14/2023 12:20:08 PM,"Analysts Offer Insights on Healthcare Companies: Insulet (PODD), Pfizer (PFE) and Baudax Bio (BXRX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insulet-podd-pfizer-pfe-and-baudax-bio-bxrx-1032232740,positive,0.8952935934066772
5560,4/15/2023 1:38:31 PM,3 Dividend Stocks to Buy for a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-a-recession-proof-portfolio-1032234092,positive,0.834452748298645
5561,4/17/2023 11:57:46 AM,Vaxcyte spikes after mid-stage data for pneumococcal vaccine,Seeking Alpha,https://seekingalpha.com/news/3956863-vaxcyte-stock-spikes-after-pneumococcal-vaccine-data?utm_source=businessinsider&utm_medium=referral,neutral,0.8200432062149048
5562,4/17/2023 2:48:07 PM,Supreme Court turns down Sanofi bid to revive EpiPen lawsuit against Viatris,Seeking Alpha,https://seekingalpha.com/news/3956965-sanofi-stock-bid-revive-epipen-lawsuit-against-viatris-fails?utm_source=businessinsider&utm_medium=referral,neutral,0.5614740252494812
5563,4/18/2023 2:10:46 PM,Second updated COVID booster dose OKd by FDA for at-risk individuals,Seeking Alpha,https://seekingalpha.com/news/3957356-second-updated-covid-booster-dose-okd-fda-at-risk-individuals?utm_source=businessinsider&utm_medium=referral,positive,0.7884523868560791
5564,4/18/2023 6:26:12 PM,Vaxcyte initiated at outperform at TD Cowen on pneumococcal vaccine,Seeking Alpha,https://seekingalpha.com/news/3957456-vaxcyte-initiated-outperform-td-cowen-pneumococcal-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8721319437026978
5565,4/18/2023 10:35:07 PM,3 Dividend-Paying Stocks to Buy for Incredible Passive Income in Retirement,InvestorPlace,/news/stocks/3-dividend-paying-stocks-to-buy-for-incredible-passive-income-in-retirement-1032241201,positive,0.8909452557563782
5566,4/19/2023 8:00:17 AM,"FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines ",RTTNews,/news/stocks/fda-authorizes-changes-to-simplify-use-of-moderna-pfizer-bivalent-covid-19-vaccines-1032242316,positive,0.5904836654663086
5567,4/19/2023 1:01:34 PM,"Alnylam, Intra-Cellular among potential biotech take-out targets - RBC",Seeking Alpha,https://seekingalpha.com/news/3957656-alnylam-intra-cellular-among-potential-biotech-take-out-targets-rbc?utm_source=businessinsider&utm_medium=referral,positive,0.5791764855384827
5568,4/19/2023 10:38:35 PM,"CDC endorses second updated COVID jab for seniors, immunocompromised",Seeking Alpha,https://seekingalpha.com/news/3958022-cdc-endorses-second-updated-covid-jab-seniors-immunocompromised?utm_source=businessinsider&utm_medium=referral,positive,0.7584391236305237
5569,4/20/2023 12:22:14 AM,The Most Overlooked 7 Stocks in the Market Today,InvestorPlace,/news/stocks/the-most-overlooked-7-stocks-in-the-market-today-undervalued-stocks-1032244894,positive,0.8164888620376587
5570,4/20/2023 9:36:15 AM,GSK consumer health spinoff Haleon eyes FY23 organic revenue growth at top end of outlook,Seeking Alpha,https://seekingalpha.com/news/3958087-gsk-spinoff-haleon-eyes-fy23-organic-revenue-growth-outlook-top-end?utm_source=businessinsider&utm_medium=referral,negative,0.5165045857429504
5571,4/20/2023 12:57:48 PM,Novavax downgraded at TD Cowen citing COVID uncertainty,Seeking Alpha,https://seekingalpha.com/news/3958223-novavax-stock-downgraded-at-td-cowen?utm_source=businessinsider&utm_medium=referral,neutral,0.7157629728317261
5572,4/21/2023 2:36:56 PM,OmniAb a new buy at Benchmark on technology to develop monoclonal antibodies,Seeking Alpha,https://seekingalpha.com/news/3958719-omniab-new-buy-benchmark-technology-develop-monoclonal-antibodies?utm_source=businessinsider&utm_medium=referral,negative,0.6924192905426025
5573,4/22/2023 8:00:00 PM,Ulcerative colitis market set to hit $9.6B by 2031,Seeking Alpha,https://seekingalpha.com/news/3958777-ulcerative-colitis-market-set-to-hit-96b-by-2031?utm_source=businessinsider&utm_medium=referral,negative,0.7096775770187378
5574,4/23/2023 4:00:00 PM,What is behind biotech M&A resurgence?,Seeking Alpha,https://seekingalpha.com/news/3958874-reasons-for-biotech-buyout-resurgence?utm_source=businessinsider&utm_medium=referral,positive,0.9020150899887085
5575,4/24/2023 10:15:15 AM,3 Low P/E Stocks That Will Double in One Year,InvestorPlace,/news/stocks/3-low-p-e-stocks-that-will-double-in-one-year-1032253575,neutral,0.8814970254898071
5576,4/24/2023 12:39:37 PM,"Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate",Seeking Alpha,https://seekingalpha.com/news/3959032-lantheus-point-biopharma-receive-fda-fast-track-status-prostate-cancer-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.8532596230506897
5577,4/25/2023 3:38:42 PM,Bipartisan agreement reached in Senate prescription drug price legislation,Seeking Alpha,https://seekingalpha.com/news/3959793-bipartisan-agreement-reached-senate-prescription-drug-price-legislation?utm_source=businessinsider&utm_medium=referral,negative,0.8105085492134094
5578,4/26/2023 5:15:33 PM,"Pfizer, BioNTech hit new 52-week lows",Seeking Alpha,https://seekingalpha.com/news/3960630-pfizer-stock-biontech-stock-hit-new-52-week-lows?utm_source=businessinsider&utm_medium=referral,neutral,0.8583164215087891
5579,4/26/2023 5:21:35 PM,Democratic senators introduce bill to enhance CMS drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3960629-democratic-senators-introduce-bill-enhance-cms-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.8721349239349365
5580,4/26/2023 8:54:05 PM,Pfizer declares $0.41 dividend,Seeking Alpha,https://seekingalpha.com/news/3960891-pfizer-inc-declares-0_41-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.9031793475151062
5581,4/26/2023 10:29:39 PM,7 Low-Risk Stocks to Buy if You Only Want to Beat Inflation,InvestorPlace,/news/stocks/7-low-risk-stocks-to-buy-if-you-only-want-to-beat-inflation-1032265540,positive,0.920756459236145
5582,4/27/2023 10:49:19 AM,GSK RSV vaccine for older adults inches towards EU approval after EMA nod,Seeking Alpha,https://seekingalpha.com/news/3961165-gsk-rsv-vaccine-for-older-adults-inches-towards-eu-approval-after-ema-nod?utm_source=businessinsider&utm_medium=referral,negative,0.9501198530197144
5583,4/27/2023 10:55:09 AM,Lilly obesity therapy shows ~16% weight loss in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3961177-lilly-stock-obesity-therapy-shows-weight-loss?utm_source=businessinsider&utm_medium=referral,negative,0.5685485601425171
5584,4/28/2023 11:48:16 AM,Pfizer's RSV shot could take years to reach low income countries — report,Seeking Alpha,https://seekingalpha.com/news/3961989-pfizers-rsv-shot-could-take-years-reach-low-income-countries?utm_source=businessinsider&utm_medium=referral,positive,0.8190204501152039
5585,4/28/2023 5:30:26 PM,"Earnings Week Ahead: Apple, Ford, Starbucks, Anheuser Busch, and more",Seeking Alpha,https://seekingalpha.com/news/3962032-earnings-week-ahead-apple-ford-starbucks-anheuser-busch-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9001802802085876
5586,4/29/2023 4:45:00 PM,XTANDI® (enzalutamide) plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide,PR Newswire,/news/stocks/xtandi-enzalutamide-plus-leuprolide-reduced-the-risk-of-metastasis-by-58-in-non-metastatic-hormone-sensitive-prostate-cancer-versus-placebo-plus-leuprolide-1032275335,negative,0.9497886896133423
5587,4/29/2023 8:00:00 PM,"Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts",Seeking Alpha,https://seekingalpha.com/news/3962345-pfizer-gsk-abbvie-among-pharmas-rise-may-catalysts?utm_source=businessinsider&utm_medium=referral,negative,0.9250966310501099
5588,4/30/2023 6:48:26 PM,7 High-Yield Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-to-buy-and-hold-forever-1032276200,positive,0.9397075772285461
5589,5/1/2023 10:12:52 AM,"Pfizer, Astellas' Xtandi combo cuts risk of death by 58% in prostate cancer patients",Seeking Alpha,https://seekingalpha.com/news/3962462-pfizer-astellas-xtandi-combo-cuts-risk-death-by-58-prostate-cancer-patients?utm_source=businessinsider&utm_medium=referral,negative,0.9314215779304504
5590,5/1/2023 2:43:33 PM,European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals,Benzinga,/news/stocks/european-union-s-amended-covid-19-vaccine-deal-with-pfizer-biontech-near-monopoly-status-potential-threat-to-rivals-1032277997,neutral,0.8747879266738892
5591,5/1/2023 3:01:13 PM,Pfizer is about to announce its earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-stock-q1-earnings-preview-1032278153,positive,0.9325799345970154
5592,5/1/2023 3:58:37 PM,"First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories",Benzinga,/news/stocks/first-republic-folds-amid-banking-crisis-elon-musk-expects-starship-to-make-orbit-on-next-launch-doj-probes-mastercard-over-anti-competitive-debit-card-practices-today-s-top-stories-1032278446,positive,0.8544761538505554
5593,5/1/2023 4:08:27 PM,"All eyes on Pfizer earnings as Q1 saw focus on M&A, RSV vaccine race",Seeking Alpha,https://seekingalpha.com/news/3962686-all-eyes-on-pfizer-earnings-as-q1-saw-focus-on-ma-rsv-race?utm_source=businessinsider&utm_medium=referral,positive,0.9088423848152161
5594,5/2/2023 1:41:11 AM,"U.S. to end COVID vaccine mandates for foreign travelers, others next week",Seeking Alpha,https://seekingalpha.com/news/3963092-us-to-end-covid-vaccine-mandate-foreign-travelers-others?utm_source=businessinsider&utm_medium=referral,positive,0.7654039263725281
5595,5/2/2023 8:19:13 AM,Investor Optimism Improves Slightly Following JPMorgan's Purchase Of First Republic's Assets,Benzinga,/news/stocks/investor-optimism-improves-slightly-following-jpmorgan-s-purchase-of-first-republic-s-assets-1032280944,negative,0.9265836477279663
5596,5/2/2023 10:49:57 AM,Pfizer beats Q1 top and bottom line estimates; reaffirms FY23 outlook,Seeking Alpha,https://seekingalpha.com/news/3963190-pfizer-beats-q1-top-and-bottom-line-estimates-reaffirms-fy23-outlook?utm_source=businessinsider&utm_medium=referral,negative,0.9188030958175659
5597,5/2/2023 11:00:53 AM,3 Dividend Stocks to Buy for 100% Total Returns in One Year,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-100-total-returns-in-one-year-1032281671,positive,0.834439754486084
5598,5/2/2023 11:40:03 AM,Pfizer tops Q1 2023 forecasts as COVID franchise outperforms,Seeking Alpha,https://seekingalpha.com/news/3963245-pfizer-stock-tops-q1-2023-forecasts-covid-franchise-outperforms?utm_source=businessinsider&utm_medium=referral,negative,0.9392815232276917
5599,5/2/2023 12:50:05 PM,"Pfizer Inc. Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/pfizer-inc-q1-profit-decreases-but-beats-estimates-1032281571,neutral,0.9630827903747559
5600,5/2/2023 1:00:20 PM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Harmony Biosciences Holdings (HRMY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-harmony-biosciences-holdings-hrmy-1032282722,positive,0.9122118353843689
5601,5/2/2023 1:42:21 PM,Pfizer Q1 Results Top Estimates; Reaffirms FY23 Outlook ,RTTNews,/news/stocks/pfizer-q1-results-top-estimates-reaffirms-fy23-outlook-1032281866,positive,0.5444149971008301
5602,5/2/2023 7:45:20 PM,Jefferies Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-its-hold-rating-for-pfizer-pfe-1032283878,positive,0.8285176157951355
5603,5/3/2023 9:11:35 AM,"Haleon Q1 profit rises, margins squeeze; Pfizer plans stake sale in coming months",Seeking Alpha,https://seekingalpha.com/news/3964229-haleon-q1-profit-rises-margins-squeeze-pfizer-plans-stake-sale?utm_source=businessinsider&utm_medium=referral,neutral,0.7484626173973083
5604,5/3/2023 10:08:01 AM,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",Seeking Alpha,https://seekingalpha.com/news/3964240-fentanyl-overdose-deaths-rose-279-oxycodone-deaths-fell-in-5-years?utm_source=businessinsider&utm_medium=referral,negative,0.9210435748100281
5605,5/3/2023 10:11:04 AM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Premier (PINC),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-premier-pinc-1032286750,positive,0.8931626677513123
5606,5/3/2023 10:56:43 AM,Pfizer spinout Cerevel names Bain Capital partner Ron Renaud as new CEO,Seeking Alpha,https://seekingalpha.com/news/3964297-pfizer-spinout-cerevel-names-bain-capital-partner-ron-renaud-new-ceo?utm_source=businessinsider&utm_medium=referral,positive,0.9224616289138794
5607,5/3/2023 11:01:56 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Sarepta Therapeutics (SRPT) and Rhythm Pharmaceuticals (RYTM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-sarepta-therapeutics-srpt-and-rhythm-pharmaceuticals-rytm-1032287022,positive,0.9047827124595642
5608,5/3/2023 11:15:48 AM,BMO Capital Reaffirms Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/bmo-capital-reaffirms-their-buy-rating-on-pfizer-pfe-1032287097,positive,0.8244349956512451
5609,5/3/2023 1:30:40 PM,AMD To Rally Around 32%? Here Are 10 Other Analyst Forecasts For Wednesday,Benzinga,/news/stocks/amd-to-rally-around-32-here-are-10-other-analyst-forecasts-for-wednesday-1032287125,positive,0.9217808842658997
5610,5/3/2023 5:23:54 PM,GSK’s Arexvy becomes first U.S.-cleared shot for respiratory syncytial virus,Seeking Alpha,https://seekingalpha.com/news/3964734-gsks-arexvy-becomes-first-us-cleared-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,positive,0.5251410007476807
5611,5/4/2023 6:28:34 PM,WHO meeting is set to decide whether to end COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3965903-who-meeting-is-set-to-decide-whether-to-end-covid-emergency?utm_source=businessinsider&utm_medium=referral,positive,0.8873199820518494
5612,5/4/2023 9:48:23 PM,The 7 Best Bargain Stocks to Buy for May 2023,InvestorPlace,/news/stocks/the-7-best-bargain-stocks-to-buy-for-may-2023-1032294507,positive,0.9196375012397766
5613,5/5/2023 10:11:47 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Irhythm Technologies (IRTC) and Paragon 28 (FNA)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-irhythm-technologies-irtc-and-paragon-28-fna-1032296735,positive,0.908867597579956
5614,5/5/2023 3:15:41 PM,SVB Securities Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/svb-securities-remains-a-hold-on-pfizer-pfe-1032298043,positive,0.9062769412994385
5615,5/5/2023 5:32:36 PM,Rochelle Walensky stepping down as CDC director on June 30,Seeking Alpha,https://seekingalpha.com/news/3966632-rochelle-walensky-stepping-down-cdc-director-june-30?utm_source=businessinsider&utm_medium=referral,neutral,0.6770878434181213
5616,5/6/2023 3:00:34 AM,XLV: 5 Reasons to Put This Healthcare ETF on Your Radar,TipRanks,/news/stocks/xlv-5-reasons-to-put-this-healthcare-etf-on-your-radar-1032298857,positive,0.9032704830169678
5617,5/7/2023 4:00:27 PM,Spending on weight loss drugs to rise 378% in 2023 – 2027: report,Seeking Alpha,https://seekingalpha.com/news/3966814-spending-weight-loss-drugs-wegovy-mounjaro-2023-2027?utm_source=businessinsider&utm_medium=referral,negative,0.9277639389038086
5618,5/8/2023 11:41:02 AM,Viatris expects return to growth as Q1 topline contracts 11%,Seeking Alpha,https://seekingalpha.com/news/3966948-viatris-expects-return-growth-q1-topline-contracts?utm_source=businessinsider&utm_medium=referral,negative,0.9525508880615234
5619,5/8/2023 1:36:15 PM,BioNTech Q1 Net Profit Declines; Reiterates 2023 COVID-19 Vaccine Revenue Guidance ,RTTNews,/news/stocks/biontech-q1-net-profit-declines-reiterates-2023-covid-19-vaccine-revenue-guidance-1032301714,neutral,0.9602709412574768
5620,5/8/2023 3:09:19 PM,CDC COVID data collection to decline once public health emergency ends,Seeking Alpha,https://seekingalpha.com/news/3967125-cdc-covid-data-collection-to-decline-once-public-health-emergency-ends?utm_source=businessinsider&utm_medium=referral,neutral,0.9657461047172546
5621,5/9/2023 12:56:49 PM,Big pharma maps legal strategy against U.S. drug pricing regulation – Reuters,Seeking Alpha,https://seekingalpha.com/news/3967966-big-pharma-maps-legal-strategy-against-drug-pricing-regulation?utm_source=businessinsider&utm_medium=referral,positive,0.9252361059188843
5622,5/9/2023 3:54:50 PM,"Thermo Fisher, Pfizer partner for genomic cancer testing",Seeking Alpha,https://seekingalpha.com/news/3968183-thermo-fisher-pfizer-partner-genomic-cancer-testing?utm_source=businessinsider&utm_medium=referral,positive,0.9333162307739258
5623,5/10/2023 11:03:05 AM,Cerevel appoints former ImmunoGen exec as CFO,Seeking Alpha,https://seekingalpha.com/news/3968934-cerevel-appoints-former-immunogen-exec-as-cfo?utm_source=businessinsider&utm_medium=referral,positive,0.9303872585296631
5624,5/10/2023 1:53:22 PM,Insiders Buying Pfizer And 2 Other Stocks,Benzinga,/news/stocks/insiders-buying-pfizer-and-2-other-stocks-1032312044,positive,0.9146413803100586
5625,5/10/2023 4:59:39 PM,Martin Shkreli pharma company files for Chapter 11 bankruptcy,Seeking Alpha,https://seekingalpha.com/news/3969245-martin-shkreli-pharma-company-files-chapter-11-bankruptcy?utm_source=businessinsider&utm_medium=referral,neutral,0.7932363748550415
5626,5/10/2023 8:33:44 PM,Is ChatGPT A Better Financial Advisor? We're Going To Find Out,Benzinga,/news/etf/is-chatgpt-a-better-financial-advisor-we-re-going-to-find-out-1032313893,positive,0.8116571307182312
5627,5/11/2023 4:38:03 PM,"3 Penny Stocks That Could Turn $1,000 into $10,000 in a Year",InvestorPlace,/news/stocks/3-penny-stocks-that-could-turn-1000-into-10000-in-a-year-1032318987,positive,0.8374410271644592
5628,5/11/2023 5:00:43 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-11-2023-1032318624,positive,0.4960373044013977
5629,5/11/2023 5:56:56 PM,Pfizer's COVID-19 profits supporting development of cancer therapies - Reuters,Seeking Alpha,https://seekingalpha.com/news/3970256-pfizer-covid-19-profits-supporting-development-cancer-therapies?utm_source=businessinsider&utm_medium=referral,positive,0.8599651455879211
5630,5/11/2023 7:02:15 PM,Analyst Ratings for Pfizer,Benzinga,/news/stocks/analyst-ratings-for-pfizer-1032319148,positive,0.9225926399230957
5631,5/12/2023 8:56:41 AM,GSK says Canadian court dismisses potential Zantac class suit,Seeking Alpha,https://seekingalpha.com/news/3970652-gsk-says-canadian-court-dismisses-potential-zantac-class-suit?utm_source=businessinsider&utm_medium=referral,neutral,0.8448159098625183
5632,5/12/2023 10:41:00 AM,GSK cuts its Haleon stake in $1B share sale,Seeking Alpha,https://seekingalpha.com/news/3970233-gsk-stock-cut-haelon-stake-1b-share-sale?utm_source=businessinsider&utm_medium=referral,neutral,0.8855074644088745
5633,5/12/2023 11:30:07 AM,Celcuity gedatolisib combo shows promise in phase 1b trial in breast cancer patients,Seeking Alpha,https://seekingalpha.com/news/3970723-celcuity-gedatolisib-combo-shows-promise-breast-cancer-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9035670161247253
5634,5/13/2023 8:00:00 PM,Cancer therapies spending set to surge through end of decade,Seeking Alpha,https://seekingalpha.com/news/3971001-cancer-therapies-spending-set-surge-through-end-decade?utm_source=businessinsider&utm_medium=referral,negative,0.9407323002815247
5635,5/15/2023 12:00:54 PM,Pfizer subsidiary launches debt offering,Seeking Alpha,https://seekingalpha.com/news/3971258-pfizer-subsidiary-launches-debt-offering?utm_source=businessinsider&utm_medium=referral,positive,0.8770524859428406
5636,5/15/2023 3:51:24 PM,Pfizer launches debt offering for Seagen acquisition,Seeking Alpha,https://seekingalpha.com/news/3971258-pfizer-subsidiary-launches-debt-offering-seagen-acquisition?utm_source=businessinsider&utm_medium=referral,positive,0.8839548826217651
5637,5/16/2023 12:00:00 PM,IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma,PR Newswire,/news/stocks/ideaya-expands-clinical-trial-collaboration-and-supply-agreements-with-pfizer-to-support-registrational-trial-evaluating-darovasertib-and-crizotinib-combination-in-first-line-metastatic-uveal-melanoma-1032330532,negative,0.9204994440078735
5638,5/16/2023 12:38:52 PM,IDEAYA Announces Amended Clinical Trial Collaboration And Supply Agreements With Pfizer ,RTTNews,/news/stocks/ideaya-announces-amended-clinical-trial-collaboration-and-supply-agreements-with-pfizer-1032330655,positive,0.783885657787323
5639,5/16/2023 12:41:41 PM,"Seagen, Prometheus Biosciences fall amid news of FTC planned block of Horizon/Amgen deal",Seeking Alpha,https://seekingalpha.com/news/3972034-seagen-prometheus-biosciences-fall-amid-news-of-ftc-planned-block-of-horizonamgen-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.9247511029243469
5640,5/16/2023 12:52:10 PM,AstraZeneca to exit leading U.S. drug industry group PhRMA,Seeking Alpha,https://seekingalpha.com/news/3972045-astrazeneca-stock-exits-leading-us-drug-lobby-phrma?utm_source=businessinsider&utm_medium=referral,positive,0.6984096169471741
5641,5/16/2023 1:49:09 PM,Pfizer draws FDA comments on maternal RSV shot ahead of AdCom meeting,Seeking Alpha,https://seekingalpha.com/news/3972105-pfizer-stock-draws-fda-comments-on-maternal-rsv-shot-ahead?utm_source=businessinsider&utm_medium=referral,positive,0.9296330809593201
5642,5/16/2023 2:09:18 PM,"Ray Dalio's Bridgewater takes new stake in FHN, buys more META, PYPL, GOOGL",Seeking Alpha,https://seekingalpha.com/news/3972125-ray-dalios-bridgewater-takes-new-stake-in-fhn-buys-more-meta-pypl-googl?utm_source=businessinsider&utm_medium=referral,positive,0.9273435473442078
5643,5/16/2023 6:04:07 PM,FTC suit against Horizon deal may have chilling effect on biotech M&A,Seeking Alpha,https://seekingalpha.com/news/3972260-ftc-suit-against-horizon-amgen-deal-chilling-effect-biotech?utm_source=businessinsider&utm_medium=referral,neutral,0.6934927701950073
5644,5/16/2023 6:30:14 PM,Pfizer bond offering to fund Seagen deal said to be among largest on record,Seeking Alpha,https://seekingalpha.com/news/3972277-pfizer-bond-offering-fund-seagen-deal-among-largest?utm_source=businessinsider&utm_medium=referral,negative,0.520749032497406
5645,5/16/2023 8:17:55 PM,Horizon Therapeutics plunges as FTC lawsuit increases risk to Amgen deal (update),Seeking Alpha,https://seekingalpha.com/news/3972015-horizon-therapeutics-plunges-as-potential-ftc-lawsuit-increases-risk-to-amgen-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.9064087271690369
5646,5/16/2023 10:26:14 PM,"Seagen, impacted by FTC Amgen/Horizon suit, closes down 6%",Seeking Alpha,https://seekingalpha.com/news/3972383-seagen-impacted-by-ftc-amgen-horizon-suit-closed-down-6?utm_source=businessinsider&utm_medium=referral,neutral,0.970109760761261
5647,5/17/2023 11:15:09 AM,Pfizer prices an eight series $31B debt offering to fund the acquisition of Seagen,Seeking Alpha,https://seekingalpha.com/news/3972475-pfizer-prices-an-eight-series-31b-debt-offering-to-fund-the-acquisition-of-seagen?utm_source=businessinsider&utm_medium=referral,positive,0.751427948474884
5648,5/17/2023 11:23:48 AM,Google Cloud unveils AI-led solutions to speed up drug discovery,Seeking Alpha,https://seekingalpha.com/news/3972477-google-cloud-brings-ai-solutions-speed-up-drug-discovery?utm_source=businessinsider&utm_medium=referral,negative,0.6108337044715881
5649,5/17/2023 4:30:58 PM,"Analysts Offer Insights on Healthcare Companies: Durect (DRRX), Pfizer (PFE) and BioVie (BIVI)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-durect-drrx-pfizer-pfe-and-biovie-bivi-1032335681,positive,0.9043324589729309
5650,5/18/2023 4:13:46 PM,Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron,Seeking Alpha,https://seekingalpha.com/news/3973082-supreme-court-rules-against-amgen-rapatha-patent-dispute?utm_source=businessinsider&utm_medium=referral,neutral,0.7930806875228882
5651,5/18/2023 6:13:29 PM,WHO recommends updating COVID shots to add XBB.1 variants,Seeking Alpha,https://seekingalpha.com/news/3973169-who-recommends-updating-covid-shots-to-add-xbb1-variants?utm_source=businessinsider&utm_medium=referral,positive,0.9085717797279358
5652,5/18/2023 9:12:36 PM,Pfizer wins FDA AdCom backing for maternal RSV vaccine,Seeking Alpha,https://seekingalpha.com/news/3973217-pfizer-wins-fda-adcom-nod-maternal-rsv-shot?utm_source=businessinsider&utm_medium=referral,negative,0.8013427257537842
5653,5/19/2023 3:21:04 AM,FDA Advisory Committee Backs Pfizer's Maternal RSV Vaccine ,RTTNews,/news/stocks/fda-advisory-committee-backs-pfizer-s-maternal-rsv-vaccine-1032338647,neutral,0.4472138285636902
5654,5/19/2023 12:10:10 PM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytokinetics (CYTK) and Pfizer (PFE),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cytokinetics-cytk-and-pfizer-pfe-1032339645,neutral,0.9249625205993652
5655,5/19/2023 12:41:07 PM,CureVac accelerates COVID patent dispute with Pfizer/BioNTech as court grants motion,Seeking Alpha,https://seekingalpha.com/news/3973439-curevac-accelerates-covid-patent-row-pfizerbiontech?utm_source=businessinsider&utm_medium=referral,neutral,0.5529507994651794
5656,5/19/2023 3:27:21 PM,3 Undervalued Pharma Stocks to Buy for High Total Returns,InvestorPlace,/news/stocks/3-undervalued-pharma-stocks-to-buy-for-high-total-returns-1032340158,negative,0.9090120792388916
5657,5/19/2023 4:51:21 PM,"WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake",Benzinga,/news/stocks/who-recommends-new-covid-booster-shots-to-target-xbb-variants-despite-slower-uptake-1032340045,negative,0.6635165810585022
5658,5/21/2023 4:00:17 PM,Billions of dollars at stake as FDA shortcut allows half-proven drugs - report,Seeking Alpha,https://seekingalpha.com/news/3973623-billions-fda-shortcut-allows-half-proven-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.7357143759727478
5659,5/22/2023 11:08:26 AM,3 High-Reward Stocks Riding the Healthcare Boom,InvestorPlace,/news/stocks/3-high-reward-stocks-riding-the-healthcare-boom-1032342271,positive,0.7161930799484253
5660,5/22/2023 3:56:08 PM,Pfizer gains on peer-reviewed data for oral weight loss therapy,Seeking Alpha,https://seekingalpha.com/news/3973837-pfizer-stock-gains-phase-2-data-oral-obesity-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8939200043678284
5661,5/23/2023 11:15:28 AM,Debt ceiling crisis is already changing market dynamics - what could come next?,Seeking Alpha,https://seekingalpha.com/news/3974100-debt-ceiling-crisis-is-already-changing-market-dynamics-what-could-come-next?utm_source=businessinsider&utm_medium=referral,neutral,0.5529876351356506
5662,5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral,positive,0.912303626537323
5663,5/23/2023 2:51:44 PM,Pfizer stock yet to imply obesity drug’s blockbuster potential – Cantor,Seeking Alpha,https://seekingalpha.com/news/3974223-pfizer-stock-to-imply-obesity-drugs-potential-cantor?utm_source=businessinsider&utm_medium=referral,negative,0.7164328098297119
5664,5/23/2023 3:45:19 PM,SVB Securities Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/svb-securities-sticks-to-their-hold-rating-for-pfizer-pfe-1032346106,positive,0.895103931427002
5665,5/23/2023 6:10:22 PM,COVID vaccine stocks light up amid fears of new infections in China,Seeking Alpha,https://seekingalpha.com/news/3974303-vaccine-stocks-rise-amid-fears-new-covid-wave-china?utm_source=businessinsider&utm_medium=referral,negative,0.9354971647262573
5666,5/24/2023 11:24:10 AM,Apexigen surges ~40% on all-stock acquisition by Pyxis Oncology,Seeking Alpha,https://seekingalpha.com/news/3974517-apexigen-surges-40-on-all-stock-acquisition-by-pyxis-oncology?utm_source=businessinsider&utm_medium=referral,negative,0.9397895932197571
5667,5/24/2023 2:00:57 PM,Zura Bio soars 37% as Raymond James starts with Strong Buy,Seeking Alpha,https://seekingalpha.com/news/3974613-zura-bio-stock-soars-raymond-james-strong-buy?utm_source=businessinsider&utm_medium=referral,negative,0.9122418165206909
5668,5/24/2023 2:47:24 PM,"Why Novavax, Pfizer And BioNTech Shares Are Rising Today",Benzinga,/news/stocks/why-novavax-pfizer-and-biontech-shares-are-rising-today-1032348459,negative,0.587943434715271
5669,5/24/2023 8:42:38 PM,"Zura Bio's Veteran Leadership Eyes Repeat Success, Confident Analyst Sees 150% Upside",Benzinga,/news/stocks/zura-bio-s-veteran-leadership-eyes-repeat-success-confident-analyst-sees-150-upside-1032349587,negative,0.9441695213317871
5670,5/25/2023 10:30:12 AM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Krystal Biotech (KRYS) and Pfizer (PFE),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-krystal-biotech-krys-and-pfizer-pfe-1032351154,neutral,0.7353322505950928
5671,5/25/2023 1:29:45 PM,BioNTech readying next COVID shot in line with WHO guidance,Seeking Alpha,https://seekingalpha.com/news/3975080-biontech-stock-readying-next-covid-shot-per-who-guidance?utm_source=businessinsider&utm_medium=referral,positive,0.776036262512207
5672,5/25/2023 2:41:49 PM,Pfizer granted full FDA approval for COVID-19 pill,Seeking Alpha,https://seekingalpha.com/news/3975124-pfizer-stock-granted-full-fda-approval-covid-19-pill?utm_source=businessinsider&utm_medium=referral,negative,0.8998886346817017
5673,5/25/2023 4:29:40 PM,7 Top Stock Tips for June 2023,InvestorPlace,/news/stocks/7-top-stock-tips-for-june-2023-1032352462,positive,0.9229313731193542
5674,5/25/2023 11:00:00 PM,Astellas Highlights Continued Delivery of Strong Cancer Portfolio and Pipeline at 2023 ASCO Annual Meeting,PR Newswire,/news/stocks/astellas-highlights-continued-delivery-of-strong-cancer-portfolio-and-pipeline-at-2023-asco-annual-meeting-1032352896,negative,0.9184880256652832
5675,5/26/2023 9:01:52 AM,"Analysts Are Neutral on These Healthcare Stocks: Illumina (ILMN), Pfizer (PFE)",TipRanks,/news/stocks/analysts-are-neutral-on-these-healthcare-stocks-illumina-ilmn-pfizer-pfe-1032353788,positive,0.7568650245666504
5676,5/26/2023 9:36:08 AM,FDA Approves Pfizer's COVID-19 Pill Paxlovid ,RTTNews,/news/stocks/fda-approves-pfizer-s-covid-19-pill-paxlovid-1032353644,negative,0.6038357615470886
5677,5/26/2023 11:33:26 AM,"Pfizer, BioNTech agree to revise EU COVID vaccine deal",Seeking Alpha,https://seekingalpha.com/news/3975364-pfizer-biontech-agree-revise-eu-covid-vaccine-deal?utm_source=businessinsider&utm_medium=referral,negative,0.8222038745880127
5678,5/26/2023 6:01:57 PM,Oncolytics falls 16% after mid-stage data for breast cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3975527-oncolytics-stock-falls-data-breast-cancer-therapy?utm_source=businessinsider&utm_medium=referral,neutral,0.9655440449714661
5679,5/26/2023 7:00:30 PM,"Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event",Seeking Alpha,https://seekingalpha.com/news/3975507-catalyst-watch-c3ai-and-salesforce-earnings-knife-river-debut-kenvue-ratings-faraday-future-event?utm_source=businessinsider&utm_medium=referral,positive,0.9356293082237244
5680,5/29/2023 7:13:25 PM,The 3 Best Healthcare Stocks to Buy for June 2023,InvestorPlace,/news/stocks/the-3-best-healthcare-stocks-to-buy-for-june-2023-1032356782,positive,0.8993728756904602
5681,5/30/2023 10:56:03 AM,Next set of COVID boosters to target new Omicron variants – WSJ,Seeking Alpha,https://seekingalpha.com/news/3975713-next-set-of-covid-boosters-to-target-new-omicron-variants?utm_source=businessinsider&utm_medium=referral,positive,0.8483840823173523
5682,5/30/2023 11:23:21 AM,Pfizer succeeds in Phase 3 trial for hemophilia candidate,Seeking Alpha,https://seekingalpha.com/news/3975728-pfizer-stock-succeeds-phase-3-trial-hemophilia-drug?utm_source=businessinsider&utm_medium=referral,negative,0.9199200868606567
5683,5/30/2023 1:00:53 PM,Pfizer Says Pivotal Phase 3 BASIS Clinical Trial Of Marstacimab Met Primary Endpoints ,RTTNews,/news/stocks/pfizer-says-pivotal-phase-3-basis-clinical-trial-of-marstacimab-met-primary-endpoints-1032357931,negative,0.7397029995918274
5684,5/30/2023 7:30:57 PM,Eli Lilly partners with XtalPi on AI drug discovery in up to $250M deal,Seeking Alpha,https://seekingalpha.com/news/3975939-eli-lilly-partners-xtalpi-artificial-intelligence-drug-discovery-250m-deal?utm_source=businessinsider&utm_medium=referral,negative,0.7498099207878113
5685,5/30/2023 7:46:36 PM,Seagen shareholders OK acquisition by Pfizer,Seeking Alpha,https://seekingalpha.com/news/3975945-seagen-shareholders-ok-acquisition-pfizer?utm_source=businessinsider&utm_medium=referral,positive,0.9191935062408447
5686,5/31/2023 1:05:25 PM,SVB Securities Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/svb-securities-sticks-to-its-hold-rating-for-pfizer-pfe-1032361139,positive,0.8710426092147827
5687,5/31/2023 10:08:30 PM,Pfizer RSV vaccine gets FDA nod,Seeking Alpha,https://seekingalpha.com/news/3976421-pfizer-rsv-vaccine-abrysvo-gets-fda-nod?utm_source=businessinsider&utm_medium=referral,positive,0.5121349096298218
5688,6/1/2023 7:15:05 AM,Pfizer (PFE) Gets a Buy from Goldman Sachs,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-goldman-sachs-1032363317,positive,0.5706905722618103
5689,6/1/2023 9:35:09 AM,Bank of America Securities Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/bank-of-america-securities-remains-a-hold-on-pfizer-pfe-1032363602,positive,0.8613510131835938
5690,6/1/2023 2:43:36 PM,Pfizer posts promising Phase 3 data for AbbVie-partnered antibiotic,Seeking Alpha,https://seekingalpha.com/news/3976637-pfizer-stock-posts-data-for-abbvie-partnered-antibiotic?utm_source=businessinsider&utm_medium=referral,negative,0.9472237825393677
5691,6/1/2023 4:48:53 PM,Pfizer Says Its Antibiotic Combination Can Help Patients With Life-threatening Bacterial Infections ,RTTNews,/news/stocks/pfizer-says-its-antibiotic-combination-can-help-patients-with-life-threatening-bacterial-infections-1032364901,negative,0.8811474442481995
5692,6/1/2023 5:42:26 PM,Biohaven hits an all-time high after R&D Day,Seeking Alpha,https://seekingalpha.com/news/3976775-biohaven-stock-hits-all-time-high-after-rd-day?utm_source=businessinsider&utm_medium=referral,negative,0.8533404469490051
5693,6/1/2023 6:59:10 PM,"AI, Tech Fuel Rebound Of Vanguard Growth ETF, Eroding Value's 2022 Outperformance",Benzinga,/news/etf/ai-tech-fuel-rebound-of-vanguard-growth-etf-eroding-value-s-2022-outperformance-1032365404,neutral,0.6888307332992554
5694,6/2/2023 12:04:48 AM,7 Deeply Undervalued Growth Stocks to Buy in June,InvestorPlace,/news/stocks/7-deeply-undervalued-growth-stocks-to-buy-in-june-1032366043,negative,0.5245308876037598
5695,6/2/2023 11:55:32 AM,3 Undervalued Biotech Stocks to Buy Before They Blast Off,InvestorPlace,/news/stocks/3-undervalued-biotech-stocks-to-buy-before-they-blast-off-1032367065,positive,0.8576158881187439
5696,6/2/2023 8:18:41 PM,Johnson & Johnson COVID vaccine authorization revoked by FDA,Seeking Alpha,https://seekingalpha.com/news/3977355-johnson-johnson-janssen-covid-vaccine-authorization-revoked-by-fda?utm_source=businessinsider&utm_medium=referral,neutral,0.8185676336288452
5697,6/4/2023 4:00:08 PM,Morgan Stanley sees broader MedTech impact from weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/3977410-morgan-stanley-sees-medtech-impact-from-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.44781309366226196
5698,6/4/2023 6:53:53 PM,"Novo Nordisk, Lilly facing increased competition in obesity drug market",Seeking Alpha,https://seekingalpha.com/news/3977415-novo-nordisk-lilly-facing-increased-competition-in-obesity-drug-market?utm_source=businessinsider&utm_medium=referral,negative,0.6209858059883118
5699,6/5/2023 11:15:15 AM,BMO Capital Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/bmo-capital-sticks-to-their-buy-rating-for-pfizer-pfe-1032369986,positive,0.6399110555648804
5700,6/6/2023 10:42:00 AM,"Narrow market proving a headwind for mutual funds, opportunity for hedge funds",Seeking Alpha,https://seekingalpha.com/news/3977589-narrow-market-a-headwind-for-active-mutual-funds-opportunity-for-hedge-funds?utm_source=businessinsider&utm_medium=referral,positive,0.5176432132720947
5701,6/6/2023 1:11:23 PM,3 Biotech Stocks to Sell in June Before They Crash and Burn,InvestorPlace,/news/stocks/3-biotech-stocks-to-sell-in-june-before-they-crash-and-burn-1032373119,positive,0.844161868095398
5702,6/6/2023 3:32:37 PM,Novavax's New Vaccine Approach Set to Tackle Rising COVID-19 Emerging Variants,Benzinga,/news/stocks/novavax-s-new-vaccine-approach-set-to-tackle-rising-covid-19-emerging-variants-1032373156,negative,0.8478131294250488
5703,6/6/2023 3:44:11 PM,"SEC Accuses Binance & Coinbase Of Acting As Unregistered Broker, Binance Takes Biggest Hit As $300M In Crypto Positions Liquidated In 24 Hours, JPMorgan Clarifies CEO Jamie Dimon Not Running For...",Benzinga,/news/stocks/sec-accuses-binance-coinbase-of-acting-as-unregistered-broker-binance-takes-biggest-hit-as-300m-in-crypto-positions-liquidated-in-24-hours-jpmorgan-clarifies-ceo-jamie-dimon-not-running-for-presidency-today-s-top-stories-1032373198,neutral,0.8141845464706421
5704,6/7/2023 9:55:26 AM,Pfizer (PFE) Receives a Hold from SVB Securities,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-svb-securities-1032375298,positive,0.9312999844551086
5705,6/7/2023 11:07:57 AM,"Pfizer, Moderna face new patent lawsuits over COVID vaccine tech",Seeking Alpha,https://seekingalpha.com/news/3978138-pfizer-moderna-face-patent-lawsuits-covid-vaccine-tech?utm_source=businessinsider&utm_medium=referral,neutral,0.9191079139709473
5706,6/9/2023 1:26:24 PM,"AbbVie, Amgen among firms targeted for Medicare inflation penalties",Seeking Alpha,https://seekingalpha.com/news/3978943-abbvie-among-firms-targeted-for-medicare-inflation-penalties?utm_source=businessinsider&utm_medium=referral,positive,0.5447219014167786
5707,6/9/2023 6:52:57 PM,Seagen gains as antitrust deadline for Pfizer purchase nears on Monday,Seeking Alpha,https://seekingalpha.com/news/3979010-seagen-gains-as-antitrust-deadline-for-pfizer-purchases-nears-on-monday?utm_source=businessinsider&utm_medium=referral,negative,0.8200448155403137
5708,6/9/2023 7:17:22 PM,FDA reportedly looking for suppliers to ease methotrexate shortage,Seeking Alpha,https://seekingalpha.com/news/3979011-fda-reportedly-looking-for-suppliers-to-ease-methotrexate-shortage?utm_source=businessinsider&utm_medium=referral,negative,0.8018022775650024
5709,6/11/2023 8:25:20 PM,7 Top Blue-Chip Stocks to Buy in June 2023,InvestorPlace,/news/stocks/7-top-blue-chip-stocks-to-buy-in-june-2023-1032382217,positive,0.9089648127555847
5710,6/12/2023 9:56:28 AM,Lawsuits pile up against BioNTech over alleged COVID jab side effects - report,Seeking Alpha,https://seekingalpha.com/news/3979112-biontech-lawsuits-alleged-covid-vaccine-side-effects?utm_source=businessinsider&utm_medium=referral,neutral,0.9511937499046326
5711,6/12/2023 5:27:35 PM,"Olema, Arvinas spike after analyst remarks on breast cancer drugs",Seeking Alpha,https://seekingalpha.com/news/3979288-olema-stock-arvinas-stock-spike-breast-cancer-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.7674927115440369
5712,6/12/2023 6:06:55 PM,Stability Meets Growth: 3 Undervalued Blue-Chip Stock Picks,InvestorPlace,/news/stocks/stability-meets-growth-3-undervalued-blue-chip-stock-picks-1032384313,positive,0.6133998036384583
5713,6/12/2023 7:43:39 PM,"COVID shots should be updated for XBB variants, FDA says",Seeking Alpha,https://seekingalpha.com/news/3979315-covid-shots-should-reflect-xbb-variants-fda?utm_source=businessinsider&utm_medium=referral,positive,0.8617483973503113
5714,6/13/2023 11:03:59 AM,Seagen posts 93% complete remission for lymphoma therapy in Phase 2 trial,Seeking Alpha,https://seekingalpha.com/news/3979459-seagen-lymphoma-drug-adcetris-sets-93-complete-remission?utm_source=businessinsider&utm_medium=referral,negative,0.9012816548347473
5715,6/13/2023 4:53:44 PM,Pfizer is running out of penicillin products amid supply constraints,Seeking Alpha,https://seekingalpha.com/news/3979601-pfizer-stock-running-penicillin-antibiotics?utm_source=businessinsider&utm_medium=referral,neutral,0.9589824676513672
5716,6/14/2023 11:21:10 AM,"Pfizer pulls, refiles merger notification with FTC over Seagen deal",Seeking Alpha,https://seekingalpha.com/news/3979755-pfizer-pulls-refiles-merger-notification-with-ftc-over-seagen-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.8581382036209106
5717,6/14/2023 9:05:24 PM,"Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating",Benzinga,/news/stocks/investor-opportunities-ahead-of-clinical-updates-says-analyst-initiating-coverage-on-ambrx-biopharma-with-buy-rating-1032389936,negative,0.7461115717887878
5718,6/15/2023 8:55:25 AM,Bank of America Securities Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/bank-of-america-securities-remains-a-hold-on-pfizer-pfe-1032390999,positive,0.8613510131835938
5719,6/15/2023 8:49:22 PM,FDA advisors recommend updated COVID shots against XBB variants,Seeking Alpha,https://seekingalpha.com/news/3980249-fda-advisors-recommend-updated-covid-shots-against-xbb-variants?utm_source=businessinsider&utm_medium=referral,positive,0.8463571667671204
5720,6/16/2023 11:00:51 AM,Exit Strategy: Get Out of These 3 Poor-Performing Stocks Now,InvestorPlace,/news/stocks/3-poor-performing-stocks-to-avoid-1032394080,neutral,0.46157172322273254
5721,6/16/2023 11:02:36 AM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Verve Therapeutics (VERV),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-verve-therapeutics-verv-1032394121,positive,0.9094055891036987
5722,6/16/2023 2:54:53 PM,"Pfizer, Moderna, and Novavax Gear Up for XBB.1.5 Strain Targeted Vaccines as FDA AdCom Unanimously Support",Benzinga,/news/stocks/pfizer-moderna-and-novavax-gear-up-for-xbb-1-5-strain-targeted-vaccines-as-fda-adcom-unanimously-support-1032394381,negative,0.5075206160545349
5723,6/16/2023 5:21:44 PM,Eli Lilly migraine drug Emgality fails to beat Pfizer's Nurtec,Seeking Alpha,https://seekingalpha.com/news/3980545-eli-lilly-migraine-drug-emgality-fails-beat-pfizer-nurtec?utm_source=businessinsider&utm_medium=referral,neutral,0.5928570032119751
5724,6/16/2023 8:40:35 PM,FDA advises COVID vaccine makers to produce updated shots against XBB1.5,Seeking Alpha,https://seekingalpha.com/news/3980587-fda-advises-covid-vaccine-makers-produce-updated-shots-against-xbb15?utm_source=businessinsider&utm_medium=referral,positive,0.7885151505470276
5725,6/17/2023 8:00:00 PM,Biologic drugs will lead European pharmas to surpass US counterparts in sales,Seeking Alpha,https://seekingalpha.com/news/3979912-biologic-drugs-lead-european-pharmas-surpass-us-counterparts-sales?utm_source=businessinsider&utm_medium=referral,negative,0.9524824023246765
5726,6/18/2023 9:45:31 PM,Unlock the Potential of These 7 Cash-Flow Machines,InvestorPlace,/news/stocks/7-high-cash-flow-stocks-that-can-power-your-portfolio-1032395855,positive,0.728817880153656
5727,6/20/2023 12:25:13 PM,3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-long-term-biotech-stock-investments-that-may-make-millionaire-1032398780,positive,0.8955403566360474
5728,6/20/2023 2:38:52 PM,Sanofi gains after winning arbitration case over Zantac claims,Seeking Alpha,https://seekingalpha.com/news/3981028-sanofi-stock-gains-after-winning-zantac-arbitration-case?utm_source=businessinsider&utm_medium=referral,negative,0.8040518164634705
5729,6/20/2023 6:40:09 PM,Ready for a Rebound: 7 Blue-Chips Set to Regain Their Market Mojo,InvestorPlace,/news/stocks/ready-for-a-rebound-7-blue-chips-set-to-regain-their-market-mojo-1032400066,negative,0.7723432779312134
5730,6/20/2023 9:47:39 PM,Pfizer's Talzenna gains prostate cancer indication,Seeking Alpha,https://seekingalpha.com/news/3981218-pfizer-talzenna-gains-prostate-cancer-indication?utm_source=businessinsider&utm_medium=referral,positive,0.5524634718894958
5731,6/21/2023 3:16:48 AM,Pfizer : FDA Approves Talzenna-Xtandi Combination To Treat Prostate Cancer ,RTTNews,/news/stocks/pfizer-fda-approves-talzenna-xtandi-combination-to-treat-prostate-cancer-1032400442,negative,0.9285712838172913
5732,6/21/2023 3:44:52 PM,Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3981469-top-pharma-lobby-sues-us-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral,neutral,0.9452309608459473
5733,6/22/2023 1:57:58 AM,"Pfizer, GSK win over CDC advisors for a limited rollout of RSV vaccines",Seeking Alpha,https://seekingalpha.com/news/3981778-pfizer-gsk-win-cdc-advisors-limited-rollout-rsv-shots?utm_source=businessinsider&utm_medium=referral,negative,0.7554907202720642
5734,6/22/2023 10:49:24 AM,Pfizer declares $0.41 dividend,Seeking Alpha,https://seekingalpha.com/news/3981833-pfizer-inc-declares-0_41-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.9031793475151062
5735,6/22/2023 12:03:31 PM,Talaris jumps 29% on merger with Tourmaline Bio in all-stock deal,Seeking Alpha,https://seekingalpha.com/news/3981866-talaris-stock-to-merge-tourmaline-bio-all-stock-deal?utm_source=businessinsider&utm_medium=referral,negative,0.910981297492981
5736,6/22/2023 12:32:13 PM,Roivant rises after long-term data for ulcerative colitis candidate,Seeking Alpha,https://seekingalpha.com/news/3981882-roivant-stock-data-ulcerative-colitis-candidate?utm_source=businessinsider&utm_medium=referral,neutral,0.4917682707309723
5737,6/22/2023 4:00:58 PM,Analyst Ratings for Pfizer,Benzinga,/news/stocks/analyst-ratings-for-pfizer-1032404816,positive,0.9225926399230957
5738,6/22/2023 4:30:31 PM,"Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-axsome-therapeutics-axsm-vertex-pharmaceuticals-vrtx-and-pfizer-pfe-1032405301,positive,0.9012991786003113
5739,6/22/2023 9:18:00 PM,Moderna files application with FDA for updated COVID shot,Seeking Alpha,https://seekingalpha.com/news/3982235-moderna-files-application-fda-updated-covid-shot?utm_source=businessinsider&utm_medium=referral,positive,0.9146848917007446
5740,6/23/2023 10:30:20 AM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Jazz Pharmaceuticals (JAZZ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-jazz-pharmaceuticals-jazz-1032406564,positive,0.9108933210372925
5741,6/23/2023 10:59:42 AM,GSK settles landmark Zantac lawsuit in California,Seeking Alpha,https://seekingalpha.com/news/3982327-gsk-settles-landmark-zantac-lawsuit-california?utm_source=businessinsider&utm_medium=referral,neutral,0.46587347984313965
5742,6/23/2023 11:33:50 AM,"Dividend Roundup: Starbucks, Pfizer, ConocoPhillips, Mondelez, and more",Seeking Alpha,https://seekingalpha.com/news/3982333-dividend-roundup-starbucks-pfizer-conocophillips-mondelez-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9388176798820496
5743,6/23/2023 1:50:46 PM,Viatris cut to Underweight at Barclays citing a “show-me” story,Seeking Alpha,https://seekingalpha.com/news/3982397-viatris-stock-downgraded-barclays-citing-show-me-story?utm_source=businessinsider&utm_medium=referral,neutral,0.9507773518562317
5744,6/25/2023 4:00:43 PM,What is behind big pharma's underperformance?,Seeking Alpha,https://seekingalpha.com/news/3982575-pharma-underperforms-amid-regulatory-woes?utm_source=businessinsider&utm_medium=referral,neutral,0.6917394399642944
5745,6/26/2023 6:45:22 AM,Pfizer (PFE) Gets a Hold from SVB Securities,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-svb-securities-1032408781,positive,0.9317357540130615
5746,6/26/2023 10:04:00 AM,Affordable Blue-Chips: 3 High-Potential Stocks With Low P/E Ratios,InvestorPlace,/news/stocks/affordable-blue-chips-3-high-potential-stocks-with-low-p-e-ratios-1032409185,positive,0.8524057865142822
5747,6/26/2023 12:13:14 PM,3 Stocks to Buy for Long-Term Dividends and Buybacks,InvestorPlace,/news/stocks/3-stocks-to-buy-for-long-term-dividends-and-buybacks-1032409567,positive,0.9368475675582886
5748,6/26/2023 12:57:05 PM,Pfizer Issues Update On GLP-1-RA Development Program; To Discontinue Development Of Lotiglipron ,RTTNews,/news/stocks/pfizer-issues-update-on-glp-1-ra-development-program-to-discontinue-development-of-lotiglipron-1032409304,positive,0.6174922585487366
5749,6/26/2023 2:28:42 PM,Pfizer to drop studies for weight-loss pill,Seeking Alpha,https://seekingalpha.com/news/3982779-pfizer-stock-falls-plans-discontinue-weight-loss-pill?utm_source=businessinsider&utm_medium=referral,neutral,0.942676305770874
5750,6/26/2023 2:46:56 PM,"Biggest stock movers today: Pfizer, FibroGen, Lucid and more",Seeking Alpha,https://seekingalpha.com/news/3982635-biggest-stock-movers-today-lucid-applied-digital-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.8914222717285156
5751,6/26/2023 3:00:02 PM,"Sutro, Blackstone in pact for royalties from Vaxcyte’s products",Seeking Alpha,https://seekingalpha.com/news/3982801-sutro-blackstone-join-royalties-vaxcyte-products?utm_source=businessinsider&utm_medium=referral,positive,0.77337646484375
5752,6/26/2023 4:36:33 PM,Pfizer wins FDA approval for oral hair loss therapy,Seeking Alpha,https://seekingalpha.com/news/3982832-pfizer-wins-fda-nod-oral-hair-loss-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.899830162525177
5753,6/27/2023 11:17:19 AM,Pfizer gene therapy for hemophilia B undergoes U.S. and EU review,Seeking Alpha,https://seekingalpha.com/news/3983078-pfizer-gene-therapy-hemophilia-undergoes-us-eu-review?utm_source=businessinsider&utm_medium=referral,positive,0.7929614782333374
5754,6/27/2023 1:13:06 PM,FDA Accepts Pfizer's BLA For Fidanacogene Elaparvovec To Treat Hemophilia B ,RTTNews,/news/stocks/fda-accepts-pfizer-s-bla-for-fidanacogene-elaparvovec-to-treat-hemophilia-b-1032411884,negative,0.8931394815444946
5755,6/27/2023 7:58:39 PM,"Pfizer and Moderna: The Vaccine Boom is Over, and Shares are Plunging",TipRanks,/news/stocks/pfizer-and-moderna-the-vaccine-boom-is-over-and-shares-are-plunging-1032413482,positive,0.6341514587402344
5756,6/27/2023 8:26:48 PM,3 Blue-Chip Dividend Stocks That Will Double in One Year,InvestorPlace,/news/stocks/3-blue-chip-dividend-stocks-that-will-double-in-one-year-1032413521,negative,0.659890353679657
5757,6/28/2023 10:00:16 AM,3 Pharma Stocks That Have Big Investors Running for the Exit,InvestorPlace,/news/stocks/3-pharma-stocks-to-sell-as-big-investors-run-for-the-exit-1032414444,positive,0.9156886339187622
5758,6/28/2023 10:49:41 AM,Citi screens for most crowded short stocks with new model,Seeking Alpha,https://seekingalpha.com/news/3983369-citi-screens-for-most-crowded-short-stock-with-new-model?utm_source=businessinsider&utm_medium=referral,positive,0.8693737983703613
5759,6/28/2023 11:00:45 AM,Fresh Blood: 3 Stocks Ready to Rally Under New CEOs,InvestorPlace,/news/stocks/3-stocks-ready-to-rally-under-new-ceos-1032414676,negative,0.6786441802978516
5760,6/28/2023 12:49:10 PM,"Pfizer, OPKO Health win FDA nod for dwarfism therapy (update)",Seeking Alpha,https://seekingalpha.com/news/3983563-pfizer-opko-health-win-fda-nod-dwarfism-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.7424825429916382
5761,6/28/2023 1:31:58 PM,Pfizer Says Its NGENLA Gets FDA Approval To Treat Pediatric Growth Hormone Deficiency ,RTTNews,/news/stocks/pfizer-says-its-ngenla-gets-fda-approval-to-treat-pediatric-growth-hormone-deficiency-1032414708,negative,0.90638667345047
5762,6/28/2023 1:45:28 PM,SVB Securities Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/svb-securities-sticks-to-their-hold-rating-for-pfizer-pfe-1032415338,positive,0.895103931427002
5763,6/28/2023 2:00:34 PM,"Biggest stock movers today: Pinterest, OPKO Health, AST SpaceMobile and more",Seeking Alpha,https://seekingalpha.com/news/3983501-biggest-stock-movers-today-ast-spacemobile-kartoon-studios-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.885421097278595
5764,6/28/2023 5:40:34 PM,Biora gains after new patent wins for NaviCap platform,Seeking Alpha,https://seekingalpha.com/news/3983849-biora-stock-gains-after-new-patent-wins-navicap-platform?utm_source=businessinsider&utm_medium=referral,negative,0.9394021034240723
5765,6/28/2023 7:43:20 PM,Why Opko Health Stock Is Moving Today,Benzinga,/news/stocks/why-opko-health-stock-is-moving-today-1032416000,positive,0.9067898988723755
5766,6/29/2023 9:08:31 AM,Morgan Stanley shakes up its global dividend portfolio,Seeking Alpha,https://seekingalpha.com/news/3983853-morgan-stanley-shakes-up-its-global-dividend-portfolio?utm_source=businessinsider&utm_medium=referral,neutral,0.947080135345459
5767,6/29/2023 11:00:27 AM,7 Safe Dividend Stocks for Investors to Buy Right Now: June 2023,InvestorPlace,/news/stocks/7-safe-dividend-stocks-for-investors-to-buy-right-now-june-2023-1032417479,positive,0.9270476698875427
5768,6/29/2023 11:45:50 AM,Pfizer in pact with CSPC to sell oral COVID therapy in China,Seeking Alpha,https://seekingalpha.com/news/3984052-pfizer-pact-cspc-sell-oral-covid-therapy-in-china?utm_source=businessinsider&utm_medium=referral,negative,0.7958514094352722
5769,6/29/2023 2:18:14 PM,CDC director endorses RSV shots for certain adults aged 60 or older,Seeking Alpha,https://seekingalpha.com/news/3984121-cdc-director-endorses-rsv-shots-for-certain-adults-aged-60-or-older?utm_source=businessinsider&utm_medium=referral,positive,0.9268537163734436
5770,6/29/2023 2:53:04 PM,Schrödinger To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday,Benzinga,/news/stocks/schrödinger-to-rally-around-14-here-are-10-other-analyst-forecasts-for-thursday-1032417820,positive,0.908440351486206
5771,6/29/2023 5:02:41 PM,"Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-june-29-2023-1032418279,positive,0.4930301308631897
5772,6/29/2023 6:00:35 PM,The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-biotech-stocks-to-buy-now-june-2023-1032418755,positive,0.9014137983322144
5773,6/29/2023 6:05:28 PM,"Credit Suisse cuts Pfizer to neutral, citing limited pipeline catalysts",Seeking Alpha,https://seekingalpha.com/news/3984238-credit-suisse-cuts-pfizer-to-neutral-citing-limited-pipeline-catalysts?utm_source=businessinsider&utm_medium=referral,neutral,0.876425564289093
5774,6/29/2023 6:23:06 PM,Moderna says updated COVID vaccine will be ready for the fall,Seeking Alpha,https://seekingalpha.com/news/3984241-moderna-says-updated-covid-vaccine-ready-fall?utm_source=businessinsider&utm_medium=referral,positive,0.7449838519096375
5775,6/29/2023 7:43:11 PM,Pfizer sees second request as likely in FTC's review of Seagen deal - analyst,Seeking Alpha,https://seekingalpha.com/news/3984259-pfizer-sees-second-request-as-likely-in-ftcs-review-of-seagen-deal-analyst?utm_source=businessinsider&utm_medium=referral,positive,0.9223060011863708
5776,6/30/2023 4:41:16 PM,Medicare revises guidance on drug price negotiations amid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3984642-medicare-revises-guidance-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.901573121547699
5777,6/30/2023 10:14:07 PM,New CDC Director Mandy Cohen taking over July 9,Seeking Alpha,https://seekingalpha.com/news/3984777-new-cdc-director-mandy-cohen-taking-over-july-9?utm_source=businessinsider&utm_medium=referral,positive,0.8880683183670044
5778,7/1/2023 8:00:00 PM,"Lilly, Vertex top pharma performers in H1; Moderna, Pfizer the worst",Seeking Alpha,https://seekingalpha.com/news/3984694-lilly-vertex-top-pharma-performers-h1-moderna-pfizer-worst?utm_source=businessinsider&utm_medium=referral,negative,0.6028405427932739
5779,7/2/2023 7:10:59 PM,The 7 Most Undervalued S&P 500 Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-most-undervalued-sp-500-stocks-to-buy-now-1032422285,positive,0.6623328924179077
5780,7/4/2023 11:32:00 AM,3 Cheap Stocks to Buy Before They Bounce Back,InvestorPlace,/news/stocks/3-cheap-stocks-to-buy-before-they-bounce-back-1032425406,positive,0.8862494230270386
5781,7/4/2023 4:45:39 PM,Best Under-the-Radar Stocks: 3 That AI Predicts Will Soar in July,InvestorPlace,/news/stocks/best-under-the-radar-stocks-3-that-ai-predicts-will-soar-in-july-1032425911,negative,0.7225651741027832
5782,7/5/2023 3:23:57 PM,"Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories",Benzinga,/news/stocks/apple-loses-appeal-over-4g-patent-infringement-in-london-court-ai-can-drive-tsmc-s-revenue-rebound-alibaba-conducts-strategic-review-of-youku-and-tudou-amidst-rivalry-today-s-top-stories-1032427590,positive,0.7864140868186951
5783,7/6/2023 12:49:41 PM,Pfizer invests $25M in gene editing firm Caribou,Seeking Alpha,https://seekingalpha.com/news/3985911-caribou-stock-soars-pfizer-invests-25m?utm_source=businessinsider&utm_medium=referral,positive,0.8526449203491211
5784,7/6/2023 3:02:28 PM,"Arvinas, Pfizer to examine breast cancer therapy combo with Carrick",Seeking Alpha,https://seekingalpha.com/news/3985965-arvinas-pfizer-examine-breast-cancer-therapy-combo-carrick?utm_source=businessinsider&utm_medium=referral,positive,0.7379744648933411
5785,7/6/2023 3:44:51 PM,Caribou Gains In Pre-market After Getting $25 Mln Equity Investment From Pfizer ,RTTNews,/news/stocks/caribou-gains-in-pre-market-after-getting-25-mln-equity-investment-from-pfizer-1032430250,negative,0.9386466145515442
5786,7/6/2023 3:52:29 PM,The $25 Million Reason Caribou Biosciences (CRBU) Stock Is Soaring Today,InvestorPlace,/news/stocks/the-25-million-reason-caribou-biosciences-crbu-stock-is-soaring-today-1032430566,negative,0.9437907934188843
5787,7/6/2023 4:12:33 PM,Pfizer Is Driving Caribou Biosciences Stock Higher Today: What's Going On?,Benzinga,/news/stocks/pfizer-is-driving-caribou-biosciences-stock-higher-today-what-s-going-on-1032430357,positive,0.5832726955413818
5788,7/6/2023 6:55:08 PM,Roivant Sciences has reportedly drawn pharma interest in $7B+ bowel drug,Seeking Alpha,https://seekingalpha.com/news/3986057-roivant-stock-rises-amid-buyout-interest-bowel-drug?utm_source=businessinsider&utm_medium=referral,negative,0.6549409627914429
5789,7/7/2023 2:10:01 PM,3 Stocks to Snag for Less Than Book Value,InvestorPlace,/news/stocks/3-stocks-to-snag-for-less-than-book-value-1032432341,neutral,0.6860368847846985
5790,7/7/2023 3:04:42 PM,Benzinga's Stock Whisper Index: 5 Tickers Investors Secretly Monitor But Don't Talk About... Yet,Benzinga,/news/stocks/benzinga-s-stock-whisper-index-5-tickers-investors-secretly-monitor-but-don-t-talk-about-yet-1032432281,positive,0.9360008239746094
5791,7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral,negative,0.937191367149353
5792,7/9/2023 7:34:36 PM,The 7 Best Value Stocks to Buy in July,InvestorPlace,/news/stocks/the-7-best-value-stocks-to-buy-in-july-1032433488,positive,0.9127336144447327
5793,7/9/2023 9:24:16 PM,7 Blue-Chip Stocks to Sell Before They Do Your Portfolio In,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-sell-before-they-do-your-portfolio-in-1032433504,positive,0.9360936880111694
5794,7/10/2023 5:42:30 PM,What's Going On With Novavax (NVAX) Stock?,Benzinga,/news/stocks/what-s-going-on-with-novavax-nvax-stock-1032435367,neutral,0.5886027216911316
5795,7/11/2023 12:27:50 AM,The 7 Most Reliable Dividend Stocks to Buy for July 2023,InvestorPlace,/news/stocks/the-7-most-reliable-dividend-stocks-to-buy-for-july-2023-1032435994,positive,0.8966158628463745
5796,7/11/2023 9:35:11 AM,Pfizer (PFE) Receives a Hold from Barclays,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-barclays-1032437139,positive,0.8307812809944153
5797,7/11/2023 3:07:52 PM,Vaxcyte advances infant vaccine pneumonia candidate,Seeking Alpha,https://seekingalpha.com/news/3986807-vaxcyte-advances-infant-vaccine-pneumonia-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.5704950094223022
5798,7/11/2023 3:37:40 PM,"iRobot, Seagen, Horizon gain amid Microsoft win in Activision case",Seeking Alpha,https://seekingalpha.com/news/3986814-irobot-seagen-horizon-gain-amid-microsoft-win-in-activision-case?utm_source=businessinsider&utm_medium=referral,negative,0.8703763484954834
5799,7/12/2023 12:53:33 AM,Why These 7 Stocks Are the Best Ways to Play Biotech Right Now,InvestorPlace,/news/stocks/why-these-7-stocks-are-the-best-ways-to-play-biotech-right-now-1032439054,positive,0.9327079057693481
5800,7/13/2023 11:10:17 AM,"Analysts’ Top Healthcare Picks: Genmab (GMAB), Pfizer (PFE)",TipRanks,/news/stocks/analysts-top-healthcare-picks-genmab-gmab-pfizer-pfe-1032444048,negative,0.6821550726890564
5801,7/13/2023 2:15:35 PM,Credit Suisse Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/credit-suisse-sticks-to-its-hold-rating-for-pfizer-pfe-1032445127,positive,0.7862234711647034
5802,7/13/2023 2:29:45 PM,HHS secretary asks COVID vaccine makers to price shots fairly,Seeking Alpha,https://seekingalpha.com/news/3987416-hhs-secretary-asks-covid-vaccine-makers-price-shots-fairly?utm_source=businessinsider&utm_medium=referral,positive,0.9106236696243286
5803,7/13/2023 3:54:05 PM,CureVac - Pfizer/BioNTech patent fight extends to updated COVID shots,Seeking Alpha,https://seekingalpha.com/news/3987455-curevac-pfizer-biontech-patent-fight-widens-to-updated-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.8882575035095215
5804,7/13/2023 6:15:36 PM,CDC to offer free COVID vaccines for Americans without insurance,Seeking Alpha,https://seekingalpha.com/news/3987497-cdc-offers-free-covid-shots-those-without-insurance?utm_source=businessinsider&utm_medium=referral,positive,0.5969369411468506
5805,7/13/2023 11:22:04 PM,Roivant reportedly could sell colitis drug to Roche for over $7B,Seeking Alpha,https://seekingalpha.com/news/3987582-roivant-reportedly-could-sell-colitis-drug-to-roche-for-over-7b?utm_source=businessinsider&utm_medium=referral,positive,0.9101323485374451
5806,7/14/2023 1:24:24 AM,3 Pharma Stocks That AI is Loving in July,InvestorPlace,/news/stocks/3-pharma-stocks-that-ai-is-loving-in-july-1032445958,positive,0.9090803265571594
5807,7/14/2023 1:20:24 PM,CureVac announces resignation of science chief,Seeking Alpha,https://seekingalpha.com/news/3987702-curevac-stock-falls-science-chief-resigns?utm_source=businessinsider&utm_medium=referral,neutral,0.7483858466148376
5808,7/14/2023 2:35:47 PM,Seagen pares loss amid report it will get 2nd request from FTC in Pfizer deal,Seeking Alpha,https://seekingalpha.com/news/3987737-seagen-drops-on-report-it-will-get-2nd-request-from-ftc-in-pfizer-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.8504857420921326
5809,7/14/2023 3:27:59 PM,Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M,Benzinga,/news/stocks/caribou-biosciences-raises-125m-via-equity-just-one-week-after-pfizer-invested-25m-1032447513,negative,0.6618283987045288
5810,7/14/2023 5:02:15 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-14-2023-1032447974,positive,0.4949893355369568
5811,7/14/2023 10:15:46 PM,"Seagen, Pfizer get second info request from FTC on $43B merger deal",Seeking Alpha,https://seekingalpha.com/news/3987846-seagen-pfizer-get-second-info-request-from-ftc-on-43b-merger-deal?utm_source=businessinsider&utm_medium=referral,positive,0.8566860556602478
5812,7/15/2023 6:00:00 PM,Atrial fibrillation drug market expected to decline as brand therapies go generic,Seeking Alpha,https://seekingalpha.com/news/3987824-atrial-fibrillation-drug-market-expected-decline-brand-therapies-generic?utm_source=businessinsider&utm_medium=referral,neutral,0.9694817066192627
5813,7/15/2023 6:23:14 PM,7 Undervalued Blue-Chip Stocks for High Total Returns,InvestorPlace,/news/stocks/7-undervalued-blue-chip-stocks-for-high-total-returns-1032448718,negative,0.9381999373435974
5814,7/16/2023 4:00:00 PM,"Eli Lilly, Merck among top pharma picks in Barclays Q2 preview",Seeking Alpha,https://seekingalpha.com/news/3987868-eli-lilly-merck-among-top-pharma-picks-in-barclays-q2-preview?utm_source=businessinsider&utm_medium=referral,positive,0.4974316656589508
5815,7/17/2023 12:14:12 AM,"HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna",Seeking Alpha,https://seekingalpha.com/news/3987876-hsbc-bullish-on-roche-lonza-bearish-on-bristol-myers-gsk-moderna?utm_source=businessinsider&utm_medium=referral,negative,0.4802684485912323
5816,7/17/2023 2:45:32 AM,3 Cheap Retirement Stocks for Your July Must-Buy List,InvestorPlace,/news/stocks/3-cheap-retirement-stocks-for-your-july-must-buy-list-1032449285,positive,0.9100825786590576
5817,7/17/2023 10:30:31 AM,Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-argenx-se-argx-and-pfizer-pfe-1032450876,positive,0.9180102944374084
5818,7/18/2023 1:00:00 PM,Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs,PR Newswire,/news/stocks/flagship-pioneering-and-pfizer-partner-to-accelerate-development-of-innovative-medicines-targeting-unmet-needs-1032454403,negative,0.8626371622085571
5819,7/18/2023 1:13:59 PM,"Pfizer, venture capital company to work on drugs for unmet needs",Seeking Alpha,https://seekingalpha.com/news/3988360-pfizer-venture-capital-company-work-drugs-unmet-needs?utm_source=businessinsider&utm_medium=referral,positive,0.7402923703193665
5820,7/18/2023 1:47:52 PM,"Flagship Pioneering, Pfizer Partner To Develop Innovative Medicines ",RTTNews,/news/stocks/flagship-pioneering-pfizer-partner-to-develop-innovative-medicines-1032454519,negative,0.6436284184455872
5821,7/19/2023 9:37:09 PM,Pfizer plant in NC severely damaged by strong tornado,Seeking Alpha,https://seekingalpha.com/news/3988992-pfizer-plant-nc-severely-damaged-tornado?utm_source=businessinsider&utm_medium=referral,neutral,0.9567554593086243
5822,7/19/2023 10:12:51 PM,Pfizer says phase 2 data shows efficacy of maternal strep vaccine,Seeking Alpha,https://seekingalpha.com/news/3988997-pfizer-phase-2-data-efficacy-maternal-strep-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8039102554321289
5823,7/20/2023 12:44:30 PM,3 Blue-Chip Stocks Trading at a Valuation Gap,InvestorPlace,/news/stocks/3-blue-chip-stocks-trading-at-a-valuation-gap-1032462457,positive,0.818688690662384
5824,7/20/2023 5:58:57 PM,Lawmakers reintroduce bill to offer Medicare coverage for weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/3989310-bill-offer-medicare-coverage-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral,negative,0.5810311436653137
5825,7/20/2023 6:51:55 PM,Morgan Stanley sees tornado-ravaged plant's impact on Pfizer as minimal,Seeking Alpha,https://seekingalpha.com/news/3989334-morgan-stanley-sees-tornado-ravaged-plants-impact-on-pfizer-as-minimal?utm_source=businessinsider&utm_medium=referral,neutral,0.8180175423622131
5826,7/21/2023 11:04:04 AM,"Dividend Roundup: Bank of America, Ford, Pfizer, Kinder Morgan, and more",Seeking Alpha,https://seekingalpha.com/news/3989246-dividend-roundup-bank-of-america-ford-f-pfizer-pfe-kinder-morgan-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9455329179763794
5827,7/21/2023 1:53:59 PM,Pfizer wins EU backing for RSV vaccine,Seeking Alpha,https://seekingalpha.com/news/3989658-pfizer-wins-eu-backing-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8294965028762817
5828,7/21/2023 7:00:25 PM,The Latest Analyst Ratings for Pfizer,Benzinga,/news/stocks/the-latest-analyst-ratings-for-pfizer-1032466650,positive,0.9401854276657104
5829,7/22/2023 6:00:00 PM,"Pfizer, Gilead, GSK set to dominate infectious diseases market",Seeking Alpha,https://seekingalpha.com/news/3989757-pfizer-gilead-gsk-dominate-infectious-diseases-market?utm_source=businessinsider&utm_medium=referral,positive,0.8319868445396423
5830,7/24/2023 2:03:56 PM,Syros falls as Pfizer ends collaboration,Seeking Alpha,https://seekingalpha.com/news/3990068-syros-stock-falls-pfizer-ends-collaboration?utm_source=businessinsider&utm_medium=referral,neutral,0.5013824105262756
5831,7/24/2023 4:47:18 PM,GSK announces EU nod for HIV prevention therapy,Seeking Alpha,https://seekingalpha.com/news/3990137-gsk-announces-eu-nod-hiv-prevention-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.717473566532135
5832,7/24/2023 7:17:16 PM,Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition,Benzinga,/news/stocks/analyst-initiates-arcturus-sees-attractive-growth-trajectory-with-vaccine-franchise-despite-competition-1032471176,negative,0.9477967619895935
5833,7/25/2023 5:55:55 PM,GSK’s plans for RSV shot in focus ahead of Q2 2023 results,Seeking Alpha,https://seekingalpha.com/news/3990729-gsk-previews-plans-rsv-shot-ahead-q2-2023-results?utm_source=businessinsider&utm_medium=referral,positive,0.6828890442848206
5834,7/27/2023 1:40:11 PM,Biohaven falls as FDA rejects filing for movement disorder therapy,Seeking Alpha,https://seekingalpha.com/news/3992141-biohaven-stock-falls-fda-snubs-movement-disorder-therapy?utm_source=businessinsider&utm_medium=referral,neutral,0.9527302384376526
5835,7/27/2023 5:10:10 PM,Merck pneumococcal vaccine outperforms PCV20 in Phase 3 trials,Seeking Alpha,https://seekingalpha.com/news/3992254-merck-pneumococcal-shot-outperforms-pcv20-in-phase-3-trials?utm_source=businessinsider&utm_medium=referral,negative,0.9348018765449524
5836,7/27/2023 8:41:30 PM,Pfizer restructuring leadership in R&D,Seeking Alpha,https://seekingalpha.com/news/3992454-pfizer-restructuring-leadership-research-development?utm_source=businessinsider&utm_medium=referral,positive,0.8248466849327087
5837,7/28/2023 10:51:22 AM,AstraZeneca unit in $1B deal with Pfizer for gene therapies,Seeking Alpha,https://seekingalpha.com/news/3992731-astrazeneca-unit-1b-deal-pfizer-gene-therapies?utm_source=businessinsider&utm_medium=referral,negative,0.563864529132843
5838,7/28/2023 12:21:42 PM,"AstraZeneca Q2 Profit Surges, Signs Gene Therapy Deal With Pfizer; Stock Up ",RTTNews,/news/stocks/astrazeneca-q2-profit-surges-signs-gene-therapy-deal-with-pfizer-stock-up-1032489406,negative,0.9269058108329773
5839,7/28/2023 5:56:18 PM,Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated,Benzinga,/news/stocks/reata-s-acquisition-fits-biogen-s-strategy-despite-high-cost-analyst-says-high-level-regulatory-scrutiny-not-anticipated-1032490800,positive,0.5035784840583801
5840,7/28/2023 6:00:40 PM,"Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?",Seeking Alpha,https://seekingalpha.com/news/3992944-catalyst-watch-amazon-earnings-jobs-report-and-will-apple-talk-ai?utm_source=businessinsider&utm_medium=referral,positive,0.9321873188018799
5841,7/30/2023 6:00:00 PM,RSV treatment market to surge past $9B by 2029,Seeking Alpha,https://seekingalpha.com/news/3993213-rsv-treatment-market-surge-past-9b-by-2029?utm_source=businessinsider&utm_medium=referral,negative,0.9445205330848694
5842,7/30/2023 7:00:57 PM,3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes,InvestorPlace,/news/stocks/3-millionaire-maker-biotech-stocks-to-buy-before-the-window-closes-1032492374,positive,0.8541695475578308
5843,7/30/2023 7:24:28 PM,7 Dow Stocks to Buy as Recession Fears Roll Back,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-as-recession-fears-roll-back-1032492376,positive,0.43502503633499146
5844,7/31/2023 9:34:27 AM,3 Pharma Stocks to Buy for Their Promising Progress,InvestorPlace,/news/stocks/3-pharma-stocks-to-buy-for-their-promising-progress-1032494547,negative,0.7185419797897339
5845,7/31/2023 9:46:38 AM,Biotech Stocks Facing FDA Decision In August 2023 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-august-2023-1032494050,positive,0.9162535071372986
5846,7/31/2023 9:53:55 AM,"If You Can Only Buy 1 Blue-Chip Stock, It Better Be One of These Names",InvestorPlace,/news/stocks/if-you-can-only-buy-1-blue-chip-stock-it-better-be-one-of-these-names-1032494568,positive,0.9402691125869751
5847,7/31/2023 10:10:05 AM,7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick,InvestorPlace,/news/stocks/7-healthcare-stocks-to-ditch-before-they-make-your-portfolio-sick-1032494609,positive,0.7387374043464661
5848,7/31/2023 2:46:05 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3993451-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
5849,7/31/2023 3:01:13 PM,Pfizer earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/pfizer-stock-price-quarter-earnings-preview-q2-1032495406,positive,0.9320189952850342
5850,7/31/2023 7:46:32 PM,Pfizer seen reporting sharply lower Q2 sales as COVID-19 vaccine demand wanes,Seeking Alpha,https://seekingalpha.com/news/3993675-pfizer-seen-reporting-sharply-lower-q2-sales-as-covid-19-vaccine-demand-wanes?utm_source=businessinsider&utm_medium=referral,neutral,0.9745243191719055
5851,7/31/2023 7:52:35 PM,7 Stocks to Buy Before They Surpass 2021 Highs,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-surpass-2021-highs-stocks-to-watch-before-new-peaks-1032496877,positive,0.8164246082305908
5852,8/1/2023 8:45:22 AM,Bank of America Securities Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/bank-of-america-securities-sticks-to-their-hold-rating-for-pfizer-pfe-1032499643,positive,0.9064830541610718
5853,8/1/2023 10:48:50 AM,Pfizer reports mixed Q2 earnings; narrows FY23 outlook,Seeking Alpha,https://seekingalpha.com/news/3994002-pfizer-reports-mixed-q2-earnings-narrows-fy23-outlook?utm_source=businessinsider&utm_medium=referral,neutral,0.9728455543518066
5854,8/1/2023 11:10:35 AM,Looking for a Bargain? 7 Blue-Chip Stocks to Buy That Are Down 5% in 2023,InvestorPlace,/news/stocks/looking-for-a-bargain-7-blue-chip-stocks-to-buy-that-are-down-5-in-2023-1032500151,neutral,0.9714455604553223
5855,8/1/2023 12:15:50 PM,Pfizer reports 54% contraction in Q2 sales amid COVID cliff,Seeking Alpha,https://seekingalpha.com/news/3994109-pfizer-reports-contraction-q2-sales-amid-covid-cliff?utm_source=businessinsider&utm_medium=referral,neutral,0.9758301973342896
5856,8/1/2023 12:40:08 PM,Analysts Conflicted on These Healthcare Names: Cidara Therapeutics (CDTX) and Pfizer (PFE),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-cidara-therapeutics-cdtx-and-pfizer-pfe-1032500490,neutral,0.5113035440444946
5857,8/1/2023 12:51:49 PM,"Pfizer Inc. Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/pfizer-inc-q2-profit-decreases-but-beats-estimates-1032499984,neutral,0.9636946320533752
5858,8/1/2023 1:15:00 PM,"6 stocks to watch on Tuesday: Uber, Pfizer, Caterpillar, AMD and more",Seeking Alpha,https://seekingalpha.com/news/3994161-6-stocks-to-watch-on-tuesday-uber-pfizer-caterpillar-amd-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9243804216384888
5859,8/1/2023 1:18:43 PM,Pfizer Reaffirms FY23 Adj. EPS Outlook - Update ,RTTNews,/news/stocks/pfizer-reaffirms-fy23-adj-eps-outlook-update-1032500139,positive,0.9168490767478943
5860,8/1/2023 3:51:40 PM,US Stocks Mixed; Pfizer Earnings Beat Views,Benzinga,/news/stocks/us-stocks-mixed-pfizer-earnings-beat-views-1032501209,negative,0.8312426209449768
5861,8/1/2023 5:32:44 PM,Daiichi COVID vaccine endorsed in Japan; Shionogi’s shot declined,Seeking Alpha,https://seekingalpha.com/news/3994458-daiichi-covid-shot-endorsed-japan-shionogi-shot-declined?utm_source=businessinsider&utm_medium=referral,positive,0.8569828271865845
5862,8/1/2023 8:35:25 PM,Jefferies Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-its-hold-rating-for-pfizer-pfe-1032502572,positive,0.8285176157951355
5863,8/1/2023 8:55:04 PM,Credit Suisse Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/credit-suisse-reaffirms-their-hold-rating-on-pfizer-pfe-1032502633,positive,0.8161340951919556
5864,8/2/2023 9:25:58 AM,Barclays Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-pfizer-pfe-1032505700,positive,0.847312331199646
5865,8/2/2023 10:45:30 AM,Goldman Sachs Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/goldman-sachs-sticks-to-their-buy-rating-for-pfizer-pfe-1032506061,positive,0.8834558129310608
5866,8/2/2023 11:16:10 AM,BMO Capital Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/bmo-capital-remains-a-buy-on-pfizer-pfe-1032506205,positive,0.9483590126037598
5867,8/2/2023 3:29:15 PM,GSK sues Pfizer over patents in RSV vaccine,Seeking Alpha,https://seekingalpha.com/news/3995253-gsk-sues-pfizer-patents-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,neutral,0.9320486187934875
5868,8/2/2023 5:42:49 PM,Cerevel Therapeutics falls on delayed data readouts,Seeking Alpha,https://seekingalpha.com/news/3995478-cerevel-therapeutics-stock-falls-delay-key-readout?utm_source=businessinsider&utm_medium=referral,neutral,0.9609677791595459
5869,8/3/2023 10:00:25 AM,Get Out Now! 7 Stocks to Dump After Sorry Q2 Earnings,InvestorPlace,/news/stocks/get-out-now-7-stocks-to-dump-after-sorry-q2-earnings-1032511780,neutral,0.5909273028373718
5870,8/4/2023 8:58:49 PM,Pfizer alerts hospitals to drug shortages caused by damage to NC plant,Seeking Alpha,https://seekingalpha.com/news/3997907-pfizer-alerts-hospitals-to-drug-shortages-caused-by-damage-to-nc-plant?utm_source=businessinsider&utm_medium=referral,neutral,0.948944091796875
5871,8/4/2023 10:48:12 PM,Pfizer Faces Distribution Restrictions Following Tornado Damage To North Carolina Plant ,RTTNews,/news/stocks/pfizer-faces-distribution-restrictions-following-tornado-damage-to-north-carolina-plant-1032519279,neutral,0.9263595342636108
5872,8/6/2023 12:20:32 PM,3 Cheap Long-Term Stocks That Smart Investors Will Snap Up Now,InvestorPlace,/news/stocks/3-cheap-long-term-stocks-that-smart-investors-will-snap-up-now-1032520071,positive,0.8588322401046753
5873,8/6/2023 4:00:54 PM,Nearly half of U.S. adults want weight-loss drugs – KFF poll,Seeking Alpha,https://seekingalpha.com/news/3997955-nearly-half-of-americans-want-weight-loss-drugs-kff-poll?utm_source=businessinsider&utm_medium=referral,positive,0.856417715549469
5874,8/6/2023 7:35:00 PM,2023 shaping up to be biggest year for biopharma M&A since pandemic,Seeking Alpha,https://seekingalpha.com/news/3997958-2023-shaping-up-to-be-biggest-year-for-biopharma-ma-since-pandemic?utm_source=businessinsider&utm_medium=referral,negative,0.8588072657585144
5875,8/7/2023 9:16:41 AM,BMO Capital Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/bmo-capital-remains-a-buy-on-pfizer-pfe-1032523182,positive,0.9483590126037598
5876,8/7/2023 11:01:00 AM,BioNTech reins in costs amid hit to COVID-driven sales boom,Seeking Alpha,https://seekingalpha.com/news/3998038-biontech-controls-costs-amid-hit-covid-driven-sales-boom?utm_source=businessinsider&utm_medium=referral,neutral,0.9215219616889954
5877,8/7/2023 11:43:11 AM,Viatris posts first topline beat in over a year as Q2 revenue improves,Seeking Alpha,https://seekingalpha.com/news/3998067-viatris-posts-first-topline-beat-over-year-q2?utm_source=businessinsider&utm_medium=referral,negative,0.9367648363113403
5878,8/7/2023 5:14:48 PM,Can Novavax beat in Q2 amid pressure on COVID vaccine sales,Seeking Alpha,https://seekingalpha.com/news/3998362-can-novavax-beat-q2-amid-pressure-covid-vaccine-sales?utm_source=businessinsider&utm_medium=referral,negative,0.8561626672744751
5879,8/8/2023 1:16:03 PM,Maravai LifeSciences falls as Q2 miss prompts KeyBanc downgrade,Seeking Alpha,https://seekingalpha.com/news/3999053-maravai-stock-falls-q2-miss-prompts-keybanc-downgrade?utm_source=businessinsider&utm_medium=referral,neutral,0.9695918560028076
5880,8/8/2023 2:47:02 PM,Watch weight loss stocks after cardiovascular data for Wegovy,Seeking Alpha,https://seekingalpha.com/news/3999115-watch-weight-loss-stocks-cardiovascular-data-for-wegovy?utm_source=businessinsider&utm_medium=referral,positive,0.8803889155387878
5881,8/8/2023 4:45:03 PM,Cardiff Oncology soars as Pfizer backs lead program,Seeking Alpha,https://seekingalpha.com/news/3999197-cardiff-oncology-stock-soars-pfizer-backing?utm_source=businessinsider&utm_medium=referral,negative,0.37631887197494507
5882,8/9/2023 12:13:17 AM,Pfizer Stock’s (NYSE:PFE) Future: Not as Bleak as You’d Think,TipRanks,/news/stocks/pfizer-stock-s-nyse-pfe-future-not-as-bleak-as-you-d-think-1032531144,positive,0.5116505026817322
5883,8/9/2023 1:55:29 AM,3 Massively Undervalued Blue-Chip Stocks for High Total Returns,InvestorPlace,/news/stocks/3-massively-undervalued-blue-chip-stocks-for-high-total-returns-1032531183,negative,0.9129492044448853
5884,8/9/2023 9:00:31 AM,7 Dividend Stocks to Buy for Income and Upside,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-income-and-upside-1032533962,positive,0.9386195540428162
5885,8/9/2023 5:10:29 PM,WHO names newly dominant EG.5 strain as COVID 'variant of interest',Seeking Alpha,https://seekingalpha.com/news/4000251-who-names-new-eg5-covid-strain-variant-of-interest?utm_source=businessinsider&utm_medium=referral,positive,0.8653609156608582
5886,8/9/2023 10:35:51 PM,3 Healthcare Stocks to Sell in August Before They Crash and Burn,InvestorPlace,/news/stocks/healthcare-stocks-to-sell-in-august-1032536970,positive,0.7637110352516174
5887,8/10/2023 12:55:02 AM,The 7 Best Sleeper Stocks to Buy in August,InvestorPlace,/news/stocks/the-7-best-sleeper-stocks-to-buy-in-august-1032537041,positive,0.8513137102127075
5888,8/10/2023 1:49:21 AM,7 Blue-Chip Stocks to Buy at an All-Time Low in August,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-at-an-all-time-low-in-august-1032537064,neutral,0.9019711017608643
5889,8/10/2023 2:20:13 PM,Atea downgraded at JPMorgan on shrinking COVID opportunity,Seeking Alpha,https://seekingalpha.com/news/4000990-atea-stock-downgraded-jpmorgan-covid-concerns?utm_source=businessinsider&utm_medium=referral,positive,0.6330673098564148
5890,8/10/2023 3:00:00 PM,Medicare Part D drug price increases far exceed inflation - AARP,Seeking Alpha,https://seekingalpha.com/news/4000101-medicare-part-d-drug-price-increases-far-exceed-inflation?utm_source=businessinsider&utm_medium=referral,negative,0.8962883353233337
5891,8/11/2023 1:39:08 AM,7 Dirt-Cheap Stocks to Buy in August,InvestorPlace,/news/stocks/7-dirt-cheap-stocks-to-buy-in-august-1032542556,positive,0.5013045072555542
5892,8/11/2023 9:09:35 PM,"Pfizer Collaboration Offers Potential Milestone Windfalls For TBIO, Despite Financial Hurdles: Analyst",Benzinga,/news/stocks/pfizer-collaboration-offers-potential-milestone-windfalls-for-tbio-despite-financial-hurdles-analyst-1032547839,negative,0.928033173084259
5893,8/11/2023 11:25:26 PM,"Pfizer, Scripps sue over planned Vyndamax copycat",Seeking Alpha,https://seekingalpha.com/news/4002018-pfizer-scripps-sue-planned-vyndamax-copycat?utm_source=businessinsider&utm_medium=referral,neutral,0.8042605519294739
5894,8/13/2023 1:24:10 PM,"Horizon Therapeutics, Activision among best bets for M&A deals to close",Seeking Alpha,https://seekingalpha.com/news/4002057-horizon-therapeutics-activision-among-best-bets-for-ma-deals-to-close?utm_source=businessinsider&utm_medium=referral,positive,0.5431340932846069
5895,8/13/2023 4:00:00 PM,Inside COVID-19 vaccine makers: Hope vs hype,Seeking Alpha,https://seekingalpha.com/news/4002033-inside-covid-19-vaccine-makers-hope-vs-hype?utm_source=businessinsider&utm_medium=referral,positive,0.8822358250617981
5896,8/13/2023 6:00:00 PM,Pharma under threat from bill to expand drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4002034-pharma-under-threat-bill-expand-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.5231574177742004
5897,8/14/2023 7:08:13 PM,Pfizer wins FDA nod for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4002480-pfizer-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8381549715995789
5898,8/14/2023 9:58:46 PM,Catalent accused of misleading investors in shareholder suit,Seeking Alpha,https://seekingalpha.com/news/4002679-catalent-accused-misleading-investors-shareholder-suit?utm_source=businessinsider&utm_medium=referral,positive,0.4857162833213806
5899,8/16/2023 12:52:48 PM,Seagen Tukysa combo breast cancer treatment successful in phase 3,Seeking Alpha,https://seekingalpha.com/news/4003406-seagen-tukysa-kadcyla-combo-breast-cancer-treatment-successful-phase-3?utm_source=businessinsider&utm_medium=referral,negative,0.7306926846504211
5900,8/16/2023 8:12:17 PM,Seagen's Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa's Current Market,Benzinga,/news/stocks/seagen-s-positive-trial-outcomes-analyst-says-the-update-might-double-tukysa-s-current-market-1032560932,negative,0.956159234046936
5901,8/16/2023 11:07:03 PM,The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-healthcare-stocks-to-buy-now-august-2023-1032561356,positive,0.8634922504425049
5902,8/17/2023 9:12:48 AM,The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-biotech-stocks-to-buy-now-august-2023-1032562527,positive,0.901785671710968
5903,8/17/2023 10:34:21 PM,Why did BioNTech stock go up today? Rising COVID rates,Seeking Alpha,https://seekingalpha.com/news/4004195-why-did-biontech-stock-go-up-today-rising-covid-rates?utm_source=businessinsider&utm_medium=referral,negative,0.41098275780677795
5904,8/18/2023 4:21:55 PM,"SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories",Benzinga,/news/stocks/spacex-on-par-with-intel-disney-us-weight-loss-drugs-pricier-moderna-pfizer-s-shot-effective-against-new-variant-today-s-top-stories-1032566971,negative,0.7262046933174133
5905,8/18/2023 5:10:25 PM,"AARP, Public Citizen file briefs in Medicare drug price negotiations case",Seeking Alpha,https://seekingalpha.com/news/4004411-aarp-public-citizen-file-briefs-medicare-drug-price-negotiations-case?utm_source=businessinsider&utm_medium=referral,positive,0.8961257338523865
5906,8/20/2023 11:00:45 AM,The 3 Most Undervalued Dividend Stocks With Growth Potential to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dividend-stocks-with-growth-potential-to-buy-now-august-2023-1032567946,positive,0.861354649066925
5907,8/20/2023 4:00:00 PM,RSV vaccine sales for elderly expected to top $10B by 2030 in G7 nations,Seeking Alpha,https://seekingalpha.com/news/4004505-rsv-vaccine-sales-elderly-top-10b-by-2030-g7?utm_source=businessinsider&utm_medium=referral,negative,0.895885705947876
5908,8/20/2023 4:15:42 PM,7 Top Stock Opportunities on the Heels of the Latest Jobs Report,InvestorPlace,/news/stocks/7-top-stock-opportunities-on-the-heels-of-the-latest-jobs-report-1032568116,neutral,0.41960081458091736
5909,8/21/2023 9:30:10 AM,The 3 Most Undervalued Pharma Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-pharma-stocks-to-buy-now-august-2023-1032569068,positive,0.8989936709403992
5910,8/21/2023 3:28:18 PM,5 Safe Stocks Under $40 to Buy Immediately,InvestorPlace,/news/stocks/5-safe-stocks-under-40-to-buy-immediately-1032570520,positive,0.8483371734619141
5911,8/21/2023 5:53:35 PM,Vaccine makers light up as COVID hospitalizations rise,Seeking Alpha,https://seekingalpha.com/news/4004883-vaccine-makers-light-up-covid-hospitalizations-rise?utm_source=businessinsider&utm_medium=referral,positive,0.7403080463409424
5912,8/21/2023 7:58:31 PM,"Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk",Seeking Alpha,https://seekingalpha.com/news/4004913-lillys-market-cap-soared-in-q2-eclipsing-jnj-merck-novo-nordisk?utm_source=businessinsider&utm_medium=referral,negative,0.9460121989250183
5913,8/21/2023 10:34:07 PM,FDA approves Pfizer's RSV vaccine as maternal immunization for babies,Seeking Alpha,https://seekingalpha.com/news/4004992-fda-approves-pfizers-rsv-vaccine-as-maternal-immunization-for-babies?utm_source=businessinsider&utm_medium=referral,positive,0.5777451992034912
5914,8/22/2023 7:26:02 AM,FDA Approves Pfizer's Abrysvo For Pregnant Individuals To Prevent RSV In Infants ,RTTNews,/news/stocks/fda-approves-pfizer-s-abrysvo-for-pregnant-individuals-to-prevent-rsv-in-infants-1032571616,negative,0.7487779855728149
5915,8/22/2023 9:52:31 AM,Lions Gate brings back mask mandate as COVID cases resurge in LA,Seeking Alpha,https://seekingalpha.com/news/4005018-lions-gate-brings-back-mask-mandate-as-covid-cases-resurge-in-la?utm_source=businessinsider&utm_medium=referral,negative,0.5908417701721191
5916,8/22/2023 1:31:03 PM,Novavax (NVAX) Stock Is Getting Ready to Rally Again,InvestorPlace,/news/stocks/novavax-nvax-stock-is-getting-ready-to-rally-again-1032573242,negative,0.9096896052360535
5917,8/22/2023 10:00:59 PM,The Latest Analyst Ratings for Pfizer,Benzinga,/news/stocks/the-latest-analyst-ratings-for-pfizer-1032574349,positive,0.9401854276657104
5918,8/23/2023 8:25:32 AM,Cantor Fitzgerald Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-pfizer-pfe-1032575467,positive,0.9459741115570068
5919,8/23/2023 9:11:20 AM,3 Pharma Stocks to Buy as Summer COVID Cases Spike,InvestorPlace,/news/stocks/3-pharma-stocks-to-buy-as-summer-covid-cases-spike-1032575620,positive,0.8442111015319824
5920,8/23/2023 11:00:04 AM,7 Blue-Chip Bargains to Grab Now at Their All-Time Lows,InvestorPlace,/news/stocks/7-blue-chip-bargains-to-grab-now-at-their-all-time-lows-1032575926,neutral,0.8560904860496521
5921,8/23/2023 12:12:30 PM,"Pfizer, Astellas win FDA priority review for Xtandi label expansion",Seeking Alpha,https://seekingalpha.com/news/4005470-pfizer-astellas-win-fda-priority-review-widen-xtandi-use?utm_source=businessinsider&utm_medium=referral,negative,0.8792129755020142
5922,8/23/2023 12:45:00 PM,FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence,PR Newswire,/news/stocks/fda-grants-priority-review-for-xtandi-in-non-metastatic-castration-sensitive-prostate-cancer-with-high-risk-biochemical-recurrence-1032575842,negative,0.8726021647453308
5923,8/23/2023 1:21:21 PM,"Pfizer, Astellas' XTANDI Gets Priority Review In Non-metastatic Castration-sensitive Prostate Cancer ",RTTNews,/news/stocks/pfizer-astellas-xtandi-gets-priority-review-in-non-metastatic-castration-sensitive-prostate-cancer-1032575965,negative,0.8949735164642334
5924,8/23/2023 5:08:28 PM,New COVID variant can cause infection in those previously vaccinated - CDC,Seeking Alpha,https://seekingalpha.com/news/4005635-new-covid-variant-cause-infection-those-previously-vaccinated-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.6834173798561096
5925,8/23/2023 7:16:03 PM,7 Very Oversold High-Yield Stocks to Buy Right Now,InvestorPlace,/news/stocks/7-very-oversold-high-yield-stocks-to-buy-right-now-1032577760,neutral,0.625315248966217
5926,8/24/2023 2:15:00 AM,Everest Medicines Announces Interim Results for First Half of 2023,PR Newswire,/news/stocks/everest-medicines-announces-interim-results-for-first-half-of-2023-1032578058,positive,0.9051584005355835
5927,8/24/2023 1:44:18 PM,Drugs picked for Medicare price negotiations to be announced on Tuesday – Politico,Seeking Alpha,https://seekingalpha.com/news/4005992-drug-list-picked-medicare-price-negotiations-due-tuesday?utm_source=businessinsider&utm_medium=referral,positive,0.9293889403343201
5928,8/24/2023 4:51:17 PM,Pfizer wins EU approval for RSV vaccine,Seeking Alpha,https://seekingalpha.com/news/4006085-pfizer-wins-eu-approval-rsv-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.8159151673316956
5929,8/24/2023 8:18:35 PM,eFFECTOR Stock To Rally Over 500%? Analyst Predict Blockbuster Status For Cancer Candidates,Benzinga,/news/stocks/effector-stock-to-rally-over-500-analyst-predict-blockbuster-status-for-cancer-candidates-1032580948,negative,0.9168234467506409
5930,8/25/2023 3:38:26 AM,EU Approves Pfizer' Abrysvo To Help Protect Infants And Older Adults From RSV ,RTTNews,/news/stocks/eu-approves-pfizer-abrysvo-to-help-protect-infants-and-older-adults-from-rsv-1032581345,negative,0.8526825308799744
5931,8/25/2023 6:17:23 PM,CDC advisors to meet Sept. 12 to discuss new COVID shots (updated),Seeking Alpha,https://seekingalpha.com/news/4006524-cdc-advisors-meet-sept-12-discuss-new-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.9317560195922852
5932,8/25/2023 9:08:21 PM,Horizon Therapeutics jumps as FTC withdraws in-house trial on $28B Amgen deal (update),Seeking Alpha,https://seekingalpha.com/news/4006558-horizon-therapeutics-jumps-as-ftc-withdraws-in-house-trial-on-28b-amgen-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.809974730014801
5933,8/25/2023 9:30:54 PM,"HC Wainwright starts eFFECTOR at buy, cites drug technology platform",Seeking Alpha,https://seekingalpha.com/news/4006567-hc-wainwright-starts-effector-at-buy-cites-drug-technology-platform?utm_source=businessinsider&utm_medium=referral,positive,0.8681713342666626
5934,8/26/2023 6:00:00 PM,Crohn's disease drugmakers set to benefit from expected rise in cases,Seeking Alpha,https://seekingalpha.com/news/4006563-crohns-disease-drugmakers-benefit-expected-rise-cases?utm_source=businessinsider&utm_medium=referral,negative,0.9470040202140808
5935,8/27/2023 4:00:00 PM,Wall Street lists potential targets for Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4006581-wall-street-lists-targets-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.8904427886009216
5936,8/28/2023 10:35:42 AM,Hedge and mutual funds rotate from tech; see the stocks they love and shun,Seeking Alpha,https://seekingalpha.com/news/4006637-hedge-and-mutual-funds-rotate-from-tech-see-the-stocks-they-love-and-shun?utm_source=businessinsider&utm_medium=referral,positive,0.6943780183792114
5937,8/28/2023 12:15:27 PM,Horizon Therapeutics jumps after FTC pauses Amgen challenge for settlement talks,Seeking Alpha,https://seekingalpha.com/news/4006682-horizon-therapeutics-jumps-after-ftc-pauses-amgen-challenge-for-settlement-talks?utm_source=businessinsider&utm_medium=referral,neutral,0.6587751507759094
5938,8/28/2023 2:21:53 PM,Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-3-dividend-yields-1032585778,positive,0.8560808897018433
5939,8/28/2023 7:20:21 PM,Pfizer sees Q4 restart at tornado damaged N.C. facility,Seeking Alpha,https://seekingalpha.com/news/4006836-pfizer-sees-q4-restart-tornado-damaged-nc-facility?utm_source=businessinsider&utm_medium=referral,positive,0.8246124982833862
5940,8/28/2023 8:16:00 PM,Alnylam appealing patent ruling in case against Moderna,Seeking Alpha,https://seekingalpha.com/news/4006849-alnylam-appealing-patent-ruling-case-against-moderna?utm_source=businessinsider&utm_medium=referral,neutral,0.39562463760375977
5941,8/29/2023 12:06:34 AM,Timeless Titans: 3 Blue-Chip Stocks Destined for 100% Gains by 2024,InvestorPlace,/news/stocks/timeless-titans-3-blue-chip-stocks-destined-for-100-gains-by-2024-1032587294,negative,0.7848394513130188
5942,8/29/2023 11:45:20 AM,Medicare lists first ten drugs selected for pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/4006764-medicare-lists-first-ten-drugs-picked-pricing-talks?utm_source=businessinsider&utm_medium=referral,positive,0.9310519099235535
5943,8/29/2023 7:29:57 PM,Republicans say Medicare drug negotiations will mean fewer new meds,Seeking Alpha,https://seekingalpha.com/news/4007245-republicans-say-medicare-drug-negotiations-fewer-new-meds?utm_source=businessinsider&utm_medium=referral,neutral,0.8554677963256836
5944,8/30/2023 4:18:34 PM,"Pfizer, BioNTech Obtain Positive CHMP Opinion For Omicron XBB.1.5-adapted COVID-19 Vaccine In EU ",RTTNews,/news/stocks/pfizer-biontech-obtain-positive-chmp-opinion-for-omicron-xbb-1-5-adapted-covid-19-vaccine-in-eu-1032593441,negative,0.8982232809066772
5945,8/30/2023 7:17:38 PM,"Pfizer, BioNTech updated COVID booster gets EMA panel endorsement",Seeking Alpha,https://seekingalpha.com/news/4007670-pfizer-biontech-updated-covid-booster-ema-panel-endorsement?utm_source=businessinsider&utm_medium=referral,positive,0.7340220808982849
5946,8/31/2023 4:20:37 AM,"Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Pfizer (PFE) and Humana (HUM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-catalent-ctlt-pfizer-pfe-and-humana-hum-1032594626,positive,0.9080490469932556
5947,8/31/2023 1:38:48 PM,Market Crash Coming? 3 Healthcare Stocks to Buy for a Soft Landing.,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-3-1032596488,neutral,0.6612724661827087
5948,8/31/2023 9:09:37 PM,7 Ultimate Buy-and-Hold Stock Picks for Forever Investors,InvestorPlace,/news/stocks/7-ultimate-buy-and-hold-stock-picks-for-forever-investors-1032597904,positive,0.9230831861495972
5949,8/31/2023 10:36:44 PM,7 Growth Stocks the Big Money Is Buying Now,InvestorPlace,/news/stocks/7-growth-stocks-the-big-money-is-buying-now-1032597956,positive,0.8461413979530334
5950,9/1/2023 10:54:42 AM,"Pfizer, BioNTech granted EU nod for new Omicron-adapted COVID shot",Seeking Alpha,https://seekingalpha.com/news/4008277-pfizer-biontech-win-eu-nod-new-omicron-adapted-covid-shot?utm_source=businessinsider&utm_medium=referral,negative,0.9079946279525757
5951,9/1/2023 1:14:19 PM,Horizon Therapeutics gains afer FTC settles with Amgen over $28B deal  (update),Seeking Alpha,https://seekingalpha.com/news/4008313-horizon-therapeutics-gains-after-ftc-settles-with-amgen-over-28b-deal?utm_source=businessinsider&utm_medium=referral,positive,0.5760496854782104
5952,9/1/2023 4:45:33 PM,Bavarian Nordic drops COVID booster from pipeline,Seeking Alpha,https://seekingalpha.com/news/4008450-bavarian-nordic-drops-covid-booster-pipeline?utm_source=businessinsider&utm_medium=referral,neutral,0.673255980014801
5953,9/3/2023 4:00:00 PM,Why is big pharma unmoved despite Medicare pricing threat?,Seeking Alpha,https://seekingalpha.com/news/4008703-why-big-pharma-unmoved-despite-medicare-pricing-threat?utm_source=businessinsider&utm_medium=referral,positive,0.7872201800346375
5954,9/4/2023 7:43:41 PM,The 3 Best Biotech Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-to-buy-now-september-2023-1032603521,positive,0.9307847023010254
5955,9/5/2023 10:42:18 AM,Viatris wins tentative FDA approval for HIV therapy in children,Seeking Alpha,https://seekingalpha.com/news/4008963-viatris-nabs-tentative-fda-nod-pediatric-hiv-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.9250267744064331
5956,9/5/2023 11:10:57 AM,"Seagen, Genmab succeed in Phase 3 trial for cervical cancer therapy",Seeking Alpha,https://seekingalpha.com/news/4008970-seagen-genmab-hit-phase-3-win-cervical-cancer-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8755035996437073
5957,9/5/2023 2:13:43 PM,"Arcturus, CSL granted EU review for COVID vaccine",Seeking Alpha,https://seekingalpha.com/news/4009075-arcturus-csl-granted-eu-review-covid-shot?utm_source=businessinsider&utm_medium=referral,negative,0.8963785171508789
5958,9/5/2023 5:54:34 PM,Alnylam picked for positive catalyst watch at Citi on amyloidosis therapy.,Seeking Alpha,https://seekingalpha.com/news/4009216-alnylam-picked-positive-catalyst-watch-citi?utm_source=businessinsider&utm_medium=referral,negative,0.7371878623962402
5959,9/5/2023 6:43:15 PM,Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst,Benzinga,/news/stocks/pyxis-oncology-m-a-spotlight-signals-potential-growth-amidst-competitive-adc-landscape-analyst-1032606429,negative,0.8796048164367676
5960,9/6/2023 12:26:55 AM,Cantor Fitzgerald Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-pfizer-pfe-1032607022,positive,0.9459741115570068
5961,9/6/2023 7:45:43 PM,FDA said to clear updated COVID shots as early as Friday,Seeking Alpha,https://seekingalpha.com/news/4009649-fda-clear-updated-covid-shots-friday?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9374686479568481
5962,9/6/2023 8:46:35 PM,Pfizer stock hits 52-week low as Moderna rolls out data on rival COVID shot,Seeking Alpha,https://seekingalpha.com/news/4009707-pfizer-stock-hits-52-week-low-as-moderna-rolls-out-data-on-rival-covid-shot?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9300441741943359
5963,9/6/2023 10:40:36 PM,Non-Disappearing COVID Creates Another Chapter For The Pharmaceutical Industry,Benzinga,/news/stocks/non-disappearing-covid-creates-another-chapter-for-the-pharmaceutical-industry-1032610743,positive,0.8437894582748413
5964,9/7/2023 12:37:27 AM,How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low,Benzinga,/news/stocks/how-to-earn-500-from-pfizer-stock-with-shares-trading-at-52-week-low-1032610884,positive,0.9390365481376648
5965,9/7/2023 7:10:17 AM,Pfizer Stock (NYSE:PFE) Hits a New Low; What’s Ahead?,TipRanks,/news/stocks/pfizer-stock-nyse-pfe-hits-a-new-low-what-s-ahead-1032611493,neutral,0.8704847097396851
5966,9/7/2023 10:56:20 AM,"Pfizer, Valneva post Phase 2 booster data for Lyme disease vaccine",Seeking Alpha,https://seekingalpha.com/news/4009828-pfizer-valneva-post--booster-data-lyme-disease-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5687076449394226
5967,9/7/2023 1:32:42 PM,"Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster",Benzinga,/news/stocks/pfizer-valneva-s-tick-borne-infection-shot-companies-say-positive-result-for-lyme-disease-vaccine-candidate-booster-1032612402,negative,0.93175208568573
5968,9/8/2023 8:18:30 PM,Existing antibodies reportedly effective against new COVID-19 variant,Seeking Alpha,https://seekingalpha.com/news/4010395-existing-antibodies-reportedly-effective-against-new-covid-19-variant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9375434517860413
5969,9/8/2023 11:13:21 PM,The 5 Best Healthcare Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-5-best-healthcare-stocks-to-buy-now-september-2023-1032617337,positive,0.9341099262237549
5970,9/10/2023 4:00:00 PM,"Eli Lilly, Novo to lead $100B weight loss drug market in 2030: JPMorgan",Seeking Alpha,https://seekingalpha.com/news/4010426-eli-lilly-novo-lead-weight-loss-drug-market-jpmorgan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5451600551605225
5971,9/11/2023 2:15:39 PM,Alnylam amyloidosis drug led to “small” benefits in Phase 3 trial: FDA,Seeking Alpha,https://seekingalpha.com/news/4010608-alnylam-amyloidosis-drug-patisiran-small-benefits-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8899328112602234
5972,9/11/2023 6:46:53 PM,"FDA green lights Moderna, Pfizer updated COVID-19 vaccines",Seeking Alpha,https://seekingalpha.com/news/4010688-fda-green-lights-moderna-pfizer-updated-covid-19-vaccines?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8712636828422546
5973,9/11/2023 7:30:31 PM,AI Integration In Biotech & Pharma: Companies Positioned To Benefit,Benzinga,/news/stocks/ai-integration-in-biotech-pharma-companies-positioned-to-benefit-1032621068,negative,0.5679945945739746
5974,9/11/2023 8:31:38 PM,Novavax updated COVID vaccine ready for US distribution,Seeking Alpha,https://seekingalpha.com/news/4010730-novavax-updated-covid-vaccine-ready-us-distribution?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9003236293792725
5975,9/12/2023 1:59:15 AM,Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold,InvestorPlace,/news/stocks/pound-for-pound-3-buzzworthy-drug-stocks-worth-their-weight-in-gold-1032621509,positive,0.8567546606063843
5976,9/12/2023 3:10:20 AM,FDA Approves Pfizer-BioNTech's Updated COVID-19 Vaccine ,RTTNews,/news/stocks/fda-approves-pfizer-biontech-s-updated-covid-19-vaccine-1032621490,positive,0.6497249603271484
5977,9/12/2023 4:32:57 PM,"DraftKings Apologizes For 9/11 'Never Forget' Parlay Promotion, Apple Set For Selling 'Made In India' iPhone 15 on Launch Day, MGM Resorts Faces Ongoing Cyber Incident: Today's Top Stories",Benzinga,/news/stocks/draftkings-apologizes-for-9-11-never-forget-parlay-promotion-apple-set-for-selling-made-in-india-iphone-15-on-launch-day-mgm-resorts-faces-ongoing-cyber-incident-today-s-top-stories-1032624052,positive,0.492730975151062
5978,9/12/2023 5:55:43 PM,Novavax updated COVID shot to be reviewed by FDA 'expeditiously',Seeking Alpha,https://seekingalpha.com/news/4011069-novavax-updated-covid-shot-reviewed-fda-expeditiously?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8902459740638733
5979,9/12/2023 10:35:45 PM,"Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years, NY Consulting Firm Predicts",Benzinga,/news/stocks/ny-consulting-firm-predicts-psychedelic-drugs-market-will-generate-over-12b-in-next-12-years-1032624903,negative,0.7848308682441711
5980,9/12/2023 10:41:50 PM,CDC recommends COVID-19 shots for people age six months and older (update),Seeking Alpha,https://seekingalpha.com/news/4011075-cdc-recommends-updated-covid-19-shots-for-ages-six-months-older?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9003927111625671
5981,9/12/2023 11:19:20 PM,Novavax Stock (NASDAQ:NVAX) Has a Shot at Recovering,TipRanks,/news/stocks/novavax-stock-nasdaq-nvax-has-a-shot-at-recovering-1032625046,positive,0.6711668372154236
5982,9/13/2023 1:22:52 AM,The 3 Most Undervalued Biotech Stocks to Buy in September 2023,InvestorPlace,/news/stocks/undervalued-biotech-stocks-to-buy-1032625098,positive,0.7739697098731995
5983,9/13/2023 1:29:07 AM,3 Overlooked High-Yield Stocks Trading at a P/E of Less Than 10,InvestorPlace,/news/stocks/3-overlooked-high-yield-stocks-trading-at-a-p-e-of-less-than-10-1032625105,positive,0.8353150486946106
5984,9/13/2023 1:30:00 AM,European Medicines Agency Validates Type II Variation for Astellas' XTANDI® (enzalutamide) for Treatment of Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence,PR Newswire,/news/stocks/european-medicines-agency-validates-type-ii-variation-for-astellas-xtandi-enzalutamide-for-treatment-of-non-metastatic-hormone-sensitive-prostate-cancer-with-high-risk-biochemical-recurrence-1032625048,negative,0.8441988229751587
5985,9/13/2023 1:05:28 PM,"CDC Recommends Updated Pfizer, Moderna COVID-19 Vaccine ",RTTNews,/news/stocks/cdc-recommends-updated-pfizer-moderna-covid-19-vaccine-1032626422,positive,0.9358567595481873
5986,9/13/2023 4:15:21 PM,"Europe Set To Launch Anti-Subsidy Probe Into Chinese EVs, American Airlines and Spirit Lower Profit Outlook, Manchester United's New Shirt Sponsor: Today's Top Stories",Benzinga,/news/stocks/europe-set-to-launch-anti-subsidy-probe-into-chinese-evs-american-airlines-and-spirit-lower-profit-outlook-manchester-united-s-new-shirt-sponsor-today-s-top-stories-1032627649,positive,0.8328827619552612
5987,9/13/2023 5:14:43 PM,Barclays projects over $5B COVID booster sales in fall 2023,Seeking Alpha,https://seekingalpha.com/news/4011444-barclays-projects-covid-booster-sales-fall-2023?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6129745244979858
5988,9/14/2023 8:30:37 PM,The 3 Most Undervalued Pharma Stocks to Buy in September 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-pharma-stocks-to-buy-in-september-2023-1032631934,positive,0.7669093608856201
5989,9/14/2023 8:56:27 PM,"CDC says COVID, flu, and RSV could cause 'tripledemic'",Seeking Alpha,https://seekingalpha.com/news/4012086-cdc-says-covid-flu-rsv-could-cause-tripledemic?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8985856771469116
5990,9/15/2023 11:32:58 AM,Pfizer's $43B deal for Seagen gets European Union review,Seeking Alpha,https://seekingalpha.com/news/4012199-pfizers-43b-deal-for-seagen-gets-european-union-review?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5934094190597534
5991,9/15/2023 10:19:16 PM,"More Than Half Of Americans Want New COVID-19 Booster, But Ron DeSantis Will Fight Virus With His Charisma Alone",Benzinga,/news/stocks/more-than-half-of-americans-want-new-covid-19-booster-but-ron-desantis-will-fight-virus-with-his-charisma-alone-1032634725,positive,0.7462060451507568
5992,9/18/2023 5:33:10 PM,Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?,Benzinga,/news/stocks/is-this-250-year-old-japanese-big-pharma-giant-selling-for-half-price-right-now-1032637731,positive,0.815968930721283
5993,9/19/2023 8:35:12 AM,GSK : EC Authorizes ViiV Healthcare's Apretude For HIV Prevention ,RTTNews,/news/stocks/gsk-ec-authorizes-viiv-healthcare-s-apretude-for-hiv-prevention-1032638696,positive,0.7508238554000854
5994,9/19/2023 9:21:14 AM,Pfizer's LITFULO To Treat Severe Alopecia Areata Gets Approval In EU ,RTTNews,/news/stocks/pfizer-s-litfulo-to-treat-severe-alopecia-areata-gets-approval-in-eu-1032638816,negative,0.9372162222862244
5995,9/19/2023 10:50:15 AM,The Top 7 Underrated Dividend Stocks Yielding 3% or More,InvestorPlace,/news/stocks/the-top-7-underrated-dividend-stocks-yielding-3-or-more-1032639458,positive,0.6728805303573608
5996,9/19/2023 2:25:23 PM,"Cramer Says 'I Can't Tell You To Sell It Here,' As Massive Pharma Stock Falls 34% YTD",Benzinga,/news/stocks/cramer-says-i-can-t-tell-you-to-sell-it-here-as-massive-pharma-stock-falls-34-so-far-this-year-1032639843,neutral,0.9521336555480957
5997,9/19/2023 9:00:51 PM,"3 Stocks to Avoid Like the Plague Right Now: MRNA, GPS, PTON",InvestorPlace,/news/stocks/3-stocks-to-avoid-like-the-plague-right-now-mrna-gps-pton-1032641623,positive,0.9372102618217468
5998,9/20/2023 9:20:20 AM,Beware! 3 Nasdaq Stocks Waving Massive Red Flags Right Now.,InvestorPlace,/news/stocks/beware-3-nasdaq-stocks-waving-massive-red-flags-right-now-1032642734,neutral,0.5925348401069641
5999,9/20/2023 3:28:22 PM,Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now,InvestorPlace,/news/stocks/beware-3-biotech-stocks-waving-massive-red-flags-right-now-1032644285,positive,0.7782996892929077
6000,9/23/2023 6:13:50 AM,CDC Recommends Pfizer's Vaccine 'Abrysvo' To Help Protect Babies Against Severe RSV Illness ,RTTNews,/news/stocks/cdc-recommends-pfizer-s-vaccine-abrysvo-to-help-protect-babies-against-severe-rsv-illness-1032650793,positive,0.5717985033988953
6001,9/24/2023 8:00:35 PM,Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.,InvestorPlace,/news/stocks/beware-3-healthcare-stocks-waving-massive-red-flags-right-now-1032651288,neutral,0.7834725975990295
6002,9/24/2023 10:55:57 PM,Goldman Sachs Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/goldman-sachs-remains-a-buy-on-pfizer-pfe-1032651303,positive,0.9394385814666748
6003,9/26/2023 4:59:13 AM,Pfizer Plant In North Carolina Restarts Production After Tornado Damage ,RTTNews,/news/stocks/pfizer-plant-in-north-carolina-restarts-production-after-tornado-damage-1032654348,neutral,0.9382440447807312
6004,9/27/2023 1:01:00 PM,Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer,PR Newswire,/news/stocks/ginkgo-bioworks-announces-multi-target-rna-discovery-collaboration-with-pfizer-1032658835,negative,0.4995694160461426
6005,9/27/2023 1:33:01 PM,DNA Stock Alert: Ginkgo Bioworks Announces Major Partnership With Pfizer,InvestorPlace,/news/stocks/dna-stock-alert-ginkgo-bioworks-announces-major-partnership-with-pfizer-1032659578,positive,0.6284780502319336
6006,9/27/2023 3:04:09 PM,Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields-1032659408,positive,0.8461886048316956
6007,9/27/2023 6:56:14 PM,Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher,InvestorPlace,/news/stocks/dont-miss-the-boom-3-pharma-stocks-set-to-explode-higher-1032660795,positive,0.8992198705673218
6008,9/27/2023 7:05:22 PM,What's Going On Pfizer's Subsidiary Biohaven Stock?,Benzinga,/news/stocks/what-s-going-on-pfizer-s-subsidiary-biohaven-stock-1032660550,positive,0.5377773642539978
6009,9/27/2023 8:44:53 PM,"Challenging Road Ahead for Cancer Drugs, Nuvalent Seeks to Break the Mold",Benzinga,/news/stocks/challenging-road-ahead-for-cancer-drugs-nuvalent-seeks-to-break-the-mold-1032660787,positive,0.6122877597808838
6010,9/28/2023 11:10:52 AM,Smart Picks: 7 Blue-Chips Trading Below True Value,InvestorPlace,/news/stocks/smart-picks-7-blue-chips-trading-below-true-value-1032662446,positive,0.8083928823471069
6011,9/29/2023 3:59:01 PM,Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet,Benzinga,/news/stocks/benzinga-s-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-yet-1032666877,positive,0.9360675811767578
6012,10/2/2023 3:32:07 PM,Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024,InvestorPlace,/news/stocks/q4-stock-predictions-3-pharma-stocks-ready-to-roar-into-2024-1032671152,positive,0.8758504986763
6013,10/2/2023 7:55:18 PM,3 Massively Undervalued Dividend Stocks to Buy for High Total Returns,InvestorPlace,/news/stocks/3-massively-undervalued-dividend-stocks-to-buy-for-high-total-returns-1032671660,negative,0.7739423513412476
6014,10/2/2023 8:00:39 PM,The Latest Analyst Ratings for Pfizer,Benzinga,/news/stocks/the-latest-analyst-ratings-for-pfizer-1032671506,positive,0.9401854276657104
6015,10/3/2023 8:07:42 AM,"Pfizer's Hospira Recalls Sodium Bicarbonate, Lidocaine HCl Injections ",RTTNews,/news/stocks/pfizer-s-hospira-recalls-sodium-bicarbonate-lidocaine-hcl-injections-1032672212,positive,0.8894225358963013
6016,10/3/2023 8:25:32 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-pfizer-pfe-1032672634,positive,0.8587514758110046
6017,10/3/2023 10:00:25 AM,The 3 Top Value Stocks to Watch in Q4 2023,InvestorPlace,/news/stocks/the-3-top-value-stocks-to-watch-in-q4-2023-1032673804,positive,0.9232873916625977
6018,10/3/2023 9:17:37 PM,Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?,Benzinga,/news/stocks/novavax-stock-soars-on-fda-clearance-for-updated-covid-19-shot-what-s-going-on-1032675769,neutral,0.6210645437240601
6019,10/4/2023 2:30:22 AM,Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-iqvia-holdings-iqv-and-pfizer-pfe-1032676108,positive,0.9164672493934631
6020,10/4/2023 10:45:07 AM,Sure Winners: 7 Stocks Set to Outperform in the Next Recession,InvestorPlace,/news/stocks/sure-winners-7-stocks-set-to-outperform-in-the-next-recession-1032677445,negative,0.8112358450889587
6021,10/4/2023 1:41:17 PM,Short Sellers Are Betting Against Novavax (NVAX) Stock,InvestorPlace,/news/stocks/short-sellers-are-betting-against-novavax-nvax-stock-1032678114,positive,0.9054498672485352
6022,10/5/2023 1:22:24 AM,Why Novavax Stock Fell Today,Benzinga,/news/stocks/why-novavax-stock-fell-today-1032679532,neutral,0.8890910744667053
6023,10/5/2023 9:04:33 PM,"Small Biotech Promosome Drops Lawsuit Against Pfizer, BioNTech in COVID-19 Vaccine Patent Dispute",Benzinga,/news/stocks/small-biotech-promosome-drops-lawsuit-against-pfizer-biontech-in-covid-19-vaccine-patent-dispute-1032682715,neutral,0.7600285410881042
6024,10/7/2023 1:00:48 PM,3 Biotech Stocks Ready to Break Out in 2024,InvestorPlace,/news/stocks/3-biotech-stocks-ready-to-break-out-in-2024-1032685969,positive,0.8537952303886414
6025,10/8/2023 12:00:48 PM,3 Pharma Stocks to Dump Before the Damage Is Done,InvestorPlace,/news/stocks/3-pharma-stocks-to-dump-before-the-damage-is-done-1032686332,positive,0.842827558517456
6026,10/9/2023 10:40:11 AM,7 F-Rated Stocks to Kick to the Curb in October,InvestorPlace,/news/stocks/7-f-rated-stocks-to-kick-to-the-curb-in-october-1032688231,neutral,0.49260401725769043
6027,10/9/2023 2:06:06 PM,7 Dividend Stocks Ready to Roar Into 2024,InvestorPlace,/news/stocks/7-dividend-stocks-ready-to-roar-into-2024-1032689295,positive,0.911455512046814
6028,10/9/2023 8:23:27 PM,"Timing Favors Novavax's Delayed Approval, Arrival Ahead of Peak COVID Vaccine Demand",Benzinga,/news/stocks/timing-favors-novavax-s-delayed-approval-arrival-ahead-of-peak-covid-vaccine-demand-1032689900,neutral,0.8208670020103455
6029,10/10/2023 11:52:20 AM,Dividend Alert: Buy Pfizer Stock Before This Date!,InvestorPlace,/news/stocks/dividend-alert-buy-pfe-stock-before-this-date-1032691957,positive,0.9423964023590088
6030,10/10/2023 7:54:24 PM,Big Pharma Could Transform Into BioTech Pharma,Benzinga,/news/stocks/big-pharma-could-transform-into-biotech-pharma-1032693663,positive,0.9183996319770813
6031,10/12/2023 10:20:33 AM,PFE Stock Warning: Avoid This Big Pharma Value Trap at All Costs,InvestorPlace,/news/stocks/pfe-stock-warning-avoid-this-big-pharma-value-trap-at-all-costs-1032699832,positive,0.7923605442047119
6032,10/12/2023 10:30:34 AM,"3 Stocks That Are Down Big, But Are Due to Fall Much Further",InvestorPlace,/news/stocks/3-stocks-that-are-down-big-but-are-due-to-fall-much-further-1032699889,neutral,0.937265932559967
6033,10/12/2023 1:11:34 PM,Pfizer: FDA Approves BRAFTOVI + MEKTOVI In Treatment Of Metastatic NSCLC With BRAF V600E Mutation ,RTTNews,/news/stocks/pfizer-fda-approves-braftovi-mektovi-in-treatment-of-metastatic-nsclc-with-braf-v600e-mutation-1032700029,negative,0.888592004776001
6034,10/12/2023 3:19:24 PM,Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields-1032700617,positive,0.8461886048316956
6035,10/13/2023 10:30:10 AM,"ABBV Stock: Buy for the Yield, Hold for This Other Reason",InvestorPlace,/news/stocks/abbv-stock-buy-for-the-yield-hold-for-this-other-reason-1032703357,positive,0.9456968307495117
6036,10/13/2023 12:00:35 PM,3 Healthcare Stocks To Make You The Millionaire Next Door: October Edition,InvestorPlace,/news/stocks/3-healthcare-stocks-to-make-you-the-millionaire-next-door-october-edition-1032704000,positive,0.9228014945983887
6037,10/13/2023 3:28:52 PM,Pfizer Says FDA Approves VELSIPITY For Adults With Moderately To Severely Active Ulcerative Colitis ,RTTNews,/news/stocks/pfizer-says-fda-approves-velsipity-for-adults-with-moderately-to-severely-active-ulcerative-colitis-1032703931,negative,0.5216676592826843
6038,10/16/2023 12:37:00 AM,Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023,PR Newswire,/news/stocks/astellas-to-share-new-data-across-hard-to-treat-cancers-during-esmo-congress-2023-1032706049,positive,0.7692582607269287
6039,10/16/2023 1:44:00 AM,Everest Medicines' Licensing Partner Pfizer Announces U.S. FDA Approves Etrasimod for Adults with Moderately to Severely Active Ulcerative Colitis,PR Newswire,/news/stocks/everest-medicines-licensing-partner-pfizer-announces-u-s-fda-approves-etrasimod-for-adults-with-moderately-to-severely-active-ulcerative-colitis-1032706058,negative,0.8637549877166748
6040,10/16/2023 7:36:06 AM,"Pfizer, Charles Schwab And 3 Stocks To Watch Heading Into Monday",Benzinga,/news/stocks/pfizer-charles-schwab-and-3-stocks-to-watch-heading-into-monday-1032706913,positive,0.9299823045730591
6041,10/16/2023 8:47:44 AM,Optimistic Outlook for Pfizer: Analyst Upgrades Stock to ‘Buy’ with 21% Upside Potential,TipRanks,/news/stocks/optimistic-outlook-for-pfizer-analyst-upgrades-stock-to-buy-with-21-upside-potential-1032707529,negative,0.9235794544219971
6042,10/16/2023 10:45:31 AM,Cut Your Losses: Sell These 7 Weak Stocks Now,InvestorPlace,/news/stocks/cut-your-losses-sell-these-7-weak-stocks-now-1032707893,positive,0.698919951915741
6043,10/16/2023 10:56:05 AM,Neutral Stance on Pfizer Amid Restructuring and Pipeline Prospects: An Analyst’s Perspective,TipRanks,/news/stocks/neutral-stance-on-pfizer-amid-restructuring-and-pipeline-prospects-an-analyst-s-perspective-1032707895,positive,0.7936042547225952
6044,10/16/2023 2:04:45 PM,"Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine",Benzinga,/news/stocks/novavax-faces-setback-european-authority-delays-decision-on-variant-tailored-covid-19-vaccine-1032708167,neutral,0.9579142332077026
6045,10/16/2023 3:27:20 PM,JPMorgan To Rally Over 29%? Here Are Top 10 Analyst Forecasts For Monday,Benzinga,/news/stocks/jpmorgan-to-rally-over-29-here-are-10-other-analyst-forecasts-for-monday-1032708631,positive,0.916592001914978
6046,10/16/2023 4:35:11 PM,"Bitcoin's ETF Approval Rumor, Pfizer Slashes Annual Outlook, Activist Shareholder Shakes Up News Corp's Status Quo: Today's Top Stories",Benzinga,/news/stocks/bitcoin-s-etf-approval-rumor-pfizer-slashes-annual-outlook-activist-shareholder-shakes-up-news-corp-s-status-quo-today-s-top-stories-1032709109,neutral,0.8249424695968628
6047,10/16/2023 5:00:44 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 16, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-16-2023-1032709217,positive,0.49145349860191345
6048,10/16/2023 7:56:29 PM,"Analysts Divided Over Pfizer's Outlook, Some See Positives Amid Negative Sentiment",Benzinga,/news/stocks/analysts-divided-over-pfizer-s-outlook-some-see-positives-amid-negative-sentiment-1032709685,neutral,0.8534102439880371
6049,10/17/2023 4:49:01 AM,Financial Uncertainty and Reduced Guidance Leads to Hold Rating for Pfizer: An Analysis by David Risinger,TipRanks,/news/stocks/financial-uncertainty-and-reduced-guidance-leads-to-hold-rating-for-pfizer-an-analysis-by-david-risinger-1032710797,positive,0.8157944679260254
6050,10/17/2023 4:08:15 PM,"Hold Rating for Pfizer: Updated Guidance, Cost Realignment, and Pipeline Programs Shape Future Projections",TipRanks,/news/stocks/hold-rating-for-pfizer-updated-guidance-cost-realignment-and-pipeline-programs-shape-future-projections-1032713624,positive,0.8113893270492554
6051,10/18/2023 12:27:52 PM,7 Undervalued Stocks Poised for Explosive Growth in Q4,InvestorPlace,/news/stocks/7-undervalued-stocks-poised-for-explosive-growth-in-q4-1032716784,negative,0.9099953174591064
6052,10/18/2023 2:16:50 PM,Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts,InvestorPlace,/news/stocks/pfizer-layoffs-2023-what-to-know-about-the-latest-pfe-job-cuts-1032717649,neutral,0.8561679720878601
6053,10/18/2023 2:31:59 PM,Why Are Stocks Down Today?,InvestorPlace,/news/stocks/why-are-stocks-down-today-oct-18th-1032717693,neutral,0.9098419547080994
6054,10/19/2023 1:59:14 PM,7 Stocks That Are Heading for a Train Wreck,InvestorPlace,/news/stocks/7-stocks-that-are-heading-for-a-train-wreck-1032721509,positive,0.6113612651824951
6055,10/19/2023 7:46:24 PM,Alphabet Stock (NASDAQ:GOOGL) Q3 Earnings Preview: Can Its Strength be Sustained?,TipRanks,/news/stocks/alphabet-stock-nasdaq-googl-q3-earnings-preview-can-its-strength-be-sustained-1032722222,negative,0.8771464228630066
6056,10/19/2023 8:11:36 PM,7 Healthcare Stocks That Can Cure a Lackluster Portfolio,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-4-1032722294,positive,0.7649615406990051
6057,10/20/2023 4:25:32 AM,LLY vs. PFE: Which Pharma Stock is the Better Buy?,TipRanks,/news/stocks/lly-vs-pfe-which-pharma-stock-is-the-better-buy-1032722758,positive,0.9144653081893921
6058,10/20/2023 10:45:17 AM,7 Dividend Stocks to Buy and Hold Forever and Ever,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-hold-forever-and-ever-1032723968,positive,0.9360319375991821
6059,10/20/2023 8:00:30 PM,19 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/19-analysts-have-this-to-say-about-pfizer-1032725094,positive,0.9278751015663147
6060,10/20/2023 10:24:03 PM,Pfizer Secures FDA Approval For Penbraya ,RTTNews,/news/stocks/pfizer-secures-fda-approval-for-penbraya-1032725214,negative,0.9047488570213318
6061,10/23/2023 2:31:54 PM,Why Is Roivant Sciences (ROIV) Stock Up Today?,InvestorPlace,/news/stocks/why-is-roivant-sciences-roiv-stock-up-today-1032729508,positive,0.7288841605186462
6062,10/25/2023 4:54:44 PM,Pfizer To Expand Access To Cadence Products And Programming Toolkits For Advanced Molecular Design ,RTTNews,/news/stocks/pfizer-to-expand-access-to-cadence-products-and-programming-toolkits-for-advanced-molecular-design-1032739577,negative,0.7132560014724731
6063,10/26/2023 1:56:26 PM,Pfizer Reports Positive Data For MRNA-based Combination Vaccine Program Against Influenza & COVID-19 ,RTTNews,/news/stocks/pfizer-reports-positive-data-for-mrna-based-combination-vaccine-program-against-influenza-covid-19-1032743504,negative,0.9459567070007324
6064,10/26/2023 6:50:06 PM,7 Undervalued Stocks That Analysts Love Right Now,InvestorPlace,/news/stocks/7-undervalued-stocks-that-analysts-love-right-now-1032745359,positive,0.7995253801345825
6065,10/27/2023 6:59:01 AM,Hold Rating for Pfizer: Risinger’s Analysis on Danuglipron’s Potential and Challenges,TipRanks,/news/stocks/hold-rating-for-pfizer-risinger-s-analysis-on-danuglipron-s-potential-and-challenges-1032749747,positive,0.8907286524772644
6066,10/27/2023 10:05:00 AM,The 7 Most Undervalued Dividend Stocks to Buy: October 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-october-2023-1032748167,positive,0.8712580800056458
6067,10/27/2023 1:25:10 PM,SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff,InvestorPlace,/news/stocks/sny-stock-sinks-15-as-sanofi-plans-consumer-unit-spinoff-1032748736,neutral,0.9670206308364868
6068,10/27/2023 7:10:25 PM,CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy,InvestorPlace,/news/stocks/crsp-stock-fda-considers-additional-review-crispr-therapeutics-gene-therapy-1032749721,positive,0.9248803853988647
6069,10/27/2023 10:33:58 PM,"Bears Roam Wall Street As Middle East Conflict, Earnings Outlook Raise Concerns Despite Strong Q3 US Economic Growth: This Week In Markets",Benzinga,/news/etf/bears-roam-wall-street-as-middle-east-conflict-earnings-outlook-raise-concerns-despite-strong-q3-us-economic-growth-this-week-in-markets-1032749881,neutral,0.7046886682510376
6070,10/29/2023 9:21:08 PM,The 7 Most Undervalued Long-Term Stocks to Buy: October 2023 ,InvestorPlace,/news/stocks/undervalued-long-term-stocks-7-to-buy-in-october-2023-1032751361,positive,0.8410292863845825
6071,10/30/2023 3:01:13 PM,Pfizer earnings preview: what to expect,Markets Insider Automation,/news/stocks/pfizer-quarter-earnings-preview-q3-1032754397,positive,0.9113932847976685
6072,10/30/2023 7:39:47 PM,7 Low-Risk Stock Picks to Double Your Money,InvestorPlace,/news/stocks/7-low-risk-stock-picks-to-double-your-money-1032755599,positive,0.5780191421508789
6073,10/30/2023 8:35:21 PM,Jefferies Reaffirms Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/jefferies-reaffirms-their-buy-rating-on-pfizer-pfe-1032758048,positive,0.8210693597793579
6074,10/31/2023 9:43:41 AM,"Hold Rating on Pfizer: Anticipating the Impact of 3Q23 Results, Product Growth Trends, and Strategic Updates",TipRanks,/news/stocks/hold-rating-on-pfizer-anticipating-the-impact-of-3q23-results-product-growth-trends-and-strategic-updates-1032761383,positive,0.8499757647514343
6075,10/31/2023 11:51:16 AM,Pfizer Inc. Q3 Earnings Summary,RTTNews,/news/stocks/pfizer-inc-q3-earnings-summary-1032758562,positive,0.6771915555000305
6076,10/31/2023 12:18:22 PM,Pfizer Reaffirms FY23 Outlook - Update ,RTTNews,/news/stocks/pfizer-reaffirms-fy23-outlook-update-1032758707,positive,0.8852706551551819
6077,10/31/2023 12:50:06 PM,"Analysts Conflicted on These Healthcare Names: Iradimed (IRMD), Harmony Biosciences Holdings (HRMY) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-iradimed-irmd-harmony-biosciences-holdings-hrmy-and-pfizer-pfe-1032761685,neutral,0.6245081424713135
6078,10/31/2023 2:01:15 PM,Analysts Offer Insights on Healthcare Companies: aTyr Pharma (LIFE) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-atyr-pharma-life-and-pfizer-pfe-1032761737,positive,0.9136965870857239
6079,10/31/2023 5:01:24 PM,"Treasury Announcement More Important Than Fed's, Japan Abandons Yield Control, Tesla Under $200",Benzinga,/news/stocks/treasury-announcement-more-important-than-fed-s-japan-abandons-yield-control-tesla-under-200-1032760413,neutral,0.6439569592475891
6080,10/31/2023 6:14:37 PM,"Stocks Lack Direction As Traders Remain Cautious Ahead Of Fed Meeting, Nvidia Falls On Export Controls: What's Driving Markets Tuesday?",Benzinga,/news/etf/stocks-lack-direction-as-traders-remain-cautious-ahead-of-fed-meeting-nvidia-falls-on-export-controls-what-s-driving-markets-tuesday-1032760794,neutral,0.89947110414505
6081,10/31/2023 8:08:33 PM,3 Top Dividend Stocks to Buy for Long-Term Growth,InvestorPlace,/news/stocks/3-top-dividend-stocks-to-buy-for-long-term-growth-1032761132,positive,0.895444929599762
6082,11/1/2023 9:40:00 AM,Inside Cathie Wood’s Portfolio: 3 Stocks She Is Betting Millions On,InvestorPlace,/news/stocks/inside-cathie-woods-portfolio-3-stocks-she-is-betting-millions-on-1032764221,positive,0.9386062026023865
6083,11/1/2023 11:31:55 AM,Undervalued Potential: A Buy Recommendation for Pfizer Stock Based on Strong Fundamentals and Strategic Acquisitions,TipRanks,/news/stocks/undervalued-potential-a-buy-recommendation-for-pfizer-stock-based-on-strong-fundamentals-and-strategic-acquisitions-1032767636,negative,0.7916256785392761
6084,11/1/2023 12:41:15 PM,Cantor Fitzgerald Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-pfizer-pfe-1032767717,positive,0.8677467703819275
6085,11/1/2023 2:09:49 PM,7 Dividend Stocks That Are a Recipe for Disaster,InvestorPlace,/news/stocks/7-dividend-stocks-that-are-a-recipe-for-disaster-1032765843,positive,0.9022884964942932
6086,11/1/2023 7:29:17 PM,Pfizer Analysts Cut Their Forecasts Following Q3 Results,Benzinga,/news/stocks/pfizer-analysts-cut-their-forecasts-following-q3-results-1032766933,neutral,0.9630441665649414
6087,11/2/2023 4:20:13 AM,Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-dentsply-sirona-xray-and-pfizer-pfe-1032771468,positive,0.8993657231330872
6088,11/2/2023 5:21:57 AM,David Risinger Maintains Hold Rating on Pfizer Amid Revenue Pressures and Anticipation for Key Pharmaceutical Developments,TipRanks,/news/stocks/david-risinger-maintains-hold-rating-on-pfizer-amid-revenue-pressures-and-anticipation-for-key-pharmaceutical-developments-1032771694,neutral,0.9252907037734985
6089,11/2/2023 3:01:49 PM,7 Growth Stocks Gearing Up to Breakout in Late 2023,InvestorPlace,/news/stocks/7-growth-stocks-gearing-up-to-breakout-in-late-2023-1032771289,negative,0.9064989686012268
6090,11/3/2023 2:27:03 AM,Pfizer (PFE) Gets a Buy from Truist Financial,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-truist-financial-1032776472,positive,0.6106163263320923
6091,11/3/2023 12:33:46 PM,Why These 7 Overlooked Value Stocks Could Be Your Golden Opportunity,InvestorPlace,/news/stocks/why-these-7-overlooked-value-stocks-could-be-your-golden-opportunity-1032776108,positive,0.8642510175704956
6092,11/4/2023 10:00:00 PM,3 Stocks Priced Under $100 That You Can’t Afford to Miss,InvestorPlace,/news/stocks/3-stocks-priced-under-100-that-you-cant-afford-to-miss-1032778389,positive,0.9093043208122253
6093,11/5/2023 3:00:00 PM,"CPRI, SGEN, VMW: Why These 3 Stocks Are on the Tip of Bill Gross’ Tongue",InvestorPlace,/news/stocks/cpri-sgen-vmw-why-these-3-stocks-are-on-the-tip-of-bill-gross-tongue-1032779089,positive,0.8956044912338257
6094,11/7/2023 12:20:22 AM,3 Blue-Chip Stocks With Strong Dividends,InvestorPlace,/news/stocks/3-blue-chip-stocks-with-dividends-1032784137,negative,0.6295008659362793
6095,11/7/2023 5:17:43 PM,Your Smartest Buys Now: The Top 7 Bargain Stocks to Buy in November,InvestorPlace,/news/stocks/your-smartest-buys-now-the-top-7-bargain-stocks-to-buy-in-november-1032789205,positive,0.9154351353645325
6096,11/8/2023 5:16:20 PM,6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%,InvestorPlace,/news/stocks/6-nasdaq-100-stocks-down-40-or-more-that-will-soar-as-much-367-1032795885,neutral,0.9700539112091064
6097,11/10/2023 3:01:38 AM,7 Underappreciated Biotech Stocks to Pick Up on the Cheap,InvestorPlace,/news/stocks/7-underappreciated-biotech-stocks-to-pick-up-on-the-cheap-1032803108,negative,0.8734825849533081
6098,11/10/2023 12:56:00 PM,7 Blue-Chip Stocks to Sell and Never Buy Back,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-sell-and-never-buy-back-1032806688,positive,0.924509584903717
6099,11/11/2023 8:49:32 PM,7 Undervalued Stocks With Potential to Hit Trillion-Dollar Milestone,InvestorPlace,/news/stocks/7-undervalued-stocks-with-potential-to-hit-trillion-dollar-milestone-1032809147,neutral,0.6216179132461548
6100,11/14/2023 8:12:15 PM,Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts,InvestorPlace,/news/stocks/pfizer-layoffs-2023-what-to-know-about-the-latest-pfe-job-cuts-now-1032819350,neutral,0.8561679720878601
6101,11/15/2023 2:30:35 AM,"Analysts Are Bullish on These Healthcare Stocks: Intellia Therapeutics (NTLA), Pfizer (PFE)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-intellia-therapeutics-ntla-pfizer-pfe-1032823301,negative,0.6053321361541748
6102,11/15/2023 3:09:26 AM,3 Undervalued Growth Stocks to Double Your Wealth in 2024,InvestorPlace,/news/stocks/3-undervalued-growth-stocks-to-double-your-wealth-in-2024-1032819956,negative,0.9103740453720093
6103,11/15/2023 2:15:24 PM,Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology,Benzinga,/news/stocks/acuitas-challenges-curevac-in-legal-tussle-over-covid-19-vaccine-technology-1032822722,neutral,0.9366191029548645
6104,11/16/2023 1:00:00 PM,3 Long-Term Stocks You’ll Regret Not Buying Soon: November 2023,InvestorPlace,/news/stocks/3-long-term-stocks-youll-regret-not-buying-soon-november-2023-1032827495,positive,0.933594286441803
6105,11/17/2023 4:33:00 AM,Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting,PR Newswire,/news/stocks/pfizer-and-astellas-xtandi-approved-by-u-s-fda-in-earlier-prostate-cancer-treatment-setting-1032829689,negative,0.8598074316978455
6106,11/17/2023 5:14:16 AM,"Pfizer, Astellas' XTANDI Gets FDA Approval For Nonmetastatic Castration-sensitive Prostate Cancer ",RTTNews,/news/stocks/pfizer-astellas-xtandi-gets-fda-approval-for-nonmetastatic-castration-sensitive-prostate-cancer-1032829703,negative,0.9327545762062073
6107,11/19/2023 11:15:43 PM,The 7 Most Undervalued Sleeper Stocks to Buy Now: November 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-sleeper-stocks-to-buy-now-november-2023-1032833708,positive,0.8741517663002014
6108,11/20/2023 7:00:39 PM,18 Analysts Have This to Say About Pfizer,Benzinga,/news/stocks/18-analysts-have-this-to-say-about-pfizer-1032836655,positive,0.928687572479248
6109,11/20/2023 8:58:21 PM,Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence,Benzinga,/news/stocks/analyst-assess-implications-of-bristol-myers-investigational-blood-thinner-post-bayer-trial-setback-amid-shaken-investor-confidence-1032836877,neutral,0.9359135627746582
6110,11/21/2023 12:54:21 AM,Dual Powerhouses: 7 Dividend Stocks Marrying High Yield With High Growth,InvestorPlace,/news/stocks/dual-powerhouses-7-dividend-stocks-marrying-high-yield-with-high-growth-1032837225,positive,0.5962643623352051
6111,11/21/2023 8:25:56 AM,Cantor Fitzgerald Keeps Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-pfizer-pfe-1032840639,positive,0.9205372333526611
6112,11/21/2023 2:55:13 PM,Can Weight-Loss Drug Ozempic Tip The Scales For Tema's New Healthcare ETF?,Benzinga,/news/etf/can-weight-loss-drug-ozempic-tip-the-scales-for-tema-s-new-healthcare-etf-1032839197,positive,0.7884793281555176
6113,11/27/2023 10:47:29 AM,J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-keeps-their-hold-rating-on-pfizer-pfe-1032852719,positive,0.9021230936050415
6114,11/27/2023 2:37:27 PM,Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-hold-these-3-health-care-stocks-with-over-4-dividend-yields-1032851232,positive,0.8461886048316956
6115,11/27/2023 7:55:51 PM,3 Top-Rated Value Stocks That Analysts Are Loving Now,InvestorPlace,/news/stocks/3-top-rated-value-stocks-that-analysts-are-loving-now-1032852479,positive,0.8831608295440674
6116,11/28/2023 6:03:11 PM,"Merck Highlights Data On New Vaccine, Compares 'Tolerability And Safety' To Pfizer's",Benzinga,/news/stocks/merck-highlights-data-on-new-vaccine-compares-tolerability-and-safety-to-pfizer-s-1032855892,negative,0.7452610731124878
6117,11/29/2023 6:20:01 AM,Hold Rating on Pfizer’s Obesity Drug danuglipron Amid Competitive and Safety Considerations,TipRanks,/news/stocks/hold-rating-on-pfizer-s-obesity-drug-danuglipron-amid-competitive-and-safety-considerations-1032859804,negative,0.5446359515190125
6118,11/29/2023 7:46:40 PM,3 Synthetic Biology Stocks Likely to Mint New Millionaires,InvestorPlace,/news/stocks/3-synthetic-biology-stocks-likely-to-mint-new-millionaires-1032859991,positive,0.7694628238677979
6119,11/30/2023 9:33:26 PM,Billionaire Favorites: 3 Ultra-High Yield Stocks the Elite Love,InvestorPlace,/news/stocks/billionaire-favorites-3-ultra-high-yield-stocks-the-elite-love-1032864414,positive,0.9308335781097412
6120,12/1/2023 1:11:28 PM,Pfizer Reports Topline Phase 2b Results Danuglipron In Obesity - Quick Facts ,RTTNews,/news/stocks/pfizer-reports-topline-phase-2b-results-danuglipron-in-obesity-quick-facts-1032866079,negative,0.7325055003166199
6121,12/1/2023 1:30:47 PM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Progyny (PGNY) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-progyny-pgny-and-iqvia-holdings-iqv-1032867916,positive,0.9191668629646301
6122,12/1/2023 2:10:12 PM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Eli Lilly & Co (LLY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-eli-lilly-co-lly-1032867939,positive,0.9248926639556885
6123,12/1/2023 3:06:41 PM,"Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower",Benzinga,/news/stocks/tale-of-two-investigational-obesity-drugs-altimmune-stock-jumps-while-pfizer-trades-lower-1032866447,negative,0.6565707921981812
6124,12/1/2023 3:36:14 PM,Pfizer (PFE) Gets a Hold from UBS,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-ubs-1032867953,positive,0.8746450543403625
6125,12/1/2023 4:22:36 PM,Pfizer Layoffs 2023: What to Know About the Latest PFE Job Cuts,InvestorPlace,/news/stocks/pfizer-layoffs-2023-what-to-know-about-the-latest-pfe-job-cuts-dec-1st-1032867052,neutral,0.8561679720878601
6126,12/1/2023 4:45:23 PM,Why Is Altimmune (ALT) Stock Up 43% Today?,InvestorPlace,/news/stocks/why-is-altimmune-alt-stock-up-43-today-1032867221,negative,0.6246684193611145
6127,12/1/2023 5:10:35 PM,Why Is Hub Cyber Security (HUBC) Stock Up 30% Today?,InvestorPlace,/news/stocks/why-is-hub-cyber-security-hubc-stock-up-30-today-1032867220,negative,0.9245932698249817
6128,12/1/2023 8:37:15 PM,"Stocks, Gold, Bonds Rally Further, Dollars Tumbles As Traders Anticipate Fed Cuts: What's Driving Markets Friday?",Benzinga,/news/etf/stocks-gold-bonds-rally-further-dollars-tumbles-as-traders-anticipate-fed-cuts-what-s-driving-markets-friday-1032867482,neutral,0.8257403373718262
6129,12/4/2023 10:20:43 AM,"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Apellis Pharmaceuticals (APLS) and Bausch + Lomb Corporation (BLCO)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-apellis-pharmaceuticals-apls-and-bausch-+-lomb-corporation-blco-1032872099,neutral,0.7852148413658142
6130,12/4/2023 10:20:13 PM,"Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market",Benzinga,/news/etf/roche-pfizer-race-to-find-next-ozempic-as-pharma-giants-hustle-to-join-obesity-treatment-market-1032871966,positive,0.8253699541091919
6131,12/5/2023 7:10:45 AM,"Analysts Conflicted on These Healthcare Names: Natera (NTRA), ImmunoGen (IMGN) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-natera-ntra-immunogen-imgn-and-pfizer-pfe-1032875757,positive,0.514793872833252
6132,12/5/2023 1:41:33 PM,7 Compelling Stocks to Buy That are Sitting at 52-Week Lows,InvestorPlace,/news/stocks/7-compelling-stocks-to-buy-that-are-sitting-at-52-week-lows-1032874241,neutral,0.8884294629096985
6133,12/5/2023 2:11:09 PM,3 Stocks at the Forefront of Personalized Medicine Trend,InvestorPlace,/news/stocks/3-stocks-at-the-forefront-of-personalized-medicine-trend-1032874551,positive,0.7963790893554688
6134,12/5/2023 6:56:11 PM,Diamonds in the Rough: 3 Undervalued Stocks with Huge Upside,InvestorPlace,/news/stocks/diamonds-in-the-rough-3-undervalued-stocks-with-huge-upside-1032875749,positive,0.5744411945343018
6135,12/6/2023 2:50:33 PM,"Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate",Benzinga,/news/stocks/arvinas-pfizer-plan-to-broaden-development-of-breast-cancer-candidate-1032878117,negative,0.6315551996231079
6136,12/6/2023 3:26:56 PM,2024's Potential Stock Surprises: Goldman Sachs Unveils S&P 500 Laggards For Major Gains,Benzinga,/news/stocks/2024-s-potential-stock-surprises-goldman-sachs-unveils-s-p-500-laggards-for-major-gains-1032878413,positive,0.775144100189209
6137,12/6/2023 5:23:37 PM,"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities",Benzinga,/news/stocks/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities-1032879077,positive,0.8401648998260498
6138,12/7/2023 10:15:00 AM,Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy,InvestorPlace,/news/stocks/next-gen-biotech-3-companies-leading-the-charge-in-gene-therapy-1032881188,positive,0.8742164969444275
6139,12/7/2023 9:27:45 PM,"Vaccine Player Vaxcyte Can Potentially Disrupt Pfizer's 20-Plus-Year Near Monopoly, Says Analyst",Benzinga,/news/stocks/vaccine-player-vaxcyte-can-potentially-disrupt-pfizer-s-20-plus-year-near-monopoly-says-analyst-1032883467,neutral,0.9635785222053528
6140,12/8/2023 12:10:00 PM,7 F-Rated Stocks to Sell in December,InvestorPlace,/news/stocks/7-f-rated-stocks-to-sell-in-december-1032885284,positive,0.8499491810798645
6141,12/8/2023 12:30:00 PM,7 Tech Stocks to Light Up Your Portfolio This Holiday Season,InvestorPlace,/news/stocks/7-tech-stocks-to-light-up-your-portfolio-this-holiday-season-1032885360,positive,0.7529719471931458
6142,12/8/2023 2:33:32 PM,Pfizer's ELREXFIO Receives Conditional Marketing Authorization From European Commission ,RTTNews,/news/stocks/pfizer-s-elrexfio-receives-conditional-marketing-authorization-from-european-commission-1032885495,negative,0.6134891510009766
6143,12/9/2023 2:00:00 AM,3 Blue-Chip Stocks Set to Make a Comeback in 2024,InvestorPlace,/news/stocks/3-blue-chip-stocks-set-to-make-a-comeback-in-2024-1032887098,negative,0.5998537540435791
6144,12/11/2023 12:18:05 PM,Buy Rating for Pfizer: Marstacimab’s Success and Strategic Acquisitions Signal Strong Prospects,TipRanks,/news/stocks/buy-rating-for-pfizer-marstacimab-s-success-and-strategic-acquisitions-signal-strong-prospects-1032891208,negative,0.9530519843101501
6145,12/12/2023 1:05:55 PM,Pfizer Receives All Required Regulatory Approvals To Complete Seagen Acquisition ,RTTNews,/news/stocks/pfizer-receives-all-required-regulatory-approvals-to-complete-seagen-acquisition-1032892736,negative,0.5917929410934448
6146,12/12/2023 2:25:43 PM,Pfizer (PFE) Receives a Buy from Jefferies,TipRanks,/news/stocks/pfizer-pfe-receives-a-buy-from-jefferies-1032895251,positive,0.547299861907959
6147,12/12/2023 3:00:06 PM,Bristol Myers Squibb's Mega $8.4B Oncology Bet - Secures Exclusive License With SystImmune,Benzinga,/news/stocks/bristol-myers-squibb-further-diversifies-oncology-portfolio-with-mega-8-4b-deal-1032893319,negative,0.6502244472503662
6148,12/13/2023 9:46:34 AM,Pfizer’s Moderate Growth Potential and Market Outlook: A Hold Rating Analysis,TipRanks,/news/stocks/pfizer-s-moderate-growth-potential-and-market-outlook-a-hold-rating-analysis-1032898818,positive,0.7347627878189087
6149,12/13/2023 10:31:56 AM,Goldman Sachs Says These 3 Healthcare Giants Look Very Attractive Right Now,TipRanks,/news/stocks/goldman-sachs-says-these-3-healthcare-giants-look-very-attractive-right-now-1032898893,negative,0.7411935925483704
6150,12/13/2023 12:00:00 PM,Seeking Passive Income? 7 Dividend Stocks You Don’t Want to Miss.,InvestorPlace,/news/stocks/seeking-passive-income-7-dividend-stocks-you-dont-want-to-miss-1032896670,positive,0.8886902928352356
6151,12/13/2023 1:22:24 PM,"Pfizer Sees FY24 Adj. EPS, Revenues Below Market; Stock Down In Pre Market ",RTTNews,/news/stocks/pfizer-sees-fy24-adj-eps-revenues-below-market-stock-down-in-pre-market-1032896722,neutral,0.970421314239502
6152,12/13/2023 2:26:58 PM,Pfizer (PFE) Gets a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-j-p-morgan-1032899141,positive,0.7275578379631042
6153,12/13/2023 5:03:11 PM,"Pfizer Issues FY24 Forecast, Joins Target Hospitality, Southwest Airlines And Other Big Stocks Moving Lower On Wednesday",Benzinga,/news/stocks/pfizer-issues-fy24-forecast-joins-target-hospitality-southwest-airlines-and-other-big-stocks-moving-lower-on-wednesday-1032897965,neutral,0.9580525159835815
6154,12/13/2023 5:20:50 PM,3 Sleepy Stocks Ready to Wake up in 2024,InvestorPlace,/news/stocks/stocks-to-buy-for-2024-3-sleepy-choices-ready-to-wake-up-1032898218,positive,0.7128385305404663
6155,12/13/2023 6:45:09 PM,"Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?",Benzinga,/news/etf/stocks-hold-steady-yields-decline-as-fed-meeting-looms-what-s-driving-markets-wednesday-1032898290,neutral,0.9202335476875305
6156,12/13/2023 7:40:34 PM,Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/why-despegar-com-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesday-s-mid-day-session-1032898412,positive,0.8775336146354675
6157,12/14/2023 1:46:48 AM,Pfizer’s Mixed Financial Outlook Post-Seagen Deal: Meacham’s Hold Rating with Revised Price Objective,TipRanks,/news/stocks/pfizer-s-mixed-financial-outlook-post-seagen-deal-meacham-s-hold-rating-with-revised-price-objective-1032901071,positive,0.5237023830413818
6158,12/14/2023 12:41:41 PM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alnylam-pharma-alny-and-pfizer-pfe-1032903070,positive,0.9099569320678711
6159,12/14/2023 1:55:31 PM,Pfizer Closes $43 Bln All-cash Acquisition Of Seagen ,RTTNews,/news/stocks/pfizer-closes-43-bln-all-cash-acquisition-of-seagen-1032900775,positive,0.9068245887756348
6160,12/14/2023 1:57:44 PM,Harmonic To Rally Over 80%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/harmonic-to-rally-over-80-here-are-10-top-analyst-forecasts-for-thursday-1032900811,positive,0.9102341532707214
6161,12/14/2023 7:34:25 PM,"Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast",Benzinga,/news/stocks/pfizer-s-2030-vision-bolstered-by-seagen-deal-analyst-cuts-price-target-amid-conservative-2024-forecast-1032902419,negative,0.8939580321311951
6162,12/14/2023 9:21:33 PM,3 Stocks That Are About to Get Absolutely Crushed,InvestorPlace,/news/stocks/3-stocks-that-are-about-to-get-absolutely-crushed-1032902754,positive,0.612317681312561
6163,12/14/2023 9:30:51 PM,MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer,InvestorPlace,/news/stocks/mrna-stock-surges-as-moderna-teams-up-with-merck-to-fight-cancer-1032902845,negative,0.7755407691001892
6164,12/15/2023 8:41:12 AM,Pfizer’s Hold Rating Justified by Cautious Financial Projections and Market Performance,TipRanks,/news/stocks/pfizer-s-hold-rating-justified-by-cautious-financial-projections-and-market-performance-1032905989,neutral,0.9268434643745422
6165,12/15/2023 3:56:03 PM,DZ BANK AG Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/dz-bank-ag-remains-a-buy-on-pfizer-pfe-1032906381,positive,0.9469180703163147
6166,12/15/2023 11:00:00 PM,PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer,PR Newswire,/news/stocks/padcev-enfortumab-vedotin-ejfv-with-keytruda-pembrolizumab-approved-by-fda-as-the-first-and-only-adc-plus-pd-1-to-treat-advanced-bladder-cancer-1032906121,negative,0.8259427547454834
6167,12/16/2023 12:38:01 PM,Pfizer : FDA Approves Padcev-Keytruda To Treat Advanced Bladder Cancer ,RTTNews,/news/stocks/pfizer-fda-approves-padcev-keytruda-to-treat-advanced-bladder-cancer-1032906454,negative,0.926000714302063
6168,12/16/2023 10:00:00 PM,3 S&P 500 Stocks That Are About to Get Absolutely Crushed,InvestorPlace,/news/stocks/3-sp-500-stocks-that-are-about-to-get-absolutely-crushed-1032906578,positive,0.711497962474823
6169,12/17/2023 5:03:57 PM,7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar,InvestorPlace,/news/stocks/7-undervalued-biotech-stocks-that-are-flying-under-the-clinical-radar-1032907065,positive,0.6885424256324768
6170,12/17/2023 7:00:00 PM,3 of the Most Attractive Dividend Stocks in the Pharma Space,InvestorPlace,/news/stocks/3-of-the-most-attractive-dividend-stocks-in-the-pharma-space-1032907116,negative,0.585765540599823
6171,12/18/2023 10:30:24 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Elevance Health (ELV) and Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-elevance-health-elv-and-eli-lilly-co-lly-1032910493,positive,0.9175032377243042
6172,12/18/2023 2:10:28 PM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Checkpoint Therapeutics (CKPT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-checkpoint-therapeutics-ckpt-1032910705,positive,0.902938723564148
6173,12/18/2023 11:44:11 PM,3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?,InvestorPlace,/news/stocks/3-stocks-that-just-hit-a-52-week-low-time-to-back-up-the-truck-1032910565,neutral,0.5922106504440308
6174,12/19/2023 4:31:11 PM,Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?,Benzinga,/news/stocks/why-is-covid-19-vaccine-player-curevac-stock-plummeting-today-1032913221,neutral,0.9309581518173218
6175,12/19/2023 7:55:18 PM,"Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What's Driving Markets Tuesday?",Benzinga,/news/stocks/tech-stocks-set-new-all-time-high-small-caps-on-fire-as-wall-street-bulls-run-wild-what-s-driving-markets-tuesday-1032913804,positive,0.7031859755516052
6176,12/19/2023 9:24:13 PM,Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now,InvestorPlace,/news/stocks/dont-waste-another-minute-dump-these-3-f-rated-stocks-now-1032914057,positive,0.8875674605369568
6177,12/20/2023 1:37:09 AM,3 Stocks to Snatch Up on Tax-Loss Harvesting Dips,InvestorPlace,/news/stocks/3-stocks-to-snatch-up-on-tax-loss-harvesting-dips-1032914425,negative,0.6225064396858215
6178,12/25/2023 10:16:21 AM,3 Blue-Chip Stocks Set for a 50% Surge in the Coming Year,InvestorPlace,/news/stocks/3-blue-chip-stocks-set-for-a-50-surge-in-the-coming-year-1032924464,negative,0.9327011704444885
6179,12/26/2023 1:14:10 AM,Top 3 Healthcare Stock Picks for the New Year,InvestorPlace,/news/stocks/top-3-healthcare-stock-picks-for-the-new-year-1032925142,positive,0.9152405261993408
6180,12/27/2023 5:26:44 PM,The Next Bull Run: 3 Stocks Poised for Unprecedented Growth in 2024,InvestorPlace,/news/stocks/the-next-bull-run-3-stocks-poised-for-unprecedented-growth-in-2024-1032928570,negative,0.5633116960525513
6181,12/27/2023 10:31:53 PM,Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness,InvestorPlace,/news/stocks/healthcare-heroes-3-stocks-innovating-in-medicine-and-wellness-1032928865,positive,0.8069815635681152
6182,12/28/2023 3:34:45 AM,Top Performers: 7 High-Efficiency Stocks With Stellar Profit Per Employee Ratios,InvestorPlace,/news/stocks/top-performers-7-high-efficiency-stocks-with-stellar-profit-per-employee-ratios-1032928973,negative,0.9014782905578613
6183,12/29/2023 7:35:36 PM,"The 500 Top Stocks to Buy for 2024, Ranked by AI",InvestorPlace,/news/stocks/the-500-top-stocks-to-buy-for-2024-ranked-by-ai-1032933022,positive,0.9372130632400513
6184,1/3/2024 6:47:03 PM,7 Most Undervalued Stocks to Buy Now,InvestorPlace,/news/stocks/undervalued-stocks-1031609433,positive,0.5772642493247986
6185,1/3/2024 7:43:03 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/best-blue-chip-stocks-1031627772,positive,0.8018679618835449
6186,1/4/2024 10:50:14 AM,"Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Pfizer (PFE) and Neurogene (NGNE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-illumina-ilmn-pfizer-pfe-and-neurogene-ngne-1032944574,positive,0.9033819437026978
6187,1/4/2024 2:00:32 PM,Peeling Back The Layers: Exploring Pfizer Through Analyst Insights,Benzinga,/news/stocks/peeling-back-the-layers-exploring-pfizer-through-analyst-insights-1032942954,positive,0.9002078175544739
6188,1/4/2024 8:29:37 PM,"EXCLUSIVE: Buy The Dip — There's A Lot More Upside To Come, Says Marc Chaikin",Benzinga,/news/stocks/exclusive-buy-the-dip-—-there-s-a-lot-more-upside-to-come-says-marc-chaikin-1032944300,negative,0.6770836114883423
6189,1/5/2024 3:25:22 PM,Short Sellers' Nightmare: $195B Evaporates In 2023's Market Surge,Benzinga,/news/etf/short-sellers-nightmare-195b-evaporates-in-2023-s-market-surge-1032946074,neutral,0.9086310267448425
6190,1/5/2024 6:20:23 PM,Dry January Investing: Trading Pints For Portfolio Growth,Benzinga,/news/etf/dry-january-investing-trading-pints-for-portfolio-growth-1032946780,positive,0.8352900147438049
6191,1/8/2024 7:02:27 PM,2024’s Top 7 Rebound Picks: Contrarian Stocks in Rising Sectors,InvestorPlace,/news/stocks/2024s-top-7-rebound-picks-contrarian-stocks-in-rising-sectors-1032951421,neutral,0.7404904961585999
6192,1/9/2024 2:39:35 AM,EU Approves Pfizer's Talzenna Combination To Treat Metastatic Castration-resistant Prostate Cancer ,RTTNews,/news/stocks/eu-approves-pfizer-s-talzenna-combination-to-treat-metastatic-castration-resistant-prostate-cancer-1032951926,negative,0.9290989637374878
6193,1/9/2024 10:21:48 AM,Pfizer’s Strategic Realignment and Pipeline Potential: A Hold Rating Amidst Market Skepticism and Long-Term Growth Prospects,TipRanks,/news/stocks/pfizer-s-strategic-realignment-and-pipeline-potential-a-hold-rating-amidst-market-skepticism-and-long-term-growth-prospects-1032955176,negative,0.8669784069061279
6194,1/9/2024 12:18:13 PM,Cantor Fitzgerald Keeps Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-pfizer-pfe-1032955319,positive,0.9205372333526611
6195,1/9/2024 1:23:22 PM,FDA Accepted Supplemental Biologics License Application For TIVDAK For Priority Review: Pfizer ,RTTNews,/news/stocks/fda-accepted-supplemental-biologics-license-application-for-tivdak-for-priority-review-pfizer-1032953342,positive,0.9017882347106934
6196,1/10/2024 1:34:20 AM,Your Path to Wealth: 3 Stocks Predicted to Double Your Investment by 2025,InvestorPlace,/news/stocks/your-path-to-wealth-3-stocks-predicted-to-double-your-investment-by-2025-1032955396,negative,0.8109602928161621
6197,1/11/2024 2:15:56 PM,Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?,InvestorPlace,/news/stocks/pfizers-2024-outlook-is-pfe-stock-poised-for-a-major-rebound-1032960713,negative,0.7994892597198486
6198,1/11/2024 5:40:37 PM,"Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance",Benzinga,/news/stocks/large-drugmakers-show-enthusiasm-to-embrace-100b-obesity-market-despite-novo-and-lilly-s-dominance-1032961467,negative,0.9427829384803772
6199,1/11/2024 8:05:07 PM,Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation,InvestorPlace,/news/stocks/dividend-dynasty-7-high-yield-stocks-for-long-term-wealth-accumulation-1032961916,positive,0.9331802129745483
6200,1/12/2024 12:05:10 AM,3 Megatrend Stocks that Will Revolutionize Your Portfolio,InvestorPlace,/news/stocks/3-megatrend-stocks-that-will-revolutionize-your-portfolio-1032962173,positive,0.8460121154785156
6201,1/12/2024 2:26:27 PM,Beat Inflation With These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts,Benzinga,/news/stocks/beat-inflation-with-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-street-s-most-accurate-analysts-1032963710,negative,0.9167076349258423
6202,1/14/2024 11:15:00 AM,Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends ,InvestorPlace,/news/stocks/7-overlooked-high-yield-dividend-stocks-for-your-2024-portfolio-1032965321,positive,0.8044857382774353
6203,1/15/2024 9:05:41 PM,Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold,InvestorPlace,/news/stocks/are-you-kidding-me-3-meme-stocks-you-should-have-already-sold-1032968400,positive,0.8940779566764832
6204,1/17/2024 4:39:40 AM,Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units,Benzinga,/news/etf/cathie-wood-s-ark-invest-liquidates-15-8m-worth-of-proshares-bitcoin-strategy-etf-units-1032972078,positive,0.7561768889427185
6205,1/17/2024 4:07:00 PM,Why Pfizer Stock Is a Fantastic Pharma Comeback Candidate,InvestorPlace,/news/stocks/why-pfizer-stock-is-a-fantastic-pharma-comeback-candidate-1032974686,positive,0.7358517646789551
6206,1/18/2024 9:00:00 PM,3 Pharma Stocks Could Be the Pills Your Portfolio Needs,InvestorPlace,/news/stocks/?p=2625106-1032978288,positive,0.9179866313934326
6207,1/19/2024 11:54:04 AM,Ex-Pfizer employee convicted of insider trading on COVID-19 trial results,Seeking Alpha,https://seekingalpha.com/news/4056316-ex-pfizer-employee-guilty-insider-trading-covid-19-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6790302395820618
6208,1/19/2024 1:20:04 PM,"Dividend Roundup: Costco, Target, Dell Technologies, Pfizer, and more",Seeking Alpha,https://seekingalpha.com/news/4056360-dividend-roundup-costco-target-dell-technologies-pfizer-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.950224757194519
6209,1/19/2024 1:36:31 PM,Pfizer wins NICE nod for breast cancer therapy Talzenna,Seeking Alpha,https://seekingalpha.com/news/4056373-pfizer-wins-nice-nod-breast-cancer-therapy-talzenna?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9050809741020203
6210,1/22/2024 10:49:49 PM,Bristol's Opdivo + Yervoy combo excels over long term in kidney cancer,Seeking Alpha,https://seekingalpha.com/news/4057161-bristol-opdivo-yervoy-combo-excels-long-term-kidney-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9244074821472168
6211,1/23/2024 8:26:06 AM,Barclays Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-pfizer-pfe-1032987152,positive,0.847312331199646
6212,1/23/2024 6:29:56 PM,Maximizing Tax Deductions: 3 Charity-Friendly Stocks to Consider,InvestorPlace,/news/stocks/maximizing-tax-deductions-3-charity-friendly-stocks-to-consider-1032989163,positive,0.6736466884613037
6213,1/23/2024 8:00:40 PM,Watch GSK amid evidence hearing on Zantac litigation,Seeking Alpha,https://seekingalpha.com/news/4057520-watch-gsk-amid-hearing-on-zantac-litigation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.532893180847168
6214,1/25/2024 11:52:00 AM,7 Over-Hyped Stocks to Sell Before They Plunge,InvestorPlace,/news/stocks/7-overhyped-stocks-to-sell-before-they-plunge-1032996232,positive,0.6774160265922546
6215,1/25/2024 12:20:31 PM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Boston Scientific (BSX) and Ultragenyx Pharmaceutical (RARE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-boston-scientific-bsx-and-ultragenyx-pharmaceutical-rare-1032997600,positive,0.9148014187812805
6216,1/25/2024 7:21:36 PM,3 Stocks to Sell Before Their Earnings Reports Disappoint in 2024,InvestorPlace,/news/stocks/3-stocks-to-sell-before-their-earnings-reports-disappoint-in-2024-1032998321,positive,0.8293253779411316
6217,1/26/2024 12:16:34 PM,PBMs ramp up lobbying efforts amid growing public scrutiny,Seeking Alpha,https://seekingalpha.com/news/4058952-pbms-ramp-up-lobbying-amid-growing-public-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9376139640808105
6218,1/26/2024 5:01:25 PM,3 Healthcare Stocks at 52-Week Lows: Buy or Bye?,InvestorPlace,/news/stocks/3-healthcare-stocks-at-52-week-lows-buy-or-bye-1033001939,neutral,0.7319077253341675
6219,1/26/2024 5:58:45 PM,Merck’s Keytruda cuts bladder cancer risk by 31% in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/4059223-mercks-keytruda-cuts-bladder-cancer-risk-31?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8827193975448608
6220,1/26/2024 6:39:17 PM,3 Dividend Stocks to Buy and Hold for Long-Term Income in 2024,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-and-hold-for-long-term-income-in-2024-1033002127,positive,0.9364053010940552
6221,1/26/2024 8:00:55 PM,"Catalyst watch: Apple earnings, Boeing on the hot seat, FOMC meeting and Amer Sports IPO",Seeking Alpha,https://seekingalpha.com/news/4059230-catalyst-watch-apple-earnings-boeing-on-the-hot-seat-fomc-meeting-and-amer-sports-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9197294116020203
6222,1/28/2024 5:00:53 PM,Big Pharma earnings season in spotlight amid positive sentiment,Seeking Alpha,https://seekingalpha.com/news/4059361-big-pharma-earnings-spotlight-positive-sentiment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8954368233680725
6223,1/29/2024 3:01:13 PM,What Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-stock-q4-earnings-preview-1033005644,positive,0.9330461025238037
6224,1/29/2024 3:20:56 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4059548-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8660826683044434
6225,1/29/2024 5:00:22 PM,Pfizer Gears Up For Q4 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts,Benzinga,/news/stocks/pfizer-gears-up-for-q4-print-here-s-a-look-at-recent-price-target-changes-by-the-most-accurate-analysts-1033006450,positive,0.9375824332237244
6226,1/29/2024 5:14:01 PM,"Marathon Petroleum, Exxon among BofA picks for options opportunity on earnings surprise",Seeking Alpha,https://seekingalpha.com/news/4059539-marathon-petroleum-exxon-among-bofa-picks-for-options-opportunity-on-earnings-surprise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7842940092086792
6227,1/29/2024 5:15:22 PM,Pfizer Q4 results on deck amid gloomy earnings outlook,Seeking Alpha,https://seekingalpha.com/news/4059615-pfizer-q4-results-focus-gloomy-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.935627818107605
6228,1/29/2024 9:17:56 PM,7 High-Yield Dividend Stocks With High-Upside Potential,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-with-high-upside-potential-1033007214,positive,0.7934351563453674
6229,1/30/2024 2:10:18 AM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sarepta Therapeutics (SRPT),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-sarepta-therapeutics-srpt-1033007569,positive,0.9012042284011841
6230,1/30/2024 9:03:46 AM,"Investor Optimism Improves Slightly Ahead Of Big Earnings, Fed's Policy Decision",Benzinga,/news/stocks/investor-optimism-improves-slightly-ahead-of-big-earnings-fed-s-policy-decision-1033008638,negative,0.8492740988731384
6231,1/30/2024 11:47:42 AM,Pfizer reports mixed Q4 results; reaffirms FY24 outlook,Seeking Alpha,https://seekingalpha.com/news/4059921-pfizer-reports-mixed-q4-results-reaffirms-fy24-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.945578396320343
6232,1/30/2024 12:35:41 PM,Pfizer in charts: Biopharma revenue shows sequential improvement in Q4,Seeking Alpha,https://seekingalpha.com/news/4059952-pfizer-in-charts-biopharma-revenue-shows-sequential-improvement-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9550402164459229
6233,1/30/2024 12:49:35 PM,Pfizer Inc. Q4 Earnings Summary,RTTNews,/news/stocks/pfizer-inc-q4-earnings-summary-1033009449,positive,0.712622880935669
6234,1/30/2024 12:50:11 PM,Pfizer beats with COVID franchise despite Q4 revenue miss,Seeking Alpha,https://seekingalpha.com/news/4059957-pfizer-beats-covid-franchise-despite-q4-revenue-miss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7736051678657532
6235,1/30/2024 1:50:19 PM,"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Artivion (AORT) and Apollo Medical Holdings (AMEH)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-artivion-aort-and-apollo-medical-holdings-ameh-1033011208,neutral,0.7408721446990967
6236,1/30/2024 2:08:00 PM,"5 stocks to watch on Tuesday: Pfizer, AMD, Microsoft and more",Seeking Alpha,https://seekingalpha.com/news/4060030-5-stocks-to-watch-on-tuesday-pfizer-amd-microsoft-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9156125783920288
6237,1/30/2024 2:25:15 PM,UBS Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/ubs-sticks-to-their-hold-rating-for-pfizer-pfe-1033011326,positive,0.8647460341453552
6238,1/30/2024 6:35:28 PM,DZ BANK AG Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/dz-bank-ag-remains-a-buy-on-pfizer-pfe-1033011847,positive,0.9469180703163147
6239,1/30/2024 10:01:15 PM,"Analysts Are Bullish on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Pfizer (PFE)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-syndax-pharmaceuticals-sndx-pfizer-pfe-1033012064,negative,0.4918287694454193
6240,1/31/2024 6:00:42 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Silence Therapeutics (SLN) and Dyne Therapeutics (DYN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-silence-therapeutics-sln-and-dyne-therapeutics-dyn-1033013930,positive,0.9120407700538635
6241,1/31/2024 8:30:41 AM,Wall Street Analysts Are Neutral on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-neutral-on-top-healthcare-picks-1033014357,neutral,0.700346827507019
6242,1/31/2024 10:49:07 AM,Pfizer: A Hold Rating Amid Stable Guidance and Emerging Competitive Pressures,TipRanks,/news/stocks/pfizer-a-hold-rating-amid-stable-guidance-and-emerging-competitive-pressures-1033015056,negative,0.90044105052948
6243,1/31/2024 12:10:40 PM,GSK lifts long-term outlook; eyes 12 major launches from 2025,Seeking Alpha,https://seekingalpha.com/news/4060536-gsk-lifts-outlook-eyes-12-launches-from-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8916764259338379
6244,1/31/2024 12:20:52 PM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX) and Pfizer (PFE),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-syndax-pharmaceuticals-sndx-and-pfizer-pfe-1033015904,neutral,0.8100292682647705
6245,1/31/2024 6:33:21 PM,Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts,InvestorPlace,/news/stocks/novavax-layoffs-2024-what-to-know-about-the-latest-nvax-job-cuts-1033016774,neutral,0.9126667976379395
6246,1/31/2024 7:06:24 PM,3 Standout Stocks That Crushed Q4 Earnings Estimates,InvestorPlace,/news/stocks/3-standout-stocks-that-crushed-q4-earnings-estimates-1033016841,neutral,0.9458149671554565
6247,1/31/2024 7:35:35 PM,Listen to Wall Street and Buy These 3 Stocks Now,InvestorPlace,/news/stocks/listen-to-wall-street-and-buy-these-3-stocks-now-1033016909,positive,0.9226931929588318
6248,1/31/2024 8:00:49 PM,Peeling Back The Layers: Exploring Pfizer Through Analyst Insights,Benzinga,/news/stocks/peeling-back-the-layers-exploring-pfizer-through-analyst-insights-1033016820,positive,0.9002078175544739
6249,1/31/2024 9:00:00 PM,3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge Potential,InvestorPlace,/news/stocks/3-once-in-a-lifetime-penny-stocks-with-unprecedented-surge-potential-1033017046,negative,0.8924419283866882
6250,1/31/2024 9:24:30 PM,Viking Therapeutics gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4060945-viking-therapeutics-gains-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8269633054733276
6251,2/1/2024 4:15:58 AM,Pfizer (PFE) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-cantor-fitzgerald-1033018902,positive,0.7369114756584167
6252,2/1/2024 5:06:21 AM,Pfizer’s Hold Rating Maintained Amid Cautious 2024 Guidance and Growth Potential,TipRanks,/news/stocks/pfizer-s-hold-rating-maintained-amid-cautious-2024-guidance-and-growth-potential-1033019014,negative,0.9474055171012878
6253,2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-ppening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49058476090431213
6254,2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-opening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49058476090431213
6255,2/1/2024 5:22:12 PM,Pfizer’s 2024 Comeback: A Dividend Gem in the Pharma Market,InvestorPlace,/news/stocks/pfizers-2024-comeback-a-dividend-gem-in-the-pharma-market-1033022001,positive,0.7212376594543457
6256,2/1/2024 8:42:17 PM,Arvinas draws Buy at Goldman Sachs on breast cancer therapy,Seeking Alpha,https://seekingalpha.com/news/4061605-arvinas-stock-draws-buy-goldman-sachs-breast-cancer-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.775884211063385
6257,2/2/2024 11:50:00 AM,Million-Dollar Bets: 7 Stocks to Buy Before They Blast Off,InvestorPlace,/news/stocks/million-dollar-bets-7-stocks-to-buy-before-they-blast-off-1033026415,positive,0.8867817521095276
6258,2/2/2024 11:50:00 AM,Million-Dollar Bets: 7 Stocks to Buy Before They Blast Off,InvestorPlace,/news/stocks/?p=2655343-1033024574,positive,0.8867817521095276
6259,2/2/2024 12:13:49 PM,Pfizer-Genmab cervical cancer drug gets accepted for EU review,Seeking Alpha,https://seekingalpha.com/news/4061950-pfizer-genmab-cervical-cancer-drug-gets-accepted-for-eu-review?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9029963612556458
6260,2/2/2024 12:49:26 PM,Bristol-Myers Squibb beats in Q4 as Eliquis and Opdivo outperform,Seeking Alpha,https://seekingalpha.com/news/4061968-bristol-myers-squibb-q4-beats-driven-eliquis-and-opdivo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8962094187736511
6261,2/2/2024 1:09:54 PM,Genmab: EMA To Review MAA Of Tisotumab Vedotin - Quick Facts ,RTTNews,/news/stocks/genmab-ema-to-review-maa-of-tisotumab-vedotin-quick-facts-1033024634,positive,0.8870991468429565
6262,2/3/2024 2:42:43 PM,"Benzinga Bulls And Bears: Meta, Tesla, AMD And Crypto Analyst Predicts That 'DOGE Is Gonna Pop'",Benzinga,/news/stocks/benzinga-bulls-and-bears-meta-tesla-amd-and-crypto-analyst-predicts-that-doge-is-gonna-pop-1033026765,positive,0.6644731760025024
6263,2/4/2024 5:00:49 PM,Pharma giants turn to China in search of targeted cancer drugs,Seeking Alpha,https://seekingalpha.com/news/4062374-pharma-antibody-drug-conjugates-china?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8160377740859985
6264,2/4/2024 6:43:01 PM,Barron's picks trailed the benchmarks in 2023 as it missed the megacap boat,Seeking Alpha,https://seekingalpha.com/news/4062393-barrons-picks-trailed-the-benchmarks-in-2023-as-it-missed-the-megacap-boat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9319317936897278
6265,2/5/2024 12:56:15 PM,BridgeBio Pharma granted FDA review for amyloidosis therapy,Seeking Alpha,https://seekingalpha.com/news/4062509-bridgebio-pharma-granted-fda-review-amyloidosis-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8250182867050171
6266,2/5/2024 7:18:07 PM,"NVO, LLY or AZN: Which Pharma Stock Is the Best Weight-Loss Investment?",InvestorPlace,/news/stocks/nvo-lly-or-azn-which-pharma-stock-is-the-best-weight-loss-investment-1033031555,positive,0.9268656969070435
6267,2/6/2024 12:32:06 AM,3 Magnificent Stocks to Buy on the Dip: February 2024,InvestorPlace,/news/stocks/3-magnificent-stocks-to-buy-on-the-dip-february-2024-1033032050,positive,0.8995673060417175
6268,2/6/2024 12:37:06 AM,3 Sleeper Stocks to Buy for the Next Bull Run: February 2024,InvestorPlace,/news/stocks/3-sleeper-stocks-to-buy-for-the-next-bull-run-february-2024-1033032049,positive,0.9297648668289185
6269,2/6/2024 11:15:00 AM,The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-invest-in-for-big-gains-in-2024-1033035941,negative,0.8954083323478699
6270,2/6/2024 12:03:50 PM,"Pfizer, Arvinas' breast cancer therapy gets FDA fast track status",Seeking Alpha,https://seekingalpha.com/news/4063022-arvinas-stock-rises-on-fast-track-status-for-breast-cancer-candidate-with-pfizer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8386751413345337
6271,2/6/2024 1:46:40 PM,GSK RSV vaccine under FDA priority review for label expansion,Seeking Alpha,https://seekingalpha.com/news/4063102-gsk-rsv-shot-under-fda-priority-review-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4937930703163147
6272,2/7/2024 1:53:13 AM,7 Retirement Stocks to Buy at 52-Week Lows,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-at-52-week-lows-1033037241,neutral,0.8820657730102539
6273,2/7/2024 12:35:00 PM,3 Biotech Stocks to Buy on the Dip: February 2024 ,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-on-the-dip-february-2024-1033040262,positive,0.8917143940925598
6274,2/7/2024 6:40:44 PM,3 Blue-Chip Stocks to Buy at a 52-Week Low in February,InvestorPlace,/news/stocks/want-blue-chip-stocks-at-a-low-price-here-are-3-solid-options-1033042564,neutral,0.8401287198066711
6275,2/7/2024 10:44:45 PM,3 Value Stocks to Buy at 52-Week Low in February,InvestorPlace,/news/stocks/3-value-stocks-to-buy-at-52-week-low-in-february-1033043143,neutral,0.9145441055297852
6276,2/8/2024 6:49:40 PM,3 Blue-Chip Stocks to Buy for High Total Returns by 2025,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-high-total-returns-by-2025-1033047965,negative,0.8034754395484924
6277,2/8/2024 8:32:06 PM,Moderna RSV vaccine lags rival shots in long-term efficacy: TD Cowen,Seeking Alpha,https://seekingalpha.com/news/4064766-moderna-rsv-vaccine-lags-rival-shots-long-term-efficacy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.41935503482818604
6278,2/9/2024 12:24:06 PM,Pharma CEOs defend high drug prices; blame PBMs at Senate hearing,Seeking Alpha,https://seekingalpha.com/news/4065061-pharma-ceos-defend-high-drug-prices-blame-pbms-senate-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6773600578308105
6279,2/9/2024 6:23:22 PM,Moderna drops on long-term data for RSV vaccine (update),Seeking Alpha,https://seekingalpha.com/news/4065217-moderna-stock-drops-data-rsv-shot?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7093925476074219
6280,2/11/2024 5:00:03 PM,Booming weight-loss drug market to lift “pick-and-shovel” plays: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4065355-weight-loss-drug-market-lifts-pick-and-shovel-plays?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6393693685531616
6281,2/11/2024 10:00:00 PM,3 Doomed Biotech Stocks to Dump Before They Dive: February 2024,InvestorPlace,/news/stocks/3-doomed-biotech-stocks-to-dump-before-they-dive-february-2024-1033053676,positive,0.8058238625526428
6282,2/12/2024 12:18:25 PM,Pfizer touts cancer efforts in first Super Bowl commercial,Seeking Alpha,https://seekingalpha.com/news/4065432-pfizer-touts-cancer-efforts-first-super-bowl-ad?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5786221623420715
6283,2/12/2024 1:57:56 PM,7 Dividend Stocks to Buy at a 52-Week Low ,InvestorPlace,/news/stocks/7-dividend-stocks-that-are-ready-for-a-bounce-back-year-1033057146,positive,0.8719375133514404
6284,2/12/2024 8:35:27 PM,"Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst",Benzinga,/news/stocks/gene-therapy-player-regenxbio-s-rgx-121-marks-success-in-trial-yet-faces-challenges-in-a-crowded-market-analyst-1033058351,negative,0.40678277611732483
6285,2/12/2024 11:01:45 PM,The 7 Best Momentum Stocks You Can Purchase Today,InvestorPlace,/news/stocks/the-7-best-momentum-stocks-you-can-purchase-today-1033058723,positive,0.9128717184066772
6286,2/13/2024 2:01:27 AM,Federal judge dismisses PhRMA challenge to Medicare price negotiations,Seeking Alpha,https://seekingalpha.com/news/4065840-federal-judge-tosses-phrma-lawsuit-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6178923845291138
6287,2/13/2024 11:57:52 AM,Bicycle Therapeutics gains as former Seagen holder boosts stake,Seeking Alpha,https://seekingalpha.com/news/4065938-bicycle-therapeutics-stock-gains-baker-bros-boosts-stake?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9256365299224854
6288,2/13/2024 1:00:00 PM,The 3 Best Biotech Stocks to Buy in February 2024,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-to-buy-in-february-2024-1033060772,positive,0.8215212225914001
6289,2/13/2024 6:07:35 PM,Eli Lilly partner BioAge wins $170M to study Zepbound combo,Seeking Alpha,https://seekingalpha.com/news/4066258-eli-lilly-partner-bioage-wins-170m-zepbound-combo-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8227844834327698
6290,2/13/2024 6:32:23 PM,3 Blue-Chip Stocks Drowning in Earnings Despair,InvestorPlace,/news/stocks/3-blue-chip-stocks-drowning-in-earnings-despair-1033062663,neutral,0.7077822685241699
6291,2/13/2024 7:57:57 PM,7 High-Yield Dividend Stocks for the Ultimate Retirement Portfolio,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-for-the-ultimate-retirement-portfolio-1033062805,positive,0.9449952840805054
6292,2/14/2024 12:54:01 PM,Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields-1033066002,positive,0.7807832360267639
6293,2/14/2024 4:43:00 PM,CDC to relax COVID isolation requirements: WaPo,Seeking Alpha,https://seekingalpha.com/news/4066920-cdc-to-relax-covid-isolation-requirements?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8257278203964233
6294,2/14/2024 7:43:49 PM,7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution,InvestorPlace,/news/stocks/7-must-buy-pharma-stocks-amid-the-weight-loss-drug-revolution-1033068096,negative,0.6460100412368774
6295,2/15/2024 2:20:22 AM,Biden Boom: 7 Stocks to Buy if Democrats Win the Election in 2024,InvestorPlace,/news/stocks/biden-boom-7-stocks-to-buy-if-democrats-win-the-election-in-2024-1033068646,positive,0.8830666542053223
6296,2/15/2024 10:26:31 AM,Pfizer to settle Lipitor antitrust lawsuit for $93M,Seeking Alpha,https://seekingalpha.com/news/4067428-pfizer-to-settle-lipitor-antitrust-lawsuit-for-93m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7869212627410889
6297,2/15/2024 11:15:00 AM,7 Undervalued Dividend Stocks to Buy in February for High Total Returns,InvestorPlace,/news/stocks/7-undervalued-dividend-stocks-to-buy-in-february-for-high-total-returns-1033070978,negative,0.8412001729011536
6298,2/15/2024 2:05:58 PM,The 7 Best Dividend Stocks to Buy in February 2024,InvestorPlace,/news/stocks/the-7-best-dividend-stocks-to-buy-in-february-2024-1033071830,positive,0.9052000045776367
6299,2/15/2024 2:12:07 PM,Alnylam posts Q4 topline miss; pushes back key data readout,Seeking Alpha,https://seekingalpha.com/news/4067638-alnylam-stock-falls-q4-topline-miss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8973800539970398
6300,2/15/2024 4:57:01 PM,The 3 Biotech Stocks That Could Make Your February Unforgettable,InvestorPlace,/news/stocks/the-3-biotech-stocks-that-could-make-your-february-unforgettable-1033073000,positive,0.8924350142478943
6301,2/16/2024 11:50:00 AM,7 F-Rated Stocks to Sell for February 2024,InvestorPlace,/news/stocks/7-f-rated-stocks-to-sell-for-february-2024-1033075494,positive,0.9289473295211792
6302,2/16/2024 3:29:22 PM,Novartis aiming to develop next-generation weight-loss drugs,Seeking Alpha,https://seekingalpha.com/news/4068274-novartis-aiming-to-develop-next-generation-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6095861792564392
6303,2/16/2024 3:31:25 PM,ARCT: Why Have Analysts Rated this Small-Cap Biotech Stock a “Strong Buy”?,TipRanks,/news/stocks/arct-why-have-analysts-rated-this-small-cap-biotech-stock-a-strong-buy-1033077198,positive,0.6994123458862305
6304,2/16/2024 5:34:51 PM,Viking Therapeutics gains amid renewed takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4068347-viking-therapeutics-gains-amid-renewed-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8901377320289612
6305,2/18/2024 9:06:26 PM,7 Blue-Chip Stocks to Pick Up While They’re Down,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-pick-up-while-theyre-down-1033078345,negative,0.8449326753616333
6306,2/19/2024 2:05:26 PM,EU Approves Pfizer's Velsipity For Treatment Of Ulcerative Colitis In Patients 16 Years And Older ,RTTNews,/news/stocks/eu-approves-pfizer-s-velsipity-for-treatment-of-ulcerative-colitis-in-patients-16-years-and-older-1033079925,negative,0.8560425043106079
6307,2/20/2024 6:00:33 PM,Wall Street Favorites: 7 Long-Term Stocks With Strong Buy Ratings for February 2024,InvestorPlace,/news/stocks/wall-street-favorites-7-long-term-stocks-with-strong-buy-ratings-for-february-2024-1033084535,positive,0.5208563208580017
6308,2/20/2024 6:33:06 PM,Get Rich Quick with These 7 Growth Stocks to Buy Now,InvestorPlace,/news/stocks/7-growth-stocks-to-buy-if-the-bull-market-expands-1033084600,positive,0.7758291959762573
6309,2/20/2024 8:36:00 PM,3 Cheap Dividend Stocks to Snatch Up Now,InvestorPlace,/news/stocks/3-cheap-dividend-stocks-to-snatch-up-now-1033085289,positive,0.7684123516082764
6310,2/21/2024 6:58:16 PM,Moderna to preview post COVID prospects in Q4 results,Seeking Alpha,https://seekingalpha.com/news/4069812-moderna-to-preview-post-covid-prospects-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4999629259109497
6311,2/22/2024 3:37:07 AM,Avanos Medical Issues Voluntary Recall Amid Nurse Assist Sterile Water Product Recall ,RTTNews,/news/stocks/avanos-medical-issues-voluntary-recall-amid-nurse-assist-sterile-water-product-recall-1033090132,neutral,0.8921836614608765
6312,2/22/2024 1:28:00 PM,7 Stocks to Buy for Bargain Hunters on the Prowl,InvestorPlace,/news/stocks/7-stocks-to-buy-for-bargain-hunters-on-the-prowl-1033092926,positive,0.9054515957832336
6313,2/22/2024 7:41:34 PM,Obesity drugs to expand U.S. GDP by 1% in the coming years: Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/4070545-obesity-drugs-expand-us-gdp-goldman-sachs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8677510023117065
6314,2/23/2024 12:05:00 PM,Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth,InvestorPlace,/news/stocks/recession-proof-riches-7-stocks-to-buy-for-bulletproof-portfolio-growth-1033097068,positive,0.9154767990112305
6315,2/23/2024 1:39:04 PM,Pfizer adds bull at Guggenheim on ex-COVID prospects,Seeking Alpha,https://seekingalpha.com/news/4071044-pfizer-stock-adds-bull-guggenheim-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8891551494598389
6316,2/23/2024 8:00:00 PM,"Catalyst Watch: Nvidia phenomenon, Amazon to the Dow and Anheuser-Busch drama",Seeking Alpha,https://seekingalpha.com/news/4070803-catalyst-watch-nvidia-phenomenon-amazon-to-the-dow-and-anheuser-busch-drama?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9187498688697815
6317,2/23/2024 9:45:19 PM,Pfizer files automatic mixed shelf,Seeking Alpha,https://seekingalpha.com/news/4071337-pfizer-files-automatic-mixed-shelf?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9364632368087769
6318,2/23/2024 10:06:58 PM,Pfizer files prospectus for mixed shelf offering,Seeking Alpha,https://seekingalpha.com/news/4071348-pfizer-files-prospectus-mixed-shelf-offering?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9161580801010132
6319,2/26/2024 12:15:00 PM,7 Struggling Stocks to Sell Before Q2 2024,InvestorPlace,/news/stocks/7-struggling-stocks-to-sell-before-q2-2024-1033102130,neutral,0.8838693499565125
6320,2/26/2024 5:31:36 PM,"Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors",Benzinga,/news/etf/eli-lilly-novo-nordisk-s-strategies-against-new-weight-loss-drug-competitors-1033103712,positive,0.8304937481880188
6321,2/26/2024 6:48:44 PM,3 Steal-of-a-Deal Stocks to Snap Up Right Now,InvestorPlace,/news/stocks/3-steal-of-a-deal-stocks-that-look-too-good-to-pass-up-1033104169,positive,0.7115805745124817
6322,2/26/2024 7:25:33 PM,"Amgen's Upcoming Catalysts In 2024 Set To Unlock Multi-Billion Dollar Markets, Says Goldman Sachs",Benzinga,/news/stocks/amgen-s-upcoming-catalysts-in-2024-set-to-unlock-multi-billion-dollar-markets-says-goldman-sachs-1033104128,negative,0.9065037369728088
6323,2/26/2024 7:44:36 PM,3 Blue-Chip Stocks to Buy to Bolster Your Portfolio,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-to-bolster-your-portfolio-1033104264,positive,0.6486648917198181
6324,2/26/2024 8:33:41 PM,7 Defensive Stocks to Weather Any Downturn With Ease,InvestorPlace,/news/stocks/7-defensive-stocks-to-weather-any-downturn-with-ease-1033104330,positive,0.7618197202682495
6325,2/27/2024 12:23:30 PM,Pfizer’s Oncology Strategy and Pipeline Development: A Hold Rating Amidst Transition and Long-Term Growth Prospects,TipRanks,/news/stocks/pfizer-s-oncology-strategy-and-pipeline-development-a-hold-rating-amidst-transition-and-long-term-growth-prospects-1033108305,negative,0.49897417426109314
6326,2/27/2024 5:24:52 PM,Eli Lilly talks with Viking Therapeutics may have stalled - report,Seeking Alpha,https://seekingalpha.com/news/4072391-eli-lilly-talks-with-viking-therapeutics-may-have-stalled-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9397096633911133
6327,2/27/2024 5:45:21 PM,Beam stock jumps as Eli Lilly deal drives Q4 beat,Seeking Alpha,https://seekingalpha.com/news/4072415-beam-stock-jumps-as-eli-lilly-deal-brings-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5264666080474854
6328,2/27/2024 6:44:00 PM,‘Tripledemic’ burden lower this winter despite COVID impact: Airfinity,Seeking Alpha,https://seekingalpha.com/news/4072482-tripledemic-burden-lower-winter-covid-impact?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7414758205413818
6329,2/27/2024 8:19:52 PM,3 Overextended Stocks That Need to Slash Their Dividends ASAP,InvestorPlace,/news/stocks/3-overextended-stocks-that-need-to-slash-their-dividends-asap-1033109211,neutral,0.9424558281898499
6330,2/28/2024 2:50:20 PM,7 Dividend Stocks to Buy to Secure Steady Income,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-to-secure-steady-income-1033113212,positive,0.7853256464004517
6331,2/28/2024 3:07:08 PM,3 Forgotten Dividend Stocks With a Yield of Over 5%,InvestorPlace,/news/stocks/3-forgotten-dividend-stocks-with-a-yield-of-over-5-1033113623,positive,0.8510164022445679
6332,2/28/2024 6:16:57 PM,3 Starter Long-Term Stocks Every New Investor Should Own,InvestorPlace,/news/stocks/3-starter-long-term-stocks-every-new-investor-should-own-1033114575,positive,0.9076948165893555
6333,2/28/2024 11:17:12 PM,CDC panel recommends COVID-19 booster shots for seniors,Seeking Alpha,https://seekingalpha.com/news/4073591-cdc-panel-recommends-covid-19-booster-shots-for-seniors?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.869775116443634
6334,2/29/2024 1:40:48 PM,Pfizer’s RSV shot maintains protective efficacy through two seasons,Seeking Alpha,https://seekingalpha.com/news/4073884-pfizers-rsv-shot-maintains-protective-efficacy-through-two-seasons?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9280234575271606
6335,2/29/2024 4:39:08 PM,Pfizer Announces Positive Data For Abrysvo Vaccine Against Syncytial Virus In Older Adults ,RTTNews,/news/stocks/pfizer-announces-positive-data-for-abrysvo-vaccine-against-syncytial-virus-in-older-adults-1033119238,negative,0.9447020888328552
6336,2/29/2024 5:28:55 PM,IMUNON stock rallies 19% on early results for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/4074047-imunon-stock-rallies-on-early-results-for-covid-19-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9294909238815308
6337,2/29/2024 6:25:26 PM,"Pfizer’s RSV Vaccine Abrysvo Poised for Significant Market Share Despite Competitors, Salveen Richter Recommends Buy",TipRanks,/news/stocks/pfizer-s-rsv-vaccine-abrysvo-poised-for-significant-market-share-despite-competitors-salveen-richter-recommends-buy-1033120543,negative,0.9514696002006531
6338,2/29/2024 10:45:49 PM,"Gritstone to cut 40% of staff due to funding delay, stock plunges 23%",Seeking Alpha,https://seekingalpha.com/news/4074241-gritstone-to-cut-40-percent-of-staff-due-to-funding-delay-stock-plunges?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.968572735786438
6339,3/1/2024 11:18:33 AM,Pfizer’s Growth and Diversification: A Hold Rating Analysis by Terence Flynn,TipRanks,/news/stocks/pfizer-s-growth-and-diversification-a-hold-rating-analysis-by-terence-flynn-1033123580,positive,0.9077170491218567
6340,3/1/2024 11:30:00 AM,3 Overhyped Stocks Every Smart Investor Should Ignore,InvestorPlace,/news/stocks/3-overhyped-stocks-every-smart-investor-should-ignore-1033122944,positive,0.8673546314239502
6341,3/1/2024 12:06:55 PM,Pfizer (PFE) Gets a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-j-p-morgan-1033124107,positive,0.7275578379631042
6342,3/1/2024 12:35:34 PM,Truist Financial Reaffirms Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/truist-financial-reaffirms-their-buy-rating-on-pfizer-pfe-1033124268,positive,0.7616189122200012
6343,3/1/2024 4:00:52 PM,Analyst Scoreboard: 9 Ratings For Pfizer,Benzinga,/news/stocks/analyst-scoreboard-9-ratings-for-pfizer-1033124049,positive,0.9191573858261108
6344,3/1/2024 6:10:27 PM,Medicare price negotiations survive another legal challenge,Seeking Alpha,https://seekingalpha.com/news/4074801-medicare-price-negotiations-survive-legal-challenge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8509966135025024
6345,3/2/2024 1:48:45 PM,RSV shots linked to slightly increased risk of rare neuro condition,Seeking Alpha,https://seekingalpha.com/news/4074978-rsv-shots-linked-higher-risk-rare-neuro-condition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7122730016708374
6346,3/2/2024 6:00:00 PM,Hot on the Hedge Funds’ Trail: 3 Stocks Worth Your Bet?,InvestorPlace,/news/stocks/hot-on-the-hedge-funds-trail-3-stocks-worth-your-bet-1033125664,positive,0.9182671308517456
6347,3/2/2024 7:00:00 PM,"Pfizer, Gilead, Roche seen benefitting the most from antibody-drug conjugates",Seeking Alpha,https://seekingalpha.com/news/4074834-pfizer-gilead-roche-seen-benefitting-most-antibody-drug-conjugates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9174003601074219
6348,3/3/2024 1:00:00 PM,"3 Volatility-Busting, Low-Beta Stocks to Grab Now",InvestorPlace,/news/stocks/3-volatility-busting-low-beta-stocks-to-grab-now-1033125878,positive,0.8188393712043762
6349,3/3/2024 3:14:19 PM,Plan Ahead! 7 Stocks to Buy Before Any Market Downturn Occurs,InvestorPlace,/news/stocks/plan-ahead-7-stocks-to-buy-before-any-market-downturn-occurs-1033126175,positive,0.8794475793838501
6350,3/3/2024 3:33:41 PM,Wells Fargo Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/wells-fargo-keeps-their-hold-rating-on-pfizer-pfe-1033126298,positive,0.9170138835906982
6351,3/3/2024 7:08:04 PM,Biggest contributors and detractors to the S&P's run,Seeking Alpha,https://seekingalpha.com/news/4075016-biggest-contributors-and-detractors-to-the-sps-run?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7131364941596985
6352,3/4/2024 11:29:25 AM,Pfizer’s Oncology Prospects: A Cautious Hold Amidst Intense Market Competition,TipRanks,/news/stocks/pfizer-s-oncology-prospects-a-cautious-hold-amidst-intense-market-competition-1033128750,negative,0.42704200744628906
6353,3/4/2024 7:08:25 PM,Biden says drugmakers to continue to engage in Medicare drug price negoiations,Seeking Alpha,https://seekingalpha.com/news/4075531-biden-says-drugmakers-continue-engage-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8006861805915833
6354,3/4/2024 7:56:37 PM,Biden to launch task force to target health care costs - report,Seeking Alpha,https://seekingalpha.com/news/4075586-biden-launch-task-force-target-health-care-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8196350932121277
6355,3/4/2024 11:42:36 PM,Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound,InvestorPlace,/news/stocks/hidden-gems-7-oversold-stocks-ready-for-a-major-rebound-1033130535,neutral,0.6336252689361572
6356,3/5/2024 4:15:26 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-pfizer-pfe-1033131282,positive,0.8511348366737366
6357,3/5/2024 1:09:09 PM,"Another update to COVID shots expected this year, CDC chief says",Seeking Alpha,https://seekingalpha.com/news/4075911-another-update-covid-shots-expected-this-year?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8100907802581787
6358,3/5/2024 3:28:49 PM,Lava gets $7M from Pfizer as trial for cancer drug advances,Seeking Alpha,https://seekingalpha.com/news/4076029-lava-stock-slips-despite-7m-from-pfizer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5272656679153442
6359,3/5/2024 7:41:24 PM,Strong Buy Alert: Analysts Say to Scoop Up These 7 Stocks,InvestorPlace,/news/stocks/strong-buy-alert-analysts-say-to-scoop-up-these-7-stocks-1033134530,negative,0.5175505876541138
6360,3/5/2024 11:05:00 PM,The Top 3 Stocks for Beginners With Little Money in March 2024,InvestorPlace,/news/stocks/the-top-3-stocks-for-beginners-with-little-money-in-march-2024-1033137674,positive,0.9153985381126404
6361,3/6/2024 1:40:00 PM,Millionaire’s Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town,InvestorPlace,/news/stocks/millionaires-blueprint-7-must-have-stocks-for-your-road-to-wealthy-town-1033137473,positive,0.8420637845993042
6362,3/6/2024 5:14:26 PM,Fulcrum hits 52-week high as CEO buys shares,Seeking Alpha,https://seekingalpha.com/news/4076709-fulcrum-stock-jumps-ceo-buys-shares?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5955303311347961
6363,3/6/2024 6:09:00 PM,Pfizer wins challenge to diversity program in appeals court ruling,Seeking Alpha,https://seekingalpha.com/news/4076741-pfizer-wins-diversity-program-challenge-appeals-court?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4851227104663849
6364,3/6/2024 7:31:39 PM,ViiV’s long-acting HIV therapy outperforms daily therapy in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/4076783-viivs-long-acting-hiv-therapy-outperforms-daily-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9460234045982361
6365,3/6/2024 8:28:23 PM,Pfizer wins FDA nod for antibody drug conjugate Besponsa in children,Seeking Alpha,https://seekingalpha.com/news/4076792-pfizer-wins-fda-nod-besponsa-in-children?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9113014340400696
6366,3/6/2024 10:13:29 PM,The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar,InvestorPlace,/news/stocks/the-short-list-3-meme-stock-battlegrounds-to-keep-on-your-radar-1033139635,positive,0.9339020252227783
6367,3/6/2024 10:40:54 PM,Biden to push for expanding Medicare drug pricing program,Seeking Alpha,https://seekingalpha.com/news/4076912-biden-to-push-for-expanding-medicare-drug-pricing-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7659493088722229
6368,3/7/2024 7:25:40 AM,Pfizer (PFE) Gets a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-j-p-morgan-1033141406,positive,0.7275578379631042
6369,3/7/2024 6:29:15 PM,FDA experts recommend changes to flu shots,Seeking Alpha,https://seekingalpha.com/news/4077314-fda-experts-recommend-changes-flu-shots?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8502257466316223
6370,3/7/2024 8:00:00 PM,3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise,InvestorPlace,/news/stocks/3-cancer-fighting-biotech-stocks-showing-clinical-trial-promise-1033143819,negative,0.5083664655685425
6371,3/8/2024 12:06:31 AM,Novo Nordisk expects Wegovy approval in China this year: report,Seeking Alpha,https://seekingalpha.com/news/4077511-novo-nordisk-expects-wegovy-approval-in-china-this-year-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7831695079803467
6372,3/8/2024 4:25:31 PM,Novo Nordisk sees launching new obesity drugs before Wegovy patent expires,Seeking Alpha,https://seekingalpha.com/news/4077692-novo-nordisk-sees-launching-new-obesity-drugs-before-wegovy-patent-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7814866900444031
6373,3/8/2024 5:11:45 PM,IDEAYA a new Buy at BTIG on underappreciated pipeline,Seeking Alpha,https://seekingalpha.com/news/4077704-ideaya-stock-new-buy-btig-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8870851397514343
6374,3/8/2024 6:03:07 PM,"3 Stock Winners That Are Up 1,000% or More in 2024",InvestorPlace,/news/stocks/3-stock-winners-that-are-up-1000-or-more-in-2024-1033147452,negative,0.9275887608528137
6375,3/8/2024 7:43:24 PM,"This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO",Benzinga,/news/stocks/this-gene-therapy-player-duchenne-data-is-impressive-analyst-upgrades-regenxbio-1033147486,negative,0.8448131680488586
6376,3/10/2024 5:08:00 PM,Cantor sees strong year ahead for oncology M&A,Seeking Alpha,https://seekingalpha.com/news/4077812-patent-cliffs-could-fuel-increased-ma-in-oncology-this-year-cantor-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9445049166679382
6377,3/10/2024 7:05:39 PM,Obesity Drugs 2024: The Skinny on the Top 3 Weight-Loss Stocks,InvestorPlace,/news/stocks/obesity-drugs-2024-the-skinny-on-the-top-3-weight-loss-stocks-1033148628,positive,0.8908045887947083
6378,3/12/2024 11:45:49 AM,Pfizer succeeds in Phase 3 trial for Adcetris in new lymphoma condition,Seeking Alpha,https://seekingalpha.com/news/4078347-pfizer-wins-phase-3-trial-adcetris-lymphoma-condition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9327848553657532
6379,3/12/2024 12:43:40 PM,Pfizer: ADCETRIS Phase 3 Trial In Blood Cancer Shows Positive Overall Survival ,RTTNews,/news/stocks/pfizer-adcetris-phase-3-trial-in-blood-cancer-shows-positive-overall-survival-1033154592,negative,0.95125412940979
6380,3/13/2024 9:37:27 AM,Pfizer’s pneumococcal vaccine approved for infants and children in EU,Seeking Alpha,https://seekingalpha.com/news/4078745-pfizers-pneumococcal-shot-approved-for-infants-and-children-in-eu?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8266622424125671
6381,3/13/2024 9:43:56 AM,Pfizer's PREVENAR 20 Pneumococcal Conjugate Vaccine For Infants And Children Gets EU Approval ,RTTNews,/news/stocks/pfizer-s-prevenar-20-pneumococcal-conjugate-vaccine-for-infants-and-children-gets-eu-approval-1033158192,negative,0.9420549869537354
6382,3/13/2024 10:24:00 AM,7 Elite Blue-Chip Stocks Predicted to Double Your Fortune by 2028,InvestorPlace,/news/stocks/7-elite-blue-chip-stocks-predicted-to-double-your-fortune-by-2028-1033158750,negative,0.6566172242164612
6383,3/13/2024 2:55:32 PM,The 3 Most Undervalued Biotech Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-biotech-stocks-to-buy-in-march-2024-1033160441,positive,0.7386067509651184
6384,3/13/2024 3:07:00 PM,Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio,InvestorPlace,/news/stocks/billionaires-biotech-bets-3-stocks-dominating-bill-gates-portfolio-1033161056,positive,0.9177296757698059
6385,3/13/2024 5:46:03 PM,Catalyst announces US launch of Duchenne drug Agamree,Seeking Alpha,https://seekingalpha.com/news/4079109-catalyst-announces-us-launch-of-duchenne-md-drug-agamree?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7494844794273376
6386,3/14/2024 10:33:00 AM,Want $2K Per Month in Retirement? Buy These 3 Dividend Stocks Now.,InvestorPlace,/news/stocks/want-2k-per-month-in-retirement-buy-these-3-dividend-stocks-now-1033163252,positive,0.9381493926048279
6387,3/14/2024 12:02:33 PM,The 3 Most Undervalued Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-healthcare-stocks-to-buy-in-march-2024-1033163673,positive,0.7171444892883301
6388,3/14/2024 3:44:36 PM,UBS sees Lilly GLP-1/sleep apnea study falling short of Street estimates,Seeking Alpha,https://seekingalpha.com/news/4079564-ubs-sees-lilly-glp-1sleep-apnea-study-falling-short-of-street-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9086613655090332
6389,3/14/2024 10:49:54 PM,3 Pharma Stocks to Sell in March Before They Crash & Burn,InvestorPlace,/news/stocks/3-pharma-stocks-to-sell-in-march-before-they-crash-burn-1033165973,positive,0.7923381924629211
6390,3/14/2024 11:23:16 PM,Terns to report Phase 1 data on GLP-1 drug in 2H 2024,Seeking Alpha,https://seekingalpha.com/news/4079774-terns-to-report-phase-1-data-on-glp-1-drug-in-2h-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9183884859085083
6391,3/15/2024 12:15:00 PM,3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold,InvestorPlace,/news/stocks/3-weight-loss-stocks-to-buy-as-glp-1-mania-takes-hold-1033167937,positive,0.5437567234039307
6392,3/15/2024 4:39:32 PM,3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise,InvestorPlace,/news/stocks/3-precision-medicine-stocks-that-could-benefit-from-the-industrys-rise-1033169120,negative,0.8233184218406677
6393,3/15/2024 8:29:25 PM,"Cancer Treatment Focused Immuneering Faces Analyst Downgrades, Who Cite Underwhelming Solid Tumor Trial Data",Benzinga,/news/stocks/cancer-treatment-focused-immuneering-faces-analyst-downgrades-who-cite-underwhelming-solid-tumor-trial-data-1033169512,neutral,0.968410074710846
6394,3/16/2024 4:57:30 PM,NASH drug market expected to surpass $48B by 2035,Seeking Alpha,https://seekingalpha.com/news/4080234-nash-drug-market-expected-top-48b-2035?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8953897953033447
6395,3/18/2024 9:05:24 AM,Pfizer Plans To Sell About 630 Mln Haleon Shares ,RTTNews,/news/stocks/pfizer-plans-to-sell-about-630-mln-haleon-shares-1033171165,positive,0.9403409957885742
6396,3/18/2024 10:38:51 AM,Pfizer to trim Haleon stake in ~£2B share sale,Seeking Alpha,https://seekingalpha.com/news/4080353-pfizer-to-trim-haleon-stake-in-2b-share-sale?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9295158386230469
6397,3/18/2024 11:00:00 AM,7 Dangerous Dividend Stocks to Avoid at All Costs: March 2024,InvestorPlace,/news/stocks/7-dangerous-dividend-stocks-to-avoid-at-all-costs-march-2024-1033171868,positive,0.9243103265762329
6398,3/18/2024 7:36:31 PM,Puma Biotechnology dips after dismissal of its suit was granted by a federal judge,Seeking Alpha,https://seekingalpha.com/news/4080727-puma-biotechnology-dips-after-dismissal-of-its-suit-was-granted-by-a-federal-judge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9381958246231079
6399,3/19/2024 5:36:07 AM,Pfizer’s Hold Rating: Balancing Pipeline Potential with Clinical and Regulatory Uncertainties,TipRanks,/news/stocks/pfizer-s-hold-rating-balancing-pipeline-potential-with-clinical-and-regulatory-uncertainties-1033175062,negative,0.8343629837036133
6400,3/19/2024 8:51:02 AM,Haleon Announces Pricing And Upsize Of Secondary Offering By Pfizer At $7.85/ADS ,RTTNews,/news/stocks/haleon-announces-pricing-and-upsize-of-secondary-offering-by-pfizer-at-7-85-ads-1033174911,positive,0.9208657145500183
6401,3/19/2024 9:37:25 AM,Pfizer sells £3B of shares in Haleon,Seeking Alpha,https://seekingalpha.com/news/4080906-pfizer-sells-3b-of-shares-in-haleon?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9463491439819336
6402,3/19/2024 9:07:51 PM,3 Juicy Stocks Serving Up 5% Dividends That You Can Snag for $50,InvestorPlace,/news/stocks/3-juicy-stocks-serving-up-5-dividends-that-you-can-snag-for-50-1033178210,positive,0.6467196941375732
6403,3/20/2024 11:05:16 AM,Pfizer partner BioNTech ekes out Q4 profit despite 65% revenue drop,Seeking Alpha,https://seekingalpha.com/news/4081490-biontech-stock-slips-q4-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5967369079589844
6404,3/20/2024 1:35:50 PM,J&J alleges ex-staffer downloaded thousands of files in move to Pfizer,Seeking Alpha,https://seekingalpha.com/news/4081583-jj-alleges-staffer-downloaded-thousands-files-pfizer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.528218150138855
6405,3/21/2024 11:00:14 AM,Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts,Benzinga,/news/etf/is-cathie-wood-buying-the-rumor-ark-more-than-doubles-stake-in-this-covid-19-vaccine-maker-ahead-of-flurry-of-catalysts-1033183763,positive,0.8969354033470154
6406,3/21/2024 5:21:53 PM,China's Xi Jinping plans to meet with U.S. CEOs in China next week - report,Seeking Alpha,https://seekingalpha.com/news/4082269-chinas-xi-jinping-plans-to-meet-with-us-ceos-in-china-next-week-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9264614582061768
6407,3/22/2024 11:40:37 AM,"Analysts Offer Insights on Healthcare Companies: Bruker (BRKR), Inspire Medical Systems (INSP) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-bruker-brkr-inspire-medical-systems-insp-and-pfizer-pfe-1033188939,positive,0.9109885692596436
6408,3/22/2024 12:17:50 PM,Pfizer gets EU backing for new antibiotic combination,Seeking Alpha,https://seekingalpha.com/news/4082574-pfizer-gets-eu-backing-for-new-antibiotic-combination?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8922004699707031
6409,3/22/2024 1:41:41 PM,"Argus cuts Pfizer to hold, cites concerns about topline growth",Seeking Alpha,https://seekingalpha.com/news/4082673-argus-cuts-pfizer-to-hold-cites-concerns-about-topline-growth?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9265572428703308
6410,3/22/2024 9:21:48 PM,7 High-Value Stocks With Massive Wealth-Building Potential,InvestorPlace,/news/stocks/7-high-value-stocks-with-massive-wealth-building-potential-1033190214,positive,0.8194270133972168
6411,3/23/2024 10:00:00 AM,7 Stocks That Will Make Your Friends Green With Envy,InvestorPlace,/news/stocks/7-stocks-that-will-make-your-friends-green-with-envy-1033190349,positive,0.8948740363121033
6412,3/25/2024 5:05:25 PM,Buffett’s Backdoor Buys: 3 Stocks His Secret Portfolio Is Quietly Accumulating,InvestorPlace,/news/stocks/buffetts-backdoor-buys-3-stocks-his-secret-portfolio-is-quietly-accumulating-1033194278,positive,0.8625479340553284
6413,3/26/2024 11:37:54 AM,Viking Therapeutics gains on early data for oral weight loss therapy,Seeking Alpha,https://seekingalpha.com/news/4083623-viking-therapeutics-stock-gains-data-weight-loss-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8850501775741577
6414,3/26/2024 4:04:32 PM,Zoetis comes under EU antitrust probe over dog pain drug,Seeking Alpha,https://seekingalpha.com/news/4083831-zoetis-stock-falls-eu-antitrust-probe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9356966018676758
6415,3/26/2024 5:06:57 PM,Harnessing AI for Drug Discovery: Top 3 Stocks to Watch,InvestorPlace,/news/stocks/harnessing-ai-for-drug-discovery-top-3-stocks-to-watch-1033198242,positive,0.8686332106590271
6416,3/27/2024 9:54:19 AM,The 2025 Double: 3 Stocks Poised to Deliver 100% Gains in Just 12 Months,InvestorPlace,/news/stocks/the-2025-double-3-stocks-poised-to-deliver-100-gains-in-just-12-months-1033200341,negative,0.9273695945739746
6417,3/27/2024 5:07:58 PM,3 Biotech Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-on-the-dip-march-2024-1033202429,positive,0.8910178542137146
6418,3/28/2024 3:54:15 PM,"Pfizer, Astellas first-line bladder cancer therapy accepted for review in China",Seeking Alpha,https://seekingalpha.com/news/4085046-pfizer-astellas--bladder-cancer-therapy-under-review-in-china?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7267119288444519
6419,3/29/2024 10:00:00 AM,7 Dividend Stocks to Secure Your Financial Freedom by 2026,InvestorPlace,/news/stocks/7-dividend-stocks-to-secure-your-financial-freedom-by-2026-1033208056,positive,0.771780252456665
6420,3/29/2024 11:10:00 AM,Spring Cleaning Alert: 7 Dreadful Stocks to Ditch Now,InvestorPlace,/news/stocks/spring-cleaning-alert-7-dreadful-stocks-to-ditch-now-1033208108,neutral,0.8312435150146484
6421,3/30/2024 2:50:43 PM,U.S. CDC warns bacteria causing meningitis are on the rise,Seeking Alpha,https://seekingalpha.com/news/4085358-cdc-warns-bacteria-causing-meningitis-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8889533281326294
6422,4/1/2024 2:17:11 PM,Solid Biosciences gets FDA rare pediatric disease status for DMD therapy,Seeking Alpha,https://seekingalpha.com/news/4085656-solid-biosciences-gets-fda-rare-pediatric-disease-status-for-dmd-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7840417623519897
6423,4/1/2024 3:00:33 PM,"Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'",Benzinga,/news/stocks/jim-cramer-says-chevron-is-doing-pretty-well-will-give-this-pharma-giant-a-chance-1033210968,negative,0.93790203332901
6424,4/1/2024 5:47:23 PM,Blue-Chip Bulldozers: 7 Stock Giants to Plow Through a Wall of Worries,InvestorPlace,/news/stocks/blue-chip-bulldozers-7-stock-giants-to-plow-through-a-wall-of-worries-1033212279,positive,0.8862956166267395
6425,4/1/2024 8:30:00 PM,Unbeatable Blue Chips: 7 Must-Own Stocks for Every Portfolio,InvestorPlace,/news/stocks/unbeatable-blue-chips-7-must-own-stocks-for-every-portfolio-1033212576,positive,0.8898559808731079
6426,4/2/2024 4:13:19 PM,Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts,InvestorPlace,/news/stocks/merger-mania-3-potential-takeover-targets-to-watch-for-lucrative-buyouts-1033216143,positive,0.921463668346405
6427,4/4/2024 12:55:15 PM,Viatris- Theramex deal for women's care products raises antitrust concerns in U.K.,Seeking Alpha,https://seekingalpha.com/news/4087219-viatris-deal-raises-uk-antitrust-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9332636594772339
6428,4/4/2024 8:30:00 PM,The Comeback Kids: 7 Stocks Ready to Rise from the Ashes,InvestorPlace,/news/stocks/the-comeback-kids-7-stocks-ready-to-rise-from-the-ashes-1033223972,positive,0.5020761489868164
6429,4/5/2024 5:54:07 PM,The 3 Most Undervalued Biotech Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-biotech-stocks-to-buy-in-april-2024-1033226729,positive,0.7530437707901001
6430,4/5/2024 6:35:10 PM,3 Healthcare Stocks Short Sellers Are Prescribing for Trouble,InvestorPlace,/news/stocks/3-healthcare-stocks-short-sellers-are-prescribing-for-trouble-1033226817,positive,0.9139937162399292
6431,4/5/2024 8:30:00 PM,The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-russell-2000-stocks-to-buy-in-april-1033226998,positive,0.7935512661933899
6432,4/6/2024 4:20:25 AM,"Analysts’ Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-top-healthcare-picks-pfizer-pfe-eli-lilly-co-lly-1033227104,positive,0.5149402618408203
6433,4/6/2024 3:54:38 PM,Jury sides with SEC in trial over insider trading charges against former pharma executive,Seeking Alpha,https://seekingalpha.com/news/4087719-jury-sides-with-sec-in-trial-over-insider-trading-charges-against-former-pharma-executive?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.865902304649353
6434,4/7/2024 12:00:00 PM,"Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst",Seeking Alpha,https://seekingalpha.com/news/4087726-phathom-pharma-rhythm-vaxcyte-most-likely-takeover-targets-in-pharma-analyst?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9427610635757446
6435,4/7/2024 5:31:00 PM,Morgan Stanley sees Fed rate cut fueling biotech stocks,Seeking Alpha,https://seekingalpha.com/news/4087727-fed-rate-cut-should-fuel-biotech-outperformance-morgan-stanley-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5271168947219849
6436,4/8/2024 12:00:00 PM,The 3 Most Undervalued Healthcare Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-healthcare-stocks-to-buy-in-april-2024-1033229501,positive,0.7351499199867249
6437,4/8/2024 2:57:49 PM,Why Is Ocugen (OCGN) Stock Up 7% Today?,InvestorPlace,/news/stocks/why-is-ocugen-ocgn-stock-up-7-today-2-1033230444,negative,0.8057873249053955
6438,4/8/2024 4:15:07 PM,"GSK, Pfizer-backed ViiV gets FDA okay for HIV drug for adolescents",Seeking Alpha,https://seekingalpha.com/news/4087977-gsk-pfizer-backed-viiv-gets-fda-okay-for-hiv-drug-for-adolescents?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9129928946495056
6439,4/9/2024 10:15:00 AM,3 Dirt-Cheap Stocks That Could Make You Filthy Rich,InvestorPlace,/news/stocks/3-dirt-cheap-stocks-that-could-make-you-filthy-rich-1033232729,positive,0.6970013380050659
6440,4/9/2024 11:19:52 AM,Pfizer RSV shot meets key goal in trial of high-risk adults under age 60,Seeking Alpha,https://seekingalpha.com/news/4088141-pfizer-rsv-shot-meets-key-goal-in-trial-of-high-risk-adults-under-age-60?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8131424188613892
6441,4/9/2024 1:26:37 PM,Pfizer Reports Positive Results From Phase 3 Abrysvo Vaccine Study ,RTTNews,/news/stocks/pfizer-reports-positive-results-from-phase-3-abrysvo-vaccine-study-1033232948,negative,0.9493035078048706
6442,4/9/2024 8:30:00 PM,Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?,InvestorPlace,/news/stocks/election-year-encore-can-2020s-top-7-stock-winners-repeat-their-performance-in-2024-1033234848,positive,0.8704662322998047
6443,4/10/2024 8:57:13 AM,Pfizer’s Hold Rating Balances Vaccine Growth Potential with Competitive and Financial Challenges,TipRanks,/news/stocks/pfizer-s-hold-rating-balances-vaccine-growth-potential-with-competitive-and-financial-challenges-1033236808,negative,0.621803343296051
6444,4/10/2024 11:30:19 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Fusion Pharmaceuticals (FUSN),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pfizer-pfe-and-fusion-pharmaceuticals-fusn-1033237952,neutral,0.9335699677467346
6445,4/10/2024 4:15:08 PM,Pfizer (PFE) Receives a Hold from Berenberg Bank,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-berenberg-bank-1033238709,positive,0.8919239640235901
6446,4/10/2024 5:22:18 PM,7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape,InvestorPlace,/news/stocks/7-healthcare-stocks-to-keep-your-portfolio-in-tip-top-shape-1033238450,positive,0.9137315154075623
6447,4/10/2024 8:42:40 PM,"Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says",Benzinga,/news/stocks/vaccine-player-vaxcyte-has-advantage-over-pfizer-merck-s-pneumococcal-shots---analyst-says-1033238661,negative,0.8393562436103821
6448,4/11/2024 1:48:46 PM,Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-views-on-3-health-care-stocks-with-over-3-dividend-yields-1033240637,positive,0.869409441947937
6449,4/11/2024 3:12:32 PM,Pfizer unit to settle Effexor XR antitrust claims in $39M deal,Seeking Alpha,https://seekingalpha.com/news/4088965-pfizer-unit-pay-39m-settle-effexor-xr-antitrust-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5011584162712097
6450,4/11/2024 5:49:13 PM,"If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-biotech-stock-in-april-it-better-be-one-of-these-3-names-1033242242,positive,0.942658543586731
6451,4/12/2024 9:26:13 AM,Pfizer’s Hold Rating Upheld Amid Modest Sales Outperformance and Market Uncertainty,TipRanks,/news/stocks/pfizer-s-hold-rating-upheld-amid-modest-sales-outperformance-and-market-uncertainty-1033244085,neutral,0.5342614650726318
6452,4/13/2024 2:52:04 PM,AbbVie keeps Humira market share near 100% despite biosimilars: report,Seeking Alpha,https://seekingalpha.com/news/4089412-abbvie-retains-humira-market-despite-copycats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5874672532081604
6453,4/15/2024 11:40:06 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-vertex-pharmaceuticals-vrtx-and-amgen-amgn-1033249994,positive,0.9092313051223755
6454,4/16/2024 4:22:50 PM,"As more rare disease therapies launch, their prices are rising",Seeking Alpha,https://seekingalpha.com/news/4089415-more-rare-disease-therapies-launch-their-prices-rising?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.752937912940979
6455,4/17/2024 1:26:31 PM,CVS favors Humira copycats hurting AbbVie’s market share: Evercore,Seeking Alpha,https://seekingalpha.com/news/4090466-cvs-favors-humira-copycats-hurting-abbvies-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8803040981292725
6456,4/17/2024 5:27:11 PM,Pfizer-Connect Biopharma deal for anti-inflammatory agent ends,Seeking Alpha,https://seekingalpha.com/news/4090625-pfizer-connect-biopharma-deal-inflammatory-drug-ends?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6282867789268494
6457,4/17/2024 9:48:55 PM,The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback,InvestorPlace,/news/stocks/the-3-most-overlooked-stocks-set-for-a-triple-digit-comeback-1033259700,positive,0.4628124535083771
6458,4/19/2024 7:00:19 PM,"Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks",Seeking Alpha,https://seekingalpha.com/news/4091531-catalyst-watch-tesla-boeing-and-general-motors-brace-for-earnings-fireworks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8319826126098633
6459,4/21/2024 6:42:04 PM,Goldman picks top capex and R&D stocks,Seeking Alpha,https://seekingalpha.com/news/4091724-goldman-picks-top-capex-and-rd-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9173789024353027
6460,4/22/2024 12:04:07 AM,13 new obesity drugs could hit the market by 2029 amid surging demand,Seeking Alpha,https://seekingalpha.com/news/4091726-13-new-obesity-drugs-could-hit-the-market-by-2029-amid-surging-demand?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8077118992805481
6461,4/22/2024 2:14:17 PM,EU regulators approve Pfizer antibiotic Emblaveo,Seeking Alpha,https://seekingalpha.com/news/4091933-eu-regulators-approve-pfizer-antibiotic-emblaveo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.698655903339386
6462,4/22/2024 2:50:25 PM,Pfizer's Emblaveo Gets EU Marketing Authorization For Serious Infectious Disease ,RTTNews,/news/stocks/pfizer-s-emblaveo-gets-eu-marketing-authorization-for-serious-infectious-disease-1033270883,negative,0.8872044086456299
6463,4/22/2024 4:03:46 PM,Sanofi reportedly settles 4K Zantac cases for $100M,Seeking Alpha,https://seekingalpha.com/news/4092016-sanofi-reportedly-settles-4k-zantac-cases-for-100m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7949344515800476
6464,4/22/2024 9:44:15 PM,3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years,InvestorPlace,/news/stocks/3-blue-chip-stocks-that-will-beat-index-returns-over-the-next-3-years-1033272930,negative,0.8999062776565552
6465,4/23/2024 9:32:21 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), Pfizer (PFE) and Cardinal Health (CAH)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-addus-homecare-adus-pfizer-pfe-and-cardinal-health-cah-1033275870,neutral,0.7110518217086792
6466,4/23/2024 2:29:06 PM,Edgewise gets EU orphan drug status for muscular dystrophy drug,Seeking Alpha,https://seekingalpha.com/news/4092546-edgewise-gets-eu-orphan-drug-status-for-muscular-dystrophy-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6116942167282104
6467,4/23/2024 7:00:00 PM,3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge,InvestorPlace,/news/stocks/3-underappreciated-pharmaceutical-stocks-to-buy-before-they-surge-1033277779,neutral,0.8864841461181641
6468,4/24/2024 10:33:00 AM,3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains,InvestorPlace,/news/stocks/3-speculative-weight-loss-drug-stocks-to-bet-on-for-big-gains-1033280935,positive,0.8868301510810852
6469,4/24/2024 11:25:00 AM,The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-2024-to-build-lasting-wealth-1033281279,negative,0.722620964050293
6470,4/24/2024 8:38:45 PM,Pfizer declares $0.42 dividend,Seeking Alpha,https://seekingalpha.com/news/4093670-pfizer-inc-declares-0_42-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.873785674571991
6471,4/25/2024 11:56:55 AM,Bristol-Myers posts Q1 beat despite growth headwinds,Seeking Alpha,https://seekingalpha.com/news/4094029-bristol-myers-stock-falls-despite-q1-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.934116780757904
6472,4/25/2024 2:56:02 PM,"GSK sues Pfizer, BioNTech over COVID-19 vaccines patents",Seeking Alpha,https://seekingalpha.com/news/4094203-gsk-suing-pfizer-biontech-over-covid-19-vaccines-patents?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7948645949363708
6473,4/25/2024 7:35:07 PM,Takeda said to have left industry trade group BIO,Seeking Alpha,https://seekingalpha.com/news/4094442-takeda-leaves-industry-trade-group-bio?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5699460506439209
6474,4/26/2024 4:16:21 AM,"Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat",Benzinga,/news/stocks/bristol-myers-q1-loss-narrower-than-expected-sales-beat-1033290926,neutral,0.9027858972549438
6475,4/26/2024 1:20:25 PM,Pfizer's Beqvez Receives FDA Approval For Treatment Of Adults With Hemophilia B ,RTTNews,/news/stocks/pfizer-s-beqvez-receives-fda-approval-for-treatment-of-adults-with-hemophilia-b-1033293445,negative,0.9361693263053894
6476,4/26/2024 4:01:10 PM,Pfizer gets FDA approve for hemophilia B gene therapy,Seeking Alpha,https://seekingalpha.com/news/4095010-pfizer-gets-fda-approve-for-hemophila-b-gene-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7379922866821289
6477,4/26/2024 4:38:41 PM,Pfizer gets FDA approval for hemophilia B gene therapy Beqvez,Seeking Alpha,https://seekingalpha.com/news/4095010-pfizer-gets-fda-approval-for-hemophila-b-gene-therapy-beqvez?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8875094652175903
6478,4/26/2024 4:56:53 PM,19 out 20 S&P 500 healthcare companies beat profit estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4095057-19-out-20-sp-500-healthcare-companies-beat-profit-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6158705353736877
6479,4/26/2024 7:00:06 PM,"Catalyst Watch: Apple earnings, Viking IPO, Chinese EV deliveries and Russell indices' Rank Day",Seeking Alpha,https://seekingalpha.com/news/4094989-catalyst-watch-apple-earnings-viking-ipo-chinese-ev-deliveries-and-russell-indices-rank-day?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9245423674583435
6480,4/26/2024 7:11:32 PM,More than half of the S&P 500 names that reported results this week beat top and bottom line - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4095089-more-than-half-of-the-sp-500-names-that-reported-results-this-week-beat-top-and-bottom-line-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5653102397918701
6481,4/27/2024 10:00:00 AM,7 Dividend Stocks to Buy Now for Steady Returns in Any Market,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-now-for-steady-returns-in-any-market-1033296020,positive,0.7497531175613403
6482,4/27/2024 6:11:33 PM,WHO picks JN.1 variant for next set of COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/4095216-who-picks-jn1-variant-next-covid-vaccines?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.92928546667099
6483,4/28/2024 12:00:00 PM,"Earnings week ahead: Amazon, Apple, Pfizer, AMD, Coca-Cola, Starbucks and more",Seeking Alpha,https://seekingalpha.com/news/4094953-earnings-week-ahead-amazon-apple-pfizer-amd-qualcomm-coca-cola-starbucks-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9127193093299866
6484,4/29/2024 10:00:00 AM,3 Dividend Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-on-the-dip-april-2024-1033299436,positive,0.9317060708999634
6485,4/29/2024 11:30:15 AM,Labcorp’s companion diagnostic approved for use with Pfizer’s hemophilia B gene therapy,Seeking Alpha,https://seekingalpha.com/news/4095360-labcorps-companion-diagnostic-approved-for-use-with-pfizers-hemophilia-b-gene-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6554811596870422
6486,4/29/2024 11:53:17 AM,Pfizer (PFE) Gets a Buy from Truist Financial,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-truist-financial-1033301140,positive,0.6106163263320923
6487,4/29/2024 1:19:03 PM,Labcorp: FDA Approves NAbCyte Companion Diagnostic - Quick Facts ,RTTNews,/news/stocks/labcorp-fda-approves-nabcyte-companion-diagnostic-quick-facts-1033299627,negative,0.5543848872184753
6488,4/29/2024 2:20:44 PM,Merck late-stage data strengthens profile of pneumonia vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/4095517-merck-late-stage-data-strengthens-profile-pneumonia-vaccine-candidate?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9475334286689758
6489,4/30/2024 4:53:47 AM,"Pfizer,Genmab: FDA Grants Full Approval For TIVDAK To Treat Recurrent Or Metastatic 
Cervical Cancer ",RTTNews,/news/stocks/pfizer-genmab-fda-grants-full-approval-for-tivdak-to-treat-recurrent-or-metastatic-cervical-cancer-1033302590,negative,0.9042778611183167
6490,4/30/2024 10:26:54 AM,"Pfizer, Genmab cervical cancer therapy wins full FDA approval",Seeking Alpha,https://seekingalpha.com/news/4096045-pfizer-genmab-cervical-cancer-therapy-wins-full-fda-approval?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.921509325504303
6491,4/30/2024 1:49:06 PM,"J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations",Seeking Alpha,https://seekingalpha.com/news/4096283-jj-bristol-myers-lose-bid-halt-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9564803242683411
6492,4/30/2024 3:01:13 PM,What Wall Street expects from Pfizer's earnings,Markets Insider Automation,/news/stocks/pfizer-q1-earnings-preview-1033306428,positive,0.9330461025238037
6493,4/30/2024 5:18:51 PM,"Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings",Benzinga,/news/stocks/pfizer-sees-less-revenue-from-covid-19-treatments-stock-faces-headwinds-ahead-of-q1-earnings-1033307639,neutral,0.9692655801773071
6494,4/30/2024 5:50:57 PM,7 Safe Haven Stocks That Can Withstand the Market’s Worst Meltdowns,InvestorPlace,/news/stocks/7-safe-haven-stocks-that-can-withstand-the-markets-worst-meltdowns-1033308490,positive,0.5131520628929138
6495,4/30/2024 6:03:57 PM,Pfizer Q1 Earnings Preview: Covid assets to remain the focus this quarter,Seeking Alpha,https://seekingalpha.com/news/4096673-pfizer-q1-earnings-preview-covid-assets-to-remain-the-focus-this-quarter?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.534663200378418
6496,4/30/2024 7:47:54 PM,Biotech Stocks Facing FDA Decision In May 2024 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-may-2024-1033308434,positive,0.9209955334663391
6497,5/1/2024 10:01:13 AM,"Pfizer plans direct-to-consumer platform to sell Covid, migraine drugs - report",Seeking Alpha,https://seekingalpha.com/news/4097035-pfizer-plans-direct-to-consumer-platform-to-sell-covid-migraine-drugs-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8115430474281311
6498,5/1/2024 10:48:13 AM,Pfizer beats top-line and bottom-line estimates; reaffirms FY24 outlook,Seeking Alpha,https://seekingalpha.com/news/4097068-pfizer-beats-top-line-and-bottom-line-estimates-reaffirms-fy24-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.897162139415741
6499,5/1/2024 11:21:10 AM,"Earnings Summary: Pfizer tops expectations in Q1, reaffirms FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4097132-earnings-summary-pfizer-tops-expectations-in-q1-reaffirms-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9285873174667358
6500,5/1/2024 12:37:31 PM,Pfizer raises guidance amid cost savings,Seeking Alpha,https://seekingalpha.com/news/4097227-pfizer-stock-gains-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8998525142669678
6501,5/1/2024 12:50:04 PM,"Pfizer Inc. Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/pfizer-inc-q1-profit-decreases-but-beats-estimates-1033312311,neutral,0.9630827903747559
6502,5/1/2024 1:05:01 PM,Analysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-surmodics-srdx-and-pfizer-pfe-1033314654,positive,0.9072989821434021
6503,5/1/2024 1:05:28 PM,UBS Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/ubs-reaffirms-their-hold-rating-on-pfizer-pfe-1033314651,positive,0.8490313291549683
6504,5/1/2024 1:05:54 PM,Pfizer Boost FY24 Adj. EPS Outlook - Update ,RTTNews,/news/stocks/pfizer-boost-fy24-adj-eps-outlook-update-1033312452,positive,0.8649564385414124
6505,5/1/2024 1:10:00 PM,"4 stocks to watch on Wednesday: PFE, QCOM and more",Seeking Alpha,https://seekingalpha.com/news/4097279-4-stocks-to-watch-on-wednesday-pfe-qcom-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9247291088104248
6506,5/1/2024 2:52:53 PM,"PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/pfe-stock-earnings-pfizer-for-q1-of-2024-1033314235,negative,0.6843344569206238
6507,5/1/2024 7:07:03 PM,"US Stocks Mixed Ahead Of Fed Meeting, Chipmakers Tumble After AMD Earnings, Bitcoin Sinks: What's Driving Markets Wednesday?",Benzinga,/news/etf/us-stocks-mixed-ahead-of-fed-meeting-chipmakers-tumble-after-amd-earnings-bitcoin-sinks-what-s-driving-markets-wednesday-1033314859,neutral,0.9239674210548401
6508,5/1/2024 8:35:34 PM,Jefferies Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/jefferies-remains-a-buy-on-pfizer-pfe-1033315924,positive,0.9468463659286499
6509,5/2/2024 5:15:55 AM,Buy Rating Affirmed for Pfizer Amid Strong Q1 Performance and Strategic Cost Savings,TipRanks,/news/stocks/buy-rating-affirmed-for-pfizer-amid-strong-q1-performance-and-strategic-cost-savings-1033318287,negative,0.9501200318336487
6510,5/2/2024 7:50:32 AM,Pfizer (PFE) Receives a Hold from Barclays,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-barclays-1033318911,positive,0.8307812809944153
6511,5/2/2024 9:20:14 AM,Pfizer’s Mixed Financial Signals: A Delicate Balance Between Growth and Uncertainty,TipRanks,/news/stocks/pfizer-s-mixed-financial-signals-a-delicate-balance-between-growth-and-uncertainty-1033319536,positive,0.49178773164749146
6512,5/2/2024 10:32:01 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Alkermes (ALKS)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-pfizer-pfe-sagimet-biosciences-inc-class-a-sgmt-and-alkermes-alks-1033320142,neutral,0.9147515892982483
6513,5/2/2024 11:22:00 AM,3 Contrarian Stocks That Could Make You a Fortune (If You Dare),InvestorPlace,/news/stocks/3-contrarian-stocks-that-could-make-you-a-fortune-if-you-dare-1033319302,positive,0.8858699202537537
6514,5/2/2024 11:38:53 AM,Pfizer Exceeds Q1 Expectations with Strong Earnings and Raises 2024 Guidance: A Buy Rating by Evan Seigerman,TipRanks,/news/stocks/pfizer-exceeds-q1-expectations-with-strong-earnings-and-raises-2024-guidance-a-buy-rating-by-evan-seigerman-1033320823,negative,0.6658713221549988
6515,5/2/2024 5:48:51 PM,Moderna to seek parity for RSV shot as rivals lead in market,Seeking Alpha,https://seekingalpha.com/news/4099014-moderna-to-seek-parity-for-rsv-shot-as-rivals-lead-in-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8504931926727295
6516,5/2/2024 8:10:19 PM,Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-inmode-inmd-and-pfizer-pfe-1033322734,positive,0.601169764995575
6517,5/2/2024 9:15:40 PM,"Pfizer Prospects Garner Mixed Sentiment From Analysts: 'Finally, The Pivot Investors Have Been Waiting For'",Benzinga,/news/stocks/pfizer-prospects-garner-mixed-sentiment-from-analysts-finally-the-pivot-investors-have-been-waiting-for-1033322072,negative,0.6883327960968018
6518,5/3/2024 11:00:00 AM,3 Ultra-Safe Stocks to Buy So You Can Rest Easy in Any Market,InvestorPlace,/news/stocks/3-ultra-safe-stocks-to-buy-so-you-can-rest-easy-in-any-market-1033326049,positive,0.8846898674964905
6519,5/3/2024 2:28:54 PM,Amgen stock rallies 13% on GLP-1 weight-loss drug update,Seeking Alpha,https://seekingalpha.com/news/4099749-amgen-stock-rallies-on-glp-1-weight-loss-drug-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8914835453033447
6520,5/4/2024 7:30:00 PM,Pharma R&D productivity seen improving for the first time in years - Deloitte,Seeking Alpha,https://seekingalpha.com/news/4099974-pharma-research-development-productivity-improving-first-time-years?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9528807997703552
6521,5/4/2024 8:47:00 PM,16 out of 24 health care companies beat topline numbers this week- Earnings scorecard,Seeking Alpha,https://seekingalpha.com/news/4099757-16-out-of-24-health-care-companies-beat-topline-numbers-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8876544833183289
6522,5/5/2024 8:08:00 PM,About 79% of the S&P 500 names beat on EPS during the busiest week of Q1 reporting - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4099902-about-79-of-the-sp-500-names-beat-on-eps-during-the-busiest-week-of-q1-reporting-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.648939847946167
6523,5/6/2024 10:00:00 AM,Revive Your Portfolio: 3 Undervalued Stocks Poised for Growth,InvestorPlace,/news/stocks/revive-your-portfolio-3-undervalued-stocks-poised-for-growth-1033332151,negative,0.762345552444458
6524,5/6/2024 3:08:32 PM,BioNTech swings to quarterly net loss on massive decline in COVID shot revenue,Seeking Alpha,https://seekingalpha.com/news/4100407-biontech-swings-quarterly-net-loss-massive-decline-covid-shot-revenue?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9735012650489807
6525,5/6/2024 5:43:19 PM,Pfizer hires Citi healthcare analyst Baum to lead strategy and innovation,Seeking Alpha,https://seekingalpha.com/news/4100608-pfizer-hires-citi-healthcare-analyst-baum-lead-strategy-innovation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9097871780395508
6526,5/6/2024 6:22:51 PM,Maximize Your Dividends: 7 Stocks Trading Under $50 with 5%+ Yields,InvestorPlace,/news/stocks/maximize-your-dividends-7-stocks-trading-under-50-with-5-yields-1033334935,positive,0.8463087677955627
6527,5/6/2024 9:38:35 PM,"Andrew Baum To Oversee Pfizer's Innovation, Portfolio Strategy ",RTTNews,/news/stocks/andrew-baum-to-oversee-pfizer-s-innovation-portfolio-strategy-1033335054,positive,0.9451685547828674
6528,5/7/2024 6:04:24 PM,Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare,InvestorPlace,/news/stocks/biotech-breakthroughs-7-stocks-driving-the-next-wave-in-healthcare-1033341676,positive,0.8313630819320679
6529,5/7/2024 8:16:50 PM,Boy given Pfizer experimental Duchenne muscular dystrophy therapy dies,Seeking Alpha,https://seekingalpha.com/news/4101733-boy-given-pfizer-experimental-duchenne-muscular-dystrophy-therapy-dies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6545227766036987
6530,5/8/2024 11:06:13 AM,AstraZeneca is withdrawing COVID shot worldwide due to vaccine glut,Seeking Alpha,https://seekingalpha.com/news/4102264-astrazeneca-withdrawing-covid-shot-vaccine-glut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9458288550376892
6531,5/8/2024 2:30:00 PM,Just Say No to Drugs: 3 Pharma Stocks to Avoid,InvestorPlace,/news/stocks/just-say-no-to-drugs-3-pharma-stocks-to-avoid-1033348744,positive,0.915638267993927
6532,5/8/2024 2:46:32 PM,"Pfizer to settle over 10,000 Zantac-related cancer claims: report",Seeking Alpha,https://seekingalpha.com/news/4102555-pfizer-settle-zantac-related-cancer-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8470604419708252
6533,5/9/2024 2:34:23 PM,7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025,InvestorPlace,/news/stocks/7-weight-loss-drug-stocks-poised-for-explosive-growth-by-2025-1033357058,negative,0.8605071902275085
6534,5/9/2024 4:41:08 PM,A Look at Pharma ETFs Post Q1 Earnings,Benzinga,/news/etf/a-look-at-pharma-etfs-post-q1-earnings-1033357001,positive,0.9325221180915833
6535,5/9/2024 5:55:25 PM,3 Profitable Dividend Stocks to Buy at Near-Lows,InvestorPlace,/news/stocks/3-profitable-dividend-stocks-to-buy-at-near-lows-1033357931,positive,0.6503015756607056
6536,5/9/2024 10:44:45 PM,HHS panel to vote in Nov. on DMD screening for newborns,Seeking Alpha,https://seekingalpha.com/news/4104342-hhs-panel-to-vote-in-nov-on-dmd-screening-for-newborns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8794383406639099
6537,5/10/2024 12:12:14 AM,Safeguard Your Future: Top 3 Stocks to Weather Any Market Downturn,InvestorPlace,/news/stocks/safeguard-your-future-top-3-stocks-to-weather-any-market-downturn-1033358931,positive,0.8061447739601135
6538,5/10/2024 10:01:00 AM,The 3 Most Undervalued Healthcare Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-healthcare-stocks-to-buy-in-may-2024-1033362256,positive,0.7676413655281067
6539,5/10/2024 10:30:00 AM,3 Biotech Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-biotech-stocks-to-sell-in-may-before-they-crash-burn-1033362353,positive,0.8534220457077026
6540,5/10/2024 11:17:32 AM,Moderna announces delay in RSV vaccine review in U.S.,Seeking Alpha,https://seekingalpha.com/news/4104468-moderna-stock-slips-rsv-vaccine-review-drags?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.905786395072937
6541,5/10/2024 11:30:43 AM,7 F-Rated Stock Picks to Avoid Like the Plague in May,InvestorPlace,/news/stocks/7-f-rated-stock-picks-to-avoid-like-the-plague-in-may-1033362559,positive,0.8103131651878357
6542,5/10/2024 4:54:35 PM,Novavax hits 52-week high as Sanofi deal brings upgrades (update),Seeking Alpha,https://seekingalpha.com/news/4104693-novavax-stock-surges-jp-morgan-upgrades-sanofi-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6570422053337097
6543,5/10/2024 10:09:07 PM,"Stocks Surge On Healthy Earnings Season, Rising Jobless Claims: This Week In The Markets",Benzinga,/news/etf/stocks-surge-on-healthy-earnings-season-rising-jobless-claims-this-week-in-the-markets-1033364809,neutral,0.6915622353553772
6544,5/12/2024 3:00:00 PM,Cantor picks 14 undervalued biotech stocks worth a second look,Seeking Alpha,https://seekingalpha.com/news/4104913-cantor-picks-14-undervalued-biotech-stocks-worth-a-second-look?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6954953074455261
6545,5/13/2024 11:19:54 AM,"Amazon, Microsoft, Pfizer To Invest Billions In French Projects ",RTTNews,/news/stocks/amazon-microsoft-pfizer-to-invest-billions-in-french-projects-1033369865,positive,0.8091022372245789
6546,5/13/2024 5:24:17 PM,"Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets",Seeking Alpha,https://seekingalpha.com/news/4105325-corbus-pharmaceutical-new-outperform-rbc-cancer-obesity-assets?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6085924506187439
6547,5/13/2024 5:53:13 PM,"AstraZeneca, Pfizer to invest combined $900M+ in France for R&D, production",Seeking Alpha,https://seekingalpha.com/news/4105350-astrazeneca-pfizer-invest-combined-900m-france-for-research-development-production?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5853603482246399
6548,5/15/2024 10:00:00 AM,7 Cheap Value Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-now-may-2024-1033383327,positive,0.9349449872970581
6549,5/15/2024 3:40:47 PM,"Dividend picks by SA analysts: PFE, DVN, SBUX and LOW",Seeking Alpha,https://seekingalpha.com/news/4106553-dividend-picks-by-sa-analysts-pfe-dvn-sbux-and-low?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9400588870048523
6550,5/16/2024 9:47:27 AM,Pfizer agrees to pay up to $250M to settle Zantac cancer lawsuits - report,Seeking Alpha,https://seekingalpha.com/news/4107148-pfizer-agrees-to-pay-up-to-250m-to-settle-zantac-cancer-lawsuits-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8489351868629456
6551,5/16/2024 10:15:00 AM,Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade,InvestorPlace,/news/stocks/patent-peril-3-stocks-at-risk-from-the-ftcs-drug-crusade-1033392050,neutral,0.9288397431373596
6552,5/16/2024 10:48:39 AM,Roche obesity therapy leads to ~19% weight loss in Phase 1 trial,Seeking Alpha,https://seekingalpha.com/news/4107185-roche-obesity-therapy-causes-19-weight-loss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8494001626968384
6553,5/16/2024 11:15:00 AM,7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs,InvestorPlace,/news/stocks/7-pharma-stocks-harnessing-ai-brainpower-for-big-breakthroughs-1033392344,negative,0.5881011486053467
6554,5/16/2024 1:35:15 PM,"Arvinas, Pfizer, Report 6-month Follow Up Data From Phase 1b Study Of Vepdegestrant+Palbociclib ",RTTNews,/news/stocks/arvinas-pfizer-report-6-month-follow-up-data-from-phase-1b-study-of-vepdegestrant-palbociclib-1033392313,positive,0.7822633385658264
6555,5/16/2024 4:29:52 PM,GSK to sell entire Haleon stake,Seeking Alpha,https://seekingalpha.com/news/4107601-gsk-sell-entire-haleon-stake?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9423266649246216
6556,5/17/2024 9:21:52 AM,UK Stocks: GSK to Divest Remaining Stake in Haleon,TipRanks,/news/stocks/uk-stocks-gsk-to-divest-remaining-stake-in-haleon-1033398974,positive,0.8034617900848389
6557,5/17/2024 11:11:00 AM,7 Value Stocks to Buy and Hold for a Decade of Dominance,InvestorPlace,/news/stocks/7-value-stocks-to-buy-and-hold-for-a-decade-of-dominance-1033398745,positive,0.9146937727928162
6558,5/17/2024 5:25:19 PM,Moderna vaccine patent upheld by European Patent Office: report,Seeking Alpha,https://seekingalpha.com/news/4107992-moderna-vaccine-patent-upheld-by-european-patent-office-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8520667552947998
6559,5/17/2024 7:10:02 PM,Puma Biotech pares gain amid Wyeth victory in Tagrisso patent case against AstraZeneca,Seeking Alpha,https://seekingalpha.com/news/4108031-puma-biotech-surges-amid-wyeth-victory-in-tagrisso-patent-case?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8725233674049377
6560,5/17/2024 9:24:26 PM,"4 Stocks That Could Break Novo Nordisk, Lilly's Obesity Duopoly",Benzinga,/news/stocks/4-stocks-that-could-break-novo-nordisk-lilly-s-obesity-duopoly-1033400634,negative,0.5076711177825928
6561,5/18/2024 4:19:14 PM,"Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch",Benzinga,/news/stocks/cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch-1033400987,positive,0.9329438805580139
6562,5/18/2024 6:52:07 PM,"Novo Nordisk, J&J lead R&D rankings in big pharma: report",Seeking Alpha,https://seekingalpha.com/news/4108110-novo-nordisk-j-j-lead-rd-big-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8400077223777771
6563,5/19/2024 7:05:03 PM,SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?,Seeking Alpha,https://seekingalpha.com/news/4108152-sa-roundtable-are-eli-lilly-and-novo-nordisk-overvalued?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8515272736549377
6564,5/20/2024 1:58:45 PM,PTC Therapeutics rallies 18% on EU authorization update for Translarna,Seeking Alpha,https://seekingalpha.com/news/4108342-ptc-therapeutics-rallies-on-eu-authorization-update-for-translarna?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9447431564331055
6565,5/20/2024 6:09:46 PM,3 Blue-Chip Stocks Set to Triple Soon,InvestorPlace,/news/stocks/3-blue-chip-stocks-set-to-triple-soon-1033404474,negative,0.7259917855262756
6566,5/21/2024 1:30:00 PM,3 Blue-Chip Stocks to Buy on the Dip: May 2024,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-on-the-dip-may-2024-1033407490,positive,0.8826157450675964
6567,5/21/2024 7:04:59 PM,3 Healthcare Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-now-may-2024-1033408783,positive,0.9365553259849548
6568,5/21/2024 9:22:48 PM,Pfizer tax practices targeted by Senate Finance Committee Chair Wyden,Seeking Alpha,https://seekingalpha.com/news/4109094-pfizer-tax-practices-targeted-senate-finance-committee-chair-wyden?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6564592123031616
6569,5/22/2024 9:45:52 AM,Wells Fargo Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/wells-fargo-remains-a-hold-on-pfizer-pfe-1033411489,positive,0.7956233620643616
6570,5/22/2024 1:48:14 PM,7 Safe-Haven Stocks to Weather Any Storm,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-weather-any-storm-1033411814,positive,0.6809397339820862
6571,5/22/2024 4:59:29 PM,Pfizer launching cost reduction program expected to rein in $1.5B by end of 2027,Seeking Alpha,https://seekingalpha.com/news/4109435-pfizer-launching-cost-reduction-program-expected-rein-15b-end-2027?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9129492044448853
6572,5/22/2024 6:00:26 PM,COVID-19 vaccine makers rebound amid post-pandemic prospects,Seeking Alpha,https://seekingalpha.com/news/4109471-covid-19-vaccine-makers-gain-post-pandemic-prospects?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8279330134391785
6573,5/22/2024 9:43:22 PM,"Moderna, BioNTech close with double-digit percentage gains amid bird flu fears",Seeking Alpha,https://seekingalpha.com/news/4109643-moderna-biontech-close-with-double-digit-percentage-gains-amid-bird-flu-fears?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.929969310760498
6574,5/22/2024 10:09:14 PM,"Pfizer, Moderna in talks with HHS over avian flu vaccine: report (update)",Seeking Alpha,https://seekingalpha.com/news/4109651-pfizer-moderna-in-talks-with-hhs-over-avian-flu-vaccine-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.904943585395813
6575,5/23/2024 11:49:55 AM,Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units ,RTTNews,/news/stocks/pfizer-s-hospira-recalls-select-hydrochloride-injection-carpuject-units-1033415107,positive,0.8562249541282654
6576,5/23/2024 6:01:14 PM,3 Biotech Stocks to Buy on the Dip: May 2024,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-on-the-dip-may-2024-1033417162,positive,0.8900653719902039
6577,5/23/2024 6:20:37 PM,New COVID FLiRT variants spike as FDA delays key vaccine meeting,Seeking Alpha,https://seekingalpha.com/news/4109969-covid-flirt-variants-spike-fda-delays-key-vaccine-meeting?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.94333815574646
6578,5/23/2024 6:31:12 PM,The Savvy Investor’s Cheat Sheet: 3 Deep Value Picks for May 2024,InvestorPlace,/news/stocks/the-savvy-investors-cheat-sheet-3-deep-value-picks-for-may-2024-1033417218,positive,0.9246503114700317
6579,5/24/2024 6:09:50 PM,Cogent Bio spikes after updating late-stage data for lead asset,Seeking Alpha,https://seekingalpha.com/news/4110329-cogent-bio-stock-gains-after-cancer-trial-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.49603143334388733
6580,5/24/2024 7:00:53 PM,"Catalyst Watch: Costco earnings, M&A drama, Viking ratings, and a key inflation read",Seeking Alpha,https://seekingalpha.com/news/4110251-catalyst-watch-costco-earnings-ma-drama-viking-ratings-and-a-key-inflation-read?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9077320694923401
6581,5/25/2024 2:24:03 PM,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",Seeking Alpha,https://seekingalpha.com/news/4110471-viking-crispr-cytokinetics-m-a-targets-wells-fargo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9204940795898438
6582,5/26/2024 5:36:00 PM,SA Asks: Who will launch the next big weight-loss drug?,Seeking Alpha,https://seekingalpha.com/news/4110093-sa-asks-who-will-launch-the-next-big-weight-loss-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9171247482299805
6583,5/27/2024 4:59:56 PM,Dividend Deals: 3 Overlooked Stocks Offering Incredible Value,InvestorPlace,/news/stocks/dividend-deals-3-overlooked-stocks-offering-incredible-value-1033424895,negative,0.5130628347396851
6584,5/28/2024 5:15:12 AM,Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/berenberg-bank-reaffirms-their-hold-rating-on-pfizer-pfe-1033426172,positive,0.8553645610809326
6585,5/28/2024 2:11:30 PM,Revenge of the Apes: 3 Reddit WallStreetBets Stocks That Could Pop Next,InvestorPlace,/news/stocks/revenge-of-the-apes-3-reddit-wallstreetbets-stocks-that-could-pop-next-1033427684,positive,0.8793312311172485
6586,5/28/2024 8:43:24 PM,"Sarepta Downgraded As FDA Decision Date Approaches, Shares Up 50% Over Last Six Months",Benzinga,/news/stocks/sarepta-downgraded-as-fda-decision-date-approaches-shares-up-50-over-last-six-months-1033428422,negative,0.9543492794036865
6587,5/29/2024 10:00:00 AM,"If You Can Only Buy One Value Stock in May, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-value-stock-in-may-it-better-be-one-of-these-3-names-1033430889,positive,0.9381660223007202
6588,5/29/2024 10:30:00 AM,"If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-biotech-stock-in-may-it-better-be-one-of-these-3-names-1033431002,positive,0.9427831172943115
6589,5/29/2024 1:31:02 PM,7 Must-Own Stocks to Hold for the Second Half of 2024,InvestorPlace,/news/stocks/7-must-own-stocks-to-hold-for-the-second-half-of-2024-1033431883,positive,0.743518590927124
6590,5/29/2024 9:11:50 PM,BridgeBio reports additional positive data for acoramidis in ATTR-CM,Seeking Alpha,https://seekingalpha.com/news/4111338-bridgebio-reports-additional-positive-data-for-acoramidis-in-attr-cm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9314294457435608
6591,5/30/2024 10:40:00 AM,"Steady Gains, Solid Yields: 7 Low-Beta Stocks Paying 5%+ Dividends",InvestorPlace,/news/stocks/steady-gains-solid-yields-7-low-beta-stocks-paying-5-dividends-1033435522,negative,0.7910261750221252
6592,5/30/2024 11:04:27 AM,Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT,Seeking Alpha,https://seekingalpha.com/news/4111439-moderna-stock-gains-us-fund--bird-flu-shot?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7250252962112427
6593,5/30/2024 3:22:06 PM,Goldman Sachs raises obesity drug market estimate to $130B,Seeking Alpha,https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6894457936286926
6594,5/30/2024 5:46:56 PM,Third human bird flu case found in U.S.,Seeking Alpha,https://seekingalpha.com/news/4111670-third-human-bird-flu-case-found-in-us?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8130267262458801
6595,5/31/2024 2:16:50 AM,Pfizer’s Acoramidis Shows Promising Survival Trends: A Buy Rating Endorsement,TipRanks,/news/stocks/pfizer-s-acoramidis-shows-promising-survival-trends-a-buy-rating-endorsement-1033439698,negative,0.9269242882728577
6596,5/31/2024 2:59:11 AM,Balanced Outlook Amidst Strategic Shifts: Pfizer’s Hold Rating Explained,TipRanks,/news/stocks/balanced-outlook-amidst-strategic-shifts-pfizer-s-hold-rating-explained-1033439828,positive,0.6064020991325378
6597,5/31/2024 12:13:08 PM,Pfizer gene therapy for haemophilia B therapy endorsed in EU,Seeking Alpha,https://seekingalpha.com/news/4111903-pfizer-gene-therapy-for-haemophilia-b-therapy-endorsed-in-eu?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8350472450256348
6598,5/31/2024 1:48:36 PM,Pfizer posts long-term data to support lung cancer therapy Lorbrena,Seeking Alpha,https://seekingalpha.com/news/4111942-pfizer-data-supports-lung-cancer-drug-lorbrena?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.51694256067276
6599,5/31/2024 4:19:46 PM,Novartis boasts Scemblix beats tyrosine kinase inhibitors for chronic myeloid leukemia,Seeking Alpha,https://seekingalpha.com/news/4111998-novartis-boasts-scemblix-beats-tyrosine-kinase-inhibitors-chronic-myeloid-leukemia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7673793435096741
6600,5/31/2024 4:33:33 PM,Pfizer's Phase 3 Crown Trial Of Lobrena Reports 5-year Non-progression Results In NSCLC Patients ,RTTNews,/news/stocks/pfizer-s-phase-3-crown-trial-of-lobrena-reports-5-year-non-progression-results-in-nsclc-patients-1033441668,negative,0.704371988773346
6601,5/31/2024 6:55:00 PM,Moderna falls as efficacy concerns overshadow new RSV shot (update),Seeking Alpha,https://seekingalpha.com/news/4111991-moderna-stock-gains-fda-clears-rsv-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9558308720588684
6602,6/1/2024 3:05:00 PM,"GSK, Pfizer must face tens of thousands of Zantac cases in Delaware",Seeking Alpha,https://seekingalpha.com/news/4112129-gsk-pfizer-must-face-tens-thousands-zantac-cases-delaware?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.526770293712616
6603,6/1/2024 9:52:36 PM,"Corbus outlines phase 1 results from ADC trial for bladder, cervical cancers",Seeking Alpha,https://seekingalpha.com/news/4112140-corbus-outlines-phase-1-results-adc-trial-bladder-cervical-cancers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7882280349731445
6604,6/2/2024 10:30:00 AM,Blue-Chip Blunders: 7 Stocks to Sell as Management Missteps Mount,InvestorPlace,/news/stocks/blue-chip-blunders-7-stocks-to-sell-as-management-missteps-mount-1033443183,neutral,0.9579668045043945
6605,6/2/2024 11:22:00 AM,3 Discounted Stocks Poised for a Major Upswing,InvestorPlace,/news/stocks/3-discounted-stocks-poised-for-a-major-upswing-1033443201,negative,0.5642337203025818
6606,6/2/2024 2:00:00 PM,SA Asks: Which weight-loss stocks should investors be watching?,Seeking Alpha,https://seekingalpha.com/news/4112116-sa-asks-which-weight-loss-stocks-should-investors-be-watching?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9329712986946106
6607,6/3/2024 10:00:00 AM,7 Overlooked Stocks That Belong in Every Portfolio ,InvestorPlace,/news/stocks/7-must-own-overlooked-stocks-that-can-work-in-any-portfolio-1033445074,positive,0.9365252256393433
6608,6/3/2024 6:24:35 PM,"Pfizer, Takeda say four-year data support Adcetris as Hodgkin lymphoma treatment",Seeking Alpha,https://seekingalpha.com/news/4112421-pfizer-takeda-say-four-year-data-supports-adcetris-hodgkin-lymphoma-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6065847277641296
6609,6/4/2024 10:00:00 AM,7 High-Yield Dividend Stocks That Work While You Sleep,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-that-work-while-you-sleep-1033448657,positive,0.9349055886268616
6610,6/4/2024 10:37:00 AM,The Income Investor’s Dream Team: 7 Sturdy Dividend Stocks Yielding 6%,InvestorPlace,/news/stocks/the-income-investors-dream-team-7-sturdy-dividend-stocks-yielding-6-1033448879,positive,0.8566088676452637
6611,6/4/2024 6:03:15 PM,Pfizer data for breast cancer therapy sends Olema higher,Seeking Alpha,https://seekingalpha.com/news/4112798-pfizer-data-breast-cancer-drug-drives-olema?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8644782900810242
6612,6/5/2024 10:40:00 AM,7 Dividend Stocks to Invest In for a Lifetime of Income,InvestorPlace,/news/stocks/7-dividend-stocks-to-invest-in-for-a-lifetime-of-income-1033452830,positive,0.930995762348175
6613,6/5/2024 2:52:27 PM,COVID vaccine makers ready updated shots for fall immunization drive,Seeking Alpha,https://seekingalpha.com/news/4113216-covid-vaccine-makers-ready-updated-shots-fall-immunization?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8891397714614868
6614,6/5/2024 8:30:31 PM,FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall,Seeking Alpha,https://seekingalpha.com/news/4113349-fda-advisors-unanimously-agree-covid-jn1-lineage-vaccine-fall?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8286686539649963
6615,6/5/2024 8:48:37 PM,Bird flu death in Mexico linked to strain not seen in humans before,Seeking Alpha,https://seekingalpha.com/news/4113375-bird-flu-death-mexico-linked-strain-not-seen-humans-before?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7871726751327515
6616,6/5/2024 8:51:18 PM,Why Is Novavax (NVAX) Stock Up 20% Today?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-up-20-today-1033455390,negative,0.8138962388038635
6617,6/6/2024 12:04:56 PM,Novavax marketing application for COVID shot undergoes FDA review,Seeking Alpha,https://seekingalpha.com/news/4113540-novavax-stock-gains-covid-shot-gets-fda-look?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8747193813323975
6618,6/6/2024 1:28:58 PM,Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?,InvestorPlace,/news/stocks/is-a-giant-short-squeeze-brewing-in-novavax-nvax-stock-1033457699,neutral,0.6661053895950317
6619,6/6/2024 9:36:29 PM,Halozyme's ENHANZE Product Gets New Patent Grant in EU,Benzinga,/news/stocks/halozyme-s-enhanze-product-gets-new-patent-grant-in-eu-1033459113,negative,0.7392569780349731
6620,6/7/2024 4:11:30 PM,FDA selects JN.1 variant for next COVID vaccine campaign,Seeking Alpha,https://seekingalpha.com/news/4114180-omicron-jn1-picked-next-covid-vaccines?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7379314303398132
6621,6/7/2024 7:00:58 PM,"Catalyst Watch: Apple's WWDC, Tesla's annual meeting, Fed's dot plot, and GameStop volatility",Seeking Alpha,https://seekingalpha.com/news/4114173-catalyst-watch-apples-wwdc-teslas-shareholder-meeting-fomc-meeting-and-gamestop-volatility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8829660415649414
6622,6/7/2024 8:21:08 PM,Pfizer's Paxlovid ineffective in treating long COVID symptoms: study,Seeking Alpha,https://seekingalpha.com/news/4114253-pfizers-paxlovid-ineffective-in-treating-long-covid-symptoms-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5635466575622559
6623,6/8/2024 11:45:22 AM,GSK wins FDA nod to expand label for RSV vaccine,Seeking Alpha,https://seekingalpha.com/news/4114295-gsk-wins-fda-nod-expand-rsv-vaccine-label?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8826696276664734
6624,6/10/2024 6:58:39 PM,CSL Seqirus to provide more than 40M bird flu vaccine doses to Europe,Seeking Alpha,https://seekingalpha.com/news/4114582-csl-seqirus-provide-40m-bird-flu-vaccine-doses-europe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5378116369247437
6625,6/10/2024 9:53:18 PM,Moderna Submits Updated COVID-19 Jab to FDA for Review,Benzinga,/news/stocks/moderna-submits-updated-covid-19-jab-to-fda-for-review-1033466949,positive,0.9077591896057129
6626,6/11/2024 10:00:00 AM,3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants,InvestorPlace,/news/stocks/3-vaccine-stocks-to-buy-as-the-fda-cracks-down-on-new-variants-1033468275,neutral,0.737201452255249
6627,6/11/2024 11:23:55 AM,"GSK, Pfizer to appeal Delaware ruling that allowed trials for thousands of Zantac cases",Seeking Alpha,https://seekingalpha.com/news/4114747-gsk-pfizer-appeal-delaware-zantac-ruling?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5567856431007385
6628,6/11/2024 2:00:00 PM,3 Penny Stocks to Buy if You Want to Spend Less and Earn More,InvestorPlace,/news/stocks/3-penny-stocks-to-buy-if-you-want-to-spend-less-and-earn-more-1033469513,positive,0.8977554440498352
6629,6/11/2024 6:49:39 PM,7 Recession-Proof Stocks to Buy Now for Peace of Mind,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-now-for-peace-of-mind-1033470311,positive,0.8757135272026062
6630,6/12/2024 6:26:45 AM,Pfizer’s Hold Rating Affirmed Amid Legal Developments and Vaccine Definition Debate,TipRanks,/news/stocks/pfizer-s-hold-rating-affirmed-amid-legal-developments-and-vaccine-definition-debate-1033471818,negative,0.94507896900177
6631,6/12/2024 2:55:44 PM,Citi opens upside catalyst watch on Alnylam ahead of ATTR-CM data,Seeking Alpha,https://seekingalpha.com/news/4115223-citi-opens-upside-catalyst-watch-on-alnylam-ahead-of-attr-cm-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9159435629844666
6632,6/12/2024 4:33:43 PM,GLP-1 obesity drug coverage dropped by Blue Cross Michigan: report,Seeking Alpha,https://seekingalpha.com/news/4115246-glp-1-drug-coverage-dropped-by-blue-cross-michigan-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9600133299827576
6633,6/12/2024 5:39:39 PM,"Pfizer, Flagship to collaborate on obesity drug discovery",Seeking Alpha,https://seekingalpha.com/news/4115288-pfizer-flagship-to-collaborate-on-obesity-drug-discovery?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5698086619377136
6634,6/12/2024 7:20:36 PM,3 Hidden-Gem Value Stocks to Buy and Never Let Go,InvestorPlace,/news/stocks/3-hidden-gem-value-stocks-to-buy-and-never-let-go-1033474101,positive,0.9183838367462158
6635,6/12/2024 9:02:28 PM,Pfizer Duchenne muscular dystrophy gene therapy fails in phase 3,Seeking Alpha,https://seekingalpha.com/news/4115379-pfizer-duchenne-muscular-dystrophy-gene-therapy-fails-phase-3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7755961418151855
6636,6/13/2024 3:22:56 AM,Pfizer's Phase 3 Duchenne Gene Therapy Trial Fails To Meet Primary And Secondary Endpoints ,RTTNews,/news/stocks/pfizer-s-phase-3-duchenne-gene-therapy-trial-fails-to-meet-primary-and-secondary-endpoints-1033474404,neutral,0.941840410232544
6637,6/13/2024 9:55:42 AM,Hold Rating for Pfizer Amid DMD Gene Therapy Program Setbacks and Competitive Pressures,TipRanks,/news/stocks/hold-rating-for-pfizer-amid-dmd-gene-therapy-program-setbacks-and-competitive-pressures-1033476044,neutral,0.9616317749023438
6638,6/13/2024 10:08:08 AM,"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Abbott Laboratories (ABT) and Dyne Therapeutics (DYN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-abbott-laboratories-abt-and-dyne-therapeutics-dyn-1033476155,neutral,0.7128983736038208
6639,6/13/2024 11:00:26 AM,Sarepta gains after Pfizer’s late-stage setback for Duchenne therapy,Seeking Alpha,https://seekingalpha.com/news/4115467-sarepta-stock-gains-after-pfizer-setback-for-duchenne-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.49103084206581116
6640,6/13/2024 1:00:00 PM,"4 stocks to watch on Thursday: ADBE, KMB and more",Seeking Alpha,https://seekingalpha.com/news/4115577-4-stocks-to-watch-on-thursday-adbe-kmb-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9226678013801575
6641,6/13/2024 7:02:10 PM,Pfizer Phase III DMD Gene Therapy Study Misses Goal,Benzinga,/news/stocks/pfizer-phase-iii-dmd-gene-therapy-study-misses-goal-1033477418,positive,0.8804572224617004
6642,6/13/2024 10:34:04 PM,FDA recommends KP.2 strain be used in updated COVID-19 shots,Seeking Alpha,https://seekingalpha.com/news/4116006-fda-recommends-kp2-strain-be-used-in-updated-covid-19-shots?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8910152316093445
6643,6/14/2024 10:37:00 AM,3 Stocks to Sell as Ozempic Surges in Popularity,InvestorPlace,/news/stocks/3-stocks-to-sell-as-ozempic-surges-in-popularity-1033479269,negative,0.7905429601669312
6644,6/14/2024 12:49:30 PM,Pfizer's Elrexfio buoyed by multiple myeloma survival data,Seeking Alpha,https://seekingalpha.com/news/4116165-pfizer-elrexfio-buoyed-by-multiple-myeloma-survival-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9433483481407166
6645,6/14/2024 2:59:33 PM,CDC 'preparing for the possibility' bird flu could spread more easily,Seeking Alpha,https://seekingalpha.com/news/4116212-cdc-preparing-possibility-bird-flu-could-spread-more-easily?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.42003464698791504
6646,6/14/2024 7:39:10 PM,"Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails",Benzinga,/news/stocks/pharma-stock-roundup-fda-panel-endorses-lly-s-donanemab-pfe-s-dmd-therapy-study-fails-1033480819,positive,0.6571053266525269
6647,6/14/2024 8:21:41 PM,Pfizer stock traded in the red for seven straight days,Seeking Alpha,https://seekingalpha.com/news/4116415-pfizer-stock-traded-in-the-red-for-seven-straight-days?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7116929292678833
6648,6/18/2024 9:01:14 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Patterson Companies (PDCO) and Neurocrine (NBIX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-patterson-companies-pdco-and-neurocrine-nbix-1033486838,positive,0.9154314398765564
6649,6/18/2024 1:01:00 PM,Merck gets FDA approval for Capvaxive pneumonia vaccine (update),Seeking Alpha,https://seekingalpha.com/news/4116816-merck-gets-fda-approval-for-capvaxive-21-pneumonia-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.671528160572052
6650,6/18/2024 5:13:38 PM,Day One in licensing pact with MabCare for cancer therapy,Seeking Alpha,https://seekingalpha.com/news/4117092-day-one-stock-licensing-deal-cancer-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7664035558700562
6651,6/18/2024 6:13:37 PM,Pfizer sued in Kansas over COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/4117114-pfizer-sued-in-kansas-over-covid-19-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.841026246547699
6652,6/18/2024 7:03:18 PM,GeoVax stock rockets 50% on BARDA award for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/4117122-geovax-stock-rockets-on-barda-award-for-covid-19-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7779902815818787
6653,6/18/2024 7:25:23 PM,Novavax Seeks FDA Nod for Updated COVID-19 Vaccine,Benzinga,/news/stocks/novavax-seeks-fda-nod-for-updated-covid-19-vaccine-1033488280,negative,0.7918103337287903
6654,6/20/2024 11:30:00 AM,7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027,InvestorPlace,/news/stocks/7-high-value-blue-chip-stocks-to-boost-your-wealth-by-2027-1033492560,negative,0.8014839887619019
6655,6/20/2024 12:00:00 PM,3 Underrated Dividend Stock Machines to Turbocharge Your Income,InvestorPlace,/news/stocks/3-underrated-dividend-stock-machines-to-turbocharge-your-income-1033492705,positive,0.8984619975090027
6656,6/20/2024 4:43:45 PM,Skip Meme Mania: 3 Undervalued Blue-Chip Stocks for Steady Returns,InvestorPlace,/news/stocks/skip-meme-mania-3-undervalued-blue-chip-stocks-for-steady-returns-1033493944,negative,0.7472666501998901
6657,6/21/2024 4:25:36 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-pfizer-pfe-1033494968,positive,0.8511348366737366
6658,6/21/2024 9:31:14 PM,"The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly",Benzinga,/news/stocks/the-zacks-analyst-blog-highlights-pfizer-johnson-johnson-and-eli-lilly-1033497156,positive,0.9443087577819824
6659,6/23/2024 5:38:49 PM,7 Dividend Stocks to Buy Now: June 2024 ,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-now-june-2024-1033498164,positive,0.9362931251525879
6660,6/23/2024 6:00:00 PM,"Lilly, Novo Nordisk to dominate weight loss therapy market: SA Investing Summit",Seeking Alpha,https://seekingalpha.com/news/4118072-lilly-novo-nordisk-dominate-weight-loss-therapy-sa-investing-summit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7935812473297119
6661,6/24/2024 2:33:45 PM,Alnylam (ALNY) Stock Soars 30% on Heart Disease Drug Success,InvestorPlace,/news/stocks/alnylam-alny-stock-soars-30-on-heart-disease-drug-success-1033500601,negative,0.5999979972839355
6662,6/24/2024 8:30:00 PM,3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains,InvestorPlace,/news/stocks/3-undervalued-pharma-stocks-to-buy-for-dividends-and-capital-gains-1033501636,negative,0.592124342918396
6663,6/25/2024 10:18:33 AM,Pfizer CEO reveals new weight loss drug mechanism in works,Seeking Alpha,https://seekingalpha.com/news/4118698-pfizer-ceo-reveals-new-weight-loss-drug-mechanism-in-works?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7948918342590332
6664,6/25/2024 4:31:58 PM,Bird flu shots to begin in Finland,Seeking Alpha,https://seekingalpha.com/news/4119085-bird-flu-shots-begin-finland?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9374563694000244
6665,6/26/2024 10:33:00 AM,3 Blue-Chip Stocks to Buy on the Dip: June 2024,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-on-the-dip-june-2024-1033506995,positive,0.8851924538612366
6666,6/26/2024 3:29:54 PM,Moderna dips after latest RSV vaccine efficacy data,Seeking Alpha,https://seekingalpha.com/news/4119662-moderna-stock-dips-rsv-vaccine-efficacy-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9385072588920593
6667,6/26/2024 8:35:45 PM,Pfizer declares $0.42 dividend,Seeking Alpha,https://seekingalpha.com/news/4119814-pfizer-inc-declares-0_42-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.873785674571991
6668,6/26/2024 8:38:07 PM,"GSK, Pfizer decline as CDC advisors recommend narrower age range for RSV shots",Seeking Alpha,https://seekingalpha.com/news/4119818-gsk-pfizer-decline-cdc-advisors-recommend-narrower-age-range-rsv-shots?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9518330097198486
6669,6/27/2024 1:18:24 AM,Maintaining Hold on Moderna Amidst Uncertainties in RSV Vaccine Market and ACIP Decisions,TipRanks,/news/stocks/maintaining-hold-on-moderna-amidst-uncertainties-in-rsv-vaccine-market-and-acip-decisions-1033509712,negative,0.5963432788848877
6670,6/27/2024 4:15:11 AM,Cantor Fitzgerald Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-pfizer-pfe-1033510155,positive,0.9459741115570068
6671,6/27/2024 10:20:00 AM,3 Beautiful Blue-Chip Stocks You Can Buy for Less Than $100,InvestorPlace,/news/stocks/3-beautiful-blue-chip-stocks-you-can-buy-for-less-than-100-1033510776,positive,0.9168869853019714
6672,6/27/2024 4:49:14 PM,3 Dividend Stocks to Buy If You Want Cash for Life,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-if-you-want-cash-for-life-1033512613,positive,0.9401898384094238
6673,6/27/2024 5:14:55 PM,You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.,InvestorPlace,/news/stocks/youve-been-warned-3-pharma-stocks-to-buy-now-or-regret-forever-1033512708,positive,0.8092414140701294
6674,6/27/2024 7:00:41 PM,"Pfizer, BioNTech Get CHMP's Positive Opinion For Marketing Authorization Of Omicron JN.1  Vaccine ",RTTNews,/news/stocks/pfizer-biontech-get-chmp-s-positive-opinion-for-marketing-authorization-of-omicron-jn-1-vaccine-1033512643,negative,0.8511883616447449
6675,6/28/2024 10:00:00 AM,The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains,InvestorPlace,/news/stocks/the-top-3-weight-loss-drug-stocks-to-buy-for-huge-gains-1033514451,positive,0.7380595803260803
6676,6/28/2024 11:55:34 AM,"Dividend Roundup: Kroger, AT&T, Pfizer, JPMorgan, and more",Seeking Alpha,https://seekingalpha.com/news/4120524-dividend-roundup-kroger-att-pfizer-jpmorgan-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9469661712646484
6677,6/29/2024 10:30:00 AM,3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt,InvestorPlace,/news/stocks/3-sectors-that-could-get-slammed-by-attempts-to-reduce-u-s-debt-1033516833,neutral,0.9460068345069885
6678,6/29/2024 12:00:00 PM,Shhh! 7 Stocks Quietly Lining Up for a Massive Surge in July.,InvestorPlace,/news/stocks/shhh-7-stocks-quietly-lining-up-for-a-massive-surge-in-july-1033516850,negative,0.8362378478050232
6679,6/29/2024 7:44:55 PM,Rising drug costs force a third of Americans to leave prescriptions unfilled: report,Seeking Alpha,https://seekingalpha.com/news/4120808-many-prescriptions-remain-unfilled-amid-soaring-drug-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7290322184562683
6680,7/1/2024 4:19:57 PM,3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks,InvestorPlace,/news/stocks/3-dividend-stocks-yielding-over-3-with-multi-decade-payout-growth-streaks-1033520688,negative,0.9196974039077759
6681,7/1/2024 6:01:09 PM,A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts,Benzinga,/news/stocks/a-glimpse-into-the-expert-outlook-on-pfizer-through-9-analysts-1033520569,positive,0.8877639174461365
6682,7/2/2024 12:25:16 AM,Pfizer (PFE) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-cantor-fitzgerald-1033521214,positive,0.7369114756584167
6683,7/2/2024 10:24:00 AM,3 Under-the-Radar Biotech Stocks With Blockbuster Potential,InvestorPlace,/news/stocks/3-under-the-radar-biotech-stocks-with-blockbuster-potential-1033522419,positive,0.6027738451957703
6684,7/2/2024 11:48:18 AM,Moderna wins $176M flu vaccine contract from U.S.,Seeking Alpha,https://seekingalpha.com/news/4121545-moderna-wins-176m-vaccine-contract-us?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9503676295280457
6685,7/2/2024 3:49:49 PM,COVID infections could be seeing a summer surge based on CDC data,Seeking Alpha,https://seekingalpha.com/news/4121762-covid-infections-could-seeing-summer-surge-based-cdc-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9087452292442322
6686,7/3/2024 8:35:18 AM,GSK Acquires Global Rights For MRNA Vaccines For Influenza & COVID-19 In CureVac Deal - Quick Facts ,RTTNews,/news/stocks/gsk-acquires-global-rights-for-mrna-vaccines-for-influenza-covid-19-in-curevac-deal-quick-facts-1033525314,negative,0.550710916519165
6687,7/3/2024 12:39:17 PM,3 Undervalued Stocks Poised for a Jaw-Dropping Breakout,InvestorPlace,/news/stocks/3-undervalued-stocks-poised-for-a-jaw-dropping-breakout-1033526467,neutral,0.6978078484535217
6688,7/3/2024 1:26:20 PM,Pfizer (PFE) Gets a Hold from Berenberg Bank,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-berenberg-bank-1033527573,positive,0.898871898651123
6689,7/4/2024 10:24:00 AM,7 Juicy Dividend Stocks That Have Grown for More Than a Decade,InvestorPlace,/news/stocks/7-juicy-dividend-stocks-that-have-grown-for-more-than-a-decade-1033529158,positive,0.7763111591339111
6690,7/4/2024 4:00:00 PM,Upcoming Stock Spinoffs: Should You Pounce or Pass? ,InvestorPlace,/news/stocks/upcoming-stock-spinoffs-should-you-pounce-or-pass-1033530130,positive,0.7419286370277405
6691,7/5/2024 1:18:15 PM,Pfizer names former State Street CEO Taraporevala to board,Seeking Alpha,https://seekingalpha.com/news/4122361-pfizer-names-former-state-street-ceo-taraporevala-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9290643930435181
6692,7/5/2024 7:04:46 PM,"Study links GLP-1 drugs, metformin to lower risk of certain cancers",Seeking Alpha,https://seekingalpha.com/news/4122404-study-links-glp-1-drugs-metformin-to-lower-risk-of-certain-cancers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8924569487571716
6693,7/7/2024 11:10:00 AM,3 Bargain Stocks With the Potential for Mind-Boggling Returns,InvestorPlace,/news/stocks/3-bargain-stocks-with-the-potential-for-mind-boggling-returns-1033533845,positive,0.8141787052154541
6694,7/7/2024 3:39:52 PM,"EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO",Benzinga,/news/stocks/exclusive-glp-1-weight-loss-drugs-could-become-a-trillion-dollar-market-predicts-tema-etfs-ceo-1033533664,positive,0.6258196830749512
6695,7/8/2024 4:32:20 PM,3 Overlooked Giants-in-the-Making for Patient Investors,InvestorPlace,/news/stocks/3-overlooked-giants-in-the-making-for-patient-investors-1033536832,positive,0.8439481854438782
6696,7/9/2024 11:00:00 AM,The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024,InvestorPlace,/news/stocks/3-undervalued-gene-editing-stocks-for-patient-investors-1033538875,positive,0.7962018847465515
6697,7/9/2024 11:03:43 AM,Pfizer R&D head Mikael Dolsten to depart,Seeking Alpha,https://seekingalpha.com/news/4122814-pfizer-stock-watch-rd-head-depart?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9254194498062134
6698,7/9/2024 5:00:03 PM,Pfizer Chief Scientific Officer Mikael Dolsten To Step Down ,RTTNews,/news/stocks/pfizer-chief-scientific-officer-mikael-dolsten-to-step-down-1033540165,positive,0.5022947192192078
6699,7/9/2024 5:02:20 PM,The 3 Most Undervalued Large-Cap Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-large-cap-stocks-to-buy-in-july-2024-1033540648,positive,0.751778244972229
6700,7/10/2024 6:55:18 AM,J.P. Morgan Keeps Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-keeps-their-hold-rating-on-pfizer-pfe-1033542511,positive,0.9021230936050415
6701,7/10/2024 8:50:20 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Merck & Company (MRK), UnitedHealth (UNH) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-merck-company-mrk-unitedhealth-unh-and-pfizer-pfe-1033542846,neutral,0.9382280707359314
6702,7/10/2024 11:09:08 AM,"Pfizer, Evotec ink drug discovery deal",Seeking Alpha,https://seekingalpha.com/news/4123222-evotec-stock-gains-pfizer-r-d-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9001368880271912
6703,7/10/2024 7:22:59 PM,7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-for-positive-inflation-adjusted-returns-1033544701,positive,0.5849413871765137
6704,7/11/2024 12:22:11 AM,Analysts Offer Insights on Healthcare Companies: Illumina (ILMN) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-illumina-ilmn-and-pfizer-pfe-1033545010,positive,0.9109916687011719
6705,7/11/2024 10:45:00 AM,3 High-Dividend Stocks to Buy if You Are Seeking Consistent Payouts,InvestorPlace,/news/stocks/3-high-dividend-stocks-to-buy-if-you-are-seeking-consistent-payouts-1033546491,positive,0.8762954473495483
6706,7/11/2024 11:18:20 AM,Pfizer advances development of once-daily weight-loss pill,Seeking Alpha,https://seekingalpha.com/news/4123562-pfizer-advances-development-of-once-daily-weight-loss-pill?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.496343195438385
6707,7/11/2024 12:00:00 PM,7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-to-buy-and-hold-forever-july-edition-1033546848,positive,0.9369655847549438
6708,7/11/2024 12:45:43 PM,Morgan Stanley Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-pfizer-pfe-1033548028,positive,0.8363025784492493
6709,7/11/2024 1:24:00 PM,"4 stocks to watch on Thursday: PEP, PFE and more",Seeking Alpha,https://seekingalpha.com/news/4123669-4-stocks-to-watch-on-thursday-pep-pfe-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9294354915618896
6710,7/11/2024 1:36:45 PM,Pfizer Advances Once-Daily Formulation Of Oral GLP-1 Receptor Agonist Danuglipron ,RTTNews,/news/stocks/pfizer-advances-once-daily-formulation-of-oral-glp-1-receptor-agonist-danuglipron-1033546655,negative,0.8914743661880493
6711,7/11/2024 7:55:05 PM,Jefferies Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-their-buy-rating-for-pfizer-pfe-1033548722,positive,0.8576091527938843
6712,7/12/2024 8:12:28 AM,"This weight loss stock is the best alternative to Eli Lilly, Novo - SA Sentiment",Seeking Alpha,https://seekingalpha.com/news/4123754-weight-loss-amgen-stock-obesity-plays?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7048126459121704
6713,7/12/2024 8:50:07 AM,Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-demant-otherwillf-and-pfizer-pfe-1033550171,positive,0.9039966464042664
6714,7/12/2024 8:56:04 AM,Hold Rating on Pfizer: Caution Advised Amid Uncertainties Surrounding Danuglipron,TipRanks,/news/stocks/hold-rating-on-pfizer-caution-advised-amid-uncertainties-surrounding-danuglipron-1033550167,positive,0.5505675673484802
6715,7/12/2024 9:06:40 AM,Pfizer’s Danuglipron Progress Met with Cautious Optimism Amidst Competitive Landscape,TipRanks,/news/stocks/pfizer-s-danuglipron-progress-met-with-cautious-optimism-amidst-competitive-landscape-1033550224,negative,0.7584757804870605
6716,7/12/2024 11:06:18 AM,Truist Financial Keeps Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/truist-financial-keeps-their-buy-rating-on-pfizer-pfe-1033550889,positive,0.8904772996902466
6717,7/12/2024 12:41:47 PM,Moderna rival CSPC cleared to study RSV shot in China,Seeking Alpha,https://seekingalpha.com/news/4123935-moderna-rival-cspc-cleared-study-rsv-shot-china?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7044698596000671
6718,7/12/2024 2:27:31 PM,Novo’s Ozempic linked to improved brain health: study,Seeking Alpha,https://seekingalpha.com/news/4123974-novos-ozempic-linked-to-improved-brain-health-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8598303198814392
6719,7/12/2024 6:26:43 PM,"With Oral Anti-Obesity Candidate Development, Pfizer Seeks Relevant And Competitive Presence - Goldman Sachs",Benzinga,/news/stocks/with-oral-anti-obesity-candidate-development-pfizer-seeks-relevant-and-competitive-presence---goldman-sachs-1033551299,negative,0.7830184102058411
6720,7/12/2024 10:33:07 PM,"Inflation Drop Fuels Rate Cut Speculation, Investors Shift To Sector Laggards, Russell 2000 Surges Over 3.6%: This Week In The Markets",Benzinga,/news/stocks/inflation-drop-fuels-rate-cut-speculation-investors-shift-to-sector-laggards-russell-2000-surges-over-3-6-this-week-in-the-markets-1033551578,neutral,0.6852118372917175
6721,7/13/2024 2:10:44 PM,Colorado reports three possible bird flu cases in humans,Seeking Alpha,https://seekingalpha.com/news/4124103-three-human-bird-flu-cases-found-colorado?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9407454133033752
6722,7/13/2024 3:00:00 PM,The 7 Most Undervalued Healthcare Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-healthcare-stocks-to-buy-in-july-2024-1033551810,positive,0.752497673034668
6723,7/13/2024 6:03:47 PM,"Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A",Seeking Alpha,https://seekingalpha.com/news/4124109-morgan-stanley-sees-180b-patent-cliff-380b-deal-capacity-fueling-biopharma-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8902468085289001
6724,7/15/2024 4:10:22 PM,"Pfizer Stock (NYSE:PFE): Super Cheap, 5.7% Yield, Potential Weight Loss Catalyst",TipRanks,/news/stocks/pfizer-stock-nyse-pfe-super-cheap-5-7-yield-potential-weight-loss-catalyst-1033556570,negative,0.4457395076751709
6725,7/15/2024 8:08:21 PM,Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-dividend-yields-1033556516,negative,0.5285109281539917
6726,7/16/2024 4:20:55 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: KalVista Pharmaceuticals (KALV), Roche Holding AG (OtherRHHVF) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-kalvista-pharmaceuticals-kalv-roche-holding-ag-otherrhhvf-and-pfizer-pfe-1033557973,neutral,0.8140798807144165
6727,7/16/2024 6:00:00 PM,7 High-Yield Dividend Stocks Beating Inflation,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-beating-inflation-1033560590,negative,0.795750617980957
6728,7/17/2024 10:00:00 AM,3 Under $50 Stocks to Buy Now: Q3 Edition,InvestorPlace,/news/stocks/3-under-50-stocks-to-buy-now-q3-edition-1033563271,positive,0.8772966861724854
6729,7/17/2024 10:06:00 AM,3 Moonshot Stocks With the Potential to Turn $10K Into $100K,InvestorPlace,/news/stocks/3-moonshot-stocks-with-the-potential-to-turn-10k-into-1-million-1033540783,negative,0.6585848331451416
6730,7/17/2024 3:41:30 PM,"Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Corcept Therapeutics (CORT) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-roche-holding-ag-otherrhhvf-corcept-therapeutics-cort-and-pfizer-pfe-1033565229,positive,0.910282552242279
6731,7/17/2024 3:43:08 PM,Pfizer’s Mixed Outlook: Hold Rating Amidst Vyndaqel’s Growth and Falling Demand for Comirnaty and Paxlovid,TipRanks,/news/stocks/pfizer-s-mixed-outlook-hold-rating-amidst-vyndaqel-s-growth-and-falling-demand-for-comirnaty-and-paxlovid-1033565367,neutral,0.9698115587234497
6732,7/18/2024 10:05:00 AM,Alnylam Stock Is a Blockbuster Biopharma In the Making,InvestorPlace,/news/stocks/alnylam-stock-is-a-blockbuster-biopharma-in-the-making-1033567646,positive,0.7778480052947998
6733,7/18/2024 12:00:00 PM,7 Hated Stocks Set to Make a Major Comeback This Year,InvestorPlace,/news/stocks/7-hated-stocks-set-to-make-a-major-comeback-this-year-1033568150,negative,0.7654317021369934
6734,7/18/2024 5:40:56 PM,"Pfizer Stock Nears Golden Cross, Signals Potential Upside With Strong Oncology Portfolio",Benzinga,/news/stocks/pfizer-stock-nears-golden-cross-signals-potential-upside-with-strong-oncology-portfolio-1033569545,negative,0.9488814473152161
6735,7/18/2024 8:05:29 PM,"VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?",Benzinga,/news/etf/vix-stages-double-digit-spike-as-risk-off-takes-over-chipmakers-fail-to-rebound-weight-loss-giants-eli-lilly-novo-tumble-what-s-driving-markets-thursday-1033569954,neutral,0.5287970304489136
6736,7/18/2024 8:51:35 PM,"Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst",Benzinga,/news/stocks/johnson-johnson-prioritizes-sustainable-growth-in-m-a-amid-sector-diversification-says-analyst-1033569993,negative,0.9231750965118408
6737,7/18/2024 9:59:26 PM,"COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch",Benzinga,/news/etf/covid-activity-is-elevated-across-26-states-in-summer-surge-biden-remains-in-isolation-3-vaccine-stocks-to-watch-1033570084,positive,0.6359333992004395
6738,7/18/2024 10:59:13 PM,"EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'",Benzinga,/news/stocks/exclusive-weight-loss-duopoly-breaks-as-eli-lilly-novo-plummet-market-won-t-be-dominated-by-just-2-players-1033570253,positive,0.5957275629043579
6739,7/19/2024 12:05:17 PM,"Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and more",Seeking Alpha,https://seekingalpha.com/news/4125792-dividend-roundup-goldman-sachs-johnson-johnson-qualcomm-caterpillar-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9485202431678772
6740,7/21/2024 11:00:00 AM,Here are Big Pharma’s leading blockbuster makers,Seeking Alpha,https://seekingalpha.com/news/4126044-eli-lilly-astrazeneca-top-blockbuster-makers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7739253044128418
6741,7/22/2024 1:02:13 AM,Kamala Harris' potential impact on health care stocks,Seeking Alpha,https://seekingalpha.com/news/4126065-kamala-harris-potential-impact-health-care-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49974918365478516
6742,7/23/2024 3:58:41 PM,ViiV's Dovato as effective as Gilead's Biktarvy for HIV but with less weight gain,Seeking Alpha,https://seekingalpha.com/news/4126871-viiv-dovato-effective-gilead-biktarvy-hiv-less-weight-gain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7562788724899292
6743,7/24/2024 11:16:36 AM,Pfizer/ Sangamo gene therapy for hemophilia A succeeds in late-stage trial,Seeking Alpha,https://seekingalpha.com/news/4127400-pfizer-posts-late-stage-win-hemophilia-a-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.776289165019989
6744,7/24/2024 1:30:34 PM,Pfizer's Phase 3 AFFINE Study Of Hemophilia A Gene Therapy Candidate Meets Primary Goal ,RTTNews,/news/stocks/pfizer-s-phase-3-affine-study-of-hemophilia-a-gene-therapy-candidate-meets-primary-goal-1033588043,positive,0.6391921043395996
6745,7/24/2024 5:40:20 PM,Pfizer/ BioNTech win U.K. nod for JN.1-adjusted COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/4127761-pfizer-biontech-jn1-covid-19-shot-cleared-uk?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8874781131744385
6746,7/24/2024 7:59:20 PM,Why Is Sangamo Therapeutics (SGMO) Stock Up 40% Today?,InvestorPlace,/news/stocks/why-is-sangamo-therapeutics-sgmo-stock-up-40-today-1033590732,negative,0.9050886034965515
6747,7/25/2024 11:00:00 AM,7 Dividend Stocks to Hold On Tight to for the Next Decade,InvestorPlace,/news/stocks/7-dividend-stocks-to-hold-on-tight-to-for-the-next-decade-1033593953,neutral,0.6417301297187805
6748,7/25/2024 11:01:43 AM,"Viking sends Lilly, Novo lower as obesity drug enters late-stage program",Seeking Alpha,https://seekingalpha.com/news/4128191-viking-stock-climbs-obesity-drug-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7345916032791138
6749,7/25/2024 4:13:04 PM,Pfizer hemophilia B gene therapy Durveqtix wins EC authorization,Seeking Alpha,https://seekingalpha.com/news/4128465-pfizer-hemophilia-b-gene-therapy-durveqtix-wins-ec-authorization?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9089868664741516
6750,7/25/2024 5:30:55 PM,Pfizer Gets EC's Conditional Authorization For Durveqtix Genetherapy In Hemophilia B ,RTTNews,/news/stocks/pfizer-gets-ec-s-conditional-authorization-for-durveqtix-genetherapy-in-hemophilia-b-1033595705,negative,0.819693922996521
6751,7/26/2024 10:31:00 AM,Get Your Money Out of These 3 Dividend Stocks by 2025,InvestorPlace,/news/stocks/get-your-money-out-of-these-3-dividend-stocks-by-2025-1033599506,positive,0.9142249226570129
6752,7/26/2024 12:37:22 PM,"Pfizer, Merck bladder cancer therapy endorsed for approval in EU",Seeking Alpha,https://seekingalpha.com/news/4128941-pfizer-merck-bladder-cancer-drug-endorsed-eu?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5862034559249878
6753,7/26/2024 4:38:46 PM,Sangamo rallies for third day in wake of positive gene therapy results,Seeking Alpha,https://seekingalpha.com/news/4129061-sangamo-rallies-for-third-day-in-wake-of-positive-gene-therapy-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5220169425010681
6754,7/26/2024 5:00:03 PM,Bristol-Myers hits three-month high on Q2 beat and trial win (update),Seeking Alpha,https://seekingalpha.com/news/4128916-bristol-myers-stock-gains-q2-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6772703528404236
6755,7/26/2024 7:00:38 PM,"Catalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earnings",Seeking Alpha,https://seekingalpha.com/news/4129063-catalyst-watch-tech-blitz-with-apple-amazon-microsoft-and-meta-on-tap-for-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9092090129852295
6756,7/27/2024 6:25:55 PM,RSV vaccine market to decline 64% on CDC decision: report,Seeking Alpha,https://seekingalpha.com/news/4129251-rsv-vaccine-market-to-decline-64-on-cdc-decision-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9659538865089417
6757,7/27/2024 8:56:00 PM,Wall Street in the haze of the tech selloff as the AI promise lingers - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4129216-wall-street-in-the-haze-of-the-tech-selloff-as-the-ai-promise-lingers-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6713942289352417
6758,7/28/2024 12:00:00 PM,"Earnings week ahead: MSFT, AMZN, AAPL, META, PFE, MCD, SBUX, XOM, CVX and more",Seeking Alpha,https://seekingalpha.com/news/4129069-earnings-week-ahead-msft-amzn-aapl-meta-qcom-pfe-mcd-sbux-ma-xom-cvx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9346819519996643
6759,7/28/2024 2:00:00 PM,Most U.S. pharmas don't pay any U.S. income tax,Seeking Alpha,https://seekingalpha.com/news/4129257-most-us-pharmas-dont-pay-any-us-income-tax?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9261671304702759
6760,7/29/2024 3:01:13 PM,Pfizer earnings preview: what to expect,Markets Insider Automation,/news/stocks/pfizer-stock-q2-earnings-preview-1033606155,positive,0.9113932847976685
6761,7/29/2024 3:04:21 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4129508-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8660826683044434
6762,7/29/2024 4:11:46 PM,"Pfizer Q2 Earnings Preview: Focus on oncology, obesity treatments",Seeking Alpha,https://seekingalpha.com/news/4129553-pfizer-q2-earnings-preview-focus-on-oncology-obesity-treatments?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9159641861915588
6763,7/29/2024 7:03:08 PM,Pfizer laying off workers involved in failed Duchenne muscular dystrophy therapy,Seeking Alpha,https://seekingalpha.com/news/4129681-pfizer-laying-off-workers-involved-failed-duchenne-muscular-dystrophy-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9498904347419739
6764,7/30/2024 10:47:08 AM,"Pfizer Non-GAAP EPS of $0.60 beats by $0.14, revenue of $13.28B beats by $260M, raises FY24 guidance",Seeking Alpha,https://seekingalpha.com/news/4129958-pfizer-non-gaap-eps-of-0_60-beats-0_14-revenue-of-13_28b-beats-260m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.828448474407196
6765,7/30/2024 10:57:59 AM,"Earnings Summary: Pfizer tops estimates in Q2, raises FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4129967-earnings-summary-pfizer-tops-estimates-in-q2-raises-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8840512037277222
6766,7/30/2024 11:13:18 AM,Pfizer stock gains after raising annual earnings outlook,Seeking Alpha,https://seekingalpha.com/news/4129993-pfizer-stock-gains-after-raising-annual-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9412181973457336
6767,7/30/2024 12:52:20 PM,"Pfizer in charts: Primary Care takes a hit in Q2, Specialty Care and Oncology thrive",Seeking Alpha,https://seekingalpha.com/news/4130100-pfizer-in-charts-primary-care-takes-a-hit-in-q2-specialty-care-and-oncology-thrive?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5170819163322449
6768,7/30/2024 12:54:43 PM,"Pfizer Inc. Q2 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/pfizer-inc-q2-profit-decreases-but-beats-estimates-1033611022,neutral,0.9636946320533752
6769,7/30/2024 1:07:34 PM,Pfizer Boost FY24 Outlook - Update ,RTTNews,/news/stocks/pfizer-boost-fy24-outlook-update-1033611111,positive,0.8123285174369812
6770,7/30/2024 1:35:15 PM,J.P. Morgan Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-sticks-to-its-hold-rating-for-pfizer-pfe-1033613442,positive,0.7579091787338257
6771,7/30/2024 2:45:00 PM,Pfizer hosts conference call for investors,Markets Insider Automation,/news/stocks/pfizer_conference-1030020090,positive,0.9411717057228088
6772,7/30/2024 2:53:02 PM,"PFE Stock Earnings: Pfizer Beats EPS, Beats Revenue for Q2 2024",InvestorPlace,/news/stocks/pfe-stock-earnings-pfizer-for-q2-of-2024-1033613052,negative,0.6889291405677795
6773,7/30/2024 5:55:27 PM,Jefferies Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-their-buy-rating-for-pfizer-pfe-1033614024,positive,0.8576091527938843
6774,7/30/2024 11:37:14 PM,PepGen stock tumbles 25% following release of DMD drug data,Seeking Alpha,https://seekingalpha.com/news/4130739-pepgen-stock-tumbles-following-release-of-dmd-drug-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9665219187736511
6775,7/31/2024 6:55:30 AM,Pfizer’s Strong Q2 Performance and Raised Guidance Affirm Buy Rating,TipRanks,/news/stocks/pfizer-s-strong-q2-performance-and-raised-guidance-affirm-buy-rating-1033616922,negative,0.9528006315231323
6776,7/31/2024 7:59:36 AM,Barclays Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/barclays-remains-a-hold-on-pfizer-pfe-1033617369,positive,0.9005104899406433
6777,7/31/2024 10:20:53 AM,Pfizer Hold Rating Maintained Amid Growth Challenges and Valuation Concerns,TipRanks,/news/stocks/pfizer-hold-rating-maintained-amid-growth-challenges-and-valuation-concerns-1033618475,negative,0.6211630702018738
6778,7/31/2024 11:35:47 AM,GSK dips as vaccine headwinds overshadow guidance raise,Seeking Alpha,https://seekingalpha.com/news/4130945-gsk-stock-dips-despite-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9577241539955139
6779,7/31/2024 11:40:29 AM,Truist Financial Keeps Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/truist-financial-keeps-their-buy-rating-on-pfizer-pfe-1033619201,positive,0.8904772996902466
6780,7/31/2024 11:46:00 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-pfizer-pfe-1033619315,positive,0.8511348366737366
6781,7/31/2024 12:28:42 PM,Morgan Stanley Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-pfizer-pfe-1033619594,positive,0.8363025784492493
6782,7/31/2024 1:49:42 PM,Bank of America Securities Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/bank-of-america-securities-remains-a-hold-on-pfizer-pfe-1033620198,positive,0.8613510131835938
6783,7/31/2024 2:55:10 PM,DZ BANK AG Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/dz-bank-ag-remains-a-buy-on-pfizer-pfe-1033620345,positive,0.9469180703163147
6784,7/31/2024 3:57:36 PM,Pfizer inks deal with Telescope Innovations to boost R&D capabilities,Seeking Alpha,https://seekingalpha.com/news/4131193-pfizer-inks-deal-telescope-innovations-boost-rd-capabilities?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9334815740585327
6785,7/31/2024 4:46:17 PM,ViiV Healthcare Reports Positive Data For 2-Drug Regimen DOVATO In HIV-1 Treatment ,RTTNews,/news/stocks/viiv-healthcare-reports-positive-data-for-2-drug-regimen-dovato-in-hiv-1-treatment-1033619291,negative,0.9529081583023071
6786,7/31/2024 6:06:13 PM,UBS Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/ubs-sticks-to-their-hold-rating-for-pfizer-pfe-1033621008,positive,0.8647460341453552
6787,7/31/2024 8:24:26 PM,The Top 7 Stocks to Buy Now: Summer 2024,InvestorPlace,/news/stocks/the-top-7-stocks-to-buy-now-summer-2024-1033620882,positive,0.933110237121582
6788,8/1/2024 6:08:33 AM,Pfizer’s Financial Prospects: Balancing Cost Efficiencies Against Growth Uncertainties,TipRanks,/news/stocks/pfizer-s-financial-prospects-balancing-cost-efficiencies-against-growth-uncertainties-1033625017,positive,0.5720399618148804
6789,8/1/2024 11:15:21 AM,Moderna drops as lower COVID vaccine sales prompt guidance cut,Seeking Alpha,https://seekingalpha.com/news/4132092-moderna-stock-drops-guidance-cut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9591776728630066
6790,8/1/2024 2:00:00 PM,Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/bargain-hunters-paradise-7-value-stocks-that-are-too-cheap-to-ignore-1033627397,positive,0.9074242115020752
6791,8/1/2024 2:26:58 PM,Argus Research Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/argus-research-sticks-to-their-hold-rating-for-pfizer-pfe-1033628457,positive,0.8890774846076965
6792,8/1/2024 3:34:49 PM,REGENXBIO releases new data on DMD drug ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/4132398-regenxbio-releases-new-data-on-dmd-drug-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9292389750480652
6793,8/1/2024 7:44:38 PM,OS Therapies stock falls 20% following downsized IPO (update),Seeking Alpha,https://seekingalpha.com/news/4132494-os-therapies-stock-falls-following-downsized-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9606504440307617
6794,8/2/2024 11:45:00 AM,7 Subdued Blue-Chip Stocks That Will Reward Patient Investors,InvestorPlace,/news/stocks/7-subdued-blue-chip-stocks-that-will-reward-patient-investors-1033631551,positive,0.5382464528083801
6795,8/2/2024 6:22:14 PM,What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.,InvestorPlace,/news/stocks/what-are-the-hottest-biotech-stocks-right-now-3-top-picks-1033633924,positive,0.8953362703323364
6796,8/4/2024 11:00:05 AM,"Weekly Biotech Buzz: FGEN Cuts Jobs, FDA OKs ADAP's Groundbreaking Cell Therapy, ME Rebuffs CEO Bid ",RTTNews,/news/stocks/weekly-biotech-buzz-fgen-cuts-jobs-fda-oks-adap-s-groundbreaking-cell-therapy-me-rebuffs-ceo-bid-1033634796,positive,0.5439757108688354
6797,8/4/2024 2:54:00 PM,19 out of 21 Healthcare companies topped profit estimates this week: Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4132480-healthcare-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6591749787330627
6798,8/5/2024 5:11:04 PM,Genmab stock slides 7% as BioNTech ends acasunlimab collaboration,Seeking Alpha,https://seekingalpha.com/news/4134234-genmab-stock-slides-as-biontech-ends-acasunlimab-collaboration?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9578553438186646
6799,8/6/2024 10:30:00 AM,3 Cheap Stocks to Buy in August for Under $50,InvestorPlace,/news/stocks/3-cheap-stocks-to-buy-in-august-for-under-50-1033644203,positive,0.8779928684234619
6800,8/6/2024 11:01:27 AM,GSK wins latest Zantac lawsuit in Illinois,Seeking Alpha,https://seekingalpha.com/news/4134696-gsk-wins-latest-zantac-lawsuit-in-illinois?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4566493332386017
6801,8/6/2024 11:29:52 AM,Pfizer (PFE) Receives a Buy from Truist Financial,TipRanks,/news/stocks/pfizer-pfe-receives-a-buy-from-truist-financial-1033646183,positive,0.6349560618400574
6802,8/7/2024 10:54:00 AM,Forget Tech! 3 Value Stocks That Could Win Big From Rate Cuts.,InvestorPlace,/news/stocks/forget-tech-3-value-stocks-that-could-win-big-from-rate-cuts-1033651975,positive,0.800544798374176
6803,8/7/2024 4:28:39 PM,Pfizer Tagrisso patent case against AstraZeneca upheld by judge,Seeking Alpha,https://seekingalpha.com/news/4136227-pfizer-tagrisso-patent-case-against-astrazeneca-upheld-by-judge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.3866253197193146
6804,8/7/2024 6:34:03 PM,BioNTech sued by University of Pennsylvania over COVID-19 vaccine patent royalties,Seeking Alpha,https://seekingalpha.com/news/4136368-biontech-sued-university-pennsylvania-covid-19-vaccine-patent-royalties?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8479450941085815
6805,8/7/2024 7:42:03 PM,Bicycle Therapeutics cut at B. Riley ahead of data readouts,Seeking Alpha,https://seekingalpha.com/news/4136423-bicycle-therapeutics-stock-cut-b-riley?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9051406383514404
6806,8/8/2024 10:30:00 AM,The 3 Best Biotech Stocks to Buy in August 2024,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-to-buy-in-august-2024-1033659856,positive,0.8261002898216248
6807,8/8/2024 10:41:00 AM,The 7 Best Stocks to Buy in August 2024,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-in-august-2024-1033659854,positive,0.9105228781700134
6808,8/8/2024 11:40:00 AM,3 High-Growth Dividend Stocks to Own for the Next 10 Years,InvestorPlace,/news/stocks/3-high-growth-dividend-stocks-to-own-for-the-next-10-years-1033660209,positive,0.8585622310638428
6809,8/8/2024 2:45:19 PM,Viatris hits seven-month high after Q2 beat,Seeking Alpha,https://seekingalpha.com/news/4137318-viatris-stock-gains-q2-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8716593980789185
6810,8/8/2024 3:56:02 PM,3 Dividend Stocks to Buy Now for a Winning Portfolio,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-now-for-a-winning-portfolio-1033662011,positive,0.7808771133422852
6811,8/8/2024 7:32:27 PM,Pyxis Oncology draws Buy at Stifel on lead asset,Seeking Alpha,https://seekingalpha.com/news/4137471-pyxis-oncology-stock-gains-stifel-says-buy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8279826045036316
6812,8/9/2024 3:13:05 PM,74 S&P 500 stocks that can beat the cash yield - BofA,Seeking Alpha,https://seekingalpha.com/news/4138195-74-sp-500-stocks-that-can-beat-the-cash-yield-bofa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6393481492996216
6813,8/12/2024 11:13:03 AM,Pfizer’s RSV vaccine shows strong response in immunocompromised adults,Seeking Alpha,https://seekingalpha.com/news/4138512-pfizers-rsv-vaccine-shows-strong-response-in-immunocompromised-adults?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9484968781471252
6814,8/12/2024 1:24:01 PM,Pfizer's RSV Vaccine ABRYSVO Shows Positive Results In Phase 3 Study In Immunocompromised Adults ,RTTNews,/news/stocks/pfizer-s-rsv-vaccine-abrysvo-shows-positive-results-in-phase-3-study-in-immunocompromised-adults-1033676549,negative,0.9534422755241394
6815,8/12/2024 8:15:42 PM,Pfizer trades in the red for seven straight days,Seeking Alpha,https://seekingalpha.com/news/4138831-pfizer-trades-in-the-red-for-seven-straight-days?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4443207085132599
6816,8/13/2024 12:12:06 PM,Maravai cut at Morgan Stanley; Pfizer/BioNTech headwinds cited,Seeking Alpha,https://seekingalpha.com/news/4139073-maravai-stock-downgraded-morgan-stanley?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9653795957565308
6817,8/13/2024 1:59:43 PM,3 Undervalued Low-Beta Stocks to Buy to Protect Yourself From Volatility,InvestorPlace,/news/stocks/3-undervalued-low-beta-stocks-to-buy-to-protect-yourself-from-volatility-1033682608,positive,0.8596611618995667
6818,8/13/2024 7:05:47 PM,7 Divine Dividend Stocks to Buy for Another Market Crash,InvestorPlace,/news/stocks/7-divine-dividend-stocks-to-buy-for-another-market-crash-1033683668,positive,0.9146420955657959
6819,8/13/2024 9:00:56 PM,3 Top Investing Opportunities During Stock Market Chaos,InvestorPlace,/news/stocks/3-top-investing-opportunities-during-stock-market-chaos-1033684024,positive,0.8383490443229675
6820,8/14/2024 10:15:00 AM,3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct,InvestorPlace,/news/stocks/3-pharmaceutical-stocks-that-can-surge-higher-even-if-the-markets-correct-1033687347,negative,0.85259610414505
6821,8/14/2024 10:44:00 AM,7 Dependable Dividend Stocks for Long-Term Income,InvestorPlace,/news/stocks/7-dependable-dividend-stocks-for-long-term-income-1033687408,positive,0.9273225665092468
6822,8/14/2024 5:10:27 PM,Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso,Seeking Alpha,https://seekingalpha.com/news/4139922-puma-biotechnology-quickly-drops-after-patents-for-tagrisso-ruled-invalid?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9482015371322632
6823,8/14/2024 5:32:50 PM,Puma Biotech drops after patents ruled invalid in fight with AstraZeneca over Tagrisso,Seeking Alpha,https://seekingalpha.com/news/4139922-puma-biotechnology-drops-after-patents-ruled-invalid?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9482015371322632
6824,8/15/2024 11:27:19 AM,U.S. government targets $6B in savings from first Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4140341-us-government-targets-6b-in-saving-from-first-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9052250385284424
6825,8/15/2024 11:44:07 AM,U.S. announces final drug prices after Medicare negotiations,Seeking Alpha,https://seekingalpha.com/news/4140356-us-posts-final-drug-prices-medicare-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.802365779876709
6826,8/15/2024 1:40:39 PM,Puma Biotech confirms court ruling on patent dispute with AstraZeneca,Seeking Alpha,https://seekingalpha.com/news/4140469-puma-biotech-confirms-court-ruling-on-patent-invalidity-disagrees-with-verdict?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8462010622024536
6827,8/15/2024 2:17:57 PM,"Bristol Myers, Novartis react as Medicare prices for key drugs announced",Seeking Alpha,https://seekingalpha.com/news/4140530-bristol-myers-novartis-slam-medicare-prices-key-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.37344467639923096
6828,8/16/2024 11:18:36 AM,"Pfizer, BioNTech post partial win in late-stage trial for COVID/flu combo shot",Seeking Alpha,https://seekingalpha.com/news/4140959-pfizer-biontech-post-trial-data-covidflu-shot?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9393923878669739
6829,8/16/2024 1:34:59 PM,GSK to seek dismissal of Zantac lawsuit after favorable court ruling in Florida,Seeking Alpha,https://seekingalpha.com/news/4141043-gsk-seek-zantac-lawsuit-dismissal-florida?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9059933423995972
6830,8/16/2024 5:24:18 PM,"Pfizer, BioNTech Announce Top-line Results In Phase 3 Trial Of MRNA-based Combination Vaccine ",RTTNews,/news/stocks/pfizer-biontech-announce-top-line-results-in-phase-3-trial-of-mrna-based-combination-vaccine-1033701044,negative,0.7061498165130615
6831,8/17/2024 2:09:07 PM,Trending stocks this week as U.S. equities notch their best week of 2024,Seeking Alpha,https://seekingalpha.com/news/4141247-trending-stocks-this-week-as-us-equities-notch-their-best-week-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7283941507339478
6832,8/17/2024 5:54:50 PM,FDA is said to clear updated COVID shots as early as next week,Seeking Alpha,https://seekingalpha.com/news/4141257-fda-is-said-to-clear-updated-covid-shots-as-early-as-next-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8831928372383118
6833,8/18/2024 7:43:59 AM,"Biotech Buzz: VIRX Cuts 23% Jobs, FDA Oks New Drug For Hypoparathyroidism, SIGA Down But Not Out ",RTTNews,/news/stocks/biotech-buzz-virx-cuts-23-jobs-fda-oks-new-drug-for-hypoparathyroidism-siga-down-but-not-out-1033702057,neutral,0.8887053728103638
6834,8/19/2024 7:07:33 PM,Small-cap and mid-cap Health Care has room to rally - Roth MKM,Seeking Alpha,https://seekingalpha.com/news/4141609-small-cap-and-mid-cap-health-care-has-room-to-rally-roth-mkm?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7902520298957825
6835,8/20/2024 6:07:51 PM,"FTC says FDA biosimilar guidance would increase competition, lead to lower prices",Seeking Alpha,https://seekingalpha.com/news/4142026-ftc-says-fda-biosimilar-guidance-would-increase-competition-lead-lower-prices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5784038305282593
6836,8/22/2024 6:17:51 PM,"Moderna, Pfizer updated mRNA COVID vaccines authorized by FDA",Seeking Alpha,https://seekingalpha.com/news/4143040-moderna-pfizer-updated-mrna-covid-vaccines-authorized-by-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8984440565109253
6837,8/23/2024 3:14:41 AM,"Pfizer, BioNTech Obtain FDA Approval & Authorization For Omicron KP.2-adapted COVID-19 Vaccine ",RTTNews,/news/stocks/pfizer-biontech-obtain-fda-approval-authorization-for-omicron-kp-2-adapted-covid-19-vaccine-1033716249,negative,0.8997930884361267
6838,8/23/2024 10:26:18 AM,Berenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/berenberg-bank-reaffirms-their-hold-rating-on-pfizer-pfe-1033718101,positive,0.8553645610809326
6839,8/23/2024 10:44:06 AM,"FDA Approves Updated Pfizer, Moderna Covid Vaccines Against Current Variants ",RTTNews,/news/stocks/fda-approves-updated-pfizer-moderna-covid-vaccines-against-current-variants-1033717471,negative,0.5517078638076782
6840,8/23/2024 5:54:10 PM,U.S. to restart free COVID test program as cases spike,Seeking Alpha,https://seekingalpha.com/news/4143466-us-to-deliver-free-covid-tests-cases-spike?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8563349843025208
6841,8/25/2024 5:57:37 AM,"Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug ",RTTNews,/news/stocks/weekly-biotech-buzz-aadi-trims-r-d-jobs-jnj-loosens-purse-strings-fda-snubs-regn-s-myeloma-drug-1033719571,neutral,0.8108912110328674
6842,8/27/2024 11:14:45 AM,"Pfizer launches direct sales website for common vaccines, medicines",Seeking Alpha,https://seekingalpha.com/news/4144069-pfizer-launches-direct-sales-website-for-common-vaccines-medicines?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8609997630119324
6843,8/27/2024 1:05:03 PM,Pfizer Launches Digital Platform PfizerForAll ,RTTNews,/news/stocks/pfizer-launches-digital-platform-pfizerforall-1033724954,positive,0.9467335939407349
6844,8/27/2024 6:20:34 PM,"Walgreens, Hims stocks drop as Lilly rolls out cheap weight-loss drugs",Seeking Alpha,https://seekingalpha.com/news/4144270-walgreens-hims-stocks-drop-as-lilly-rolls-out-cheap-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8896263241767883
6845,8/28/2024 4:21:31 PM,"Pfizer in collaboration with Quotient Therapeutics for CV, kidney disease therapies",Seeking Alpha,https://seekingalpha.com/news/4144668-pfizer-collaboration-quotient-therapeutics-cv-kidney-disease-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6247407793998718
6846,8/29/2024 10:26:46 AM,"New Medicare drug price caps could help seniors save over $1,000 a year - AARP",Seeking Alpha,https://seekingalpha.com/news/4144962-new-medicare-drug-price-caps-could-help-seniors-save-over-1000-a-year-aarp?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8434954881668091
6847,8/30/2024 11:03:00 AM,Alnylam falls after full data for heart drug that can rival Pfizer’s,Seeking Alpha,https://seekingalpha.com/news/4145421-alnylam-stock-falls-vutrisiran-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8494566679000854
6848,8/30/2024 2:18:33 PM,NuCana plunges after trial setback for cancer drug,Seeking Alpha,https://seekingalpha.com/news/4145521-nucana-stock-gains-despite-trial-setback?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9518116116523743
6849,8/30/2024 6:23:34 PM,"Alnylam tumbles, BridgeBio gains after heart drug data",Seeking Alpha,https://seekingalpha.com/news/4145618-alnylam-stock-falls-bridgebio-stock-gains-attr-cm-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6835491061210632
6850,8/30/2024 6:54:23 PM,Novavax gains on FDA emergency nod for updated COVID shot,Seeking Alpha,https://seekingalpha.com/news/4145623-novavax-stock-gains-fda-nod-covid-shot?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.885498046875
6851,9/1/2024 7:26:06 PM,"Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies ",RTTNews,/news/stocks/weekly-biotech-buzz-bmrn-cuts-jobs-fda-approves-new-mpox-vaccine-mrk-halts-2-keytruda-studies-1033738673,neutral,0.7506183385848999
6852,9/3/2024 7:20:32 AM,"Pfizer, Valneva Report Further Positive Phase 2 Booster Results For Lyme Disease Vaccine Candidate ",RTTNews,/news/stocks/pfizer-valneva-report-further-positive-phase-2-booster-results-for-lyme-disease-vaccine-candidate-1033742059,negative,0.9495893716812134
6853,9/3/2024 11:44:19 AM,Merck’s Keytruda with Pfizer’s Padcev approved in EU for first-line bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4146053-mercks-keytruda-with-pfizers-padcev-approved-in-eu-for-first-line-bladder-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7387112379074097
6854,9/3/2024 12:13:08 PM,Vaxcyte pneumococcal shot matches Pfizer’s in early trial for safety,Seeking Alpha,https://seekingalpha.com/news/4146081-vaxcyte-stock-on-data-pneumococcal-shot?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8043230772018433
6855,9/3/2024 8:48:57 PM,"Dyne stock tumbles 31% amid drug updates, management changes",Seeking Alpha,https://seekingalpha.com/news/4146464-dyne-stock-tumbles-amid-drug-updates-management-changes?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9654690027236938
6856,9/5/2024 12:45:02 PM,Moderna updated COVID shot endorsed in EU,Seeking Alpha,https://seekingalpha.com/news/4147259-moderna-updated-covid-shot-endorsed-in-eu?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9038075804710388
6857,9/5/2024 8:58:09 PM,Vor Bio stock rallies post-market on trem-cel study data,Seeking Alpha,https://seekingalpha.com/news/4147513-vor-bio-stock-rallies-post-market-on-trem-cel-study-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5345923900604248
6858,9/6/2024 7:26:13 AM,Basilea Receives $25 Mln Milestone Payment Following Strong Cresemba Sales Performance In Europe ,RTTNews,/news/stocks/basilea-receives-25-mln-milestone-payment-following-strong-cresemba-sales-performance-in-europe-1033752621,negative,0.9519948363304138
6859,9/10/2024 10:56:30 PM,16 new GLP-1 weight-loss drugs could be launched by 2029: report,Seeking Alpha,https://seekingalpha.com/news/4148522-16-new-glp-1-weight-loss-drugs-could-be-launched-by-2029-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8558949828147888
6860,9/13/2024 2:01:00 PM,Novavax COVID-19 vaccines now available,Seeking Alpha,https://seekingalpha.com/news/4149482-novavax-covid-19-vaccines-now-available?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9144639372825623
6861,9/14/2024 11:14:45 AM,Pfizer's BRAFTOVI + MEKTOVI Delivers Long-Term Benefits In BRAF V600E-Mutant NSCLC ,RTTNews,/news/stocks/pfizer-s-braftovi-mektovi-delivers-long-term-benefits-in-braf-v600e-mutant-nsclc-1033771572,negative,0.917493999004364
6862,9/14/2024 1:56:11 PM,Pfizer therapy succeeds in mid-stage trial for cancer-related weight loss,Seeking Alpha,https://seekingalpha.com/news/4149786-pfizer-posts-trial-win-cancer-weight-loss?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9417805671691895
6863,9/14/2024 3:47:00 PM,Pfizer : Phase 2 Study Of Ponsegromab In Cancer Cachexia Meets Primary Endpoint ,RTTNews,/news/stocks/pfizer-phase-2-study-of-ponsegromab-in-cancer-cachexia-meets-primary-endpoint-1033771631,positive,0.5039016604423523
6864,9/14/2024 7:37:59 PM,J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report,Seeking Alpha,https://seekingalpha.com/news/4149797-jj-leads-h1-2024-healthcare-dealmaking?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9156707525253296
6865,9/15/2024 2:07:52 PM,Do queasy side effects mean the end of weight-loss drug stock hype?,Seeking Alpha,https://seekingalpha.com/news/4149819-do-nauseating-side-effects-mean-the-end-of-weight-loss-drug-stock-hype?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6545578837394714
6866,9/16/2024 2:05:06 PM,Puma Biotechnology rises on appeal of AstraZeneca Tagrisso patent dispute,Seeking Alpha,https://seekingalpha.com/news/4149984-puma-biotechnology-rises-appeal-astrazeneca-tagrisso-patent-dispute?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5605560541152954
6867,9/17/2024 12:16:59 PM,Pfizer (PFE) Receives a Buy from Jefferies,TipRanks,/news/stocks/pfizer-pfe-receives-a-buy-from-jefferies-1033778004,positive,0.547299861907959
6868,9/20/2024 2:42:55 PM,"CHMP Recommends Marketing Authorization For Pfizer, BioNTech's Omicron KP.2-adapted COVID-19 Vaccine ",RTTNews,/news/stocks/chmp-recommends-marketing-authorization-for-pfizer-biontech-s-omicron-kp-2-adapted-covid-19-vaccine-1033786316,positive,0.5157865285873413
6869,9/20/2024 8:53:30 PM,Pfizer/BioNTech new COVID shot endorsed by EMA advisory panel,Seeking Alpha,https://seekingalpha.com/news/4151724-pfizer-biontech-new-covid-shot-endorsed-by-ema-advisory-panel?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8819876909255981
6870,9/23/2024 12:25:19 PM,Jefferies Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-its-buy-rating-for-pfizer-pfe-1033791107,positive,0.8057987093925476
6871,9/23/2024 7:17:40 PM,UCB gets expanded FDA approval for psoriasis drug Bimzelx,Seeking Alpha,https://seekingalpha.com/news/4152277-ucb-gets-expanded-fda-approval-for-psoriasis-drug-bimzelx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9338517189025879
6872,9/25/2024 6:55:41 PM,Next frontier in anti-obesity landscape: oral GLP-1s with potential OTC switch,Seeking Alpha,https://seekingalpha.com/news/4153415-next-frontier-in-anti-obesity-drugs-oral-glp-1s-with-otc-switch?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5640956163406372
6873,9/25/2024 10:08:43 PM,Pfizer withdraws sickle cell drug Oxbryta over safety concerns,Seeking Alpha,https://seekingalpha.com/news/4153485-pfizer-withdraws-sickle-cell-drug-oxbryta-over-safety-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9518337845802307
6874,9/25/2024 10:55:17 PM,Pfizer’s Investment Outlook: A Cautious Hold Amid Oxbryta Withdrawal and Mixed Acquisition Results,TipRanks,/news/stocks/pfizer-s-investment-outlook-a-cautious-hold-amid-oxbryta-withdrawal-and-mixed-acquisition-results-1033798587,neutral,0.8512600660324097
6875,9/26/2024 9:46:09 AM,Pfizer’s Hold Rating: Evaluating the Impact of Oxbryta Withdrawal and Pipeline Uncertainties,TipRanks,/news/stocks/pfizer-s-hold-rating-evaluating-the-impact-of-oxbryta-withdrawal-and-pipeline-uncertainties-1033800598,positive,0.8917116522789001
6876,9/26/2024 9:56:52 AM,Pfizer’s Stock Faces Challenges as Oxbryta Recall Impacts Drug Pipeline and Financial Projections,TipRanks,/news/stocks/pfizer-s-stock-faces-challenges-as-oxbryta-recall-impacts-drug-pipeline-and-financial-projections-1033800717,neutral,0.9197284579277039
6877,9/26/2024 11:17:07 AM,Pfizer’s Solid Fundamentals and Strategic Acquisitions Affirm Buy Rating Despite Oxbryta Setback,TipRanks,/news/stocks/pfizer-s-solid-fundamentals-and-strategic-acquisitions-affirm-buy-rating-despite-oxbryta-setback-1033801270,negative,0.9529105424880981
6878,9/26/2024 7:02:00 PM,Fulcrum Therapeutics swings up 17% on Pfizer sickle cell drug setback,Seeking Alpha,https://seekingalpha.com/news/4153881-fulcrum-therapeutics-swings-up-17-pfizer-sickle-cell-drug-setback?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9459434747695923
6879,9/27/2024 7:05:19 AM,Jefferies Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/jefferies-remains-a-buy-on-pfizer-pfe-1033803225,positive,0.9468463659286499
6880,9/27/2024 2:33:08 PM,Agios cut at Leerink on overhang from Pfizer’s Oxbryta withdrawal,Seeking Alpha,https://seekingalpha.com/news/4154135-agios-stock-cut-leerink-pfizers-recall?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.48059460520744324
6881,9/27/2024 7:37:11 PM,"Achieve, INmune, Lenz gain on bullish initiations from Raymond James",Seeking Alpha,https://seekingalpha.com/news/4154219-achieve-inmune-lenz-stocks-win-bullish-view-rayjay?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9136362671852112
6882,9/28/2024 5:06:10 PM,Here are the Medicare Part D drugs expected to face 2025 price negotiations,Seeking Alpha,https://seekingalpha.com/news/4154318-these-medicare-drugs-set-to-face-2025-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.941364049911499
6883,9/29/2024 4:12:57 PM,"Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales",Seeking Alpha,https://seekingalpha.com/news/4154326-novo-nordisk-ozempic-regeneron-sanofi-dupixent-advance-top-drug-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9307808876037598
6884,9/29/2024 4:28:46 PM,Stocks with the highest consensus of expected ROE growth - Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/4154349-stocks-with-the-highest-consensus-of-expected-roe-growth-goldman-sachs-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5588743090629578
6885,9/30/2024 3:25:11 PM,Roche sees Carmot obesity drugs' potential peak sales at $3.6B+: report,Seeking Alpha,https://seekingalpha.com/news/4154563-roche-sees-carmot-obesity-drugs-potential-peak-sales-at-4b-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8101692199707031
6886,10/1/2024 8:26:22 AM,Pfizer's Total Interest In Haleon To Reduce From Approx. 22.6% To Approx. 15.0% ,RTTNews,/news/stocks/pfizer-s-total-interest-in-haleon-to-reduce-from-approx-22-6-to-approx-15-0-1033809697,neutral,0.7355446815490723
6887,10/1/2024 10:56:22 AM,Pfizer cuts Haleon stake in $3.3B share sale,Seeking Alpha,https://seekingalpha.com/news/4154901-pfizer-cuts-haleon-stake-in-latest-share-sale?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6187404990196228
6888,10/1/2024 2:22:33 PM,Lilly looking to test Zepbound as health maintenance drug: report,Seeking Alpha,https://seekingalpha.com/news/4155026-lilly-looking-to-test-zepbound-as-health-maintenance-drug-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7170921564102173
6889,10/1/2024 7:35:29 PM,U.S. port strike expected to have limited impact on healthcare supply chain: HHS,Seeking Alpha,https://seekingalpha.com/news/4155196-us-port-strike-have-limited-impact-medical-supplies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9400646090507507
6890,10/2/2024 2:07:42 PM,J&J prostate cancer therapy outperforms in real-world study,Seeking Alpha,https://seekingalpha.com/news/4155516-jj-prostate-cancer-therapy-outperforms-in-real-world-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8590224981307983
6891,10/3/2024 12:02:11 PM,U.S. tweaks 2025 Medicare price negotiation process,Seeking Alpha,https://seekingalpha.com/news/4155891-us-tweaks-2025-medicare-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7824940085411072
6892,10/3/2024 1:08:07 PM,BridgeBio granted Perform rating at Oppenheimer on market challenges,Seeking Alpha,https://seekingalpha.com/news/4155947-bridgebio-granted-perform-rating-at-oppenheimer-on-market-challenges?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5913575291633606
6893,10/4/2024 6:02:06 PM,Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August,Seeking Alpha,https://seekingalpha.com/news/4156522-q3-pharma-biotech-layoffs-charts-more-than-1000-each-july-august?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9607917070388794
6894,10/7/2024 12:28:29 AM,Activist Starboard takes $1B stake in Pfizer - WSJ,Seeking Alpha,https://seekingalpha.com/news/4156615-activist-starboard-takes-1b-stake-in-pfizer-wsj?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9046366810798645
6895,10/7/2024 3:17:30 AM,"Starboard Takes $1 Bln Stake In Pfizer, Pushes For Major Changes : Report ",RTTNews,/news/stocks/starboard-takes-1-bln-stake-in-pfizer-pushes-for-major-changes-report-1033822918,positive,0.8618223071098328
6896,10/7/2024 7:31:09 AM,Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Biogen (BIIB),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-and-biogen-biib-1033824143,positive,0.8960067629814148
6897,10/7/2024 11:07:23 AM,Pfizer (PFE) Gets a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-j-p-morgan-1033825182,positive,0.7275578379631042
6898,10/7/2024 11:15:53 AM,Pfizer’s Stock Buy Rating: Undervalued with Growth Potential and Strategic Management Actions,TipRanks,/news/stocks/pfizer-s-stock-buy-rating-undervalued-with-growth-potential-and-strategic-management-actions-1033825228,negative,0.5778631567955017
6899,10/7/2024 1:33:50 PM,"Biggest stock movers Monday: PFE, MULN, and more",Seeking Alpha,https://seekingalpha.com/news/4156633-biggest-stock-movers-monday-pfe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9079235196113586
6900,10/7/2024 2:03:41 PM,Pfizer stock climbs 4% amid reports Starboard has taken $1B stake,Seeking Alpha,https://seekingalpha.com/news/4156751-pfizer-stock-climbs-amid-reports-starboard-has-taken-1b-stake?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7593421936035156
6901,10/7/2024 2:44:52 PM,U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report,Seeking Alpha,https://seekingalpha.com/news/4156762-uk-court-rules-in-pfizers-favor-in-gsk-rsv-vaccine-dispute-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6640604138374329
6902,10/7/2024 11:05:37 PM,Pfizer Hold Rating: Balancing Valuation Concerns and Growth Challenges,TipRanks,/news/stocks/pfizer-hold-rating-balancing-valuation-concerns-and-growth-challenges-1033826107,positive,0.7971383929252625
6903,10/8/2024 7:36:38 AM,Pfizer’s Hold Rating: Balancing Activist Influence and Growth Challenges,TipRanks,/news/stocks/pfizer-s-hold-rating-balancing-activist-influence-and-growth-challenges-1033827428,positive,0.7406887412071228
6904,10/8/2024 12:32:13 PM,GSK Arexvy protects from RSV over three full seasons,Seeking Alpha,https://seekingalpha.com/news/4156966-gsk-arexvy-protects-from-rsv-over-three-seasons?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8124100565910339
6905,10/8/2024 3:01:08 PM,"Pfizer, BioNTech win lawsuit against CureVac over COVID vaccine patents in U.K.",Seeking Alpha,https://seekingalpha.com/news/4157042-pfizer-biontech-invalidate-curevac-covid-patents?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.750558078289032
6906,10/8/2024 3:26:18 PM,"Activist investor may not be able to do much for Pfizer, analyst says",Seeking Alpha,https://seekingalpha.com/news/4157048-activist-investor-may-not-be-able-to-do-much-for-pfizer-analyst-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8162676692008972
6907,10/8/2024 6:03:33 PM,Harris home health care benefit likely funded through Medicare drug negotiations savings,Seeking Alpha,https://seekingalpha.com/news/4157079-harris-home-health-care-benefit-could-funded-through-medicare-drug-negotiations-savings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8432395458221436
6908,10/8/2024 7:41:42 PM,Pfizer is said to have dropped RSV candidate from pipeline,Seeking Alpha,https://seekingalpha.com/news/4157094-pfizer-is-said-to-have-dropped-rsv-candidate-from-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5839717388153076
6909,10/8/2024 9:26:55 PM,Pfizer CEO Albert Bourla expected to meet with activist Starboard next week - FT,Seeking Alpha,https://seekingalpha.com/news/4157135-pfizer-ceo-albert-bourla-expected-to-meet-with-activist-starboard-next-week-ft?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.910161018371582
6910,10/9/2024 3:51:19 PM,Novavax gets EU authorization for updated COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/4157332-novavax-gets-eu-authorization-for-updated-covid-19-vaccine?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8339697122573853
6911,10/9/2024 5:24:21 PM,"GSK, Pfizer seeing drop in demand for RSV vaccines: report",Seeking Alpha,https://seekingalpha.com/news/4157353-gsk-pfizer-seeing-drop-in-demand-for-rsv-vaccines-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9703715443611145
6912,10/9/2024 8:31:22 PM,Pfizer declares $0.42 dividend,Seeking Alpha,https://seekingalpha.com/news/4157406-pfizer-declares-0_42-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.873785674571991
6913,10/10/2024 5:15:08 AM,Former Pfizer Executives Ian Read And Frank D'Amelio Decline Involvement With Starboard's Efforts ,RTTNews,/news/stocks/former-pfizer-executives-ian-read-and-frank-d-amelio-decline-involvement-with-starboard-s-efforts-1033833176,positive,0.7185924649238586
6914,10/10/2024 1:17:00 PM,"6 stocks to watch on Thursday: DPZ, PFE, AMZN, AAPL and more",Seeking Alpha,https://seekingalpha.com/news/4157571-6-stocks-to-watch-on-thursday-dpz-pfe-amzn-aapl-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9336996674537659
6915,10/10/2024 1:33:00 PM,Pfizer Reports Positive Topline Data From Phase 3 TALAPRO-2 Study Of Talzenna Plus Xtandi ,RTTNews,/news/stocks/pfizer-reports-positive-topline-data-from-phase-3-talapro-2-study-of-talzenna-plus-xtandi-1033835119,negative,0.9525306820869446
6916,10/10/2024 2:20:21 PM,Pfizer ex-CEO and CFO exit Starboard activist campaign (update),Seeking Alpha,https://seekingalpha.com/news/4157499-pfizer-former-executives-exit-activist-drive?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6683108806610107
6917,10/10/2024 3:45:44 PM,Pfizer reports positive Phase 3 results for Talzenna/Xtandi combo,Seeking Alpha,https://seekingalpha.com/news/4157633-pfizer-reports-positive-phase-3-results-for-talzennaxtandi-combo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9494718909263611
6918,10/10/2024 7:39:30 PM,Will Pfizer transform in response to Starboard’s activism?,Seeking Alpha,https://seekingalpha.com/news/4157703-will-pfizer-transform-amid-starboards-activism?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8450762629508972
6919,10/11/2024 7:17:07 AM,Pfizer’s Leadership Stability and Activist Investor Watch: A Hold Rating Analysis,TipRanks,/news/stocks/pfizer-s-leadership-stability-and-activist-investor-watch-a-hold-rating-analysis-1033838067,positive,0.7798756957054138
6920,10/11/2024 12:05:32 PM,Jefferies Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-its-buy-rating-for-pfizer-pfe-1033839182,positive,0.8057987093925476
6921,10/11/2024 12:29:30 PM,"Dividend Roundup: Pfizer, Caterpillar, PNC Financial, AbbVie, and more",Seeking Alpha,https://seekingalpha.com/news/4157846-dividend-roundup-pfizer-caterpillar-pnc-financial-abbvie-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9448760747909546
6922,10/11/2024 12:37:01 PM,Morgan Stanley Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/morgan-stanley-reaffirms-their-hold-rating-on-pfizer-pfe-1033839268,positive,0.854205846786499
6923,10/11/2024 3:52:49 PM,Roche gets FDA approval for Itovebi combo therapy for breast cancer,Seeking Alpha,https://seekingalpha.com/news/4157952-roche-gets-fda-approval-for-itovebi-combo-therapy-for-breast-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9179785251617432
6924,10/11/2024 6:12:34 PM,Pfizer gets FDA approval for Hympavzi for hemophilia,Seeking Alpha,https://seekingalpha.com/news/4157988-pfizer-gets-fda-approval-for-hympavzi-for-hemophilia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9235244393348694
6925,10/12/2024 5:04:50 AM,FDA Approves Pfizer's HYMPAVZI For Hemophilia A And B Treatment In Adults And Adolescents ,RTTNews,/news/stocks/fda-approves-pfizer-s-hympavzi-for-hemophilia-a-and-b-treatment-in-adults-and-adolescents-1033839743,negative,0.827782392501831
6926,10/12/2024 4:10:00 PM,Trending stocks in another record week for Wall Street,Seeking Alpha,https://seekingalpha.com/news/4158044-trending-stocks-in-another-record-week-for-wall-street?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4753957986831665
6927,10/16/2024 4:26:40 PM,ViiV reports positive real-world data for HIV prevention drug,Seeking Alpha,https://seekingalpha.com/news/4166105-viiv-reports-positive-real-world-data-for-hiv-prevention-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.95647794008255
6928,10/16/2024 9:05:09 PM,"Lilly, Gilead, Amgen started at outperform by Bernstein",Seeking Alpha,https://seekingalpha.com/news/4167588-lilly-gilead-amgen-started-at-outperform-by-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7325470447540283
6929,10/16/2024 10:18:07 PM,Pfizer's Ibrance shows promise in treating appendix cancer: study,Seeking Alpha,https://seekingalpha.com/news/4167843-pfizers-ibrance-shows-promise-in-treating-appendix-cancer-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8130162954330444
6930,10/17/2024 7:30:03 PM,"Consumer, labor groups urge FTC to block Catalent sale to Novo Holdings - report",Seeking Alpha,https://seekingalpha.com/news/4172071-consumer-labor-groups-urge-ftc-to-block-catalent-sale-to-novo-nordisk-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7672764658927917
6931,10/18/2024 5:05:26 PM,BioNTech and Moderna: A tale of two mRNA developers,Seeking Alpha,https://seekingalpha.com/news/4175119-biontech-and-moderna-a-tale-of-two-m-rna-developers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9157522916793823
6932,10/20/2024 11:05:10 AM,"UPS among dividend stocks with yield of 4%-plus, Barron’s says",TipRanks,/news/stocks/ups-among-dividend-stocks-with-yield-of-4--plus-barron-s-says-1033861099,positive,0.5449894070625305
6933,10/22/2024 9:56:25 AM,Mixed Prospects and Uncertainty Lead to Hold Rating for Pfizer Amid COVID-19 Revenue Fluctuations,TipRanks,/news/stocks/mixed-prospects-and-uncertainty-lead-to-hold-rating-for-pfizer-amid-covid-19-revenue-fluctuations-1033870587,neutral,0.9626443386077881
6934,10/22/2024 1:25:54 PM,"Pfizer, Lilly pressed about telehealth prescriber relationships, STAT reports",TipRanks,/news/stocks/pfizer-lilly-pressed-about-telehealth-prescriber-relationships-stat-reports-1033872465,positive,0.9403422474861145
6935,10/22/2024 4:01:16 PM,"GE Aerospace, GM report quarterly earnings beats: Morning Buzz",TipRanks,/news/stocks/ge-aerospace-gm-report-quarterly-earnings-beats-morning-buzz-1033873047,positive,0.8467079997062683
6936,10/22/2024 4:25:17 PM,"Starboard urges Pfizer board to ‘hold management accountable’, FT reports",TipRanks,/news/stocks/starboard-urges-pfizer-board-to-hold-management-accountable-ft-reports-1033873060,positive,0.8984898924827576
6937,10/22/2024 5:19:03 PM,"Pfizer, Lilly relationships with telehealth platforms draw Sen. Durbin's attention",Seeking Alpha,https://seekingalpha.com/news/4190392-pfizer-lilly-relationships-telehealth-platforms-draw-sen-durbin-attention?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8783955574035645
6938,10/22/2024 8:51:00 PM,Pfizer announces FDA approval of Abrysvo,TipRanks,/news/stocks/pfizer-announces-fda-approval-of-abrysvo-1033873712,positive,0.7546588778495789
6939,10/22/2024 10:09:29 PM,Pfizer RSV vaccine Abrysvo gains expanded indication,Seeking Alpha,https://seekingalpha.com/news/4192748-pfizer-rsv-vaccine-abrysvo-gains-expanded-indication?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9487055540084839
6940,10/23/2024 3:00:49 AM,FDA Okays Pfizer's RSV Vaccine ABRYSVO For Adults Aged 18 To 59 At Increased Risk For Disease ,RTTNews,/news/stocks/fda-okays-pfizer-s-rsv-vaccine-abrysvo-for-adults-aged-18-to-59-at-increased-risk-for-disease-1033873848,negative,0.6090487837791443
6941,10/23/2024 6:46:50 AM,Hold Recommendation on Pfizer Amid Promising but Early Stage Cancer Cachexia Drug Development,TipRanks,/news/stocks/hold-recommendation-on-pfizer-amid-promising-but-early-stage-cancer-cachexia-drug-development-1033877215,neutral,0.5920467376708984
6942,10/23/2024 8:50:26 PM,Pfizer: CDC Advisory Committee expands recommendation for use of Prevnar 20,TipRanks,/news/stocks/pfizer-cdc-advisory-committee-expands-recommendation-for-use-of-prevnar-20-1033881720,positive,0.7810401916503906
6943,10/23/2024 9:45:25 PM,"Pfizer, Merck pneumonia shots gain ACIP endorsement for wider indication",Seeking Alpha,https://seekingalpha.com/news/4197601-pfizer-merck-pneumonia-shots-gain-acip-endorsement-wider-indication?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7737689018249512
6944,10/24/2024 3:35:56 AM,CDC Panel Backs Expanded Use Of Pfizer's Pneumococcal Vaccine ,RTTNews,/news/stocks/cdc-panel-backs-expanded-use-of-pfizer-s-pneumococcal-vaccine-1033881891,negative,0.7339096069335938
6945,10/24/2024 11:35:51 PM,Pfizer (PFE) Receives a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-j-p-morgan-1033889749,positive,0.6905474662780762
6946,10/25/2024 10:26:25 AM,Pfizer maintained Neutral on analyst transfer at Citi,TipRanks,/news/stocks/pfizer-maintained-neutral-on-analyst-transfer-at-citi-1033892683,positive,0.9004090428352356
6947,10/25/2024 12:25:40 PM,Pfizer (PFE) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-cantor-fitzgerald-1033893949,positive,0.7369114756584167
6948,10/25/2024 7:00:00 PM,"Catalyst Watch: Eyes on tech with Apple, Amazon, Alphabet, and Meta reporting",Seeking Alpha,https://seekingalpha.com/news/4201499-catalyst-watch-eyes-on-tech-with-apple-amazon-alphabet-and-meta-reporting?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9125537276268005
6949,10/26/2024 5:46:00 PM,About 75% of companies that reported earnings this week delivered EPS wins-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4205854-about-75-of-companies-that-reported-earnings-this-week-delivered-eps-wins-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8234386444091797
6950,10/28/2024 4:23:31 AM,"Earnings week ahead: MSFT, AMZN, AAPL, META, GOOG, AMD, PFE, F, MCD, SBUX, XOM, CVX and more",Seeking Alpha,https://seekingalpha.com/news/4205996-earnings-week-ahead-msft-amzn-aapl-meta-goog-amd-pfe-f-mcd-sbux-xom-cvx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9362694025039673
6951,10/28/2024 12:24:42 PM,Investors eye earnings data volatility movements as it reflects highest levels in 15 years,Seeking Alpha,https://seekingalpha.com/news/4213053-investors-eye-earnings-data-as-volatility-movements-reflects-highest-levels-in-15-years?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5034686923027039
6952,10/28/2024 5:48:41 PM,Pfizer Q3 Earnings Preview: Strong earnings growth expected,Seeking Alpha,https://seekingalpha.com/news/4215007-pfizer-q3-earnings-preview-strong-earnings-growth-expected?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9536412358283997
6953,10/28/2024 6:00:32 PM,Notable companies reporting before tomorrow’s open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1033904044,positive,0.9220908284187317
6954,10/28/2024 10:00:33 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4215158-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9330109357833862
6955,10/29/2024 10:46:23 AM,"Pfizer Non-GAAP EPS of $1.06 beats by $0.45, revenue of $17.7B beats by $2.83B",Seeking Alpha,https://seekingalpha.com/news/4217345-pfizer-non-gaap-eps-of-1_06-beats-0_45-revenue-of-17_7b-beats-2_83b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6161984801292419
6956,10/29/2024 10:50:43 AM,Pfizer sees ‘at least’ $4B by 2024-end from cost realignment program,TipRanks,/news/stocks/pfizer-sees-at-least-4b-by-2024-end-from-cost-realignment-program-1033909381,negative,0.7738083004951477
6957,10/29/2024 10:51:13 AM,Pfizer raises FY24 adjusted EPS view to $2.75-$2.95 from $2.45-$2.65,TipRanks,/news/stocks/pfizer-raises-fy24-adjusted-eps-view-to-2-75--2-95-from-2-45--2-65-1033909377,negative,0.9364058971405029
6958,10/29/2024 10:52:00 AM,"Pfizer reports Q3 adjusted EPS $1.06, consensus 62c",TipRanks,/news/stocks/pfizer-reports-q3-adjusted-eps-1-06-consensus-62c-1033909372,positive,0.8764455914497375
6959,10/29/2024 10:57:26 AM,"Earnings Snapshot: Pfizer exceeds Q3 expectations, further raises FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4217355-earnings-snapshot-pfizer-exceeds-q3-expectations-further-raises-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7690813541412354
6960,10/29/2024 11:30:13 AM,"Pfizer: FY24 guidance includes ~$10.5B in revenue from Comirnaty, Paxlovid",TipRanks,/news/stocks/pfizer-fy24-guidance-includes-~-10-5b-in-revenue-from-comirnaty-paxlovid-1033909816,positive,0.8416295051574707
6961,10/29/2024 11:42:23 AM,Pfizer raises guidance as COVID franchise drives Q3 beat,Seeking Alpha,https://seekingalpha.com/news/4217552-pfizer-stock-gains-after-q-3-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5399951338768005
6962,10/29/2024 11:52:53 AM,Pfizer Inc. Q3 Earnings Summary ,RTTNews,/news/stocks/pfizer-inc-q3-earnings-summary-1033908075,positive,0.6771915555000305
6963,10/29/2024 12:04:48 PM,Pfizer Again Boost FY24 Outlook - Update ,RTTNews,/news/stocks/pfizer-again-boost-fy24-outlook-update-1033908111,negative,0.9278011918067932
6964,10/29/2024 12:06:18 PM,Pfizer’s Hold Rating: Impact of Ponsegromab Trial Delays and Strategic Uncertainties,TipRanks,/news/stocks/pfizer-s-hold-rating-impact-of-ponsegromab-trial-delays-and-strategic-uncertainties-1033910325,neutral,0.5501217246055603
6965,10/29/2024 12:37:07 PM,Pfizer in charts: Primary Care revenue soars 83% Q/Q and 44% Y/Y in Q3,Seeking Alpha,https://seekingalpha.com/news/4217803-pfizer-in-charts-primary-care-revenue-soars-83-qq-and-44-yy-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.858354926109314
6966,10/29/2024 12:55:52 PM,"Morning Movers: McDonald’s lower, Pfizer higher after earnings releases",TipRanks,/news/stocks/morning-movers-mcdonald-s-lower-pfizer-higher-after-earnings-releases-1033910635,neutral,0.7844797968864441
6967,10/29/2024 1:15:00 PM,"5 stocks to watch on Tuesday: GOOG/GOOGL, MCD, PFE and more",Seeking Alpha,https://seekingalpha.com/news/4217916-5-stocks-to-watch-on-tuesday-googgoogl-mcd-pfe-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9335761070251465
6968,10/29/2024 1:40:18 PM,Unusually active option classes on open October 29th,TipRanks,/news/stocks/unusually-active-option-classes-on-open-october-29th-1033910879,positive,0.6858137845993042
6969,10/29/2024 3:35:08 PM,Jefferies Keeps Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/jefferies-keeps-their-buy-rating-on-pfizer-pfe-1033911398,positive,0.9183027148246765
6970,10/29/2024 4:10:38 PM,"McDonald’s, Ford, Pfizer report Q3 earnings beats: Morning Buzz",TipRanks,/news/stocks/mcdonald-s-ford-pfizer-report-q3-earnings-beats-morning-buzz-1033911458,positive,0.8381390571594238
6971,10/29/2024 6:26:37 PM,Why is Pfizer stock falling after Q3 results?,Seeking Alpha,https://seekingalpha.com/news/4220246-why-is-pfizer-stock-falling-after-q-3-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9524312615394592
6972,10/29/2024 6:45:18 PM,Incyte price target raised to $75 from $73 at Stifel,TipRanks,/news/stocks/incyte-price-target-raised-to-75-from-73-at-stifel-1033912161,negative,0.9414701461791992
6973,10/29/2024 8:11:02 PM,Shionogi's Xocova effective in preventing symptomatic COVID-19: study,Seeking Alpha,https://seekingalpha.com/news/4220829-shionogi-xocova-effective-in-preventing-symptomatic-covid-19-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8585025668144226
6974,10/29/2024 10:15:49 PM,Pfizer’s Hold Rating Maintained Amid Unsustainable Surprises and Limited Growth Prospects,TipRanks,/news/stocks/pfizer-s-hold-rating-maintained-amid-unsustainable-surprises-and-limited-growth-prospects-1033912605,neutral,0.9562757611274719
6975,10/29/2024 10:16:44 PM,Pfizer’s Balanced Outlook: Hold Rating Amid Strong Q3 Results and Future Challenges,TipRanks,/news/stocks/pfizer-s-balanced-outlook-hold-rating-amid-strong-q3-results-and-future-challenges-1033912599,negative,0.9437138438224792
6976,10/30/2024 9:18:43 AM,"Pfizer Inc. Reports Strong Q3 2024 Results, Raises Guidance",TipRanks,/news/stocks/pfizer-inc-reports-strong-q3-2024-results-raises-guidance-1033917066,negative,0.9435275197029114
6977,10/30/2024 10:43:34 AM,GSK dips as lower vaccine sales weigh on Q3 2024 results,Seeking Alpha,https://seekingalpha.com/news/4222380-gsk-stock-dips-on-lower-q-3-vaccine-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9616642594337463
6978,10/30/2024 10:47:41 AM,Pfizer’s Financial Outlook: Balancing Strong Q3 Performance with Future Uncertainties and Strategic Developments,TipRanks,/news/stocks/pfizer-s-financial-outlook-balancing-strong-q3-performance-with-future-uncertainties-and-strategic-developments-1033917941,negative,0.8636488914489746
6979,10/30/2024 11:10:47 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: DaVita (DVA), Pfizer (PFE) and Collegium Pharmaceutical (COLL)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-davita-dva-pfizer-pfe-and-collegium-pharmaceutical-coll-1033918076,neutral,0.786593496799469
6980,10/30/2024 11:17:42 AM,Positive Outlook on Pfizer Driven by Strategic Execution and Growth Opportunities,TipRanks,/news/stocks/positive-outlook-on-pfizer-driven-by-strategic-execution-and-growth-opportunities-1033918261,negative,0.9435408115386963
6981,10/30/2024 11:47:59 AM,TD Cowen Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/td-cowen-sticks-to-its-hold-rating-for-pfizer-pfe-1033918575,positive,0.8278870582580566
6982,10/30/2024 12:40:12 PM,Evercore ISI Reaffirms Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/evercore-isi-reaffirms-their-buy-rating-on-pfizer-pfe-1033919258,positive,0.8645608425140381
6983,10/30/2024 12:41:07 PM,Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-and-pfizer-pfe-1033919244,positive,0.9100172519683838
6984,10/30/2024 12:50:06 PM,Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Pfizer (PFE),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-roche-holding-ag-otherrhhvf-and-pfizer-pfe-1033919390,positive,0.9198620319366455
6985,10/30/2024 1:01:46 PM,Notable open interest changes for October 30th,TipRanks,/news/stocks/notable-open-interest-changes-for-october-30th-1033919563,positive,0.9172897338867188
6986,10/30/2024 1:49:06 PM,Bank of America Securities Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-hold-rating-on-pfizer-pfe-1033919831,positive,0.8462256789207458
6987,10/30/2024 9:37:25 PM,Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?,TipRanks,/news/stocks/is-pfizer-nyse-pfe-a-high-yielding-dividend-stock-worth-buying-1033921772,positive,0.87018221616745
6988,11/1/2024 8:06:06 PM,Pfizer (PFE) Receives a Hold from UBS,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-ubs-1033939033,positive,0.8622891902923584
6989,11/4/2024 9:17:29 AM,Barclays Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/barclays-sticks-to-its-hold-rating-for-pfizer-pfe-1033943536,positive,0.8443052172660828
6990,11/4/2024 12:16:58 PM,Pfizer (PFE) Gets a Buy from Truist Financial,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-truist-financial-1033945067,positive,0.6106163263320923
6991,11/4/2024 1:20:02 PM,Evercore ISI Reaffirms Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/evercore-isi-reaffirms-their-buy-rating-on-pfizer-pfe-1033945550,positive,0.8645608425140381
6992,11/5/2024 5:36:38 AM,Pfizer’s Ponsegromab: A Promising Yet Uncertain Opportunity Influencing Hold Rating,TipRanks,/news/stocks/pfizer-s-ponsegromab-a-promising-yet-uncertain-opportunity-influencing-hold-rating-1033949967,negative,0.5505077838897705
6993,11/5/2024 3:40:10 PM,Pfizer management to meet with Jefferies,TipRanks,/news/stocks/pfizer-management-to-meet-with-jefferies-1033954161,positive,0.9392078518867493
6994,11/6/2024 8:17:19 PM,SA Asks: How will the U.S. election results impact healthcare stocks?,Seeking Alpha,https://seekingalpha.com/news/4257322-sa-asks-how-will-the-us-election-results-impact-healthcare-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7067018747329712
6995,11/7/2024 3:42:14 PM,Viatris nears 11-month high after Q3 beat,Seeking Alpha,https://seekingalpha.com/news/4261515-viatris-stock-jumps-after-q-3-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8214934468269348
6996,11/7/2024 7:53:42 PM,"Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market",Seeking Alpha,https://seekingalpha.com/news/4262493-pfizer-gsk-moderna-struggle-rsv-vaccine-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9344662427902222
6997,11/8/2024 6:21:44 PM,Pfizer to invest $1B in China over next five years,Seeking Alpha,https://seekingalpha.com/news/4267505-pfizer-invest-1-b-china-over-next-five-years?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7308340072631836
6998,11/11/2024 3:00:18 PM,"GSK to quit lobbying group BIO, STAT reports",TipRanks,/news/stocks/gsk-to-quit-lobbying-group-bio-stat-reports-1033993976,positive,0.7454394698143005
6999,11/12/2024 1:06:50 PM,Jefferies Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/jefferies-remains-a-buy-on-pfizer-pfe-1034000611,positive,0.9468463659286499
7000,11/12/2024 2:50:58 PM,"Pfizer exploring sale of hospital drugs unit, Reuters reports",TipRanks,/news/stocks/pfizer-exploring-sale-of-hospital-drugs-unit-reuters-reports-1034001361,positive,0.9061720967292786
7001,11/12/2024 2:55:32 PM,"Pfizer said to be exploring sale of hospital drugs unit, Reuters reports",TipRanks,/news/stocks/pfizer-said-to-be-exploring-sale-of-hospital-drugs-unit-reuters-reports-1034001349,positive,0.9322524666786194
7002,11/12/2024 3:06:21 PM,Pfizer reportedly eyeing sale of hospital drugs unit,Seeking Alpha,https://seekingalpha.com/news/4280369-pfizer-eyeing-sale-hospital-drugs-unit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8279516100883484
7003,11/12/2024 5:05:59 PM,"Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz",TipRanks,/news/stocks/elliott-confirms-big-honeywell-stake-home-deport-reports-q3-beat-morning-buzz-1034001929,positive,0.8393925428390503
7004,11/13/2024 2:02:02 PM,Notable open interest changes for November 13th,TipRanks,/news/stocks/notable-open-interest-changes-for-november-13th-1034010332,positive,0.9100954532623291
7005,11/14/2024 11:37:36 AM,UBS Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/ubs-remains-a-hold-on-pfizer-pfe-1034018010,positive,0.8731019496917725
7006,11/14/2024 9:22:16 PM,Pfizer initiated with an Underperform at Wolfe Research,TipRanks,/news/stocks/pfizer-initiated-with-an-underperform-at-wolfe-research-1034021152,neutral,0.8982245326042175
7007,11/14/2024 9:26:00 PM,Trump names Robert Kennedy as Secretary of Health and Human Services,TipRanks,/news/stocks/trump-names-robert-kennedy-as-secretary-of-health-and-human-services-1034021141,positive,0.9236841797828674
7008,11/14/2024 9:35:35 PM,Vaccine makers fall after Trump nominates RFK to head HHS,TipRanks,/news/stocks/vaccine-makers-fall-after-trump-nominates-rfk-to-head-hhs-1034021236,neutral,0.9510136246681213
7009,11/14/2024 11:07:05 PM,Vaccine makers close lower amid reports RFK Jr may head HHS (update),Seeking Alpha,https://seekingalpha.com/news/4292433-vaccines-makers-close-lower-on-reports-rfk-jr-may-head-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9338276982307434
7010,11/14/2024 11:45:35 PM,"Wolfe starts Pfizer at Underperform, notes underperformance versus peers",TipRanks,/news/stocks/wolfe-starts-pfizer-at-underperform-notes-underperformance-versus-peers-1034021611,neutral,0.9152478575706482
7011,11/15/2024 11:02:48 AM,"RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up",Seeking Alpha,https://seekingalpha.com/news/4293676-rfk-and-the-maha-trade-vaccine-makers-down-psychedelic-shares-up?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9539552330970764
7012,11/15/2024 11:10:27 AM,"New York Times files lawsuit against EC over Covid vaccine deal, NY Times says",TipRanks,/news/stocks/new-york-times-files-lawsuit-against-ec-over-covid-vaccine-deal-ny-times-says-1034024293,neutral,0.8174992799758911
7013,11/15/2024 5:08:27 PM,Vaccine stocks drop on concerns about RFK Jr. heading HHS (update),Seeking Alpha,https://seekingalpha.com/news/4295685-vaccine-stocks-drop-on-concerns-about-rfk-jr-heading-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9465009570121765
7014,11/15/2024 7:29:29 PM,U.S. Pharma is largely immune from 'MAHA' impact: Wolfe,Seeking Alpha,https://seekingalpha.com/news/4296178-us-pharma-largely-immune-from-maha-impact-wolfe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9049097299575806
7015,11/15/2024 7:30:36 PM,"Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS",Seeking Alpha,https://seekingalpha.com/news/4296140-large-pharmas-biotechs-down-industries-grapple-with-rfk-jr-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9230126738548279
7016,11/16/2024 5:09:00 PM,Trending stocks this week as Wall Street sells off amid Fed remarks,Seeking Alpha,https://seekingalpha.com/news/4297347-trending-stocks-this-week-as-wall-street-sells-off-amid-fed-remarks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8001051545143127
7017,11/18/2024 12:40:51 PM,Arvinas initiated with an Overweight at Stephens,TipRanks,/news/stocks/arvinas-initiated-with-an-overweight-at-stephens-1034031442,positive,0.7759023308753967
7018,11/19/2024 11:47:41 AM,"Pfizer, Arvinas delay late-stage trial for breast cancer therapy",Seeking Alpha,https://seekingalpha.com/news/4305935-pfizer-arvinas-delay-breast-cancer-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7090303897857666
7019,11/20/2024 10:45:09 AM,Pfizer announces EC approval for Hympavzi,TipRanks,/news/stocks/pfizer-announces-ec-approval-for-hympavzi-1034042097,positive,0.8198732137680054
7020,11/20/2024 10:50:23 AM,Pfizer's HYMPAVZI Approved In EU For Treatment Of Severe Hemophilia A Or B Without Inhibitors ,RTTNews,/news/stocks/pfizer-s-hympavzi-approved-in-eu-for-treatment-of-severe-hemophilia-a-or-b-without-inhibitors-1034040923,negative,0.8347090482711792
7021,11/20/2024 11:25:09 AM,"Pfizer selects Chris Boshoff as chief scientific officer, WSJ reports",TipRanks,/news/stocks/pfizer-selects-chris-boshoff-as-chief-scientific-officer-wsj-reports-1034042310,positive,0.9369320869445801
7022,11/20/2024 11:50:33 AM,Pfizer confirms Chris Boshoff as chief scientific officer,TipRanks,/news/stocks/pfizer-confirms-chris-boshoff-as-chief-scientific-officer-1034042531,positive,0.9396309852600098
7023,11/20/2024 11:58:26 AM,Pfizer names head of oncology as new R&D chief,Seeking Alpha,https://seekingalpha.com/news/4310914-pfizer-names-new-r-d-chief?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9251222610473633
7024,11/20/2024 1:16:27 PM,"Pfizer Names Chris Boshoff Chief Scientific Officer And President, R&D, Effective Jan.1 ",RTTNews,/news/stocks/pfizer-names-chris-boshoff-chief-scientific-officer-and-president-r-d-effective-jan-1-1034041572,positive,0.9362637996673584
7025,11/20/2024 6:06:24 PM,"U.K.’s CAT fines Pfizer, Flynn GBP 69M for excessive pricing after CMA probe",TipRanks,/news/stocks/u-k-s-cat-fines-pfizer-flynn-gbp-69m-for-excessive-pricing-after-cma-probe-1034044456,neutral,0.9531469345092773
7026,11/20/2024 6:16:10 PM,Leerink views Chris Boshoff as ‘strong choice’ for Pfizer’s CSO,TipRanks,/news/stocks/leerink-views-chris-boshoff-as-strong-choice-for-pfizer-s-cso-1034044508,positive,0.7927733659744263
7027,11/21/2024 10:30:34 AM,"Zai Lab, Pfizer enter collaboration for Xacduro",TipRanks,/news/stocks/zai-lab-pfizer-enter-collaboration-for-xacduro-1034048483,positive,0.5586627125740051
7028,11/21/2024 3:20:34 PM,"Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade",Seeking Alpha,https://seekingalpha.com/news/4317287-pyxis-stock-craters-amid-phase-1-data-william-blair-downgrade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8993014097213745
7029,11/21/2024 6:45:46 PM,Optimism over global healthcare sector rises: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4318258-optimism-over-global-healthcare-sector-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7575292587280273
7030,11/22/2024 2:50:12 PM,"Trump expected to pick Martin Makary to head FDA, Reuters reports",TipRanks,/news/stocks/trump-expected-to-pick-martin-makary-to-head-fda-reuters-reports-1034056320,positive,0.9290669560432434
7031,11/22/2024 4:30:23 PM,Trump Trade: Trump Media considers developing crypto payment service,TipRanks,/news/stocks/trump-trade-trump-media-considers-developing-crypto-payment-service-1034056553,positive,0.8859369158744812
7032,11/23/2024 2:25:05 AM,"Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC",Seeking Alpha,https://seekingalpha.com/news/4323803-trump-picks-surgeon-makary-to-head-fda-rep-dave-weldon-to-lead-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9368929862976074
7033,11/23/2024 1:26:02 PM,Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby,Seeking Alpha,https://seekingalpha.com/news/4324609-pfizer-amyloidosis-rival-bridge-bio-wins-fda-nod?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8890742659568787
7034,11/25/2024 12:20:57 PM,"BridgeBio FDA approval ‘significant clearing event,’ says Citi",TipRanks,/news/stocks/bridgebio-fda-approval-significant-clearing-event-says-citi-1034061287,negative,0.47685879468917847
7035,11/25/2024 3:29:07 PM,Morgan Stanley Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-pfizer-pfe-1034062416,positive,0.8586774468421936
7036,11/26/2024 12:18:47 PM,Amgen posts mid-stage data for weight loss therapy,Seeking Alpha,https://seekingalpha.com/news/4334405-amgen-stock-slips-on-data-weight-loss-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4569445550441742
7037,11/27/2024 11:23:42 AM,Trump taps Jay Bhattacharya to lead National Institutes of Health,Seeking Alpha,https://seekingalpha.com/news/4338432-trump-taps-jay-bhattacharya-to-lead-national-institutes-of-health?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8861560225486755
7038,11/29/2024 1:55:06 PM,Berenberg Bank Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/berenberg-bank-sticks-to-their-hold-rating-for-pfizer-pfe-1034081053,positive,0.8066825270652771
7039,12/3/2024 1:16:29 PM,Whitefort Capital sends letter to Arbutus Biopharma board of directors,TipRanks,/news/stocks/whitefort-capital-sends-letter-to-arbutus-biopharma-board-of-directors-1034092903,positive,0.886593222618103
7040,12/3/2024 7:40:10 PM,Truist biopharma analyst to hold an analyst/industry conference call,TipRanks,/news/stocks/truist-biopharma-analyst-to-hold-an-analyst-industry-conference-call-1034094073,positive,0.9468002915382385
7041,12/5/2024 2:12:26 PM,Merck begins trial of molnupiravir for COVID-19 with high risk of disease progression,Seeking Alpha,https://seekingalpha.com/news/4366009-merck-begins-trial-of-molnupiravir-for-covidminus-19-high-risk-of-disease-progression?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5902831554412842
7042,12/5/2024 5:49:19 PM,"Pfizer, Lilly CEOs have dinner at Mar-a-Lago with Trump, RFK Jr. - report",Seeking Alpha,https://seekingalpha.com/news/4367278-pfizer-lilly-ceos-dinner-mar-a-lago-trump-rfk-jr?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9428231716156006
7043,12/9/2024 3:15:15 PM,Pfizer put volume heavy and directionally bearish,TipRanks,/news/stocks/pfizer-put-volume-heavy-and-directionally-bearish-1034115575,neutral,0.8937133550643921
7044,12/10/2024 12:22:22 PM,Pfizer reinstated with a Neutral at BofA,TipRanks,/news/stocks/pfizer-reinstated-with-a-neutral-at-bofa-1034119786,positive,0.8711968660354614
7045,12/10/2024 2:25:34 PM,"Arvinas, Pfizer announce initial Phase 1b data from TACTIVE-U sub-study",TipRanks,/news/stocks/arvinas-pfizer-announce-initial-phase-1b-data-from-tactive-u-sub-study-1034120631,positive,0.8197526931762695
7046,12/10/2024 2:45:24 PM,"eBay downgraded, GM upgraded: Wall Street’s top analyst calls",TipRanks,/news/stocks/ebay-downgraded-gm-upgraded-wall-street-s-top-analyst-calls-1034120783,positive,0.8453127145767212
7047,12/10/2024 4:44:29 PM,"Arvinas, Pfizer Report Positive Data From Phase 1b Study Of Vepdegestrant Combination Therapy ",RTTNews,/news/stocks/arvinas-pfizer-report-positive-data-from-phase-1b-study-of-vepdegestrant-combination-therapy-1034119969,negative,0.9447668194770813
7048,12/10/2024 10:01:32 PM,BofA restarts coverage of 11 large-cap biopharmas,Seeking Alpha,https://seekingalpha.com/news/4384456-bofa-restarts-coverage-of-11-large-cap-biopharmas?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8290336728096008
7049,12/11/2024 11:10:46 AM,Relay Therapeutics reports updated interim clinical data for RLY-2608,TipRanks,/news/stocks/relay-therapeutics-reports-updated-interim-clinical-data-for-rly-2608-1034124401,positive,0.9301611185073853
7050,12/11/2024 1:16:03 PM,Pfizer (PFE) Gets a Buy from Evercore ISI,TipRanks,/news/stocks/pfizer-pfe-gets-a-buy-from-evercore-isi-1034125740,negative,0.6429387331008911
7051,12/11/2024 1:55:15 PM,Pfizer price target lowered to $33 from $35 at Guggenheim,TipRanks,/news/stocks/pfizer-price-target-lowered-to-33-from-35-at-guggenheim-1034125884,neutral,0.5622966289520264
7052,12/11/2024 2:01:05 PM,Notable open interest changes for December 11th,TipRanks,/news/stocks/notable-open-interest-changes-for-december-11th-1034126071,positive,0.9075397849082947
7053,12/12/2024 8:55:26 AM,Pfizer (PFE) Gets a Hold from J.P. Morgan,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-j-p-morgan-1034129002,positive,0.7275578379631042
7054,12/12/2024 1:20:29 PM,Pfizer announces results from PATINA trial,TipRanks,/news/stocks/pfizer-announces-results-from-patina-trial-1034131059,positive,0.8818523287773132
7055,12/12/2024 5:38:51 PM,"Pfizer's Ibrance shows promise in HR+, HER2+ breast cancer",Seeking Alpha,https://seekingalpha.com/news/4386014-pfizers-ibrance-shows-promise-in-hr-her2-breast-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9103128910064697
7056,12/12/2024 10:30:14 PM,Pfizer raises quarterly dividend to 43c per share,TipRanks,/news/stocks/pfizer-raises-quarterly-dividend-to-43c-per-share-1034132661,negative,0.8178020119667053
7057,12/13/2024 5:13:50 AM,Pfizer raises dividend by 2.4% to $0.43 a share,Seeking Alpha,https://seekingalpha.com/news/4386162-pfizer-raises-dividend-by-24-to-043-a-share?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8734872341156006
7058,12/13/2024 8:00:06 PM,"Catalyst Watch: FOMC meeting, govt. funding drama, earnings for Micron, Nike, and FedEx",Seeking Alpha,https://seekingalpha.com/news/4386420-catalyst-watch-fomc-meeting-govt-funding-drama-earnings-for-micron-nike-and-fedex?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9228434562683105
7059,12/15/2024 10:16:27 PM,SA Asks: How should investors position portfolios ahead of Fed vote?,Seeking Alpha,https://seekingalpha.com/news/4386607-sa-asks-how-should-investors-position-portfolios-ahead-of-fed-vote?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9357923269271851
7060,12/16/2024 1:45:52 PM,Jefferies Sticks to Their Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/jefferies-sticks-to-their-buy-rating-for-pfizer-pfe-1034141894,positive,0.8576091527938843
7061,12/16/2024 3:15:24 PM,GSK’s ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria,TipRanks,/news/stocks/gsk-s-viiv-healthcare-says-the-chmp-of-ema-issued-positive-opinion-for-vocabria-1034142336,negative,0.9320905208587646
7062,12/16/2024 7:58:24 PM,Sangamo surges 24% after Roche ends development of hemophilia A gene therapy,Seeking Alpha,https://seekingalpha.com/news/4386986-sangamo-surges-24-after-roche-ends-development-of-hemophilia-a-gene-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6148884892463684
7063,12/17/2024 12:59:33 AM,Pfizer (PFE) Gets a Hold from Wells Fargo,TipRanks,/news/stocks/pfizer-pfe-gets-a-hold-from-wells-fargo-1034143615,positive,0.78740394115448
7064,12/17/2024 11:50:13 AM,"Pfizer backs FY24 adjusted EPS view $2.75-$2.95, consensus $2.93",TipRanks,/news/stocks/pfizer-backs-fy24-adjusted-eps-view-2-75--2-95-consensus-2-93-1034146083,positive,0.53559809923172
7065,12/17/2024 11:50:55 AM,"Pfizer sees FY25 adjusted EPS $2.80-$3.00, consensus $2.88",TipRanks,/news/stocks/pfizer-sees-fy25-adjusted-eps-2-80--3-00-consensus-2-88-1034146077,positive,0.7894338965415955
7066,12/17/2024 11:55:31 AM,Pfizer CEO sees additional $500M in operating expense savings in 2025,TipRanks,/news/stocks/pfizer-ceo-sees-additional-500m-in-operating-expense-savings-in-2025-1034146070,negative,0.9451345801353455
7067,12/17/2024 12:01:27 PM,Pfizer sees FY25 adjusted R&D expenses $10.7B-$11.7B,TipRanks,/news/stocks/pfizer-sees-fy25-adjusted-r-d-expenses-10-7b--11-7b-1034146481,positive,0.9000373482704163
7068,12/17/2024 12:05:44 PM,"Pfizer issues 2025 outlook, reiterates 2024 guidance",Seeking Alpha,https://seekingalpha.com/news/4387227-pfizer-stock-gains-2025-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9393776059150696
7069,12/17/2024 1:06:55 PM,Pfizer Expects 2025 Adj. EPS Operational Growth Of 10% To 18%; Reaffirms 2024 Guidance ,RTTNews,/news/stocks/pfizer-expects-2025-adj-eps-operational-growth-of-10-to-18-reaffirms-2024-guidance-1034145148,negative,0.9339941740036011
7070,12/17/2024 1:19:05 PM,Pfizer Projects Strong Financial Growth for 2025,TipRanks,/news/stocks/pfizer-projects-strong-financial-growth-for-2025-1034146909,negative,0.9455589056015015
7071,12/17/2024 2:06:00 PM,J.P. Morgan Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/j-p-morgan-reaffirms-their-hold-rating-on-pfizer-pfe-1034147288,positive,0.8251071572303772
7072,12/17/2024 2:11:29 PM,Morning Movers: Rockwell Medical jumps following product purchase agreement,TipRanks,/news/stocks/morning-movers-rockwell-medical-jumps-following-product-purchase-agreement-1034147263,positive,0.8357619643211365
7073,12/17/2024 2:50:42 PM,"Biggest stock movers Tuesday: TSLA, TEVA, ZYME, EVGO, and more",Seeking Alpha,https://seekingalpha.com/news/4387172-biggest-stock-movers-tuesday?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9165351390838623
7074,12/17/2024 3:02:23 PM,Early notable gainers among liquid option names on December 17th,TipRanks,/news/stocks/early-notable-gainers-among-liquid-option-names-on-december-17th-1034147586,negative,0.9032526016235352
7075,12/17/2024 3:20:12 PM,"UnitedHealth, CVS Health extend decline as Pfizer CEO cites Trump’s PBM comments",Seeking Alpha,https://seekingalpha.com/news/4387339-unitedhealth-cvs-stocks-drop-pfizer-cites-trump-comments?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9491370320320129
7076,12/17/2024 4:35:21 PM,UBS Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/ubs-sticks-to-its-hold-rating-for-pfizer-pfe-1034147775,positive,0.8557706475257874
7077,12/17/2024 4:55:30 PM,"Pfizer provides FY25 outlook, McCormick in talks for Sauer Brands: Morning Buzz",TipRanks,/news/stocks/pfizer-provides-fy25-outlook-mccormick-in-talks-for-sauer-brands-morning-buzz-1034147805,positive,0.9260346293449402
7078,12/17/2024 6:45:36 PM,Barclays fact-checked Trump comments on pharmacy benefit managers,TipRanks,/news/stocks/barclays-fact-checked-trump-comments-on-pharmacy-benefit-managers-1034148099,positive,0.9219222068786621
7079,12/17/2024 7:35:13 PM,"Pfizer’s 2025 guidance positions company for EPS expansion, says BMO",TipRanks,/news/stocks/pfizer-s-2025-guidance-positions-company-for-eps-expansion-says-bmo-1034148164,negative,0.6955419778823853
7080,12/17/2024 7:45:12 PM,Positive Outlook for Pfizer: Strategic Positioning and Growth Potential Highlight Undervaluation,TipRanks,/news/stocks/positive-outlook-for-pfizer-strategic-positioning-and-growth-potential-highlight-undervaluation-1034148174,negative,0.8450934290885925
7081,12/18/2024 1:35:53 AM,Pfizer’s Stable Outlook Amid Growth Challenges and Policy Risks Leads to Hold Rating,TipRanks,/news/stocks/pfizer-s-stable-outlook-amid-growth-challenges-and-policy-risks-leads-to-hold-rating-1034148755,neutral,0.8725752830505371
7082,12/18/2024 1:36:50 AM,Pfizer’s Balanced Outlook: Hold Rating Amid Uncertainties and Growth Potential,TipRanks,/news/stocks/pfizer-s-balanced-outlook-hold-rating-amid-uncertainties-and-growth-potential-1034148750,negative,0.6540022492408752
7083,12/18/2024 1:37:25 AM,Cautious Hold Rating for Pfizer Amidst Stable Near-Term Outlook and Long-Term Concerns,TipRanks,/news/stocks/cautious-hold-rating-for-pfizer-amidst-stable-near-term-outlook-and-long-term-concerns-1034148746,negative,0.9198804497718811
7084,12/18/2024 11:40:09 AM,Pfizer price target raised to $28 from $27 at Wells Fargo,TipRanks,/news/stocks/pfizer-price-target-raised-to-28-from-27-at-wells-fargo-1034151179,negative,0.9433123469352722
7085,12/18/2024 12:19:45 PM,Merck enters obesity drug race in pact with Chinese pharma Hansoh,Seeking Alpha,https://seekingalpha.com/news/4387598-merck-enters-obesity-drug-race-in-pact-with-hansoh?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8321036100387573
7086,12/18/2024 12:25:33 PM,Truist Financial Gives a Buy Rating to Pfizer (PFE),TipRanks,/news/stocks/truist-financial-gives-a-buy-rating-to-pfizer-pfe-1034151756,positive,0.8390333652496338
7087,12/18/2024 2:40:22 PM,Pfizer price target lowered to $32 from $36 at Truist,TipRanks,/news/stocks/pfizer-price-target-lowered-to-32-from-36-at-truist-1034152580,neutral,0.6650583148002625
7088,12/18/2024 3:20:29 PM,Trump Trade: Analyst says Trump win ‘not as positive as you’d think’ for Tesla,TipRanks,/news/stocks/trump-trade-analyst-says-trump-win-not-as-positive-as-you-d-think-for-tesla-1034152752,positive,0.7262119650840759
7089,12/18/2024 3:49:06 PM,Merck-Hansoh deal for oral GLP-1 hurts obesity drug developers,Seeking Alpha,https://seekingalpha.com/news/4387714-merck-hansoh-deal-hurts-obesity-drug-developers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6005010008811951
7090,12/18/2024 8:27:05 PM,California Gov. Newsom declares State of Emergency over bird flu,Seeking Alpha,https://seekingalpha.com/news/4387844-california-gov-newsom-declares-state-emergency-bird-flu?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8893551826477051
7091,12/19/2024 6:16:03 PM,Regeneron reports positive results for two anti-coagulant drugs,Seeking Alpha,https://seekingalpha.com/news/4388091-regeneron-reports-positive-results-for-two-anti-coagulant-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9454735517501831
7092,12/20/2024 7:05:11 PM,Pfizer announces FDA approval of Braftovi combination,TipRanks,/news/stocks/pfizer-announces-fda-approval-of-braftovi-combination-1034164237,positive,0.6284258365631104
7093,12/20/2024 8:36:52 PM,Pfizer gets FDA accelerated approval for Braftovi,Seeking Alpha,https://seekingalpha.com/news/4389412-pfizer-gets-fda-accelerated-approval-for-braftovi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8788320422172546
7094,12/21/2024 2:37:25 AM,FDA Grants Accelerated Approval To Pfizer's BRAFTOVI Combination For Metastatic Colorectal Cancer ,RTTNews,/news/stocks/fda-grants-accelerated-approval-to-pfizer-s-braftovi-combination-for-metastatic-colorectal-cancer-1034164464,negative,0.9264627695083618
7095,12/22/2024 9:12:14 PM,SA Asks: Which Big Pharmas are likely to announce big M&A deals?,Seeking Alpha,https://seekingalpha.com/news/4389614-sa-asks-which-big-pharmas-are-likely-to-announce-big-m-deals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9418226480484009
7096,12/23/2024 2:15:11 AM,TD Cowen Sticks to Its Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/td-cowen-sticks-to-its-hold-rating-for-pfizer-pfe-1034165521,positive,0.8278870582580566
7097,12/24/2024 12:28:38 PM,Enanta to appeal as Pfizer wins Paxlovid patent ruling,Seeking Alpha,https://seekingalpha.com/news/4390536-enanta-stock-slips-pfizer-wins-paxlovid-patent?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7154814004898071
7098,12/24/2024 12:30:12 PM,Enanta to appeal ruling related to ‘953 patent infringement lawsuit,TipRanks,/news/stocks/enanta-to-appeal-ruling-related-to-953-patent-infringement-lawsuit-1034171667,neutral,0.9198815822601318
7099,12/24/2024 1:21:39 PM,Enanta Plans To Appeal Court Ruling Related To 953 Patent Infringement Lawsuit ,RTTNews,/news/stocks/enanta-plans-to-appeal-court-ruling-related-to-953-patent-infringement-lawsuit-1034170884,neutral,0.8359928727149963
7100,12/27/2024 12:59:10 PM,BioNTech inks $791.5M COVID vaccine settlement with NIH,Seeking Alpha,https://seekingalpha.com/news/4391146-biontech-stock-slips-nih-covid-vaccine-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8941595554351807
7101,12/27/2024 1:38:52 PM,BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claims,Seeking Alpha,https://seekingalpha.com/news/4391146-biontech-stock-slips-covid-vaccine-royalty-deals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8303305506706238
7102,12/27/2024 2:35:07 PM,BioNTech to pay $791.5M in settlement agreement with the NIH,TipRanks,/news/stocks/biontech-to-pay-791-5m-in-settlement-agreement-with-the-nih-1034176920,negative,0.7840968370437622
7103,12/27/2024 2:40:17 PM,BioNTech to pay $467M in settlement agreement with University of Pennsylvania,TipRanks,/news/stocks/biontech-to-pay-467m-in-settlement-agreement-with-university-of-pennsylvania-1034176902,negative,0.8034273982048035
7104,12/27/2024 5:11:26 PM,"BioNTech Enters Into Settlements With U.S. Agency, UPenn Over COVID-19 Vaccine Royalties ",RTTNews,/news/stocks/biontech-enters-into-settlements-with-u-s-agency-upenn-over-covid-19-vaccine-royalties-1034176627,neutral,0.8870618939399719
7105,12/28/2024 3:31:10 PM,Here are Morgan Stanley’s key oncology catalysts for 2025,Seeking Alpha,https://seekingalpha.com/news/4391298-morgan-stanley-lists-2025-oncology-catalysts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9273046255111694
7106,12/30/2024 1:30:11 PM,"NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley",TipRanks,/news/stocks/nih-settlement-manageable-headwind-for-biontech-pfizer-says-morgan-stanley-1034180363,negative,0.5926513075828552
7107,12/30/2024 9:22:54 PM,Takeda-backed Ascentage Pharma files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4391588-takeda-backed-ascentage-pharma-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9013777375221252
7108,12/30/2024 9:25:28 PM,Sangamo to regain rights to giroctocogene fitelparvovec from Pfizer,TipRanks,/news/stocks/sangamo-to-regain-rights-to-giroctocogene-fitelparvovec-from-pfizer-1034181089,negative,0.7024933099746704
7109,12/30/2024 9:38:33 PM,Sangamo plunges 38% after Pfizer ends agreement on hemophilia A gene therapy,Seeking Alpha,https://seekingalpha.com/news/4391599-sangamo-plunges-38-after-pfizer-ends-agreement-on-hemophilia-a-gene-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.953916609287262
7110,12/30/2024 11:26:32 PM,Sangamo To Regain Rights To Hemophilia Therapy After Pfizer's Decides To Terminate Collaboration ,RTTNews,/news/stocks/sangamo-to-regain-rights-to-hemophilia-therapy-after-pfizer-s-decides-to-terminate-collaboration-1034181004,negative,0.8740399479866028
7111,12/31/2024 1:40:13 AM,"Sangamo decline on Pfizer collaboration decision ‘overdone’, says Barclays",TipRanks,/news/stocks/sangamo-decline-on-pfizer-collaboration-decision-overdone-says-barclays-1034181391,neutral,0.9285948276519775
7112,12/31/2024 9:35:08 AM,TD Cowen ‘disappointed’ Pfizer ended Sangamo collaboration,TipRanks,/news/stocks/td-cowen-disappointed-pfizer-ended-sangamo-collaboration-1034182199,neutral,0.8910465240478516
7113,12/31/2024 9:35:16 AM,"Sangamo cash an overhang after Pfizer termination, says Truist",TipRanks,/news/stocks/sangamo-cash-an-overhang-after-pfizer-termination-says-truist-1034182198,neutral,0.8623888492584229
7114,12/31/2024 10:15:28 AM,Sangamo price target lowered to $2 from $3 at Wells Fargo,TipRanks,/news/stocks/sangamo-price-target-lowered-to-2-from-3-at-wells-fargo-1034182271,neutral,0.8547542095184326
7115,12/31/2024 1:55:19 PM,Morning Movers: EHang jumps following guidance raise,TipRanks,/news/stocks/morning-movers-ehang-jumps-following-guidance-raise-1034183192,positive,0.9197055101394653
7116,12/31/2024 2:55:29 PM,Why did Pfizer's exit from gene therapy program hit Sangamo hard?,Seeking Alpha,https://seekingalpha.com/news/4391725-why-sangamo-stock-plunged-pfizer-deal-exit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6020379066467285
7117,12/31/2024 4:00:19 PM,Sangamo price target lowered to $3 from $7 at Jefferies,TipRanks,/news/stocks/sangamo-price-target-lowered-to-3-from-7-at-jefferies-1034183553,neutral,0.8501651287078857
7118,12/31/2024 4:20:11 PM,"Sangamo selloff on Pfizer decision overdone, says H.C. Wainwright",TipRanks,/news/stocks/sangamo-selloff-on-pfizer-decision-overdone-says-h-c-wainwright-1034183558,neutral,0.5241380333900452
7119,12/31/2024 5:05:32 PM,"CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz",TipRanks,/news/stocks/composecure-to-spin-off-resolute-ehang-raises-q4-revenue-view-morning-buzz-1034183597,negative,0.8169342875480652
7120,1/1/2025 2:00:28 PM,Brand prescription drugs to rise an average 4.5% in 2025,Seeking Alpha,https://seekingalpha.com/news/4391754-brand-prescription-drugs-rise-average-4_5-percent-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9456416964530945
7121,1/2/2025 1:38:55 PM,"Atavistik Bio, Pfizer Collaborate To Accelerate Discovery Of Novel Precision Allosteric Therapeutics ",RTTNews,/news/stocks/atavistik-bio-pfizer-collaborate-to-accelerate-discovery-of-novel-precision-allosteric-therapeutics-1034186297,negative,0.8511084318161011
7122,1/2/2025 3:54:28 PM,"Pfizer, Atavistik to collaborate on allosteric drug discovery",Seeking Alpha,https://seekingalpha.com/news/4391991-pfizer-atavistik-to-collaborate-on-allosteric-drug-discovery?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5149376392364502
7123,1/6/2025 11:00:13 AM,Study suggests Paxlovid could be beneficial for ‘some people’ with long Covid,TipRanks,/news/stocks/study-suggests-paxlovid-could-be-beneficial-for-some-people-with-long-covid-1034194591,negative,0.8401248455047607
7124,1/6/2025 5:52:14 PM,"FDA issues first draft guidance on use of AI in drug, medical device development",Seeking Alpha,https://seekingalpha.com/news/4392790-fda-issues-first-draft-guidance-use-ai-drug-medical-device-development?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9278177618980408
7125,1/6/2025 10:22:53 PM,Bird flu claims first U.S. life in Louisiana,Seeking Alpha,https://seekingalpha.com/news/4392855-bird-flu-claims-first-u-s-life-in-louisiana?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6066654920578003
7126,1/7/2025 3:15:35 PM,"Bird flu vaccine maker Moderna shares jump after first US death, Barron’s says",TipRanks,/news/stocks/bird-flu-vaccine-maker-moderna-shares-jump-after-first-us-death-barron-s-says-1034201871,negative,0.8165022730827332
7127,1/7/2025 4:12:58 PM,"Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns",Seeking Alpha,https://seekingalpha.com/news/4393113-moderna-novavax-stocks-gain-covid-flu?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.868003785610199
7128,1/7/2025 4:53:02 PM,FDA issues draft guidance on developing weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/4393123-fda-issues-draft-guidance-developing-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9205100536346436
7129,1/7/2025 7:58:34 PM,Arbutus could benefit from Big Pharma bird flu vaccines: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4393173-arbutus-could-benefit-from-big-pharma-bird-flu-vaccines-jefferies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.815019428730011
7130,1/7/2025 10:30:27 PM,"GSK, Pfizer RSV shots to get warning of rare neurological disorder",Seeking Alpha,https://seekingalpha.com/news/4393259-gsk-pfizer-rsv-shots-get-warning-rare-neurological-disorder?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4534492492675781
7131,1/8/2025 6:15:34 AM,Truist Financial Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/truist-financial-sticks-to-its-buy-rating-for-pfizer-pfe-1034203890,positive,0.5046171545982361
7132,1/8/2025 11:45:55 AM,Pfizer price target lowered to $29 from $31 at UBS,TipRanks,/news/stocks/pfizer-price-target-lowered-to-29-from-31-at-ubs-1034205558,neutral,0.7161521911621094
7133,1/8/2025 2:36:32 PM,"GSK, Pfizer RSV vaccines to carry warnings of GBS, Reuters reports",TipRanks,/news/stocks/gsk-pfizer-rsv-vaccines-to-carry-warnings-of-gbs-reuters-reports-1034206992,neutral,0.7009438872337341
7134,1/8/2025 2:55:50 PM,Trump Trade: New administration to invest $20B to build data centers,TipRanks,/news/stocks/trump-trade-new-administration-to-invest-20b-to-build-data-centers-1034207027,positive,0.6268939971923828
7135,1/8/2025 5:00:51 PM,"Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz",TipRanks,/news/stocks/exxon-and-shell-cautious-on-q4-flutter-cuts-guidance-morning-buzz-1034207318,neutral,0.5844774842262268
7136,1/8/2025 8:14:20 PM,"Pfizer, Astellas win China nod for Padcev in bladder cancer with Merck’s Keytruda",Seeking Alpha,https://seekingalpha.com/news/4393558-pfizer-astellas-win-china-nod-padcev?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8854827880859375
7137,1/9/2025 9:00:32 AM,FDA Urges Guillain-Barré Syndrome Warning On Labels Of RSV Vaccines Abrysvo And Arexvy ,RTTNews,/news/stocks/fda-urges-guillain-barré-syndrome-warning-on-labels-of-rsv-vaccines-abrysvo-and-arexvy-1034208670,neutral,0.676430344581604
7138,1/9/2025 1:56:22 PM,"Novo, Eli Lilly to dominate global pharma sales in 2025: report",Seeking Alpha,https://seekingalpha.com/news/4393716-novo-eli-lilly-lead-2025-global-pharma-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6913239359855652
7139,1/9/2025 4:35:33 PM,Drugs not selected for Medicare negotiations saw prices nearly double - report,Seeking Alpha,https://seekingalpha.com/news/4393809-drugs-not-selected-medicare-price-negotiation-nearly-doubled-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5023412108421326
7140,1/9/2025 8:36:08 PM,Pharma companies welcome new year with 583 drug price hikes so far,Seeking Alpha,https://seekingalpha.com/news/4393873-2025-start-583-drug-price-hikes?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9193293452262878
7141,1/10/2025 11:56:07 AM,Pfizer announces ‘positive’ results from Phase 3 CREST trial of sasanlimab,TipRanks,/news/stocks/pfizer-announces-positive-results-from-phase-3-crest-trial-of-sasanlimab-1034214575,negative,0.7507250308990479
7142,1/10/2025 12:47:43 PM,Pfizer’s bladder cancer treatment achieves main goal in late-stage trial,Seeking Alpha,https://seekingalpha.com/news/4394029-pfizers-bladder-cancer-treatment-achieves-main-goal-in-late-stage-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8274969458580017
7143,1/10/2025 5:10:13 PM,"Pfizer study impact on CG Oncology to be minimal, says H.C. Wainwright",TipRanks,/news/stocks/pfizer-study-impact-on-cg-oncology-to-be-minimal-says-h-c-wainwright-1034216354,positive,0.7967168688774109
7144,1/11/2025 3:27:59 PM,Bernstein Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/bernstein-sticks-to-their-hold-rating-for-pfizer-pfe-1034217294,positive,0.8848497271537781
7145,1/11/2025 8:06:44 PM,Can 2025 J.P. Morgan Healthcare Conference spark biotech M&A?,Seeking Alpha,https://seekingalpha.com/news/4394318-can-2025-jp-morgan-healthcare-conference-spark-biotech-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8774529099464417
7146,1/13/2025 1:05:47 PM,Pfizer’s Strategic Initiatives and Growth Prospects Drive Buy Rating,TipRanks,/news/stocks/pfizer-s-strategic-initiatives-and-growth-prospects-drive-buy-rating-1034221666,negative,0.7832686305046082
7147,1/14/2025 11:21:51 AM,"Pfizer CEO Bourla says Starboard Value wants minimal changes, Bloomberg says",TipRanks,/news/stocks/pfizer-ceo-bourla-says-starboard-value-wants-minimal-changes-bloomberg-says-1034225450,positive,0.9262152314186096
7148,1/14/2025 11:40:09 AM,Pfizer (PFE) Receives a Hold from Citi,TipRanks,/news/stocks/pfizer-pfe-receives-a-hold-from-citi-1034225539,positive,0.7704062461853027
7149,1/14/2025 11:40:09 AM,Analysts Conflicted on These Healthcare Names: Xencor (XNCR) and Pfizer (PFE),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-xencor-xncr-and-pfizer-pfe-1034225538,positive,0.6045007705688477
7150,1/14/2025 12:46:33 PM,Pfizer’s Growth Potential and Strategic Focus Justify Buy Rating Amid Healthcare Policy Shifts,TipRanks,/news/stocks/pfizer-s-growth-potential-and-strategic-focus-justify-buy-rating-amid-healthcare-policy-shifts-1034226389,negative,0.8657295107841492
7151,1/14/2025 2:40:39 PM,"Drugmakers to push Trump to pause price negotiations, Bloomberg reports",TipRanks,/news/stocks/drugmakers-to-push-trump-to-pause-price-negotiations-bloomberg-reports-1034226968,neutral,0.7503699064254761
7152,1/14/2025 4:40:15 PM,Pfizer to sell 700M ordinary shares of Haleon,TipRanks,/news/stocks/pfizer-to-sell-700m-ordinary-shares-of-haleon-1034227187,positive,0.9446516633033752
7153,1/14/2025 5:00:54 PM,"Lilly cuts FY24 outlook, United Rentals to acquire H&E: Morning Buzz",TipRanks,/news/stocks/lilly-cuts-fy24-outlook-united-rentals-to-acquire-h-e-morning-buzz-1034227251,positive,0.7771710157394409
7154,1/14/2025 5:10:42 PM,Pfizer to cut Haleon stake in 700M share sale,Seeking Alpha,https://seekingalpha.com/news/4394989-pfizer-cut-haleon-stake-700m-share-sale?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6368045806884766
7155,1/14/2025 11:26:58 PM,Bernstein Reaffirms Their Hold Rating on Pfizer (PFE),TipRanks,/news/stocks/bernstein-reaffirms-their-hold-rating-on-pfizer-pfe-1034227763,positive,0.8832070827484131
7156,1/15/2025 10:08:21 AM,Pfizer Sells GBP 2.50 Bln Of Shares In Haleon ,RTTNews,/news/stocks/pfizer-sells-gbp-2-50-bln-of-shares-in-haleon-1034229397,positive,0.9452979564666748
7157,1/15/2025 1:02:18 PM,Zai Lab to seek China approval for cervical cancer therapy after positive trial data,Seeking Alpha,https://seekingalpha.com/news/4395222-zai-lab-stock-rises-tivdak-trial-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9105975031852722
7158,1/16/2025 1:21:30 PM,JPMorgan says Pfizer needs further pipeline progress to change current narrative,TipRanks,/news/stocks/jpmorgan-says-pfizer-needs-further-pipeline-progress-to-change-current-narrative-1034236597,negative,0.8338042497634888
7159,1/16/2025 4:27:08 PM,AbbVie keeps Humira lead as biosimilar entry nears two-year mark,Seeking Alpha,https://seekingalpha.com/news/4395783-abbvie-retains-humira-market-share-biosimilars?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8774941563606262
7160,1/17/2025 1:19:18 PM,Wegovy included as Medicare lists 15 drugs selected for next pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/4396094-wegovy-latest-medicare-pricing-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9195981025695801
7161,1/17/2025 1:20:48 PM,"Ozempic, Xtandi among next 15 drugs selected for U.S. price talks",TipRanks,/news/stocks/ozempic-xtandi-among-next-15-drugs-selected-for-u-s-price-talks-1034240882,positive,0.6648421883583069
7162,1/17/2025 4:58:51 PM,"Pharma lobby slams IRA, PBMs as Medicare lists 15 more drugs for price setting",Seeking Alpha,https://seekingalpha.com/news/4396192-pharma-lobby-slams-ira-pbms-as-medicare-lists-15-more-drugs-for-price-setting?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.826055109500885
7163,1/17/2025 8:35:26 PM,Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations,TipRanks,/news/stocks/sector-spotlight-big-pharma-will-push-to-pause-medicare-drug-price-negotiations-1034241772,positive,0.4902459383010864
7164,1/17/2025 9:16:37 PM,Odyssey Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4396327-odyssey-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.930002748966217
7165,1/21/2025 11:30:43 PM,Takeda-backed Ascentage Pharma sets terms for $170M IPO,Seeking Alpha,https://seekingalpha.com/news/4396905-takeda-backed-ascentage-pharma-sets-terms-for-170m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9381498694419861
7166,1/23/2025 1:26:22 PM,Jefferies Keeps Their Buy Rating on Pfizer (PFE),TipRanks,/news/stocks/jefferies-keeps-their-buy-rating-on-pfizer-pfe-1034260941,positive,0.9183027148246765
7167,1/23/2025 11:07:44 PM,Allurion stock soars 70% on weight-loss therapy update,Seeking Alpha,https://seekingalpha.com/news/4398176-allurion-stock-soars-on-weight-loss-therapy-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9079923629760742
7168,1/24/2025 3:27:51 PM,Ascentage Pharma raises $126M via U.S. IPO (update),Seeking Alpha,https://seekingalpha.com/news/4398391-takeda-backed-ascentage-pharma-prices-126m-u_s_-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8579893112182617
7169,1/24/2025 9:50:13 PM,Pfizer to pay ~$60M to settle Medicare false claims,TipRanks,/news/stocks/pfizer-to-pay-~-60m-to-settle-medicare-false-claims-1034268031,positive,0.4862297773361206
7170,1/24/2025 10:45:09 PM,Pfizer settles Biohaven kickback case with DOJ for $60M,Seeking Alpha,https://seekingalpha.com/news/4398650-pfizer-settles-biohaven-kickback-case-with-doj-for-60m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7479526996612549
7171,1/25/2025 8:36:19 PM,Pfizer succeeds in late-stage trial for colorectal cancer therapy,Seeking Alpha,https://seekingalpha.com/news/4398681-pfizer-posts-trial-win-colorectal-cancer-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8531913161277771
7172,1/26/2025 5:25:52 AM,PFE : BRAFTOVI Combination Shows Improved Response In Phase 3 Trial For Metastatic Colorectal Cancer ,RTTNews,/news/stocks/pfe-braftovi-combination-shows-improved-response-in-phase-3-trial-for-metastatic-colorectal-cancer-1034268387,negative,0.9540275931358337
7173,1/27/2025 3:11:09 PM,Activist Starboard not pursuing Pfizer proxy fight - CNBC,Seeking Alpha,https://seekingalpha.com/news/4398903-activist-starboard-not-pursuing-pfizer-proxy-fight-cnbc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8972794413566589
7174,1/27/2025 4:35:21 PM,"Starboard did not nominate Pfizer board members, Bloomberg says",TipRanks,/news/stocks/starboard-did-not-nominate-pfizer-board-members-bloomberg-says-1034273679,positive,0.9388920664787292
7175,1/27/2025 5:07:48 PM,Intellia downgraded at Morgan Stanley on lowered expectations for rare disease asset,Seeking Alpha,https://seekingalpha.com/news/4398940-intellia-downgraded-morgan-stanley-lowered-expectations-rare-disease-asset?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9529727101325989
7176,1/28/2025 11:10:42 AM,"Drugmakers modestly raise price on drugs at start of year, WSJ reports",TipRanks,/news/stocks/drugmakers-modestly-raise-price-on-drugs-at-start-of-year-wsj-reports-1034276940,negative,0.9214922189712524
7177,1/28/2025 11:36:06 AM,Pfizer price target lowered to $29 from $30 at Citi,TipRanks,/news/stocks/pfizer-price-target-lowered-to-29-from-30-at-citi-1034277163,neutral,0.7620404362678528
7178,1/28/2025 4:19:40 PM,RFK Jr. reportedly softens his antivaccine stance ahead of confirmation hearing,Seeking Alpha,https://seekingalpha.com/news/4399431-rfk-jr-says-not-antivaccine-ahead-senate-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8104958534240723
7179,1/28/2025 5:10:31 PM,"GM, Boeing report quarterly results: Morning Buzz",TipRanks,/news/stocks/gm-boeing-report-quarterly-results-morning-buzz-1034278980,positive,0.8086592555046082
7180,1/28/2025 8:15:30 PM,Novo Nordisk's Ozempic gets FDA approval for kidney disease,Seeking Alpha,https://seekingalpha.com/news/4399631-novo-nordisk-ozempic-gets-fda-approval-for-kidney-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8510880470275879
7181,1/28/2025 10:20:02 PM,Nurix plans to advance BTK degrader asset for chronic lymphocytic leukemia,Seeking Alpha,https://seekingalpha.com/news/4399769-nurix-plans-advance-btk-degrader-asset-chronic-lymphocytic-leukemia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6131805777549744
7182,1/29/2025 3:48:40 PM,Vaccine stocks in focus as RFK Jr. faces confirmation hearing,Seeking Alpha,https://seekingalpha.com/news/4400073-vaccine-stocks-in-focus-as-rfk-jr-faces-confirmation-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.79876708984375
7183,1/29/2025 6:55:13 PM,"RFK Jr. comments contradict anti-vaccine legacy, says Truist",TipRanks,/news/stocks/rfk-jr-comments-contradict-anti-vaccine-legacy-says-truist-1034284331,positive,0.638435423374176
7184,1/29/2025 7:30:50 PM,CMS aiming for more transparency in drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/4400241-cms-aiming-for-more-transparency-in-drug-pricing-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7420770525932312
7185,1/29/2025 8:54:46 PM,HHS Secretary nominee RFK Jr. faces contentious Senate hearing,Seeking Alpha,https://seekingalpha.com/news/4400271-hhs-secretary-nominee-rfk-jr_-faces-contentious-senate-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8407506346702576
7186,1/30/2025 12:56:48 PM,Neutral Outlook for Pfizer Amidst Revenue Adjustments and Competitive Pressures,TipRanks,/news/stocks/neutral-outlook-for-pfizer-amidst-revenue-adjustments-and-competitive-pressures-1034289237,neutral,0.5712300539016724
7187,1/30/2025 7:41:17 PM,These global stocks have seen the most increase in market share within their industries,Seeking Alpha,https://seekingalpha.com/news/4401004-these-global-stocks-have-seen-the-most-increase-in-market-share-within-their-industries?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8971638083457947
7188,1/31/2025 7:17:21 AM,Bernstein Remains a Hold on Pfizer (PFE),TipRanks,/news/stocks/bernstein-remains-a-hold-on-pfizer-pfe-1034293647,positive,0.8305892944335938
7189,1/31/2025 11:25:30 AM,European Commission authorizes Vocabria + Rekambys for HIV treatment,TipRanks,/news/stocks/european-commission-authorizes-vocabria-+-rekambys-for-hiv-treatment-1034294678,positive,0.8628990054130554
7190,1/31/2025 1:48:54 PM,Pfizer antibody-drug conjugate Tivdak gains EMA panel endorsement,Seeking Alpha,https://seekingalpha.com/news/4401393-pfizer-antibody-drug-conjugate-tivdak-gains-ema-panel-endorsement?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8331493139266968
7191,1/31/2025 6:08:16 PM,Metsera sees stock rally 54% following $275M IPO,Seeking Alpha,https://seekingalpha.com/news/4401417-metsera-sees-stock-rally-54-following-275m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9370744228363037
7192,1/31/2025 8:00:55 PM,"Catalyst Watch: Tariff drama, OPEC+, Alphabet and Amazon earnings, Lennar spinoff",Seeking Alpha,https://seekingalpha.com/news/4401505-catalyst-watch-tariff-drama-opec-alphabet-and-amazon-earnings-lennar-spinoff?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9292561411857605
7193,2/1/2025 12:53:24 PM,Are healthcare stocks on the rebound?,Seeking Alpha,https://seekingalpha.com/news/4401695-are-healthcare-stocks-rebound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7119130492210388
7194,2/1/2025 11:30:00 PM,Over 75% of companies beat EPS estimates this week - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4401476-over-75-of-companies-beat-eps-estimates-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.873219907283783
7195,2/2/2025 1:00:00 PM,"Earnings week ahead: PLTR, AMZN, GOOG, AMD, LLY, PEP, F, PFE, MRK, PYPL and more",Seeking Alpha,https://seekingalpha.com/news/4401431-earnings-week-ahead-pltr-amzn-goog-amd-lly-pep-f-pfe-mrk-pypl-qcom-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9316384792327881
7196,2/3/2025 11:50:56 AM,Pfizer’s Braftovi improves survival in Phase 3 colorectal cancer trial,TipRanks,/news/stocks/pfizer-s-braftovi-improves-survival-in-phase-3-colorectal-cancer-trial-1034302760,negative,0.9490642547607422
7197,2/3/2025 1:52:22 PM,Pfizer: BRAFTOVI Combination Regimen Shows Significant Improvement In PFS In Phase 3 Trial In MCRC ,RTTNews,/news/stocks/pfizer-braftovi-combination-regimen-shows-significant-improvement-in-pfs-in-phase-3-trial-in-mcrc-1034303236,negative,0.9539433717727661
7198,2/3/2025 3:25:10 PM,Pfizer call volume above normal and directionally bullish,TipRanks,/news/stocks/pfizer-call-volume-above-normal-and-directionally-bullish-1034304499,negative,0.9048137664794922
7199,2/3/2025 4:27:26 PM,Pfizer reports positive Phase 3 results for Braftovi,Seeking Alpha,https://seekingalpha.com/news/4401948-pfizer-reports-positive-phase-3-results-for-braftovi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9459148049354553
7200,2/3/2025 5:30:39 PM,SA Asks: What's the most attractive weight-loss stock right now?,Seeking Alpha,https://seekingalpha.com/news/4401656-sa-asks-whats-the-most-attractive-weight-loss-stock-right-now?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9177672266960144
7201,2/3/2025 5:44:37 PM,"Sens. Wyden, Warren press RFK Jr. on conflicts of interest ahead of vote",Seeking Alpha,https://seekingalpha.com/news/4402094-senators-wyden-warren-press-rfk-jr-conflicts-of-interest-ahead-vote?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7472131252288818
7202,2/3/2025 6:10:10 PM,Pfizer pays California $59.75M to settle Medicaid kickback claims,TipRanks,/news/stocks/pfizer-pays-california-59-75m-to-settle-medicaid-kickback-claims-1034305273,positive,0.43818196654319763
7203,2/3/2025 7:10:20 PM,Notable companies reporting before tomorrow’s open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1034305420,positive,0.9220908284187317
7204,2/3/2025 7:26:19 PM,Pfizer Q4 Earnings Preview: Strong top line growth expected on COVID-19 product demand,Seeking Alpha,https://seekingalpha.com/news/4402210-pfizer-q4-earnings-preview-strong-top-line-growth-expected-on-covid-19-product-demand?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9532395601272583
7205,2/3/2025 9:46:48 PM,Here’s What NOT to Do the Next Time Tariffs Hit,InvestorPlace,/news/stocks/next-time-tariffs-hit-dont-do-this-1034310402,positive,0.9343576431274414
7206,2/3/2025 11:00:37 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4402088-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9330109357833862
7207,2/4/2025 9:00:45 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), HOYA (OtherHOCPF) and Novartis AG (Six Swiss: CH:NOVN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-hoya-otherhocpf-and-novartis-ag-six-swiss-ch-novn-1034307864,positive,0.8901823163032532
7208,2/4/2025 11:46:45 AM,"Pfizer Non-GAAP EPS of $0.63 beats by $0.17, revenue of $17.8B beats by $540M",Seeking Alpha,https://seekingalpha.com/news/4402570-pfizer-non-gaap-eps-of-0_63-beats-by-0_17-revenue-of-17_8b-beats-by-540m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5891621112823486
7209,2/4/2025 11:50:22 AM,Pfizer says on track to deliver ~$4.5B in cost savings by end of 2025,TipRanks,/news/stocks/pfizer-says-on-track-to-deliver-~-4-5b-in-cost-savings-by-end-of-2025-1034308497,negative,0.9420807361602783
7210,2/4/2025 11:51:19 AM,"Pfizer backs FY25 adjusted EPS view $2.80-$3.00, consensus $2.93",TipRanks,/news/stocks/pfizer-backs-fy25-adjusted-eps-view-2-80--3-00-consensus-2-93-1034308492,positive,0.6827693581581116
7211,2/4/2025 11:51:44 AM,"Pfizer reports Q4 adjusted EPS 63c, consensus 46c",TipRanks,/news/stocks/pfizer-reports-q4-adjusted-eps-63c-consensus-46c-1034308486,positive,0.8015046119689941
7212,2/4/2025 12:11:55 PM,"Earnings Snapshot: Pfizer tops Q4, but FY2025 outlook falls short of expectations",Seeking Alpha,https://seekingalpha.com/news/4402596-earnings-snapshot-pfizer-tops-q4-but-fy2025-outlook-falls-short-of-expectations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9522358179092407
7213,2/4/2025 12:48:51 PM,"Pfizer in charts: Primary Care revenue +26.5% Y/Y, Specialty Care +12.3%, and Oncology +27.4% in Q4",Seeking Alpha,https://seekingalpha.com/news/4402628-pfizer-in-charts-primary-care-revenue-265-yy-specialty-care-123-and-oncology-274-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8781273365020752
7214,2/4/2025 12:50:57 PM,Pfizer Inc. Q4 Earnings Summary ,RTTNews,/news/stocks/pfizer-inc-q4-earnings-summary-1034308467,positive,0.712622880935669
7215,2/4/2025 1:19:58 PM,Pfizer Q4 Results Beat Market; Confirms FY25 Outlook - Update ,RTTNews,/news/stocks/pfizer-q4-results-beat-market-confirms-fy25-outlook-update-1034308696,negative,0.8639838099479675
7216,2/4/2025 1:23:08 PM,PFE Earnings: Pfizer Stock Jumps on Q4 Beats,TipRanks,/news/stocks/pfe-earnings-pfizer-stock-jumps-on-q4-beats-1034309183,negative,0.9090054631233215
7217,2/4/2025 1:27:30 PM,Pfizer's 2025 guidance falls short of expectations,Seeking Alpha,https://seekingalpha.com/news/4402612-pfizer-2025-guidance-falls-short-expectations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9602089524269104
7218,2/4/2025 2:00:33 PM,Morning Movers: Spotify and Pfizer climb after fourth quarter results,TipRanks,/news/stocks/morning-movers-spotify-and-pfizer-climb-after-fourth-quarter-results-1034309577,negative,0.8022207021713257
7219,2/4/2025 2:23:45 PM,"4 stocks to watch on Tuesday: PFE, GOOG/GOOGL and more",Seeking Alpha,https://seekingalpha.com/news/4402665-4-stocks-to-watch-on-tuesday-pfe-googgoogl-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9289643168449402
7220,2/4/2025 3:50:10 PM,Analysts Conflicted on These Healthcare Names: Rezolute (RZLT) and Pfizer (PFE),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-rezolute-rzlt-and-pfizer-pfe-1034310259,positive,0.5226503014564514
7221,2/4/2025 3:52:32 PM,RFK Jr. HHS nomination advances out of Senate Finance Committee,Seeking Alpha,https://seekingalpha.com/news/4402747-rfk-jr-hhs-nomination-advances-out-senate-finance-committee?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8293061852455139
7222,2/4/2025 4:30:24 PM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE) and Supernus Pharmaceuticals (SUPN),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-pfizer-pfe-and-supernus-pharmaceuticals-supn-1034310417,neutral,0.7619086503982544
7223,2/4/2025 5:05:31 PM,"China retaliates with tariffs on U.S., Merck falls after earnings: Morning Buzz",TipRanks,/news/stocks/china-retaliates-with-tariffs-on-u-s-merck-falls-after-earnings-morning-buzz-1034310568,neutral,0.9223615527153015
7224,2/4/2025 5:15:16 PM,"Senate panel advances Kennedy’s nomination for HHS secretary, CNBC reports",TipRanks,/news/stocks/senate-panel-advances-kennedy-s-nomination-for-hhs-secretary-cnbc-reports-1034310628,positive,0.8860395550727844
7225,2/4/2025 7:05:08 PM,Pfizer (PFE) Receives a Buy from Jefferies,TipRanks,/news/stocks/pfizer-pfe-receives-a-buy-from-jefferies-1034310881,positive,0.547299861907959
7226,2/4/2025 11:35:07 PM,Pfizer CEO: Our stock is very cheap with lots of upside potential,TipRanks,/news/stocks/pfizer-ceo-our-stock-is-very-cheap-with-lots-of-upside-potential-1034311759,negative,0.8054298758506775
7227,2/5/2025 12:19:25 PM,Truist Financial Remains a Buy on Pfizer (PFE),TipRanks,/news/stocks/truist-financial-remains-a-buy-on-pfizer-pfe-1034315084,positive,0.92479407787323
7228,2/5/2025 12:46:16 PM,TD Cowen Sticks to Their Hold Rating for Pfizer (PFE),TipRanks,/news/stocks/td-cowen-sticks-to-their-hold-rating-for-pfizer-pfe-1034315329,positive,0.8478463888168335
7229,2/5/2025 4:00:26 PM,"MRNA, PFE, BNTX: Pharma Stocks Fall as RFK Jr. Set to Become U.S. Health Secretary",TipRanks,/news/stocks/mrna-pfe-bntx-pharma-stocks-fall-as-rfk-jr-set-to-become-u-s-health-secretary-1034316763,neutral,0.9681417942047119
7230,2/5/2025 6:35:33 PM,DZ BANK AG Sticks to Its Buy Rating for Pfizer (PFE),TipRanks,/news/stocks/dz-bank-ag-sticks-to-its-buy-rating-for-pfizer-pfe-1034317368,negative,0.7854679226875305
7231,2/6/2025 12:47:26 PM,Bristol-Myers Squibb slips as 2025 outlook disappoints,Seeking Alpha,https://seekingalpha.com/news/4404333-bristol-myers-stock-slips-amid-outlook-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9675890207290649
7232,2/6/2025 6:35:50 PM,"White House readying order to fire thousands of federal health workers, WSJ says",TipRanks,/news/stocks/white-house-readying-order-to-fire-thousands-of-federal-health-workers-wsj-says-1034324421,neutral,0.9388383626937866
7233,2/7/2025 3:21:13 PM,Trump Trade: President advocates to close carried interest tax loophole,TipRanks,/news/stocks/trump-trade-president-advocates-to-close-carried-interest-tax-loophole-1034328479,positive,0.6031154990196228
7234,2/7/2025 4:09:53 PM,Bird flu reaches NYC as live poultry markets shut down,Seeking Alpha,https://seekingalpha.com/news/4405179-bird-flu-reaches-nyc-as-live-poultry-markets-shut-down?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9346794486045837
7235,2/7/2025 7:42:50 PM,AbbVie gets FDA approval for antibiotic treatment Emblaveo (update),Seeking Alpha,https://seekingalpha.com/news/4405254-abbvie-gets-fda-approval-for-antibiotic-treatment-emblaveo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5456146597862244
7236,2/8/2025 1:51:26 AM,AbbVie: FDA Approves Emblaveo - Metronidazole Combination For Complicated Intra-Abdominal Infections ,RTTNews,/news/stocks/abbvie-fda-approves-emblaveo-metronidazole-combination-for-complicated-intra-abdominal-infections-1034329518,negative,0.9221829771995544
7237,2/8/2025 6:46:00 PM,Another strong earnings week as over 75% of companies deliver EPS wins-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4405204-another-strong-earnings-week-as-over-75-of-companies-deliver-eps-wins-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9524391889572144
7238,2/8/2025 9:04:00 PM,18 out of 21 healthcare companies beat profit estimates this week- Earnings scorecard,Seeking Alpha,https://seekingalpha.com/news/4405247-18-out-of-21-healthcare-companies-beat-profit-estimates-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8692342042922974
